data_2mqn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mqn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.981 0.42 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.86 -5.88 24.24 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.077 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.6 m -148.47 152.73 39.1 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -85.48 2.35 7.77 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.659 3.573 . . . . 0.0 112.34 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.94 152.23 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.906 0.482 . . . . 0.0 111.356 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.54 170.3 15.96 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.719 0.807 . . . . 0.0 110.445 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.38 149.71 47.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.916 0.486 . . . . 0.0 110.207 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.99 150.39 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.794 0.438 . . . . 0.0 110.952 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.478 ' CE2' ' HE2' ' A' ' 412' ' ' MET . 16.1 m-85 -140.25 168.99 18.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.82 0.848 . . . . 0.0 109.514 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.99 -5.1 77.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.945 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.596 HD21 ' H ' ' A' ' 386' ' ' LEU . 2.1 pt? -72.0 176.68 4.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.83 0.815 . . . . 0.0 110.586 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.06 131.85 25.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -68.12 -7.88 33.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.7 t -91.81 -15.69 27.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.663 0.665 . . . . 0.0 112.104 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.38 5.26 1.24 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 15.4 tpt -150.9 102.52 2.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -141.86 -166.44 2.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.941 0.497 . . . . 0.0 110.342 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 78.0 m -52.53 -27.08 15.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.13 -28.2 24.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.378 0.536 . . . . 0.0 111.674 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -83.91 -31.85 25.45 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.23 -26.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.4 -30.58 62.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -81.5 -17.77 47.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.318 -0.372 . . . . 0.0 111.914 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.27 -22.2 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -110.95 -18.8 12.99 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.94 -21.89 60.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.327 0.967 . . . . 0.0 112.333 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.57 10.43 1.72 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.618 -0.676 . . . . 0.0 112.467 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -121.43 -2.71 9.45 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.923 0.889 . . . . 0.0 110.975 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 152.0 154.43 6.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.23 134.95 51.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.277 0.538 . . . . 0.0 110.298 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.07 154.02 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.05 -59.6 1.67 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.018 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . 0.404 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.1 pttm -160.93 162.33 31.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.648 0.379 . . . . 0.0 111.296 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.35 150.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 123.924 0.889 . . . . 0.0 109.792 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.23 145.3 26.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.505 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.24 145.34 27.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.478 ' HE2' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -132.1 141.66 49.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -167.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.19 33.93 21.06 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 125.769 1.628 . . . . 0.0 112.371 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 53.02 14.79 0.5 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 142.83 57.89 Favored Pre-proline 0 N--CA 1.456 -0.144 0 CA-C-N 118.802 0.728 . . . . 0.0 109.956 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.9 -0.19 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.412 2.741 . . . . 0.0 110.471 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.13 31.92 2.4 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.479 -0.623 . . . . 0.0 112.887 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -148.34 134.08 18.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.001 0.901 . . . . 0.0 110.154 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.8 170.93 19.09 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.951 0.405 . . . . 0.0 111.642 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -141.5 144.21 34.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.95 0.9 . . . . 0.0 109.505 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.93 146.73 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.145 0.578 . . . . 0.0 111.031 -171.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -131.01 145.26 51.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.482 0.713 . . . . 0.0 109.758 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 76.8 mtp -126.52 164.41 21.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.665 0.386 . . . . 0.0 110.758 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.29 -19.31 64.69 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.85 154.81 31.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.23 0.468 . . . . 0.0 110.243 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.72 -14.41 78.05 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.92 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -70.68 -20.14 62.72 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.341 1.57 . . . . 0.0 110.707 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.68 -31.98 18.23 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.1 t -67.73 -37.59 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -67.06 -30.65 70.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.501 0.321 . . . . 0.0 111.145 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -37.1 65.95 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.56 -24.85 41.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.437 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 8.2 mm -77.13 -30.92 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.708 0.803 . . . . 0.0 110.56 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.9 m -93.17 -21.64 19.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -138.7 -19.17 1.05 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -95.76 -15.14 22.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.222 0.919 . . . . 0.0 109.158 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -54.08 142.97 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.116 0.966 . . . . 0.0 110.153 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.15 1.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -87.81 142.53 27.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.735 1.607 . . . . 0.0 109.522 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.298 0.1 OUTLIER -130.88 164.04 26.13 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 171.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.14 143.35 50.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.909 1.283 . . . . 0.0 108.573 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 63.64 32.52 13.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.23 15.99 80.85 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 116.039 1.175 . . . . 0.0 116.039 168.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -83.17 153.0 25.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.392 1.596 . . . . 0.0 110.557 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 141.87 34.89 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -96.29 122.09 38.78 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -140.72 115.74 9.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.08 142.06 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.057 0 CA-C-N 118.348 0.522 . . . . 0.0 110.234 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 98.2 m -147.19 168.83 20.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.704 0.802 . . . . 0.0 110.054 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 152.67 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 27.1 t -126.51 163.14 24.02 Favored 'General case' 0 CA--C 1.526 0.027 0 CA-C-N 117.845 0.293 . . . . 0.0 110.582 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -103.88 8.89 36.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.805 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -65.56 149.99 96.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.924 -0.485 . . . . 0.0 109.782 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.05 -27.5 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.855 2.37 . . . . 0.0 111.992 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.48 171.65 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.161 0.585 . . . . 0.0 110.357 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . 0.404 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 40.6 mm -68.89 135.67 27.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.4 mtt -95.72 150.31 37.23 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 122.07 0.148 . . . . 0.0 110.819 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.94 163.81 37.04 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.887 3.058 . . . . 0.0 111.494 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.72 -174.56 44.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.93 151.47 38.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.4 p -140.12 159.06 43.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.127 0.571 . . . . 0.0 110.365 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.09 167.7 28.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.216 0.607 . . . . 0.0 109.895 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.59 141.44 25.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.59 168.09 13.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.793 0.837 . . . . 0.0 109.54 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.6 -20.17 66.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.072 -0.392 . . . . 0.0 111.519 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.22 -1.3 44.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.83 0.452 . . . . 0.0 111.392 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.72 -4.5 86.19 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.632 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.1 m -93.33 160.79 14.66 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.23 1.015 . . . . 0.0 110.276 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 73.2 m -81.38 153.37 27.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.009 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.6 p -71.13 -10.8 60.37 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.82 0.448 . . . . 0.0 111.625 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -129.88 141.78 50.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.354 1.061 . . . . 0.0 109.393 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -154.51 158.89 40.55 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.416 0.286 . . . . 0.0 110.715 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -131.04 148.55 52.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.127 0.971 . . . . 0.0 109.355 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -136.85 7.81 2.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.687 0.395 . . . . 0.0 111.855 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.454 -0.256 0 C-N-CA 122.576 0.35 . . . . 0.0 111.209 -175.074 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -66.2 162.62 45.92 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.93 150.15 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.154 3.236 . . . . 0.0 113.499 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 37.9 m -123.95 18.92 9.3 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.548 0.739 . . . . 0.0 111.566 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.1 m120 59.92 10.78 2.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.407 1.083 . . . . 0.0 113.559 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.4 t -142.12 145.27 24.11 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 48.9 mt -117.55 166.56 12.23 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.201 0.524 . . . . 0.0 111.557 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 503' ' ' PHE . 1.5 t60 -137.56 148.81 46.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.784 0.834 . . . . 0.0 109.027 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -133.57 153.25 51.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.663 0.385 . . . . 0.0 110.882 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . 0.528 ' CZ ' ' CD2' ' A' ' 501' ' ' HIS . 75.4 m-85 -147.64 171.29 15.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.624 0.369 . . . . 0.0 111.33 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 24.9 m120 61.57 16.54 7.74 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -79.96 156.19 74.79 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.24 157.09 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.671 2.248 . . . . 0.0 111.888 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . 0.4 ' H ' ' CD2' ' A' ' 507' ' ' LEU . 2.3 pt? -72.45 -1.26 15.08 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.64 8.73 29.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.967 0.349 . . . . 0.0 111.93 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.42 150.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.91 0.323 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 71.8 p -145.9 175.63 10.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.787 0.835 . . . . 0.0 109.693 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.38 -25.65 68.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.446 -0.158 . . . . 0.0 111.019 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -74.99 -24.64 58.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.614 0.188 . . . . 0.0 110.714 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -79.41 -29.96 42.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -73.26 -25.46 60.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.297 -0.252 . . . . 0.0 110.44 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -78.95 -36.58 41.35 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.983 -0.448 . . . . 0.0 111.661 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.12 -15.7 55.15 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.143 0.428 . . . . 0.0 111.612 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.97 -35.09 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.199 0.454 . . . . 0.0 109.832 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.8 m -70.52 -17.8 62.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.736 -0.602 . . . . 0.0 110.215 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.43 -30.27 61.83 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.578 -0.249 . . . . 0.0 111.512 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.05 -14.8 30.64 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.373 0.533 . . . . 0.0 111.421 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.62 -13.05 24.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.865 0.466 . . . . 0.0 111.301 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 70.57 6.52 58.89 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.82 -0.433 . . . . 0.0 112.791 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.2 m -85.93 167.31 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.679 0.739 . . . . 0.0 110.802 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -74.64 150.01 39.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 111.063 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.31 150.71 41.9 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 123.498 0.719 . . . . 0.0 110.283 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.9 156.56 65.42 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.472 2.781 . . . . 0.0 110.669 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.8 m -86.26 -22.8 26.65 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.864 0.466 . . . . 0.0 110.605 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 14.8 t -149.38 155.23 40.14 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.53 144.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.769 0.427 . . . . 0.0 110.457 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -134.58 130.53 36.65 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.23 143.45 35.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.754 0.422 . . . . 0.0 109.919 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -154.0 135.11 13.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.028 0.531 . . . . 0.0 110.025 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.9 m . . . . . 0 C--O 1.23 0.078 0 C-N-CA 122.51 0.324 . . . . 0.0 110.25 -179.535 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 75.2 p -145.13 168.28 20.73 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.895 0.378 . . . . 0.0 111.321 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 48.4 t -133.38 150.65 51.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.159 0.984 . . . . 0.0 110.781 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 37.0 m -145.55 162.97 36.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.031 1.333 . . . . 0.0 109.055 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.57 -168.8 41.26 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.485 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.29 159.74 22.21 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.091 0.556 . . . . 0.0 111.403 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 87.6 mt -137.38 135.06 36.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.694 1.198 . . . . 0.0 107.836 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.78 110.36 12.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.468 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.1 p90 -165.99 156.03 12.46 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.425 1.49 . . . . 0.0 107.477 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.73 117.1 6.49 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.652 0.66 . . . . 0.0 112.719 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 28.7 m -159.54 153.06 22.57 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 126.149 1.78 . . . . 0.0 106.28 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.83 -51.39 49.08 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.512 0.596 . . . . 0.0 111.509 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 50.2 m -79.71 -24.33 41.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.92 -34.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.39 0.541 . . . . 0.0 111.677 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.41 -26.42 38.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.015 0.37 . . . . 0.0 111.038 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.1 tp -85.12 -29.52 24.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.255 0.48 . . . . 0.0 111.73 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -75.45 -38.5 59.66 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.088 0.404 . . . . 0.0 110.042 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.0 m -70.15 -33.93 72.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.7 -42.75 90.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.18 -24.7 75.04 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.292 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -113.86 -14.78 12.47 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.627 1.214 . . . . 0.0 114.105 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.43 -20.65 17.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.524 1.056 . . . . 0.0 111.085 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -74.41 139.44 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.6 t60 52.23 35.88 17.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.587 0.755 . . . . 0.0 112.122 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -99.2 151.32 21.14 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.25 136.31 36.91 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.585 1.554 . . . . 0.0 111.139 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.434 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.7 ttt -64.07 174.51 1.52 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.438 0.695 . . . . 0.0 112.078 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . 0.434 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.5 ttmm -68.65 -2.1 8.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.174 0.99 . . . . 0.0 112.504 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -60.96 141.95 93.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 121.492 -0.755 . . . . 0.0 110.569 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.18 -28.54 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.74 2.96 . . . . 0.0 113.918 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -121.01 -0.94 9.92 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.07 0.395 . . . . 0.0 111.829 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.39 41.27 99.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.997 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 79.1 Cg_endo -69.9 -10.7 29.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.884 2.39 . . . . 0.0 111.888 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.46 148.41 47.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.187 0.595 . . . . 0.0 109.959 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.63 153.36 38.81 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.707 2.938 . . . . 0.0 111.149 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -147.99 0.7 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.081 0.553 . . . . 0.0 111.41 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 12.3 t -66.43 125.55 26.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.283 -0.885 . . . . 0.0 110.781 -170.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.14 144.63 50.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.355 1.062 . . . . 0.0 109.991 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.6 157.82 16.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.285 0.234 . . . . 0.0 110.732 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.43 144.97 50.86 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.229 0.611 . . . . 0.0 109.689 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 27.9 p -160.49 167.37 27.36 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.159 0.584 . . . . 0.0 110.408 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -82.07 139.0 34.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 38.0 t -135.6 145.13 46.58 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.148 0.179 . . . . 0.0 110.883 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 19.3 p -79.98 102.28 9.15 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.12 161.56 34.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.954 0.902 . . . . 0.0 110.325 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 -12.44 11.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.782 0.433 . . . . 0.0 110.987 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -161.13 162.48 31.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.681 0.792 . . . . 0.0 109.538 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -91.35 76.83 5.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.518 0.327 . . . . 0.0 110.132 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.217 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.529 179.672 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.54 -7.4 59.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.965 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.6 m -147.49 152.15 41.34 Favored Pre-proline 0 C--N 1.34 0.156 0 C-N-CA 123.15 0.58 . . . . 0.0 110.89 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -82.5 3.34 7.89 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.446 3.431 . . . . 0.0 112.631 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.8 164.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 112.464 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.3 pp -149.45 171.23 16.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.23 1.012 . . . . 0.0 109.149 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' MET . . . . . 0.4 ' CE ' ' HE2' ' A' ' 412' ' ' MET . 80.8 mtp -138.11 152.12 48.45 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.411 0.284 . . . . 0.0 111.257 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.02 144.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -135.86 168.03 20.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.953 0.501 . . . . 0.0 110.411 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.31 69.26 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.972 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.618 HD21 ' H ' ' A' ' 386' ' ' LEU . 1.9 pt? -70.06 170.71 10.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.501 0.65 . . . . 0.0 111.741 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -127.01 130.85 50.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.613 0.765 . . . . 0.0 109.434 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -71.87 6.83 1.82 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.6 p -121.28 0.67 10.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.98 -13.12 2.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.164 0.586 . . . . 0.0 110.704 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -141.84 121.02 12.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.133 0.973 . . . . 0.0 108.795 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.571 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 19.4 m120 -141.89 -179.97 6.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.87 0.868 . . . . 0.0 109.337 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.99 -22.79 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.982 0.113 . . . . 0.0 111.231 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -88.03 -26.06 22.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.014 -0.429 . . . . 0.0 111.717 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . 0.571 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.4 mpt_? -83.36 -32.0 26.45 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.271 0.487 . . . . 0.0 109.702 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.9 p -72.44 -31.46 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -69.09 -29.57 67.7 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -80.78 -17.3 51.36 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.6 t -109.62 -23.78 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 118.437 0.562 . . . . 0.0 112.378 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.96 -16.37 14.16 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.689 0.677 . . . . 0.0 112.423 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 t -77.49 -16.02 58.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.124 0.875 . . . . 0.0 110.977 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.6 10.72 1.58 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.803 -0.561 . . . . 0.0 112.296 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 -3.17 9.38 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.721 0.808 . . . . 0.0 111.071 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.07 164.54 11.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.45 147.26 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.9 0.85 . . . . 0.0 111.702 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.49 155.47 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -96.76 -63.88 1.1 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -163.1 166.57 23.35 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.4 0.68 . . . . 0.0 110.338 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.51 151.7 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.214 0.606 . . . . 0.0 110.501 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -149.99 139.49 21.51 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.301 0.241 . . . . 0.0 110.822 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -77.25 152.28 34.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.4 ' HE2' ' CE ' ' A' ' 382' ' ' MET . 6.0 ptm -130.85 141.64 50.33 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -167.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 60.28 33.76 20.89 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.77 1.228 . . . . 0.0 112.275 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.3 m 55.42 14.79 1.22 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.296 1.039 . . . . 0.0 113.435 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -89.02 137.6 29.54 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.35 -8.56 18.57 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.964 2.443 . . . . 0.0 109.332 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.65 23.3 17.83 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.69 1.138 . . . . 0.0 113.128 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -150.75 137.27 18.78 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.973 1.387 . . . . 0.0 111.268 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -159.61 170.61 21.24 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.128 0.489 . . . . 0.0 111.363 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.5 ptm -139.39 147.44 41.46 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.375 0.67 . . . . 0.0 109.96 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.5 t -128.23 152.15 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.24 0.616 . . . . 0.0 110.76 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -129.58 141.46 50.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.585 0.754 . . . . 0.0 109.4 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 97.9 mmm -114.43 162.53 16.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.849 0.46 . . . . 0.0 110.719 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.83 60.74 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.318 0.247 . . . . 0.0 111.604 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.91 160.88 40.51 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.86 -12.22 84.76 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.199 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -75.38 -17.63 60.16 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.857 1.328 . . . . 0.0 111.32 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -89.84 -26.23 20.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.249 -0.282 . . . . 0.0 110.486 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.22 -34.27 37.07 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.29 -26.64 56.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.517 0.199 . . . . 0.0 110.625 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -25.74 48.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.68 31.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.038 0.135 . . . . 0.0 110.766 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 3.1 tp -82.65 -30.95 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 121.813 -0.554 . . . . 0.0 111.121 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 24.0 m -94.82 -19.69 20.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -136.22 -5.91 2.07 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.59 -19.21 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.168 0.895 . . . . 0.0 109.461 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -51.95 143.13 14.22 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.895 0.878 . . . . 0.0 110.629 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.8 1.42 0.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.819 1.648 . . . . 0.0 114.992 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -88.47 142.76 27.45 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.544 -1.348 . . . . 0.0 109.117 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.271 0.1 OUTLIER -130.94 163.98 26.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 171.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.25 143.47 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.175 0.99 . . . . 0.0 109.625 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 64.72 30.5 12.4 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.368 1.467 . . . . 0.0 114.45 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.43 15.64 77.3 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 168.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.25 161.28 21.55 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.506 1.153 . . . . 0.0 110.19 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.507 ' H ' ' HD3' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -91.63 128.59 37.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.329 0.513 . . . . 0.0 110.825 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.62 142.42 30.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -140.71 127.2 20.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.34 140.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-N 118.359 0.527 . . . . 0.0 110.718 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.7 m -150.59 163.69 37.86 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.26 1.024 . . . . 0.0 109.923 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.86 156.43 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.8 t -131.23 162.99 28.75 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 122.912 0.485 . . . . 0.0 109.725 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -105.69 5.69 31.3 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -67.42 144.93 98.24 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 121.694 -0.629 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.96 -24.68 11.13 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.151 2.567 . . . . 0.0 111.692 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.89 173.2 12.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.841 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.7 mm -71.33 142.52 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.43 154.89 37.85 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 117.472 0.124 . . . . 0.0 111.268 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.65 165.37 8.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.104 3.203 . . . . 0.0 112.477 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.89 177.86 37.77 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -81.81 166.07 20.31 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.834 0.453 . . . . 0.0 110.199 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.3 p -143.04 159.94 41.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.75 0.42 . . . . 0.0 110.973 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -151.33 173.15 14.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.768 0.827 . . . . 0.0 109.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.66 135.07 13.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.99 173.1 12.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.345 0.658 . . . . 0.0 109.828 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.4 -23.02 67.14 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.703 0.401 . . . . 0.0 111.329 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -81.7 -1.4 46.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.017 0.527 . . . . 0.0 111.332 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.27 84.43 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.087 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 77.6 p -84.06 163.96 19.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.537 0.668 . . . . 0.0 110.78 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.72 151.83 28.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 111.056 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 75.5 m -73.16 -10.45 59.79 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.435 0.694 . . . . 0.0 111.841 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -133.73 143.45 48.48 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.665 0.786 . . . . 0.0 109.762 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -157.18 156.86 33.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.733 0.413 . . . . 0.0 110.551 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -127.65 149.28 50.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.269 1.028 . . . . 0.0 109.503 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.99 13.89 2.87 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.84 0.456 . . . . 0.0 111.413 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 CA--C 1.53 0.197 0 O-C-N 122.079 -0.388 . . . . 0.0 111.784 -174.546 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -62.35 159.41 40.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.44 131.32 36.21 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.304 2.669 . . . . 0.0 112.492 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.6 m -124.07 23.86 8.37 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.691 0.796 . . . . 0.0 111.464 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 60.75 10.99 2.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.891 1.276 . . . . 0.0 114.043 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.53 141.78 36.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 40.8 mt -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.326 0.65 . . . . 0.0 110.283 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . 0.435 ' CG ' ' HB3' ' A' ' 580' ' ' SER . 0.6 OUTLIER -141.51 161.98 36.59 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.377 0.271 . . . . 0.0 110.956 173.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -139.06 157.06 46.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.726 0.41 . . . . 0.0 111.328 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -150.53 174.3 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.203 0.601 . . . . 0.0 111.066 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 11.7 t30 64.98 11.35 6.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.911 1.284 . . . . 0.0 113.656 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -73.2 161.66 78.19 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -70.33 155.68 63.51 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.903 1.735 . . . . 0.0 110.18 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.73 -1.12 8.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.31 9.0 18.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.95 151.21 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 118.009 0.368 . . . . 0.0 110.932 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.9 p -142.15 173.28 11.67 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.361 0.664 . . . . 0.0 110.516 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.18 -21.31 64.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.885 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.05 -22.81 58.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.348 -0.22 . . . . 0.0 110.487 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -82.34 -30.19 30.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.79 -25.66 61.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.761 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -84.34 -34.96 23.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.11 0.414 . . . . 0.0 111.468 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -76.88 -21.99 54.1 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.281 0.491 . . . . 0.0 111.133 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 74.0 mt -84.83 -37.88 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.937 0.335 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.5 m -66.64 -24.68 66.33 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.113 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.91 -30.42 63.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.245 -0.284 . . . . 0.0 111.761 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -91.04 -11.09 39.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.375 0.534 . . . . 0.0 112.0 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.6 mt -96.19 -7.7 35.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.774 0.429 . . . . 0.0 111.084 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.88 7.97 81.73 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.77 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -97.78 165.2 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 117.83 0.815 . . . . 0.0 110.645 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -83.19 151.67 25.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.742 0.417 . . . . 0.0 111.065 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -91.08 155.2 44.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.474 0.71 . . . . 0.0 110.717 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.95 158.74 45.73 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.296 2.664 . . . . 0.0 111.285 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 81.5 m -89.96 -26.39 20.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.0 m -139.38 150.06 44.87 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.06 144.27 25.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 123.042 0.537 . . . . 0.0 110.849 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -142.16 138.89 31.89 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 29.6 t -136.39 145.77 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 122.595 0.358 . . . . 0.0 110.425 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -151.94 164.19 37.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 N--CA 1.457 -0.085 0 O-C-N 121.867 -0.52 . . . . 0.0 111.242 -178.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 99.0 p -137.47 169.58 17.55 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.802 0.441 . . . . 0.0 111.538 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.6 t -125.43 153.88 42.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.371 1.068 . . . . 0.0 110.799 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 78.4 p -152.88 171.22 18.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.72 1.208 . . . . 0.0 109.627 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 166.63 -172.91 41.97 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.129 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.54 152.68 32.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 66.8 mt -136.71 134.89 37.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.73 1.212 . . . . 0.0 107.856 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -127.78 113.1 15.53 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -166.09 153.94 10.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.639 1.576 . . . . 0.0 106.775 167.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -148.87 118.6 7.04 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.3 t -159.46 153.1 22.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.582 1.553 . . . . 0.0 107.025 168.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.38 -63.8 1.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.971 0.35 . . . . 0.0 111.739 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 74.2 p -82.28 -17.25 46.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.09 -41.35 28.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.298 0.499 . . . . 0.0 110.682 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -78.14 -31.78 49.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.596 -0.24 . . . . 0.0 110.968 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.5 tp -77.25 -30.49 54.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.671 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -74.8 -40.2 61.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.94 -0.475 . . . . 0.0 110.548 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.3 m -63.99 -49.98 70.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.59 -0.243 . . . . 0.0 110.347 -175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.5 pp -77.51 -18.9 56.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.833 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -69.21 -26.58 74.51 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.12 -7.38 11.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.596 0.698 . . . . 0.0 112.604 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 46.3 tp -98.23 -19.36 17.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 0.0 111.701 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -74.48 144.43 44.17 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 80.2 t60 51.11 35.83 14.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.019 0.528 . . . . 0.0 112.039 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -97.27 151.42 19.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.709 0.804 . . . . 0.0 111.691 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -102.6 136.33 42.62 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.181 1.392 . . . . 0.0 110.549 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.3 ttt -64.11 173.87 1.77 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.066 0.547 . . . . 0.0 111.499 -174.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -70.25 9.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -66.5 146.84 99.09 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 118.55 0.614 . . . . 0.0 110.081 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.84 -30.02 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.42 2.747 . . . . 0.0 113.917 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -121.06 2.18 10.41 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.438 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.14 40.16 98.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.686 -1.064 . . . . 0.0 112.891 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 80.9 Cg_endo -69.45 -9.99 27.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.272 2.648 . . . . 0.0 112.073 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -142.61 148.26 45.92 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 122.823 0.449 . . . . 0.0 110.086 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.84 156.69 43.72 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.603 2.868 . . . . 0.0 111.477 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -148.59 6.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.038 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 3.0 t -66.48 122.1 16.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.611 -0.681 . . . . 0.0 110.118 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 575' ' ' LEU . 1.9 pt? -124.97 144.6 50.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 109.78 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -96.16 142.12 28.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.526 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.62 144.91 41.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 41.8 t -163.14 163.2 25.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -75.83 148.37 38.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.435 ' HB3' ' CG ' ' A' ' 501' ' ' HIS . 92.9 p -135.4 149.16 49.58 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.171 0.188 . . . . 0.0 110.606 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 31.3 p -90.02 102.19 14.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.36 161.47 34.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.654 0.782 . . . . 0.0 111.156 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -97.73 -25.79 14.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -163.85 152.72 13.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.506 1.122 . . . . 0.0 108.57 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -85.94 76.51 9.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.942 0.401 . . . . 0.0 110.35 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 36.3 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.869 177.484 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.777 0.323 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -144.79 17.03 1.61 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.22 0.608 . . . . 0.0 110.535 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.2 m -143.44 152.8 57.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 122.395 0.278 . . . . 0.0 111.13 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.209 3.273 . . . . 0.0 112.831 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 89.3 t -123.28 148.13 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 118.684 0.675 . . . . 0.0 110.811 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.3 164.12 30.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 110.692 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 73.6 mmm -127.33 149.38 50.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.505 0.722 . . . . 0.0 110.331 -176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.36 148.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.645 0.259 . . . . 0.0 110.743 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -141.13 170.99 14.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.702 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.46 -4.54 81.3 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.299 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.609 HD21 ' H ' ' A' ' 386' ' ' LEU . 1.9 pt? -71.72 175.75 5.43 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.038 0.919 . . . . 0.0 110.522 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.69 135.57 44.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.802 0.441 . . . . 0.0 109.889 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -73.46 4.84 4.29 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -172.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.9 m -115.36 -2.11 12.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.076 0.398 . . . . 0.0 111.845 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -138.12 -0.95 2.0 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.435 0.694 . . . . 0.0 110.685 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -154.53 121.11 5.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -141.97 -176.52 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.79 0.436 . . . . 0.0 110.62 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 25.5 p -57.01 -30.22 64.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.301 0.641 . . . . 0.0 112.671 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.0 -25.92 25.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.023 -0.423 . . . . 0.0 110.756 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -79.99 -32.48 39.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -75.6 -27.05 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -68.82 -29.42 67.76 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 171.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.38 -23.05 47.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.026 -0.421 . . . . 0.0 111.981 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 71.4 t -94.61 -21.36 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -114.59 -13.93 12.11 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.2 t -73.9 -21.92 59.89 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.306 0.957 . . . . 0.0 111.085 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.48 10.41 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.645 -0.659 . . . . 0.0 112.385 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.45 -11.41 8.73 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.248 0.619 . . . . 0.0 111.434 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 160.97 174.61 31.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -68.41 141.47 55.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.535 -0.391 . . . . 0.0 110.871 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.6 t -104.56 147.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -101.38 -58.32 1.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.231 -0.293 . . . . 0.0 110.351 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -165.3 169.41 15.89 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.957 0.503 . . . . 0.0 110.685 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.35 150.88 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.069 0 C-N-CA 123.739 0.816 . . . . 0.0 110.216 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.41 ' HE3' ' O ' ' A' ' 411' ' ' PHE . 51.4 tptt -147.18 137.54 23.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.749 0.82 . . . . 0.0 109.093 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . 0.41 ' O ' ' HE3' ' A' ' 410' ' ' LYS . 4.3 m-85 -76.53 136.2 39.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 22.1 ttp -93.64 140.97 29.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 47.42 33.84 3.01 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 112.248 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.5 m 52.95 17.99 1.0 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.443 1.097 . . . . 0.0 113.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -75.95 149.53 82.82 Favored Pre-proline 0 N--CA 1.456 -0.159 0 CA-C-N 118.564 0.62 . . . . 0.0 109.897 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.43 4.4 6.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.882 3.055 . . . . 0.0 110.975 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.51 32.06 1.36 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.299 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.83 141.76 25.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.187 0.993 . . . . 0.0 110.439 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.37 170.28 22.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.941 0.4 . . . . 0.0 111.373 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.4 ptm -145.76 145.06 30.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.733 0.813 . . . . 0.0 109.512 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.37 153.22 38.58 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.299 0.639 . . . . 0.0 110.32 -173.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -127.67 143.67 51.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.691 0.797 . . . . 0.0 110.07 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 79.4 mtp -129.38 166.64 19.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.425 0.69 . . . . 0.0 110.134 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.54 -23.82 65.47 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.17 160.21 38.52 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.252 0.478 . . . . 0.0 110.576 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.77 -12.35 80.82 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.451 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -67.93 -25.56 65.53 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.231 1.515 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.9 -27.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.5 t -73.54 -32.96 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.75 -25.96 66.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.048 0.539 . . . . 0.0 110.212 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -82.43 -27.19 32.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.375 -0.203 . . . . 0.0 110.691 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.21 -28.34 29.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.464 0.173 . . . . 0.0 110.56 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.84 -31.11 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.336 0.654 . . . . 0.0 110.853 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 m -98.88 -19.55 17.3 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -135.59 -4.28 2.3 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.72 -15.29 11.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.857 0.753 . . . . 0.0 109.458 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -58.02 149.87 22.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.481 0.658 . . . . 0.0 111.954 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 56.83 1.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.024 1.73 . . . . 0.0 114.616 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -88.04 142.56 27.68 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.961 1.255 . . . . 0.0 109.46 168.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.321 0.1 OUTLIER -130.93 164.03 26.2 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 170.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 18.7 ptm -125.26 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 66.07 24.01 11.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.01 16.01 80.98 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -83.2 156.31 23.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.085 1.443 . . . . 0.0 111.811 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.86 139.96 49.1 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.58 0.752 . . . . 0.0 109.592 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.96 122.04 39.5 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -140.75 119.75 12.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.12 142.61 20.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 118.008 0.367 . . . . 0.0 110.751 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 73.3 m -148.41 174.92 11.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.682 0.793 . . . . 0.0 110.715 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.71 156.05 13.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 34.9 t -137.27 146.12 44.34 Favored 'General case' 0 N--CA 1.461 0.101 0 O-C-N 122.1 -0.375 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -85.43 6.56 26.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.076 0.551 . . . . 0.0 112.237 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.09 132.24 93.69 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.02 -32.05 84.01 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.691 2.261 . . . . 0.0 112.515 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -161.79 171.55 17.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.792 0.437 . . . . 0.0 110.9 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.74 143.26 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.81 149.61 44.07 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 122.227 0.211 . . . . 0.0 110.745 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.91 161.92 43.47 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.761 2.974 . . . . 0.0 111.765 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 166.39 -179.51 40.35 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -80.89 173.54 12.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.815 0.446 . . . . 0.0 109.834 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.1 p -140.43 161.86 36.71 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -150.99 165.18 34.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.722 0.809 . . . . 0.0 109.632 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 137.88 20.0 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.98 174.71 8.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.202 1.001 . . . . 0.0 109.437 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -68.41 -21.78 64.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.85 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -83.08 4.24 27.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.103 0.561 . . . . 0.0 111.792 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.62 -2.42 73.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.622 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.2 p -90.82 163.02 14.58 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.074 0.937 . . . . 0.0 110.222 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.3 m -81.28 153.41 27.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.032 -0.417 . . . . 0.0 111.114 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 89.5 p -71.18 -8.88 56.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -130.65 142.79 50.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.386 1.074 . . . . 0.0 109.036 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -153.21 157.38 40.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.721 0.408 . . . . 0.0 110.278 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.31 148.46 50.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.77 0.828 . . . . 0.0 109.812 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -137.2 14.93 3.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.999 0.52 . . . . 0.0 111.583 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.1 p . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.595 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 121.194 0.521 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -82.48 167.59 29.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 124.936 1.295 . . . . 0.0 109.991 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -49.82 125.67 14.93 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.099 2.533 . . . . 0.0 111.62 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.2 m -124.07 23.85 8.37 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.621 0.768 . . . . 0.0 112.292 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.6 m120 61.65 8.18 2.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.219 1.008 . . . . 0.0 113.52 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.98 146.27 20.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.851 0.86 . . . . 0.0 108.902 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.36 151.58 42.37 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.973 0.509 . . . . 0.0 110.667 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 580' ' ' SER . 0.3 OUTLIER -126.03 143.55 51.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -129.7 152.04 49.64 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.416 0.15 . . . . 0.0 110.829 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -150.12 172.27 15.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.815 0.446 . . . . 0.0 111.246 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.18 30.19 19.91 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.766 0.826 . . . . 0.0 112.791 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -94.16 153.98 40.6 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -56.55 150.87 49.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.732 2.288 . . . . 0.0 111.937 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -70.03 -0.98 8.53 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.96 6.95 23.58 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.41 151.61 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.964 -0.46 . . . . 0.0 110.826 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 59.9 p -143.73 171.39 14.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.421 0.689 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.32 -24.48 67.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.683 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.08 -22.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.187 -0.321 . . . . 0.0 110.447 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -81.35 -29.23 34.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.76 -25.13 58.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.054 -0.404 . . . . 0.0 110.875 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -80.96 -37.72 28.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.107 0.412 . . . . 0.0 111.246 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -76.34 -21.75 55.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.076 0.398 . . . . 0.0 111.199 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 64.0 mt -82.02 -37.77 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.2 m -66.82 -25.78 66.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.852 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.14 -30.16 64.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.77 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -91.06 -11.91 37.3 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.405 0.548 . . . . 0.0 111.818 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.7 mt -91.36 -10.32 41.62 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.991 0.517 . . . . 0.0 110.992 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.04 71.09 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.747 -0.474 . . . . 0.0 112.33 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.0 m -94.96 167.75 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 117.683 0.742 . . . . 0.0 110.438 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.42 147.41 27.88 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.91 0.386 . . . . 0.0 111.12 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -82.23 157.18 68.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.789 0.835 . . . . 0.0 111.25 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.16 155.16 69.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.414 2.743 . . . . 0.0 110.327 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.452 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -86.0 -24.9 26.27 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.716 0.406 . . . . 0.0 110.93 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 22.0 t -144.04 152.46 41.03 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -140.34 142.71 30.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.06 0.544 . . . . 0.0 109.975 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 129.52 21.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.39 147.8 32.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.826 0.451 . . . . 0.0 110.785 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -149.74 154.93 39.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.321 0.648 . . . . 0.0 109.947 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.231 0.08 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.863 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.5 t -145.33 162.23 37.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.622 0.369 . . . . 0.0 110.987 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 45.8 t -131.0 154.76 47.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.976 0.91 . . . . 0.0 111.435 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.9 p -149.39 171.21 16.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.073 1.349 . . . . 0.0 109.063 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.89 37.82 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.739 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.72 150.86 48.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.367 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.57 133.18 39.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -127.65 108.22 10.58 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.452 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -165.98 154.01 10.69 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.705 1.602 . . . . 0.0 106.926 167.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.21 122.75 7.92 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 46.3 t -159.56 153.37 23.01 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.007 1.723 . . . . 0.0 106.504 168.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.44 -54.72 39.82 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.322 0.51 . . . . 0.0 111.572 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.6 p -87.34 -21.5 25.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.67 -36.67 37.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.243 0.474 . . . . 0.0 110.801 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.56 -32.63 28.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.675 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.73 -27.32 60.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.991 0.359 . . . . 0.0 110.75 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.91 -43.96 33.54 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.037 -0.414 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 95.7 m -70.44 -31.05 68.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.25 -42.16 93.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.56 -28.67 69.01 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.364 -0.686 . . . . 0.0 112.81 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.13 -13.43 15.44 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.0 -23.48 14.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.411 1.005 . . . . 0.0 112.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -69.95 142.35 52.9 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 48.96 35.29 6.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.817 0.847 . . . . 0.0 113.025 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -95.96 151.39 19.47 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -92.14 136.34 33.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.286 1.434 . . . . 0.0 111.324 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.409 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 4.2 ttt -64.36 176.0 1.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.251 0.62 . . . . 0.0 111.828 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . 0.409 ' H ' ' HG2' ' A' ' 564' ' ' MET . 64.8 pttt -71.86 6.54 1.98 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -67.34 142.79 96.92 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.667 0.667 . . . . 0.0 110.6 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.45 -29.74 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.464 2.776 . . . . 0.0 113.672 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -120.58 1.01 10.58 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.968 0.349 . . . . 0.0 111.744 -174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.439 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.77 40.81 98.66 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.749 -1.029 . . . . 0.0 113.092 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 78.8 Cg_endo -69.16 -10.55 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.852 2.368 . . . . 0.0 111.993 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -144.24 147.57 37.77 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.053 0.541 . . . . 0.0 109.807 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.48 153.07 39.26 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.52 2.813 . . . . 0.0 111.3 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -149.03 -0.84 0.5 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.174 0.589 . . . . 0.0 111.583 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 10.2 t -66.49 124.86 23.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.521 -0.737 . . . . 0.0 109.687 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . 0.46 HD21 ' H ' ' A' ' 575' ' ' LEU . 1.8 pt? -124.99 144.56 50.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 0.0 110.939 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -82.66 147.6 28.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 49.5 tp -139.68 144.91 37.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.5 p -163.81 167.06 21.31 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -84.63 125.66 32.67 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.466 ' HB3' ' CE1' ' A' ' 501' ' ' HIS . 31.8 t -135.69 148.79 49.03 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 85.0 m -79.53 105.43 10.83 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.556 0.217 . . . . 0.0 110.762 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.17 161.45 34.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.016 0.927 . . . . 0.0 109.75 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -126.67 -1.57 6.73 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.592 0.357 . . . . 0.0 110.996 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -148.82 161.62 41.46 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.881 0.872 . . . . 0.0 110.031 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.48 0.99 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.32 -1.324 . . . . 0.0 110.163 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.88 -8.67 55.49 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.504 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 40.7 m -148.06 152.48 40.02 Favored Pre-proline 0 N--CA 1.456 -0.146 0 C-N-CA 122.657 0.383 . . . . 0.0 111.205 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -83.57 0.28 9.49 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.276 3.318 . . . . 0.0 112.816 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.16 164.37 33.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.697 0.681 . . . . 0.0 112.465 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.28 164.16 35.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.087 0.955 . . . . 0.0 108.933 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 79.4 mtp -133.29 150.85 51.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.642 0.377 . . . . 0.0 110.811 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.92 149.15 23.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.868 0.467 . . . . 0.0 110.638 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.444 ' CE2' ' HE1' ' A' ' 412' ' ' MET . 16.0 m-85 -139.38 163.98 31.07 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.648 0.779 . . . . 0.0 110.113 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.34 -2.86 69.45 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.734 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.64 171.76 11.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.021 0.911 . . . . 0.0 110.98 178.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -126.09 137.4 53.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.688 0.395 . . . . 0.0 110.016 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -67.82 -7.86 31.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 60.9 p -99.11 -8.78 24.72 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -134.35 -8.46 2.57 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.174 0.443 . . . . 0.0 111.317 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.5 tpt -147.97 108.34 4.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.142 0.577 . . . . 0.0 109.588 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.447 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 51.4 p-10 -141.91 -173.12 3.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.328 0.651 . . . . 0.0 109.884 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 24.4 p -56.03 -27.66 54.08 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.864 0.466 . . . . 0.0 112.154 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.05 -37.96 21.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.071 -0.393 . . . . 0.0 110.891 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . 0.447 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 7.8 mpt_? -75.76 -29.81 58.95 Favored 'General case' 0 C--O 1.23 0.041 0 O-C-N 122.206 -0.309 . . . . 0.0 110.805 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.42 -30.75 26.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -73.91 -27.48 61.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.642 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.16 -26.54 59.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.849 -0.532 . . . . 0.0 111.703 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.3 -24.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -106.24 -10.92 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.785 0.721 . . . . 0.0 112.846 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.51 -23.21 58.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.767 0.712 . . . . 0.0 111.772 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.7 pp -77.28 12.56 1.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.631 -0.668 . . . . 0.0 112.263 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -120.74 -5.98 9.66 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.181 0.592 . . . . 0.0 111.088 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 151.85 -179.63 28.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -73.51 150.89 41.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.4 t -118.08 155.17 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.7 -57.45 2.25 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 118.712 0.687 . . . . 0.0 112.006 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . 0.402 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.9 pttm -161.72 164.06 29.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.986 0.422 . . . . 0.0 111.782 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.66 150.88 16.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.93 0.892 . . . . 0.0 109.871 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -151.91 145.07 24.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.01 144.5 30.82 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.444 ' HE1' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -126.11 141.54 51.9 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -167.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.21 34.08 21.03 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.576 1.55 . . . . 0.0 112.565 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.4 m 53.46 15.06 0.64 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.053 1.341 . . . . 0.0 114.201 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -82.7 136.95 44.49 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 118.444 0.566 . . . . 0.0 109.582 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.86 -9.56 16.9 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.873 2.382 . . . . 0.0 109.571 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.22 19.66 24.47 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.202 0.906 . . . . 0.0 112.977 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -152.24 143.2 23.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.61 1.205 . . . . 0.0 110.848 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.89 167.61 29.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.846 0.355 . . . . 0.0 111.672 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 24.5 ptm -142.38 146.45 34.94 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.118 0.567 . . . . 0.0 109.812 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.6 154.96 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 122.601 0.361 . . . . 0.0 110.982 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.84 141.71 51.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.846 0.858 . . . . 0.0 110.714 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 66.9 mtp -119.02 163.36 17.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.853 0.461 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.99 67.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.21 164.35 30.48 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.724 0.409 . . . . 0.0 110.159 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.12 -8.09 61.01 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.333 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -69.69 -28.28 65.71 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.55 1.675 . . . . 0.0 110.218 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -87.21 -24.8 24.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.8 t -75.88 -25.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.89 -42.61 73.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.243 -0.285 . . . . 0.0 110.431 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -69.05 -26.81 65.16 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.76 -40.22 33.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.095 -0.378 . . . . 0.0 111.294 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.4 tp -81.38 -30.99 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.572 0.349 . . . . 0.0 111.902 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -99.9 -20.12 16.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -129.67 -8.59 4.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -174.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.48 -20.92 10.03 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.314 0.961 . . . . 0.0 109.635 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.31 144.79 12.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 58.02 1.38 0.14 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.235 2.214 . . . . 0.0 115.374 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -88.08 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.337 1.426 . . . . 0.0 108.307 168.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.308 0.0 OUTLIER -130.93 163.93 26.42 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 174.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.6 ptm -125.39 143.39 51.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.582 1.553 . . . . 0.0 109.86 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 63.92 32.59 13.09 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.121 1.368 . . . . 0.0 114.551 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.06 15.92 80.85 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.542 -0.588 . . . . 0.0 114.267 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.16 153.97 24.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.124 0.962 . . . . 0.0 110.122 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.509 ' H ' ' HD3' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -88.85 131.28 35.17 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 175.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.59 130.92 45.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -140.76 113.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.15 139.93 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.415 0.552 . . . . 0.0 110.523 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 84.4 m -149.13 161.54 41.77 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.038 0.935 . . . . 0.0 110.113 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.4 p -82.47 156.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 43.9 t -132.94 157.9 43.99 Favored 'General case' 0 N--CA 1.459 0.024 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -99.57 6.21 45.83 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -65.66 142.59 98.3 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.49 -25.72 10.85 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.942 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.11 15.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 110.066 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . 0.402 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 37.0 mm -69.35 138.57 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.68 151.22 42.13 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 122.395 0.278 . . . . 0.0 110.468 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.33 164.13 36.2 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.606 2.871 . . . . 0.0 110.81 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.87 -177.42 41.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -76.29 155.42 34.3 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.85 0.46 . . . . 0.0 110.032 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.6 p -133.09 165.57 24.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.625 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -147.38 161.16 41.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -83.41 135.29 13.67 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.93 168.85 13.0 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.539 0.735 . . . . 0.0 110.013 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -20.81 64.92 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.343 -0.223 . . . . 0.0 111.224 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.22 0.81 23.65 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 111.267 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.18 -3.15 82.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 123.542 0.591 . . . . 0.0 112.598 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.0 t -93.98 163.57 13.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.603 0.702 . . . . 0.0 110.286 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.42 153.39 21.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.722 0.296 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -66.19 -10.46 41.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.526 0.33 . . . . 0.0 111.601 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -120.62 141.87 49.95 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.141 0.976 . . . . 0.0 109.115 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -151.62 156.87 41.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.619 0.247 . . . . 0.0 110.464 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -126.31 150.16 48.68 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.637 0.775 . . . . 0.0 110.17 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -140.05 12.8 2.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.25 0.62 . . . . 0.0 111.566 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 22.4 t . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -173.968 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -60.95 159.72 25.41 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.215 0.606 . . . . 0.0 110.544 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.19 147.69 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.372 2.715 . . . . 0.0 112.93 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 55.7 m -124.0 19.4 9.22 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.34 0.656 . . . . 0.0 111.169 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.28 3.81 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.179 1.392 . . . . 0.0 114.591 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 37.0 t -141.54 147.38 22.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . 0.44 HD13 ' CH2' ' A' ' 546' ' ' TRP . 53.2 mt -121.8 163.38 19.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.895 0.478 . . . . 0.0 110.457 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.58 158.66 43.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.566 0.346 . . . . 0.0 110.807 174.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -137.59 153.83 49.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.407 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -148.39 169.65 19.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.143 0.577 . . . . 0.0 110.33 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 15.8 t30 62.51 18.92 10.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.877 0.871 . . . . 0.0 113.324 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -77.52 164.63 56.92 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.48 152.91 37.59 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.728 2.285 . . . . 0.0 111.995 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . 0.443 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -74.66 -1.77 23.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.838 0.455 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -125.13 16.78 8.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.496 0.719 . . . . 0.0 111.421 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.64 151.32 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 122.019 -0.426 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 74.7 p -141.75 170.46 15.67 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 123.125 0.57 . . . . 0.0 110.69 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.2 -22.6 66.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.98 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.91 -24.48 48.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.205 -0.309 . . . . 0.0 110.493 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.44 -32.04 37.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -73.41 -29.88 62.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.235 -0.291 . . . . 0.0 110.747 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -77.88 -37.28 48.43 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.149 0.431 . . . . 0.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.91 -25.23 43.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.859 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.91 -40.66 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.4 m -65.11 -29.01 69.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.277 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.21 -29.3 61.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.854 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.98 -10.94 40.48 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.415 0.552 . . . . 0.0 112.014 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 85.2 mt -91.1 -3.71 56.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.758 0.423 . . . . 0.0 110.768 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.9 80.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.779 -0.456 . . . . 0.0 112.499 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -112.81 172.14 3.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.524 0.662 . . . . 0.0 111.403 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.18 149.19 41.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.207 0.603 . . . . 0.0 110.073 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -98.06 151.55 37.6 Favored Pre-proline 0 CA--C 1.528 0.13 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.54 147.17 93.22 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.788 2.325 . . . . 0.0 110.492 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.435 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.3 m -82.71 -28.4 30.54 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 122.938 0.495 . . . . 0.0 110.997 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -140.32 147.32 39.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 2.4 p -154.36 144.63 13.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 122.744 0.418 . . . . 0.0 110.799 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -149.2 156.47 42.2 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.354 0.662 . . . . 0.0 109.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.59 145.51 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.416 0.686 . . . . 0.0 109.23 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -150.63 142.52 23.86 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.735 0.302 . . . . 0.0 110.95 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 123.366 0.666 . . . . 0.0 111.555 -179.223 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 59.3 m -148.9 -178.1 6.17 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.882 1.673 . . . . 0.0 108.784 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 8.6 t -140.26 160.86 39.02 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.116 -0.365 . . . . 0.0 110.981 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.8 m -146.35 164.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.698 0.799 . . . . 0.0 110.741 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 176.2 -166.52 37.65 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.591 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 63.3 mt -120.62 155.65 33.31 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.437 0.695 . . . . 0.0 111.265 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 91.9 mt -140.31 132.19 27.6 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.012 0.925 . . . . 0.0 108.816 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -127.89 119.48 25.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.44 ' CH2' HD13 ' A' ' 500' ' ' LEU . 2.6 p90 -166.05 150.47 8.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.385 1.474 . . . . 0.0 107.08 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -145.84 110.39 5.09 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -172.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.0 t -159.5 153.0 22.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -67.33 -42.02 84.28 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.528 0.604 . . . . 0.0 110.437 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 31.6 m -83.92 -30.55 26.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.808 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.81 -30.21 26.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.69 0.677 . . . . 0.0 111.48 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.73 -30.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.162 0.437 . . . . 0.0 111.316 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 29.8 tp -83.55 -29.29 27.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.879 0.763 . . . . 0.0 111.793 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.4 -42.67 43.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.256 0.48 . . . . 0.0 110.02 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 55.5 m -68.99 -31.85 71.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.9 -41.84 58.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.01 -19.99 75.9 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.366 -0.686 . . . . 0.0 113.115 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.71 -11.65 13.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.326 1.063 . . . . 0.0 113.052 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 30.4 tp -104.97 -16.88 14.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.087 0.858 . . . . 0.0 112.386 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -72.59 143.81 48.1 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.748 -0.595 . . . . 0.0 109.545 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 51.11 21.18 0.98 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.879 0.872 . . . . 0.0 113.128 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -78.43 151.44 32.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.11 136.38 50.24 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.095 1.358 . . . . 0.0 109.181 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.419 ' HE2' ' CD1' ' A' ' 573' ' ' TYR . 49.9 ttm -64.24 162.15 15.2 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.252 0.549 . . . . 0.0 110.915 -173.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -66.69 15.66 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.866 1.666 . . . . 0.0 114.055 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -65.09 152.86 90.46 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.75 -46.89 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.728 2.286 . . . . 0.0 113.951 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -121.13 16.19 11.55 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.94 47.91 84.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.088 -0.84 . . . . 0.0 112.761 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 -10.09 21.97 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.147 2.565 . . . . 0.0 111.122 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -148.55 149.49 31.36 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 123.829 0.852 . . . . 0.0 109.603 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.86 156.37 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.577 2.851 . . . . 0.0 111.632 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . 0.419 ' CD1' ' HE2' ' A' ' 564' ' ' MET . 79.6 t80 -144.79 1.27 1.0 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.849 0.86 . . . . 0.0 110.588 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 57.3 m -66.44 116.53 7.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . 0.445 HD21 ' H ' ' A' ' 575' ' ' LEU . 1.7 pt? -124.89 144.53 50.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.508 0.723 . . . . 0.0 111.961 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.05 143.59 31.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.6 mt -131.21 144.73 51.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 36.8 t -163.8 176.34 9.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.34 145.31 28.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.928 0.491 . . . . 0.0 110.933 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 35.0 t -135.54 147.22 48.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.094 0.558 . . . . 0.0 110.112 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 25.4 m -89.61 102.13 14.81 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.62 34.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.598 0.759 . . . . 0.0 110.293 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -96.43 -21.52 17.7 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -164.26 153.81 14.0 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.073 0.949 . . . . 0.0 109.962 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -109.97 76.32 0.98 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.465 -1.255 . . . . 0.0 110.631 178.58 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.19 6.44 5.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.826 0.451 . . . . 0.0 111.946 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.4 m -142.92 146.03 35.77 Favored Pre-proline 0 C--O 1.232 0.133 0 O-C-N 121.93 -0.481 . . . . 0.0 111.389 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -82.0 1.8 8.97 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 124.598 3.532 . . . . 0.0 112.834 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.26 146.35 28.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-N 118.374 0.534 . . . . 0.0 110.943 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.84 167.68 21.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.695 0.798 . . . . 0.0 109.609 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.9 mtp -138.83 151.17 46.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.672 0.273 . . . . 0.0 110.856 -175.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.09 150.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.043 0.537 . . . . 0.0 110.63 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.76 166.52 24.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.489 0.716 . . . . 0.0 109.519 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.08 89.46 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.701 -0.499 . . . . 0.0 112.934 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.15 175.71 7.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.774 0.787 . . . . 0.0 110.689 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -138.3 142.08 39.8 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.544 0.338 . . . . 0.0 110.103 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -73.94 -2.35 23.61 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.8 p -110.38 -2.68 16.52 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.205 0.457 . . . . 0.0 112.126 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -131.65 -5.72 3.66 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.164 0.586 . . . . 0.0 110.922 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.8 tpt -146.19 123.33 11.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.216 0.606 . . . . 0.0 109.545 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 22.5 m120 -141.94 176.26 9.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.883 0.873 . . . . 0.0 109.082 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 81.6 m -59.54 -25.97 64.96 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.225 -0.297 . . . . 0.0 110.94 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.14 -23.12 26.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.255 -0.278 . . . . 0.0 111.593 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . 0.45 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 49.0 mmt-85 -82.16 -31.3 30.57 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.418 0.554 . . . . 0.0 109.586 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.43 -30.0 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.94 -30.89 68.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -71.96 -32.03 66.87 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.94 -0.475 . . . . 0.0 110.889 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.3 t -88.03 -27.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -104.95 -8.41 18.62 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.36 -39.46 78.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.825 0.739 . . . . 0.0 110.967 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.03 14.96 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.936 -0.478 . . . . 0.0 112.145 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.31 -1.89 9.63 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.188 0.595 . . . . 0.0 111.067 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.83 174.19 19.48 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -74.71 136.03 41.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.317 -0.52 . . . . 0.0 110.957 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 7.7 m -94.44 164.52 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 124.571 1.148 . . . . 0.0 110.365 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -129.91 -63.34 0.92 Allowed 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.261 0.224 . . . . 0.0 110.884 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -163.32 166.04 23.48 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.771 0.429 . . . . 0.0 111.353 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.54 153.27 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.553 0.741 . . . . 0.0 110.625 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -149.65 145.06 26.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -77.47 155.2 31.87 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 8.3 ttm -107.78 141.11 39.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -168.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 48.72 33.99 4.77 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.217 1.007 . . . . 0.0 112.64 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.9 m 53.03 17.64 0.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.828 0.851 . . . . 0.0 113.099 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.66 147.77 53.07 Favored Pre-proline 0 N--CA 1.455 -0.204 0 CA-C-N 118.023 0.374 . . . . 0.0 110.428 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -81.61 -1.63 11.07 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.43 2.753 . . . . 0.0 110.427 170.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -124.54 17.28 7.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.587 -173.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.79 143.91 25.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.747 1.274 . . . . 0.0 110.976 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.95 168.66 26.83 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.8 ptm -141.6 145.14 34.67 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.427 0.691 . . . . 0.0 109.946 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 14.6 t -131.95 150.96 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 122.746 0.418 . . . . 0.0 110.838 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -128.24 143.26 51.02 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.389 0.675 . . . . 0.0 110.311 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 81.3 mmm -117.1 162.64 17.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.434 0.694 . . . . 0.0 109.323 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -73.25 -19.28 61.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.055 -0.403 . . . . 0.0 111.921 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -156.62 162.5 39.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.776 0.43 . . . . 0.0 110.172 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.64 -17.95 73.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.458 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -67.49 -26.52 66.4 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.976 1.388 . . . . 0.0 110.172 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.57 -24.17 45.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.416 0.286 . . . . 0.0 110.621 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.25 -31.81 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.75 -32.38 73.9 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -82.22 -30.5 30.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.349 0.26 . . . . 0.0 111.681 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.59 -28.22 31.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.33 0.514 . . . . 0.0 111.073 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.4 tp -82.59 -31.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.918 0.487 . . . . 0.0 110.992 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.0 m -93.74 -21.99 18.99 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -124.24 -13.32 7.24 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.66 -20.47 10.11 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.072 0.851 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -52.28 143.26 15.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.963 0.905 . . . . 0.0 111.497 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 14.3 p30 56.91 1.53 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.004 2.522 . . . . 0.0 115.864 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -88.04 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.183 1.356 . . . . 0.0 108.184 168.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.286 0.0 OUTLIER -130.95 163.95 26.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 176.379 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.7 ptm -125.28 143.44 50.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.162 1.385 . . . . 0.0 109.946 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 65.07 31.57 10.98 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.025 1.33 . . . . 0.0 114.042 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.02 15.86 72.25 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.344 -0.698 . . . . 0.0 114.805 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -83.27 162.05 21.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.427 1.114 . . . . 0.0 110.337 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 131.68 35.66 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.961 0.41 . . . . 0.0 110.527 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.61 132.96 43.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -169.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.68 117.46 11.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.7 139.9 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 118.393 0.542 . . . . 0.0 110.523 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.4 m -150.23 161.98 41.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.982 0.913 . . . . 0.0 110.162 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.9 p -84.82 155.5 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 38.3 t -134.38 142.54 47.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.977 0.353 . . . . 0.0 111.246 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -85.7 65.95 9.4 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.03 0.532 . . . . 0.0 110.43 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -127.81 143.78 48.91 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.18 -26.54 6.25 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.878 2.386 . . . . 0.0 111.805 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.02 170.51 15.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.558 0.343 . . . . 0.0 111.031 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.1 mm -71.62 147.02 11.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.33 151.98 41.07 Favored Pre-proline 0 C--O 1.231 0.128 0 C-N-CA 122.416 0.286 . . . . 0.0 110.239 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.41 164.49 32.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.673 2.915 . . . . 0.0 111.874 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 171.21 -174.35 44.87 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -74.12 148.85 41.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.844 0.322 . . . . 0.0 110.25 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 24.9 m -142.59 160.89 39.42 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.249 0.62 . . . . 0.0 109.919 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -150.91 164.23 36.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.463 0.305 . . . . 0.0 110.568 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.14 135.27 16.27 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.95 169.5 12.42 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.539 0.736 . . . . 0.0 109.702 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.15 -20.31 65.73 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.081 -0.387 . . . . 0.0 111.376 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.0 -0.9 26.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.962 0.505 . . . . 0.0 111.283 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 85.73 -7.58 76.32 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.635 0.636 . . . . 0.0 112.783 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.7 m -93.83 156.19 16.79 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 117.896 0.848 . . . . 0.0 110.397 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 47.5 t -77.44 153.26 33.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.398 0.279 . . . . 0.0 110.261 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -68.14 -10.42 53.96 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.249 0.619 . . . . 0.0 111.678 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -123.48 136.27 54.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.11 0.964 . . . . 0.0 109.297 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -155.72 159.26 39.35 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -125.0 157.4 36.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.927 0.891 . . . . 0.0 110.454 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -139.56 13.53 2.54 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.107 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -61.43 163.82 10.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.139 0.975 . . . . 0.0 110.828 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.22 143.06 20.12 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.23 2.62 . . . . 0.0 112.258 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 51.3 m -119.77 23.58 11.03 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.261 0.624 . . . . 0.0 112.259 -172.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 61.96 -7.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.42 1.488 . . . . 0.0 114.098 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.72 147.65 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.757 0.708 . . . . 0.0 109.661 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 59.5 mt -119.1 151.64 37.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.786 0.434 . . . . 0.0 110.222 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . 0.498 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 11.7 m170 -119.55 155.41 32.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.25 149.91 44.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.333 0.253 . . . . 0.0 110.524 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -145.78 169.28 18.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.747 0.419 . . . . 0.0 110.987 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 46.4 t30 56.68 33.12 22.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.994 0.918 . . . . 0.0 112.843 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.82 163.74 39.74 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.94 151.0 68.64 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.007 2.472 . . . . 0.0 111.847 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . 0.435 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -75.27 -1.19 22.38 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.34 9.59 11.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.899 0.48 . . . . 0.0 111.919 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.6 149.49 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 118.019 0.372 . . . . 0.0 111.058 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.8 p -142.07 173.98 11.02 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.536 0.735 . . . . 0.0 110.265 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.63 -21.74 65.9 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.77 -22.08 58.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.234 -0.291 . . . . 0.0 110.407 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -83.25 -32.17 26.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.86 -27.63 63.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -84.53 -37.54 21.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.135 0.425 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -76.03 -21.28 57.01 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.756 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.6 mt -92.1 -36.14 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.922 0.328 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 18.2 p -70.31 -20.85 62.98 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.47 -29.03 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.567 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.99 -12.93 34.41 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.447 0.567 . . . . 0.0 111.333 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.06 -9.58 55.1 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.716 0.406 . . . . 0.0 110.838 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.22 11.08 82.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.765 -0.464 . . . . 0.0 112.803 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.5 m -98.8 169.82 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.103 0 CA-C-N 117.738 0.769 . . . . 0.0 111.291 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.54 151.68 42.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.343 0.657 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -101.04 151.98 37.76 Favored Pre-proline 0 C--O 1.231 0.111 0 C-N-CA 122.729 0.412 . . . . 0.0 109.899 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.31 153.38 78.26 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.962 2.442 . . . . 0.0 110.471 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 80.6 m -86.14 -24.84 26.05 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.621 0.368 . . . . 0.0 110.53 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -142.84 150.35 39.78 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.168 0.587 . . . . 0.0 109.599 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.55 147.97 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 120.872 0.368 . . . . 0.0 110.387 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -142.28 132.26 24.46 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.91 142.4 39.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -154.24 150.65 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 110.468 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.909 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.2 t -149.52 162.88 39.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.922 0.489 . . . . 0.0 110.433 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 42.2 t -124.82 152.59 43.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.47 0.708 . . . . 0.0 111.519 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 52.5 m -147.73 165.26 31.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.73 1.212 . . . . 0.0 108.93 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.81 -165.88 37.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.745 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -127.41 156.28 42.32 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.755 0.822 . . . . 0.0 110.351 -176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.86 133.62 30.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.482 1.113 . . . . 0.0 108.004 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.83 113.3 15.77 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.411 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.9 p90 -166.02 151.35 8.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 168.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -150.77 116.2 5.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 35.2 t -159.41 152.92 22.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.93 -38.0 79.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.746 0.703 . . . . 0.0 111.432 -174.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 47.4 m -87.78 -28.6 21.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -85.37 -28.32 25.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.414 0.552 . . . . 0.0 111.12 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.17 -34.42 37.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 117.949 0.341 . . . . 0.0 110.397 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.88 -30.73 45.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.439 0.563 . . . . 0.0 112.016 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -72.72 -43.73 62.6 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.261 0.482 . . . . 0.0 109.979 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 44.4 m -69.27 -40.26 77.91 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -42.79 98.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.901 -0.499 . . . . 0.0 109.864 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.15 -21.57 77.11 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.86 -0.966 . . . . 0.0 113.447 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -117.68 -14.97 10.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.857 1.329 . . . . 0.0 113.276 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 17.4 tp -88.22 -21.93 24.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.347 0.976 . . . . 0.0 110.623 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -76.49 151.32 36.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 39.8 t60 55.91 22.66 5.89 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.64 151.46 37.77 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.194 0.598 . . . . 0.0 112.537 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -110.78 136.18 50.23 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.06 0.944 . . . . 0.0 111.433 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.25 176.83 0.94 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.076 0.95 . . . . 0.0 111.417 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.9 10.71 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.709 0.803 . . . . 0.0 112.459 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.04 146.71 87.43 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 123.288 0.635 . . . . 0.0 111.051 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.92 -40.63 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.134 2.556 . . . . 0.0 112.734 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -120.96 2.38 10.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 65.82 60.26 6.71 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.767 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.67 -8.5 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.322 2.681 . . . . 0.0 110.984 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.45 151.03 46.16 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 123.576 0.75 . . . . 0.0 109.74 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.58 154.33 39.75 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.637 2.892 . . . . 0.0 110.356 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -133.16 -4.58 3.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.8 t -66.55 131.95 47.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.668 -0.645 . . . . 0.0 110.653 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 1.8 pp -116.43 144.67 44.01 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.373 0.669 . . . . 0.0 110.79 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.64 138.09 39.85 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.03 155.89 43.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 111.412 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.9 p -163.76 167.98 20.27 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.23 131.61 39.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.498 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 26.2 t -135.64 150.13 49.53 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.521 0.201 . . . . 0.0 111.247 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.2 m -84.77 102.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.16 161.63 34.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.742 0.817 . . . . 0.0 110.061 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -109.75 -11.9 14.68 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.422 0.289 . . . . 0.0 111.634 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -160.52 162.83 33.11 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.079 0.552 . . . . 0.0 109.995 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -95.83 76.5 3.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.268 0.627 . . . . 0.0 109.717 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.252 1.204 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.222 -179.677 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.724 0.297 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -142.32 14.46 2.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.044 0.538 . . . . 0.0 111.192 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.1 m -141.38 150.11 56.9 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 122.126 -0.359 . . . . 0.0 111.379 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.39 -5.6 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.137 3.225 . . . . 0.0 111.98 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.89 151.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 122.832 0.453 . . . . 0.0 111.276 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.42 167.88 21.88 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.71 0.804 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 74.6 mtp -133.61 150.41 51.61 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.359 0.264 . . . . 0.0 111.316 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.05 151.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.161 0.584 . . . . 0.0 110.603 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -140.05 164.95 28.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.472 0.709 . . . . 0.0 109.637 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 78.94 -2.69 67.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.384 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.457 ' CD2' ' H ' ' A' ' 386' ' ' LEU . 1.8 pt? -71.41 134.64 46.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.988 0.894 . . . . 0.0 109.794 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -83.48 122.65 28.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -75.03 6.79 3.79 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.9 p -116.0 -1.02 12.6 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.788 0.435 . . . . 0.0 111.658 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -130.3 -9.09 4.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.791 0.836 . . . . 0.0 110.472 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 11.0 tpt -139.86 128.08 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.24 1.016 . . . . 0.0 108.785 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -141.92 -172.92 3.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.132 0.573 . . . . 0.0 109.822 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.22 -22.65 64.97 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.19 -33.27 20.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.964 -0.46 . . . . 0.0 110.851 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 41.2 mmt-85 -81.66 -25.35 35.64 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.275 -0.266 . . . . 0.0 110.987 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.43 -30.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.018 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.22 -25.49 63.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -75.09 -39.81 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.14 -0.35 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.3 -20.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.994 -0.441 . . . . 0.0 111.979 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -109.81 -18.02 13.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.65 -21.6 57.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.16 0.891 . . . . 0.0 111.499 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.23 7.3 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.705 -0.622 . . . . 0.0 112.469 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -121.62 -1.85 9.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.538 0.735 . . . . 0.0 111.41 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.96 173.31 20.21 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -68.28 146.97 52.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.346 -0.502 . . . . 0.0 111.23 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.51 155.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.783 0.833 . . . . 0.0 108.813 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -101.02 -65.37 0.97 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -163.31 164.41 24.86 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.595 0.758 . . . . 0.0 110.232 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 11.2 p -144.2 151.27 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 C-N-CA 123.116 0.566 . . . . 0.0 110.437 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.07 139.77 19.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.924 0.14 . . . . 0.0 111.282 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.71 152.3 28.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -133.86 141.42 47.39 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 60.0 33.74 21.4 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 126.472 1.909 . . . . 0.0 114.231 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.1 m 52.84 16.0 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -72.0 158.38 87.77 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.613 0.642 . . . . 0.0 110.712 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.77 -22.4 44.67 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.223 2.615 . . . . 0.0 112.023 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -171.06 97.9 0.13 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -158.67 134.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -153.89 168.31 26.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.367 0.603 . . . . 0.0 112.462 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.9 ptp -139.63 145.34 38.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.147 0.979 . . . . 0.0 109.038 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.07 146.6 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.949 0.404 . . . . 0.0 110.617 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -124.94 146.41 49.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 109.866 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 75.3 mtp -122.35 164.12 18.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.793 0.437 . . . . 0.0 110.431 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.93 61.87 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -156.93 158.04 35.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.051 0.387 . . . . 0.0 110.181 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.13 80.67 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.116 -0.824 . . . . 0.0 113.578 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -69.17 -25.77 64.52 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.198 1.499 . . . . 0.0 110.839 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.29 -25.24 27.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.14 -27.51 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.25 -37.33 77.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.324 -0.235 . . . . 0.0 110.449 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -71.96 -30.79 65.65 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.84 57.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.314 -0.241 . . . . 0.0 111.078 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.2 tp -83.65 -30.9 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.6 m -99.02 -16.27 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.93 -6.68 2.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.62 -20.57 10.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.251 0.932 . . . . 0.0 109.56 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -52.77 142.32 19.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.044 0.938 . . . . 0.0 110.872 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.09 1.28 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.101 2.16 . . . . 0.0 115.659 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -87.84 142.52 27.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 120.242 1.383 . . . . 0.0 108.507 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -130.84 164.06 26.03 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.2 ptm -125.43 143.47 50.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.991 1.316 . . . . 0.0 108.985 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 67.01 25.7 9.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.05 80.54 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 168.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -83.06 159.77 22.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.014 1.407 . . . . 0.0 110.65 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 141.93 32.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.19 0.596 . . . . 0.0 111.025 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -98.22 124.15 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -140.68 111.3 6.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 169.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.09 140.2 17.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 CA-C-N 118.118 0.417 . . . . 0.0 109.957 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 96.8 m -149.47 159.94 43.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.775 0.83 . . . . 0.0 110.352 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.0 p -80.12 160.4 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 46.2 t -134.29 168.47 18.84 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 122.811 0.444 . . . . 0.0 110.515 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.08 12.71 11.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.566 0.746 . . . . 0.0 112.337 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.05 147.06 99.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.39 -36.5 77.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.81 2.34 . . . . 0.0 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.01 173.69 6.77 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.622 0.769 . . . . 0.0 110.047 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.4 mm -68.77 144.69 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.6 mtt -105.55 146.66 33.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 117.646 0.203 . . . . 0.0 110.994 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.2 172.85 15.55 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.253 3.302 . . . . 0.0 111.457 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.06 46.82 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.377 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 55.15 21.78 4.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.04 0.936 . . . . 0.0 112.857 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.5 p -79.42 153.93 29.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.716 0.293 . . . . 0.0 110.928 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -154.09 163.45 40.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.146 0.579 . . . . 0.0 110.343 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.2 136.0 16.56 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.92 169.32 12.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.277 0.631 . . . . 0.0 110.12 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.67 -21.13 66.66 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 110.316 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -77.94 -1.38 31.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.666 0.787 . . . . 0.0 111.452 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.76 70.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.398 0.523 . . . . 0.0 113.16 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.1 m -93.77 163.79 13.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.642 0.721 . . . . 0.0 110.798 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.51 153.33 37.55 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.7 p -70.23 -10.57 59.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -119.68 146.57 45.47 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.593 0.633 . . . . 0.0 112.156 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -157.0 156.12 32.4 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 110.142 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -124.49 152.31 43.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.798 0.839 . . . . 0.0 109.713 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.93 10.04 2.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.013 0.525 . . . . 0.0 111.282 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 94.3 p . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.286 8.5 pt20 . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -141.19 95.84 7.33 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.78 138.49 16.91 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.487 2.792 . . . . 0.0 110.255 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 56.4 m -124.04 23.93 8.37 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.362 0.665 . . . . 0.0 111.4 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.45 18.91 9.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.811 0.844 . . . . 0.0 112.717 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.9 t -134.42 146.82 30.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . 0.41 HD13 ' CH2' ' A' ' 546' ' ' TRP . 28.8 mt -118.22 160.61 21.3 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.8 0.44 . . . . 0.0 110.196 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -121.64 157.41 30.88 Favored 'General case' 0 N--CA 1.46 0.059 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -142.73 152.85 42.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.852 0.461 . . . . 0.0 110.409 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.85 173.07 12.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.126 0.57 . . . . 0.0 110.549 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 64.8 t30 66.5 28.41 9.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.451 1.1 . . . . 0.0 113.329 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.14 160.42 46.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 122.12 -0.363 . . . . 0.0 110.723 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 156.0 39.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.08 2.52 . . . . 0.0 111.644 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . 0.443 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -77.97 -0.76 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -122.52 13.1 10.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.174 0.589 . . . . 0.0 111.548 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.57 152.68 7.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 O-C-N 122.081 -0.387 . . . . 0.0 110.926 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.6 p -142.39 170.99 14.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.489 0.715 . . . . 0.0 110.437 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.74 -20.65 65.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.819 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -72.89 -23.65 60.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.6 -33.37 28.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -69.46 -28.66 66.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.514 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -82.26 -35.64 27.91 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.965 -0.46 . . . . 0.0 111.788 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -78.27 -17.3 56.83 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.329 0.513 . . . . 0.0 112.006 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.01 -25.36 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.122 0.419 . . . . 0.0 110.663 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.18 -24.24 63.1 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.404 -0.81 . . . . 0.0 109.753 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.94 -10.78 54.62 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.04 -18.82 23.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 110.332 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.7 mt -112.92 -0.44 14.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.75 5.77 70.15 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.678 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.86 169.75 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.852 0.826 . . . . 0.0 111.044 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.49 145.37 34.99 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.882 0.473 . . . . 0.0 110.275 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.67 146.67 47.19 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.944 0.498 . . . . 0.0 110.218 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 158.22 58.12 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.251 2.634 . . . . 0.0 110.685 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 61.8 m -90.4 -28.34 18.72 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.015 0.526 . . . . 0.0 110.698 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.2 m -142.35 153.67 44.02 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.142 0.577 . . . . 0.0 109.505 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 94.8 t -139.13 146.62 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 122.976 0.51 . . . . 0.0 110.284 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 586' ' ' SER . 30.0 ttmt -138.24 140.01 39.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.71 145.16 31.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -136.04 157.99 45.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -172.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 123.906 0.882 . . . . 0.0 110.198 177.164 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 65.2 m -141.15 167.0 23.23 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.661 1.184 . . . . 0.0 109.575 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.1 t -132.0 166.01 22.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.016 0.526 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 77.6 p -153.47 172.35 17.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.495 1.118 . . . . 0.0 110.111 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.35 -161.05 33.43 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.63 -0.795 . . . . 0.0 114.028 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.09 157.18 32.02 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.57 1.148 . . . . 0.0 110.523 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.46 133.31 30.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 124.232 1.013 . . . . 0.0 108.345 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -127.8 119.37 25.55 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.454 ' HB3' ' H ' ' A' ' 527' ' ' THR . 3.0 p90 -166.09 153.21 9.82 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.418 1.487 . . . . 0.0 107.498 168.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -148.98 118.62 6.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.671 -0.811 . . . . 0.0 112.974 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.0 t -159.6 152.97 22.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 169.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -65.01 -53.0 53.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.716 0.689 . . . . 0.0 111.03 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 53.0 m -81.49 -23.85 37.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -91.48 -28.75 17.41 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.518 0.599 . . . . 0.0 111.966 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.58 38.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.335 0.516 . . . . 0.0 110.529 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 50.6 tp -82.25 -31.93 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.17 -36.72 47.16 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.825 -0.547 . . . . 0.0 110.273 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.5 m -72.52 -42.54 64.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.44 -47.83 84.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.34 -15.07 67.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.097 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.9 2.19 2.84 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.688 1.744 . . . . 0.0 114.377 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -104.05 -26.5 12.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.531 0.605 . . . . 0.0 109.727 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -65.16 155.17 35.79 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.686 -0.634 . . . . 0.0 110.369 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 55.4 20.84 3.85 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.33 151.26 35.03 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -110.93 136.51 49.84 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.902 1.681 . . . . 0.0 110.184 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.475 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.6 ttt -64.16 171.92 2.72 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.245 0.618 . . . . 0.0 111.006 -175.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -75.73 15.5 0.5 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -65.94 149.94 97.06 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.325 0.512 . . . . 0.0 110.132 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.53 -45.8 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.956 2.437 . . . . 0.0 113.347 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -121.04 13.69 11.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.63 52.23 50.22 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.237 -0.757 . . . . 0.0 112.263 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.82 -8.81 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.196 2.597 . . . . 0.0 111.315 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -146.31 149.43 37.89 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 123.698 0.799 . . . . 0.0 109.315 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.73 147.03 39.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.425 2.75 . . . . 0.0 110.881 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . 0.475 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.0 t80 -144.88 -2.6 0.81 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.27 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 62.3 m -66.37 110.63 3.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.41 144.55 25.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.901 0.48 . . . . 0.0 111.208 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -103.33 122.48 44.91 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.03 146.87 37.78 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 58.8 m -153.98 -178.14 6.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.67 1.188 . . . . 0.0 109.019 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.9 149.75 49.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.5 t -135.49 160.08 39.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.732 0.813 . . . . 0.0 110.328 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 87.8 m -105.82 102.13 11.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.38 161.56 34.67 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.213 1.005 . . . . 0.0 110.186 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -87.09 -38.25 16.67 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -158.06 153.02 25.28 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.985 1.314 . . . . 0.0 109.377 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -99.66 76.5 2.0 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.421 ' N ' ' HE2' ' A' ' 530' ' ' LYS . 78.3 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.122 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.935 0.397 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -123.94 -0.51 8.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.249 0.62 . . . . 0.0 111.809 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 31.2 t -164.06 150.93 10.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.253 0.621 . . . . 0.0 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.42 2.78 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.579 2.853 . . . . 0.0 111.617 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.02 151.15 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.837 0.855 . . . . 0.0 109.904 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -139.51 165.08 28.17 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.633 0.773 . . . . 0.0 109.706 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' MET . . . . . 0.417 ' HE3' ' HE2' ' A' ' 412' ' ' MET . 64.8 mtp -136.43 149.91 48.49 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.617 0.246 . . . . 0.0 111.223 -176.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.9 148.53 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.729 0.812 . . . . 0.0 109.591 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -140.03 162.99 33.88 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.972 0.509 . . . . 0.0 109.86 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.49 -0.34 86.87 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.713 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.68 176.82 5.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.063 0.932 . . . . 0.0 110.264 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -139.77 141.59 36.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.265 -0.272 . . . . 0.0 110.562 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -71.7 -1.73 14.87 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 46.7 m -104.99 -9.12 18.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.049 0.386 . . . . 0.0 111.92 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -136.22 -2.86 2.24 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.059 0.544 . . . . 0.0 111.222 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -145.2 122.72 11.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.566 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 20.2 m120 -141.83 177.01 8.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.631 0.773 . . . . 0.0 109.204 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -58.16 -28.13 64.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -91.73 -25.91 18.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.81 -0.556 . . . . 0.0 111.751 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . 0.566 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.8 mpt_? -73.59 -31.54 63.64 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.06 -32.33 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -68.1 -30.98 70.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.68 -27.53 62.15 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.13 -35.03 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.387 0.54 . . . . 0.0 111.829 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -89.93 -8.97 50.53 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.0 t -70.2 -26.94 64.12 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.525 0.602 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 26.8 mt -67.11 -4.46 10.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.749 -0.594 . . . . 0.0 111.822 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -121.45 4.05 10.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.84 -132.39 3.56 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -141.33 157.02 45.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 6.2 m -115.87 156.46 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.477 0.711 . . . . 0.0 111.003 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -110.04 -51.15 2.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.082 0.553 . . . . 0.0 110.908 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -167.6 167.6 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.476 0.711 . . . . 0.0 111.0 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.85 151.61 16.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.969 0.908 . . . . 0.0 110.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -149.94 143.82 25.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.151 0.58 . . . . 0.0 110.144 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -87.2 102.99 15.0 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.417 ' HE2' ' HE3' ' A' ' 382' ' ' MET . 0.0 OUTLIER -81.46 141.48 33.84 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.152 1.381 . . . . 0.0 112.966 -171.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 60.09 33.93 21.25 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.93 1.292 . . . . 0.0 112.47 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 92.0 p 52.88 12.37 0.27 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.839 1.656 . . . . 0.0 115.317 172.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -84.85 126.5 68.06 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-N 118.753 0.706 . . . . 0.0 110.308 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.96 -9.95 18.63 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.26 2.64 . . . . 0.0 111.853 171.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -106.9 17.23 38.75 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.359 0.98 . . . . 0.0 112.726 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -146.25 140.38 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.412 1.106 . . . . 0.0 110.934 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.29 158.23 39.88 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.946 0.498 . . . . 0.0 111.316 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.1 ptm -140.7 147.59 39.46 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.599 0.36 . . . . 0.0 110.251 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.82 148.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.78 0.432 . . . . 0.0 110.775 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -114.72 139.02 50.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.479 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 86.6 mmm -104.49 161.29 14.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.519 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.49 -18.97 61.62 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.45 -0.157 . . . . 0.0 111.395 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -156.57 158.92 37.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.159 0.584 . . . . 0.0 109.893 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.57 -17.54 74.82 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.166 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -24.02 62.83 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 119.002 1.401 . . . . 0.0 110.767 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.72 -22.5 37.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.292 0.237 . . . . 0.0 111.03 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.79 -36.65 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -68.6 -26.76 65.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.91 -26.0 29.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 121.933 0.093 . . . . 0.0 110.945 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.52 50.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.65 -31.07 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.83 0.852 . . . . 0.0 110.783 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 22.5 m -98.84 -20.4 16.87 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -134.34 -7.32 2.59 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.67 -19.85 10.37 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.196 0.907 . . . . 0.0 109.441 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -52.47 145.79 10.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.835 0.854 . . . . 0.0 111.567 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 56.87 1.54 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.13 2.172 . . . . 0.0 115.408 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -88.08 142.51 27.72 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.578 1.535 . . . . 0.0 108.772 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.309 0.0 OUTLIER -130.97 163.9 26.52 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.0 ptm -125.21 143.35 50.99 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.038 1.335 . . . . 0.0 109.385 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . 0.404 ' H ' ' CG ' ' A' ' 554' ' ' GLU . 97.0 m-85 67.52 28.54 7.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.33 1.452 . . . . 0.0 114.192 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 68.39 16.01 68.79 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -83.3 162.07 21.24 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.422 1.111 . . . . 0.0 110.318 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.2 133.52 34.59 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.47 134.14 41.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -140.69 123.58 16.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.58 144.34 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.028 0 CA-C-N 118.116 0.416 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 t -158.5 165.56 34.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.2 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.9 152.97 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.262 0.625 . . . . 0.0 109.615 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 13.1 t -100.51 -167.0 1.38 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 110.475 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -138.41 6.18 2.52 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.938 0.895 . . . . 0.0 110.857 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -80.04 144.63 59.41 Favored Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.22 -24.86 12.08 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.873 2.382 . . . . 0.0 111.101 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.49 169.01 17.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.699 0.799 . . . . 0.0 109.489 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.09 142.55 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.2 mtt -111.34 159.56 32.5 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 122.417 0.287 . . . . 0.0 110.735 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -55.61 160.08 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.926 3.084 . . . . 0.0 112.646 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 172.29 179.57 43.23 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -74.96 153.54 38.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 48.2 t -138.23 157.14 46.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.051 0.54 . . . . 0.0 109.841 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -146.13 161.79 39.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.309 0.644 . . . . 0.0 110.17 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 135.06 14.83 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 70.7 mt -86.86 173.81 9.15 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.454 0.702 . . . . 0.0 109.513 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.222 -0.299 . . . . 0.0 111.414 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.4 -1.34 49.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.042 0.537 . . . . 0.0 111.178 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.66 -1.05 88.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.402 0.525 . . . . 0.0 112.578 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.8 t -93.63 160.15 14.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.775 0.787 . . . . 0.0 110.226 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.7 m -78.35 153.3 31.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.953 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 84.8 p -73.26 -10.6 59.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.858 0.463 . . . . 0.0 111.913 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -120.63 138.55 53.86 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -155.86 157.29 36.13 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.495 0.318 . . . . 0.0 110.776 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.15 156.96 32.56 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.467 0.707 . . . . 0.0 110.404 176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -140.07 11.14 2.39 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 122.903 0.481 . . . . 0.0 111.886 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -173.686 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 120.706 0.289 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -64.64 167.57 8.68 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.696 1.198 . . . . 0.0 109.56 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.55 137.91 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.39 2.726 . . . . 0.0 112.554 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 499' ' ' VAL . 49.6 m -123.97 24.01 8.4 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.585 0.754 . . . . 0.0 112.848 -168.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.4 -14.74 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 113.779 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 497' ' ' SER . 29.9 t -134.09 151.66 32.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 118.648 0.658 . . . . 0.0 109.994 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.4 mt -126.18 138.63 53.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.771 0.829 . . . . 0.0 109.718 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 16.0 m170 -105.65 154.82 19.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -137.34 147.41 45.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.465 0.174 . . . . 0.0 110.789 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -148.77 168.02 24.05 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.448 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.4 t30 58.18 30.52 19.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.327 1.051 . . . . 0.0 113.191 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.35 156.64 51.03 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.27 155.63 34.18 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.131 2.554 . . . . 0.0 111.805 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . 0.425 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -77.11 -1.24 28.17 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.88 9.1 24.6 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.08 151.43 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 118.011 0.369 . . . . 0.0 111.11 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.2 p -142.88 172.03 13.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.557 0.743 . . . . 0.0 110.241 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.25 -20.55 64.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.55 -24.92 59.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -81.62 -29.78 33.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -70.52 -30.81 67.67 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.824 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.48 -36.59 26.34 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.334 0.515 . . . . 0.0 111.772 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -76.54 -23.87 53.61 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.06 0.391 . . . . 0.0 111.783 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.4 mt -88.85 -33.49 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 117.932 0.333 . . . . 0.0 110.16 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 75.6 m -65.47 -22.99 66.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.868 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.13 -34.7 75.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.09 -12.75 34.69 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.07 -7.53 59.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.878 0.308 . . . . 0.0 111.36 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.37 11.15 75.88 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.761 -0.466 . . . . 0.0 112.907 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.4 m -111.16 171.18 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 117.852 0.826 . . . . 0.0 111.177 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -68.5 154.55 41.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.415 0.686 . . . . 0.0 110.51 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -108.25 151.07 41.27 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.14 153.5 75.92 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.217 2.612 . . . . 0.0 111.339 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 83.9 m -94.59 -21.58 18.74 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.209 0.604 . . . . 0.0 111.244 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 50.8 m -142.31 153.87 44.24 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.15 150.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.166 0.508 . . . . 0.0 111.878 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -145.4 140.65 27.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.19 140.99 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -153.66 156.5 38.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.251 0.62 . . . . 0.0 110.089 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.456 -0.137 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.748 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.1 m -138.13 160.29 39.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.13 0.572 . . . . 0.0 110.371 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.8 t -120.4 150.42 40.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.694 0.798 . . . . 0.0 111.236 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 57.0 m -147.21 164.32 33.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.231 1.412 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.84 -162.41 33.15 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.658 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 87.6 mt -128.57 151.31 49.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.095 0.958 . . . . 0.0 110.767 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.7 mt -142.28 133.39 26.03 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -127.81 124.7 38.26 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -166.02 149.06 7.41 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -146.77 114.1 6.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 34.7 t -159.56 152.91 22.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 168.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -66.99 -36.82 83.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.469 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 45.9 m -83.92 -36.18 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.184 0.194 . . . . 0.0 111.354 -176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.4 -24.57 31.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.568 0.622 . . . . 0.0 111.612 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.63 21.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.491 0.587 . . . . 0.0 111.557 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.48 -23.79 24.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.053 0.842 . . . . 0.0 111.61 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 442' ' ' PHE . 65.4 mt-10 -77.93 -44.71 26.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.985 -0.447 . . . . 0.0 109.891 175.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 60.9 m -69.15 -31.87 70.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.9 -43.41 75.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.63 -19.32 72.91 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.28 -0.733 . . . . 0.0 112.757 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -114.39 -9.78 12.72 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.172 0.986 . . . . 0.0 113.046 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 13.7 tp -112.69 4.84 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.848 0.749 . . . . 0.0 112.18 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -92.9 143.01 26.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.333 -0.855 . . . . 0.0 109.675 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 49.13 35.94 8.07 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.644 0.777 . . . . 0.0 112.684 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -92.18 151.35 20.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -97.98 136.44 38.26 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.76 1.624 . . . . 0.0 111.389 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.478 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.06 173.93 1.73 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.72 0.808 . . . . 0.0 111.354 -177.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -70.05 14.34 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.859 0.864 . . . . 0.0 113.106 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.46 140.62 92.02 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.939 0.495 . . . . 0.0 111.065 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -81.0 -29.53 2.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.299 2.666 . . . . 0.0 112.766 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -121.01 -11.37 8.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.409 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.12 43.83 95.02 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 82.9 Cg_endo -72.41 -6.6 19.38 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.32 2.68 . . . . 0.0 112.047 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -142.61 150.82 55.5 Favored Pre-proline 0 N--CA 1.455 -0.189 0 C-N-CA 123.559 0.744 . . . . 0.0 109.689 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 152.27 34.24 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.505 2.804 . . . . 0.0 110.738 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . 0.478 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 80.0 t80 -146.38 -2.66 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.518 0.327 . . . . 0.0 111.619 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.37 122.35 17.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.72 -0.613 . . . . 0.0 109.825 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.0 144.61 50.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.228 1.011 . . . . 0.0 109.324 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.89 158.11 17.58 Favored 'General case' 0 CA--C 1.523 -0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 111.247 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.62 155.74 47.03 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.169 0.988 . . . . 0.0 108.789 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 42.6 t -163.55 146.32 9.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -76.69 127.55 32.99 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 23.1 t -135.68 154.7 51.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.73 0.3 . . . . 0.0 111.091 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 37.0 m -83.59 103.4 12.89 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -133.98 161.16 35.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.498 0.719 . . . . 0.0 109.662 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -93.87 -26.1 17.05 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.406 -0.184 . . . . 0.0 111.172 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -160.66 157.83 27.81 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.966 0.506 . . . . 0.0 109.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -89.73 76.4 7.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.36 -1.305 . . . . 0.0 110.154 178.846 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -141.36 7.19 1.95 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 30.7 m -146.94 154.19 46.7 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 122.509 0.324 . . . . 0.0 110.551 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.45 -0.55 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.61 3.54 . . . . 0.0 113.399 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.78 162.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 118.686 0.676 . . . . 0.0 112.203 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -147.18 167.22 24.72 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.935 0.894 . . . . 0.0 109.122 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 73.8 mtp -133.57 151.24 51.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.404 0.282 . . . . 0.0 110.576 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.1 148.93 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.978 0.511 . . . . 0.0 110.827 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.95 167.55 21.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.474 0.71 . . . . 0.0 109.55 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.66 88.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.586 -0.563 . . . . 0.0 112.897 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.602 HD21 ' H ' ' A' ' 386' ' ' LEU . 1.9 pt? -70.2 173.56 6.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.828 0.814 . . . . 0.0 110.326 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -136.66 139.78 42.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -71.96 -3.98 25.79 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.1 p -109.83 -1.19 18.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.378 0.535 . . . . 0.0 112.407 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -133.5 -6.44 2.91 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.288 0.635 . . . . 0.0 110.969 175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.5 tpt -148.5 122.25 9.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.225 0.61 . . . . 0.0 109.47 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -141.88 -173.37 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.106 0.562 . . . . 0.0 109.768 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 72.3 m -59.54 -23.61 63.0 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -92.03 -23.8 19.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.231 0.468 . . . . 0.0 111.5 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -83.93 -29.71 26.89 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.1 p -77.52 -32.58 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -68.85 -31.17 69.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.38 -46.43 55.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.172 -0.33 . . . . 0.0 111.329 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.18 -20.32 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 122.233 -0.292 . . . . 0.0 111.48 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -110.47 -7.33 14.77 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.24 -31.7 55.22 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.843 0.747 . . . . 0.0 110.958 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 11.38 1.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.805 -0.56 . . . . 0.0 112.18 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -121.51 -5.34 9.28 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.743 0.817 . . . . 0.0 110.931 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.68 177.94 24.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -75.49 148.67 38.83 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.376 -0.485 . . . . 0.0 110.834 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.05 154.26 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.597 0.759 . . . . 0.0 109.413 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -104.02 -58.79 1.82 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.212 -0.305 . . . . 0.0 110.552 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -165.78 166.65 17.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.973 0.509 . . . . 0.0 110.736 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.92 150.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 122.985 0.514 . . . . 0.0 110.345 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -151.88 144.34 24.13 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.343 0.257 . . . . 0.0 110.599 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -79.06 152.0 31.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -129.97 141.49 50.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -168.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 60.01 34.0 21.4 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.923 1.289 . . . . 0.0 111.802 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m 52.77 16.67 0.71 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.883 1.273 . . . . 0.0 114.035 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.76 143.21 46.37 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 118.357 0.526 . . . . 0.0 109.903 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.34 -1.14 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.651 2.901 . . . . 0.0 110.262 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -132.54 27.68 3.52 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.739 0.685 . . . . 0.0 113.071 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.69 133.92 19.46 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.08 0.94 . . . . 0.0 110.333 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.12 168.67 26.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.5 ptm -144.32 146.99 32.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.19 151.62 27.65 Favored 'Isoleucine or valine' 0 C--N 1.337 0.028 0 C-N-CA 123.161 0.585 . . . . 0.0 110.736 -170.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -128.38 136.77 51.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.5 mmm -107.72 162.64 13.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.644 0.378 . . . . 0.0 110.565 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.95 61.14 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.158 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -157.73 161.76 38.51 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.429 0.691 . . . . 0.0 109.578 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.97 -14.54 70.83 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.391 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -67.96 -30.57 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.134 1.467 . . . . 0.0 110.46 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.33 -20.56 51.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.51 -31.78 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.32 -36.05 66.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -32.2 67.02 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.011 -0.43 . . . . 0.0 110.508 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.22 -38.05 25.09 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.12 -0.363 . . . . 0.0 111.862 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 7.5 tp -72.87 -32.02 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.529 -0.732 . . . . 0.0 111.803 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.1 m -93.66 -21.14 19.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -117.97 -14.09 10.02 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.75 -17.4 11.07 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.941 0.791 . . . . 0.0 110.507 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -51.73 142.01 15.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.46 0.648 . . . . 0.0 111.702 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 57.08 1.54 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.787 2.035 . . . . 0.0 115.742 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -87.91 142.49 27.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.719 1.6 . . . . 0.0 108.667 169.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -130.85 163.84 26.53 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.34 143.43 50.97 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.397 1.479 . . . . 0.0 109.576 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 67.77 27.12 7.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.989 1.316 . . . . 0.0 114.486 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.48 15.86 75.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 168.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -83.25 160.76 21.68 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.683 1.242 . . . . 0.0 110.074 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.62 132.46 34.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.54 133.26 43.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -140.69 120.43 13.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.06 141.92 15.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-N 118.263 0.483 . . . . 0.0 110.346 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 25.6 t -160.13 162.37 33.95 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.791 0.436 . . . . 0.0 110.166 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.07 158.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 109.949 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.1 t -137.67 151.28 48.1 Favored 'General case' 0 C--N 1.337 0.032 0 O-C-N 121.991 -0.443 . . . . 0.0 110.451 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -89.37 -0.58 57.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.683 0.793 . . . . 0.0 112.654 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -62.14 144.39 94.45 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 121.478 -0.764 . . . . 0.0 109.654 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.1 -25.04 12.09 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.832 2.355 . . . . 0.0 112.013 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.86 173.78 12.31 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.013 0.525 . . . . 0.0 110.214 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -66.68 138.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -90.07 163.03 33.45 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.813 0.445 . . . . 0.0 110.699 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.21 -42.5 64.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.14 2.56 . . . . 0.0 112.009 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 50.23 -142.75 13.46 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.252 0.453 . . . . 0.0 112.442 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -133.65 160.5 37.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.214 1.006 . . . . 0.0 108.536 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.0 p -143.3 156.04 44.62 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.693 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -155.19 163.34 40.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.36 136.68 17.79 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.96 165.86 15.54 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.174 0.59 . . . . 0.0 110.232 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.92 -20.13 65.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.243 0.217 . . . . 0.0 111.463 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -80.35 1.25 29.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 111.476 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.91 0.63 85.76 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 39.6 m -91.37 165.05 13.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.419 0.688 . . . . 0.0 110.528 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.36 153.34 22.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.74 0.305 . . . . 0.0 110.5 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.3 p -69.89 -10.25 57.84 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.027 0.531 . . . . 0.0 111.697 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -118.47 138.06 52.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.99 0.916 . . . . 0.0 109.87 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -154.42 155.2 34.54 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.423 0.289 . . . . 0.0 110.661 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -124.61 156.6 37.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 110.415 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.81 15.92 2.31 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.041 0.536 . . . . 0.0 111.334 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 91.2 p . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.617 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . 0.409 ' CG ' ' HD2' ' A' ' 496' ' ' PRO . 67.8 t60 -59.87 148.56 76.11 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 495' ' ' HIS . 87.1 Cg_exo -46.3 140.73 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.45 2.767 . . . . 0.0 112.817 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.1 m -123.99 24.05 8.37 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.606 0.762 . . . . 0.0 111.34 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.52 7.86 2.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 113.987 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 32.3 t -141.54 147.02 22.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 123.41 0.684 . . . . 0.0 109.233 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . 0.475 HD12 ' CH2' ' A' ' 546' ' ' TRP . 91.5 mt -129.38 160.35 33.35 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.62 0.768 . . . . 0.0 110.086 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . 0.601 ' CE1' ' HG ' ' A' ' 578' ' ' CYS . 0.0 OUTLIER -143.65 163.16 34.03 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.285 175.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -135.94 156.94 48.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.407 0.683 . . . . 0.0 111.133 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -147.3 170.76 16.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.46 26.19 15.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 0.0 113.281 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.95 158.3 70.41 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -68.99 159.43 54.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.282 1.988 . . . . 0.0 110.602 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -71.58 -1.09 12.32 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -112.0 7.1 19.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -173.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.45 148.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 118.308 0.504 . . . . 0.0 111.209 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.5 p -142.98 173.3 11.68 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.925 0.89 . . . . 0.0 110.313 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.4 -22.79 65.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.752 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.68 -23.71 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -82.95 -31.78 27.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -68.82 -28.34 66.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.964 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.37 -35.07 18.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.192 0.451 . . . . 0.0 112.087 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -75.85 -18.87 59.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.458 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.79 -35.53 5.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 117.884 0.311 . . . . 0.0 110.868 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 17.3 p -70.1 -21.84 63.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.167 0.894 . . . . 0.0 110.643 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.38 -28.44 61.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 119.552 -0.261 . . . . 0.0 111.633 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.07 -12.6 35.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.278 0.49 . . . . 0.0 111.205 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.12 -9.9 51.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.523 0.329 . . . . 0.0 110.489 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.28 6.41 65.11 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.704 -0.498 . . . . 0.0 112.927 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.2 m -89.17 170.88 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.938 0.869 . . . . 0.0 111.161 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -71.11 146.77 49.01 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.356 0.663 . . . . 0.0 110.044 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -91.94 153.11 43.46 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.625 0.37 . . . . 0.0 110.256 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 155.55 69.34 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.555 2.17 . . . . 0.0 109.535 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 82.2 m -95.1 -19.12 20.38 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.955 0.502 . . . . 0.0 110.763 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.0 t -148.76 152.73 37.07 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.945 0.498 . . . . 0.0 109.762 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.9 t -140.62 140.9 33.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 123.097 0.559 . . . . 0.0 110.084 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.25 126.35 12.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.48 152.36 37.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.829 0.452 . . . . 0.0 110.971 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -144.23 160.82 40.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.984 0.914 . . . . 0.0 109.438 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.231 0.097 0 C-N-CA 122.827 0.451 . . . . 0.0 110.293 -178.286 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 71.1 m -138.22 157.96 45.25 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.987 0.515 . . . . 0.0 110.734 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 156.01 40.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.525 0.73 . . . . 0.0 111.192 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.5 m -147.72 166.53 27.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.887 1.275 . . . . 0.0 108.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.62 -176.75 47.48 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.2 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.2 mp -111.57 154.93 24.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.282 1.033 . . . . 0.0 110.132 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.3 mt -138.35 134.38 34.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.72 117.99 22.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.475 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.9 p90 -165.71 153.63 10.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 168.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -146.81 115.11 6.65 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.9 t -159.52 153.04 22.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 168.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -69.79 -48.38 59.4 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 118.637 0.653 . . . . 0.0 110.722 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 44.7 m -82.71 -22.96 34.29 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -89.28 -33.17 17.05 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.711 0.687 . . . . 0.0 111.481 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -72.13 -33.92 68.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.798 0.726 . . . . 0.0 110.477 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.52 -35.68 58.16 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.034 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.99 -40.37 53.87 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.102 -0.374 . . . . 0.0 110.604 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 98.6 m -65.95 -49.23 68.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.159 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.15 -22.4 62.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.109 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -64.72 -31.39 80.74 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.427 -0.652 . . . . 0.0 111.83 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -116.36 -6.86 11.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.912 0.856 . . . . 0.0 113.103 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.5 tp -95.93 -13.47 23.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.66 0.664 . . . . 0.0 111.664 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -81.16 151.44 28.23 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.695 -0.628 . . . . 0.0 110.199 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 31.4 m80 51.18 22.97 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 151.23 29.81 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -102.13 136.33 42.15 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.381 1.472 . . . . 0.0 110.683 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.484 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 6.2 ttt -64.17 173.24 2.03 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.15 0.58 . . . . 0.0 111.612 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 564' ' ' MET . 27.8 mtpp -75.4 14.78 0.54 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.932 . . . . 0.0 112.564 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -66.11 149.93 97.26 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 118.03 0.377 . . . . 0.0 110.137 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.87 -46.92 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.895 2.397 . . . . 0.0 113.898 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -121.08 13.3 11.26 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 63.34 52.8 44.05 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.312 -0.716 . . . . 0.0 112.594 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.62 -9.42 19.9 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.539 2.826 . . . . 0.0 111.44 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -148.42 151.41 36.5 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.671 0.788 . . . . 0.0 109.676 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.26 151.1 37.98 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.563 2.842 . . . . 0.0 110.821 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 91.0 t80 -143.03 -6.45 0.84 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.758 0.423 . . . . 0.0 111.902 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 75.2 p -66.48 132.02 47.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.891 -0.506 . . . . 0.0 110.233 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 1.6 pp -125.03 144.55 50.34 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.595 0.758 . . . . 0.0 110.791 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -77.28 144.38 38.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.76 144.97 50.4 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . 0.601 ' HG ' ' CE1' ' A' ' 501' ' ' HIS . 2.8 p -163.92 172.09 14.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.703 0.401 . . . . 0.0 110.331 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -82.82 148.91 27.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.734 0.414 . . . . 0.0 111.207 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.7 t -135.6 137.71 42.21 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 122.575 0.35 . . . . 0.0 110.971 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 16.5 p -82.45 102.13 11.12 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.18 161.57 34.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.353 0.661 . . . . 0.0 111.59 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.77 -3.31 7.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.402 0.681 . . . . 0.0 110.294 173.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -157.68 165.91 34.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.754 1.222 . . . . 0.0 109.777 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.12 76.68 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.247 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.888 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.878 0.37 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -140.36 6.1 2.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.199 0.6 . . . . 0.0 110.917 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.6 m -152.91 157.01 33.21 Favored Pre-proline 0 N--CA 1.456 -0.157 0 C-N-CA 123.711 0.805 . . . . 0.0 110.207 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.69 2.51 8.48 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.614 3.543 . . . . 0.0 112.938 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.0 p -126.17 148.33 30.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 118.736 0.698 . . . . 0.0 111.478 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.38 167.3 23.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.222 0.609 . . . . 0.0 110.094 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' MET . . . . . 0.405 ' CE ' ' SD ' ' A' ' 412' ' ' MET . 77.1 mtp -132.96 152.0 51.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.539 0.335 . . . . 0.0 110.571 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.6 149.45 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.761 0.425 . . . . 0.0 110.693 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -141.21 166.38 24.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.407 0.683 . . . . 0.0 110.1 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.13 -0.11 84.5 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.847 -0.418 . . . . 0.0 112.67 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.538 HD13 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.24 -179.65 4.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.503 0.651 . . . . 0.0 110.687 176.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -139.62 134.62 32.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -69.82 -11.73 61.08 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.5 p -93.44 -9.92 36.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -132.56 -8.87 3.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.268 0.486 . . . . 0.0 111.654 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.7 tpt -147.73 104.84 3.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.317 0.647 . . . . 0.0 109.497 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.458 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 23.4 p30 -141.97 -173.59 3.85 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.878 0.871 . . . . 0.0 109.669 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 0.477 ' HG ' HG13 ' A' ' 409' ' ' VAL . 64.4 m -55.33 -28.83 56.33 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.96 -27.69 21.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.215 0.461 . . . . 0.0 110.994 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . 0.458 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 2.2 mmp_? -78.11 -33.44 50.58 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 122.123 -0.361 . . . . 0.0 110.038 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.89 -31.31 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -64.82 -35.24 80.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -72.1 -31.04 65.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.43 -0.319 . . . . 0.0 111.398 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.77 -26.61 5.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.151 0.432 . . . . 0.0 111.875 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.52 -10.07 20.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 p -65.68 -37.8 87.51 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.041 0.837 . . . . 0.0 111.565 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.81 14.43 1.75 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.322 0.51 . . . . 0.0 112.156 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -121.46 -1.91 9.55 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.604 0.762 . . . . 0.0 109.93 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 140.45 167.08 10.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -74.83 146.54 41.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.156 -0.614 . . . . 0.0 111.167 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.29 154.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.498 0.719 . . . . 0.0 109.095 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -104.2 -60.1 1.63 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.62 0.368 . . . . 0.0 110.013 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -165.42 163.66 19.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.434 0.694 . . . . 0.0 110.703 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.477 HG13 ' HG ' ' A' ' 393' ' ' CYS . 92.0 t -136.28 146.83 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.215 1.006 . . . . 0.0 109.344 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -148.45 144.18 27.24 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 172.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -86.53 155.67 20.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.405 ' SD ' ' CE ' ' A' ' 382' ' ' MET . 26.0 ptt? -136.02 141.43 44.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -167.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt 60.22 34.04 21.01 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.849 1.26 . . . . 0.0 112.339 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.8 m 52.97 16.29 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -94.21 142.53 25.03 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 118.405 0.548 . . . . 0.0 110.461 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.48 -3.81 13.65 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.555 2.837 . . . . 0.0 110.357 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -115.49 19.69 14.33 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.234 0.921 . . . . 0.0 112.795 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -145.68 131.85 19.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.204 1.002 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.86 168.3 27.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -145.54 150.19 35.98 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.35 0.66 . . . . 0.0 110.028 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 3.4 p -144.42 151.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.951 0.5 . . . . 0.0 111.076 -173.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -126.56 146.86 49.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.04 0.936 . . . . 0.0 109.615 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 91.1 mmm -112.28 163.28 14.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.601 0.76 . . . . 0.0 110.482 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.7 -15.36 61.69 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -155.1 156.96 36.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.86 0.464 . . . . 0.0 109.886 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.01 -17.59 75.7 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.166 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -29.81 66.54 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.882 1.341 . . . . 0.0 110.13 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.09 61.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.507 0.194 . . . . 0.0 110.536 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.2 t -78.99 -38.07 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.91 -25.88 68.35 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.771 0.26 . . . . 0.0 110.667 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -82.81 -35.04 26.77 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.156 0.582 . . . . 0.0 110.563 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -74.96 -29.63 60.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.873 -0.517 . . . . 0.0 110.009 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 14.7 mm -77.83 -30.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.854 1.262 . . . . 0.0 111.701 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.9 m -106.5 -14.75 14.98 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -134.17 -9.54 2.61 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.72 -16.52 11.24 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.763 0.711 . . . . 0.0 109.633 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -54.02 142.09 26.12 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.27 1.028 . . . . 0.0 111.832 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.81 1.51 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.564 1.946 . . . . 0.0 115.927 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -88.03 142.55 27.69 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.794 1.634 . . . . 0.0 108.532 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.1 OUTLIER -130.81 163.87 26.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.512 1.125 . . . . 0.0 109.384 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 63.64 22.95 13.35 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.154 1.382 . . . . 0.0 114.589 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.15 15.91 61.77 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 169.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -83.2 150.99 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.987 1.393 . . . . 0.0 110.961 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.08 138.7 38.07 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -98.07 122.01 40.68 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -140.72 116.92 10.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.37 140.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 118.774 0.715 . . . . 0.0 110.691 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.8 m -148.71 159.41 44.15 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.166 0.986 . . . . 0.0 109.841 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.23 156.13 3.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.3 t -130.22 161.36 31.34 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.862 0.465 . . . . 0.0 110.418 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.56 10.94 27.03 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.501 0.72 . . . . 0.0 112.519 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -67.66 147.51 98.65 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 118.105 0.411 . . . . 0.0 109.95 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.39 -36.0 80.51 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.802 2.335 . . . . 0.0 112.348 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.95 176.04 7.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.559 0.744 . . . . 0.0 109.92 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 136.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -84.85 149.8 54.43 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.337 0.255 . . . . 0.0 110.614 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.39 167.23 25.85 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.721 2.948 . . . . 0.0 111.223 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 167.59 179.35 40.3 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -77.12 154.53 33.16 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.701 0.4 . . . . 0.0 109.937 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 83.1 p -134.08 159.37 41.02 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.962 0.505 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -155.26 164.3 38.98 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 109.805 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.62 136.73 19.0 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 79.3 mt -86.25 169.61 12.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.974 0.91 . . . . 0.0 109.672 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.22 -20.16 65.65 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.85 4.07 42.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.665 0.386 . . . . 0.0 111.522 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.97 -6.38 79.22 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.376 0.512 . . . . 0.0 112.647 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 52.9 m -83.77 155.39 23.05 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 117.838 0.819 . . . . 0.0 109.942 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.3 153.29 24.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 99.4 p -72.6 -10.34 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 111.664 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -137.0 139.59 41.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.226 1.011 . . . . 0.0 109.477 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -155.16 157.32 37.23 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.18 0.192 . . . . 0.0 110.928 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.71 150.45 51.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.231 1.012 . . . . 0.0 109.937 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -142.45 14.33 1.99 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 CA--C 1.527 0.063 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.226 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 111.31 0.115 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -147.96 150.63 36.17 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.236 0.614 . . . . 0.0 109.391 -174.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.21 147.73 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 112.691 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 62.9 m -124.18 24.0 8.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.269 0.628 . . . . 0.0 112.092 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.6 3.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.377 1.071 . . . . 0.0 113.461 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.4 152.04 21.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . 0.421 HD21 ' CH2' ' A' ' 546' ' ' TRP . 4.7 mp -132.69 164.18 27.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.291 0.637 . . . . 0.0 109.669 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.92 149.33 36.68 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.001 0.429 . . . . 0.0 111.957 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -114.74 145.56 41.94 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.759 1.223 . . . . 0.0 109.599 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.77 165.41 30.62 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.374 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 58.02 23.78 10.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.403 1.081 . . . . 0.0 113.422 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -81.74 157.89 68.84 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.86 156.35 28.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . 0.439 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -80.38 -1.17 40.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -103.53 5.26 36.64 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.662 0.385 . . . . 0.0 111.983 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -89.79 152.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.061 0.391 . . . . 0.0 111.672 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 68.5 p -144.86 175.62 10.07 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.181 0.992 . . . . 0.0 109.654 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.78 -26.25 68.62 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.439 -0.163 . . . . 0.0 111.149 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.58 -26.22 60.72 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.439 -0.163 . . . . 0.0 110.574 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -79.64 -31.67 41.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.59 -26.52 62.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.22 -0.3 . . . . 0.0 110.486 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -80.03 -39.36 30.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.933 0.333 . . . . 0.0 111.558 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.11 -17.1 53.49 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.24 0.473 . . . . 0.0 112.275 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.21 -36.53 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 82.2 m -67.95 -22.15 65.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.676 -0.64 . . . . 0.0 110.573 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.44 -30.5 63.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 119.658 -0.21 . . . . 0.0 111.565 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.12 -11.73 37.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.108 0.413 . . . . 0.0 111.527 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.32 -7.15 48.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.657 0.383 . . . . 0.0 110.411 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.9 11.33 78.39 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.855 -0.414 . . . . 0.0 112.665 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.6 m -95.58 170.83 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 117.817 0.809 . . . . 0.0 111.61 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -74.14 147.91 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.477 0.711 . . . . 0.0 110.236 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -97.07 146.17 30.85 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.21 148.97 92.61 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.01 2.473 . . . . 0.0 110.375 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.442 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 84.7 m -82.11 -25.01 34.83 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.467 0.307 . . . . 0.0 110.841 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 51.1 m -143.4 151.63 40.61 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.936 0.494 . . . . 0.0 109.848 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.59 141.82 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 122.952 0.501 . . . . 0.0 110.328 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.7 120.18 7.42 Favored 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.09 147.53 30.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 C-N-CA 123.353 0.661 . . . . 0.0 109.557 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -148.65 130.05 14.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.513 0.196 . . . . 0.0 111.317 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 CA--C 1.533 0.324 0 C-N-CA 123.005 0.522 . . . . 0.0 110.983 176.501 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 85.4 p -145.4 173.22 12.18 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.386 1.475 . . . . 0.0 109.119 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -124.3 148.38 47.47 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 122.631 0.372 . . . . 0.0 111.65 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.4 m -145.16 158.53 43.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.268 1.027 . . . . 0.0 109.12 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 179.45 178.48 48.39 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.943 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.6 mp -116.9 144.64 44.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 109.82 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.93 142.04 51.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.87 113.2 15.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.442 ' HB3' ' H ' ' A' ' 527' ' ' THR . 4.2 p90 -165.93 149.13 7.57 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -155.35 126.34 7.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 43.6 t -159.53 161.32 35.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 169.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.56 -51.21 45.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.881 0.764 . . . . 0.0 110.448 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 72.5 p -89.28 -27.24 20.69 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 25.0 m-20 -82.42 -27.57 31.9 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.987 0.812 . . . . 0.0 110.802 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -85.58 -31.99 22.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.432 0.56 . . . . 0.0 110.576 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 41.6 tp -73.92 -30.09 62.38 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.228 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.52 -42.7 58.44 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.6 m -68.24 -39.16 82.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.71 -42.21 82.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.96 -19.49 77.09 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.145 -0.808 . . . . 0.0 113.582 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -113.86 -16.95 12.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.685 1.242 . . . . 0.0 112.903 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.67 -21.79 22.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.061 0.846 . . . . 0.0 111.801 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -74.21 147.83 42.15 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.573 0.624 . . . . 0.0 109.721 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.8 t60 53.81 29.01 9.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.92 0.888 . . . . 0.0 113.259 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.98 151.39 24.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -117.51 136.42 53.25 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.873 1.269 . . . . 0.0 110.427 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.432 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 4.8 ttt -64.18 169.47 4.48 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.767 0.827 . . . . 0.0 111.464 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -79.39 22.99 0.41 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 112.831 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 36.5 p30 -64.65 147.52 97.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 122.109 -0.369 . . . . 0.0 110.331 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.72 -32.31 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.419 2.746 . . . . 0.0 113.872 -169.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -121.04 2.02 10.41 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.46 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.53 37.92 95.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.072 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 92.6 Cg_endo -71.37 -9.05 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.97 2.446 . . . . 0.0 112.291 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -145.75 150.39 42.99 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.311 0.505 . . . . 0.0 110.765 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.77 156.21 39.57 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.059 3.173 . . . . 0.0 110.634 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . 0.432 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 70.4 t80 -140.86 -1.44 1.41 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 4.9 t -66.39 131.92 47.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.484 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.93 144.65 50.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.917 0.887 . . . . 0.0 109.086 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -89.7 134.75 34.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 153.19 39.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.944 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 32.1 p -163.36 176.76 9.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.861 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -72.19 143.19 48.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.8 t -135.64 146.27 47.68 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.363 0.665 . . . . 0.0 110.451 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 51.8 m -87.17 102.16 14.2 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.25 161.47 34.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.997 0.919 . . . . 0.0 110.053 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -93.92 -19.6 20.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -161.27 162.45 31.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.141 0.976 . . . . 0.0 109.441 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.17 76.48 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.637 -1.173 . . . . 0.0 110.253 -179.472 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 120.769 0.318 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.1 -2.95 53.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.7 m -152.06 153.86 31.81 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.158 0.583 . . . . 0.0 110.979 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.44 -5.03 10.16 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.507 3.471 . . . . 0.0 113.546 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.2 t -126.91 151.33 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 118.498 0.59 . . . . 0.0 111.176 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.12 164.46 29.08 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.71 0.804 . . . . 0.0 109.531 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.3 mtp -136.45 148.29 47.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.736 0.414 . . . . 0.0 110.11 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.56 149.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 122.85 0.46 . . . . 0.0 110.424 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -140.44 165.85 26.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.666 0.786 . . . . 0.0 109.286 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 81.9 -1.21 87.15 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.703 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.597 HD21 ' H ' ' A' ' 386' ' ' LEU . 2.0 pt? -71.64 172.39 9.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.194 0.997 . . . . 0.0 110.048 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -130.42 127.25 38.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -68.11 -2.91 8.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 87.8 p -108.29 -2.84 18.9 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -130.13 -12.23 4.12 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.376 0.67 . . . . 0.0 111.055 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.07 125.95 10.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.372 0.669 . . . . 0.0 109.328 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -141.87 -172.16 3.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.0 -25.65 61.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.83 -25.78 24.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.879 -0.513 . . . . 0.0 111.799 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -91.97 -25.2 18.98 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 122.265 -0.272 . . . . 0.0 111.178 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.8 -27.26 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.55 -42.89 67.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.695 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -80.63 -8.64 59.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.564 0.62 . . . . 0.0 112.653 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.78 -24.35 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 118.214 0.461 . . . . 0.0 110.932 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -107.33 -13.72 15.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.4 t -69.56 -28.71 66.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.27 0.941 . . . . 0.0 111.562 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.76 14.2 1.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.734 -0.604 . . . . 0.0 112.209 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -119.59 -2.75 10.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.419 0.688 . . . . 0.0 110.22 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 143.07 165.84 10.85 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.17 152.67 44.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.212 -0.581 . . . . 0.0 110.957 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.07 146.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.82 -57.75 2.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.997 -0.439 . . . . 0.0 109.905 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -166.38 164.83 17.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.971 0.509 . . . . 0.0 110.687 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.89 149.73 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.483 0.713 . . . . 0.0 110.105 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -152.22 144.18 23.75 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -75.52 154.52 36.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -129.33 141.16 51.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.285 0.564 . . . . 0.0 112.51 -168.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.51 33.75 19.6 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.69 1.596 . . . . 0.0 111.885 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.2 m 52.91 15.84 0.62 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.354 1.062 . . . . 0.0 113.59 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.74 145.63 75.04 Favored Pre-proline 0 C--N 1.339 0.122 0 CA-C-N 118.156 0.435 . . . . 0.0 110.086 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 4.03 6.97 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.83 3.02 . . . . 0.0 110.604 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -146.84 30.73 1.51 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.278 -0.735 . . . . 0.0 113.209 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.78 138.31 20.75 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.355 1.078 . . . . 0.0 110.537 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.89 19.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.034 0.445 . . . . 0.0 111.808 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 7.6 ptp -135.76 150.6 49.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.806 0.843 . . . . 0.0 110.394 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.47 149.47 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.286 0.634 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -130.71 133.44 46.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.531 0.732 . . . . 0.0 109.913 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.1 mmm -106.1 161.29 14.63 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.943 0.497 . . . . 0.0 110.981 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.79 -18.79 60.41 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.448 0.299 . . . . 0.0 111.762 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -154.28 155.86 35.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.679 0.392 . . . . 0.0 110.222 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.44 -15.95 75.39 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.429 -0.65 . . . . 0.0 113.078 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -26.45 59.62 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.057 1.428 . . . . 0.0 110.701 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.78 -27.23 60.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.72 -29.79 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.39 -40.54 73.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.187 -0.321 . . . . 0.0 110.626 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.45 -34.92 35.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.52 -29.96 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 121.964 -0.46 . . . . 0.0 111.404 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 17.7 m -95.26 -18.9 20.45 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -136.46 -10.78 1.89 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -108.03 -21.76 12.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.376 0.989 . . . . 0.0 108.802 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -51.87 143.46 13.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.218 1.007 . . . . 0.0 110.956 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 57.11 1.47 0.1 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.535 1.934 . . . . 0.0 115.733 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.88 142.43 27.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 120.757 1.617 . . . . 0.0 107.968 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.332 0.0 OUTLIER -130.88 163.88 26.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 175.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 20.5 ptm -125.37 143.34 51.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.651 1.18 . . . . 0.0 110.405 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.73 28.3 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.96 15.71 64.63 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.14 151.02 25.9 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.093 1.447 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.456 ' H ' ' HD3' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -84.7 137.91 32.95 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -94.54 123.97 38.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -168.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -140.72 115.87 9.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 141.01 16.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.214 0.461 . . . . 0.0 110.178 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.41 163.34 37.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.663 0.785 . . . . 0.0 110.126 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.1 p -84.57 155.64 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.6 t -136.6 155.37 50.01 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.073 0.397 . . . . 0.0 111.22 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -93.17 7.04 45.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -66.54 140.02 96.33 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.94 -25.8 10.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.944 2.429 . . . . 0.0 111.319 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.1 171.28 15.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.487 0.715 . . . . 0.0 109.87 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 41.9 mm -68.68 136.91 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -91.73 153.85 43.85 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.32 164.4 8.85 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.847 3.031 . . . . 0.0 112.53 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 163.84 174.73 34.0 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.31 160.97 29.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.1 p -137.33 153.87 50.17 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.048 0.539 . . . . 0.0 110.512 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -144.59 165.09 29.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.249 0.62 . . . . 0.0 109.848 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.62 137.66 17.78 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.22 167.34 14.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 109.551 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.97 -20.0 65.01 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.056 -0.403 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.87 0.88 37.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.909 0.322 . . . . 0.0 111.235 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.7 -2.04 87.17 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.594 -0.559 . . . . 0.0 113.211 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.39 163.19 13.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.103 0.952 . . . . 0.0 110.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.3 m -84.54 153.36 23.31 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.811 0.444 . . . . 0.0 110.902 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.8 p -73.09 -10.33 59.67 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.025 0.53 . . . . 0.0 111.577 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -132.8 143.65 49.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.151 0.98 . . . . 0.0 109.747 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -156.1 159.24 38.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.578 0.351 . . . . 0.0 110.3 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.95 153.23 52.15 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.189 0.595 . . . . 0.0 110.851 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.63 15.49 2.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.034 0.534 . . . . 0.0 111.282 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.0 p . . . . . 0 CA--C 1.53 0.19 0 C-N-CA 123.361 0.664 . . . . 0.0 112.544 -175.426 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.97 119.75 44.28 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.564 1.075 . . . . 0.0 110.324 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.08 113.35 3.59 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.567 2.845 . . . . 0.0 110.804 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 52.4 m -123.96 13.42 9.13 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.388 0.675 . . . . 0.0 111.942 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 57.14 16.91 3.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.725 1.21 . . . . 0.0 113.722 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 74.1 t -134.51 141.44 43.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 118.419 0.554 . . . . 0.0 109.886 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.58 163.69 18.5 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 108.7 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.26 146.88 35.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.864 0.364 . . . . 0.0 111.729 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -112.71 150.01 32.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.572 1.149 . . . . 0.0 109.565 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -147.63 169.95 18.54 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 122.674 0.39 . . . . 0.0 111.175 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 29.0 m120 59.71 17.91 6.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.599 1.16 . . . . 0.0 113.747 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.69 156.09 73.08 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.85 154.79 36.07 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.921 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -72.69 -1.08 14.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.94 4.74 32.15 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.084 0.402 . . . . 0.0 111.723 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -81.64 148.69 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 O-C-N 122.062 -0.398 . . . . 0.0 110.6 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 72.4 p -144.14 174.01 11.25 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.849 0.86 . . . . 0.0 109.93 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.5 -24.59 67.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.796 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.97 -23.11 55.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.428 -0.17 . . . . 0.0 110.657 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -82.05 -28.88 32.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.85 -31.36 66.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -74.74 -38.7 62.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.753 0.252 . . . . 0.0 111.187 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.86 -14.4 59.26 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.09 0.405 . . . . 0.0 111.569 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.69 -38.51 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.617 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.5 m -67.06 -24.69 66.0 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.826 0.739 . . . . 0.0 110.537 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.16 -28.1 61.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.98 -17.5 26.22 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 4.3 pp -102.58 5.24 39.16 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 79.45 35.25 29.87 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.867 1.107 . . . . 0.0 115.867 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.1 m -130.47 168.3 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.2 1.5 . . . . 0.0 111.833 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.29 150.64 31.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.973 0.909 . . . . 0.0 110.855 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -87.58 152.89 52.58 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.364 0.666 . . . . 0.0 110.186 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.61 153.4 75.29 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.516 2.811 . . . . 0.0 111.105 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.446 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 86.4 m -82.34 -25.03 34.24 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.679 0.392 . . . . 0.0 110.707 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 13.6 t -142.83 156.48 44.96 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.562 0.345 . . . . 0.0 110.115 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.9 p -149.51 141.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.094 0.558 . . . . 0.0 110.758 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 121.59 8.85 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.16 144.63 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 122.848 0.459 . . . . 0.0 110.997 -173.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -149.89 159.22 44.55 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.271 1.028 . . . . 0.0 109.547 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--O 1.232 0.171 0 C-N-CA 122.979 0.511 . . . . 0.0 110.942 -178.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.5 m -137.75 161.15 37.31 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.532 0.333 . . . . 0.0 111.349 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.9 t -132.07 155.0 48.86 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.179 0.991 . . . . 0.0 111.071 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 80.3 p -152.95 166.69 31.6 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.231 1.012 . . . . 0.0 110.37 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.01 177.89 44.45 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.873 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.2 mp -112.79 144.28 42.6 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.84 0.856 . . . . 0.0 110.196 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.06 139.86 52.7 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.78 108.35 10.66 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.446 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.9 OUTLIER -166.1 155.72 11.95 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.548 1.539 . . . . 0.0 107.347 168.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -153.87 126.01 7.89 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.9 t -159.63 153.05 22.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.603 1.561 . . . . 0.0 107.013 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.46 -52.24 64.3 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.096 0.407 . . . . 0.0 111.728 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 38.8 m -85.4 -21.9 28.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -78.95 -35.43 43.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.175 -0.328 . . . . 0.0 110.795 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.96 39.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.28 -0.391 . . . . 0.0 111.166 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 47.1 tp -76.22 -29.7 57.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.776 0.716 . . . . 0.0 111.48 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.81 -40.1 55.61 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.826 -0.546 . . . . 0.0 110.221 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 49.0 m -68.73 -36.8 78.87 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.1 -41.74 99.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.61 -23.02 78.56 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.784 -172.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.14 -20.37 7.42 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.095 1.447 . . . . 0.0 113.883 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 37.3 tp -93.73 -23.16 18.31 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.635 1.107 . . . . 0.0 112.022 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -75.18 136.42 41.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 53.15 27.14 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.845 0.858 . . . . 0.0 113.093 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -78.19 151.38 33.22 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.185 0.594 . . . . 0.0 112.169 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -101.58 136.41 41.46 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.838 1.255 . . . . 0.0 110.03 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.4 ttt -64.17 169.56 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.645 0.378 . . . . 0.0 111.032 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -75.61 17.49 0.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -69.0 145.64 96.76 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.872 -0.518 . . . . 0.0 109.764 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.97 -30.56 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.487 2.791 . . . . 0.0 113.924 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -120.89 0.57 10.31 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.157 0.435 . . . . 0.0 112.114 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 39.81 97.76 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.77 -1.017 . . . . 0.0 112.75 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 74.9 Cg_endo -69.56 -10.11 27.88 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 112.016 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -142.67 148.35 46.1 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.28 154.41 36.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.921 3.081 . . . . 0.0 111.333 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -148.34 -0.7 0.56 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.904 0.482 . . . . 0.0 111.534 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 48.1 p -66.38 129.28 39.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.11 144.56 50.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.647 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -96.09 139.81 31.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.516 0.726 . . . . 0.0 109.09 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.66 151.94 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.578 0.228 . . . . 0.0 111.007 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.2 p -161.7 178.96 8.52 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.974 0.509 . . . . 0.0 110.082 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -71.64 144.27 49.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.442 0.297 . . . . 0.0 110.48 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 30.9 t -135.55 145.04 46.59 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 122.888 0.475 . . . . 0.0 110.782 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 88.5 m -93.88 102.22 14.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.3 161.53 34.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.904 0.882 . . . . 0.0 110.258 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.44 -14.47 17.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -161.36 166.85 26.81 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.586 1.154 . . . . 0.0 108.655 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -79.24 76.39 5.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.447 -1.263 . . . . 0.0 110.031 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -142.87 12.53 1.86 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.095 0.558 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 39.8 t -155.98 147.41 16.84 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 123.462 0.705 . . . . 0.0 110.044 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 4.86 5.22 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.635 2.89 . . . . 0.0 111.454 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.54 151.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.694 0.798 . . . . 0.0 110.382 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -142.7 167.95 20.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.728 0.811 . . . . 0.0 109.771 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 71.6 mtp -135.57 152.8 51.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.637 0.256 . . . . 0.0 111.052 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.06 149.02 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 122.901 0.48 . . . . 0.0 110.413 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -141.41 168.75 19.02 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.477 0.711 . . . . 0.0 109.5 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.87 -2.0 87.34 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.874 -0.403 . . . . 0.0 112.616 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.605 HD21 ' H ' ' A' ' 386' ' ' LEU . 2.1 pt? -74.44 171.97 12.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.48 0.64 . . . . 0.0 110.649 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -132.57 132.26 42.37 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -68.58 -4.51 15.59 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.5 t -102.11 -12.2 18.26 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.616 0.366 . . . . 0.0 111.9 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -131.98 -13.9 3.14 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.139 0.427 . . . . 0.0 111.876 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.0 tpt -148.59 106.01 3.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.758 0.823 . . . . 0.0 109.242 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -141.81 -166.78 2.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.766 0.426 . . . . 0.0 110.397 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 73.2 m -53.93 -27.74 32.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.118 0.567 . . . . 0.0 112.509 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.43 -34.12 28.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.922 -0.486 . . . . 0.0 111.007 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -83.51 -28.4 28.69 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.266 -0.271 . . . . 0.0 110.322 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.08 -30.29 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -68.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -70.51 -27.9 64.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.297 -0.382 . . . . 0.0 111.901 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 75.1 t -95.11 -21.55 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -109.51 -12.05 14.74 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.94 -27.34 65.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.143 0.883 . . . . 0.0 111.418 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.46 14.57 1.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.46 2.87 10.24 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.8 0.84 . . . . 0.0 109.982 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 130.6 158.32 9.26 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -172.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -68.96 153.57 43.56 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.056 0.928 . . . . 0.0 111.228 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.72 154.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -97.84 -60.75 1.5 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -164.18 163.42 22.93 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.466 0.706 . . . . 0.0 110.854 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.36 150.74 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -152.13 145.35 24.66 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.509 0.324 . . . . 0.0 110.181 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -79.34 158.91 27.36 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -136.66 141.4 43.17 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -168.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 59.79 33.95 21.81 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 125.136 1.374 . . . . 0.0 112.505 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 23.2 m 53.01 15.39 0.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -81.87 132.56 53.91 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 118.691 0.678 . . . . 0.0 110.043 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.61 -3.68 8.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.543 2.828 . . . . 0.0 112.351 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.19 33.35 2.25 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.478 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.77 133.7 19.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.125 0.962 . . . . 0.0 110.357 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.38 169.17 24.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.198 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.2 ptm -143.49 146.56 33.49 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.278 0.631 . . . . 0.0 109.658 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.31 147.79 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.12 0.568 . . . . 0.0 110.586 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -122.18 135.96 54.84 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.5 mmm -105.25 164.25 11.98 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.485 0.314 . . . . 0.0 110.878 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.99 66.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.99 159.2 36.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.35 0.66 . . . . 0.0 109.333 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.33 -17.0 69.9 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.068 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -68.37 -29.92 68.74 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.004 1.402 . . . . 0.0 110.178 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -73.51 -21.82 60.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.197 -0.314 . . . . 0.0 110.707 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.71 -35.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.88 -36.5 78.14 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.666 0.212 . . . . 0.0 110.677 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.08 -35.01 78.88 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.05 56.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.099 -0.376 . . . . 0.0 110.621 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -29.12 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.184 0.516 . . . . 0.0 111.855 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.8 p -91.17 -13.22 33.32 Favored 'General case' 0 C--N 1.342 0.277 0 O-C-N 121.067 -1.021 . . . . 0.0 113.592 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -138.44 -10.62 1.42 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.3 -14.52 13.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.226 0.921 . . . . 0.0 110.456 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -56.1 142.38 36.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 56.96 1.42 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.72 1.608 . . . . 0.0 114.991 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -87.77 142.6 27.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 120.058 1.299 . . . . 0.0 109.164 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.263 0.1 OUTLIER -130.91 164.0 26.23 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.4 ptm -125.18 143.42 50.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.86 1.264 . . . . 0.0 108.44 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 68.76 21.87 7.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.359 1.463 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.94 15.8 78.35 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -83.07 162.14 21.45 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.815 1.308 . . . . 0.0 110.68 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 132.34 36.17 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.292 0.237 . . . . 0.0 110.493 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.58 135.69 39.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -170.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -140.72 120.19 13.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.36 145.27 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 118.316 0.507 . . . . 0.0 110.378 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -157.68 161.25 38.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.754 0.422 . . . . 0.0 110.408 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.6 p -83.15 151.44 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 21.1 t -100.58 -169.03 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.639 0.375 . . . . 0.0 110.018 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -136.83 0.21 2.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.826 0.45 . . . . 0.0 110.691 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -74.27 148.94 86.62 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.29 -24.77 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.868 2.378 . . . . 0.0 111.794 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.09 170.11 15.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.319 0.647 . . . . 0.0 110.352 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.3 mm -67.14 143.92 15.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.1 mtt -107.77 156.89 37.26 Favored Pre-proline 0 C--O 1.232 0.15 0 C-N-CA 122.338 0.255 . . . . 0.0 111.109 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.68 157.88 21.98 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.928 3.085 . . . . 0.0 112.604 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.3 -179.13 42.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -74.02 150.13 40.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.615 -0.344 . . . . 0.0 110.481 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.9 m -143.69 147.66 34.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -145.97 167.88 22.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.861 0.464 . . . . 0.0 110.477 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.98 137.47 20.0 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.3 167.44 14.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.287 0.635 . . . . 0.0 110.007 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.72 -20.19 65.23 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.368 0.267 . . . . 0.0 111.379 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.1 -1.22 31.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.997 0.519 . . . . 0.0 110.954 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.2 -5.2 73.19 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.89 -0.506 . . . . 0.0 112.237 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 63.9 m -87.2 161.2 18.17 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.799 0.8 . . . . 0.0 110.072 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 80.3 m -85.22 153.35 22.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.48 0.181 . . . . 0.0 110.582 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.5 p -73.01 -10.48 59.85 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.466 0.306 . . . . 0.0 111.416 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.25 141.64 51.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.127 0.971 . . . . 0.0 109.487 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -155.25 156.84 36.31 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.548 0.339 . . . . 0.0 110.191 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.89 154.65 50.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.462 0.705 . . . . 0.0 110.547 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.12 15.85 2.08 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 122.723 0.409 . . . . 0.0 111.514 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.771 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -103.4 120.97 50.18 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.92 131.55 15.81 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.015 2.477 . . . . 0.0 110.557 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 87.8 p -124.16 -1.3 8.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.544 0.738 . . . . 0.0 112.119 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.53 16.21 5.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.069 0.948 . . . . 0.0 112.167 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.2 t -135.97 138.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.9 mt -120.26 152.69 37.41 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.08 145.8 49.02 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -131.93 151.71 51.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.613 0.244 . . . . 0.0 110.576 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -147.36 171.08 16.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 111.094 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.46 25.95 14.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.512 1.125 . . . . 0.0 113.236 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.74 63.93 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.88 159.7 52.36 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.206 1.938 . . . . 0.0 110.194 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -73.95 -1.07 18.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.87 4.51 42.81 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -86.41 150.22 3.93 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 CA-C-N 118.251 0.478 . . . . 0.0 111.347 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -147.2 174.34 11.7 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.939 0.896 . . . . 0.0 109.522 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.23 -24.67 67.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.499 -0.126 . . . . 0.0 110.925 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.1 -24.95 51.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.179 -0.325 . . . . 0.0 110.718 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.3 -28.35 38.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -73.71 -30.79 63.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.203 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -75.25 -36.32 61.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.287 -0.258 . . . . 0.0 111.544 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.46 -21.24 42.24 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.266 0.485 . . . . 0.0 111.55 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.91 -37.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 86.8 m -67.38 -26.48 66.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.091 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.42 -29.12 62.37 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -91.06 -11.84 37.49 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.526 0.603 . . . . 0.0 111.895 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 86.3 mt -100.7 -5.44 26.5 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.644 0.377 . . . . 0.0 111.277 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.24 5.62 72.27 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.866 -0.408 . . . . 0.0 112.907 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.4 m -91.43 167.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 117.65 0.725 . . . . 0.0 110.953 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -76.63 151.84 36.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.384 0.674 . . . . 0.0 110.173 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -102.16 150.9 37.91 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.15 158.98 27.89 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.404 2.736 . . . . 0.0 112.64 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.518 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 91.4 m -86.36 -25.07 25.55 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.072 0.549 . . . . 0.0 110.499 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.1 t -145.23 152.25 39.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.1 t -141.37 140.93 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.348 0.659 . . . . 0.0 109.775 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.97 126.51 15.94 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.8 t -132.05 149.43 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.032 0 C-N-CA 122.667 0.387 . . . . 0.0 110.673 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -152.3 153.75 34.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.272 0.629 . . . . 0.0 110.17 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 62.5 p . . . . . 0 N--CA 1.457 -0.117 0 C-N-CA 123.106 0.563 . . . . 0.0 109.907 178.288 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 36.2 m -139.61 164.45 29.89 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.396 0.678 . . . . 0.0 110.351 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 34.3 t -132.91 153.7 51.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 111.089 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 67.6 m -146.65 164.61 32.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.059 1.343 . . . . 0.0 108.854 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -179.26 -175.07 45.91 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.01 -1.091 . . . . 0.0 113.857 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.11 153.49 42.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.188 0.995 . . . . 0.0 109.763 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 72.8 mt -136.52 136.9 39.76 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.043 0.937 . . . . 0.0 108.903 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -127.86 109.2 11.38 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.518 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.8 OUTLIER -166.12 155.01 11.28 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.826 1.25 . . . . 0.0 108.579 168.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -149.78 121.02 7.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 37.8 t -159.55 153.22 22.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -66.47 -46.92 74.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.767 0.712 . . . . 0.0 111.211 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 67.7 p -85.89 -27.84 24.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 48.6 m-20 -84.05 -30.01 26.41 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.578 0.626 . . . . 0.0 111.078 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.04 27.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.339 0.518 . . . . 0.0 111.236 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.74 -30.6 28.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.853 0.751 . . . . 0.0 112.024 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.82 -42.58 49.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.475 0.58 . . . . 0.0 110.482 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 43.3 m -68.88 -36.38 78.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.68 -41.48 83.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.7 -17.3 76.53 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.957 -0.913 . . . . 0.0 113.544 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.92 -19.22 7.33 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.757 1.279 . . . . 0.0 114.29 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -90.82 -31.25 16.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.056 0.844 . . . . 0.0 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -62.29 139.58 58.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 51.39 23.23 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.366 1.066 . . . . 0.0 113.604 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -74.4 151.33 39.69 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -99.87 136.25 40.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.482 1.113 . . . . 0.0 109.733 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.425 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.3 ttt -64.34 172.42 2.55 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.311 0.577 . . . . 0.0 112.208 -172.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . 0.425 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.3 ptmt -66.94 3.43 1.09 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.699 1.2 . . . . 0.0 113.712 -176.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -67.86 144.74 97.53 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 118.634 0.652 . . . . 0.0 110.727 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.98 -27.32 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.542 2.828 . . . . 0.0 113.784 -171.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -121.08 -3.06 9.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.205 0.457 . . . . 0.0 112.026 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.06 40.52 98.24 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.69 -1.061 . . . . 0.0 112.806 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 83.5 Cg_endo -69.69 -9.64 26.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.103 2.535 . . . . 0.0 111.823 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -142.19 147.74 45.18 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.023 0.529 . . . . 0.0 109.648 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.48 152.85 34.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.805 3.004 . . . . 0.0 111.565 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -148.83 -3.21 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.133 0.573 . . . . 0.0 111.493 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.44 120.94 14.22 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.701 -0.624 . . . . 0.0 110.044 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.96 144.63 50.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.093 0.957 . . . . 0.0 109.934 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -86.3 154.55 21.16 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 55.0 tp -144.12 144.84 31.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.96 168.38 19.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -77.07 130.86 37.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.9 t -135.57 138.2 42.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 32.9 p -79.7 102.25 8.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.336 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 159.92 39.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 109.144 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -81.85 -32.47 31.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.189 -0.319 . . . . 0.0 110.228 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -153.66 165.81 34.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.944 0.898 . . . . 0.0 109.571 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.43 76.32 7.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.354 -179.473 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.89 0.376 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.43 -0.58 57.35 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.336 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 43.0 t -160.27 146.56 11.81 Favored Pre-proline 0 N--CA 1.456 -0.164 0 C-N-CA 123.197 0.599 . . . . 0.0 110.355 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.14 4.34 6.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.118 3.212 . . . . 0.0 112.091 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.05 151.79 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 123.364 0.666 . . . . 0.0 110.699 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.58 167.07 23.03 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.807 0.843 . . . . 0.0 109.627 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 70.0 mtp -134.19 151.08 51.15 Favored 'General case' 0 N--CA 1.458 -0.042 0 C-N-CA 122.459 0.304 . . . . 0.0 111.084 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.9 148.15 19.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.834 0.454 . . . . 0.0 110.427 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -140.11 168.06 20.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.488 0.715 . . . . 0.0 109.369 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.45 -6.44 80.04 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.354 -0.692 . . . . 0.0 113.05 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.576 HD21 ' H ' ' A' ' 386' ' ' LEU . 2.1 pt? -68.98 177.67 2.54 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.998 0.899 . . . . 0.0 110.387 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -142.78 136.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -73.63 -7.14 50.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 96.0 p -93.2 -12.03 31.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.605 0.639 . . . . 0.0 112.592 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.47 5.89 0.94 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.5 ttt -141.26 129.14 21.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.94 177.81 7.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.755 0.422 . . . . 0.0 110.213 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.57 -28.06 63.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.56 0.344 . . . . 0.0 111.203 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.66 -23.08 29.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.052 -0.405 . . . . 0.0 111.376 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -83.85 -34.5 24.62 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.1 -27.48 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.5 -33.84 73.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.018 -0.427 . . . . 0.0 110.183 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -67.88 -29.54 68.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.853 -0.529 . . . . 0.0 111.086 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 80.3 t -90.36 -29.64 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -101.72 -8.68 21.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 53.0 t -71.55 -38.34 71.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.872 0.76 . . . . 0.0 111.333 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.66 12.92 1.45 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.731 -0.606 . . . . 0.0 112.407 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.21 0.75 11.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.278 0.631 . . . . 0.0 111.152 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.16 170.05 14.52 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -70.26 136.42 49.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.351 -0.5 . . . . 0.0 110.759 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 4.5 m -95.1 164.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.773 1.229 . . . . 0.0 110.321 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -125.8 -65.54 0.99 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.325 0.25 . . . . 0.0 110.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -163.37 165.54 23.9 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.067 0.547 . . . . 0.0 111.194 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.63 151.63 14.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.674 0.79 . . . . 0.0 110.363 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.05 147.64 26.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -78.17 158.98 28.85 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.23 141.46 42.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.05 33.9 21.33 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.845 1.258 . . . . 0.0 112.402 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.4 m 53.06 16.06 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 114.129 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -80.61 144.73 57.12 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 118.449 0.568 . . . . 0.0 109.599 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.18 1.83 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.843 3.029 . . . . 0.0 110.831 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -143.27 33.41 1.81 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.164 -173.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.03 19.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.933 0.867 . . . . 0.0 110.133 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.28 170.6 21.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.073 0.464 . . . . 0.0 110.808 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 17.7 ptm -145.05 146.53 31.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.983 0.513 . . . . 0.0 109.672 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.25 147.75 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.026 0 C-N-CA 123.322 0.649 . . . . 0.0 110.742 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -124.58 142.42 51.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.535 0.734 . . . . 0.0 109.773 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.0 mmm -115.63 164.21 14.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 109.797 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.85 64.18 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.392 -0.192 . . . . 0.0 111.251 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.86 160.13 33.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.12 -14.51 63.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.377 -0.679 . . . . 0.0 113.097 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -64.38 -31.19 72.29 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.398 1.599 . . . . 0.0 110.233 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.67 -23.78 45.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.52 -0.113 . . . . 0.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.03 -31.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.04 -31.18 62.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.134 0.425 . . . . 0.0 110.865 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -29.62 65.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.067 -0.396 . . . . 0.0 109.986 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.66 -28.8 40.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.735 0.243 . . . . 0.0 110.59 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.8 tp -81.83 -35.25 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 122.775 0.43 . . . . 0.0 110.059 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 m -89.24 -26.09 21.38 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.91 -11.09 6.6 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.78 -16.76 11.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.424 1.011 . . . . 0.0 110.339 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -54.05 141.67 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.83 0.852 . . . . 0.0 111.514 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 57.04 1.39 0.09 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.045 2.138 . . . . 0.0 115.956 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.75 142.59 27.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 120.786 1.63 . . . . 0.0 108.01 169.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.276 0.0 OUTLIER -130.98 163.86 26.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.3 ptm -125.25 143.47 50.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.466 1.106 . . . . 0.0 109.607 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 66.46 32.94 7.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.178 1.391 . . . . 0.0 113.784 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.0 15.88 72.23 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.654 169.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -83.02 152.82 25.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.521 1.161 . . . . 0.0 110.736 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.504 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -75.42 136.19 40.73 Favored 'General case' 0 C--N 1.337 0.028 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -97.21 127.16 42.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -140.6 115.87 9.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.83 139.44 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.5 m -148.17 164.37 34.15 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.579 0.752 . . . . 0.0 109.99 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.62 151.9 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.5 t -102.29 -174.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.085 0.554 . . . . 0.0 110.304 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -135.4 7.12 3.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.799 0.84 . . . . 0.0 110.341 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -78.86 147.56 70.74 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.79 -25.46 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.835 2.357 . . . . 0.0 111.978 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.46 170.75 12.58 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.155 0.582 . . . . 0.0 110.443 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -68.22 140.61 18.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.6 mtt -102.37 151.45 38.17 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.416 0.286 . . . . 0.0 110.723 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 161.54 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.729 2.952 . . . . 0.0 111.337 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.65 -175.68 44.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -72.96 158.26 35.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.664 0.385 . . . . 0.0 110.17 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.1 p -146.41 162.49 38.11 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.167 0.587 . . . . 0.0 110.543 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -150.15 163.7 37.53 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.96 0.504 . . . . 0.0 110.208 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.87 135.42 17.88 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.4 mt -86.97 176.4 7.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.904 0.882 . . . . 0.0 109.954 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -65.27 -20.29 66.35 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.392 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.23 0.15 49.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.359 0.664 . . . . 0.0 111.573 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.52 -3.52 77.95 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.286 0.469 . . . . 0.0 112.504 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 60.5 m -93.82 156.69 16.52 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.681 0.74 . . . . 0.0 110.269 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.81 153.35 36.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.456 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.0 p -66.33 -10.39 42.44 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.775 0.43 . . . . 0.0 111.79 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -118.52 137.48 53.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.174 0.99 . . . . 0.0 109.391 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -151.87 154.92 37.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -124.28 152.36 43.11 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.02 0.928 . . . . 0.0 109.84 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -137.94 12.57 2.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.144 0.578 . . . . 0.0 112.276 -175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 97.2 p . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.316 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 . . . . . 0 CA--C 1.529 0.159 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -65.37 163.96 28.38 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.401 0.681 . . . . 0.0 110.756 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.61 151.86 13.66 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.764 2.976 . . . . 0.0 112.764 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 45.1 p -124.05 23.89 8.38 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.907 0.883 . . . . 0.0 112.122 -173.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 54.67 13.13 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.792 1.637 . . . . 0.0 115.051 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.85 150.24 22.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.96 143.84 50.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -109.37 152.48 25.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.731 0.413 . . . . 0.0 109.92 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -130.38 135.71 48.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.09 0.956 . . . . 0.0 108.482 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -146.56 168.18 21.88 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.858 0.463 . . . . 0.0 111.073 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.8 m120 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.906 0.882 . . . . 0.0 112.623 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.42 156.35 50.96 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 122.984 0.514 . . . . 0.0 109.765 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.18 156.95 64.04 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.286 1.99 . . . . 0.0 110.407 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.5 -1.19 26.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.17 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.6 7.8 28.83 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.095 -0.378 . . . . 0.0 111.983 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.51 153.09 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.168 0.44 . . . . 0.0 111.668 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 75.5 p -146.91 172.6 13.43 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.935 0.894 . . . . 0.0 110.114 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -60.79 -24.31 65.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.796 177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -73.59 -26.69 60.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.178 -0.326 . . . . 0.0 110.455 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.37 -28.93 37.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.47 -29.43 63.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.6 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.81 -38.99 31.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.575 0.625 . . . . 0.0 111.605 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.91 -18.96 52.99 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.174 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.5 mt -90.85 -33.5 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 118.285 0.493 . . . . 0.0 110.095 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.33 -22.27 64.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.635 -0.666 . . . . 0.0 110.285 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.58 -30.55 64.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.13 -13.0 33.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.365 0.53 . . . . 0.0 112.075 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.5 mt -91.82 -6.53 51.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.517 0.327 . . . . 0.0 110.428 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.41 7.73 64.77 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.693 -0.504 . . . . 0.0 112.966 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.1 m -87.54 169.13 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 117.833 0.817 . . . . 0.0 111.222 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -71.16 132.33 44.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -76.81 147.0 77.07 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.92 148.29 91.77 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.909 2.406 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.482 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.1 m -89.55 -19.9 24.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.544 0.337 . . . . 0.0 110.431 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.5 t -147.25 148.98 32.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.41 138.93 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.656 0.382 . . . . 0.0 110.328 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -142.91 139.92 30.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.32 154.97 41.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 110.428 -175.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -152.05 161.15 43.07 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.441 1.096 . . . . 0.0 109.166 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.695 178.818 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 158.26 44.55 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.81 0.444 . . . . 0.0 111.411 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -115.8 157.38 24.47 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.07 0.948 . . . . 0.0 111.884 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -149.88 175.15 11.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.256 1.422 . . . . 0.0 109.199 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.7 45.7 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.647 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.25 132.79 47.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.632 0.773 . . . . 0.0 109.01 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 9.4 mp -128.12 144.78 51.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.76 120.46 27.95 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.482 ' HB3' ' H ' ' A' ' 527' ' ' THR . 9.6 p90 -164.94 147.4 8.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -156.21 123.4 5.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 17.3 m -159.64 152.89 22.16 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.341 1.856 . . . . 0.0 106.304 169.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -59.95 -54.26 48.22 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.718 0.69 . . . . 0.0 111.897 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 26.9 m -83.5 -27.28 29.51 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.96 -30.82 31.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.06 0.391 . . . . 0.0 111.024 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -30.36 38.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.9 tp -78.08 -29.61 49.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.624 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -71.98 -41.72 67.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 O-C-N 121.938 -0.476 . . . . 0.0 109.983 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 24.1 m -73.44 -39.24 65.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.992 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.66 -46.78 74.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.676 -0.64 . . . . 0.0 109.815 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.15 -16.41 78.58 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.552 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -123.7 -6.18 8.03 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.795 1.298 . . . . 0.0 113.48 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.87 -16.36 14.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.3 0.5 . . . . 0.0 111.265 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -68.07 143.6 55.42 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.266 -0.896 . . . . 0.0 109.924 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 52.64 29.41 7.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.06 0.944 . . . . 0.0 113.354 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.7 151.42 39.23 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -103.76 136.42 43.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.063 1.745 . . . . 0.0 110.635 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.467 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.13 173.68 1.85 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.935 0.494 . . . . 0.0 111.202 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . 0.414 ' H ' ' HG2' ' A' ' 564' ' ' MET . 65.2 pttt -73.3 9.77 1.19 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -66.28 143.86 98.48 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.715 0.688 . . . . 0.0 110.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.0 -29.58 3.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.569 2.846 . . . . 0.0 114.04 -169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -121.02 1.37 10.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.961 0.346 . . . . 0.0 111.912 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.428 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.74 41.55 99.09 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.929 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.6 Cg_endo -68.94 -10.87 30.37 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.247 2.631 . . . . 0.0 112.048 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.11 147.61 38.38 Favored Pre-proline 0 N--CA 1.455 -0.201 0 C-N-CA 122.832 0.453 . . . . 0.0 109.824 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.81 152.37 41.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.859 3.039 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.7 t80 -144.17 -2.79 0.88 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 126.17 28.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.809 -0.557 . . . . 0.0 109.998 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.14 144.71 50.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.232 1.013 . . . . 0.0 110.372 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -79.46 135.98 36.81 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.5 pp -146.99 146.85 30.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 25.5 p -163.72 169.99 17.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.082 0.553 . . . . 0.0 110.304 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -73.78 130.67 40.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 74.6 m -135.55 140.07 44.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.79 0.436 . . . . 0.0 110.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 65.0 m -79.82 102.34 9.03 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.012 0.434 . . . . 0.0 110.573 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 161.6 34.44 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.076 0.95 . . . . 0.0 109.43 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . 0.452 ' CD ' ' H ' ' A' ' 583' ' ' GLN . 0.0 OUTLIER -98.87 -15.92 19.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.573 0.349 . . . . 0.0 111.511 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -160.58 164.56 31.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.205 0.602 . . . . 0.0 109.824 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.17 76.4 9.24 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.945 179.113 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.744 0.306 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -139.08 10.75 2.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.29 0.636 . . . . 0.0 110.917 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 37.6 t -155.71 150.71 20.78 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.177 0.591 . . . . 0.0 110.323 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.34 -4.39 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.562 2.841 . . . . 0.0 111.473 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.77 145.3 17.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.098 0.559 . . . . 0.0 111.019 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.99 165.16 27.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.243 1.017 . . . . 0.0 109.43 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.2 mtp -137.87 153.17 49.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.674 0.274 . . . . 0.0 111.58 -175.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.63 150.39 15.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.064 0.546 . . . . 0.0 110.357 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.24 166.16 24.89 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.59 86.93 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.115 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.543 HD13 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.58 178.14 4.27 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.209 1.005 . . . . 0.0 110.992 177.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.44 143.8 35.78 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -73.29 0.22 12.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.4 p -113.67 -4.33 13.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.552 0.614 . . . . 0.0 112.376 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -131.81 -6.9 3.58 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.141 0.577 . . . . 0.0 110.882 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 27.8 ttt -145.43 128.19 16.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 32.8 m-80 -141.88 176.75 8.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.701 0.801 . . . . 0.0 109.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.0 m -57.98 -27.84 63.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.314 0.246 . . . . 0.0 111.142 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -85.15 -26.21 26.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.267 -0.271 . . . . 0.0 111.451 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . 0.45 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 48.8 mmt-85 -81.07 -33.85 33.12 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.194 0.452 . . . . 0.0 109.804 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -25.12 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -71.52 -29.33 64.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.66 -26.74 50.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.684 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 74.5 t -90.18 -21.28 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.298 0.499 . . . . 0.0 112.301 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -114.43 -12.91 12.29 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.79 -25.65 62.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.44 1.018 . . . . 0.0 111.754 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.6 pp -77.67 11.16 2.22 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.649 -0.657 . . . . 0.0 112.164 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.75 -7.78 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.454 0.701 . . . . 0.0 110.609 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.32 170.71 19.81 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -70.41 138.49 51.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.065 -0.668 . . . . 0.0 111.008 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 62.0 t -97.25 145.14 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.07 -57.89 1.98 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.323 -0.236 . . . . 0.0 110.721 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -160.0 165.23 32.36 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.972 0.415 . . . . 0.0 111.54 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.21 151.8 15.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 123.85 0.86 . . . . 0.0 109.987 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -151.64 144.56 24.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.762 0.425 . . . . 0.0 110.007 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -76.05 157.4 33.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 34.4 ttp -119.67 141.15 49.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -168.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt 51.93 33.88 12.54 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.722 1.209 . . . . 0.0 112.26 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.8 m 55.68 15.76 1.7 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 113.323 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -81.29 142.18 50.46 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.42 -2.47 11.98 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.467 2.778 . . . . 0.0 109.518 169.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.01 15.79 10.99 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.556 1.074 . . . . 0.0 113.822 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.181 1.49 . . . . 0.0 111.129 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -158.89 168.06 27.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.169 0.509 . . . . 0.0 111.964 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.2 ptp -136.07 148.79 48.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.913 0.885 . . . . 0.0 109.93 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.53 151.35 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.556 0.742 . . . . 0.0 109.834 -175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -130.77 145.04 51.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.736 0.414 . . . . 0.0 110.493 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 73.7 mtp -124.34 165.43 17.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.02 66.58 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -158.81 160.79 36.63 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.73 -13.33 78.35 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.509 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -65.51 -26.79 68.07 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.166 1.483 . . . . 0.0 110.741 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.98 -25.61 25.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.219 0.208 . . . . 0.0 110.841 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.39 -30.36 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.6 -33.4 72.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.497 0.319 . . . . 0.0 110.355 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -76.08 -25.35 55.42 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.175 -0.328 . . . . 0.0 110.514 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.84 -28.57 44.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.984 -0.448 . . . . 0.0 109.868 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -80.47 -31.04 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.102 0.961 . . . . 0.0 111.096 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 45.7 p -100.54 -13.17 18.74 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -134.05 -11.97 2.55 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.049 1.295 . . . . 0.0 114.391 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.82 -10.45 11.71 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.96 0.8 . . . . 0.0 109.718 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -58.88 145.24 41.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.403 0.62 . . . . 0.0 112.443 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 21.3 m120 56.9 1.35 0.09 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.543 1.937 . . . . 0.0 115.536 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -87.95 142.52 27.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.55 1.523 . . . . 0.0 108.493 169.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.0 OUTLIER -130.69 163.97 26.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 174.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.3 ptm -125.26 143.36 50.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.642 1.177 . . . . 0.0 109.171 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 63.86 27.09 14.46 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.953 1.301 . . . . 0.0 114.483 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.83 15.92 76.4 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -83.04 150.63 26.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.979 1.389 . . . . 0.0 110.14 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 141.49 38.28 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.79 122.99 40.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -140.73 115.72 9.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.14 140.22 24.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.926 0.33 . . . . 0.0 110.341 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 99.4 m -149.43 168.21 24.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.878 0.871 . . . . 0.0 110.158 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.68 153.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 23.2 t -105.82 -168.23 1.42 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.653 0.381 . . . . 0.0 110.276 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -141.57 4.43 1.75 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.115 0.566 . . . . 0.0 111.146 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -74.38 150.93 87.46 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -27.7 12.35 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.646 2.231 . . . . 0.0 112.382 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.71 170.15 14.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.298 0.499 . . . . 0.0 111.28 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 30.0 mm -71.82 151.49 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.01 133.07 23.15 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.22 158.55 41.29 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.523 2.815 . . . . 0.0 111.427 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 151.84 160.23 9.4 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 48.27 -95.9 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.703 1.201 . . . . 0.0 112.741 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.0 t 63.14 146.75 0.02 OUTLIER 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.653 1.581 . . . . 0.0 112.938 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -148.31 165.3 31.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.913 0.885 . . . . 0.0 109.699 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.45 132.65 11.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.1 mt -87.06 172.5 9.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.315 0.646 . . . . 0.0 110.341 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.48 -22.12 66.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.848 0.459 . . . . 0.0 110.951 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.7 1.2 35.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.199 0.599 . . . . 0.0 111.41 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.45 -2.11 79.1 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.076 0.369 . . . . 0.0 112.402 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.35 156.59 16.7 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.655 0.727 . . . . 0.0 110.067 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 83.9 m -78.77 150.42 32.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.447 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 86.3 p -73.22 -10.33 59.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.455 0.302 . . . . 0.0 111.464 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -119.44 130.59 55.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.561 0.744 . . . . 0.0 109.062 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -151.62 159.44 44.06 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -130.62 147.88 52.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.794 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -136.2 12.77 3.3 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.052 0.541 . . . . 0.0 111.415 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.53 0.189 0 C-N-CA 122.913 0.485 . . . . 0.0 111.594 -174.879 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.965 0.412 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -89.1 166.48 21.64 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.29 1.036 . . . . 0.0 109.882 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.03 129.96 30.02 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.0 2.467 . . . . 0.0 111.412 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 70.8 m -123.99 22.73 8.74 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.195 0.598 . . . . 0.0 112.291 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 60.2 3.29 0.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.06 1.344 . . . . 0.0 114.012 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.6 t -142.29 146.96 21.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 49.1 mt -121.48 162.1 21.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.036 0.534 . . . . 0.0 110.545 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -141.96 152.78 43.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.502 0.321 . . . . 0.0 110.676 175.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -138.01 154.25 49.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.837 0.455 . . . . 0.0 111.344 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -146.01 172.17 13.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.048 0.539 . . . . 0.0 111.197 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.4 m120 61.08 27.66 17.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 575' ' ' LEU . . . -82.64 160.55 61.29 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 122.44 0.296 . . . . 0.0 110.609 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.92 152.71 62.38 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.692 2.261 . . . . 0.0 110.7 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -73.46 -2.56 23.0 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.23 9.22 13.41 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.204 0.602 . . . . 0.0 111.88 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.9 152.44 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.121 -0.362 . . . . 0.0 110.298 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.6 p -145.65 170.97 15.41 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.061 0.544 . . . . 0.0 110.442 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.87 -23.25 66.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.894 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.16 -26.07 58.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.657 0.208 . . . . 0.0 110.492 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -78.56 -30.57 46.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -73.48 -27.04 61.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.303 -0.248 . . . . 0.0 110.878 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -78.85 -39.52 35.09 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.972 -0.455 . . . . 0.0 111.178 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -78.89 -21.74 46.96 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 84.1 mt -86.36 -35.89 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.281 0.491 . . . . 0.0 110.315 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.87 -28.45 68.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.086 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.58 -28.62 65.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.84 -12.18 37.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.557 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.41 -2.89 58.59 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.882 0.473 . . . . 0.0 111.257 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.32 79.94 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.929 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.77 165.07 22.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 117.817 0.809 . . . . 0.0 110.885 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -73.83 146.66 43.99 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.922 0.392 . . . . 0.0 110.605 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . 0.449 ' HD2' ' H ' ' A' ' 525' ' ' ARG . 0.4 OUTLIER -88.07 152.92 51.35 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.27 0.628 . . . . 0.0 110.354 176.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.85 152.47 69.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.252 2.635 . . . . 0.0 111.413 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 95.4 m -85.51 -27.8 25.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.359 0.263 . . . . 0.0 111.171 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.6 m -140.35 149.43 42.7 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.529 . . . . 0.0 109.813 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.9 t -141.76 147.02 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.971 0.509 . . . . 0.0 110.472 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.31 124.63 10.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.39 144.65 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.586 0.354 . . . . 0.0 110.921 -175.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -149.58 161.38 42.28 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.749 0.82 . . . . 0.0 109.661 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 82.6 p . . . . . 0 C--O 1.233 0.222 0 C-N-CA 122.917 0.487 . . . . 0.0 110.926 179.797 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 98.4 p -147.92 170.23 18.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.798 0.439 . . . . 0.0 111.089 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.2 m -131.37 160.83 33.91 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.661 0.784 . . . . 0.0 111.77 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.9 p -149.33 165.39 32.14 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.592 1.157 . . . . 0.0 109.79 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.08 40.87 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.691 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.98 157.82 39.55 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.74 0.816 . . . . 0.0 110.309 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 71.3 mt -133.51 134.98 44.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.347 1.059 . . . . 0.0 108.43 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.77 111.84 14.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -166.01 153.76 10.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.71 1.604 . . . . 0.0 106.898 167.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.17 124.75 8.35 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 39.6 t -159.56 153.04 22.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 168.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -50.67 70.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.606 0.639 . . . . 0.0 111.7 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 52.1 m -87.75 -29.44 21.05 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.0 -34.28 71.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.268 0.486 . . . . 0.0 110.441 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.64 -34.32 35.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.33 -0.367 . . . . 0.0 110.555 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 38.0 tp -75.96 -29.94 58.46 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.757 0.708 . . . . 0.0 111.241 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -68.61 -43.48 76.31 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.8 m -72.79 -34.76 67.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.41 -42.27 98.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.755 -0.591 . . . . 0.0 109.601 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.78 -23.05 78.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.833 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -112.15 -7.48 14.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.504 1.152 . . . . 0.0 113.457 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.3 tp -112.52 -9.85 13.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.001 0.819 . . . . 0.0 111.927 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -78.05 140.74 39.13 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.232 -0.918 . . . . 0.0 108.823 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 50.72 26.95 2.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.695 0.798 . . . . 0.0 112.652 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.84 151.32 44.9 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -103.79 136.51 43.33 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.751 1.621 . . . . 0.0 111.085 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.485 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.0 ttt -64.21 173.45 1.97 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.181 0.592 . . . . 0.0 111.307 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -74.02 11.5 0.89 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.8 p30 -65.85 143.53 98.53 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.41 0.55 . . . . 0.0 110.179 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.21 -30.53 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.36 2.707 . . . . 0.0 114.132 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -121.06 1.7 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.211 0.459 . . . . 0.0 112.043 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 40.61 98.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.775 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 84.7 Cg_endo -69.56 -9.5 26.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.984 2.456 . . . . 0.0 112.319 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.23 147.94 39.26 Favored Pre-proline 0 N--CA 1.455 -0.185 0 C-N-CA 122.74 0.416 . . . . 0.0 109.968 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.33 153.01 45.1 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.767 2.978 . . . . 0.0 111.127 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . 0.485 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.9 t80 -148.28 0.81 0.61 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.729 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 66.7 p -66.42 125.83 26.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.398 -0.814 . . . . 0.0 110.261 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 505' ' ' ALA . 24.5 mt -99.58 144.54 28.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.452 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -81.36 122.61 27.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -133.61 144.63 49.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 18.6 t -164.02 175.82 9.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.251 0.62 . . . . 0.0 110.18 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.46 144.53 33.95 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.014 0.525 . . . . 0.0 109.801 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 37.6 t -135.63 142.35 45.19 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.427 0.158 . . . . 0.0 111.427 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.7 p -79.89 102.27 9.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.14 161.58 34.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.192 0.597 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -123.89 -1.42 8.36 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.344 0.657 . . . . 0.0 109.979 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -159.93 167.21 28.55 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.529 1.132 . . . . 0.0 109.864 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.47 0.99 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.759 0.424 . . . . 0.0 109.93 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.884 -179.773 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.658 0.266 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.26 -1.15 4.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.849 0.46 . . . . 0.0 111.633 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.3 m -146.7 148.83 34.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 C-N-CA 122.596 0.359 . . . . 0.0 110.528 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -82.41 -5.49 11.81 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.253 3.302 . . . . 0.0 112.49 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 72.9 t -119.25 147.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 118.472 0.578 . . . . 0.0 111.229 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.46 166.06 25.74 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.012 0.925 . . . . 0.0 109.382 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 85.5 mtp -135.17 150.49 50.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.517 0.199 . . . . 0.0 111.245 -175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 30.9 t -140.21 145.18 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.323 0.649 . . . . 0.0 109.951 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.466 ' CE2' ' HE3' ' A' ' 412' ' ' MET . 10.0 m-85 -137.26 165.05 27.07 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.427 0.691 . . . . 0.0 109.564 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.31 0.15 89.97 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.355 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.539 HD11 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -73.88 177.97 5.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.989 0.895 . . . . 0.0 110.976 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.83 137.23 50.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.678 0.391 . . . . 0.0 110.266 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.93 -1.64 23.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 23.1 t -112.62 -13.56 13.28 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.354 0.525 . . . . 0.0 111.59 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -114.58 -9.92 12.58 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.736 0.415 . . . . 0.0 110.32 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.3 ttt -150.88 126.98 10.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.281 0.633 . . . . 0.0 109.898 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -141.94 -174.43 4.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.208 0.603 . . . . 0.0 109.449 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 22.3 p -57.97 -30.42 66.01 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.09 -21.67 23.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.735 -0.603 . . . . 0.0 111.496 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -94.71 -19.36 20.47 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.457 0.303 . . . . 0.0 110.697 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.92 -30.43 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.09 -31.33 71.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -66.92 -42.37 85.5 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.133 -0.354 . . . . 0.0 110.848 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 65.3 t -79.45 -26.09 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 119.278 -0.391 . . . . 0.0 112.002 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -101.97 -10.01 20.15 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 19.7 t -74.01 -33.57 63.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.961 0.801 . . . . 0.0 111.59 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.36 12.54 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.687 -0.633 . . . . 0.0 111.369 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.47 -2.15 9.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 110.656 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.96 173.3 18.06 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -80.35 155.49 27.17 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.389 0.595 . . . . 0.0 110.053 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.33 155.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.304 0.642 . . . . 0.0 110.141 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -102.39 -58.36 1.89 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.717 0.407 . . . . 0.0 110.084 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.16 167.91 17.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.432 0.693 . . . . 0.0 110.466 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.25 148.57 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 122.995 0.518 . . . . 0.0 110.181 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -155.61 148.9 24.76 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 110.844 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -77.92 156.44 30.28 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 171.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.466 ' HE3' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -141.02 141.41 34.34 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -169.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.22 33.94 21.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.3 m 52.84 13.45 0.35 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.33 138.12 45.23 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-N 119.083 0.856 . . . . 0.0 109.837 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.17 -6.86 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.185 2.59 . . . . 0.0 110.181 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -114.41 18.19 18.13 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.26 0.933 . . . . 0.0 112.717 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -150.42 142.73 24.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.747 1.274 . . . . 0.0 111.528 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.54 169.03 25.23 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.729 0.411 . . . . 0.0 111.468 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.4 ptp -136.26 149.43 48.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.594 . . . . 0.0 110.535 176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.77 148.21 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.072 0.549 . . . . 0.0 110.289 -174.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -127.23 131.37 50.61 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 87.4 mmm -100.4 162.83 12.69 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.449 0.3 . . . . 0.0 110.874 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.86 61.82 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -157.92 163.06 38.25 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.25 -16.21 70.87 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.102 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -68.46 -24.19 64.68 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.139 1.469 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -86.76 -22.27 26.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.254 0.222 . . . . 0.0 110.594 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.5 t -78.08 -33.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.44 -28.88 67.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.155 0.182 . . . . 0.0 110.525 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -86.73 -29.38 22.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.104 -0.372 . . . . 0.0 111.194 -177.198 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.83 -26.94 40.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -84.55 -30.95 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 122.143 -0.348 . . . . 0.0 111.585 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.3 p -99.04 -11.18 21.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -132.33 -11.03 3.24 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.8 -21.28 9.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.401 1.0 . . . . 0.0 110.477 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -51.46 142.29 14.07 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.539 0.736 . . . . 0.0 112.226 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . 0.465 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 77.0 m-20 58.41 1.69 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.89 142.52 27.74 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 121.14 1.791 . . . . 0.0 109.287 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 0.1 OUTLIER -130.86 164.05 26.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.3 ptm -125.39 143.43 50.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.548 1.139 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . 0.45 ' CE1' ' CD1' ' A' ' 558' ' ' PHE . 37.5 m-85 62.91 27.88 16.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 177.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.8 15.88 58.98 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.314 0.885 . . . . 0.0 115.314 168.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -83.09 141.78 31.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.833 1.317 . . . . 0.0 109.756 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -74.85 139.01 42.9 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.19 121.94 39.64 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -140.77 115.74 9.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 107.871 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.465 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 1.9 p -153.34 139.82 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 118.692 0.678 . . . . 0.0 110.594 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -158.24 161.63 37.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.438 0.695 . . . . 0.0 109.796 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.41 155.68 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 36.0 t -133.43 144.23 49.38 Favored 'General case' 0 CA--C 1.522 -0.115 0 O-C-N 122.102 -0.374 . . . . 0.0 111.318 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -87.92 65.1 8.16 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.283 0.633 . . . . 0.0 111.12 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -127.38 144.06 49.48 Favored Pre-proline 0 CA--C 1.529 0.144 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.74 -25.24 9.44 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.281 2.654 . . . . 0.0 111.76 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.48 172.42 14.49 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.79 0.436 . . . . 0.0 110.617 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.37 140.41 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.99 151.74 42.21 Favored Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 122.425 0.29 . . . . 0.0 110.925 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.96 158.98 55.79 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.93 3.087 . . . . 0.0 111.189 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.08 -172.4 43.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -77.83 164.87 24.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.645 0.378 . . . . 0.0 110.8 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 77.6 p -145.71 158.58 43.84 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.387 0.675 . . . . 0.0 110.114 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -154.16 165.66 35.54 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.742 0.417 . . . . 0.0 110.258 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.02 137.44 22.13 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -86.96 176.14 7.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.628 0.771 . . . . 0.0 110.354 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.97 -20.12 66.09 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.474 0.309 . . . . 0.0 111.441 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -85.65 -0.07 54.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 0.98 89.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.256 0.455 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 24.4 t -93.55 160.76 14.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.195 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.76 153.21 35.21 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.921 0.391 . . . . 0.0 110.824 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.9 p -72.54 -10.46 59.82 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.745 0.418 . . . . 0.0 111.807 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -117.39 141.7 48.01 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.692 0.797 . . . . 0.0 110.112 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -154.68 154.41 32.87 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.776 0.43 . . . . 0.0 110.185 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -127.25 155.1 44.01 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.118 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -138.05 1.76 2.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 85.0 p . . . . . 0 CA--C 1.528 0.122 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.592 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.286 0.565 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -80.74 162.39 60.44 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.156 0.982 . . . . 0.0 108.551 170.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.54 138.41 64.83 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.159 1.906 . . . . 0.0 110.55 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 69.2 m -124.08 23.97 8.32 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.04 5.83 4.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.182 0.993 . . . . 0.0 113.321 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 54.9 t -140.07 142.31 32.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 O-C-N 121.706 -0.621 . . . . 0.0 109.748 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . 0.443 HD11 ' CH2' ' A' ' 546' ' ' TRP . 89.1 mt -130.86 163.48 27.33 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.187 0.995 . . . . 0.0 108.826 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . 0.545 ' CE1' ' HG ' ' A' ' 578' ' ' CYS . 0.0 OUTLIER -146.34 165.75 28.38 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 122.01 -0.431 . . . . 0.0 112.004 178.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.52 156.93 47.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.237 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -147.51 170.63 17.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.285 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.5 t30 61.01 26.57 16.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.274 1.03 . . . . 0.0 113.607 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.42 157.8 55.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.14 161.33 16.46 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 0.0 111.955 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . 0.41 ' H ' ' CD2' ' A' ' 507' ' ' LEU . 2.2 pt? -83.06 -1.16 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.52 5.69 31.68 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.603 0.361 . . . . 0.0 111.873 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.32 150.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.918 0.326 . . . . 0.0 111.602 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -143.44 172.21 13.09 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.581 0.752 . . . . 0.0 110.471 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 2.9 pm0 -61.49 -19.88 62.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.511 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.86 -25.75 60.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.017 0.371 . . . . 0.0 110.134 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -81.99 -28.54 32.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -72.9 -29.11 62.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.806 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -83.33 -37.52 23.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 111.503 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.23 -24.36 51.22 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.98 -33.07 5.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.165 0.439 . . . . 0.0 110.187 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 67.7 m -67.25 -21.48 65.72 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.948 174.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.96 -33.61 73.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -90.99 -13.2 33.8 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.69 -9.97 47.51 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.666 0.386 . . . . 0.0 110.841 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.04 62.24 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.175 0.417 . . . . 0.0 112.724 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -87.65 160.44 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.964 0.882 . . . . 0.0 110.645 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.46 120.22 18.77 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -71.18 150.75 94.58 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.97 149.28 92.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.859 2.373 . . . . 0.0 110.563 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.419 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 94.1 m -84.78 -21.04 30.12 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.76 0.424 . . . . 0.0 110.839 -174.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 15.3 t -146.04 153.45 40.75 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.34 140.71 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 122.995 0.518 . . . . 0.0 110.359 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.18 124.13 12.04 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.3 148.93 30.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.695 0.398 . . . . 0.0 111.082 -172.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -151.81 151.02 30.79 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.544 0.738 . . . . 0.0 110.418 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 109.939 177.25 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.4 m -145.49 167.98 21.69 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.539 0.736 . . . . 0.0 110.449 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.6 t -135.36 155.11 51.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.495 0.718 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.5 m -145.35 163.71 33.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.399 1.079 . . . . 0.0 109.542 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -178.6 177.54 48.46 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 119.993 -1.098 . . . . 0.0 114.359 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.6 mp -112.98 156.5 22.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.012 . . . . 0.0 109.59 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.9 mt -138.61 143.19 39.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.434 1.094 . . . . 0.0 109.078 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -127.8 109.43 11.62 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.443 ' CH2' HD11 ' A' ' 500' ' ' LEU . 2.2 p90 -166.04 153.4 10.07 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 168.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -154.46 118.79 4.78 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.8 t -159.6 153.53 23.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.62 -40.02 95.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.619 0.645 . . . . 0.0 110.613 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 66.8 p -85.28 -27.26 26.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -83.68 -29.59 27.47 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.728 0.695 . . . . 0.0 110.859 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.74 26.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.986 0.357 . . . . 0.0 111.402 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.4 tp -84.7 -27.8 26.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.336 0.516 . . . . 0.0 112.047 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -77.36 -39.1 48.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.293 0.497 . . . . 0.0 110.273 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 89.7 m -67.84 -38.78 83.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.5 tp -60.63 -42.91 97.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.523 -0.735 . . . . 0.0 110.176 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -75.5 -14.17 82.25 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.244 -173.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . 0.45 ' CD1' ' CE1' ' A' ' 442' ' ' PHE . 23.5 m-85 -126.39 -12.28 6.21 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.763 1.282 . . . . 0.0 113.379 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 18.4 tp -105.79 -14.93 15.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.19 0.904 . . . . 0.0 112.567 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.44 136.4 40.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.2 m170 50.21 34.94 9.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.831 0.852 . . . . 0.0 113.003 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.71 151.29 28.97 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.246 0.618 . . . . 0.0 112.37 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -101.24 136.41 41.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.999 1.719 . . . . 0.0 110.999 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.426 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.3 ttt -64.07 179.93 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.846 0.858 . . . . 0.0 111.367 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . 0.426 ' H ' ' HG2' ' A' ' 564' ' ' MET . 19.7 ptpt -64.27 6.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.59 143.17 93.85 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.115 0.416 . . . . 0.0 110.924 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.55 -30.44 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.389 2.726 . . . . 0.0 112.917 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -121.05 -7.18 9.45 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.7 44.06 96.91 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.007 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 86.7 Cg_endo -72.01 -6.24 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.325 2.683 . . . . 0.0 112.042 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -138.88 150.33 65.0 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.928 0.491 . . . . 0.0 109.917 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.88 144.09 30.29 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.161 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . 0.424 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 89.8 t80 -145.09 -3.63 0.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.306 0.643 . . . . 0.0 111.27 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 132.02 47.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.872 -0.518 . . . . 0.0 110.764 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.8 pp -125.04 144.59 50.32 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.526 0.73 . . . . 0.0 111.125 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.04 140.46 33.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.263 0.625 . . . . 0.0 109.977 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.55 144.99 46.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . 0.545 ' HG ' ' CE1' ' A' ' 501' ' ' HIS . 1.9 p -163.93 173.02 13.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.568 0.347 . . . . 0.0 110.982 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -84.12 148.69 26.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.919 0.39 . . . . 0.0 110.711 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 28.0 t -135.53 159.93 40.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.502 0.721 . . . . 0.0 109.8 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 44.5 m -117.32 101.96 8.86 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.56 34.61 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.164 0.986 . . . . 0.0 109.928 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -78.85 -31.03 45.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -153.57 162.35 41.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.772 1.229 . . . . 0.0 109.054 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.62 76.49 7.49 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.185 179.153 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.031 0.444 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.82 -13.35 39.54 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.425 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 m -148.7 155.31 41.45 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 122.846 0.458 . . . . 0.0 110.691 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.91 -0.84 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.659 3.573 . . . . 0.0 113.242 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.17 158.85 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.551 0.614 . . . . 0.0 110.969 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.3 pp -145.32 170.28 16.62 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.157 0.583 . . . . 0.0 110.606 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 77.5 mtp -135.15 153.36 52.01 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.761 0.424 . . . . 0.0 111.099 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.7 149.62 18.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.211 0.604 . . . . 0.0 110.25 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -141.89 167.57 21.83 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.037 0.535 . . . . 0.0 110.152 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.57 76.87 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.15 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.572 HD22 ' H ' ' A' ' 386' ' ' LEU . 1.9 pt? -67.85 165.33 17.77 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.798 0.799 . . . . 0.0 111.002 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -119.72 128.4 53.75 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.66 1.68 5.01 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 84.0 p -116.62 0.59 12.68 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.55 -6.42 3.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.169 0.588 . . . . 0.0 110.591 174.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 9.3 tpt -150.11 122.95 8.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.701 0.8 . . . . 0.0 109.4 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -141.94 -174.78 4.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.086 0.555 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.6 p -60.73 -23.99 65.36 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.887 0.475 . . . . 0.0 112.023 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.0 -30.73 21.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.917 0.326 . . . . 0.0 111.63 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -82.07 -30.76 31.15 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.571 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.98 -28.48 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -70.02 -33.87 72.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.963 -0.461 . . . . 0.0 110.052 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.23 -16.38 52.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.3 -18.88 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.716 0.407 . . . . 0.0 110.942 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -116.95 -18.96 10.01 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.26 -20.89 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.658 1.117 . . . . 0.0 111.057 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.955 -0.466 . . . . 0.0 111.887 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -121.46 -1.42 9.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.827 0.851 . . . . 0.0 111.268 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.56 169.6 16.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -65.67 142.67 57.95 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.468 -0.431 . . . . 0.0 111.493 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.08 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.652 0.781 . . . . 0.0 109.306 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -99.83 -65.92 0.94 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -165.13 168.52 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 110.313 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 9.3 p -147.18 151.75 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -152.47 144.71 23.93 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.647 0.379 . . . . 0.0 110.374 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.64 160.32 25.09 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 3.3 ptp -136.4 141.42 43.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 56.76 33.82 23.62 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.8 1.64 . . . . 0.0 114.217 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.0 m 52.77 17.81 0.91 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -71.11 158.13 88.79 Favored Pre-proline 0 CA--C 1.528 0.118 0 CA-C-N 118.367 0.53 . . . . 0.0 110.405 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.11 -19.25 32.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -177.53 102.2 0.16 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -157.8 136.71 11.5 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 109.088 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.83 171.28 20.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.231 0.539 . . . . 0.0 110.897 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.6 ptm -143.63 144.34 31.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.602 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.8 t -130.69 139.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 C-N-CA 122.857 0.463 . . . . 0.0 110.395 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -118.06 141.19 48.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.121 0.568 . . . . 0.0 110.062 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 92.3 mmm -111.01 161.85 15.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.139 0.576 . . . . 0.0 110.121 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.33 -22.94 63.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.13 -0.356 . . . . 0.0 111.138 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -159.46 160.34 34.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.518 0.727 . . . . 0.0 109.398 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.74 69.02 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.841 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.432 1.616 . . . . 0.0 110.671 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.46 -25.91 30.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.564 0.221 . . . . 0.0 110.51 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.6 -28.15 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.17 -42.8 71.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.291 -0.256 . . . . 0.0 110.849 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.62 84.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.102 0.41 . . . . 0.0 110.013 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.4 -34.55 58.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.6 tp -79.85 -30.92 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 O-C-N 122.184 -0.323 . . . . 0.0 111.525 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.7 t -94.94 -12.24 27.14 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -138.89 -24.4 0.91 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -95.67 -20.15 19.15 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.064 0.847 . . . . 0.0 108.997 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -51.82 142.66 14.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.502 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.08 1.59 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.617 1.967 . . . . 0.0 115.565 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -87.92 142.62 27.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.274 1.397 . . . . 0.0 108.847 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . 0.428 ' HB2' ' HG3' ' A' ' 446' ' ' MET 0.328 0.0 OUTLIER -131.0 164.14 26.02 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 175.339 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.7 ptm -125.16 143.28 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.476 1.11 . . . . 0.0 109.263 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 64.42 30.12 13.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.89 81.26 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 167.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -83.14 156.9 23.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.499 1.649 . . . . 0.0 111.359 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.547 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -77.76 141.97 38.96 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.902 0.881 . . . . 0.0 110.627 178.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' MET . . . . . 0.428 ' HG3' ' HB2' ' A' ' 440' ' ' PHE . 1.9 mpt? -98.5 122.01 41.16 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -140.69 110.75 6.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.53 139.43 17.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 92.7 m -149.66 160.43 43.52 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.596 0.759 . . . . 0.0 110.23 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -85.09 154.23 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.0 t -144.68 163.26 34.5 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.457 0.703 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -121.17 30.18 6.95 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.511 0.596 . . . . 0.0 112.25 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -63.64 147.91 94.97 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.56 -25.24 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.701 2.267 . . . . 0.0 111.88 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.98 170.22 13.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.453 0.701 . . . . 0.0 109.913 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.01 137.12 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 147.72 57.66 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 110.729 -0.101 . . . . 0.0 110.729 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.84 168.41 23.04 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.098 3.199 . . . . 0.0 111.973 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 177.56 170.99 40.56 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -84.82 -12.72 53.01 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.944 0.372 . . . . 0.0 111.701 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 7.4 m 57.72 169.32 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.145 1.378 . . . . 0.0 113.296 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -155.74 168.31 27.59 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.138 0.575 . . . . 0.0 109.9 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.54 137.79 17.36 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.92 170.24 11.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.313 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.23 -22.79 65.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.545 0.338 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.28 4.69 25.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.529 0.332 . . . . 0.0 111.467 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.57 -0.49 87.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.504 -0.609 . . . . 0.0 113.151 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.9 p -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 117.977 0.889 . . . . 0.0 110.556 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.16 152.4 30.74 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 122.245 -0.285 . . . . 0.0 110.382 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 90.1 p -73.39 -10.37 59.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.532 0.333 . . . . 0.0 111.774 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -127.67 145.21 50.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.797 0.839 . . . . 0.0 110.437 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.09 158.11 38.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.964 0.506 . . . . 0.0 110.058 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.64 148.26 51.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.466 0.706 . . . . 0.0 109.974 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.56 13.69 2.97 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.996 0.518 . . . . 0.0 111.128 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.631 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -60.98 159.62 26.23 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.72 145.13 31.87 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.703 2.935 . . . . 0.0 112.606 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.1 m -124.01 23.9 8.4 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.711 0.804 . . . . 0.0 110.89 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 61.21 14.74 5.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.676 1.191 . . . . 0.0 112.883 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 47.3 t -139.07 141.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.42 148.48 43.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.968 0.507 . . . . 0.0 109.923 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -114.87 151.54 33.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 151.21 46.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.534 0.207 . . . . 0.0 110.677 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -147.89 173.63 12.66 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.635 0.374 . . . . 0.0 111.217 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.2 t30 56.39 34.03 23.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.216 1.006 . . . . 0.0 112.825 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -91.67 157.32 41.98 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.82 148.89 63.76 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.81 2.34 . . . . 0.0 111.588 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.7 -1.28 18.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.82 8.27 15.99 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.15 151.16 4.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 118.007 0.367 . . . . 0.0 110.814 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.4 p -142.32 171.87 13.47 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.348 0.659 . . . . 0.0 110.529 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 -22.17 66.73 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -71.2 -25.03 62.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -83.65 -30.13 27.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.17 -27.1 63.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.03 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.7 -38.12 18.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.488 0.586 . . . . 0.0 111.522 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -74.95 -20.08 59.83 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.467 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.23 -33.88 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 117.792 0.269 . . . . 0.0 110.723 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 69.1 m -67.71 -21.68 65.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.974 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.49 -30.44 63.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.07 -13.13 33.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 111.916 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 99.8 mt -91.57 -9.84 42.77 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.791 0.436 . . . . 0.0 111.057 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.68 5.15 63.36 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.752 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.0 m -87.08 168.4 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.777 0.789 . . . . 0.0 110.836 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -77.28 146.59 36.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.763 0.425 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -96.13 151.64 38.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.573 0.349 . . . . 0.0 110.099 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.25 156.0 68.12 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.186 2.591 . . . . 0.0 111.122 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.446 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -89.54 -23.32 22.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.916 0.486 . . . . 0.0 110.696 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.1 t -143.84 156.87 44.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.01 144.93 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.221 0.534 . . . . 0.0 110.954 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -141.2 128.81 21.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.6 144.07 35.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 122.597 0.359 . . . . 0.0 110.132 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -154.88 153.66 31.47 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.172 0.589 . . . . 0.0 110.034 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.232 0.132 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.468 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.1 t -143.08 158.93 43.16 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.192 0.597 . . . . 0.0 110.642 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 47.1 t -122.16 150.73 41.82 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.78 0.832 . . . . 0.0 111.109 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.7 m -147.07 168.47 21.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.085 1.354 . . . . 0.0 109.185 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.51 -169.2 42.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.891 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.02 154.05 47.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.385 1.074 . . . . 0.0 109.686 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.39 140.47 39.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.007 0.923 . . . . 0.0 108.723 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -127.8 109.75 11.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.446 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.9 p90 -166.13 152.83 9.44 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.019 1.328 . . . . 0.0 107.77 168.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.31 123.73 7.13 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 39.6 t -159.62 152.97 22.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -47.48 80.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.474 0.579 . . . . 0.0 111.348 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.5 p -85.82 -26.2 25.86 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -82.73 -29.13 29.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.231 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.78 30.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.103 0.411 . . . . 0.0 110.931 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.85 -28.05 36.24 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.406 0.548 . . . . 0.0 111.599 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -76.65 -41.05 47.13 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.133 0.424 . . . . 0.0 110.558 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.5 m -68.73 -34.97 76.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.93 -52.17 65.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.855 -0.528 . . . . 0.0 110.12 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.66 -17.1 76.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.005 -0.886 . . . . 0.0 114.258 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -119.22 -9.2 10.0 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.742 1.271 . . . . 0.0 113.67 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.7 tp -89.61 -21.7 22.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.439 1.018 . . . . 0.0 110.328 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.57 147.66 50.45 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.138 -0.351 . . . . 0.0 110.479 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 51.24 24.79 2.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.448 1.099 . . . . 0.0 113.607 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.31 151.38 38.3 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.247 0.546 . . . . 0.0 112.222 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -111.38 136.24 50.79 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.949 0.9 . . . . 0.0 110.855 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.415 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.0 ttt -64.7 178.32 0.79 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.852 0.861 . . . . 0.0 111.006 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 564' ' ' MET . 19.8 ptpt -68.18 7.95 0.5 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.28 140.0 91.58 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.31 -28.95 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.472 2.782 . . . . 0.0 112.86 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -121.04 -7.14 9.46 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.41 44.23 97.92 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.926 -0.93 . . . . 0.0 113.421 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 94.0 Cg_endo -71.27 -7.01 20.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.128 2.552 . . . . 0.0 111.993 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -143.82 149.27 45.81 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.125 0.57 . . . . 0.0 109.867 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.53 154.23 39.91 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.601 2.867 . . . . 0.0 110.796 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -136.54 -0.83 2.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.64 0.376 . . . . 0.0 111.604 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 8.3 t -68.31 132.03 46.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.931 -0.481 . . . . 0.0 111.222 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.94 144.62 50.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 0.0 109.701 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -85.11 145.16 27.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.12 146.79 30.05 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.098 0.559 . . . . 0.0 110.683 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.29 169.71 21.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.896 0.478 . . . . 0.0 110.898 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -72.65 133.51 44.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 25.7 t -135.66 148.43 48.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 60.7 m -89.82 102.34 15.04 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.978 0.418 . . . . 0.0 110.587 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 161.53 34.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.817 0.847 . . . . 0.0 109.456 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -99.38 -15.36 18.8 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.175 0.19 . . . . 0.0 110.919 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -160.22 160.59 32.9 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.193 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.01 76.41 0.99 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.88 0.472 . . . . 0.0 110.087 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.54 -1.219 . . . . 0.0 110.489 -179.423 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.691 0.281 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -132.07 19.98 4.5 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.927 0.491 . . . . 0.0 111.145 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 47.0 t -148.81 145.91 20.78 Favored Pre-proline 0 N--CA 1.453 -0.283 0 O-C-N 122.219 -0.301 . . . . 0.0 111.018 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.0 -0.96 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.778 2.985 . . . . 0.0 112.66 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.2 m -124.83 163.06 25.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 119.18 0.9 . . . . 0.0 112.786 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -149.4 161.92 41.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.293 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 75.1 mmm -118.93 144.45 46.43 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.667 0.787 . . . . 0.0 110.099 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.54 144.81 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.048 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -139.32 166.94 23.23 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.383 0.673 . . . . 0.0 109.23 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.82 86.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.318 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.53 HD13 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.6 173.86 10.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.924 0.862 . . . . 0.0 110.501 176.008 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.39 146.56 51.24 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.019 0.528 . . . . 0.0 110.271 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -81.98 -4.83 57.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.9 t -104.68 -9.2 18.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.883 0.31 . . . . 0.0 111.447 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.31 -5.55 3.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.219 0.608 . . . . 0.0 111.109 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -142.13 126.69 17.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -141.68 -174.97 4.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.019 0.528 . . . . 0.0 109.992 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.61 -26.81 65.76 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.941 0.496 . . . . 0.0 112.036 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.14 -38.39 27.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.99 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -74.79 -28.96 60.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.106 0.412 . . . . 0.0 110.954 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.93 -28.66 24.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -72.1 -30.29 64.93 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 172.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -76.25 -24.82 54.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.6 t -96.58 -26.43 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.399 0.545 . . . . 0.0 112.184 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.27 -14.2 17.07 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 35.3 t -78.57 -17.6 55.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.09 0.859 . . . . 0.0 112.473 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 10.72 1.22 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.272 -0.892 . . . . 0.0 112.171 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -121.38 -1.59 9.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.765 0.826 . . . . 0.0 110.819 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.44 165.5 12.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.44 164.47 22.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.009 0.433 . . . . 0.0 111.161 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 5.4 m -121.11 161.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 C-N-CA 124.237 1.015 . . . . 0.0 109.789 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.58 -52.22 2.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.324 -0.235 . . . . 0.0 111.289 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.16 164.34 27.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.493 0.317 . . . . 0.0 110.795 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.59 151.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.398 0.679 . . . . 0.0 110.262 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.03 148.55 27.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 419' ' ' ALA . 3.9 m-30 -78.65 145.79 34.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 25.1 ttp -99.4 141.04 32.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -168.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 49.8 33.95 7.0 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 112.031 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 83.7 p 52.88 16.02 0.64 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.362 1.465 . . . . 0.0 113.409 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -77.84 132.75 67.19 Favored Pre-proline 0 C--N 1.34 0.192 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.43 -7.43 17.69 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.659 2.239 . . . . 0.0 111.494 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.96 16.54 10.15 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.772 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -144.33 145.33 31.92 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 119.212 1.506 . . . . 0.0 111.056 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 411' ' ' PHE . . . -154.52 163.93 39.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.243 0.544 . . . . 0.0 111.7 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 23.0 ptm -145.23 143.57 30.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.723 0.809 . . . . 0.0 109.757 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.2 p -136.71 153.29 30.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.72 0.408 . . . . 0.0 110.446 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -125.08 138.48 54.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.947 0.499 . . . . 0.0 110.663 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 77.0 mmm -104.42 161.63 13.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.455 0.702 . . . . 0.0 110.145 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.19 -18.67 62.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -157.67 158.85 36.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.974 0.51 . . . . 0.0 109.782 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.6 -14.95 72.86 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.201 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -70.69 -19.82 62.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.03 1.415 . . . . 0.0 111.095 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.44 -24.43 31.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.72 -26.98 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.02 -36.78 82.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.262 -0.274 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -80.13 -31.77 39.05 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.296 -0.253 . . . . 0.0 110.535 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.03 70.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.999 -0.438 . . . . 0.0 110.116 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.6 tp -85.49 -30.93 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.2 m -95.04 -19.99 19.7 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -130.63 -12.04 3.88 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.7 -17.9 10.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.114 0.87 . . . . 0.0 110.031 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.17 142.2 21.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.509 0.724 . . . . 0.0 111.439 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . 0.407 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 76.1 m-20 57.15 1.63 0.1 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.952 1.701 . . . . 0.0 115.214 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.92 142.42 27.81 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 120.579 1.536 . . . . 0.0 108.899 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 0.1 OUTLIER -130.68 163.91 26.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 174.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.7 ptm -125.39 143.52 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.651 1.58 . . . . 0.0 109.314 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 64.12 30.91 13.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.002 1.321 . . . . 0.0 114.454 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.93 79.9 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.17 145.02 29.42 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.357 1.079 . . . . 0.0 109.789 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 141.62 37.97 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.051 -0.405 . . . . 0.0 109.934 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.86 122.0 40.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -168.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -140.68 114.37 8.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.407 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.99 141.69 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 CA-C-N 118.29 0.496 . . . . 0.0 110.493 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 34.1 t -160.04 162.71 34.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.379 0.671 . . . . 0.0 109.617 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.18 158.68 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 110.265 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 45.6 t -138.01 151.41 47.87 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -89.43 4.95 47.42 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -59.6 139.11 89.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -23.43 11.55 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.921 2.414 . . . . 0.0 112.249 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.05 170.62 14.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 110.806 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.57 147.41 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.2 mmt -104.62 150.19 38.29 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.432 0.293 . . . . 0.0 110.56 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.29 177.82 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 124.161 3.24 . . . . 0.0 111.927 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 73.78 -176.72 45.57 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.475 0.559 . . . . 0.0 112.354 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 56.77 19.95 4.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.244 1.018 . . . . 0.0 113.62 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.9 m -97.12 142.67 28.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.247 0.476 . . . . 0.0 111.116 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -148.19 174.26 12.15 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.742 1.217 . . . . 0.0 109.217 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.4 135.96 15.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.74 171.39 10.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.729 0.812 . . . . 0.0 110.44 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -68.6 -20.46 64.5 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.645 0.378 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -80.59 1.3 30.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.108 0.563 . . . . 0.0 111.604 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.84 -2.76 72.86 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 122.054 -0.404 . . . . 0.0 112.231 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 28.0 t -93.36 163.4 13.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.182 0.593 . . . . 0.0 109.453 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 48.6 t -84.3 153.19 23.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.043 0.449 . . . . 0.0 110.645 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 59.5 m -64.79 -10.42 27.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.001 0.92 . . . . 0.0 111.343 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -119.2 142.14 48.27 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.801 0.84 . . . . 0.0 110.137 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.16 156.22 38.19 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.675 0.274 . . . . 0.0 110.703 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -124.73 151.03 45.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.24 1.016 . . . . 0.0 109.941 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.02 10.88 2.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.389 0.676 . . . . 0.0 111.755 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 CA--C 1.533 0.3 0 O-C-N 122.056 -0.403 . . . . 0.0 111.732 -173.786 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -69.07 148.25 97.74 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.875 0.87 . . . . 0.0 109.32 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.09 152.44 14.47 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.702 2.935 . . . . 0.0 113.211 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.2 m -123.95 22.01 8.91 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.057 0.543 . . . . 0.0 112.04 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 19.1 m120 59.72 12.55 2.99 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.77 152.35 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.0 mt -125.42 155.49 40.33 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.942 0.497 . . . . 0.0 111.053 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . 0.433 ' CD2' ' CZ ' ' A' ' 503' ' ' PHE . 2.2 t-160 -132.26 137.71 47.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -124.92 149.94 47.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.033 0.533 . . . . 0.0 110.858 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 501' ' ' HIS . 79.3 m-85 -144.3 172.79 12.44 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 111.251 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 49.4 t30 57.57 31.78 20.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.407 1.083 . . . . 0.0 112.993 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -85.14 157.44 59.5 Favored Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.84 158.89 55.25 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.608 2.205 . . . . 0.0 110.446 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 22.1 tp -70.89 -0.97 10.31 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.013 1.325 . . . . 0.0 112.856 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.47 9.53 7.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.99 151.82 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 118.334 0.516 . . . . 0.0 111.259 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.7 p -142.6 171.43 14.06 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.651 0.78 . . . . 0.0 110.071 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.1 -24.29 67.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.519 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.91 -24.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.355 -0.215 . . . . 0.0 110.67 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -76.77 -35.05 57.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -71.13 -23.79 62.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.909 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -79.42 -40.7 29.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.172 0.442 . . . . 0.0 111.009 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.92 -13.04 60.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 85.4 mt -95.5 -32.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.262 0.483 . . . . 0.0 110.403 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.8 m -68.42 -22.8 64.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.408 -0.807 . . . . 0.0 109.568 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.02 -28.78 61.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.645 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -90.98 -12.83 34.73 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.637 0.653 . . . . 0.0 111.636 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.85 -8.96 27.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.966 0.506 . . . . 0.0 111.257 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.19 64.58 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.248 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.1 168.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.156 0.978 . . . . 0.0 111.212 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -68.34 133.93 49.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.029 0.532 . . . . 0.0 110.119 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -78.22 149.34 75.91 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 148.86 90.21 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.811 2.341 . . . . 0.0 110.138 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.427 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.9 m -93.83 -18.97 21.45 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.848 0.459 . . . . 0.0 110.847 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.3 t -149.47 148.79 29.84 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.01 137.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.211 0.604 . . . . 0.0 109.609 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . 0.507 ' HZ2' ' HB3' ' A' ' 530' ' ' LYS . 0.0 OUTLIER -148.28 104.58 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 89.9 t -126.88 148.01 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.265 0.626 . . . . 0.0 109.925 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -147.64 161.92 40.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.105 0.479 . . . . 0.0 111.937 -176.7 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 89.6 p -140.24 171.54 14.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.5 0.72 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 60.1 m -128.04 150.87 49.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.56 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 58.4 m -147.83 159.9 43.34 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 125.005 1.322 . . . . 0.0 109.353 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.29 -174.97 44.99 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.278 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.4 146.39 28.9 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.33 1.052 . . . . 0.0 110.236 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 5.8 mp -137.66 138.04 39.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -127.74 126.34 41.63 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.427 ' HB3' ' H ' ' A' ' 527' ' ' THR . 8.9 p90 -165.56 148.69 7.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.88 120.4 7.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 42.3 t -159.57 153.34 22.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 168.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -64.79 -52.21 58.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.916 0.78 . . . . 0.0 111.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.9 p -78.7 -27.2 44.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -84.97 -31.11 23.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.786 0.721 . . . . 0.0 111.463 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.41 -30.88 60.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.208 0.458 . . . . 0.0 110.641 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -83.48 -27.15 29.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.37 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -77.37 -39.01 48.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.087 0.403 . . . . 0.0 110.523 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 30.2 m -73.76 -38.66 64.65 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.059 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.98 -47.3 75.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.15 -17.29 75.67 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.542 -173.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.47 -11.67 8.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.916 1.358 . . . . 0.0 113.173 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -95.84 -18.05 20.67 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.382 0.537 . . . . 0.0 110.65 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -65.55 144.89 56.7 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.747 -0.596 . . . . 0.0 109.452 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 60.5 t60 55.61 24.72 7.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.569 1.147 . . . . 0.0 113.252 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 151.33 34.69 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -117.76 136.35 53.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.845 1.258 . . . . 0.0 110.701 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 3.7 ttt -64.2 176.4 1.04 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 111.323 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -65.86 141.26 97.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.092 0.86 . . . . 0.0 110.288 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -79.91 -29.42 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.659 2.906 . . . . 0.0 113.796 -169.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -121.05 2.79 10.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.06 0.391 . . . . 0.0 112.029 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 59.45 42.57 97.62 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.768 -1.018 . . . . 0.0 112.792 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.7 Cg_endo -68.67 -9.96 27.67 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.244 2.63 . . . . 0.0 111.608 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -144.12 147.06 36.16 Favored Pre-proline 0 N--CA 1.454 -0.26 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.91 150.61 38.89 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.689 2.926 . . . . 0.0 110.546 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -143.44 -4.15 0.89 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.679 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 72.5 p -66.56 126.46 28.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 35.8 mt -99.47 144.55 28.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.873 0.469 . . . . 0.0 111.905 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -82.01 130.59 35.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -146.45 147.26 31.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 112.016 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.1 p -161.37 169.72 21.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.952 0.901 . . . . 0.0 109.319 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -74.95 140.57 43.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.6 t -135.39 143.6 46.12 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 35.3 m -81.37 102.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.1 161.5 34.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.975 0.91 . . . . 0.0 110.325 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -109.64 -12.13 14.69 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.925 0.49 . . . . 0.0 110.669 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -160.54 168.55 24.79 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.998 0.919 . . . . 0.0 109.132 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -78.74 77.29 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.891 0.476 . . . . 0.0 109.797 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.415 ' HA ' ' HE3' ' A' ' 530' ' ' LYS . 74.7 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.476 -1.25 . . . . 0.0 110.002 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.136 0.493 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -141.17 18.5 2.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.096 0.958 . . . . 0.0 109.814 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.1 m -142.7 153.87 62.07 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 122.848 0.459 . . . . 0.0 110.609 -174.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.38 3.09 7.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.117 3.212 . . . . 0.0 113.225 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.64 161.83 39.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 118.893 0.769 . . . . 0.0 112.866 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.81 170.46 16.07 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.23 1.012 . . . . 0.0 109.227 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.1 mtp -137.16 148.04 46.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.9 149.21 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.861 0.464 . . . . 0.0 110.661 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.482 ' CE2' ' HE3' ' A' ' 412' ' ' MET . 19.8 m-85 -140.01 164.99 28.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.651 0.78 . . . . 0.0 109.823 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.41 -6.79 75.23 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.304 0.478 . . . . 0.0 112.828 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.5 pt? -69.42 174.62 4.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.916 0.858 . . . . 0.0 110.648 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -134.61 146.74 49.86 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -74.66 -1.91 23.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 93.7 p -117.99 -8.49 10.73 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.027 0.376 . . . . 0.0 111.646 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.4 -17.53 13.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 83.0 mmm -139.21 141.28 37.92 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.946 . . . . 0.0 109.758 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.89 173.93 11.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.39 -27.06 67.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.815 0.28 . . . . 0.0 110.947 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -79.37 -33.41 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.213 0.205 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -79.17 -35.57 41.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.746 0.248 . . . . 0.0 110.9 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.8 p -73.87 -26.7 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -66.89 -41.83 86.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.954 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.0 -8.3 57.32 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.0 112.915 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.34 -22.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.706 0.684 . . . . 0.0 110.231 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.52 -14.99 13.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 50.9 t -71.45 -25.59 62.37 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.071 0.851 . . . . 0.0 111.345 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.09 13.39 1.11 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.537 -0.727 . . . . 0.0 112.068 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -121.43 -3.62 9.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 110.841 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.91 165.43 12.79 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.91 150.03 46.14 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.067 -0.666 . . . . 0.0 110.826 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.42 148.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.87 -53.33 2.63 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.954 -0.466 . . . . 0.0 111.212 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.91 162.78 26.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.003 0.43 . . . . 0.0 111.448 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.6 p -143.23 150.42 17.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.08 142.65 22.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.347 0.259 . . . . 0.0 110.388 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -76.89 146.38 37.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 168.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.482 ' HE3' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -130.09 141.48 50.7 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 59.99 33.92 21.43 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.065 1.746 . . . . 0.0 112.495 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 36.7 m 52.97 14.02 0.41 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -77.3 146.96 75.27 Favored Pre-proline 0 N--CA 1.455 -0.218 0 CA-C-N 118.673 0.67 . . . . 0.0 110.1 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.9 -0.81 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.686 2.924 . . . . 0.0 110.849 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.44 40.0 1.01 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.004 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -148.9 134.84 19.01 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.93 0.865 . . . . 0.0 110.593 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.52 169.19 23.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 22.1 ptm -143.19 147.36 34.77 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.316 0.646 . . . . 0.0 110.028 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.5 t -127.87 153.17 36.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.172 0.589 . . . . 0.0 110.333 -172.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -129.48 135.3 48.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.947 0.499 . . . . 0.0 110.59 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.3 165.0 11.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.805 0.842 . . . . 0.0 109.956 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.56 -20.83 62.76 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -156.54 159.64 38.75 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.9 -15.73 71.84 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.215 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -69.29 -28.63 66.45 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 119.116 1.458 . . . . 0.0 110.383 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -76.26 -20.08 57.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 77.7 t -81.18 -28.13 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.98 -34.99 66.8 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -72.63 -31.85 65.46 Favored 'General case' 0 N--CA 1.457 -0.08 0 O-C-N 122.146 -0.347 . . . . 0.0 110.341 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.82 -29.22 58.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.326 -0.234 . . . . 0.0 110.977 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.4 tp -86.33 -30.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 O-C-N 122.36 -0.212 . . . . 0.0 111.112 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 82.7 p -94.83 -6.8 42.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -136.0 -15.63 1.74 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.62 -20.07 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.93 0.786 . . . . 0.0 110.027 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -51.59 144.31 10.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.704 0.802 . . . . 0.0 111.206 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 57.51 1.39 0.12 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.92 2.088 . . . . 0.0 115.526 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.86 142.5 27.76 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.873 1.669 . . . . 0.0 108.726 169.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.298 0.0 OUTLIER -130.94 163.9 26.49 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 172.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 19.2 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.159 1.384 . . . . 0.0 109.904 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . 0.25 29.0 m-85 66.16 27.02 10.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.976 1.311 . . . . 0.0 114.143 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.7 81.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 168.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -83.04 160.54 21.93 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.909 1.354 . . . . 0.0 110.543 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.532 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -86.31 129.41 34.86 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.596 0.758 . . . . 0.0 110.191 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.58 130.35 45.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -140.61 123.61 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.1 140.97 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.396 0.544 . . . . 0.0 110.655 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 71.5 m -147.11 165.24 30.57 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.88 0.872 . . . . 0.0 110.005 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 p -90.64 155.96 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.851 0.46 . . . . 0.0 109.912 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.6 t -133.89 158.95 42.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 123.12 0.568 . . . . 0.0 109.765 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.62 9.41 39.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -68.25 144.52 96.8 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.78 -24.36 11.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.918 2.412 . . . . 0.0 111.772 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -162.86 172.77 14.64 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.151 0.58 . . . . 0.0 109.992 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.71 143.55 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -100.21 155.98 35.8 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.132 0.173 . . . . 0.0 111.334 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.28 164.01 9.36 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.773 2.982 . . . . 0.0 112.227 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.37 178.97 38.25 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -72.66 163.55 27.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.949 0.5 . . . . 0.0 110.786 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.4 p -144.28 160.36 41.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.898 0.479 . . . . 0.0 110.745 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -151.81 165.04 35.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.557 0.743 . . . . 0.0 110.107 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.74 137.92 18.08 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 67.7 mt -87.06 170.47 11.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.719 0.808 . . . . 0.0 110.188 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.23 -20.41 64.82 Favored 'General case' 0 N--CA 1.461 0.115 0 O-C-N 122.142 -0.349 . . . . 0.0 111.752 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -88.39 6.0 39.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.974 0.509 . . . . 0.0 111.664 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.58 84.74 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.468 0.556 . . . . 0.0 112.797 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.8 m -88.76 161.55 16.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.125 0.963 . . . . 0.0 110.527 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.1 m -82.87 153.34 25.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 110.735 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.2 p -67.83 -10.28 51.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.321 0.649 . . . . 0.0 111.531 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -127.62 137.79 52.65 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.141 0.976 . . . . 0.0 110.123 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -156.36 157.58 35.89 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 122.59 0.356 . . . . 0.0 110.922 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.39 156.64 41.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.688 0.795 . . . . 0.0 110.878 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.64 13.71 2.32 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.324 0.649 . . . . 0.0 111.54 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 122.928 0.491 . . . . 0.0 112.025 -174.58 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.45 121.14 79.56 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 119.363 0.983 . . . . 0.0 110.145 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.94 135.15 15.34 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.992 2.462 . . . . 0.0 109.81 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 97.1 p -124.17 -7.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.042 0.537 . . . . 0.0 112.208 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 58.45 18.42 5.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.595 0.758 . . . . 0.0 111.759 -170.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.78 136.71 55.32 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 123.404 0.682 . . . . 0.0 109.7 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . 0.445 HD13 ' CH2' ' A' ' 546' ' ' TRP . 59.0 mt -118.91 148.59 42.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . 0.498 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 16.0 m170 -114.83 154.55 28.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -135.8 149.16 49.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.455 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -146.69 171.74 14.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.822 0.449 . . . . 0.0 110.714 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 26.4 m120 60.73 21.81 11.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.981 . . . . 0.0 113.42 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -78.48 163.35 62.03 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.96 154.43 50.71 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.001 2.467 . . . . 0.0 111.605 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . 0.443 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -77.84 -1.0 29.46 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -123.71 12.04 9.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.737 0.415 . . . . 0.0 111.976 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.79 154.99 4.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 121.904 -0.498 . . . . 0.0 111.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.9 p -144.67 170.24 16.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.472 0.709 . . . . 0.0 110.437 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 3.1 pm0 -62.37 -21.97 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.629 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.96 -30.82 69.33 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.976 -0.452 . . . . 0.0 109.921 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -78.36 -32.73 49.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.63 -28.62 67.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.184 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -84.08 -37.57 21.9 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.714 -0.616 . . . . 0.0 111.522 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.5 -9.09 59.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.355 0.525 . . . . 0.0 112.148 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.49 -32.51 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 117.783 0.265 . . . . 0.0 110.387 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 60.2 m -67.39 -21.61 65.59 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.0 -29.84 64.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.93 -16.54 27.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.554 0.615 . . . . 0.0 111.776 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.19 -11.85 42.59 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.53 0.332 . . . . 0.0 111.199 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 4.63 58.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.848 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.65 169.67 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 118.013 0.906 . . . . 0.0 110.603 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.74 153.42 35.04 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -102.43 153.21 38.28 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.459 0.304 . . . . 0.0 110.361 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.5 148.85 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.1 2.533 . . . . 0.0 111.143 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.487 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.5 m -81.97 -25.07 35.11 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.72 0.408 . . . . 0.0 110.555 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.9 t -144.53 158.46 43.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.84 145.31 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 122.84 0.456 . . . . 0.0 110.599 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -144.28 127.15 16.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.681 0.792 . . . . 0.0 108.983 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 32.9 t -130.64 149.03 33.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -143.41 165.87 26.32 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.779 0.324 . . . . 0.0 111.697 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.233 0.186 0 C-N-CA 123.653 0.781 . . . . 0.0 110.526 -179.323 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 49.8 m -141.86 168.48 19.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.372 1.069 . . . . 0.0 109.391 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 23.2 t -127.75 160.07 32.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.275 0.56 . . . . 0.0 111.226 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.1 p -149.64 167.05 27.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.233 1.013 . . . . 0.0 109.785 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.99 -172.88 45.49 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.344 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.51 153.91 39.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.915 0.886 . . . . 0.0 110.365 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.8 mt -138.07 142.22 40.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.383 1.073 . . . . 0.0 108.693 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -127.79 106.49 9.16 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.487 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -166.02 153.49 10.18 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.961 1.304 . . . . 0.0 107.853 168.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -152.82 122.64 6.92 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 45.2 t -159.6 153.04 22.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -66.45 -42.29 87.82 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.545 0.611 . . . . 0.0 110.943 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.4 p -85.76 -29.02 24.18 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -83.39 -28.74 28.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.543 0.611 . . . . 0.0 111.267 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -84.72 -30.0 25.1 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.256 0.48 . . . . 0.0 110.943 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.22 -28.2 34.95 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.419 0.554 . . . . 0.0 111.355 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.11 -40.78 37.18 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.884 -0.51 . . . . 0.0 110.39 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 61.3 m -68.25 -36.18 79.05 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.13 -43.22 95.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.837 -0.539 . . . . 0.0 109.738 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.3 -14.18 79.36 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.619 -1.1 . . . . 0.0 114.094 -173.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -128.54 -10.71 5.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.093 1.446 . . . . 0.0 113.77 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.85 -18.5 29.12 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.301 0.955 . . . . 0.0 109.852 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.475 HD21 ' CD2' ' A' ' 561' ' ' HIS . 1.2 t30 -85.79 153.42 22.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 171.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . 0.475 ' CD2' HD21 ' A' ' 560' ' ' ASN . 78.0 m-70 57.51 15.97 3.05 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . 0.414 ' CZ ' ' CE2' ' A' ' 573' ' ' TYR . 0.0 OUTLIER -79.15 151.48 31.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -112.27 136.28 51.9 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.076 0.95 . . . . 0.0 110.576 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.401 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.9 ttt -64.23 176.11 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.775 0.83 . . . . 0.0 111.227 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 564' ' ' MET . 67.0 mttm -73.69 11.79 0.77 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.516 0.726 . . . . 0.0 112.874 -177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -64.86 144.88 99.02 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.401 0.546 . . . . 0.0 110.646 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.79 -27.78 4.59 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.428 2.752 . . . . 0.0 113.676 -170.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -120.97 -3.29 9.64 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.197 0.453 . . . . 0.0 111.955 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.87 39.71 97.64 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.751 -1.027 . . . . 0.0 113.211 -177.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 93.9 Cg_endo -71.29 -7.97 22.43 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.847 2.365 . . . . 0.0 112.115 -176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -144.22 147.78 38.65 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.157 0.435 . . . . 0.0 110.4 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.32 160.9 38.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.086 3.191 . . . . 0.0 110.902 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . 0.414 ' CE2' ' CZ ' ' A' ' 562' ' ' TYR . 42.4 t80 -141.77 -2.62 1.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.7 t -66.4 132.08 47.51 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 2.1 pp -120.23 144.61 47.66 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.748 0.819 . . . . 0.0 110.197 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -76.07 148.58 37.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.22 145.0 48.76 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.524 0.729 . . . . 0.0 109.661 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.5 p -163.39 161.37 24.37 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -74.33 131.75 41.42 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.498 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 39.4 t -135.63 137.69 42.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 66.2 m -79.27 102.4 8.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.012 0.435 . . . . 0.0 110.901 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 159.49 40.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.127 0.971 . . . . 0.0 109.245 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -85.99 -25.13 26.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.341 -0.225 . . . . 0.0 110.781 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -164.18 168.6 18.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.625 0.77 . . . . 0.0 109.954 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.22 76.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.179 -179.676 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.139 0.495 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.78 8.03 4.83 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.378 0.671 . . . . 0.0 110.282 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.2 m -146.38 154.67 49.52 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.169 0.588 . . . . 0.0 110.573 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.18 4.52 6.99 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.225 3.283 . . . . 0.0 112.825 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.5 162.28 35.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 119.164 0.893 . . . . 0.0 112.672 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.04 166.06 26.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 109.644 173.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.2 mmm -121.89 150.81 41.44 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.7 0.8 . . . . 0.0 110.149 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.32 145.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.485 ' CE2' ' HE1' ' A' ' 412' ' ' MET . 2.7 m-85 -142.79 166.66 24.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.907 0.483 . . . . 0.0 109.898 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.53 -0.6 84.98 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.607 173.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.11 177.42 5.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.175 0.988 . . . . 0.0 110.727 176.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.46 136.5 52.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.781 0.432 . . . . 0.0 110.231 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -75.77 4.4 8.01 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 18.3 t -112.53 -8.04 13.87 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.753 0.421 . . . . 0.0 111.556 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 -8.42 4.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 111.216 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.1 tpt -142.51 121.0 12.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.576 0.75 . . . . 0.0 109.211 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -141.9 -178.82 5.87 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.765 0.426 . . . . 0.0 110.406 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.2 m -60.5 -22.13 63.2 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.8 -25.88 19.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.829 -0.544 . . . . 0.0 111.637 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -87.82 -23.55 23.99 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.666 0.666 . . . . 0.0 109.873 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.2 p -78.38 -33.9 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.29 -33.77 76.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -71.33 -29.63 65.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.996 -0.44 . . . . 0.0 111.507 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 42.3 t -85.43 -13.02 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.058 -0.401 . . . . 0.0 111.592 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -118.94 -7.07 10.47 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.4 -35.47 75.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.332 0.969 . . . . 0.0 111.204 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.28 12.26 1.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.837 -0.539 . . . . 0.0 112.095 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -121.46 -4.74 9.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.481 0.712 . . . . 0.0 111.132 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.94 175.7 20.08 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.1 146.26 43.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.599 -0.353 . . . . 0.0 110.539 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.95 150.67 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -98.46 -60.48 1.54 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -167.51 166.1 14.37 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.576 0.75 . . . . 0.0 110.474 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.33 146.65 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 123.087 0.555 . . . . 0.0 110.312 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.47 ' HE2' ' CD1' ' A' ' 471' ' ' TYR . 39.0 ttmt -150.22 148.58 29.08 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.184 0.194 . . . . 0.0 111.135 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -82.48 149.07 27.77 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.485 ' HE1' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -135.66 141.43 45.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -168.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt 60.12 33.81 21.19 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 126.713 2.005 . . . . 0.0 114.13 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.7 m 52.91 18.03 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.62 157.59 87.88 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 118.587 0.63 . . . . 0.0 110.393 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.63 -18.82 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.601 2.868 . . . . 0.0 111.948 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -179.24 100.9 0.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -160.91 143.42 12.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.26 171.49 19.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.314 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.0 ptm -144.44 143.96 31.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.35 151.67 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 C-N-CA 123.145 0.578 . . . . 0.0 110.284 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -129.52 137.5 50.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 90.5 mmm -109.22 164.04 12.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.431 0.692 . . . . 0.0 110.025 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.58 64.29 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.457 -0.152 . . . . 0.0 111.078 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -159.73 161.61 34.79 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.494 0.717 . . . . 0.0 109.404 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.96 -16.11 68.01 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.249 -0.751 . . . . 0.0 112.905 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 427' ' ' TYR . 2.5 p90 -65.45 -28.36 69.17 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.048 1.424 . . . . 0.0 110.925 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.0 -19.77 43.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.3 t -80.28 -23.75 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.9 -38.38 88.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.51 -26.37 45.87 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.98 -36.2 59.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.039 0.381 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.5 tp -85.16 -30.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 122.251 -0.281 . . . . 0.0 111.54 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.8 m -91.38 -21.51 20.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -124.57 -14.32 6.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.56 -19.05 10.77 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.947 0.794 . . . . 0.0 110.389 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.97 139.07 23.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.383 0.611 . . . . 0.0 111.36 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . 0.412 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 69.7 m-20 56.76 1.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.212 1.805 . . . . 0.0 115.735 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.77 142.46 27.81 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 120.869 1.668 . . . . 0.0 109.144 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.297 0.1 OUTLIER -130.9 163.84 26.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 174.547 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.2 ptm -125.29 143.33 51.01 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.029 1.331 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 63.05 33.07 14.99 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.33 15.6 78.05 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.95 140.9 32.53 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.323 1.061 . . . . 0.0 109.496 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -77.72 141.38 39.36 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.81 125.34 41.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -168.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -140.71 112.07 7.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.412 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.71 134.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.054 0.388 . . . . 0.0 110.715 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 81.6 m -149.52 165.04 33.37 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 124.394 1.078 . . . . 0.0 109.855 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.8 156.8 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.0 t -135.26 159.59 41.07 Favored 'General case' 0 C--O 1.23 0.046 0 C-N-CA 122.961 0.504 . . . . 0.0 110.333 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -99.3 5.76 46.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -67.03 144.92 98.75 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.796 -0.565 . . . . 0.0 109.551 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.92 -26.1 8.29 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.079 2.519 . . . . 0.0 112.244 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.6 173.59 11.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.051 0.54 . . . . 0.0 110.328 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.04 141.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.68 153.2 55.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 C-N-CA 122.208 0.203 . . . . 0.0 111.138 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.41 156.45 65.59 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.51 2.807 . . . . 0.0 111.231 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.25 169.14 28.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -78.28 157.82 29.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.752 0.421 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.9 p -134.27 159.78 39.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.987 0.515 . . . . 0.0 110.662 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -155.73 168.07 28.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.07 0.548 . . . . 0.0 109.732 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -76.91 140.83 25.44 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.69 170.75 13.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.874 0.87 . . . . 0.0 109.418 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.4 -20.03 65.48 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -90.14 5.27 47.59 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.24 85.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.017 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.4 m -89.14 155.76 19.23 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 118.413 1.107 . . . . 0.0 110.201 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.9 m -81.79 150.36 27.93 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.145 -0.347 . . . . 0.0 111.162 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -73.21 -10.37 59.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.785 0.434 . . . . 0.0 111.969 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . 0.47 ' CD1' ' HE2' ' A' ' 410' ' ' LYS . 41.8 t80 -139.05 141.11 38.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.68 0.792 . . . . 0.0 110.699 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -156.77 153.35 28.22 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.807 0.443 . . . . 0.0 110.603 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.06 154.07 40.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.194 0.998 . . . . 0.0 109.701 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -135.93 -3.77 2.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.034 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -74.28 157.91 86.03 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.808 0.843 . . . . 0.0 109.786 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.38 133.88 31.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.978 2.452 . . . . 0.0 110.401 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.0 m -124.17 23.99 8.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.885 0.874 . . . . 0.0 111.73 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.31 17.63 3.81 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.675 1.59 . . . . 0.0 114.674 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.9 t -140.57 144.66 26.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . 0.438 HD13 ' CH2' ' A' ' 546' ' ' TRP . 70.5 mt -123.31 163.56 20.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.14 0.576 . . . . 0.0 110.465 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.24 160.6 41.76 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.69 0.396 . . . . 0.0 110.523 174.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -136.59 155.53 49.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.336 0.654 . . . . 0.0 110.821 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -146.12 173.92 11.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.484 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.6 t30 62.35 33.98 16.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.373 1.069 . . . . 0.0 112.566 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -90.0 158.7 44.03 Favored Pre-proline 0 N--CA 1.454 -0.251 0 C-N-CA 122.744 0.418 . . . . 0.0 110.203 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 153.16 72.54 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.362 2.042 . . . . 0.0 109.558 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -70.93 -1.21 11.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.75 8.26 20.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.4 p -79.16 151.92 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.324 0.511 . . . . 0.0 110.938 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.3 p -144.72 171.93 13.71 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.437 0.695 . . . . 0.0 110.274 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.44 -19.87 65.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.88 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -72.33 -23.91 61.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.42 -31.48 26.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -70.66 -29.87 66.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.953 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -84.17 -36.2 23.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.435 0.561 . . . . 0.0 111.668 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.71 -21.89 59.13 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.384 0.538 . . . . 0.0 111.752 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.8 mt -92.77 -33.96 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 117.854 0.297 . . . . 0.0 110.614 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 87.4 m -68.29 -21.03 64.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.445 -0.784 . . . . 0.0 110.74 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.15 -30.8 65.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.378 -0.201 . . . . 0.0 111.507 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.03 -13.42 33.27 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.31 0.505 . . . . 0.0 111.997 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.25 -11.03 33.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.519 0.328 . . . . 0.0 111.102 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.72 4.67 62.3 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.408 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.9 162.06 3.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 118.24 1.02 . . . . 0.0 110.697 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -69.49 142.91 53.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -92.32 151.47 41.53 Favored Pre-proline 0 CA--C 1.528 0.132 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.08 154.7 71.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.204 2.603 . . . . 0.0 110.329 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 99.0 m -89.95 -26.76 20.23 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 122.722 0.409 . . . . 0.0 110.859 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 52.0 m -141.51 152.76 44.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 3.5 p -149.56 147.12 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.878 0.471 . . . . 0.0 110.72 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 122.55 9.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.77 145.93 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.79 0.436 . . . . 0.0 110.329 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -155.12 151.37 28.21 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.88 0.472 . . . . 0.0 110.38 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.232 0.156 0 C-N-CA 122.918 0.487 . . . . 0.0 110.892 -178.766 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 69.8 m -139.27 162.74 34.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.15 0.58 . . . . 0.0 110.487 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 35.1 t -127.39 158.44 37.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.672 0.789 . . . . 0.0 111.877 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -154.29 168.32 26.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.103 1.361 . . . . 0.0 109.59 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.31 -178.86 48.28 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.911 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.22 154.24 28.24 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.3 mt -139.2 134.47 32.79 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.441 1.096 . . . . 0.0 108.703 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.85 114.89 17.8 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.438 ' CH2' HD13 ' A' ' 500' ' ' LEU . 1.3 p90 -166.11 155.0 11.28 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -150.66 117.48 5.85 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.979 1.104 . . . . 0.0 113.979 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 48.2 t -159.49 153.05 22.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 168.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -65.87 -42.41 90.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.389 0.54 . . . . 0.0 110.491 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 71.9 p -82.29 -26.3 33.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -81.94 -35.24 29.31 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.63 0.65 . . . . 0.0 110.89 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -77.65 -29.6 51.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.407 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.28 -28.22 23.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.397 0.544 . . . . 0.0 111.568 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -75.19 -34.84 61.57 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.458 0.572 . . . . 0.0 110.041 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 41.3 m -72.88 -40.99 65.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 28.7 tp -59.92 -52.26 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.242 -0.911 . . . . 0.0 109.164 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.6 -11.69 72.95 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.591 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.43 -4.27 2.64 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 119.476 1.638 . . . . 0.0 113.869 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -97.48 -30.28 12.98 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.771 0.714 . . . . 0.0 109.561 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -67.42 155.86 37.96 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.355 -0.841 . . . . 0.0 109.279 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 34.4 m80 61.25 18.82 9.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.396 1.078 . . . . 0.0 113.643 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.46 151.45 27.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.332 0.587 . . . . 0.0 112.308 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -120.71 136.36 54.88 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.189 0.996 . . . . 0.0 110.734 -175.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.448 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 6.3 ttt -64.21 175.39 1.29 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.657 0.783 . . . . 0.0 111.575 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 564' ' ' MET . 48.6 mtmt -70.32 5.82 1.59 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.053 0.941 . . . . 0.0 113.233 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -64.52 142.54 98.45 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.058 0.844 . . . . 0.0 110.895 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.57 -28.23 3.63 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.662 2.908 . . . . 0.0 113.782 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.09 1.27 10.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.257 0.48 . . . . 0.0 111.788 -175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.444 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.52 40.14 98.29 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.293 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.2 Cg_endo -68.26 -9.07 24.72 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.076 2.517 . . . . 0.0 111.802 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -145.53 145.94 27.82 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.55 156.46 40.57 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.801 3.0 . . . . 0.0 110.848 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . 0.407 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.5 t80 -142.29 -1.59 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.2 m -66.47 120.92 14.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 29.3 mt -98.82 144.49 27.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.563 0.745 . . . . 0.0 110.329 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -93.77 136.8 33.68 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.58 156.33 43.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.843 0.354 . . . . 0.0 111.647 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 22.4 p -163.72 -179.99 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.763 0.825 . . . . 0.0 110.084 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -75.6 143.63 42.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.518 0.327 . . . . 0.0 111.163 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.1 t -135.52 142.84 45.49 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.253 0.621 . . . . 0.0 110.501 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 59.8 m -90.75 102.21 14.97 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.2 161.51 34.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.558 0.743 . . . . 0.0 110.663 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -110.76 -8.24 14.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.868 0.467 . . . . 0.0 110.59 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -159.82 161.95 34.63 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.22 1.008 . . . . 0.0 109.394 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -83.67 76.41 9.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.466 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.9 -6.69 42.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.559 0.344 . . . . 0.0 111.624 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.8 m -147.22 152.37 42.78 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -86.42 0.17 8.08 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.787 3.658 . . . . 0.0 112.246 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.8 151.74 36.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 118.472 0.578 . . . . 0.0 111.244 -174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -146.71 169.14 19.66 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.205 0.602 . . . . 0.0 110.183 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.4 mtp -135.08 154.06 51.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.286 0.234 . . . . 0.0 110.853 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.1 p -144.41 150.76 16.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 122.711 0.404 . . . . 0.0 110.948 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.17 168.78 18.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.856 0.862 . . . . 0.0 109.141 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.56 -3.29 86.9 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.766 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.2 pt? -72.7 176.65 5.36 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.654 0.727 . . . . 0.0 110.319 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -145.12 134.89 23.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -70.03 -5.06 23.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 97.1 p -93.86 -11.72 30.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 0.61 0.92 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.5 tpt -136.85 123.94 21.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -141.93 177.24 8.33 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.42 0.288 . . . . 0.0 111.029 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 77.1 m -59.03 -26.38 64.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.063 0.545 . . . . 0.0 111.897 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -82.92 -22.68 33.79 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.27 -0.269 . . . . 0.0 111.078 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -85.95 -36.45 19.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.87 -28.37 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.65 -38.27 83.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.095 -0.378 . . . . 0.0 110.038 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -80.73 -29.68 36.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.735 0.698 . . . . 0.0 112.664 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.41 -20.74 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 118.628 0.649 . . . . 0.0 110.789 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -113.69 -19.93 11.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 44.9 t -73.87 -26.81 60.76 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.564 1.075 . . . . 0.0 111.14 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.49 7.47 1.83 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.498 -0.751 . . . . 0.0 111.406 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.41 -0.04 9.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.014 0.926 . . . . 0.0 111.463 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 155.01 170.88 21.15 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.38 150.1 48.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.033 0.444 . . . . 0.0 111.338 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 7.2 m -117.67 164.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -134.92 -52.23 0.79 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.171 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -163.8 163.18 24.01 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.655 0.661 . . . . 0.0 112.176 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.82 153.3 13.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.853 0.861 . . . . 0.0 110.44 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -151.97 145.58 24.96 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.47 0.308 . . . . 0.0 110.335 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.36 163.24 25.01 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 30.6 ttp -123.14 141.11 52.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 49.47 33.93 6.19 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.2 1.4 . . . . 0.0 112.311 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 24.3 m 52.95 18.23 1.04 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.146 0.978 . . . . 0.0 113.303 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.38 147.21 67.93 Favored Pre-proline 0 N--CA 1.456 -0.125 0 O-C-N 121.929 -0.482 . . . . 0.0 109.859 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -79.18 -2.44 12.36 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.495 2.797 . . . . 0.0 110.678 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -137.62 30.67 2.57 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.427 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.31 137.03 22.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.158 0.979 . . . . 0.0 110.149 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.11 167.72 29.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.74 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.8 ptm -142.54 142.02 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.776 0.831 . . . . 0.0 109.663 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.81 147.49 23.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.65 0.38 . . . . 0.0 110.916 -173.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -124.88 145.12 49.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.983 0.513 . . . . 0.0 111.154 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 78.5 mmm -111.61 162.74 14.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.334 1.054 . . . . 0.0 109.397 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.84 -20.84 62.51 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.027 -0.421 . . . . 0.0 111.8 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.23 161.4 39.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.119 0.568 . . . . 0.0 109.791 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.59 -12.92 70.84 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.177 -0.79 . . . . 0.0 113.553 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.49 -27.3 66.89 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.411 1.605 . . . . 0.0 110.24 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.7 -28.74 45.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.687 0.28 . . . . 0.0 110.256 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.0 t -75.66 -24.83 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.37 -39.88 67.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.127 -0.358 . . . . 0.0 110.957 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.68 67.93 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.87 -33.39 34.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.14 -0.35 . . . . 0.0 111.931 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -83.06 -30.98 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.871 -0.518 . . . . 0.0 111.36 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.8 m -98.62 -14.14 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.35 -8.43 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.69 -20.11 10.25 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.281 0.946 . . . . 0.0 109.578 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -52.01 143.63 13.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.703 0.801 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.2 1.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.367 2.267 . . . . 0.0 115.971 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.77 142.32 27.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.647 1.567 . . . . 0.0 108.679 169.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.363 0.0 OUTLIER -130.92 165.07 23.9 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.9 ptp -125.13 143.53 50.88 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.011 1.324 . . . . 0.0 109.632 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 66.18 26.45 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.12 15.76 74.65 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -83.0 161.89 21.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.531 1.166 . . . . 0.0 110.087 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.403 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -83.79 132.4 34.83 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.48 133.83 42.3 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.76 117.23 10.79 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.69 143.73 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.236 0.471 . . . . 0.0 110.19 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 26.3 t -158.94 160.41 36.01 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.666 0.386 . . . . 0.0 110.057 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.14 158.22 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.677 0.391 . . . . 0.0 110.055 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.8 t -133.1 158.76 41.97 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.262 0.625 . . . . 0.0 109.837 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -110.86 14.02 22.17 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -66.94 151.07 97.44 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.31 -28.5 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.783 2.322 . . . . 0.0 111.862 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.66 172.23 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.284 0.634 . . . . 0.0 110.254 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.6 mm -66.44 137.81 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -89.01 149.3 43.01 Favored Pre-proline 0 N--CA 1.455 -0.179 0 O-C-N 122.404 -0.185 . . . . 0.0 110.869 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.17 162.77 39.83 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.665 2.91 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 168.03 -177.55 42.19 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -75.78 162.64 28.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.5 p -136.9 162.62 32.76 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.843 0.457 . . . . 0.0 110.914 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.55 163.42 32.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.569 0.748 . . . . 0.0 109.617 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.68 134.34 13.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.76 171.11 11.16 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.493 0.717 . . . . 0.0 110.063 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.02 -20.47 66.2 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.557 0.343 . . . . 0.0 111.432 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.72 1.94 47.43 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.838 0.455 . . . . 0.0 111.603 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.24 -3.68 85.5 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.874 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 68.4 m -91.38 159.14 16.14 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 118.196 0.998 . . . . 0.0 110.525 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.8 m -80.0 153.46 28.85 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.511 0.324 . . . . 0.0 110.478 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.0 p -70.01 -10.41 58.57 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.339 0.656 . . . . 0.0 111.656 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -126.53 139.28 53.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.307 1.043 . . . . 0.0 109.272 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -155.83 156.15 34.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.231 0.212 . . . . 0.0 110.845 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.22 156.37 35.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.879 0.872 . . . . 0.0 110.704 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -139.93 16.91 2.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.395 0.678 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.741 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -66.93 164.89 30.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.637 0.775 . . . . 0.0 110.044 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.9 145.75 23.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.915 3.076 . . . . 0.0 113.523 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 49.1 m -124.11 23.7 8.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.729 0.812 . . . . 0.0 111.809 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 60.54 10.23 2.44 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.22 1.408 . . . . 0.0 114.306 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 29.8 t -140.41 144.96 26.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . 0.424 HD12 ' CH2' ' A' ' 546' ' ' TRP . 65.5 mt -122.79 150.53 42.69 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.804 0.441 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.92 150.12 50.02 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.212 0.605 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.71 151.91 47.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -145.47 169.21 18.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.85 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.7 t30 58.56 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.023 0.929 . . . . 0.0 112.487 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.8 163.41 49.08 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 122.778 0.431 . . . . 0.0 109.863 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.83 150.53 62.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.853 2.369 . . . . 0.0 111.549 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . 0.411 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.8 pt? -72.85 -1.09 15.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.48 13.58 5.0 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -76.26 154.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.129 0.422 . . . . 0.0 110.578 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 66.3 p -142.22 171.04 14.6 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.961 0.504 . . . . 0.0 110.088 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.64 -22.03 66.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.097 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.81 -26.08 56.92 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.24 -0.287 . . . . 0.0 110.71 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -79.04 -30.98 44.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.77 -30.02 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.398 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -76.78 -39.85 50.19 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.1 0.409 . . . . 0.0 111.672 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.94 -18.19 56.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.732 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.23 -33.9 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.222 0.464 . . . . 0.0 110.251 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.84 -21.65 65.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.556 -0.715 . . . . 0.0 110.174 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.96 -28.86 60.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.769 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.99 -14.35 31.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.345 0.521 . . . . 0.0 111.892 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.6 mt -95.4 -7.05 39.49 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.566 0.346 . . . . 0.0 110.903 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.36 4.72 61.14 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.224 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.6 m -80.67 169.47 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.092 0.946 . . . . 0.0 111.033 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -80.91 147.62 30.24 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.984 0.513 . . . . 0.0 110.736 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -88.29 147.53 40.42 Favored Pre-proline 0 C--O 1.232 0.132 0 C-N-CA 123.064 0.546 . . . . 0.0 109.964 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.53 156.13 61.96 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.534 2.823 . . . . 0.0 110.195 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.427 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.2 m -86.95 -25.91 24.12 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.341 0.256 . . . . 0.0 110.608 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.7 m -144.52 151.76 39.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.865 0.466 . . . . 0.0 109.824 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.57 144.56 29.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 123.496 0.718 . . . . 0.0 109.124 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 124.13 11.45 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.08 151.57 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -145.66 147.51 32.07 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.941 0.4 . . . . 0.0 111.694 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.7 t . . . . . 0 N--CA 1.454 -0.256 0 C-N-CA 123.924 0.889 . . . . 0.0 109.066 172.221 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 79.8 p -152.52 175.32 12.88 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.595 1.158 . . . . 0.0 109.898 177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 69.2 m -132.16 161.18 33.98 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.885 0.474 . . . . 0.0 110.934 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.2 m -145.53 159.59 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.912 0.885 . . . . 0.0 109.606 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -174.86 -175.74 42.6 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.638 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.78 155.37 34.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.898 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.4 mt -135.91 132.6 36.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.489 1.116 . . . . 0.0 108.042 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.76 112.56 14.93 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.427 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -166.04 155.42 11.81 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.59 1.556 . . . . 0.0 107.368 168.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -150.01 122.89 8.73 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.2 t -159.53 152.97 22.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.64 -46.83 77.72 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.778 0.717 . . . . 0.0 111.213 -174.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 78.2 p -84.34 -25.4 29.22 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -85.36 -28.58 25.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.725 0.693 . . . . 0.0 111.271 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.247 0.476 . . . . 0.0 110.663 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.97 -29.84 35.22 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.19 0.45 . . . . 0.0 111.045 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -77.83 -38.56 45.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.352 0.524 . . . . 0.0 110.179 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 38.2 m -73.21 -42.64 62.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.54 -46.61 89.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -67.53 -14.87 65.38 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.355 -1.247 . . . . 0.0 114.032 -172.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.07 -6.81 2.69 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.327 1.564 . . . . 0.0 113.976 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.95 -22.3 25.69 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.557 0.617 . . . . 0.0 109.749 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.08 151.51 30.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.22 -0.3 . . . . 0.0 111.023 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 49.24 30.0 2.9 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 151.42 25.65 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -110.91 136.33 50.1 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.213 1.405 . . . . 0.0 110.628 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.2 ttt -64.28 174.95 1.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.154 0.982 . . . . 0.0 112.18 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.87 12.58 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.37 1.068 . . . . 0.0 112.835 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.48 141.41 88.05 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.21 0.604 . . . . 0.0 111.147 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.55 -29.8 2.18 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.356 2.704 . . . . 0.0 113.021 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -121.05 -7.9 9.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.395 0.516 . . . . 0.0 112.395 -177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.12 42.84 97.9 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.412 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 88.8 Cg_endo -71.9 -6.55 19.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.134 2.556 . . . . 0.0 112.208 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.1 149.98 47.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.135 0.574 . . . . 0.0 110.341 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.44 156.24 41.03 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.627 2.885 . . . . 0.0 110.595 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -137.87 -2.46 1.91 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.524 0.33 . . . . 0.0 111.478 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.0 t -66.69 131.95 47.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.164 0.507 . . . . 0.0 110.73 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.03 144.6 50.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.595 1.158 . . . . 0.0 109.638 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -72.48 147.08 46.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 54.9 tp -142.05 144.7 33.73 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.97 172.64 13.64 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 111.502 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -88.46 132.94 34.27 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.2 t -135.57 150.67 49.77 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.068 0.147 . . . . 0.0 110.783 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 40.9 m -87.1 102.56 14.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.945 0.403 . . . . 0.0 111.154 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.39 34.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.697 0.799 . . . . 0.0 109.892 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -109.7 -14.06 14.4 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.939 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -160.84 164.83 31.05 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.485 0.714 . . . . 0.0 109.457 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.52 102.9 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.645 -178.448 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.0 1.4 3.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 50.0 m -145.42 151.7 47.97 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 117.872 0.306 . . . . 0.0 111.285 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.26 -3.06 10.17 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 124.339 3.36 . . . . 0.0 111.934 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.03 151.74 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.286 0.494 . . . . 0.0 111.585 -173.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.72 174.58 11.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.728 0.811 . . . . 0.0 110.27 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.7 mtp -135.4 149.89 49.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.422 0.289 . . . . 0.0 111.207 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.5 148.77 28.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.574 0.75 . . . . 0.0 109.971 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.443 ' CE2' ' HE3' ' A' ' 412' ' ' MET . 45.7 m-85 -139.4 168.4 19.9 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.992 0.517 . . . . 0.0 110.289 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.03 -6.05 68.65 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.411 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.443 HD21 ' H ' ' A' ' 386' ' ' LEU . 2.3 pt? -71.85 -175.48 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.163 0.982 . . . . 0.0 110.598 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -146.12 149.7 34.51 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 121.981 -0.449 . . . . 0.0 110.559 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -76.2 -2.08 29.47 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 m -108.89 -4.1 17.07 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.608 0.363 . . . . 0.0 111.701 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -130.27 -12.28 4.04 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.014 0.526 . . . . 0.0 111.011 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 85.5 mtp -141.28 135.25 30.43 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.923 0.489 . . . . 0.0 110.342 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -141.87 174.14 10.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.35 -31.15 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.783 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.18 -25.3 29.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -89.15 -28.72 19.85 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 122.234 0.214 . . . . 0.0 110.902 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.73 -26.76 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -66.8 -35.56 80.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.46 -30.4 70.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.195 -0.316 . . . . 0.0 110.83 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.74 -21.6 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -110.44 -10.69 14.55 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.0 t -70.4 -36.38 74.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.851 0.75 . . . . 0.0 111.977 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.96 13.29 1.45 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.715 -0.616 . . . . 0.0 112.251 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -121.41 -1.27 9.66 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.469 0.707 . . . . 0.0 110.861 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 141.16 174.1 14.0 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -75.83 145.16 40.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.534 -0.392 . . . . 0.0 110.685 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.59 154.28 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -105.02 -55.86 2.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 110.523 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -164.47 162.25 21.83 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.105 0.479 . . . . 0.0 111.202 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 15.0 p -145.88 151.28 14.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.8 0.84 . . . . 0.0 110.249 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -154.07 147.19 24.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.335 0.254 . . . . 0.0 110.928 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -76.77 146.99 37.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' MET . . . . . 0.443 ' HE3' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -133.12 141.54 48.22 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -167.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.36 33.99 20.74 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.343 1.457 . . . . 0.0 112.647 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 54.59 19.94 2.66 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -103.82 141.27 22.17 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.02 -14.63 21.03 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.915 2.41 . . . . 0.0 109.622 171.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.05 65.96 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.378 0.989 . . . . 0.0 112.418 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.75 129.91 15.52 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.303 1.052 . . . . 0.0 111.17 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -150.75 167.37 27.62 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.326 0.651 . . . . 0.0 110.891 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 20.2 ptm -144.78 143.98 30.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.656 0.382 . . . . 0.0 110.207 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.64 143.06 41.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.08 0.552 . . . . 0.0 110.694 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -126.54 138.0 53.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.201 0.6 . . . . 0.0 110.135 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 85.6 mmm -102.52 164.95 11.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.0 110.322 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.3 -20.74 62.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.451 -0.155 . . . . 0.0 111.221 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -158.06 161.54 38.03 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.302 0.641 . . . . 0.0 109.74 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.24 -14.33 68.62 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.414 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -67.44 -25.59 65.98 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.064 1.432 . . . . 0.0 110.446 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.58 -18.1 28.79 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.17 0.188 . . . . 0.0 111.182 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.72 -31.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.86 -31.86 71.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -79.62 -29.18 40.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.823 0.449 . . . . 0.0 110.864 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.34 -32.23 26.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.251 0.478 . . . . 0.0 110.819 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.9 tp -79.22 -31.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 122.166 -0.334 . . . . 0.0 111.279 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -97.1 -21.33 17.42 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -122.54 -12.68 8.12 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.3 -20.21 10.43 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 118.864 0.756 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -55.58 144.82 25.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.794 0.838 . . . . 0.0 110.581 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 60.01 1.31 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.772 2.029 . . . . 0.0 114.89 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -88.14 142.68 27.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.397 1.453 . . . . 0.0 109.047 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.307 0.1 OUTLIER -130.81 163.93 26.29 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.5 ptm -125.36 143.43 50.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.655 1.182 . . . . 0.0 108.804 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 62.86 28.42 16.38 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.86 72.24 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -83.07 152.58 25.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.432 1.616 . . . . 0.0 111.095 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 141.83 36.26 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.5 122.02 35.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -168.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.96 118.88 11.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.437 0.695 . . . . 0.0 109.28 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 3.1 p -154.47 138.23 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.164 0.438 . . . . 0.0 110.275 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.9 m -147.69 155.51 41.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.38 157.06 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 48.1 t -130.1 167.57 18.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.118 0.567 . . . . 0.0 109.991 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -119.47 12.43 12.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.848 0.459 . . . . 0.0 111.997 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -63.94 150.79 90.92 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.51 -30.58 9.78 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.472 2.114 . . . . 0.0 111.849 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.58 164.78 10.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.711 0.405 . . . . 0.0 110.77 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.7 mm -70.56 140.31 18.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.0 mmt -102.26 130.38 24.3 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.97 -31.52 9.8 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.6 2.2 . . . . 0.0 112.196 -172.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 58.52 -152.48 30.33 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -101.67 -15.41 17.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.737 0.415 . . . . 0.0 110.543 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 3.1 m 55.86 176.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.671 1.588 . . . . 0.0 113.442 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -153.8 165.34 36.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.519 0.728 . . . . 0.0 109.275 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -86.61 123.85 6.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.97 176.48 7.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.932 0.493 . . . . 0.0 111.228 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -59.96 -24.57 64.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.1 -0.61 25.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.912 -0.492 . . . . 0.0 111.389 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.98 -3.8 78.5 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.614 0.626 . . . . 0.0 112.112 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 23.2 t -93.64 170.32 9.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.515 0.726 . . . . 0.0 110.329 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 16.4 p -85.67 153.32 22.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.99 0.424 . . . . 0.0 111.165 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.0 m -71.7 -10.39 59.69 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.546 0.738 . . . . 0.0 112.576 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -120.14 143.48 48.17 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.068 0.547 . . . . 0.0 110.87 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -153.8 156.55 37.9 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.692 0.397 . . . . 0.0 110.354 177.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -133.17 156.43 47.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.82 15.13 1.94 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.978 0.511 . . . . 0.0 111.608 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.045 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -65.61 162.87 39.15 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.078 0.551 . . . . 0.0 110.3 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.37 145.97 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.519 2.813 . . . . 0.0 112.489 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.7 m -124.05 24.0 8.34 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.452 0.701 . . . . 0.0 111.402 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.81 12.04 2.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.538 1.135 . . . . 0.0 113.618 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.71 151.18 22.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.3 mt -132.4 151.22 51.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.652 0.781 . . . . 0.0 109.689 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -121.09 142.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -125.33 148.02 48.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.206 0.602 . . . . 0.0 110.503 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -144.6 172.71 12.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.737 0.415 . . . . 0.0 111.035 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 66.8 t30 62.23 32.21 17.28 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.325 1.05 . . . . 0.0 113.126 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -89.22 158.29 46.7 Favored Pre-proline 0 N--CA 1.454 -0.242 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 156.81 52.07 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.242 1.961 . . . . 0.0 109.645 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' LEU . . . . . 0.417 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.9 pt? -68.33 -1.17 5.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.666 0.787 . . . . 0.0 112.866 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.52 11.58 12.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.6 p -76.59 153.63 5.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 118.287 0.494 . . . . 0.0 110.725 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 78.4 p -143.76 169.24 18.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.278 0.631 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.04 -24.62 68.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.253 -0.28 . . . . 0.0 110.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.13 -26.01 60.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -78.31 -32.22 49.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.85 -28.54 64.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.236 -0.29 . . . . 0.0 110.708 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -80.37 -36.43 33.97 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.024 0.375 . . . . 0.0 111.941 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.65 -19.5 38.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 80.6 mt -86.86 -34.46 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.11 -21.73 64.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.693 -0.629 . . . . 0.0 109.824 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.54 -31.17 68.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -91.14 -15.9 28.64 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.209 0.459 . . . . 0.0 111.947 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.5 mt -91.52 -9.73 43.32 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.637 0.199 . . . . 0.0 111.201 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.53 4.63 57.98 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.958 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.51 165.64 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.998 0.899 . . . . 0.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -72.2 123.95 24.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -76.59 150.79 82.37 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -63.71 151.03 86.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.84 2.36 . . . . 0.0 110.721 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.6 m -88.23 -19.99 26.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.866 0.467 . . . . 0.0 110.903 -175.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.1 t -146.64 154.16 41.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.37 138.9 46.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 122.413 0.285 . . . . 0.0 110.896 -175.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -147.1 125.49 12.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.191 0.996 . . . . 0.0 108.352 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.63 150.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 C-N-CA 122.728 0.411 . . . . 0.0 110.333 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -145.0 161.12 40.18 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.779 0.832 . . . . 0.0 109.119 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.457 -0.115 0 C-N-CA 122.403 0.281 . . . . 0.0 111.075 -176.675 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.3 t -140.61 158.13 44.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.979 0.512 . . . . 0.0 110.147 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.8 m -125.13 153.43 43.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.612 0.765 . . . . 0.0 112.034 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.0 m -147.9 162.14 39.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.478 1.511 . . . . 0.0 108.528 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.07 177.8 39.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.475 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 84.6 mt -98.91 139.47 34.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.817 -173.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -127.87 116.37 20.03 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' TRP . . . . . 0.426 ' HB3' ' H ' ' A' ' 527' ' ' THR . 3.0 p90 -166.09 150.47 8.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.744 1.618 . . . . 0.0 107.058 168.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.58 120.83 7.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 42.3 t -159.48 152.9 22.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -66.45 -46.1 77.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.97 0.804 . . . . 0.0 111.17 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 68.6 p -84.34 -33.3 23.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.859 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -76.5 -31.31 57.63 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.843 0.747 . . . . 0.0 110.903 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.95 -31.28 58.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.052 0.387 . . . . 0.0 110.752 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.13 -29.73 38.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.132 0.424 . . . . 0.0 111.575 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -71.86 -40.7 68.8 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.39 . . . . 0.0 109.992 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 33.1 m -70.1 -31.68 69.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.41 -45.87 85.74 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.335 -0.853 . . . . 0.0 110.529 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.21 -27.19 70.51 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.041 -0.866 . . . . 0.0 113.421 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.75 -10.7 13.58 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.627 1.213 . . . . 0.0 114.198 -176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -26.84 13.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.304 0.956 . . . . 0.0 110.941 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -60.39 138.21 58.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.059 -1.026 . . . . 0.0 110.951 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 40.3 m170 51.61 26.33 3.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.409 1.084 . . . . 0.0 113.544 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.4 151.36 47.57 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.173 0.511 . . . . 0.0 112.336 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -103.69 136.4 43.46 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.183 0.993 . . . . 0.0 110.694 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 564' ' ' MET . . . . . 0.421 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.4 ttt -64.34 174.92 1.47 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.06 0.544 . . . . 0.0 111.255 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -75.32 11.91 1.09 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -68.68 146.67 97.75 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 118.271 0.487 . . . . 0.0 110.332 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.39 -37.95 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.252 2.634 . . . . 0.0 113.831 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -121.03 6.83 10.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 569' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.1 45.24 92.52 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.107 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 570' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.4 Cg_endo -68.99 -9.8 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.22 2.613 . . . . 0.0 111.866 -178.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -146.17 149.07 37.22 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.011 0.524 . . . . 0.0 109.721 174.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.83 148.96 41.83 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.903 3.068 . . . . 0.0 110.97 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 573' ' ' TYR . . . . . 0.421 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.5 t80 -149.92 15.47 0.84 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.847 0.459 . . . . 0.0 110.932 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 81.9 p -80.18 91.06 5.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.123 -0.986 . . . . 0.0 110.752 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.94 144.55 38.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -107.61 154.02 22.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -143.44 151.54 40.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 111.437 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.64 163.79 39.47 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.699 0.8 . . . . 0.0 110.032 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.38 140.58 50.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 73.8 p -135.58 143.47 45.66 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.553 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 28.0 p -84.4 102.26 12.62 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.45 34.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.664 0.786 . . . . 0.0 110.976 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.67 -8.64 12.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.036 0.535 . . . . 0.0 110.595 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -160.92 162.9 32.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.016 0.926 . . . . 0.0 109.326 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.93 76.4 9.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.866 178.857 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -145.17 136.54 25.12 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.919 0.488 . . . . 0.0 109.979 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 67.12 -179.21 14.72 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.675 0.655 . . . . 0.0 112.741 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.21 -172.89 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 125.028 3.819 . . . . 0.0 110.217 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -138.1 150.76 47.16 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.613 0.365 . . . . 0.0 110.568 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -81.01 167.1 20.18 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.925 0.49 . . . . 0.0 111.125 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.86 -5.88 24.24 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.077 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.6 m -148.47 152.73 39.1 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -85.48 2.35 7.77 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.659 3.573 . . . . 0.0 112.34 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.94 152.23 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.906 0.482 . . . . 0.0 111.356 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.54 170.3 15.96 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.719 0.807 . . . . 0.0 110.445 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.38 149.71 47.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.916 0.486 . . . . 0.0 110.207 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.99 150.39 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.794 0.438 . . . . 0.0 110.952 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.478 ' CE2' ' HE2' ' A' ' 412' ' ' MET . 16.1 m-85 -140.25 168.99 18.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.82 0.848 . . . . 0.0 109.514 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.99 -5.1 77.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.945 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.596 HD21 ' H ' ' A' ' 386' ' ' LEU . 2.1 pt? -72.0 176.68 4.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.83 0.815 . . . . 0.0 110.586 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.06 131.85 25.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -68.12 -7.88 33.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.7 t -91.81 -15.69 27.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.663 0.665 . . . . 0.0 112.104 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.38 5.26 1.24 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 15.4 tpt -150.9 102.52 2.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -141.86 -166.44 2.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.941 0.497 . . . . 0.0 110.342 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 78.0 m -52.53 -27.08 15.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.13 -28.2 24.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.378 0.536 . . . . 0.0 111.674 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -83.91 -31.85 25.45 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.23 -26.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.4 -30.58 62.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -81.5 -17.77 47.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.318 -0.372 . . . . 0.0 111.914 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.27 -22.2 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -110.95 -18.8 12.99 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.94 -21.89 60.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.327 0.967 . . . . 0.0 112.333 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.57 10.43 1.72 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.618 -0.676 . . . . 0.0 112.467 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -121.43 -2.71 9.45 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.923 0.889 . . . . 0.0 110.975 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 152.0 154.43 6.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.23 134.95 51.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.277 0.538 . . . . 0.0 110.298 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.07 154.02 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.05 -59.6 1.67 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.018 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . 0.404 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.1 pttm -160.93 162.33 31.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.648 0.379 . . . . 0.0 111.296 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.35 150.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 123.924 0.889 . . . . 0.0 109.792 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.23 145.3 26.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.505 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.24 145.34 27.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.478 ' HE2' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -132.1 141.66 49.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -167.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.19 33.93 21.06 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 125.769 1.628 . . . . 0.0 112.371 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 53.02 14.79 0.5 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 142.83 57.89 Favored Pre-proline 0 N--CA 1.456 -0.144 0 CA-C-N 118.802 0.728 . . . . 0.0 109.956 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.9 -0.19 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.412 2.741 . . . . 0.0 110.471 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.13 31.92 2.4 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.479 -0.623 . . . . 0.0 112.887 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -148.34 134.08 18.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.001 0.901 . . . . 0.0 110.154 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.8 170.93 19.09 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.951 0.405 . . . . 0.0 111.642 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -141.5 144.21 34.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.95 0.9 . . . . 0.0 109.505 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.93 146.73 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.145 0.578 . . . . 0.0 111.031 -171.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -131.01 145.26 51.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.482 0.713 . . . . 0.0 109.758 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 76.8 mtp -126.52 164.41 21.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.665 0.386 . . . . 0.0 110.758 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.29 -19.31 64.69 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.85 154.81 31.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.23 0.468 . . . . 0.0 110.243 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.72 -14.41 78.05 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.92 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -70.68 -20.14 62.72 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.341 1.57 . . . . 0.0 110.707 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.68 -31.98 18.23 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.1 t -67.73 -37.59 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -67.06 -30.65 70.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.501 0.321 . . . . 0.0 111.145 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -37.1 65.95 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.56 -24.85 41.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.437 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 8.2 mm -77.13 -30.92 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.708 0.803 . . . . 0.0 110.56 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.9 m -93.17 -21.64 19.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -138.7 -19.17 1.05 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -95.76 -15.14 22.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.222 0.919 . . . . 0.0 109.158 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -54.08 142.97 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.116 0.966 . . . . 0.0 110.153 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.15 1.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -87.81 142.53 27.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.735 1.607 . . . . 0.0 109.522 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.298 0.1 OUTLIER -130.88 164.04 26.13 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 171.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.14 143.35 50.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.909 1.283 . . . . 0.0 108.573 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 63.64 32.52 13.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.23 15.99 80.85 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 116.039 1.175 . . . . 0.0 116.039 168.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -83.17 153.0 25.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.392 1.596 . . . . 0.0 110.557 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 141.87 34.89 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -96.29 122.09 38.78 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -140.72 115.74 9.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.08 142.06 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.057 0 CA-C-N 118.348 0.522 . . . . 0.0 110.234 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 98.2 m -147.19 168.83 20.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.704 0.802 . . . . 0.0 110.054 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 152.67 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 27.1 t -126.51 163.14 24.02 Favored 'General case' 0 CA--C 1.526 0.027 0 CA-C-N 117.845 0.293 . . . . 0.0 110.582 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -103.88 8.89 36.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.805 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -65.56 149.99 96.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.924 -0.485 . . . . 0.0 109.782 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.05 -27.5 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.855 2.37 . . . . 0.0 111.992 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.48 171.65 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.161 0.585 . . . . 0.0 110.357 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . 0.404 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 40.6 mm -68.89 135.67 27.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.4 mtt -95.72 150.31 37.23 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 122.07 0.148 . . . . 0.0 110.819 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.94 163.81 37.04 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.887 3.058 . . . . 0.0 111.494 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.72 -174.56 44.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.93 151.47 38.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.4 p -140.12 159.06 43.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.127 0.571 . . . . 0.0 110.365 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.09 167.7 28.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.216 0.607 . . . . 0.0 109.895 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.59 141.44 25.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.59 168.09 13.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.793 0.837 . . . . 0.0 109.54 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.6 -20.17 66.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.072 -0.392 . . . . 0.0 111.519 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.22 -1.3 44.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.83 0.452 . . . . 0.0 111.392 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.72 -4.5 86.19 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.632 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.1 m -93.33 160.79 14.66 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.23 1.015 . . . . 0.0 110.276 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 73.2 m -81.38 153.37 27.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.009 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.6 p -71.13 -10.8 60.37 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.82 0.448 . . . . 0.0 111.625 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -129.88 141.78 50.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.354 1.061 . . . . 0.0 109.393 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -154.51 158.89 40.55 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.416 0.286 . . . . 0.0 110.715 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -131.04 148.55 52.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.127 0.971 . . . . 0.0 109.355 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -136.85 7.81 2.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.687 0.395 . . . . 0.0 111.855 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 13.5 t -70.2 -13.74 62.31 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.576 0.35 . . . . 0.0 111.209 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -93.45 2.77 56.36 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.007 0.523 . . . . 0.0 111.642 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.2 t -73.85 140.05 45.49 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.122 -0.361 . . . . 0.0 110.995 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -122.07 12.13 10.32 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 123.706 0.802 . . . . 0.0 111.4 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -87.07 11.29 14.13 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.127 0.571 . . . . 0.0 112.398 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -126.47 148.82 49.62 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.387 0.613 . . . . 0.0 111.662 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -82.08 9.65 8.11 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.258 1.023 . . . . 0.0 110.855 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -138.84 18.31 2.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.197 0.999 . . . . 0.0 110.667 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.8 p -79.53 -3.05 45.05 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.918 0.487 . . . . 0.0 111.295 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 5.7 t -146.12 143.78 20.1 Favored Pre-proline 0 N--CA 1.456 -0.175 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.66 -12.89 37.16 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.041 2.494 . . . . 0.0 113.334 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.46 -27.04 25.96 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.964 0.802 . . . . 0.0 111.42 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -90.61 -26.74 19.51 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 117.614 0.188 . . . . 0.0 110.581 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.96 36.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.668 0.387 . . . . 0.0 111.243 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -98.64 -2.35 38.64 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.575 0.75 . . . . 0.0 111.547 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -127.02 16.92 7.29 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.709 0.804 . . . . 0.0 110.909 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -142.23 161.13 38.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.41 1.084 . . . . 0.0 108.336 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -129.81 159.84 35.32 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 122.095 -0.378 . . . . 0.0 111.955 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.7 mm -113.68 141.69 28.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -151.42 157.48 42.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -66.2 162.62 45.92 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.93 150.15 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.154 3.236 . . . . 0.0 113.499 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 37.9 m -123.95 18.92 9.3 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.548 0.739 . . . . 0.0 111.566 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.1 m120 59.92 10.78 2.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.407 1.083 . . . . 0.0 113.559 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.4 t -142.12 145.27 24.11 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 48.9 mt -117.55 166.56 12.23 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.201 0.524 . . . . 0.0 111.557 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 503' ' ' PHE . 1.5 t60 -137.56 148.81 46.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.784 0.834 . . . . 0.0 109.027 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -133.57 153.25 51.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.663 0.385 . . . . 0.0 110.882 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . 0.528 ' CZ ' ' CD2' ' A' ' 501' ' ' HIS . 75.4 m-85 -147.64 171.29 15.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.624 0.369 . . . . 0.0 111.33 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 24.9 m120 61.57 16.54 7.74 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -79.96 156.19 74.79 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.24 157.09 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.671 2.248 . . . . 0.0 111.888 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . 0.4 ' H ' ' CD2' ' A' ' 507' ' ' LEU . 2.3 pt? -72.45 -1.26 15.08 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.64 8.73 29.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.967 0.349 . . . . 0.0 111.93 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.42 150.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.91 0.323 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 71.8 p -145.9 175.63 10.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.787 0.835 . . . . 0.0 109.693 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.38 -25.65 68.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.446 -0.158 . . . . 0.0 111.019 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -74.99 -24.64 58.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.614 0.188 . . . . 0.0 110.714 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -79.41 -29.96 42.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -73.26 -25.46 60.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.297 -0.252 . . . . 0.0 110.44 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -78.95 -36.58 41.35 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.983 -0.448 . . . . 0.0 111.661 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.12 -15.7 55.15 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.143 0.428 . . . . 0.0 111.612 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.97 -35.09 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.199 0.454 . . . . 0.0 109.832 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.8 m -70.52 -17.8 62.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.736 -0.602 . . . . 0.0 110.215 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.43 -30.27 61.83 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.578 -0.249 . . . . 0.0 111.512 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.05 -14.8 30.64 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.373 0.533 . . . . 0.0 111.421 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.62 -13.05 24.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.865 0.466 . . . . 0.0 111.301 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 70.57 6.52 58.89 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.82 -0.433 . . . . 0.0 112.791 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.2 m -85.93 167.31 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.679 0.739 . . . . 0.0 110.802 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -74.64 150.01 39.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 111.063 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.31 150.71 41.9 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 123.498 0.719 . . . . 0.0 110.283 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.9 156.56 65.42 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.472 2.781 . . . . 0.0 110.669 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.8 m -86.26 -22.8 26.65 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.864 0.466 . . . . 0.0 110.605 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 14.8 t -149.38 155.23 40.14 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.53 144.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.769 0.427 . . . . 0.0 110.457 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -134.58 130.53 36.65 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.23 143.45 35.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.754 0.422 . . . . 0.0 109.919 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -154.0 135.11 13.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.028 0.531 . . . . 0.0 110.025 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.9 m -105.12 138.31 41.52 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 122.51 0.324 . . . . 0.0 110.25 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -82.69 148.17 25.88 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -79.86 133.75 36.28 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 37.9 m 55.11 18.6 2.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -109.93 -8.0 14.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.628 0.371 . . . . 0.0 111.185 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 48.44 29.51 2.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.392 1.077 . . . . 0.0 113.459 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 75.2 p -145.13 168.28 20.73 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.895 0.378 . . . . 0.0 111.321 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 48.4 t -133.38 150.65 51.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.159 0.984 . . . . 0.0 110.781 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 37.0 m -145.55 162.97 36.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.031 1.333 . . . . 0.0 109.055 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.57 -168.8 41.26 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.485 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.29 159.74 22.21 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.091 0.556 . . . . 0.0 111.403 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 87.6 mt -137.38 135.06 36.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.694 1.198 . . . . 0.0 107.836 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.78 110.36 12.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.468 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.1 p90 -165.99 156.03 12.46 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.425 1.49 . . . . 0.0 107.477 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.73 117.1 6.49 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.652 0.66 . . . . 0.0 112.719 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 28.7 m -159.54 153.06 22.57 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 126.149 1.78 . . . . 0.0 106.28 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.83 -51.39 49.08 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.512 0.596 . . . . 0.0 111.509 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 50.2 m -79.71 -24.33 41.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.92 -34.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.39 0.541 . . . . 0.0 111.677 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.41 -26.42 38.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.015 0.37 . . . . 0.0 111.038 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.1 tp -85.12 -29.52 24.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.255 0.48 . . . . 0.0 111.73 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -75.45 -38.5 59.66 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.088 0.404 . . . . 0.0 110.042 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.0 m -70.15 -33.93 72.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.7 -42.75 90.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.18 -24.7 75.04 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.292 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -113.86 -14.78 12.47 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.627 1.214 . . . . 0.0 114.105 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.43 -20.65 17.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.524 1.056 . . . . 0.0 111.085 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -74.41 139.44 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.6 t60 52.23 35.88 17.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.587 0.755 . . . . 0.0 112.122 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -99.2 151.32 21.14 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.25 136.31 36.91 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.585 1.554 . . . . 0.0 111.139 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.434 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.7 ttt -64.07 174.51 1.52 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.438 0.695 . . . . 0.0 112.078 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . 0.434 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.5 ttmm -68.65 -2.1 8.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.174 0.99 . . . . 0.0 112.504 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -60.96 141.95 93.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 121.492 -0.755 . . . . 0.0 110.569 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.18 -28.54 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.74 2.96 . . . . 0.0 113.918 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -121.01 -0.94 9.92 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.07 0.395 . . . . 0.0 111.829 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.39 41.27 99.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.997 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 79.1 Cg_endo -69.9 -10.7 29.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.884 2.39 . . . . 0.0 111.888 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.46 148.41 47.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.187 0.595 . . . . 0.0 109.959 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.63 153.36 38.81 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.707 2.938 . . . . 0.0 111.149 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -147.99 0.7 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.081 0.553 . . . . 0.0 111.41 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 12.3 t -66.43 125.55 26.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.283 -0.885 . . . . 0.0 110.781 -170.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.14 144.63 50.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.355 1.062 . . . . 0.0 109.991 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.6 157.82 16.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.285 0.234 . . . . 0.0 110.732 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.43 144.97 50.86 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.229 0.611 . . . . 0.0 109.689 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 27.9 p -160.49 167.37 27.36 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.159 0.584 . . . . 0.0 110.408 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -82.07 139.0 34.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 38.0 t -135.6 145.13 46.58 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.148 0.179 . . . . 0.0 110.883 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 19.3 p -79.98 102.28 9.15 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.12 161.56 34.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.954 0.902 . . . . 0.0 110.325 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 -12.44 11.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.782 0.433 . . . . 0.0 110.987 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -161.13 162.48 31.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.681 0.792 . . . . 0.0 109.538 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -91.35 76.83 5.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.518 0.327 . . . . 0.0 110.132 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.217 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.529 179.672 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -136.91 21.08 3.05 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.309 0.643 . . . . 0.0 110.983 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 84.16 156.16 23.34 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.36 -178.15 4.42 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.494 3.463 . . . . 0.0 111.096 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -98.25 157.27 16.27 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.212 0.605 . . . . 0.0 110.389 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -77.05 163.4 26.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.804 0.441 . . . . 0.0 110.509 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.54 -7.4 59.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.965 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.6 m -147.49 152.15 41.34 Favored Pre-proline 0 C--N 1.34 0.156 0 C-N-CA 123.15 0.58 . . . . 0.0 110.89 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -82.5 3.34 7.89 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.446 3.431 . . . . 0.0 112.631 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.8 164.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 112.464 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.3 pp -149.45 171.23 16.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.23 1.012 . . . . 0.0 109.149 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' MET . . . . . 0.4 ' CE ' ' HE2' ' A' ' 412' ' ' MET . 80.8 mtp -138.11 152.12 48.45 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.411 0.284 . . . . 0.0 111.257 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.02 144.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -135.86 168.03 20.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.953 0.501 . . . . 0.0 110.411 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.31 69.26 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.972 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.618 HD21 ' H ' ' A' ' 386' ' ' LEU . 1.9 pt? -70.06 170.71 10.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.501 0.65 . . . . 0.0 111.741 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -127.01 130.85 50.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.613 0.765 . . . . 0.0 109.434 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -71.87 6.83 1.82 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.6 p -121.28 0.67 10.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.98 -13.12 2.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.164 0.586 . . . . 0.0 110.704 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -141.84 121.02 12.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.133 0.973 . . . . 0.0 108.795 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.571 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 19.4 m120 -141.89 -179.97 6.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.87 0.868 . . . . 0.0 109.337 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.99 -22.79 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.982 0.113 . . . . 0.0 111.231 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -88.03 -26.06 22.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.014 -0.429 . . . . 0.0 111.717 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . 0.571 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.4 mpt_? -83.36 -32.0 26.45 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.271 0.487 . . . . 0.0 109.702 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.9 p -72.44 -31.46 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -69.09 -29.57 67.7 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -80.78 -17.3 51.36 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.6 t -109.62 -23.78 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 118.437 0.562 . . . . 0.0 112.378 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.96 -16.37 14.16 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.689 0.677 . . . . 0.0 112.423 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 t -77.49 -16.02 58.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.124 0.875 . . . . 0.0 110.977 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.6 10.72 1.58 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.803 -0.561 . . . . 0.0 112.296 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 -3.17 9.38 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.721 0.808 . . . . 0.0 111.071 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.07 164.54 11.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.45 147.26 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.9 0.85 . . . . 0.0 111.702 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.49 155.47 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -96.76 -63.88 1.1 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -163.1 166.57 23.35 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.4 0.68 . . . . 0.0 110.338 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.51 151.7 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.214 0.606 . . . . 0.0 110.501 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -149.99 139.49 21.51 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.301 0.241 . . . . 0.0 110.822 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -77.25 152.28 34.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.4 ' HE2' ' CE ' ' A' ' 382' ' ' MET . 6.0 ptm -130.85 141.64 50.33 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -167.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 60.28 33.76 20.89 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.77 1.228 . . . . 0.0 112.275 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.3 m 55.42 14.79 1.22 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.296 1.039 . . . . 0.0 113.435 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -89.02 137.6 29.54 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.35 -8.56 18.57 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.964 2.443 . . . . 0.0 109.332 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.65 23.3 17.83 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.69 1.138 . . . . 0.0 113.128 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -150.75 137.27 18.78 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.973 1.387 . . . . 0.0 111.268 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -159.61 170.61 21.24 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.128 0.489 . . . . 0.0 111.363 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.5 ptm -139.39 147.44 41.46 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.375 0.67 . . . . 0.0 109.96 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.5 t -128.23 152.15 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.24 0.616 . . . . 0.0 110.76 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -129.58 141.46 50.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.585 0.754 . . . . 0.0 109.4 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 97.9 mmm -114.43 162.53 16.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.849 0.46 . . . . 0.0 110.719 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.83 60.74 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.318 0.247 . . . . 0.0 111.604 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.91 160.88 40.51 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.86 -12.22 84.76 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.199 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -75.38 -17.63 60.16 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.857 1.328 . . . . 0.0 111.32 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -89.84 -26.23 20.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.249 -0.282 . . . . 0.0 110.486 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.22 -34.27 37.07 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.29 -26.64 56.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.517 0.199 . . . . 0.0 110.625 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -25.74 48.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.68 31.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.038 0.135 . . . . 0.0 110.766 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 3.1 tp -82.65 -30.95 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 121.813 -0.554 . . . . 0.0 111.121 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 24.0 m -94.82 -19.69 20.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -136.22 -5.91 2.07 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.59 -19.21 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.168 0.895 . . . . 0.0 109.461 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -51.95 143.13 14.22 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.895 0.878 . . . . 0.0 110.629 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.8 1.42 0.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.819 1.648 . . . . 0.0 114.992 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -88.47 142.76 27.45 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.544 -1.348 . . . . 0.0 109.117 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.271 0.1 OUTLIER -130.94 163.98 26.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 171.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.25 143.47 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.175 0.99 . . . . 0.0 109.625 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 64.72 30.5 12.4 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.368 1.467 . . . . 0.0 114.45 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.43 15.64 77.3 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 168.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.25 161.28 21.55 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.506 1.153 . . . . 0.0 110.19 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.507 ' H ' ' HD3' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -91.63 128.59 37.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.329 0.513 . . . . 0.0 110.825 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.62 142.42 30.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -140.71 127.2 20.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.34 140.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-N 118.359 0.527 . . . . 0.0 110.718 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.7 m -150.59 163.69 37.86 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.26 1.024 . . . . 0.0 109.923 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.86 156.43 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.8 t -131.23 162.99 28.75 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 122.912 0.485 . . . . 0.0 109.725 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -105.69 5.69 31.3 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -67.42 144.93 98.24 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 121.694 -0.629 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.96 -24.68 11.13 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.151 2.567 . . . . 0.0 111.692 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.89 173.2 12.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.841 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.7 mm -71.33 142.52 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.43 154.89 37.85 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 117.472 0.124 . . . . 0.0 111.268 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.65 165.37 8.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.104 3.203 . . . . 0.0 112.477 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.89 177.86 37.77 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -81.81 166.07 20.31 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.834 0.453 . . . . 0.0 110.199 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.3 p -143.04 159.94 41.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.75 0.42 . . . . 0.0 110.973 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -151.33 173.15 14.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.768 0.827 . . . . 0.0 109.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.66 135.07 13.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.99 173.1 12.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.345 0.658 . . . . 0.0 109.828 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.4 -23.02 67.14 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.703 0.401 . . . . 0.0 111.329 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -81.7 -1.4 46.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.017 0.527 . . . . 0.0 111.332 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.27 84.43 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.087 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 77.6 p -84.06 163.96 19.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.537 0.668 . . . . 0.0 110.78 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.72 151.83 28.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 111.056 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 75.5 m -73.16 -10.45 59.79 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.435 0.694 . . . . 0.0 111.841 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -133.73 143.45 48.48 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.665 0.786 . . . . 0.0 109.762 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -157.18 156.86 33.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.733 0.413 . . . . 0.0 110.551 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -127.65 149.28 50.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.269 1.028 . . . . 0.0 109.503 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.99 13.89 2.87 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.84 0.456 . . . . 0.0 111.413 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 29.2 t -66.22 -16.55 64.09 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.079 -0.388 . . . . 0.0 111.784 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -79.79 -11.76 59.81 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.966 -0.459 . . . . 0.0 111.178 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.9 m -87.97 17.63 4.79 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.23 0.612 . . . . 0.0 111.47 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -75.0 8.97 2.16 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.396 0.679 . . . . 0.0 112.011 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -110.5 17.18 21.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.961 0.904 . . . . 0.0 110.544 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -81.37 23.43 0.61 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.987 0.915 . . . . 0.0 112.455 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 53.71 29.52 9.63 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.86 19.14 0.69 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.959 0.345 . . . . 0.0 111.802 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 67.2 p -84.56 4.24 32.94 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -171.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 39.4 p -136.47 159.35 70.94 Favored Pre-proline 0 C--O 1.231 0.082 0 CA-C-N 118.378 0.536 . . . . 0.0 110.055 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.63 -17.14 33.67 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.47 2.78 . . . . 0.0 112.863 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -94.69 -26.39 16.33 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 117.827 0.285 . . . . 0.0 111.06 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -90.5 -24.08 20.76 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 122.351 0.26 . . . . 0.0 110.8 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.12 62.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.302 -0.249 . . . . 0.0 110.982 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -80.42 -16.02 55.41 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.348 -0.22 . . . . 0.0 110.604 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -96.27 -13.82 23.09 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 123.431 0.692 . . . . 0.0 110.577 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.62 7.2 45.42 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.573 0.749 . . . . 0.0 109.43 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 50.81 54.06 11.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.668 1.187 . . . . 0.0 112.229 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.92 108.61 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -155.75 167.99 28.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.683 0.793 . . . . 0.0 109.034 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -62.35 159.41 40.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.44 131.32 36.21 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.304 2.669 . . . . 0.0 112.492 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.6 m -124.07 23.86 8.37 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.691 0.796 . . . . 0.0 111.464 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 60.75 10.99 2.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.891 1.276 . . . . 0.0 114.043 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.53 141.78 36.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 40.8 mt -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.326 0.65 . . . . 0.0 110.283 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.435 ' CG ' ' HB3' ' A' ' 580' ' ' SER . 0.6 OUTLIER -141.51 161.98 36.59 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.377 0.271 . . . . 0.0 110.956 173.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -139.06 157.06 46.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.726 0.41 . . . . 0.0 111.328 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -150.53 174.3 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.203 0.601 . . . . 0.0 111.066 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 11.7 t30 64.98 11.35 6.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.911 1.284 . . . . 0.0 113.656 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -73.2 161.66 78.19 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -70.33 155.68 63.51 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.903 1.735 . . . . 0.0 110.18 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.73 -1.12 8.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.31 9.0 18.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.95 151.21 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 118.009 0.368 . . . . 0.0 110.932 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.9 p -142.15 173.28 11.67 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.361 0.664 . . . . 0.0 110.516 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.18 -21.31 64.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.885 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.05 -22.81 58.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.348 -0.22 . . . . 0.0 110.487 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -82.34 -30.19 30.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.79 -25.66 61.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.761 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -84.34 -34.96 23.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.11 0.414 . . . . 0.0 111.468 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -76.88 -21.99 54.1 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.281 0.491 . . . . 0.0 111.133 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 74.0 mt -84.83 -37.88 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.937 0.335 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.5 m -66.64 -24.68 66.33 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.113 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.91 -30.42 63.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.245 -0.284 . . . . 0.0 111.761 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -91.04 -11.09 39.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.375 0.534 . . . . 0.0 112.0 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.6 mt -96.19 -7.7 35.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.774 0.429 . . . . 0.0 111.084 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.88 7.97 81.73 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.77 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -97.78 165.2 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 117.83 0.815 . . . . 0.0 110.645 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -83.19 151.67 25.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.742 0.417 . . . . 0.0 111.065 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -91.08 155.2 44.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.474 0.71 . . . . 0.0 110.717 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.95 158.74 45.73 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.296 2.664 . . . . 0.0 111.285 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 81.5 m -89.96 -26.39 20.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.0 m -139.38 150.06 44.87 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.06 144.27 25.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 123.042 0.537 . . . . 0.0 110.849 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -142.16 138.89 31.89 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 29.6 t -136.39 145.77 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 122.595 0.358 . . . . 0.0 110.425 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -151.94 164.19 37.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 79.4 p -122.31 144.82 48.77 Favored 'General case' 0 N--CA 1.457 -0.085 0 O-C-N 121.867 -0.52 . . . . 0.0 111.242 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -83.34 149.54 26.28 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.0 130.74 35.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 21.2 m 56.22 15.06 1.73 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.401 1.08 . . . . 0.0 113.589 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -105.38 -10.27 17.07 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.841 0.457 . . . . 0.0 111.043 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 49.4 33.17 5.19 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.871 0.868 . . . . 0.0 112.103 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 99.0 p -137.47 169.58 17.55 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.802 0.441 . . . . 0.0 111.538 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.6 t -125.43 153.88 42.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.371 1.068 . . . . 0.0 110.799 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 78.4 p -152.88 171.22 18.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.72 1.208 . . . . 0.0 109.627 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 166.63 -172.91 41.97 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.129 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.54 152.68 32.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 66.8 mt -136.71 134.89 37.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.73 1.212 . . . . 0.0 107.856 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -127.78 113.1 15.53 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -166.09 153.94 10.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.639 1.576 . . . . 0.0 106.775 167.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -148.87 118.6 7.04 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.3 t -159.46 153.1 22.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.582 1.553 . . . . 0.0 107.025 168.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.38 -63.8 1.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.971 0.35 . . . . 0.0 111.739 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 74.2 p -82.28 -17.25 46.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.09 -41.35 28.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.298 0.499 . . . . 0.0 110.682 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -78.14 -31.78 49.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.596 -0.24 . . . . 0.0 110.968 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.5 tp -77.25 -30.49 54.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.671 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -74.8 -40.2 61.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.94 -0.475 . . . . 0.0 110.548 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.3 m -63.99 -49.98 70.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.59 -0.243 . . . . 0.0 110.347 -175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.5 pp -77.51 -18.9 56.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.833 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -69.21 -26.58 74.51 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.12 -7.38 11.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.596 0.698 . . . . 0.0 112.604 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 46.3 tp -98.23 -19.36 17.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 0.0 111.701 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -74.48 144.43 44.17 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 80.2 t60 51.11 35.83 14.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.019 0.528 . . . . 0.0 112.039 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -97.27 151.42 19.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.709 0.804 . . . . 0.0 111.691 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -102.6 136.33 42.62 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.181 1.392 . . . . 0.0 110.549 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.3 ttt -64.11 173.87 1.77 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.066 0.547 . . . . 0.0 111.499 -174.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -70.25 9.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -66.5 146.84 99.09 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 118.55 0.614 . . . . 0.0 110.081 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.84 -30.02 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.42 2.747 . . . . 0.0 113.917 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -121.06 2.18 10.41 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.438 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.14 40.16 98.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.686 -1.064 . . . . 0.0 112.891 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 80.9 Cg_endo -69.45 -9.99 27.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.272 2.648 . . . . 0.0 112.073 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -142.61 148.26 45.92 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 122.823 0.449 . . . . 0.0 110.086 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.84 156.69 43.72 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.603 2.868 . . . . 0.0 111.477 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -148.59 6.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.038 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 3.0 t -66.48 122.1 16.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.611 -0.681 . . . . 0.0 110.118 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 575' ' ' LEU . 1.9 pt? -124.97 144.6 50.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 109.78 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -96.16 142.12 28.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.526 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.62 144.91 41.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 41.8 t -163.14 163.2 25.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -75.83 148.37 38.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.435 ' HB3' ' CG ' ' A' ' 501' ' ' HIS . 92.9 p -135.4 149.16 49.58 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.171 0.188 . . . . 0.0 110.606 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 31.3 p -90.02 102.19 14.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.36 161.47 34.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.654 0.782 . . . . 0.0 111.156 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -97.73 -25.79 14.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -163.85 152.72 13.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.506 1.122 . . . . 0.0 108.57 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -85.94 76.51 9.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.942 0.401 . . . . 0.0 110.35 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 36.3 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.869 177.484 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -136.65 6.46 2.96 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.936 0.494 . . . . 0.0 111.962 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -179.36 175.85 47.36 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.41 169.15 23.17 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.4 3.4 . . . . 0.0 110.94 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -155.84 168.84 25.93 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.091 0.556 . . . . 0.0 110.322 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -123.32 158.47 30.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.79 0.436 . . . . 0.0 110.443 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -144.79 17.03 1.61 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.22 0.608 . . . . 0.0 110.535 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.2 m -143.44 152.8 57.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 122.395 0.278 . . . . 0.0 111.13 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.209 3.273 . . . . 0.0 112.831 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 89.3 t -123.28 148.13 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 118.684 0.675 . . . . 0.0 110.811 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.3 164.12 30.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 110.692 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 73.6 mmm -127.33 149.38 50.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.505 0.722 . . . . 0.0 110.331 -176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.36 148.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.645 0.259 . . . . 0.0 110.743 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -141.13 170.99 14.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.702 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.46 -4.54 81.3 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.299 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.609 HD21 ' H ' ' A' ' 386' ' ' LEU . 1.9 pt? -71.72 175.75 5.43 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.038 0.919 . . . . 0.0 110.522 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.69 135.57 44.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.802 0.441 . . . . 0.0 109.889 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -73.46 4.84 4.29 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -172.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.9 m -115.36 -2.11 12.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.076 0.398 . . . . 0.0 111.845 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -138.12 -0.95 2.0 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.435 0.694 . . . . 0.0 110.685 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -154.53 121.11 5.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -141.97 -176.52 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.79 0.436 . . . . 0.0 110.62 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 25.5 p -57.01 -30.22 64.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.301 0.641 . . . . 0.0 112.671 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.0 -25.92 25.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.023 -0.423 . . . . 0.0 110.756 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -79.99 -32.48 39.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -75.6 -27.05 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -68.82 -29.42 67.76 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 171.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.38 -23.05 47.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.026 -0.421 . . . . 0.0 111.981 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 71.4 t -94.61 -21.36 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -114.59 -13.93 12.11 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.2 t -73.9 -21.92 59.89 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.306 0.957 . . . . 0.0 111.085 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.48 10.41 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.645 -0.659 . . . . 0.0 112.385 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.45 -11.41 8.73 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.248 0.619 . . . . 0.0 111.434 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 160.97 174.61 31.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -68.41 141.47 55.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.535 -0.391 . . . . 0.0 110.871 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.6 t -104.56 147.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -101.38 -58.32 1.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.231 -0.293 . . . . 0.0 110.351 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -165.3 169.41 15.89 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.957 0.503 . . . . 0.0 110.685 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.35 150.88 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.069 0 C-N-CA 123.739 0.816 . . . . 0.0 110.216 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.41 ' HE3' ' O ' ' A' ' 411' ' ' PHE . 51.4 tptt -147.18 137.54 23.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.749 0.82 . . . . 0.0 109.093 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . 0.41 ' O ' ' HE3' ' A' ' 410' ' ' LYS . 4.3 m-85 -76.53 136.2 39.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 22.1 ttp -93.64 140.97 29.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 47.42 33.84 3.01 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 112.248 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.5 m 52.95 17.99 1.0 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.443 1.097 . . . . 0.0 113.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -75.95 149.53 82.82 Favored Pre-proline 0 N--CA 1.456 -0.159 0 CA-C-N 118.564 0.62 . . . . 0.0 109.897 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.43 4.4 6.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.882 3.055 . . . . 0.0 110.975 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.51 32.06 1.36 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.299 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.83 141.76 25.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.187 0.993 . . . . 0.0 110.439 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.37 170.28 22.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.941 0.4 . . . . 0.0 111.373 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.4 ptm -145.76 145.06 30.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.733 0.813 . . . . 0.0 109.512 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.37 153.22 38.58 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.299 0.639 . . . . 0.0 110.32 -173.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -127.67 143.67 51.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.691 0.797 . . . . 0.0 110.07 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 79.4 mtp -129.38 166.64 19.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.425 0.69 . . . . 0.0 110.134 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.54 -23.82 65.47 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.17 160.21 38.52 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.252 0.478 . . . . 0.0 110.576 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.77 -12.35 80.82 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.451 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -67.93 -25.56 65.53 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.231 1.515 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.9 -27.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.5 t -73.54 -32.96 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.75 -25.96 66.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.048 0.539 . . . . 0.0 110.212 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -82.43 -27.19 32.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.375 -0.203 . . . . 0.0 110.691 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.21 -28.34 29.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.464 0.173 . . . . 0.0 110.56 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.84 -31.11 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.336 0.654 . . . . 0.0 110.853 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 m -98.88 -19.55 17.3 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -135.59 -4.28 2.3 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.72 -15.29 11.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.857 0.753 . . . . 0.0 109.458 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -58.02 149.87 22.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.481 0.658 . . . . 0.0 111.954 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 56.83 1.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.024 1.73 . . . . 0.0 114.616 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -88.04 142.56 27.68 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.961 1.255 . . . . 0.0 109.46 168.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.321 0.1 OUTLIER -130.93 164.03 26.2 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 170.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 18.7 ptm -125.26 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 66.07 24.01 11.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.01 16.01 80.98 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -83.2 156.31 23.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.085 1.443 . . . . 0.0 111.811 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.86 139.96 49.1 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.58 0.752 . . . . 0.0 109.592 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.96 122.04 39.5 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -140.75 119.75 12.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.12 142.61 20.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 118.008 0.367 . . . . 0.0 110.751 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 73.3 m -148.41 174.92 11.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.682 0.793 . . . . 0.0 110.715 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.71 156.05 13.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 34.9 t -137.27 146.12 44.34 Favored 'General case' 0 N--CA 1.461 0.101 0 O-C-N 122.1 -0.375 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -85.43 6.56 26.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.076 0.551 . . . . 0.0 112.237 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.09 132.24 93.69 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.02 -32.05 84.01 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.691 2.261 . . . . 0.0 112.515 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -161.79 171.55 17.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.792 0.437 . . . . 0.0 110.9 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.74 143.26 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.81 149.61 44.07 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 122.227 0.211 . . . . 0.0 110.745 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.91 161.92 43.47 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.761 2.974 . . . . 0.0 111.765 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 166.39 -179.51 40.35 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -80.89 173.54 12.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.815 0.446 . . . . 0.0 109.834 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.1 p -140.43 161.86 36.71 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -150.99 165.18 34.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.722 0.809 . . . . 0.0 109.632 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 137.88 20.0 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.98 174.71 8.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.202 1.001 . . . . 0.0 109.437 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -68.41 -21.78 64.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.85 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -83.08 4.24 27.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.103 0.561 . . . . 0.0 111.792 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.62 -2.42 73.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.622 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.2 p -90.82 163.02 14.58 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.074 0.937 . . . . 0.0 110.222 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.3 m -81.28 153.41 27.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.032 -0.417 . . . . 0.0 111.114 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 89.5 p -71.18 -8.88 56.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -130.65 142.79 50.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.386 1.074 . . . . 0.0 109.036 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -153.21 157.38 40.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.721 0.408 . . . . 0.0 110.278 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.31 148.46 50.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.77 0.828 . . . . 0.0 109.812 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -137.2 14.93 3.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.999 0.52 . . . . 0.0 111.583 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.1 p -68.41 -5.35 18.58 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -88.59 -2.42 58.58 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.727 0.411 . . . . 0.0 111.228 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.4 m -89.15 11.17 19.37 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.42 0.688 . . . . 0.0 111.933 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -75.89 31.21 0.11 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.83 0.852 . . . . 0.0 112.617 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -136.28 41.85 2.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.918 0.887 . . . . 0.0 109.493 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -118.32 -174.68 2.71 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.714 0.806 . . . . 0.0 110.531 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -64.42 -18.79 65.06 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -171.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -149.41 10.49 0.76 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 119.474 1.034 . . . . 0.0 112.886 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.4 p -86.27 2.71 46.18 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 121.951 -0.468 . . . . 0.0 111.301 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 5.0 t -139.67 141.96 29.85 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.35 -10.63 29.33 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.233 2.622 . . . . 0.0 113.765 -172.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -88.92 -26.48 21.54 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.028 0.831 . . . . 0.0 111.381 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -90.47 -27.0 19.53 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.978 0.353 . . . . 0.0 110.853 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.36 -6.76 31.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.696 0.398 . . . . 0.0 111.875 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -89.49 -0.94 57.85 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.995 0.518 . . . . 0.0 111.38 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -127.11 8.15 6.64 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.826 0.85 . . . . 0.0 111.333 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -139.53 171.92 13.55 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.436 0.694 . . . . 0.0 110.071 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -140.39 157.99 44.7 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.63 137.81 45.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -148.69 160.85 42.77 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 121.194 0.521 . . . . 0.0 111.436 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -82.48 167.59 29.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 124.936 1.295 . . . . 0.0 109.991 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -49.82 125.67 14.93 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.099 2.533 . . . . 0.0 111.62 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.2 m -124.07 23.85 8.37 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.621 0.768 . . . . 0.0 112.292 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.6 m120 61.65 8.18 2.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.219 1.008 . . . . 0.0 113.52 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.98 146.27 20.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.851 0.86 . . . . 0.0 108.902 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.36 151.58 42.37 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.973 0.509 . . . . 0.0 110.667 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 580' ' ' SER . 0.3 OUTLIER -126.03 143.55 51.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -129.7 152.04 49.64 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.416 0.15 . . . . 0.0 110.829 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -150.12 172.27 15.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.815 0.446 . . . . 0.0 111.246 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.18 30.19 19.91 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.766 0.826 . . . . 0.0 112.791 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -94.16 153.98 40.6 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -56.55 150.87 49.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.732 2.288 . . . . 0.0 111.937 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -70.03 -0.98 8.53 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.96 6.95 23.58 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.41 151.61 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.964 -0.46 . . . . 0.0 110.826 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 59.9 p -143.73 171.39 14.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.421 0.689 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.32 -24.48 67.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.683 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.08 -22.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.187 -0.321 . . . . 0.0 110.447 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -81.35 -29.23 34.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.76 -25.13 58.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.054 -0.404 . . . . 0.0 110.875 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -80.96 -37.72 28.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.107 0.412 . . . . 0.0 111.246 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -76.34 -21.75 55.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.076 0.398 . . . . 0.0 111.199 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 64.0 mt -82.02 -37.77 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.2 m -66.82 -25.78 66.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.852 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.14 -30.16 64.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.77 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -91.06 -11.91 37.3 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.405 0.548 . . . . 0.0 111.818 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.7 mt -91.36 -10.32 41.62 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.991 0.517 . . . . 0.0 110.992 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.04 71.09 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.747 -0.474 . . . . 0.0 112.33 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.0 m -94.96 167.75 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 117.683 0.742 . . . . 0.0 110.438 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.42 147.41 27.88 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.91 0.386 . . . . 0.0 111.12 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -82.23 157.18 68.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.789 0.835 . . . . 0.0 111.25 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.16 155.16 69.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.414 2.743 . . . . 0.0 110.327 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.452 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -86.0 -24.9 26.27 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.716 0.406 . . . . 0.0 110.93 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 22.0 t -144.04 152.46 41.03 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -140.34 142.71 30.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.06 0.544 . . . . 0.0 109.975 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 129.52 21.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.39 147.8 32.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.826 0.451 . . . . 0.0 110.785 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -149.74 154.93 39.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.321 0.648 . . . . 0.0 109.947 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.0 m -130.84 135.05 47.36 Favored 'General case' 0 C--O 1.231 0.08 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -81.14 153.34 33.87 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -79.66 143.61 34.48 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.548 -0.384 . . . . 0.0 110.26 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 36.9 m 54.22 19.37 2.15 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.621 0.768 . . . . 0.0 112.772 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -111.89 -16.84 13.05 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.036 0.534 . . . . 0.0 111.42 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 50.19 33.63 7.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.75 0.82 . . . . 0.0 112.162 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.5 t -145.33 162.23 37.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.622 0.369 . . . . 0.0 110.987 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 45.8 t -131.0 154.76 47.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.976 0.91 . . . . 0.0 111.435 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.9 p -149.39 171.21 16.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.073 1.349 . . . . 0.0 109.063 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.89 37.82 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.739 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.72 150.86 48.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.367 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.57 133.18 39.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -127.65 108.22 10.58 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.452 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -165.98 154.01 10.69 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.705 1.602 . . . . 0.0 106.926 167.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.21 122.75 7.92 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 46.3 t -159.56 153.37 23.01 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.007 1.723 . . . . 0.0 106.504 168.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.44 -54.72 39.82 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.322 0.51 . . . . 0.0 111.572 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.6 p -87.34 -21.5 25.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.67 -36.67 37.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.243 0.474 . . . . 0.0 110.801 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.56 -32.63 28.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.675 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.73 -27.32 60.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.991 0.359 . . . . 0.0 110.75 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.91 -43.96 33.54 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.037 -0.414 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 95.7 m -70.44 -31.05 68.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.25 -42.16 93.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.56 -28.67 69.01 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.364 -0.686 . . . . 0.0 112.81 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.13 -13.43 15.44 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.0 -23.48 14.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.411 1.005 . . . . 0.0 112.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -69.95 142.35 52.9 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 48.96 35.29 6.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.817 0.847 . . . . 0.0 113.025 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -95.96 151.39 19.47 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -92.14 136.34 33.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.286 1.434 . . . . 0.0 111.324 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.409 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 4.2 ttt -64.36 176.0 1.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.251 0.62 . . . . 0.0 111.828 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . 0.409 ' H ' ' HG2' ' A' ' 564' ' ' MET . 64.8 pttt -71.86 6.54 1.98 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -67.34 142.79 96.92 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.667 0.667 . . . . 0.0 110.6 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.45 -29.74 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.464 2.776 . . . . 0.0 113.672 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -120.58 1.01 10.58 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.968 0.349 . . . . 0.0 111.744 -174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.439 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.77 40.81 98.66 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.749 -1.029 . . . . 0.0 113.092 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 78.8 Cg_endo -69.16 -10.55 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.852 2.368 . . . . 0.0 111.993 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -144.24 147.57 37.77 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.053 0.541 . . . . 0.0 109.807 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.48 153.07 39.26 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.52 2.813 . . . . 0.0 111.3 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -149.03 -0.84 0.5 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.174 0.589 . . . . 0.0 111.583 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 10.2 t -66.49 124.86 23.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.521 -0.737 . . . . 0.0 109.687 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . 0.46 HD21 ' H ' ' A' ' 575' ' ' LEU . 1.8 pt? -124.99 144.56 50.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 0.0 110.939 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -82.66 147.6 28.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 49.5 tp -139.68 144.91 37.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.5 p -163.81 167.06 21.31 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -84.63 125.66 32.67 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.466 ' HB3' ' CE1' ' A' ' 501' ' ' HIS . 31.8 t -135.69 148.79 49.03 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 85.0 m -79.53 105.43 10.83 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.556 0.217 . . . . 0.0 110.762 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.17 161.45 34.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.016 0.927 . . . . 0.0 109.75 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -126.67 -1.57 6.73 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.592 0.357 . . . . 0.0 110.996 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -148.82 161.62 41.46 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.881 0.872 . . . . 0.0 110.031 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.48 0.99 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.32 -1.324 . . . . 0.0 110.163 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 119.618 -0.229 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 55.98 15.2 1.65 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.502 1.121 . . . . 0.0 113.455 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 162.04 160.38 10.95 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.19 -168.23 0.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.45 3.434 . . . . 0.0 110.326 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -105.63 145.58 30.83 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -70.63 152.84 43.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.002 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.88 -8.67 55.49 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.504 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 40.7 m -148.06 152.48 40.02 Favored Pre-proline 0 N--CA 1.456 -0.146 0 C-N-CA 122.657 0.383 . . . . 0.0 111.205 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -83.57 0.28 9.49 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.276 3.318 . . . . 0.0 112.816 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.16 164.37 33.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.697 0.681 . . . . 0.0 112.465 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.28 164.16 35.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.087 0.955 . . . . 0.0 108.933 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 79.4 mtp -133.29 150.85 51.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.642 0.377 . . . . 0.0 110.811 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.92 149.15 23.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.868 0.467 . . . . 0.0 110.638 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.444 ' CE2' ' HE1' ' A' ' 412' ' ' MET . 16.0 m-85 -139.38 163.98 31.07 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.648 0.779 . . . . 0.0 110.113 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.34 -2.86 69.45 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.734 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.64 171.76 11.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.021 0.911 . . . . 0.0 110.98 178.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -126.09 137.4 53.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.688 0.395 . . . . 0.0 110.016 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -67.82 -7.86 31.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 60.9 p -99.11 -8.78 24.72 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -134.35 -8.46 2.57 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.174 0.443 . . . . 0.0 111.317 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.5 tpt -147.97 108.34 4.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.142 0.577 . . . . 0.0 109.588 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.447 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 51.4 p-10 -141.91 -173.12 3.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.328 0.651 . . . . 0.0 109.884 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 24.4 p -56.03 -27.66 54.08 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.864 0.466 . . . . 0.0 112.154 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.05 -37.96 21.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.071 -0.393 . . . . 0.0 110.891 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . 0.447 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 7.8 mpt_? -75.76 -29.81 58.95 Favored 'General case' 0 C--O 1.23 0.041 0 O-C-N 122.206 -0.309 . . . . 0.0 110.805 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.42 -30.75 26.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -73.91 -27.48 61.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.642 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.16 -26.54 59.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.849 -0.532 . . . . 0.0 111.703 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.3 -24.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -106.24 -10.92 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.785 0.721 . . . . 0.0 112.846 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.51 -23.21 58.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.767 0.712 . . . . 0.0 111.772 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.7 pp -77.28 12.56 1.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.631 -0.668 . . . . 0.0 112.263 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -120.74 -5.98 9.66 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.181 0.592 . . . . 0.0 111.088 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 151.85 -179.63 28.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -73.51 150.89 41.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.4 t -118.08 155.17 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.7 -57.45 2.25 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 118.712 0.687 . . . . 0.0 112.006 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . 0.402 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.9 pttm -161.72 164.06 29.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.986 0.422 . . . . 0.0 111.782 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.66 150.88 16.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.93 0.892 . . . . 0.0 109.871 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -151.91 145.07 24.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.01 144.5 30.82 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.444 ' HE1' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -126.11 141.54 51.9 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -167.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.21 34.08 21.03 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.576 1.55 . . . . 0.0 112.565 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.4 m 53.46 15.06 0.64 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.053 1.341 . . . . 0.0 114.201 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -82.7 136.95 44.49 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 118.444 0.566 . . . . 0.0 109.582 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.86 -9.56 16.9 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.873 2.382 . . . . 0.0 109.571 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.22 19.66 24.47 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.202 0.906 . . . . 0.0 112.977 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -152.24 143.2 23.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.61 1.205 . . . . 0.0 110.848 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.89 167.61 29.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.846 0.355 . . . . 0.0 111.672 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 24.5 ptm -142.38 146.45 34.94 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.118 0.567 . . . . 0.0 109.812 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.6 154.96 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 122.601 0.361 . . . . 0.0 110.982 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.84 141.71 51.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.846 0.858 . . . . 0.0 110.714 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 66.9 mtp -119.02 163.36 17.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.853 0.461 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.99 67.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.21 164.35 30.48 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.724 0.409 . . . . 0.0 110.159 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.12 -8.09 61.01 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.333 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -69.69 -28.28 65.71 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.55 1.675 . . . . 0.0 110.218 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -87.21 -24.8 24.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.8 t -75.88 -25.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.89 -42.61 73.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.243 -0.285 . . . . 0.0 110.431 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -69.05 -26.81 65.16 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.76 -40.22 33.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.095 -0.378 . . . . 0.0 111.294 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.4 tp -81.38 -30.99 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.572 0.349 . . . . 0.0 111.902 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -99.9 -20.12 16.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -129.67 -8.59 4.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -174.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.48 -20.92 10.03 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.314 0.961 . . . . 0.0 109.635 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.31 144.79 12.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 58.02 1.38 0.14 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.235 2.214 . . . . 0.0 115.374 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -88.08 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.337 1.426 . . . . 0.0 108.307 168.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.308 0.0 OUTLIER -130.93 163.93 26.42 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 174.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.6 ptm -125.39 143.39 51.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.582 1.553 . . . . 0.0 109.86 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 63.92 32.59 13.09 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.121 1.368 . . . . 0.0 114.551 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.06 15.92 80.85 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.542 -0.588 . . . . 0.0 114.267 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.16 153.97 24.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.124 0.962 . . . . 0.0 110.122 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.509 ' H ' ' HD3' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -88.85 131.28 35.17 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 175.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.59 130.92 45.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -140.76 113.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.15 139.93 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.415 0.552 . . . . 0.0 110.523 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 84.4 m -149.13 161.54 41.77 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.038 0.935 . . . . 0.0 110.113 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.4 p -82.47 156.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 43.9 t -132.94 157.9 43.99 Favored 'General case' 0 N--CA 1.459 0.024 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -99.57 6.21 45.83 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -65.66 142.59 98.3 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.49 -25.72 10.85 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.942 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.11 15.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 110.066 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . 0.402 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 37.0 mm -69.35 138.57 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.68 151.22 42.13 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 122.395 0.278 . . . . 0.0 110.468 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.33 164.13 36.2 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.606 2.871 . . . . 0.0 110.81 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.87 -177.42 41.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -76.29 155.42 34.3 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.85 0.46 . . . . 0.0 110.032 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.6 p -133.09 165.57 24.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.625 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -147.38 161.16 41.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -83.41 135.29 13.67 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.93 168.85 13.0 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.539 0.735 . . . . 0.0 110.013 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -20.81 64.92 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.343 -0.223 . . . . 0.0 111.224 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.22 0.81 23.65 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 111.267 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.18 -3.15 82.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 123.542 0.591 . . . . 0.0 112.598 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.0 t -93.98 163.57 13.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.603 0.702 . . . . 0.0 110.286 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.42 153.39 21.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.722 0.296 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -66.19 -10.46 41.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.526 0.33 . . . . 0.0 111.601 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -120.62 141.87 49.95 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.141 0.976 . . . . 0.0 109.115 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -151.62 156.87 41.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.619 0.247 . . . . 0.0 110.464 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -126.31 150.16 48.68 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.637 0.775 . . . . 0.0 110.17 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -140.05 12.8 2.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.25 0.62 . . . . 0.0 111.566 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 22.4 t -65.94 -9.67 31.91 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -173.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.88 -6.91 59.52 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.722 0.409 . . . . 0.0 110.858 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.6 m -87.21 13.53 9.41 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.621 0.768 . . . . 0.0 111.833 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -73.87 12.35 0.7 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.394 0.678 . . . . 0.0 112.44 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -103.16 4.54 37.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.812 0.845 . . . . 0.0 111.476 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -73.75 153.66 39.92 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.749 -0.595 . . . . 0.0 110.078 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.0 7.12 4.34 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.39 0.676 . . . . 0.0 112.257 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -138.44 29.38 2.43 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.558 0.743 . . . . 0.0 111.05 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 39.2 m -76.8 2.61 13.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.97 0.508 . . . . 0.0 112.338 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 52.7 p -134.37 154.65 79.97 Favored Pre-proline 0 C--O 1.231 0.089 0 C-N-CA 123.052 0.541 . . . . 0.0 109.877 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.85 -11.12 31.05 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.14 2.56 . . . . 0.0 111.767 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.11 -32.69 14.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.032 0.378 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -90.46 -19.17 24.18 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 122.174 -0.329 . . . . 0.0 110.894 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -67.51 -16.05 63.99 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.062 -0.399 . . . . 0.0 111.12 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -81.33 -2.39 48.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.91 0.484 . . . . 0.0 111.544 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -115.96 9.21 14.84 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.756 0.823 . . . . 0.0 111.109 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -130.65 20.87 5.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.58 0.752 . . . . 0.0 111.122 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 51.99 45.5 28.2 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.956 0.903 . . . . 0.0 112.635 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 51.5 mm -81.0 93.93 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -156.59 -171.49 3.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.848 0.859 . . . . 0.0 109.96 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -60.95 159.72 25.41 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.215 0.606 . . . . 0.0 110.544 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.19 147.69 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.372 2.715 . . . . 0.0 112.93 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 55.7 m -124.0 19.4 9.22 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.34 0.656 . . . . 0.0 111.169 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.28 3.81 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.179 1.392 . . . . 0.0 114.591 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 37.0 t -141.54 147.38 22.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . 0.44 HD13 ' CH2' ' A' ' 546' ' ' TRP . 53.2 mt -121.8 163.38 19.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.895 0.478 . . . . 0.0 110.457 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.58 158.66 43.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.566 0.346 . . . . 0.0 110.807 174.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -137.59 153.83 49.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.407 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -148.39 169.65 19.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.143 0.577 . . . . 0.0 110.33 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 15.8 t30 62.51 18.92 10.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.877 0.871 . . . . 0.0 113.324 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -77.52 164.63 56.92 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.48 152.91 37.59 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.728 2.285 . . . . 0.0 111.995 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . 0.443 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -74.66 -1.77 23.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.838 0.455 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -125.13 16.78 8.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.496 0.719 . . . . 0.0 111.421 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.64 151.32 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 122.019 -0.426 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 74.7 p -141.75 170.46 15.67 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 123.125 0.57 . . . . 0.0 110.69 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.2 -22.6 66.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.98 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.91 -24.48 48.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.205 -0.309 . . . . 0.0 110.493 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.44 -32.04 37.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -73.41 -29.88 62.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.235 -0.291 . . . . 0.0 110.747 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -77.88 -37.28 48.43 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.149 0.431 . . . . 0.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.91 -25.23 43.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.859 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.91 -40.66 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.4 m -65.11 -29.01 69.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.277 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.21 -29.3 61.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.854 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.98 -10.94 40.48 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.415 0.552 . . . . 0.0 112.014 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 85.2 mt -91.1 -3.71 56.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.758 0.423 . . . . 0.0 110.768 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.9 80.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.779 -0.456 . . . . 0.0 112.499 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -112.81 172.14 3.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.524 0.662 . . . . 0.0 111.403 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.18 149.19 41.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.207 0.603 . . . . 0.0 110.073 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -98.06 151.55 37.6 Favored Pre-proline 0 CA--C 1.528 0.13 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.54 147.17 93.22 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.788 2.325 . . . . 0.0 110.492 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.435 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.3 m -82.71 -28.4 30.54 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 122.938 0.495 . . . . 0.0 110.997 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -140.32 147.32 39.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 2.4 p -154.36 144.63 13.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 122.744 0.418 . . . . 0.0 110.799 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -149.2 156.47 42.2 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.354 0.662 . . . . 0.0 109.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.59 145.51 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.416 0.686 . . . . 0.0 109.23 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -150.63 142.52 23.86 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.735 0.302 . . . . 0.0 110.95 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p -130.78 50.61 2.2 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.366 0.666 . . . . 0.0 111.555 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -73.66 -13.06 80.58 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.889 -0.507 . . . . 0.0 111.837 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -155.07 169.86 23.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.122 1.369 . . . . 0.0 108.307 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 18.4 m 58.31 29.58 18.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.13 0.423 . . . . 0.0 110.962 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.19 -9.92 1.09 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.695 1.598 . . . . 0.0 114.821 -169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -67.58 -10.99 56.97 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.045 0.839 . . . . 0.0 110.38 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 59.3 m -148.9 -178.1 6.17 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.882 1.673 . . . . 0.0 108.784 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 8.6 t -140.26 160.86 39.02 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.116 -0.365 . . . . 0.0 110.981 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.8 m -146.35 164.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.698 0.799 . . . . 0.0 110.741 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 176.2 -166.52 37.65 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.591 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 63.3 mt -120.62 155.65 33.31 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.437 0.695 . . . . 0.0 111.265 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 91.9 mt -140.31 132.19 27.6 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.012 0.925 . . . . 0.0 108.816 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -127.89 119.48 25.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.44 ' CH2' HD13 ' A' ' 500' ' ' LEU . 2.6 p90 -166.05 150.47 8.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.385 1.474 . . . . 0.0 107.08 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -145.84 110.39 5.09 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -172.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.0 t -159.5 153.0 22.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -67.33 -42.02 84.28 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.528 0.604 . . . . 0.0 110.437 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 31.6 m -83.92 -30.55 26.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.808 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.81 -30.21 26.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.69 0.677 . . . . 0.0 111.48 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.73 -30.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.162 0.437 . . . . 0.0 111.316 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 29.8 tp -83.55 -29.29 27.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.879 0.763 . . . . 0.0 111.793 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.4 -42.67 43.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.256 0.48 . . . . 0.0 110.02 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 55.5 m -68.99 -31.85 71.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.9 -41.84 58.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.01 -19.99 75.9 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.366 -0.686 . . . . 0.0 113.115 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.71 -11.65 13.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.326 1.063 . . . . 0.0 113.052 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 30.4 tp -104.97 -16.88 14.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.087 0.858 . . . . 0.0 112.386 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -72.59 143.81 48.1 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.748 -0.595 . . . . 0.0 109.545 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 51.11 21.18 0.98 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.879 0.872 . . . . 0.0 113.128 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -78.43 151.44 32.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.11 136.38 50.24 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.095 1.358 . . . . 0.0 109.181 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.419 ' HE2' ' CD1' ' A' ' 573' ' ' TYR . 49.9 ttm -64.24 162.15 15.2 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.252 0.549 . . . . 0.0 110.915 -173.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -66.69 15.66 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.866 1.666 . . . . 0.0 114.055 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -65.09 152.86 90.46 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.75 -46.89 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.728 2.286 . . . . 0.0 113.951 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -121.13 16.19 11.55 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.94 47.91 84.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.088 -0.84 . . . . 0.0 112.761 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 -10.09 21.97 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.147 2.565 . . . . 0.0 111.122 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -148.55 149.49 31.36 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 123.829 0.852 . . . . 0.0 109.603 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.86 156.37 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.577 2.851 . . . . 0.0 111.632 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . 0.419 ' CD1' ' HE2' ' A' ' 564' ' ' MET . 79.6 t80 -144.79 1.27 1.0 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.849 0.86 . . . . 0.0 110.588 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 57.3 m -66.44 116.53 7.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . 0.445 HD21 ' H ' ' A' ' 575' ' ' LEU . 1.7 pt? -124.89 144.53 50.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.508 0.723 . . . . 0.0 111.961 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.05 143.59 31.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.6 mt -131.21 144.73 51.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 36.8 t -163.8 176.34 9.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.34 145.31 28.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.928 0.491 . . . . 0.0 110.933 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 35.0 t -135.54 147.22 48.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.094 0.558 . . . . 0.0 110.112 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 25.4 m -89.61 102.13 14.81 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.62 34.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.598 0.759 . . . . 0.0 110.293 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -96.43 -21.52 17.7 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -164.26 153.81 14.0 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.073 0.949 . . . . 0.0 109.962 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -109.97 76.32 0.98 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.465 -1.255 . . . . 0.0 110.631 178.58 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 39.5 t80 52.72 26.1 4.24 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.595 0.758 . . . . 0.0 112.285 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -172.51 -170.49 36.37 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.51 166.77 1.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.863 3.709 . . . . 0.0 113.841 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 57.26 52.32 8.99 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.1 0.96 . . . . 0.0 111.795 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -58.09 156.37 9.61 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.81 0.444 . . . . 0.0 110.42 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.19 6.44 5.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.826 0.451 . . . . 0.0 111.946 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.4 m -142.92 146.03 35.77 Favored Pre-proline 0 C--O 1.232 0.133 0 O-C-N 121.93 -0.481 . . . . 0.0 111.389 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -82.0 1.8 8.97 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 124.598 3.532 . . . . 0.0 112.834 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.26 146.35 28.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-N 118.374 0.534 . . . . 0.0 110.943 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.84 167.68 21.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.695 0.798 . . . . 0.0 109.609 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.9 mtp -138.83 151.17 46.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.672 0.273 . . . . 0.0 110.856 -175.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.09 150.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.043 0.537 . . . . 0.0 110.63 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.76 166.52 24.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.489 0.716 . . . . 0.0 109.519 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.08 89.46 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.701 -0.499 . . . . 0.0 112.934 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.15 175.71 7.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.774 0.787 . . . . 0.0 110.689 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -138.3 142.08 39.8 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.544 0.338 . . . . 0.0 110.103 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -73.94 -2.35 23.61 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.8 p -110.38 -2.68 16.52 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.205 0.457 . . . . 0.0 112.126 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -131.65 -5.72 3.66 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.164 0.586 . . . . 0.0 110.922 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.8 tpt -146.19 123.33 11.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.216 0.606 . . . . 0.0 109.545 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 22.5 m120 -141.94 176.26 9.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.883 0.873 . . . . 0.0 109.082 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 81.6 m -59.54 -25.97 64.96 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.225 -0.297 . . . . 0.0 110.94 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.14 -23.12 26.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.255 -0.278 . . . . 0.0 111.593 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . 0.45 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 49.0 mmt-85 -82.16 -31.3 30.57 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.418 0.554 . . . . 0.0 109.586 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.43 -30.0 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.94 -30.89 68.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -71.96 -32.03 66.87 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.94 -0.475 . . . . 0.0 110.889 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.3 t -88.03 -27.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -104.95 -8.41 18.62 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.36 -39.46 78.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.825 0.739 . . . . 0.0 110.967 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.03 14.96 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.936 -0.478 . . . . 0.0 112.145 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.31 -1.89 9.63 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.188 0.595 . . . . 0.0 111.067 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.83 174.19 19.48 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -74.71 136.03 41.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.317 -0.52 . . . . 0.0 110.957 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 7.7 m -94.44 164.52 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 124.571 1.148 . . . . 0.0 110.365 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -129.91 -63.34 0.92 Allowed 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.261 0.224 . . . . 0.0 110.884 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -163.32 166.04 23.48 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.771 0.429 . . . . 0.0 111.353 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.54 153.27 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.553 0.741 . . . . 0.0 110.625 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -149.65 145.06 26.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -77.47 155.2 31.87 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 8.3 ttm -107.78 141.11 39.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -168.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 48.72 33.99 4.77 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.217 1.007 . . . . 0.0 112.64 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.9 m 53.03 17.64 0.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.828 0.851 . . . . 0.0 113.099 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.66 147.77 53.07 Favored Pre-proline 0 N--CA 1.455 -0.204 0 CA-C-N 118.023 0.374 . . . . 0.0 110.428 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -81.61 -1.63 11.07 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.43 2.753 . . . . 0.0 110.427 170.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -124.54 17.28 7.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.587 -173.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.79 143.91 25.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.747 1.274 . . . . 0.0 110.976 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.95 168.66 26.83 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.8 ptm -141.6 145.14 34.67 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.427 0.691 . . . . 0.0 109.946 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 14.6 t -131.95 150.96 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 122.746 0.418 . . . . 0.0 110.838 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -128.24 143.26 51.02 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.389 0.675 . . . . 0.0 110.311 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 81.3 mmm -117.1 162.64 17.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.434 0.694 . . . . 0.0 109.323 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -73.25 -19.28 61.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.055 -0.403 . . . . 0.0 111.921 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -156.62 162.5 39.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.776 0.43 . . . . 0.0 110.172 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.64 -17.95 73.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.458 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -67.49 -26.52 66.4 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.976 1.388 . . . . 0.0 110.172 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.57 -24.17 45.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.416 0.286 . . . . 0.0 110.621 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.25 -31.81 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.75 -32.38 73.9 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -82.22 -30.5 30.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.349 0.26 . . . . 0.0 111.681 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.59 -28.22 31.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.33 0.514 . . . . 0.0 111.073 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.4 tp -82.59 -31.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.918 0.487 . . . . 0.0 110.992 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.0 m -93.74 -21.99 18.99 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -124.24 -13.32 7.24 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.66 -20.47 10.11 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.072 0.851 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -52.28 143.26 15.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.963 0.905 . . . . 0.0 111.497 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 14.3 p30 56.91 1.53 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.004 2.522 . . . . 0.0 115.864 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -88.04 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.183 1.356 . . . . 0.0 108.184 168.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.286 0.0 OUTLIER -130.95 163.95 26.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 176.379 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.7 ptm -125.28 143.44 50.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.162 1.385 . . . . 0.0 109.946 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 65.07 31.57 10.98 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.025 1.33 . . . . 0.0 114.042 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.02 15.86 72.25 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.344 -0.698 . . . . 0.0 114.805 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -83.27 162.05 21.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.427 1.114 . . . . 0.0 110.337 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 131.68 35.66 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.961 0.41 . . . . 0.0 110.527 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.61 132.96 43.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -169.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.68 117.46 11.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.7 139.9 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 118.393 0.542 . . . . 0.0 110.523 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.4 m -150.23 161.98 41.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.982 0.913 . . . . 0.0 110.162 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.9 p -84.82 155.5 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 38.3 t -134.38 142.54 47.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.977 0.353 . . . . 0.0 111.246 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -85.7 65.95 9.4 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.03 0.532 . . . . 0.0 110.43 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -127.81 143.78 48.91 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.18 -26.54 6.25 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.878 2.386 . . . . 0.0 111.805 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.02 170.51 15.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.558 0.343 . . . . 0.0 111.031 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.1 mm -71.62 147.02 11.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.33 151.98 41.07 Favored Pre-proline 0 C--O 1.231 0.128 0 C-N-CA 122.416 0.286 . . . . 0.0 110.239 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.41 164.49 32.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.673 2.915 . . . . 0.0 111.874 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 171.21 -174.35 44.87 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -74.12 148.85 41.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.844 0.322 . . . . 0.0 110.25 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 24.9 m -142.59 160.89 39.42 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.249 0.62 . . . . 0.0 109.919 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -150.91 164.23 36.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.463 0.305 . . . . 0.0 110.568 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.14 135.27 16.27 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.95 169.5 12.42 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.539 0.736 . . . . 0.0 109.702 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.15 -20.31 65.73 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.081 -0.387 . . . . 0.0 111.376 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.0 -0.9 26.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.962 0.505 . . . . 0.0 111.283 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 85.73 -7.58 76.32 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.635 0.636 . . . . 0.0 112.783 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.7 m -93.83 156.19 16.79 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 117.896 0.848 . . . . 0.0 110.397 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 47.5 t -77.44 153.26 33.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.398 0.279 . . . . 0.0 110.261 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -68.14 -10.42 53.96 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.249 0.619 . . . . 0.0 111.678 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -123.48 136.27 54.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.11 0.964 . . . . 0.0 109.297 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -155.72 159.26 39.35 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -125.0 157.4 36.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.927 0.891 . . . . 0.0 110.454 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -139.56 13.53 2.54 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.6 p -69.81 1.72 4.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' A' ' 478' ' ' ARG . 58.7 mm-40 -85.36 11.95 9.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.693 0.797 . . . . 0.0 110.686 175.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 77.4 p -72.06 22.29 0.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.222 1.409 . . . . 0.0 112.587 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' A' ' 476' ' ' GLU . 22.5 mmt180 -76.07 30.84 0.11 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.025 0.93 . . . . 0.0 112.66 -174.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -134.0 31.13 3.6 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.747 0.819 . . . . 0.0 110.533 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -138.45 172.76 12.42 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.838 0.455 . . . . 0.0 110.682 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -62.55 -13.73 34.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.12 0.968 . . . . 0.0 112.632 -174.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.93 24.89 11.64 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.662 0.385 . . . . 0.0 111.984 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 41.3 t -60.6 -23.08 64.42 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.032 0.533 . . . . 0.0 111.365 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 72.5 p -137.16 155.84 75.79 Favored Pre-proline 0 N--CA 1.456 -0.13 0 C-N-CA 123.564 0.745 . . . . 0.0 109.389 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -70.54 -9.02 24.95 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.183 2.589 . . . . 0.0 111.517 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.13 -30.02 16.19 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.872 0.305 . . . . 0.0 110.707 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -90.43 -24.75 20.65 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.36 -13.83 62.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.288 0.235 . . . . 0.0 110.733 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.38 3.09 37.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.156 0.582 . . . . 0.0 111.131 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -118.47 22.28 12.17 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.948 0.899 . . . . 0.0 110.887 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -78.84 171.68 14.84 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.745 0.418 . . . . 0.0 111.812 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -135.51 37.87 2.9 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.653 0.781 . . . . 0.0 109.823 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 46.6 mm -80.97 130.87 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 O-C-N 122.034 -0.417 . . . . 0.0 110.008 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -156.64 -174.04 4.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.592 0.757 . . . . 0.0 110.031 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -61.43 163.82 10.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.139 0.975 . . . . 0.0 110.828 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.22 143.06 20.12 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.23 2.62 . . . . 0.0 112.258 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 51.3 m -119.77 23.58 11.03 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.261 0.624 . . . . 0.0 112.259 -172.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 61.96 -7.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.42 1.488 . . . . 0.0 114.098 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.72 147.65 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.757 0.708 . . . . 0.0 109.661 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 59.5 mt -119.1 151.64 37.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.786 0.434 . . . . 0.0 110.222 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.498 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 11.7 m170 -119.55 155.41 32.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.25 149.91 44.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.333 0.253 . . . . 0.0 110.524 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -145.78 169.28 18.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.747 0.419 . . . . 0.0 110.987 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 46.4 t30 56.68 33.12 22.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.994 0.918 . . . . 0.0 112.843 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.82 163.74 39.74 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.94 151.0 68.64 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.007 2.472 . . . . 0.0 111.847 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . 0.435 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -75.27 -1.19 22.38 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.34 9.59 11.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.899 0.48 . . . . 0.0 111.919 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.6 149.49 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 118.019 0.372 . . . . 0.0 111.058 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.8 p -142.07 173.98 11.02 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.536 0.735 . . . . 0.0 110.265 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.63 -21.74 65.9 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.77 -22.08 58.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.234 -0.291 . . . . 0.0 110.407 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -83.25 -32.17 26.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.86 -27.63 63.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -84.53 -37.54 21.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.135 0.425 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -76.03 -21.28 57.01 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.756 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.6 mt -92.1 -36.14 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.922 0.328 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 18.2 p -70.31 -20.85 62.98 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.47 -29.03 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.567 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.99 -12.93 34.41 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.447 0.567 . . . . 0.0 111.333 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.06 -9.58 55.1 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.716 0.406 . . . . 0.0 110.838 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.22 11.08 82.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.765 -0.464 . . . . 0.0 112.803 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.5 m -98.8 169.82 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.103 0 CA-C-N 117.738 0.769 . . . . 0.0 111.291 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.54 151.68 42.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.343 0.657 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -101.04 151.98 37.76 Favored Pre-proline 0 C--O 1.231 0.111 0 C-N-CA 122.729 0.412 . . . . 0.0 109.899 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.31 153.38 78.26 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.962 2.442 . . . . 0.0 110.471 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 80.6 m -86.14 -24.84 26.05 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.621 0.368 . . . . 0.0 110.53 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -142.84 150.35 39.78 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.168 0.587 . . . . 0.0 109.599 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.55 147.97 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 120.872 0.368 . . . . 0.0 110.387 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -142.28 132.26 24.46 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.91 142.4 39.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -154.24 150.65 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 110.468 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m -130.82 133.2 45.74 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.05 158.0 45.7 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -71.22 130.55 41.72 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 26.3 m 55.68 15.31 1.52 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -86.54 -15.4 40.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.707 0.685 . . . . 0.0 111.328 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 49.42 29.28 2.77 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.967 0.907 . . . . 0.0 112.757 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.2 t -149.52 162.88 39.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.922 0.489 . . . . 0.0 110.433 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 42.2 t -124.82 152.59 43.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.47 0.708 . . . . 0.0 111.519 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 52.5 m -147.73 165.26 31.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.73 1.212 . . . . 0.0 108.93 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.81 -165.88 37.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.745 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -127.41 156.28 42.32 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.755 0.822 . . . . 0.0 110.351 -176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.86 133.62 30.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.482 1.113 . . . . 0.0 108.004 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.83 113.3 15.77 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.411 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.9 p90 -166.02 151.35 8.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 168.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -150.77 116.2 5.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 35.2 t -159.41 152.92 22.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.93 -38.0 79.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.746 0.703 . . . . 0.0 111.432 -174.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 47.4 m -87.78 -28.6 21.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -85.37 -28.32 25.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.414 0.552 . . . . 0.0 111.12 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.17 -34.42 37.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 117.949 0.341 . . . . 0.0 110.397 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.88 -30.73 45.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.439 0.563 . . . . 0.0 112.016 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -72.72 -43.73 62.6 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.261 0.482 . . . . 0.0 109.979 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 44.4 m -69.27 -40.26 77.91 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -42.79 98.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.901 -0.499 . . . . 0.0 109.864 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.15 -21.57 77.11 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.86 -0.966 . . . . 0.0 113.447 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -117.68 -14.97 10.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.857 1.329 . . . . 0.0 113.276 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 17.4 tp -88.22 -21.93 24.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.347 0.976 . . . . 0.0 110.623 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -76.49 151.32 36.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 39.8 t60 55.91 22.66 5.89 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.64 151.46 37.77 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.194 0.598 . . . . 0.0 112.537 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -110.78 136.18 50.23 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.06 0.944 . . . . 0.0 111.433 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.25 176.83 0.94 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.076 0.95 . . . . 0.0 111.417 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.9 10.71 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.709 0.803 . . . . 0.0 112.459 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.04 146.71 87.43 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 123.288 0.635 . . . . 0.0 111.051 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.92 -40.63 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.134 2.556 . . . . 0.0 112.734 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -120.96 2.38 10.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 65.82 60.26 6.71 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.767 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.67 -8.5 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.322 2.681 . . . . 0.0 110.984 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.45 151.03 46.16 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 123.576 0.75 . . . . 0.0 109.74 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.58 154.33 39.75 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.637 2.892 . . . . 0.0 110.356 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -133.16 -4.58 3.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.8 t -66.55 131.95 47.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.668 -0.645 . . . . 0.0 110.653 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 1.8 pp -116.43 144.67 44.01 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.373 0.669 . . . . 0.0 110.79 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.64 138.09 39.85 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.03 155.89 43.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 111.412 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.9 p -163.76 167.98 20.27 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.23 131.61 39.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.498 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 26.2 t -135.64 150.13 49.53 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.521 0.201 . . . . 0.0 111.247 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.2 m -84.77 102.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.16 161.63 34.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.742 0.817 . . . . 0.0 110.061 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -109.75 -11.9 14.68 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.422 0.289 . . . . 0.0 111.634 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -160.52 162.83 33.11 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.079 0.552 . . . . 0.0 109.995 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -95.83 76.5 3.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.268 0.627 . . . . 0.0 109.717 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.252 1.204 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.222 -179.677 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 119.587 -0.244 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -80.41 -27.08 38.13 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.981 0.355 . . . . 0.0 110.582 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -96.66 -150.09 26.41 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 172.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -54.1 164.09 2.86 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.915 3.077 . . . . 0.0 112.278 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 54.14 91.72 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.861 1.264 . . . . 0.0 112.389 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -71.54 159.72 33.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.56 0.344 . . . . 0.0 110.495 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -142.32 14.46 2.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.044 0.538 . . . . 0.0 111.192 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.1 m -141.38 150.11 56.9 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 122.126 -0.359 . . . . 0.0 111.379 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.39 -5.6 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.137 3.225 . . . . 0.0 111.98 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.89 151.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 122.832 0.453 . . . . 0.0 111.276 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.42 167.88 21.88 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.71 0.804 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 74.6 mtp -133.61 150.41 51.61 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.359 0.264 . . . . 0.0 111.316 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.05 151.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.161 0.584 . . . . 0.0 110.603 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -140.05 164.95 28.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.472 0.709 . . . . 0.0 109.637 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 78.94 -2.69 67.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.384 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.457 ' CD2' ' H ' ' A' ' 386' ' ' LEU . 1.8 pt? -71.41 134.64 46.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.988 0.894 . . . . 0.0 109.794 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -83.48 122.65 28.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -75.03 6.79 3.79 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.9 p -116.0 -1.02 12.6 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.788 0.435 . . . . 0.0 111.658 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -130.3 -9.09 4.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.791 0.836 . . . . 0.0 110.472 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 11.0 tpt -139.86 128.08 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.24 1.016 . . . . 0.0 108.785 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -141.92 -172.92 3.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.132 0.573 . . . . 0.0 109.822 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.22 -22.65 64.97 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.19 -33.27 20.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.964 -0.46 . . . . 0.0 110.851 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 41.2 mmt-85 -81.66 -25.35 35.64 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.275 -0.266 . . . . 0.0 110.987 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.43 -30.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.018 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.22 -25.49 63.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -75.09 -39.81 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.14 -0.35 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.3 -20.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.994 -0.441 . . . . 0.0 111.979 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -109.81 -18.02 13.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.65 -21.6 57.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.16 0.891 . . . . 0.0 111.499 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.23 7.3 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.705 -0.622 . . . . 0.0 112.469 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -121.62 -1.85 9.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.538 0.735 . . . . 0.0 111.41 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.96 173.31 20.21 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -68.28 146.97 52.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.346 -0.502 . . . . 0.0 111.23 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.51 155.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.783 0.833 . . . . 0.0 108.813 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -101.02 -65.37 0.97 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -163.31 164.41 24.86 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.595 0.758 . . . . 0.0 110.232 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 11.2 p -144.2 151.27 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 C-N-CA 123.116 0.566 . . . . 0.0 110.437 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.07 139.77 19.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.924 0.14 . . . . 0.0 111.282 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.71 152.3 28.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -133.86 141.42 47.39 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 60.0 33.74 21.4 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 126.472 1.909 . . . . 0.0 114.231 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.1 m 52.84 16.0 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -72.0 158.38 87.77 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.613 0.642 . . . . 0.0 110.712 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.77 -22.4 44.67 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.223 2.615 . . . . 0.0 112.023 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -171.06 97.9 0.13 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -158.67 134.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -153.89 168.31 26.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.367 0.603 . . . . 0.0 112.462 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.9 ptp -139.63 145.34 38.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.147 0.979 . . . . 0.0 109.038 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.07 146.6 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.949 0.404 . . . . 0.0 110.617 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -124.94 146.41 49.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 109.866 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 75.3 mtp -122.35 164.12 18.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.793 0.437 . . . . 0.0 110.431 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.93 61.87 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -156.93 158.04 35.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.051 0.387 . . . . 0.0 110.181 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.13 80.67 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.116 -0.824 . . . . 0.0 113.578 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -69.17 -25.77 64.52 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.198 1.499 . . . . 0.0 110.839 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.29 -25.24 27.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.14 -27.51 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.25 -37.33 77.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.324 -0.235 . . . . 0.0 110.449 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -71.96 -30.79 65.65 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.84 57.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.314 -0.241 . . . . 0.0 111.078 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.2 tp -83.65 -30.9 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.6 m -99.02 -16.27 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.93 -6.68 2.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.62 -20.57 10.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.251 0.932 . . . . 0.0 109.56 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -52.77 142.32 19.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.044 0.938 . . . . 0.0 110.872 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.09 1.28 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.101 2.16 . . . . 0.0 115.659 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -87.84 142.52 27.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 120.242 1.383 . . . . 0.0 108.507 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -130.84 164.06 26.03 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.2 ptm -125.43 143.47 50.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.991 1.316 . . . . 0.0 108.985 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 67.01 25.7 9.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.05 80.54 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 168.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -83.06 159.77 22.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.014 1.407 . . . . 0.0 110.65 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 141.93 32.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.19 0.596 . . . . 0.0 111.025 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -98.22 124.15 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -140.68 111.3 6.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 169.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.09 140.2 17.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 CA-C-N 118.118 0.417 . . . . 0.0 109.957 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 96.8 m -149.47 159.94 43.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.775 0.83 . . . . 0.0 110.352 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.0 p -80.12 160.4 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 46.2 t -134.29 168.47 18.84 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 122.811 0.444 . . . . 0.0 110.515 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.08 12.71 11.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.566 0.746 . . . . 0.0 112.337 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.05 147.06 99.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.39 -36.5 77.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.81 2.34 . . . . 0.0 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.01 173.69 6.77 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.622 0.769 . . . . 0.0 110.047 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.4 mm -68.77 144.69 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.6 mtt -105.55 146.66 33.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 117.646 0.203 . . . . 0.0 110.994 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.2 172.85 15.55 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.253 3.302 . . . . 0.0 111.457 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.06 46.82 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.377 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 55.15 21.78 4.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.04 0.936 . . . . 0.0 112.857 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.5 p -79.42 153.93 29.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.716 0.293 . . . . 0.0 110.928 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -154.09 163.45 40.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.146 0.579 . . . . 0.0 110.343 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.2 136.0 16.56 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.92 169.32 12.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.277 0.631 . . . . 0.0 110.12 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.67 -21.13 66.66 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 110.316 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -77.94 -1.38 31.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.666 0.787 . . . . 0.0 111.452 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.76 70.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.398 0.523 . . . . 0.0 113.16 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.1 m -93.77 163.79 13.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.642 0.721 . . . . 0.0 110.798 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.51 153.33 37.55 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.7 p -70.23 -10.57 59.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -119.68 146.57 45.47 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.593 0.633 . . . . 0.0 112.156 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -157.0 156.12 32.4 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 110.142 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -124.49 152.31 43.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.798 0.839 . . . . 0.0 109.713 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.93 10.04 2.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.013 0.525 . . . . 0.0 111.282 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 94.3 p -67.61 -11.18 57.56 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.72 -3.7 39.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.614 0.366 . . . . 0.0 111.202 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 19.9 t -104.85 18.23 22.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.783 0.833 . . . . 0.0 110.989 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -73.95 0.99 11.8 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.906 -0.496 . . . . 0.0 111.197 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -100.94 6.28 43.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.814 0.446 . . . . 0.0 110.684 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -81.25 166.15 20.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.882 0.473 . . . . 0.0 110.277 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -72.8 5.35 3.25 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.06 23.3 4.17 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.571 0.623 . . . . 0.0 112.45 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 88.5 p -73.67 -8.03 54.36 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.991 -0.443 . . . . 0.0 111.806 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 53.4 p -140.94 154.61 68.63 Favored Pre-proline 0 C--O 1.232 0.139 0 C-N-CA 123.764 0.826 . . . . 0.0 109.386 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.68 -11.66 31.42 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.014 2.476 . . . . 0.0 111.662 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -90.49 -29.93 17.62 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.171 0.442 . . . . 0.0 111.381 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -90.56 -27.88 18.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.775 0.261 . . . . 0.0 110.469 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.53 -19.7 62.14 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.567 0.347 . . . . 0.0 111.666 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -73.57 1.12 10.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.203 0.601 . . . . 0.0 111.77 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -120.19 12.75 11.89 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.102 0.961 . . . . 0.0 111.049 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -132.9 27.08 4.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.0 0.52 . . . . 0.0 111.109 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.526 ' HD2' ' H ' ' A' ' 581' ' ' THR . 64.3 mtm-85 58.64 22.65 10.1 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.054 0.942 . . . . 0.0 113.281 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.4 mm -81.02 148.86 5.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 125.029 1.332 . . . . 0.0 110.763 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.286 8.5 pt20 64.69 14.41 9.05 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.545 1.938 . . . . 0.0 115.213 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -141.19 95.84 7.33 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.78 138.49 16.91 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.487 2.792 . . . . 0.0 110.255 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 56.4 m -124.04 23.93 8.37 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.362 0.665 . . . . 0.0 111.4 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.45 18.91 9.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.811 0.844 . . . . 0.0 112.717 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.9 t -134.42 146.82 30.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . 0.41 HD13 ' CH2' ' A' ' 546' ' ' TRP . 28.8 mt -118.22 160.61 21.3 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.8 0.44 . . . . 0.0 110.196 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -121.64 157.41 30.88 Favored 'General case' 0 N--CA 1.46 0.059 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -142.73 152.85 42.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.852 0.461 . . . . 0.0 110.409 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.85 173.07 12.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.126 0.57 . . . . 0.0 110.549 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 64.8 t30 66.5 28.41 9.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.451 1.1 . . . . 0.0 113.329 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.14 160.42 46.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 122.12 -0.363 . . . . 0.0 110.723 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 156.0 39.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.08 2.52 . . . . 0.0 111.644 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . 0.443 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -77.97 -0.76 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -122.52 13.1 10.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.174 0.589 . . . . 0.0 111.548 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.57 152.68 7.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 O-C-N 122.081 -0.387 . . . . 0.0 110.926 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.6 p -142.39 170.99 14.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.489 0.715 . . . . 0.0 110.437 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.74 -20.65 65.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.819 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -72.89 -23.65 60.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.6 -33.37 28.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -69.46 -28.66 66.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.514 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -82.26 -35.64 27.91 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.965 -0.46 . . . . 0.0 111.788 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -78.27 -17.3 56.83 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.329 0.513 . . . . 0.0 112.006 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.01 -25.36 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.122 0.419 . . . . 0.0 110.663 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.18 -24.24 63.1 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.404 -0.81 . . . . 0.0 109.753 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.94 -10.78 54.62 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.04 -18.82 23.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 110.332 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.7 mt -112.92 -0.44 14.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.75 5.77 70.15 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.678 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.86 169.75 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.852 0.826 . . . . 0.0 111.044 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.49 145.37 34.99 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.882 0.473 . . . . 0.0 110.275 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.67 146.67 47.19 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.944 0.498 . . . . 0.0 110.218 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 158.22 58.12 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.251 2.634 . . . . 0.0 110.685 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 61.8 m -90.4 -28.34 18.72 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.015 0.526 . . . . 0.0 110.698 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.2 m -142.35 153.67 44.02 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.142 0.577 . . . . 0.0 109.505 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 94.8 t -139.13 146.62 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 122.976 0.51 . . . . 0.0 110.284 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 586' ' ' SER . 30.0 ttmt -138.24 140.01 39.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.71 145.16 31.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -136.04 157.99 45.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -172.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.1 p -130.77 153.02 49.48 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.906 0.882 . . . . 0.0 110.198 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . 173.16 -147.18 9.45 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.04 160.6 12.23 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 23.0 m 61.68 29.01 17.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.198 0.454 . . . . 0.0 111.961 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.84 -7.51 0.74 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.954 1.302 . . . . 0.0 113.858 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.95 -10.88 43.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.469 0.577 . . . . 0.0 110.28 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 65.2 m -141.15 167.0 23.23 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.661 1.184 . . . . 0.0 109.575 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.1 t -132.0 166.01 22.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.016 0.526 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 77.6 p -153.47 172.35 17.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.495 1.118 . . . . 0.0 110.111 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.35 -161.05 33.43 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.63 -0.795 . . . . 0.0 114.028 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.09 157.18 32.02 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.57 1.148 . . . . 0.0 110.523 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.46 133.31 30.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 124.232 1.013 . . . . 0.0 108.345 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -127.8 119.37 25.55 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.454 ' HB3' ' H ' ' A' ' 527' ' ' THR . 3.0 p90 -166.09 153.21 9.82 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.418 1.487 . . . . 0.0 107.498 168.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -148.98 118.62 6.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.671 -0.811 . . . . 0.0 112.974 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.0 t -159.6 152.97 22.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 169.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -65.01 -53.0 53.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.716 0.689 . . . . 0.0 111.03 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 53.0 m -81.49 -23.85 37.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -91.48 -28.75 17.41 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.518 0.599 . . . . 0.0 111.966 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.58 38.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.335 0.516 . . . . 0.0 110.529 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 50.6 tp -82.25 -31.93 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.17 -36.72 47.16 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.825 -0.547 . . . . 0.0 110.273 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.5 m -72.52 -42.54 64.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.44 -47.83 84.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.34 -15.07 67.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.097 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.9 2.19 2.84 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.688 1.744 . . . . 0.0 114.377 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -104.05 -26.5 12.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.531 0.605 . . . . 0.0 109.727 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -65.16 155.17 35.79 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.686 -0.634 . . . . 0.0 110.369 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 55.4 20.84 3.85 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.33 151.26 35.03 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -110.93 136.51 49.84 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.902 1.681 . . . . 0.0 110.184 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.475 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.6 ttt -64.16 171.92 2.72 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.245 0.618 . . . . 0.0 111.006 -175.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -75.73 15.5 0.5 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -65.94 149.94 97.06 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.325 0.512 . . . . 0.0 110.132 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.53 -45.8 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.956 2.437 . . . . 0.0 113.347 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -121.04 13.69 11.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.63 52.23 50.22 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.237 -0.757 . . . . 0.0 112.263 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.82 -8.81 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.196 2.597 . . . . 0.0 111.315 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -146.31 149.43 37.89 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 123.698 0.799 . . . . 0.0 109.315 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.73 147.03 39.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.425 2.75 . . . . 0.0 110.881 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . 0.475 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.0 t80 -144.88 -2.6 0.81 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.27 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 62.3 m -66.37 110.63 3.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.41 144.55 25.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.901 0.48 . . . . 0.0 111.208 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -103.33 122.48 44.91 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.03 146.87 37.78 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 58.8 m -153.98 -178.14 6.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.67 1.188 . . . . 0.0 109.019 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.9 149.75 49.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.5 t -135.49 160.08 39.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.732 0.813 . . . . 0.0 110.328 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' THR . . . . . 0.526 ' H ' ' HD2' ' A' ' 492' ' ' ARG . 87.8 m -105.82 102.13 11.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.38 161.56 34.67 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.213 1.005 . . . . 0.0 110.186 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -87.09 -38.25 16.67 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -158.06 153.02 25.28 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.985 1.314 . . . . 0.0 109.377 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -99.66 76.5 2.0 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.421 ' N ' ' HE2' ' A' ' 530' ' ' LYS . 78.3 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.122 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -87.96 -10.75 49.52 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.891 0.476 . . . . 0.0 111.533 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 76.27 174.14 37.45 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.49 172.3 15.99 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.535 3.49 . . . . 0.0 111.021 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -148.58 157.81 43.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.264 0.626 . . . . 0.0 109.794 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -81.62 165.7 20.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.89 0.476 . . . . 0.0 111.149 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -123.94 -0.51 8.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.249 0.62 . . . . 0.0 111.809 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 31.2 t -164.06 150.93 10.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.253 0.621 . . . . 0.0 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.42 2.78 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.579 2.853 . . . . 0.0 111.617 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.02 151.15 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.837 0.855 . . . . 0.0 109.904 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -139.51 165.08 28.17 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.633 0.773 . . . . 0.0 109.706 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' MET . . . . . 0.417 ' HE3' ' HE2' ' A' ' 412' ' ' MET . 64.8 mtp -136.43 149.91 48.49 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.617 0.246 . . . . 0.0 111.223 -176.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.9 148.53 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.729 0.812 . . . . 0.0 109.591 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -140.03 162.99 33.88 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.972 0.509 . . . . 0.0 109.86 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.49 -0.34 86.87 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.713 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.68 176.82 5.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.063 0.932 . . . . 0.0 110.264 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -139.77 141.59 36.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.265 -0.272 . . . . 0.0 110.562 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -71.7 -1.73 14.87 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 46.7 m -104.99 -9.12 18.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.049 0.386 . . . . 0.0 111.92 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -136.22 -2.86 2.24 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.059 0.544 . . . . 0.0 111.222 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -145.2 122.72 11.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.566 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 20.2 m120 -141.83 177.01 8.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.631 0.773 . . . . 0.0 109.204 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -58.16 -28.13 64.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -91.73 -25.91 18.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.81 -0.556 . . . . 0.0 111.751 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . 0.566 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.8 mpt_? -73.59 -31.54 63.64 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.06 -32.33 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -68.1 -30.98 70.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.68 -27.53 62.15 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.13 -35.03 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.387 0.54 . . . . 0.0 111.829 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -89.93 -8.97 50.53 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.0 t -70.2 -26.94 64.12 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.525 0.602 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 26.8 mt -67.11 -4.46 10.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.749 -0.594 . . . . 0.0 111.822 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -121.45 4.05 10.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.84 -132.39 3.56 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -141.33 157.02 45.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 6.2 m -115.87 156.46 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.477 0.711 . . . . 0.0 111.003 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -110.04 -51.15 2.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.082 0.553 . . . . 0.0 110.908 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -167.6 167.6 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.476 0.711 . . . . 0.0 111.0 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.85 151.61 16.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.969 0.908 . . . . 0.0 110.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -149.94 143.82 25.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.151 0.58 . . . . 0.0 110.144 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -87.2 102.99 15.0 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.417 ' HE2' ' HE3' ' A' ' 382' ' ' MET . 0.0 OUTLIER -81.46 141.48 33.84 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.152 1.381 . . . . 0.0 112.966 -171.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 60.09 33.93 21.25 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.93 1.292 . . . . 0.0 112.47 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 92.0 p 52.88 12.37 0.27 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.839 1.656 . . . . 0.0 115.317 172.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -84.85 126.5 68.06 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-N 118.753 0.706 . . . . 0.0 110.308 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.96 -9.95 18.63 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.26 2.64 . . . . 0.0 111.853 171.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -106.9 17.23 38.75 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.359 0.98 . . . . 0.0 112.726 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -146.25 140.38 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.412 1.106 . . . . 0.0 110.934 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.29 158.23 39.88 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.946 0.498 . . . . 0.0 111.316 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.1 ptm -140.7 147.59 39.46 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.599 0.36 . . . . 0.0 110.251 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.82 148.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.78 0.432 . . . . 0.0 110.775 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -114.72 139.02 50.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.479 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 86.6 mmm -104.49 161.29 14.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.519 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.49 -18.97 61.62 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.45 -0.157 . . . . 0.0 111.395 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -156.57 158.92 37.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.159 0.584 . . . . 0.0 109.893 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.57 -17.54 74.82 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.166 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -24.02 62.83 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 119.002 1.401 . . . . 0.0 110.767 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.72 -22.5 37.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.292 0.237 . . . . 0.0 111.03 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.79 -36.65 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -68.6 -26.76 65.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.91 -26.0 29.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 121.933 0.093 . . . . 0.0 110.945 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.52 50.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.65 -31.07 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.83 0.852 . . . . 0.0 110.783 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 22.5 m -98.84 -20.4 16.87 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -134.34 -7.32 2.59 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.67 -19.85 10.37 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.196 0.907 . . . . 0.0 109.441 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -52.47 145.79 10.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.835 0.854 . . . . 0.0 111.567 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 56.87 1.54 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.13 2.172 . . . . 0.0 115.408 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -88.08 142.51 27.72 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.578 1.535 . . . . 0.0 108.772 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.309 0.0 OUTLIER -130.97 163.9 26.52 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.0 ptm -125.21 143.35 50.99 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.038 1.335 . . . . 0.0 109.385 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . 0.404 ' H ' ' CG ' ' A' ' 554' ' ' GLU . 97.0 m-85 67.52 28.54 7.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.33 1.452 . . . . 0.0 114.192 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 68.39 16.01 68.79 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -83.3 162.07 21.24 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.422 1.111 . . . . 0.0 110.318 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.2 133.52 34.59 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.47 134.14 41.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -140.69 123.58 16.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.58 144.34 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.028 0 CA-C-N 118.116 0.416 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 t -158.5 165.56 34.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.2 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.9 152.97 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.262 0.625 . . . . 0.0 109.615 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 13.1 t -100.51 -167.0 1.38 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 110.475 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -138.41 6.18 2.52 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.938 0.895 . . . . 0.0 110.857 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -80.04 144.63 59.41 Favored Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.22 -24.86 12.08 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.873 2.382 . . . . 0.0 111.101 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.49 169.01 17.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.699 0.799 . . . . 0.0 109.489 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.09 142.55 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.2 mtt -111.34 159.56 32.5 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 122.417 0.287 . . . . 0.0 110.735 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -55.61 160.08 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.926 3.084 . . . . 0.0 112.646 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 172.29 179.57 43.23 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -74.96 153.54 38.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 48.2 t -138.23 157.14 46.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.051 0.54 . . . . 0.0 109.841 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -146.13 161.79 39.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.309 0.644 . . . . 0.0 110.17 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 135.06 14.83 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 70.7 mt -86.86 173.81 9.15 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.454 0.702 . . . . 0.0 109.513 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.222 -0.299 . . . . 0.0 111.414 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.4 -1.34 49.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.042 0.537 . . . . 0.0 111.178 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.66 -1.05 88.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.402 0.525 . . . . 0.0 112.578 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.8 t -93.63 160.15 14.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.775 0.787 . . . . 0.0 110.226 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.7 m -78.35 153.3 31.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.953 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 84.8 p -73.26 -10.6 59.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.858 0.463 . . . . 0.0 111.913 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -120.63 138.55 53.86 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -155.86 157.29 36.13 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.495 0.318 . . . . 0.0 110.776 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.15 156.96 32.56 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.467 0.707 . . . . 0.0 110.404 176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -140.07 11.14 2.39 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 122.903 0.481 . . . . 0.0 111.886 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.5 p -65.55 -15.3 62.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -85.11 -2.99 58.63 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.832 0.453 . . . . 0.0 110.932 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 43.0 m -103.77 21.21 16.64 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.044 0.937 . . . . 0.0 110.544 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 35.8 ptt-85 -73.93 7.42 2.61 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.913 0.885 . . . . 0.0 112.511 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -84.63 10.73 10.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.451 0.701 . . . . 0.0 111.777 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -66.39 153.4 42.84 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -10.31 59.38 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -136.35 34.54 2.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.281 0.632 . . . . 0.0 111.163 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 81.7 p -74.82 -5.59 44.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 55.1 p -135.82 155.13 78.18 Favored Pre-proline 0 CA--C 1.523 -0.082 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.58 -10.93 30.5 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.771 2.314 . . . . 0.0 111.534 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -89.88 -32.09 17.02 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.935 0.334 . . . . 0.0 110.728 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -90.56 -19.1 24.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.405 0.282 . . . . 0.0 110.552 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -74.85 -1.45 22.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.784 0.433 . . . . 0.0 111.315 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.37 -4.64 59.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.796 0.438 . . . . 0.0 111.081 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -109.2 7.95 25.63 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.576 0.75 . . . . 0.0 110.938 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -145.56 176.62 9.47 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.57 1.148 . . . . 0.0 108.18 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.96 147.95 36.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.776 -0.577 . . . . 0.0 110.373 176.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.55 145.87 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.534 0.734 . . . . 0.0 109.305 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -156.82 158.38 36.69 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.706 0.289 . . . . 0.0 111.061 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -64.64 167.57 8.68 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.696 1.198 . . . . 0.0 109.56 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.55 137.91 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.39 2.726 . . . . 0.0 112.554 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 499' ' ' VAL . 49.6 m -123.97 24.01 8.4 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.585 0.754 . . . . 0.0 112.848 -168.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.4 -14.74 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 113.779 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 497' ' ' SER . 29.9 t -134.09 151.66 32.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 118.648 0.658 . . . . 0.0 109.994 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.4 mt -126.18 138.63 53.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.771 0.829 . . . . 0.0 109.718 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 16.0 m170 -105.65 154.82 19.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -137.34 147.41 45.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.465 0.174 . . . . 0.0 110.789 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -148.77 168.02 24.05 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.448 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.4 t30 58.18 30.52 19.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.327 1.051 . . . . 0.0 113.191 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.35 156.64 51.03 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.27 155.63 34.18 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.131 2.554 . . . . 0.0 111.805 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . 0.425 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -77.11 -1.24 28.17 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.88 9.1 24.6 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.08 151.43 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 118.011 0.369 . . . . 0.0 111.11 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.2 p -142.88 172.03 13.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.557 0.743 . . . . 0.0 110.241 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.25 -20.55 64.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.55 -24.92 59.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -81.62 -29.78 33.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -70.52 -30.81 67.67 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.824 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.48 -36.59 26.34 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.334 0.515 . . . . 0.0 111.772 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -76.54 -23.87 53.61 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.06 0.391 . . . . 0.0 111.783 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.4 mt -88.85 -33.49 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 117.932 0.333 . . . . 0.0 110.16 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 75.6 m -65.47 -22.99 66.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.868 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.13 -34.7 75.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.09 -12.75 34.69 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.07 -7.53 59.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.878 0.308 . . . . 0.0 111.36 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.37 11.15 75.88 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.761 -0.466 . . . . 0.0 112.907 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.4 m -111.16 171.18 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 117.852 0.826 . . . . 0.0 111.177 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -68.5 154.55 41.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.415 0.686 . . . . 0.0 110.51 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -108.25 151.07 41.27 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.14 153.5 75.92 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.217 2.612 . . . . 0.0 111.339 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 83.9 m -94.59 -21.58 18.74 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.209 0.604 . . . . 0.0 111.244 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 50.8 m -142.31 153.87 44.24 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.15 150.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.166 0.508 . . . . 0.0 111.878 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -145.4 140.65 27.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.19 140.99 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -153.66 156.5 38.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.251 0.62 . . . . 0.0 110.089 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.8 m -130.73 137.66 49.61 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -76.23 151.19 39.92 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -69.53 130.43 42.44 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.4 m 55.27 13.6 0.9 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -90.41 -16.18 29.55 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.623 0.647 . . . . 0.0 111.06 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 51.38 26.74 3.26 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.224 1.009 . . . . 0.0 113.057 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.1 m -138.13 160.29 39.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.13 0.572 . . . . 0.0 110.371 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.8 t -120.4 150.42 40.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.694 0.798 . . . . 0.0 111.236 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 57.0 m -147.21 164.32 33.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.231 1.412 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.84 -162.41 33.15 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.658 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 87.6 mt -128.57 151.31 49.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.095 0.958 . . . . 0.0 110.767 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.7 mt -142.28 133.39 26.03 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -127.81 124.7 38.26 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -166.02 149.06 7.41 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -146.77 114.1 6.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 34.7 t -159.56 152.91 22.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 168.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -66.99 -36.82 83.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.469 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 45.9 m -83.92 -36.18 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.184 0.194 . . . . 0.0 111.354 -176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.4 -24.57 31.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.568 0.622 . . . . 0.0 111.612 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.63 21.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.491 0.587 . . . . 0.0 111.557 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.48 -23.79 24.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.053 0.842 . . . . 0.0 111.61 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 442' ' ' PHE . 65.4 mt-10 -77.93 -44.71 26.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.985 -0.447 . . . . 0.0 109.891 175.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 60.9 m -69.15 -31.87 70.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.9 -43.41 75.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.63 -19.32 72.91 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.28 -0.733 . . . . 0.0 112.757 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -114.39 -9.78 12.72 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.172 0.986 . . . . 0.0 113.046 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 13.7 tp -112.69 4.84 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.848 0.749 . . . . 0.0 112.18 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -92.9 143.01 26.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.333 -0.855 . . . . 0.0 109.675 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 49.13 35.94 8.07 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.644 0.777 . . . . 0.0 112.684 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -92.18 151.35 20.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -97.98 136.44 38.26 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.76 1.624 . . . . 0.0 111.389 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.478 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.06 173.93 1.73 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.72 0.808 . . . . 0.0 111.354 -177.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -70.05 14.34 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.859 0.864 . . . . 0.0 113.106 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.46 140.62 92.02 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.939 0.495 . . . . 0.0 111.065 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -81.0 -29.53 2.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.299 2.666 . . . . 0.0 112.766 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -121.01 -11.37 8.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.409 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.12 43.83 95.02 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 82.9 Cg_endo -72.41 -6.6 19.38 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.32 2.68 . . . . 0.0 112.047 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -142.61 150.82 55.5 Favored Pre-proline 0 N--CA 1.455 -0.189 0 C-N-CA 123.559 0.744 . . . . 0.0 109.689 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 152.27 34.24 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.505 2.804 . . . . 0.0 110.738 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . 0.478 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 80.0 t80 -146.38 -2.66 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.518 0.327 . . . . 0.0 111.619 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.37 122.35 17.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.72 -0.613 . . . . 0.0 109.825 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.0 144.61 50.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.228 1.011 . . . . 0.0 109.324 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.89 158.11 17.58 Favored 'General case' 0 CA--C 1.523 -0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 111.247 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.62 155.74 47.03 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.169 0.988 . . . . 0.0 108.789 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 42.6 t -163.55 146.32 9.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -76.69 127.55 32.99 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 23.1 t -135.68 154.7 51.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.73 0.3 . . . . 0.0 111.091 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 37.0 m -83.59 103.4 12.89 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -133.98 161.16 35.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.498 0.719 . . . . 0.0 109.662 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -93.87 -26.1 17.05 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.406 -0.184 . . . . 0.0 111.172 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -160.66 157.83 27.81 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.966 0.506 . . . . 0.0 109.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -89.73 76.4 7.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.36 -1.305 . . . . 0.0 110.154 178.846 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -134.42 11.03 3.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.779 0.432 . . . . 0.0 111.799 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -78.53 -67.22 1.64 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -83.53 6.88 5.53 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.549 3.5 . . . . 0.0 112.62 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -148.63 160.47 43.11 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.386 0.539 . . . . 0.0 111.708 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -130.93 150.89 51.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.595 0.758 . . . . 0.0 109.738 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -141.36 7.19 1.95 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 30.7 m -146.94 154.19 46.7 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 122.509 0.324 . . . . 0.0 110.551 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.45 -0.55 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.61 3.54 . . . . 0.0 113.399 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.78 162.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 118.686 0.676 . . . . 0.0 112.203 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -147.18 167.22 24.72 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.935 0.894 . . . . 0.0 109.122 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 73.8 mtp -133.57 151.24 51.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.404 0.282 . . . . 0.0 110.576 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.1 148.93 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.978 0.511 . . . . 0.0 110.827 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.95 167.55 21.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.474 0.71 . . . . 0.0 109.55 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.66 88.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.586 -0.563 . . . . 0.0 112.897 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.602 HD21 ' H ' ' A' ' 386' ' ' LEU . 1.9 pt? -70.2 173.56 6.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.828 0.814 . . . . 0.0 110.326 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -136.66 139.78 42.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -71.96 -3.98 25.79 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.1 p -109.83 -1.19 18.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.378 0.535 . . . . 0.0 112.407 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -133.5 -6.44 2.91 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.288 0.635 . . . . 0.0 110.969 175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.5 tpt -148.5 122.25 9.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.225 0.61 . . . . 0.0 109.47 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -141.88 -173.37 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.106 0.562 . . . . 0.0 109.768 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 72.3 m -59.54 -23.61 63.0 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -92.03 -23.8 19.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.231 0.468 . . . . 0.0 111.5 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -83.93 -29.71 26.89 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.1 p -77.52 -32.58 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -68.85 -31.17 69.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.38 -46.43 55.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.172 -0.33 . . . . 0.0 111.329 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.18 -20.32 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 122.233 -0.292 . . . . 0.0 111.48 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -110.47 -7.33 14.77 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.24 -31.7 55.22 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.843 0.747 . . . . 0.0 110.958 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 11.38 1.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.805 -0.56 . . . . 0.0 112.18 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -121.51 -5.34 9.28 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.743 0.817 . . . . 0.0 110.931 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.68 177.94 24.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -75.49 148.67 38.83 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.376 -0.485 . . . . 0.0 110.834 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.05 154.26 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.597 0.759 . . . . 0.0 109.413 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -104.02 -58.79 1.82 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.212 -0.305 . . . . 0.0 110.552 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -165.78 166.65 17.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.973 0.509 . . . . 0.0 110.736 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.92 150.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 122.985 0.514 . . . . 0.0 110.345 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -151.88 144.34 24.13 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.343 0.257 . . . . 0.0 110.599 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -79.06 152.0 31.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -129.97 141.49 50.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -168.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 60.01 34.0 21.4 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.923 1.289 . . . . 0.0 111.802 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m 52.77 16.67 0.71 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.883 1.273 . . . . 0.0 114.035 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.76 143.21 46.37 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 118.357 0.526 . . . . 0.0 109.903 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.34 -1.14 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.651 2.901 . . . . 0.0 110.262 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -132.54 27.68 3.52 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.739 0.685 . . . . 0.0 113.071 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.69 133.92 19.46 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.08 0.94 . . . . 0.0 110.333 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.12 168.67 26.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.5 ptm -144.32 146.99 32.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.19 151.62 27.65 Favored 'Isoleucine or valine' 0 C--N 1.337 0.028 0 C-N-CA 123.161 0.585 . . . . 0.0 110.736 -170.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -128.38 136.77 51.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.5 mmm -107.72 162.64 13.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.644 0.378 . . . . 0.0 110.565 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.95 61.14 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.158 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -157.73 161.76 38.51 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.429 0.691 . . . . 0.0 109.578 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.97 -14.54 70.83 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.391 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -67.96 -30.57 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.134 1.467 . . . . 0.0 110.46 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.33 -20.56 51.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.51 -31.78 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.32 -36.05 66.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -32.2 67.02 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.011 -0.43 . . . . 0.0 110.508 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.22 -38.05 25.09 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.12 -0.363 . . . . 0.0 111.862 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 7.5 tp -72.87 -32.02 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.529 -0.732 . . . . 0.0 111.803 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.1 m -93.66 -21.14 19.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -117.97 -14.09 10.02 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.75 -17.4 11.07 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.941 0.791 . . . . 0.0 110.507 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -51.73 142.01 15.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.46 0.648 . . . . 0.0 111.702 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 57.08 1.54 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.787 2.035 . . . . 0.0 115.742 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -87.91 142.49 27.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.719 1.6 . . . . 0.0 108.667 169.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -130.85 163.84 26.53 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.34 143.43 50.97 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.397 1.479 . . . . 0.0 109.576 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 67.77 27.12 7.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.989 1.316 . . . . 0.0 114.486 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.48 15.86 75.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 168.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -83.25 160.76 21.68 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.683 1.242 . . . . 0.0 110.074 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.62 132.46 34.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.54 133.26 43.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -140.69 120.43 13.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.06 141.92 15.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-N 118.263 0.483 . . . . 0.0 110.346 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 25.6 t -160.13 162.37 33.95 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.791 0.436 . . . . 0.0 110.166 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.07 158.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 109.949 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.1 t -137.67 151.28 48.1 Favored 'General case' 0 C--N 1.337 0.032 0 O-C-N 121.991 -0.443 . . . . 0.0 110.451 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -89.37 -0.58 57.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.683 0.793 . . . . 0.0 112.654 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -62.14 144.39 94.45 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 121.478 -0.764 . . . . 0.0 109.654 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.1 -25.04 12.09 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.832 2.355 . . . . 0.0 112.013 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.86 173.78 12.31 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.013 0.525 . . . . 0.0 110.214 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -66.68 138.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -90.07 163.03 33.45 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.813 0.445 . . . . 0.0 110.699 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.21 -42.5 64.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.14 2.56 . . . . 0.0 112.009 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 50.23 -142.75 13.46 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.252 0.453 . . . . 0.0 112.442 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -133.65 160.5 37.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.214 1.006 . . . . 0.0 108.536 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.0 p -143.3 156.04 44.62 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.693 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -155.19 163.34 40.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.36 136.68 17.79 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.96 165.86 15.54 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.174 0.59 . . . . 0.0 110.232 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.92 -20.13 65.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.243 0.217 . . . . 0.0 111.463 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -80.35 1.25 29.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 111.476 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.91 0.63 85.76 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 39.6 m -91.37 165.05 13.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.419 0.688 . . . . 0.0 110.528 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.36 153.34 22.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.74 0.305 . . . . 0.0 110.5 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.3 p -69.89 -10.25 57.84 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.027 0.531 . . . . 0.0 111.697 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -118.47 138.06 52.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.99 0.916 . . . . 0.0 109.87 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -154.42 155.2 34.54 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.423 0.289 . . . . 0.0 110.661 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -124.61 156.6 37.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 110.415 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.81 15.92 2.31 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.041 0.536 . . . . 0.0 111.334 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 91.2 p -66.58 -3.4 6.3 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -97.36 3.86 50.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.222 0.609 . . . . 0.0 110.86 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 11.2 t -84.05 22.32 1.2 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.581 0.752 . . . . 0.0 111.003 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 -73.95 -2.8 25.56 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.429 0.691 . . . . 0.0 111.002 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -88.25 2.43 52.34 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.376 0.671 . . . . 0.0 110.605 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -65.17 154.39 38.15 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.934 -0.479 . . . . 0.0 109.945 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -83.15 0.82 43.48 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -142.84 33.26 1.4 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.885 0.474 . . . . 0.0 111.013 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 84.0 p -71.22 -3.27 19.38 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.221 0.608 . . . . 0.0 112.624 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 7.1 t -142.14 147.63 44.9 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 123.234 0.613 . . . . 0.0 109.401 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.74 -24.39 46.02 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.771 2.981 . . . . 0.0 114.659 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.88 -25.08 35.34 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.69 0.677 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.63 -22.34 21.24 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.628 0.371 . . . . 0.0 110.482 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.28 -16.76 62.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.212 -0.305 . . . . 0.0 111.482 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -79.5 -6.81 57.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.747 0.419 . . . . 0.0 111.056 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -109.06 5.53 24.2 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.761 0.824 . . . . 0.0 110.88 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -128.05 14.19 6.78 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.458 0.703 . . . . 0.0 110.943 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 51.66 46.0 27.23 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.187 0.995 . . . . 0.0 112.437 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 41.2 mm -80.84 94.12 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -148.51 -176.49 5.33 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.098 0.959 . . . . 0.0 109.944 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . 0.409 ' CG ' ' HD2' ' A' ' 496' ' ' PRO . 67.8 t60 -59.87 148.56 76.11 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 495' ' ' HIS . 87.1 Cg_exo -46.3 140.73 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.45 2.767 . . . . 0.0 112.817 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.1 m -123.99 24.05 8.37 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.606 0.762 . . . . 0.0 111.34 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.52 7.86 2.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 113.987 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 32.3 t -141.54 147.02 22.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 123.41 0.684 . . . . 0.0 109.233 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . 0.475 HD12 ' CH2' ' A' ' 546' ' ' TRP . 91.5 mt -129.38 160.35 33.35 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.62 0.768 . . . . 0.0 110.086 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.601 ' CE1' ' HG ' ' A' ' 578' ' ' CYS . 0.0 OUTLIER -143.65 163.16 34.03 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.285 175.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -135.94 156.94 48.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.407 0.683 . . . . 0.0 111.133 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -147.3 170.76 16.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.46 26.19 15.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 0.0 113.281 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.95 158.3 70.41 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -68.99 159.43 54.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.282 1.988 . . . . 0.0 110.602 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -71.58 -1.09 12.32 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -112.0 7.1 19.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -173.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.45 148.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 118.308 0.504 . . . . 0.0 111.209 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.5 p -142.98 173.3 11.68 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.925 0.89 . . . . 0.0 110.313 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.4 -22.79 65.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.752 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.68 -23.71 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -82.95 -31.78 27.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -68.82 -28.34 66.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.964 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.37 -35.07 18.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.192 0.451 . . . . 0.0 112.087 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -75.85 -18.87 59.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.458 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.79 -35.53 5.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 117.884 0.311 . . . . 0.0 110.868 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 17.3 p -70.1 -21.84 63.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.167 0.894 . . . . 0.0 110.643 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.38 -28.44 61.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 119.552 -0.261 . . . . 0.0 111.633 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.07 -12.6 35.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.278 0.49 . . . . 0.0 111.205 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.12 -9.9 51.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.523 0.329 . . . . 0.0 110.489 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.28 6.41 65.11 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.704 -0.498 . . . . 0.0 112.927 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.2 m -89.17 170.88 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.938 0.869 . . . . 0.0 111.161 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -71.11 146.77 49.01 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.356 0.663 . . . . 0.0 110.044 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -91.94 153.11 43.46 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.625 0.37 . . . . 0.0 110.256 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 155.55 69.34 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.555 2.17 . . . . 0.0 109.535 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 82.2 m -95.1 -19.12 20.38 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.955 0.502 . . . . 0.0 110.763 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.0 t -148.76 152.73 37.07 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.945 0.498 . . . . 0.0 109.762 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.9 t -140.62 140.9 33.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 123.097 0.559 . . . . 0.0 110.084 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.25 126.35 12.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.48 152.36 37.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.829 0.452 . . . . 0.0 110.971 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -144.23 160.82 40.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.984 0.914 . . . . 0.0 109.438 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t -128.98 135.32 48.81 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.827 0.451 . . . . 0.0 110.293 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.3 147.0 31.01 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -78.46 135.04 37.29 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 25.2 m 54.14 20.34 2.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.636 0.774 . . . . 0.0 112.791 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -110.91 -17.44 13.31 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.048 0.539 . . . . 0.0 111.134 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 52.19 27.19 4.44 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.324 1.05 . . . . 0.0 113.209 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 71.1 m -138.22 157.96 45.25 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.987 0.515 . . . . 0.0 110.734 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 156.01 40.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.525 0.73 . . . . 0.0 111.192 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.5 m -147.72 166.53 27.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.887 1.275 . . . . 0.0 108.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.62 -176.75 47.48 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.2 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.2 mp -111.57 154.93 24.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.282 1.033 . . . . 0.0 110.132 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.3 mt -138.35 134.38 34.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.72 117.99 22.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.475 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.9 p90 -165.71 153.63 10.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 168.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -146.81 115.11 6.65 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.9 t -159.52 153.04 22.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 168.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -69.79 -48.38 59.4 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 118.637 0.653 . . . . 0.0 110.722 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 44.7 m -82.71 -22.96 34.29 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -89.28 -33.17 17.05 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.711 0.687 . . . . 0.0 111.481 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -72.13 -33.92 68.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.798 0.726 . . . . 0.0 110.477 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.52 -35.68 58.16 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.034 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.99 -40.37 53.87 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.102 -0.374 . . . . 0.0 110.604 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 98.6 m -65.95 -49.23 68.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.159 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.15 -22.4 62.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.109 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -64.72 -31.39 80.74 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.427 -0.652 . . . . 0.0 111.83 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -116.36 -6.86 11.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.912 0.856 . . . . 0.0 113.103 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.5 tp -95.93 -13.47 23.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.66 0.664 . . . . 0.0 111.664 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -81.16 151.44 28.23 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.695 -0.628 . . . . 0.0 110.199 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 31.4 m80 51.18 22.97 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 151.23 29.81 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -102.13 136.33 42.15 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.381 1.472 . . . . 0.0 110.683 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.484 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 6.2 ttt -64.17 173.24 2.03 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.15 0.58 . . . . 0.0 111.612 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 564' ' ' MET . 27.8 mtpp -75.4 14.78 0.54 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.932 . . . . 0.0 112.564 -177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -66.11 149.93 97.26 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 118.03 0.377 . . . . 0.0 110.137 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.87 -46.92 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.895 2.397 . . . . 0.0 113.898 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -121.08 13.3 11.26 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 63.34 52.8 44.05 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.312 -0.716 . . . . 0.0 112.594 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.62 -9.42 19.9 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.539 2.826 . . . . 0.0 111.44 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -148.42 151.41 36.5 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.671 0.788 . . . . 0.0 109.676 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.26 151.1 37.98 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.563 2.842 . . . . 0.0 110.821 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . 0.484 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 91.0 t80 -143.03 -6.45 0.84 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.758 0.423 . . . . 0.0 111.902 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 75.2 p -66.48 132.02 47.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.891 -0.506 . . . . 0.0 110.233 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 1.6 pp -125.03 144.55 50.34 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.595 0.758 . . . . 0.0 110.791 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -77.28 144.38 38.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.76 144.97 50.4 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . 0.601 ' HG ' ' CE1' ' A' ' 501' ' ' HIS . 2.8 p -163.92 172.09 14.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.703 0.401 . . . . 0.0 110.331 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -82.82 148.91 27.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.734 0.414 . . . . 0.0 111.207 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.7 t -135.6 137.71 42.21 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 122.575 0.35 . . . . 0.0 110.971 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 16.5 p -82.45 102.13 11.12 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.18 161.57 34.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.353 0.661 . . . . 0.0 111.59 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.77 -3.31 7.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.402 0.681 . . . . 0.0 110.294 173.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -157.68 165.91 34.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.754 1.222 . . . . 0.0 109.777 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.12 76.68 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.247 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.888 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 119.803 -0.141 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -135.54 9.16 3.39 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.987 0.515 . . . . 0.0 111.617 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -72.31 172.0 48.2 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.15 165.04 33.79 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.232 3.288 . . . . 0.0 111.123 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -156.81 171.2 20.82 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.521 0.729 . . . . 0.0 110.024 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -117.29 156.67 27.4 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.848 0.459 . . . . 0.0 110.519 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -140.36 6.1 2.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.199 0.6 . . . . 0.0 110.917 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.6 m -152.91 157.01 33.21 Favored Pre-proline 0 N--CA 1.456 -0.157 0 C-N-CA 123.711 0.805 . . . . 0.0 110.207 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.69 2.51 8.48 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.614 3.543 . . . . 0.0 112.938 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.0 p -126.17 148.33 30.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 118.736 0.698 . . . . 0.0 111.478 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.38 167.3 23.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.222 0.609 . . . . 0.0 110.094 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' MET . . . . . 0.405 ' CE ' ' SD ' ' A' ' 412' ' ' MET . 77.1 mtp -132.96 152.0 51.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.539 0.335 . . . . 0.0 110.571 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.6 149.45 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.761 0.425 . . . . 0.0 110.693 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -141.21 166.38 24.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.407 0.683 . . . . 0.0 110.1 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.13 -0.11 84.5 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.847 -0.418 . . . . 0.0 112.67 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.538 HD13 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.24 -179.65 4.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.503 0.651 . . . . 0.0 110.687 176.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -139.62 134.62 32.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -69.82 -11.73 61.08 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.5 p -93.44 -9.92 36.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -132.56 -8.87 3.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.268 0.486 . . . . 0.0 111.654 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.7 tpt -147.73 104.84 3.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.317 0.647 . . . . 0.0 109.497 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.458 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 23.4 p30 -141.97 -173.59 3.85 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.878 0.871 . . . . 0.0 109.669 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . 0.477 ' HG ' HG13 ' A' ' 409' ' ' VAL . 64.4 m -55.33 -28.83 56.33 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.96 -27.69 21.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.215 0.461 . . . . 0.0 110.994 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . 0.458 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 2.2 mmp_? -78.11 -33.44 50.58 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 122.123 -0.361 . . . . 0.0 110.038 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.89 -31.31 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -64.82 -35.24 80.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -72.1 -31.04 65.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.43 -0.319 . . . . 0.0 111.398 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.77 -26.61 5.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.151 0.432 . . . . 0.0 111.875 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.52 -10.07 20.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 p -65.68 -37.8 87.51 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.041 0.837 . . . . 0.0 111.565 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.81 14.43 1.75 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.322 0.51 . . . . 0.0 112.156 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -121.46 -1.91 9.55 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.604 0.762 . . . . 0.0 109.93 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 140.45 167.08 10.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -74.83 146.54 41.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.156 -0.614 . . . . 0.0 111.167 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.29 154.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.498 0.719 . . . . 0.0 109.095 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -104.2 -60.1 1.63 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.62 0.368 . . . . 0.0 110.013 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -165.42 163.66 19.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.434 0.694 . . . . 0.0 110.703 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.477 HG13 ' HG ' ' A' ' 393' ' ' CYS . 92.0 t -136.28 146.83 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.215 1.006 . . . . 0.0 109.344 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -148.45 144.18 27.24 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 172.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -86.53 155.67 20.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.405 ' SD ' ' CE ' ' A' ' 382' ' ' MET . 26.0 ptt? -136.02 141.43 44.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -167.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt 60.22 34.04 21.01 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.849 1.26 . . . . 0.0 112.339 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.8 m 52.97 16.29 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -94.21 142.53 25.03 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 118.405 0.548 . . . . 0.0 110.461 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.48 -3.81 13.65 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.555 2.837 . . . . 0.0 110.357 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -115.49 19.69 14.33 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.234 0.921 . . . . 0.0 112.795 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -145.68 131.85 19.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.204 1.002 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.86 168.3 27.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -145.54 150.19 35.98 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.35 0.66 . . . . 0.0 110.028 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 3.4 p -144.42 151.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.951 0.5 . . . . 0.0 111.076 -173.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -126.56 146.86 49.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.04 0.936 . . . . 0.0 109.615 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 91.1 mmm -112.28 163.28 14.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.601 0.76 . . . . 0.0 110.482 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.7 -15.36 61.69 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -155.1 156.96 36.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.86 0.464 . . . . 0.0 109.886 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.01 -17.59 75.7 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.166 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -29.81 66.54 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.882 1.341 . . . . 0.0 110.13 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.09 61.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.507 0.194 . . . . 0.0 110.536 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.2 t -78.99 -38.07 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.91 -25.88 68.35 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.771 0.26 . . . . 0.0 110.667 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -82.81 -35.04 26.77 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.156 0.582 . . . . 0.0 110.563 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -74.96 -29.63 60.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.873 -0.517 . . . . 0.0 110.009 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 14.7 mm -77.83 -30.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.854 1.262 . . . . 0.0 111.701 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.9 m -106.5 -14.75 14.98 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -134.17 -9.54 2.61 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.72 -16.52 11.24 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.763 0.711 . . . . 0.0 109.633 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -54.02 142.09 26.12 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.27 1.028 . . . . 0.0 111.832 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.81 1.51 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.564 1.946 . . . . 0.0 115.927 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -88.03 142.55 27.69 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.794 1.634 . . . . 0.0 108.532 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.1 OUTLIER -130.81 163.87 26.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.512 1.125 . . . . 0.0 109.384 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 63.64 22.95 13.35 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.154 1.382 . . . . 0.0 114.589 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.15 15.91 61.77 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 169.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -83.2 150.99 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.987 1.393 . . . . 0.0 110.961 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.08 138.7 38.07 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -98.07 122.01 40.68 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -140.72 116.92 10.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.37 140.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 118.774 0.715 . . . . 0.0 110.691 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.8 m -148.71 159.41 44.15 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.166 0.986 . . . . 0.0 109.841 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.23 156.13 3.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.3 t -130.22 161.36 31.34 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.862 0.465 . . . . 0.0 110.418 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.56 10.94 27.03 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.501 0.72 . . . . 0.0 112.519 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -67.66 147.51 98.65 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 118.105 0.411 . . . . 0.0 109.95 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.39 -36.0 80.51 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.802 2.335 . . . . 0.0 112.348 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.95 176.04 7.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.559 0.744 . . . . 0.0 109.92 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 136.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -84.85 149.8 54.43 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.337 0.255 . . . . 0.0 110.614 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.39 167.23 25.85 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.721 2.948 . . . . 0.0 111.223 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 167.59 179.35 40.3 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -77.12 154.53 33.16 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.701 0.4 . . . . 0.0 109.937 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 83.1 p -134.08 159.37 41.02 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.962 0.505 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -155.26 164.3 38.98 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 109.805 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.62 136.73 19.0 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 79.3 mt -86.25 169.61 12.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.974 0.91 . . . . 0.0 109.672 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.22 -20.16 65.65 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.85 4.07 42.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.665 0.386 . . . . 0.0 111.522 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.97 -6.38 79.22 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.376 0.512 . . . . 0.0 112.647 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 52.9 m -83.77 155.39 23.05 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 117.838 0.819 . . . . 0.0 109.942 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.3 153.29 24.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 99.4 p -72.6 -10.34 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 111.664 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -137.0 139.59 41.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.226 1.011 . . . . 0.0 109.477 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -155.16 157.32 37.23 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.18 0.192 . . . . 0.0 110.928 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.71 150.45 51.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.231 1.012 . . . . 0.0 109.937 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -142.45 14.33 1.99 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p -68.35 -6.41 24.19 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -77.45 -4.41 45.31 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.198 0.599 . . . . 0.0 111.15 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 88.6 p -90.93 14.72 13.01 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.095 0.558 . . . . 0.0 111.643 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -73.97 0.9 12.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -94.3 9.95 36.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.453 0.701 . . . . 0.0 110.819 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -67.47 162.66 22.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.075 0.95 . . . . 0.0 111.576 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -85.6 4.71 34.95 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.982 0.913 . . . . 0.0 112.691 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.06 34.46 1.0 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.159 0.504 . . . . 0.0 110.946 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 84.1 p -77.44 -1.82 32.21 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 51.0 p -136.63 157.4 75.18 Favored Pre-proline 0 CA--C 1.527 0.069 0 C-N-CA 123.033 0.533 . . . . 0.0 110.28 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -60.36 -19.9 60.51 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.482 2.788 . . . . 0.0 112.863 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.9 -30.1 20.36 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.708 0.231 . . . . 0.0 110.933 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -90.51 -22.29 21.41 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 122.264 -0.272 . . . . 0.0 110.537 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -72.87 -16.48 61.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.302 0.241 . . . . 0.0 110.789 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -82.12 -4.21 56.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.955 0.502 . . . . 0.0 111.019 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -105.75 9.4 33.03 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.592 0.757 . . . . 0.0 110.864 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -137.81 171.42 14.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.77 0.828 . . . . 0.0 110.058 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -85.31 27.64 0.79 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.781 0.832 . . . . 0.0 112.019 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.94 93.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 O-C-N 122.09 -0.381 . . . . 0.0 110.437 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -162.75 -65.92 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.31 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -147.96 150.63 36.17 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.236 0.614 . . . . 0.0 109.391 -174.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.21 147.73 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 112.691 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 62.9 m -124.18 24.0 8.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.269 0.628 . . . . 0.0 112.092 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.6 3.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.377 1.071 . . . . 0.0 113.461 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.4 152.04 21.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . 0.421 HD21 ' CH2' ' A' ' 546' ' ' TRP . 4.7 mp -132.69 164.18 27.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.291 0.637 . . . . 0.0 109.669 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.92 149.33 36.68 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.001 0.429 . . . . 0.0 111.957 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -114.74 145.56 41.94 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.759 1.223 . . . . 0.0 109.599 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.77 165.41 30.62 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.374 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 58.02 23.78 10.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.403 1.081 . . . . 0.0 113.422 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -81.74 157.89 68.84 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.86 156.35 28.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . 0.439 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -80.38 -1.17 40.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -103.53 5.26 36.64 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.662 0.385 . . . . 0.0 111.983 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -89.79 152.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.061 0.391 . . . . 0.0 111.672 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 68.5 p -144.86 175.62 10.07 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.181 0.992 . . . . 0.0 109.654 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.78 -26.25 68.62 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.439 -0.163 . . . . 0.0 111.149 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.58 -26.22 60.72 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.439 -0.163 . . . . 0.0 110.574 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -79.64 -31.67 41.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.59 -26.52 62.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.22 -0.3 . . . . 0.0 110.486 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -80.03 -39.36 30.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.933 0.333 . . . . 0.0 111.558 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.11 -17.1 53.49 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.24 0.473 . . . . 0.0 112.275 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.21 -36.53 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 82.2 m -67.95 -22.15 65.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.676 -0.64 . . . . 0.0 110.573 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.44 -30.5 63.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 119.658 -0.21 . . . . 0.0 111.565 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.12 -11.73 37.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.108 0.413 . . . . 0.0 111.527 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.32 -7.15 48.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.657 0.383 . . . . 0.0 110.411 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.9 11.33 78.39 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.855 -0.414 . . . . 0.0 112.665 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.6 m -95.58 170.83 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 117.817 0.809 . . . . 0.0 111.61 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -74.14 147.91 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.477 0.711 . . . . 0.0 110.236 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -97.07 146.17 30.85 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.21 148.97 92.61 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.01 2.473 . . . . 0.0 110.375 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.442 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 84.7 m -82.11 -25.01 34.83 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.467 0.307 . . . . 0.0 110.841 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 51.1 m -143.4 151.63 40.61 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.936 0.494 . . . . 0.0 109.848 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.59 141.82 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 122.952 0.501 . . . . 0.0 110.328 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.7 120.18 7.42 Favored 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.09 147.53 30.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 C-N-CA 123.353 0.661 . . . . 0.0 109.557 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -148.65 130.05 14.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.513 0.196 . . . . 0.0 111.317 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.6 p -130.98 50.58 2.22 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.005 0.522 . . . . 0.0 110.983 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -82.07 -11.78 81.96 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -151.07 155.65 39.43 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 124.532 1.133 . . . . 0.0 108.003 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 14.8 t 55.27 28.86 11.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.881 0.309 . . . . 0.0 111.014 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -57.98 -7.09 0.68 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.895 1.278 . . . . 0.0 113.909 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -66.4 -9.76 36.91 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.452 0.569 . . . . 0.0 110.303 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 85.4 p -145.4 173.22 12.18 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.386 1.475 . . . . 0.0 109.119 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -124.3 148.38 47.47 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 122.631 0.372 . . . . 0.0 111.65 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.4 m -145.16 158.53 43.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.268 1.027 . . . . 0.0 109.12 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 179.45 178.48 48.39 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.943 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.6 mp -116.9 144.64 44.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 109.82 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.93 142.04 51.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.87 113.2 15.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.442 ' HB3' ' H ' ' A' ' 527' ' ' THR . 4.2 p90 -165.93 149.13 7.57 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -155.35 126.34 7.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 43.6 t -159.53 161.32 35.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 169.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.56 -51.21 45.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.881 0.764 . . . . 0.0 110.448 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 72.5 p -89.28 -27.24 20.69 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 25.0 m-20 -82.42 -27.57 31.9 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.987 0.812 . . . . 0.0 110.802 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -85.58 -31.99 22.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.432 0.56 . . . . 0.0 110.576 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 41.6 tp -73.92 -30.09 62.38 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.228 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.52 -42.7 58.44 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.6 m -68.24 -39.16 82.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.71 -42.21 82.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.96 -19.49 77.09 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.145 -0.808 . . . . 0.0 113.582 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -113.86 -16.95 12.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.685 1.242 . . . . 0.0 112.903 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.67 -21.79 22.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.061 0.846 . . . . 0.0 111.801 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -74.21 147.83 42.15 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.573 0.624 . . . . 0.0 109.721 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.8 t60 53.81 29.01 9.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.92 0.888 . . . . 0.0 113.259 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.98 151.39 24.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -117.51 136.42 53.25 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.873 1.269 . . . . 0.0 110.427 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.432 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 4.8 ttt -64.18 169.47 4.48 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.767 0.827 . . . . 0.0 111.464 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -79.39 22.99 0.41 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 112.831 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 36.5 p30 -64.65 147.52 97.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 122.109 -0.369 . . . . 0.0 110.331 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.72 -32.31 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.419 2.746 . . . . 0.0 113.872 -169.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -121.04 2.02 10.41 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.46 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.53 37.92 95.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.072 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 92.6 Cg_endo -71.37 -9.05 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.97 2.446 . . . . 0.0 112.291 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -145.75 150.39 42.99 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.311 0.505 . . . . 0.0 110.765 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.77 156.21 39.57 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.059 3.173 . . . . 0.0 110.634 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . 0.432 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 70.4 t80 -140.86 -1.44 1.41 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 4.9 t -66.39 131.92 47.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.484 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.93 144.65 50.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.917 0.887 . . . . 0.0 109.086 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -89.7 134.75 34.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 153.19 39.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.944 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 32.1 p -163.36 176.76 9.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.861 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -72.19 143.19 48.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.8 t -135.64 146.27 47.68 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.363 0.665 . . . . 0.0 110.451 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 51.8 m -87.17 102.16 14.2 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.25 161.47 34.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.997 0.919 . . . . 0.0 110.053 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -93.92 -19.6 20.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -161.27 162.45 31.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.141 0.976 . . . . 0.0 109.441 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.17 76.48 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.637 -1.173 . . . . 0.0 110.253 -179.472 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.416 0.151 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -144.54 143.22 30.72 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . 0.436 ' N ' ' CD ' ' A' ' 374' ' ' PRO . . . 67.69 37.49 89.07 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.49 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 373' ' ' GLY . 86.5 Cg_endo -72.76 -27.94 14.31 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.238 2.019 . . . . 0.0 111.626 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -163.41 161.39 24.34 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.565 0.746 . . . . 0.0 110.38 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -80.77 163.93 23.12 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.961 0.504 . . . . 0.0 110.194 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.1 -2.95 53.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.7 m -152.06 153.86 31.81 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.158 0.583 . . . . 0.0 110.979 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.44 -5.03 10.16 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.507 3.471 . . . . 0.0 113.546 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.2 t -126.91 151.33 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 118.498 0.59 . . . . 0.0 111.176 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.12 164.46 29.08 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.71 0.804 . . . . 0.0 109.531 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.3 mtp -136.45 148.29 47.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.736 0.414 . . . . 0.0 110.11 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.56 149.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 122.85 0.46 . . . . 0.0 110.424 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -140.44 165.85 26.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.666 0.786 . . . . 0.0 109.286 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 81.9 -1.21 87.15 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.703 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.597 HD21 ' H ' ' A' ' 386' ' ' LEU . 2.0 pt? -71.64 172.39 9.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.194 0.997 . . . . 0.0 110.048 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -130.42 127.25 38.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -68.11 -2.91 8.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 87.8 p -108.29 -2.84 18.9 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -130.13 -12.23 4.12 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.376 0.67 . . . . 0.0 111.055 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.07 125.95 10.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.372 0.669 . . . . 0.0 109.328 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -141.87 -172.16 3.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.0 -25.65 61.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.83 -25.78 24.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.879 -0.513 . . . . 0.0 111.799 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -91.97 -25.2 18.98 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 122.265 -0.272 . . . . 0.0 111.178 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.8 -27.26 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.55 -42.89 67.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.695 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -80.63 -8.64 59.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.564 0.62 . . . . 0.0 112.653 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.78 -24.35 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 118.214 0.461 . . . . 0.0 110.932 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -107.33 -13.72 15.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.4 t -69.56 -28.71 66.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.27 0.941 . . . . 0.0 111.562 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.76 14.2 1.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.734 -0.604 . . . . 0.0 112.209 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -119.59 -2.75 10.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.419 0.688 . . . . 0.0 110.22 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 143.07 165.84 10.85 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.17 152.67 44.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.212 -0.581 . . . . 0.0 110.957 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.07 146.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.82 -57.75 2.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.997 -0.439 . . . . 0.0 109.905 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -166.38 164.83 17.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.971 0.509 . . . . 0.0 110.687 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.89 149.73 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.483 0.713 . . . . 0.0 110.105 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -152.22 144.18 23.75 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -75.52 154.52 36.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -129.33 141.16 51.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.285 0.564 . . . . 0.0 112.51 -168.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.51 33.75 19.6 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.69 1.596 . . . . 0.0 111.885 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.2 m 52.91 15.84 0.62 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.354 1.062 . . . . 0.0 113.59 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.74 145.63 75.04 Favored Pre-proline 0 C--N 1.339 0.122 0 CA-C-N 118.156 0.435 . . . . 0.0 110.086 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 4.03 6.97 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.83 3.02 . . . . 0.0 110.604 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -146.84 30.73 1.51 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.278 -0.735 . . . . 0.0 113.209 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.78 138.31 20.75 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.355 1.078 . . . . 0.0 110.537 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.89 19.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.034 0.445 . . . . 0.0 111.808 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 7.6 ptp -135.76 150.6 49.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.806 0.843 . . . . 0.0 110.394 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.47 149.47 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.286 0.634 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -130.71 133.44 46.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.531 0.732 . . . . 0.0 109.913 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.1 mmm -106.1 161.29 14.63 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.943 0.497 . . . . 0.0 110.981 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.79 -18.79 60.41 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.448 0.299 . . . . 0.0 111.762 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -154.28 155.86 35.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.679 0.392 . . . . 0.0 110.222 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.44 -15.95 75.39 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.429 -0.65 . . . . 0.0 113.078 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -26.45 59.62 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.057 1.428 . . . . 0.0 110.701 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.78 -27.23 60.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.72 -29.79 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.39 -40.54 73.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.187 -0.321 . . . . 0.0 110.626 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.45 -34.92 35.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.52 -29.96 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 121.964 -0.46 . . . . 0.0 111.404 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 17.7 m -95.26 -18.9 20.45 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -136.46 -10.78 1.89 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -108.03 -21.76 12.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.376 0.989 . . . . 0.0 108.802 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -51.87 143.46 13.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.218 1.007 . . . . 0.0 110.956 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 57.11 1.47 0.1 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.535 1.934 . . . . 0.0 115.733 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.88 142.43 27.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 120.757 1.617 . . . . 0.0 107.968 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.332 0.0 OUTLIER -130.88 163.88 26.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 175.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 20.5 ptm -125.37 143.34 51.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.651 1.18 . . . . 0.0 110.405 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.73 28.3 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.96 15.71 64.63 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.14 151.02 25.9 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.093 1.447 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.456 ' H ' ' HD3' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -84.7 137.91 32.95 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -94.54 123.97 38.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -168.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -140.72 115.87 9.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 141.01 16.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.214 0.461 . . . . 0.0 110.178 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.41 163.34 37.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.663 0.785 . . . . 0.0 110.126 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.1 p -84.57 155.64 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.6 t -136.6 155.37 50.01 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.073 0.397 . . . . 0.0 111.22 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -93.17 7.04 45.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -66.54 140.02 96.33 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.94 -25.8 10.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.944 2.429 . . . . 0.0 111.319 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.1 171.28 15.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.487 0.715 . . . . 0.0 109.87 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 41.9 mm -68.68 136.91 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -91.73 153.85 43.85 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.32 164.4 8.85 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.847 3.031 . . . . 0.0 112.53 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 163.84 174.73 34.0 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.31 160.97 29.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.1 p -137.33 153.87 50.17 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.048 0.539 . . . . 0.0 110.512 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -144.59 165.09 29.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.249 0.62 . . . . 0.0 109.848 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.62 137.66 17.78 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.22 167.34 14.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 109.551 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.97 -20.0 65.01 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.056 -0.403 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.87 0.88 37.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.909 0.322 . . . . 0.0 111.235 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.7 -2.04 87.17 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.594 -0.559 . . . . 0.0 113.211 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.39 163.19 13.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.103 0.952 . . . . 0.0 110.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.3 m -84.54 153.36 23.31 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.811 0.444 . . . . 0.0 110.902 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.8 p -73.09 -10.33 59.67 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.025 0.53 . . . . 0.0 111.577 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -132.8 143.65 49.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.151 0.98 . . . . 0.0 109.747 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -156.1 159.24 38.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.578 0.351 . . . . 0.0 110.3 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.95 153.23 52.15 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.189 0.595 . . . . 0.0 110.851 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.63 15.49 2.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.034 0.534 . . . . 0.0 111.282 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.0 p -66.88 -11.08 54.72 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.361 0.664 . . . . 0.0 112.544 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -81.67 -4.86 57.33 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.925 -0.485 . . . . 0.0 110.773 177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.5 m -107.8 20.12 19.2 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.661 0.784 . . . . 0.0 111.453 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -73.9 -2.43 23.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.688 0.395 . . . . 0.0 111.226 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -82.56 5.48 20.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.434 0.694 . . . . 0.0 111.095 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -59.43 155.04 15.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.968 0.907 . . . . 0.0 110.79 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -81.09 4.54 19.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.581 0.752 . . . . 0.0 112.509 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -146.52 30.49 1.0 Allowed 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.081 -0.387 . . . . 0.0 110.697 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 79.5 p -76.07 -9.75 58.87 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.051 -0.405 . . . . 0.0 111.664 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 5.1 t -150.81 149.7 26.18 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 123.483 0.713 . . . . 0.0 109.249 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -56.03 -20.7 31.31 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.717 2.945 . . . . 0.0 114.481 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.37 -22.49 30.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.462 0.573 . . . . 0.0 111.531 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -90.49 -27.31 19.3 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -78.17 22.48 0.31 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.839 0.855 . . . . 0.0 111.656 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -104.91 -7.52 19.27 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.403 0.681 . . . . 0.0 111.218 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -104.77 4.89 32.81 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.608 0.763 . . . . 0.0 110.202 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -152.72 171.96 17.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.536 1.135 . . . . 0.0 109.132 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -123.15 136.8 54.93 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.4 mm -113.56 148.56 16.38 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 123.455 0.702 . . . . 0.0 110.638 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? 60.8 -17.59 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.101 1.76 . . . . 0.0 115.373 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.97 119.75 44.28 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.564 1.075 . . . . 0.0 110.324 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.08 113.35 3.59 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.567 2.845 . . . . 0.0 110.804 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 52.4 m -123.96 13.42 9.13 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.388 0.675 . . . . 0.0 111.942 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 57.14 16.91 3.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.725 1.21 . . . . 0.0 113.722 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 74.1 t -134.51 141.44 43.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 118.419 0.554 . . . . 0.0 109.886 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.58 163.69 18.5 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 108.7 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.26 146.88 35.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.864 0.364 . . . . 0.0 111.729 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -112.71 150.01 32.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.572 1.149 . . . . 0.0 109.565 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -147.63 169.95 18.54 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 122.674 0.39 . . . . 0.0 111.175 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 29.0 m120 59.71 17.91 6.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.599 1.16 . . . . 0.0 113.747 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.69 156.09 73.08 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.85 154.79 36.07 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.921 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -72.69 -1.08 14.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.94 4.74 32.15 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.084 0.402 . . . . 0.0 111.723 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -81.64 148.69 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 O-C-N 122.062 -0.398 . . . . 0.0 110.6 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 72.4 p -144.14 174.01 11.25 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.849 0.86 . . . . 0.0 109.93 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.5 -24.59 67.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.796 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.97 -23.11 55.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.428 -0.17 . . . . 0.0 110.657 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -82.05 -28.88 32.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.85 -31.36 66.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -74.74 -38.7 62.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.753 0.252 . . . . 0.0 111.187 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.86 -14.4 59.26 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.09 0.405 . . . . 0.0 111.569 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.69 -38.51 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.617 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.5 m -67.06 -24.69 66.0 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.826 0.739 . . . . 0.0 110.537 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.16 -28.1 61.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.98 -17.5 26.22 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 4.3 pp -102.58 5.24 39.16 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 79.45 35.25 29.87 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.867 1.107 . . . . 0.0 115.867 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.1 m -130.47 168.3 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.2 1.5 . . . . 0.0 111.833 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.29 150.64 31.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.973 0.909 . . . . 0.0 110.855 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -87.58 152.89 52.58 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.364 0.666 . . . . 0.0 110.186 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.61 153.4 75.29 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.516 2.811 . . . . 0.0 111.105 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.446 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 86.4 m -82.34 -25.03 34.24 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.679 0.392 . . . . 0.0 110.707 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 13.6 t -142.83 156.48 44.96 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.562 0.345 . . . . 0.0 110.115 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.9 p -149.51 141.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.094 0.558 . . . . 0.0 110.758 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 121.59 8.85 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.16 144.63 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 122.848 0.459 . . . . 0.0 110.997 -173.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -149.89 159.22 44.55 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.271 1.028 . . . . 0.0 109.547 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.2 p -121.62 150.65 41.41 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.979 0.511 . . . . 0.0 110.942 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -89.65 151.86 22.1 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -82.55 141.06 32.9 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 27.1 m 56.33 11.1 0.74 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.309 1.044 . . . . 0.0 113.785 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -106.49 -10.27 16.33 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.05 0.387 . . . . 0.0 111.103 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 48.98 28.62 2.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.445 1.098 . . . . 0.0 113.125 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.5 m -137.75 161.15 37.31 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.532 0.333 . . . . 0.0 111.349 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.9 t -132.07 155.0 48.86 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.179 0.991 . . . . 0.0 111.071 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 80.3 p -152.95 166.69 31.6 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.231 1.012 . . . . 0.0 110.37 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.01 177.89 44.45 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.873 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.2 mp -112.79 144.28 42.6 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.84 0.856 . . . . 0.0 110.196 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.06 139.86 52.7 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.78 108.35 10.66 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.446 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.9 OUTLIER -166.1 155.72 11.95 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.548 1.539 . . . . 0.0 107.347 168.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -153.87 126.01 7.89 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.9 t -159.63 153.05 22.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.603 1.561 . . . . 0.0 107.013 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.46 -52.24 64.3 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.096 0.407 . . . . 0.0 111.728 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 38.8 m -85.4 -21.9 28.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -78.95 -35.43 43.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.175 -0.328 . . . . 0.0 110.795 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.96 39.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.28 -0.391 . . . . 0.0 111.166 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 47.1 tp -76.22 -29.7 57.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.776 0.716 . . . . 0.0 111.48 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.81 -40.1 55.61 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.826 -0.546 . . . . 0.0 110.221 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 49.0 m -68.73 -36.8 78.87 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.1 -41.74 99.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.61 -23.02 78.56 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.784 -172.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.14 -20.37 7.42 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.095 1.447 . . . . 0.0 113.883 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 37.3 tp -93.73 -23.16 18.31 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.635 1.107 . . . . 0.0 112.022 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -75.18 136.42 41.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 53.15 27.14 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.845 0.858 . . . . 0.0 113.093 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -78.19 151.38 33.22 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.185 0.594 . . . . 0.0 112.169 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -101.58 136.41 41.46 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.838 1.255 . . . . 0.0 110.03 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.4 ttt -64.17 169.56 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.645 0.378 . . . . 0.0 111.032 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -75.61 17.49 0.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -69.0 145.64 96.76 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.872 -0.518 . . . . 0.0 109.764 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.97 -30.56 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.487 2.791 . . . . 0.0 113.924 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -120.89 0.57 10.31 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.157 0.435 . . . . 0.0 112.114 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 39.81 97.76 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.77 -1.017 . . . . 0.0 112.75 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 74.9 Cg_endo -69.56 -10.11 27.88 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 112.016 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -142.67 148.35 46.1 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.28 154.41 36.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.921 3.081 . . . . 0.0 111.333 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -148.34 -0.7 0.56 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.904 0.482 . . . . 0.0 111.534 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 48.1 p -66.38 129.28 39.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.11 144.56 50.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.647 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -96.09 139.81 31.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.516 0.726 . . . . 0.0 109.09 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.66 151.94 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.578 0.228 . . . . 0.0 111.007 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.2 p -161.7 178.96 8.52 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.974 0.509 . . . . 0.0 110.082 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -71.64 144.27 49.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.442 0.297 . . . . 0.0 110.48 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 30.9 t -135.55 145.04 46.59 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 122.888 0.475 . . . . 0.0 110.782 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 88.5 m -93.88 102.22 14.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.3 161.53 34.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.904 0.882 . . . . 0.0 110.258 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.44 -14.47 17.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -161.36 166.85 26.81 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.586 1.154 . . . . 0.0 108.655 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -79.24 76.39 5.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.447 -1.263 . . . . 0.0 110.031 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -137.39 8.5 2.89 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.775 0.43 . . . . 0.0 111.781 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 176.87 177.21 45.65 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.23 168.63 23.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.876 3.05 . . . . 0.0 111.094 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -148.76 152.9 37.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.272 0.629 . . . . 0.0 109.75 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -91.12 156.78 17.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 111.118 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -142.87 12.53 1.86 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.095 0.558 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 39.8 t -155.98 147.41 16.84 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 123.462 0.705 . . . . 0.0 110.044 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 4.86 5.22 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.635 2.89 . . . . 0.0 111.454 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.54 151.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.694 0.798 . . . . 0.0 110.382 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -142.7 167.95 20.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.728 0.811 . . . . 0.0 109.771 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 71.6 mtp -135.57 152.8 51.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.637 0.256 . . . . 0.0 111.052 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.06 149.02 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 122.901 0.48 . . . . 0.0 110.413 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -141.41 168.75 19.02 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.477 0.711 . . . . 0.0 109.5 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.87 -2.0 87.34 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.874 -0.403 . . . . 0.0 112.616 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.605 HD21 ' H ' ' A' ' 386' ' ' LEU . 2.1 pt? -74.44 171.97 12.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.48 0.64 . . . . 0.0 110.649 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -132.57 132.26 42.37 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -68.58 -4.51 15.59 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.5 t -102.11 -12.2 18.26 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.616 0.366 . . . . 0.0 111.9 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -131.98 -13.9 3.14 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.139 0.427 . . . . 0.0 111.876 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.0 tpt -148.59 106.01 3.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.758 0.823 . . . . 0.0 109.242 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -141.81 -166.78 2.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.766 0.426 . . . . 0.0 110.397 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 73.2 m -53.93 -27.74 32.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.118 0.567 . . . . 0.0 112.509 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.43 -34.12 28.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.922 -0.486 . . . . 0.0 111.007 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -83.51 -28.4 28.69 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.266 -0.271 . . . . 0.0 110.322 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.08 -30.29 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -68.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -70.51 -27.9 64.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.297 -0.382 . . . . 0.0 111.901 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 75.1 t -95.11 -21.55 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -109.51 -12.05 14.74 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.94 -27.34 65.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.143 0.883 . . . . 0.0 111.418 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.46 14.57 1.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.46 2.87 10.24 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.8 0.84 . . . . 0.0 109.982 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 130.6 158.32 9.26 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -172.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -68.96 153.57 43.56 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.056 0.928 . . . . 0.0 111.228 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.72 154.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -97.84 -60.75 1.5 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -164.18 163.42 22.93 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.466 0.706 . . . . 0.0 110.854 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.36 150.74 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -152.13 145.35 24.66 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.509 0.324 . . . . 0.0 110.181 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -79.34 158.91 27.36 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -136.66 141.4 43.17 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -168.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 59.79 33.95 21.81 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 125.136 1.374 . . . . 0.0 112.505 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 23.2 m 53.01 15.39 0.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -81.87 132.56 53.91 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 118.691 0.678 . . . . 0.0 110.043 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.61 -3.68 8.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.543 2.828 . . . . 0.0 112.351 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.19 33.35 2.25 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.478 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.77 133.7 19.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.125 0.962 . . . . 0.0 110.357 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.38 169.17 24.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.198 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.2 ptm -143.49 146.56 33.49 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.278 0.631 . . . . 0.0 109.658 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.31 147.79 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.12 0.568 . . . . 0.0 110.586 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -122.18 135.96 54.84 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.5 mmm -105.25 164.25 11.98 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.485 0.314 . . . . 0.0 110.878 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.99 66.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.99 159.2 36.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.35 0.66 . . . . 0.0 109.333 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.33 -17.0 69.9 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.068 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -68.37 -29.92 68.74 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.004 1.402 . . . . 0.0 110.178 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -73.51 -21.82 60.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.197 -0.314 . . . . 0.0 110.707 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.71 -35.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.88 -36.5 78.14 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.666 0.212 . . . . 0.0 110.677 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.08 -35.01 78.88 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.05 56.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.099 -0.376 . . . . 0.0 110.621 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -29.12 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.184 0.516 . . . . 0.0 111.855 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.8 p -91.17 -13.22 33.32 Favored 'General case' 0 C--N 1.342 0.277 0 O-C-N 121.067 -1.021 . . . . 0.0 113.592 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -138.44 -10.62 1.42 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.3 -14.52 13.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.226 0.921 . . . . 0.0 110.456 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -56.1 142.38 36.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 56.96 1.42 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.72 1.608 . . . . 0.0 114.991 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -87.77 142.6 27.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 120.058 1.299 . . . . 0.0 109.164 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.263 0.1 OUTLIER -130.91 164.0 26.23 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.4 ptm -125.18 143.42 50.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.86 1.264 . . . . 0.0 108.44 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 68.76 21.87 7.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.359 1.463 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.94 15.8 78.35 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -83.07 162.14 21.45 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.815 1.308 . . . . 0.0 110.68 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 132.34 36.17 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.292 0.237 . . . . 0.0 110.493 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.58 135.69 39.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -170.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -140.72 120.19 13.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.36 145.27 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 118.316 0.507 . . . . 0.0 110.378 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -157.68 161.25 38.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.754 0.422 . . . . 0.0 110.408 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.6 p -83.15 151.44 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 21.1 t -100.58 -169.03 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.639 0.375 . . . . 0.0 110.018 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -136.83 0.21 2.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.826 0.45 . . . . 0.0 110.691 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -74.27 148.94 86.62 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.29 -24.77 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.868 2.378 . . . . 0.0 111.794 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.09 170.11 15.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.319 0.647 . . . . 0.0 110.352 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.3 mm -67.14 143.92 15.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.1 mtt -107.77 156.89 37.26 Favored Pre-proline 0 C--O 1.232 0.15 0 C-N-CA 122.338 0.255 . . . . 0.0 111.109 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.68 157.88 21.98 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.928 3.085 . . . . 0.0 112.604 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.3 -179.13 42.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -74.02 150.13 40.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.615 -0.344 . . . . 0.0 110.481 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.9 m -143.69 147.66 34.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -145.97 167.88 22.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.861 0.464 . . . . 0.0 110.477 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.98 137.47 20.0 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.3 167.44 14.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.287 0.635 . . . . 0.0 110.007 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.72 -20.19 65.23 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.368 0.267 . . . . 0.0 111.379 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.1 -1.22 31.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.997 0.519 . . . . 0.0 110.954 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.2 -5.2 73.19 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.89 -0.506 . . . . 0.0 112.237 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 63.9 m -87.2 161.2 18.17 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.799 0.8 . . . . 0.0 110.072 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 80.3 m -85.22 153.35 22.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.48 0.181 . . . . 0.0 110.582 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.5 p -73.01 -10.48 59.85 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.466 0.306 . . . . 0.0 111.416 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.25 141.64 51.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.127 0.971 . . . . 0.0 109.487 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -155.25 156.84 36.31 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.548 0.339 . . . . 0.0 110.191 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.89 154.65 50.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.462 0.705 . . . . 0.0 110.547 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.12 15.85 2.08 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 122.723 0.409 . . . . 0.0 111.514 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 87.8 p -65.65 -12.49 53.88 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.23 -6.62 59.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.992 0.36 . . . . 0.0 111.376 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.5 m -96.66 15.55 21.47 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.488 0.715 . . . . 0.0 111.321 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -74.13 -1.07 18.68 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.126 0.571 . . . . 0.0 111.756 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -94.9 19.99 9.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.319 0.648 . . . . 0.0 110.942 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -69.73 163.94 24.6 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.02 0.528 . . . . 0.0 111.025 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.08 -2.54 21.73 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.773 0.829 . . . . 0.0 112.919 -176.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -149.7 29.26 0.76 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.103 0.411 . . . . 0.0 111.549 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.3 p -72.91 -6.99 48.87 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 46.2 p -139.65 159.15 66.44 Favored Pre-proline 0 C--O 1.231 0.094 0 C-N-CA 122.894 0.478 . . . . 0.0 109.959 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -60.99 -14.03 30.71 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.282 2.655 . . . . 0.0 112.643 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -90.71 -31.01 16.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.479 0.312 . . . . 0.0 111.032 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -90.56 -23.82 20.77 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.428 0.291 . . . . 0.0 110.346 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -83.74 26.03 0.73 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.686 0.794 . . . . 0.0 111.569 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -101.5 2.71 39.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.311 0.644 . . . . 0.0 111.533 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -119.23 4.4 11.29 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.315 0.646 . . . . 0.0 111.662 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -139.34 -17.9 1.0 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 59.6 146.58 0.01 OUTLIER 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.723 1.609 . . . . 0.0 113.33 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.7 mm -113.6 148.77 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.971 0.908 . . . . 0.0 111.141 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER 55.04 11.63 0.53 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.848 2.059 . . . . 0.0 115.352 175.17 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -103.4 120.97 50.18 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.92 131.55 15.81 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.015 2.477 . . . . 0.0 110.557 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 87.8 p -124.16 -1.3 8.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.544 0.738 . . . . 0.0 112.119 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.53 16.21 5.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.069 0.948 . . . . 0.0 112.167 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.2 t -135.97 138.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.9 mt -120.26 152.69 37.41 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.08 145.8 49.02 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -131.93 151.71 51.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.613 0.244 . . . . 0.0 110.576 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -147.36 171.08 16.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 111.094 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.46 25.95 14.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.512 1.125 . . . . 0.0 113.236 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.74 63.93 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.88 159.7 52.36 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.206 1.938 . . . . 0.0 110.194 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -73.95 -1.07 18.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.87 4.51 42.81 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -86.41 150.22 3.93 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 CA-C-N 118.251 0.478 . . . . 0.0 111.347 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -147.2 174.34 11.7 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.939 0.896 . . . . 0.0 109.522 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.23 -24.67 67.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.499 -0.126 . . . . 0.0 110.925 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.1 -24.95 51.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.179 -0.325 . . . . 0.0 110.718 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.3 -28.35 38.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -73.71 -30.79 63.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.203 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -75.25 -36.32 61.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.287 -0.258 . . . . 0.0 111.544 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.46 -21.24 42.24 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.266 0.485 . . . . 0.0 111.55 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.91 -37.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 86.8 m -67.38 -26.48 66.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.091 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.42 -29.12 62.37 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -91.06 -11.84 37.49 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.526 0.603 . . . . 0.0 111.895 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 86.3 mt -100.7 -5.44 26.5 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.644 0.377 . . . . 0.0 111.277 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.24 5.62 72.27 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.866 -0.408 . . . . 0.0 112.907 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.4 m -91.43 167.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 117.65 0.725 . . . . 0.0 110.953 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -76.63 151.84 36.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.384 0.674 . . . . 0.0 110.173 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -102.16 150.9 37.91 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.15 158.98 27.89 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.404 2.736 . . . . 0.0 112.64 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.518 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 91.4 m -86.36 -25.07 25.55 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.072 0.549 . . . . 0.0 110.499 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.1 t -145.23 152.25 39.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.1 t -141.37 140.93 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.348 0.659 . . . . 0.0 109.775 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.97 126.51 15.94 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.8 t -132.05 149.43 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.032 0 C-N-CA 122.667 0.387 . . . . 0.0 110.673 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -152.3 153.75 34.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.272 0.629 . . . . 0.0 110.17 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 62.5 p -130.84 141.37 50.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.106 0.563 . . . . 0.0 109.907 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -80.99 157.51 39.35 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -72.42 130.67 41.24 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.45 -0.441 . . . . 0.0 110.052 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 27.0 m 55.94 14.93 1.53 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -90.58 -9.97 45.12 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.291 0.496 . . . . 0.0 111.356 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 44.43 26.95 0.2 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.132 1.373 . . . . 0.0 113.626 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 36.2 m -139.61 164.45 29.89 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.396 0.678 . . . . 0.0 110.351 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 34.3 t -132.91 153.7 51.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 111.089 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 67.6 m -146.65 164.61 32.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.059 1.343 . . . . 0.0 108.854 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -179.26 -175.07 45.91 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.01 -1.091 . . . . 0.0 113.857 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.11 153.49 42.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.188 0.995 . . . . 0.0 109.763 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 72.8 mt -136.52 136.9 39.76 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.043 0.937 . . . . 0.0 108.903 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -127.86 109.2 11.38 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.518 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.8 OUTLIER -166.12 155.01 11.28 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.826 1.25 . . . . 0.0 108.579 168.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -149.78 121.02 7.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 37.8 t -159.55 153.22 22.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -66.47 -46.92 74.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.767 0.712 . . . . 0.0 111.211 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 67.7 p -85.89 -27.84 24.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 48.6 m-20 -84.05 -30.01 26.41 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.578 0.626 . . . . 0.0 111.078 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.04 27.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.339 0.518 . . . . 0.0 111.236 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.74 -30.6 28.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.853 0.751 . . . . 0.0 112.024 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.82 -42.58 49.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.475 0.58 . . . . 0.0 110.482 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 43.3 m -68.88 -36.38 78.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.68 -41.48 83.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.7 -17.3 76.53 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.957 -0.913 . . . . 0.0 113.544 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.92 -19.22 7.33 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.757 1.279 . . . . 0.0 114.29 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -90.82 -31.25 16.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.056 0.844 . . . . 0.0 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -62.29 139.58 58.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 51.39 23.23 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.366 1.066 . . . . 0.0 113.604 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -74.4 151.33 39.69 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -99.87 136.25 40.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.482 1.113 . . . . 0.0 109.733 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.425 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.3 ttt -64.34 172.42 2.55 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.311 0.577 . . . . 0.0 112.208 -172.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . 0.425 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.3 ptmt -66.94 3.43 1.09 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.699 1.2 . . . . 0.0 113.712 -176.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -67.86 144.74 97.53 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 118.634 0.652 . . . . 0.0 110.727 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.98 -27.32 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.542 2.828 . . . . 0.0 113.784 -171.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -121.08 -3.06 9.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.205 0.457 . . . . 0.0 112.026 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.06 40.52 98.24 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.69 -1.061 . . . . 0.0 112.806 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 83.5 Cg_endo -69.69 -9.64 26.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.103 2.535 . . . . 0.0 111.823 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -142.19 147.74 45.18 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.023 0.529 . . . . 0.0 109.648 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.48 152.85 34.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.805 3.004 . . . . 0.0 111.565 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -148.83 -3.21 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.133 0.573 . . . . 0.0 111.493 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.44 120.94 14.22 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.701 -0.624 . . . . 0.0 110.044 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.96 144.63 50.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.093 0.957 . . . . 0.0 109.934 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -86.3 154.55 21.16 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 55.0 tp -144.12 144.84 31.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.96 168.38 19.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -77.07 130.86 37.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.9 t -135.57 138.2 42.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 32.9 p -79.7 102.25 8.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.336 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 159.92 39.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 109.144 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -81.85 -32.47 31.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.189 -0.319 . . . . 0.0 110.228 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -153.66 165.81 34.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.944 0.898 . . . . 0.0 109.571 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.43 76.32 7.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.354 -179.473 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -144.69 0.76 0.99 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.864 0.466 . . . . 0.0 111.993 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -71.5 136.02 24.3 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.64 -175.3 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.851 3.701 . . . . 0.0 110.298 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.49 149.08 38.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -70.25 158.31 36.09 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.89 0.376 . . . . 0.0 111.064 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.43 -0.58 57.35 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.336 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 43.0 t -160.27 146.56 11.81 Favored Pre-proline 0 N--CA 1.456 -0.164 0 C-N-CA 123.197 0.599 . . . . 0.0 110.355 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.14 4.34 6.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.118 3.212 . . . . 0.0 112.091 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.05 151.79 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 123.364 0.666 . . . . 0.0 110.699 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.58 167.07 23.03 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.807 0.843 . . . . 0.0 109.627 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 70.0 mtp -134.19 151.08 51.15 Favored 'General case' 0 N--CA 1.458 -0.042 0 C-N-CA 122.459 0.304 . . . . 0.0 111.084 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.9 148.15 19.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.834 0.454 . . . . 0.0 110.427 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -140.11 168.06 20.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.488 0.715 . . . . 0.0 109.369 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.45 -6.44 80.04 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.354 -0.692 . . . . 0.0 113.05 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.576 HD21 ' H ' ' A' ' 386' ' ' LEU . 2.1 pt? -68.98 177.67 2.54 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.998 0.899 . . . . 0.0 110.387 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -142.78 136.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -73.63 -7.14 50.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 96.0 p -93.2 -12.03 31.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.605 0.639 . . . . 0.0 112.592 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.47 5.89 0.94 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.5 ttt -141.26 129.14 21.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.94 177.81 7.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.755 0.422 . . . . 0.0 110.213 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.57 -28.06 63.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.56 0.344 . . . . 0.0 111.203 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.66 -23.08 29.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.052 -0.405 . . . . 0.0 111.376 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -83.85 -34.5 24.62 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.1 -27.48 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.5 -33.84 73.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.018 -0.427 . . . . 0.0 110.183 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -67.88 -29.54 68.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.853 -0.529 . . . . 0.0 111.086 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 80.3 t -90.36 -29.64 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -101.72 -8.68 21.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 53.0 t -71.55 -38.34 71.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.872 0.76 . . . . 0.0 111.333 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.66 12.92 1.45 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.731 -0.606 . . . . 0.0 112.407 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.21 0.75 11.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.278 0.631 . . . . 0.0 111.152 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.16 170.05 14.52 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -70.26 136.42 49.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.351 -0.5 . . . . 0.0 110.759 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 4.5 m -95.1 164.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.773 1.229 . . . . 0.0 110.321 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -125.8 -65.54 0.99 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.325 0.25 . . . . 0.0 110.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -163.37 165.54 23.9 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.067 0.547 . . . . 0.0 111.194 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.63 151.63 14.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.674 0.79 . . . . 0.0 110.363 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.05 147.64 26.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -78.17 158.98 28.85 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.23 141.46 42.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.05 33.9 21.33 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.845 1.258 . . . . 0.0 112.402 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.4 m 53.06 16.06 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 114.129 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -80.61 144.73 57.12 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 118.449 0.568 . . . . 0.0 109.599 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.18 1.83 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.843 3.029 . . . . 0.0 110.831 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -143.27 33.41 1.81 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.164 -173.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.03 19.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.933 0.867 . . . . 0.0 110.133 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.28 170.6 21.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.073 0.464 . . . . 0.0 110.808 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 17.7 ptm -145.05 146.53 31.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.983 0.513 . . . . 0.0 109.672 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.25 147.75 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.026 0 C-N-CA 123.322 0.649 . . . . 0.0 110.742 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -124.58 142.42 51.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.535 0.734 . . . . 0.0 109.773 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.0 mmm -115.63 164.21 14.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 109.797 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.85 64.18 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.392 -0.192 . . . . 0.0 111.251 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.86 160.13 33.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.12 -14.51 63.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.377 -0.679 . . . . 0.0 113.097 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -64.38 -31.19 72.29 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.398 1.599 . . . . 0.0 110.233 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.67 -23.78 45.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.52 -0.113 . . . . 0.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.03 -31.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.04 -31.18 62.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.134 0.425 . . . . 0.0 110.865 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -29.62 65.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.067 -0.396 . . . . 0.0 109.986 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.66 -28.8 40.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.735 0.243 . . . . 0.0 110.59 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.8 tp -81.83 -35.25 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 122.775 0.43 . . . . 0.0 110.059 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 m -89.24 -26.09 21.38 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.91 -11.09 6.6 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.78 -16.76 11.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.424 1.011 . . . . 0.0 110.339 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -54.05 141.67 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.83 0.852 . . . . 0.0 111.514 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 57.04 1.39 0.09 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.045 2.138 . . . . 0.0 115.956 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.75 142.59 27.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 120.786 1.63 . . . . 0.0 108.01 169.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.276 0.0 OUTLIER -130.98 163.86 26.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.3 ptm -125.25 143.47 50.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.466 1.106 . . . . 0.0 109.607 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 66.46 32.94 7.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.178 1.391 . . . . 0.0 113.784 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.0 15.88 72.23 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.654 169.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -83.02 152.82 25.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.521 1.161 . . . . 0.0 110.736 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.504 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -75.42 136.19 40.73 Favored 'General case' 0 C--N 1.337 0.028 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -97.21 127.16 42.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -140.6 115.87 9.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.83 139.44 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.5 m -148.17 164.37 34.15 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.579 0.752 . . . . 0.0 109.99 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.62 151.9 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.5 t -102.29 -174.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.085 0.554 . . . . 0.0 110.304 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -135.4 7.12 3.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.799 0.84 . . . . 0.0 110.341 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -78.86 147.56 70.74 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.79 -25.46 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.835 2.357 . . . . 0.0 111.978 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.46 170.75 12.58 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.155 0.582 . . . . 0.0 110.443 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -68.22 140.61 18.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.6 mtt -102.37 151.45 38.17 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.416 0.286 . . . . 0.0 110.723 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 161.54 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.729 2.952 . . . . 0.0 111.337 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.65 -175.68 44.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -72.96 158.26 35.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.664 0.385 . . . . 0.0 110.17 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.1 p -146.41 162.49 38.11 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.167 0.587 . . . . 0.0 110.543 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -150.15 163.7 37.53 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.96 0.504 . . . . 0.0 110.208 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.87 135.42 17.88 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.4 mt -86.97 176.4 7.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.904 0.882 . . . . 0.0 109.954 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -65.27 -20.29 66.35 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.392 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.23 0.15 49.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.359 0.664 . . . . 0.0 111.573 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.52 -3.52 77.95 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.286 0.469 . . . . 0.0 112.504 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 60.5 m -93.82 156.69 16.52 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.681 0.74 . . . . 0.0 110.269 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.81 153.35 36.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.456 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.0 p -66.33 -10.39 42.44 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.775 0.43 . . . . 0.0 111.79 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -118.52 137.48 53.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.174 0.99 . . . . 0.0 109.391 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -151.87 154.92 37.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -124.28 152.36 43.11 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.02 0.928 . . . . 0.0 109.84 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -137.94 12.57 2.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.144 0.578 . . . . 0.0 112.276 -175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 97.2 p -70.38 4.53 2.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -107.93 17.31 22.58 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.493 0.717 . . . . 0.0 111.176 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.8 t -58.8 142.19 50.98 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.684 0.394 . . . . 0.0 111.161 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -122.07 22.47 10.25 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.02 0.928 . . . . 0.0 112.276 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -63.15 -30.62 71.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.888 0.313 . . . . 0.0 110.643 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 55.18 2.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.197 1.799 . . . . 0.0 115.732 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -89.88 -13.69 35.88 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.091 0.859 . . . . 0.0 110.744 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -165.2 18.43 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.908 0.883 . . . . 0.0 110.823 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 21.0 m -76.66 -1.52 28.18 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.817 0.447 . . . . 0.0 112.196 -176.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 70.7 p -139.61 156.72 71.11 Favored Pre-proline 0 C--O 1.233 0.22 0 C-N-CA 123.658 0.783 . . . . 0.0 109.15 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.15 -8.84 23.96 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.789 2.326 . . . . 0.0 111.209 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.87 -28.02 15.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.096 -0.378 . . . . 0.0 110.949 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -90.43 -25.7 20.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.872 0.306 . . . . 0.0 110.481 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -75.93 -9.71 58.83 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.392 0.277 . . . . 0.0 111.395 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -95.93 -14.13 23.35 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.846 0.458 . . . . 0.0 111.211 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -107.55 11.73 28.42 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 123.603 0.761 . . . . 0.0 110.861 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -140.62 161.52 37.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.111 0.964 . . . . 0.0 108.83 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -134.97 142.08 46.4 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.931 0.492 . . . . 0.0 110.388 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 50.2 mm -113.65 138.9 41.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 123.668 0.787 . . . . 0.0 109.674 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -146.3 177.25 9.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.509 0.724 . . . . 0.0 110.195 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -65.37 163.96 28.38 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.401 0.681 . . . . 0.0 110.756 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.61 151.86 13.66 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.764 2.976 . . . . 0.0 112.764 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 45.1 p -124.05 23.89 8.38 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.907 0.883 . . . . 0.0 112.122 -173.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 54.67 13.13 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.792 1.637 . . . . 0.0 115.051 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.85 150.24 22.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.96 143.84 50.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -109.37 152.48 25.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.731 0.413 . . . . 0.0 109.92 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -130.38 135.71 48.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.09 0.956 . . . . 0.0 108.482 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -146.56 168.18 21.88 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.858 0.463 . . . . 0.0 111.073 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.8 m120 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.906 0.882 . . . . 0.0 112.623 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.42 156.35 50.96 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 122.984 0.514 . . . . 0.0 109.765 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.18 156.95 64.04 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.286 1.99 . . . . 0.0 110.407 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.5 -1.19 26.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.17 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.6 7.8 28.83 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.095 -0.378 . . . . 0.0 111.983 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.51 153.09 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.168 0.44 . . . . 0.0 111.668 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 75.5 p -146.91 172.6 13.43 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.935 0.894 . . . . 0.0 110.114 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -60.79 -24.31 65.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.796 177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -73.59 -26.69 60.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.178 -0.326 . . . . 0.0 110.455 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.37 -28.93 37.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.47 -29.43 63.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.6 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.81 -38.99 31.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.575 0.625 . . . . 0.0 111.605 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.91 -18.96 52.99 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.174 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.5 mt -90.85 -33.5 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 118.285 0.493 . . . . 0.0 110.095 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.33 -22.27 64.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.635 -0.666 . . . . 0.0 110.285 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.58 -30.55 64.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.13 -13.0 33.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.365 0.53 . . . . 0.0 112.075 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.5 mt -91.82 -6.53 51.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.517 0.327 . . . . 0.0 110.428 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.41 7.73 64.77 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.693 -0.504 . . . . 0.0 112.966 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.1 m -87.54 169.13 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 117.833 0.817 . . . . 0.0 111.222 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -71.16 132.33 44.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -76.81 147.0 77.07 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.92 148.29 91.77 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.909 2.406 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.482 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.1 m -89.55 -19.9 24.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.544 0.337 . . . . 0.0 110.431 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.5 t -147.25 148.98 32.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.41 138.93 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.656 0.382 . . . . 0.0 110.328 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -142.91 139.92 30.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.32 154.97 41.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 110.428 -175.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -152.05 161.15 43.07 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.441 1.096 . . . . 0.0 109.166 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 74.9 p -130.82 141.96 50.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.695 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -82.3 179.46 53.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -111.56 139.6 46.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.737 0.415 . . . . 0.0 110.55 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 23.6 m 54.29 10.25 0.3 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.967 1.307 . . . . 0.0 114.174 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -111.96 -7.64 14.12 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.366 0.53 . . . . 0.0 111.918 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 47.8 42.09 15.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.999 0.919 . . . . 0.0 112.517 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 158.26 44.55 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.81 0.444 . . . . 0.0 111.411 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -115.8 157.38 24.47 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.07 0.948 . . . . 0.0 111.884 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -149.88 175.15 11.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.256 1.422 . . . . 0.0 109.199 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.7 45.7 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.647 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.25 132.79 47.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.632 0.773 . . . . 0.0 109.01 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 9.4 mp -128.12 144.78 51.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.76 120.46 27.95 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.482 ' HB3' ' H ' ' A' ' 527' ' ' THR . 9.6 p90 -164.94 147.4 8.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -156.21 123.4 5.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 17.3 m -159.64 152.89 22.16 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.341 1.856 . . . . 0.0 106.304 169.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -59.95 -54.26 48.22 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.718 0.69 . . . . 0.0 111.897 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 26.9 m -83.5 -27.28 29.51 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.96 -30.82 31.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.06 0.391 . . . . 0.0 111.024 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -30.36 38.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.9 tp -78.08 -29.61 49.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.624 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -71.98 -41.72 67.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 O-C-N 121.938 -0.476 . . . . 0.0 109.983 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 24.1 m -73.44 -39.24 65.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.992 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.66 -46.78 74.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.676 -0.64 . . . . 0.0 109.815 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.15 -16.41 78.58 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.552 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -123.7 -6.18 8.03 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.795 1.298 . . . . 0.0 113.48 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.87 -16.36 14.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.3 0.5 . . . . 0.0 111.265 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -68.07 143.6 55.42 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.266 -0.896 . . . . 0.0 109.924 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 52.64 29.41 7.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.06 0.944 . . . . 0.0 113.354 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.7 151.42 39.23 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -103.76 136.42 43.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.063 1.745 . . . . 0.0 110.635 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.467 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.13 173.68 1.85 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.935 0.494 . . . . 0.0 111.202 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . 0.414 ' H ' ' HG2' ' A' ' 564' ' ' MET . 65.2 pttt -73.3 9.77 1.19 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -66.28 143.86 98.48 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.715 0.688 . . . . 0.0 110.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.0 -29.58 3.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.569 2.846 . . . . 0.0 114.04 -169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -121.02 1.37 10.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.961 0.346 . . . . 0.0 111.912 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.428 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.74 41.55 99.09 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.929 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.6 Cg_endo -68.94 -10.87 30.37 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.247 2.631 . . . . 0.0 112.048 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.11 147.61 38.38 Favored Pre-proline 0 N--CA 1.455 -0.201 0 C-N-CA 122.832 0.453 . . . . 0.0 109.824 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.81 152.37 41.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.859 3.039 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.7 t80 -144.17 -2.79 0.88 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 126.17 28.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.809 -0.557 . . . . 0.0 109.998 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.14 144.71 50.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.232 1.013 . . . . 0.0 110.372 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -79.46 135.98 36.81 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.5 pp -146.99 146.85 30.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 25.5 p -163.72 169.99 17.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.082 0.553 . . . . 0.0 110.304 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -73.78 130.67 40.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 74.6 m -135.55 140.07 44.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.79 0.436 . . . . 0.0 110.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 65.0 m -79.82 102.34 9.03 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.012 0.434 . . . . 0.0 110.573 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 161.6 34.44 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.076 0.95 . . . . 0.0 109.43 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . 0.452 ' CD ' ' H ' ' A' ' 583' ' ' GLN . 0.0 OUTLIER -98.87 -15.92 19.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.573 0.349 . . . . 0.0 111.511 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -160.58 164.56 31.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.205 0.602 . . . . 0.0 109.824 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.17 76.4 9.24 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.945 179.113 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.02 7.84 2.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.928 0.491 . . . . 0.0 111.866 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 75.1 -172.75 53.25 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.7 171.97 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 124.309 3.339 . . . . 0.0 110.934 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -148.42 162.81 38.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.139 0.576 . . . . 0.0 110.768 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -95.57 156.72 16.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.563 0.345 . . . . 0.0 111.189 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -139.08 10.75 2.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.29 0.636 . . . . 0.0 110.917 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 37.6 t -155.71 150.71 20.78 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.177 0.591 . . . . 0.0 110.323 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.34 -4.39 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.562 2.841 . . . . 0.0 111.473 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.77 145.3 17.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.098 0.559 . . . . 0.0 111.019 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.99 165.16 27.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.243 1.017 . . . . 0.0 109.43 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.2 mtp -137.87 153.17 49.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.674 0.274 . . . . 0.0 111.58 -175.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.63 150.39 15.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.064 0.546 . . . . 0.0 110.357 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.24 166.16 24.89 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.59 86.93 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.115 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.543 HD13 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.58 178.14 4.27 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.209 1.005 . . . . 0.0 110.992 177.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.44 143.8 35.78 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -73.29 0.22 12.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.4 p -113.67 -4.33 13.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.552 0.614 . . . . 0.0 112.376 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -131.81 -6.9 3.58 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.141 0.577 . . . . 0.0 110.882 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 27.8 ttt -145.43 128.19 16.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 32.8 m-80 -141.88 176.75 8.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.701 0.801 . . . . 0.0 109.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.0 m -57.98 -27.84 63.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.314 0.246 . . . . 0.0 111.142 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -85.15 -26.21 26.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.267 -0.271 . . . . 0.0 111.451 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . 0.45 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 48.8 mmt-85 -81.07 -33.85 33.12 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.194 0.452 . . . . 0.0 109.804 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -25.12 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -71.52 -29.33 64.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.66 -26.74 50.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.684 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 74.5 t -90.18 -21.28 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.298 0.499 . . . . 0.0 112.301 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -114.43 -12.91 12.29 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.79 -25.65 62.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.44 1.018 . . . . 0.0 111.754 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.6 pp -77.67 11.16 2.22 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.649 -0.657 . . . . 0.0 112.164 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.75 -7.78 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.454 0.701 . . . . 0.0 110.609 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.32 170.71 19.81 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -70.41 138.49 51.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.065 -0.668 . . . . 0.0 111.008 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 62.0 t -97.25 145.14 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.07 -57.89 1.98 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.323 -0.236 . . . . 0.0 110.721 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -160.0 165.23 32.36 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.972 0.415 . . . . 0.0 111.54 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.21 151.8 15.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 123.85 0.86 . . . . 0.0 109.987 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -151.64 144.56 24.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.762 0.425 . . . . 0.0 110.007 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -76.05 157.4 33.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 34.4 ttp -119.67 141.15 49.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -168.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt 51.93 33.88 12.54 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.722 1.209 . . . . 0.0 112.26 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.8 m 55.68 15.76 1.7 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 113.323 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -81.29 142.18 50.46 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.42 -2.47 11.98 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.467 2.778 . . . . 0.0 109.518 169.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.01 15.79 10.99 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.556 1.074 . . . . 0.0 113.822 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.181 1.49 . . . . 0.0 111.129 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -158.89 168.06 27.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.169 0.509 . . . . 0.0 111.964 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.2 ptp -136.07 148.79 48.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.913 0.885 . . . . 0.0 109.93 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.53 151.35 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.556 0.742 . . . . 0.0 109.834 -175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -130.77 145.04 51.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.736 0.414 . . . . 0.0 110.493 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 73.7 mtp -124.34 165.43 17.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.02 66.58 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -158.81 160.79 36.63 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.73 -13.33 78.35 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.509 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -65.51 -26.79 68.07 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.166 1.483 . . . . 0.0 110.741 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.98 -25.61 25.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.219 0.208 . . . . 0.0 110.841 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.39 -30.36 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.6 -33.4 72.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.497 0.319 . . . . 0.0 110.355 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -76.08 -25.35 55.42 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.175 -0.328 . . . . 0.0 110.514 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.84 -28.57 44.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.984 -0.448 . . . . 0.0 109.868 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -80.47 -31.04 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.102 0.961 . . . . 0.0 111.096 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 45.7 p -100.54 -13.17 18.74 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -134.05 -11.97 2.55 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.049 1.295 . . . . 0.0 114.391 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.82 -10.45 11.71 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.96 0.8 . . . . 0.0 109.718 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -58.88 145.24 41.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.403 0.62 . . . . 0.0 112.443 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 21.3 m120 56.9 1.35 0.09 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.543 1.937 . . . . 0.0 115.536 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -87.95 142.52 27.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.55 1.523 . . . . 0.0 108.493 169.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.0 OUTLIER -130.69 163.97 26.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 174.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.3 ptm -125.26 143.36 50.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.642 1.177 . . . . 0.0 109.171 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 63.86 27.09 14.46 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.953 1.301 . . . . 0.0 114.483 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.83 15.92 76.4 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -83.04 150.63 26.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.979 1.389 . . . . 0.0 110.14 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 141.49 38.28 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.79 122.99 40.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -140.73 115.72 9.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.14 140.22 24.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.926 0.33 . . . . 0.0 110.341 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 99.4 m -149.43 168.21 24.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.878 0.871 . . . . 0.0 110.158 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.68 153.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 23.2 t -105.82 -168.23 1.42 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.653 0.381 . . . . 0.0 110.276 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -141.57 4.43 1.75 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.115 0.566 . . . . 0.0 111.146 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -74.38 150.93 87.46 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -27.7 12.35 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.646 2.231 . . . . 0.0 112.382 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.71 170.15 14.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.298 0.499 . . . . 0.0 111.28 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 30.0 mm -71.82 151.49 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.01 133.07 23.15 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.22 158.55 41.29 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.523 2.815 . . . . 0.0 111.427 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 151.84 160.23 9.4 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 48.27 -95.9 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.703 1.201 . . . . 0.0 112.741 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.0 t 63.14 146.75 0.02 OUTLIER 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.653 1.581 . . . . 0.0 112.938 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -148.31 165.3 31.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.913 0.885 . . . . 0.0 109.699 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.45 132.65 11.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.1 mt -87.06 172.5 9.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.315 0.646 . . . . 0.0 110.341 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.48 -22.12 66.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.848 0.459 . . . . 0.0 110.951 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.7 1.2 35.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.199 0.599 . . . . 0.0 111.41 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.45 -2.11 79.1 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.076 0.369 . . . . 0.0 112.402 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.35 156.59 16.7 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.655 0.727 . . . . 0.0 110.067 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 83.9 m -78.77 150.42 32.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.447 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 86.3 p -73.22 -10.33 59.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.455 0.302 . . . . 0.0 111.464 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -119.44 130.59 55.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.561 0.744 . . . . 0.0 109.062 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -151.62 159.44 44.06 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -130.62 147.88 52.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.794 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -136.2 12.77 3.3 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.052 0.541 . . . . 0.0 111.415 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 14.8 t -72.14 164.42 26.24 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.913 0.485 . . . . 0.0 111.594 -174.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 53.18 25.96 4.68 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.133 0.973 . . . . 0.0 113.28 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.9 t -65.38 150.02 49.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.98 -0.45 . . . . 0.0 110.533 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -122.01 7.52 9.81 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.619 0.768 . . . . 0.0 111.383 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -93.88 14.52 19.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.403 0.681 . . . . 0.0 111.333 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -144.41 155.43 43.75 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 121.866 -0.521 . . . . 0.0 111.346 -178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -89.63 -9.97 47.68 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.711 0.804 . . . . 0.0 111.538 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -130.69 38.64 3.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.569 0.748 . . . . 0.0 110.376 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.6 p -71.33 -3.27 19.72 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.216 0.606 . . . . 0.0 112.5 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 36.2 p -139.05 154.79 72.78 Favored Pre-proline 0 C--O 1.231 0.131 0 C-N-CA 123.146 0.579 . . . . 0.0 109.513 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.1 -6.05 18.35 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.143 2.562 . . . . 0.0 111.514 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.33 -30.59 13.33 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.558 0.343 . . . . 0.0 110.924 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -90.56 -17.44 26.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.299 -0.251 . . . . 0.0 110.474 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -68.85 -8.29 42.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -76.2 -11.78 59.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.444 0.298 . . . . 0.0 110.967 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -94.63 6.21 49.54 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.556 0.742 . . . . 0.0 111.181 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -141.21 171.38 14.14 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.835 0.854 . . . . 0.0 109.413 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -132.56 155.7 48.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.305 0.642 . . . . 0.0 109.912 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.05 147.89 12.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -140.69 158.75 43.52 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.965 0.412 . . . . 0.0 110.915 -176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -89.1 166.48 21.64 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.29 1.036 . . . . 0.0 109.882 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.03 129.96 30.02 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.0 2.467 . . . . 0.0 111.412 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 70.8 m -123.99 22.73 8.74 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.195 0.598 . . . . 0.0 112.291 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 60.2 3.29 0.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.06 1.344 . . . . 0.0 114.012 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.6 t -142.29 146.96 21.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 49.1 mt -121.48 162.1 21.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.036 0.534 . . . . 0.0 110.545 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -141.96 152.78 43.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.502 0.321 . . . . 0.0 110.676 175.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -138.01 154.25 49.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.837 0.455 . . . . 0.0 111.344 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -146.01 172.17 13.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.048 0.539 . . . . 0.0 111.197 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.4 m120 61.08 27.66 17.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 575' ' ' LEU . . . -82.64 160.55 61.29 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 122.44 0.296 . . . . 0.0 110.609 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.92 152.71 62.38 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.692 2.261 . . . . 0.0 110.7 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -73.46 -2.56 23.0 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.23 9.22 13.41 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.204 0.602 . . . . 0.0 111.88 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.9 152.44 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.121 -0.362 . . . . 0.0 110.298 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.6 p -145.65 170.97 15.41 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.061 0.544 . . . . 0.0 110.442 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.87 -23.25 66.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.894 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.16 -26.07 58.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.657 0.208 . . . . 0.0 110.492 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -78.56 -30.57 46.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -73.48 -27.04 61.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.303 -0.248 . . . . 0.0 110.878 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -78.85 -39.52 35.09 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.972 -0.455 . . . . 0.0 111.178 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -78.89 -21.74 46.96 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 84.1 mt -86.36 -35.89 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.281 0.491 . . . . 0.0 110.315 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.87 -28.45 68.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.086 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.58 -28.62 65.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.84 -12.18 37.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.557 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.41 -2.89 58.59 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.882 0.473 . . . . 0.0 111.257 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.32 79.94 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.929 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.77 165.07 22.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 117.817 0.809 . . . . 0.0 110.885 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -73.83 146.66 43.99 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.922 0.392 . . . . 0.0 110.605 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . 0.449 ' HD2' ' H ' ' A' ' 525' ' ' ARG . 0.4 OUTLIER -88.07 152.92 51.35 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.27 0.628 . . . . 0.0 110.354 176.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.85 152.47 69.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.252 2.635 . . . . 0.0 111.413 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 95.4 m -85.51 -27.8 25.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.359 0.263 . . . . 0.0 111.171 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.6 m -140.35 149.43 42.7 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.529 . . . . 0.0 109.813 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.9 t -141.76 147.02 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.971 0.509 . . . . 0.0 110.472 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.31 124.63 10.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.39 144.65 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.586 0.354 . . . . 0.0 110.921 -175.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -149.58 161.38 42.28 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.749 0.82 . . . . 0.0 109.661 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 82.6 p -99.5 150.12 22.53 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 122.917 0.487 . . . . 0.0 110.926 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -89.46 147.27 19.4 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -74.69 130.49 39.59 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.6 m 57.12 12.18 1.22 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -97.5 -13.16 21.87 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.583 0.628 . . . . 0.0 111.069 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 52.23 28.88 5.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.939 0.896 . . . . 0.0 111.95 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 98.4 p -147.92 170.23 18.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.798 0.439 . . . . 0.0 111.089 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.2 m -131.37 160.83 33.91 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.661 0.784 . . . . 0.0 111.77 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.9 p -149.33 165.39 32.14 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.592 1.157 . . . . 0.0 109.79 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.08 40.87 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.691 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.98 157.82 39.55 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.74 0.816 . . . . 0.0 110.309 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 71.3 mt -133.51 134.98 44.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.347 1.059 . . . . 0.0 108.43 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.77 111.84 14.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -166.01 153.76 10.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.71 1.604 . . . . 0.0 106.898 167.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.17 124.75 8.35 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 39.6 t -159.56 153.04 22.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 168.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -50.67 70.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.606 0.639 . . . . 0.0 111.7 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 52.1 m -87.75 -29.44 21.05 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.0 -34.28 71.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.268 0.486 . . . . 0.0 110.441 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.64 -34.32 35.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.33 -0.367 . . . . 0.0 110.555 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 38.0 tp -75.96 -29.94 58.46 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.757 0.708 . . . . 0.0 111.241 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -68.61 -43.48 76.31 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.8 m -72.79 -34.76 67.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.41 -42.27 98.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.755 -0.591 . . . . 0.0 109.601 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.78 -23.05 78.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.833 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -112.15 -7.48 14.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.504 1.152 . . . . 0.0 113.457 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.3 tp -112.52 -9.85 13.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.001 0.819 . . . . 0.0 111.927 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -78.05 140.74 39.13 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.232 -0.918 . . . . 0.0 108.823 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 50.72 26.95 2.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.695 0.798 . . . . 0.0 112.652 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.84 151.32 44.9 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -103.79 136.51 43.33 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.751 1.621 . . . . 0.0 111.085 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.485 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.0 ttt -64.21 173.45 1.97 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.181 0.592 . . . . 0.0 111.307 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -74.02 11.5 0.89 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.8 p30 -65.85 143.53 98.53 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.41 0.55 . . . . 0.0 110.179 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.21 -30.53 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.36 2.707 . . . . 0.0 114.132 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -121.06 1.7 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.211 0.459 . . . . 0.0 112.043 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 40.61 98.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.775 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 84.7 Cg_endo -69.56 -9.5 26.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.984 2.456 . . . . 0.0 112.319 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.23 147.94 39.26 Favored Pre-proline 0 N--CA 1.455 -0.185 0 C-N-CA 122.74 0.416 . . . . 0.0 109.968 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.33 153.01 45.1 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.767 2.978 . . . . 0.0 111.127 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . 0.485 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.9 t80 -148.28 0.81 0.61 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.729 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 66.7 p -66.42 125.83 26.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.398 -0.814 . . . . 0.0 110.261 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 505' ' ' ALA . 24.5 mt -99.58 144.54 28.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.452 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -81.36 122.61 27.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -133.61 144.63 49.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 18.6 t -164.02 175.82 9.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.251 0.62 . . . . 0.0 110.18 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.46 144.53 33.95 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.014 0.525 . . . . 0.0 109.801 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 37.6 t -135.63 142.35 45.19 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.427 0.158 . . . . 0.0 111.427 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.7 p -79.89 102.27 9.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.14 161.58 34.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.192 0.597 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -123.89 -1.42 8.36 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.344 0.657 . . . . 0.0 109.979 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -159.93 167.21 28.55 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.529 1.132 . . . . 0.0 109.864 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.47 0.99 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.759 0.424 . . . . 0.0 109.93 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.884 -179.773 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.476 0.179 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -88.43 -19.76 26.12 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.269 0.228 . . . . 0.0 111.131 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 154.46 -174.28 32.84 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.43 -13.11 20.65 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.57 2.847 . . . . 0.0 110.963 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -156.28 164.12 38.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.645 0.778 . . . . 0.0 109.891 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -83.38 170.36 14.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.743 0.417 . . . . 0.0 110.367 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.26 -1.15 4.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.849 0.46 . . . . 0.0 111.633 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.3 m -146.7 148.83 34.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 C-N-CA 122.596 0.359 . . . . 0.0 110.528 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -82.41 -5.49 11.81 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.253 3.302 . . . . 0.0 112.49 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 72.9 t -119.25 147.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 118.472 0.578 . . . . 0.0 111.229 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.46 166.06 25.74 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.012 0.925 . . . . 0.0 109.382 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 85.5 mtp -135.17 150.49 50.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.517 0.199 . . . . 0.0 111.245 -175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 30.9 t -140.21 145.18 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.323 0.649 . . . . 0.0 109.951 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.466 ' CE2' ' HE3' ' A' ' 412' ' ' MET . 10.0 m-85 -137.26 165.05 27.07 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.427 0.691 . . . . 0.0 109.564 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.31 0.15 89.97 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.355 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.539 HD11 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -73.88 177.97 5.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.989 0.895 . . . . 0.0 110.976 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.83 137.23 50.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.678 0.391 . . . . 0.0 110.266 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.93 -1.64 23.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 23.1 t -112.62 -13.56 13.28 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.354 0.525 . . . . 0.0 111.59 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -114.58 -9.92 12.58 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.736 0.415 . . . . 0.0 110.32 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.3 ttt -150.88 126.98 10.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.281 0.633 . . . . 0.0 109.898 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -141.94 -174.43 4.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.208 0.603 . . . . 0.0 109.449 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 22.3 p -57.97 -30.42 66.01 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.09 -21.67 23.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.735 -0.603 . . . . 0.0 111.496 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -94.71 -19.36 20.47 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.457 0.303 . . . . 0.0 110.697 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.92 -30.43 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.09 -31.33 71.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -66.92 -42.37 85.5 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.133 -0.354 . . . . 0.0 110.848 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 65.3 t -79.45 -26.09 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 119.278 -0.391 . . . . 0.0 112.002 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -101.97 -10.01 20.15 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 19.7 t -74.01 -33.57 63.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.961 0.801 . . . . 0.0 111.59 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.36 12.54 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.687 -0.633 . . . . 0.0 111.369 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.47 -2.15 9.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 110.656 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.96 173.3 18.06 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -80.35 155.49 27.17 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.389 0.595 . . . . 0.0 110.053 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.33 155.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.304 0.642 . . . . 0.0 110.141 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -102.39 -58.36 1.89 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.717 0.407 . . . . 0.0 110.084 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.16 167.91 17.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.432 0.693 . . . . 0.0 110.466 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.25 148.57 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 122.995 0.518 . . . . 0.0 110.181 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -155.61 148.9 24.76 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 110.844 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -77.92 156.44 30.28 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 171.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.466 ' HE3' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -141.02 141.41 34.34 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -169.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.22 33.94 21.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.3 m 52.84 13.45 0.35 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.33 138.12 45.23 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-N 119.083 0.856 . . . . 0.0 109.837 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.17 -6.86 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.185 2.59 . . . . 0.0 110.181 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -114.41 18.19 18.13 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.26 0.933 . . . . 0.0 112.717 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -150.42 142.73 24.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.747 1.274 . . . . 0.0 111.528 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.54 169.03 25.23 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.729 0.411 . . . . 0.0 111.468 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.4 ptp -136.26 149.43 48.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.594 . . . . 0.0 110.535 176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.77 148.21 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.072 0.549 . . . . 0.0 110.289 -174.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -127.23 131.37 50.61 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 87.4 mmm -100.4 162.83 12.69 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.449 0.3 . . . . 0.0 110.874 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.86 61.82 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -157.92 163.06 38.25 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.25 -16.21 70.87 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.102 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -68.46 -24.19 64.68 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.139 1.469 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -86.76 -22.27 26.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.254 0.222 . . . . 0.0 110.594 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.5 t -78.08 -33.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.44 -28.88 67.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.155 0.182 . . . . 0.0 110.525 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -86.73 -29.38 22.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.104 -0.372 . . . . 0.0 111.194 -177.198 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.83 -26.94 40.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -84.55 -30.95 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 122.143 -0.348 . . . . 0.0 111.585 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.3 p -99.04 -11.18 21.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -132.33 -11.03 3.24 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.8 -21.28 9.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.401 1.0 . . . . 0.0 110.477 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -51.46 142.29 14.07 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.539 0.736 . . . . 0.0 112.226 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . 0.465 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 77.0 m-20 58.41 1.69 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.89 142.52 27.74 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 121.14 1.791 . . . . 0.0 109.287 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 0.1 OUTLIER -130.86 164.05 26.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.3 ptm -125.39 143.43 50.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.548 1.139 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . 0.45 ' CE1' ' CD1' ' A' ' 558' ' ' PHE . 37.5 m-85 62.91 27.88 16.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 177.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.8 15.88 58.98 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.314 0.885 . . . . 0.0 115.314 168.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -83.09 141.78 31.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.833 1.317 . . . . 0.0 109.756 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -74.85 139.01 42.9 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.19 121.94 39.64 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -140.77 115.74 9.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 107.871 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.465 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 1.9 p -153.34 139.82 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 118.692 0.678 . . . . 0.0 110.594 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -158.24 161.63 37.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.438 0.695 . . . . 0.0 109.796 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.41 155.68 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 36.0 t -133.43 144.23 49.38 Favored 'General case' 0 CA--C 1.522 -0.115 0 O-C-N 122.102 -0.374 . . . . 0.0 111.318 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -87.92 65.1 8.16 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.283 0.633 . . . . 0.0 111.12 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -127.38 144.06 49.48 Favored Pre-proline 0 CA--C 1.529 0.144 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.74 -25.24 9.44 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.281 2.654 . . . . 0.0 111.76 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.48 172.42 14.49 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.79 0.436 . . . . 0.0 110.617 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.37 140.41 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.99 151.74 42.21 Favored Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 122.425 0.29 . . . . 0.0 110.925 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.96 158.98 55.79 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.93 3.087 . . . . 0.0 111.189 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.08 -172.4 43.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -77.83 164.87 24.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.645 0.378 . . . . 0.0 110.8 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 77.6 p -145.71 158.58 43.84 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.387 0.675 . . . . 0.0 110.114 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -154.16 165.66 35.54 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.742 0.417 . . . . 0.0 110.258 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.02 137.44 22.13 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -86.96 176.14 7.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.628 0.771 . . . . 0.0 110.354 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.97 -20.12 66.09 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.474 0.309 . . . . 0.0 111.441 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -85.65 -0.07 54.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 0.98 89.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.256 0.455 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 24.4 t -93.55 160.76 14.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.195 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.76 153.21 35.21 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.921 0.391 . . . . 0.0 110.824 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.9 p -72.54 -10.46 59.82 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.745 0.418 . . . . 0.0 111.807 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -117.39 141.7 48.01 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.692 0.797 . . . . 0.0 110.112 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -154.68 154.41 32.87 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.776 0.43 . . . . 0.0 110.185 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -127.25 155.1 44.01 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.118 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -138.05 1.76 2.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 85.0 p -68.36 -10.79 57.4 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.04 11.94 4.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.945 0.898 . . . . 0.0 110.729 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 44.3 t -85.2 162.52 19.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.034 0.533 . . . . 0.0 110.991 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -119.43 9.33 11.56 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.524 0.73 . . . . 0.0 110.922 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -83.69 -0.52 51.11 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.997 0.519 . . . . 0.0 111.353 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -67.74 148.36 51.39 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -72.71 -8.54 55.89 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -143.16 35.2 1.35 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.33 0.652 . . . . 0.0 110.356 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 91.8 p -65.48 -12.58 53.93 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.928 0.891 . . . . 0.0 112.684 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 5.7 t -145.1 148.11 37.07 Favored Pre-proline 0 C--O 1.232 0.164 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -56.18 -22.76 41.68 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.823 3.015 . . . . 0.0 113.967 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.05 -24.8 35.09 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.595 0.634 . . . . 0.0 111.337 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -90.54 -22.28 21.38 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.936 0.335 . . . . 0.0 110.345 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -72.35 -10.61 60.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.899 0.48 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -95.61 3.35 54.1 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.268 0.627 . . . . 0.0 110.526 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -126.77 6.98 6.74 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.92 0.888 . . . . 0.0 110.56 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -147.24 147.87 30.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.463 0.705 . . . . 0.0 110.014 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.28 160.44 41.49 Favored 'General case' 0 C--O 1.23 0.067 0 C-N-CA 123.531 0.733 . . . . 0.0 109.777 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.7 mm -101.61 121.0 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -160.99 171.92 17.81 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.286 0.565 . . . . 0.0 111.524 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -80.74 162.39 60.44 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.156 0.982 . . . . 0.0 108.551 170.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.54 138.41 64.83 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.159 1.906 . . . . 0.0 110.55 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 69.2 m -124.08 23.97 8.32 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.04 5.83 4.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.182 0.993 . . . . 0.0 113.321 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 54.9 t -140.07 142.31 32.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 O-C-N 121.706 -0.621 . . . . 0.0 109.748 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . 0.443 HD11 ' CH2' ' A' ' 546' ' ' TRP . 89.1 mt -130.86 163.48 27.33 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.187 0.995 . . . . 0.0 108.826 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.545 ' CE1' ' HG ' ' A' ' 578' ' ' CYS . 0.0 OUTLIER -146.34 165.75 28.38 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 122.01 -0.431 . . . . 0.0 112.004 178.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.52 156.93 47.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.237 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -147.51 170.63 17.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.285 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.5 t30 61.01 26.57 16.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.274 1.03 . . . . 0.0 113.607 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.42 157.8 55.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.14 161.33 16.46 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 0.0 111.955 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . 0.41 ' H ' ' CD2' ' A' ' 507' ' ' LEU . 2.2 pt? -83.06 -1.16 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.52 5.69 31.68 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.603 0.361 . . . . 0.0 111.873 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.32 150.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.918 0.326 . . . . 0.0 111.602 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -143.44 172.21 13.09 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.581 0.752 . . . . 0.0 110.471 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 2.9 pm0 -61.49 -19.88 62.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.511 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.86 -25.75 60.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.017 0.371 . . . . 0.0 110.134 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -81.99 -28.54 32.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -72.9 -29.11 62.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.806 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -83.33 -37.52 23.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 111.503 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.23 -24.36 51.22 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.98 -33.07 5.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.165 0.439 . . . . 0.0 110.187 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 67.7 m -67.25 -21.48 65.72 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.948 174.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.96 -33.61 73.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -90.99 -13.2 33.8 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.69 -9.97 47.51 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.666 0.386 . . . . 0.0 110.841 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.04 62.24 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.175 0.417 . . . . 0.0 112.724 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -87.65 160.44 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.964 0.882 . . . . 0.0 110.645 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.46 120.22 18.77 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -71.18 150.75 94.58 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.97 149.28 92.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.859 2.373 . . . . 0.0 110.563 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.419 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 94.1 m -84.78 -21.04 30.12 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.76 0.424 . . . . 0.0 110.839 -174.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 15.3 t -146.04 153.45 40.75 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.34 140.71 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 122.995 0.518 . . . . 0.0 110.359 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.18 124.13 12.04 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.3 148.93 30.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.695 0.398 . . . . 0.0 111.082 -172.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -151.81 151.02 30.79 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.544 0.738 . . . . 0.0 110.418 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 76.1 p -130.76 138.19 49.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 109.939 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -81.63 161.64 42.65 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -72.88 141.11 47.92 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.263 0.532 . . . . 0.0 109.994 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 21.8 m 54.32 18.03 1.73 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -88.19 -18.58 28.4 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.174 -0.329 . . . . 0.0 111.029 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 54.89 14.42 0.91 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.552 1.141 . . . . 0.0 113.528 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.4 m -145.49 167.98 21.69 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.539 0.736 . . . . 0.0 110.449 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.6 t -135.36 155.11 51.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.495 0.718 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.5 m -145.35 163.71 33.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.399 1.079 . . . . 0.0 109.542 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -178.6 177.54 48.46 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 119.993 -1.098 . . . . 0.0 114.359 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.6 mp -112.98 156.5 22.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.012 . . . . 0.0 109.59 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.9 mt -138.61 143.19 39.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.434 1.094 . . . . 0.0 109.078 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -127.8 109.43 11.62 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.443 ' CH2' HD11 ' A' ' 500' ' ' LEU . 2.2 p90 -166.04 153.4 10.07 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 168.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -154.46 118.79 4.78 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.8 t -159.6 153.53 23.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.62 -40.02 95.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.619 0.645 . . . . 0.0 110.613 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 66.8 p -85.28 -27.26 26.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -83.68 -29.59 27.47 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.728 0.695 . . . . 0.0 110.859 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.74 26.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.986 0.357 . . . . 0.0 111.402 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.4 tp -84.7 -27.8 26.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.336 0.516 . . . . 0.0 112.047 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -77.36 -39.1 48.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.293 0.497 . . . . 0.0 110.273 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 89.7 m -67.84 -38.78 83.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.5 tp -60.63 -42.91 97.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.523 -0.735 . . . . 0.0 110.176 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -75.5 -14.17 82.25 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.244 -173.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . 0.45 ' CD1' ' CE1' ' A' ' 442' ' ' PHE . 23.5 m-85 -126.39 -12.28 6.21 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.763 1.282 . . . . 0.0 113.379 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 18.4 tp -105.79 -14.93 15.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.19 0.904 . . . . 0.0 112.567 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.44 136.4 40.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.2 m170 50.21 34.94 9.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.831 0.852 . . . . 0.0 113.003 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.71 151.29 28.97 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.246 0.618 . . . . 0.0 112.37 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -101.24 136.41 41.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.999 1.719 . . . . 0.0 110.999 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.426 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.3 ttt -64.07 179.93 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.846 0.858 . . . . 0.0 111.367 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . 0.426 ' H ' ' HG2' ' A' ' 564' ' ' MET . 19.7 ptpt -64.27 6.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.59 143.17 93.85 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.115 0.416 . . . . 0.0 110.924 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.55 -30.44 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.389 2.726 . . . . 0.0 112.917 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -121.05 -7.18 9.45 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.7 44.06 96.91 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.007 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 86.7 Cg_endo -72.01 -6.24 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.325 2.683 . . . . 0.0 112.042 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -138.88 150.33 65.0 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.928 0.491 . . . . 0.0 109.917 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.88 144.09 30.29 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.161 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . 0.424 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 89.8 t80 -145.09 -3.63 0.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.306 0.643 . . . . 0.0 111.27 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 132.02 47.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.872 -0.518 . . . . 0.0 110.764 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.8 pp -125.04 144.59 50.32 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.526 0.73 . . . . 0.0 111.125 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.04 140.46 33.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.263 0.625 . . . . 0.0 109.977 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.55 144.99 46.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . 0.545 ' HG ' ' CE1' ' A' ' 501' ' ' HIS . 1.9 p -163.93 173.02 13.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.568 0.347 . . . . 0.0 110.982 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -84.12 148.69 26.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.919 0.39 . . . . 0.0 110.711 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 28.0 t -135.53 159.93 40.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.502 0.721 . . . . 0.0 109.8 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 44.5 m -117.32 101.96 8.86 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.56 34.61 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.164 0.986 . . . . 0.0 109.928 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -78.85 -31.03 45.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -153.57 162.35 41.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.772 1.229 . . . . 0.0 109.054 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.62 76.49 7.49 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.185 179.153 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 120.512 0.196 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -144.16 142.43 30.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.898 0.479 . . . . 0.0 110.072 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . 0.416 ' N ' ' CD ' ' A' ' 374' ' ' PRO . . . 65.24 42.26 96.38 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.979 -0.901 . . . . 0.0 113.191 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 373' ' ' GLY . 94.6 Cg_endo -75.19 -24.54 12.44 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.139 1.893 . . . . 0.0 111.516 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -161.64 156.65 23.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.691 0.397 . . . . 0.0 110.225 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -80.21 166.31 21.54 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.031 0.444 . . . . 0.0 110.904 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.82 -13.35 39.54 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.425 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 m -148.7 155.31 41.45 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 122.846 0.458 . . . . 0.0 110.691 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.91 -0.84 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.659 3.573 . . . . 0.0 113.242 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.17 158.85 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.551 0.614 . . . . 0.0 110.969 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.3 pp -145.32 170.28 16.62 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.157 0.583 . . . . 0.0 110.606 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 77.5 mtp -135.15 153.36 52.01 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.761 0.424 . . . . 0.0 111.099 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.7 149.62 18.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.211 0.604 . . . . 0.0 110.25 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -141.89 167.57 21.83 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.037 0.535 . . . . 0.0 110.152 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.57 76.87 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.15 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.572 HD22 ' H ' ' A' ' 386' ' ' LEU . 1.9 pt? -67.85 165.33 17.77 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.798 0.799 . . . . 0.0 111.002 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -119.72 128.4 53.75 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.66 1.68 5.01 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 84.0 p -116.62 0.59 12.68 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.55 -6.42 3.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.169 0.588 . . . . 0.0 110.591 174.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 9.3 tpt -150.11 122.95 8.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.701 0.8 . . . . 0.0 109.4 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -141.94 -174.78 4.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.086 0.555 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.6 p -60.73 -23.99 65.36 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.887 0.475 . . . . 0.0 112.023 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.0 -30.73 21.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.917 0.326 . . . . 0.0 111.63 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -82.07 -30.76 31.15 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.571 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.98 -28.48 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -70.02 -33.87 72.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.963 -0.461 . . . . 0.0 110.052 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.23 -16.38 52.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.3 -18.88 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.716 0.407 . . . . 0.0 110.942 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -116.95 -18.96 10.01 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.26 -20.89 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.658 1.117 . . . . 0.0 111.057 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.955 -0.466 . . . . 0.0 111.887 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -121.46 -1.42 9.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.827 0.851 . . . . 0.0 111.268 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.56 169.6 16.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -65.67 142.67 57.95 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.468 -0.431 . . . . 0.0 111.493 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.08 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.652 0.781 . . . . 0.0 109.306 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -99.83 -65.92 0.94 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -165.13 168.52 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 110.313 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 9.3 p -147.18 151.75 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -152.47 144.71 23.93 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.647 0.379 . . . . 0.0 110.374 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.64 160.32 25.09 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 3.3 ptp -136.4 141.42 43.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 56.76 33.82 23.62 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.8 1.64 . . . . 0.0 114.217 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.0 m 52.77 17.81 0.91 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -71.11 158.13 88.79 Favored Pre-proline 0 CA--C 1.528 0.118 0 CA-C-N 118.367 0.53 . . . . 0.0 110.405 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.11 -19.25 32.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -177.53 102.2 0.16 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -157.8 136.71 11.5 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 109.088 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.83 171.28 20.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.231 0.539 . . . . 0.0 110.897 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.6 ptm -143.63 144.34 31.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.602 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.8 t -130.69 139.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 C-N-CA 122.857 0.463 . . . . 0.0 110.395 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -118.06 141.19 48.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.121 0.568 . . . . 0.0 110.062 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 92.3 mmm -111.01 161.85 15.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.139 0.576 . . . . 0.0 110.121 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.33 -22.94 63.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.13 -0.356 . . . . 0.0 111.138 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -159.46 160.34 34.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.518 0.727 . . . . 0.0 109.398 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.74 69.02 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.841 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.432 1.616 . . . . 0.0 110.671 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.46 -25.91 30.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.564 0.221 . . . . 0.0 110.51 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.6 -28.15 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.17 -42.8 71.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.291 -0.256 . . . . 0.0 110.849 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.62 84.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.102 0.41 . . . . 0.0 110.013 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.4 -34.55 58.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.6 tp -79.85 -30.92 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 O-C-N 122.184 -0.323 . . . . 0.0 111.525 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.7 t -94.94 -12.24 27.14 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -138.89 -24.4 0.91 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -95.67 -20.15 19.15 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.064 0.847 . . . . 0.0 108.997 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -51.82 142.66 14.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.502 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.08 1.59 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.617 1.967 . . . . 0.0 115.565 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -87.92 142.62 27.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.274 1.397 . . . . 0.0 108.847 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . 0.428 ' HB2' ' HG3' ' A' ' 446' ' ' MET 0.328 0.0 OUTLIER -131.0 164.14 26.02 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 175.339 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.7 ptm -125.16 143.28 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.476 1.11 . . . . 0.0 109.263 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 64.42 30.12 13.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.89 81.26 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 167.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -83.14 156.9 23.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.499 1.649 . . . . 0.0 111.359 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.547 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -77.76 141.97 38.96 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.902 0.881 . . . . 0.0 110.627 178.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' MET . . . . . 0.428 ' HG3' ' HB2' ' A' ' 440' ' ' PHE . 1.9 mpt? -98.5 122.01 41.16 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -140.69 110.75 6.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.53 139.43 17.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 92.7 m -149.66 160.43 43.52 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.596 0.759 . . . . 0.0 110.23 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -85.09 154.23 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.0 t -144.68 163.26 34.5 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.457 0.703 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -121.17 30.18 6.95 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.511 0.596 . . . . 0.0 112.25 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -63.64 147.91 94.97 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.56 -25.24 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.701 2.267 . . . . 0.0 111.88 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.98 170.22 13.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.453 0.701 . . . . 0.0 109.913 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.01 137.12 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 147.72 57.66 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 110.729 -0.101 . . . . 0.0 110.729 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.84 168.41 23.04 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.098 3.199 . . . . 0.0 111.973 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 177.56 170.99 40.56 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -84.82 -12.72 53.01 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.944 0.372 . . . . 0.0 111.701 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 7.4 m 57.72 169.32 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.145 1.378 . . . . 0.0 113.296 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -155.74 168.31 27.59 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.138 0.575 . . . . 0.0 109.9 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.54 137.79 17.36 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.92 170.24 11.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.313 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.23 -22.79 65.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.545 0.338 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.28 4.69 25.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.529 0.332 . . . . 0.0 111.467 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.57 -0.49 87.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.504 -0.609 . . . . 0.0 113.151 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.9 p -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 117.977 0.889 . . . . 0.0 110.556 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.16 152.4 30.74 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 122.245 -0.285 . . . . 0.0 110.382 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 90.1 p -73.39 -10.37 59.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.532 0.333 . . . . 0.0 111.774 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -127.67 145.21 50.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.797 0.839 . . . . 0.0 110.437 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.09 158.11 38.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.964 0.506 . . . . 0.0 110.058 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.64 148.26 51.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.466 0.706 . . . . 0.0 109.974 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.56 13.69 2.97 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.996 0.518 . . . . 0.0 111.128 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.3 p -65.48 -14.46 61.03 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -90.08 -1.71 57.99 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.105 0.562 . . . . 0.0 111.248 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 57.0 m -85.36 13.7 6.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.621 0.368 . . . . 0.0 111.506 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -74.26 5.26 4.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.315 0.646 . . . . 0.0 111.363 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -80.38 34.13 0.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.84 0.856 . . . . 0.0 110.686 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -139.12 159.73 41.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.225 1.01 . . . . 0.0 109.35 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 53.5 ttp85 -80.18 38.23 0.41 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.021 0.928 . . . . 0.0 112.371 -173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.1 17.29 1.92 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.164 0.586 . . . . 0.0 111.748 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.7 p -73.88 -2.82 25.41 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.961 0.505 . . . . 0.0 111.837 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 4.9 t -148.09 145.25 20.28 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.119 0.968 . . . . 0.0 108.786 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.44 -17.44 57.85 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.315 2.677 . . . . 0.0 113.478 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.8 -25.21 32.94 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 119.073 0.851 . . . . 0.0 111.429 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -90.51 -29.75 17.7 Favored 'General case' 0 C--N 1.338 0.092 0 O-C-N 122.24 -0.288 . . . . 0.0 110.453 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -70.44 -21.23 62.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.433 0.293 . . . . 0.0 111.392 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -75.63 -4.15 38.49 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.973 0.509 . . . . 0.0 111.077 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -127.06 19.07 7.08 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.517 1.127 . . . . 0.0 110.187 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -116.58 23.96 11.65 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.804 0.842 . . . . 0.0 110.83 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 56.24 27.45 11.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.193 0.997 . . . . 0.0 113.397 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.6 mm -80.97 118.33 28.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -161.26 167.74 25.4 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.397 0.679 . . . . 0.0 109.266 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -60.98 159.62 26.23 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.72 145.13 31.87 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.703 2.935 . . . . 0.0 112.606 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.1 m -124.01 23.9 8.4 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.711 0.804 . . . . 0.0 110.89 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 61.21 14.74 5.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.676 1.191 . . . . 0.0 112.883 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 47.3 t -139.07 141.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.42 148.48 43.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.968 0.507 . . . . 0.0 109.923 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -114.87 151.54 33.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 151.21 46.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.534 0.207 . . . . 0.0 110.677 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -147.89 173.63 12.66 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.635 0.374 . . . . 0.0 111.217 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.2 t30 56.39 34.03 23.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.216 1.006 . . . . 0.0 112.825 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -91.67 157.32 41.98 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.82 148.89 63.76 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.81 2.34 . . . . 0.0 111.588 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.7 -1.28 18.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.82 8.27 15.99 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.15 151.16 4.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 118.007 0.367 . . . . 0.0 110.814 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.4 p -142.32 171.87 13.47 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.348 0.659 . . . . 0.0 110.529 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 -22.17 66.73 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -71.2 -25.03 62.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -83.65 -30.13 27.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.17 -27.1 63.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.03 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.7 -38.12 18.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.488 0.586 . . . . 0.0 111.522 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -74.95 -20.08 59.83 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.467 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.23 -33.88 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 117.792 0.269 . . . . 0.0 110.723 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 69.1 m -67.71 -21.68 65.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.974 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.49 -30.44 63.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.07 -13.13 33.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 111.916 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 99.8 mt -91.57 -9.84 42.77 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.791 0.436 . . . . 0.0 111.057 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.68 5.15 63.36 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.752 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.0 m -87.08 168.4 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.777 0.789 . . . . 0.0 110.836 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -77.28 146.59 36.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.763 0.425 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -96.13 151.64 38.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.573 0.349 . . . . 0.0 110.099 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.25 156.0 68.12 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.186 2.591 . . . . 0.0 111.122 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.446 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -89.54 -23.32 22.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.916 0.486 . . . . 0.0 110.696 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.1 t -143.84 156.87 44.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.01 144.93 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.221 0.534 . . . . 0.0 110.954 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -141.2 128.81 21.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.6 144.07 35.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 122.597 0.359 . . . . 0.0 110.132 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -154.88 153.66 31.47 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.172 0.589 . . . . 0.0 110.034 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.8 m -130.82 133.77 46.24 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.22 150.08 34.9 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -74.34 139.02 43.87 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 14.4 m 57.86 11.23 1.32 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -100.05 -10.15 21.87 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.229 0.468 . . . . 0.0 111.367 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 43.15 34.05 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.84 1.256 . . . . 0.0 113.368 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.1 t -143.08 158.93 43.16 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.192 0.597 . . . . 0.0 110.642 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 47.1 t -122.16 150.73 41.82 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.78 0.832 . . . . 0.0 111.109 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.7 m -147.07 168.47 21.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.085 1.354 . . . . 0.0 109.185 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.51 -169.2 42.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.891 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.02 154.05 47.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.385 1.074 . . . . 0.0 109.686 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.39 140.47 39.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.007 0.923 . . . . 0.0 108.723 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -127.8 109.75 11.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.446 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.9 p90 -166.13 152.83 9.44 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.019 1.328 . . . . 0.0 107.77 168.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.31 123.73 7.13 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 39.6 t -159.62 152.97 22.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -47.48 80.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.474 0.579 . . . . 0.0 111.348 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.5 p -85.82 -26.2 25.86 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -82.73 -29.13 29.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.231 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.78 30.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.103 0.411 . . . . 0.0 110.931 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.85 -28.05 36.24 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.406 0.548 . . . . 0.0 111.599 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -76.65 -41.05 47.13 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.133 0.424 . . . . 0.0 110.558 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.5 m -68.73 -34.97 76.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.93 -52.17 65.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.855 -0.528 . . . . 0.0 110.12 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.66 -17.1 76.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.005 -0.886 . . . . 0.0 114.258 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -119.22 -9.2 10.0 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.742 1.271 . . . . 0.0 113.67 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.7 tp -89.61 -21.7 22.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.439 1.018 . . . . 0.0 110.328 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.57 147.66 50.45 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.138 -0.351 . . . . 0.0 110.479 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 51.24 24.79 2.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.448 1.099 . . . . 0.0 113.607 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.31 151.38 38.3 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.247 0.546 . . . . 0.0 112.222 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -111.38 136.24 50.79 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.949 0.9 . . . . 0.0 110.855 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.415 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.0 ttt -64.7 178.32 0.79 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.852 0.861 . . . . 0.0 111.006 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 564' ' ' MET . 19.8 ptpt -68.18 7.95 0.5 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.28 140.0 91.58 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.31 -28.95 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.472 2.782 . . . . 0.0 112.86 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -121.04 -7.14 9.46 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.41 44.23 97.92 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.926 -0.93 . . . . 0.0 113.421 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 94.0 Cg_endo -71.27 -7.01 20.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.128 2.552 . . . . 0.0 111.993 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -143.82 149.27 45.81 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.125 0.57 . . . . 0.0 109.867 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.53 154.23 39.91 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.601 2.867 . . . . 0.0 110.796 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -136.54 -0.83 2.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.64 0.376 . . . . 0.0 111.604 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 8.3 t -68.31 132.03 46.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.931 -0.481 . . . . 0.0 111.222 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.94 144.62 50.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 0.0 109.701 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -85.11 145.16 27.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.12 146.79 30.05 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.098 0.559 . . . . 0.0 110.683 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.29 169.71 21.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.896 0.478 . . . . 0.0 110.898 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -72.65 133.51 44.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 25.7 t -135.66 148.43 48.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 60.7 m -89.82 102.34 15.04 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.978 0.418 . . . . 0.0 110.587 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 161.53 34.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.817 0.847 . . . . 0.0 109.456 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -99.38 -15.36 18.8 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.175 0.19 . . . . 0.0 110.919 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -160.22 160.59 32.9 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.193 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.01 76.41 0.99 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.88 0.472 . . . . 0.0 110.087 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.54 -1.219 . . . . 0.0 110.489 -179.423 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 119.677 -0.201 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -133.96 -2.81 2.88 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -82.12 177.07 53.83 Favored Glycine 0 CA--C 1.527 0.804 0 O-C-N 122.285 -0.259 . . . . 0.0 112.631 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.68 -175.77 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.732 3.621 . . . . 0.0 111.256 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 64.6 t60 57.53 58.21 3.91 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.407 1.083 . . . . 0.0 110.939 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -59.52 156.51 13.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.018 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -132.07 19.98 4.5 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.927 0.491 . . . . 0.0 111.145 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 47.0 t -148.81 145.91 20.78 Favored Pre-proline 0 N--CA 1.453 -0.283 0 O-C-N 122.219 -0.301 . . . . 0.0 111.018 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.0 -0.96 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.778 2.985 . . . . 0.0 112.66 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.2 m -124.83 163.06 25.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 119.18 0.9 . . . . 0.0 112.786 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -149.4 161.92 41.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.293 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 75.1 mmm -118.93 144.45 46.43 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.667 0.787 . . . . 0.0 110.099 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.54 144.81 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.048 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -139.32 166.94 23.23 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.383 0.673 . . . . 0.0 109.23 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.82 86.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.318 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.53 HD13 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.6 173.86 10.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.924 0.862 . . . . 0.0 110.501 176.008 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.39 146.56 51.24 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.019 0.528 . . . . 0.0 110.271 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -81.98 -4.83 57.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.9 t -104.68 -9.2 18.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.883 0.31 . . . . 0.0 111.447 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.31 -5.55 3.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.219 0.608 . . . . 0.0 111.109 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -142.13 126.69 17.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -141.68 -174.97 4.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.019 0.528 . . . . 0.0 109.992 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.61 -26.81 65.76 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.941 0.496 . . . . 0.0 112.036 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.14 -38.39 27.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.99 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -74.79 -28.96 60.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.106 0.412 . . . . 0.0 110.954 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.93 -28.66 24.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -72.1 -30.29 64.93 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 172.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -76.25 -24.82 54.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.6 t -96.58 -26.43 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.399 0.545 . . . . 0.0 112.184 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.27 -14.2 17.07 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 35.3 t -78.57 -17.6 55.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.09 0.859 . . . . 0.0 112.473 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 10.72 1.22 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.272 -0.892 . . . . 0.0 112.171 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -121.38 -1.59 9.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.765 0.826 . . . . 0.0 110.819 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.44 165.5 12.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.44 164.47 22.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.009 0.433 . . . . 0.0 111.161 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 5.4 m -121.11 161.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 C-N-CA 124.237 1.015 . . . . 0.0 109.789 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.58 -52.22 2.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.324 -0.235 . . . . 0.0 111.289 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.16 164.34 27.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.493 0.317 . . . . 0.0 110.795 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.59 151.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.398 0.679 . . . . 0.0 110.262 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.03 148.55 27.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 419' ' ' ALA . 3.9 m-30 -78.65 145.79 34.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 25.1 ttp -99.4 141.04 32.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -168.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 49.8 33.95 7.0 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 112.031 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 83.7 p 52.88 16.02 0.64 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.362 1.465 . . . . 0.0 113.409 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -77.84 132.75 67.19 Favored Pre-proline 0 C--N 1.34 0.192 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.43 -7.43 17.69 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.659 2.239 . . . . 0.0 111.494 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.96 16.54 10.15 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.772 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -144.33 145.33 31.92 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 119.212 1.506 . . . . 0.0 111.056 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 411' ' ' PHE . . . -154.52 163.93 39.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.243 0.544 . . . . 0.0 111.7 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 23.0 ptm -145.23 143.57 30.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.723 0.809 . . . . 0.0 109.757 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.2 p -136.71 153.29 30.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.72 0.408 . . . . 0.0 110.446 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -125.08 138.48 54.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.947 0.499 . . . . 0.0 110.663 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 77.0 mmm -104.42 161.63 13.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.455 0.702 . . . . 0.0 110.145 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.19 -18.67 62.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -157.67 158.85 36.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.974 0.51 . . . . 0.0 109.782 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.6 -14.95 72.86 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.201 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -70.69 -19.82 62.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.03 1.415 . . . . 0.0 111.095 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.44 -24.43 31.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.72 -26.98 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.02 -36.78 82.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.262 -0.274 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -80.13 -31.77 39.05 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.296 -0.253 . . . . 0.0 110.535 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.03 70.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.999 -0.438 . . . . 0.0 110.116 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.6 tp -85.49 -30.93 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.2 m -95.04 -19.99 19.7 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -130.63 -12.04 3.88 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.7 -17.9 10.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.114 0.87 . . . . 0.0 110.031 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.17 142.2 21.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.509 0.724 . . . . 0.0 111.439 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . 0.407 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 76.1 m-20 57.15 1.63 0.1 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.952 1.701 . . . . 0.0 115.214 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.92 142.42 27.81 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 120.579 1.536 . . . . 0.0 108.899 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 0.1 OUTLIER -130.68 163.91 26.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 174.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.7 ptm -125.39 143.52 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.651 1.58 . . . . 0.0 109.314 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 64.12 30.91 13.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.002 1.321 . . . . 0.0 114.454 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.93 79.9 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.17 145.02 29.42 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.357 1.079 . . . . 0.0 109.789 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 141.62 37.97 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.051 -0.405 . . . . 0.0 109.934 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.86 122.0 40.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -168.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -140.68 114.37 8.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.407 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.99 141.69 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 CA-C-N 118.29 0.496 . . . . 0.0 110.493 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 34.1 t -160.04 162.71 34.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.379 0.671 . . . . 0.0 109.617 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.18 158.68 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 110.265 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 45.6 t -138.01 151.41 47.87 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -89.43 4.95 47.42 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -59.6 139.11 89.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -23.43 11.55 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.921 2.414 . . . . 0.0 112.249 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.05 170.62 14.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 110.806 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.57 147.41 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.2 mmt -104.62 150.19 38.29 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.432 0.293 . . . . 0.0 110.56 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.29 177.82 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 124.161 3.24 . . . . 0.0 111.927 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 73.78 -176.72 45.57 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.475 0.559 . . . . 0.0 112.354 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 56.77 19.95 4.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.244 1.018 . . . . 0.0 113.62 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.9 m -97.12 142.67 28.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.247 0.476 . . . . 0.0 111.116 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -148.19 174.26 12.15 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.742 1.217 . . . . 0.0 109.217 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.4 135.96 15.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.74 171.39 10.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.729 0.812 . . . . 0.0 110.44 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -68.6 -20.46 64.5 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.645 0.378 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -80.59 1.3 30.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.108 0.563 . . . . 0.0 111.604 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.84 -2.76 72.86 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 122.054 -0.404 . . . . 0.0 112.231 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 28.0 t -93.36 163.4 13.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.182 0.593 . . . . 0.0 109.453 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 48.6 t -84.3 153.19 23.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.043 0.449 . . . . 0.0 110.645 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 59.5 m -64.79 -10.42 27.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.001 0.92 . . . . 0.0 111.343 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -119.2 142.14 48.27 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.801 0.84 . . . . 0.0 110.137 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.16 156.22 38.19 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.675 0.274 . . . . 0.0 110.703 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -124.73 151.03 45.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.24 1.016 . . . . 0.0 109.941 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.02 10.88 2.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.389 0.676 . . . . 0.0 111.755 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 16.8 t -70.2 -1.37 10.01 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.056 -0.403 . . . . 0.0 111.732 -173.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -121.91 15.7 10.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.902 0.881 . . . . 0.0 110.815 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 89.6 p -68.51 155.61 39.59 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.991 0.516 . . . . 0.0 111.705 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.06 34.49 5.15 Favored 'General case' 0 C--N 1.335 -0.03 0 C-N-CA 124.289 1.036 . . . . 0.0 110.827 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -65.26 -8.53 18.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.976 0.511 . . . . 0.0 112.229 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 482' ' ' PHE . 3.5 t-20 59.01 176.25 0.07 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.115 1.366 . . . . 0.0 113.567 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? 60.69 -20.16 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.676 1.99 . . . . 0.0 114.617 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 480' ' ' ASN . 1.1 p90 -160.11 8.9 0.1 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.573 0.624 . . . . 0.0 112.047 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 70.8 p -74.88 -0.06 17.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.536 0.607 . . . . 0.0 111.885 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 5.4 t -149.83 146.85 21.18 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -57.25 -20.02 37.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.555 2.837 . . . . 0.0 114.368 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.47 -22.26 28.33 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.574 0.625 . . . . 0.0 111.431 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -90.57 -28.42 18.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 117.966 0.348 . . . . 0.0 110.312 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.34 -6.11 27.6 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.924 0.489 . . . . 0.0 111.936 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -104.18 -3.67 24.08 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.94 0.496 . . . . 0.0 111.115 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -98.1 -0.41 44.48 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.28 0.632 . . . . 0.0 111.198 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -142.52 169.05 18.31 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -131.65 157.46 43.65 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 31.3 mm -110.68 141.09 27.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -149.9 171.42 16.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.076 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -69.07 148.25 97.74 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.875 0.87 . . . . 0.0 109.32 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.09 152.44 14.47 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.702 2.935 . . . . 0.0 113.211 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.2 m -123.95 22.01 8.91 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.057 0.543 . . . . 0.0 112.04 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 19.1 m120 59.72 12.55 2.99 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.77 152.35 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.0 mt -125.42 155.49 40.33 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.942 0.497 . . . . 0.0 111.053 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.433 ' CD2' ' CZ ' ' A' ' 503' ' ' PHE . 2.2 t-160 -132.26 137.71 47.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -124.92 149.94 47.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.033 0.533 . . . . 0.0 110.858 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 501' ' ' HIS . 79.3 m-85 -144.3 172.79 12.44 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 111.251 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 49.4 t30 57.57 31.78 20.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.407 1.083 . . . . 0.0 112.993 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -85.14 157.44 59.5 Favored Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.84 158.89 55.25 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.608 2.205 . . . . 0.0 110.446 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 22.1 tp -70.89 -0.97 10.31 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.013 1.325 . . . . 0.0 112.856 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.47 9.53 7.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.99 151.82 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 118.334 0.516 . . . . 0.0 111.259 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.7 p -142.6 171.43 14.06 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.651 0.78 . . . . 0.0 110.071 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.1 -24.29 67.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.519 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.91 -24.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.355 -0.215 . . . . 0.0 110.67 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -76.77 -35.05 57.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -71.13 -23.79 62.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.909 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -79.42 -40.7 29.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.172 0.442 . . . . 0.0 111.009 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.92 -13.04 60.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 85.4 mt -95.5 -32.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.262 0.483 . . . . 0.0 110.403 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.8 m -68.42 -22.8 64.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.408 -0.807 . . . . 0.0 109.568 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.02 -28.78 61.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.645 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -90.98 -12.83 34.73 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.637 0.653 . . . . 0.0 111.636 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.85 -8.96 27.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.966 0.506 . . . . 0.0 111.257 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.19 64.58 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.248 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.1 168.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.156 0.978 . . . . 0.0 111.212 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -68.34 133.93 49.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.029 0.532 . . . . 0.0 110.119 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -78.22 149.34 75.91 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 148.86 90.21 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.811 2.341 . . . . 0.0 110.138 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.427 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.9 m -93.83 -18.97 21.45 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.848 0.459 . . . . 0.0 110.847 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.3 t -149.47 148.79 29.84 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.01 137.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.211 0.604 . . . . 0.0 109.609 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . 0.507 ' HZ2' ' HB3' ' A' ' 530' ' ' LYS . 0.0 OUTLIER -148.28 104.58 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 89.9 t -126.88 148.01 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.265 0.626 . . . . 0.0 109.925 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -147.64 161.92 40.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p -90.04 149.11 22.66 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.105 0.479 . . . . 0.0 111.937 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -86.54 147.79 21.57 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.75 131.04 37.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.182 0.491 . . . . 0.0 110.109 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.4 m 55.65 18.53 2.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -111.07 -11.36 14.29 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.114 0.416 . . . . 0.0 111.692 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 50.29 31.02 4.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.508 0.723 . . . . 0.0 112.692 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 89.6 p -140.24 171.54 14.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.5 0.72 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 60.1 m -128.04 150.87 49.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.56 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 58.4 m -147.83 159.9 43.34 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 125.005 1.322 . . . . 0.0 109.353 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.29 -174.97 44.99 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.278 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.4 146.39 28.9 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.33 1.052 . . . . 0.0 110.236 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 5.8 mp -137.66 138.04 39.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -127.74 126.34 41.63 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.427 ' HB3' ' H ' ' A' ' 527' ' ' THR . 8.9 p90 -165.56 148.69 7.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.88 120.4 7.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 42.3 t -159.57 153.34 22.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 168.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -64.79 -52.21 58.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.916 0.78 . . . . 0.0 111.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.9 p -78.7 -27.2 44.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -84.97 -31.11 23.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.786 0.721 . . . . 0.0 111.463 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.41 -30.88 60.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.208 0.458 . . . . 0.0 110.641 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -83.48 -27.15 29.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.37 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -77.37 -39.01 48.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.087 0.403 . . . . 0.0 110.523 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 30.2 m -73.76 -38.66 64.65 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.059 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.98 -47.3 75.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.15 -17.29 75.67 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.542 -173.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.47 -11.67 8.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.916 1.358 . . . . 0.0 113.173 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -95.84 -18.05 20.67 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.382 0.537 . . . . 0.0 110.65 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -65.55 144.89 56.7 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.747 -0.596 . . . . 0.0 109.452 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 60.5 t60 55.61 24.72 7.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.569 1.147 . . . . 0.0 113.252 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 151.33 34.69 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -117.76 136.35 53.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.845 1.258 . . . . 0.0 110.701 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 3.7 ttt -64.2 176.4 1.04 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 111.323 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -65.86 141.26 97.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.092 0.86 . . . . 0.0 110.288 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -79.91 -29.42 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.659 2.906 . . . . 0.0 113.796 -169.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -121.05 2.79 10.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.06 0.391 . . . . 0.0 112.029 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 59.45 42.57 97.62 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.768 -1.018 . . . . 0.0 112.792 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.7 Cg_endo -68.67 -9.96 27.67 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.244 2.63 . . . . 0.0 111.608 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -144.12 147.06 36.16 Favored Pre-proline 0 N--CA 1.454 -0.26 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.91 150.61 38.89 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.689 2.926 . . . . 0.0 110.546 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -143.44 -4.15 0.89 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.679 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 72.5 p -66.56 126.46 28.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 35.8 mt -99.47 144.55 28.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.873 0.469 . . . . 0.0 111.905 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -82.01 130.59 35.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -146.45 147.26 31.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 112.016 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.1 p -161.37 169.72 21.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.952 0.901 . . . . 0.0 109.319 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -74.95 140.57 43.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.6 t -135.39 143.6 46.12 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 35.3 m -81.37 102.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.1 161.5 34.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.975 0.91 . . . . 0.0 110.325 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -109.64 -12.13 14.69 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.925 0.49 . . . . 0.0 110.669 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -160.54 168.55 24.79 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.998 0.919 . . . . 0.0 109.132 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -78.74 77.29 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.891 0.476 . . . . 0.0 109.797 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.415 ' HA ' ' HE3' ' A' ' 530' ' ' LYS . 74.7 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.476 -1.25 . . . . 0.0 110.002 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -135.81 6.54 3.18 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.54 0.336 . . . . 0.0 111.806 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 178.2 176.46 46.16 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.07 172.73 13.32 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.313 3.342 . . . . 0.0 111.303 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -152.78 164.57 37.55 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.867 0.867 . . . . 0.0 109.3 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -132.45 148.65 52.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.136 0.493 . . . . 0.0 111.281 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -141.17 18.5 2.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.096 0.958 . . . . 0.0 109.814 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.1 m -142.7 153.87 62.07 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 122.848 0.459 . . . . 0.0 110.609 -174.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.38 3.09 7.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.117 3.212 . . . . 0.0 113.225 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.64 161.83 39.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 118.893 0.769 . . . . 0.0 112.866 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.81 170.46 16.07 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.23 1.012 . . . . 0.0 109.227 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.1 mtp -137.16 148.04 46.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.9 149.21 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.861 0.464 . . . . 0.0 110.661 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.482 ' CE2' ' HE3' ' A' ' 412' ' ' MET . 19.8 m-85 -140.01 164.99 28.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.651 0.78 . . . . 0.0 109.823 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.41 -6.79 75.23 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.304 0.478 . . . . 0.0 112.828 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.5 pt? -69.42 174.62 4.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.916 0.858 . . . . 0.0 110.648 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -134.61 146.74 49.86 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -74.66 -1.91 23.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 93.7 p -117.99 -8.49 10.73 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.027 0.376 . . . . 0.0 111.646 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.4 -17.53 13.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 83.0 mmm -139.21 141.28 37.92 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.946 . . . . 0.0 109.758 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.89 173.93 11.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.39 -27.06 67.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.815 0.28 . . . . 0.0 110.947 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -79.37 -33.41 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.213 0.205 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -79.17 -35.57 41.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.746 0.248 . . . . 0.0 110.9 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.8 p -73.87 -26.7 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -66.89 -41.83 86.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.954 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.0 -8.3 57.32 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.0 112.915 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.34 -22.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.706 0.684 . . . . 0.0 110.231 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.52 -14.99 13.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 50.9 t -71.45 -25.59 62.37 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.071 0.851 . . . . 0.0 111.345 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.09 13.39 1.11 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.537 -0.727 . . . . 0.0 112.068 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -121.43 -3.62 9.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 110.841 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.91 165.43 12.79 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.91 150.03 46.14 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.067 -0.666 . . . . 0.0 110.826 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.42 148.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.87 -53.33 2.63 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.954 -0.466 . . . . 0.0 111.212 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.91 162.78 26.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.003 0.43 . . . . 0.0 111.448 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.6 p -143.23 150.42 17.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.08 142.65 22.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.347 0.259 . . . . 0.0 110.388 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -76.89 146.38 37.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 168.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.482 ' HE3' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -130.09 141.48 50.7 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 59.99 33.92 21.43 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.065 1.746 . . . . 0.0 112.495 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 36.7 m 52.97 14.02 0.41 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -77.3 146.96 75.27 Favored Pre-proline 0 N--CA 1.455 -0.218 0 CA-C-N 118.673 0.67 . . . . 0.0 110.1 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.9 -0.81 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.686 2.924 . . . . 0.0 110.849 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.44 40.0 1.01 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.004 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -148.9 134.84 19.01 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.93 0.865 . . . . 0.0 110.593 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.52 169.19 23.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 22.1 ptm -143.19 147.36 34.77 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.316 0.646 . . . . 0.0 110.028 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.5 t -127.87 153.17 36.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.172 0.589 . . . . 0.0 110.333 -172.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -129.48 135.3 48.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.947 0.499 . . . . 0.0 110.59 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.3 165.0 11.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.805 0.842 . . . . 0.0 109.956 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.56 -20.83 62.76 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -156.54 159.64 38.75 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.9 -15.73 71.84 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.215 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -69.29 -28.63 66.45 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 119.116 1.458 . . . . 0.0 110.383 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -76.26 -20.08 57.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 77.7 t -81.18 -28.13 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.98 -34.99 66.8 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -72.63 -31.85 65.46 Favored 'General case' 0 N--CA 1.457 -0.08 0 O-C-N 122.146 -0.347 . . . . 0.0 110.341 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.82 -29.22 58.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.326 -0.234 . . . . 0.0 110.977 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.4 tp -86.33 -30.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 O-C-N 122.36 -0.212 . . . . 0.0 111.112 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 82.7 p -94.83 -6.8 42.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -136.0 -15.63 1.74 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.62 -20.07 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.93 0.786 . . . . 0.0 110.027 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -51.59 144.31 10.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.704 0.802 . . . . 0.0 111.206 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 57.51 1.39 0.12 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.92 2.088 . . . . 0.0 115.526 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.86 142.5 27.76 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.873 1.669 . . . . 0.0 108.726 169.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.298 0.0 OUTLIER -130.94 163.9 26.49 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 172.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 19.2 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.159 1.384 . . . . 0.0 109.904 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . 0.25 29.0 m-85 66.16 27.02 10.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.976 1.311 . . . . 0.0 114.143 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.7 81.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 168.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -83.04 160.54 21.93 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.909 1.354 . . . . 0.0 110.543 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.532 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -86.31 129.41 34.86 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.596 0.758 . . . . 0.0 110.191 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.58 130.35 45.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -140.61 123.61 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.1 140.97 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.396 0.544 . . . . 0.0 110.655 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 71.5 m -147.11 165.24 30.57 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.88 0.872 . . . . 0.0 110.005 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 p -90.64 155.96 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.851 0.46 . . . . 0.0 109.912 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.6 t -133.89 158.95 42.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 123.12 0.568 . . . . 0.0 109.765 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.62 9.41 39.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -68.25 144.52 96.8 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.78 -24.36 11.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.918 2.412 . . . . 0.0 111.772 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -162.86 172.77 14.64 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.151 0.58 . . . . 0.0 109.992 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.71 143.55 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -100.21 155.98 35.8 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.132 0.173 . . . . 0.0 111.334 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.28 164.01 9.36 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.773 2.982 . . . . 0.0 112.227 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.37 178.97 38.25 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -72.66 163.55 27.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.949 0.5 . . . . 0.0 110.786 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.4 p -144.28 160.36 41.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.898 0.479 . . . . 0.0 110.745 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -151.81 165.04 35.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.557 0.743 . . . . 0.0 110.107 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.74 137.92 18.08 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 67.7 mt -87.06 170.47 11.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.719 0.808 . . . . 0.0 110.188 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.23 -20.41 64.82 Favored 'General case' 0 N--CA 1.461 0.115 0 O-C-N 122.142 -0.349 . . . . 0.0 111.752 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -88.39 6.0 39.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.974 0.509 . . . . 0.0 111.664 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.58 84.74 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.468 0.556 . . . . 0.0 112.797 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.8 m -88.76 161.55 16.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.125 0.963 . . . . 0.0 110.527 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.1 m -82.87 153.34 25.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 110.735 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.2 p -67.83 -10.28 51.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.321 0.649 . . . . 0.0 111.531 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -127.62 137.79 52.65 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.141 0.976 . . . . 0.0 110.123 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -156.36 157.58 35.89 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 122.59 0.356 . . . . 0.0 110.922 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.39 156.64 41.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.688 0.795 . . . . 0.0 110.878 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.64 13.71 2.32 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.324 0.649 . . . . 0.0 111.54 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 15.8 t -62.76 162.28 11.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.928 0.491 . . . . 0.0 112.025 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 57.76 17.5 4.19 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.862 1.265 . . . . 0.0 113.816 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 44.0 t -77.88 137.06 38.16 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.975 -0.453 . . . . 0.0 110.479 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -122.01 0.06 9.59 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.598 0.759 . . . . 0.0 111.582 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -86.35 60.41 6.22 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.262 0.625 . . . . 0.0 111.988 -174.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -145.86 163.08 36.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.08 0.552 . . . . 0.0 110.331 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -86.79 27.99 0.93 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.488 0.715 . . . . 0.0 112.684 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.38 16.8 1.17 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.153 -0.342 . . . . 0.0 111.22 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.3 p -72.16 -9.48 58.49 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.726 0.41 . . . . 0.0 111.636 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 37.7 p -142.84 157.85 60.58 Favored Pre-proline 0 C--O 1.231 0.127 0 C-N-CA 123.844 0.858 . . . . 0.0 108.867 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.26 -8.44 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.733 2.289 . . . . 0.0 111.177 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -93.86 -23.97 17.91 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.497 0.319 . . . . 0.0 111.13 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -90.49 -35.6 15.01 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.495 0.318 . . . . 0.0 110.262 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -70.12 -23.06 62.96 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.436 -0.165 . . . . 0.0 111.356 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.9 -10.52 57.02 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -117.56 11.99 13.95 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.15 0.58 . . . . 0.0 111.734 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.25 -36.25 0.81 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.052 0.541 . . . . 0.0 110.544 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 60.51 157.98 0.04 OUTLIER 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.776 1.631 . . . . 0.0 113.315 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.54 148.66 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.982 0.913 . . . . 0.0 110.083 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 63.25 -26.32 0.07 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.451 1.901 . . . . 0.0 115.467 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.45 121.14 79.56 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 119.363 0.983 . . . . 0.0 110.145 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.94 135.15 15.34 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.992 2.462 . . . . 0.0 109.81 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 97.1 p -124.17 -7.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.042 0.537 . . . . 0.0 112.208 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 58.45 18.42 5.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.595 0.758 . . . . 0.0 111.759 -170.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.78 136.71 55.32 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 123.404 0.682 . . . . 0.0 109.7 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . 0.445 HD13 ' CH2' ' A' ' 546' ' ' TRP . 59.0 mt -118.91 148.59 42.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.498 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 16.0 m170 -114.83 154.55 28.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -135.8 149.16 49.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.455 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -146.69 171.74 14.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.822 0.449 . . . . 0.0 110.714 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 26.4 m120 60.73 21.81 11.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.981 . . . . 0.0 113.42 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -78.48 163.35 62.03 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.96 154.43 50.71 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.001 2.467 . . . . 0.0 111.605 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . 0.443 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -77.84 -1.0 29.46 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -123.71 12.04 9.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.737 0.415 . . . . 0.0 111.976 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.79 154.99 4.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 121.904 -0.498 . . . . 0.0 111.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.9 p -144.67 170.24 16.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.472 0.709 . . . . 0.0 110.437 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 3.1 pm0 -62.37 -21.97 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.629 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.96 -30.82 69.33 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.976 -0.452 . . . . 0.0 109.921 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -78.36 -32.73 49.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.63 -28.62 67.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.184 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -84.08 -37.57 21.9 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.714 -0.616 . . . . 0.0 111.522 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.5 -9.09 59.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.355 0.525 . . . . 0.0 112.148 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.49 -32.51 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 117.783 0.265 . . . . 0.0 110.387 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 60.2 m -67.39 -21.61 65.59 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.0 -29.84 64.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.93 -16.54 27.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.554 0.615 . . . . 0.0 111.776 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.19 -11.85 42.59 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.53 0.332 . . . . 0.0 111.199 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 4.63 58.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.848 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.65 169.67 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 118.013 0.906 . . . . 0.0 110.603 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.74 153.42 35.04 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -102.43 153.21 38.28 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.459 0.304 . . . . 0.0 110.361 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.5 148.85 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.1 2.533 . . . . 0.0 111.143 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.487 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.5 m -81.97 -25.07 35.11 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.72 0.408 . . . . 0.0 110.555 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.9 t -144.53 158.46 43.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.84 145.31 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 122.84 0.456 . . . . 0.0 110.599 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -144.28 127.15 16.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.681 0.792 . . . . 0.0 108.983 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 32.9 t -130.64 149.03 33.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -143.41 165.87 26.32 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.779 0.324 . . . . 0.0 111.697 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m -130.8 154.71 47.73 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.653 0.781 . . . . 0.0 110.526 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . 174.09 -146.4 8.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -63.65 168.64 4.62 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.305 0.552 . . . . 0.0 109.75 175.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 25.1 m 58.54 29.0 17.8 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.82 -7.5 0.74 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.829 1.252 . . . . 0.0 114.084 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.81 -7.81 47.93 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.647 0.658 . . . . 0.0 110.705 175.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 49.8 m -141.86 168.48 19.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.372 1.069 . . . . 0.0 109.391 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 23.2 t -127.75 160.07 32.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.275 0.56 . . . . 0.0 111.226 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.1 p -149.64 167.05 27.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.233 1.013 . . . . 0.0 109.785 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.99 -172.88 45.49 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.344 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.51 153.91 39.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.915 0.886 . . . . 0.0 110.365 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.8 mt -138.07 142.22 40.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.383 1.073 . . . . 0.0 108.693 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -127.79 106.49 9.16 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.487 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -166.02 153.49 10.18 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.961 1.304 . . . . 0.0 107.853 168.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -152.82 122.64 6.92 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 45.2 t -159.6 153.04 22.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -66.45 -42.29 87.82 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.545 0.611 . . . . 0.0 110.943 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.4 p -85.76 -29.02 24.18 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -83.39 -28.74 28.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.543 0.611 . . . . 0.0 111.267 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -84.72 -30.0 25.1 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.256 0.48 . . . . 0.0 110.943 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.22 -28.2 34.95 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.419 0.554 . . . . 0.0 111.355 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.11 -40.78 37.18 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.884 -0.51 . . . . 0.0 110.39 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 61.3 m -68.25 -36.18 79.05 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.13 -43.22 95.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.837 -0.539 . . . . 0.0 109.738 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.3 -14.18 79.36 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.619 -1.1 . . . . 0.0 114.094 -173.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -128.54 -10.71 5.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.093 1.446 . . . . 0.0 113.77 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.85 -18.5 29.12 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.301 0.955 . . . . 0.0 109.852 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.475 HD21 ' CD2' ' A' ' 561' ' ' HIS . 1.2 t30 -85.79 153.42 22.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 171.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . 0.475 ' CD2' HD21 ' A' ' 560' ' ' ASN . 78.0 m-70 57.51 15.97 3.05 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . 0.414 ' CZ ' ' CE2' ' A' ' 573' ' ' TYR . 0.0 OUTLIER -79.15 151.48 31.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -112.27 136.28 51.9 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.076 0.95 . . . . 0.0 110.576 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.401 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.9 ttt -64.23 176.11 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.775 0.83 . . . . 0.0 111.227 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 564' ' ' MET . 67.0 mttm -73.69 11.79 0.77 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.516 0.726 . . . . 0.0 112.874 -177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -64.86 144.88 99.02 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.401 0.546 . . . . 0.0 110.646 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.79 -27.78 4.59 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.428 2.752 . . . . 0.0 113.676 -170.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -120.97 -3.29 9.64 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.197 0.453 . . . . 0.0 111.955 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.87 39.71 97.64 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.751 -1.027 . . . . 0.0 113.211 -177.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 93.9 Cg_endo -71.29 -7.97 22.43 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.847 2.365 . . . . 0.0 112.115 -176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -144.22 147.78 38.65 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.157 0.435 . . . . 0.0 110.4 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.32 160.9 38.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.086 3.191 . . . . 0.0 110.902 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . 0.414 ' CE2' ' CZ ' ' A' ' 562' ' ' TYR . 42.4 t80 -141.77 -2.62 1.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.7 t -66.4 132.08 47.51 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 2.1 pp -120.23 144.61 47.66 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.748 0.819 . . . . 0.0 110.197 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -76.07 148.58 37.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.22 145.0 48.76 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.524 0.729 . . . . 0.0 109.661 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.5 p -163.39 161.37 24.37 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -74.33 131.75 41.42 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.498 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 39.4 t -135.63 137.69 42.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 66.2 m -79.27 102.4 8.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.012 0.435 . . . . 0.0 110.901 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 159.49 40.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.127 0.971 . . . . 0.0 109.245 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -85.99 -25.13 26.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.341 -0.225 . . . . 0.0 110.781 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -164.18 168.6 18.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.625 0.77 . . . . 0.0 109.954 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.22 76.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.179 -179.676 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 22.6 t0 . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.385 0.136 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -144.48 8.27 1.34 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.124 0.57 . . . . 0.0 110.654 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 89.42 -159.95 28.85 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.12 171.01 10.8 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.154 3.236 . . . . 0.0 111.459 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -146.6 163.11 36.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.873 0.469 . . . . 0.0 111.378 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -96.92 165.4 12.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.335 1.054 . . . . 0.0 110.997 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.78 8.03 4.83 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.378 0.671 . . . . 0.0 110.282 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.2 m -146.38 154.67 49.52 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.169 0.588 . . . . 0.0 110.573 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.18 4.52 6.99 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.225 3.283 . . . . 0.0 112.825 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.5 162.28 35.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 119.164 0.893 . . . . 0.0 112.672 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.04 166.06 26.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 109.644 173.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.2 mmm -121.89 150.81 41.44 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.7 0.8 . . . . 0.0 110.149 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.32 145.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.485 ' CE2' ' HE1' ' A' ' 412' ' ' MET . 2.7 m-85 -142.79 166.66 24.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.907 0.483 . . . . 0.0 109.898 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.53 -0.6 84.98 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.607 173.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.11 177.42 5.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.175 0.988 . . . . 0.0 110.727 176.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.46 136.5 52.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.781 0.432 . . . . 0.0 110.231 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -75.77 4.4 8.01 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 18.3 t -112.53 -8.04 13.87 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.753 0.421 . . . . 0.0 111.556 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 -8.42 4.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 111.216 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.1 tpt -142.51 121.0 12.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.576 0.75 . . . . 0.0 109.211 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -141.9 -178.82 5.87 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.765 0.426 . . . . 0.0 110.406 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.2 m -60.5 -22.13 63.2 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.8 -25.88 19.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.829 -0.544 . . . . 0.0 111.637 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -87.82 -23.55 23.99 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.666 0.666 . . . . 0.0 109.873 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.2 p -78.38 -33.9 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.29 -33.77 76.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -71.33 -29.63 65.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.996 -0.44 . . . . 0.0 111.507 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 42.3 t -85.43 -13.02 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.058 -0.401 . . . . 0.0 111.592 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -118.94 -7.07 10.47 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.4 -35.47 75.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.332 0.969 . . . . 0.0 111.204 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.28 12.26 1.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.837 -0.539 . . . . 0.0 112.095 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -121.46 -4.74 9.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.481 0.712 . . . . 0.0 111.132 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.94 175.7 20.08 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.1 146.26 43.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.599 -0.353 . . . . 0.0 110.539 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.95 150.67 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -98.46 -60.48 1.54 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -167.51 166.1 14.37 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.576 0.75 . . . . 0.0 110.474 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.33 146.65 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 123.087 0.555 . . . . 0.0 110.312 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.47 ' HE2' ' CD1' ' A' ' 471' ' ' TYR . 39.0 ttmt -150.22 148.58 29.08 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.184 0.194 . . . . 0.0 111.135 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -82.48 149.07 27.77 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.485 ' HE1' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -135.66 141.43 45.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -168.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt 60.12 33.81 21.19 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 126.713 2.005 . . . . 0.0 114.13 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.7 m 52.91 18.03 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.62 157.59 87.88 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 118.587 0.63 . . . . 0.0 110.393 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.63 -18.82 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.601 2.868 . . . . 0.0 111.948 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -179.24 100.9 0.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -160.91 143.42 12.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.26 171.49 19.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.314 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.0 ptm -144.44 143.96 31.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.35 151.67 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 C-N-CA 123.145 0.578 . . . . 0.0 110.284 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -129.52 137.5 50.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 90.5 mmm -109.22 164.04 12.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.431 0.692 . . . . 0.0 110.025 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.58 64.29 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.457 -0.152 . . . . 0.0 111.078 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -159.73 161.61 34.79 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.494 0.717 . . . . 0.0 109.404 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.96 -16.11 68.01 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.249 -0.751 . . . . 0.0 112.905 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 427' ' ' TYR . 2.5 p90 -65.45 -28.36 69.17 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.048 1.424 . . . . 0.0 110.925 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.0 -19.77 43.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.3 t -80.28 -23.75 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.9 -38.38 88.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.51 -26.37 45.87 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.98 -36.2 59.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.039 0.381 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.5 tp -85.16 -30.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 122.251 -0.281 . . . . 0.0 111.54 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.8 m -91.38 -21.51 20.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -124.57 -14.32 6.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.56 -19.05 10.77 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.947 0.794 . . . . 0.0 110.389 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.97 139.07 23.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.383 0.611 . . . . 0.0 111.36 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . 0.412 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 69.7 m-20 56.76 1.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.212 1.805 . . . . 0.0 115.735 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.77 142.46 27.81 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 120.869 1.668 . . . . 0.0 109.144 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.297 0.1 OUTLIER -130.9 163.84 26.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 174.547 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.2 ptm -125.29 143.33 51.01 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.029 1.331 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 63.05 33.07 14.99 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.33 15.6 78.05 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.95 140.9 32.53 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.323 1.061 . . . . 0.0 109.496 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -77.72 141.38 39.36 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.81 125.34 41.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -168.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -140.71 112.07 7.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.412 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.71 134.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.054 0.388 . . . . 0.0 110.715 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 81.6 m -149.52 165.04 33.37 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 124.394 1.078 . . . . 0.0 109.855 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.8 156.8 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.0 t -135.26 159.59 41.07 Favored 'General case' 0 C--O 1.23 0.046 0 C-N-CA 122.961 0.504 . . . . 0.0 110.333 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -99.3 5.76 46.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -67.03 144.92 98.75 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.796 -0.565 . . . . 0.0 109.551 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.92 -26.1 8.29 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.079 2.519 . . . . 0.0 112.244 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.6 173.59 11.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.051 0.54 . . . . 0.0 110.328 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.04 141.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.68 153.2 55.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 C-N-CA 122.208 0.203 . . . . 0.0 111.138 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.41 156.45 65.59 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.51 2.807 . . . . 0.0 111.231 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.25 169.14 28.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -78.28 157.82 29.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.752 0.421 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.9 p -134.27 159.78 39.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.987 0.515 . . . . 0.0 110.662 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -155.73 168.07 28.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.07 0.548 . . . . 0.0 109.732 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -76.91 140.83 25.44 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.69 170.75 13.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.874 0.87 . . . . 0.0 109.418 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.4 -20.03 65.48 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -90.14 5.27 47.59 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.24 85.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.017 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.4 m -89.14 155.76 19.23 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 118.413 1.107 . . . . 0.0 110.201 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.9 m -81.79 150.36 27.93 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.145 -0.347 . . . . 0.0 111.162 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -73.21 -10.37 59.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.785 0.434 . . . . 0.0 111.969 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . 0.47 ' CD1' ' HE2' ' A' ' 410' ' ' LYS . 41.8 t80 -139.05 141.11 38.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.68 0.792 . . . . 0.0 110.699 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -156.77 153.35 28.22 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.807 0.443 . . . . 0.0 110.603 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.06 154.07 40.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.194 0.998 . . . . 0.0 109.701 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -135.93 -3.77 2.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 78.4 p -75.32 -9.34 58.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -109.13 3.91 22.43 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.659 0.383 . . . . 0.0 111.594 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.8 t -84.62 141.64 30.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.964 0.347 . . . . 0.0 110.49 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -119.37 16.25 13.03 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.724 0.809 . . . . 0.0 110.554 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -113.71 14.72 18.82 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.51 0.724 . . . . 0.0 111.257 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -83.88 172.37 12.19 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.528 0.331 . . . . 0.0 110.242 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -69.85 -6.16 30.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.568 1.147 . . . . 0.0 113.2 -174.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.68 22.24 0.4 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.285 0.493 . . . . 0.0 111.847 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 67.6 p -88.34 15.07 8.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 67.6 p -135.01 153.78 78.72 Favored Pre-proline 0 C--O 1.231 0.109 0 C-N-CA 123.284 0.633 . . . . 0.0 109.476 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.19 -4.19 13.16 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.306 2.671 . . . . 0.0 112.224 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -103.29 -31.01 10.28 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.069 0.395 . . . . 0.0 111.093 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -90.68 -23.54 20.71 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.957 0.344 . . . . 0.0 111.09 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.7 -20.55 61.9 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.233 -0.292 . . . . 0.0 110.747 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.54 0.45 49.84 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.023 0.529 . . . . 0.0 110.868 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -127.18 23.82 6.42 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.067 0.947 . . . . 0.0 110.78 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -65.34 160.53 21.58 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 111.035 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -135.45 38.78 2.89 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.378 0.671 . . . . 0.0 110.707 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.98 122.92 36.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -163.02 176.99 9.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -74.28 157.91 86.03 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.808 0.843 . . . . 0.0 109.786 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.38 133.88 31.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.978 2.452 . . . . 0.0 110.401 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.0 m -124.17 23.99 8.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.885 0.874 . . . . 0.0 111.73 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.31 17.63 3.81 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.675 1.59 . . . . 0.0 114.674 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.9 t -140.57 144.66 26.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . 0.438 HD13 ' CH2' ' A' ' 546' ' ' TRP . 70.5 mt -123.31 163.56 20.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.14 0.576 . . . . 0.0 110.465 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.24 160.6 41.76 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.69 0.396 . . . . 0.0 110.523 174.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -136.59 155.53 49.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.336 0.654 . . . . 0.0 110.821 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -146.12 173.92 11.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.484 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.6 t30 62.35 33.98 16.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.373 1.069 . . . . 0.0 112.566 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -90.0 158.7 44.03 Favored Pre-proline 0 N--CA 1.454 -0.251 0 C-N-CA 122.744 0.418 . . . . 0.0 110.203 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 153.16 72.54 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.362 2.042 . . . . 0.0 109.558 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -70.93 -1.21 11.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.75 8.26 20.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.4 p -79.16 151.92 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.324 0.511 . . . . 0.0 110.938 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.3 p -144.72 171.93 13.71 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.437 0.695 . . . . 0.0 110.274 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.44 -19.87 65.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.88 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -72.33 -23.91 61.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.42 -31.48 26.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -70.66 -29.87 66.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.953 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -84.17 -36.2 23.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.435 0.561 . . . . 0.0 111.668 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.71 -21.89 59.13 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.384 0.538 . . . . 0.0 111.752 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.8 mt -92.77 -33.96 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 117.854 0.297 . . . . 0.0 110.614 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 87.4 m -68.29 -21.03 64.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.445 -0.784 . . . . 0.0 110.74 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.15 -30.8 65.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.378 -0.201 . . . . 0.0 111.507 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.03 -13.42 33.27 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.31 0.505 . . . . 0.0 111.997 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.25 -11.03 33.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.519 0.328 . . . . 0.0 111.102 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.72 4.67 62.3 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.408 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.9 162.06 3.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 118.24 1.02 . . . . 0.0 110.697 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -69.49 142.91 53.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -92.32 151.47 41.53 Favored Pre-proline 0 CA--C 1.528 0.132 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.08 154.7 71.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.204 2.603 . . . . 0.0 110.329 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 99.0 m -89.95 -26.76 20.23 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 122.722 0.409 . . . . 0.0 110.859 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 52.0 m -141.51 152.76 44.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 3.5 p -149.56 147.12 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.878 0.471 . . . . 0.0 110.72 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 122.55 9.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.77 145.93 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.79 0.436 . . . . 0.0 110.329 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -155.12 151.37 28.21 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.88 0.472 . . . . 0.0 110.38 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.3 m -104.64 144.08 32.2 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.918 0.487 . . . . 0.0 110.892 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.16 148.57 33.07 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.74 132.11 41.37 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.2 m 54.37 19.17 2.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.652 0.781 . . . . 0.0 112.881 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -107.06 -17.35 14.2 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.84 0.456 . . . . 0.0 110.884 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 53.03 25.4 4.05 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.284 1.034 . . . . 0.0 112.964 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 69.8 m -139.27 162.74 34.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.15 0.58 . . . . 0.0 110.487 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 35.1 t -127.39 158.44 37.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.672 0.789 . . . . 0.0 111.877 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -154.29 168.32 26.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.103 1.361 . . . . 0.0 109.59 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.31 -178.86 48.28 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.911 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.22 154.24 28.24 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.3 mt -139.2 134.47 32.79 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.441 1.096 . . . . 0.0 108.703 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.85 114.89 17.8 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.438 ' CH2' HD13 ' A' ' 500' ' ' LEU . 1.3 p90 -166.11 155.0 11.28 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -150.66 117.48 5.85 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.979 1.104 . . . . 0.0 113.979 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 48.2 t -159.49 153.05 22.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 168.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -65.87 -42.41 90.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.389 0.54 . . . . 0.0 110.491 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 71.9 p -82.29 -26.3 33.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -81.94 -35.24 29.31 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.63 0.65 . . . . 0.0 110.89 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -77.65 -29.6 51.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.407 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.28 -28.22 23.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.397 0.544 . . . . 0.0 111.568 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -75.19 -34.84 61.57 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.458 0.572 . . . . 0.0 110.041 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 41.3 m -72.88 -40.99 65.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 28.7 tp -59.92 -52.26 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.242 -0.911 . . . . 0.0 109.164 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.6 -11.69 72.95 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.591 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.43 -4.27 2.64 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 119.476 1.638 . . . . 0.0 113.869 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -97.48 -30.28 12.98 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.771 0.714 . . . . 0.0 109.561 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -67.42 155.86 37.96 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.355 -0.841 . . . . 0.0 109.279 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 34.4 m80 61.25 18.82 9.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.396 1.078 . . . . 0.0 113.643 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.46 151.45 27.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.332 0.587 . . . . 0.0 112.308 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -120.71 136.36 54.88 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.189 0.996 . . . . 0.0 110.734 -175.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.448 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 6.3 ttt -64.21 175.39 1.29 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.657 0.783 . . . . 0.0 111.575 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 564' ' ' MET . 48.6 mtmt -70.32 5.82 1.59 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.053 0.941 . . . . 0.0 113.233 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -64.52 142.54 98.45 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.058 0.844 . . . . 0.0 110.895 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.57 -28.23 3.63 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.662 2.908 . . . . 0.0 113.782 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.09 1.27 10.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.257 0.48 . . . . 0.0 111.788 -175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.444 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.52 40.14 98.29 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.293 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.2 Cg_endo -68.26 -9.07 24.72 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.076 2.517 . . . . 0.0 111.802 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -145.53 145.94 27.82 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.55 156.46 40.57 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.801 3.0 . . . . 0.0 110.848 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . 0.407 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.5 t80 -142.29 -1.59 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.2 m -66.47 120.92 14.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 29.3 mt -98.82 144.49 27.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.563 0.745 . . . . 0.0 110.329 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -93.77 136.8 33.68 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.58 156.33 43.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.843 0.354 . . . . 0.0 111.647 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 22.4 p -163.72 -179.99 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.763 0.825 . . . . 0.0 110.084 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -75.6 143.63 42.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.518 0.327 . . . . 0.0 111.163 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.1 t -135.52 142.84 45.49 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.253 0.621 . . . . 0.0 110.501 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 59.8 m -90.75 102.21 14.97 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.2 161.51 34.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.558 0.743 . . . . 0.0 110.663 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -110.76 -8.24 14.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.868 0.467 . . . . 0.0 110.59 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -159.82 161.95 34.63 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.22 1.008 . . . . 0.0 109.394 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -83.67 76.41 9.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.466 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 28.0 t0 . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -140.35 17.46 2.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.313 0.645 . . . . 0.0 111.229 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -70.75 169.94 47.28 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.352 0.501 . . . . 0.0 112.592 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -80.52 -15.68 10.97 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 124.705 3.603 . . . . 0.0 112.24 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -154.85 153.44 31.15 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.001 0.521 . . . . 0.0 110.127 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -88.64 162.68 16.19 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.012 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.9 -6.69 42.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.559 0.344 . . . . 0.0 111.624 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.8 m -147.22 152.37 42.78 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -86.42 0.17 8.08 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.787 3.658 . . . . 0.0 112.246 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.8 151.74 36.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 118.472 0.578 . . . . 0.0 111.244 -174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -146.71 169.14 19.66 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.205 0.602 . . . . 0.0 110.183 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.4 mtp -135.08 154.06 51.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.286 0.234 . . . . 0.0 110.853 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.1 p -144.41 150.76 16.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 122.711 0.404 . . . . 0.0 110.948 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.17 168.78 18.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.856 0.862 . . . . 0.0 109.141 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.56 -3.29 86.9 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.766 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.2 pt? -72.7 176.65 5.36 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.654 0.727 . . . . 0.0 110.319 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -145.12 134.89 23.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -70.03 -5.06 23.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 97.1 p -93.86 -11.72 30.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 0.61 0.92 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.5 tpt -136.85 123.94 21.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -141.93 177.24 8.33 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.42 0.288 . . . . 0.0 111.029 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 77.1 m -59.03 -26.38 64.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.063 0.545 . . . . 0.0 111.897 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -82.92 -22.68 33.79 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.27 -0.269 . . . . 0.0 111.078 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -85.95 -36.45 19.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.87 -28.37 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.65 -38.27 83.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.095 -0.378 . . . . 0.0 110.038 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -80.73 -29.68 36.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.735 0.698 . . . . 0.0 112.664 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.41 -20.74 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 118.628 0.649 . . . . 0.0 110.789 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -113.69 -19.93 11.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 44.9 t -73.87 -26.81 60.76 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.564 1.075 . . . . 0.0 111.14 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.49 7.47 1.83 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.498 -0.751 . . . . 0.0 111.406 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.41 -0.04 9.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.014 0.926 . . . . 0.0 111.463 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 155.01 170.88 21.15 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.38 150.1 48.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.033 0.444 . . . . 0.0 111.338 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 7.2 m -117.67 164.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -134.92 -52.23 0.79 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.171 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -163.8 163.18 24.01 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.655 0.661 . . . . 0.0 112.176 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.82 153.3 13.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.853 0.861 . . . . 0.0 110.44 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -151.97 145.58 24.96 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.47 0.308 . . . . 0.0 110.335 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.36 163.24 25.01 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 30.6 ttp -123.14 141.11 52.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 49.47 33.93 6.19 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.2 1.4 . . . . 0.0 112.311 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 24.3 m 52.95 18.23 1.04 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.146 0.978 . . . . 0.0 113.303 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.38 147.21 67.93 Favored Pre-proline 0 N--CA 1.456 -0.125 0 O-C-N 121.929 -0.482 . . . . 0.0 109.859 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -79.18 -2.44 12.36 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.495 2.797 . . . . 0.0 110.678 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -137.62 30.67 2.57 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.427 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.31 137.03 22.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.158 0.979 . . . . 0.0 110.149 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.11 167.72 29.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.74 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.8 ptm -142.54 142.02 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.776 0.831 . . . . 0.0 109.663 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.81 147.49 23.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.65 0.38 . . . . 0.0 110.916 -173.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -124.88 145.12 49.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.983 0.513 . . . . 0.0 111.154 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 78.5 mmm -111.61 162.74 14.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.334 1.054 . . . . 0.0 109.397 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.84 -20.84 62.51 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.027 -0.421 . . . . 0.0 111.8 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.23 161.4 39.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.119 0.568 . . . . 0.0 109.791 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.59 -12.92 70.84 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.177 -0.79 . . . . 0.0 113.553 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.49 -27.3 66.89 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.411 1.605 . . . . 0.0 110.24 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.7 -28.74 45.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.687 0.28 . . . . 0.0 110.256 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.0 t -75.66 -24.83 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.37 -39.88 67.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.127 -0.358 . . . . 0.0 110.957 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.68 67.93 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.87 -33.39 34.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.14 -0.35 . . . . 0.0 111.931 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -83.06 -30.98 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.871 -0.518 . . . . 0.0 111.36 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.8 m -98.62 -14.14 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.35 -8.43 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.69 -20.11 10.25 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.281 0.946 . . . . 0.0 109.578 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -52.01 143.63 13.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.703 0.801 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.2 1.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.367 2.267 . . . . 0.0 115.971 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.77 142.32 27.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.647 1.567 . . . . 0.0 108.679 169.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.363 0.0 OUTLIER -130.92 165.07 23.9 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.9 ptp -125.13 143.53 50.88 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.011 1.324 . . . . 0.0 109.632 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 66.18 26.45 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.12 15.76 74.65 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -83.0 161.89 21.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.531 1.166 . . . . 0.0 110.087 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.403 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -83.79 132.4 34.83 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.48 133.83 42.3 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.76 117.23 10.79 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.69 143.73 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.236 0.471 . . . . 0.0 110.19 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 26.3 t -158.94 160.41 36.01 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.666 0.386 . . . . 0.0 110.057 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.14 158.22 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.677 0.391 . . . . 0.0 110.055 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.8 t -133.1 158.76 41.97 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.262 0.625 . . . . 0.0 109.837 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -110.86 14.02 22.17 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -66.94 151.07 97.44 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.31 -28.5 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.783 2.322 . . . . 0.0 111.862 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.66 172.23 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.284 0.634 . . . . 0.0 110.254 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.6 mm -66.44 137.81 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -89.01 149.3 43.01 Favored Pre-proline 0 N--CA 1.455 -0.179 0 O-C-N 122.404 -0.185 . . . . 0.0 110.869 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.17 162.77 39.83 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.665 2.91 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 168.03 -177.55 42.19 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -75.78 162.64 28.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.5 p -136.9 162.62 32.76 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.843 0.457 . . . . 0.0 110.914 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.55 163.42 32.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.569 0.748 . . . . 0.0 109.617 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.68 134.34 13.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.76 171.11 11.16 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.493 0.717 . . . . 0.0 110.063 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.02 -20.47 66.2 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.557 0.343 . . . . 0.0 111.432 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.72 1.94 47.43 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.838 0.455 . . . . 0.0 111.603 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.24 -3.68 85.5 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.874 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 68.4 m -91.38 159.14 16.14 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 118.196 0.998 . . . . 0.0 110.525 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.8 m -80.0 153.46 28.85 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.511 0.324 . . . . 0.0 110.478 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.0 p -70.01 -10.41 58.57 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.339 0.656 . . . . 0.0 111.656 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -126.53 139.28 53.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.307 1.043 . . . . 0.0 109.272 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -155.83 156.15 34.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.231 0.212 . . . . 0.0 110.845 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.22 156.37 35.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.879 0.872 . . . . 0.0 110.704 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -139.93 16.91 2.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.395 0.678 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p -68.59 3.15 1.97 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.12 -6.22 58.58 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.932 -0.48 . . . . 0.0 110.401 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 22.8 t -86.29 7.81 23.88 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.457 0.703 . . . . 0.0 111.558 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.02 10.99 0.99 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.008 0.523 . . . . 0.0 111.866 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -125.94 8.06 7.4 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.975 0.91 . . . . 0.0 110.792 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -78.74 170.1 17.19 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.775 0.83 . . . . 0.0 110.805 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -70.15 1.59 4.57 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.773 0.829 . . . . 0.0 113.139 -175.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -144.62 29.23 1.26 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.092 0.557 . . . . 0.0 110.396 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.2 p -65.9 -12.47 54.88 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.6 0.76 . . . . 0.0 112.559 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 6.8 t -144.73 151.2 49.22 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 123.724 0.809 . . . . 0.0 109.084 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.41 -19.56 36.25 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.085 2.523 . . . . 0.0 113.411 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -78.39 -31.94 48.61 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 117.845 0.293 . . . . 0.0 110.957 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -90.63 -23.45 20.8 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.64 0.376 . . . . 0.0 111.225 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.67 -20.48 63.57 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.359 -0.213 . . . . 0.0 110.613 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -89.15 0.52 56.67 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.143 0.577 . . . . 0.0 111.125 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -115.8 7.61 14.63 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.099 0.959 . . . . 0.0 110.809 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -130.64 14.97 5.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.586 0.754 . . . . 0.0 110.562 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 46.72 59.75 3.75 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.79 1.236 . . . . 0.0 112.867 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.77 106.21 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -144.55 178.08 8.22 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.778 0.831 . . . . 0.0 110.231 -173.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -66.93 164.89 30.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.637 0.775 . . . . 0.0 110.044 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.9 145.75 23.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.915 3.076 . . . . 0.0 113.523 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 49.1 m -124.11 23.7 8.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.729 0.812 . . . . 0.0 111.809 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 60.54 10.23 2.44 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.22 1.408 . . . . 0.0 114.306 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 29.8 t -140.41 144.96 26.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . 0.424 HD12 ' CH2' ' A' ' 546' ' ' TRP . 65.5 mt -122.79 150.53 42.69 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.804 0.441 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.92 150.12 50.02 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.212 0.605 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.71 151.91 47.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -145.47 169.21 18.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.85 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.7 t30 58.56 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.023 0.929 . . . . 0.0 112.487 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.8 163.41 49.08 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 122.778 0.431 . . . . 0.0 109.863 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.83 150.53 62.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.853 2.369 . . . . 0.0 111.549 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . 0.411 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.8 pt? -72.85 -1.09 15.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.48 13.58 5.0 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -76.26 154.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.129 0.422 . . . . 0.0 110.578 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 66.3 p -142.22 171.04 14.6 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.961 0.504 . . . . 0.0 110.088 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.64 -22.03 66.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.097 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.81 -26.08 56.92 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.24 -0.287 . . . . 0.0 110.71 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -79.04 -30.98 44.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.77 -30.02 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.398 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -76.78 -39.85 50.19 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.1 0.409 . . . . 0.0 111.672 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.94 -18.19 56.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.732 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.23 -33.9 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.222 0.464 . . . . 0.0 110.251 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.84 -21.65 65.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.556 -0.715 . . . . 0.0 110.174 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.96 -28.86 60.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.769 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.99 -14.35 31.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.345 0.521 . . . . 0.0 111.892 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.6 mt -95.4 -7.05 39.49 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.566 0.346 . . . . 0.0 110.903 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.36 4.72 61.14 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.224 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.6 m -80.67 169.47 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.092 0.946 . . . . 0.0 111.033 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -80.91 147.62 30.24 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.984 0.513 . . . . 0.0 110.736 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -88.29 147.53 40.42 Favored Pre-proline 0 C--O 1.232 0.132 0 C-N-CA 123.064 0.546 . . . . 0.0 109.964 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.53 156.13 61.96 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.534 2.823 . . . . 0.0 110.195 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.427 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.2 m -86.95 -25.91 24.12 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.341 0.256 . . . . 0.0 110.608 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.7 m -144.52 151.76 39.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.865 0.466 . . . . 0.0 109.824 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.57 144.56 29.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 123.496 0.718 . . . . 0.0 109.124 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 124.13 11.45 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.08 151.57 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -145.66 147.51 32.07 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.941 0.4 . . . . 0.0 111.694 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.7 t -130.81 146.0 52.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.924 0.889 . . . . 0.0 109.066 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . 168.55 -21.6 0.09 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -152.23 159.62 43.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.74 1.216 . . . . 0.0 108.024 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 20.4 m 54.55 28.75 10.21 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.094 0.407 . . . . 0.0 110.604 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -57.83 -7.53 0.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.669 1.588 . . . . 0.0 114.189 -169.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.01 -10.35 52.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.65 0.659 . . . . 0.0 110.532 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 79.8 p -152.52 175.32 12.88 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.595 1.158 . . . . 0.0 109.898 177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 69.2 m -132.16 161.18 33.98 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.885 0.474 . . . . 0.0 110.934 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.2 m -145.53 159.59 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.912 0.885 . . . . 0.0 109.606 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -174.86 -175.74 42.6 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.638 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.78 155.37 34.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.898 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.4 mt -135.91 132.6 36.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.489 1.116 . . . . 0.0 108.042 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.76 112.56 14.93 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.427 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -166.04 155.42 11.81 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.59 1.556 . . . . 0.0 107.368 168.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -150.01 122.89 8.73 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.2 t -159.53 152.97 22.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.64 -46.83 77.72 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.778 0.717 . . . . 0.0 111.213 -174.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 78.2 p -84.34 -25.4 29.22 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -85.36 -28.58 25.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.725 0.693 . . . . 0.0 111.271 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.247 0.476 . . . . 0.0 110.663 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.97 -29.84 35.22 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.19 0.45 . . . . 0.0 111.045 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -77.83 -38.56 45.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.352 0.524 . . . . 0.0 110.179 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 38.2 m -73.21 -42.64 62.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.54 -46.61 89.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -67.53 -14.87 65.38 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.355 -1.247 . . . . 0.0 114.032 -172.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.07 -6.81 2.69 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.327 1.564 . . . . 0.0 113.976 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.95 -22.3 25.69 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.557 0.617 . . . . 0.0 109.749 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.08 151.51 30.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.22 -0.3 . . . . 0.0 111.023 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 49.24 30.0 2.9 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 151.42 25.65 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -110.91 136.33 50.1 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.213 1.405 . . . . 0.0 110.628 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.2 ttt -64.28 174.95 1.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.154 0.982 . . . . 0.0 112.18 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.87 12.58 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.37 1.068 . . . . 0.0 112.835 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.48 141.41 88.05 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.21 0.604 . . . . 0.0 111.147 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.55 -29.8 2.18 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.356 2.704 . . . . 0.0 113.021 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -121.05 -7.9 9.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.395 0.516 . . . . 0.0 112.395 -177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.12 42.84 97.9 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.412 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 88.8 Cg_endo -71.9 -6.55 19.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.134 2.556 . . . . 0.0 112.208 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.1 149.98 47.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.135 0.574 . . . . 0.0 110.341 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.44 156.24 41.03 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.627 2.885 . . . . 0.0 110.595 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -137.87 -2.46 1.91 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.524 0.33 . . . . 0.0 111.478 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.0 t -66.69 131.95 47.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.164 0.507 . . . . 0.0 110.73 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.03 144.6 50.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.595 1.158 . . . . 0.0 109.638 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -72.48 147.08 46.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 54.9 tp -142.05 144.7 33.73 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.97 172.64 13.64 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 111.502 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -88.46 132.94 34.27 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.2 t -135.57 150.67 49.77 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.068 0.147 . . . . 0.0 110.783 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 40.9 m -87.1 102.56 14.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.945 0.403 . . . . 0.0 111.154 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.39 34.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.697 0.799 . . . . 0.0 109.892 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -109.7 -14.06 14.4 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.939 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -160.84 164.83 31.05 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.485 0.714 . . . . 0.0 109.457 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.52 102.9 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.645 -178.448 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.775 -0.155 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.58 10.28 4.36 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.86 0.464 . . . . 0.0 111.629 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 85.86 151.11 16.18 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.73 0.681 . . . . 0.0 112.118 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.26 -1.55 10.33 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 124.526 3.484 . . . . 0.0 112.157 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -149.12 170.73 17.74 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.095 0.474 . . . . 0.0 111.641 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -125.93 165.37 18.87 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.958 0.903 . . . . 0.0 109.478 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.0 1.4 3.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 50.0 m -145.42 151.7 47.97 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 117.872 0.306 . . . . 0.0 111.285 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.26 -3.06 10.17 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 124.339 3.36 . . . . 0.0 111.934 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.03 151.74 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.286 0.494 . . . . 0.0 111.585 -173.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.72 174.58 11.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.728 0.811 . . . . 0.0 110.27 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.7 mtp -135.4 149.89 49.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.422 0.289 . . . . 0.0 111.207 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.5 148.77 28.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.574 0.75 . . . . 0.0 109.971 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.443 ' CE2' ' HE3' ' A' ' 412' ' ' MET . 45.7 m-85 -139.4 168.4 19.9 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.992 0.517 . . . . 0.0 110.289 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.03 -6.05 68.65 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.411 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.443 HD21 ' H ' ' A' ' 386' ' ' LEU . 2.3 pt? -71.85 -175.48 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.163 0.982 . . . . 0.0 110.598 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -146.12 149.7 34.51 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 121.981 -0.449 . . . . 0.0 110.559 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -76.2 -2.08 29.47 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 m -108.89 -4.1 17.07 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.608 0.363 . . . . 0.0 111.701 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -130.27 -12.28 4.04 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.014 0.526 . . . . 0.0 111.011 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 85.5 mtp -141.28 135.25 30.43 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.923 0.489 . . . . 0.0 110.342 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -141.87 174.14 10.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.35 -31.15 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.783 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.18 -25.3 29.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -89.15 -28.72 19.85 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 122.234 0.214 . . . . 0.0 110.902 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.73 -26.76 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -66.8 -35.56 80.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.46 -30.4 70.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.195 -0.316 . . . . 0.0 110.83 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.74 -21.6 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -110.44 -10.69 14.55 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.0 t -70.4 -36.38 74.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.851 0.75 . . . . 0.0 111.977 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.96 13.29 1.45 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.715 -0.616 . . . . 0.0 112.251 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -121.41 -1.27 9.66 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.469 0.707 . . . . 0.0 110.861 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 141.16 174.1 14.0 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -75.83 145.16 40.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.534 -0.392 . . . . 0.0 110.685 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.59 154.28 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -105.02 -55.86 2.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 110.523 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -164.47 162.25 21.83 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.105 0.479 . . . . 0.0 111.202 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 15.0 p -145.88 151.28 14.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.8 0.84 . . . . 0.0 110.249 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -154.07 147.19 24.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.335 0.254 . . . . 0.0 110.928 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -76.77 146.99 37.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' MET . . . . . 0.443 ' HE3' ' CE2' ' A' ' 384' ' ' TYR . 0.0 OUTLIER -133.12 141.54 48.22 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -167.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.36 33.99 20.74 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.343 1.457 . . . . 0.0 112.647 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 54.59 19.94 2.66 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -103.82 141.27 22.17 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.02 -14.63 21.03 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.915 2.41 . . . . 0.0 109.622 171.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.05 65.96 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.378 0.989 . . . . 0.0 112.418 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.75 129.91 15.52 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.303 1.052 . . . . 0.0 111.17 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -150.75 167.37 27.62 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.326 0.651 . . . . 0.0 110.891 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 20.2 ptm -144.78 143.98 30.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.656 0.382 . . . . 0.0 110.207 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.64 143.06 41.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.08 0.552 . . . . 0.0 110.694 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -126.54 138.0 53.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.201 0.6 . . . . 0.0 110.135 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 85.6 mmm -102.52 164.95 11.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.0 110.322 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.3 -20.74 62.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.451 -0.155 . . . . 0.0 111.221 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -158.06 161.54 38.03 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.302 0.641 . . . . 0.0 109.74 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.24 -14.33 68.62 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.414 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -67.44 -25.59 65.98 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.064 1.432 . . . . 0.0 110.446 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.58 -18.1 28.79 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.17 0.188 . . . . 0.0 111.182 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.72 -31.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.86 -31.86 71.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -79.62 -29.18 40.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.823 0.449 . . . . 0.0 110.864 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.34 -32.23 26.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.251 0.478 . . . . 0.0 110.819 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.9 tp -79.22 -31.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 122.166 -0.334 . . . . 0.0 111.279 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -97.1 -21.33 17.42 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -122.54 -12.68 8.12 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.3 -20.21 10.43 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 118.864 0.756 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -55.58 144.82 25.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.794 0.838 . . . . 0.0 110.581 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 60.01 1.31 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.772 2.029 . . . . 0.0 114.89 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -88.14 142.68 27.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.397 1.453 . . . . 0.0 109.047 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.307 0.1 OUTLIER -130.81 163.93 26.29 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.5 ptm -125.36 143.43 50.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.655 1.182 . . . . 0.0 108.804 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 62.86 28.42 16.38 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.86 72.24 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -83.07 152.58 25.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.432 1.616 . . . . 0.0 111.095 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 141.83 36.26 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.5 122.02 35.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -168.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.96 118.88 11.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.437 0.695 . . . . 0.0 109.28 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 3.1 p -154.47 138.23 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.164 0.438 . . . . 0.0 110.275 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.9 m -147.69 155.51 41.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.38 157.06 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 48.1 t -130.1 167.57 18.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.118 0.567 . . . . 0.0 109.991 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -119.47 12.43 12.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.848 0.459 . . . . 0.0 111.997 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -63.94 150.79 90.92 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.51 -30.58 9.78 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.472 2.114 . . . . 0.0 111.849 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.58 164.78 10.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.711 0.405 . . . . 0.0 110.77 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.7 mm -70.56 140.31 18.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.0 mmt -102.26 130.38 24.3 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.97 -31.52 9.8 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.6 2.2 . . . . 0.0 112.196 -172.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 58.52 -152.48 30.33 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -101.67 -15.41 17.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.737 0.415 . . . . 0.0 110.543 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 3.1 m 55.86 176.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.671 1.588 . . . . 0.0 113.442 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -153.8 165.34 36.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.519 0.728 . . . . 0.0 109.275 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -86.61 123.85 6.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.97 176.48 7.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.932 0.493 . . . . 0.0 111.228 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -59.96 -24.57 64.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.1 -0.61 25.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.912 -0.492 . . . . 0.0 111.389 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.98 -3.8 78.5 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.614 0.626 . . . . 0.0 112.112 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 23.2 t -93.64 170.32 9.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.515 0.726 . . . . 0.0 110.329 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 16.4 p -85.67 153.32 22.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.99 0.424 . . . . 0.0 111.165 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.0 m -71.7 -10.39 59.69 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.546 0.738 . . . . 0.0 112.576 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -120.14 143.48 48.17 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.068 0.547 . . . . 0.0 110.87 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -153.8 156.55 37.9 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.692 0.397 . . . . 0.0 110.354 177.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -133.17 156.43 47.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.82 15.13 1.94 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.978 0.511 . . . . 0.0 111.608 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.7 p -67.69 0.96 2.76 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -108.91 2.0 21.16 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.257 0.623 . . . . 0.0 111.235 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.6 m -82.91 36.28 0.5 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.598 0.759 . . . . 0.0 111.324 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -77.98 29.23 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.458 1.103 . . . . 0.0 112.398 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -136.31 32.48 2.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.613 0.365 . . . . 0.0 111.205 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -94.93 21.55 7.5 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.69 0.396 . . . . 0.0 111.902 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 62.46 -0.22 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.073 1.349 . . . . 0.0 114.381 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -156.22 16.31 0.34 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.485 0.584 . . . . 0.0 110.605 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 11.0 p -83.76 2.74 36.52 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 34.9 p -140.23 160.01 61.6 Favored Pre-proline 0 CA--C 1.524 -0.056 0 CA-C-N 118.394 0.543 . . . . 0.0 109.89 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.18 -14.21 22.99 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.555 2.837 . . . . 0.0 112.823 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.63 -24.72 15.87 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.485 0.314 . . . . 0.0 110.94 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -90.46 -25.56 20.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.795 0.438 . . . . 0.0 110.154 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -75.61 1.29 14.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.224 0.61 . . . . 0.0 111.564 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -91.15 1.71 56.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.006 0.522 . . . . 0.0 111.233 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.44 6.34 8.33 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.856 0.862 . . . . 0.0 111.342 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -149.22 170.44 18.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.753 0.821 . . . . 0.0 109.334 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -137.81 143.52 41.06 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.735 0.414 . . . . 0.0 110.691 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 42.6 mm -113.57 131.16 66.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -146.01 179.4 7.51 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.378 0.671 . . . . 0.0 110.004 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -65.61 162.87 39.15 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.078 0.551 . . . . 0.0 110.3 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.37 145.97 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.519 2.813 . . . . 0.0 112.489 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.7 m -124.05 24.0 8.34 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.452 0.701 . . . . 0.0 111.402 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.81 12.04 2.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.538 1.135 . . . . 0.0 113.618 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.71 151.18 22.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.3 mt -132.4 151.22 51.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.652 0.781 . . . . 0.0 109.689 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -121.09 142.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -125.33 148.02 48.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.206 0.602 . . . . 0.0 110.503 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -144.6 172.71 12.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.737 0.415 . . . . 0.0 111.035 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 66.8 t30 62.23 32.21 17.28 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.325 1.05 . . . . 0.0 113.126 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -89.22 158.29 46.7 Favored Pre-proline 0 N--CA 1.454 -0.242 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 156.81 52.07 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.242 1.961 . . . . 0.0 109.645 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . 0.417 ' CD2' ' H ' ' A' ' 507' ' ' LEU . 1.9 pt? -68.33 -1.17 5.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.666 0.787 . . . . 0.0 112.866 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.52 11.58 12.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.6 p -76.59 153.63 5.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 118.287 0.494 . . . . 0.0 110.725 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 78.4 p -143.76 169.24 18.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.278 0.631 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.04 -24.62 68.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.253 -0.28 . . . . 0.0 110.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.13 -26.01 60.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -78.31 -32.22 49.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.85 -28.54 64.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.236 -0.29 . . . . 0.0 110.708 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -80.37 -36.43 33.97 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.024 0.375 . . . . 0.0 111.941 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.65 -19.5 38.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 80.6 mt -86.86 -34.46 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.11 -21.73 64.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.693 -0.629 . . . . 0.0 109.824 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.54 -31.17 68.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -91.14 -15.9 28.64 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.209 0.459 . . . . 0.0 111.947 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.5 mt -91.52 -9.73 43.32 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.637 0.199 . . . . 0.0 111.201 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.53 4.63 57.98 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.958 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.51 165.64 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.998 0.899 . . . . 0.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -72.2 123.95 24.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -76.59 150.79 82.37 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -63.71 151.03 86.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.84 2.36 . . . . 0.0 110.721 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.6 m -88.23 -19.99 26.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.866 0.467 . . . . 0.0 110.903 -175.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.1 t -146.64 154.16 41.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.37 138.9 46.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 122.413 0.285 . . . . 0.0 110.896 -175.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -147.1 125.49 12.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.191 0.996 . . . . 0.0 108.352 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.63 150.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 C-N-CA 122.728 0.411 . . . . 0.0 110.333 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -145.0 161.12 40.18 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.779 0.832 . . . . 0.0 109.119 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 19.5 m -118.96 142.15 48.04 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.403 0.281 . . . . 0.0 111.075 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.68 150.5 34.66 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -78.35 132.99 37.64 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 21.0 m 54.35 19.61 2.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.965 0.906 . . . . 0.0 112.786 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -110.63 -14.5 14.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.744 0.418 . . . . 0.0 111.109 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 50.28 31.26 5.06 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.991 0.916 . . . . 0.0 112.868 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.3 t -140.61 158.13 44.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.979 0.512 . . . . 0.0 110.147 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.8 m -125.13 153.43 43.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.612 0.765 . . . . 0.0 112.034 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.0 m -147.9 162.14 39.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.478 1.511 . . . . 0.0 108.528 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.07 177.8 39.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.475 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 84.6 mt -98.91 139.47 34.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.817 -173.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -127.87 116.37 20.03 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' TRP . . . . . 0.426 ' HB3' ' H ' ' A' ' 527' ' ' THR . 3.0 p90 -166.09 150.47 8.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.744 1.618 . . . . 0.0 107.058 168.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.58 120.83 7.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 42.3 t -159.48 152.9 22.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -66.45 -46.1 77.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.97 0.804 . . . . 0.0 111.17 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 68.6 p -84.34 -33.3 23.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.859 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -76.5 -31.31 57.63 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.843 0.747 . . . . 0.0 110.903 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.95 -31.28 58.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.052 0.387 . . . . 0.0 110.752 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.13 -29.73 38.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.132 0.424 . . . . 0.0 111.575 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -71.86 -40.7 68.8 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.39 . . . . 0.0 109.992 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 33.1 m -70.1 -31.68 69.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.41 -45.87 85.74 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.335 -0.853 . . . . 0.0 110.529 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.21 -27.19 70.51 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.041 -0.866 . . . . 0.0 113.421 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.75 -10.7 13.58 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.627 1.213 . . . . 0.0 114.198 -176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -26.84 13.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.304 0.956 . . . . 0.0 110.941 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -60.39 138.21 58.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.059 -1.026 . . . . 0.0 110.951 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 40.3 m170 51.61 26.33 3.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.409 1.084 . . . . 0.0 113.544 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.4 151.36 47.57 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.173 0.511 . . . . 0.0 112.336 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -103.69 136.4 43.46 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.183 0.993 . . . . 0.0 110.694 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 564' ' ' MET . . . . . 0.421 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.4 ttt -64.34 174.92 1.47 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.06 0.544 . . . . 0.0 111.255 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -75.32 11.91 1.09 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -68.68 146.67 97.75 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 118.271 0.487 . . . . 0.0 110.332 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.39 -37.95 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.252 2.634 . . . . 0.0 113.831 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -121.03 6.83 10.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.1 45.24 92.52 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.107 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 570' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.4 Cg_endo -68.99 -9.8 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.22 2.613 . . . . 0.0 111.866 -178.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -146.17 149.07 37.22 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.011 0.524 . . . . 0.0 109.721 174.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.83 148.96 41.83 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.903 3.068 . . . . 0.0 110.97 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' TYR . . . . . 0.421 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.5 t80 -149.92 15.47 0.84 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.847 0.459 . . . . 0.0 110.932 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 81.9 p -80.18 91.06 5.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.123 -0.986 . . . . 0.0 110.752 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.94 144.55 38.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -107.61 154.02 22.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -143.44 151.54 40.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 111.437 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.64 163.79 39.47 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.699 0.8 . . . . 0.0 110.032 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.38 140.58 50.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 73.8 p -135.58 143.47 45.66 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.553 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 28.0 p -84.4 102.26 12.62 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.45 34.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.664 0.786 . . . . 0.0 110.976 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.67 -8.64 12.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.036 0.535 . . . . 0.0 110.595 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -160.92 162.9 32.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.016 0.926 . . . . 0.0 109.326 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.93 76.4 9.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.866 178.857 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.981 0.42 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.86 -5.88 24.24 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.077 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.6 m -148.47 152.73 39.1 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -85.48 2.35 7.77 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.659 3.573 . . . . 0.0 112.34 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.94 152.23 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.906 0.482 . . . . 0.0 111.356 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.1 pp -142.54 170.3 15.96 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.719 0.807 . . . . 0.0 110.445 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.38 149.71 47.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.916 0.486 . . . . 0.0 110.207 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.99 150.39 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.794 0.438 . . . . 0.0 110.952 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -140.25 168.99 18.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.82 0.848 . . . . 0.0 109.514 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.99 -5.1 77.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.945 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.761 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -72.0 176.68 4.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.83 0.815 . . . . 0.0 110.586 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.06 131.85 25.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -68.12 -7.88 33.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.7 t -91.81 -15.69 27.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.663 0.665 . . . . 0.0 112.104 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.38 5.26 1.24 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 15.4 tpt -150.9 102.52 2.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -141.86 -166.44 2.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.941 0.497 . . . . 0.0 110.342 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 78.0 m -52.53 -27.08 15.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.13 -28.2 24.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.378 0.536 . . . . 0.0 111.674 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -83.91 -31.85 25.45 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.23 -26.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.4 -30.58 62.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -81.5 -17.77 47.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.318 -0.372 . . . . 0.0 111.914 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.27 -22.2 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -110.95 -18.8 12.99 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.94 -21.89 60.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.327 0.967 . . . . 0.0 112.333 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.57 10.43 1.72 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.618 -0.676 . . . . 0.0 112.467 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -121.43 -2.71 9.45 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.923 0.889 . . . . 0.0 110.975 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 152.0 154.43 6.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.23 134.95 51.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.277 0.538 . . . . 0.0 110.298 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.07 154.02 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.05 -59.6 1.67 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.018 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' LYS . . . . . 0.439 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.1 pttm -160.93 162.33 31.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.648 0.379 . . . . 0.0 111.296 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.35 150.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 123.924 0.889 . . . . 0.0 109.792 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.23 145.3 26.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.505 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.24 145.34 27.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.595 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -132.1 141.66 49.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -167.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.19 33.93 21.06 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 125.769 1.628 . . . . 0.0 112.371 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 53.02 14.79 0.5 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 142.83 57.89 Favored Pre-proline 0 N--CA 1.456 -0.144 0 CA-C-N 118.802 0.728 . . . . 0.0 109.956 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.9 -0.19 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.412 2.741 . . . . 0.0 110.471 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.13 31.92 2.4 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.479 -0.623 . . . . 0.0 112.887 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.595 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -148.34 134.08 18.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.001 0.901 . . . . 0.0 110.154 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.8 170.93 19.09 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.951 0.405 . . . . 0.0 111.642 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -141.5 144.21 34.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.95 0.9 . . . . 0.0 109.505 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.93 146.73 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.145 0.578 . . . . 0.0 111.031 -171.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -131.01 145.26 51.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.482 0.713 . . . . 0.0 109.758 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 76.8 mtp -126.52 164.41 21.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.665 0.386 . . . . 0.0 110.758 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.29 -19.31 64.69 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.85 154.81 31.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.23 0.468 . . . . 0.0 110.243 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.72 -14.41 78.05 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.92 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -70.68 -20.14 62.72 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.341 1.57 . . . . 0.0 110.707 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.68 -31.98 18.23 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.1 t -67.73 -37.59 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -67.06 -30.65 70.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.501 0.321 . . . . 0.0 111.145 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -37.1 65.95 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.56 -24.85 41.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.437 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 8.2 mm -77.13 -30.92 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.708 0.803 . . . . 0.0 110.56 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.9 m -93.17 -21.64 19.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -138.7 -19.17 1.05 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -95.76 -15.14 22.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.222 0.919 . . . . 0.0 109.158 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -54.08 142.97 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.116 0.966 . . . . 0.0 110.153 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.15 1.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -87.81 142.53 27.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.735 1.607 . . . . 0.0 109.522 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.409 ' HB2' ' HG3' ' A' ' 446' ' ' MET 0.298 0.1 OUTLIER -130.88 164.04 26.13 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 171.726 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.14 143.35 50.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.909 1.283 . . . . 0.0 108.573 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 63.64 32.52 13.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.23 15.99 80.85 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 116.039 1.175 . . . . 0.0 116.039 168.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -83.17 153.0 25.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.392 1.596 . . . . 0.0 110.557 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 141.87 34.89 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' MET . . . . . 0.409 ' HG3' ' HB2' ' A' ' 440' ' ' PHE . 1.6 mpt? -96.29 122.09 38.78 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -140.72 115.74 9.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.08 142.06 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.057 0 CA-C-N 118.348 0.522 . . . . 0.0 110.234 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 98.2 m -147.19 168.83 20.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.704 0.802 . . . . 0.0 110.054 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 152.67 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 27.1 t -126.51 163.14 24.02 Favored 'General case' 0 CA--C 1.526 0.027 0 CA-C-N 117.845 0.293 . . . . 0.0 110.582 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -103.88 8.89 36.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.805 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -65.56 149.99 96.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.924 -0.485 . . . . 0.0 109.782 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.05 -27.5 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.855 2.37 . . . . 0.0 111.992 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.48 171.65 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.161 0.585 . . . . 0.0 110.357 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ILE . . . . . 0.439 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 40.6 mm -68.89 135.67 27.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.4 mtt -95.72 150.31 37.23 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 122.07 0.148 . . . . 0.0 110.819 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.94 163.81 37.04 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.887 3.058 . . . . 0.0 111.494 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.72 -174.56 44.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.93 151.47 38.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.4 p -140.12 159.06 43.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.127 0.571 . . . . 0.0 110.365 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.09 167.7 28.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.216 0.607 . . . . 0.0 109.895 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.59 141.44 25.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.59 168.09 13.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.793 0.837 . . . . 0.0 109.54 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.6 -20.17 66.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.072 -0.392 . . . . 0.0 111.519 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.22 -1.3 44.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.83 0.452 . . . . 0.0 111.392 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.72 -4.5 86.19 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.632 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.1 m -93.33 160.79 14.66 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.23 1.015 . . . . 0.0 110.276 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 73.2 m -81.38 153.37 27.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.009 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.6 p -71.13 -10.8 60.37 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.82 0.448 . . . . 0.0 111.625 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -129.88 141.78 50.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.354 1.061 . . . . 0.0 109.393 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -154.51 158.89 40.55 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.416 0.286 . . . . 0.0 110.715 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -131.04 148.55 52.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.127 0.971 . . . . 0.0 109.355 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -136.85 7.81 2.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.687 0.395 . . . . 0.0 111.855 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.454 -0.256 0 C-N-CA 122.576 0.35 . . . . 0.0 111.209 -175.074 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -66.2 162.62 45.92 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.93 150.15 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.154 3.236 . . . . 0.0 113.499 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 37.9 m -123.95 18.92 9.3 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.548 0.739 . . . . 0.0 111.566 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.1 m120 59.92 10.78 2.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.407 1.083 . . . . 0.0 113.559 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.4 t -142.12 145.27 24.11 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 48.9 mt -117.55 166.56 12.23 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.201 0.524 . . . . 0.0 111.557 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -137.56 148.81 46.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.784 0.834 . . . . 0.0 109.027 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -133.57 153.25 51.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.663 0.385 . . . . 0.0 110.882 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -147.64 171.29 15.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.624 0.369 . . . . 0.0 111.33 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 24.9 m120 61.57 16.54 7.74 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -79.96 156.19 74.79 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.24 157.09 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.671 2.248 . . . . 0.0 111.888 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.3 pt? -72.45 -1.26 15.08 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.64 8.73 29.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.967 0.349 . . . . 0.0 111.93 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.42 150.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.91 0.323 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 71.8 p -145.9 175.63 10.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.787 0.835 . . . . 0.0 109.693 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.38 -25.65 68.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.446 -0.158 . . . . 0.0 111.019 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -74.99 -24.64 58.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.614 0.188 . . . . 0.0 110.714 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -79.41 -29.96 42.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -73.26 -25.46 60.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.297 -0.252 . . . . 0.0 110.44 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -78.95 -36.58 41.35 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.983 -0.448 . . . . 0.0 111.661 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.12 -15.7 55.15 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.143 0.428 . . . . 0.0 111.612 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.97 -35.09 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.199 0.454 . . . . 0.0 109.832 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.8 m -70.52 -17.8 62.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.736 -0.602 . . . . 0.0 110.215 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.43 -30.27 61.83 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.578 -0.249 . . . . 0.0 111.512 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.05 -14.8 30.64 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.373 0.533 . . . . 0.0 111.421 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.62 -13.05 24.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.865 0.466 . . . . 0.0 111.301 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 70.57 6.52 58.89 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.82 -0.433 . . . . 0.0 112.791 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.2 m -85.93 167.31 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.679 0.739 . . . . 0.0 110.802 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -74.64 150.01 39.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 111.063 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.31 150.71 41.9 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 123.498 0.719 . . . . 0.0 110.283 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.9 156.56 65.42 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.472 2.781 . . . . 0.0 110.669 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.8 m -86.26 -22.8 26.65 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.864 0.466 . . . . 0.0 110.605 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 14.8 t -149.38 155.23 40.14 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.53 144.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.769 0.427 . . . . 0.0 110.457 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -134.58 130.53 36.65 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.23 143.45 35.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.754 0.422 . . . . 0.0 109.919 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -154.0 135.11 13.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.028 0.531 . . . . 0.0 110.025 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.9 m . . . . . 0 C--O 1.23 0.078 0 C-N-CA 122.51 0.324 . . . . 0.0 110.25 -179.535 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 75.2 p -145.13 168.28 20.73 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.895 0.378 . . . . 0.0 111.321 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 48.4 t -133.38 150.65 51.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.159 0.984 . . . . 0.0 110.781 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 37.0 m -145.55 162.97 36.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.031 1.333 . . . . 0.0 109.055 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.57 -168.8 41.26 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.485 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.29 159.74 22.21 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.091 0.556 . . . . 0.0 111.403 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 87.6 mt -137.38 135.06 36.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.694 1.198 . . . . 0.0 107.836 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.78 110.36 12.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.458 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.1 p90 -165.99 156.03 12.46 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.425 1.49 . . . . 0.0 107.477 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.73 117.1 6.49 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.652 0.66 . . . . 0.0 112.719 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 28.7 m -159.54 153.06 22.57 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 126.149 1.78 . . . . 0.0 106.28 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.83 -51.39 49.08 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.512 0.596 . . . . 0.0 111.509 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 50.2 m -79.71 -24.33 41.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.92 -34.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.39 0.541 . . . . 0.0 111.677 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.41 -26.42 38.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.015 0.37 . . . . 0.0 111.038 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.1 tp -85.12 -29.52 24.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.255 0.48 . . . . 0.0 111.73 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -75.45 -38.5 59.66 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.088 0.404 . . . . 0.0 110.042 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.0 m -70.15 -33.93 72.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.7 -42.75 90.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.18 -24.7 75.04 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.292 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -113.86 -14.78 12.47 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.627 1.214 . . . . 0.0 114.105 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.43 -20.65 17.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.524 1.056 . . . . 0.0 111.085 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -74.41 139.44 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.6 t60 52.23 35.88 17.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.587 0.755 . . . . 0.0 112.122 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -99.2 151.32 21.14 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.25 136.31 36.91 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.585 1.554 . . . . 0.0 111.139 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 564' ' ' MET . . . . . 0.422 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.7 ttt -64.07 174.51 1.52 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.438 0.695 . . . . 0.0 112.078 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 565' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.5 ttmm -68.65 -2.1 8.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.174 0.99 . . . . 0.0 112.504 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -60.96 141.95 93.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 121.492 -0.755 . . . . 0.0 110.569 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.18 -28.54 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.74 2.96 . . . . 0.0 113.918 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -121.01 -0.94 9.92 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.07 0.395 . . . . 0.0 111.829 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.39 41.27 99.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.997 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 79.1 Cg_endo -69.9 -10.7 29.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.884 2.39 . . . . 0.0 111.888 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.46 148.41 47.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.187 0.595 . . . . 0.0 109.959 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.63 153.36 38.81 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.707 2.938 . . . . 0.0 111.149 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -147.99 0.7 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.081 0.553 . . . . 0.0 111.41 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 12.3 t -66.43 125.55 26.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.283 -0.885 . . . . 0.0 110.781 -170.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.14 144.63 50.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.355 1.062 . . . . 0.0 109.991 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.6 157.82 16.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.285 0.234 . . . . 0.0 110.732 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.43 144.97 50.86 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.229 0.611 . . . . 0.0 109.689 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 27.9 p -160.49 167.37 27.36 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.159 0.584 . . . . 0.0 110.408 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -82.07 139.0 34.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 38.0 t -135.6 145.13 46.58 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.148 0.179 . . . . 0.0 110.883 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 19.3 p -79.98 102.28 9.15 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.12 161.56 34.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.954 0.902 . . . . 0.0 110.325 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 -12.44 11.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.782 0.433 . . . . 0.0 110.987 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -161.13 162.48 31.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.681 0.792 . . . . 0.0 109.538 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -91.35 76.83 5.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.518 0.327 . . . . 0.0 110.132 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.217 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.529 179.672 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.54 -7.4 59.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.965 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.6 m -147.49 152.15 41.34 Favored Pre-proline 0 C--N 1.34 0.156 0 C-N-CA 123.15 0.58 . . . . 0.0 110.89 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -82.5 3.34 7.89 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.446 3.431 . . . . 0.0 112.631 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.8 164.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 112.464 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 381' ' ' LEU . 4.3 pp -149.45 171.23 16.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.23 1.012 . . . . 0.0 109.149 174.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' MET . . . . . 0.407 ' CE ' ' HE1' ' A' ' 412' ' ' MET . 80.8 mtp -138.11 152.12 48.45 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.411 0.284 . . . . 0.0 111.257 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.02 144.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -135.86 168.03 20.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.953 0.501 . . . . 0.0 110.411 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.31 69.26 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.972 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.757 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -70.06 170.71 10.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.501 0.65 . . . . 0.0 111.741 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -127.01 130.85 50.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.613 0.765 . . . . 0.0 109.434 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -71.87 6.83 1.82 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.6 p -121.28 0.67 10.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.98 -13.12 2.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.164 0.586 . . . . 0.0 110.704 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -141.84 121.02 12.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.133 0.973 . . . . 0.0 108.795 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.565 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 19.4 m120 -141.89 -179.97 6.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.87 0.868 . . . . 0.0 109.337 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.99 -22.79 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.982 0.113 . . . . 0.0 111.231 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -88.03 -26.06 22.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.014 -0.429 . . . . 0.0 111.717 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ARG . . . . . 0.565 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.4 mpt_? -83.36 -32.0 26.45 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.271 0.487 . . . . 0.0 109.702 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.9 p -72.44 -31.46 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -69.09 -29.57 67.7 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -80.78 -17.3 51.36 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.6 t -109.62 -23.78 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 118.437 0.562 . . . . 0.0 112.378 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.96 -16.37 14.16 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.689 0.677 . . . . 0.0 112.423 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 t -77.49 -16.02 58.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.124 0.875 . . . . 0.0 110.977 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.6 10.72 1.58 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.803 -0.561 . . . . 0.0 112.296 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 -3.17 9.38 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.721 0.808 . . . . 0.0 111.071 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.07 164.54 11.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.45 147.26 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.9 0.85 . . . . 0.0 111.702 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.49 155.47 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -96.76 -63.88 1.1 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -163.1 166.57 23.35 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.4 0.68 . . . . 0.0 110.338 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.51 151.7 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.214 0.606 . . . . 0.0 110.501 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -149.99 139.49 21.51 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.301 0.241 . . . . 0.0 110.822 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -77.25 152.28 34.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.407 ' HE1' ' CE ' ' A' ' 382' ' ' MET . 6.0 ptm -130.85 141.64 50.33 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -167.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 60.28 33.76 20.89 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.77 1.228 . . . . 0.0 112.275 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.3 m 55.42 14.79 1.22 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.296 1.039 . . . . 0.0 113.435 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -89.02 137.6 29.54 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.35 -8.56 18.57 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.964 2.443 . . . . 0.0 109.332 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.65 23.3 17.83 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.69 1.138 . . . . 0.0 113.128 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -150.75 137.27 18.78 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.973 1.387 . . . . 0.0 111.268 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -159.61 170.61 21.24 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.128 0.489 . . . . 0.0 111.363 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.5 ptm -139.39 147.44 41.46 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.375 0.67 . . . . 0.0 109.96 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.5 t -128.23 152.15 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.24 0.616 . . . . 0.0 110.76 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -129.58 141.46 50.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.585 0.754 . . . . 0.0 109.4 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 97.9 mmm -114.43 162.53 16.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.849 0.46 . . . . 0.0 110.719 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.83 60.74 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.318 0.247 . . . . 0.0 111.604 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.91 160.88 40.51 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.86 -12.22 84.76 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.199 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -75.38 -17.63 60.16 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.857 1.328 . . . . 0.0 111.32 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -89.84 -26.23 20.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.249 -0.282 . . . . 0.0 110.486 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.22 -34.27 37.07 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.29 -26.64 56.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.517 0.199 . . . . 0.0 110.625 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -25.74 48.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.68 31.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.038 0.135 . . . . 0.0 110.766 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 433' ' ' ILE . 3.1 tp -82.65 -30.95 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 121.813 -0.554 . . . . 0.0 111.121 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 24.0 m -94.82 -19.69 20.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -136.22 -5.91 2.07 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.59 -19.21 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.168 0.895 . . . . 0.0 109.461 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -51.95 143.13 14.22 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.895 0.878 . . . . 0.0 110.629 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.8 1.42 0.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.819 1.648 . . . . 0.0 114.992 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -88.47 142.76 27.45 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.544 -1.348 . . . . 0.0 109.117 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.271 0.1 OUTLIER -130.94 163.98 26.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 171.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.25 143.47 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.175 0.99 . . . . 0.0 109.625 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 64.72 30.5 12.4 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.368 1.467 . . . . 0.0 114.45 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.43 15.64 77.3 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 168.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.25 161.28 21.55 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.506 1.153 . . . . 0.0 110.19 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.587 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -91.63 128.59 37.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.329 0.513 . . . . 0.0 110.825 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.62 142.42 30.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -140.71 127.2 20.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.34 140.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-N 118.359 0.527 . . . . 0.0 110.718 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.7 m -150.59 163.69 37.86 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.26 1.024 . . . . 0.0 109.923 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.86 156.43 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.8 t -131.23 162.99 28.75 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 122.912 0.485 . . . . 0.0 109.725 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -105.69 5.69 31.3 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -67.42 144.93 98.24 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 121.694 -0.629 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.96 -24.68 11.13 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.151 2.567 . . . . 0.0 111.692 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.89 173.2 12.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.841 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.7 mm -71.33 142.52 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.43 154.89 37.85 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 117.472 0.124 . . . . 0.0 111.268 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.65 165.37 8.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.104 3.203 . . . . 0.0 112.477 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.89 177.86 37.77 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -81.81 166.07 20.31 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.834 0.453 . . . . 0.0 110.199 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.3 p -143.04 159.94 41.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.75 0.42 . . . . 0.0 110.973 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -151.33 173.15 14.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.768 0.827 . . . . 0.0 109.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.66 135.07 13.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.99 173.1 12.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.345 0.658 . . . . 0.0 109.828 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.4 -23.02 67.14 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.703 0.401 . . . . 0.0 111.329 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -81.7 -1.4 46.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.017 0.527 . . . . 0.0 111.332 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.27 84.43 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.087 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 77.6 p -84.06 163.96 19.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.537 0.668 . . . . 0.0 110.78 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.72 151.83 28.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 111.056 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 75.5 m -73.16 -10.45 59.79 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.435 0.694 . . . . 0.0 111.841 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -133.73 143.45 48.48 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.665 0.786 . . . . 0.0 109.762 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -157.18 156.86 33.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.733 0.413 . . . . 0.0 110.551 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -127.65 149.28 50.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.269 1.028 . . . . 0.0 109.503 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.99 13.89 2.87 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.84 0.456 . . . . 0.0 111.413 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 CA--C 1.53 0.197 0 O-C-N 122.079 -0.388 . . . . 0.0 111.784 -174.546 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -62.35 159.41 40.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.44 131.32 36.21 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.304 2.669 . . . . 0.0 112.492 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.6 m -124.07 23.86 8.37 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.691 0.796 . . . . 0.0 111.464 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 60.75 10.99 2.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.891 1.276 . . . . 0.0 114.043 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.53 141.78 36.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 40.8 mt -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.326 0.65 . . . . 0.0 110.283 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 580' ' ' SER . 0.6 OUTLIER -141.51 161.98 36.59 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.377 0.271 . . . . 0.0 110.956 173.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -139.06 157.06 46.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.726 0.41 . . . . 0.0 111.328 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -150.53 174.3 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.203 0.601 . . . . 0.0 111.066 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 11.7 t30 64.98 11.35 6.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.911 1.284 . . . . 0.0 113.656 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -73.2 161.66 78.19 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -70.33 155.68 63.51 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.903 1.735 . . . . 0.0 110.18 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.9 pt? -69.73 -1.12 8.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.31 9.0 18.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.95 151.21 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 118.009 0.368 . . . . 0.0 110.932 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.9 p -142.15 173.28 11.67 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.361 0.664 . . . . 0.0 110.516 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.18 -21.31 64.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.885 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.05 -22.81 58.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.348 -0.22 . . . . 0.0 110.487 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -82.34 -30.19 30.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.79 -25.66 61.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.761 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -84.34 -34.96 23.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.11 0.414 . . . . 0.0 111.468 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -76.88 -21.99 54.1 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.281 0.491 . . . . 0.0 111.133 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 74.0 mt -84.83 -37.88 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.937 0.335 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.5 m -66.64 -24.68 66.33 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.113 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.91 -30.42 63.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.245 -0.284 . . . . 0.0 111.761 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -91.04 -11.09 39.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.375 0.534 . . . . 0.0 112.0 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.6 mt -96.19 -7.7 35.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.774 0.429 . . . . 0.0 111.084 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.88 7.97 81.73 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.77 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -97.78 165.2 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 117.83 0.815 . . . . 0.0 110.645 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -83.19 151.67 25.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.742 0.417 . . . . 0.0 111.065 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -91.08 155.2 44.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.474 0.71 . . . . 0.0 110.717 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.95 158.74 45.73 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.296 2.664 . . . . 0.0 111.285 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 81.5 m -89.96 -26.39 20.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.0 m -139.38 150.06 44.87 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.06 144.27 25.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 123.042 0.537 . . . . 0.0 110.849 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -142.16 138.89 31.89 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 29.6 t -136.39 145.77 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 122.595 0.358 . . . . 0.0 110.425 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -151.94 164.19 37.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 N--CA 1.457 -0.085 0 O-C-N 121.867 -0.52 . . . . 0.0 111.242 -178.829 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 99.0 p -137.47 169.58 17.55 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.802 0.441 . . . . 0.0 111.538 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.6 t -125.43 153.88 42.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.371 1.068 . . . . 0.0 110.799 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 78.4 p -152.88 171.22 18.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.72 1.208 . . . . 0.0 109.627 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 166.63 -172.91 41.97 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.129 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.54 152.68 32.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 66.8 mt -136.71 134.89 37.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.73 1.212 . . . . 0.0 107.856 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -127.78 113.1 15.53 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -166.09 153.94 10.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.639 1.576 . . . . 0.0 106.775 167.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -148.87 118.6 7.04 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.3 t -159.46 153.1 22.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.582 1.553 . . . . 0.0 107.025 168.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.38 -63.8 1.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.971 0.35 . . . . 0.0 111.739 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 74.2 p -82.28 -17.25 46.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.09 -41.35 28.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.298 0.499 . . . . 0.0 110.682 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -78.14 -31.78 49.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.596 -0.24 . . . . 0.0 110.968 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.5 tp -77.25 -30.49 54.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.671 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -74.8 -40.2 61.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.94 -0.475 . . . . 0.0 110.548 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.3 m -63.99 -49.98 70.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.59 -0.243 . . . . 0.0 110.347 -175.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 556' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 556' ' ' LEU . 3.5 pp -77.51 -18.9 56.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.833 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -69.21 -26.58 74.51 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.12 -7.38 11.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.596 0.698 . . . . 0.0 112.604 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 46.3 tp -98.23 -19.36 17.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 0.0 111.701 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -74.48 144.43 44.17 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 80.2 t60 51.11 35.83 14.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.019 0.528 . . . . 0.0 112.039 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -97.27 151.42 19.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.709 0.804 . . . . 0.0 111.691 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -102.6 136.33 42.62 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.181 1.392 . . . . 0.0 110.549 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.3 ttt -64.11 173.87 1.77 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.066 0.547 . . . . 0.0 111.499 -174.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -70.25 9.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -66.5 146.84 99.09 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 118.55 0.614 . . . . 0.0 110.081 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.84 -30.02 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.42 2.747 . . . . 0.0 113.917 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -121.06 2.18 10.41 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.438 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.14 40.16 98.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.686 -1.064 . . . . 0.0 112.891 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 80.9 Cg_endo -69.45 -9.99 27.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.272 2.648 . . . . 0.0 112.073 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -142.61 148.26 45.92 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 122.823 0.449 . . . . 0.0 110.086 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.84 156.69 43.72 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.603 2.868 . . . . 0.0 111.477 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -148.59 6.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.038 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 3.0 t -66.48 122.1 16.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.611 -0.681 . . . . 0.0 110.118 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 575' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.9 pt? -124.97 144.6 50.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 109.78 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -96.16 142.12 28.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.526 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.62 144.91 41.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 41.8 t -163.14 163.2 25.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -75.83 148.37 38.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.448 ' HB3' ' CG ' ' A' ' 501' ' ' HIS . 92.9 p -135.4 149.16 49.58 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.171 0.188 . . . . 0.0 110.606 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 31.3 p -90.02 102.19 14.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.36 161.47 34.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.654 0.782 . . . . 0.0 111.156 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -97.73 -25.79 14.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -163.85 152.72 13.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.506 1.122 . . . . 0.0 108.57 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -85.94 76.51 9.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.942 0.401 . . . . 0.0 110.35 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 36.3 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.869 177.484 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.777 0.323 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -144.79 17.03 1.61 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.22 0.608 . . . . 0.0 110.535 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.2 m -143.44 152.8 57.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 122.395 0.278 . . . . 0.0 111.13 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.209 3.273 . . . . 0.0 112.831 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 89.3 t -123.28 148.13 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 118.684 0.675 . . . . 0.0 110.811 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.3 164.12 30.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 110.692 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 73.6 mmm -127.33 149.38 50.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.505 0.722 . . . . 0.0 110.331 -176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.36 148.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.645 0.259 . . . . 0.0 110.743 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -141.13 170.99 14.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.702 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.46 -4.54 81.3 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.299 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -71.72 175.75 5.43 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.038 0.919 . . . . 0.0 110.522 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.69 135.57 44.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.802 0.441 . . . . 0.0 109.889 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -73.46 4.84 4.29 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -172.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.9 m -115.36 -2.11 12.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.076 0.398 . . . . 0.0 111.845 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -138.12 -0.95 2.0 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.435 0.694 . . . . 0.0 110.685 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -154.53 121.11 5.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -141.97 -176.52 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.79 0.436 . . . . 0.0 110.62 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 25.5 p -57.01 -30.22 64.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.301 0.641 . . . . 0.0 112.671 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.0 -25.92 25.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.023 -0.423 . . . . 0.0 110.756 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -79.99 -32.48 39.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -75.6 -27.05 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -68.82 -29.42 67.76 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 171.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.38 -23.05 47.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.026 -0.421 . . . . 0.0 111.981 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 71.4 t -94.61 -21.36 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -114.59 -13.93 12.11 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.2 t -73.9 -21.92 59.89 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.306 0.957 . . . . 0.0 111.085 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.48 10.41 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.645 -0.659 . . . . 0.0 112.385 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.45 -11.41 8.73 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.248 0.619 . . . . 0.0 111.434 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 160.97 174.61 31.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -68.41 141.47 55.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.535 -0.391 . . . . 0.0 110.871 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.6 t -104.56 147.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -101.38 -58.32 1.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.231 -0.293 . . . . 0.0 110.351 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -165.3 169.41 15.89 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.957 0.503 . . . . 0.0 110.685 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.35 150.88 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.069 0 C-N-CA 123.739 0.816 . . . . 0.0 110.216 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 411' ' ' PHE . 51.4 tptt -147.18 137.54 23.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.749 0.82 . . . . 0.0 109.093 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' PHE . . . . . 0.405 ' O ' ' HE3' ' A' ' 410' ' ' LYS . 4.3 m-85 -76.53 136.2 39.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 22.1 ttp -93.64 140.97 29.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 47.42 33.84 3.01 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 112.248 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.5 m 52.95 17.99 1.0 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.443 1.097 . . . . 0.0 113.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -75.95 149.53 82.82 Favored Pre-proline 0 N--CA 1.456 -0.159 0 CA-C-N 118.564 0.62 . . . . 0.0 109.897 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.43 4.4 6.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.882 3.055 . . . . 0.0 110.975 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.51 32.06 1.36 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.299 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.83 141.76 25.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.187 0.993 . . . . 0.0 110.439 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.37 170.28 22.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.941 0.4 . . . . 0.0 111.373 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.4 ptm -145.76 145.06 30.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.733 0.813 . . . . 0.0 109.512 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.37 153.22 38.58 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.299 0.639 . . . . 0.0 110.32 -173.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -127.67 143.67 51.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.691 0.797 . . . . 0.0 110.07 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 79.4 mtp -129.38 166.64 19.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.425 0.69 . . . . 0.0 110.134 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.54 -23.82 65.47 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.17 160.21 38.52 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.252 0.478 . . . . 0.0 110.576 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.77 -12.35 80.82 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.451 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -67.93 -25.56 65.53 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.231 1.515 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.9 -27.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.5 t -73.54 -32.96 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.75 -25.96 66.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.048 0.539 . . . . 0.0 110.212 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -82.43 -27.19 32.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.375 -0.203 . . . . 0.0 110.691 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.21 -28.34 29.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.464 0.173 . . . . 0.0 110.56 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.84 -31.11 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.336 0.654 . . . . 0.0 110.853 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 m -98.88 -19.55 17.3 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -135.59 -4.28 2.3 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.72 -15.29 11.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.857 0.753 . . . . 0.0 109.458 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -58.02 149.87 22.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.481 0.658 . . . . 0.0 111.954 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 56.83 1.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.024 1.73 . . . . 0.0 114.616 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -88.04 142.56 27.68 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.961 1.255 . . . . 0.0 109.46 168.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.321 0.1 OUTLIER -130.93 164.03 26.2 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 170.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 18.7 ptm -125.26 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 66.07 24.01 11.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.01 16.01 80.98 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -83.2 156.31 23.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.085 1.443 . . . . 0.0 111.811 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.86 139.96 49.1 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.58 0.752 . . . . 0.0 109.592 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.96 122.04 39.5 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -140.75 119.75 12.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.12 142.61 20.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 118.008 0.367 . . . . 0.0 110.751 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 73.3 m -148.41 174.92 11.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.682 0.793 . . . . 0.0 110.715 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.71 156.05 13.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 34.9 t -137.27 146.12 44.34 Favored 'General case' 0 N--CA 1.461 0.101 0 O-C-N 122.1 -0.375 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -85.43 6.56 26.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.076 0.551 . . . . 0.0 112.237 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' GLN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 454' ' ' PRO . 47.4 mt-30 -62.09 132.24 93.69 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 453' ' ' GLN . 37.0 Cg_exo -62.02 -32.05 84.01 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.691 2.261 . . . . 0.0 112.515 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -161.79 171.55 17.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.792 0.437 . . . . 0.0 110.9 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.74 143.26 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.81 149.61 44.07 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 122.227 0.211 . . . . 0.0 110.745 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.91 161.92 43.47 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.761 2.974 . . . . 0.0 111.765 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 166.39 -179.51 40.35 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -80.89 173.54 12.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.815 0.446 . . . . 0.0 109.834 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.1 p -140.43 161.86 36.71 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -150.99 165.18 34.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.722 0.809 . . . . 0.0 109.632 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 137.88 20.0 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.98 174.71 8.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.202 1.001 . . . . 0.0 109.437 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -68.41 -21.78 64.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.85 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -83.08 4.24 27.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.103 0.561 . . . . 0.0 111.792 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.62 -2.42 73.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.622 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.2 p -90.82 163.02 14.58 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.074 0.937 . . . . 0.0 110.222 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.3 m -81.28 153.41 27.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.032 -0.417 . . . . 0.0 111.114 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 89.5 p -71.18 -8.88 56.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -130.65 142.79 50.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.386 1.074 . . . . 0.0 109.036 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -153.21 157.38 40.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.721 0.408 . . . . 0.0 110.278 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.31 148.46 50.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.77 0.828 . . . . 0.0 109.812 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -137.2 14.93 3.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.999 0.52 . . . . 0.0 111.583 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.1 p . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.595 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 121.194 0.521 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -82.48 167.59 29.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 124.936 1.295 . . . . 0.0 109.991 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -49.82 125.67 14.93 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.099 2.533 . . . . 0.0 111.62 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.2 m -124.07 23.85 8.37 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.621 0.768 . . . . 0.0 112.292 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.6 m120 61.65 8.18 2.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.219 1.008 . . . . 0.0 113.52 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.98 146.27 20.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.851 0.86 . . . . 0.0 108.902 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.36 151.58 42.37 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.973 0.509 . . . . 0.0 110.667 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' HIS . . . . . 0.465 ' CE1' ' HB3' ' A' ' 580' ' ' SER . 0.3 OUTLIER -126.03 143.55 51.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -129.7 152.04 49.64 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.416 0.15 . . . . 0.0 110.829 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -150.12 172.27 15.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.815 0.446 . . . . 0.0 111.246 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.18 30.19 19.91 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.766 0.826 . . . . 0.0 112.791 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -94.16 153.98 40.6 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -56.55 150.87 49.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.732 2.288 . . . . 0.0 111.937 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -70.03 -0.98 8.53 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.96 6.95 23.58 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.41 151.61 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.964 -0.46 . . . . 0.0 110.826 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 59.9 p -143.73 171.39 14.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.421 0.689 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.32 -24.48 67.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.683 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.08 -22.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.187 -0.321 . . . . 0.0 110.447 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -81.35 -29.23 34.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.76 -25.13 58.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.054 -0.404 . . . . 0.0 110.875 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -80.96 -37.72 28.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.107 0.412 . . . . 0.0 111.246 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -76.34 -21.75 55.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.076 0.398 . . . . 0.0 111.199 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 64.0 mt -82.02 -37.77 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.2 m -66.82 -25.78 66.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.852 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.14 -30.16 64.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.77 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -91.06 -11.91 37.3 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.405 0.548 . . . . 0.0 111.818 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.7 mt -91.36 -10.32 41.62 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.991 0.517 . . . . 0.0 110.992 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.04 71.09 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.747 -0.474 . . . . 0.0 112.33 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.0 m -94.96 167.75 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 117.683 0.742 . . . . 0.0 110.438 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.42 147.41 27.88 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.91 0.386 . . . . 0.0 111.12 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -82.23 157.18 68.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.789 0.835 . . . . 0.0 111.25 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.16 155.16 69.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.414 2.743 . . . . 0.0 110.327 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.457 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -86.0 -24.9 26.27 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.716 0.406 . . . . 0.0 110.93 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 22.0 t -144.04 152.46 41.03 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -140.34 142.71 30.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.06 0.544 . . . . 0.0 109.975 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 129.52 21.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.39 147.8 32.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.826 0.451 . . . . 0.0 110.785 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -149.74 154.93 39.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.321 0.648 . . . . 0.0 109.947 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.231 0.08 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.863 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.5 t -145.33 162.23 37.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.622 0.369 . . . . 0.0 110.987 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 45.8 t -131.0 154.76 47.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.976 0.91 . . . . 0.0 111.435 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.9 p -149.39 171.21 16.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.073 1.349 . . . . 0.0 109.063 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.89 37.82 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.739 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.72 150.86 48.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.367 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.57 133.18 39.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -127.65 108.22 10.58 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.457 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -165.98 154.01 10.69 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.705 1.602 . . . . 0.0 106.926 167.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.21 122.75 7.92 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 548' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 551' ' ' ASP . 46.3 t -159.56 153.37 23.01 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.007 1.723 . . . . 0.0 106.504 168.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.44 -54.72 39.82 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.322 0.51 . . . . 0.0 111.572 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.6 p -87.34 -21.5 25.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 551' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 548' ' ' SER . 10.9 t70 -79.67 -36.67 37.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.243 0.474 . . . . 0.0 110.801 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.56 -32.63 28.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.675 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.73 -27.32 60.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.991 0.359 . . . . 0.0 110.75 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.91 -43.96 33.54 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.037 -0.414 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 95.7 m -70.44 -31.05 68.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 556' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.0 tm? -65.25 -42.16 93.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.56 -28.67 69.01 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.364 -0.686 . . . . 0.0 112.81 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.13 -13.43 15.44 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.0 -23.48 14.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.411 1.005 . . . . 0.0 112.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -69.95 142.35 52.9 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 48.96 35.29 6.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.817 0.847 . . . . 0.0 113.025 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -95.96 151.39 19.47 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -92.14 136.34 33.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.286 1.434 . . . . 0.0 111.324 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.2 ttt -64.36 176.0 1.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.251 0.62 . . . . 0.0 111.828 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -71.86 6.54 1.98 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -67.34 142.79 96.92 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.667 0.667 . . . . 0.0 110.6 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.45 -29.74 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.464 2.776 . . . . 0.0 113.672 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -120.58 1.01 10.58 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.968 0.349 . . . . 0.0 111.744 -174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.439 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.77 40.81 98.66 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.749 -1.029 . . . . 0.0 113.092 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 78.8 Cg_endo -69.16 -10.55 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.852 2.368 . . . . 0.0 111.993 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -144.24 147.57 37.77 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.053 0.541 . . . . 0.0 109.807 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.48 153.07 39.26 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.52 2.813 . . . . 0.0 111.3 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -149.03 -0.84 0.5 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.174 0.589 . . . . 0.0 111.583 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 10.2 t -66.49 124.86 23.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.521 -0.737 . . . . 0.0 109.687 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 575' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.8 pt? -124.99 144.56 50.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 0.0 110.939 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -82.66 147.6 28.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 49.5 tp -139.68 144.91 37.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.5 p -163.81 167.06 21.31 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -84.63 125.66 32.67 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 501' ' ' HIS . 31.8 t -135.69 148.79 49.03 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 85.0 m -79.53 105.43 10.83 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.556 0.217 . . . . 0.0 110.762 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.17 161.45 34.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.016 0.927 . . . . 0.0 109.75 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -126.67 -1.57 6.73 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.592 0.357 . . . . 0.0 110.996 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -148.82 161.62 41.46 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.881 0.872 . . . . 0.0 110.031 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.48 0.99 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.32 -1.324 . . . . 0.0 110.163 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.88 -8.67 55.49 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.504 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 40.7 m -148.06 152.48 40.02 Favored Pre-proline 0 N--CA 1.456 -0.146 0 C-N-CA 122.657 0.383 . . . . 0.0 111.205 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -83.57 0.28 9.49 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.276 3.318 . . . . 0.0 112.816 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.16 164.37 33.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.697 0.681 . . . . 0.0 112.465 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.28 164.16 35.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.087 0.955 . . . . 0.0 108.933 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 79.4 mtp -133.29 150.85 51.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.642 0.377 . . . . 0.0 110.811 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.92 149.15 23.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.868 0.467 . . . . 0.0 110.638 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -139.38 163.98 31.07 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.648 0.779 . . . . 0.0 110.113 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.34 -2.86 69.45 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.734 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.627 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.64 171.76 11.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.021 0.911 . . . . 0.0 110.98 178.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -126.09 137.4 53.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.688 0.395 . . . . 0.0 110.016 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -67.82 -7.86 31.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 60.9 p -99.11 -8.78 24.72 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -134.35 -8.46 2.57 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.174 0.443 . . . . 0.0 111.317 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.5 tpt -147.97 108.34 4.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.142 0.577 . . . . 0.0 109.588 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.452 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 51.4 p-10 -141.91 -173.12 3.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.328 0.651 . . . . 0.0 109.884 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 24.4 p -56.03 -27.66 54.08 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.864 0.466 . . . . 0.0 112.154 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.05 -37.96 21.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.071 -0.393 . . . . 0.0 110.891 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ARG . . . . . 0.452 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 7.8 mpt_? -75.76 -29.81 58.95 Favored 'General case' 0 C--O 1.23 0.041 0 O-C-N 122.206 -0.309 . . . . 0.0 110.805 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.42 -30.75 26.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -73.91 -27.48 61.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.642 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.16 -26.54 59.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.849 -0.532 . . . . 0.0 111.703 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.3 -24.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -106.24 -10.92 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.785 0.721 . . . . 0.0 112.846 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.51 -23.21 58.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.767 0.712 . . . . 0.0 111.772 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 402' ' ' LEU . 1.7 pp -77.28 12.56 1.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.631 -0.668 . . . . 0.0 112.263 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -120.74 -5.98 9.66 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.181 0.592 . . . . 0.0 111.088 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 151.85 -179.63 28.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -73.51 150.89 41.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.4 t -118.08 155.17 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.7 -57.45 2.25 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 118.712 0.687 . . . . 0.0 112.006 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' LYS . . . . . 0.426 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.9 pttm -161.72 164.06 29.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.986 0.422 . . . . 0.0 111.782 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.66 150.88 16.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.93 0.892 . . . . 0.0 109.871 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -151.91 145.07 24.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.01 144.5 30.82 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.724 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -126.11 141.54 51.9 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -167.614 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.21 34.08 21.03 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.576 1.55 . . . . 0.0 112.565 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.4 m 53.46 15.06 0.64 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.053 1.341 . . . . 0.0 114.201 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -82.7 136.95 44.49 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 118.444 0.566 . . . . 0.0 109.582 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.86 -9.56 16.9 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.873 2.382 . . . . 0.0 109.571 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.22 19.66 24.47 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.202 0.906 . . . . 0.0 112.977 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.724 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -152.24 143.2 23.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.61 1.205 . . . . 0.0 110.848 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.89 167.61 29.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.846 0.355 . . . . 0.0 111.672 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 24.5 ptm -142.38 146.45 34.94 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.118 0.567 . . . . 0.0 109.812 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.6 154.96 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 122.601 0.361 . . . . 0.0 110.982 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.84 141.71 51.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.846 0.858 . . . . 0.0 110.714 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 66.9 mtp -119.02 163.36 17.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.853 0.461 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.99 67.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.21 164.35 30.48 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.724 0.409 . . . . 0.0 110.159 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.12 -8.09 61.01 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.333 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -69.69 -28.28 65.71 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.55 1.675 . . . . 0.0 110.218 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -87.21 -24.8 24.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.8 t -75.88 -25.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.89 -42.61 73.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.243 -0.285 . . . . 0.0 110.431 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -69.05 -26.81 65.16 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.76 -40.22 33.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.095 -0.378 . . . . 0.0 111.294 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 433' ' ' ILE . 4.4 tp -81.38 -30.99 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.572 0.349 . . . . 0.0 111.902 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -99.9 -20.12 16.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -129.67 -8.59 4.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -174.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.48 -20.92 10.03 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.314 0.961 . . . . 0.0 109.635 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.31 144.79 12.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 58.02 1.38 0.14 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.235 2.214 . . . . 0.0 115.374 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -88.08 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.337 1.426 . . . . 0.0 108.307 168.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.308 0.0 OUTLIER -130.93 163.93 26.42 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 174.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.6 ptm -125.39 143.39 51.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.582 1.553 . . . . 0.0 109.86 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 63.92 32.59 13.09 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.121 1.368 . . . . 0.0 114.551 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.06 15.92 80.85 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.542 -0.588 . . . . 0.0 114.267 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.16 153.97 24.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.124 0.962 . . . . 0.0 110.122 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.578 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -88.85 131.28 35.17 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 175.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.59 130.92 45.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -140.76 113.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.15 139.93 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.415 0.552 . . . . 0.0 110.523 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 84.4 m -149.13 161.54 41.77 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.038 0.935 . . . . 0.0 110.113 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.4 p -82.47 156.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 43.9 t -132.94 157.9 43.99 Favored 'General case' 0 N--CA 1.459 0.024 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -99.57 6.21 45.83 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -65.66 142.59 98.3 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.49 -25.72 10.85 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.942 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.11 15.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 110.066 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ILE . . . . . 0.426 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 37.0 mm -69.35 138.57 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.68 151.22 42.13 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 122.395 0.278 . . . . 0.0 110.468 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.33 164.13 36.2 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.606 2.871 . . . . 0.0 110.81 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.87 -177.42 41.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -76.29 155.42 34.3 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.85 0.46 . . . . 0.0 110.032 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.6 p -133.09 165.57 24.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.625 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -147.38 161.16 41.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -83.41 135.29 13.67 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.93 168.85 13.0 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.539 0.735 . . . . 0.0 110.013 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -20.81 64.92 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.343 -0.223 . . . . 0.0 111.224 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.22 0.81 23.65 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 111.267 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.18 -3.15 82.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 123.542 0.591 . . . . 0.0 112.598 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.0 t -93.98 163.57 13.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.603 0.702 . . . . 0.0 110.286 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.42 153.39 21.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.722 0.296 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -66.19 -10.46 41.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.526 0.33 . . . . 0.0 111.601 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -120.62 141.87 49.95 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.141 0.976 . . . . 0.0 109.115 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -151.62 156.87 41.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.619 0.247 . . . . 0.0 110.464 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -126.31 150.16 48.68 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.637 0.775 . . . . 0.0 110.17 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -140.05 12.8 2.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.25 0.62 . . . . 0.0 111.566 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 22.4 t . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -173.968 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -60.95 159.72 25.41 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.215 0.606 . . . . 0.0 110.544 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.19 147.69 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.372 2.715 . . . . 0.0 112.93 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 55.7 m -124.0 19.4 9.22 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.34 0.656 . . . . 0.0 111.169 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.28 3.81 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.179 1.392 . . . . 0.0 114.591 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 37.0 t -141.54 147.38 22.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.475 HD12 ' CH2' ' A' ' 546' ' ' TRP . 53.2 mt -121.8 163.38 19.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.895 0.478 . . . . 0.0 110.457 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.58 158.66 43.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.566 0.346 . . . . 0.0 110.807 174.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -137.59 153.83 49.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.407 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -148.39 169.65 19.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.143 0.577 . . . . 0.0 110.33 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 15.8 t30 62.51 18.92 10.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.877 0.871 . . . . 0.0 113.324 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -77.52 164.63 56.92 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.48 152.91 37.59 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.728 2.285 . . . . 0.0 111.995 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.51 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -74.66 -1.77 23.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.838 0.455 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -125.13 16.78 8.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.496 0.719 . . . . 0.0 111.421 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.64 151.32 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 122.019 -0.426 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 74.7 p -141.75 170.46 15.67 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 123.125 0.57 . . . . 0.0 110.69 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.2 -22.6 66.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.98 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.91 -24.48 48.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.205 -0.309 . . . . 0.0 110.493 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.44 -32.04 37.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -73.41 -29.88 62.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.235 -0.291 . . . . 0.0 110.747 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -77.88 -37.28 48.43 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.149 0.431 . . . . 0.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.91 -25.23 43.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.859 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.91 -40.66 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.4 m -65.11 -29.01 69.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.277 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.21 -29.3 61.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.854 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.98 -10.94 40.48 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.415 0.552 . . . . 0.0 112.014 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 85.2 mt -91.1 -3.71 56.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.758 0.423 . . . . 0.0 110.768 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.9 80.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.779 -0.456 . . . . 0.0 112.499 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -112.81 172.14 3.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.524 0.662 . . . . 0.0 111.403 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.18 149.19 41.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.207 0.603 . . . . 0.0 110.073 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -98.06 151.55 37.6 Favored Pre-proline 0 CA--C 1.528 0.13 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.54 147.17 93.22 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.788 2.325 . . . . 0.0 110.492 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.416 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.3 m -82.71 -28.4 30.54 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 122.938 0.495 . . . . 0.0 110.997 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -140.32 147.32 39.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 2.4 p -154.36 144.63 13.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 122.744 0.418 . . . . 0.0 110.799 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -149.2 156.47 42.2 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.354 0.662 . . . . 0.0 109.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.59 145.51 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.416 0.686 . . . . 0.0 109.23 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -150.63 142.52 23.86 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.735 0.302 . . . . 0.0 110.95 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 123.366 0.666 . . . . 0.0 111.555 -179.223 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 59.3 m -148.9 -178.1 6.17 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.882 1.673 . . . . 0.0 108.784 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 8.6 t -140.26 160.86 39.02 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.116 -0.365 . . . . 0.0 110.981 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.8 m -146.35 164.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.698 0.799 . . . . 0.0 110.741 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 176.2 -166.52 37.65 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.591 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 63.3 mt -120.62 155.65 33.31 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.437 0.695 . . . . 0.0 111.265 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 91.9 mt -140.31 132.19 27.6 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.012 0.925 . . . . 0.0 108.816 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -127.89 119.48 25.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.475 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.6 p90 -166.05 150.47 8.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.385 1.474 . . . . 0.0 107.08 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -145.84 110.39 5.09 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -172.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.0 t -159.5 153.0 22.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -67.33 -42.02 84.28 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.528 0.604 . . . . 0.0 110.437 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 31.6 m -83.92 -30.55 26.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.808 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.81 -30.21 26.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.69 0.677 . . . . 0.0 111.48 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.73 -30.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.162 0.437 . . . . 0.0 111.316 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 29.8 tp -83.55 -29.29 27.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.879 0.763 . . . . 0.0 111.793 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.4 -42.67 43.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.256 0.48 . . . . 0.0 110.02 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 55.5 m -68.99 -31.85 71.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.9 -41.84 58.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.01 -19.99 75.9 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.366 -0.686 . . . . 0.0 113.115 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.71 -11.65 13.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.326 1.063 . . . . 0.0 113.052 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 30.4 tp -104.97 -16.88 14.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.087 0.858 . . . . 0.0 112.386 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -72.59 143.81 48.1 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.748 -0.595 . . . . 0.0 109.545 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 51.11 21.18 0.98 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.879 0.872 . . . . 0.0 113.128 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -78.43 151.44 32.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.11 136.38 50.24 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.095 1.358 . . . . 0.0 109.181 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 49.9 ttm -64.24 162.15 15.2 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.252 0.549 . . . . 0.0 110.915 -173.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -66.69 15.66 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.866 1.666 . . . . 0.0 114.055 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -65.09 152.86 90.46 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.75 -46.89 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.728 2.286 . . . . 0.0 113.951 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -121.13 16.19 11.55 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.94 47.91 84.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.088 -0.84 . . . . 0.0 112.761 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 -10.09 21.97 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.147 2.565 . . . . 0.0 111.122 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -148.55 149.49 31.36 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 123.829 0.852 . . . . 0.0 109.603 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.86 156.37 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.577 2.851 . . . . 0.0 111.632 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 573' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 573' ' ' TYR . 79.6 t80 -144.79 1.27 1.0 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.849 0.86 . . . . 0.0 110.588 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 57.3 m -66.44 116.53 7.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 575' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.7 pt? -124.89 144.53 50.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.508 0.723 . . . . 0.0 111.961 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.05 143.59 31.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.6 mt -131.21 144.73 51.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 36.8 t -163.8 176.34 9.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.34 145.31 28.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.928 0.491 . . . . 0.0 110.933 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 35.0 t -135.54 147.22 48.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.094 0.558 . . . . 0.0 110.112 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 25.4 m -89.61 102.13 14.81 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.62 34.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.598 0.759 . . . . 0.0 110.293 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -96.43 -21.52 17.7 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -164.26 153.81 14.0 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.073 0.949 . . . . 0.0 109.962 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -109.97 76.32 0.98 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.465 -1.255 . . . . 0.0 110.631 178.58 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.19 6.44 5.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.826 0.451 . . . . 0.0 111.946 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.4 m -142.92 146.03 35.77 Favored Pre-proline 0 C--O 1.232 0.133 0 O-C-N 121.93 -0.481 . . . . 0.0 111.389 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -82.0 1.8 8.97 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 124.598 3.532 . . . . 0.0 112.834 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.26 146.35 28.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-N 118.374 0.534 . . . . 0.0 110.943 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.4 pp -141.84 167.68 21.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.695 0.798 . . . . 0.0 109.609 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.9 mtp -138.83 151.17 46.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.672 0.273 . . . . 0.0 110.856 -175.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.09 150.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.043 0.537 . . . . 0.0 110.63 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.76 166.52 24.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.489 0.716 . . . . 0.0 109.519 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.08 89.46 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.701 -0.499 . . . . 0.0 112.934 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.765 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.15 175.71 7.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.774 0.787 . . . . 0.0 110.689 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -138.3 142.08 39.8 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.544 0.338 . . . . 0.0 110.103 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -73.94 -2.35 23.61 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.8 p -110.38 -2.68 16.52 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.205 0.457 . . . . 0.0 112.126 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -131.65 -5.72 3.66 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.164 0.586 . . . . 0.0 110.922 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.8 tpt -146.19 123.33 11.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.216 0.606 . . . . 0.0 109.545 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.454 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 22.5 m120 -141.94 176.26 9.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.883 0.873 . . . . 0.0 109.082 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 81.6 m -59.54 -25.97 64.96 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.225 -0.297 . . . . 0.0 110.94 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.14 -23.12 26.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.255 -0.278 . . . . 0.0 111.593 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ARG . . . . . 0.454 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 49.0 mmt-85 -82.16 -31.3 30.57 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.418 0.554 . . . . 0.0 109.586 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.43 -30.0 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.94 -30.89 68.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -71.96 -32.03 66.87 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.94 -0.475 . . . . 0.0 110.889 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.3 t -88.03 -27.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -104.95 -8.41 18.62 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.36 -39.46 78.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.825 0.739 . . . . 0.0 110.967 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.03 14.96 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.936 -0.478 . . . . 0.0 112.145 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.31 -1.89 9.63 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.188 0.595 . . . . 0.0 111.067 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.83 174.19 19.48 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -74.71 136.03 41.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.317 -0.52 . . . . 0.0 110.957 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 474' ' ' PHE . 7.7 m -94.44 164.52 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 124.571 1.148 . . . . 0.0 110.365 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -129.91 -63.34 0.92 Allowed 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.261 0.224 . . . . 0.0 110.884 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -163.32 166.04 23.48 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.771 0.429 . . . . 0.0 111.353 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.54 153.27 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.553 0.741 . . . . 0.0 110.625 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -149.65 145.06 26.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -77.47 155.2 31.87 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.521 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 8.3 ttm -107.78 141.11 39.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -168.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 48.72 33.99 4.77 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.217 1.007 . . . . 0.0 112.64 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.9 m 53.03 17.64 0.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.828 0.851 . . . . 0.0 113.099 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.66 147.77 53.07 Favored Pre-proline 0 N--CA 1.455 -0.204 0 CA-C-N 118.023 0.374 . . . . 0.0 110.428 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -81.61 -1.63 11.07 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.43 2.753 . . . . 0.0 110.427 170.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -124.54 17.28 7.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.587 -173.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.521 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -149.79 143.91 25.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.747 1.274 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.95 168.66 26.83 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.8 ptm -141.6 145.14 34.67 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.427 0.691 . . . . 0.0 109.946 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 14.6 t -131.95 150.96 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 122.746 0.418 . . . . 0.0 110.838 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -128.24 143.26 51.02 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.389 0.675 . . . . 0.0 110.311 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 81.3 mmm -117.1 162.64 17.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.434 0.694 . . . . 0.0 109.323 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -73.25 -19.28 61.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.055 -0.403 . . . . 0.0 111.921 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -156.62 162.5 39.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.776 0.43 . . . . 0.0 110.172 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.64 -17.95 73.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.458 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -67.49 -26.52 66.4 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.976 1.388 . . . . 0.0 110.172 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.57 -24.17 45.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.416 0.286 . . . . 0.0 110.621 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.25 -31.81 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.75 -32.38 73.9 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -82.22 -30.5 30.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.349 0.26 . . . . 0.0 111.681 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.59 -28.22 31.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.33 0.514 . . . . 0.0 111.073 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.4 tp -82.59 -31.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.918 0.487 . . . . 0.0 110.992 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.0 m -93.74 -21.99 18.99 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -124.24 -13.32 7.24 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.66 -20.47 10.11 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.072 0.851 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -52.28 143.26 15.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.963 0.905 . . . . 0.0 111.497 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 14.3 p30 56.91 1.53 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.004 2.522 . . . . 0.0 115.864 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -88.04 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.183 1.356 . . . . 0.0 108.184 168.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.286 0.0 OUTLIER -130.95 163.95 26.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 176.379 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.7 ptm -125.28 143.44 50.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.162 1.385 . . . . 0.0 109.946 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 65.07 31.57 10.98 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.025 1.33 . . . . 0.0 114.042 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.02 15.86 72.25 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.344 -0.698 . . . . 0.0 114.805 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -83.27 162.05 21.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.427 1.114 . . . . 0.0 110.337 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 131.68 35.66 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.961 0.41 . . . . 0.0 110.527 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.61 132.96 43.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -169.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.68 117.46 11.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.7 139.9 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 118.393 0.542 . . . . 0.0 110.523 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.4 m -150.23 161.98 41.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.982 0.913 . . . . 0.0 110.162 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.9 p -84.82 155.5 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 38.3 t -134.38 142.54 47.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.977 0.353 . . . . 0.0 111.246 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -85.7 65.95 9.4 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.03 0.532 . . . . 0.0 110.43 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -127.81 143.78 48.91 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.18 -26.54 6.25 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.878 2.386 . . . . 0.0 111.805 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.02 170.51 15.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.558 0.343 . . . . 0.0 111.031 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.1 mm -71.62 147.02 11.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.33 151.98 41.07 Favored Pre-proline 0 C--O 1.231 0.128 0 C-N-CA 122.416 0.286 . . . . 0.0 110.239 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.41 164.49 32.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.673 2.915 . . . . 0.0 111.874 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 171.21 -174.35 44.87 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -74.12 148.85 41.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.844 0.322 . . . . 0.0 110.25 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 24.9 m -142.59 160.89 39.42 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.249 0.62 . . . . 0.0 109.919 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -150.91 164.23 36.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.463 0.305 . . . . 0.0 110.568 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.14 135.27 16.27 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.95 169.5 12.42 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.539 0.736 . . . . 0.0 109.702 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.15 -20.31 65.73 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.081 -0.387 . . . . 0.0 111.376 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.0 -0.9 26.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.962 0.505 . . . . 0.0 111.283 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 85.73 -7.58 76.32 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.635 0.636 . . . . 0.0 112.783 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.7 m -93.83 156.19 16.79 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 117.896 0.848 . . . . 0.0 110.397 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 47.5 t -77.44 153.26 33.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.398 0.279 . . . . 0.0 110.261 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -68.14 -10.42 53.96 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.249 0.619 . . . . 0.0 111.678 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -123.48 136.27 54.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.11 0.964 . . . . 0.0 109.297 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -155.72 159.26 39.35 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -125.0 157.4 36.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.927 0.891 . . . . 0.0 110.454 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' A' ' 406' ' ' VAL . 24.5 m-85 -139.56 13.53 2.54 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.107 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -61.43 163.82 10.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.139 0.975 . . . . 0.0 110.828 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.22 143.06 20.12 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.23 2.62 . . . . 0.0 112.258 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 51.3 m -119.77 23.58 11.03 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.261 0.624 . . . . 0.0 112.259 -172.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 61.96 -7.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.42 1.488 . . . . 0.0 114.098 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.72 147.65 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.757 0.708 . . . . 0.0 109.661 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.416 HD12 ' CH2' ' A' ' 546' ' ' TRP . 59.5 mt -119.1 151.64 37.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.786 0.434 . . . . 0.0 110.222 177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -119.55 155.41 32.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.25 149.91 44.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.333 0.253 . . . . 0.0 110.524 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -145.78 169.28 18.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.747 0.419 . . . . 0.0 110.987 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 46.4 t30 56.68 33.12 22.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.994 0.918 . . . . 0.0 112.843 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.82 163.74 39.74 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.94 151.0 68.64 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.007 2.472 . . . . 0.0 111.847 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -75.27 -1.19 22.38 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.34 9.59 11.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.899 0.48 . . . . 0.0 111.919 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.6 149.49 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 118.019 0.372 . . . . 0.0 111.058 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.8 p -142.07 173.98 11.02 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.536 0.735 . . . . 0.0 110.265 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.63 -21.74 65.9 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.77 -22.08 58.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.234 -0.291 . . . . 0.0 110.407 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -83.25 -32.17 26.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.86 -27.63 63.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -84.53 -37.54 21.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.135 0.425 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -76.03 -21.28 57.01 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.756 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.6 mt -92.1 -36.14 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.922 0.328 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 18.2 p -70.31 -20.85 62.98 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.47 -29.03 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.567 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.99 -12.93 34.41 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.447 0.567 . . . . 0.0 111.333 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.06 -9.58 55.1 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.716 0.406 . . . . 0.0 110.838 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.22 11.08 82.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.765 -0.464 . . . . 0.0 112.803 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.5 m -98.8 169.82 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.103 0 CA-C-N 117.738 0.769 . . . . 0.0 111.291 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.54 151.68 42.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.343 0.657 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -101.04 151.98 37.76 Favored Pre-proline 0 C--O 1.231 0.111 0 C-N-CA 122.729 0.412 . . . . 0.0 109.899 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.31 153.38 78.26 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.962 2.442 . . . . 0.0 110.471 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 80.6 m -86.14 -24.84 26.05 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.621 0.368 . . . . 0.0 110.53 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -142.84 150.35 39.78 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.168 0.587 . . . . 0.0 109.599 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.55 147.97 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 120.872 0.368 . . . . 0.0 110.387 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -142.28 132.26 24.46 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.91 142.4 39.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -154.24 150.65 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 110.468 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.909 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.2 t -149.52 162.88 39.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.922 0.489 . . . . 0.0 110.433 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 42.2 t -124.82 152.59 43.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.47 0.708 . . . . 0.0 111.519 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 52.5 m -147.73 165.26 31.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.73 1.212 . . . . 0.0 108.93 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.81 -165.88 37.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.745 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -127.41 156.28 42.32 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.755 0.822 . . . . 0.0 110.351 -176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.86 133.62 30.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.482 1.113 . . . . 0.0 108.004 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.83 113.3 15.77 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.416 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.9 p90 -166.02 151.35 8.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 168.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -150.77 116.2 5.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 35.2 t -159.41 152.92 22.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.93 -38.0 79.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.746 0.703 . . . . 0.0 111.432 -174.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 47.4 m -87.78 -28.6 21.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -85.37 -28.32 25.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.414 0.552 . . . . 0.0 111.12 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.17 -34.42 37.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 117.949 0.341 . . . . 0.0 110.397 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.88 -30.73 45.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.439 0.563 . . . . 0.0 112.016 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -72.72 -43.73 62.6 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.261 0.482 . . . . 0.0 109.979 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 44.4 m -69.27 -40.26 77.91 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -42.79 98.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.901 -0.499 . . . . 0.0 109.864 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.15 -21.57 77.11 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.86 -0.966 . . . . 0.0 113.447 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -117.68 -14.97 10.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.857 1.329 . . . . 0.0 113.276 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 17.4 tp -88.22 -21.93 24.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.347 0.976 . . . . 0.0 110.623 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -76.49 151.32 36.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 39.8 t60 55.91 22.66 5.89 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.64 151.46 37.77 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.194 0.598 . . . . 0.0 112.537 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -110.78 136.18 50.23 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.06 0.944 . . . . 0.0 111.433 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.25 176.83 0.94 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.076 0.95 . . . . 0.0 111.417 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.9 10.71 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.709 0.803 . . . . 0.0 112.459 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.04 146.71 87.43 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 123.288 0.635 . . . . 0.0 111.051 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.92 -40.63 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.134 2.556 . . . . 0.0 112.734 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -120.96 2.38 10.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 65.82 60.26 6.71 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.767 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.67 -8.5 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.322 2.681 . . . . 0.0 110.984 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.45 151.03 46.16 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 123.576 0.75 . . . . 0.0 109.74 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.58 154.33 39.75 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.637 2.892 . . . . 0.0 110.356 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -133.16 -4.58 3.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.8 t -66.55 131.95 47.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.668 -0.645 . . . . 0.0 110.653 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 575' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 575' ' ' LEU . 1.8 pp -116.43 144.67 44.01 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.373 0.669 . . . . 0.0 110.79 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.64 138.09 39.85 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.03 155.89 43.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 111.412 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.9 p -163.76 167.98 20.27 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.23 131.61 39.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 26.2 t -135.64 150.13 49.53 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.521 0.201 . . . . 0.0 111.247 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.2 m -84.77 102.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.16 161.63 34.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.742 0.817 . . . . 0.0 110.061 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -109.75 -11.9 14.68 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.422 0.289 . . . . 0.0 111.634 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -160.52 162.83 33.11 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.079 0.552 . . . . 0.0 109.995 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -95.83 76.5 3.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.268 0.627 . . . . 0.0 109.717 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.252 1.204 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.222 -179.677 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.724 0.297 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -142.32 14.46 2.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.044 0.538 . . . . 0.0 111.192 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.1 m -141.38 150.11 56.9 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 122.126 -0.359 . . . . 0.0 111.379 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.39 -5.6 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.137 3.225 . . . . 0.0 111.98 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.89 151.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 122.832 0.453 . . . . 0.0 111.276 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.42 167.88 21.88 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.71 0.804 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 74.6 mtp -133.61 150.41 51.61 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.359 0.264 . . . . 0.0 111.316 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.05 151.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.161 0.584 . . . . 0.0 110.603 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -140.05 164.95 28.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.472 0.709 . . . . 0.0 109.637 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 78.94 -2.69 67.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.384 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.8 pt? -71.41 134.64 46.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.988 0.894 . . . . 0.0 109.794 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -83.48 122.65 28.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -75.03 6.79 3.79 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.9 p -116.0 -1.02 12.6 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.788 0.435 . . . . 0.0 111.658 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -130.3 -9.09 4.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.791 0.836 . . . . 0.0 110.472 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 11.0 tpt -139.86 128.08 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.24 1.016 . . . . 0.0 108.785 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -141.92 -172.92 3.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.132 0.573 . . . . 0.0 109.822 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.22 -22.65 64.97 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.19 -33.27 20.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.964 -0.46 . . . . 0.0 110.851 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 41.2 mmt-85 -81.66 -25.35 35.64 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.275 -0.266 . . . . 0.0 110.987 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.43 -30.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.018 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.22 -25.49 63.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -75.09 -39.81 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.14 -0.35 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.3 -20.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.994 -0.441 . . . . 0.0 111.979 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -109.81 -18.02 13.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.65 -21.6 57.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.16 0.891 . . . . 0.0 111.499 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.404 ' C ' HD12 ' A' ' 402' ' ' LEU . 1.1 pp -72.23 7.3 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.705 -0.622 . . . . 0.0 112.469 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -121.62 -1.85 9.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.538 0.735 . . . . 0.0 111.41 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.96 173.31 20.21 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -68.28 146.97 52.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.346 -0.502 . . . . 0.0 111.23 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.51 155.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.783 0.833 . . . . 0.0 108.813 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -101.02 -65.37 0.97 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -163.31 164.41 24.86 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.595 0.758 . . . . 0.0 110.232 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 11.2 p -144.2 151.27 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 C-N-CA 123.116 0.566 . . . . 0.0 110.437 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.07 139.77 19.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.924 0.14 . . . . 0.0 111.282 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.71 152.3 28.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -133.86 141.42 47.39 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 60.0 33.74 21.4 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 126.472 1.909 . . . . 0.0 114.231 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.1 m 52.84 16.0 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -72.0 158.38 87.77 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.613 0.642 . . . . 0.0 110.712 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.77 -22.4 44.67 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.223 2.615 . . . . 0.0 112.023 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -171.06 97.9 0.13 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -158.67 134.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -153.89 168.31 26.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.367 0.603 . . . . 0.0 112.462 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.9 ptp -139.63 145.34 38.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.147 0.979 . . . . 0.0 109.038 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.07 146.6 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.949 0.404 . . . . 0.0 110.617 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -124.94 146.41 49.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 109.866 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 75.3 mtp -122.35 164.12 18.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.793 0.437 . . . . 0.0 110.431 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.93 61.87 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -156.93 158.04 35.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.051 0.387 . . . . 0.0 110.181 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.13 80.67 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.116 -0.824 . . . . 0.0 113.578 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -69.17 -25.77 64.52 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.198 1.499 . . . . 0.0 110.839 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.29 -25.24 27.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.14 -27.51 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.25 -37.33 77.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.324 -0.235 . . . . 0.0 110.449 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -71.96 -30.79 65.65 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.84 57.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.314 -0.241 . . . . 0.0 111.078 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.2 tp -83.65 -30.9 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.6 m -99.02 -16.27 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.93 -6.68 2.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.62 -20.57 10.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.251 0.932 . . . . 0.0 109.56 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -52.77 142.32 19.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.044 0.938 . . . . 0.0 110.872 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.09 1.28 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.101 2.16 . . . . 0.0 115.659 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -87.84 142.52 27.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 120.242 1.383 . . . . 0.0 108.507 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -130.84 164.06 26.03 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.2 ptm -125.43 143.47 50.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.991 1.316 . . . . 0.0 108.985 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 67.01 25.7 9.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.05 80.54 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 168.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -83.06 159.77 22.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.014 1.407 . . . . 0.0 110.65 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 141.93 32.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.19 0.596 . . . . 0.0 111.025 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -98.22 124.15 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -140.68 111.3 6.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 169.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.09 140.2 17.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 CA-C-N 118.118 0.417 . . . . 0.0 109.957 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 96.8 m -149.47 159.94 43.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.775 0.83 . . . . 0.0 110.352 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.0 p -80.12 160.4 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 46.2 t -134.29 168.47 18.84 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 122.811 0.444 . . . . 0.0 110.515 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.08 12.71 11.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.566 0.746 . . . . 0.0 112.337 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.05 147.06 99.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.39 -36.5 77.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.81 2.34 . . . . 0.0 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.01 173.69 6.77 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.622 0.769 . . . . 0.0 110.047 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.4 mm -68.77 144.69 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.6 mtt -105.55 146.66 33.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 117.646 0.203 . . . . 0.0 110.994 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.2 172.85 15.55 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.253 3.302 . . . . 0.0 111.457 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.06 46.82 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.377 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 55.15 21.78 4.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.04 0.936 . . . . 0.0 112.857 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.5 p -79.42 153.93 29.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.716 0.293 . . . . 0.0 110.928 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -154.09 163.45 40.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.146 0.579 . . . . 0.0 110.343 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.2 136.0 16.56 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.92 169.32 12.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.277 0.631 . . . . 0.0 110.12 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.67 -21.13 66.66 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 110.316 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -77.94 -1.38 31.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.666 0.787 . . . . 0.0 111.452 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.76 70.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.398 0.523 . . . . 0.0 113.16 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.1 m -93.77 163.79 13.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.642 0.721 . . . . 0.0 110.798 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.51 153.33 37.55 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.7 p -70.23 -10.57 59.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -119.68 146.57 45.47 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.593 0.633 . . . . 0.0 112.156 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -157.0 156.12 32.4 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 110.142 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -124.49 152.31 43.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.798 0.839 . . . . 0.0 109.713 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.93 10.04 2.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.013 0.525 . . . . 0.0 111.282 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 94.3 p . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.984 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.286 8.5 pt20 . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -141.19 95.84 7.33 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.78 138.49 16.91 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.487 2.792 . . . . 0.0 110.255 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 56.4 m -124.04 23.93 8.37 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.362 0.665 . . . . 0.0 111.4 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.45 18.91 9.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.811 0.844 . . . . 0.0 112.717 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.9 t -134.42 146.82 30.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.477 HD12 ' CH2' ' A' ' 546' ' ' TRP . 28.8 mt -118.22 160.61 21.3 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.8 0.44 . . . . 0.0 110.196 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -121.64 157.41 30.88 Favored 'General case' 0 N--CA 1.46 0.059 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -142.73 152.85 42.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.852 0.461 . . . . 0.0 110.409 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.85 173.07 12.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.126 0.57 . . . . 0.0 110.549 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 64.8 t30 66.5 28.41 9.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.451 1.1 . . . . 0.0 113.329 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.14 160.42 46.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 122.12 -0.363 . . . . 0.0 110.723 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 156.0 39.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.08 2.52 . . . . 0.0 111.644 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -77.97 -0.76 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -122.52 13.1 10.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.174 0.589 . . . . 0.0 111.548 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.57 152.68 7.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 O-C-N 122.081 -0.387 . . . . 0.0 110.926 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.6 p -142.39 170.99 14.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.489 0.715 . . . . 0.0 110.437 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.74 -20.65 65.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.819 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -72.89 -23.65 60.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.6 -33.37 28.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -69.46 -28.66 66.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.514 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -82.26 -35.64 27.91 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.965 -0.46 . . . . 0.0 111.788 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -78.27 -17.3 56.83 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.329 0.513 . . . . 0.0 112.006 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.01 -25.36 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.122 0.419 . . . . 0.0 110.663 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.18 -24.24 63.1 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.404 -0.81 . . . . 0.0 109.753 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.94 -10.78 54.62 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.04 -18.82 23.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 110.332 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.7 mt -112.92 -0.44 14.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.75 5.77 70.15 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.678 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.86 169.75 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.852 0.826 . . . . 0.0 111.044 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.49 145.37 34.99 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.882 0.473 . . . . 0.0 110.275 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.67 146.67 47.19 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.944 0.498 . . . . 0.0 110.218 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 158.22 58.12 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.251 2.634 . . . . 0.0 110.685 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 61.8 m -90.4 -28.34 18.72 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.015 0.526 . . . . 0.0 110.698 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.2 m -142.35 153.67 44.02 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.142 0.577 . . . . 0.0 109.505 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 94.8 t -139.13 146.62 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 122.976 0.51 . . . . 0.0 110.284 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 530' ' ' LYS . . . . . 0.442 ' HE2' ' N ' ' A' ' 586' ' ' SER . 30.0 ttmt -138.24 140.01 39.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.71 145.16 31.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -136.04 157.99 45.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -172.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 123.906 0.882 . . . . 0.0 110.198 177.164 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 65.2 m -141.15 167.0 23.23 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.661 1.184 . . . . 0.0 109.575 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.1 t -132.0 166.01 22.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.016 0.526 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 77.6 p -153.47 172.35 17.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.495 1.118 . . . . 0.0 110.111 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.35 -161.05 33.43 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.63 -0.795 . . . . 0.0 114.028 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.09 157.18 32.02 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.57 1.148 . . . . 0.0 110.523 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.46 133.31 30.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 124.232 1.013 . . . . 0.0 108.345 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -127.8 119.37 25.55 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.477 ' CH2' HD12 ' A' ' 500' ' ' LEU . 3.0 p90 -166.09 153.21 9.82 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.418 1.487 . . . . 0.0 107.498 168.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -148.98 118.62 6.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.671 -0.811 . . . . 0.0 112.974 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.0 t -159.6 152.97 22.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 169.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -65.01 -53.0 53.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.716 0.689 . . . . 0.0 111.03 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 53.0 m -81.49 -23.85 37.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -91.48 -28.75 17.41 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.518 0.599 . . . . 0.0 111.966 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.58 38.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.335 0.516 . . . . 0.0 110.529 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 50.6 tp -82.25 -31.93 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.17 -36.72 47.16 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.825 -0.547 . . . . 0.0 110.273 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.5 m -72.52 -42.54 64.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 556' ' ' LEU . . . . . 0.453 ' C ' HD13 ' A' ' 556' ' ' LEU . 2.8 tm? -60.44 -47.83 84.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.34 -15.07 67.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.097 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.9 2.19 2.84 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.688 1.744 . . . . 0.0 114.377 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 559' ' ' LEU . 2.5 tm? -104.05 -26.5 12.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.531 0.605 . . . . 0.0 109.727 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -65.16 155.17 35.79 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.686 -0.634 . . . . 0.0 110.369 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 55.4 20.84 3.85 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.33 151.26 35.03 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -110.93 136.51 49.84 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.902 1.681 . . . . 0.0 110.184 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 564' ' ' MET . . . . . 0.46 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.6 ttt -64.16 171.92 2.72 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.245 0.618 . . . . 0.0 111.006 -175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -75.73 15.5 0.5 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -65.94 149.94 97.06 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.325 0.512 . . . . 0.0 110.132 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.53 -45.8 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.956 2.437 . . . . 0.0 113.347 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -121.04 13.69 11.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.63 52.23 50.22 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.237 -0.757 . . . . 0.0 112.263 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.82 -8.81 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.196 2.597 . . . . 0.0 111.315 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -146.31 149.43 37.89 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 123.698 0.799 . . . . 0.0 109.315 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.73 147.03 39.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.425 2.75 . . . . 0.0 110.881 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 573' ' ' TYR . . . . . 0.46 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.0 t80 -144.88 -2.6 0.81 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.27 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 62.3 m -66.37 110.63 3.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.41 144.55 25.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.901 0.48 . . . . 0.0 111.208 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -103.33 122.48 44.91 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.03 146.87 37.78 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 58.8 m -153.98 -178.14 6.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.67 1.188 . . . . 0.0 109.019 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.9 149.75 49.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.5 t -135.49 160.08 39.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.732 0.813 . . . . 0.0 110.328 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 87.8 m -105.82 102.13 11.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.38 161.56 34.67 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.213 1.005 . . . . 0.0 110.186 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -87.09 -38.25 16.67 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -158.06 153.02 25.28 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.985 1.314 . . . . 0.0 109.377 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -99.66 76.5 2.0 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.442 ' N ' ' HE2' ' A' ' 530' ' ' LYS . 78.3 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.122 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.935 0.397 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -123.94 -0.51 8.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.249 0.62 . . . . 0.0 111.809 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 31.2 t -164.06 150.93 10.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.253 0.621 . . . . 0.0 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.42 2.78 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.579 2.853 . . . . 0.0 111.617 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.02 151.15 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.837 0.855 . . . . 0.0 109.904 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -139.51 165.08 28.17 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.633 0.773 . . . . 0.0 109.706 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 64.8 mtp -136.43 149.91 48.49 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.617 0.246 . . . . 0.0 111.223 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.9 148.53 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.729 0.812 . . . . 0.0 109.591 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -140.03 162.99 33.88 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.972 0.509 . . . . 0.0 109.86 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.49 -0.34 86.87 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.713 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.748 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.68 176.82 5.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.063 0.932 . . . . 0.0 110.264 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -139.77 141.59 36.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.265 -0.272 . . . . 0.0 110.562 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -71.7 -1.73 14.87 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 46.7 m -104.99 -9.12 18.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.049 0.386 . . . . 0.0 111.92 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -136.22 -2.86 2.24 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.059 0.544 . . . . 0.0 111.222 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -145.2 122.72 11.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.573 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 37.8 m-80 -141.83 177.01 8.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.631 0.773 . . . . 0.0 109.204 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -58.16 -28.13 64.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -91.73 -25.91 18.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.81 -0.556 . . . . 0.0 111.751 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ARG . . . . . 0.573 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.8 mpt_? -73.59 -31.54 63.64 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.06 -32.33 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -68.1 -30.98 70.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.68 -27.53 62.15 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.13 -35.03 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.387 0.54 . . . . 0.0 111.829 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -89.93 -8.97 50.53 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.0 t -70.2 -26.94 64.12 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.525 0.602 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 26.8 mt -67.11 -4.46 10.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.749 -0.594 . . . . 0.0 111.822 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -121.45 4.05 10.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.84 -132.39 3.56 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -141.33 157.02 45.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 6.2 m -115.87 156.46 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.477 0.711 . . . . 0.0 111.003 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -110.04 -51.15 2.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.082 0.553 . . . . 0.0 110.908 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -167.6 167.6 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.476 0.711 . . . . 0.0 111.0 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.85 151.61 16.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.969 0.908 . . . . 0.0 110.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -149.94 143.82 25.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.151 0.58 . . . . 0.0 110.144 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -87.2 102.99 15.0 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.502 ' HE1' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -81.46 141.48 33.84 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.152 1.381 . . . . 0.0 112.966 -171.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 60.09 33.93 21.25 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.93 1.292 . . . . 0.0 112.47 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 92.0 p 52.88 12.37 0.27 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.839 1.656 . . . . 0.0 115.317 172.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -84.85 126.5 68.06 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-N 118.753 0.706 . . . . 0.0 110.308 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.96 -9.95 18.63 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.26 2.64 . . . . 0.0 111.853 171.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -106.9 17.23 38.75 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.359 0.98 . . . . 0.0 112.726 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.502 ' HB1' ' HE1' ' A' ' 412' ' ' MET . . . -146.25 140.38 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.412 1.106 . . . . 0.0 110.934 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.29 158.23 39.88 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.946 0.498 . . . . 0.0 111.316 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.1 ptm -140.7 147.59 39.46 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.599 0.36 . . . . 0.0 110.251 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.82 148.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.78 0.432 . . . . 0.0 110.775 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -114.72 139.02 50.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.479 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 86.6 mmm -104.49 161.29 14.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.519 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.49 -18.97 61.62 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.45 -0.157 . . . . 0.0 111.395 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -156.57 158.92 37.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.159 0.584 . . . . 0.0 109.893 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.57 -17.54 74.82 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.166 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -24.02 62.83 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 119.002 1.401 . . . . 0.0 110.767 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.72 -22.5 37.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.292 0.237 . . . . 0.0 111.03 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.79 -36.65 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -68.6 -26.76 65.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.91 -26.0 29.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 121.933 0.093 . . . . 0.0 110.945 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.52 50.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.65 -31.07 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.83 0.852 . . . . 0.0 110.783 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 22.5 m -98.84 -20.4 16.87 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -134.34 -7.32 2.59 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.67 -19.85 10.37 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.196 0.907 . . . . 0.0 109.441 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -52.47 145.79 10.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.835 0.854 . . . . 0.0 111.567 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 56.87 1.54 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.13 2.172 . . . . 0.0 115.408 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -88.08 142.51 27.72 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.578 1.535 . . . . 0.0 108.772 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.309 0.0 OUTLIER -130.97 163.9 26.52 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.0 ptm -125.21 143.35 50.99 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.038 1.335 . . . . 0.0 109.385 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' PHE . . . . . 0.408 ' H ' ' CG ' ' A' ' 554' ' ' GLU . 97.0 m-85 67.52 28.54 7.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.33 1.452 . . . . 0.0 114.192 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 68.39 16.01 68.79 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -83.3 162.07 21.24 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.422 1.111 . . . . 0.0 110.318 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.2 133.52 34.59 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.47 134.14 41.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -140.69 123.58 16.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.58 144.34 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.028 0 CA-C-N 118.116 0.416 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 t -158.5 165.56 34.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.2 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.9 152.97 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.262 0.625 . . . . 0.0 109.615 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 13.1 t -100.51 -167.0 1.38 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 110.475 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -138.41 6.18 2.52 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.938 0.895 . . . . 0.0 110.857 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -80.04 144.63 59.41 Favored Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.22 -24.86 12.08 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.873 2.382 . . . . 0.0 111.101 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.49 169.01 17.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.699 0.799 . . . . 0.0 109.489 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.09 142.55 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.2 mtt -111.34 159.56 32.5 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 122.417 0.287 . . . . 0.0 110.735 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -55.61 160.08 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.926 3.084 . . . . 0.0 112.646 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 172.29 179.57 43.23 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -74.96 153.54 38.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 48.2 t -138.23 157.14 46.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.051 0.54 . . . . 0.0 109.841 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -146.13 161.79 39.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.309 0.644 . . . . 0.0 110.17 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 135.06 14.83 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 70.7 mt -86.86 173.81 9.15 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.454 0.702 . . . . 0.0 109.513 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.222 -0.299 . . . . 0.0 111.414 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.4 -1.34 49.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.042 0.537 . . . . 0.0 111.178 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.66 -1.05 88.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.402 0.525 . . . . 0.0 112.578 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.8 t -93.63 160.15 14.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.775 0.787 . . . . 0.0 110.226 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.7 m -78.35 153.3 31.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.953 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 84.8 p -73.26 -10.6 59.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.858 0.463 . . . . 0.0 111.913 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -120.63 138.55 53.86 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -155.86 157.29 36.13 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.495 0.318 . . . . 0.0 110.776 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.15 156.96 32.56 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.467 0.707 . . . . 0.0 110.404 176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -140.07 11.14 2.39 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 122.903 0.481 . . . . 0.0 111.886 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -173.686 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 120.706 0.289 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -64.64 167.57 8.68 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.696 1.198 . . . . 0.0 109.56 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.55 137.91 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.39 2.726 . . . . 0.0 112.554 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 49.6 m -123.97 24.01 8.4 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.585 0.754 . . . . 0.0 112.848 -168.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.4 -14.74 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 113.779 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 29.9 t -134.09 151.66 32.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 118.648 0.658 . . . . 0.0 109.994 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.433 HD12 ' CH2' ' A' ' 546' ' ' TRP . 27.4 mt -126.18 138.63 53.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.771 0.829 . . . . 0.0 109.718 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 501' ' ' HIS . . . . . 0.444 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 16.0 m170 -105.65 154.82 19.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -137.34 147.41 45.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.465 0.174 . . . . 0.0 110.789 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -148.77 168.02 24.05 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.448 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.4 t30 58.18 30.52 19.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.327 1.051 . . . . 0.0 113.191 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.35 156.64 51.03 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.27 155.63 34.18 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.131 2.554 . . . . 0.0 111.805 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -77.11 -1.24 28.17 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.88 9.1 24.6 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.08 151.43 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 118.011 0.369 . . . . 0.0 111.11 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.2 p -142.88 172.03 13.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.557 0.743 . . . . 0.0 110.241 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.25 -20.55 64.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.55 -24.92 59.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -81.62 -29.78 33.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -70.52 -30.81 67.67 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.824 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.48 -36.59 26.34 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.334 0.515 . . . . 0.0 111.772 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -76.54 -23.87 53.61 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.06 0.391 . . . . 0.0 111.783 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.4 mt -88.85 -33.49 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 117.932 0.333 . . . . 0.0 110.16 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 75.6 m -65.47 -22.99 66.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.868 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.13 -34.7 75.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.09 -12.75 34.69 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.07 -7.53 59.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.878 0.308 . . . . 0.0 111.36 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.37 11.15 75.88 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.761 -0.466 . . . . 0.0 112.907 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.4 m -111.16 171.18 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 117.852 0.826 . . . . 0.0 111.177 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -68.5 154.55 41.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.415 0.686 . . . . 0.0 110.51 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -108.25 151.07 41.27 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.14 153.5 75.92 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.217 2.612 . . . . 0.0 111.339 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 83.9 m -94.59 -21.58 18.74 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.209 0.604 . . . . 0.0 111.244 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 50.8 m -142.31 153.87 44.24 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.15 150.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.166 0.508 . . . . 0.0 111.878 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -145.4 140.65 27.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.19 140.99 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -153.66 156.5 38.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.251 0.62 . . . . 0.0 110.089 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.456 -0.137 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.748 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.1 m -138.13 160.29 39.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.13 0.572 . . . . 0.0 110.371 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.8 t -120.4 150.42 40.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.694 0.798 . . . . 0.0 111.236 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 57.0 m -147.21 164.32 33.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.231 1.412 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.84 -162.41 33.15 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.658 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 87.6 mt -128.57 151.31 49.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.095 0.958 . . . . 0.0 110.767 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.7 mt -142.28 133.39 26.03 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -127.81 124.7 38.26 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.433 ' CH2' HD12 ' A' ' 500' ' ' LEU . 4.2 p90 -166.02 149.06 7.41 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -146.77 114.1 6.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 34.7 t -159.56 152.91 22.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 168.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -66.99 -36.82 83.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.469 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 45.9 m -83.92 -36.18 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.184 0.194 . . . . 0.0 111.354 -176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.4 -24.57 31.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.568 0.622 . . . . 0.0 111.612 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.63 21.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.491 0.587 . . . . 0.0 111.557 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.48 -23.79 24.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.053 0.842 . . . . 0.0 111.61 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.408 ' CG ' ' H ' ' A' ' 442' ' ' PHE . 65.4 mt-10 -77.93 -44.71 26.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.985 -0.447 . . . . 0.0 109.891 175.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 60.9 m -69.15 -31.87 70.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 556' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.3 tm? -68.9 -43.41 75.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.63 -19.32 72.91 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.28 -0.733 . . . . 0.0 112.757 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -114.39 -9.78 12.72 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.172 0.986 . . . . 0.0 113.046 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 13.7 tp -112.69 4.84 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.848 0.749 . . . . 0.0 112.18 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -92.9 143.01 26.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.333 -0.855 . . . . 0.0 109.675 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 49.13 35.94 8.07 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.644 0.777 . . . . 0.0 112.684 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 562' ' ' TYR . . . . . 0.404 ' HD1' ' H ' ' A' ' 562' ' ' TYR . 3.3 p90 -92.18 151.35 20.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -97.98 136.44 38.26 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.76 1.624 . . . . 0.0 111.389 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 564' ' ' MET . . . . . 0.463 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.06 173.93 1.73 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.72 0.808 . . . . 0.0 111.354 -177.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -70.05 14.34 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.859 0.864 . . . . 0.0 113.106 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.46 140.62 92.02 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.939 0.495 . . . . 0.0 111.065 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -81.0 -29.53 2.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.299 2.666 . . . . 0.0 112.766 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -121.01 -11.37 8.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.409 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.12 43.83 95.02 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 82.9 Cg_endo -72.41 -6.6 19.38 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.32 2.68 . . . . 0.0 112.047 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -142.61 150.82 55.5 Favored Pre-proline 0 N--CA 1.455 -0.189 0 C-N-CA 123.559 0.744 . . . . 0.0 109.689 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 152.27 34.24 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.505 2.804 . . . . 0.0 110.738 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 573' ' ' TYR . . . . . 0.463 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 80.0 t80 -146.38 -2.66 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.518 0.327 . . . . 0.0 111.619 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.37 122.35 17.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.72 -0.613 . . . . 0.0 109.825 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.0 144.61 50.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.228 1.011 . . . . 0.0 109.324 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.89 158.11 17.58 Favored 'General case' 0 CA--C 1.523 -0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 111.247 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.62 155.74 47.03 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.169 0.988 . . . . 0.0 108.789 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 42.6 t -163.55 146.32 9.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -76.69 127.55 32.99 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 23.1 t -135.68 154.7 51.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.73 0.3 . . . . 0.0 111.091 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 37.0 m -83.59 103.4 12.89 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -133.98 161.16 35.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.498 0.719 . . . . 0.0 109.662 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -93.87 -26.1 17.05 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.406 -0.184 . . . . 0.0 111.172 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -160.66 157.83 27.81 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.966 0.506 . . . . 0.0 109.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -89.73 76.4 7.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.36 -1.305 . . . . 0.0 110.154 178.846 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -141.36 7.19 1.95 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 30.7 m -146.94 154.19 46.7 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 122.509 0.324 . . . . 0.0 110.551 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.45 -0.55 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.61 3.54 . . . . 0.0 113.399 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.78 162.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 118.686 0.676 . . . . 0.0 112.203 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -147.18 167.22 24.72 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.935 0.894 . . . . 0.0 109.122 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' MET . . . . . 0.412 ' HE2' ' SD ' ' A' ' 412' ' ' MET . 73.8 mtp -133.57 151.24 51.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.404 0.282 . . . . 0.0 110.576 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.1 148.93 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.978 0.511 . . . . 0.0 110.827 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.95 167.55 21.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.474 0.71 . . . . 0.0 109.55 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.66 88.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.586 -0.563 . . . . 0.0 112.897 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -70.2 173.56 6.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.828 0.814 . . . . 0.0 110.326 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -136.66 139.78 42.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -71.96 -3.98 25.79 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.1 p -109.83 -1.19 18.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.378 0.535 . . . . 0.0 112.407 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -133.5 -6.44 2.91 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.288 0.635 . . . . 0.0 110.969 175.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.5 tpt -148.5 122.25 9.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.225 0.61 . . . . 0.0 109.47 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -141.88 -173.37 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.106 0.562 . . . . 0.0 109.768 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 72.3 m -59.54 -23.61 63.0 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -92.03 -23.8 19.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.231 0.468 . . . . 0.0 111.5 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -83.93 -29.71 26.89 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 409' ' ' VAL . 10.1 p -77.52 -32.58 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -68.85 -31.17 69.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.38 -46.43 55.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.172 -0.33 . . . . 0.0 111.329 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.18 -20.32 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 122.233 -0.292 . . . . 0.0 111.48 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -110.47 -7.33 14.77 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.24 -31.7 55.22 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.843 0.747 . . . . 0.0 110.958 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 11.38 1.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.805 -0.56 . . . . 0.0 112.18 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -121.51 -5.34 9.28 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.743 0.817 . . . . 0.0 110.931 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.68 177.94 24.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -75.49 148.67 38.83 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.376 -0.485 . . . . 0.0 110.834 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.05 154.26 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.597 0.759 . . . . 0.0 109.413 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -104.02 -58.79 1.82 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.212 -0.305 . . . . 0.0 110.552 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -165.78 166.65 17.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.973 0.509 . . . . 0.0 110.736 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 396' ' ' VAL . 7.6 p -147.92 150.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 122.985 0.514 . . . . 0.0 110.345 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -151.88 144.34 24.13 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.343 0.257 . . . . 0.0 110.599 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -79.06 152.0 31.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.412 ' SD ' ' HE2' ' A' ' 382' ' ' MET . 25.3 ptt? -129.97 141.49 50.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -168.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 60.01 34.0 21.4 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.923 1.289 . . . . 0.0 111.802 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m 52.77 16.67 0.71 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.883 1.273 . . . . 0.0 114.035 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.76 143.21 46.37 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 118.357 0.526 . . . . 0.0 109.903 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.34 -1.14 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.651 2.901 . . . . 0.0 110.262 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -132.54 27.68 3.52 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.739 0.685 . . . . 0.0 113.071 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.69 133.92 19.46 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.08 0.94 . . . . 0.0 110.333 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.12 168.67 26.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.5 ptm -144.32 146.99 32.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.19 151.62 27.65 Favored 'Isoleucine or valine' 0 C--N 1.337 0.028 0 C-N-CA 123.161 0.585 . . . . 0.0 110.736 -170.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -128.38 136.77 51.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.5 mmm -107.72 162.64 13.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.644 0.378 . . . . 0.0 110.565 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.95 61.14 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.158 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -157.73 161.76 38.51 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.429 0.691 . . . . 0.0 109.578 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.97 -14.54 70.83 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.391 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -67.96 -30.57 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.134 1.467 . . . . 0.0 110.46 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.33 -20.56 51.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.51 -31.78 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.32 -36.05 66.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -32.2 67.02 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.011 -0.43 . . . . 0.0 110.508 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.22 -38.05 25.09 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.12 -0.363 . . . . 0.0 111.862 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 7.5 tp -72.87 -32.02 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.529 -0.732 . . . . 0.0 111.803 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.1 m -93.66 -21.14 19.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -117.97 -14.09 10.02 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.75 -17.4 11.07 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.941 0.791 . . . . 0.0 110.507 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -51.73 142.01 15.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.46 0.648 . . . . 0.0 111.702 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 57.08 1.54 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.787 2.035 . . . . 0.0 115.742 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -87.91 142.49 27.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.719 1.6 . . . . 0.0 108.667 169.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -130.85 163.84 26.53 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.34 143.43 50.97 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.397 1.479 . . . . 0.0 109.576 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 67.77 27.12 7.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.989 1.316 . . . . 0.0 114.486 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.48 15.86 75.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 168.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -83.25 160.76 21.68 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.683 1.242 . . . . 0.0 110.074 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.62 132.46 34.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.54 133.26 43.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -140.69 120.43 13.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.06 141.92 15.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-N 118.263 0.483 . . . . 0.0 110.346 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 25.6 t -160.13 162.37 33.95 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.791 0.436 . . . . 0.0 110.166 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.07 158.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 109.949 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.1 t -137.67 151.28 48.1 Favored 'General case' 0 C--N 1.337 0.032 0 O-C-N 121.991 -0.443 . . . . 0.0 110.451 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -89.37 -0.58 57.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.683 0.793 . . . . 0.0 112.654 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -62.14 144.39 94.45 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 121.478 -0.764 . . . . 0.0 109.654 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.1 -25.04 12.09 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.832 2.355 . . . . 0.0 112.013 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.86 173.78 12.31 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.013 0.525 . . . . 0.0 110.214 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -66.68 138.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -90.07 163.03 33.45 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.813 0.445 . . . . 0.0 110.699 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.21 -42.5 64.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.14 2.56 . . . . 0.0 112.009 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 50.23 -142.75 13.46 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.252 0.453 . . . . 0.0 112.442 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -133.65 160.5 37.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.214 1.006 . . . . 0.0 108.536 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.0 p -143.3 156.04 44.62 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.693 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -155.19 163.34 40.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.36 136.68 17.79 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.96 165.86 15.54 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.174 0.59 . . . . 0.0 110.232 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.92 -20.13 65.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.243 0.217 . . . . 0.0 111.463 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -80.35 1.25 29.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 111.476 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.91 0.63 85.76 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 39.6 m -91.37 165.05 13.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.419 0.688 . . . . 0.0 110.528 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.36 153.34 22.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.74 0.305 . . . . 0.0 110.5 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.3 p -69.89 -10.25 57.84 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.027 0.531 . . . . 0.0 111.697 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -118.47 138.06 52.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.99 0.916 . . . . 0.0 109.87 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -154.42 155.2 34.54 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.423 0.289 . . . . 0.0 110.661 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -124.61 156.6 37.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 110.415 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.81 15.92 2.31 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.041 0.536 . . . . 0.0 111.334 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 91.2 p . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.617 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 495' ' ' HIS . . . . . 0.425 ' CG ' ' HD2' ' A' ' 496' ' ' PRO . 67.8 t60 -59.87 148.56 76.11 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 495' ' ' HIS . 87.1 Cg_exo -46.3 140.73 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.45 2.767 . . . . 0.0 112.817 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.1 m -123.99 24.05 8.37 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.606 0.762 . . . . 0.0 111.34 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.52 7.86 2.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 113.987 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 32.3 t -141.54 147.02 22.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 123.41 0.684 . . . . 0.0 109.233 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.482 HD12 ' CH2' ' A' ' 546' ' ' TRP . 91.5 mt -129.38 160.35 33.35 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.62 0.768 . . . . 0.0 110.086 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -143.65 163.16 34.03 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.285 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -135.94 156.94 48.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.407 0.683 . . . . 0.0 111.133 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -147.3 170.76 16.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.46 26.19 15.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 0.0 113.281 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.95 158.3 70.41 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -68.99 159.43 54.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.282 1.988 . . . . 0.0 110.602 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -71.58 -1.09 12.32 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -112.0 7.1 19.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -173.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.45 148.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 118.308 0.504 . . . . 0.0 111.209 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.5 p -142.98 173.3 11.68 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.925 0.89 . . . . 0.0 110.313 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.4 -22.79 65.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.752 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.68 -23.71 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -82.95 -31.78 27.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -68.82 -28.34 66.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.964 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.37 -35.07 18.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.192 0.451 . . . . 0.0 112.087 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -75.85 -18.87 59.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.458 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.79 -35.53 5.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 117.884 0.311 . . . . 0.0 110.868 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 17.3 p -70.1 -21.84 63.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.167 0.894 . . . . 0.0 110.643 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.38 -28.44 61.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 119.552 -0.261 . . . . 0.0 111.633 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.07 -12.6 35.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.278 0.49 . . . . 0.0 111.205 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.12 -9.9 51.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.523 0.329 . . . . 0.0 110.489 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.28 6.41 65.11 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.704 -0.498 . . . . 0.0 112.927 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.2 m -89.17 170.88 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.938 0.869 . . . . 0.0 111.161 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -71.11 146.77 49.01 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.356 0.663 . . . . 0.0 110.044 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -91.94 153.11 43.46 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.625 0.37 . . . . 0.0 110.256 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 155.55 69.34 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.555 2.17 . . . . 0.0 109.535 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 82.2 m -95.1 -19.12 20.38 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.955 0.502 . . . . 0.0 110.763 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.0 t -148.76 152.73 37.07 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.945 0.498 . . . . 0.0 109.762 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.9 t -140.62 140.9 33.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 123.097 0.559 . . . . 0.0 110.084 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.25 126.35 12.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.48 152.36 37.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.829 0.452 . . . . 0.0 110.971 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -144.23 160.82 40.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.984 0.914 . . . . 0.0 109.438 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.231 0.097 0 C-N-CA 122.827 0.451 . . . . 0.0 110.293 -178.286 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 71.1 m -138.22 157.96 45.25 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.987 0.515 . . . . 0.0 110.734 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 156.01 40.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.525 0.73 . . . . 0.0 111.192 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.5 m -147.72 166.53 27.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.887 1.275 . . . . 0.0 108.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.62 -176.75 47.48 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.2 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.2 mp -111.57 154.93 24.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.282 1.033 . . . . 0.0 110.132 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.3 mt -138.35 134.38 34.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.72 117.99 22.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.482 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.9 p90 -165.71 153.63 10.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 168.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -146.81 115.11 6.65 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.9 t -159.52 153.04 22.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 168.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -69.79 -48.38 59.4 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 118.637 0.653 . . . . 0.0 110.722 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 44.7 m -82.71 -22.96 34.29 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -89.28 -33.17 17.05 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.711 0.687 . . . . 0.0 111.481 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -72.13 -33.92 68.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.798 0.726 . . . . 0.0 110.477 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.52 -35.68 58.16 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.034 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.99 -40.37 53.87 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.102 -0.374 . . . . 0.0 110.604 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 98.6 m -65.95 -49.23 68.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.159 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 556' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 556' ' ' LEU . 2.0 pp -70.15 -22.4 62.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.109 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -64.72 -31.39 80.74 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.427 -0.652 . . . . 0.0 111.83 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -116.36 -6.86 11.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.912 0.856 . . . . 0.0 113.103 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.5 tp -95.93 -13.47 23.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.66 0.664 . . . . 0.0 111.664 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -81.16 151.44 28.23 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.695 -0.628 . . . . 0.0 110.199 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 31.4 m80 51.18 22.97 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 151.23 29.81 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -102.13 136.33 42.15 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.381 1.472 . . . . 0.0 110.683 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 564' ' ' MET . . . . . 0.466 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 6.2 ttt -64.17 173.24 2.03 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.15 0.58 . . . . 0.0 111.612 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -75.4 14.78 0.54 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.932 . . . . 0.0 112.564 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -66.11 149.93 97.26 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 118.03 0.377 . . . . 0.0 110.137 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.87 -46.92 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.895 2.397 . . . . 0.0 113.898 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -121.08 13.3 11.26 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 63.34 52.8 44.05 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.312 -0.716 . . . . 0.0 112.594 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.62 -9.42 19.9 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.539 2.826 . . . . 0.0 111.44 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -148.42 151.41 36.5 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.671 0.788 . . . . 0.0 109.676 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.26 151.1 37.98 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.563 2.842 . . . . 0.0 110.821 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 573' ' ' TYR . . . . . 0.466 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 91.0 t80 -143.03 -6.45 0.84 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.758 0.423 . . . . 0.0 111.902 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 75.2 p -66.48 132.02 47.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.891 -0.506 . . . . 0.0 110.233 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 575' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 575' ' ' LEU . 1.6 pp -125.03 144.55 50.34 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.595 0.758 . . . . 0.0 110.791 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -77.28 144.38 38.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.76 144.97 50.4 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 2.8 p -163.92 172.09 14.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.703 0.401 . . . . 0.0 110.331 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -82.82 148.91 27.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.734 0.414 . . . . 0.0 111.207 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.7 t -135.6 137.71 42.21 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 122.575 0.35 . . . . 0.0 110.971 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 16.5 p -82.45 102.13 11.12 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.18 161.57 34.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.353 0.661 . . . . 0.0 111.59 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.77 -3.31 7.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.402 0.681 . . . . 0.0 110.294 173.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -157.68 165.91 34.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.754 1.222 . . . . 0.0 109.777 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.12 76.68 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.247 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.888 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.878 0.37 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -140.36 6.1 2.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.199 0.6 . . . . 0.0 110.917 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.6 m -152.91 157.01 33.21 Favored Pre-proline 0 N--CA 1.456 -0.157 0 C-N-CA 123.711 0.805 . . . . 0.0 110.207 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.69 2.51 8.48 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.614 3.543 . . . . 0.0 112.938 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.0 p -126.17 148.33 30.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 118.736 0.698 . . . . 0.0 111.478 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.38 167.3 23.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.222 0.609 . . . . 0.0 110.094 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' MET . . . . . 0.405 ' CE ' ' SD ' ' A' ' 412' ' ' MET . 77.1 mtp -132.96 152.0 51.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.539 0.335 . . . . 0.0 110.571 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.6 149.45 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.761 0.425 . . . . 0.0 110.693 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -141.21 166.38 24.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.407 0.683 . . . . 0.0 110.1 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.13 -0.11 84.5 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.847 -0.418 . . . . 0.0 112.67 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.758 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.24 -179.65 4.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.503 0.651 . . . . 0.0 110.687 176.146 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -139.62 134.62 32.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -69.82 -11.73 61.08 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.5 p -93.44 -9.92 36.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -132.56 -8.87 3.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.268 0.486 . . . . 0.0 111.654 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.7 tpt -147.73 104.84 3.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.317 0.647 . . . . 0.0 109.497 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.435 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 23.4 p30 -141.97 -173.59 3.85 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.878 0.871 . . . . 0.0 109.669 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 64.4 m -55.33 -28.83 56.33 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.96 -27.69 21.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.215 0.461 . . . . 0.0 110.994 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ARG . . . . . 0.435 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 2.2 mmp_? -78.11 -33.44 50.58 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 122.123 -0.361 . . . . 0.0 110.038 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.89 -31.31 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -64.82 -35.24 80.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -72.1 -31.04 65.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.43 -0.319 . . . . 0.0 111.398 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.77 -26.61 5.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.151 0.432 . . . . 0.0 111.875 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.52 -10.07 20.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 p -65.68 -37.8 87.51 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.041 0.837 . . . . 0.0 111.565 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.81 14.43 1.75 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.322 0.51 . . . . 0.0 112.156 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -121.46 -1.91 9.55 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.604 0.762 . . . . 0.0 109.93 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 140.45 167.08 10.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -74.83 146.54 41.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.156 -0.614 . . . . 0.0 111.167 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.29 154.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.498 0.719 . . . . 0.0 109.095 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -104.2 -60.1 1.63 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.62 0.368 . . . . 0.0 110.013 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -165.42 163.66 19.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.434 0.694 . . . . 0.0 110.703 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.488 HG22 HG23 ' A' ' 421' ' ' VAL . 92.0 t -136.28 146.83 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.215 1.006 . . . . 0.0 109.344 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -148.45 144.18 27.24 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 172.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -86.53 155.67 20.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.405 ' SD ' ' CE ' ' A' ' 382' ' ' MET . 26.0 ptt? -136.02 141.43 44.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -167.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt 60.22 34.04 21.01 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.849 1.26 . . . . 0.0 112.339 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.8 m 52.97 16.29 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -94.21 142.53 25.03 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 118.405 0.548 . . . . 0.0 110.461 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.48 -3.81 13.65 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.555 2.837 . . . . 0.0 110.357 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -115.49 19.69 14.33 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.234 0.921 . . . . 0.0 112.795 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -145.68 131.85 19.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.204 1.002 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.86 168.3 27.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -145.54 150.19 35.98 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.35 0.66 . . . . 0.0 110.028 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' VAL . . . . . 0.488 HG23 HG22 ' A' ' 409' ' ' VAL . 3.4 p -144.42 151.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.951 0.5 . . . . 0.0 111.076 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -126.56 146.86 49.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.04 0.936 . . . . 0.0 109.615 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 91.1 mmm -112.28 163.28 14.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.601 0.76 . . . . 0.0 110.482 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.7 -15.36 61.69 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -155.1 156.96 36.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.86 0.464 . . . . 0.0 109.886 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.01 -17.59 75.7 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.166 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -29.81 66.54 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.882 1.341 . . . . 0.0 110.13 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.09 61.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.507 0.194 . . . . 0.0 110.536 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.2 t -78.99 -38.07 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.91 -25.88 68.35 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.771 0.26 . . . . 0.0 110.667 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -82.81 -35.04 26.77 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.156 0.582 . . . . 0.0 110.563 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -74.96 -29.63 60.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.873 -0.517 . . . . 0.0 110.009 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 14.7 mm -77.83 -30.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.854 1.262 . . . . 0.0 111.701 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.9 m -106.5 -14.75 14.98 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -134.17 -9.54 2.61 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.72 -16.52 11.24 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.763 0.711 . . . . 0.0 109.633 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -54.02 142.09 26.12 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.27 1.028 . . . . 0.0 111.832 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.81 1.51 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.564 1.946 . . . . 0.0 115.927 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -88.03 142.55 27.69 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.794 1.634 . . . . 0.0 108.532 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.1 OUTLIER -130.81 163.87 26.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.512 1.125 . . . . 0.0 109.384 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 63.64 22.95 13.35 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.154 1.382 . . . . 0.0 114.589 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.15 15.91 61.77 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 169.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -83.2 150.99 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.987 1.393 . . . . 0.0 110.961 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.08 138.7 38.07 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -98.07 122.01 40.68 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -140.72 116.92 10.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.37 140.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 118.774 0.715 . . . . 0.0 110.691 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.8 m -148.71 159.41 44.15 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.166 0.986 . . . . 0.0 109.841 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.23 156.13 3.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.3 t -130.22 161.36 31.34 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.862 0.465 . . . . 0.0 110.418 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.56 10.94 27.03 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.501 0.72 . . . . 0.0 112.519 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -67.66 147.51 98.65 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 118.105 0.411 . . . . 0.0 109.95 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.39 -36.0 80.51 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.802 2.335 . . . . 0.0 112.348 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.95 176.04 7.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.559 0.744 . . . . 0.0 109.92 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 136.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -84.85 149.8 54.43 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.337 0.255 . . . . 0.0 110.614 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.39 167.23 25.85 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.721 2.948 . . . . 0.0 111.223 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 167.59 179.35 40.3 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -77.12 154.53 33.16 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.701 0.4 . . . . 0.0 109.937 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 83.1 p -134.08 159.37 41.02 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.962 0.505 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -155.26 164.3 38.98 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 109.805 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.62 136.73 19.0 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 79.3 mt -86.25 169.61 12.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.974 0.91 . . . . 0.0 109.672 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.22 -20.16 65.65 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.85 4.07 42.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.665 0.386 . . . . 0.0 111.522 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.97 -6.38 79.22 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.376 0.512 . . . . 0.0 112.647 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 52.9 m -83.77 155.39 23.05 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 117.838 0.819 . . . . 0.0 109.942 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.3 153.29 24.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 99.4 p -72.6 -10.34 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 111.664 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -137.0 139.59 41.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.226 1.011 . . . . 0.0 109.477 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -155.16 157.32 37.23 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.18 0.192 . . . . 0.0 110.928 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.71 150.45 51.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.231 1.012 . . . . 0.0 109.937 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -142.45 14.33 1.99 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 CA--C 1.527 0.063 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.226 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 111.31 0.115 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -147.96 150.63 36.17 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.236 0.614 . . . . 0.0 109.391 -174.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.21 147.73 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 112.691 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 62.9 m -124.18 24.0 8.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.269 0.628 . . . . 0.0 112.092 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.6 3.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.377 1.071 . . . . 0.0 113.461 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.4 152.04 21.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.439 HD22 ' CH2' ' A' ' 546' ' ' TRP . 4.7 mp -132.69 164.18 27.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.291 0.637 . . . . 0.0 109.669 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.92 149.33 36.68 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.001 0.429 . . . . 0.0 111.957 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -114.74 145.56 41.94 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.759 1.223 . . . . 0.0 109.599 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.77 165.41 30.62 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.374 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 58.02 23.78 10.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.403 1.081 . . . . 0.0 113.422 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -81.74 157.89 68.84 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.86 156.35 28.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -80.38 -1.17 40.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -103.53 5.26 36.64 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.662 0.385 . . . . 0.0 111.983 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -89.79 152.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.061 0.391 . . . . 0.0 111.672 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 68.5 p -144.86 175.62 10.07 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.181 0.992 . . . . 0.0 109.654 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.78 -26.25 68.62 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.439 -0.163 . . . . 0.0 111.149 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.58 -26.22 60.72 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.439 -0.163 . . . . 0.0 110.574 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -79.64 -31.67 41.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.59 -26.52 62.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.22 -0.3 . . . . 0.0 110.486 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -80.03 -39.36 30.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.933 0.333 . . . . 0.0 111.558 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.11 -17.1 53.49 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.24 0.473 . . . . 0.0 112.275 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.21 -36.53 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 82.2 m -67.95 -22.15 65.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.676 -0.64 . . . . 0.0 110.573 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.44 -30.5 63.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 119.658 -0.21 . . . . 0.0 111.565 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.12 -11.73 37.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.108 0.413 . . . . 0.0 111.527 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.32 -7.15 48.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.657 0.383 . . . . 0.0 110.411 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.9 11.33 78.39 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.855 -0.414 . . . . 0.0 112.665 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.6 m -95.58 170.83 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 117.817 0.809 . . . . 0.0 111.61 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -74.14 147.91 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.477 0.711 . . . . 0.0 110.236 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -97.07 146.17 30.85 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.21 148.97 92.61 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.01 2.473 . . . . 0.0 110.375 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 84.7 m -82.11 -25.01 34.83 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.467 0.307 . . . . 0.0 110.841 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 51.1 m -143.4 151.63 40.61 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.936 0.494 . . . . 0.0 109.848 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.59 141.82 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 122.952 0.501 . . . . 0.0 110.328 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.7 120.18 7.42 Favored 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.09 147.53 30.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 C-N-CA 123.353 0.661 . . . . 0.0 109.557 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -148.65 130.05 14.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.513 0.196 . . . . 0.0 111.317 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 CA--C 1.533 0.324 0 C-N-CA 123.005 0.522 . . . . 0.0 110.983 176.501 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 85.4 p -145.4 173.22 12.18 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.386 1.475 . . . . 0.0 109.119 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -124.3 148.38 47.47 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 122.631 0.372 . . . . 0.0 111.65 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.4 m -145.16 158.53 43.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.268 1.027 . . . . 0.0 109.12 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 179.45 178.48 48.39 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.943 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.497 ' C ' HD22 ' A' ' 544' ' ' LEU . 8.6 mp -116.9 144.64 44.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 109.82 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.497 HD22 ' C ' ' A' ' 543' ' ' LEU . 3.2 mm? -128.93 142.04 51.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.87 113.2 15.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.439 ' CH2' HD22 ' A' ' 500' ' ' LEU . 4.2 p90 -165.93 149.13 7.57 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -155.35 126.34 7.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 548' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 43.6 t -159.53 161.32 35.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 169.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.56 -51.21 45.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.881 0.764 . . . . 0.0 110.448 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 72.5 p -89.28 -27.24 20.69 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 551' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 25.0 m-20 -82.42 -27.57 31.9 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.987 0.812 . . . . 0.0 110.802 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -85.58 -31.99 22.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.432 0.56 . . . . 0.0 110.576 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 41.6 tp -73.92 -30.09 62.38 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.228 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.52 -42.7 58.44 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.6 m -68.24 -39.16 82.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.71 -42.21 82.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.96 -19.49 77.09 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.145 -0.808 . . . . 0.0 113.582 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -113.86 -16.95 12.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.685 1.242 . . . . 0.0 112.903 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.67 -21.79 22.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.061 0.846 . . . . 0.0 111.801 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -74.21 147.83 42.15 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.573 0.624 . . . . 0.0 109.721 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.8 t60 53.81 29.01 9.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.92 0.888 . . . . 0.0 113.259 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.98 151.39 24.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -117.51 136.42 53.25 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.873 1.269 . . . . 0.0 110.427 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 564' ' ' MET . . . . . 0.411 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 4.8 ttt -64.18 169.47 4.48 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.767 0.827 . . . . 0.0 111.464 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -79.39 22.99 0.41 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 112.831 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 36.5 p30 -64.65 147.52 97.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 122.109 -0.369 . . . . 0.0 110.331 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.72 -32.31 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.419 2.746 . . . . 0.0 113.872 -169.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -121.04 2.02 10.41 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.46 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.53 37.92 95.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.072 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 92.6 Cg_endo -71.37 -9.05 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.97 2.446 . . . . 0.0 112.291 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -145.75 150.39 42.99 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.311 0.505 . . . . 0.0 110.765 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.77 156.21 39.57 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.059 3.173 . . . . 0.0 110.634 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 573' ' ' TYR . . . . . 0.411 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 70.4 t80 -140.86 -1.44 1.41 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 4.9 t -66.39 131.92 47.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.484 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.93 144.65 50.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.917 0.887 . . . . 0.0 109.086 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -89.7 134.75 34.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 153.19 39.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.944 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 32.1 p -163.36 176.76 9.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.861 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -72.19 143.19 48.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.8 t -135.64 146.27 47.68 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.363 0.665 . . . . 0.0 110.451 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 51.8 m -87.17 102.16 14.2 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.25 161.47 34.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.997 0.919 . . . . 0.0 110.053 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -93.92 -19.6 20.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -161.27 162.45 31.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.141 0.976 . . . . 0.0 109.441 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.17 76.48 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.637 -1.173 . . . . 0.0 110.253 -179.472 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 120.769 0.318 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.1 -2.95 53.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.7 m -152.06 153.86 31.81 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.158 0.583 . . . . 0.0 110.979 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.44 -5.03 10.16 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.507 3.471 . . . . 0.0 113.546 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.2 t -126.91 151.33 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 118.498 0.59 . . . . 0.0 111.176 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' LEU . . . . . 0.403 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.6 pp -138.12 164.46 29.08 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.71 0.804 . . . . 0.0 109.531 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.3 mtp -136.45 148.29 47.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.736 0.414 . . . . 0.0 110.11 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.56 149.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 122.85 0.46 . . . . 0.0 110.424 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -140.44 165.85 26.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.666 0.786 . . . . 0.0 109.286 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 81.9 -1.21 87.15 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.703 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.72 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.0 pt? -71.64 172.39 9.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.194 0.997 . . . . 0.0 110.048 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -130.42 127.25 38.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -68.11 -2.91 8.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 87.8 p -108.29 -2.84 18.9 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -130.13 -12.23 4.12 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.376 0.67 . . . . 0.0 111.055 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.07 125.95 10.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.372 0.669 . . . . 0.0 109.328 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -141.87 -172.16 3.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.0 -25.65 61.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.83 -25.78 24.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.879 -0.513 . . . . 0.0 111.799 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -91.97 -25.2 18.98 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 122.265 -0.272 . . . . 0.0 111.178 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.8 -27.26 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.55 -42.89 67.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.695 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -80.63 -8.64 59.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.564 0.62 . . . . 0.0 112.653 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.78 -24.35 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 118.214 0.461 . . . . 0.0 110.932 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -107.33 -13.72 15.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.4 t -69.56 -28.71 66.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.27 0.941 . . . . 0.0 111.562 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.76 14.2 1.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.734 -0.604 . . . . 0.0 112.209 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -119.59 -2.75 10.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.419 0.688 . . . . 0.0 110.22 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 143.07 165.84 10.85 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.17 152.67 44.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.212 -0.581 . . . . 0.0 110.957 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.07 146.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.82 -57.75 2.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.997 -0.439 . . . . 0.0 109.905 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -166.38 164.83 17.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.971 0.509 . . . . 0.0 110.687 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.89 149.73 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.483 0.713 . . . . 0.0 110.105 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -152.22 144.18 23.75 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -75.52 154.52 36.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.654 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 9.1 tmm? -129.33 141.16 51.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.285 0.564 . . . . 0.0 112.51 -168.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.51 33.75 19.6 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.69 1.596 . . . . 0.0 111.885 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.2 m 52.91 15.84 0.62 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.354 1.062 . . . . 0.0 113.59 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.74 145.63 75.04 Favored Pre-proline 0 C--N 1.339 0.122 0 CA-C-N 118.156 0.435 . . . . 0.0 110.086 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 4.03 6.97 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.83 3.02 . . . . 0.0 110.604 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -146.84 30.73 1.51 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.278 -0.735 . . . . 0.0 113.209 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.654 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -149.78 138.31 20.75 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.355 1.078 . . . . 0.0 110.537 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.89 19.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.034 0.445 . . . . 0.0 111.808 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 7.6 ptp -135.76 150.6 49.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.806 0.843 . . . . 0.0 110.394 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.47 149.47 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.286 0.634 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -130.71 133.44 46.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.531 0.732 . . . . 0.0 109.913 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.1 mmm -106.1 161.29 14.63 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.943 0.497 . . . . 0.0 110.981 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.79 -18.79 60.41 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.448 0.299 . . . . 0.0 111.762 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -154.28 155.86 35.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.679 0.392 . . . . 0.0 110.222 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.44 -15.95 75.39 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.429 -0.65 . . . . 0.0 113.078 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -26.45 59.62 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.057 1.428 . . . . 0.0 110.701 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.78 -27.23 60.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.72 -29.79 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.39 -40.54 73.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.187 -0.321 . . . . 0.0 110.626 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.45 -34.92 35.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.52 -29.96 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 121.964 -0.46 . . . . 0.0 111.404 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 17.7 m -95.26 -18.9 20.45 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -136.46 -10.78 1.89 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -108.03 -21.76 12.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.376 0.989 . . . . 0.0 108.802 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -51.87 143.46 13.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.218 1.007 . . . . 0.0 110.956 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 57.11 1.47 0.1 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.535 1.934 . . . . 0.0 115.733 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.88 142.43 27.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 120.757 1.617 . . . . 0.0 107.968 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.332 0.0 OUTLIER -130.88 163.88 26.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 175.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 20.5 ptm -125.37 143.34 51.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.651 1.18 . . . . 0.0 110.405 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.73 28.3 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.96 15.71 64.63 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.14 151.02 25.9 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.093 1.447 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -84.7 137.91 32.95 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -94.54 123.97 38.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -168.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -140.72 115.87 9.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 141.01 16.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.214 0.461 . . . . 0.0 110.178 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.41 163.34 37.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.663 0.785 . . . . 0.0 110.126 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.1 p -84.57 155.64 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.6 t -136.6 155.37 50.01 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.073 0.397 . . . . 0.0 111.22 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -93.17 7.04 45.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -66.54 140.02 96.33 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.94 -25.8 10.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.944 2.429 . . . . 0.0 111.319 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.1 171.28 15.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.487 0.715 . . . . 0.0 109.87 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 41.9 mm -68.68 136.91 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -91.73 153.85 43.85 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.32 164.4 8.85 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.847 3.031 . . . . 0.0 112.53 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 163.84 174.73 34.0 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.31 160.97 29.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.1 p -137.33 153.87 50.17 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.048 0.539 . . . . 0.0 110.512 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -144.59 165.09 29.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.249 0.62 . . . . 0.0 109.848 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.62 137.66 17.78 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.22 167.34 14.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 109.551 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.97 -20.0 65.01 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.056 -0.403 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.87 0.88 37.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.909 0.322 . . . . 0.0 111.235 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.7 -2.04 87.17 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.594 -0.559 . . . . 0.0 113.211 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.39 163.19 13.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.103 0.952 . . . . 0.0 110.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.3 m -84.54 153.36 23.31 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.811 0.444 . . . . 0.0 110.902 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.8 p -73.09 -10.33 59.67 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.025 0.53 . . . . 0.0 111.577 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -132.8 143.65 49.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.151 0.98 . . . . 0.0 109.747 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -156.1 159.24 38.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.578 0.351 . . . . 0.0 110.3 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.95 153.23 52.15 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.189 0.595 . . . . 0.0 110.851 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.63 15.49 2.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.034 0.534 . . . . 0.0 111.282 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.0 p . . . . . 0 CA--C 1.53 0.19 0 C-N-CA 123.361 0.664 . . . . 0.0 112.544 -175.426 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.97 119.75 44.28 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.564 1.075 . . . . 0.0 110.324 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.08 113.35 3.59 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.567 2.845 . . . . 0.0 110.804 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 52.4 m -123.96 13.42 9.13 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.388 0.675 . . . . 0.0 111.942 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 57.14 16.91 3.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.725 1.21 . . . . 0.0 113.722 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 74.1 t -134.51 141.44 43.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 118.419 0.554 . . . . 0.0 109.886 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.58 163.69 18.5 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 108.7 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.26 146.88 35.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.864 0.364 . . . . 0.0 111.729 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -112.71 150.01 32.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.572 1.149 . . . . 0.0 109.565 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -147.63 169.95 18.54 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 122.674 0.39 . . . . 0.0 111.175 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 29.0 m120 59.71 17.91 6.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.599 1.16 . . . . 0.0 113.747 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.69 156.09 73.08 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.85 154.79 36.07 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.921 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.5 pt? -72.69 -1.08 14.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.94 4.74 32.15 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.084 0.402 . . . . 0.0 111.723 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -81.64 148.69 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 O-C-N 122.062 -0.398 . . . . 0.0 110.6 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 72.4 p -144.14 174.01 11.25 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.849 0.86 . . . . 0.0 109.93 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.5 -24.59 67.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.796 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.97 -23.11 55.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.428 -0.17 . . . . 0.0 110.657 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -82.05 -28.88 32.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.85 -31.36 66.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -74.74 -38.7 62.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.753 0.252 . . . . 0.0 111.187 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.86 -14.4 59.26 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.09 0.405 . . . . 0.0 111.569 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.69 -38.51 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.617 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.5 m -67.06 -24.69 66.0 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.826 0.739 . . . . 0.0 110.537 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.16 -28.1 61.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.98 -17.5 26.22 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' LEU . . . . . 0.437 HD11 HG22 ' A' ' 523' ' ' VAL . 4.3 pp -102.58 5.24 39.16 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 79.45 35.25 29.87 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.867 1.107 . . . . 0.0 115.867 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.437 HG22 HD11 ' A' ' 521' ' ' LEU . 11.1 m -130.47 168.3 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.2 1.5 . . . . 0.0 111.833 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.29 150.64 31.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.973 0.909 . . . . 0.0 110.855 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -87.58 152.89 52.58 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.364 0.666 . . . . 0.0 110.186 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.61 153.4 75.29 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.516 2.811 . . . . 0.0 111.105 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.427 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 86.4 m -82.34 -25.03 34.24 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.679 0.392 . . . . 0.0 110.707 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 13.6 t -142.83 156.48 44.96 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.562 0.345 . . . . 0.0 110.115 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.9 p -149.51 141.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.094 0.558 . . . . 0.0 110.758 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 121.59 8.85 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.16 144.63 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 122.848 0.459 . . . . 0.0 110.997 -173.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -149.89 159.22 44.55 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.271 1.028 . . . . 0.0 109.547 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--O 1.232 0.171 0 C-N-CA 122.979 0.511 . . . . 0.0 110.942 -178.978 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.5 m -137.75 161.15 37.31 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.532 0.333 . . . . 0.0 111.349 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.9 t -132.07 155.0 48.86 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.179 0.991 . . . . 0.0 111.071 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 80.3 p -152.95 166.69 31.6 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.231 1.012 . . . . 0.0 110.37 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.01 177.89 44.45 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.873 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.43 ' C ' HD22 ' A' ' 544' ' ' LEU . 11.2 mp -112.79 144.28 42.6 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.84 0.856 . . . . 0.0 110.196 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.43 HD22 ' C ' ' A' ' 543' ' ' LEU . 3.2 mm? -127.06 139.86 52.7 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.78 108.35 10.66 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.427 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.9 OUTLIER -166.1 155.72 11.95 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.548 1.539 . . . . 0.0 107.347 168.167 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -153.87 126.01 7.89 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.9 t -159.63 153.05 22.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.603 1.561 . . . . 0.0 107.013 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.46 -52.24 64.3 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.096 0.407 . . . . 0.0 111.728 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 38.8 m -85.4 -21.9 28.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -78.95 -35.43 43.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.175 -0.328 . . . . 0.0 110.795 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.96 39.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.28 -0.391 . . . . 0.0 111.166 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 47.1 tp -76.22 -29.7 57.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.776 0.716 . . . . 0.0 111.48 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.81 -40.1 55.61 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.826 -0.546 . . . . 0.0 110.221 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 49.0 m -68.73 -36.8 78.87 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.1 -41.74 99.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.61 -23.02 78.56 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.784 -172.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.14 -20.37 7.42 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.095 1.447 . . . . 0.0 113.883 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 37.3 tp -93.73 -23.16 18.31 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.635 1.107 . . . . 0.0 112.022 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -75.18 136.42 41.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 53.15 27.14 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.845 0.858 . . . . 0.0 113.093 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -78.19 151.38 33.22 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.185 0.594 . . . . 0.0 112.169 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -101.58 136.41 41.46 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.838 1.255 . . . . 0.0 110.03 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.4 ttt -64.17 169.56 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.645 0.378 . . . . 0.0 111.032 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -75.61 17.49 0.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -69.0 145.64 96.76 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.872 -0.518 . . . . 0.0 109.764 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.97 -30.56 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.487 2.791 . . . . 0.0 113.924 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -120.89 0.57 10.31 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.157 0.435 . . . . 0.0 112.114 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 39.81 97.76 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.77 -1.017 . . . . 0.0 112.75 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 74.9 Cg_endo -69.56 -10.11 27.88 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 112.016 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -142.67 148.35 46.1 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.28 154.41 36.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.921 3.081 . . . . 0.0 111.333 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -148.34 -0.7 0.56 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.904 0.482 . . . . 0.0 111.534 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 48.1 p -66.38 129.28 39.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.11 144.56 50.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.647 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -96.09 139.81 31.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.516 0.726 . . . . 0.0 109.09 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.66 151.94 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.578 0.228 . . . . 0.0 111.007 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.2 p -161.7 178.96 8.52 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.974 0.509 . . . . 0.0 110.082 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -71.64 144.27 49.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.442 0.297 . . . . 0.0 110.48 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 30.9 t -135.55 145.04 46.59 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 122.888 0.475 . . . . 0.0 110.782 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 88.5 m -93.88 102.22 14.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.3 161.53 34.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.904 0.882 . . . . 0.0 110.258 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.44 -14.47 17.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -161.36 166.85 26.81 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.586 1.154 . . . . 0.0 108.655 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -79.24 76.39 5.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.447 -1.263 . . . . 0.0 110.031 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -142.87 12.53 1.86 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.095 0.558 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 39.8 t -155.98 147.41 16.84 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 123.462 0.705 . . . . 0.0 110.044 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 4.86 5.22 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.635 2.89 . . . . 0.0 111.454 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.54 151.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.694 0.798 . . . . 0.0 110.382 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.5 pp -142.7 167.95 20.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.728 0.811 . . . . 0.0 109.771 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 71.6 mtp -135.57 152.8 51.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.637 0.256 . . . . 0.0 111.052 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.06 149.02 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 122.901 0.48 . . . . 0.0 110.413 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -141.41 168.75 19.02 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.477 0.711 . . . . 0.0 109.5 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.87 -2.0 87.34 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.874 -0.403 . . . . 0.0 112.616 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.775 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -74.44 171.97 12.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.48 0.64 . . . . 0.0 110.649 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -132.57 132.26 42.37 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -68.58 -4.51 15.59 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.5 t -102.11 -12.2 18.26 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.616 0.366 . . . . 0.0 111.9 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -131.98 -13.9 3.14 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.139 0.427 . . . . 0.0 111.876 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.0 tpt -148.59 106.01 3.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.758 0.823 . . . . 0.0 109.242 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -141.81 -166.78 2.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.766 0.426 . . . . 0.0 110.397 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 73.2 m -53.93 -27.74 32.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.118 0.567 . . . . 0.0 112.509 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.43 -34.12 28.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.922 -0.486 . . . . 0.0 111.007 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -83.51 -28.4 28.69 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.266 -0.271 . . . . 0.0 110.322 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.08 -30.29 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -68.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -70.51 -27.9 64.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.297 -0.382 . . . . 0.0 111.901 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 75.1 t -95.11 -21.55 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -109.51 -12.05 14.74 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.94 -27.34 65.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.143 0.883 . . . . 0.0 111.418 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.46 14.57 1.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.46 2.87 10.24 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.8 0.84 . . . . 0.0 109.982 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 130.6 158.32 9.26 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -172.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -68.96 153.57 43.56 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.056 0.928 . . . . 0.0 111.228 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.72 154.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -97.84 -60.75 1.5 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -164.18 163.42 22.93 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.466 0.706 . . . . 0.0 110.854 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.36 150.74 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -152.13 145.35 24.66 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.509 0.324 . . . . 0.0 110.181 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -79.34 158.91 27.36 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -136.66 141.4 43.17 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -168.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 59.79 33.95 21.81 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 125.136 1.374 . . . . 0.0 112.505 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 23.2 m 53.01 15.39 0.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -81.87 132.56 53.91 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 118.691 0.678 . . . . 0.0 110.043 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.61 -3.68 8.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.543 2.828 . . . . 0.0 112.351 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.19 33.35 2.25 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.478 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.77 133.7 19.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.125 0.962 . . . . 0.0 110.357 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.38 169.17 24.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.198 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.2 ptm -143.49 146.56 33.49 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.278 0.631 . . . . 0.0 109.658 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.31 147.79 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.12 0.568 . . . . 0.0 110.586 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -122.18 135.96 54.84 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.5 mmm -105.25 164.25 11.98 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.485 0.314 . . . . 0.0 110.878 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.99 66.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.99 159.2 36.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.35 0.66 . . . . 0.0 109.333 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.33 -17.0 69.9 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.068 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -68.37 -29.92 68.74 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.004 1.402 . . . . 0.0 110.178 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -73.51 -21.82 60.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.197 -0.314 . . . . 0.0 110.707 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.71 -35.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.88 -36.5 78.14 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.666 0.212 . . . . 0.0 110.677 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.08 -35.01 78.88 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.05 56.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.099 -0.376 . . . . 0.0 110.621 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -29.12 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.184 0.516 . . . . 0.0 111.855 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.8 p -91.17 -13.22 33.32 Favored 'General case' 0 C--N 1.342 0.277 0 O-C-N 121.067 -1.021 . . . . 0.0 113.592 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -138.44 -10.62 1.42 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.3 -14.52 13.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.226 0.921 . . . . 0.0 110.456 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -56.1 142.38 36.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 56.96 1.42 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.72 1.608 . . . . 0.0 114.991 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -87.77 142.6 27.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 120.058 1.299 . . . . 0.0 109.164 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.263 0.1 OUTLIER -130.91 164.0 26.23 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.316 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.4 ptm -125.18 143.42 50.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.86 1.264 . . . . 0.0 108.44 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 68.76 21.87 7.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.359 1.463 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.94 15.8 78.35 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -83.07 162.14 21.45 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.815 1.308 . . . . 0.0 110.68 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.46 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -79.71 132.34 36.17 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.292 0.237 . . . . 0.0 110.493 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.58 135.69 39.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -170.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -140.72 120.19 13.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.36 145.27 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 118.316 0.507 . . . . 0.0 110.378 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -157.68 161.25 38.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.754 0.422 . . . . 0.0 110.408 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.6 p -83.15 151.44 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 21.1 t -100.58 -169.03 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.639 0.375 . . . . 0.0 110.018 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -136.83 0.21 2.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.826 0.45 . . . . 0.0 110.691 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -74.27 148.94 86.62 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.29 -24.77 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.868 2.378 . . . . 0.0 111.794 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.09 170.11 15.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.319 0.647 . . . . 0.0 110.352 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.3 mm -67.14 143.92 15.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.1 mtt -107.77 156.89 37.26 Favored Pre-proline 0 C--O 1.232 0.15 0 C-N-CA 122.338 0.255 . . . . 0.0 111.109 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.68 157.88 21.98 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.928 3.085 . . . . 0.0 112.604 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.3 -179.13 42.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -74.02 150.13 40.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.615 -0.344 . . . . 0.0 110.481 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.9 m -143.69 147.66 34.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -145.97 167.88 22.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.861 0.464 . . . . 0.0 110.477 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.98 137.47 20.0 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.3 167.44 14.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.287 0.635 . . . . 0.0 110.007 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.72 -20.19 65.23 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.368 0.267 . . . . 0.0 111.379 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.1 -1.22 31.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.997 0.519 . . . . 0.0 110.954 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.2 -5.2 73.19 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.89 -0.506 . . . . 0.0 112.237 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 63.9 m -87.2 161.2 18.17 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.799 0.8 . . . . 0.0 110.072 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 80.3 m -85.22 153.35 22.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.48 0.181 . . . . 0.0 110.582 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.5 p -73.01 -10.48 59.85 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.466 0.306 . . . . 0.0 111.416 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.25 141.64 51.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.127 0.971 . . . . 0.0 109.487 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -155.25 156.84 36.31 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.548 0.339 . . . . 0.0 110.191 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.89 154.65 50.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.462 0.705 . . . . 0.0 110.547 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.12 15.85 2.08 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 122.723 0.409 . . . . 0.0 111.514 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.771 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -103.4 120.97 50.18 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.92 131.55 15.81 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.015 2.477 . . . . 0.0 110.557 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 87.8 p -124.16 -1.3 8.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.544 0.738 . . . . 0.0 112.119 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.53 16.21 5.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.069 0.948 . . . . 0.0 112.167 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.2 t -135.97 138.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.418 HD12 ' CH2' ' A' ' 546' ' ' TRP . 46.9 mt -120.26 152.69 37.41 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.08 145.8 49.02 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -131.93 151.71 51.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.613 0.244 . . . . 0.0 110.576 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -147.36 171.08 16.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 111.094 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.46 25.95 14.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.512 1.125 . . . . 0.0 113.236 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.74 63.93 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.88 159.7 52.36 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.206 1.938 . . . . 0.0 110.194 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.2 pt? -73.95 -1.07 18.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.87 4.51 42.81 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -86.41 150.22 3.93 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 CA-C-N 118.251 0.478 . . . . 0.0 111.347 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -147.2 174.34 11.7 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.939 0.896 . . . . 0.0 109.522 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.23 -24.67 67.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.499 -0.126 . . . . 0.0 110.925 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.1 -24.95 51.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.179 -0.325 . . . . 0.0 110.718 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.3 -28.35 38.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -73.71 -30.79 63.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.203 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -75.25 -36.32 61.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.287 -0.258 . . . . 0.0 111.544 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.46 -21.24 42.24 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.266 0.485 . . . . 0.0 111.55 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.91 -37.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 86.8 m -67.38 -26.48 66.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.091 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.42 -29.12 62.37 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -91.06 -11.84 37.49 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.526 0.603 . . . . 0.0 111.895 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 86.3 mt -100.7 -5.44 26.5 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.644 0.377 . . . . 0.0 111.277 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.24 5.62 72.27 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.866 -0.408 . . . . 0.0 112.907 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.4 m -91.43 167.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 117.65 0.725 . . . . 0.0 110.953 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -76.63 151.84 36.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.384 0.674 . . . . 0.0 110.173 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 525' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 526' ' ' PRO . 4.7 ptp180 -102.16 150.9 37.91 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 526' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 525' ' ' ARG . 32.1 Cg_exo -60.15 158.98 27.89 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.404 2.736 . . . . 0.0 112.64 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.501 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 91.4 m -86.36 -25.07 25.55 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.072 0.549 . . . . 0.0 110.499 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.1 t -145.23 152.25 39.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.1 t -141.37 140.93 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.348 0.659 . . . . 0.0 109.775 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.97 126.51 15.94 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.8 t -132.05 149.43 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.032 0 C-N-CA 122.667 0.387 . . . . 0.0 110.673 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -152.3 153.75 34.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.272 0.629 . . . . 0.0 110.17 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 62.5 p . . . . . 0 N--CA 1.457 -0.117 0 C-N-CA 123.106 0.563 . . . . 0.0 109.907 178.288 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 36.2 m -139.61 164.45 29.89 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.396 0.678 . . . . 0.0 110.351 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 34.3 t -132.91 153.7 51.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 111.089 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 67.6 m -146.65 164.61 32.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.059 1.343 . . . . 0.0 108.854 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -179.26 -175.07 45.91 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.01 -1.091 . . . . 0.0 113.857 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.11 153.49 42.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.188 0.995 . . . . 0.0 109.763 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 72.8 mt -136.52 136.9 39.76 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.043 0.937 . . . . 0.0 108.903 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -127.86 109.2 11.38 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.501 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.8 OUTLIER -166.12 155.01 11.28 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.826 1.25 . . . . 0.0 108.579 168.525 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -149.78 121.02 7.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 548' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 37.8 t -159.55 153.22 22.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -66.47 -46.92 74.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.767 0.712 . . . . 0.0 111.211 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 67.7 p -85.89 -27.84 24.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 551' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 48.6 m-20 -84.05 -30.01 26.41 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.578 0.626 . . . . 0.0 111.078 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.04 27.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.339 0.518 . . . . 0.0 111.236 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.74 -30.6 28.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.853 0.751 . . . . 0.0 112.024 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.82 -42.58 49.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.475 0.58 . . . . 0.0 110.482 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 43.3 m -68.88 -36.38 78.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.68 -41.48 83.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.7 -17.3 76.53 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.957 -0.913 . . . . 0.0 113.544 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.92 -19.22 7.33 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.757 1.279 . . . . 0.0 114.29 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -90.82 -31.25 16.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.056 0.844 . . . . 0.0 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -62.29 139.58 58.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 51.39 23.23 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.366 1.066 . . . . 0.0 113.604 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -74.4 151.33 39.69 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -99.87 136.25 40.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.482 1.113 . . . . 0.0 109.733 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 564' ' ' MET . . . . . 0.421 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.3 ttt -64.34 172.42 2.55 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.311 0.577 . . . . 0.0 112.208 -172.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 565' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.3 ptmt -66.94 3.43 1.09 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.699 1.2 . . . . 0.0 113.712 -176.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -67.86 144.74 97.53 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 118.634 0.652 . . . . 0.0 110.727 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.98 -27.32 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.542 2.828 . . . . 0.0 113.784 -171.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -121.08 -3.06 9.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.205 0.457 . . . . 0.0 112.026 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.06 40.52 98.24 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.69 -1.061 . . . . 0.0 112.806 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 83.5 Cg_endo -69.69 -9.64 26.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.103 2.535 . . . . 0.0 111.823 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -142.19 147.74 45.18 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.023 0.529 . . . . 0.0 109.648 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.48 152.85 34.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.805 3.004 . . . . 0.0 111.565 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -148.83 -3.21 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.133 0.573 . . . . 0.0 111.493 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.44 120.94 14.22 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.701 -0.624 . . . . 0.0 110.044 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.96 144.63 50.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.093 0.957 . . . . 0.0 109.934 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -86.3 154.55 21.16 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 55.0 tp -144.12 144.84 31.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.96 168.38 19.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -77.07 130.86 37.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.9 t -135.57 138.2 42.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 32.9 p -79.7 102.25 8.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.336 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 159.92 39.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 109.144 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -81.85 -32.47 31.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.189 -0.319 . . . . 0.0 110.228 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -153.66 165.81 34.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.944 0.898 . . . . 0.0 109.571 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.43 76.32 7.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.354 -179.473 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.89 0.376 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.43 -0.58 57.35 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.336 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 43.0 t -160.27 146.56 11.81 Favored Pre-proline 0 N--CA 1.456 -0.164 0 C-N-CA 123.197 0.599 . . . . 0.0 110.355 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.14 4.34 6.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.118 3.212 . . . . 0.0 112.091 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.05 151.79 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 123.364 0.666 . . . . 0.0 110.699 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 381' ' ' LEU . 4.5 pp -141.58 167.07 23.03 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.807 0.843 . . . . 0.0 109.627 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 70.0 mtp -134.19 151.08 51.15 Favored 'General case' 0 N--CA 1.458 -0.042 0 C-N-CA 122.459 0.304 . . . . 0.0 111.084 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.9 148.15 19.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.834 0.454 . . . . 0.0 110.427 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -140.11 168.06 20.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.488 0.715 . . . . 0.0 109.369 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.45 -6.44 80.04 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.354 -0.692 . . . . 0.0 113.05 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.71 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -68.98 177.67 2.54 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.998 0.899 . . . . 0.0 110.387 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -142.78 136.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -73.63 -7.14 50.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 96.0 p -93.2 -12.03 31.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.605 0.639 . . . . 0.0 112.592 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.47 5.89 0.94 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.5 ttt -141.26 129.14 21.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.94 177.81 7.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.755 0.422 . . . . 0.0 110.213 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.57 -28.06 63.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.56 0.344 . . . . 0.0 111.203 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.66 -23.08 29.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.052 -0.405 . . . . 0.0 111.376 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -83.85 -34.5 24.62 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.1 -27.48 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.5 -33.84 73.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.018 -0.427 . . . . 0.0 110.183 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -67.88 -29.54 68.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.853 -0.529 . . . . 0.0 111.086 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 80.3 t -90.36 -29.64 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -101.72 -8.68 21.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 53.0 t -71.55 -38.34 71.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.872 0.76 . . . . 0.0 111.333 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.66 12.92 1.45 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.731 -0.606 . . . . 0.0 112.407 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.21 0.75 11.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.278 0.631 . . . . 0.0 111.152 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.16 170.05 14.52 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -70.26 136.42 49.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.351 -0.5 . . . . 0.0 110.759 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 4.5 m -95.1 164.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.773 1.229 . . . . 0.0 110.321 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -125.8 -65.54 0.99 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.325 0.25 . . . . 0.0 110.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -163.37 165.54 23.9 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.067 0.547 . . . . 0.0 111.194 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.63 151.63 14.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.674 0.79 . . . . 0.0 110.363 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.05 147.64 26.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -78.17 158.98 28.85 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.23 141.46 42.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.05 33.9 21.33 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.845 1.258 . . . . 0.0 112.402 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.4 m 53.06 16.06 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 114.129 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -80.61 144.73 57.12 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 118.449 0.568 . . . . 0.0 109.599 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.18 1.83 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.843 3.029 . . . . 0.0 110.831 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -143.27 33.41 1.81 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.164 -173.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.03 19.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.933 0.867 . . . . 0.0 110.133 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.28 170.6 21.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.073 0.464 . . . . 0.0 110.808 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 17.7 ptm -145.05 146.53 31.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.983 0.513 . . . . 0.0 109.672 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.25 147.75 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.026 0 C-N-CA 123.322 0.649 . . . . 0.0 110.742 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -124.58 142.42 51.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.535 0.734 . . . . 0.0 109.773 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.0 mmm -115.63 164.21 14.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 109.797 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.85 64.18 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.392 -0.192 . . . . 0.0 111.251 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.86 160.13 33.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.12 -14.51 63.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.377 -0.679 . . . . 0.0 113.097 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -64.38 -31.19 72.29 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.398 1.599 . . . . 0.0 110.233 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.67 -23.78 45.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.52 -0.113 . . . . 0.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.03 -31.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.04 -31.18 62.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.134 0.425 . . . . 0.0 110.865 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -29.62 65.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.067 -0.396 . . . . 0.0 109.986 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.66 -28.8 40.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.735 0.243 . . . . 0.0 110.59 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.8 tp -81.83 -35.25 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 122.775 0.43 . . . . 0.0 110.059 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 m -89.24 -26.09 21.38 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.91 -11.09 6.6 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.78 -16.76 11.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.424 1.011 . . . . 0.0 110.339 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -54.05 141.67 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.83 0.852 . . . . 0.0 111.514 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 57.04 1.39 0.09 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.045 2.138 . . . . 0.0 115.956 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.75 142.59 27.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 120.786 1.63 . . . . 0.0 108.01 169.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.276 0.0 OUTLIER -130.98 163.86 26.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.3 ptm -125.25 143.47 50.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.466 1.106 . . . . 0.0 109.607 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 66.46 32.94 7.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.178 1.391 . . . . 0.0 113.784 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.0 15.88 72.23 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.654 169.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -83.02 152.82 25.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.521 1.161 . . . . 0.0 110.736 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.564 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -75.42 136.19 40.73 Favored 'General case' 0 C--N 1.337 0.028 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.795 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -97.21 127.16 42.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -140.6 115.87 9.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.83 139.44 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.5 m -148.17 164.37 34.15 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.579 0.752 . . . . 0.0 109.99 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.62 151.9 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.5 t -102.29 -174.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.085 0.554 . . . . 0.0 110.304 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -135.4 7.12 3.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.799 0.84 . . . . 0.0 110.341 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -78.86 147.56 70.74 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.79 -25.46 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.835 2.357 . . . . 0.0 111.978 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.46 170.75 12.58 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.155 0.582 . . . . 0.0 110.443 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -68.22 140.61 18.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.6 mtt -102.37 151.45 38.17 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.416 0.286 . . . . 0.0 110.723 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 161.54 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.729 2.952 . . . . 0.0 111.337 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.65 -175.68 44.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -72.96 158.26 35.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.664 0.385 . . . . 0.0 110.17 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.1 p -146.41 162.49 38.11 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.167 0.587 . . . . 0.0 110.543 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -150.15 163.7 37.53 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.96 0.504 . . . . 0.0 110.208 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.87 135.42 17.88 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.4 mt -86.97 176.4 7.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.904 0.882 . . . . 0.0 109.954 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -65.27 -20.29 66.35 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.392 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.23 0.15 49.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.359 0.664 . . . . 0.0 111.573 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.52 -3.52 77.95 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.286 0.469 . . . . 0.0 112.504 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 60.5 m -93.82 156.69 16.52 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.681 0.74 . . . . 0.0 110.269 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.81 153.35 36.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.456 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.0 p -66.33 -10.39 42.44 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.775 0.43 . . . . 0.0 111.79 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -118.52 137.48 53.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.174 0.99 . . . . 0.0 109.391 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -151.87 154.92 37.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -124.28 152.36 43.11 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.02 0.928 . . . . 0.0 109.84 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -137.94 12.57 2.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.144 0.578 . . . . 0.0 112.276 -175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 97.2 p . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.316 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 . . . . . 0 CA--C 1.529 0.159 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -65.37 163.96 28.38 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.401 0.681 . . . . 0.0 110.756 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.61 151.86 13.66 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.764 2.976 . . . . 0.0 112.764 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 45.1 p -124.05 23.89 8.38 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.907 0.883 . . . . 0.0 112.122 -173.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 54.67 13.13 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.792 1.637 . . . . 0.0 115.051 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.85 150.24 22.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.96 143.84 50.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -109.37 152.48 25.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.731 0.413 . . . . 0.0 109.92 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -130.38 135.71 48.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.09 0.956 . . . . 0.0 108.482 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -146.56 168.18 21.88 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.858 0.463 . . . . 0.0 111.073 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.8 m120 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.906 0.882 . . . . 0.0 112.623 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.42 156.35 50.96 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 122.984 0.514 . . . . 0.0 109.765 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.18 156.95 64.04 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.286 1.99 . . . . 0.0 110.407 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.5 -1.19 26.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.17 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.6 7.8 28.83 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.095 -0.378 . . . . 0.0 111.983 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.51 153.09 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.168 0.44 . . . . 0.0 111.668 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 75.5 p -146.91 172.6 13.43 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.935 0.894 . . . . 0.0 110.114 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 511' ' ' GLU . 3.6 pm0 -60.79 -24.31 65.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.796 177.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -73.59 -26.69 60.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.178 -0.326 . . . . 0.0 110.455 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.37 -28.93 37.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.47 -29.43 63.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.6 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.81 -38.99 31.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.575 0.625 . . . . 0.0 111.605 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.91 -18.96 52.99 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.174 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.5 mt -90.85 -33.5 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 118.285 0.493 . . . . 0.0 110.095 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.33 -22.27 64.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.635 -0.666 . . . . 0.0 110.285 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.58 -30.55 64.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.13 -13.0 33.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.365 0.53 . . . . 0.0 112.075 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.5 mt -91.82 -6.53 51.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.517 0.327 . . . . 0.0 110.428 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.41 7.73 64.77 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.693 -0.504 . . . . 0.0 112.966 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.1 m -87.54 169.13 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 117.833 0.817 . . . . 0.0 111.222 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -71.16 132.33 44.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -76.81 147.0 77.07 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.92 148.29 91.77 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.909 2.406 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.1 m -89.55 -19.9 24.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.544 0.337 . . . . 0.0 110.431 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.5 t -147.25 148.98 32.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.41 138.93 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.656 0.382 . . . . 0.0 110.328 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -142.91 139.92 30.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.32 154.97 41.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 110.428 -175.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -152.05 161.15 43.07 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.441 1.096 . . . . 0.0 109.166 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.695 178.818 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 158.26 44.55 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.81 0.444 . . . . 0.0 111.411 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -115.8 157.38 24.47 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.07 0.948 . . . . 0.0 111.884 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -149.88 175.15 11.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.256 1.422 . . . . 0.0 109.199 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.7 45.7 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.647 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.484 ' C ' HD12 ' A' ' 544' ' ' LEU . 6.3 mp -129.25 132.79 47.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.632 0.773 . . . . 0.0 109.01 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 543' ' ' LEU . 9.4 mp -128.12 144.78 51.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.76 120.46 27.95 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.468 ' HB3' ' H ' ' A' ' 527' ' ' THR . 9.6 p90 -164.94 147.4 8.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -156.21 123.4 5.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 17.3 m -159.64 152.89 22.16 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.341 1.856 . . . . 0.0 106.304 169.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -59.95 -54.26 48.22 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.718 0.69 . . . . 0.0 111.897 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 26.9 m -83.5 -27.28 29.51 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.96 -30.82 31.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.06 0.391 . . . . 0.0 111.024 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -30.36 38.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.9 tp -78.08 -29.61 49.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.624 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -71.98 -41.72 67.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 O-C-N 121.938 -0.476 . . . . 0.0 109.983 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 24.1 m -73.44 -39.24 65.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.992 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 556' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 556' ' ' LEU . 3.0 tm? -66.66 -46.78 74.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.676 -0.64 . . . . 0.0 109.815 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.15 -16.41 78.58 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.552 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -123.7 -6.18 8.03 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.795 1.298 . . . . 0.0 113.48 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.87 -16.36 14.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.3 0.5 . . . . 0.0 111.265 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -68.07 143.6 55.42 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.266 -0.896 . . . . 0.0 109.924 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 52.64 29.41 7.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.06 0.944 . . . . 0.0 113.354 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 562' ' ' TYR . . . . . 0.406 ' H ' ' HD1' ' A' ' 562' ' ' TYR . 0.4 OUTLIER -74.7 151.42 39.23 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -103.76 136.42 43.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.063 1.745 . . . . 0.0 110.635 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 564' ' ' MET . . . . . 0.447 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.13 173.68 1.85 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.935 0.494 . . . . 0.0 111.202 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 565' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 564' ' ' MET . 65.2 pttt -73.3 9.77 1.19 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -66.28 143.86 98.48 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.715 0.688 . . . . 0.0 110.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.0 -29.58 3.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.569 2.846 . . . . 0.0 114.04 -169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -121.02 1.37 10.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.961 0.346 . . . . 0.0 111.912 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.428 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.74 41.55 99.09 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.929 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.6 Cg_endo -68.94 -10.87 30.37 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.247 2.631 . . . . 0.0 112.048 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.11 147.61 38.38 Favored Pre-proline 0 N--CA 1.455 -0.201 0 C-N-CA 122.832 0.453 . . . . 0.0 109.824 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.81 152.37 41.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.859 3.039 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 573' ' ' TYR . . . . . 0.447 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.7 t80 -144.17 -2.79 0.88 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 126.17 28.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.809 -0.557 . . . . 0.0 109.998 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.14 144.71 50.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.232 1.013 . . . . 0.0 110.372 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -79.46 135.98 36.81 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.5 pp -146.99 146.85 30.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 25.5 p -163.72 169.99 17.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.082 0.553 . . . . 0.0 110.304 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -73.78 130.67 40.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 74.6 m -135.55 140.07 44.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.79 0.436 . . . . 0.0 110.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 65.0 m -79.82 102.34 9.03 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.012 0.434 . . . . 0.0 110.573 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 161.6 34.44 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.076 0.95 . . . . 0.0 109.43 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 583' ' ' GLN . . . . . 0.508 ' H ' ' CD ' ' A' ' 583' ' ' GLN . 0.0 OUTLIER -98.87 -15.92 19.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.573 0.349 . . . . 0.0 111.511 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -160.58 164.56 31.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.205 0.602 . . . . 0.0 109.824 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.17 76.4 9.24 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.945 179.113 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.744 0.306 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -139.08 10.75 2.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.29 0.636 . . . . 0.0 110.917 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 37.6 t -155.71 150.71 20.78 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.177 0.591 . . . . 0.0 110.323 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.34 -4.39 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.562 2.841 . . . . 0.0 111.473 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.77 145.3 17.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.098 0.559 . . . . 0.0 111.019 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.99 165.16 27.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.243 1.017 . . . . 0.0 109.43 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.2 mtp -137.87 153.17 49.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.674 0.274 . . . . 0.0 111.58 -175.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.63 150.39 15.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.064 0.546 . . . . 0.0 110.357 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.24 166.16 24.89 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.59 86.93 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.115 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.769 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.58 178.14 4.27 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.209 1.005 . . . . 0.0 110.992 177.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.44 143.8 35.78 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -73.29 0.22 12.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.4 p -113.67 -4.33 13.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.552 0.614 . . . . 0.0 112.376 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -131.81 -6.9 3.58 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.141 0.577 . . . . 0.0 110.882 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 27.8 ttt -145.43 128.19 16.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.433 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 32.8 m-80 -141.88 176.75 8.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.701 0.801 . . . . 0.0 109.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.0 m -57.98 -27.84 63.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.314 0.246 . . . . 0.0 111.142 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -85.15 -26.21 26.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.267 -0.271 . . . . 0.0 111.451 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ARG . . . . . 0.433 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 48.8 mmt-85 -81.07 -33.85 33.12 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.194 0.452 . . . . 0.0 109.804 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -25.12 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -71.52 -29.33 64.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.66 -26.74 50.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.684 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 74.5 t -90.18 -21.28 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.298 0.499 . . . . 0.0 112.301 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -114.43 -12.91 12.29 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.79 -25.65 62.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.44 1.018 . . . . 0.0 111.754 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.6 pp -77.67 11.16 2.22 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.649 -0.657 . . . . 0.0 112.164 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.75 -7.78 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.454 0.701 . . . . 0.0 110.609 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.32 170.71 19.81 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -70.41 138.49 51.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.065 -0.668 . . . . 0.0 111.008 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 62.0 t -97.25 145.14 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.07 -57.89 1.98 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.323 -0.236 . . . . 0.0 110.721 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -160.0 165.23 32.36 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.972 0.415 . . . . 0.0 111.54 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.21 151.8 15.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 123.85 0.86 . . . . 0.0 109.987 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -151.64 144.56 24.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.762 0.425 . . . . 0.0 110.007 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -76.05 157.4 33.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 34.4 ttp -119.67 141.15 49.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -168.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt 51.93 33.88 12.54 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.722 1.209 . . . . 0.0 112.26 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.8 m 55.68 15.76 1.7 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 113.323 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -81.29 142.18 50.46 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.42 -2.47 11.98 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.467 2.778 . . . . 0.0 109.518 169.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.01 15.79 10.99 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.556 1.074 . . . . 0.0 113.822 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.181 1.49 . . . . 0.0 111.129 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -158.89 168.06 27.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.169 0.509 . . . . 0.0 111.964 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.2 ptp -136.07 148.79 48.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.913 0.885 . . . . 0.0 109.93 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.53 151.35 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.556 0.742 . . . . 0.0 109.834 -175.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -130.77 145.04 51.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.736 0.414 . . . . 0.0 110.493 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 73.7 mtp -124.34 165.43 17.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.02 66.58 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -158.81 160.79 36.63 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.73 -13.33 78.35 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.509 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -65.51 -26.79 68.07 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.166 1.483 . . . . 0.0 110.741 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.98 -25.61 25.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.219 0.208 . . . . 0.0 110.841 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.39 -30.36 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.6 -33.4 72.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.497 0.319 . . . . 0.0 110.355 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -76.08 -25.35 55.42 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.175 -0.328 . . . . 0.0 110.514 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.84 -28.57 44.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.984 -0.448 . . . . 0.0 109.868 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -80.47 -31.04 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.102 0.961 . . . . 0.0 111.096 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 45.7 p -100.54 -13.17 18.74 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -134.05 -11.97 2.55 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.049 1.295 . . . . 0.0 114.391 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.82 -10.45 11.71 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.96 0.8 . . . . 0.0 109.718 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -58.88 145.24 41.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.403 0.62 . . . . 0.0 112.443 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 21.3 m120 56.9 1.35 0.09 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.543 1.937 . . . . 0.0 115.536 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -87.95 142.52 27.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.55 1.523 . . . . 0.0 108.493 169.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.0 OUTLIER -130.69 163.97 26.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 174.367 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.3 ptm -125.26 143.36 50.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.642 1.177 . . . . 0.0 109.171 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 63.86 27.09 14.46 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.953 1.301 . . . . 0.0 114.483 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.83 15.92 76.4 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -83.04 150.63 26.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.979 1.389 . . . . 0.0 110.14 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 141.49 38.28 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.79 122.99 40.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -140.73 115.72 9.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.14 140.22 24.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.926 0.33 . . . . 0.0 110.341 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 99.4 m -149.43 168.21 24.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.878 0.871 . . . . 0.0 110.158 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.68 153.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 23.2 t -105.82 -168.23 1.42 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.653 0.381 . . . . 0.0 110.276 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -141.57 4.43 1.75 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.115 0.566 . . . . 0.0 111.146 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -74.38 150.93 87.46 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -27.7 12.35 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.646 2.231 . . . . 0.0 112.382 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.71 170.15 14.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.298 0.499 . . . . 0.0 111.28 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 30.0 mm -71.82 151.49 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.01 133.07 23.15 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.22 158.55 41.29 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.523 2.815 . . . . 0.0 111.427 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 151.84 160.23 9.4 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 48.27 -95.9 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.703 1.201 . . . . 0.0 112.741 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.0 t 63.14 146.75 0.02 OUTLIER 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.653 1.581 . . . . 0.0 112.938 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -148.31 165.3 31.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.913 0.885 . . . . 0.0 109.699 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.45 132.65 11.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.1 mt -87.06 172.5 9.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.315 0.646 . . . . 0.0 110.341 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.48 -22.12 66.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.848 0.459 . . . . 0.0 110.951 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.7 1.2 35.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.199 0.599 . . . . 0.0 111.41 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.45 -2.11 79.1 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.076 0.369 . . . . 0.0 112.402 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.35 156.59 16.7 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.655 0.727 . . . . 0.0 110.067 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 83.9 m -78.77 150.42 32.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.447 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 86.3 p -73.22 -10.33 59.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.455 0.302 . . . . 0.0 111.464 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -119.44 130.59 55.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.561 0.744 . . . . 0.0 109.062 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -151.62 159.44 44.06 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -130.62 147.88 52.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.794 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -136.2 12.77 3.3 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.052 0.541 . . . . 0.0 111.415 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.53 0.189 0 C-N-CA 122.913 0.485 . . . . 0.0 111.594 -174.879 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.965 0.412 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -89.1 166.48 21.64 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.29 1.036 . . . . 0.0 109.882 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.03 129.96 30.02 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.0 2.467 . . . . 0.0 111.412 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 70.8 m -123.99 22.73 8.74 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.195 0.598 . . . . 0.0 112.291 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 60.2 3.29 0.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.06 1.344 . . . . 0.0 114.012 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.6 t -142.29 146.96 21.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 49.1 mt -121.48 162.1 21.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.036 0.534 . . . . 0.0 110.545 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.96 152.78 43.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.502 0.321 . . . . 0.0 110.676 175.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -138.01 154.25 49.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.837 0.455 . . . . 0.0 111.344 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -146.01 172.17 13.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.048 0.539 . . . . 0.0 111.197 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.4 m120 61.08 27.66 17.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -82.64 160.55 61.29 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 122.44 0.296 . . . . 0.0 110.609 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.92 152.71 62.38 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.692 2.261 . . . . 0.0 110.7 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -73.46 -2.56 23.0 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.23 9.22 13.41 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.204 0.602 . . . . 0.0 111.88 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.9 152.44 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.121 -0.362 . . . . 0.0 110.298 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.6 p -145.65 170.97 15.41 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.061 0.544 . . . . 0.0 110.442 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.87 -23.25 66.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.894 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.16 -26.07 58.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.657 0.208 . . . . 0.0 110.492 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -78.56 -30.57 46.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -73.48 -27.04 61.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.303 -0.248 . . . . 0.0 110.878 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -78.85 -39.52 35.09 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.972 -0.455 . . . . 0.0 111.178 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -78.89 -21.74 46.96 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 84.1 mt -86.36 -35.89 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.281 0.491 . . . . 0.0 110.315 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.87 -28.45 68.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.086 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.58 -28.62 65.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.84 -12.18 37.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.557 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.41 -2.89 58.59 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.882 0.473 . . . . 0.0 111.257 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.32 79.94 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.929 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.77 165.07 22.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 117.817 0.809 . . . . 0.0 110.885 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -73.83 146.66 43.99 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.922 0.392 . . . . 0.0 110.605 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 525' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 525' ' ' ARG . 0.4 OUTLIER -88.07 152.92 51.35 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.27 0.628 . . . . 0.0 110.354 176.468 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.85 152.47 69.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.252 2.635 . . . . 0.0 111.413 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 95.4 m -85.51 -27.8 25.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.359 0.263 . . . . 0.0 111.171 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.6 m -140.35 149.43 42.7 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.529 . . . . 0.0 109.813 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.9 t -141.76 147.02 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.971 0.509 . . . . 0.0 110.472 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.31 124.63 10.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.39 144.65 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.586 0.354 . . . . 0.0 110.921 -175.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -149.58 161.38 42.28 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.749 0.82 . . . . 0.0 109.661 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 82.6 p . . . . . 0 C--O 1.233 0.222 0 C-N-CA 122.917 0.487 . . . . 0.0 110.926 179.797 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 98.4 p -147.92 170.23 18.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.798 0.439 . . . . 0.0 111.089 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.2 m -131.37 160.83 33.91 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.661 0.784 . . . . 0.0 111.77 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.9 p -149.33 165.39 32.14 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.592 1.157 . . . . 0.0 109.79 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.08 40.87 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.691 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.98 157.82 39.55 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.74 0.816 . . . . 0.0 110.309 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 71.3 mt -133.51 134.98 44.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.347 1.059 . . . . 0.0 108.43 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.77 111.84 14.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -166.01 153.76 10.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.71 1.604 . . . . 0.0 106.898 167.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.17 124.75 8.35 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 548' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 551' ' ' ASP . 39.6 t -159.56 153.04 22.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 168.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -50.67 70.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.606 0.639 . . . . 0.0 111.7 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 52.1 m -87.75 -29.44 21.05 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 551' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 548' ' ' SER . 12.1 t70 -71.0 -34.28 71.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.268 0.486 . . . . 0.0 110.441 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.64 -34.32 35.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.33 -0.367 . . . . 0.0 110.555 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 38.0 tp -75.96 -29.94 58.46 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.757 0.708 . . . . 0.0 111.241 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -68.61 -43.48 76.31 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.8 m -72.79 -34.76 67.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.41 -42.27 98.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.755 -0.591 . . . . 0.0 109.601 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.78 -23.05 78.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.833 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -112.15 -7.48 14.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.504 1.152 . . . . 0.0 113.457 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.3 tp -112.52 -9.85 13.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.001 0.819 . . . . 0.0 111.927 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -78.05 140.74 39.13 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.232 -0.918 . . . . 0.0 108.823 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 50.72 26.95 2.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.695 0.798 . . . . 0.0 112.652 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.84 151.32 44.9 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -103.79 136.51 43.33 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.751 1.621 . . . . 0.0 111.085 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 564' ' ' MET . . . . . 0.467 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.0 ttt -64.21 173.45 1.97 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.181 0.592 . . . . 0.0 111.307 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -74.02 11.5 0.89 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.8 p30 -65.85 143.53 98.53 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.41 0.55 . . . . 0.0 110.179 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.21 -30.53 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.36 2.707 . . . . 0.0 114.132 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -121.06 1.7 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.211 0.459 . . . . 0.0 112.043 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 40.61 98.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.775 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 84.7 Cg_endo -69.56 -9.5 26.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.984 2.456 . . . . 0.0 112.319 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.23 147.94 39.26 Favored Pre-proline 0 N--CA 1.455 -0.185 0 C-N-CA 122.74 0.416 . . . . 0.0 109.968 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.33 153.01 45.1 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.767 2.978 . . . . 0.0 111.127 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 573' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.9 t80 -148.28 0.81 0.61 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.729 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 66.7 p -66.42 125.83 26.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.398 -0.814 . . . . 0.0 110.261 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 24.5 mt -99.58 144.54 28.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.452 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -81.36 122.61 27.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -133.61 144.63 49.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 18.6 t -164.02 175.82 9.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.251 0.62 . . . . 0.0 110.18 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.46 144.53 33.95 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.014 0.525 . . . . 0.0 109.801 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 37.6 t -135.63 142.35 45.19 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.427 0.158 . . . . 0.0 111.427 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.7 p -79.89 102.27 9.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.14 161.58 34.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.192 0.597 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -123.89 -1.42 8.36 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.344 0.657 . . . . 0.0 109.979 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -159.93 167.21 28.55 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.529 1.132 . . . . 0.0 109.864 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.47 0.99 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.759 0.424 . . . . 0.0 109.93 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.884 -179.773 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.658 0.266 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.26 -1.15 4.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.849 0.46 . . . . 0.0 111.633 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.3 m -146.7 148.83 34.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 C-N-CA 122.596 0.359 . . . . 0.0 110.528 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -82.41 -5.49 11.81 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.253 3.302 . . . . 0.0 112.49 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 72.9 t -119.25 147.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 118.472 0.578 . . . . 0.0 111.229 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.46 166.06 25.74 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.012 0.925 . . . . 0.0 109.382 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 85.5 mtp -135.17 150.49 50.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.517 0.199 . . . . 0.0 111.245 -175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 30.9 t -140.21 145.18 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.323 0.649 . . . . 0.0 109.951 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -137.26 165.05 27.07 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.427 0.691 . . . . 0.0 109.564 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.31 0.15 89.97 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.355 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.75 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -73.88 177.97 5.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.989 0.895 . . . . 0.0 110.976 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.83 137.23 50.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.678 0.391 . . . . 0.0 110.266 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.93 -1.64 23.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 23.1 t -112.62 -13.56 13.28 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.354 0.525 . . . . 0.0 111.59 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -114.58 -9.92 12.58 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.736 0.415 . . . . 0.0 110.32 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.3 ttt -150.88 126.98 10.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.281 0.633 . . . . 0.0 109.898 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -141.94 -174.43 4.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.208 0.603 . . . . 0.0 109.449 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 22.3 p -57.97 -30.42 66.01 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.09 -21.67 23.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.735 -0.603 . . . . 0.0 111.496 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -94.71 -19.36 20.47 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.457 0.303 . . . . 0.0 110.697 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.92 -30.43 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.09 -31.33 71.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -66.92 -42.37 85.5 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.133 -0.354 . . . . 0.0 110.848 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 65.3 t -79.45 -26.09 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 119.278 -0.391 . . . . 0.0 112.002 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -101.97 -10.01 20.15 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 19.7 t -74.01 -33.57 63.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.961 0.801 . . . . 0.0 111.59 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.36 12.54 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.687 -0.633 . . . . 0.0 111.369 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.47 -2.15 9.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 110.656 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.96 173.3 18.06 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -80.35 155.49 27.17 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.389 0.595 . . . . 0.0 110.053 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.33 155.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.304 0.642 . . . . 0.0 110.141 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -102.39 -58.36 1.89 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.717 0.407 . . . . 0.0 110.084 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.16 167.91 17.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.432 0.693 . . . . 0.0 110.466 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.25 148.57 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 122.995 0.518 . . . . 0.0 110.181 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -155.61 148.9 24.76 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 110.844 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -77.92 156.44 30.28 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 171.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.703 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -141.02 141.41 34.34 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -169.221 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.22 33.94 21.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.3 m 52.84 13.45 0.35 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.33 138.12 45.23 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-N 119.083 0.856 . . . . 0.0 109.837 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.17 -6.86 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.185 2.59 . . . . 0.0 110.181 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -114.41 18.19 18.13 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.26 0.933 . . . . 0.0 112.717 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.703 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -150.42 142.73 24.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.747 1.274 . . . . 0.0 111.528 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.54 169.03 25.23 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.729 0.411 . . . . 0.0 111.468 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.4 ptp -136.26 149.43 48.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.594 . . . . 0.0 110.535 176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.77 148.21 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.072 0.549 . . . . 0.0 110.289 -174.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -127.23 131.37 50.61 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 87.4 mmm -100.4 162.83 12.69 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.449 0.3 . . . . 0.0 110.874 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.86 61.82 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -157.92 163.06 38.25 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.25 -16.21 70.87 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.102 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -68.46 -24.19 64.68 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.139 1.469 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -86.76 -22.27 26.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.254 0.222 . . . . 0.0 110.594 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.5 t -78.08 -33.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.44 -28.88 67.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.155 0.182 . . . . 0.0 110.525 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.412 ' HA ' ' NE ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -86.73 -29.38 22.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.104 -0.372 . . . . 0.0 111.194 -177.198 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.83 -26.94 40.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -84.55 -30.95 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 122.143 -0.348 . . . . 0.0 111.585 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.3 p -99.04 -11.18 21.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -132.33 -11.03 3.24 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.8 -21.28 9.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.401 1.0 . . . . 0.0 110.477 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -51.46 142.29 14.07 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.539 0.736 . . . . 0.0 112.226 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.491 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 77.0 m-20 58.41 1.69 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.89 142.52 27.74 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 121.14 1.791 . . . . 0.0 109.287 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 0.1 OUTLIER -130.86 164.05 26.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.3 ptm -125.39 143.43 50.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.548 1.139 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' PHE . . . . . 0.45 ' CE1' ' CD1' ' A' ' 558' ' ' PHE . 37.5 m-85 62.91 27.88 16.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 177.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.8 15.88 58.98 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.314 0.885 . . . . 0.0 115.314 168.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -83.09 141.78 31.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.833 1.317 . . . . 0.0 109.756 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -74.85 139.01 42.9 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.19 121.94 39.64 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -140.77 115.74 9.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 107.871 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.491 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 1.9 p -153.34 139.82 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 118.692 0.678 . . . . 0.0 110.594 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -158.24 161.63 37.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.438 0.695 . . . . 0.0 109.796 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.41 155.68 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 36.0 t -133.43 144.23 49.38 Favored 'General case' 0 CA--C 1.522 -0.115 0 O-C-N 122.102 -0.374 . . . . 0.0 111.318 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -87.92 65.1 8.16 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.283 0.633 . . . . 0.0 111.12 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -127.38 144.06 49.48 Favored Pre-proline 0 CA--C 1.529 0.144 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.74 -25.24 9.44 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.281 2.654 . . . . 0.0 111.76 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.48 172.42 14.49 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.79 0.436 . . . . 0.0 110.617 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.37 140.41 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.99 151.74 42.21 Favored Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 122.425 0.29 . . . . 0.0 110.925 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.96 158.98 55.79 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.93 3.087 . . . . 0.0 111.189 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.08 -172.4 43.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -77.83 164.87 24.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.645 0.378 . . . . 0.0 110.8 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 77.6 p -145.71 158.58 43.84 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.387 0.675 . . . . 0.0 110.114 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -154.16 165.66 35.54 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.742 0.417 . . . . 0.0 110.258 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.02 137.44 22.13 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -86.96 176.14 7.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.628 0.771 . . . . 0.0 110.354 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.97 -20.12 66.09 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.474 0.309 . . . . 0.0 111.441 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -85.65 -0.07 54.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 0.98 89.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.256 0.455 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 24.4 t -93.55 160.76 14.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.195 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.76 153.21 35.21 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.921 0.391 . . . . 0.0 110.824 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.9 p -72.54 -10.46 59.82 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.745 0.418 . . . . 0.0 111.807 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -117.39 141.7 48.01 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.692 0.797 . . . . 0.0 110.112 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -154.68 154.41 32.87 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.776 0.43 . . . . 0.0 110.185 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -127.25 155.1 44.01 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.118 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -138.05 1.76 2.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 85.0 p . . . . . 0 CA--C 1.528 0.122 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.592 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.286 0.565 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 495' ' ' HIS . . . . . 0.401 ' HB2' ' HD2' ' A' ' 496' ' ' PRO . 49.0 p-80 -80.74 162.39 60.44 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.156 0.982 . . . . 0.0 108.551 170.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 495' ' ' HIS . 47.4 Cg_endo -63.54 138.41 64.83 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.159 1.906 . . . . 0.0 110.55 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 69.2 m -124.08 23.97 8.32 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.04 5.83 4.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.182 0.993 . . . . 0.0 113.321 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 54.9 t -140.07 142.31 32.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 O-C-N 121.706 -0.621 . . . . 0.0 109.748 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.472 HD12 ' CH2' ' A' ' 546' ' ' TRP . 89.1 mt -130.86 163.48 27.33 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.187 0.995 . . . . 0.0 108.826 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -146.34 165.75 28.38 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 122.01 -0.431 . . . . 0.0 112.004 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.52 156.93 47.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.237 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -147.51 170.63 17.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.285 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.5 t30 61.01 26.57 16.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.274 1.03 . . . . 0.0 113.607 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.42 157.8 55.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.14 161.33 16.46 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 0.0 111.955 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.2 pt? -83.06 -1.16 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.52 5.69 31.68 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.603 0.361 . . . . 0.0 111.873 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.32 150.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.918 0.326 . . . . 0.0 111.602 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -143.44 172.21 13.09 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.581 0.752 . . . . 0.0 110.471 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 2.9 pm0 -61.49 -19.88 62.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.511 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.86 -25.75 60.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.017 0.371 . . . . 0.0 110.134 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -81.99 -28.54 32.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -72.9 -29.11 62.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.806 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -83.33 -37.52 23.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 111.503 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.23 -24.36 51.22 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.98 -33.07 5.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.165 0.439 . . . . 0.0 110.187 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 67.7 m -67.25 -21.48 65.72 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.948 174.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.96 -33.61 73.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -90.99 -13.2 33.8 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.69 -9.97 47.51 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.666 0.386 . . . . 0.0 110.841 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.04 62.24 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.175 0.417 . . . . 0.0 112.724 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -87.65 160.44 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.964 0.882 . . . . 0.0 110.645 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.46 120.22 18.77 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -71.18 150.75 94.58 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.97 149.28 92.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.859 2.373 . . . . 0.0 110.563 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 94.1 m -84.78 -21.04 30.12 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.76 0.424 . . . . 0.0 110.839 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 15.3 t -146.04 153.45 40.75 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.34 140.71 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 122.995 0.518 . . . . 0.0 110.359 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.18 124.13 12.04 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.3 148.93 30.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.695 0.398 . . . . 0.0 111.082 -172.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -151.81 151.02 30.79 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.544 0.738 . . . . 0.0 110.418 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 109.939 177.25 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.4 m -145.49 167.98 21.69 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.539 0.736 . . . . 0.0 110.449 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.6 t -135.36 155.11 51.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.495 0.718 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.5 m -145.35 163.71 33.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.399 1.079 . . . . 0.0 109.542 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -178.6 177.54 48.46 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 119.993 -1.098 . . . . 0.0 114.359 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.6 mp -112.98 156.5 22.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.012 . . . . 0.0 109.59 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.9 mt -138.61 143.19 39.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.434 1.094 . . . . 0.0 109.078 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -127.8 109.43 11.62 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.472 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.2 p90 -166.04 153.4 10.07 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 168.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -154.46 118.79 4.78 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.8 t -159.6 153.53 23.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.62 -40.02 95.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.619 0.645 . . . . 0.0 110.613 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 66.8 p -85.28 -27.26 26.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -83.68 -29.59 27.47 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.728 0.695 . . . . 0.0 110.859 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.74 26.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.986 0.357 . . . . 0.0 111.402 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.4 tp -84.7 -27.8 26.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.336 0.516 . . . . 0.0 112.047 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -77.36 -39.1 48.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.293 0.497 . . . . 0.0 110.273 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 89.7 m -67.84 -38.78 83.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.5 tp -60.63 -42.91 97.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.523 -0.735 . . . . 0.0 110.176 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -75.5 -14.17 82.25 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.244 -173.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 558' ' ' PHE . . . . . 0.45 ' CD1' ' CE1' ' A' ' 442' ' ' PHE . 23.5 m-85 -126.39 -12.28 6.21 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.763 1.282 . . . . 0.0 113.379 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 18.4 tp -105.79 -14.93 15.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.19 0.904 . . . . 0.0 112.567 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.44 136.4 40.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.2 m170 50.21 34.94 9.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.831 0.852 . . . . 0.0 113.003 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.71 151.29 28.97 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.246 0.618 . . . . 0.0 112.37 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -101.24 136.41 41.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.999 1.719 . . . . 0.0 110.999 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 564' ' ' MET . . . . . 0.408 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.3 ttt -64.07 179.93 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.846 0.858 . . . . 0.0 111.367 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 565' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 564' ' ' MET . 19.7 ptpt -64.27 6.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.59 143.17 93.85 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.115 0.416 . . . . 0.0 110.924 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.55 -30.44 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.389 2.726 . . . . 0.0 112.917 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -121.05 -7.18 9.45 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.7 44.06 96.91 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.007 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 86.7 Cg_endo -72.01 -6.24 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.325 2.683 . . . . 0.0 112.042 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -138.88 150.33 65.0 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.928 0.491 . . . . 0.0 109.917 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.88 144.09 30.29 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.161 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 573' ' ' TYR . . . . . 0.408 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 89.8 t80 -145.09 -3.63 0.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.306 0.643 . . . . 0.0 111.27 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 132.02 47.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.872 -0.518 . . . . 0.0 110.764 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.8 pp -125.04 144.59 50.32 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.526 0.73 . . . . 0.0 111.125 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.04 140.46 33.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.263 0.625 . . . . 0.0 109.977 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.55 144.99 46.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 1.9 p -163.93 173.02 13.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.568 0.347 . . . . 0.0 110.982 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -84.12 148.69 26.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.919 0.39 . . . . 0.0 110.711 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 28.0 t -135.53 159.93 40.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.502 0.721 . . . . 0.0 109.8 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 44.5 m -117.32 101.96 8.86 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.56 34.61 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.164 0.986 . . . . 0.0 109.928 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -78.85 -31.03 45.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -153.57 162.35 41.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.772 1.229 . . . . 0.0 109.054 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.62 76.49 7.49 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.185 179.153 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.031 0.444 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.82 -13.35 39.54 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.425 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 m -148.7 155.31 41.45 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 122.846 0.458 . . . . 0.0 110.691 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.91 -0.84 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.659 3.573 . . . . 0.0 113.242 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.17 158.85 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.551 0.614 . . . . 0.0 110.969 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.3 pp -145.32 170.28 16.62 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.157 0.583 . . . . 0.0 110.606 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 77.5 mtp -135.15 153.36 52.01 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.761 0.424 . . . . 0.0 111.099 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.7 149.62 18.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.211 0.604 . . . . 0.0 110.25 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -141.89 167.57 21.83 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.037 0.535 . . . . 0.0 110.152 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.57 76.87 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.15 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -67.85 165.33 17.77 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.798 0.799 . . . . 0.0 111.002 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -119.72 128.4 53.75 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.66 1.68 5.01 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 84.0 p -116.62 0.59 12.68 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.55 -6.42 3.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.169 0.588 . . . . 0.0 110.591 174.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 9.3 tpt -150.11 122.95 8.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.701 0.8 . . . . 0.0 109.4 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -141.94 -174.78 4.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.086 0.555 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.6 p -60.73 -23.99 65.36 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.887 0.475 . . . . 0.0 112.023 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.0 -30.73 21.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.917 0.326 . . . . 0.0 111.63 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -82.07 -30.76 31.15 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.571 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.98 -28.48 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -70.02 -33.87 72.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.963 -0.461 . . . . 0.0 110.052 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.23 -16.38 52.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.3 -18.88 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.716 0.407 . . . . 0.0 110.942 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -116.95 -18.96 10.01 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.26 -20.89 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.658 1.117 . . . . 0.0 111.057 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.955 -0.466 . . . . 0.0 111.887 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -121.46 -1.42 9.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.827 0.851 . . . . 0.0 111.268 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.56 169.6 16.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -65.67 142.67 57.95 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.468 -0.431 . . . . 0.0 111.493 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.08 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.652 0.781 . . . . 0.0 109.306 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -99.83 -65.92 0.94 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -165.13 168.52 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 110.313 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 9.3 p -147.18 151.75 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -152.47 144.71 23.93 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.647 0.379 . . . . 0.0 110.374 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.64 160.32 25.09 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 3.3 ptp -136.4 141.42 43.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 56.76 33.82 23.62 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.8 1.64 . . . . 0.0 114.217 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.0 m 52.77 17.81 0.91 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -71.11 158.13 88.79 Favored Pre-proline 0 CA--C 1.528 0.118 0 CA-C-N 118.367 0.53 . . . . 0.0 110.405 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.11 -19.25 32.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -177.53 102.2 0.16 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -157.8 136.71 11.5 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 109.088 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.83 171.28 20.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.231 0.539 . . . . 0.0 110.897 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.6 ptm -143.63 144.34 31.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.602 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.8 t -130.69 139.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 C-N-CA 122.857 0.463 . . . . 0.0 110.395 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -118.06 141.19 48.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.121 0.568 . . . . 0.0 110.062 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 92.3 mmm -111.01 161.85 15.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.139 0.576 . . . . 0.0 110.121 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.33 -22.94 63.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.13 -0.356 . . . . 0.0 111.138 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -159.46 160.34 34.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.518 0.727 . . . . 0.0 109.398 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.74 69.02 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.841 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.432 1.616 . . . . 0.0 110.671 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.46 -25.91 30.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.564 0.221 . . . . 0.0 110.51 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.6 -28.15 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.17 -42.8 71.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.291 -0.256 . . . . 0.0 110.849 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.62 84.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.102 0.41 . . . . 0.0 110.013 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.4 -34.55 58.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.6 tp -79.85 -30.92 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 O-C-N 122.184 -0.323 . . . . 0.0 111.525 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.7 t -94.94 -12.24 27.14 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -138.89 -24.4 0.91 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -95.67 -20.15 19.15 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.064 0.847 . . . . 0.0 108.997 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -51.82 142.66 14.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.502 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.08 1.59 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.617 1.967 . . . . 0.0 115.565 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -87.92 142.62 27.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.274 1.397 . . . . 0.0 108.847 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' PHE . . . . . 0.45 ' HB2' ' HG3' ' A' ' 446' ' ' MET 0.328 0.0 OUTLIER -131.0 164.14 26.02 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 175.339 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.7 ptm -125.16 143.28 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.476 1.11 . . . . 0.0 109.263 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 64.42 30.12 13.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.89 81.26 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 167.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -83.14 156.9 23.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.499 1.649 . . . . 0.0 111.359 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.606 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -77.76 141.97 38.96 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.902 0.881 . . . . 0.0 110.627 178.627 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 446' ' ' MET . . . . . 0.45 ' HG3' ' HB2' ' A' ' 440' ' ' PHE . 1.9 mpt? -98.5 122.01 41.16 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -140.69 110.75 6.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.53 139.43 17.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 92.7 m -149.66 160.43 43.52 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.596 0.759 . . . . 0.0 110.23 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -85.09 154.23 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.0 t -144.68 163.26 34.5 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.457 0.703 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -121.17 30.18 6.95 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.511 0.596 . . . . 0.0 112.25 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -63.64 147.91 94.97 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.56 -25.24 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.701 2.267 . . . . 0.0 111.88 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.98 170.22 13.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.453 0.701 . . . . 0.0 109.913 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.01 137.12 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 147.72 57.66 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 110.729 -0.101 . . . . 0.0 110.729 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.84 168.41 23.04 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.098 3.199 . . . . 0.0 111.973 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 177.56 170.99 40.56 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -84.82 -12.72 53.01 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.944 0.372 . . . . 0.0 111.701 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 7.4 m 57.72 169.32 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.145 1.378 . . . . 0.0 113.296 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -155.74 168.31 27.59 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.138 0.575 . . . . 0.0 109.9 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.54 137.79 17.36 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.92 170.24 11.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.313 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.23 -22.79 65.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.545 0.338 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.28 4.69 25.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.529 0.332 . . . . 0.0 111.467 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.57 -0.49 87.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.504 -0.609 . . . . 0.0 113.151 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.9 p -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 117.977 0.889 . . . . 0.0 110.556 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.16 152.4 30.74 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 122.245 -0.285 . . . . 0.0 110.382 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 90.1 p -73.39 -10.37 59.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.532 0.333 . . . . 0.0 111.774 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -127.67 145.21 50.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.797 0.839 . . . . 0.0 110.437 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.09 158.11 38.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.964 0.506 . . . . 0.0 110.058 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.64 148.26 51.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.466 0.706 . . . . 0.0 109.974 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.56 13.69 2.97 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.996 0.518 . . . . 0.0 111.128 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.631 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -60.98 159.62 26.23 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.72 145.13 31.87 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.703 2.935 . . . . 0.0 112.606 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.1 m -124.01 23.9 8.4 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.711 0.804 . . . . 0.0 110.89 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 61.21 14.74 5.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.676 1.191 . . . . 0.0 112.883 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 47.3 t -139.07 141.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.418 HD12 ' CH2' ' A' ' 546' ' ' TRP . 58.6 mt -119.42 148.48 43.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.968 0.507 . . . . 0.0 109.923 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.87 151.54 33.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 151.21 46.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.534 0.207 . . . . 0.0 110.677 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -147.89 173.63 12.66 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.635 0.374 . . . . 0.0 111.217 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.2 t30 56.39 34.03 23.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.216 1.006 . . . . 0.0 112.825 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -91.67 157.32 41.98 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.82 148.89 63.76 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.81 2.34 . . . . 0.0 111.588 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -73.7 -1.28 18.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.82 8.27 15.99 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.15 151.16 4.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 118.007 0.367 . . . . 0.0 110.814 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.4 p -142.32 171.87 13.47 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.348 0.659 . . . . 0.0 110.529 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 -22.17 66.73 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -71.2 -25.03 62.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -83.65 -30.13 27.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.17 -27.1 63.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.03 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.7 -38.12 18.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.488 0.586 . . . . 0.0 111.522 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -74.95 -20.08 59.83 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.467 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.23 -33.88 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 117.792 0.269 . . . . 0.0 110.723 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 69.1 m -67.71 -21.68 65.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.974 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.49 -30.44 63.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.07 -13.13 33.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 111.916 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 99.8 mt -91.57 -9.84 42.77 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.791 0.436 . . . . 0.0 111.057 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.68 5.15 63.36 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.752 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.0 m -87.08 168.4 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.777 0.789 . . . . 0.0 110.836 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -77.28 146.59 36.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.763 0.425 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -96.13 151.64 38.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.573 0.349 . . . . 0.0 110.099 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.25 156.0 68.12 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.186 2.591 . . . . 0.0 111.122 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -89.54 -23.32 22.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.916 0.486 . . . . 0.0 110.696 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.1 t -143.84 156.87 44.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.01 144.93 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.221 0.534 . . . . 0.0 110.954 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -141.2 128.81 21.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.6 144.07 35.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 122.597 0.359 . . . . 0.0 110.132 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -154.88 153.66 31.47 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.172 0.589 . . . . 0.0 110.034 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.232 0.132 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.468 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.1 t -143.08 158.93 43.16 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.192 0.597 . . . . 0.0 110.642 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 47.1 t -122.16 150.73 41.82 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.78 0.832 . . . . 0.0 111.109 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.7 m -147.07 168.47 21.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.085 1.354 . . . . 0.0 109.185 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.51 -169.2 42.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.891 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.02 154.05 47.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.385 1.074 . . . . 0.0 109.686 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.39 140.47 39.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.007 0.923 . . . . 0.0 108.723 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -127.8 109.75 11.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.423 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.9 p90 -166.13 152.83 9.44 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.019 1.328 . . . . 0.0 107.77 168.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.31 123.73 7.13 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 548' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 39.6 t -159.62 152.97 22.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -47.48 80.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.474 0.579 . . . . 0.0 111.348 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.5 p -85.82 -26.2 25.86 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 551' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 54.3 m-20 -82.73 -29.13 29.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.231 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.78 30.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.103 0.411 . . . . 0.0 110.931 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.85 -28.05 36.24 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.406 0.548 . . . . 0.0 111.599 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -76.65 -41.05 47.13 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.133 0.424 . . . . 0.0 110.558 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.5 m -68.73 -34.97 76.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.93 -52.17 65.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.855 -0.528 . . . . 0.0 110.12 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.66 -17.1 76.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.005 -0.886 . . . . 0.0 114.258 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -119.22 -9.2 10.0 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.742 1.271 . . . . 0.0 113.67 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.7 tp -89.61 -21.7 22.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.439 1.018 . . . . 0.0 110.328 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.57 147.66 50.45 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.138 -0.351 . . . . 0.0 110.479 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 51.24 24.79 2.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.448 1.099 . . . . 0.0 113.607 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.31 151.38 38.3 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.247 0.546 . . . . 0.0 112.222 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -111.38 136.24 50.79 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.949 0.9 . . . . 0.0 110.855 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.0 ttt -64.7 178.32 0.79 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.852 0.861 . . . . 0.0 111.006 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -68.18 7.95 0.5 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.28 140.0 91.58 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.31 -28.95 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.472 2.782 . . . . 0.0 112.86 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -121.04 -7.14 9.46 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.41 44.23 97.92 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.926 -0.93 . . . . 0.0 113.421 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 94.0 Cg_endo -71.27 -7.01 20.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.128 2.552 . . . . 0.0 111.993 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -143.82 149.27 45.81 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.125 0.57 . . . . 0.0 109.867 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.53 154.23 39.91 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.601 2.867 . . . . 0.0 110.796 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -136.54 -0.83 2.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.64 0.376 . . . . 0.0 111.604 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 8.3 t -68.31 132.03 46.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.931 -0.481 . . . . 0.0 111.222 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.94 144.62 50.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 0.0 109.701 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -85.11 145.16 27.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 577' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 577' ' ' LEU . 2.0 pt? -147.12 146.79 30.05 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.098 0.559 . . . . 0.0 110.683 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.29 169.71 21.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.896 0.478 . . . . 0.0 110.898 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -72.65 133.51 44.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 25.7 t -135.66 148.43 48.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 60.7 m -89.82 102.34 15.04 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.978 0.418 . . . . 0.0 110.587 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 161.53 34.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.817 0.847 . . . . 0.0 109.456 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -99.38 -15.36 18.8 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.175 0.19 . . . . 0.0 110.919 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -160.22 160.59 32.9 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.193 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.01 76.41 0.99 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.88 0.472 . . . . 0.0 110.087 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.54 -1.219 . . . . 0.0 110.489 -179.423 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.691 0.281 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -132.07 19.98 4.5 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.927 0.491 . . . . 0.0 111.145 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 47.0 t -148.81 145.91 20.78 Favored Pre-proline 0 N--CA 1.453 -0.283 0 O-C-N 122.219 -0.301 . . . . 0.0 111.018 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.0 -0.96 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.778 2.985 . . . . 0.0 112.66 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.2 m -124.83 163.06 25.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 119.18 0.9 . . . . 0.0 112.786 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -149.4 161.92 41.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.293 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 75.1 mmm -118.93 144.45 46.43 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.667 0.787 . . . . 0.0 110.099 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.54 144.81 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.048 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -139.32 166.94 23.23 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.383 0.673 . . . . 0.0 109.23 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.82 86.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.318 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.737 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.6 173.86 10.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.924 0.862 . . . . 0.0 110.501 176.008 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.39 146.56 51.24 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.019 0.528 . . . . 0.0 110.271 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -81.98 -4.83 57.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.9 t -104.68 -9.2 18.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.883 0.31 . . . . 0.0 111.447 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.31 -5.55 3.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.219 0.608 . . . . 0.0 111.109 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -142.13 126.69 17.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -141.68 -174.97 4.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.019 0.528 . . . . 0.0 109.992 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.61 -26.81 65.76 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.941 0.496 . . . . 0.0 112.036 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.14 -38.39 27.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.99 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -74.79 -28.96 60.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.106 0.412 . . . . 0.0 110.954 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.93 -28.66 24.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' PHE . . . . . 0.407 ' CD1' HG21 ' A' ' 406' ' ' VAL . 4.3 t80 -72.1 -30.29 64.93 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 172.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -76.25 -24.82 54.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.6 t -96.58 -26.43 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.399 0.545 . . . . 0.0 112.184 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.27 -14.2 17.07 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 35.3 t -78.57 -17.6 55.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.09 0.859 . . . . 0.0 112.473 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 10.72 1.22 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.272 -0.892 . . . . 0.0 112.171 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -121.38 -1.59 9.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.765 0.826 . . . . 0.0 110.819 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.44 165.5 12.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.44 164.47 22.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.009 0.433 . . . . 0.0 111.161 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' VAL . . . . . 0.407 HG21 ' CD1' ' A' ' 397' ' ' PHE . 5.4 m -121.11 161.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 C-N-CA 124.237 1.015 . . . . 0.0 109.789 -177.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.58 -52.22 2.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.324 -0.235 . . . . 0.0 111.289 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.16 164.34 27.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.493 0.317 . . . . 0.0 110.795 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.59 151.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.398 0.679 . . . . 0.0 110.262 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.03 148.55 27.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 419' ' ' ALA . 3.9 m-30 -78.65 145.79 34.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 25.1 ttp -99.4 141.04 32.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -168.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 49.8 33.95 7.0 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 112.031 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 83.7 p 52.88 16.02 0.64 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.362 1.465 . . . . 0.0 113.409 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -77.84 132.75 67.19 Favored Pre-proline 0 C--N 1.34 0.192 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.43 -7.43 17.69 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.659 2.239 . . . . 0.0 111.494 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.96 16.54 10.15 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.772 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -144.33 145.33 31.92 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 119.212 1.506 . . . . 0.0 111.056 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 411' ' ' PHE . . . -154.52 163.93 39.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.243 0.544 . . . . 0.0 111.7 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 23.0 ptm -145.23 143.57 30.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.723 0.809 . . . . 0.0 109.757 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.2 p -136.71 153.29 30.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.72 0.408 . . . . 0.0 110.446 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -125.08 138.48 54.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.947 0.499 . . . . 0.0 110.663 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 77.0 mmm -104.42 161.63 13.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.455 0.702 . . . . 0.0 110.145 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.19 -18.67 62.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -157.67 158.85 36.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.974 0.51 . . . . 0.0 109.782 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.6 -14.95 72.86 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.201 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -70.69 -19.82 62.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.03 1.415 . . . . 0.0 111.095 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.44 -24.43 31.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.72 -26.98 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.02 -36.78 82.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.262 -0.274 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -80.13 -31.77 39.05 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.296 -0.253 . . . . 0.0 110.535 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.03 70.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.999 -0.438 . . . . 0.0 110.116 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 433' ' ' ILE . 5.6 tp -85.49 -30.93 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.2 m -95.04 -19.99 19.7 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -130.63 -12.04 3.88 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.7 -17.9 10.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.114 0.87 . . . . 0.0 110.031 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.17 142.2 21.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.509 0.724 . . . . 0.0 111.439 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.427 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 76.1 m-20 57.15 1.63 0.1 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.952 1.701 . . . . 0.0 115.214 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.92 142.42 27.81 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 120.579 1.536 . . . . 0.0 108.899 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 0.1 OUTLIER -130.68 163.91 26.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 174.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.7 ptm -125.39 143.52 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.651 1.58 . . . . 0.0 109.314 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 64.12 30.91 13.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.002 1.321 . . . . 0.0 114.454 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.93 79.9 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.17 145.02 29.42 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.357 1.079 . . . . 0.0 109.789 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 141.62 37.97 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.051 -0.405 . . . . 0.0 109.934 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.86 122.0 40.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -168.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -140.68 114.37 8.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.427 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.99 141.69 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 CA-C-N 118.29 0.496 . . . . 0.0 110.493 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 34.1 t -160.04 162.71 34.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.379 0.671 . . . . 0.0 109.617 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.18 158.68 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 110.265 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 45.6 t -138.01 151.41 47.87 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -89.43 4.95 47.42 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -59.6 139.11 89.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -23.43 11.55 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.921 2.414 . . . . 0.0 112.249 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.05 170.62 14.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 110.806 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.57 147.41 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.2 mmt -104.62 150.19 38.29 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.432 0.293 . . . . 0.0 110.56 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.29 177.82 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 124.161 3.24 . . . . 0.0 111.927 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 73.78 -176.72 45.57 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.475 0.559 . . . . 0.0 112.354 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 56.77 19.95 4.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.244 1.018 . . . . 0.0 113.62 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.9 m -97.12 142.67 28.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.247 0.476 . . . . 0.0 111.116 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -148.19 174.26 12.15 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.742 1.217 . . . . 0.0 109.217 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.4 135.96 15.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.74 171.39 10.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.729 0.812 . . . . 0.0 110.44 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -68.6 -20.46 64.5 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.645 0.378 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -80.59 1.3 30.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.108 0.563 . . . . 0.0 111.604 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.84 -2.76 72.86 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 122.054 -0.404 . . . . 0.0 112.231 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 28.0 t -93.36 163.4 13.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.182 0.593 . . . . 0.0 109.453 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 48.6 t -84.3 153.19 23.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.043 0.449 . . . . 0.0 110.645 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 59.5 m -64.79 -10.42 27.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.001 0.92 . . . . 0.0 111.343 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -119.2 142.14 48.27 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.801 0.84 . . . . 0.0 110.137 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.16 156.22 38.19 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.675 0.274 . . . . 0.0 110.703 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -124.73 151.03 45.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.24 1.016 . . . . 0.0 109.941 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.02 10.88 2.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.389 0.676 . . . . 0.0 111.755 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 CA--C 1.533 0.3 0 O-C-N 122.056 -0.403 . . . . 0.0 111.732 -173.786 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -69.07 148.25 97.74 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.875 0.87 . . . . 0.0 109.32 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.09 152.44 14.47 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.702 2.935 . . . . 0.0 113.211 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.2 m -123.95 22.01 8.91 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.057 0.543 . . . . 0.0 112.04 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 19.1 m120 59.72 12.55 2.99 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.77 152.35 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.0 mt -125.42 155.49 40.33 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.942 0.497 . . . . 0.0 111.053 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -132.26 137.71 47.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -124.92 149.94 47.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.033 0.533 . . . . 0.0 110.858 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -144.3 172.79 12.44 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 111.251 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 49.4 t30 57.57 31.78 20.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.407 1.083 . . . . 0.0 112.993 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -85.14 157.44 59.5 Favored Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.84 158.89 55.25 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.608 2.205 . . . . 0.0 110.446 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 22.1 tp -70.89 -0.97 10.31 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.013 1.325 . . . . 0.0 112.856 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.47 9.53 7.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.99 151.82 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 118.334 0.516 . . . . 0.0 111.259 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.7 p -142.6 171.43 14.06 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.651 0.78 . . . . 0.0 110.071 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.1 -24.29 67.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.519 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.91 -24.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.355 -0.215 . . . . 0.0 110.67 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -76.77 -35.05 57.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -71.13 -23.79 62.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.909 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -79.42 -40.7 29.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.172 0.442 . . . . 0.0 111.009 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.92 -13.04 60.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 85.4 mt -95.5 -32.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.262 0.483 . . . . 0.0 110.403 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.8 m -68.42 -22.8 64.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.408 -0.807 . . . . 0.0 109.568 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.02 -28.78 61.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.645 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -90.98 -12.83 34.73 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.637 0.653 . . . . 0.0 111.636 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.85 -8.96 27.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.966 0.506 . . . . 0.0 111.257 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.19 64.58 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.248 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.1 168.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.156 0.978 . . . . 0.0 111.212 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -68.34 133.93 49.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.029 0.532 . . . . 0.0 110.119 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -78.22 149.34 75.91 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 148.86 90.21 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.811 2.341 . . . . 0.0 110.138 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.417 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.9 m -93.83 -18.97 21.45 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.848 0.459 . . . . 0.0 110.847 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.3 t -149.47 148.79 29.84 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.01 137.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.211 0.604 . . . . 0.0 109.609 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 530' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -148.28 104.58 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 89.9 t -126.88 148.01 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.265 0.626 . . . . 0.0 109.925 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -147.64 161.92 40.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.105 0.479 . . . . 0.0 111.937 -176.7 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 89.6 p -140.24 171.54 14.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.5 0.72 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 60.1 m -128.04 150.87 49.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.56 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 58.4 m -147.83 159.9 43.34 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 125.005 1.322 . . . . 0.0 109.353 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.29 -174.97 44.99 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.278 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.4 146.39 28.9 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.33 1.052 . . . . 0.0 110.236 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 5.8 mp -137.66 138.04 39.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -127.74 126.34 41.63 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.417 ' HB3' ' H ' ' A' ' 527' ' ' THR . 8.9 p90 -165.56 148.69 7.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.88 120.4 7.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 42.3 t -159.57 153.34 22.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 168.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -64.79 -52.21 58.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.916 0.78 . . . . 0.0 111.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.9 p -78.7 -27.2 44.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -84.97 -31.11 23.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.786 0.721 . . . . 0.0 111.463 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.41 -30.88 60.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.208 0.458 . . . . 0.0 110.641 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -83.48 -27.15 29.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.37 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -77.37 -39.01 48.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.087 0.403 . . . . 0.0 110.523 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 30.2 m -73.76 -38.66 64.65 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.059 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 556' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.0 tm? -65.98 -47.3 75.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.15 -17.29 75.67 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.542 -173.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.47 -11.67 8.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.916 1.358 . . . . 0.0 113.173 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -95.84 -18.05 20.67 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.382 0.537 . . . . 0.0 110.65 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -65.55 144.89 56.7 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.747 -0.596 . . . . 0.0 109.452 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 60.5 t60 55.61 24.72 7.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.569 1.147 . . . . 0.0 113.252 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 151.33 34.69 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -117.76 136.35 53.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.845 1.258 . . . . 0.0 110.701 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 3.7 ttt -64.2 176.4 1.04 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 111.323 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -65.86 141.26 97.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.092 0.86 . . . . 0.0 110.288 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -79.91 -29.42 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.659 2.906 . . . . 0.0 113.796 -169.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -121.05 2.79 10.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.06 0.391 . . . . 0.0 112.029 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 59.45 42.57 97.62 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.768 -1.018 . . . . 0.0 112.792 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.7 Cg_endo -68.67 -9.96 27.67 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.244 2.63 . . . . 0.0 111.608 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -144.12 147.06 36.16 Favored Pre-proline 0 N--CA 1.454 -0.26 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.91 150.61 38.89 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.689 2.926 . . . . 0.0 110.546 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -143.44 -4.15 0.89 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.679 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 72.5 p -66.56 126.46 28.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 35.8 mt -99.47 144.55 28.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.873 0.469 . . . . 0.0 111.905 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -82.01 130.59 35.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -146.45 147.26 31.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 112.016 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.1 p -161.37 169.72 21.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.952 0.901 . . . . 0.0 109.319 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -74.95 140.57 43.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.6 t -135.39 143.6 46.12 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 35.3 m -81.37 102.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.1 161.5 34.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.975 0.91 . . . . 0.0 110.325 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -109.64 -12.13 14.69 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.925 0.49 . . . . 0.0 110.669 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -160.54 168.55 24.79 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.998 0.919 . . . . 0.0 109.132 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -78.74 77.29 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.891 0.476 . . . . 0.0 109.797 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.417 ' HA ' ' HE3' ' A' ' 530' ' ' LYS . 74.7 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.476 -1.25 . . . . 0.0 110.002 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.136 0.493 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -141.17 18.5 2.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.096 0.958 . . . . 0.0 109.814 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.1 m -142.7 153.87 62.07 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 122.848 0.459 . . . . 0.0 110.609 -174.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.38 3.09 7.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.117 3.212 . . . . 0.0 113.225 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.64 161.83 39.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 118.893 0.769 . . . . 0.0 112.866 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' LEU . . . . . 0.403 ' C ' HD12 ' A' ' 381' ' ' LEU . 3.1 pp -144.81 170.46 16.07 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.23 1.012 . . . . 0.0 109.227 172.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.1 mtp -137.16 148.04 46.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.9 149.21 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.861 0.464 . . . . 0.0 110.661 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -140.01 164.99 28.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.651 0.78 . . . . 0.0 109.823 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.41 -6.79 75.23 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.304 0.478 . . . . 0.0 112.828 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.5 pt? -69.42 174.62 4.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.916 0.858 . . . . 0.0 110.648 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -134.61 146.74 49.86 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -74.66 -1.91 23.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 93.7 p -117.99 -8.49 10.73 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.027 0.376 . . . . 0.0 111.646 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.4 -17.53 13.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 83.0 mmm -139.21 141.28 37.92 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.946 . . . . 0.0 109.758 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.89 173.93 11.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.39 -27.06 67.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.815 0.28 . . . . 0.0 110.947 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -79.37 -33.41 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.213 0.205 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -79.17 -35.57 41.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.746 0.248 . . . . 0.0 110.9 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.8 p -73.87 -26.7 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -66.89 -41.83 86.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.954 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.0 -8.3 57.32 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.0 112.915 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.34 -22.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.706 0.684 . . . . 0.0 110.231 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.52 -14.99 13.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 50.9 t -71.45 -25.59 62.37 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.071 0.851 . . . . 0.0 111.345 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.09 13.39 1.11 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.537 -0.727 . . . . 0.0 112.068 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -121.43 -3.62 9.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 110.841 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.91 165.43 12.79 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.91 150.03 46.14 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.067 -0.666 . . . . 0.0 110.826 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.42 148.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.87 -53.33 2.63 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.954 -0.466 . . . . 0.0 111.212 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.91 162.78 26.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.003 0.43 . . . . 0.0 111.448 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.6 p -143.23 150.42 17.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.08 142.65 22.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.347 0.259 . . . . 0.0 110.388 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -76.89 146.38 37.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 168.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.637 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -130.09 141.48 50.7 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.499 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 59.99 33.92 21.43 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.065 1.746 . . . . 0.0 112.495 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 36.7 m 52.97 14.02 0.41 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -77.3 146.96 75.27 Favored Pre-proline 0 N--CA 1.455 -0.218 0 CA-C-N 118.673 0.67 . . . . 0.0 110.1 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.9 -0.81 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.686 2.924 . . . . 0.0 110.849 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.44 40.0 1.01 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.004 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.637 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -148.9 134.84 19.01 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.93 0.865 . . . . 0.0 110.593 174.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.52 169.19 23.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 22.1 ptm -143.19 147.36 34.77 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.316 0.646 . . . . 0.0 110.028 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.5 t -127.87 153.17 36.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.172 0.589 . . . . 0.0 110.333 -172.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -129.48 135.3 48.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.947 0.499 . . . . 0.0 110.59 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.3 165.0 11.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.805 0.842 . . . . 0.0 109.956 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.56 -20.83 62.76 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -156.54 159.64 38.75 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.9 -15.73 71.84 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.215 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -69.29 -28.63 66.45 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 119.116 1.458 . . . . 0.0 110.383 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -76.26 -20.08 57.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 77.7 t -81.18 -28.13 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.98 -34.99 66.8 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -72.63 -31.85 65.46 Favored 'General case' 0 N--CA 1.457 -0.08 0 O-C-N 122.146 -0.347 . . . . 0.0 110.341 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.82 -29.22 58.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.326 -0.234 . . . . 0.0 110.977 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.4 tp -86.33 -30.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 O-C-N 122.36 -0.212 . . . . 0.0 111.112 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 82.7 p -94.83 -6.8 42.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -136.0 -15.63 1.74 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.62 -20.07 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.93 0.786 . . . . 0.0 110.027 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -51.59 144.31 10.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.704 0.802 . . . . 0.0 111.206 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 57.51 1.39 0.12 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.92 2.088 . . . . 0.0 115.526 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.86 142.5 27.76 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.873 1.669 . . . . 0.0 108.726 169.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.298 0.0 OUTLIER -130.94 163.9 26.49 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 172.607 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 19.2 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.159 1.384 . . . . 0.0 109.904 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . 0.25 29.0 m-85 66.16 27.02 10.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.976 1.311 . . . . 0.0 114.143 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.7 81.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 168.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -83.04 160.54 21.93 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.909 1.354 . . . . 0.0 110.543 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.598 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -86.31 129.41 34.86 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.596 0.758 . . . . 0.0 110.191 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.58 130.35 45.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -140.61 123.61 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.1 140.97 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.396 0.544 . . . . 0.0 110.655 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 71.5 m -147.11 165.24 30.57 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.88 0.872 . . . . 0.0 110.005 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 p -90.64 155.96 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.851 0.46 . . . . 0.0 109.912 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.6 t -133.89 158.95 42.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 123.12 0.568 . . . . 0.0 109.765 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.62 9.41 39.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -68.25 144.52 96.8 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.78 -24.36 11.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.918 2.412 . . . . 0.0 111.772 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -162.86 172.77 14.64 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.151 0.58 . . . . 0.0 109.992 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.71 143.55 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -100.21 155.98 35.8 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.132 0.173 . . . . 0.0 111.334 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.28 164.01 9.36 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.773 2.982 . . . . 0.0 112.227 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.37 178.97 38.25 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -72.66 163.55 27.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.949 0.5 . . . . 0.0 110.786 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.4 p -144.28 160.36 41.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.898 0.479 . . . . 0.0 110.745 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -151.81 165.04 35.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.557 0.743 . . . . 0.0 110.107 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.74 137.92 18.08 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 67.7 mt -87.06 170.47 11.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.719 0.808 . . . . 0.0 110.188 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.23 -20.41 64.82 Favored 'General case' 0 N--CA 1.461 0.115 0 O-C-N 122.142 -0.349 . . . . 0.0 111.752 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -88.39 6.0 39.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.974 0.509 . . . . 0.0 111.664 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.58 84.74 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.468 0.556 . . . . 0.0 112.797 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.8 m -88.76 161.55 16.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.125 0.963 . . . . 0.0 110.527 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.1 m -82.87 153.34 25.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 110.735 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.2 p -67.83 -10.28 51.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.321 0.649 . . . . 0.0 111.531 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -127.62 137.79 52.65 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.141 0.976 . . . . 0.0 110.123 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -156.36 157.58 35.89 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 122.59 0.356 . . . . 0.0 110.922 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.39 156.64 41.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.688 0.795 . . . . 0.0 110.878 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.64 13.71 2.32 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.324 0.649 . . . . 0.0 111.54 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 122.928 0.491 . . . . 0.0 112.025 -174.58 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.45 121.14 79.56 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 119.363 0.983 . . . . 0.0 110.145 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.94 135.15 15.34 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.992 2.462 . . . . 0.0 109.81 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 97.1 p -124.17 -7.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.042 0.537 . . . . 0.0 112.208 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 58.45 18.42 5.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.595 0.758 . . . . 0.0 111.759 -170.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.78 136.71 55.32 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 123.404 0.682 . . . . 0.0 109.7 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.452 HD12 ' CH2' ' A' ' 546' ' ' TRP . 59.0 mt -118.91 148.59 42.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.83 154.55 28.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -135.8 149.16 49.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.455 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -146.69 171.74 14.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.822 0.449 . . . . 0.0 110.714 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 26.4 m120 60.73 21.81 11.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.981 . . . . 0.0 113.42 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -78.48 163.35 62.03 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.96 154.43 50.71 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.001 2.467 . . . . 0.0 111.605 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -77.84 -1.0 29.46 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -123.71 12.04 9.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.737 0.415 . . . . 0.0 111.976 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.79 154.99 4.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 121.904 -0.498 . . . . 0.0 111.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.9 p -144.67 170.24 16.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.472 0.709 . . . . 0.0 110.437 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 3.1 pm0 -62.37 -21.97 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.629 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.96 -30.82 69.33 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.976 -0.452 . . . . 0.0 109.921 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -78.36 -32.73 49.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.63 -28.62 67.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.184 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -84.08 -37.57 21.9 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.714 -0.616 . . . . 0.0 111.522 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.5 -9.09 59.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.355 0.525 . . . . 0.0 112.148 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.49 -32.51 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 117.783 0.265 . . . . 0.0 110.387 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 60.2 m -67.39 -21.61 65.59 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.0 -29.84 64.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.93 -16.54 27.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.554 0.615 . . . . 0.0 111.776 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.19 -11.85 42.59 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.53 0.332 . . . . 0.0 111.199 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 4.63 58.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.848 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.65 169.67 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 118.013 0.906 . . . . 0.0 110.603 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.74 153.42 35.04 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -102.43 153.21 38.28 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.459 0.304 . . . . 0.0 110.361 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.5 148.85 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.1 2.533 . . . . 0.0 111.143 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.47 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.5 m -81.97 -25.07 35.11 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.72 0.408 . . . . 0.0 110.555 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.9 t -144.53 158.46 43.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.84 145.31 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 122.84 0.456 . . . . 0.0 110.599 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -144.28 127.15 16.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.681 0.792 . . . . 0.0 108.983 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 32.9 t -130.64 149.03 33.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -143.41 165.87 26.32 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.779 0.324 . . . . 0.0 111.697 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.233 0.186 0 C-N-CA 123.653 0.781 . . . . 0.0 110.526 -179.323 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 49.8 m -141.86 168.48 19.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.372 1.069 . . . . 0.0 109.391 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 23.2 t -127.75 160.07 32.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.275 0.56 . . . . 0.0 111.226 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.1 p -149.64 167.05 27.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.233 1.013 . . . . 0.0 109.785 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.99 -172.88 45.49 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.344 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.51 153.91 39.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.915 0.886 . . . . 0.0 110.365 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.8 mt -138.07 142.22 40.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.383 1.073 . . . . 0.0 108.693 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -127.79 106.49 9.16 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.47 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -166.02 153.49 10.18 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.961 1.304 . . . . 0.0 107.853 168.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -152.82 122.64 6.92 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 45.2 t -159.6 153.04 22.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -66.45 -42.29 87.82 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.545 0.611 . . . . 0.0 110.943 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.4 p -85.76 -29.02 24.18 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -83.39 -28.74 28.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.543 0.611 . . . . 0.0 111.267 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -84.72 -30.0 25.1 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.256 0.48 . . . . 0.0 110.943 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.22 -28.2 34.95 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.419 0.554 . . . . 0.0 111.355 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.11 -40.78 37.18 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.884 -0.51 . . . . 0.0 110.39 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 61.3 m -68.25 -36.18 79.05 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.13 -43.22 95.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.837 -0.539 . . . . 0.0 109.738 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.3 -14.18 79.36 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.619 -1.1 . . . . 0.0 114.094 -173.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -128.54 -10.71 5.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.093 1.446 . . . . 0.0 113.77 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.85 -18.5 29.12 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.301 0.955 . . . . 0.0 109.852 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -85.79 153.42 22.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 171.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 57.51 15.97 3.05 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 562' ' ' TYR . . . . . 0.414 ' CZ ' ' CE2' ' A' ' 573' ' ' TYR . 0.0 OUTLIER -79.15 151.48 31.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.38 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -112.27 136.28 51.9 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.076 0.95 . . . . 0.0 110.576 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.9 ttt -64.23 176.11 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.775 0.83 . . . . 0.0 111.227 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -73.69 11.79 0.77 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.516 0.726 . . . . 0.0 112.874 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -64.86 144.88 99.02 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.401 0.546 . . . . 0.0 110.646 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.79 -27.78 4.59 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.428 2.752 . . . . 0.0 113.676 -170.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -120.97 -3.29 9.64 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.197 0.453 . . . . 0.0 111.955 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.87 39.71 97.64 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.751 -1.027 . . . . 0.0 113.211 -177.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 93.9 Cg_endo -71.29 -7.97 22.43 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.847 2.365 . . . . 0.0 112.115 -176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -144.22 147.78 38.65 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.157 0.435 . . . . 0.0 110.4 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.32 160.9 38.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.086 3.191 . . . . 0.0 110.902 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 573' ' ' TYR . . . . . 0.414 ' CE2' ' CZ ' ' A' ' 562' ' ' TYR . 42.4 t80 -141.77 -2.62 1.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.7 t -66.4 132.08 47.51 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 575' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 575' ' ' LEU . 2.1 pp -120.23 144.61 47.66 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.748 0.819 . . . . 0.0 110.197 175.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -76.07 148.58 37.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.22 145.0 48.76 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.524 0.729 . . . . 0.0 109.661 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.5 p -163.39 161.37 24.37 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -74.33 131.75 41.42 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 39.4 t -135.63 137.69 42.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 66.2 m -79.27 102.4 8.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.012 0.435 . . . . 0.0 110.901 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 159.49 40.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.127 0.971 . . . . 0.0 109.245 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -85.99 -25.13 26.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.341 -0.225 . . . . 0.0 110.781 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -164.18 168.6 18.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.625 0.77 . . . . 0.0 109.954 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.22 76.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.179 -179.676 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.139 0.495 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.78 8.03 4.83 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.378 0.671 . . . . 0.0 110.282 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.2 m -146.38 154.67 49.52 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.169 0.588 . . . . 0.0 110.573 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.18 4.52 6.99 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.225 3.283 . . . . 0.0 112.825 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.5 162.28 35.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 119.164 0.893 . . . . 0.0 112.672 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.04 166.06 26.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 109.644 173.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.2 mmm -121.89 150.81 41.44 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.7 0.8 . . . . 0.0 110.149 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.32 145.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -142.79 166.66 24.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.907 0.483 . . . . 0.0 109.898 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.53 -0.6 84.98 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.607 173.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.737 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.11 177.42 5.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.175 0.988 . . . . 0.0 110.727 176.622 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.46 136.5 52.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.781 0.432 . . . . 0.0 110.231 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -75.77 4.4 8.01 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 18.3 t -112.53 -8.04 13.87 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.753 0.421 . . . . 0.0 111.556 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 -8.42 4.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 111.216 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.1 tpt -142.51 121.0 12.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.576 0.75 . . . . 0.0 109.211 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -141.9 -178.82 5.87 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.765 0.426 . . . . 0.0 110.406 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.2 m -60.5 -22.13 63.2 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.8 -25.88 19.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.829 -0.544 . . . . 0.0 111.637 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -87.82 -23.55 23.99 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.666 0.666 . . . . 0.0 109.873 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.2 p -78.38 -33.9 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.29 -33.77 76.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -71.33 -29.63 65.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.996 -0.44 . . . . 0.0 111.507 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 42.3 t -85.43 -13.02 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.058 -0.401 . . . . 0.0 111.592 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -118.94 -7.07 10.47 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.4 -35.47 75.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.332 0.969 . . . . 0.0 111.204 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.28 12.26 1.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.837 -0.539 . . . . 0.0 112.095 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -121.46 -4.74 9.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.481 0.712 . . . . 0.0 111.132 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.94 175.7 20.08 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.1 146.26 43.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.599 -0.353 . . . . 0.0 110.539 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.95 150.67 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -98.46 -60.48 1.54 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -167.51 166.1 14.37 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.576 0.75 . . . . 0.0 110.474 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.33 146.65 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 123.087 0.555 . . . . 0.0 110.312 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.489 ' HE2' ' CD1' ' A' ' 471' ' ' TYR . 39.0 ttmt -150.22 148.58 29.08 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.184 0.194 . . . . 0.0 111.135 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -82.48 149.07 27.77 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.555 ' HE1' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -135.66 141.43 45.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -168.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt 60.12 33.81 21.19 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 126.713 2.005 . . . . 0.0 114.13 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.7 m 52.91 18.03 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.62 157.59 87.88 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 118.587 0.63 . . . . 0.0 110.393 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.63 -18.82 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.601 2.868 . . . . 0.0 111.948 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -179.24 100.9 0.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.555 ' HB1' ' HE1' ' A' ' 412' ' ' MET . . . -160.91 143.42 12.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.26 171.49 19.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.314 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.0 ptm -144.44 143.96 31.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.35 151.67 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 C-N-CA 123.145 0.578 . . . . 0.0 110.284 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -129.52 137.5 50.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 90.5 mmm -109.22 164.04 12.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.431 0.692 . . . . 0.0 110.025 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.58 64.29 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.457 -0.152 . . . . 0.0 111.078 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -159.73 161.61 34.79 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.494 0.717 . . . . 0.0 109.404 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.96 -16.11 68.01 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.249 -0.751 . . . . 0.0 112.905 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 427' ' ' TYR . 2.5 p90 -65.45 -28.36 69.17 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.048 1.424 . . . . 0.0 110.925 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.0 -19.77 43.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.3 t -80.28 -23.75 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.9 -38.38 88.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.51 -26.37 45.87 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.98 -36.2 59.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.039 0.381 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.5 tp -85.16 -30.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 122.251 -0.281 . . . . 0.0 111.54 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.8 m -91.38 -21.51 20.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -124.57 -14.32 6.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 436' ' ' LEU . 2.4 tm? -115.56 -19.05 10.77 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.947 0.794 . . . . 0.0 110.389 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.97 139.07 23.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.383 0.611 . . . . 0.0 111.36 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.432 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 69.7 m-20 56.76 1.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.212 1.805 . . . . 0.0 115.735 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.77 142.46 27.81 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 120.869 1.668 . . . . 0.0 109.144 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.297 0.1 OUTLIER -130.9 163.84 26.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 174.547 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.2 ptm -125.29 143.33 51.01 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.029 1.331 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 63.05 33.07 14.99 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.33 15.6 78.05 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.95 140.9 32.53 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.323 1.061 . . . . 0.0 109.496 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -77.72 141.38 39.36 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.81 125.34 41.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -168.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -140.71 112.07 7.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.432 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.71 134.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.054 0.388 . . . . 0.0 110.715 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 81.6 m -149.52 165.04 33.37 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 124.394 1.078 . . . . 0.0 109.855 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.8 156.8 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.0 t -135.26 159.59 41.07 Favored 'General case' 0 C--O 1.23 0.046 0 C-N-CA 122.961 0.504 . . . . 0.0 110.333 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -99.3 5.76 46.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -67.03 144.92 98.75 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.796 -0.565 . . . . 0.0 109.551 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.92 -26.1 8.29 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.079 2.519 . . . . 0.0 112.244 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.6 173.59 11.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.051 0.54 . . . . 0.0 110.328 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.04 141.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.68 153.2 55.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 C-N-CA 122.208 0.203 . . . . 0.0 111.138 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.41 156.45 65.59 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.51 2.807 . . . . 0.0 111.231 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.25 169.14 28.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -78.28 157.82 29.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.752 0.421 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.9 p -134.27 159.78 39.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.987 0.515 . . . . 0.0 110.662 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -155.73 168.07 28.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.07 0.548 . . . . 0.0 109.732 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -76.91 140.83 25.44 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.69 170.75 13.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.874 0.87 . . . . 0.0 109.418 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.4 -20.03 65.48 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -90.14 5.27 47.59 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.24 85.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.017 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.4 m -89.14 155.76 19.23 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 118.413 1.107 . . . . 0.0 110.201 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.9 m -81.79 150.36 27.93 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.145 -0.347 . . . . 0.0 111.162 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -73.21 -10.37 59.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.785 0.434 . . . . 0.0 111.969 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' TYR . . . . . 0.489 ' CD1' ' HE2' ' A' ' 410' ' ' LYS . 41.8 t80 -139.05 141.11 38.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.68 0.792 . . . . 0.0 110.699 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -156.77 153.35 28.22 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.807 0.443 . . . . 0.0 110.603 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.06 154.07 40.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.194 0.998 . . . . 0.0 109.701 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -135.93 -3.77 2.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.034 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -74.28 157.91 86.03 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.808 0.843 . . . . 0.0 109.786 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.38 133.88 31.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.978 2.452 . . . . 0.0 110.401 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.0 m -124.17 23.99 8.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.885 0.874 . . . . 0.0 111.73 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.31 17.63 3.81 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.675 1.59 . . . . 0.0 114.674 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.9 t -140.57 144.66 26.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.446 HD12 ' CH2' ' A' ' 546' ' ' TRP . 70.5 mt -123.31 163.56 20.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.14 0.576 . . . . 0.0 110.465 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.24 160.6 41.76 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.69 0.396 . . . . 0.0 110.523 174.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -136.59 155.53 49.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.336 0.654 . . . . 0.0 110.821 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -146.12 173.92 11.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.484 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.6 t30 62.35 33.98 16.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.373 1.069 . . . . 0.0 112.566 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -90.0 158.7 44.03 Favored Pre-proline 0 N--CA 1.454 -0.251 0 C-N-CA 122.744 0.418 . . . . 0.0 110.203 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 153.16 72.54 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.362 2.042 . . . . 0.0 109.558 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -70.93 -1.21 11.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.75 8.26 20.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.4 p -79.16 151.92 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.324 0.511 . . . . 0.0 110.938 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.3 p -144.72 171.93 13.71 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.437 0.695 . . . . 0.0 110.274 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.44 -19.87 65.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.88 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -72.33 -23.91 61.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.42 -31.48 26.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -70.66 -29.87 66.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.953 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -84.17 -36.2 23.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.435 0.561 . . . . 0.0 111.668 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.71 -21.89 59.13 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.384 0.538 . . . . 0.0 111.752 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.8 mt -92.77 -33.96 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 117.854 0.297 . . . . 0.0 110.614 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 87.4 m -68.29 -21.03 64.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.445 -0.784 . . . . 0.0 110.74 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.15 -30.8 65.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.378 -0.201 . . . . 0.0 111.507 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.03 -13.42 33.27 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.31 0.505 . . . . 0.0 111.997 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.25 -11.03 33.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.519 0.328 . . . . 0.0 111.102 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.72 4.67 62.3 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.408 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.9 162.06 3.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 118.24 1.02 . . . . 0.0 110.697 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -69.49 142.91 53.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -92.32 151.47 41.53 Favored Pre-proline 0 CA--C 1.528 0.132 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.08 154.7 71.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.204 2.603 . . . . 0.0 110.329 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 99.0 m -89.95 -26.76 20.23 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 122.722 0.409 . . . . 0.0 110.859 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 52.0 m -141.51 152.76 44.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 3.5 p -149.56 147.12 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.878 0.471 . . . . 0.0 110.72 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 122.55 9.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.77 145.93 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.79 0.436 . . . . 0.0 110.329 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -155.12 151.37 28.21 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.88 0.472 . . . . 0.0 110.38 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.232 0.156 0 C-N-CA 122.918 0.487 . . . . 0.0 110.892 -178.766 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 69.8 m -139.27 162.74 34.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.15 0.58 . . . . 0.0 110.487 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 35.1 t -127.39 158.44 37.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.672 0.789 . . . . 0.0 111.877 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -154.29 168.32 26.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.103 1.361 . . . . 0.0 109.59 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.31 -178.86 48.28 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.911 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.22 154.24 28.24 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.3 mt -139.2 134.47 32.79 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.441 1.096 . . . . 0.0 108.703 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.85 114.89 17.8 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.446 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.3 p90 -166.11 155.0 11.28 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -150.66 117.48 5.85 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.979 1.104 . . . . 0.0 113.979 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 48.2 t -159.49 153.05 22.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 168.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -65.87 -42.41 90.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.389 0.54 . . . . 0.0 110.491 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 71.9 p -82.29 -26.3 33.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -81.94 -35.24 29.31 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.63 0.65 . . . . 0.0 110.89 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -77.65 -29.6 51.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.407 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.28 -28.22 23.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.397 0.544 . . . . 0.0 111.568 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -75.19 -34.84 61.57 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.458 0.572 . . . . 0.0 110.041 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 41.3 m -72.88 -40.99 65.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 28.7 tp -59.92 -52.26 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.242 -0.911 . . . . 0.0 109.164 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.6 -11.69 72.95 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.591 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.43 -4.27 2.64 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 119.476 1.638 . . . . 0.0 113.869 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 559' ' ' LEU . 2.0 tm? -97.48 -30.28 12.98 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.771 0.714 . . . . 0.0 109.561 176.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -67.42 155.86 37.96 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.355 -0.841 . . . . 0.0 109.279 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 34.4 m80 61.25 18.82 9.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.396 1.078 . . . . 0.0 113.643 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.46 151.45 27.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.332 0.587 . . . . 0.0 112.308 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -120.71 136.36 54.88 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.189 0.996 . . . . 0.0 110.734 -175.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 564' ' ' MET . . . . . 0.441 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 6.3 ttt -64.21 175.39 1.29 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.657 0.783 . . . . 0.0 111.575 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 565' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 564' ' ' MET . 48.6 mtmt -70.32 5.82 1.59 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.053 0.941 . . . . 0.0 113.233 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -64.52 142.54 98.45 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.058 0.844 . . . . 0.0 110.895 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.57 -28.23 3.63 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.662 2.908 . . . . 0.0 113.782 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.09 1.27 10.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.257 0.48 . . . . 0.0 111.788 -175.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.444 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.52 40.14 98.29 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.293 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.2 Cg_endo -68.26 -9.07 24.72 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.076 2.517 . . . . 0.0 111.802 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -145.53 145.94 27.82 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.55 156.46 40.57 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.801 3.0 . . . . 0.0 110.848 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -142.29 -1.59 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.2 m -66.47 120.92 14.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 29.3 mt -98.82 144.49 27.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.563 0.745 . . . . 0.0 110.329 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -93.77 136.8 33.68 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.58 156.33 43.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.843 0.354 . . . . 0.0 111.647 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 22.4 p -163.72 -179.99 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.763 0.825 . . . . 0.0 110.084 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -75.6 143.63 42.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.518 0.327 . . . . 0.0 111.163 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.1 t -135.52 142.84 45.49 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.253 0.621 . . . . 0.0 110.501 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 59.8 m -90.75 102.21 14.97 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.2 161.51 34.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.558 0.743 . . . . 0.0 110.663 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -110.76 -8.24 14.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.868 0.467 . . . . 0.0 110.59 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -159.82 161.95 34.63 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.22 1.008 . . . . 0.0 109.394 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -83.67 76.41 9.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.466 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.9 -6.69 42.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.559 0.344 . . . . 0.0 111.624 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.8 m -147.22 152.37 42.78 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -86.42 0.17 8.08 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.787 3.658 . . . . 0.0 112.246 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.8 151.74 36.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 118.472 0.578 . . . . 0.0 111.244 -174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -146.71 169.14 19.66 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.205 0.602 . . . . 0.0 110.183 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.4 mtp -135.08 154.06 51.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.286 0.234 . . . . 0.0 110.853 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.1 p -144.41 150.76 16.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 122.711 0.404 . . . . 0.0 110.948 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.17 168.78 18.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.856 0.862 . . . . 0.0 109.141 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.56 -3.29 86.9 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.766 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.734 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.2 pt? -72.7 176.65 5.36 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.654 0.727 . . . . 0.0 110.319 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -145.12 134.89 23.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -70.03 -5.06 23.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 97.1 p -93.86 -11.72 30.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 0.61 0.92 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.5 tpt -136.85 123.94 21.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -141.93 177.24 8.33 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.42 0.288 . . . . 0.0 111.029 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 77.1 m -59.03 -26.38 64.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.063 0.545 . . . . 0.0 111.897 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -82.92 -22.68 33.79 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.27 -0.269 . . . . 0.0 111.078 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -85.95 -36.45 19.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.87 -28.37 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.65 -38.27 83.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.095 -0.378 . . . . 0.0 110.038 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -80.73 -29.68 36.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.735 0.698 . . . . 0.0 112.664 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.41 -20.74 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 118.628 0.649 . . . . 0.0 110.789 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -113.69 -19.93 11.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 44.9 t -73.87 -26.81 60.76 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.564 1.075 . . . . 0.0 111.14 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.49 7.47 1.83 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.498 -0.751 . . . . 0.0 111.406 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.41 -0.04 9.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.014 0.926 . . . . 0.0 111.463 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 428' ' ' ALA . . . 155.01 170.88 21.15 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.38 150.1 48.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.033 0.444 . . . . 0.0 111.338 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 7.2 m -117.67 164.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -134.92 -52.23 0.79 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.171 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -163.8 163.18 24.01 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.655 0.661 . . . . 0.0 112.176 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.82 153.3 13.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.853 0.861 . . . . 0.0 110.44 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -151.97 145.58 24.96 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.47 0.308 . . . . 0.0 110.335 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.36 163.24 25.01 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 30.6 ttp -123.14 141.11 52.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 49.47 33.93 6.19 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.2 1.4 . . . . 0.0 112.311 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 24.3 m 52.95 18.23 1.04 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.146 0.978 . . . . 0.0 113.303 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.38 147.21 67.93 Favored Pre-proline 0 N--CA 1.456 -0.125 0 O-C-N 121.929 -0.482 . . . . 0.0 109.859 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -79.18 -2.44 12.36 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.495 2.797 . . . . 0.0 110.678 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -137.62 30.67 2.57 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.427 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.31 137.03 22.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.158 0.979 . . . . 0.0 110.149 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.11 167.72 29.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.74 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.8 ptm -142.54 142.02 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.776 0.831 . . . . 0.0 109.663 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.81 147.49 23.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.65 0.38 . . . . 0.0 110.916 -173.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -124.88 145.12 49.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.983 0.513 . . . . 0.0 111.154 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 78.5 mmm -111.61 162.74 14.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.334 1.054 . . . . 0.0 109.397 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.84 -20.84 62.51 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.027 -0.421 . . . . 0.0 111.8 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.23 161.4 39.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.119 0.568 . . . . 0.0 109.791 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.59 -12.92 70.84 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.177 -0.79 . . . . 0.0 113.553 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.49 -27.3 66.89 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.411 1.605 . . . . 0.0 110.24 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 404' ' ' GLY . . . -78.7 -28.74 45.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.687 0.28 . . . . 0.0 110.256 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.0 t -75.66 -24.83 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.37 -39.88 67.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.127 -0.358 . . . . 0.0 110.957 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.68 67.93 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.87 -33.39 34.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.14 -0.35 . . . . 0.0 111.931 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -83.06 -30.98 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.871 -0.518 . . . . 0.0 111.36 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.8 m -98.62 -14.14 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.35 -8.43 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.69 -20.11 10.25 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.281 0.946 . . . . 0.0 109.578 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -52.01 143.63 13.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.703 0.801 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.2 1.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.367 2.267 . . . . 0.0 115.971 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.77 142.32 27.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.647 1.567 . . . . 0.0 108.679 169.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.363 0.0 OUTLIER -130.92 165.07 23.9 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.9 ptp -125.13 143.53 50.88 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.011 1.324 . . . . 0.0 109.632 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 66.18 26.45 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.12 15.76 74.65 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -83.0 161.89 21.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.531 1.166 . . . . 0.0 110.087 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -83.79 132.4 34.83 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.48 133.83 42.3 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.76 117.23 10.79 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.69 143.73 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.236 0.471 . . . . 0.0 110.19 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 26.3 t -158.94 160.41 36.01 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.666 0.386 . . . . 0.0 110.057 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.14 158.22 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.677 0.391 . . . . 0.0 110.055 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.8 t -133.1 158.76 41.97 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.262 0.625 . . . . 0.0 109.837 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -110.86 14.02 22.17 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -66.94 151.07 97.44 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.31 -28.5 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.783 2.322 . . . . 0.0 111.862 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.66 172.23 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.284 0.634 . . . . 0.0 110.254 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.6 mm -66.44 137.81 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -89.01 149.3 43.01 Favored Pre-proline 0 N--CA 1.455 -0.179 0 O-C-N 122.404 -0.185 . . . . 0.0 110.869 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.17 162.77 39.83 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.665 2.91 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 168.03 -177.55 42.19 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -75.78 162.64 28.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.5 p -136.9 162.62 32.76 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.843 0.457 . . . . 0.0 110.914 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.55 163.42 32.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.569 0.748 . . . . 0.0 109.617 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.68 134.34 13.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.76 171.11 11.16 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.493 0.717 . . . . 0.0 110.063 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.02 -20.47 66.2 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.557 0.343 . . . . 0.0 111.432 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.72 1.94 47.43 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.838 0.455 . . . . 0.0 111.603 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.24 -3.68 85.5 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.874 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 68.4 m -91.38 159.14 16.14 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 118.196 0.998 . . . . 0.0 110.525 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.8 m -80.0 153.46 28.85 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.511 0.324 . . . . 0.0 110.478 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.0 p -70.01 -10.41 58.57 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.339 0.656 . . . . 0.0 111.656 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -126.53 139.28 53.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.307 1.043 . . . . 0.0 109.272 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -155.83 156.15 34.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.231 0.212 . . . . 0.0 110.845 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.22 156.37 35.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.879 0.872 . . . . 0.0 110.704 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -139.93 16.91 2.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.395 0.678 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.741 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -66.93 164.89 30.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.637 0.775 . . . . 0.0 110.044 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.9 145.75 23.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.915 3.076 . . . . 0.0 113.523 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 49.1 m -124.11 23.7 8.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.729 0.812 . . . . 0.0 111.809 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 60.54 10.23 2.44 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.22 1.408 . . . . 0.0 114.306 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 29.8 t -140.41 144.96 26.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' LEU . . . . . 0.444 HD12 ' CH2' ' A' ' 546' ' ' TRP . 65.5 mt -122.79 150.53 42.69 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.804 0.441 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.92 150.12 50.02 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.212 0.605 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.71 151.91 47.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -145.47 169.21 18.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.85 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.7 t30 58.56 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.023 0.929 . . . . 0.0 112.487 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.8 163.41 49.08 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 122.778 0.431 . . . . 0.0 109.863 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.83 150.53 62.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.853 2.369 . . . . 0.0 111.549 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.47 ' H ' ' CD2' ' A' ' 507' ' ' LEU . 1.8 pt? -72.85 -1.09 15.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.48 13.58 5.0 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -76.26 154.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.129 0.422 . . . . 0.0 110.578 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 66.3 p -142.22 171.04 14.6 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.961 0.504 . . . . 0.0 110.088 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.64 -22.03 66.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.097 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.81 -26.08 56.92 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.24 -0.287 . . . . 0.0 110.71 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -79.04 -30.98 44.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.77 -30.02 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.398 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -76.78 -39.85 50.19 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.1 0.409 . . . . 0.0 111.672 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.94 -18.19 56.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.732 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.23 -33.9 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.222 0.464 . . . . 0.0 110.251 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.84 -21.65 65.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.556 -0.715 . . . . 0.0 110.174 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.96 -28.86 60.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.769 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.99 -14.35 31.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.345 0.521 . . . . 0.0 111.892 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.6 mt -95.4 -7.05 39.49 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.566 0.346 . . . . 0.0 110.903 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.36 4.72 61.14 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.224 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.6 m -80.67 169.47 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.092 0.946 . . . . 0.0 111.033 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -80.91 147.62 30.24 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.984 0.513 . . . . 0.0 110.736 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -88.29 147.53 40.42 Favored Pre-proline 0 C--O 1.232 0.132 0 C-N-CA 123.064 0.546 . . . . 0.0 109.964 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.53 156.13 61.96 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.534 2.823 . . . . 0.0 110.195 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.43 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.2 m -86.95 -25.91 24.12 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.341 0.256 . . . . 0.0 110.608 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.7 m -144.52 151.76 39.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.865 0.466 . . . . 0.0 109.824 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.57 144.56 29.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 123.496 0.718 . . . . 0.0 109.124 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 124.13 11.45 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.08 151.57 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -145.66 147.51 32.07 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.941 0.4 . . . . 0.0 111.694 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.7 t . . . . . 0 N--CA 1.454 -0.256 0 C-N-CA 123.924 0.889 . . . . 0.0 109.066 172.221 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 79.8 p -152.52 175.32 12.88 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.595 1.158 . . . . 0.0 109.898 177.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 69.2 m -132.16 161.18 33.98 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.885 0.474 . . . . 0.0 110.934 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.2 m -145.53 159.59 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.912 0.885 . . . . 0.0 109.606 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -174.86 -175.74 42.6 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.638 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.78 155.37 34.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.898 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.4 mt -135.91 132.6 36.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.489 1.116 . . . . 0.0 108.042 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.76 112.56 14.93 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.444 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.2 p90 -166.04 155.42 11.81 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.59 1.556 . . . . 0.0 107.368 168.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -150.01 122.89 8.73 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.2 t -159.53 152.97 22.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.64 -46.83 77.72 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.778 0.717 . . . . 0.0 111.213 -174.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 78.2 p -84.34 -25.4 29.22 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -85.36 -28.58 25.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.725 0.693 . . . . 0.0 111.271 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.247 0.476 . . . . 0.0 110.663 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.97 -29.84 35.22 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.19 0.45 . . . . 0.0 111.045 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -77.83 -38.56 45.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.352 0.524 . . . . 0.0 110.179 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 38.2 m -73.21 -42.64 62.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 556' ' ' LEU . . . . . 0.446 ' C ' HD13 ' A' ' 556' ' ' LEU . 2.3 tm? -60.54 -46.61 89.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -67.53 -14.87 65.38 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.355 -1.247 . . . . 0.0 114.032 -172.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.07 -6.81 2.69 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.327 1.564 . . . . 0.0 113.976 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.95 -22.3 25.69 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.557 0.617 . . . . 0.0 109.749 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.08 151.51 30.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.22 -0.3 . . . . 0.0 111.023 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 49.24 30.0 2.9 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 151.42 25.65 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -110.91 136.33 50.1 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.213 1.405 . . . . 0.0 110.628 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.2 ttt -64.28 174.95 1.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.154 0.982 . . . . 0.0 112.18 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.87 12.58 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.37 1.068 . . . . 0.0 112.835 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.48 141.41 88.05 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.21 0.604 . . . . 0.0 111.147 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.55 -29.8 2.18 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.356 2.704 . . . . 0.0 113.021 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -121.05 -7.9 9.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.395 0.516 . . . . 0.0 112.395 -177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.12 42.84 97.9 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.412 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 88.8 Cg_endo -71.9 -6.55 19.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.134 2.556 . . . . 0.0 112.208 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.1 149.98 47.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.135 0.574 . . . . 0.0 110.341 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.44 156.24 41.03 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.627 2.885 . . . . 0.0 110.595 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -137.87 -2.46 1.91 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.524 0.33 . . . . 0.0 111.478 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.0 t -66.69 131.95 47.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.164 0.507 . . . . 0.0 110.73 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 575' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 575' ' ' LEU . 0.9 OUTLIER -125.03 144.6 50.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.595 1.158 . . . . 0.0 109.638 177.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -72.48 147.08 46.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 54.9 tp -142.05 144.7 33.73 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.97 172.64 13.64 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 111.502 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -88.46 132.94 34.27 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.2 t -135.57 150.67 49.77 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.068 0.147 . . . . 0.0 110.783 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 40.9 m -87.1 102.56 14.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.945 0.403 . . . . 0.0 111.154 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.39 34.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.697 0.799 . . . . 0.0 109.892 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -109.7 -14.06 14.4 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.939 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -160.84 164.83 31.05 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.485 0.714 . . . . 0.0 109.457 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.52 102.9 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.645 -178.448 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.0 1.4 3.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 50.0 m -145.42 151.7 47.97 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 117.872 0.306 . . . . 0.0 111.285 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.26 -3.06 10.17 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 124.339 3.36 . . . . 0.0 111.934 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.03 151.74 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.286 0.494 . . . . 0.0 111.585 -173.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.72 174.58 11.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.728 0.811 . . . . 0.0 110.27 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.7 mtp -135.4 149.89 49.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.422 0.289 . . . . 0.0 111.207 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.5 148.77 28.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.574 0.75 . . . . 0.0 109.971 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -139.4 168.4 19.9 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.992 0.517 . . . . 0.0 110.289 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.03 -6.05 68.65 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.411 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.615 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.3 pt? -71.85 -175.48 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.163 0.982 . . . . 0.0 110.598 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -146.12 149.7 34.51 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 121.981 -0.449 . . . . 0.0 110.559 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -76.2 -2.08 29.47 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 m -108.89 -4.1 17.07 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.608 0.363 . . . . 0.0 111.701 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -130.27 -12.28 4.04 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.014 0.526 . . . . 0.0 111.011 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 85.5 mtp -141.28 135.25 30.43 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.923 0.489 . . . . 0.0 110.342 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 29.0 m120 -141.87 174.14 10.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.35 -31.15 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.783 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.18 -25.3 29.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ARG . . . . . 0.402 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 59.6 mtt85 -89.15 -28.72 19.85 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 122.234 0.214 . . . . 0.0 110.902 -178.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.73 -26.76 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -66.8 -35.56 80.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.46 -30.4 70.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.195 -0.316 . . . . 0.0 110.83 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.74 -21.6 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -110.44 -10.69 14.55 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.0 t -70.4 -36.38 74.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.851 0.75 . . . . 0.0 111.977 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.96 13.29 1.45 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.715 -0.616 . . . . 0.0 112.251 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -121.41 -1.27 9.66 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.469 0.707 . . . . 0.0 110.861 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 141.16 174.1 14.0 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -75.83 145.16 40.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.534 -0.392 . . . . 0.0 110.685 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.59 154.28 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -105.02 -55.86 2.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 110.523 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -164.47 162.25 21.83 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.105 0.479 . . . . 0.0 111.202 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 15.0 p -145.88 151.28 14.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.8 0.84 . . . . 0.0 110.249 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -154.07 147.19 24.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.335 0.254 . . . . 0.0 110.928 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -76.77 146.99 37.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' MET . . . . . 0.47 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -133.12 141.54 48.22 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -167.811 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.36 33.99 20.74 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.343 1.457 . . . . 0.0 112.647 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 54.59 19.94 2.66 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -103.82 141.27 22.17 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.02 -14.63 21.03 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.915 2.41 . . . . 0.0 109.622 171.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.05 65.96 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.378 0.989 . . . . 0.0 112.418 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' ALA . . . . . 0.47 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -147.75 129.91 15.52 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.303 1.052 . . . . 0.0 111.17 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -150.75 167.37 27.62 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.326 0.651 . . . . 0.0 110.891 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 20.2 ptm -144.78 143.98 30.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.656 0.382 . . . . 0.0 110.207 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.64 143.06 41.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.08 0.552 . . . . 0.0 110.694 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -126.54 138.0 53.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.201 0.6 . . . . 0.0 110.135 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 85.6 mmm -102.52 164.95 11.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.0 110.322 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.3 -20.74 62.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.451 -0.155 . . . . 0.0 111.221 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -158.06 161.54 38.03 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.302 0.641 . . . . 0.0 109.74 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.24 -14.33 68.62 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.414 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -67.44 -25.59 65.98 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.064 1.432 . . . . 0.0 110.446 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.58 -18.1 28.79 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.17 0.188 . . . . 0.0 111.182 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.72 -31.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.86 -31.86 71.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -79.62 -29.18 40.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.823 0.449 . . . . 0.0 110.864 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.34 -32.23 26.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.251 0.478 . . . . 0.0 110.819 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 433' ' ' ILE . 6.9 tp -79.22 -31.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 122.166 -0.334 . . . . 0.0 111.279 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -97.1 -21.33 17.42 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -122.54 -12.68 8.12 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.3 -20.21 10.43 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 118.864 0.756 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -55.58 144.82 25.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.794 0.838 . . . . 0.0 110.581 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 60.01 1.31 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.772 2.029 . . . . 0.0 114.89 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -88.14 142.68 27.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.397 1.453 . . . . 0.0 109.047 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.307 0.1 OUTLIER -130.81 163.93 26.29 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.5 ptm -125.36 143.43 50.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.655 1.182 . . . . 0.0 108.804 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 62.86 28.42 16.38 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.86 72.24 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -83.07 152.58 25.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.432 1.616 . . . . 0.0 111.095 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 141.83 36.26 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.5 122.02 35.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -168.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.96 118.88 11.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.437 0.695 . . . . 0.0 109.28 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 3.1 p -154.47 138.23 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.164 0.438 . . . . 0.0 110.275 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.9 m -147.69 155.51 41.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.38 157.06 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 48.1 t -130.1 167.57 18.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.118 0.567 . . . . 0.0 109.991 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -119.47 12.43 12.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.848 0.459 . . . . 0.0 111.997 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -63.94 150.79 90.92 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.51 -30.58 9.78 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.472 2.114 . . . . 0.0 111.849 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.58 164.78 10.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.711 0.405 . . . . 0.0 110.77 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.7 mm -70.56 140.31 18.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.0 mmt -102.26 130.38 24.3 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.97 -31.52 9.8 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.6 2.2 . . . . 0.0 112.196 -172.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 58.52 -152.48 30.33 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -101.67 -15.41 17.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.737 0.415 . . . . 0.0 110.543 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 3.1 m 55.86 176.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.671 1.588 . . . . 0.0 113.442 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -153.8 165.34 36.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.519 0.728 . . . . 0.0 109.275 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -86.61 123.85 6.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.97 176.48 7.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.932 0.493 . . . . 0.0 111.228 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -59.96 -24.57 64.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.1 -0.61 25.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.912 -0.492 . . . . 0.0 111.389 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.98 -3.8 78.5 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.614 0.626 . . . . 0.0 112.112 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 23.2 t -93.64 170.32 9.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.515 0.726 . . . . 0.0 110.329 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 16.4 p -85.67 153.32 22.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.99 0.424 . . . . 0.0 111.165 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.0 m -71.7 -10.39 59.69 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.546 0.738 . . . . 0.0 112.576 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -120.14 143.48 48.17 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.068 0.547 . . . . 0.0 110.87 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -153.8 156.55 37.9 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.692 0.397 . . . . 0.0 110.354 177.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -133.17 156.43 47.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.82 15.13 1.94 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.978 0.511 . . . . 0.0 111.608 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.045 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -65.61 162.87 39.15 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.078 0.551 . . . . 0.0 110.3 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.37 145.97 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.519 2.813 . . . . 0.0 112.489 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.7 m -124.05 24.0 8.34 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.452 0.701 . . . . 0.0 111.402 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.81 12.04 2.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.538 1.135 . . . . 0.0 113.618 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.71 151.18 22.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.3 mt -132.4 151.22 51.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.652 0.781 . . . . 0.0 109.689 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -121.09 142.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 544' ' ' LEU . 11.3 m-85 -125.33 148.02 48.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.206 0.602 . . . . 0.0 110.503 -175.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -144.6 172.71 12.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.737 0.415 . . . . 0.0 111.035 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 66.8 t30 62.23 32.21 17.28 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.325 1.05 . . . . 0.0 113.126 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -89.22 158.29 46.7 Favored Pre-proline 0 N--CA 1.454 -0.242 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 156.81 52.07 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.242 1.961 . . . . 0.0 109.645 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.9 pt? -68.33 -1.17 5.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.666 0.787 . . . . 0.0 112.866 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.52 11.58 12.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.6 p -76.59 153.63 5.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 118.287 0.494 . . . . 0.0 110.725 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 78.4 p -143.76 169.24 18.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.278 0.631 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.04 -24.62 68.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.253 -0.28 . . . . 0.0 110.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.13 -26.01 60.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -78.31 -32.22 49.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.85 -28.54 64.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.236 -0.29 . . . . 0.0 110.708 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -80.37 -36.43 33.97 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.024 0.375 . . . . 0.0 111.941 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.65 -19.5 38.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 80.6 mt -86.86 -34.46 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.11 -21.73 64.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.693 -0.629 . . . . 0.0 109.824 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.54 -31.17 68.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -91.14 -15.9 28.64 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.209 0.459 . . . . 0.0 111.947 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.5 mt -91.52 -9.73 43.32 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.637 0.199 . . . . 0.0 111.201 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.53 4.63 57.98 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.958 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.51 165.64 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.998 0.899 . . . . 0.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -72.2 123.95 24.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -76.59 150.79 82.37 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -63.71 151.03 86.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.84 2.36 . . . . 0.0 110.721 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 527' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.6 m -88.23 -19.99 26.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.866 0.467 . . . . 0.0 110.903 -175.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.1 t -146.64 154.16 41.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.37 138.9 46.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 122.413 0.285 . . . . 0.0 110.896 -175.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -147.1 125.49 12.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.191 0.996 . . . . 0.0 108.352 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.63 150.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 C-N-CA 122.728 0.411 . . . . 0.0 110.333 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -145.0 161.12 40.18 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.779 0.832 . . . . 0.0 109.119 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.457 -0.115 0 C-N-CA 122.403 0.281 . . . . 0.0 111.075 -176.675 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.3 t -140.61 158.13 44.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.979 0.512 . . . . 0.0 110.147 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.8 m -125.13 153.43 43.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.612 0.765 . . . . 0.0 112.034 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.0 m -147.9 162.14 39.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.478 1.511 . . . . 0.0 108.528 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.07 177.8 39.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.475 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.488 ' C ' HD22 ' A' ' 544' ' ' LEU . 84.6 mt -98.91 139.47 34.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.817 -173.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 502' ' ' PHE . 3.6 mm? -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -127.87 116.37 20.03 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 546' ' ' TRP . . . . . 0.411 ' HB3' ' H ' ' A' ' 527' ' ' THR . 3.0 p90 -166.09 150.47 8.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.744 1.618 . . . . 0.0 107.058 168.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.58 120.83 7.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 548' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 42.3 t -159.48 152.9 22.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -66.45 -46.1 77.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.97 0.804 . . . . 0.0 111.17 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 68.6 p -84.34 -33.3 23.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.859 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 551' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 38.3 m-20 -76.5 -31.31 57.63 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.843 0.747 . . . . 0.0 110.903 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.95 -31.28 58.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.052 0.387 . . . . 0.0 110.752 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.13 -29.73 38.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.132 0.424 . . . . 0.0 111.575 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -71.86 -40.7 68.8 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.39 . . . . 0.0 109.992 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 33.1 m -70.1 -31.68 69.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.41 -45.87 85.74 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.335 -0.853 . . . . 0.0 110.529 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.21 -27.19 70.51 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.041 -0.866 . . . . 0.0 113.421 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.75 -10.7 13.58 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.627 1.213 . . . . 0.0 114.198 -176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 559' ' ' LEU . 0.4 OUTLIER -99.62 -26.84 13.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.304 0.956 . . . . 0.0 110.941 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -60.39 138.21 58.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.059 -1.026 . . . . 0.0 110.951 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 40.3 m170 51.61 26.33 3.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.409 1.084 . . . . 0.0 113.544 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.4 151.36 47.57 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.173 0.511 . . . . 0.0 112.336 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -103.69 136.4 43.46 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.183 0.993 . . . . 0.0 110.694 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 564' ' ' MET . . . . . 0.401 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.4 ttt -64.34 174.92 1.47 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.06 0.544 . . . . 0.0 111.255 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -75.32 11.91 1.09 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -68.68 146.67 97.75 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 118.271 0.487 . . . . 0.0 110.332 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.39 -37.95 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.252 2.634 . . . . 0.0 113.831 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -121.03 6.83 10.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 569' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.1 45.24 92.52 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.107 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 570' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.4 Cg_endo -68.99 -9.8 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.22 2.613 . . . . 0.0 111.866 -178.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -146.17 149.07 37.22 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.011 0.524 . . . . 0.0 109.721 174.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.83 148.96 41.83 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.903 3.068 . . . . 0.0 110.97 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 573' ' ' TYR . . . . . 0.401 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.5 t80 -149.92 15.47 0.84 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.847 0.459 . . . . 0.0 110.932 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 81.9 p -80.18 91.06 5.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.123 -0.986 . . . . 0.0 110.752 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.94 144.55 38.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -107.61 154.02 22.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 577' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 577' ' ' LEU . 2.1 pt? -143.44 151.54 40.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 111.437 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.64 163.79 39.47 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.699 0.8 . . . . 0.0 110.032 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.38 140.58 50.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 73.8 p -135.58 143.47 45.66 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.553 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 28.0 p -84.4 102.26 12.62 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.45 34.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.664 0.786 . . . . 0.0 110.976 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.67 -8.64 12.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.036 0.535 . . . . 0.0 110.595 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -160.92 162.9 32.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.016 0.926 . . . . 0.0 109.326 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.93 76.4 9.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.866 178.857 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -145.17 136.54 25.12 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.919 0.488 . . . . 0.0 109.979 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 67.12 -179.21 14.72 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.675 0.655 . . . . 0.0 112.741 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.21 -172.89 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 125.028 3.819 . . . . 0.0 110.217 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -138.1 150.76 47.16 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.613 0.365 . . . . 0.0 110.568 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -81.01 167.1 20.18 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.925 0.49 . . . . 0.0 111.125 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.86 -5.88 24.24 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.077 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.6 m -148.47 152.73 39.1 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -85.48 2.35 7.77 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.659 3.573 . . . . 0.0 112.34 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.94 152.23 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.906 0.482 . . . . 0.0 111.356 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.1 pp -142.54 170.3 15.96 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.719 0.807 . . . . 0.0 110.445 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.38 149.71 47.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.916 0.486 . . . . 0.0 110.207 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.99 150.39 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.794 0.438 . . . . 0.0 110.952 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -140.25 168.99 18.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.82 0.848 . . . . 0.0 109.514 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.99 -5.1 77.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.945 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.761 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -72.0 176.68 4.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.83 0.815 . . . . 0.0 110.586 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.06 131.85 25.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -68.12 -7.88 33.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.7 t -91.81 -15.69 27.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.663 0.665 . . . . 0.0 112.104 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.38 5.26 1.24 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 15.4 tpt -150.9 102.52 2.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -141.86 -166.44 2.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.941 0.497 . . . . 0.0 110.342 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 78.0 m -52.53 -27.08 15.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.13 -28.2 24.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.378 0.536 . . . . 0.0 111.674 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -83.91 -31.85 25.45 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.23 -26.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.4 -30.58 62.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -81.5 -17.77 47.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.318 -0.372 . . . . 0.0 111.914 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.27 -22.2 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -110.95 -18.8 12.99 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.94 -21.89 60.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.327 0.967 . . . . 0.0 112.333 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.57 10.43 1.72 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.618 -0.676 . . . . 0.0 112.467 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -121.43 -2.71 9.45 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.923 0.889 . . . . 0.0 110.975 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 152.0 154.43 6.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.23 134.95 51.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.277 0.538 . . . . 0.0 110.298 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.07 154.02 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.05 -59.6 1.67 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.018 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' LYS . . . . . 0.439 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.1 pttm -160.93 162.33 31.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.648 0.379 . . . . 0.0 111.296 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.35 150.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 123.924 0.889 . . . . 0.0 109.792 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.23 145.3 26.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.505 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.24 145.34 27.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.607 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -132.1 141.66 49.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -167.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.19 33.93 21.06 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 125.769 1.628 . . . . 0.0 112.371 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 53.02 14.79 0.5 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 142.83 57.89 Favored Pre-proline 0 N--CA 1.456 -0.144 0 CA-C-N 118.802 0.728 . . . . 0.0 109.956 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.9 -0.19 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.412 2.741 . . . . 0.0 110.471 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.13 31.92 2.4 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.479 -0.623 . . . . 0.0 112.887 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.607 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -148.34 134.08 18.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.001 0.901 . . . . 0.0 110.154 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.8 170.93 19.09 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.951 0.405 . . . . 0.0 111.642 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -141.5 144.21 34.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.95 0.9 . . . . 0.0 109.505 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.93 146.73 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.145 0.578 . . . . 0.0 111.031 -171.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -131.01 145.26 51.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.482 0.713 . . . . 0.0 109.758 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 76.8 mtp -126.52 164.41 21.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.665 0.386 . . . . 0.0 110.758 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.29 -19.31 64.69 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.85 154.81 31.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.23 0.468 . . . . 0.0 110.243 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.72 -14.41 78.05 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.92 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -70.68 -20.14 62.72 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.341 1.57 . . . . 0.0 110.707 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.68 -31.98 18.23 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.1 t -67.73 -37.59 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -67.06 -30.65 70.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.501 0.321 . . . . 0.0 111.145 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -37.1 65.95 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.56 -24.85 41.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.437 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 8.2 mm -77.13 -30.92 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.708 0.803 . . . . 0.0 110.56 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.9 m -93.17 -21.64 19.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -138.7 -19.17 1.05 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -95.76 -15.14 22.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.222 0.919 . . . . 0.0 109.158 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -54.08 142.97 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.116 0.966 . . . . 0.0 110.153 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.15 1.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -87.81 142.53 27.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.735 1.607 . . . . 0.0 109.522 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.409 ' HB2' ' HG3' ' A' ' 446' ' ' MET 0.298 0.1 OUTLIER -130.88 164.04 26.13 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 171.726 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.14 143.35 50.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.909 1.283 . . . . 0.0 108.573 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 63.64 32.52 13.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.23 15.99 80.85 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 116.039 1.175 . . . . 0.0 116.039 168.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -83.17 153.0 25.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.392 1.596 . . . . 0.0 110.557 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 141.87 34.89 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' MET . . . . . 0.409 ' HG3' ' HB2' ' A' ' 440' ' ' PHE . 1.6 mpt? -96.29 122.09 38.78 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -140.72 115.74 9.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.08 142.06 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.057 0 CA-C-N 118.348 0.522 . . . . 0.0 110.234 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 98.2 m -147.19 168.83 20.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.704 0.802 . . . . 0.0 110.054 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 152.67 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 27.1 t -126.51 163.14 24.02 Favored 'General case' 0 CA--C 1.526 0.027 0 CA-C-N 117.845 0.293 . . . . 0.0 110.582 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -103.88 8.89 36.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.805 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -65.56 149.99 96.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.924 -0.485 . . . . 0.0 109.782 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.05 -27.5 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.855 2.37 . . . . 0.0 111.992 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.48 171.65 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.161 0.585 . . . . 0.0 110.357 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.439 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 40.6 mm -68.89 135.67 27.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.4 mtt -95.72 150.31 37.23 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 122.07 0.148 . . . . 0.0 110.819 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.94 163.81 37.04 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.887 3.058 . . . . 0.0 111.494 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.72 -174.56 44.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.93 151.47 38.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.4 p -140.12 159.06 43.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.127 0.571 . . . . 0.0 110.365 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.09 167.7 28.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.216 0.607 . . . . 0.0 109.895 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.59 141.44 25.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.59 168.09 13.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.793 0.837 . . . . 0.0 109.54 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.6 -20.17 66.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.072 -0.392 . . . . 0.0 111.519 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.22 -1.3 44.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.83 0.452 . . . . 0.0 111.392 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.72 -4.5 86.19 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.632 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.1 m -93.33 160.79 14.66 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.23 1.015 . . . . 0.0 110.276 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 73.2 m -81.38 153.37 27.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.009 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.6 p -71.13 -10.8 60.37 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.82 0.448 . . . . 0.0 111.625 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -129.88 141.78 50.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.354 1.061 . . . . 0.0 109.393 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -154.51 158.89 40.55 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.416 0.286 . . . . 0.0 110.715 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -131.04 148.55 52.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.127 0.971 . . . . 0.0 109.355 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -136.85 7.81 2.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.687 0.395 . . . . 0.0 111.855 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 13.5 t -70.2 -13.74 62.31 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.576 0.35 . . . . 0.0 111.209 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -93.45 2.77 56.36 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.007 0.523 . . . . 0.0 111.642 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.2 t -73.85 140.05 45.49 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.122 -0.361 . . . . 0.0 110.995 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -122.07 12.13 10.32 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 123.706 0.802 . . . . 0.0 111.4 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -87.07 11.29 14.13 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.127 0.571 . . . . 0.0 112.398 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -126.47 148.82 49.62 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.387 0.613 . . . . 0.0 111.662 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -82.08 9.65 8.11 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.258 1.023 . . . . 0.0 110.855 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -138.84 18.31 2.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.197 0.999 . . . . 0.0 110.667 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.8 p -79.53 -3.05 45.05 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.918 0.487 . . . . 0.0 111.295 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 5.7 t -146.12 143.78 20.1 Favored Pre-proline 0 N--CA 1.456 -0.175 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.66 -12.89 37.16 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.041 2.494 . . . . 0.0 113.334 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.46 -27.04 25.96 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.964 0.802 . . . . 0.0 111.42 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -90.61 -26.74 19.51 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 117.614 0.188 . . . . 0.0 110.581 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.96 36.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.668 0.387 . . . . 0.0 111.243 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -98.64 -2.35 38.64 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.575 0.75 . . . . 0.0 111.547 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -127.02 16.92 7.29 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.709 0.804 . . . . 0.0 110.909 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -142.23 161.13 38.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.41 1.084 . . . . 0.0 108.336 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -129.81 159.84 35.32 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 122.095 -0.378 . . . . 0.0 111.955 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.7 mm -113.68 141.69 28.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -151.42 157.48 42.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -66.2 162.62 45.92 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.93 150.15 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.154 3.236 . . . . 0.0 113.499 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 37.9 m -123.95 18.92 9.3 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.548 0.739 . . . . 0.0 111.566 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.1 m120 59.92 10.78 2.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.407 1.083 . . . . 0.0 113.559 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.4 t -142.12 145.27 24.11 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 48.9 mt -117.55 166.56 12.23 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.201 0.524 . . . . 0.0 111.557 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -137.56 148.81 46.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.784 0.834 . . . . 0.0 109.027 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -133.57 153.25 51.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.663 0.385 . . . . 0.0 110.882 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -147.64 171.29 15.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.624 0.369 . . . . 0.0 111.33 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 24.9 m120 61.57 16.54 7.74 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -79.96 156.19 74.79 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.24 157.09 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.671 2.248 . . . . 0.0 111.888 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.3 pt? -72.45 -1.26 15.08 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.64 8.73 29.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.967 0.349 . . . . 0.0 111.93 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.42 150.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.91 0.323 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 71.8 p -145.9 175.63 10.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.787 0.835 . . . . 0.0 109.693 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.38 -25.65 68.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.446 -0.158 . . . . 0.0 111.019 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -74.99 -24.64 58.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.614 0.188 . . . . 0.0 110.714 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -79.41 -29.96 42.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -73.26 -25.46 60.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.297 -0.252 . . . . 0.0 110.44 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -78.95 -36.58 41.35 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.983 -0.448 . . . . 0.0 111.661 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.12 -15.7 55.15 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.143 0.428 . . . . 0.0 111.612 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.97 -35.09 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.199 0.454 . . . . 0.0 109.832 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.8 m -70.52 -17.8 62.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.736 -0.602 . . . . 0.0 110.215 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.43 -30.27 61.83 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.578 -0.249 . . . . 0.0 111.512 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.05 -14.8 30.64 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.373 0.533 . . . . 0.0 111.421 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.62 -13.05 24.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.865 0.466 . . . . 0.0 111.301 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 70.57 6.52 58.89 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.82 -0.433 . . . . 0.0 112.791 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.2 m -85.93 167.31 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.679 0.739 . . . . 0.0 110.802 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -74.64 150.01 39.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 111.063 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.31 150.71 41.9 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 123.498 0.719 . . . . 0.0 110.283 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.9 156.56 65.42 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.472 2.781 . . . . 0.0 110.669 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.8 m -86.26 -22.8 26.65 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.864 0.466 . . . . 0.0 110.605 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 14.8 t -149.38 155.23 40.14 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.53 144.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.769 0.427 . . . . 0.0 110.457 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -134.58 130.53 36.65 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.23 143.45 35.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.754 0.422 . . . . 0.0 109.919 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -154.0 135.11 13.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.028 0.531 . . . . 0.0 110.025 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.9 m -105.12 138.31 41.52 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 122.51 0.324 . . . . 0.0 110.25 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -82.69 148.17 25.88 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -79.86 133.75 36.28 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 37.9 m 55.11 18.6 2.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -109.93 -8.0 14.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.628 0.371 . . . . 0.0 111.185 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 48.44 29.51 2.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.392 1.077 . . . . 0.0 113.459 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 75.2 p -145.13 168.28 20.73 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.895 0.378 . . . . 0.0 111.321 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 48.4 t -133.38 150.65 51.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.159 0.984 . . . . 0.0 110.781 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 37.0 m -145.55 162.97 36.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.031 1.333 . . . . 0.0 109.055 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.57 -168.8 41.26 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.485 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.29 159.74 22.21 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.091 0.556 . . . . 0.0 111.403 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 87.6 mt -137.38 135.06 36.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.694 1.198 . . . . 0.0 107.836 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.78 110.36 12.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.458 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.1 p90 -165.99 156.03 12.46 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.425 1.49 . . . . 0.0 107.477 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.73 117.1 6.49 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.652 0.66 . . . . 0.0 112.719 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 28.7 m -159.54 153.06 22.57 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 126.149 1.78 . . . . 0.0 106.28 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.83 -51.39 49.08 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.512 0.596 . . . . 0.0 111.509 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 50.2 m -79.71 -24.33 41.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.92 -34.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.39 0.541 . . . . 0.0 111.677 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.41 -26.42 38.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.015 0.37 . . . . 0.0 111.038 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.1 tp -85.12 -29.52 24.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.255 0.48 . . . . 0.0 111.73 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -75.45 -38.5 59.66 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.088 0.404 . . . . 0.0 110.042 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.0 m -70.15 -33.93 72.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.7 -42.75 90.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.18 -24.7 75.04 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.292 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -113.86 -14.78 12.47 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.627 1.214 . . . . 0.0 114.105 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.43 -20.65 17.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.524 1.056 . . . . 0.0 111.085 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -74.41 139.44 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.6 t60 52.23 35.88 17.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.587 0.755 . . . . 0.0 112.122 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -99.2 151.32 21.14 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.25 136.31 36.91 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.585 1.554 . . . . 0.0 111.139 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 564' ' ' MET . . . . . 0.422 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.7 ttt -64.07 174.51 1.52 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.438 0.695 . . . . 0.0 112.078 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 565' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.5 ttmm -68.65 -2.1 8.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.174 0.99 . . . . 0.0 112.504 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -60.96 141.95 93.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 121.492 -0.755 . . . . 0.0 110.569 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.18 -28.54 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.74 2.96 . . . . 0.0 113.918 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -121.01 -0.94 9.92 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.07 0.395 . . . . 0.0 111.829 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.39 41.27 99.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.997 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 79.1 Cg_endo -69.9 -10.7 29.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.884 2.39 . . . . 0.0 111.888 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.46 148.41 47.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.187 0.595 . . . . 0.0 109.959 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.63 153.36 38.81 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.707 2.938 . . . . 0.0 111.149 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -147.99 0.7 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.081 0.553 . . . . 0.0 111.41 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 12.3 t -66.43 125.55 26.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.283 -0.885 . . . . 0.0 110.781 -170.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.14 144.63 50.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.355 1.062 . . . . 0.0 109.991 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.6 157.82 16.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.285 0.234 . . . . 0.0 110.732 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.43 144.97 50.86 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.229 0.611 . . . . 0.0 109.689 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 27.9 p -160.49 167.37 27.36 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.159 0.584 . . . . 0.0 110.408 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -82.07 139.0 34.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 38.0 t -135.6 145.13 46.58 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.148 0.179 . . . . 0.0 110.883 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 19.3 p -79.98 102.28 9.15 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.12 161.56 34.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.954 0.902 . . . . 0.0 110.325 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 -12.44 11.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.782 0.433 . . . . 0.0 110.987 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -161.13 162.48 31.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.681 0.792 . . . . 0.0 109.538 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -91.35 76.83 5.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.518 0.327 . . . . 0.0 110.132 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.217 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.529 179.672 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -136.91 21.08 3.05 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.309 0.643 . . . . 0.0 110.983 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 84.16 156.16 23.34 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.36 -178.15 4.42 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.494 3.463 . . . . 0.0 111.096 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -98.25 157.27 16.27 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.212 0.605 . . . . 0.0 110.389 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -77.05 163.4 26.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.804 0.441 . . . . 0.0 110.509 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.54 -7.4 59.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.965 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.6 m -147.49 152.15 41.34 Favored Pre-proline 0 C--N 1.34 0.156 0 C-N-CA 123.15 0.58 . . . . 0.0 110.89 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -82.5 3.34 7.89 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.446 3.431 . . . . 0.0 112.631 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.8 164.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 112.464 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 381' ' ' LEU . 4.3 pp -149.45 171.23 16.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.23 1.012 . . . . 0.0 109.149 174.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' MET . . . . . 0.407 ' CE ' ' HE1' ' A' ' 412' ' ' MET . 80.8 mtp -138.11 152.12 48.45 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.411 0.284 . . . . 0.0 111.257 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.02 144.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -135.86 168.03 20.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.953 0.501 . . . . 0.0 110.411 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.31 69.26 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.972 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.757 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -70.06 170.71 10.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.501 0.65 . . . . 0.0 111.741 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -127.01 130.85 50.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.613 0.765 . . . . 0.0 109.434 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -71.87 6.83 1.82 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.6 p -121.28 0.67 10.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.98 -13.12 2.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.164 0.586 . . . . 0.0 110.704 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -141.84 121.02 12.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.133 0.973 . . . . 0.0 108.795 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.565 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 19.4 m120 -141.89 -179.97 6.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.87 0.868 . . . . 0.0 109.337 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.99 -22.79 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.982 0.113 . . . . 0.0 111.231 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -88.03 -26.06 22.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.014 -0.429 . . . . 0.0 111.717 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ARG . . . . . 0.565 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.4 mpt_? -83.36 -32.0 26.45 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.271 0.487 . . . . 0.0 109.702 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.9 p -72.44 -31.46 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -69.09 -29.57 67.7 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -80.78 -17.3 51.36 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.6 t -109.62 -23.78 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 118.437 0.562 . . . . 0.0 112.378 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.96 -16.37 14.16 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.689 0.677 . . . . 0.0 112.423 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 t -77.49 -16.02 58.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.124 0.875 . . . . 0.0 110.977 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.6 10.72 1.58 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.803 -0.561 . . . . 0.0 112.296 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 -3.17 9.38 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.721 0.808 . . . . 0.0 111.071 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.07 164.54 11.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.45 147.26 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.9 0.85 . . . . 0.0 111.702 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.49 155.47 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -96.76 -63.88 1.1 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -163.1 166.57 23.35 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.4 0.68 . . . . 0.0 110.338 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.51 151.7 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.214 0.606 . . . . 0.0 110.501 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -149.99 139.49 21.51 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.301 0.241 . . . . 0.0 110.822 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -77.25 152.28 34.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.407 ' HE1' ' CE ' ' A' ' 382' ' ' MET . 6.0 ptm -130.85 141.64 50.33 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -167.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 60.28 33.76 20.89 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.77 1.228 . . . . 0.0 112.275 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.3 m 55.42 14.79 1.22 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.296 1.039 . . . . 0.0 113.435 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -89.02 137.6 29.54 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.35 -8.56 18.57 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.964 2.443 . . . . 0.0 109.332 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.65 23.3 17.83 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.69 1.138 . . . . 0.0 113.128 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -150.75 137.27 18.78 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.973 1.387 . . . . 0.0 111.268 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -159.61 170.61 21.24 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.128 0.489 . . . . 0.0 111.363 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.5 ptm -139.39 147.44 41.46 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.375 0.67 . . . . 0.0 109.96 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.5 t -128.23 152.15 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.24 0.616 . . . . 0.0 110.76 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -129.58 141.46 50.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.585 0.754 . . . . 0.0 109.4 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 97.9 mmm -114.43 162.53 16.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.849 0.46 . . . . 0.0 110.719 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.83 60.74 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.318 0.247 . . . . 0.0 111.604 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.91 160.88 40.51 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.86 -12.22 84.76 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.199 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -75.38 -17.63 60.16 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.857 1.328 . . . . 0.0 111.32 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -89.84 -26.23 20.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.249 -0.282 . . . . 0.0 110.486 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.22 -34.27 37.07 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.29 -26.64 56.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.517 0.199 . . . . 0.0 110.625 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -25.74 48.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.68 31.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.038 0.135 . . . . 0.0 110.766 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 433' ' ' ILE . 3.1 tp -82.65 -30.95 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 121.813 -0.554 . . . . 0.0 111.121 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 24.0 m -94.82 -19.69 20.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -136.22 -5.91 2.07 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.59 -19.21 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.168 0.895 . . . . 0.0 109.461 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -51.95 143.13 14.22 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.895 0.878 . . . . 0.0 110.629 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.8 1.42 0.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.819 1.648 . . . . 0.0 114.992 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -88.47 142.76 27.45 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.544 -1.348 . . . . 0.0 109.117 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.271 0.1 OUTLIER -130.94 163.98 26.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 171.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.25 143.47 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.175 0.99 . . . . 0.0 109.625 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 64.72 30.5 12.4 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.368 1.467 . . . . 0.0 114.45 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.43 15.64 77.3 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 168.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.25 161.28 21.55 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.506 1.153 . . . . 0.0 110.19 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.587 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -91.63 128.59 37.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.329 0.513 . . . . 0.0 110.825 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.62 142.42 30.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -140.71 127.2 20.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.34 140.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-N 118.359 0.527 . . . . 0.0 110.718 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.7 m -150.59 163.69 37.86 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.26 1.024 . . . . 0.0 109.923 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.86 156.43 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.8 t -131.23 162.99 28.75 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 122.912 0.485 . . . . 0.0 109.725 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -105.69 5.69 31.3 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -67.42 144.93 98.24 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 121.694 -0.629 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.96 -24.68 11.13 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.151 2.567 . . . . 0.0 111.692 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.89 173.2 12.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.841 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.7 mm -71.33 142.52 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.43 154.89 37.85 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 117.472 0.124 . . . . 0.0 111.268 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.65 165.37 8.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.104 3.203 . . . . 0.0 112.477 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.89 177.86 37.77 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -81.81 166.07 20.31 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.834 0.453 . . . . 0.0 110.199 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.3 p -143.04 159.94 41.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.75 0.42 . . . . 0.0 110.973 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -151.33 173.15 14.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.768 0.827 . . . . 0.0 109.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.66 135.07 13.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.99 173.1 12.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.345 0.658 . . . . 0.0 109.828 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.4 -23.02 67.14 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.703 0.401 . . . . 0.0 111.329 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -81.7 -1.4 46.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.017 0.527 . . . . 0.0 111.332 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.27 84.43 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.087 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 77.6 p -84.06 163.96 19.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.537 0.668 . . . . 0.0 110.78 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.72 151.83 28.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 111.056 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 75.5 m -73.16 -10.45 59.79 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.435 0.694 . . . . 0.0 111.841 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -133.73 143.45 48.48 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.665 0.786 . . . . 0.0 109.762 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -157.18 156.86 33.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.733 0.413 . . . . 0.0 110.551 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -127.65 149.28 50.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.269 1.028 . . . . 0.0 109.503 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.99 13.89 2.87 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.84 0.456 . . . . 0.0 111.413 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 29.2 t -66.22 -16.55 64.09 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.079 -0.388 . . . . 0.0 111.784 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -79.79 -11.76 59.81 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.966 -0.459 . . . . 0.0 111.178 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.9 m -87.97 17.63 4.79 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.23 0.612 . . . . 0.0 111.47 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -75.0 8.97 2.16 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.396 0.679 . . . . 0.0 112.011 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -110.5 17.18 21.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.961 0.904 . . . . 0.0 110.544 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -81.37 23.43 0.61 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.987 0.915 . . . . 0.0 112.455 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 53.71 29.52 9.63 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.86 19.14 0.69 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.959 0.345 . . . . 0.0 111.802 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 67.2 p -84.56 4.24 32.94 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -171.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 39.4 p -136.47 159.35 70.94 Favored Pre-proline 0 C--O 1.231 0.082 0 CA-C-N 118.378 0.536 . . . . 0.0 110.055 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.63 -17.14 33.67 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.47 2.78 . . . . 0.0 112.863 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -94.69 -26.39 16.33 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 117.827 0.285 . . . . 0.0 111.06 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -90.5 -24.08 20.76 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 122.351 0.26 . . . . 0.0 110.8 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.12 62.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.302 -0.249 . . . . 0.0 110.982 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -80.42 -16.02 55.41 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.348 -0.22 . . . . 0.0 110.604 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -96.27 -13.82 23.09 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 123.431 0.692 . . . . 0.0 110.577 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.62 7.2 45.42 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.573 0.749 . . . . 0.0 109.43 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 50.81 54.06 11.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.668 1.187 . . . . 0.0 112.229 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.92 108.61 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -155.75 167.99 28.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.683 0.793 . . . . 0.0 109.034 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -62.35 159.41 40.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.44 131.32 36.21 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.304 2.669 . . . . 0.0 112.492 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.6 m -124.07 23.86 8.37 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.691 0.796 . . . . 0.0 111.464 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 60.75 10.99 2.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.891 1.276 . . . . 0.0 114.043 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.53 141.78 36.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 40.8 mt -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.326 0.65 . . . . 0.0 110.283 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 580' ' ' SER . 0.6 OUTLIER -141.51 161.98 36.59 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.377 0.271 . . . . 0.0 110.956 173.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -139.06 157.06 46.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.726 0.41 . . . . 0.0 111.328 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -150.53 174.3 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.203 0.601 . . . . 0.0 111.066 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 11.7 t30 64.98 11.35 6.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.911 1.284 . . . . 0.0 113.656 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -73.2 161.66 78.19 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -70.33 155.68 63.51 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.903 1.735 . . . . 0.0 110.18 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.9 pt? -69.73 -1.12 8.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.31 9.0 18.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.95 151.21 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 118.009 0.368 . . . . 0.0 110.932 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.9 p -142.15 173.28 11.67 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.361 0.664 . . . . 0.0 110.516 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.18 -21.31 64.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.885 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.05 -22.81 58.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.348 -0.22 . . . . 0.0 110.487 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -82.34 -30.19 30.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.79 -25.66 61.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.761 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -84.34 -34.96 23.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.11 0.414 . . . . 0.0 111.468 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -76.88 -21.99 54.1 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.281 0.491 . . . . 0.0 111.133 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 74.0 mt -84.83 -37.88 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.937 0.335 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.5 m -66.64 -24.68 66.33 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.113 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.91 -30.42 63.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.245 -0.284 . . . . 0.0 111.761 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -91.04 -11.09 39.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.375 0.534 . . . . 0.0 112.0 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.6 mt -96.19 -7.7 35.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.774 0.429 . . . . 0.0 111.084 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.88 7.97 81.73 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.77 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -97.78 165.2 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 117.83 0.815 . . . . 0.0 110.645 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -83.19 151.67 25.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.742 0.417 . . . . 0.0 111.065 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -91.08 155.2 44.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.474 0.71 . . . . 0.0 110.717 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.95 158.74 45.73 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.296 2.664 . . . . 0.0 111.285 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 81.5 m -89.96 -26.39 20.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.0 m -139.38 150.06 44.87 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.06 144.27 25.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 123.042 0.537 . . . . 0.0 110.849 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -142.16 138.89 31.89 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 29.6 t -136.39 145.77 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 122.595 0.358 . . . . 0.0 110.425 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -151.94 164.19 37.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 79.4 p -122.31 144.82 48.77 Favored 'General case' 0 N--CA 1.457 -0.085 0 O-C-N 121.867 -0.52 . . . . 0.0 111.242 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -83.34 149.54 26.28 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.0 130.74 35.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 21.2 m 56.22 15.06 1.73 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.401 1.08 . . . . 0.0 113.589 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -105.38 -10.27 17.07 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.841 0.457 . . . . 0.0 111.043 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 49.4 33.17 5.19 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.871 0.868 . . . . 0.0 112.103 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 99.0 p -137.47 169.58 17.55 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.802 0.441 . . . . 0.0 111.538 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.6 t -125.43 153.88 42.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.371 1.068 . . . . 0.0 110.799 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 78.4 p -152.88 171.22 18.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.72 1.208 . . . . 0.0 109.627 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 166.63 -172.91 41.97 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.129 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.54 152.68 32.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 66.8 mt -136.71 134.89 37.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.73 1.212 . . . . 0.0 107.856 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -127.78 113.1 15.53 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -166.09 153.94 10.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.639 1.576 . . . . 0.0 106.775 167.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -148.87 118.6 7.04 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.3 t -159.46 153.1 22.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.582 1.553 . . . . 0.0 107.025 168.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.38 -63.8 1.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.971 0.35 . . . . 0.0 111.739 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 74.2 p -82.28 -17.25 46.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.09 -41.35 28.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.298 0.499 . . . . 0.0 110.682 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -78.14 -31.78 49.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.596 -0.24 . . . . 0.0 110.968 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.5 tp -77.25 -30.49 54.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.671 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -74.8 -40.2 61.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.94 -0.475 . . . . 0.0 110.548 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.3 m -63.99 -49.98 70.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.59 -0.243 . . . . 0.0 110.347 -175.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 556' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 556' ' ' LEU . 3.5 pp -77.51 -18.9 56.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.833 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -69.21 -26.58 74.51 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.12 -7.38 11.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.596 0.698 . . . . 0.0 112.604 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 46.3 tp -98.23 -19.36 17.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 0.0 111.701 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -74.48 144.43 44.17 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 80.2 t60 51.11 35.83 14.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.019 0.528 . . . . 0.0 112.039 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -97.27 151.42 19.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.709 0.804 . . . . 0.0 111.691 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -102.6 136.33 42.62 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.181 1.392 . . . . 0.0 110.549 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.3 ttt -64.11 173.87 1.77 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.066 0.547 . . . . 0.0 111.499 -174.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -70.25 9.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -66.5 146.84 99.09 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 118.55 0.614 . . . . 0.0 110.081 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.84 -30.02 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.42 2.747 . . . . 0.0 113.917 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -121.06 2.18 10.41 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.438 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.14 40.16 98.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.686 -1.064 . . . . 0.0 112.891 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 80.9 Cg_endo -69.45 -9.99 27.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.272 2.648 . . . . 0.0 112.073 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -142.61 148.26 45.92 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 122.823 0.449 . . . . 0.0 110.086 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.84 156.69 43.72 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.603 2.868 . . . . 0.0 111.477 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -148.59 6.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.038 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 3.0 t -66.48 122.1 16.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.611 -0.681 . . . . 0.0 110.118 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 575' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.9 pt? -124.97 144.6 50.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 109.78 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -96.16 142.12 28.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.526 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.62 144.91 41.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 41.8 t -163.14 163.2 25.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -75.83 148.37 38.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.448 ' HB3' ' CG ' ' A' ' 501' ' ' HIS . 92.9 p -135.4 149.16 49.58 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.171 0.188 . . . . 0.0 110.606 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 31.3 p -90.02 102.19 14.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.36 161.47 34.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.654 0.782 . . . . 0.0 111.156 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -97.73 -25.79 14.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -163.85 152.72 13.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.506 1.122 . . . . 0.0 108.57 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -85.94 76.51 9.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.942 0.401 . . . . 0.0 110.35 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 36.3 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.869 177.484 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -136.65 6.46 2.96 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.936 0.494 . . . . 0.0 111.962 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -179.36 175.85 47.36 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.41 169.15 23.17 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.4 3.4 . . . . 0.0 110.94 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -155.84 168.84 25.93 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.091 0.556 . . . . 0.0 110.322 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -123.32 158.47 30.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.79 0.436 . . . . 0.0 110.443 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -144.79 17.03 1.61 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.22 0.608 . . . . 0.0 110.535 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.2 m -143.44 152.8 57.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 122.395 0.278 . . . . 0.0 111.13 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.209 3.273 . . . . 0.0 112.831 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 89.3 t -123.28 148.13 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 118.684 0.675 . . . . 0.0 110.811 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.3 164.12 30.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 110.692 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 73.6 mmm -127.33 149.38 50.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.505 0.722 . . . . 0.0 110.331 -176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.36 148.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.645 0.259 . . . . 0.0 110.743 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -141.13 170.99 14.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.702 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.46 -4.54 81.3 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.299 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -71.72 175.75 5.43 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.038 0.919 . . . . 0.0 110.522 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.69 135.57 44.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.802 0.441 . . . . 0.0 109.889 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -73.46 4.84 4.29 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -172.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.9 m -115.36 -2.11 12.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.076 0.398 . . . . 0.0 111.845 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -138.12 -0.95 2.0 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.435 0.694 . . . . 0.0 110.685 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -154.53 121.11 5.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -141.97 -176.52 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.79 0.436 . . . . 0.0 110.62 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 25.5 p -57.01 -30.22 64.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.301 0.641 . . . . 0.0 112.671 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.0 -25.92 25.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.023 -0.423 . . . . 0.0 110.756 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -79.99 -32.48 39.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -75.6 -27.05 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -68.82 -29.42 67.76 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 171.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.38 -23.05 47.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.026 -0.421 . . . . 0.0 111.981 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 71.4 t -94.61 -21.36 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -114.59 -13.93 12.11 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.2 t -73.9 -21.92 59.89 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.306 0.957 . . . . 0.0 111.085 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.48 10.41 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.645 -0.659 . . . . 0.0 112.385 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.45 -11.41 8.73 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.248 0.619 . . . . 0.0 111.434 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 160.97 174.61 31.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -68.41 141.47 55.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.535 -0.391 . . . . 0.0 110.871 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.6 t -104.56 147.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -101.38 -58.32 1.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.231 -0.293 . . . . 0.0 110.351 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -165.3 169.41 15.89 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.957 0.503 . . . . 0.0 110.685 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.35 150.88 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.069 0 C-N-CA 123.739 0.816 . . . . 0.0 110.216 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 411' ' ' PHE . 51.4 tptt -147.18 137.54 23.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.749 0.82 . . . . 0.0 109.093 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' PHE . . . . . 0.405 ' O ' ' HE3' ' A' ' 410' ' ' LYS . 4.3 m-85 -76.53 136.2 39.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 22.1 ttp -93.64 140.97 29.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 47.42 33.84 3.01 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 112.248 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.5 m 52.95 17.99 1.0 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.443 1.097 . . . . 0.0 113.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -75.95 149.53 82.82 Favored Pre-proline 0 N--CA 1.456 -0.159 0 CA-C-N 118.564 0.62 . . . . 0.0 109.897 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.43 4.4 6.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.882 3.055 . . . . 0.0 110.975 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.51 32.06 1.36 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.299 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.83 141.76 25.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.187 0.993 . . . . 0.0 110.439 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.37 170.28 22.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.941 0.4 . . . . 0.0 111.373 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.4 ptm -145.76 145.06 30.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.733 0.813 . . . . 0.0 109.512 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.37 153.22 38.58 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.299 0.639 . . . . 0.0 110.32 -173.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -127.67 143.67 51.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.691 0.797 . . . . 0.0 110.07 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 79.4 mtp -129.38 166.64 19.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.425 0.69 . . . . 0.0 110.134 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.54 -23.82 65.47 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.17 160.21 38.52 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.252 0.478 . . . . 0.0 110.576 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.77 -12.35 80.82 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.451 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -67.93 -25.56 65.53 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.231 1.515 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.9 -27.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.5 t -73.54 -32.96 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.75 -25.96 66.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.048 0.539 . . . . 0.0 110.212 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -82.43 -27.19 32.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.375 -0.203 . . . . 0.0 110.691 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.21 -28.34 29.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.464 0.173 . . . . 0.0 110.56 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.84 -31.11 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.336 0.654 . . . . 0.0 110.853 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 m -98.88 -19.55 17.3 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -135.59 -4.28 2.3 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.72 -15.29 11.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.857 0.753 . . . . 0.0 109.458 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -58.02 149.87 22.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.481 0.658 . . . . 0.0 111.954 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 56.83 1.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.024 1.73 . . . . 0.0 114.616 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -88.04 142.56 27.68 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.961 1.255 . . . . 0.0 109.46 168.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.321 0.1 OUTLIER -130.93 164.03 26.2 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 170.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 18.7 ptm -125.26 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 66.07 24.01 11.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.01 16.01 80.98 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -83.2 156.31 23.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.085 1.443 . . . . 0.0 111.811 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.86 139.96 49.1 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.58 0.752 . . . . 0.0 109.592 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.96 122.04 39.5 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -140.75 119.75 12.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.12 142.61 20.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 118.008 0.367 . . . . 0.0 110.751 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 73.3 m -148.41 174.92 11.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.682 0.793 . . . . 0.0 110.715 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.71 156.05 13.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 34.9 t -137.27 146.12 44.34 Favored 'General case' 0 N--CA 1.461 0.101 0 O-C-N 122.1 -0.375 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -85.43 6.56 26.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.076 0.551 . . . . 0.0 112.237 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' GLN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 454' ' ' PRO . 47.4 mt-30 -62.09 132.24 93.69 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 453' ' ' GLN . 37.0 Cg_exo -62.02 -32.05 84.01 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.691 2.261 . . . . 0.0 112.515 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -161.79 171.55 17.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.792 0.437 . . . . 0.0 110.9 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.74 143.26 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.81 149.61 44.07 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 122.227 0.211 . . . . 0.0 110.745 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.91 161.92 43.47 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.761 2.974 . . . . 0.0 111.765 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 166.39 -179.51 40.35 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -80.89 173.54 12.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.815 0.446 . . . . 0.0 109.834 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.1 p -140.43 161.86 36.71 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -150.99 165.18 34.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.722 0.809 . . . . 0.0 109.632 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 137.88 20.0 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.98 174.71 8.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.202 1.001 . . . . 0.0 109.437 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -68.41 -21.78 64.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.85 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -83.08 4.24 27.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.103 0.561 . . . . 0.0 111.792 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.62 -2.42 73.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.622 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.2 p -90.82 163.02 14.58 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.074 0.937 . . . . 0.0 110.222 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.3 m -81.28 153.41 27.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.032 -0.417 . . . . 0.0 111.114 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 89.5 p -71.18 -8.88 56.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -130.65 142.79 50.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.386 1.074 . . . . 0.0 109.036 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -153.21 157.38 40.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.721 0.408 . . . . 0.0 110.278 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.31 148.46 50.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.77 0.828 . . . . 0.0 109.812 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -137.2 14.93 3.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.999 0.52 . . . . 0.0 111.583 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.1 p -68.41 -5.35 18.58 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -88.59 -2.42 58.58 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.727 0.411 . . . . 0.0 111.228 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.4 m -89.15 11.17 19.37 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.42 0.688 . . . . 0.0 111.933 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -75.89 31.21 0.11 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.83 0.852 . . . . 0.0 112.617 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -136.28 41.85 2.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.918 0.887 . . . . 0.0 109.493 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -118.32 -174.68 2.71 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.714 0.806 . . . . 0.0 110.531 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -64.42 -18.79 65.06 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -171.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -149.41 10.49 0.76 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 119.474 1.034 . . . . 0.0 112.886 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.4 p -86.27 2.71 46.18 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 121.951 -0.468 . . . . 0.0 111.301 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 5.0 t -139.67 141.96 29.85 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.35 -10.63 29.33 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.233 2.622 . . . . 0.0 113.765 -172.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -88.92 -26.48 21.54 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.028 0.831 . . . . 0.0 111.381 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -90.47 -27.0 19.53 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.978 0.353 . . . . 0.0 110.853 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.36 -6.76 31.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.696 0.398 . . . . 0.0 111.875 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -89.49 -0.94 57.85 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.995 0.518 . . . . 0.0 111.38 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -127.11 8.15 6.64 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.826 0.85 . . . . 0.0 111.333 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -139.53 171.92 13.55 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.436 0.694 . . . . 0.0 110.071 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -140.39 157.99 44.7 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.63 137.81 45.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -148.69 160.85 42.77 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 121.194 0.521 . . . . 0.0 111.436 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -82.48 167.59 29.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 124.936 1.295 . . . . 0.0 109.991 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -49.82 125.67 14.93 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.099 2.533 . . . . 0.0 111.62 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.2 m -124.07 23.85 8.37 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.621 0.768 . . . . 0.0 112.292 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.6 m120 61.65 8.18 2.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.219 1.008 . . . . 0.0 113.52 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.98 146.27 20.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.851 0.86 . . . . 0.0 108.902 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.36 151.58 42.37 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.973 0.509 . . . . 0.0 110.667 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.465 ' CE1' ' HB3' ' A' ' 580' ' ' SER . 0.3 OUTLIER -126.03 143.55 51.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -129.7 152.04 49.64 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.416 0.15 . . . . 0.0 110.829 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -150.12 172.27 15.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.815 0.446 . . . . 0.0 111.246 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.18 30.19 19.91 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.766 0.826 . . . . 0.0 112.791 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -94.16 153.98 40.6 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -56.55 150.87 49.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.732 2.288 . . . . 0.0 111.937 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -70.03 -0.98 8.53 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.96 6.95 23.58 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.41 151.61 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.964 -0.46 . . . . 0.0 110.826 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 59.9 p -143.73 171.39 14.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.421 0.689 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.32 -24.48 67.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.683 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.08 -22.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.187 -0.321 . . . . 0.0 110.447 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -81.35 -29.23 34.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.76 -25.13 58.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.054 -0.404 . . . . 0.0 110.875 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -80.96 -37.72 28.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.107 0.412 . . . . 0.0 111.246 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -76.34 -21.75 55.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.076 0.398 . . . . 0.0 111.199 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 64.0 mt -82.02 -37.77 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.2 m -66.82 -25.78 66.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.852 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.14 -30.16 64.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.77 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -91.06 -11.91 37.3 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.405 0.548 . . . . 0.0 111.818 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.7 mt -91.36 -10.32 41.62 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.991 0.517 . . . . 0.0 110.992 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.04 71.09 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.747 -0.474 . . . . 0.0 112.33 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.0 m -94.96 167.75 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 117.683 0.742 . . . . 0.0 110.438 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.42 147.41 27.88 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.91 0.386 . . . . 0.0 111.12 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -82.23 157.18 68.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.789 0.835 . . . . 0.0 111.25 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.16 155.16 69.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.414 2.743 . . . . 0.0 110.327 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.457 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -86.0 -24.9 26.27 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.716 0.406 . . . . 0.0 110.93 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 22.0 t -144.04 152.46 41.03 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -140.34 142.71 30.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.06 0.544 . . . . 0.0 109.975 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 129.52 21.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.39 147.8 32.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.826 0.451 . . . . 0.0 110.785 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -149.74 154.93 39.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.321 0.648 . . . . 0.0 109.947 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.0 m -130.84 135.05 47.36 Favored 'General case' 0 C--O 1.231 0.08 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -81.14 153.34 33.87 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -79.66 143.61 34.48 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.548 -0.384 . . . . 0.0 110.26 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 36.9 m 54.22 19.37 2.15 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.621 0.768 . . . . 0.0 112.772 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -111.89 -16.84 13.05 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.036 0.534 . . . . 0.0 111.42 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 50.19 33.63 7.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.75 0.82 . . . . 0.0 112.162 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.5 t -145.33 162.23 37.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.622 0.369 . . . . 0.0 110.987 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 45.8 t -131.0 154.76 47.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.976 0.91 . . . . 0.0 111.435 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.9 p -149.39 171.21 16.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.073 1.349 . . . . 0.0 109.063 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.89 37.82 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.739 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.72 150.86 48.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.367 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.57 133.18 39.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -127.65 108.22 10.58 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.457 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -165.98 154.01 10.69 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.705 1.602 . . . . 0.0 106.926 167.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.21 122.75 7.92 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 548' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 551' ' ' ASP . 46.3 t -159.56 153.37 23.01 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.007 1.723 . . . . 0.0 106.504 168.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.44 -54.72 39.82 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.322 0.51 . . . . 0.0 111.572 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.6 p -87.34 -21.5 25.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 551' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 548' ' ' SER . 10.9 t70 -79.67 -36.67 37.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.243 0.474 . . . . 0.0 110.801 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.56 -32.63 28.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.675 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.73 -27.32 60.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.991 0.359 . . . . 0.0 110.75 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.91 -43.96 33.54 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.037 -0.414 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 95.7 m -70.44 -31.05 68.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 556' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.0 tm? -65.25 -42.16 93.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.56 -28.67 69.01 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.364 -0.686 . . . . 0.0 112.81 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.13 -13.43 15.44 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.0 -23.48 14.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.411 1.005 . . . . 0.0 112.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -69.95 142.35 52.9 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 48.96 35.29 6.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.817 0.847 . . . . 0.0 113.025 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -95.96 151.39 19.47 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -92.14 136.34 33.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.286 1.434 . . . . 0.0 111.324 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.2 ttt -64.36 176.0 1.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.251 0.62 . . . . 0.0 111.828 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -71.86 6.54 1.98 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -67.34 142.79 96.92 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.667 0.667 . . . . 0.0 110.6 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.45 -29.74 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.464 2.776 . . . . 0.0 113.672 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -120.58 1.01 10.58 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.968 0.349 . . . . 0.0 111.744 -174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.439 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.77 40.81 98.66 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.749 -1.029 . . . . 0.0 113.092 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 78.8 Cg_endo -69.16 -10.55 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.852 2.368 . . . . 0.0 111.993 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -144.24 147.57 37.77 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.053 0.541 . . . . 0.0 109.807 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.48 153.07 39.26 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.52 2.813 . . . . 0.0 111.3 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -149.03 -0.84 0.5 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.174 0.589 . . . . 0.0 111.583 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 10.2 t -66.49 124.86 23.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.521 -0.737 . . . . 0.0 109.687 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 575' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.8 pt? -124.99 144.56 50.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 0.0 110.939 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -82.66 147.6 28.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 49.5 tp -139.68 144.91 37.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.5 p -163.81 167.06 21.31 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -84.63 125.66 32.67 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 501' ' ' HIS . 31.8 t -135.69 148.79 49.03 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 85.0 m -79.53 105.43 10.83 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.556 0.217 . . . . 0.0 110.762 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.17 161.45 34.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.016 0.927 . . . . 0.0 109.75 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -126.67 -1.57 6.73 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.592 0.357 . . . . 0.0 110.996 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -148.82 161.62 41.46 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.881 0.872 . . . . 0.0 110.031 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.48 0.99 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.32 -1.324 . . . . 0.0 110.163 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 119.618 -0.229 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 55.98 15.2 1.65 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.502 1.121 . . . . 0.0 113.455 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 162.04 160.38 10.95 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.19 -168.23 0.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.45 3.434 . . . . 0.0 110.326 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -105.63 145.58 30.83 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -70.63 152.84 43.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.002 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.88 -8.67 55.49 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.504 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 40.7 m -148.06 152.48 40.02 Favored Pre-proline 0 N--CA 1.456 -0.146 0 C-N-CA 122.657 0.383 . . . . 0.0 111.205 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -83.57 0.28 9.49 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.276 3.318 . . . . 0.0 112.816 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.16 164.37 33.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.697 0.681 . . . . 0.0 112.465 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.28 164.16 35.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.087 0.955 . . . . 0.0 108.933 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 79.4 mtp -133.29 150.85 51.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.642 0.377 . . . . 0.0 110.811 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.92 149.15 23.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.868 0.467 . . . . 0.0 110.638 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -139.38 163.98 31.07 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.648 0.779 . . . . 0.0 110.113 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.34 -2.86 69.45 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.734 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.627 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.64 171.76 11.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.021 0.911 . . . . 0.0 110.98 178.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -126.09 137.4 53.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.688 0.395 . . . . 0.0 110.016 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -67.82 -7.86 31.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 60.9 p -99.11 -8.78 24.72 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -134.35 -8.46 2.57 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.174 0.443 . . . . 0.0 111.317 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.5 tpt -147.97 108.34 4.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.142 0.577 . . . . 0.0 109.588 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.452 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 51.4 p-10 -141.91 -173.12 3.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.328 0.651 . . . . 0.0 109.884 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 24.4 p -56.03 -27.66 54.08 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.864 0.466 . . . . 0.0 112.154 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.05 -37.96 21.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.071 -0.393 . . . . 0.0 110.891 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ARG . . . . . 0.452 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 7.8 mpt_? -75.76 -29.81 58.95 Favored 'General case' 0 C--O 1.23 0.041 0 O-C-N 122.206 -0.309 . . . . 0.0 110.805 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.42 -30.75 26.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -73.91 -27.48 61.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.642 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.16 -26.54 59.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.849 -0.532 . . . . 0.0 111.703 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.3 -24.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -106.24 -10.92 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.785 0.721 . . . . 0.0 112.846 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.51 -23.21 58.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.767 0.712 . . . . 0.0 111.772 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 402' ' ' LEU . 1.7 pp -77.28 12.56 1.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.631 -0.668 . . . . 0.0 112.263 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -120.74 -5.98 9.66 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.181 0.592 . . . . 0.0 111.088 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 151.85 -179.63 28.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -73.51 150.89 41.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.4 t -118.08 155.17 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.7 -57.45 2.25 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 118.712 0.687 . . . . 0.0 112.006 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' LYS . . . . . 0.426 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.9 pttm -161.72 164.06 29.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.986 0.422 . . . . 0.0 111.782 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.66 150.88 16.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.93 0.892 . . . . 0.0 109.871 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -151.91 145.07 24.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.01 144.5 30.82 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.724 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -126.11 141.54 51.9 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -167.614 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.21 34.08 21.03 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.576 1.55 . . . . 0.0 112.565 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.4 m 53.46 15.06 0.64 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.053 1.341 . . . . 0.0 114.201 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -82.7 136.95 44.49 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 118.444 0.566 . . . . 0.0 109.582 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.86 -9.56 16.9 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.873 2.382 . . . . 0.0 109.571 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.22 19.66 24.47 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.202 0.906 . . . . 0.0 112.977 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.724 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -152.24 143.2 23.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.61 1.205 . . . . 0.0 110.848 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.89 167.61 29.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.846 0.355 . . . . 0.0 111.672 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 24.5 ptm -142.38 146.45 34.94 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.118 0.567 . . . . 0.0 109.812 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.6 154.96 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 122.601 0.361 . . . . 0.0 110.982 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.84 141.71 51.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.846 0.858 . . . . 0.0 110.714 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 66.9 mtp -119.02 163.36 17.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.853 0.461 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.99 67.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.21 164.35 30.48 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.724 0.409 . . . . 0.0 110.159 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.12 -8.09 61.01 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.333 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -69.69 -28.28 65.71 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.55 1.675 . . . . 0.0 110.218 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -87.21 -24.8 24.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.8 t -75.88 -25.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.89 -42.61 73.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.243 -0.285 . . . . 0.0 110.431 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -69.05 -26.81 65.16 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.76 -40.22 33.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.095 -0.378 . . . . 0.0 111.294 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 433' ' ' ILE . 4.4 tp -81.38 -30.99 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.572 0.349 . . . . 0.0 111.902 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -99.9 -20.12 16.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -129.67 -8.59 4.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -174.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.48 -20.92 10.03 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.314 0.961 . . . . 0.0 109.635 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.31 144.79 12.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 58.02 1.38 0.14 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.235 2.214 . . . . 0.0 115.374 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -88.08 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.337 1.426 . . . . 0.0 108.307 168.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.308 0.0 OUTLIER -130.93 163.93 26.42 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 174.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.6 ptm -125.39 143.39 51.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.582 1.553 . . . . 0.0 109.86 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 63.92 32.59 13.09 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.121 1.368 . . . . 0.0 114.551 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.06 15.92 80.85 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.542 -0.588 . . . . 0.0 114.267 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.16 153.97 24.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.124 0.962 . . . . 0.0 110.122 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.578 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -88.85 131.28 35.17 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 175.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.59 130.92 45.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -140.76 113.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.15 139.93 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.415 0.552 . . . . 0.0 110.523 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 84.4 m -149.13 161.54 41.77 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.038 0.935 . . . . 0.0 110.113 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.4 p -82.47 156.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 43.9 t -132.94 157.9 43.99 Favored 'General case' 0 N--CA 1.459 0.024 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -99.57 6.21 45.83 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -65.66 142.59 98.3 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.49 -25.72 10.85 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.942 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.11 15.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 110.066 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.426 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 37.0 mm -69.35 138.57 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.68 151.22 42.13 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 122.395 0.278 . . . . 0.0 110.468 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.33 164.13 36.2 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.606 2.871 . . . . 0.0 110.81 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.87 -177.42 41.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -76.29 155.42 34.3 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.85 0.46 . . . . 0.0 110.032 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.6 p -133.09 165.57 24.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.625 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -147.38 161.16 41.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -83.41 135.29 13.67 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.93 168.85 13.0 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.539 0.735 . . . . 0.0 110.013 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -20.81 64.92 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.343 -0.223 . . . . 0.0 111.224 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.22 0.81 23.65 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 111.267 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.18 -3.15 82.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 123.542 0.591 . . . . 0.0 112.598 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.0 t -93.98 163.57 13.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.603 0.702 . . . . 0.0 110.286 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.42 153.39 21.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.722 0.296 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -66.19 -10.46 41.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.526 0.33 . . . . 0.0 111.601 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -120.62 141.87 49.95 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.141 0.976 . . . . 0.0 109.115 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -151.62 156.87 41.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.619 0.247 . . . . 0.0 110.464 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -126.31 150.16 48.68 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.637 0.775 . . . . 0.0 110.17 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -140.05 12.8 2.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.25 0.62 . . . . 0.0 111.566 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 22.4 t -65.94 -9.67 31.91 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -173.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.88 -6.91 59.52 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.722 0.409 . . . . 0.0 110.858 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.6 m -87.21 13.53 9.41 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.621 0.768 . . . . 0.0 111.833 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -73.87 12.35 0.7 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.394 0.678 . . . . 0.0 112.44 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -103.16 4.54 37.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.812 0.845 . . . . 0.0 111.476 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -73.75 153.66 39.92 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.749 -0.595 . . . . 0.0 110.078 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.0 7.12 4.34 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.39 0.676 . . . . 0.0 112.257 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -138.44 29.38 2.43 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.558 0.743 . . . . 0.0 111.05 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 39.2 m -76.8 2.61 13.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.97 0.508 . . . . 0.0 112.338 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 52.7 p -134.37 154.65 79.97 Favored Pre-proline 0 C--O 1.231 0.089 0 C-N-CA 123.052 0.541 . . . . 0.0 109.877 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.85 -11.12 31.05 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.14 2.56 . . . . 0.0 111.767 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.11 -32.69 14.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.032 0.378 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -90.46 -19.17 24.18 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 122.174 -0.329 . . . . 0.0 110.894 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -67.51 -16.05 63.99 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.062 -0.399 . . . . 0.0 111.12 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -81.33 -2.39 48.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.91 0.484 . . . . 0.0 111.544 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -115.96 9.21 14.84 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.756 0.823 . . . . 0.0 111.109 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -130.65 20.87 5.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.58 0.752 . . . . 0.0 111.122 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 51.99 45.5 28.2 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.956 0.903 . . . . 0.0 112.635 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 51.5 mm -81.0 93.93 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -156.59 -171.49 3.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.848 0.859 . . . . 0.0 109.96 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -60.95 159.72 25.41 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.215 0.606 . . . . 0.0 110.544 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.19 147.69 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.372 2.715 . . . . 0.0 112.93 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 55.7 m -124.0 19.4 9.22 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.34 0.656 . . . . 0.0 111.169 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.28 3.81 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.179 1.392 . . . . 0.0 114.591 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 37.0 t -141.54 147.38 22.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.475 HD12 ' CH2' ' A' ' 546' ' ' TRP . 53.2 mt -121.8 163.38 19.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.895 0.478 . . . . 0.0 110.457 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.58 158.66 43.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.566 0.346 . . . . 0.0 110.807 174.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -137.59 153.83 49.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.407 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -148.39 169.65 19.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.143 0.577 . . . . 0.0 110.33 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 15.8 t30 62.51 18.92 10.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.877 0.871 . . . . 0.0 113.324 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -77.52 164.63 56.92 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.48 152.91 37.59 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.728 2.285 . . . . 0.0 111.995 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.51 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -74.66 -1.77 23.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.838 0.455 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -125.13 16.78 8.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.496 0.719 . . . . 0.0 111.421 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.64 151.32 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 122.019 -0.426 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 74.7 p -141.75 170.46 15.67 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 123.125 0.57 . . . . 0.0 110.69 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.2 -22.6 66.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.98 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.91 -24.48 48.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.205 -0.309 . . . . 0.0 110.493 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.44 -32.04 37.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -73.41 -29.88 62.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.235 -0.291 . . . . 0.0 110.747 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -77.88 -37.28 48.43 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.149 0.431 . . . . 0.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.91 -25.23 43.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.859 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.91 -40.66 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.4 m -65.11 -29.01 69.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.277 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.21 -29.3 61.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.854 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.98 -10.94 40.48 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.415 0.552 . . . . 0.0 112.014 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 85.2 mt -91.1 -3.71 56.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.758 0.423 . . . . 0.0 110.768 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.9 80.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.779 -0.456 . . . . 0.0 112.499 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -112.81 172.14 3.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.524 0.662 . . . . 0.0 111.403 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.18 149.19 41.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.207 0.603 . . . . 0.0 110.073 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -98.06 151.55 37.6 Favored Pre-proline 0 CA--C 1.528 0.13 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.54 147.17 93.22 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.788 2.325 . . . . 0.0 110.492 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.416 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.3 m -82.71 -28.4 30.54 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 122.938 0.495 . . . . 0.0 110.997 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -140.32 147.32 39.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 2.4 p -154.36 144.63 13.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 122.744 0.418 . . . . 0.0 110.799 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -149.2 156.47 42.2 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.354 0.662 . . . . 0.0 109.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.59 145.51 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.416 0.686 . . . . 0.0 109.23 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -150.63 142.52 23.86 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.735 0.302 . . . . 0.0 110.95 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p -130.78 50.61 2.2 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.366 0.666 . . . . 0.0 111.555 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -73.66 -13.06 80.58 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.889 -0.507 . . . . 0.0 111.837 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -155.07 169.86 23.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.122 1.369 . . . . 0.0 108.307 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 18.4 m 58.31 29.58 18.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.13 0.423 . . . . 0.0 110.962 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.19 -9.92 1.09 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.695 1.598 . . . . 0.0 114.821 -169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -67.58 -10.99 56.97 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.045 0.839 . . . . 0.0 110.38 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 59.3 m -148.9 -178.1 6.17 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.882 1.673 . . . . 0.0 108.784 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 8.6 t -140.26 160.86 39.02 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.116 -0.365 . . . . 0.0 110.981 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.8 m -146.35 164.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.698 0.799 . . . . 0.0 110.741 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 176.2 -166.52 37.65 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.591 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 63.3 mt -120.62 155.65 33.31 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.437 0.695 . . . . 0.0 111.265 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 91.9 mt -140.31 132.19 27.6 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.012 0.925 . . . . 0.0 108.816 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -127.89 119.48 25.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.475 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.6 p90 -166.05 150.47 8.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.385 1.474 . . . . 0.0 107.08 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -145.84 110.39 5.09 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -172.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.0 t -159.5 153.0 22.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -67.33 -42.02 84.28 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.528 0.604 . . . . 0.0 110.437 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 31.6 m -83.92 -30.55 26.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.808 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.81 -30.21 26.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.69 0.677 . . . . 0.0 111.48 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.73 -30.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.162 0.437 . . . . 0.0 111.316 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 29.8 tp -83.55 -29.29 27.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.879 0.763 . . . . 0.0 111.793 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.4 -42.67 43.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.256 0.48 . . . . 0.0 110.02 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 55.5 m -68.99 -31.85 71.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.9 -41.84 58.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.01 -19.99 75.9 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.366 -0.686 . . . . 0.0 113.115 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.71 -11.65 13.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.326 1.063 . . . . 0.0 113.052 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 30.4 tp -104.97 -16.88 14.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.087 0.858 . . . . 0.0 112.386 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -72.59 143.81 48.1 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.748 -0.595 . . . . 0.0 109.545 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 51.11 21.18 0.98 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.879 0.872 . . . . 0.0 113.128 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -78.43 151.44 32.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.11 136.38 50.24 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.095 1.358 . . . . 0.0 109.181 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 49.9 ttm -64.24 162.15 15.2 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.252 0.549 . . . . 0.0 110.915 -173.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -66.69 15.66 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.866 1.666 . . . . 0.0 114.055 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -65.09 152.86 90.46 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.75 -46.89 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.728 2.286 . . . . 0.0 113.951 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -121.13 16.19 11.55 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.94 47.91 84.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.088 -0.84 . . . . 0.0 112.761 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 -10.09 21.97 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.147 2.565 . . . . 0.0 111.122 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -148.55 149.49 31.36 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 123.829 0.852 . . . . 0.0 109.603 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.86 156.37 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.577 2.851 . . . . 0.0 111.632 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 573' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 573' ' ' TYR . 79.6 t80 -144.79 1.27 1.0 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.849 0.86 . . . . 0.0 110.588 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 57.3 m -66.44 116.53 7.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 575' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.7 pt? -124.89 144.53 50.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.508 0.723 . . . . 0.0 111.961 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.05 143.59 31.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.6 mt -131.21 144.73 51.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 36.8 t -163.8 176.34 9.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.34 145.31 28.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.928 0.491 . . . . 0.0 110.933 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 35.0 t -135.54 147.22 48.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.094 0.558 . . . . 0.0 110.112 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 25.4 m -89.61 102.13 14.81 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.62 34.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.598 0.759 . . . . 0.0 110.293 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -96.43 -21.52 17.7 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -164.26 153.81 14.0 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.073 0.949 . . . . 0.0 109.962 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -109.97 76.32 0.98 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.465 -1.255 . . . . 0.0 110.631 178.58 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 39.5 t80 52.72 26.1 4.24 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.595 0.758 . . . . 0.0 112.285 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -172.51 -170.49 36.37 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.51 166.77 1.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.863 3.709 . . . . 0.0 113.841 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 57.26 52.32 8.99 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.1 0.96 . . . . 0.0 111.795 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -58.09 156.37 9.61 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.81 0.444 . . . . 0.0 110.42 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.19 6.44 5.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.826 0.451 . . . . 0.0 111.946 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.4 m -142.92 146.03 35.77 Favored Pre-proline 0 C--O 1.232 0.133 0 O-C-N 121.93 -0.481 . . . . 0.0 111.389 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -82.0 1.8 8.97 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 124.598 3.532 . . . . 0.0 112.834 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.26 146.35 28.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-N 118.374 0.534 . . . . 0.0 110.943 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.4 pp -141.84 167.68 21.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.695 0.798 . . . . 0.0 109.609 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.9 mtp -138.83 151.17 46.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.672 0.273 . . . . 0.0 110.856 -175.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.09 150.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.043 0.537 . . . . 0.0 110.63 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.76 166.52 24.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.489 0.716 . . . . 0.0 109.519 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.08 89.46 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.701 -0.499 . . . . 0.0 112.934 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.765 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.15 175.71 7.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.774 0.787 . . . . 0.0 110.689 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -138.3 142.08 39.8 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.544 0.338 . . . . 0.0 110.103 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -73.94 -2.35 23.61 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.8 p -110.38 -2.68 16.52 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.205 0.457 . . . . 0.0 112.126 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -131.65 -5.72 3.66 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.164 0.586 . . . . 0.0 110.922 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.8 tpt -146.19 123.33 11.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.216 0.606 . . . . 0.0 109.545 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.454 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 22.5 m120 -141.94 176.26 9.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.883 0.873 . . . . 0.0 109.082 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 81.6 m -59.54 -25.97 64.96 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.225 -0.297 . . . . 0.0 110.94 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.14 -23.12 26.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.255 -0.278 . . . . 0.0 111.593 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ARG . . . . . 0.454 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 49.0 mmt-85 -82.16 -31.3 30.57 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.418 0.554 . . . . 0.0 109.586 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.43 -30.0 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.94 -30.89 68.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -71.96 -32.03 66.87 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.94 -0.475 . . . . 0.0 110.889 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.3 t -88.03 -27.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -104.95 -8.41 18.62 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.36 -39.46 78.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.825 0.739 . . . . 0.0 110.967 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.03 14.96 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.936 -0.478 . . . . 0.0 112.145 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.31 -1.89 9.63 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.188 0.595 . . . . 0.0 111.067 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.83 174.19 19.48 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -74.71 136.03 41.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.317 -0.52 . . . . 0.0 110.957 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 474' ' ' PHE . 7.7 m -94.44 164.52 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 124.571 1.148 . . . . 0.0 110.365 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -129.91 -63.34 0.92 Allowed 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.261 0.224 . . . . 0.0 110.884 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -163.32 166.04 23.48 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.771 0.429 . . . . 0.0 111.353 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.54 153.27 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.553 0.741 . . . . 0.0 110.625 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -149.65 145.06 26.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -77.47 155.2 31.87 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.521 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 8.3 ttm -107.78 141.11 39.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -168.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 48.72 33.99 4.77 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.217 1.007 . . . . 0.0 112.64 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.9 m 53.03 17.64 0.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.828 0.851 . . . . 0.0 113.099 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.66 147.77 53.07 Favored Pre-proline 0 N--CA 1.455 -0.204 0 CA-C-N 118.023 0.374 . . . . 0.0 110.428 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -81.61 -1.63 11.07 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.43 2.753 . . . . 0.0 110.427 170.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -124.54 17.28 7.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.587 -173.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.521 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -149.79 143.91 25.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.747 1.274 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.95 168.66 26.83 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.8 ptm -141.6 145.14 34.67 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.427 0.691 . . . . 0.0 109.946 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 14.6 t -131.95 150.96 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 122.746 0.418 . . . . 0.0 110.838 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -128.24 143.26 51.02 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.389 0.675 . . . . 0.0 110.311 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 81.3 mmm -117.1 162.64 17.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.434 0.694 . . . . 0.0 109.323 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -73.25 -19.28 61.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.055 -0.403 . . . . 0.0 111.921 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -156.62 162.5 39.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.776 0.43 . . . . 0.0 110.172 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.64 -17.95 73.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.458 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -67.49 -26.52 66.4 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.976 1.388 . . . . 0.0 110.172 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.57 -24.17 45.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.416 0.286 . . . . 0.0 110.621 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.25 -31.81 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.75 -32.38 73.9 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -82.22 -30.5 30.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.349 0.26 . . . . 0.0 111.681 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.59 -28.22 31.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.33 0.514 . . . . 0.0 111.073 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.4 tp -82.59 -31.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.918 0.487 . . . . 0.0 110.992 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.0 m -93.74 -21.99 18.99 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -124.24 -13.32 7.24 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.66 -20.47 10.11 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.072 0.851 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -52.28 143.26 15.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.963 0.905 . . . . 0.0 111.497 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 14.3 p30 56.91 1.53 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.004 2.522 . . . . 0.0 115.864 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -88.04 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.183 1.356 . . . . 0.0 108.184 168.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.286 0.0 OUTLIER -130.95 163.95 26.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 176.379 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.7 ptm -125.28 143.44 50.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.162 1.385 . . . . 0.0 109.946 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 65.07 31.57 10.98 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.025 1.33 . . . . 0.0 114.042 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.02 15.86 72.25 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.344 -0.698 . . . . 0.0 114.805 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -83.27 162.05 21.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.427 1.114 . . . . 0.0 110.337 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 131.68 35.66 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.961 0.41 . . . . 0.0 110.527 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.61 132.96 43.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -169.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.68 117.46 11.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.7 139.9 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 118.393 0.542 . . . . 0.0 110.523 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.4 m -150.23 161.98 41.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.982 0.913 . . . . 0.0 110.162 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.9 p -84.82 155.5 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 38.3 t -134.38 142.54 47.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.977 0.353 . . . . 0.0 111.246 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -85.7 65.95 9.4 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.03 0.532 . . . . 0.0 110.43 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -127.81 143.78 48.91 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.18 -26.54 6.25 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.878 2.386 . . . . 0.0 111.805 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.02 170.51 15.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.558 0.343 . . . . 0.0 111.031 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.1 mm -71.62 147.02 11.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.33 151.98 41.07 Favored Pre-proline 0 C--O 1.231 0.128 0 C-N-CA 122.416 0.286 . . . . 0.0 110.239 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.41 164.49 32.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.673 2.915 . . . . 0.0 111.874 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 171.21 -174.35 44.87 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -74.12 148.85 41.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.844 0.322 . . . . 0.0 110.25 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 24.9 m -142.59 160.89 39.42 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.249 0.62 . . . . 0.0 109.919 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -150.91 164.23 36.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.463 0.305 . . . . 0.0 110.568 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.14 135.27 16.27 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.95 169.5 12.42 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.539 0.736 . . . . 0.0 109.702 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.15 -20.31 65.73 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.081 -0.387 . . . . 0.0 111.376 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.0 -0.9 26.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.962 0.505 . . . . 0.0 111.283 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 85.73 -7.58 76.32 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.635 0.636 . . . . 0.0 112.783 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.7 m -93.83 156.19 16.79 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 117.896 0.848 . . . . 0.0 110.397 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 47.5 t -77.44 153.26 33.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.398 0.279 . . . . 0.0 110.261 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -68.14 -10.42 53.96 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.249 0.619 . . . . 0.0 111.678 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -123.48 136.27 54.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.11 0.964 . . . . 0.0 109.297 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -155.72 159.26 39.35 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -125.0 157.4 36.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.927 0.891 . . . . 0.0 110.454 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' A' ' 406' ' ' VAL . 24.5 m-85 -139.56 13.53 2.54 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.6 p -69.81 1.72 4.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -85.36 11.95 9.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.693 0.797 . . . . 0.0 110.686 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 77.4 p -72.06 22.29 0.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.222 1.409 . . . . 0.0 112.587 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -76.07 30.84 0.11 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.025 0.93 . . . . 0.0 112.66 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -134.0 31.13 3.6 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.747 0.819 . . . . 0.0 110.533 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -138.45 172.76 12.42 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.838 0.455 . . . . 0.0 110.682 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -62.55 -13.73 34.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.12 0.968 . . . . 0.0 112.632 -174.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.93 24.89 11.64 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.662 0.385 . . . . 0.0 111.984 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 41.3 t -60.6 -23.08 64.42 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.032 0.533 . . . . 0.0 111.365 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 72.5 p -137.16 155.84 75.79 Favored Pre-proline 0 N--CA 1.456 -0.13 0 C-N-CA 123.564 0.745 . . . . 0.0 109.389 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -70.54 -9.02 24.95 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.183 2.589 . . . . 0.0 111.517 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.13 -30.02 16.19 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.872 0.305 . . . . 0.0 110.707 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -90.43 -24.75 20.65 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.36 -13.83 62.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.288 0.235 . . . . 0.0 110.733 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.38 3.09 37.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.156 0.582 . . . . 0.0 111.131 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -118.47 22.28 12.17 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.948 0.899 . . . . 0.0 110.887 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -78.84 171.68 14.84 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.745 0.418 . . . . 0.0 111.812 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -135.51 37.87 2.9 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.653 0.781 . . . . 0.0 109.823 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 46.6 mm -80.97 130.87 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 O-C-N 122.034 -0.417 . . . . 0.0 110.008 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -156.64 -174.04 4.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.592 0.757 . . . . 0.0 110.031 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -61.43 163.82 10.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.139 0.975 . . . . 0.0 110.828 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.22 143.06 20.12 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.23 2.62 . . . . 0.0 112.258 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 51.3 m -119.77 23.58 11.03 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.261 0.624 . . . . 0.0 112.259 -172.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 61.96 -7.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.42 1.488 . . . . 0.0 114.098 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.72 147.65 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.757 0.708 . . . . 0.0 109.661 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.416 HD12 ' CH2' ' A' ' 546' ' ' TRP . 59.5 mt -119.1 151.64 37.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.786 0.434 . . . . 0.0 110.222 177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -119.55 155.41 32.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.25 149.91 44.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.333 0.253 . . . . 0.0 110.524 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -145.78 169.28 18.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.747 0.419 . . . . 0.0 110.987 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 46.4 t30 56.68 33.12 22.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.994 0.918 . . . . 0.0 112.843 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.82 163.74 39.74 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.94 151.0 68.64 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.007 2.472 . . . . 0.0 111.847 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -75.27 -1.19 22.38 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.34 9.59 11.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.899 0.48 . . . . 0.0 111.919 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.6 149.49 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 118.019 0.372 . . . . 0.0 111.058 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.8 p -142.07 173.98 11.02 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.536 0.735 . . . . 0.0 110.265 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.63 -21.74 65.9 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.77 -22.08 58.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.234 -0.291 . . . . 0.0 110.407 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -83.25 -32.17 26.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.86 -27.63 63.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -84.53 -37.54 21.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.135 0.425 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -76.03 -21.28 57.01 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.756 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.6 mt -92.1 -36.14 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.922 0.328 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 18.2 p -70.31 -20.85 62.98 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.47 -29.03 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.567 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.99 -12.93 34.41 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.447 0.567 . . . . 0.0 111.333 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.06 -9.58 55.1 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.716 0.406 . . . . 0.0 110.838 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.22 11.08 82.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.765 -0.464 . . . . 0.0 112.803 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.5 m -98.8 169.82 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.103 0 CA-C-N 117.738 0.769 . . . . 0.0 111.291 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.54 151.68 42.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.343 0.657 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -101.04 151.98 37.76 Favored Pre-proline 0 C--O 1.231 0.111 0 C-N-CA 122.729 0.412 . . . . 0.0 109.899 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.31 153.38 78.26 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.962 2.442 . . . . 0.0 110.471 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 80.6 m -86.14 -24.84 26.05 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.621 0.368 . . . . 0.0 110.53 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -142.84 150.35 39.78 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.168 0.587 . . . . 0.0 109.599 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.55 147.97 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 120.872 0.368 . . . . 0.0 110.387 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -142.28 132.26 24.46 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.91 142.4 39.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -154.24 150.65 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 110.468 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m -130.82 133.2 45.74 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.05 158.0 45.7 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -71.22 130.55 41.72 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 26.3 m 55.68 15.31 1.52 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -86.54 -15.4 40.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.707 0.685 . . . . 0.0 111.328 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 49.42 29.28 2.77 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.967 0.907 . . . . 0.0 112.757 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.2 t -149.52 162.88 39.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.922 0.489 . . . . 0.0 110.433 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 42.2 t -124.82 152.59 43.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.47 0.708 . . . . 0.0 111.519 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 52.5 m -147.73 165.26 31.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.73 1.212 . . . . 0.0 108.93 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.81 -165.88 37.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.745 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -127.41 156.28 42.32 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.755 0.822 . . . . 0.0 110.351 -176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.86 133.62 30.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.482 1.113 . . . . 0.0 108.004 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.83 113.3 15.77 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.416 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.9 p90 -166.02 151.35 8.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 168.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -150.77 116.2 5.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 35.2 t -159.41 152.92 22.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.93 -38.0 79.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.746 0.703 . . . . 0.0 111.432 -174.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 47.4 m -87.78 -28.6 21.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -85.37 -28.32 25.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.414 0.552 . . . . 0.0 111.12 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.17 -34.42 37.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 117.949 0.341 . . . . 0.0 110.397 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.88 -30.73 45.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.439 0.563 . . . . 0.0 112.016 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -72.72 -43.73 62.6 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.261 0.482 . . . . 0.0 109.979 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 44.4 m -69.27 -40.26 77.91 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -42.79 98.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.901 -0.499 . . . . 0.0 109.864 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.15 -21.57 77.11 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.86 -0.966 . . . . 0.0 113.447 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -117.68 -14.97 10.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.857 1.329 . . . . 0.0 113.276 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 17.4 tp -88.22 -21.93 24.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.347 0.976 . . . . 0.0 110.623 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -76.49 151.32 36.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 39.8 t60 55.91 22.66 5.89 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.64 151.46 37.77 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.194 0.598 . . . . 0.0 112.537 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -110.78 136.18 50.23 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.06 0.944 . . . . 0.0 111.433 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.25 176.83 0.94 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.076 0.95 . . . . 0.0 111.417 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.9 10.71 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.709 0.803 . . . . 0.0 112.459 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.04 146.71 87.43 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 123.288 0.635 . . . . 0.0 111.051 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.92 -40.63 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.134 2.556 . . . . 0.0 112.734 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -120.96 2.38 10.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 65.82 60.26 6.71 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.767 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.67 -8.5 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.322 2.681 . . . . 0.0 110.984 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.45 151.03 46.16 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 123.576 0.75 . . . . 0.0 109.74 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.58 154.33 39.75 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.637 2.892 . . . . 0.0 110.356 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -133.16 -4.58 3.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.8 t -66.55 131.95 47.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.668 -0.645 . . . . 0.0 110.653 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 575' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 575' ' ' LEU . 1.8 pp -116.43 144.67 44.01 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.373 0.669 . . . . 0.0 110.79 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.64 138.09 39.85 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.03 155.89 43.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 111.412 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.9 p -163.76 167.98 20.27 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.23 131.61 39.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 26.2 t -135.64 150.13 49.53 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.521 0.201 . . . . 0.0 111.247 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.2 m -84.77 102.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.16 161.63 34.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.742 0.817 . . . . 0.0 110.061 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -109.75 -11.9 14.68 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.422 0.289 . . . . 0.0 111.634 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -160.52 162.83 33.11 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.079 0.552 . . . . 0.0 109.995 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -95.83 76.5 3.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.268 0.627 . . . . 0.0 109.717 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.252 1.204 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.222 -179.677 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 119.587 -0.244 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -80.41 -27.08 38.13 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.981 0.355 . . . . 0.0 110.582 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -96.66 -150.09 26.41 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 172.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -54.1 164.09 2.86 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.915 3.077 . . . . 0.0 112.278 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 54.14 91.72 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.861 1.264 . . . . 0.0 112.389 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -71.54 159.72 33.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.56 0.344 . . . . 0.0 110.495 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -142.32 14.46 2.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.044 0.538 . . . . 0.0 111.192 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.1 m -141.38 150.11 56.9 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 122.126 -0.359 . . . . 0.0 111.379 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.39 -5.6 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.137 3.225 . . . . 0.0 111.98 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.89 151.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 122.832 0.453 . . . . 0.0 111.276 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.42 167.88 21.88 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.71 0.804 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 74.6 mtp -133.61 150.41 51.61 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.359 0.264 . . . . 0.0 111.316 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.05 151.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.161 0.584 . . . . 0.0 110.603 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -140.05 164.95 28.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.472 0.709 . . . . 0.0 109.637 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 78.94 -2.69 67.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.384 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.8 pt? -71.41 134.64 46.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.988 0.894 . . . . 0.0 109.794 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -83.48 122.65 28.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -75.03 6.79 3.79 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.9 p -116.0 -1.02 12.6 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.788 0.435 . . . . 0.0 111.658 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -130.3 -9.09 4.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.791 0.836 . . . . 0.0 110.472 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 11.0 tpt -139.86 128.08 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.24 1.016 . . . . 0.0 108.785 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -141.92 -172.92 3.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.132 0.573 . . . . 0.0 109.822 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.22 -22.65 64.97 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.19 -33.27 20.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.964 -0.46 . . . . 0.0 110.851 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 41.2 mmt-85 -81.66 -25.35 35.64 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.275 -0.266 . . . . 0.0 110.987 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.43 -30.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.018 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.22 -25.49 63.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -75.09 -39.81 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.14 -0.35 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.3 -20.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.994 -0.441 . . . . 0.0 111.979 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -109.81 -18.02 13.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.65 -21.6 57.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.16 0.891 . . . . 0.0 111.499 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.404 ' C ' HD12 ' A' ' 402' ' ' LEU . 1.1 pp -72.23 7.3 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.705 -0.622 . . . . 0.0 112.469 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -121.62 -1.85 9.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.538 0.735 . . . . 0.0 111.41 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.96 173.31 20.21 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -68.28 146.97 52.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.346 -0.502 . . . . 0.0 111.23 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.51 155.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.783 0.833 . . . . 0.0 108.813 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -101.02 -65.37 0.97 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -163.31 164.41 24.86 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.595 0.758 . . . . 0.0 110.232 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 11.2 p -144.2 151.27 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 C-N-CA 123.116 0.566 . . . . 0.0 110.437 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.07 139.77 19.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.924 0.14 . . . . 0.0 111.282 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.71 152.3 28.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -133.86 141.42 47.39 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 60.0 33.74 21.4 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 126.472 1.909 . . . . 0.0 114.231 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.1 m 52.84 16.0 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -72.0 158.38 87.77 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.613 0.642 . . . . 0.0 110.712 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.77 -22.4 44.67 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.223 2.615 . . . . 0.0 112.023 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -171.06 97.9 0.13 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -158.67 134.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -153.89 168.31 26.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.367 0.603 . . . . 0.0 112.462 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.9 ptp -139.63 145.34 38.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.147 0.979 . . . . 0.0 109.038 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.07 146.6 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.949 0.404 . . . . 0.0 110.617 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -124.94 146.41 49.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 109.866 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 75.3 mtp -122.35 164.12 18.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.793 0.437 . . . . 0.0 110.431 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.93 61.87 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -156.93 158.04 35.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.051 0.387 . . . . 0.0 110.181 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.13 80.67 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.116 -0.824 . . . . 0.0 113.578 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -69.17 -25.77 64.52 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.198 1.499 . . . . 0.0 110.839 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.29 -25.24 27.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.14 -27.51 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.25 -37.33 77.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.324 -0.235 . . . . 0.0 110.449 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -71.96 -30.79 65.65 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.84 57.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.314 -0.241 . . . . 0.0 111.078 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.2 tp -83.65 -30.9 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.6 m -99.02 -16.27 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.93 -6.68 2.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.62 -20.57 10.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.251 0.932 . . . . 0.0 109.56 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -52.77 142.32 19.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.044 0.938 . . . . 0.0 110.872 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.09 1.28 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.101 2.16 . . . . 0.0 115.659 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -87.84 142.52 27.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 120.242 1.383 . . . . 0.0 108.507 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -130.84 164.06 26.03 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.2 ptm -125.43 143.47 50.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.991 1.316 . . . . 0.0 108.985 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 67.01 25.7 9.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.05 80.54 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 168.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -83.06 159.77 22.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.014 1.407 . . . . 0.0 110.65 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 141.93 32.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.19 0.596 . . . . 0.0 111.025 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -98.22 124.15 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -140.68 111.3 6.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 169.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.09 140.2 17.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 CA-C-N 118.118 0.417 . . . . 0.0 109.957 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 96.8 m -149.47 159.94 43.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.775 0.83 . . . . 0.0 110.352 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.0 p -80.12 160.4 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 46.2 t -134.29 168.47 18.84 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 122.811 0.444 . . . . 0.0 110.515 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.08 12.71 11.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.566 0.746 . . . . 0.0 112.337 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.05 147.06 99.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.39 -36.5 77.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.81 2.34 . . . . 0.0 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.01 173.69 6.77 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.622 0.769 . . . . 0.0 110.047 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.4 mm -68.77 144.69 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.6 mtt -105.55 146.66 33.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 117.646 0.203 . . . . 0.0 110.994 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.2 172.85 15.55 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.253 3.302 . . . . 0.0 111.457 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.06 46.82 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.377 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 55.15 21.78 4.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.04 0.936 . . . . 0.0 112.857 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.5 p -79.42 153.93 29.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.716 0.293 . . . . 0.0 110.928 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -154.09 163.45 40.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.146 0.579 . . . . 0.0 110.343 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.2 136.0 16.56 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.92 169.32 12.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.277 0.631 . . . . 0.0 110.12 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.67 -21.13 66.66 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 110.316 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -77.94 -1.38 31.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.666 0.787 . . . . 0.0 111.452 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.76 70.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.398 0.523 . . . . 0.0 113.16 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.1 m -93.77 163.79 13.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.642 0.721 . . . . 0.0 110.798 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.51 153.33 37.55 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.7 p -70.23 -10.57 59.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -119.68 146.57 45.47 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.593 0.633 . . . . 0.0 112.156 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -157.0 156.12 32.4 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 110.142 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -124.49 152.31 43.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.798 0.839 . . . . 0.0 109.713 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.93 10.04 2.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.013 0.525 . . . . 0.0 111.282 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 94.3 p -67.61 -11.18 57.56 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.72 -3.7 39.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.614 0.366 . . . . 0.0 111.202 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 19.9 t -104.85 18.23 22.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.783 0.833 . . . . 0.0 110.989 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -73.95 0.99 11.8 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.906 -0.496 . . . . 0.0 111.197 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -100.94 6.28 43.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.814 0.446 . . . . 0.0 110.684 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -81.25 166.15 20.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.882 0.473 . . . . 0.0 110.277 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -72.8 5.35 3.25 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.06 23.3 4.17 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.571 0.623 . . . . 0.0 112.45 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 88.5 p -73.67 -8.03 54.36 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.991 -0.443 . . . . 0.0 111.806 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 53.4 p -140.94 154.61 68.63 Favored Pre-proline 0 C--O 1.232 0.139 0 C-N-CA 123.764 0.826 . . . . 0.0 109.386 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.68 -11.66 31.42 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.014 2.476 . . . . 0.0 111.662 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -90.49 -29.93 17.62 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.171 0.442 . . . . 0.0 111.381 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -90.56 -27.88 18.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.775 0.261 . . . . 0.0 110.469 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.53 -19.7 62.14 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.567 0.347 . . . . 0.0 111.666 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -73.57 1.12 10.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.203 0.601 . . . . 0.0 111.77 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -120.19 12.75 11.89 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.102 0.961 . . . . 0.0 111.049 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -132.9 27.08 4.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.0 0.52 . . . . 0.0 111.109 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.528 ' HD2' ' H ' ' A' ' 581' ' ' THR . 64.3 mtm-85 58.64 22.65 10.1 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.054 0.942 . . . . 0.0 113.281 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.4 mm -81.02 148.86 5.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 125.029 1.332 . . . . 0.0 110.763 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.286 8.5 pt20 64.69 14.41 9.05 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.545 1.938 . . . . 0.0 115.213 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -141.19 95.84 7.33 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.78 138.49 16.91 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.487 2.792 . . . . 0.0 110.255 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 56.4 m -124.04 23.93 8.37 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.362 0.665 . . . . 0.0 111.4 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.45 18.91 9.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.811 0.844 . . . . 0.0 112.717 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.9 t -134.42 146.82 30.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.477 HD12 ' CH2' ' A' ' 546' ' ' TRP . 28.8 mt -118.22 160.61 21.3 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.8 0.44 . . . . 0.0 110.196 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -121.64 157.41 30.88 Favored 'General case' 0 N--CA 1.46 0.059 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -142.73 152.85 42.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.852 0.461 . . . . 0.0 110.409 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.85 173.07 12.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.126 0.57 . . . . 0.0 110.549 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 64.8 t30 66.5 28.41 9.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.451 1.1 . . . . 0.0 113.329 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.14 160.42 46.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 122.12 -0.363 . . . . 0.0 110.723 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 156.0 39.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.08 2.52 . . . . 0.0 111.644 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -77.97 -0.76 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -122.52 13.1 10.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.174 0.589 . . . . 0.0 111.548 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.57 152.68 7.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 O-C-N 122.081 -0.387 . . . . 0.0 110.926 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.6 p -142.39 170.99 14.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.489 0.715 . . . . 0.0 110.437 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.74 -20.65 65.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.819 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -72.89 -23.65 60.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.6 -33.37 28.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -69.46 -28.66 66.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.514 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -82.26 -35.64 27.91 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.965 -0.46 . . . . 0.0 111.788 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -78.27 -17.3 56.83 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.329 0.513 . . . . 0.0 112.006 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.01 -25.36 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.122 0.419 . . . . 0.0 110.663 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.18 -24.24 63.1 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.404 -0.81 . . . . 0.0 109.753 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.94 -10.78 54.62 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.04 -18.82 23.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 110.332 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.7 mt -112.92 -0.44 14.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.75 5.77 70.15 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.678 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.86 169.75 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.852 0.826 . . . . 0.0 111.044 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.49 145.37 34.99 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.882 0.473 . . . . 0.0 110.275 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.67 146.67 47.19 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.944 0.498 . . . . 0.0 110.218 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 158.22 58.12 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.251 2.634 . . . . 0.0 110.685 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 61.8 m -90.4 -28.34 18.72 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.015 0.526 . . . . 0.0 110.698 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.2 m -142.35 153.67 44.02 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.142 0.577 . . . . 0.0 109.505 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 94.8 t -139.13 146.62 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 122.976 0.51 . . . . 0.0 110.284 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' LYS . . . . . 0.442 ' HE2' ' N ' ' A' ' 586' ' ' SER . 30.0 ttmt -138.24 140.01 39.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.71 145.16 31.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -136.04 157.99 45.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -172.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.1 p -130.77 153.02 49.48 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.906 0.882 . . . . 0.0 110.198 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . 173.16 -147.18 9.45 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.04 160.6 12.23 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 23.0 m 61.68 29.01 17.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.198 0.454 . . . . 0.0 111.961 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.84 -7.51 0.74 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.954 1.302 . . . . 0.0 113.858 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.95 -10.88 43.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.469 0.577 . . . . 0.0 110.28 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 65.2 m -141.15 167.0 23.23 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.661 1.184 . . . . 0.0 109.575 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.1 t -132.0 166.01 22.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.016 0.526 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 77.6 p -153.47 172.35 17.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.495 1.118 . . . . 0.0 110.111 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.35 -161.05 33.43 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.63 -0.795 . . . . 0.0 114.028 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.09 157.18 32.02 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.57 1.148 . . . . 0.0 110.523 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.46 133.31 30.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 124.232 1.013 . . . . 0.0 108.345 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -127.8 119.37 25.55 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.477 ' CH2' HD12 ' A' ' 500' ' ' LEU . 3.0 p90 -166.09 153.21 9.82 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.418 1.487 . . . . 0.0 107.498 168.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -148.98 118.62 6.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.671 -0.811 . . . . 0.0 112.974 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.0 t -159.6 152.97 22.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 169.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -65.01 -53.0 53.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.716 0.689 . . . . 0.0 111.03 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 53.0 m -81.49 -23.85 37.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -91.48 -28.75 17.41 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.518 0.599 . . . . 0.0 111.966 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.58 38.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.335 0.516 . . . . 0.0 110.529 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 50.6 tp -82.25 -31.93 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.17 -36.72 47.16 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.825 -0.547 . . . . 0.0 110.273 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.5 m -72.52 -42.54 64.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 556' ' ' LEU . . . . . 0.453 ' C ' HD13 ' A' ' 556' ' ' LEU . 2.8 tm? -60.44 -47.83 84.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.34 -15.07 67.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.097 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.9 2.19 2.84 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.688 1.744 . . . . 0.0 114.377 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 559' ' ' LEU . 2.5 tm? -104.05 -26.5 12.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.531 0.605 . . . . 0.0 109.727 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -65.16 155.17 35.79 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.686 -0.634 . . . . 0.0 110.369 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 55.4 20.84 3.85 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.33 151.26 35.03 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -110.93 136.51 49.84 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.902 1.681 . . . . 0.0 110.184 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 564' ' ' MET . . . . . 0.46 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.6 ttt -64.16 171.92 2.72 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.245 0.618 . . . . 0.0 111.006 -175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -75.73 15.5 0.5 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -65.94 149.94 97.06 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.325 0.512 . . . . 0.0 110.132 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.53 -45.8 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.956 2.437 . . . . 0.0 113.347 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -121.04 13.69 11.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.63 52.23 50.22 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.237 -0.757 . . . . 0.0 112.263 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.82 -8.81 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.196 2.597 . . . . 0.0 111.315 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -146.31 149.43 37.89 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 123.698 0.799 . . . . 0.0 109.315 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.73 147.03 39.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.425 2.75 . . . . 0.0 110.881 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 573' ' ' TYR . . . . . 0.46 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.0 t80 -144.88 -2.6 0.81 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.27 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 62.3 m -66.37 110.63 3.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.41 144.55 25.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.901 0.48 . . . . 0.0 111.208 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -103.33 122.48 44.91 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.03 146.87 37.78 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 58.8 m -153.98 -178.14 6.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.67 1.188 . . . . 0.0 109.019 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.9 149.75 49.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.5 t -135.49 160.08 39.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.732 0.813 . . . . 0.0 110.328 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 581' ' ' THR . . . . . 0.528 ' H ' ' HD2' ' A' ' 492' ' ' ARG . 87.8 m -105.82 102.13 11.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.38 161.56 34.67 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.213 1.005 . . . . 0.0 110.186 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -87.09 -38.25 16.67 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -158.06 153.02 25.28 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.985 1.314 . . . . 0.0 109.377 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -99.66 76.5 2.0 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.442 ' N ' ' HE2' ' A' ' 530' ' ' LYS . 78.3 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.122 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -87.96 -10.75 49.52 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.891 0.476 . . . . 0.0 111.533 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 76.27 174.14 37.45 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.49 172.3 15.99 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.535 3.49 . . . . 0.0 111.021 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -148.58 157.81 43.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.264 0.626 . . . . 0.0 109.794 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -81.62 165.7 20.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.89 0.476 . . . . 0.0 111.149 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -123.94 -0.51 8.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.249 0.62 . . . . 0.0 111.809 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 31.2 t -164.06 150.93 10.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.253 0.621 . . . . 0.0 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.42 2.78 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.579 2.853 . . . . 0.0 111.617 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.02 151.15 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.837 0.855 . . . . 0.0 109.904 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -139.51 165.08 28.17 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.633 0.773 . . . . 0.0 109.706 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 64.8 mtp -136.43 149.91 48.49 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.617 0.246 . . . . 0.0 111.223 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.9 148.53 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.729 0.812 . . . . 0.0 109.591 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -140.03 162.99 33.88 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.972 0.509 . . . . 0.0 109.86 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.49 -0.34 86.87 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.713 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.748 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.68 176.82 5.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.063 0.932 . . . . 0.0 110.264 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -139.77 141.59 36.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.265 -0.272 . . . . 0.0 110.562 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -71.7 -1.73 14.87 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 46.7 m -104.99 -9.12 18.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.049 0.386 . . . . 0.0 111.92 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -136.22 -2.86 2.24 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.059 0.544 . . . . 0.0 111.222 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -145.2 122.72 11.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.573 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 37.8 m-80 -141.83 177.01 8.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.631 0.773 . . . . 0.0 109.204 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -58.16 -28.13 64.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -91.73 -25.91 18.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.81 -0.556 . . . . 0.0 111.751 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ARG . . . . . 0.573 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.8 mpt_? -73.59 -31.54 63.64 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.06 -32.33 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -68.1 -30.98 70.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.68 -27.53 62.15 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.13 -35.03 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.387 0.54 . . . . 0.0 111.829 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -89.93 -8.97 50.53 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.0 t -70.2 -26.94 64.12 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.525 0.602 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 26.8 mt -67.11 -4.46 10.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.749 -0.594 . . . . 0.0 111.822 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -121.45 4.05 10.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.84 -132.39 3.56 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -141.33 157.02 45.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 6.2 m -115.87 156.46 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.477 0.711 . . . . 0.0 111.003 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -110.04 -51.15 2.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.082 0.553 . . . . 0.0 110.908 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -167.6 167.6 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.476 0.711 . . . . 0.0 111.0 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.85 151.61 16.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.969 0.908 . . . . 0.0 110.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -149.94 143.82 25.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.151 0.58 . . . . 0.0 110.144 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -87.2 102.99 15.0 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.502 ' HE1' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -81.46 141.48 33.84 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.152 1.381 . . . . 0.0 112.966 -171.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 60.09 33.93 21.25 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.93 1.292 . . . . 0.0 112.47 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 92.0 p 52.88 12.37 0.27 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.839 1.656 . . . . 0.0 115.317 172.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -84.85 126.5 68.06 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-N 118.753 0.706 . . . . 0.0 110.308 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.96 -9.95 18.63 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.26 2.64 . . . . 0.0 111.853 171.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -106.9 17.23 38.75 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.359 0.98 . . . . 0.0 112.726 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.502 ' HB1' ' HE1' ' A' ' 412' ' ' MET . . . -146.25 140.38 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.412 1.106 . . . . 0.0 110.934 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.29 158.23 39.88 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.946 0.498 . . . . 0.0 111.316 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.1 ptm -140.7 147.59 39.46 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.599 0.36 . . . . 0.0 110.251 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.82 148.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.78 0.432 . . . . 0.0 110.775 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -114.72 139.02 50.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.479 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 86.6 mmm -104.49 161.29 14.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.519 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.49 -18.97 61.62 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.45 -0.157 . . . . 0.0 111.395 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -156.57 158.92 37.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.159 0.584 . . . . 0.0 109.893 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.57 -17.54 74.82 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.166 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -24.02 62.83 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 119.002 1.401 . . . . 0.0 110.767 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.72 -22.5 37.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.292 0.237 . . . . 0.0 111.03 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.79 -36.65 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -68.6 -26.76 65.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.91 -26.0 29.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 121.933 0.093 . . . . 0.0 110.945 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.52 50.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.65 -31.07 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.83 0.852 . . . . 0.0 110.783 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 22.5 m -98.84 -20.4 16.87 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -134.34 -7.32 2.59 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.67 -19.85 10.37 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.196 0.907 . . . . 0.0 109.441 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -52.47 145.79 10.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.835 0.854 . . . . 0.0 111.567 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 56.87 1.54 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.13 2.172 . . . . 0.0 115.408 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -88.08 142.51 27.72 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.578 1.535 . . . . 0.0 108.772 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.309 0.0 OUTLIER -130.97 163.9 26.52 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.0 ptm -125.21 143.35 50.99 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.038 1.335 . . . . 0.0 109.385 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' PHE . . . . . 0.408 ' H ' ' CG ' ' A' ' 554' ' ' GLU . 97.0 m-85 67.52 28.54 7.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.33 1.452 . . . . 0.0 114.192 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 68.39 16.01 68.79 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -83.3 162.07 21.24 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.422 1.111 . . . . 0.0 110.318 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.2 133.52 34.59 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.47 134.14 41.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -140.69 123.58 16.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.58 144.34 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.028 0 CA-C-N 118.116 0.416 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 t -158.5 165.56 34.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.2 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.9 152.97 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.262 0.625 . . . . 0.0 109.615 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 13.1 t -100.51 -167.0 1.38 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 110.475 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -138.41 6.18 2.52 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.938 0.895 . . . . 0.0 110.857 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -80.04 144.63 59.41 Favored Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.22 -24.86 12.08 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.873 2.382 . . . . 0.0 111.101 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.49 169.01 17.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.699 0.799 . . . . 0.0 109.489 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.09 142.55 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.2 mtt -111.34 159.56 32.5 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 122.417 0.287 . . . . 0.0 110.735 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -55.61 160.08 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.926 3.084 . . . . 0.0 112.646 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 172.29 179.57 43.23 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -74.96 153.54 38.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 48.2 t -138.23 157.14 46.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.051 0.54 . . . . 0.0 109.841 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -146.13 161.79 39.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.309 0.644 . . . . 0.0 110.17 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 135.06 14.83 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 70.7 mt -86.86 173.81 9.15 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.454 0.702 . . . . 0.0 109.513 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.222 -0.299 . . . . 0.0 111.414 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.4 -1.34 49.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.042 0.537 . . . . 0.0 111.178 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.66 -1.05 88.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.402 0.525 . . . . 0.0 112.578 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.8 t -93.63 160.15 14.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.775 0.787 . . . . 0.0 110.226 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.7 m -78.35 153.3 31.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.953 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 84.8 p -73.26 -10.6 59.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.858 0.463 . . . . 0.0 111.913 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -120.63 138.55 53.86 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -155.86 157.29 36.13 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.495 0.318 . . . . 0.0 110.776 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.15 156.96 32.56 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.467 0.707 . . . . 0.0 110.404 176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -140.07 11.14 2.39 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 122.903 0.481 . . . . 0.0 111.886 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.5 p -65.55 -15.3 62.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -85.11 -2.99 58.63 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.832 0.453 . . . . 0.0 110.932 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 43.0 m -103.77 21.21 16.64 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.044 0.937 . . . . 0.0 110.544 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 35.8 ptt-85 -73.93 7.42 2.61 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.913 0.885 . . . . 0.0 112.511 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -84.63 10.73 10.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.451 0.701 . . . . 0.0 111.777 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -66.39 153.4 42.84 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -10.31 59.38 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -136.35 34.54 2.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.281 0.632 . . . . 0.0 111.163 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 81.7 p -74.82 -5.59 44.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 55.1 p -135.82 155.13 78.18 Favored Pre-proline 0 CA--C 1.523 -0.082 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.58 -10.93 30.5 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.771 2.314 . . . . 0.0 111.534 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -89.88 -32.09 17.02 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.935 0.334 . . . . 0.0 110.728 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -90.56 -19.1 24.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.405 0.282 . . . . 0.0 110.552 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -74.85 -1.45 22.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.784 0.433 . . . . 0.0 111.315 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.37 -4.64 59.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.796 0.438 . . . . 0.0 111.081 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -109.2 7.95 25.63 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.576 0.75 . . . . 0.0 110.938 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -145.56 176.62 9.47 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.57 1.148 . . . . 0.0 108.18 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 492' ' ' ARG . 0.4 OUTLIER -142.96 147.95 36.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.776 -0.577 . . . . 0.0 110.373 176.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.55 145.87 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.534 0.734 . . . . 0.0 109.305 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -156.82 158.38 36.69 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.706 0.289 . . . . 0.0 111.061 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -64.64 167.57 8.68 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.696 1.198 . . . . 0.0 109.56 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.55 137.91 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.39 2.726 . . . . 0.0 112.554 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 49.6 m -123.97 24.01 8.4 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.585 0.754 . . . . 0.0 112.848 -168.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.4 -14.74 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 113.779 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 29.9 t -134.09 151.66 32.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 118.648 0.658 . . . . 0.0 109.994 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.433 HD12 ' CH2' ' A' ' 546' ' ' TRP . 27.4 mt -126.18 138.63 53.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.771 0.829 . . . . 0.0 109.718 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.444 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 16.0 m170 -105.65 154.82 19.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -137.34 147.41 45.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.465 0.174 . . . . 0.0 110.789 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -148.77 168.02 24.05 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.448 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.4 t30 58.18 30.52 19.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.327 1.051 . . . . 0.0 113.191 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.35 156.64 51.03 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.27 155.63 34.18 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.131 2.554 . . . . 0.0 111.805 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -77.11 -1.24 28.17 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.88 9.1 24.6 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.08 151.43 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 118.011 0.369 . . . . 0.0 111.11 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.2 p -142.88 172.03 13.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.557 0.743 . . . . 0.0 110.241 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.25 -20.55 64.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.55 -24.92 59.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -81.62 -29.78 33.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -70.52 -30.81 67.67 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.824 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.48 -36.59 26.34 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.334 0.515 . . . . 0.0 111.772 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -76.54 -23.87 53.61 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.06 0.391 . . . . 0.0 111.783 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.4 mt -88.85 -33.49 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 117.932 0.333 . . . . 0.0 110.16 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 75.6 m -65.47 -22.99 66.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.868 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.13 -34.7 75.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.09 -12.75 34.69 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.07 -7.53 59.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.878 0.308 . . . . 0.0 111.36 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.37 11.15 75.88 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.761 -0.466 . . . . 0.0 112.907 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.4 m -111.16 171.18 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 117.852 0.826 . . . . 0.0 111.177 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -68.5 154.55 41.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.415 0.686 . . . . 0.0 110.51 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -108.25 151.07 41.27 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.14 153.5 75.92 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.217 2.612 . . . . 0.0 111.339 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 83.9 m -94.59 -21.58 18.74 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.209 0.604 . . . . 0.0 111.244 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 50.8 m -142.31 153.87 44.24 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.15 150.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.166 0.508 . . . . 0.0 111.878 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -145.4 140.65 27.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.19 140.99 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -153.66 156.5 38.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.251 0.62 . . . . 0.0 110.089 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.8 m -130.73 137.66 49.61 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -76.23 151.19 39.92 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -69.53 130.43 42.44 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.4 m 55.27 13.6 0.9 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -90.41 -16.18 29.55 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.623 0.647 . . . . 0.0 111.06 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 51.38 26.74 3.26 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.224 1.009 . . . . 0.0 113.057 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.1 m -138.13 160.29 39.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.13 0.572 . . . . 0.0 110.371 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.8 t -120.4 150.42 40.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.694 0.798 . . . . 0.0 111.236 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 57.0 m -147.21 164.32 33.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.231 1.412 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.84 -162.41 33.15 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.658 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 87.6 mt -128.57 151.31 49.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.095 0.958 . . . . 0.0 110.767 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.7 mt -142.28 133.39 26.03 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -127.81 124.7 38.26 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.433 ' CH2' HD12 ' A' ' 500' ' ' LEU . 4.2 p90 -166.02 149.06 7.41 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -146.77 114.1 6.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 34.7 t -159.56 152.91 22.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 168.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -66.99 -36.82 83.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.469 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 45.9 m -83.92 -36.18 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.184 0.194 . . . . 0.0 111.354 -176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.4 -24.57 31.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.568 0.622 . . . . 0.0 111.612 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.63 21.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.491 0.587 . . . . 0.0 111.557 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.48 -23.79 24.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.053 0.842 . . . . 0.0 111.61 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.408 ' CG ' ' H ' ' A' ' 442' ' ' PHE . 65.4 mt-10 -77.93 -44.71 26.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.985 -0.447 . . . . 0.0 109.891 175.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 60.9 m -69.15 -31.87 70.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.3 tm? -68.9 -43.41 75.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.63 -19.32 72.91 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.28 -0.733 . . . . 0.0 112.757 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -114.39 -9.78 12.72 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.172 0.986 . . . . 0.0 113.046 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 13.7 tp -112.69 4.84 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.848 0.749 . . . . 0.0 112.18 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -92.9 143.01 26.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.333 -0.855 . . . . 0.0 109.675 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 49.13 35.94 8.07 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.644 0.777 . . . . 0.0 112.684 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 562' ' ' TYR . . . . . 0.404 ' HD1' ' H ' ' A' ' 562' ' ' TYR . 3.3 p90 -92.18 151.35 20.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -97.98 136.44 38.26 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.76 1.624 . . . . 0.0 111.389 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 564' ' ' MET . . . . . 0.463 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.06 173.93 1.73 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.72 0.808 . . . . 0.0 111.354 -177.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -70.05 14.34 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.859 0.864 . . . . 0.0 113.106 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.46 140.62 92.02 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.939 0.495 . . . . 0.0 111.065 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -81.0 -29.53 2.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.299 2.666 . . . . 0.0 112.766 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -121.01 -11.37 8.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.409 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.12 43.83 95.02 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 82.9 Cg_endo -72.41 -6.6 19.38 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.32 2.68 . . . . 0.0 112.047 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -142.61 150.82 55.5 Favored Pre-proline 0 N--CA 1.455 -0.189 0 C-N-CA 123.559 0.744 . . . . 0.0 109.689 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 152.27 34.24 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.505 2.804 . . . . 0.0 110.738 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 573' ' ' TYR . . . . . 0.463 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 80.0 t80 -146.38 -2.66 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.518 0.327 . . . . 0.0 111.619 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.37 122.35 17.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.72 -0.613 . . . . 0.0 109.825 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.0 144.61 50.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.228 1.011 . . . . 0.0 109.324 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.89 158.11 17.58 Favored 'General case' 0 CA--C 1.523 -0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 111.247 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.62 155.74 47.03 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.169 0.988 . . . . 0.0 108.789 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 42.6 t -163.55 146.32 9.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -76.69 127.55 32.99 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 23.1 t -135.68 154.7 51.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.73 0.3 . . . . 0.0 111.091 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 37.0 m -83.59 103.4 12.89 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -133.98 161.16 35.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.498 0.719 . . . . 0.0 109.662 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -93.87 -26.1 17.05 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.406 -0.184 . . . . 0.0 111.172 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -160.66 157.83 27.81 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.966 0.506 . . . . 0.0 109.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -89.73 76.4 7.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.36 -1.305 . . . . 0.0 110.154 178.846 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -134.42 11.03 3.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.779 0.432 . . . . 0.0 111.799 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -78.53 -67.22 1.64 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -83.53 6.88 5.53 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.549 3.5 . . . . 0.0 112.62 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -148.63 160.47 43.11 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.386 0.539 . . . . 0.0 111.708 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -130.93 150.89 51.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.595 0.758 . . . . 0.0 109.738 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -141.36 7.19 1.95 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 30.7 m -146.94 154.19 46.7 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 122.509 0.324 . . . . 0.0 110.551 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.45 -0.55 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.61 3.54 . . . . 0.0 113.399 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.78 162.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 118.686 0.676 . . . . 0.0 112.203 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -147.18 167.22 24.72 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.935 0.894 . . . . 0.0 109.122 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' MET . . . . . 0.412 ' HE2' ' SD ' ' A' ' 412' ' ' MET . 73.8 mtp -133.57 151.24 51.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.404 0.282 . . . . 0.0 110.576 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.1 148.93 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.978 0.511 . . . . 0.0 110.827 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.95 167.55 21.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.474 0.71 . . . . 0.0 109.55 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.66 88.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.586 -0.563 . . . . 0.0 112.897 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -70.2 173.56 6.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.828 0.814 . . . . 0.0 110.326 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -136.66 139.78 42.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -71.96 -3.98 25.79 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.1 p -109.83 -1.19 18.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.378 0.535 . . . . 0.0 112.407 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -133.5 -6.44 2.91 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.288 0.635 . . . . 0.0 110.969 175.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.5 tpt -148.5 122.25 9.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.225 0.61 . . . . 0.0 109.47 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -141.88 -173.37 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.106 0.562 . . . . 0.0 109.768 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 72.3 m -59.54 -23.61 63.0 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -92.03 -23.8 19.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.231 0.468 . . . . 0.0 111.5 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -83.93 -29.71 26.89 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 409' ' ' VAL . 10.1 p -77.52 -32.58 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -68.85 -31.17 69.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.38 -46.43 55.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.172 -0.33 . . . . 0.0 111.329 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.18 -20.32 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 122.233 -0.292 . . . . 0.0 111.48 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -110.47 -7.33 14.77 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.24 -31.7 55.22 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.843 0.747 . . . . 0.0 110.958 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 11.38 1.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.805 -0.56 . . . . 0.0 112.18 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -121.51 -5.34 9.28 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.743 0.817 . . . . 0.0 110.931 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.68 177.94 24.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -75.49 148.67 38.83 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.376 -0.485 . . . . 0.0 110.834 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.05 154.26 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.597 0.759 . . . . 0.0 109.413 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -104.02 -58.79 1.82 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.212 -0.305 . . . . 0.0 110.552 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -165.78 166.65 17.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.973 0.509 . . . . 0.0 110.736 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 396' ' ' VAL . 7.6 p -147.92 150.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 122.985 0.514 . . . . 0.0 110.345 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -151.88 144.34 24.13 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.343 0.257 . . . . 0.0 110.599 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -79.06 152.0 31.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.412 ' SD ' ' HE2' ' A' ' 382' ' ' MET . 25.3 ptt? -129.97 141.49 50.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -168.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 60.01 34.0 21.4 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.923 1.289 . . . . 0.0 111.802 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m 52.77 16.67 0.71 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.883 1.273 . . . . 0.0 114.035 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.76 143.21 46.37 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 118.357 0.526 . . . . 0.0 109.903 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.34 -1.14 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.651 2.901 . . . . 0.0 110.262 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -132.54 27.68 3.52 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.739 0.685 . . . . 0.0 113.071 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.69 133.92 19.46 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.08 0.94 . . . . 0.0 110.333 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.12 168.67 26.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.5 ptm -144.32 146.99 32.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.19 151.62 27.65 Favored 'Isoleucine or valine' 0 C--N 1.337 0.028 0 C-N-CA 123.161 0.585 . . . . 0.0 110.736 -170.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -128.38 136.77 51.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.5 mmm -107.72 162.64 13.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.644 0.378 . . . . 0.0 110.565 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.95 61.14 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.158 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -157.73 161.76 38.51 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.429 0.691 . . . . 0.0 109.578 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.97 -14.54 70.83 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.391 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -67.96 -30.57 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.134 1.467 . . . . 0.0 110.46 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.33 -20.56 51.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.51 -31.78 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.32 -36.05 66.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -32.2 67.02 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.011 -0.43 . . . . 0.0 110.508 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.22 -38.05 25.09 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.12 -0.363 . . . . 0.0 111.862 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 7.5 tp -72.87 -32.02 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.529 -0.732 . . . . 0.0 111.803 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.1 m -93.66 -21.14 19.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -117.97 -14.09 10.02 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.75 -17.4 11.07 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.941 0.791 . . . . 0.0 110.507 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -51.73 142.01 15.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.46 0.648 . . . . 0.0 111.702 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 57.08 1.54 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.787 2.035 . . . . 0.0 115.742 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -87.91 142.49 27.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.719 1.6 . . . . 0.0 108.667 169.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -130.85 163.84 26.53 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.34 143.43 50.97 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.397 1.479 . . . . 0.0 109.576 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 67.77 27.12 7.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.989 1.316 . . . . 0.0 114.486 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.48 15.86 75.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 168.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -83.25 160.76 21.68 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.683 1.242 . . . . 0.0 110.074 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.62 132.46 34.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.54 133.26 43.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -140.69 120.43 13.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.06 141.92 15.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-N 118.263 0.483 . . . . 0.0 110.346 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 25.6 t -160.13 162.37 33.95 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.791 0.436 . . . . 0.0 110.166 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.07 158.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 109.949 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.1 t -137.67 151.28 48.1 Favored 'General case' 0 C--N 1.337 0.032 0 O-C-N 121.991 -0.443 . . . . 0.0 110.451 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -89.37 -0.58 57.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.683 0.793 . . . . 0.0 112.654 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -62.14 144.39 94.45 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 121.478 -0.764 . . . . 0.0 109.654 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.1 -25.04 12.09 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.832 2.355 . . . . 0.0 112.013 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.86 173.78 12.31 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.013 0.525 . . . . 0.0 110.214 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -66.68 138.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -90.07 163.03 33.45 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.813 0.445 . . . . 0.0 110.699 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.21 -42.5 64.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.14 2.56 . . . . 0.0 112.009 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 50.23 -142.75 13.46 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.252 0.453 . . . . 0.0 112.442 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -133.65 160.5 37.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.214 1.006 . . . . 0.0 108.536 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.0 p -143.3 156.04 44.62 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.693 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -155.19 163.34 40.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.36 136.68 17.79 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.96 165.86 15.54 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.174 0.59 . . . . 0.0 110.232 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.92 -20.13 65.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.243 0.217 . . . . 0.0 111.463 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -80.35 1.25 29.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 111.476 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.91 0.63 85.76 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 39.6 m -91.37 165.05 13.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.419 0.688 . . . . 0.0 110.528 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.36 153.34 22.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.74 0.305 . . . . 0.0 110.5 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.3 p -69.89 -10.25 57.84 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.027 0.531 . . . . 0.0 111.697 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -118.47 138.06 52.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.99 0.916 . . . . 0.0 109.87 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -154.42 155.2 34.54 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.423 0.289 . . . . 0.0 110.661 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -124.61 156.6 37.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 110.415 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.81 15.92 2.31 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.041 0.536 . . . . 0.0 111.334 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 91.2 p -66.58 -3.4 6.3 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -97.36 3.86 50.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.222 0.609 . . . . 0.0 110.86 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 11.2 t -84.05 22.32 1.2 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.581 0.752 . . . . 0.0 111.003 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 -73.95 -2.8 25.56 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.429 0.691 . . . . 0.0 111.002 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -88.25 2.43 52.34 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.376 0.671 . . . . 0.0 110.605 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -65.17 154.39 38.15 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.934 -0.479 . . . . 0.0 109.945 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -83.15 0.82 43.48 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -142.84 33.26 1.4 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.885 0.474 . . . . 0.0 111.013 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 84.0 p -71.22 -3.27 19.38 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.221 0.608 . . . . 0.0 112.624 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 485' ' ' PRO . 7.1 t -142.14 147.63 44.9 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 123.234 0.613 . . . . 0.0 109.401 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 484' ' ' THR . 75.5 Cg_exo -55.74 -24.39 46.02 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.771 2.981 . . . . 0.0 114.659 -175.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.88 -25.08 35.34 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.69 0.677 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.63 -22.34 21.24 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.628 0.371 . . . . 0.0 110.482 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.28 -16.76 62.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.212 -0.305 . . . . 0.0 111.482 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -79.5 -6.81 57.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.747 0.419 . . . . 0.0 111.056 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -109.06 5.53 24.2 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.761 0.824 . . . . 0.0 110.88 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -128.05 14.19 6.78 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.458 0.703 . . . . 0.0 110.943 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 51.66 46.0 27.23 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.187 0.995 . . . . 0.0 112.437 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 41.2 mm -80.84 94.12 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -148.51 -176.49 5.33 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.098 0.959 . . . . 0.0 109.944 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' HIS . . . . . 0.425 ' CG ' ' HD2' ' A' ' 496' ' ' PRO . 67.8 t60 -59.87 148.56 76.11 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 495' ' ' HIS . 87.1 Cg_exo -46.3 140.73 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.45 2.767 . . . . 0.0 112.817 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.1 m -123.99 24.05 8.37 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.606 0.762 . . . . 0.0 111.34 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.52 7.86 2.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 113.987 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 32.3 t -141.54 147.02 22.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 123.41 0.684 . . . . 0.0 109.233 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.482 HD12 ' CH2' ' A' ' 546' ' ' TRP . 91.5 mt -129.38 160.35 33.35 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.62 0.768 . . . . 0.0 110.086 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -143.65 163.16 34.03 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.285 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -135.94 156.94 48.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.407 0.683 . . . . 0.0 111.133 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -147.3 170.76 16.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.46 26.19 15.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 0.0 113.281 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.95 158.3 70.41 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -68.99 159.43 54.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.282 1.988 . . . . 0.0 110.602 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -71.58 -1.09 12.32 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -112.0 7.1 19.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -173.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.45 148.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 118.308 0.504 . . . . 0.0 111.209 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.5 p -142.98 173.3 11.68 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.925 0.89 . . . . 0.0 110.313 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.4 -22.79 65.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.752 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.68 -23.71 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -82.95 -31.78 27.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -68.82 -28.34 66.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.964 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.37 -35.07 18.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.192 0.451 . . . . 0.0 112.087 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -75.85 -18.87 59.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.458 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.79 -35.53 5.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 117.884 0.311 . . . . 0.0 110.868 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 17.3 p -70.1 -21.84 63.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.167 0.894 . . . . 0.0 110.643 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.38 -28.44 61.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 119.552 -0.261 . . . . 0.0 111.633 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.07 -12.6 35.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.278 0.49 . . . . 0.0 111.205 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.12 -9.9 51.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.523 0.329 . . . . 0.0 110.489 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.28 6.41 65.11 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.704 -0.498 . . . . 0.0 112.927 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.2 m -89.17 170.88 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.938 0.869 . . . . 0.0 111.161 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -71.11 146.77 49.01 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.356 0.663 . . . . 0.0 110.044 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -91.94 153.11 43.46 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.625 0.37 . . . . 0.0 110.256 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 155.55 69.34 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.555 2.17 . . . . 0.0 109.535 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 82.2 m -95.1 -19.12 20.38 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.955 0.502 . . . . 0.0 110.763 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.0 t -148.76 152.73 37.07 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.945 0.498 . . . . 0.0 109.762 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.9 t -140.62 140.9 33.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 123.097 0.559 . . . . 0.0 110.084 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.25 126.35 12.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.48 152.36 37.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.829 0.452 . . . . 0.0 110.971 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -144.23 160.82 40.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.984 0.914 . . . . 0.0 109.438 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t -128.98 135.32 48.81 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.827 0.451 . . . . 0.0 110.293 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.3 147.0 31.01 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -78.46 135.04 37.29 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 25.2 m 54.14 20.34 2.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.636 0.774 . . . . 0.0 112.791 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -110.91 -17.44 13.31 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.048 0.539 . . . . 0.0 111.134 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 52.19 27.19 4.44 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.324 1.05 . . . . 0.0 113.209 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 71.1 m -138.22 157.96 45.25 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.987 0.515 . . . . 0.0 110.734 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 156.01 40.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.525 0.73 . . . . 0.0 111.192 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.5 m -147.72 166.53 27.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.887 1.275 . . . . 0.0 108.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.62 -176.75 47.48 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.2 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.2 mp -111.57 154.93 24.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.282 1.033 . . . . 0.0 110.132 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.3 mt -138.35 134.38 34.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.72 117.99 22.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.482 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.9 p90 -165.71 153.63 10.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 168.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -146.81 115.11 6.65 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.9 t -159.52 153.04 22.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 168.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -69.79 -48.38 59.4 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 118.637 0.653 . . . . 0.0 110.722 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 44.7 m -82.71 -22.96 34.29 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -89.28 -33.17 17.05 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.711 0.687 . . . . 0.0 111.481 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -72.13 -33.92 68.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.798 0.726 . . . . 0.0 110.477 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.52 -35.68 58.16 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.034 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.99 -40.37 53.87 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.102 -0.374 . . . . 0.0 110.604 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 98.6 m -65.95 -49.23 68.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.159 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 556' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 556' ' ' LEU . 2.0 pp -70.15 -22.4 62.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.109 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -64.72 -31.39 80.74 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.427 -0.652 . . . . 0.0 111.83 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -116.36 -6.86 11.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.912 0.856 . . . . 0.0 113.103 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.5 tp -95.93 -13.47 23.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.66 0.664 . . . . 0.0 111.664 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -81.16 151.44 28.23 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.695 -0.628 . . . . 0.0 110.199 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 31.4 m80 51.18 22.97 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 151.23 29.81 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -102.13 136.33 42.15 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.381 1.472 . . . . 0.0 110.683 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 564' ' ' MET . . . . . 0.466 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 6.2 ttt -64.17 173.24 2.03 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.15 0.58 . . . . 0.0 111.612 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -75.4 14.78 0.54 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.932 . . . . 0.0 112.564 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -66.11 149.93 97.26 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 118.03 0.377 . . . . 0.0 110.137 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.87 -46.92 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.895 2.397 . . . . 0.0 113.898 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -121.08 13.3 11.26 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 63.34 52.8 44.05 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.312 -0.716 . . . . 0.0 112.594 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.62 -9.42 19.9 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.539 2.826 . . . . 0.0 111.44 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -148.42 151.41 36.5 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.671 0.788 . . . . 0.0 109.676 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.26 151.1 37.98 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.563 2.842 . . . . 0.0 110.821 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 573' ' ' TYR . . . . . 0.466 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 91.0 t80 -143.03 -6.45 0.84 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.758 0.423 . . . . 0.0 111.902 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 75.2 p -66.48 132.02 47.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.891 -0.506 . . . . 0.0 110.233 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 575' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 575' ' ' LEU . 1.6 pp -125.03 144.55 50.34 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.595 0.758 . . . . 0.0 110.791 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -77.28 144.38 38.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.76 144.97 50.4 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 2.8 p -163.92 172.09 14.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.703 0.401 . . . . 0.0 110.331 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -82.82 148.91 27.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.734 0.414 . . . . 0.0 111.207 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.7 t -135.6 137.71 42.21 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 122.575 0.35 . . . . 0.0 110.971 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 16.5 p -82.45 102.13 11.12 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.18 161.57 34.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.353 0.661 . . . . 0.0 111.59 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.77 -3.31 7.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.402 0.681 . . . . 0.0 110.294 173.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -157.68 165.91 34.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.754 1.222 . . . . 0.0 109.777 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.12 76.68 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.247 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.888 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 119.803 -0.141 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -135.54 9.16 3.39 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.987 0.515 . . . . 0.0 111.617 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -72.31 172.0 48.2 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.15 165.04 33.79 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.232 3.288 . . . . 0.0 111.123 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -156.81 171.2 20.82 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.521 0.729 . . . . 0.0 110.024 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -117.29 156.67 27.4 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.848 0.459 . . . . 0.0 110.519 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -140.36 6.1 2.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.199 0.6 . . . . 0.0 110.917 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.6 m -152.91 157.01 33.21 Favored Pre-proline 0 N--CA 1.456 -0.157 0 C-N-CA 123.711 0.805 . . . . 0.0 110.207 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.69 2.51 8.48 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.614 3.543 . . . . 0.0 112.938 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.0 p -126.17 148.33 30.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 118.736 0.698 . . . . 0.0 111.478 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.38 167.3 23.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.222 0.609 . . . . 0.0 110.094 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' MET . . . . . 0.405 ' CE ' ' SD ' ' A' ' 412' ' ' MET . 77.1 mtp -132.96 152.0 51.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.539 0.335 . . . . 0.0 110.571 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.6 149.45 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.761 0.425 . . . . 0.0 110.693 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -141.21 166.38 24.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.407 0.683 . . . . 0.0 110.1 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.13 -0.11 84.5 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.847 -0.418 . . . . 0.0 112.67 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.758 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.24 -179.65 4.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.503 0.651 . . . . 0.0 110.687 176.146 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -139.62 134.62 32.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -69.82 -11.73 61.08 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.5 p -93.44 -9.92 36.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -132.56 -8.87 3.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.268 0.486 . . . . 0.0 111.654 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.7 tpt -147.73 104.84 3.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.317 0.647 . . . . 0.0 109.497 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.435 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 23.4 p30 -141.97 -173.59 3.85 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.878 0.871 . . . . 0.0 109.669 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 64.4 m -55.33 -28.83 56.33 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.96 -27.69 21.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.215 0.461 . . . . 0.0 110.994 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ARG . . . . . 0.435 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 2.2 mmp_? -78.11 -33.44 50.58 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 122.123 -0.361 . . . . 0.0 110.038 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.89 -31.31 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -64.82 -35.24 80.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -72.1 -31.04 65.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.43 -0.319 . . . . 0.0 111.398 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.77 -26.61 5.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.151 0.432 . . . . 0.0 111.875 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.52 -10.07 20.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 p -65.68 -37.8 87.51 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.041 0.837 . . . . 0.0 111.565 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.81 14.43 1.75 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.322 0.51 . . . . 0.0 112.156 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -121.46 -1.91 9.55 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.604 0.762 . . . . 0.0 109.93 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 140.45 167.08 10.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -74.83 146.54 41.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.156 -0.614 . . . . 0.0 111.167 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.29 154.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.498 0.719 . . . . 0.0 109.095 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -104.2 -60.1 1.63 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.62 0.368 . . . . 0.0 110.013 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -165.42 163.66 19.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.434 0.694 . . . . 0.0 110.703 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.488 HG22 HG23 ' A' ' 421' ' ' VAL . 92.0 t -136.28 146.83 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.215 1.006 . . . . 0.0 109.344 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -148.45 144.18 27.24 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 172.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -86.53 155.67 20.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.405 ' SD ' ' CE ' ' A' ' 382' ' ' MET . 26.0 ptt? -136.02 141.43 44.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -167.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt 60.22 34.04 21.01 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.849 1.26 . . . . 0.0 112.339 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.8 m 52.97 16.29 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -94.21 142.53 25.03 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 118.405 0.548 . . . . 0.0 110.461 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.48 -3.81 13.65 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.555 2.837 . . . . 0.0 110.357 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -115.49 19.69 14.33 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.234 0.921 . . . . 0.0 112.795 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -145.68 131.85 19.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.204 1.002 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.86 168.3 27.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -145.54 150.19 35.98 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.35 0.66 . . . . 0.0 110.028 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' VAL . . . . . 0.488 HG23 HG22 ' A' ' 409' ' ' VAL . 3.4 p -144.42 151.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.951 0.5 . . . . 0.0 111.076 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -126.56 146.86 49.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.04 0.936 . . . . 0.0 109.615 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 91.1 mmm -112.28 163.28 14.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.601 0.76 . . . . 0.0 110.482 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.7 -15.36 61.69 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -155.1 156.96 36.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.86 0.464 . . . . 0.0 109.886 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.01 -17.59 75.7 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.166 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -29.81 66.54 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.882 1.341 . . . . 0.0 110.13 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.09 61.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.507 0.194 . . . . 0.0 110.536 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.2 t -78.99 -38.07 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.91 -25.88 68.35 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.771 0.26 . . . . 0.0 110.667 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -82.81 -35.04 26.77 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.156 0.582 . . . . 0.0 110.563 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -74.96 -29.63 60.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.873 -0.517 . . . . 0.0 110.009 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 14.7 mm -77.83 -30.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.854 1.262 . . . . 0.0 111.701 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.9 m -106.5 -14.75 14.98 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -134.17 -9.54 2.61 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.72 -16.52 11.24 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.763 0.711 . . . . 0.0 109.633 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -54.02 142.09 26.12 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.27 1.028 . . . . 0.0 111.832 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.81 1.51 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.564 1.946 . . . . 0.0 115.927 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -88.03 142.55 27.69 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.794 1.634 . . . . 0.0 108.532 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.1 OUTLIER -130.81 163.87 26.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.512 1.125 . . . . 0.0 109.384 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 63.64 22.95 13.35 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.154 1.382 . . . . 0.0 114.589 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.15 15.91 61.77 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 169.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -83.2 150.99 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.987 1.393 . . . . 0.0 110.961 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.08 138.7 38.07 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -98.07 122.01 40.68 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -140.72 116.92 10.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.37 140.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 118.774 0.715 . . . . 0.0 110.691 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.8 m -148.71 159.41 44.15 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.166 0.986 . . . . 0.0 109.841 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.23 156.13 3.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.3 t -130.22 161.36 31.34 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.862 0.465 . . . . 0.0 110.418 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.56 10.94 27.03 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.501 0.72 . . . . 0.0 112.519 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -67.66 147.51 98.65 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 118.105 0.411 . . . . 0.0 109.95 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.39 -36.0 80.51 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.802 2.335 . . . . 0.0 112.348 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.95 176.04 7.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.559 0.744 . . . . 0.0 109.92 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 136.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -84.85 149.8 54.43 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.337 0.255 . . . . 0.0 110.614 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.39 167.23 25.85 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.721 2.948 . . . . 0.0 111.223 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 167.59 179.35 40.3 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -77.12 154.53 33.16 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.701 0.4 . . . . 0.0 109.937 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 83.1 p -134.08 159.37 41.02 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.962 0.505 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -155.26 164.3 38.98 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 109.805 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.62 136.73 19.0 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 79.3 mt -86.25 169.61 12.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.974 0.91 . . . . 0.0 109.672 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.22 -20.16 65.65 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.85 4.07 42.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.665 0.386 . . . . 0.0 111.522 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.97 -6.38 79.22 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.376 0.512 . . . . 0.0 112.647 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 52.9 m -83.77 155.39 23.05 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 117.838 0.819 . . . . 0.0 109.942 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.3 153.29 24.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 99.4 p -72.6 -10.34 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 111.664 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -137.0 139.59 41.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.226 1.011 . . . . 0.0 109.477 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -155.16 157.32 37.23 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.18 0.192 . . . . 0.0 110.928 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.71 150.45 51.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.231 1.012 . . . . 0.0 109.937 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -142.45 14.33 1.99 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p -68.35 -6.41 24.19 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -77.45 -4.41 45.31 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.198 0.599 . . . . 0.0 111.15 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 88.6 p -90.93 14.72 13.01 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.095 0.558 . . . . 0.0 111.643 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -73.97 0.9 12.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -94.3 9.95 36.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.453 0.701 . . . . 0.0 110.819 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -67.47 162.66 22.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.075 0.95 . . . . 0.0 111.576 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -85.6 4.71 34.95 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.982 0.913 . . . . 0.0 112.691 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.06 34.46 1.0 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.159 0.504 . . . . 0.0 110.946 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 84.1 p -77.44 -1.82 32.21 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 51.0 p -136.63 157.4 75.18 Favored Pre-proline 0 CA--C 1.527 0.069 0 C-N-CA 123.033 0.533 . . . . 0.0 110.28 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -60.36 -19.9 60.51 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.482 2.788 . . . . 0.0 112.863 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.9 -30.1 20.36 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.708 0.231 . . . . 0.0 110.933 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -90.51 -22.29 21.41 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 122.264 -0.272 . . . . 0.0 110.537 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -72.87 -16.48 61.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.302 0.241 . . . . 0.0 110.789 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -82.12 -4.21 56.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.955 0.502 . . . . 0.0 111.019 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -105.75 9.4 33.03 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.592 0.757 . . . . 0.0 110.864 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -137.81 171.42 14.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.77 0.828 . . . . 0.0 110.058 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -85.31 27.64 0.79 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.781 0.832 . . . . 0.0 112.019 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.94 93.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 O-C-N 122.09 -0.381 . . . . 0.0 110.437 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -162.75 -65.92 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.31 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -147.96 150.63 36.17 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.236 0.614 . . . . 0.0 109.391 -174.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.21 147.73 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 112.691 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 62.9 m -124.18 24.0 8.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.269 0.628 . . . . 0.0 112.092 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.6 3.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.377 1.071 . . . . 0.0 113.461 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.4 152.04 21.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.439 HD22 ' CH2' ' A' ' 546' ' ' TRP . 4.7 mp -132.69 164.18 27.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.291 0.637 . . . . 0.0 109.669 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.92 149.33 36.68 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.001 0.429 . . . . 0.0 111.957 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -114.74 145.56 41.94 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.759 1.223 . . . . 0.0 109.599 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.77 165.41 30.62 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.374 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 58.02 23.78 10.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.403 1.081 . . . . 0.0 113.422 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -81.74 157.89 68.84 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.86 156.35 28.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -80.38 -1.17 40.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -103.53 5.26 36.64 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.662 0.385 . . . . 0.0 111.983 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -89.79 152.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.061 0.391 . . . . 0.0 111.672 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 68.5 p -144.86 175.62 10.07 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.181 0.992 . . . . 0.0 109.654 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.78 -26.25 68.62 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.439 -0.163 . . . . 0.0 111.149 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.58 -26.22 60.72 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.439 -0.163 . . . . 0.0 110.574 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -79.64 -31.67 41.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.59 -26.52 62.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.22 -0.3 . . . . 0.0 110.486 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -80.03 -39.36 30.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.933 0.333 . . . . 0.0 111.558 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.11 -17.1 53.49 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.24 0.473 . . . . 0.0 112.275 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.21 -36.53 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 82.2 m -67.95 -22.15 65.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.676 -0.64 . . . . 0.0 110.573 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.44 -30.5 63.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 119.658 -0.21 . . . . 0.0 111.565 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.12 -11.73 37.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.108 0.413 . . . . 0.0 111.527 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.32 -7.15 48.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.657 0.383 . . . . 0.0 110.411 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.9 11.33 78.39 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.855 -0.414 . . . . 0.0 112.665 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.6 m -95.58 170.83 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 117.817 0.809 . . . . 0.0 111.61 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -74.14 147.91 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.477 0.711 . . . . 0.0 110.236 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -97.07 146.17 30.85 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.21 148.97 92.61 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.01 2.473 . . . . 0.0 110.375 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 84.7 m -82.11 -25.01 34.83 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.467 0.307 . . . . 0.0 110.841 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 51.1 m -143.4 151.63 40.61 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.936 0.494 . . . . 0.0 109.848 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.59 141.82 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 122.952 0.501 . . . . 0.0 110.328 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.7 120.18 7.42 Favored 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.09 147.53 30.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 C-N-CA 123.353 0.661 . . . . 0.0 109.557 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -148.65 130.05 14.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.513 0.196 . . . . 0.0 111.317 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.6 p -130.98 50.58 2.22 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.005 0.522 . . . . 0.0 110.983 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -82.07 -11.78 81.96 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -151.07 155.65 39.43 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 124.532 1.133 . . . . 0.0 108.003 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 14.8 t 55.27 28.86 11.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.881 0.309 . . . . 0.0 111.014 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -57.98 -7.09 0.68 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.895 1.278 . . . . 0.0 113.909 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -66.4 -9.76 36.91 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.452 0.569 . . . . 0.0 110.303 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 85.4 p -145.4 173.22 12.18 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.386 1.475 . . . . 0.0 109.119 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -124.3 148.38 47.47 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 122.631 0.372 . . . . 0.0 111.65 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.4 m -145.16 158.53 43.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.268 1.027 . . . . 0.0 109.12 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 179.45 178.48 48.39 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.943 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.497 ' C ' HD22 ' A' ' 544' ' ' LEU . 8.6 mp -116.9 144.64 44.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 109.82 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.497 HD22 ' C ' ' A' ' 543' ' ' LEU . 3.2 mm? -128.93 142.04 51.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.87 113.2 15.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.439 ' CH2' HD22 ' A' ' 500' ' ' LEU . 4.2 p90 -165.93 149.13 7.57 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -155.35 126.34 7.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 548' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 43.6 t -159.53 161.32 35.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 169.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.56 -51.21 45.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.881 0.764 . . . . 0.0 110.448 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 72.5 p -89.28 -27.24 20.69 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 551' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 25.0 m-20 -82.42 -27.57 31.9 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.987 0.812 . . . . 0.0 110.802 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -85.58 -31.99 22.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.432 0.56 . . . . 0.0 110.576 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 41.6 tp -73.92 -30.09 62.38 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.228 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.52 -42.7 58.44 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.6 m -68.24 -39.16 82.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.71 -42.21 82.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.96 -19.49 77.09 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.145 -0.808 . . . . 0.0 113.582 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -113.86 -16.95 12.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.685 1.242 . . . . 0.0 112.903 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.67 -21.79 22.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.061 0.846 . . . . 0.0 111.801 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -74.21 147.83 42.15 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.573 0.624 . . . . 0.0 109.721 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.8 t60 53.81 29.01 9.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.92 0.888 . . . . 0.0 113.259 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.98 151.39 24.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -117.51 136.42 53.25 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.873 1.269 . . . . 0.0 110.427 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 564' ' ' MET . . . . . 0.411 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 4.8 ttt -64.18 169.47 4.48 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.767 0.827 . . . . 0.0 111.464 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -79.39 22.99 0.41 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 112.831 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 36.5 p30 -64.65 147.52 97.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 122.109 -0.369 . . . . 0.0 110.331 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.72 -32.31 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.419 2.746 . . . . 0.0 113.872 -169.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -121.04 2.02 10.41 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.46 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.53 37.92 95.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.072 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 92.6 Cg_endo -71.37 -9.05 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.97 2.446 . . . . 0.0 112.291 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -145.75 150.39 42.99 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.311 0.505 . . . . 0.0 110.765 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.77 156.21 39.57 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.059 3.173 . . . . 0.0 110.634 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 573' ' ' TYR . . . . . 0.411 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 70.4 t80 -140.86 -1.44 1.41 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 4.9 t -66.39 131.92 47.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.484 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.93 144.65 50.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.917 0.887 . . . . 0.0 109.086 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -89.7 134.75 34.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 153.19 39.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.944 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 32.1 p -163.36 176.76 9.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.861 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -72.19 143.19 48.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.8 t -135.64 146.27 47.68 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.363 0.665 . . . . 0.0 110.451 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 51.8 m -87.17 102.16 14.2 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.25 161.47 34.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.997 0.919 . . . . 0.0 110.053 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -93.92 -19.6 20.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -161.27 162.45 31.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.141 0.976 . . . . 0.0 109.441 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.17 76.48 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.637 -1.173 . . . . 0.0 110.253 -179.472 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.416 0.151 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -144.54 143.22 30.72 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLY . . . . . 0.436 ' N ' ' CD ' ' A' ' 374' ' ' PRO . . . 67.69 37.49 89.07 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.49 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 373' ' ' GLY . 86.5 Cg_endo -72.76 -27.94 14.31 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.238 2.019 . . . . 0.0 111.626 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -163.41 161.39 24.34 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.565 0.746 . . . . 0.0 110.38 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -80.77 163.93 23.12 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.961 0.504 . . . . 0.0 110.194 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.1 -2.95 53.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.7 m -152.06 153.86 31.81 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.158 0.583 . . . . 0.0 110.979 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.44 -5.03 10.16 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.507 3.471 . . . . 0.0 113.546 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.2 t -126.91 151.33 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 118.498 0.59 . . . . 0.0 111.176 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' LEU . . . . . 0.403 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.6 pp -138.12 164.46 29.08 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.71 0.804 . . . . 0.0 109.531 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.3 mtp -136.45 148.29 47.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.736 0.414 . . . . 0.0 110.11 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.56 149.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 122.85 0.46 . . . . 0.0 110.424 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -140.44 165.85 26.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.666 0.786 . . . . 0.0 109.286 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 81.9 -1.21 87.15 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.703 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.72 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.0 pt? -71.64 172.39 9.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.194 0.997 . . . . 0.0 110.048 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -130.42 127.25 38.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -68.11 -2.91 8.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 87.8 p -108.29 -2.84 18.9 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -130.13 -12.23 4.12 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.376 0.67 . . . . 0.0 111.055 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.07 125.95 10.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.372 0.669 . . . . 0.0 109.328 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -141.87 -172.16 3.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.0 -25.65 61.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.83 -25.78 24.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.879 -0.513 . . . . 0.0 111.799 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -91.97 -25.2 18.98 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 122.265 -0.272 . . . . 0.0 111.178 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.8 -27.26 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.55 -42.89 67.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.695 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -80.63 -8.64 59.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.564 0.62 . . . . 0.0 112.653 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.78 -24.35 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 118.214 0.461 . . . . 0.0 110.932 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -107.33 -13.72 15.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.4 t -69.56 -28.71 66.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.27 0.941 . . . . 0.0 111.562 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.76 14.2 1.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.734 -0.604 . . . . 0.0 112.209 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -119.59 -2.75 10.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.419 0.688 . . . . 0.0 110.22 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 143.07 165.84 10.85 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.17 152.67 44.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.212 -0.581 . . . . 0.0 110.957 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.07 146.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.82 -57.75 2.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.997 -0.439 . . . . 0.0 109.905 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -166.38 164.83 17.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.971 0.509 . . . . 0.0 110.687 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.89 149.73 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.483 0.713 . . . . 0.0 110.105 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -152.22 144.18 23.75 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -75.52 154.52 36.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.654 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 9.1 tmm? -129.33 141.16 51.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.285 0.564 . . . . 0.0 112.51 -168.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.51 33.75 19.6 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.69 1.596 . . . . 0.0 111.885 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.2 m 52.91 15.84 0.62 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.354 1.062 . . . . 0.0 113.59 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.74 145.63 75.04 Favored Pre-proline 0 C--N 1.339 0.122 0 CA-C-N 118.156 0.435 . . . . 0.0 110.086 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 4.03 6.97 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.83 3.02 . . . . 0.0 110.604 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -146.84 30.73 1.51 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.278 -0.735 . . . . 0.0 113.209 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.654 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -149.78 138.31 20.75 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.355 1.078 . . . . 0.0 110.537 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.89 19.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.034 0.445 . . . . 0.0 111.808 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 7.6 ptp -135.76 150.6 49.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.806 0.843 . . . . 0.0 110.394 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.47 149.47 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.286 0.634 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -130.71 133.44 46.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.531 0.732 . . . . 0.0 109.913 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.1 mmm -106.1 161.29 14.63 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.943 0.497 . . . . 0.0 110.981 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.79 -18.79 60.41 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.448 0.299 . . . . 0.0 111.762 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -154.28 155.86 35.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.679 0.392 . . . . 0.0 110.222 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.44 -15.95 75.39 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.429 -0.65 . . . . 0.0 113.078 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -26.45 59.62 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.057 1.428 . . . . 0.0 110.701 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.78 -27.23 60.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.72 -29.79 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.39 -40.54 73.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.187 -0.321 . . . . 0.0 110.626 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.45 -34.92 35.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.52 -29.96 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 121.964 -0.46 . . . . 0.0 111.404 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 17.7 m -95.26 -18.9 20.45 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -136.46 -10.78 1.89 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -108.03 -21.76 12.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.376 0.989 . . . . 0.0 108.802 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -51.87 143.46 13.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.218 1.007 . . . . 0.0 110.956 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 57.11 1.47 0.1 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.535 1.934 . . . . 0.0 115.733 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.88 142.43 27.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 120.757 1.617 . . . . 0.0 107.968 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.332 0.0 OUTLIER -130.88 163.88 26.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 175.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 20.5 ptm -125.37 143.34 51.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.651 1.18 . . . . 0.0 110.405 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.73 28.3 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.96 15.71 64.63 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.14 151.02 25.9 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.093 1.447 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -84.7 137.91 32.95 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -94.54 123.97 38.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -168.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -140.72 115.87 9.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 141.01 16.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.214 0.461 . . . . 0.0 110.178 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.41 163.34 37.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.663 0.785 . . . . 0.0 110.126 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.1 p -84.57 155.64 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.6 t -136.6 155.37 50.01 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.073 0.397 . . . . 0.0 111.22 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -93.17 7.04 45.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -66.54 140.02 96.33 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.94 -25.8 10.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.944 2.429 . . . . 0.0 111.319 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.1 171.28 15.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.487 0.715 . . . . 0.0 109.87 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 41.9 mm -68.68 136.91 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -91.73 153.85 43.85 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.32 164.4 8.85 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.847 3.031 . . . . 0.0 112.53 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 163.84 174.73 34.0 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.31 160.97 29.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.1 p -137.33 153.87 50.17 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.048 0.539 . . . . 0.0 110.512 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -144.59 165.09 29.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.249 0.62 . . . . 0.0 109.848 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.62 137.66 17.78 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.22 167.34 14.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 109.551 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.97 -20.0 65.01 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.056 -0.403 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.87 0.88 37.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.909 0.322 . . . . 0.0 111.235 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.7 -2.04 87.17 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.594 -0.559 . . . . 0.0 113.211 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.39 163.19 13.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.103 0.952 . . . . 0.0 110.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.3 m -84.54 153.36 23.31 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.811 0.444 . . . . 0.0 110.902 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.8 p -73.09 -10.33 59.67 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.025 0.53 . . . . 0.0 111.577 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -132.8 143.65 49.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.151 0.98 . . . . 0.0 109.747 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -156.1 159.24 38.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.578 0.351 . . . . 0.0 110.3 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.95 153.23 52.15 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.189 0.595 . . . . 0.0 110.851 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.63 15.49 2.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.034 0.534 . . . . 0.0 111.282 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.0 p -66.88 -11.08 54.72 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.361 0.664 . . . . 0.0 112.544 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -81.67 -4.86 57.33 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.925 -0.485 . . . . 0.0 110.773 177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.5 m -107.8 20.12 19.2 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.661 0.784 . . . . 0.0 111.453 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -73.9 -2.43 23.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.688 0.395 . . . . 0.0 111.226 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -82.56 5.48 20.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.434 0.694 . . . . 0.0 111.095 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -59.43 155.04 15.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.968 0.907 . . . . 0.0 110.79 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -81.09 4.54 19.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.581 0.752 . . . . 0.0 112.509 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -146.52 30.49 1.0 Allowed 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.081 -0.387 . . . . 0.0 110.697 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 79.5 p -76.07 -9.75 58.87 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.051 -0.405 . . . . 0.0 111.664 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 485' ' ' PRO . 5.1 t -150.81 149.7 26.18 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 123.483 0.713 . . . . 0.0 109.249 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 485' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 484' ' ' THR . 75.7 Cg_exo -56.03 -20.7 31.31 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.717 2.945 . . . . 0.0 114.481 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.37 -22.49 30.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.462 0.573 . . . . 0.0 111.531 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -90.49 -27.31 19.3 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -78.17 22.48 0.31 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.839 0.855 . . . . 0.0 111.656 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -104.91 -7.52 19.27 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.403 0.681 . . . . 0.0 111.218 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -104.77 4.89 32.81 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.608 0.763 . . . . 0.0 110.202 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -152.72 171.96 17.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.536 1.135 . . . . 0.0 109.132 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -123.15 136.8 54.93 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.4 mm -113.56 148.56 16.38 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 123.455 0.702 . . . . 0.0 110.638 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? 60.8 -17.59 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.101 1.76 . . . . 0.0 115.373 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.97 119.75 44.28 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.564 1.075 . . . . 0.0 110.324 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.08 113.35 3.59 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.567 2.845 . . . . 0.0 110.804 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 52.4 m -123.96 13.42 9.13 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.388 0.675 . . . . 0.0 111.942 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 57.14 16.91 3.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.725 1.21 . . . . 0.0 113.722 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 74.1 t -134.51 141.44 43.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 118.419 0.554 . . . . 0.0 109.886 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.58 163.69 18.5 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 108.7 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.26 146.88 35.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.864 0.364 . . . . 0.0 111.729 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -112.71 150.01 32.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.572 1.149 . . . . 0.0 109.565 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -147.63 169.95 18.54 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 122.674 0.39 . . . . 0.0 111.175 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 29.0 m120 59.71 17.91 6.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.599 1.16 . . . . 0.0 113.747 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.69 156.09 73.08 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.85 154.79 36.07 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.921 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.5 pt? -72.69 -1.08 14.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.94 4.74 32.15 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.084 0.402 . . . . 0.0 111.723 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -81.64 148.69 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 O-C-N 122.062 -0.398 . . . . 0.0 110.6 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 72.4 p -144.14 174.01 11.25 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.849 0.86 . . . . 0.0 109.93 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.5 -24.59 67.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.796 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.97 -23.11 55.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.428 -0.17 . . . . 0.0 110.657 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -82.05 -28.88 32.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.85 -31.36 66.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -74.74 -38.7 62.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.753 0.252 . . . . 0.0 111.187 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.86 -14.4 59.26 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.09 0.405 . . . . 0.0 111.569 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.69 -38.51 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.617 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.5 m -67.06 -24.69 66.0 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.826 0.739 . . . . 0.0 110.537 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.16 -28.1 61.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.98 -17.5 26.22 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' LEU . . . . . 0.437 HD11 HG22 ' A' ' 523' ' ' VAL . 4.3 pp -102.58 5.24 39.16 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 79.45 35.25 29.87 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.867 1.107 . . . . 0.0 115.867 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.437 HG22 HD11 ' A' ' 521' ' ' LEU . 11.1 m -130.47 168.3 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.2 1.5 . . . . 0.0 111.833 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.29 150.64 31.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.973 0.909 . . . . 0.0 110.855 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -87.58 152.89 52.58 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.364 0.666 . . . . 0.0 110.186 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.61 153.4 75.29 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.516 2.811 . . . . 0.0 111.105 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.427 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 86.4 m -82.34 -25.03 34.24 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.679 0.392 . . . . 0.0 110.707 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 13.6 t -142.83 156.48 44.96 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.562 0.345 . . . . 0.0 110.115 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.9 p -149.51 141.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.094 0.558 . . . . 0.0 110.758 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 121.59 8.85 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.16 144.63 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 122.848 0.459 . . . . 0.0 110.997 -173.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -149.89 159.22 44.55 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.271 1.028 . . . . 0.0 109.547 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.2 p -121.62 150.65 41.41 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.979 0.511 . . . . 0.0 110.942 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -89.65 151.86 22.1 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -82.55 141.06 32.9 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 27.1 m 56.33 11.1 0.74 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.309 1.044 . . . . 0.0 113.785 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -106.49 -10.27 16.33 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.05 0.387 . . . . 0.0 111.103 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 48.98 28.62 2.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.445 1.098 . . . . 0.0 113.125 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.5 m -137.75 161.15 37.31 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.532 0.333 . . . . 0.0 111.349 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.9 t -132.07 155.0 48.86 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.179 0.991 . . . . 0.0 111.071 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 80.3 p -152.95 166.69 31.6 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.231 1.012 . . . . 0.0 110.37 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.01 177.89 44.45 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.873 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.43 ' C ' HD22 ' A' ' 544' ' ' LEU . 11.2 mp -112.79 144.28 42.6 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.84 0.856 . . . . 0.0 110.196 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.43 HD22 ' C ' ' A' ' 543' ' ' LEU . 3.2 mm? -127.06 139.86 52.7 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.78 108.35 10.66 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.427 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.9 OUTLIER -166.1 155.72 11.95 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.548 1.539 . . . . 0.0 107.347 168.167 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -153.87 126.01 7.89 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.9 t -159.63 153.05 22.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.603 1.561 . . . . 0.0 107.013 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.46 -52.24 64.3 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.096 0.407 . . . . 0.0 111.728 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 38.8 m -85.4 -21.9 28.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -78.95 -35.43 43.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.175 -0.328 . . . . 0.0 110.795 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.96 39.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.28 -0.391 . . . . 0.0 111.166 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 47.1 tp -76.22 -29.7 57.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.776 0.716 . . . . 0.0 111.48 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.81 -40.1 55.61 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.826 -0.546 . . . . 0.0 110.221 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 49.0 m -68.73 -36.8 78.87 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.1 -41.74 99.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.61 -23.02 78.56 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.784 -172.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.14 -20.37 7.42 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.095 1.447 . . . . 0.0 113.883 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 37.3 tp -93.73 -23.16 18.31 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.635 1.107 . . . . 0.0 112.022 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -75.18 136.42 41.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 53.15 27.14 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.845 0.858 . . . . 0.0 113.093 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -78.19 151.38 33.22 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.185 0.594 . . . . 0.0 112.169 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -101.58 136.41 41.46 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.838 1.255 . . . . 0.0 110.03 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.4 ttt -64.17 169.56 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.645 0.378 . . . . 0.0 111.032 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -75.61 17.49 0.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -69.0 145.64 96.76 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.872 -0.518 . . . . 0.0 109.764 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.97 -30.56 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.487 2.791 . . . . 0.0 113.924 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -120.89 0.57 10.31 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.157 0.435 . . . . 0.0 112.114 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 39.81 97.76 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.77 -1.017 . . . . 0.0 112.75 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 74.9 Cg_endo -69.56 -10.11 27.88 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 112.016 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -142.67 148.35 46.1 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.28 154.41 36.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.921 3.081 . . . . 0.0 111.333 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -148.34 -0.7 0.56 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.904 0.482 . . . . 0.0 111.534 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 48.1 p -66.38 129.28 39.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.11 144.56 50.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.647 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -96.09 139.81 31.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.516 0.726 . . . . 0.0 109.09 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.66 151.94 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.578 0.228 . . . . 0.0 111.007 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.2 p -161.7 178.96 8.52 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.974 0.509 . . . . 0.0 110.082 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -71.64 144.27 49.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.442 0.297 . . . . 0.0 110.48 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 30.9 t -135.55 145.04 46.59 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 122.888 0.475 . . . . 0.0 110.782 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 88.5 m -93.88 102.22 14.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.3 161.53 34.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.904 0.882 . . . . 0.0 110.258 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.44 -14.47 17.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -161.36 166.85 26.81 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.586 1.154 . . . . 0.0 108.655 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -79.24 76.39 5.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.447 -1.263 . . . . 0.0 110.031 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -137.39 8.5 2.89 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.775 0.43 . . . . 0.0 111.781 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 176.87 177.21 45.65 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.23 168.63 23.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.876 3.05 . . . . 0.0 111.094 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -148.76 152.9 37.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.272 0.629 . . . . 0.0 109.75 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -91.12 156.78 17.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 111.118 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -142.87 12.53 1.86 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.095 0.558 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 39.8 t -155.98 147.41 16.84 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 123.462 0.705 . . . . 0.0 110.044 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 4.86 5.22 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.635 2.89 . . . . 0.0 111.454 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.54 151.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.694 0.798 . . . . 0.0 110.382 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.5 pp -142.7 167.95 20.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.728 0.811 . . . . 0.0 109.771 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 71.6 mtp -135.57 152.8 51.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.637 0.256 . . . . 0.0 111.052 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.06 149.02 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 122.901 0.48 . . . . 0.0 110.413 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -141.41 168.75 19.02 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.477 0.711 . . . . 0.0 109.5 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.87 -2.0 87.34 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.874 -0.403 . . . . 0.0 112.616 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.775 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -74.44 171.97 12.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.48 0.64 . . . . 0.0 110.649 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -132.57 132.26 42.37 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -68.58 -4.51 15.59 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.5 t -102.11 -12.2 18.26 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.616 0.366 . . . . 0.0 111.9 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -131.98 -13.9 3.14 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.139 0.427 . . . . 0.0 111.876 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.0 tpt -148.59 106.01 3.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.758 0.823 . . . . 0.0 109.242 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -141.81 -166.78 2.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.766 0.426 . . . . 0.0 110.397 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 73.2 m -53.93 -27.74 32.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.118 0.567 . . . . 0.0 112.509 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.43 -34.12 28.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.922 -0.486 . . . . 0.0 111.007 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -83.51 -28.4 28.69 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.266 -0.271 . . . . 0.0 110.322 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.08 -30.29 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -68.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -70.51 -27.9 64.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.297 -0.382 . . . . 0.0 111.901 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 75.1 t -95.11 -21.55 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -109.51 -12.05 14.74 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.94 -27.34 65.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.143 0.883 . . . . 0.0 111.418 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.46 14.57 1.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.46 2.87 10.24 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.8 0.84 . . . . 0.0 109.982 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 130.6 158.32 9.26 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -172.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -68.96 153.57 43.56 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.056 0.928 . . . . 0.0 111.228 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.72 154.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -97.84 -60.75 1.5 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -164.18 163.42 22.93 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.466 0.706 . . . . 0.0 110.854 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.36 150.74 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -152.13 145.35 24.66 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.509 0.324 . . . . 0.0 110.181 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -79.34 158.91 27.36 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -136.66 141.4 43.17 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -168.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 59.79 33.95 21.81 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 125.136 1.374 . . . . 0.0 112.505 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 23.2 m 53.01 15.39 0.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -81.87 132.56 53.91 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 118.691 0.678 . . . . 0.0 110.043 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.61 -3.68 8.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.543 2.828 . . . . 0.0 112.351 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.19 33.35 2.25 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.478 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.77 133.7 19.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.125 0.962 . . . . 0.0 110.357 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.38 169.17 24.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.198 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.2 ptm -143.49 146.56 33.49 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.278 0.631 . . . . 0.0 109.658 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.31 147.79 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.12 0.568 . . . . 0.0 110.586 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -122.18 135.96 54.84 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.5 mmm -105.25 164.25 11.98 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.485 0.314 . . . . 0.0 110.878 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.99 66.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.99 159.2 36.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.35 0.66 . . . . 0.0 109.333 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.33 -17.0 69.9 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.068 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -68.37 -29.92 68.74 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.004 1.402 . . . . 0.0 110.178 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -73.51 -21.82 60.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.197 -0.314 . . . . 0.0 110.707 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.71 -35.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.88 -36.5 78.14 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.666 0.212 . . . . 0.0 110.677 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.08 -35.01 78.88 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.05 56.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.099 -0.376 . . . . 0.0 110.621 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -29.12 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.184 0.516 . . . . 0.0 111.855 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.8 p -91.17 -13.22 33.32 Favored 'General case' 0 C--N 1.342 0.277 0 O-C-N 121.067 -1.021 . . . . 0.0 113.592 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -138.44 -10.62 1.42 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.3 -14.52 13.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.226 0.921 . . . . 0.0 110.456 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -56.1 142.38 36.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 56.96 1.42 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.72 1.608 . . . . 0.0 114.991 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -87.77 142.6 27.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 120.058 1.299 . . . . 0.0 109.164 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.263 0.1 OUTLIER -130.91 164.0 26.23 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.316 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.4 ptm -125.18 143.42 50.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.86 1.264 . . . . 0.0 108.44 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 68.76 21.87 7.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.359 1.463 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.94 15.8 78.35 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -83.07 162.14 21.45 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.815 1.308 . . . . 0.0 110.68 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.46 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -79.71 132.34 36.17 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.292 0.237 . . . . 0.0 110.493 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.58 135.69 39.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -170.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -140.72 120.19 13.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.36 145.27 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 118.316 0.507 . . . . 0.0 110.378 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -157.68 161.25 38.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.754 0.422 . . . . 0.0 110.408 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.6 p -83.15 151.44 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 21.1 t -100.58 -169.03 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.639 0.375 . . . . 0.0 110.018 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -136.83 0.21 2.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.826 0.45 . . . . 0.0 110.691 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -74.27 148.94 86.62 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.29 -24.77 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.868 2.378 . . . . 0.0 111.794 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.09 170.11 15.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.319 0.647 . . . . 0.0 110.352 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.3 mm -67.14 143.92 15.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.1 mtt -107.77 156.89 37.26 Favored Pre-proline 0 C--O 1.232 0.15 0 C-N-CA 122.338 0.255 . . . . 0.0 111.109 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.68 157.88 21.98 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.928 3.085 . . . . 0.0 112.604 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.3 -179.13 42.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -74.02 150.13 40.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.615 -0.344 . . . . 0.0 110.481 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.9 m -143.69 147.66 34.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -145.97 167.88 22.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.861 0.464 . . . . 0.0 110.477 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.98 137.47 20.0 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.3 167.44 14.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.287 0.635 . . . . 0.0 110.007 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.72 -20.19 65.23 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.368 0.267 . . . . 0.0 111.379 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.1 -1.22 31.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.997 0.519 . . . . 0.0 110.954 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.2 -5.2 73.19 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.89 -0.506 . . . . 0.0 112.237 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 63.9 m -87.2 161.2 18.17 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.799 0.8 . . . . 0.0 110.072 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 80.3 m -85.22 153.35 22.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.48 0.181 . . . . 0.0 110.582 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.5 p -73.01 -10.48 59.85 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.466 0.306 . . . . 0.0 111.416 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.25 141.64 51.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.127 0.971 . . . . 0.0 109.487 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -155.25 156.84 36.31 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.548 0.339 . . . . 0.0 110.191 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.89 154.65 50.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.462 0.705 . . . . 0.0 110.547 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.12 15.85 2.08 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 122.723 0.409 . . . . 0.0 111.514 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 87.8 p -65.65 -12.49 53.88 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.23 -6.62 59.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.992 0.36 . . . . 0.0 111.376 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.5 m -96.66 15.55 21.47 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.488 0.715 . . . . 0.0 111.321 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -74.13 -1.07 18.68 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.126 0.571 . . . . 0.0 111.756 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -94.9 19.99 9.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.319 0.648 . . . . 0.0 110.942 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -69.73 163.94 24.6 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.02 0.528 . . . . 0.0 111.025 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.08 -2.54 21.73 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.773 0.829 . . . . 0.0 112.919 -176.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -149.7 29.26 0.76 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.103 0.411 . . . . 0.0 111.549 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.3 p -72.91 -6.99 48.87 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 46.2 p -139.65 159.15 66.44 Favored Pre-proline 0 C--O 1.231 0.094 0 C-N-CA 122.894 0.478 . . . . 0.0 109.959 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -60.99 -14.03 30.71 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.282 2.655 . . . . 0.0 112.643 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -90.71 -31.01 16.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.479 0.312 . . . . 0.0 111.032 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -90.56 -23.82 20.77 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.428 0.291 . . . . 0.0 110.346 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -83.74 26.03 0.73 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.686 0.794 . . . . 0.0 111.569 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -101.5 2.71 39.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.311 0.644 . . . . 0.0 111.533 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -119.23 4.4 11.29 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.315 0.646 . . . . 0.0 111.662 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -139.34 -17.9 1.0 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 59.6 146.58 0.01 OUTLIER 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.723 1.609 . . . . 0.0 113.33 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.7 mm -113.6 148.77 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.971 0.908 . . . . 0.0 111.141 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER 55.04 11.63 0.53 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.848 2.059 . . . . 0.0 115.352 175.17 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -103.4 120.97 50.18 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.92 131.55 15.81 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.015 2.477 . . . . 0.0 110.557 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 87.8 p -124.16 -1.3 8.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.544 0.738 . . . . 0.0 112.119 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.53 16.21 5.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.069 0.948 . . . . 0.0 112.167 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.2 t -135.97 138.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.418 HD12 ' CH2' ' A' ' 546' ' ' TRP . 46.9 mt -120.26 152.69 37.41 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.08 145.8 49.02 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -131.93 151.71 51.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.613 0.244 . . . . 0.0 110.576 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -147.36 171.08 16.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 111.094 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.46 25.95 14.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.512 1.125 . . . . 0.0 113.236 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.74 63.93 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.88 159.7 52.36 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.206 1.938 . . . . 0.0 110.194 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.2 pt? -73.95 -1.07 18.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.87 4.51 42.81 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -86.41 150.22 3.93 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 CA-C-N 118.251 0.478 . . . . 0.0 111.347 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -147.2 174.34 11.7 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.939 0.896 . . . . 0.0 109.522 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.23 -24.67 67.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.499 -0.126 . . . . 0.0 110.925 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.1 -24.95 51.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.179 -0.325 . . . . 0.0 110.718 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.3 -28.35 38.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -73.71 -30.79 63.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.203 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -75.25 -36.32 61.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.287 -0.258 . . . . 0.0 111.544 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.46 -21.24 42.24 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.266 0.485 . . . . 0.0 111.55 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.91 -37.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 86.8 m -67.38 -26.48 66.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.091 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.42 -29.12 62.37 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -91.06 -11.84 37.49 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.526 0.603 . . . . 0.0 111.895 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 86.3 mt -100.7 -5.44 26.5 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.644 0.377 . . . . 0.0 111.277 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.24 5.62 72.27 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.866 -0.408 . . . . 0.0 112.907 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.4 m -91.43 167.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 117.65 0.725 . . . . 0.0 110.953 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -76.63 151.84 36.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.384 0.674 . . . . 0.0 110.173 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 525' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 526' ' ' PRO . 4.7 ptp180 -102.16 150.9 37.91 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 526' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 525' ' ' ARG . 32.1 Cg_exo -60.15 158.98 27.89 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.404 2.736 . . . . 0.0 112.64 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.501 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 91.4 m -86.36 -25.07 25.55 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.072 0.549 . . . . 0.0 110.499 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.1 t -145.23 152.25 39.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.1 t -141.37 140.93 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.348 0.659 . . . . 0.0 109.775 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.97 126.51 15.94 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.8 t -132.05 149.43 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.032 0 C-N-CA 122.667 0.387 . . . . 0.0 110.673 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -152.3 153.75 34.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.272 0.629 . . . . 0.0 110.17 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 62.5 p -130.84 141.37 50.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.106 0.563 . . . . 0.0 109.907 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -80.99 157.51 39.35 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -72.42 130.67 41.24 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.45 -0.441 . . . . 0.0 110.052 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 27.0 m 55.94 14.93 1.53 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -90.58 -9.97 45.12 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.291 0.496 . . . . 0.0 111.356 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 44.43 26.95 0.2 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.132 1.373 . . . . 0.0 113.626 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 36.2 m -139.61 164.45 29.89 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.396 0.678 . . . . 0.0 110.351 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 34.3 t -132.91 153.7 51.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 111.089 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 67.6 m -146.65 164.61 32.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.059 1.343 . . . . 0.0 108.854 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -179.26 -175.07 45.91 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.01 -1.091 . . . . 0.0 113.857 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.11 153.49 42.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.188 0.995 . . . . 0.0 109.763 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 72.8 mt -136.52 136.9 39.76 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.043 0.937 . . . . 0.0 108.903 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -127.86 109.2 11.38 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.501 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.8 OUTLIER -166.12 155.01 11.28 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.826 1.25 . . . . 0.0 108.579 168.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -149.78 121.02 7.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 548' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 37.8 t -159.55 153.22 22.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -66.47 -46.92 74.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.767 0.712 . . . . 0.0 111.211 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 67.7 p -85.89 -27.84 24.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 551' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 48.6 m-20 -84.05 -30.01 26.41 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.578 0.626 . . . . 0.0 111.078 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.04 27.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.339 0.518 . . . . 0.0 111.236 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.74 -30.6 28.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.853 0.751 . . . . 0.0 112.024 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.82 -42.58 49.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.475 0.58 . . . . 0.0 110.482 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 43.3 m -68.88 -36.38 78.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.68 -41.48 83.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.7 -17.3 76.53 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.957 -0.913 . . . . 0.0 113.544 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.92 -19.22 7.33 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.757 1.279 . . . . 0.0 114.29 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -90.82 -31.25 16.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.056 0.844 . . . . 0.0 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -62.29 139.58 58.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 51.39 23.23 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.366 1.066 . . . . 0.0 113.604 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -74.4 151.33 39.69 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -99.87 136.25 40.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.482 1.113 . . . . 0.0 109.733 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 564' ' ' MET . . . . . 0.421 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.3 ttt -64.34 172.42 2.55 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.311 0.577 . . . . 0.0 112.208 -172.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 565' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.3 ptmt -66.94 3.43 1.09 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.699 1.2 . . . . 0.0 113.712 -176.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -67.86 144.74 97.53 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 118.634 0.652 . . . . 0.0 110.727 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.98 -27.32 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.542 2.828 . . . . 0.0 113.784 -171.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -121.08 -3.06 9.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.205 0.457 . . . . 0.0 112.026 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.06 40.52 98.24 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.69 -1.061 . . . . 0.0 112.806 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 83.5 Cg_endo -69.69 -9.64 26.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.103 2.535 . . . . 0.0 111.823 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -142.19 147.74 45.18 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.023 0.529 . . . . 0.0 109.648 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.48 152.85 34.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.805 3.004 . . . . 0.0 111.565 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -148.83 -3.21 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.133 0.573 . . . . 0.0 111.493 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.44 120.94 14.22 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.701 -0.624 . . . . 0.0 110.044 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.96 144.63 50.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.093 0.957 . . . . 0.0 109.934 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -86.3 154.55 21.16 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 55.0 tp -144.12 144.84 31.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.96 168.38 19.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -77.07 130.86 37.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.9 t -135.57 138.2 42.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 32.9 p -79.7 102.25 8.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.336 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 159.92 39.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 109.144 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -81.85 -32.47 31.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.189 -0.319 . . . . 0.0 110.228 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -153.66 165.81 34.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.944 0.898 . . . . 0.0 109.571 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.43 76.32 7.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.354 -179.473 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -144.69 0.76 0.99 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.864 0.466 . . . . 0.0 111.993 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -71.5 136.02 24.3 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.64 -175.3 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.851 3.701 . . . . 0.0 110.298 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.49 149.08 38.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -70.25 158.31 36.09 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.89 0.376 . . . . 0.0 111.064 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.43 -0.58 57.35 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.336 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 43.0 t -160.27 146.56 11.81 Favored Pre-proline 0 N--CA 1.456 -0.164 0 C-N-CA 123.197 0.599 . . . . 0.0 110.355 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.14 4.34 6.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.118 3.212 . . . . 0.0 112.091 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.05 151.79 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 123.364 0.666 . . . . 0.0 110.699 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 381' ' ' LEU . 4.5 pp -141.58 167.07 23.03 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.807 0.843 . . . . 0.0 109.627 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 70.0 mtp -134.19 151.08 51.15 Favored 'General case' 0 N--CA 1.458 -0.042 0 C-N-CA 122.459 0.304 . . . . 0.0 111.084 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.9 148.15 19.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.834 0.454 . . . . 0.0 110.427 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -140.11 168.06 20.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.488 0.715 . . . . 0.0 109.369 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.45 -6.44 80.04 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.354 -0.692 . . . . 0.0 113.05 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.71 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -68.98 177.67 2.54 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.998 0.899 . . . . 0.0 110.387 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -142.78 136.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -73.63 -7.14 50.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 96.0 p -93.2 -12.03 31.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.605 0.639 . . . . 0.0 112.592 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.47 5.89 0.94 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.5 ttt -141.26 129.14 21.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.94 177.81 7.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.755 0.422 . . . . 0.0 110.213 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.57 -28.06 63.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.56 0.344 . . . . 0.0 111.203 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.66 -23.08 29.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.052 -0.405 . . . . 0.0 111.376 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -83.85 -34.5 24.62 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.1 -27.48 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.5 -33.84 73.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.018 -0.427 . . . . 0.0 110.183 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -67.88 -29.54 68.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.853 -0.529 . . . . 0.0 111.086 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 80.3 t -90.36 -29.64 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -101.72 -8.68 21.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 53.0 t -71.55 -38.34 71.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.872 0.76 . . . . 0.0 111.333 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.66 12.92 1.45 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.731 -0.606 . . . . 0.0 112.407 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.21 0.75 11.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.278 0.631 . . . . 0.0 111.152 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.16 170.05 14.52 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -70.26 136.42 49.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.351 -0.5 . . . . 0.0 110.759 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 4.5 m -95.1 164.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.773 1.229 . . . . 0.0 110.321 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -125.8 -65.54 0.99 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.325 0.25 . . . . 0.0 110.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -163.37 165.54 23.9 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.067 0.547 . . . . 0.0 111.194 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.63 151.63 14.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.674 0.79 . . . . 0.0 110.363 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.05 147.64 26.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -78.17 158.98 28.85 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.23 141.46 42.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.05 33.9 21.33 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.845 1.258 . . . . 0.0 112.402 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.4 m 53.06 16.06 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 114.129 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -80.61 144.73 57.12 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 118.449 0.568 . . . . 0.0 109.599 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.18 1.83 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.843 3.029 . . . . 0.0 110.831 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -143.27 33.41 1.81 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.164 -173.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.03 19.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.933 0.867 . . . . 0.0 110.133 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.28 170.6 21.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.073 0.464 . . . . 0.0 110.808 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 17.7 ptm -145.05 146.53 31.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.983 0.513 . . . . 0.0 109.672 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.25 147.75 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.026 0 C-N-CA 123.322 0.649 . . . . 0.0 110.742 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -124.58 142.42 51.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.535 0.734 . . . . 0.0 109.773 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.0 mmm -115.63 164.21 14.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 109.797 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.85 64.18 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.392 -0.192 . . . . 0.0 111.251 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.86 160.13 33.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.12 -14.51 63.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.377 -0.679 . . . . 0.0 113.097 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -64.38 -31.19 72.29 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.398 1.599 . . . . 0.0 110.233 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.67 -23.78 45.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.52 -0.113 . . . . 0.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.03 -31.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.04 -31.18 62.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.134 0.425 . . . . 0.0 110.865 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -29.62 65.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.067 -0.396 . . . . 0.0 109.986 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.66 -28.8 40.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.735 0.243 . . . . 0.0 110.59 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.8 tp -81.83 -35.25 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 122.775 0.43 . . . . 0.0 110.059 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 m -89.24 -26.09 21.38 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.91 -11.09 6.6 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.78 -16.76 11.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.424 1.011 . . . . 0.0 110.339 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -54.05 141.67 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.83 0.852 . . . . 0.0 111.514 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 57.04 1.39 0.09 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.045 2.138 . . . . 0.0 115.956 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.75 142.59 27.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 120.786 1.63 . . . . 0.0 108.01 169.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.276 0.0 OUTLIER -130.98 163.86 26.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.3 ptm -125.25 143.47 50.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.466 1.106 . . . . 0.0 109.607 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 66.46 32.94 7.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.178 1.391 . . . . 0.0 113.784 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.0 15.88 72.23 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.654 169.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -83.02 152.82 25.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.521 1.161 . . . . 0.0 110.736 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.564 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -75.42 136.19 40.73 Favored 'General case' 0 C--N 1.337 0.028 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.795 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -97.21 127.16 42.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -140.6 115.87 9.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.83 139.44 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.5 m -148.17 164.37 34.15 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.579 0.752 . . . . 0.0 109.99 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.62 151.9 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.5 t -102.29 -174.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.085 0.554 . . . . 0.0 110.304 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -135.4 7.12 3.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.799 0.84 . . . . 0.0 110.341 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -78.86 147.56 70.74 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.79 -25.46 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.835 2.357 . . . . 0.0 111.978 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.46 170.75 12.58 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.155 0.582 . . . . 0.0 110.443 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -68.22 140.61 18.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.6 mtt -102.37 151.45 38.17 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.416 0.286 . . . . 0.0 110.723 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 161.54 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.729 2.952 . . . . 0.0 111.337 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.65 -175.68 44.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -72.96 158.26 35.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.664 0.385 . . . . 0.0 110.17 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.1 p -146.41 162.49 38.11 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.167 0.587 . . . . 0.0 110.543 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -150.15 163.7 37.53 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.96 0.504 . . . . 0.0 110.208 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.87 135.42 17.88 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.4 mt -86.97 176.4 7.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.904 0.882 . . . . 0.0 109.954 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -65.27 -20.29 66.35 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.392 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.23 0.15 49.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.359 0.664 . . . . 0.0 111.573 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.52 -3.52 77.95 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.286 0.469 . . . . 0.0 112.504 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 60.5 m -93.82 156.69 16.52 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.681 0.74 . . . . 0.0 110.269 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.81 153.35 36.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.456 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.0 p -66.33 -10.39 42.44 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.775 0.43 . . . . 0.0 111.79 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -118.52 137.48 53.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.174 0.99 . . . . 0.0 109.391 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -151.87 154.92 37.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -124.28 152.36 43.11 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.02 0.928 . . . . 0.0 109.84 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -137.94 12.57 2.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.144 0.578 . . . . 0.0 112.276 -175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 97.2 p -70.38 4.53 2.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -107.93 17.31 22.58 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.493 0.717 . . . . 0.0 111.176 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.8 t -58.8 142.19 50.98 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.684 0.394 . . . . 0.0 111.161 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -122.07 22.47 10.25 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.02 0.928 . . . . 0.0 112.276 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -63.15 -30.62 71.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.888 0.313 . . . . 0.0 110.643 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 55.18 2.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.197 1.799 . . . . 0.0 115.732 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -89.88 -13.69 35.88 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.091 0.859 . . . . 0.0 110.744 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -165.2 18.43 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.908 0.883 . . . . 0.0 110.823 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 21.0 m -76.66 -1.52 28.18 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.817 0.447 . . . . 0.0 112.196 -176.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 70.7 p -139.61 156.72 71.11 Favored Pre-proline 0 C--O 1.233 0.22 0 C-N-CA 123.658 0.783 . . . . 0.0 109.15 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.15 -8.84 23.96 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.789 2.326 . . . . 0.0 111.209 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.87 -28.02 15.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.096 -0.378 . . . . 0.0 110.949 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -90.43 -25.7 20.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.872 0.306 . . . . 0.0 110.481 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -75.93 -9.71 58.83 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.392 0.277 . . . . 0.0 111.395 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -95.93 -14.13 23.35 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.846 0.458 . . . . 0.0 111.211 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -107.55 11.73 28.42 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 123.603 0.761 . . . . 0.0 110.861 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -140.62 161.52 37.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.111 0.964 . . . . 0.0 108.83 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -134.97 142.08 46.4 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.931 0.492 . . . . 0.0 110.388 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 50.2 mm -113.65 138.9 41.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 123.668 0.787 . . . . 0.0 109.674 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -146.3 177.25 9.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.509 0.724 . . . . 0.0 110.195 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -65.37 163.96 28.38 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.401 0.681 . . . . 0.0 110.756 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.61 151.86 13.66 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.764 2.976 . . . . 0.0 112.764 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 45.1 p -124.05 23.89 8.38 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.907 0.883 . . . . 0.0 112.122 -173.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 54.67 13.13 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.792 1.637 . . . . 0.0 115.051 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.85 150.24 22.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.96 143.84 50.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -109.37 152.48 25.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.731 0.413 . . . . 0.0 109.92 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -130.38 135.71 48.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.09 0.956 . . . . 0.0 108.482 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -146.56 168.18 21.88 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.858 0.463 . . . . 0.0 111.073 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.8 m120 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.906 0.882 . . . . 0.0 112.623 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.42 156.35 50.96 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 122.984 0.514 . . . . 0.0 109.765 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.18 156.95 64.04 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.286 1.99 . . . . 0.0 110.407 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.5 -1.19 26.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.17 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.6 7.8 28.83 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.095 -0.378 . . . . 0.0 111.983 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.51 153.09 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.168 0.44 . . . . 0.0 111.668 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 75.5 p -146.91 172.6 13.43 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.935 0.894 . . . . 0.0 110.114 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 511' ' ' GLU . 3.6 pm0 -60.79 -24.31 65.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.796 177.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -73.59 -26.69 60.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.178 -0.326 . . . . 0.0 110.455 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.37 -28.93 37.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.47 -29.43 63.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.6 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.81 -38.99 31.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.575 0.625 . . . . 0.0 111.605 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.91 -18.96 52.99 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.174 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.5 mt -90.85 -33.5 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 118.285 0.493 . . . . 0.0 110.095 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.33 -22.27 64.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.635 -0.666 . . . . 0.0 110.285 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.58 -30.55 64.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.13 -13.0 33.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.365 0.53 . . . . 0.0 112.075 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.5 mt -91.82 -6.53 51.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.517 0.327 . . . . 0.0 110.428 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.41 7.73 64.77 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.693 -0.504 . . . . 0.0 112.966 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.1 m -87.54 169.13 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 117.833 0.817 . . . . 0.0 111.222 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -71.16 132.33 44.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -76.81 147.0 77.07 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.92 148.29 91.77 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.909 2.406 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.1 m -89.55 -19.9 24.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.544 0.337 . . . . 0.0 110.431 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.5 t -147.25 148.98 32.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.41 138.93 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.656 0.382 . . . . 0.0 110.328 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -142.91 139.92 30.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.32 154.97 41.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 110.428 -175.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -152.05 161.15 43.07 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.441 1.096 . . . . 0.0 109.166 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 74.9 p -130.82 141.96 50.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.695 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -82.3 179.46 53.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -111.56 139.6 46.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.737 0.415 . . . . 0.0 110.55 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 23.6 m 54.29 10.25 0.3 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.967 1.307 . . . . 0.0 114.174 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -111.96 -7.64 14.12 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.366 0.53 . . . . 0.0 111.918 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 47.8 42.09 15.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.999 0.919 . . . . 0.0 112.517 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 158.26 44.55 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.81 0.444 . . . . 0.0 111.411 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -115.8 157.38 24.47 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.07 0.948 . . . . 0.0 111.884 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -149.88 175.15 11.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.256 1.422 . . . . 0.0 109.199 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.7 45.7 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.647 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.484 ' C ' HD12 ' A' ' 544' ' ' LEU . 6.3 mp -129.25 132.79 47.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.632 0.773 . . . . 0.0 109.01 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 543' ' ' LEU . 9.4 mp -128.12 144.78 51.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.76 120.46 27.95 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.468 ' HB3' ' H ' ' A' ' 527' ' ' THR . 9.6 p90 -164.94 147.4 8.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -156.21 123.4 5.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 17.3 m -159.64 152.89 22.16 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.341 1.856 . . . . 0.0 106.304 169.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -59.95 -54.26 48.22 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.718 0.69 . . . . 0.0 111.897 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 26.9 m -83.5 -27.28 29.51 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.96 -30.82 31.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.06 0.391 . . . . 0.0 111.024 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -30.36 38.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.9 tp -78.08 -29.61 49.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.624 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -71.98 -41.72 67.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 O-C-N 121.938 -0.476 . . . . 0.0 109.983 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 24.1 m -73.44 -39.24 65.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.992 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 556' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 556' ' ' LEU . 3.0 tm? -66.66 -46.78 74.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.676 -0.64 . . . . 0.0 109.815 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.15 -16.41 78.58 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.552 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -123.7 -6.18 8.03 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.795 1.298 . . . . 0.0 113.48 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.87 -16.36 14.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.3 0.5 . . . . 0.0 111.265 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -68.07 143.6 55.42 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.266 -0.896 . . . . 0.0 109.924 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 52.64 29.41 7.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.06 0.944 . . . . 0.0 113.354 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 562' ' ' TYR . . . . . 0.406 ' H ' ' HD1' ' A' ' 562' ' ' TYR . 0.4 OUTLIER -74.7 151.42 39.23 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -103.76 136.42 43.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.063 1.745 . . . . 0.0 110.635 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 564' ' ' MET . . . . . 0.447 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.13 173.68 1.85 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.935 0.494 . . . . 0.0 111.202 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 565' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 564' ' ' MET . 65.2 pttt -73.3 9.77 1.19 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -66.28 143.86 98.48 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.715 0.688 . . . . 0.0 110.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.0 -29.58 3.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.569 2.846 . . . . 0.0 114.04 -169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -121.02 1.37 10.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.961 0.346 . . . . 0.0 111.912 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.428 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.74 41.55 99.09 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.929 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.6 Cg_endo -68.94 -10.87 30.37 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.247 2.631 . . . . 0.0 112.048 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.11 147.61 38.38 Favored Pre-proline 0 N--CA 1.455 -0.201 0 C-N-CA 122.832 0.453 . . . . 0.0 109.824 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.81 152.37 41.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.859 3.039 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 573' ' ' TYR . . . . . 0.447 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.7 t80 -144.17 -2.79 0.88 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 126.17 28.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.809 -0.557 . . . . 0.0 109.998 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.14 144.71 50.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.232 1.013 . . . . 0.0 110.372 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -79.46 135.98 36.81 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.5 pp -146.99 146.85 30.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 25.5 p -163.72 169.99 17.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.082 0.553 . . . . 0.0 110.304 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -73.78 130.67 40.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 74.6 m -135.55 140.07 44.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.79 0.436 . . . . 0.0 110.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 65.0 m -79.82 102.34 9.03 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.012 0.434 . . . . 0.0 110.573 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 161.6 34.44 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.076 0.95 . . . . 0.0 109.43 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 583' ' ' GLN . . . . . 0.508 ' H ' ' CD ' ' A' ' 583' ' ' GLN . 0.0 OUTLIER -98.87 -15.92 19.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.573 0.349 . . . . 0.0 111.511 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -160.58 164.56 31.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.205 0.602 . . . . 0.0 109.824 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.17 76.4 9.24 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.945 179.113 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.02 7.84 2.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.928 0.491 . . . . 0.0 111.866 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 75.1 -172.75 53.25 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.7 171.97 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 124.309 3.339 . . . . 0.0 110.934 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -148.42 162.81 38.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.139 0.576 . . . . 0.0 110.768 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -95.57 156.72 16.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.563 0.345 . . . . 0.0 111.189 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -139.08 10.75 2.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.29 0.636 . . . . 0.0 110.917 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 37.6 t -155.71 150.71 20.78 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.177 0.591 . . . . 0.0 110.323 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.34 -4.39 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.562 2.841 . . . . 0.0 111.473 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.77 145.3 17.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.098 0.559 . . . . 0.0 111.019 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.99 165.16 27.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.243 1.017 . . . . 0.0 109.43 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.2 mtp -137.87 153.17 49.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.674 0.274 . . . . 0.0 111.58 -175.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.63 150.39 15.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.064 0.546 . . . . 0.0 110.357 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.24 166.16 24.89 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.59 86.93 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.115 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.769 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.58 178.14 4.27 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.209 1.005 . . . . 0.0 110.992 177.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.44 143.8 35.78 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -73.29 0.22 12.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.4 p -113.67 -4.33 13.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.552 0.614 . . . . 0.0 112.376 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -131.81 -6.9 3.58 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.141 0.577 . . . . 0.0 110.882 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 27.8 ttt -145.43 128.19 16.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.433 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 32.8 m-80 -141.88 176.75 8.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.701 0.801 . . . . 0.0 109.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.0 m -57.98 -27.84 63.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.314 0.246 . . . . 0.0 111.142 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -85.15 -26.21 26.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.267 -0.271 . . . . 0.0 111.451 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ARG . . . . . 0.433 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 48.8 mmt-85 -81.07 -33.85 33.12 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.194 0.452 . . . . 0.0 109.804 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -25.12 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -71.52 -29.33 64.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.66 -26.74 50.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.684 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 74.5 t -90.18 -21.28 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.298 0.499 . . . . 0.0 112.301 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -114.43 -12.91 12.29 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.79 -25.65 62.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.44 1.018 . . . . 0.0 111.754 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.6 pp -77.67 11.16 2.22 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.649 -0.657 . . . . 0.0 112.164 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.75 -7.78 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.454 0.701 . . . . 0.0 110.609 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.32 170.71 19.81 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -70.41 138.49 51.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.065 -0.668 . . . . 0.0 111.008 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 62.0 t -97.25 145.14 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.07 -57.89 1.98 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.323 -0.236 . . . . 0.0 110.721 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -160.0 165.23 32.36 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.972 0.415 . . . . 0.0 111.54 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.21 151.8 15.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 123.85 0.86 . . . . 0.0 109.987 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -151.64 144.56 24.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.762 0.425 . . . . 0.0 110.007 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -76.05 157.4 33.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 34.4 ttp -119.67 141.15 49.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -168.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt 51.93 33.88 12.54 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.722 1.209 . . . . 0.0 112.26 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.8 m 55.68 15.76 1.7 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 113.323 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -81.29 142.18 50.46 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.42 -2.47 11.98 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.467 2.778 . . . . 0.0 109.518 169.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.01 15.79 10.99 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.556 1.074 . . . . 0.0 113.822 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.181 1.49 . . . . 0.0 111.129 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -158.89 168.06 27.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.169 0.509 . . . . 0.0 111.964 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.2 ptp -136.07 148.79 48.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.913 0.885 . . . . 0.0 109.93 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.53 151.35 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.556 0.742 . . . . 0.0 109.834 -175.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -130.77 145.04 51.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.736 0.414 . . . . 0.0 110.493 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 73.7 mtp -124.34 165.43 17.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.02 66.58 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -158.81 160.79 36.63 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.73 -13.33 78.35 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.509 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -65.51 -26.79 68.07 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.166 1.483 . . . . 0.0 110.741 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.98 -25.61 25.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.219 0.208 . . . . 0.0 110.841 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.39 -30.36 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.6 -33.4 72.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.497 0.319 . . . . 0.0 110.355 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -76.08 -25.35 55.42 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.175 -0.328 . . . . 0.0 110.514 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.84 -28.57 44.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.984 -0.448 . . . . 0.0 109.868 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -80.47 -31.04 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.102 0.961 . . . . 0.0 111.096 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 45.7 p -100.54 -13.17 18.74 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -134.05 -11.97 2.55 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.049 1.295 . . . . 0.0 114.391 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.82 -10.45 11.71 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.96 0.8 . . . . 0.0 109.718 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -58.88 145.24 41.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.403 0.62 . . . . 0.0 112.443 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 21.3 m120 56.9 1.35 0.09 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.543 1.937 . . . . 0.0 115.536 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -87.95 142.52 27.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.55 1.523 . . . . 0.0 108.493 169.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.0 OUTLIER -130.69 163.97 26.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 174.367 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.3 ptm -125.26 143.36 50.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.642 1.177 . . . . 0.0 109.171 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 63.86 27.09 14.46 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.953 1.301 . . . . 0.0 114.483 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.83 15.92 76.4 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -83.04 150.63 26.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.979 1.389 . . . . 0.0 110.14 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 141.49 38.28 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.79 122.99 40.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -140.73 115.72 9.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.14 140.22 24.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.926 0.33 . . . . 0.0 110.341 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 99.4 m -149.43 168.21 24.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.878 0.871 . . . . 0.0 110.158 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.68 153.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 23.2 t -105.82 -168.23 1.42 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.653 0.381 . . . . 0.0 110.276 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -141.57 4.43 1.75 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.115 0.566 . . . . 0.0 111.146 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -74.38 150.93 87.46 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -27.7 12.35 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.646 2.231 . . . . 0.0 112.382 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.71 170.15 14.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.298 0.499 . . . . 0.0 111.28 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 30.0 mm -71.82 151.49 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.01 133.07 23.15 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.22 158.55 41.29 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.523 2.815 . . . . 0.0 111.427 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 151.84 160.23 9.4 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 48.27 -95.9 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.703 1.201 . . . . 0.0 112.741 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.0 t 63.14 146.75 0.02 OUTLIER 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.653 1.581 . . . . 0.0 112.938 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -148.31 165.3 31.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.913 0.885 . . . . 0.0 109.699 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.45 132.65 11.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.1 mt -87.06 172.5 9.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.315 0.646 . . . . 0.0 110.341 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.48 -22.12 66.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.848 0.459 . . . . 0.0 110.951 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.7 1.2 35.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.199 0.599 . . . . 0.0 111.41 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.45 -2.11 79.1 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.076 0.369 . . . . 0.0 112.402 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.35 156.59 16.7 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.655 0.727 . . . . 0.0 110.067 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 83.9 m -78.77 150.42 32.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.447 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 86.3 p -73.22 -10.33 59.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.455 0.302 . . . . 0.0 111.464 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -119.44 130.59 55.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.561 0.744 . . . . 0.0 109.062 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -151.62 159.44 44.06 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -130.62 147.88 52.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.794 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -136.2 12.77 3.3 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.052 0.541 . . . . 0.0 111.415 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 14.8 t -72.14 164.42 26.24 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.913 0.485 . . . . 0.0 111.594 -174.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 53.18 25.96 4.68 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.133 0.973 . . . . 0.0 113.28 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.9 t -65.38 150.02 49.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.98 -0.45 . . . . 0.0 110.533 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -122.01 7.52 9.81 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.619 0.768 . . . . 0.0 111.383 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -93.88 14.52 19.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.403 0.681 . . . . 0.0 111.333 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -144.41 155.43 43.75 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 121.866 -0.521 . . . . 0.0 111.346 -178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -89.63 -9.97 47.68 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.711 0.804 . . . . 0.0 111.538 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -130.69 38.64 3.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.569 0.748 . . . . 0.0 110.376 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.6 p -71.33 -3.27 19.72 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.216 0.606 . . . . 0.0 112.5 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 36.2 p -139.05 154.79 72.78 Favored Pre-proline 0 C--O 1.231 0.131 0 C-N-CA 123.146 0.579 . . . . 0.0 109.513 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.1 -6.05 18.35 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.143 2.562 . . . . 0.0 111.514 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.33 -30.59 13.33 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.558 0.343 . . . . 0.0 110.924 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -90.56 -17.44 26.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.299 -0.251 . . . . 0.0 110.474 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -68.85 -8.29 42.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -76.2 -11.78 59.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.444 0.298 . . . . 0.0 110.967 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -94.63 6.21 49.54 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.556 0.742 . . . . 0.0 111.181 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -141.21 171.38 14.14 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.835 0.854 . . . . 0.0 109.413 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -132.56 155.7 48.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.305 0.642 . . . . 0.0 109.912 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.05 147.89 12.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -140.69 158.75 43.52 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.965 0.412 . . . . 0.0 110.915 -176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -89.1 166.48 21.64 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.29 1.036 . . . . 0.0 109.882 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.03 129.96 30.02 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.0 2.467 . . . . 0.0 111.412 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 70.8 m -123.99 22.73 8.74 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.195 0.598 . . . . 0.0 112.291 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 60.2 3.29 0.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.06 1.344 . . . . 0.0 114.012 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.6 t -142.29 146.96 21.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 49.1 mt -121.48 162.1 21.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.036 0.534 . . . . 0.0 110.545 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.96 152.78 43.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.502 0.321 . . . . 0.0 110.676 175.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -138.01 154.25 49.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.837 0.455 . . . . 0.0 111.344 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -146.01 172.17 13.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.048 0.539 . . . . 0.0 111.197 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.4 m120 61.08 27.66 17.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -82.64 160.55 61.29 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 122.44 0.296 . . . . 0.0 110.609 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.92 152.71 62.38 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.692 2.261 . . . . 0.0 110.7 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -73.46 -2.56 23.0 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.23 9.22 13.41 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.204 0.602 . . . . 0.0 111.88 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.9 152.44 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.121 -0.362 . . . . 0.0 110.298 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.6 p -145.65 170.97 15.41 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.061 0.544 . . . . 0.0 110.442 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.87 -23.25 66.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.894 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.16 -26.07 58.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.657 0.208 . . . . 0.0 110.492 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -78.56 -30.57 46.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -73.48 -27.04 61.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.303 -0.248 . . . . 0.0 110.878 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -78.85 -39.52 35.09 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.972 -0.455 . . . . 0.0 111.178 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -78.89 -21.74 46.96 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 84.1 mt -86.36 -35.89 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.281 0.491 . . . . 0.0 110.315 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.87 -28.45 68.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.086 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.58 -28.62 65.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.84 -12.18 37.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.557 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.41 -2.89 58.59 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.882 0.473 . . . . 0.0 111.257 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.32 79.94 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.929 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.77 165.07 22.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 117.817 0.809 . . . . 0.0 110.885 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -73.83 146.66 43.99 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.922 0.392 . . . . 0.0 110.605 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 525' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 525' ' ' ARG . 0.4 OUTLIER -88.07 152.92 51.35 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.27 0.628 . . . . 0.0 110.354 176.468 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.85 152.47 69.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.252 2.635 . . . . 0.0 111.413 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 95.4 m -85.51 -27.8 25.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.359 0.263 . . . . 0.0 111.171 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.6 m -140.35 149.43 42.7 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.529 . . . . 0.0 109.813 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.9 t -141.76 147.02 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.971 0.509 . . . . 0.0 110.472 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.31 124.63 10.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.39 144.65 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.586 0.354 . . . . 0.0 110.921 -175.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -149.58 161.38 42.28 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.749 0.82 . . . . 0.0 109.661 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 82.6 p -99.5 150.12 22.53 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 122.917 0.487 . . . . 0.0 110.926 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -89.46 147.27 19.4 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -74.69 130.49 39.59 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.6 m 57.12 12.18 1.22 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -97.5 -13.16 21.87 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.583 0.628 . . . . 0.0 111.069 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 52.23 28.88 5.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.939 0.896 . . . . 0.0 111.95 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 98.4 p -147.92 170.23 18.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.798 0.439 . . . . 0.0 111.089 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.2 m -131.37 160.83 33.91 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.661 0.784 . . . . 0.0 111.77 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.9 p -149.33 165.39 32.14 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.592 1.157 . . . . 0.0 109.79 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.08 40.87 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.691 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.98 157.82 39.55 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.74 0.816 . . . . 0.0 110.309 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 71.3 mt -133.51 134.98 44.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.347 1.059 . . . . 0.0 108.43 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.77 111.84 14.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -166.01 153.76 10.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.71 1.604 . . . . 0.0 106.898 167.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.17 124.75 8.35 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 548' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 551' ' ' ASP . 39.6 t -159.56 153.04 22.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 168.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -50.67 70.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.606 0.639 . . . . 0.0 111.7 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 52.1 m -87.75 -29.44 21.05 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 551' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 548' ' ' SER . 12.1 t70 -71.0 -34.28 71.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.268 0.486 . . . . 0.0 110.441 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.64 -34.32 35.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.33 -0.367 . . . . 0.0 110.555 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 38.0 tp -75.96 -29.94 58.46 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.757 0.708 . . . . 0.0 111.241 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -68.61 -43.48 76.31 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.8 m -72.79 -34.76 67.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.41 -42.27 98.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.755 -0.591 . . . . 0.0 109.601 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.78 -23.05 78.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.833 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -112.15 -7.48 14.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.504 1.152 . . . . 0.0 113.457 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.3 tp -112.52 -9.85 13.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.001 0.819 . . . . 0.0 111.927 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -78.05 140.74 39.13 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.232 -0.918 . . . . 0.0 108.823 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 50.72 26.95 2.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.695 0.798 . . . . 0.0 112.652 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.84 151.32 44.9 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -103.79 136.51 43.33 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.751 1.621 . . . . 0.0 111.085 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 564' ' ' MET . . . . . 0.467 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.0 ttt -64.21 173.45 1.97 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.181 0.592 . . . . 0.0 111.307 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -74.02 11.5 0.89 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.8 p30 -65.85 143.53 98.53 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.41 0.55 . . . . 0.0 110.179 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.21 -30.53 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.36 2.707 . . . . 0.0 114.132 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -121.06 1.7 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.211 0.459 . . . . 0.0 112.043 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 40.61 98.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.775 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 84.7 Cg_endo -69.56 -9.5 26.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.984 2.456 . . . . 0.0 112.319 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.23 147.94 39.26 Favored Pre-proline 0 N--CA 1.455 -0.185 0 C-N-CA 122.74 0.416 . . . . 0.0 109.968 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.33 153.01 45.1 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.767 2.978 . . . . 0.0 111.127 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 573' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.9 t80 -148.28 0.81 0.61 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.729 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 66.7 p -66.42 125.83 26.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.398 -0.814 . . . . 0.0 110.261 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 24.5 mt -99.58 144.54 28.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.452 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -81.36 122.61 27.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -133.61 144.63 49.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 18.6 t -164.02 175.82 9.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.251 0.62 . . . . 0.0 110.18 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.46 144.53 33.95 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.014 0.525 . . . . 0.0 109.801 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 37.6 t -135.63 142.35 45.19 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.427 0.158 . . . . 0.0 111.427 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.7 p -79.89 102.27 9.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.14 161.58 34.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.192 0.597 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -123.89 -1.42 8.36 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.344 0.657 . . . . 0.0 109.979 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -159.93 167.21 28.55 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.529 1.132 . . . . 0.0 109.864 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.47 0.99 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.759 0.424 . . . . 0.0 109.93 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.884 -179.773 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.476 0.179 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -88.43 -19.76 26.12 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.269 0.228 . . . . 0.0 111.131 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 154.46 -174.28 32.84 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.43 -13.11 20.65 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.57 2.847 . . . . 0.0 110.963 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -156.28 164.12 38.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.645 0.778 . . . . 0.0 109.891 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -83.38 170.36 14.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.743 0.417 . . . . 0.0 110.367 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.26 -1.15 4.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.849 0.46 . . . . 0.0 111.633 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.3 m -146.7 148.83 34.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 C-N-CA 122.596 0.359 . . . . 0.0 110.528 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -82.41 -5.49 11.81 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.253 3.302 . . . . 0.0 112.49 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 72.9 t -119.25 147.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 118.472 0.578 . . . . 0.0 111.229 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.46 166.06 25.74 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.012 0.925 . . . . 0.0 109.382 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 85.5 mtp -135.17 150.49 50.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.517 0.199 . . . . 0.0 111.245 -175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 30.9 t -140.21 145.18 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.323 0.649 . . . . 0.0 109.951 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -137.26 165.05 27.07 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.427 0.691 . . . . 0.0 109.564 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.31 0.15 89.97 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.355 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.75 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -73.88 177.97 5.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.989 0.895 . . . . 0.0 110.976 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.83 137.23 50.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.678 0.391 . . . . 0.0 110.266 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.93 -1.64 23.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 23.1 t -112.62 -13.56 13.28 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.354 0.525 . . . . 0.0 111.59 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -114.58 -9.92 12.58 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.736 0.415 . . . . 0.0 110.32 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.3 ttt -150.88 126.98 10.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.281 0.633 . . . . 0.0 109.898 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -141.94 -174.43 4.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.208 0.603 . . . . 0.0 109.449 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 22.3 p -57.97 -30.42 66.01 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.09 -21.67 23.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.735 -0.603 . . . . 0.0 111.496 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -94.71 -19.36 20.47 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.457 0.303 . . . . 0.0 110.697 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.92 -30.43 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.09 -31.33 71.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -66.92 -42.37 85.5 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.133 -0.354 . . . . 0.0 110.848 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 65.3 t -79.45 -26.09 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 119.278 -0.391 . . . . 0.0 112.002 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -101.97 -10.01 20.15 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 19.7 t -74.01 -33.57 63.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.961 0.801 . . . . 0.0 111.59 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.36 12.54 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.687 -0.633 . . . . 0.0 111.369 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.47 -2.15 9.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 110.656 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.96 173.3 18.06 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -80.35 155.49 27.17 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.389 0.595 . . . . 0.0 110.053 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.33 155.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.304 0.642 . . . . 0.0 110.141 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -102.39 -58.36 1.89 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.717 0.407 . . . . 0.0 110.084 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.16 167.91 17.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.432 0.693 . . . . 0.0 110.466 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.25 148.57 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 122.995 0.518 . . . . 0.0 110.181 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -155.61 148.9 24.76 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 110.844 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -77.92 156.44 30.28 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 171.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.703 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -141.02 141.41 34.34 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -169.221 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.22 33.94 21.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.3 m 52.84 13.45 0.35 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.33 138.12 45.23 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-N 119.083 0.856 . . . . 0.0 109.837 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.17 -6.86 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.185 2.59 . . . . 0.0 110.181 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -114.41 18.19 18.13 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.26 0.933 . . . . 0.0 112.717 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.703 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -150.42 142.73 24.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.747 1.274 . . . . 0.0 111.528 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.54 169.03 25.23 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.729 0.411 . . . . 0.0 111.468 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.4 ptp -136.26 149.43 48.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.594 . . . . 0.0 110.535 176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.77 148.21 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.072 0.549 . . . . 0.0 110.289 -174.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -127.23 131.37 50.61 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 87.4 mmm -100.4 162.83 12.69 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.449 0.3 . . . . 0.0 110.874 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.86 61.82 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -157.92 163.06 38.25 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.25 -16.21 70.87 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.102 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -68.46 -24.19 64.68 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.139 1.469 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -86.76 -22.27 26.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.254 0.222 . . . . 0.0 110.594 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.5 t -78.08 -33.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.44 -28.88 67.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.155 0.182 . . . . 0.0 110.525 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.412 ' HA ' ' NE ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -86.73 -29.38 22.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.104 -0.372 . . . . 0.0 111.194 -177.198 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.83 -26.94 40.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -84.55 -30.95 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 122.143 -0.348 . . . . 0.0 111.585 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.3 p -99.04 -11.18 21.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -132.33 -11.03 3.24 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.8 -21.28 9.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.401 1.0 . . . . 0.0 110.477 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -51.46 142.29 14.07 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.539 0.736 . . . . 0.0 112.226 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.491 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 77.0 m-20 58.41 1.69 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.89 142.52 27.74 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 121.14 1.791 . . . . 0.0 109.287 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 0.1 OUTLIER -130.86 164.05 26.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.3 ptm -125.39 143.43 50.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.548 1.139 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' PHE . . . . . 0.45 ' CE1' ' CD1' ' A' ' 558' ' ' PHE . 37.5 m-85 62.91 27.88 16.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 177.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.8 15.88 58.98 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.314 0.885 . . . . 0.0 115.314 168.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -83.09 141.78 31.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.833 1.317 . . . . 0.0 109.756 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -74.85 139.01 42.9 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.19 121.94 39.64 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -140.77 115.74 9.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 107.871 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.491 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 1.9 p -153.34 139.82 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 118.692 0.678 . . . . 0.0 110.594 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -158.24 161.63 37.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.438 0.695 . . . . 0.0 109.796 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.41 155.68 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 36.0 t -133.43 144.23 49.38 Favored 'General case' 0 CA--C 1.522 -0.115 0 O-C-N 122.102 -0.374 . . . . 0.0 111.318 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -87.92 65.1 8.16 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.283 0.633 . . . . 0.0 111.12 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -127.38 144.06 49.48 Favored Pre-proline 0 CA--C 1.529 0.144 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.74 -25.24 9.44 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.281 2.654 . . . . 0.0 111.76 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.48 172.42 14.49 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.79 0.436 . . . . 0.0 110.617 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.37 140.41 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.99 151.74 42.21 Favored Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 122.425 0.29 . . . . 0.0 110.925 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.96 158.98 55.79 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.93 3.087 . . . . 0.0 111.189 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.08 -172.4 43.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -77.83 164.87 24.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.645 0.378 . . . . 0.0 110.8 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 77.6 p -145.71 158.58 43.84 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.387 0.675 . . . . 0.0 110.114 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -154.16 165.66 35.54 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.742 0.417 . . . . 0.0 110.258 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.02 137.44 22.13 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -86.96 176.14 7.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.628 0.771 . . . . 0.0 110.354 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.97 -20.12 66.09 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.474 0.309 . . . . 0.0 111.441 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -85.65 -0.07 54.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 0.98 89.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.256 0.455 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 24.4 t -93.55 160.76 14.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.195 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.76 153.21 35.21 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.921 0.391 . . . . 0.0 110.824 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.9 p -72.54 -10.46 59.82 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.745 0.418 . . . . 0.0 111.807 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -117.39 141.7 48.01 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.692 0.797 . . . . 0.0 110.112 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -154.68 154.41 32.87 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.776 0.43 . . . . 0.0 110.185 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -127.25 155.1 44.01 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.118 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -138.05 1.76 2.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 85.0 p -68.36 -10.79 57.4 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.04 11.94 4.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.945 0.898 . . . . 0.0 110.729 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 44.3 t -85.2 162.52 19.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.034 0.533 . . . . 0.0 110.991 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -119.43 9.33 11.56 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.524 0.73 . . . . 0.0 110.922 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -83.69 -0.52 51.11 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.997 0.519 . . . . 0.0 111.353 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -67.74 148.36 51.39 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -72.71 -8.54 55.89 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -143.16 35.2 1.35 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.33 0.652 . . . . 0.0 110.356 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 91.8 p -65.48 -12.58 53.93 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.928 0.891 . . . . 0.0 112.684 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 5.7 t -145.1 148.11 37.07 Favored Pre-proline 0 C--O 1.232 0.164 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -56.18 -22.76 41.68 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.823 3.015 . . . . 0.0 113.967 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.05 -24.8 35.09 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.595 0.634 . . . . 0.0 111.337 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -90.54 -22.28 21.38 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.936 0.335 . . . . 0.0 110.345 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -72.35 -10.61 60.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.899 0.48 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -95.61 3.35 54.1 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.268 0.627 . . . . 0.0 110.526 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -126.77 6.98 6.74 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.92 0.888 . . . . 0.0 110.56 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -147.24 147.87 30.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.463 0.705 . . . . 0.0 110.014 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.28 160.44 41.49 Favored 'General case' 0 C--O 1.23 0.067 0 C-N-CA 123.531 0.733 . . . . 0.0 109.777 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.7 mm -101.61 121.0 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -160.99 171.92 17.81 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.286 0.565 . . . . 0.0 111.524 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' HIS . . . . . 0.401 ' HB2' ' HD2' ' A' ' 496' ' ' PRO . 49.0 p-80 -80.74 162.39 60.44 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.156 0.982 . . . . 0.0 108.551 170.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 495' ' ' HIS . 47.4 Cg_endo -63.54 138.41 64.83 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.159 1.906 . . . . 0.0 110.55 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 69.2 m -124.08 23.97 8.32 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.04 5.83 4.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.182 0.993 . . . . 0.0 113.321 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 54.9 t -140.07 142.31 32.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 O-C-N 121.706 -0.621 . . . . 0.0 109.748 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.472 HD12 ' CH2' ' A' ' 546' ' ' TRP . 89.1 mt -130.86 163.48 27.33 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.187 0.995 . . . . 0.0 108.826 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -146.34 165.75 28.38 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 122.01 -0.431 . . . . 0.0 112.004 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.52 156.93 47.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.237 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -147.51 170.63 17.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.285 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.5 t30 61.01 26.57 16.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.274 1.03 . . . . 0.0 113.607 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.42 157.8 55.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.14 161.33 16.46 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 0.0 111.955 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.2 pt? -83.06 -1.16 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.52 5.69 31.68 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.603 0.361 . . . . 0.0 111.873 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.32 150.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.918 0.326 . . . . 0.0 111.602 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -143.44 172.21 13.09 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.581 0.752 . . . . 0.0 110.471 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 2.9 pm0 -61.49 -19.88 62.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.511 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.86 -25.75 60.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.017 0.371 . . . . 0.0 110.134 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -81.99 -28.54 32.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -72.9 -29.11 62.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.806 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -83.33 -37.52 23.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 111.503 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.23 -24.36 51.22 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.98 -33.07 5.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.165 0.439 . . . . 0.0 110.187 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 67.7 m -67.25 -21.48 65.72 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.948 174.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.96 -33.61 73.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -90.99 -13.2 33.8 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.69 -9.97 47.51 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.666 0.386 . . . . 0.0 110.841 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.04 62.24 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.175 0.417 . . . . 0.0 112.724 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -87.65 160.44 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.964 0.882 . . . . 0.0 110.645 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.46 120.22 18.77 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -71.18 150.75 94.58 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.97 149.28 92.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.859 2.373 . . . . 0.0 110.563 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 94.1 m -84.78 -21.04 30.12 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.76 0.424 . . . . 0.0 110.839 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 15.3 t -146.04 153.45 40.75 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.34 140.71 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 122.995 0.518 . . . . 0.0 110.359 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.18 124.13 12.04 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.3 148.93 30.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.695 0.398 . . . . 0.0 111.082 -172.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -151.81 151.02 30.79 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.544 0.738 . . . . 0.0 110.418 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 76.1 p -130.76 138.19 49.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 109.939 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -81.63 161.64 42.65 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -72.88 141.11 47.92 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.263 0.532 . . . . 0.0 109.994 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 21.8 m 54.32 18.03 1.73 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -88.19 -18.58 28.4 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.174 -0.329 . . . . 0.0 111.029 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 54.89 14.42 0.91 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.552 1.141 . . . . 0.0 113.528 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.4 m -145.49 167.98 21.69 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.539 0.736 . . . . 0.0 110.449 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.6 t -135.36 155.11 51.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.495 0.718 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.5 m -145.35 163.71 33.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.399 1.079 . . . . 0.0 109.542 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -178.6 177.54 48.46 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 119.993 -1.098 . . . . 0.0 114.359 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.6 mp -112.98 156.5 22.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.012 . . . . 0.0 109.59 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.9 mt -138.61 143.19 39.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.434 1.094 . . . . 0.0 109.078 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -127.8 109.43 11.62 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.472 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.2 p90 -166.04 153.4 10.07 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 168.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -154.46 118.79 4.78 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.8 t -159.6 153.53 23.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.62 -40.02 95.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.619 0.645 . . . . 0.0 110.613 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 66.8 p -85.28 -27.26 26.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -83.68 -29.59 27.47 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.728 0.695 . . . . 0.0 110.859 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.74 26.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.986 0.357 . . . . 0.0 111.402 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.4 tp -84.7 -27.8 26.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.336 0.516 . . . . 0.0 112.047 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -77.36 -39.1 48.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.293 0.497 . . . . 0.0 110.273 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 89.7 m -67.84 -38.78 83.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.5 tp -60.63 -42.91 97.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.523 -0.735 . . . . 0.0 110.176 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -75.5 -14.17 82.25 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.244 -173.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 558' ' ' PHE . . . . . 0.45 ' CD1' ' CE1' ' A' ' 442' ' ' PHE . 23.5 m-85 -126.39 -12.28 6.21 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.763 1.282 . . . . 0.0 113.379 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 18.4 tp -105.79 -14.93 15.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.19 0.904 . . . . 0.0 112.567 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.44 136.4 40.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.2 m170 50.21 34.94 9.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.831 0.852 . . . . 0.0 113.003 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.71 151.29 28.97 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.246 0.618 . . . . 0.0 112.37 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -101.24 136.41 41.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.999 1.719 . . . . 0.0 110.999 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 564' ' ' MET . . . . . 0.408 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.3 ttt -64.07 179.93 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.846 0.858 . . . . 0.0 111.367 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 565' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 564' ' ' MET . 19.7 ptpt -64.27 6.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.59 143.17 93.85 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.115 0.416 . . . . 0.0 110.924 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.55 -30.44 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.389 2.726 . . . . 0.0 112.917 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -121.05 -7.18 9.45 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.7 44.06 96.91 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.007 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 86.7 Cg_endo -72.01 -6.24 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.325 2.683 . . . . 0.0 112.042 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -138.88 150.33 65.0 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.928 0.491 . . . . 0.0 109.917 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.88 144.09 30.29 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.161 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 573' ' ' TYR . . . . . 0.408 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 89.8 t80 -145.09 -3.63 0.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.306 0.643 . . . . 0.0 111.27 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 132.02 47.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.872 -0.518 . . . . 0.0 110.764 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.8 pp -125.04 144.59 50.32 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.526 0.73 . . . . 0.0 111.125 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.04 140.46 33.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.263 0.625 . . . . 0.0 109.977 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.55 144.99 46.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 1.9 p -163.93 173.02 13.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.568 0.347 . . . . 0.0 110.982 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -84.12 148.69 26.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.919 0.39 . . . . 0.0 110.711 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 28.0 t -135.53 159.93 40.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.502 0.721 . . . . 0.0 109.8 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 44.5 m -117.32 101.96 8.86 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.56 34.61 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.164 0.986 . . . . 0.0 109.928 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -78.85 -31.03 45.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -153.57 162.35 41.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.772 1.229 . . . . 0.0 109.054 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.62 76.49 7.49 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.185 179.153 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 120.512 0.196 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -144.16 142.43 30.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.898 0.479 . . . . 0.0 110.072 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' GLY . . . . . 0.416 ' N ' ' CD ' ' A' ' 374' ' ' PRO . . . 65.24 42.26 96.38 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.979 -0.901 . . . . 0.0 113.191 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 373' ' ' GLY . 94.6 Cg_endo -75.19 -24.54 12.44 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.139 1.893 . . . . 0.0 111.516 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -161.64 156.65 23.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.691 0.397 . . . . 0.0 110.225 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -80.21 166.31 21.54 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.031 0.444 . . . . 0.0 110.904 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.82 -13.35 39.54 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.425 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 m -148.7 155.31 41.45 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 122.846 0.458 . . . . 0.0 110.691 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.91 -0.84 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.659 3.573 . . . . 0.0 113.242 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.17 158.85 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.551 0.614 . . . . 0.0 110.969 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.3 pp -145.32 170.28 16.62 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.157 0.583 . . . . 0.0 110.606 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 77.5 mtp -135.15 153.36 52.01 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.761 0.424 . . . . 0.0 111.099 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.7 149.62 18.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.211 0.604 . . . . 0.0 110.25 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -141.89 167.57 21.83 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.037 0.535 . . . . 0.0 110.152 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.57 76.87 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.15 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -67.85 165.33 17.77 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.798 0.799 . . . . 0.0 111.002 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -119.72 128.4 53.75 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.66 1.68 5.01 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 84.0 p -116.62 0.59 12.68 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.55 -6.42 3.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.169 0.588 . . . . 0.0 110.591 174.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 9.3 tpt -150.11 122.95 8.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.701 0.8 . . . . 0.0 109.4 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -141.94 -174.78 4.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.086 0.555 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.6 p -60.73 -23.99 65.36 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.887 0.475 . . . . 0.0 112.023 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.0 -30.73 21.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.917 0.326 . . . . 0.0 111.63 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -82.07 -30.76 31.15 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.571 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.98 -28.48 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -70.02 -33.87 72.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.963 -0.461 . . . . 0.0 110.052 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.23 -16.38 52.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.3 -18.88 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.716 0.407 . . . . 0.0 110.942 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -116.95 -18.96 10.01 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.26 -20.89 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.658 1.117 . . . . 0.0 111.057 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.955 -0.466 . . . . 0.0 111.887 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -121.46 -1.42 9.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.827 0.851 . . . . 0.0 111.268 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.56 169.6 16.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -65.67 142.67 57.95 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.468 -0.431 . . . . 0.0 111.493 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.08 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.652 0.781 . . . . 0.0 109.306 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -99.83 -65.92 0.94 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -165.13 168.52 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 110.313 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 9.3 p -147.18 151.75 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -152.47 144.71 23.93 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.647 0.379 . . . . 0.0 110.374 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.64 160.32 25.09 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 3.3 ptp -136.4 141.42 43.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 56.76 33.82 23.62 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.8 1.64 . . . . 0.0 114.217 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.0 m 52.77 17.81 0.91 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -71.11 158.13 88.79 Favored Pre-proline 0 CA--C 1.528 0.118 0 CA-C-N 118.367 0.53 . . . . 0.0 110.405 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.11 -19.25 32.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -177.53 102.2 0.16 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -157.8 136.71 11.5 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 109.088 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.83 171.28 20.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.231 0.539 . . . . 0.0 110.897 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.6 ptm -143.63 144.34 31.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.602 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.8 t -130.69 139.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 C-N-CA 122.857 0.463 . . . . 0.0 110.395 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -118.06 141.19 48.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.121 0.568 . . . . 0.0 110.062 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 92.3 mmm -111.01 161.85 15.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.139 0.576 . . . . 0.0 110.121 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.33 -22.94 63.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.13 -0.356 . . . . 0.0 111.138 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -159.46 160.34 34.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.518 0.727 . . . . 0.0 109.398 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.74 69.02 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.841 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.432 1.616 . . . . 0.0 110.671 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.46 -25.91 30.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.564 0.221 . . . . 0.0 110.51 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.6 -28.15 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.17 -42.8 71.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.291 -0.256 . . . . 0.0 110.849 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.62 84.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.102 0.41 . . . . 0.0 110.013 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.4 -34.55 58.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.6 tp -79.85 -30.92 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 O-C-N 122.184 -0.323 . . . . 0.0 111.525 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.7 t -94.94 -12.24 27.14 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -138.89 -24.4 0.91 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -95.67 -20.15 19.15 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.064 0.847 . . . . 0.0 108.997 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -51.82 142.66 14.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.502 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.08 1.59 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.617 1.967 . . . . 0.0 115.565 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -87.92 142.62 27.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.274 1.397 . . . . 0.0 108.847 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' PHE . . . . . 0.45 ' HB2' ' HG3' ' A' ' 446' ' ' MET 0.328 0.0 OUTLIER -131.0 164.14 26.02 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 175.339 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.7 ptm -125.16 143.28 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.476 1.11 . . . . 0.0 109.263 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 64.42 30.12 13.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.89 81.26 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 167.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -83.14 156.9 23.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.499 1.649 . . . . 0.0 111.359 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.606 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -77.76 141.97 38.96 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.902 0.881 . . . . 0.0 110.627 178.627 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 446' ' ' MET . . . . . 0.45 ' HG3' ' HB2' ' A' ' 440' ' ' PHE . 1.9 mpt? -98.5 122.01 41.16 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -140.69 110.75 6.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.53 139.43 17.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 92.7 m -149.66 160.43 43.52 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.596 0.759 . . . . 0.0 110.23 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -85.09 154.23 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.0 t -144.68 163.26 34.5 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.457 0.703 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -121.17 30.18 6.95 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.511 0.596 . . . . 0.0 112.25 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -63.64 147.91 94.97 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.56 -25.24 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.701 2.267 . . . . 0.0 111.88 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.98 170.22 13.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.453 0.701 . . . . 0.0 109.913 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.01 137.12 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 147.72 57.66 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 110.729 -0.101 . . . . 0.0 110.729 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.84 168.41 23.04 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.098 3.199 . . . . 0.0 111.973 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 177.56 170.99 40.56 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -84.82 -12.72 53.01 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.944 0.372 . . . . 0.0 111.701 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 7.4 m 57.72 169.32 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.145 1.378 . . . . 0.0 113.296 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -155.74 168.31 27.59 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.138 0.575 . . . . 0.0 109.9 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.54 137.79 17.36 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.92 170.24 11.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.313 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.23 -22.79 65.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.545 0.338 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.28 4.69 25.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.529 0.332 . . . . 0.0 111.467 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.57 -0.49 87.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.504 -0.609 . . . . 0.0 113.151 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.9 p -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 117.977 0.889 . . . . 0.0 110.556 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.16 152.4 30.74 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 122.245 -0.285 . . . . 0.0 110.382 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 90.1 p -73.39 -10.37 59.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.532 0.333 . . . . 0.0 111.774 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -127.67 145.21 50.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.797 0.839 . . . . 0.0 110.437 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.09 158.11 38.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.964 0.506 . . . . 0.0 110.058 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.64 148.26 51.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.466 0.706 . . . . 0.0 109.974 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.56 13.69 2.97 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.996 0.518 . . . . 0.0 111.128 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.3 p -65.48 -14.46 61.03 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -90.08 -1.71 57.99 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.105 0.562 . . . . 0.0 111.248 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 57.0 m -85.36 13.7 6.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.621 0.368 . . . . 0.0 111.506 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -74.26 5.26 4.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.315 0.646 . . . . 0.0 111.363 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -80.38 34.13 0.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.84 0.856 . . . . 0.0 110.686 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -139.12 159.73 41.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.225 1.01 . . . . 0.0 109.35 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 53.5 ttp85 -80.18 38.23 0.41 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.021 0.928 . . . . 0.0 112.371 -173.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.1 17.29 1.92 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.164 0.586 . . . . 0.0 111.748 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.7 p -73.88 -2.82 25.41 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.961 0.505 . . . . 0.0 111.837 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 4.9 t -148.09 145.25 20.28 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.119 0.968 . . . . 0.0 108.786 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.44 -17.44 57.85 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.315 2.677 . . . . 0.0 113.478 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.8 -25.21 32.94 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 119.073 0.851 . . . . 0.0 111.429 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -90.51 -29.75 17.7 Favored 'General case' 0 C--N 1.338 0.092 0 O-C-N 122.24 -0.288 . . . . 0.0 110.453 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -70.44 -21.23 62.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.433 0.293 . . . . 0.0 111.392 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -75.63 -4.15 38.49 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.973 0.509 . . . . 0.0 111.077 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -127.06 19.07 7.08 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.517 1.127 . . . . 0.0 110.187 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -116.58 23.96 11.65 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.804 0.842 . . . . 0.0 110.83 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 56.24 27.45 11.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.193 0.997 . . . . 0.0 113.397 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.6 mm -80.97 118.33 28.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -161.26 167.74 25.4 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.397 0.679 . . . . 0.0 109.266 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -60.98 159.62 26.23 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.72 145.13 31.87 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.703 2.935 . . . . 0.0 112.606 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.1 m -124.01 23.9 8.4 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.711 0.804 . . . . 0.0 110.89 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 61.21 14.74 5.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.676 1.191 . . . . 0.0 112.883 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 47.3 t -139.07 141.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.418 HD12 ' CH2' ' A' ' 546' ' ' TRP . 58.6 mt -119.42 148.48 43.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.968 0.507 . . . . 0.0 109.923 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.87 151.54 33.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 151.21 46.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.534 0.207 . . . . 0.0 110.677 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -147.89 173.63 12.66 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.635 0.374 . . . . 0.0 111.217 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.2 t30 56.39 34.03 23.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.216 1.006 . . . . 0.0 112.825 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -91.67 157.32 41.98 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.82 148.89 63.76 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.81 2.34 . . . . 0.0 111.588 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -73.7 -1.28 18.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.82 8.27 15.99 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.15 151.16 4.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 118.007 0.367 . . . . 0.0 110.814 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.4 p -142.32 171.87 13.47 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.348 0.659 . . . . 0.0 110.529 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 -22.17 66.73 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -71.2 -25.03 62.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -83.65 -30.13 27.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.17 -27.1 63.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.03 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.7 -38.12 18.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.488 0.586 . . . . 0.0 111.522 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -74.95 -20.08 59.83 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.467 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.23 -33.88 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 117.792 0.269 . . . . 0.0 110.723 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 69.1 m -67.71 -21.68 65.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.974 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.49 -30.44 63.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.07 -13.13 33.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 111.916 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 99.8 mt -91.57 -9.84 42.77 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.791 0.436 . . . . 0.0 111.057 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.68 5.15 63.36 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.752 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.0 m -87.08 168.4 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.777 0.789 . . . . 0.0 110.836 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -77.28 146.59 36.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.763 0.425 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -96.13 151.64 38.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.573 0.349 . . . . 0.0 110.099 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.25 156.0 68.12 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.186 2.591 . . . . 0.0 111.122 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -89.54 -23.32 22.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.916 0.486 . . . . 0.0 110.696 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.1 t -143.84 156.87 44.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.01 144.93 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.221 0.534 . . . . 0.0 110.954 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -141.2 128.81 21.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.6 144.07 35.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 122.597 0.359 . . . . 0.0 110.132 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -154.88 153.66 31.47 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.172 0.589 . . . . 0.0 110.034 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.8 m -130.82 133.77 46.24 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.22 150.08 34.9 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -74.34 139.02 43.87 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 14.4 m 57.86 11.23 1.32 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -100.05 -10.15 21.87 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.229 0.468 . . . . 0.0 111.367 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 43.15 34.05 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.84 1.256 . . . . 0.0 113.368 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.1 t -143.08 158.93 43.16 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.192 0.597 . . . . 0.0 110.642 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 47.1 t -122.16 150.73 41.82 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.78 0.832 . . . . 0.0 111.109 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.7 m -147.07 168.47 21.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.085 1.354 . . . . 0.0 109.185 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.51 -169.2 42.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.891 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.02 154.05 47.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.385 1.074 . . . . 0.0 109.686 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.39 140.47 39.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.007 0.923 . . . . 0.0 108.723 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -127.8 109.75 11.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.423 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.9 p90 -166.13 152.83 9.44 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.019 1.328 . . . . 0.0 107.77 168.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.31 123.73 7.13 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 548' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 39.6 t -159.62 152.97 22.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -47.48 80.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.474 0.579 . . . . 0.0 111.348 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.5 p -85.82 -26.2 25.86 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 54.3 m-20 -82.73 -29.13 29.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.231 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.78 30.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.103 0.411 . . . . 0.0 110.931 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.85 -28.05 36.24 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.406 0.548 . . . . 0.0 111.599 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -76.65 -41.05 47.13 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.133 0.424 . . . . 0.0 110.558 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.5 m -68.73 -34.97 76.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.93 -52.17 65.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.855 -0.528 . . . . 0.0 110.12 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.66 -17.1 76.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.005 -0.886 . . . . 0.0 114.258 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -119.22 -9.2 10.0 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.742 1.271 . . . . 0.0 113.67 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.7 tp -89.61 -21.7 22.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.439 1.018 . . . . 0.0 110.328 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.57 147.66 50.45 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.138 -0.351 . . . . 0.0 110.479 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 51.24 24.79 2.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.448 1.099 . . . . 0.0 113.607 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.31 151.38 38.3 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.247 0.546 . . . . 0.0 112.222 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -111.38 136.24 50.79 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.949 0.9 . . . . 0.0 110.855 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.0 ttt -64.7 178.32 0.79 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.852 0.861 . . . . 0.0 111.006 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -68.18 7.95 0.5 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.28 140.0 91.58 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.31 -28.95 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.472 2.782 . . . . 0.0 112.86 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -121.04 -7.14 9.46 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.41 44.23 97.92 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.926 -0.93 . . . . 0.0 113.421 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 94.0 Cg_endo -71.27 -7.01 20.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.128 2.552 . . . . 0.0 111.993 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -143.82 149.27 45.81 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.125 0.57 . . . . 0.0 109.867 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.53 154.23 39.91 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.601 2.867 . . . . 0.0 110.796 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -136.54 -0.83 2.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.64 0.376 . . . . 0.0 111.604 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 8.3 t -68.31 132.03 46.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.931 -0.481 . . . . 0.0 111.222 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.94 144.62 50.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 0.0 109.701 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -85.11 145.16 27.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 577' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 577' ' ' LEU . 2.0 pt? -147.12 146.79 30.05 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.098 0.559 . . . . 0.0 110.683 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.29 169.71 21.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.896 0.478 . . . . 0.0 110.898 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -72.65 133.51 44.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 25.7 t -135.66 148.43 48.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 60.7 m -89.82 102.34 15.04 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.978 0.418 . . . . 0.0 110.587 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 161.53 34.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.817 0.847 . . . . 0.0 109.456 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -99.38 -15.36 18.8 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.175 0.19 . . . . 0.0 110.919 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -160.22 160.59 32.9 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.193 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.01 76.41 0.99 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.88 0.472 . . . . 0.0 110.087 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.54 -1.219 . . . . 0.0 110.489 -179.423 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 119.677 -0.201 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -133.96 -2.81 2.88 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -82.12 177.07 53.83 Favored Glycine 0 CA--C 1.527 0.804 0 O-C-N 122.285 -0.259 . . . . 0.0 112.631 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.68 -175.77 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.732 3.621 . . . . 0.0 111.256 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 64.6 t60 57.53 58.21 3.91 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.407 1.083 . . . . 0.0 110.939 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -59.52 156.51 13.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.018 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -132.07 19.98 4.5 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.927 0.491 . . . . 0.0 111.145 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 47.0 t -148.81 145.91 20.78 Favored Pre-proline 0 N--CA 1.453 -0.283 0 O-C-N 122.219 -0.301 . . . . 0.0 111.018 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.0 -0.96 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.778 2.985 . . . . 0.0 112.66 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.2 m -124.83 163.06 25.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 119.18 0.9 . . . . 0.0 112.786 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -149.4 161.92 41.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.293 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 75.1 mmm -118.93 144.45 46.43 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.667 0.787 . . . . 0.0 110.099 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.54 144.81 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.048 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -139.32 166.94 23.23 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.383 0.673 . . . . 0.0 109.23 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.82 86.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.318 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.737 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.6 173.86 10.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.924 0.862 . . . . 0.0 110.501 176.008 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.39 146.56 51.24 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.019 0.528 . . . . 0.0 110.271 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -81.98 -4.83 57.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.9 t -104.68 -9.2 18.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.883 0.31 . . . . 0.0 111.447 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.31 -5.55 3.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.219 0.608 . . . . 0.0 111.109 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -142.13 126.69 17.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -141.68 -174.97 4.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.019 0.528 . . . . 0.0 109.992 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.61 -26.81 65.76 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.941 0.496 . . . . 0.0 112.036 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.14 -38.39 27.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.99 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -74.79 -28.96 60.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.106 0.412 . . . . 0.0 110.954 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.93 -28.66 24.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' PHE . . . . . 0.407 ' CD1' HG21 ' A' ' 406' ' ' VAL . 4.3 t80 -72.1 -30.29 64.93 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 172.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -76.25 -24.82 54.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.6 t -96.58 -26.43 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.399 0.545 . . . . 0.0 112.184 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.27 -14.2 17.07 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 35.3 t -78.57 -17.6 55.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.09 0.859 . . . . 0.0 112.473 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 10.72 1.22 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.272 -0.892 . . . . 0.0 112.171 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -121.38 -1.59 9.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.765 0.826 . . . . 0.0 110.819 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.44 165.5 12.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.44 164.47 22.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.009 0.433 . . . . 0.0 111.161 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' VAL . . . . . 0.407 HG21 ' CD1' ' A' ' 397' ' ' PHE . 5.4 m -121.11 161.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 C-N-CA 124.237 1.015 . . . . 0.0 109.789 -177.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.58 -52.22 2.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.324 -0.235 . . . . 0.0 111.289 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.16 164.34 27.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.493 0.317 . . . . 0.0 110.795 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.59 151.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.398 0.679 . . . . 0.0 110.262 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.03 148.55 27.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 419' ' ' ALA . 3.9 m-30 -78.65 145.79 34.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 25.1 ttp -99.4 141.04 32.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -168.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 49.8 33.95 7.0 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 112.031 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 83.7 p 52.88 16.02 0.64 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.362 1.465 . . . . 0.0 113.409 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -77.84 132.75 67.19 Favored Pre-proline 0 C--N 1.34 0.192 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.43 -7.43 17.69 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.659 2.239 . . . . 0.0 111.494 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.96 16.54 10.15 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.772 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -144.33 145.33 31.92 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 119.212 1.506 . . . . 0.0 111.056 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 411' ' ' PHE . . . -154.52 163.93 39.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.243 0.544 . . . . 0.0 111.7 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 23.0 ptm -145.23 143.57 30.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.723 0.809 . . . . 0.0 109.757 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.2 p -136.71 153.29 30.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.72 0.408 . . . . 0.0 110.446 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -125.08 138.48 54.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.947 0.499 . . . . 0.0 110.663 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 77.0 mmm -104.42 161.63 13.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.455 0.702 . . . . 0.0 110.145 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.19 -18.67 62.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -157.67 158.85 36.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.974 0.51 . . . . 0.0 109.782 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.6 -14.95 72.86 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.201 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -70.69 -19.82 62.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.03 1.415 . . . . 0.0 111.095 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.44 -24.43 31.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.72 -26.98 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.02 -36.78 82.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.262 -0.274 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -80.13 -31.77 39.05 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.296 -0.253 . . . . 0.0 110.535 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.03 70.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.999 -0.438 . . . . 0.0 110.116 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 433' ' ' ILE . 5.6 tp -85.49 -30.93 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.2 m -95.04 -19.99 19.7 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -130.63 -12.04 3.88 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.7 -17.9 10.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.114 0.87 . . . . 0.0 110.031 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.17 142.2 21.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.509 0.724 . . . . 0.0 111.439 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.427 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 76.1 m-20 57.15 1.63 0.1 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.952 1.701 . . . . 0.0 115.214 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.92 142.42 27.81 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 120.579 1.536 . . . . 0.0 108.899 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 0.1 OUTLIER -130.68 163.91 26.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 174.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.7 ptm -125.39 143.52 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.651 1.58 . . . . 0.0 109.314 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 64.12 30.91 13.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.002 1.321 . . . . 0.0 114.454 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.93 79.9 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.17 145.02 29.42 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.357 1.079 . . . . 0.0 109.789 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 141.62 37.97 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.051 -0.405 . . . . 0.0 109.934 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.86 122.0 40.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -168.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -140.68 114.37 8.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.427 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.99 141.69 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 CA-C-N 118.29 0.496 . . . . 0.0 110.493 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 34.1 t -160.04 162.71 34.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.379 0.671 . . . . 0.0 109.617 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.18 158.68 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 110.265 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 45.6 t -138.01 151.41 47.87 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -89.43 4.95 47.42 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -59.6 139.11 89.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -23.43 11.55 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.921 2.414 . . . . 0.0 112.249 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.05 170.62 14.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 110.806 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.57 147.41 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.2 mmt -104.62 150.19 38.29 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.432 0.293 . . . . 0.0 110.56 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.29 177.82 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 124.161 3.24 . . . . 0.0 111.927 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 73.78 -176.72 45.57 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.475 0.559 . . . . 0.0 112.354 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 56.77 19.95 4.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.244 1.018 . . . . 0.0 113.62 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.9 m -97.12 142.67 28.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.247 0.476 . . . . 0.0 111.116 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -148.19 174.26 12.15 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.742 1.217 . . . . 0.0 109.217 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.4 135.96 15.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.74 171.39 10.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.729 0.812 . . . . 0.0 110.44 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -68.6 -20.46 64.5 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.645 0.378 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -80.59 1.3 30.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.108 0.563 . . . . 0.0 111.604 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.84 -2.76 72.86 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 122.054 -0.404 . . . . 0.0 112.231 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 28.0 t -93.36 163.4 13.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.182 0.593 . . . . 0.0 109.453 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 48.6 t -84.3 153.19 23.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.043 0.449 . . . . 0.0 110.645 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 59.5 m -64.79 -10.42 27.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.001 0.92 . . . . 0.0 111.343 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -119.2 142.14 48.27 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.801 0.84 . . . . 0.0 110.137 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.16 156.22 38.19 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.675 0.274 . . . . 0.0 110.703 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -124.73 151.03 45.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.24 1.016 . . . . 0.0 109.941 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.02 10.88 2.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.389 0.676 . . . . 0.0 111.755 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 16.8 t -70.2 -1.37 10.01 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.056 -0.403 . . . . 0.0 111.732 -173.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -121.91 15.7 10.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.902 0.881 . . . . 0.0 110.815 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 89.6 p -68.51 155.61 39.59 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.991 0.516 . . . . 0.0 111.705 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.06 34.49 5.15 Favored 'General case' 0 C--N 1.335 -0.03 0 C-N-CA 124.289 1.036 . . . . 0.0 110.827 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -65.26 -8.53 18.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.976 0.511 . . . . 0.0 112.229 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 59.01 176.25 0.07 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.115 1.366 . . . . 0.0 113.567 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? 60.69 -20.16 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.676 1.99 . . . . 0.0 114.617 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -160.11 8.9 0.1 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.573 0.624 . . . . 0.0 112.047 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 70.8 p -74.88 -0.06 17.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.536 0.607 . . . . 0.0 111.885 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 485' ' ' PRO . 5.4 t -149.83 146.85 21.18 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 485' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 484' ' ' THR . 65.9 Cg_exo -57.25 -20.02 37.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.555 2.837 . . . . 0.0 114.368 -175.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.47 -22.26 28.33 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.574 0.625 . . . . 0.0 111.431 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -90.57 -28.42 18.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 117.966 0.348 . . . . 0.0 110.312 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.34 -6.11 27.6 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.924 0.489 . . . . 0.0 111.936 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -104.18 -3.67 24.08 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.94 0.496 . . . . 0.0 111.115 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -98.1 -0.41 44.48 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.28 0.632 . . . . 0.0 111.198 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -142.52 169.05 18.31 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -131.65 157.46 43.65 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 31.3 mm -110.68 141.09 27.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -149.9 171.42 16.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.076 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -69.07 148.25 97.74 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.875 0.87 . . . . 0.0 109.32 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.09 152.44 14.47 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.702 2.935 . . . . 0.0 113.211 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.2 m -123.95 22.01 8.91 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.057 0.543 . . . . 0.0 112.04 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 19.1 m120 59.72 12.55 2.99 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.77 152.35 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.0 mt -125.42 155.49 40.33 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.942 0.497 . . . . 0.0 111.053 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -132.26 137.71 47.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -124.92 149.94 47.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.033 0.533 . . . . 0.0 110.858 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -144.3 172.79 12.44 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 111.251 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 49.4 t30 57.57 31.78 20.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.407 1.083 . . . . 0.0 112.993 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -85.14 157.44 59.5 Favored Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.84 158.89 55.25 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.608 2.205 . . . . 0.0 110.446 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 22.1 tp -70.89 -0.97 10.31 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.013 1.325 . . . . 0.0 112.856 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.47 9.53 7.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.99 151.82 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 118.334 0.516 . . . . 0.0 111.259 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.7 p -142.6 171.43 14.06 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.651 0.78 . . . . 0.0 110.071 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.1 -24.29 67.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.519 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.91 -24.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.355 -0.215 . . . . 0.0 110.67 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -76.77 -35.05 57.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -71.13 -23.79 62.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.909 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -79.42 -40.7 29.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.172 0.442 . . . . 0.0 111.009 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.92 -13.04 60.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 85.4 mt -95.5 -32.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.262 0.483 . . . . 0.0 110.403 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.8 m -68.42 -22.8 64.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.408 -0.807 . . . . 0.0 109.568 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.02 -28.78 61.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.645 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -90.98 -12.83 34.73 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.637 0.653 . . . . 0.0 111.636 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.85 -8.96 27.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.966 0.506 . . . . 0.0 111.257 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.19 64.58 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.248 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.1 168.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.156 0.978 . . . . 0.0 111.212 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -68.34 133.93 49.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.029 0.532 . . . . 0.0 110.119 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -78.22 149.34 75.91 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 148.86 90.21 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.811 2.341 . . . . 0.0 110.138 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.417 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.9 m -93.83 -18.97 21.45 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.848 0.459 . . . . 0.0 110.847 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.3 t -149.47 148.79 29.84 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.01 137.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.211 0.604 . . . . 0.0 109.609 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 530' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -148.28 104.58 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 89.9 t -126.88 148.01 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.265 0.626 . . . . 0.0 109.925 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -147.64 161.92 40.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p -90.04 149.11 22.66 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.105 0.479 . . . . 0.0 111.937 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -86.54 147.79 21.57 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.75 131.04 37.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.182 0.491 . . . . 0.0 110.109 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.4 m 55.65 18.53 2.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -111.07 -11.36 14.29 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.114 0.416 . . . . 0.0 111.692 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 50.29 31.02 4.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.508 0.723 . . . . 0.0 112.692 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 89.6 p -140.24 171.54 14.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.5 0.72 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 60.1 m -128.04 150.87 49.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.56 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 58.4 m -147.83 159.9 43.34 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 125.005 1.322 . . . . 0.0 109.353 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.29 -174.97 44.99 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.278 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.4 146.39 28.9 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.33 1.052 . . . . 0.0 110.236 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 5.8 mp -137.66 138.04 39.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -127.74 126.34 41.63 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.417 ' HB3' ' H ' ' A' ' 527' ' ' THR . 8.9 p90 -165.56 148.69 7.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.88 120.4 7.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 42.3 t -159.57 153.34 22.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 168.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -64.79 -52.21 58.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.916 0.78 . . . . 0.0 111.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.9 p -78.7 -27.2 44.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -84.97 -31.11 23.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.786 0.721 . . . . 0.0 111.463 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.41 -30.88 60.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.208 0.458 . . . . 0.0 110.641 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -83.48 -27.15 29.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.37 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -77.37 -39.01 48.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.087 0.403 . . . . 0.0 110.523 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 30.2 m -73.76 -38.66 64.65 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.059 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 556' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.0 tm? -65.98 -47.3 75.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.15 -17.29 75.67 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.542 -173.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.47 -11.67 8.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.916 1.358 . . . . 0.0 113.173 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -95.84 -18.05 20.67 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.382 0.537 . . . . 0.0 110.65 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -65.55 144.89 56.7 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.747 -0.596 . . . . 0.0 109.452 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 60.5 t60 55.61 24.72 7.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.569 1.147 . . . . 0.0 113.252 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 151.33 34.69 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -117.76 136.35 53.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.845 1.258 . . . . 0.0 110.701 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 3.7 ttt -64.2 176.4 1.04 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 111.323 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -65.86 141.26 97.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.092 0.86 . . . . 0.0 110.288 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -79.91 -29.42 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.659 2.906 . . . . 0.0 113.796 -169.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -121.05 2.79 10.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.06 0.391 . . . . 0.0 112.029 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 59.45 42.57 97.62 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.768 -1.018 . . . . 0.0 112.792 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.7 Cg_endo -68.67 -9.96 27.67 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.244 2.63 . . . . 0.0 111.608 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -144.12 147.06 36.16 Favored Pre-proline 0 N--CA 1.454 -0.26 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.91 150.61 38.89 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.689 2.926 . . . . 0.0 110.546 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -143.44 -4.15 0.89 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.679 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 72.5 p -66.56 126.46 28.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 35.8 mt -99.47 144.55 28.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.873 0.469 . . . . 0.0 111.905 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -82.01 130.59 35.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -146.45 147.26 31.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 112.016 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.1 p -161.37 169.72 21.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.952 0.901 . . . . 0.0 109.319 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -74.95 140.57 43.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.6 t -135.39 143.6 46.12 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 35.3 m -81.37 102.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.1 161.5 34.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.975 0.91 . . . . 0.0 110.325 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -109.64 -12.13 14.69 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.925 0.49 . . . . 0.0 110.669 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -160.54 168.55 24.79 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.998 0.919 . . . . 0.0 109.132 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -78.74 77.29 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.891 0.476 . . . . 0.0 109.797 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.417 ' HA ' ' HE3' ' A' ' 530' ' ' LYS . 74.7 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.476 -1.25 . . . . 0.0 110.002 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -135.81 6.54 3.18 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.54 0.336 . . . . 0.0 111.806 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 178.2 176.46 46.16 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.07 172.73 13.32 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.313 3.342 . . . . 0.0 111.303 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -152.78 164.57 37.55 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.867 0.867 . . . . 0.0 109.3 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -132.45 148.65 52.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.136 0.493 . . . . 0.0 111.281 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -141.17 18.5 2.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.096 0.958 . . . . 0.0 109.814 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.1 m -142.7 153.87 62.07 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 122.848 0.459 . . . . 0.0 110.609 -174.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.38 3.09 7.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.117 3.212 . . . . 0.0 113.225 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.64 161.83 39.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 118.893 0.769 . . . . 0.0 112.866 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' LEU . . . . . 0.403 ' C ' HD12 ' A' ' 381' ' ' LEU . 3.1 pp -144.81 170.46 16.07 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.23 1.012 . . . . 0.0 109.227 172.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.1 mtp -137.16 148.04 46.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.9 149.21 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.861 0.464 . . . . 0.0 110.661 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -140.01 164.99 28.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.651 0.78 . . . . 0.0 109.823 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.41 -6.79 75.23 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.304 0.478 . . . . 0.0 112.828 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.5 pt? -69.42 174.62 4.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.916 0.858 . . . . 0.0 110.648 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -134.61 146.74 49.86 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -74.66 -1.91 23.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 93.7 p -117.99 -8.49 10.73 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.027 0.376 . . . . 0.0 111.646 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.4 -17.53 13.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 83.0 mmm -139.21 141.28 37.92 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.946 . . . . 0.0 109.758 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.89 173.93 11.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.39 -27.06 67.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.815 0.28 . . . . 0.0 110.947 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -79.37 -33.41 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.213 0.205 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -79.17 -35.57 41.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.746 0.248 . . . . 0.0 110.9 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.8 p -73.87 -26.7 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -66.89 -41.83 86.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.954 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.0 -8.3 57.32 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.0 112.915 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.34 -22.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.706 0.684 . . . . 0.0 110.231 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.52 -14.99 13.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 50.9 t -71.45 -25.59 62.37 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.071 0.851 . . . . 0.0 111.345 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.09 13.39 1.11 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.537 -0.727 . . . . 0.0 112.068 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -121.43 -3.62 9.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 110.841 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.91 165.43 12.79 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.91 150.03 46.14 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.067 -0.666 . . . . 0.0 110.826 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.42 148.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.87 -53.33 2.63 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.954 -0.466 . . . . 0.0 111.212 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.91 162.78 26.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.003 0.43 . . . . 0.0 111.448 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.6 p -143.23 150.42 17.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.08 142.65 22.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.347 0.259 . . . . 0.0 110.388 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -76.89 146.38 37.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 168.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.637 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -130.09 141.48 50.7 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.499 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 59.99 33.92 21.43 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.065 1.746 . . . . 0.0 112.495 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 36.7 m 52.97 14.02 0.41 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -77.3 146.96 75.27 Favored Pre-proline 0 N--CA 1.455 -0.218 0 CA-C-N 118.673 0.67 . . . . 0.0 110.1 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.9 -0.81 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.686 2.924 . . . . 0.0 110.849 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.44 40.0 1.01 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.004 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.637 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -148.9 134.84 19.01 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.93 0.865 . . . . 0.0 110.593 174.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.52 169.19 23.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 22.1 ptm -143.19 147.36 34.77 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.316 0.646 . . . . 0.0 110.028 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.5 t -127.87 153.17 36.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.172 0.589 . . . . 0.0 110.333 -172.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -129.48 135.3 48.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.947 0.499 . . . . 0.0 110.59 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.3 165.0 11.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.805 0.842 . . . . 0.0 109.956 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.56 -20.83 62.76 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -156.54 159.64 38.75 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.9 -15.73 71.84 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.215 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -69.29 -28.63 66.45 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 119.116 1.458 . . . . 0.0 110.383 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -76.26 -20.08 57.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 77.7 t -81.18 -28.13 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.98 -34.99 66.8 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -72.63 -31.85 65.46 Favored 'General case' 0 N--CA 1.457 -0.08 0 O-C-N 122.146 -0.347 . . . . 0.0 110.341 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.82 -29.22 58.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.326 -0.234 . . . . 0.0 110.977 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.4 tp -86.33 -30.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 O-C-N 122.36 -0.212 . . . . 0.0 111.112 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 82.7 p -94.83 -6.8 42.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -136.0 -15.63 1.74 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.62 -20.07 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.93 0.786 . . . . 0.0 110.027 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -51.59 144.31 10.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.704 0.802 . . . . 0.0 111.206 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 57.51 1.39 0.12 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.92 2.088 . . . . 0.0 115.526 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.86 142.5 27.76 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.873 1.669 . . . . 0.0 108.726 169.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.298 0.0 OUTLIER -130.94 163.9 26.49 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 172.607 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 19.2 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.159 1.384 . . . . 0.0 109.904 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . 0.25 29.0 m-85 66.16 27.02 10.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.976 1.311 . . . . 0.0 114.143 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.7 81.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 168.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -83.04 160.54 21.93 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.909 1.354 . . . . 0.0 110.543 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.598 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -86.31 129.41 34.86 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.596 0.758 . . . . 0.0 110.191 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.58 130.35 45.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -140.61 123.61 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.1 140.97 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.396 0.544 . . . . 0.0 110.655 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 71.5 m -147.11 165.24 30.57 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.88 0.872 . . . . 0.0 110.005 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 p -90.64 155.96 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.851 0.46 . . . . 0.0 109.912 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.6 t -133.89 158.95 42.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 123.12 0.568 . . . . 0.0 109.765 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.62 9.41 39.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -68.25 144.52 96.8 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.78 -24.36 11.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.918 2.412 . . . . 0.0 111.772 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -162.86 172.77 14.64 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.151 0.58 . . . . 0.0 109.992 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.71 143.55 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -100.21 155.98 35.8 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.132 0.173 . . . . 0.0 111.334 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.28 164.01 9.36 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.773 2.982 . . . . 0.0 112.227 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.37 178.97 38.25 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -72.66 163.55 27.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.949 0.5 . . . . 0.0 110.786 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.4 p -144.28 160.36 41.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.898 0.479 . . . . 0.0 110.745 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -151.81 165.04 35.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.557 0.743 . . . . 0.0 110.107 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.74 137.92 18.08 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 67.7 mt -87.06 170.47 11.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.719 0.808 . . . . 0.0 110.188 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.23 -20.41 64.82 Favored 'General case' 0 N--CA 1.461 0.115 0 O-C-N 122.142 -0.349 . . . . 0.0 111.752 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -88.39 6.0 39.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.974 0.509 . . . . 0.0 111.664 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.58 84.74 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.468 0.556 . . . . 0.0 112.797 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.8 m -88.76 161.55 16.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.125 0.963 . . . . 0.0 110.527 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.1 m -82.87 153.34 25.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 110.735 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.2 p -67.83 -10.28 51.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.321 0.649 . . . . 0.0 111.531 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -127.62 137.79 52.65 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.141 0.976 . . . . 0.0 110.123 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -156.36 157.58 35.89 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 122.59 0.356 . . . . 0.0 110.922 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.39 156.64 41.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.688 0.795 . . . . 0.0 110.878 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.64 13.71 2.32 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.324 0.649 . . . . 0.0 111.54 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 15.8 t -62.76 162.28 11.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.928 0.491 . . . . 0.0 112.025 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 57.76 17.5 4.19 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.862 1.265 . . . . 0.0 113.816 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 44.0 t -77.88 137.06 38.16 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.975 -0.453 . . . . 0.0 110.479 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -122.01 0.06 9.59 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.598 0.759 . . . . 0.0 111.582 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -86.35 60.41 6.22 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.262 0.625 . . . . 0.0 111.988 -174.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -145.86 163.08 36.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.08 0.552 . . . . 0.0 110.331 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -86.79 27.99 0.93 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.488 0.715 . . . . 0.0 112.684 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.38 16.8 1.17 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.153 -0.342 . . . . 0.0 111.22 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.3 p -72.16 -9.48 58.49 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.726 0.41 . . . . 0.0 111.636 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 37.7 p -142.84 157.85 60.58 Favored Pre-proline 0 C--O 1.231 0.127 0 C-N-CA 123.844 0.858 . . . . 0.0 108.867 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.26 -8.44 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.733 2.289 . . . . 0.0 111.177 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -93.86 -23.97 17.91 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.497 0.319 . . . . 0.0 111.13 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -90.49 -35.6 15.01 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.495 0.318 . . . . 0.0 110.262 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -70.12 -23.06 62.96 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.436 -0.165 . . . . 0.0 111.356 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.9 -10.52 57.02 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -117.56 11.99 13.95 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.15 0.58 . . . . 0.0 111.734 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.25 -36.25 0.81 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.052 0.541 . . . . 0.0 110.544 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 60.51 157.98 0.04 OUTLIER 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.776 1.631 . . . . 0.0 113.315 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.54 148.66 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.982 0.913 . . . . 0.0 110.083 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 63.25 -26.32 0.07 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.451 1.901 . . . . 0.0 115.467 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.45 121.14 79.56 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 119.363 0.983 . . . . 0.0 110.145 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.94 135.15 15.34 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.992 2.462 . . . . 0.0 109.81 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 97.1 p -124.17 -7.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.042 0.537 . . . . 0.0 112.208 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 58.45 18.42 5.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.595 0.758 . . . . 0.0 111.759 -170.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.78 136.71 55.32 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 123.404 0.682 . . . . 0.0 109.7 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.452 HD12 ' CH2' ' A' ' 546' ' ' TRP . 59.0 mt -118.91 148.59 42.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.83 154.55 28.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -135.8 149.16 49.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.455 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -146.69 171.74 14.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.822 0.449 . . . . 0.0 110.714 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 26.4 m120 60.73 21.81 11.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.981 . . . . 0.0 113.42 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -78.48 163.35 62.03 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.96 154.43 50.71 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.001 2.467 . . . . 0.0 111.605 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -77.84 -1.0 29.46 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -123.71 12.04 9.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.737 0.415 . . . . 0.0 111.976 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.79 154.99 4.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 121.904 -0.498 . . . . 0.0 111.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.9 p -144.67 170.24 16.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.472 0.709 . . . . 0.0 110.437 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 3.1 pm0 -62.37 -21.97 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.629 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.96 -30.82 69.33 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.976 -0.452 . . . . 0.0 109.921 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -78.36 -32.73 49.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.63 -28.62 67.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.184 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -84.08 -37.57 21.9 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.714 -0.616 . . . . 0.0 111.522 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.5 -9.09 59.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.355 0.525 . . . . 0.0 112.148 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.49 -32.51 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 117.783 0.265 . . . . 0.0 110.387 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 60.2 m -67.39 -21.61 65.59 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.0 -29.84 64.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.93 -16.54 27.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.554 0.615 . . . . 0.0 111.776 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.19 -11.85 42.59 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.53 0.332 . . . . 0.0 111.199 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 4.63 58.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.848 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.65 169.67 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 118.013 0.906 . . . . 0.0 110.603 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.74 153.42 35.04 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -102.43 153.21 38.28 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.459 0.304 . . . . 0.0 110.361 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.5 148.85 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.1 2.533 . . . . 0.0 111.143 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.47 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.5 m -81.97 -25.07 35.11 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.72 0.408 . . . . 0.0 110.555 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.9 t -144.53 158.46 43.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.84 145.31 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 122.84 0.456 . . . . 0.0 110.599 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -144.28 127.15 16.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.681 0.792 . . . . 0.0 108.983 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 32.9 t -130.64 149.03 33.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -143.41 165.87 26.32 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.779 0.324 . . . . 0.0 111.697 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m -130.8 154.71 47.73 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.653 0.781 . . . . 0.0 110.526 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . 174.09 -146.4 8.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -63.65 168.64 4.62 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.305 0.552 . . . . 0.0 109.75 175.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 25.1 m 58.54 29.0 17.8 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.82 -7.5 0.74 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.829 1.252 . . . . 0.0 114.084 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.81 -7.81 47.93 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.647 0.658 . . . . 0.0 110.705 175.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 49.8 m -141.86 168.48 19.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.372 1.069 . . . . 0.0 109.391 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 23.2 t -127.75 160.07 32.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.275 0.56 . . . . 0.0 111.226 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.1 p -149.64 167.05 27.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.233 1.013 . . . . 0.0 109.785 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.99 -172.88 45.49 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.344 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.51 153.91 39.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.915 0.886 . . . . 0.0 110.365 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.8 mt -138.07 142.22 40.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.383 1.073 . . . . 0.0 108.693 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -127.79 106.49 9.16 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.47 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -166.02 153.49 10.18 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.961 1.304 . . . . 0.0 107.853 168.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -152.82 122.64 6.92 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 45.2 t -159.6 153.04 22.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -66.45 -42.29 87.82 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.545 0.611 . . . . 0.0 110.943 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.4 p -85.76 -29.02 24.18 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -83.39 -28.74 28.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.543 0.611 . . . . 0.0 111.267 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -84.72 -30.0 25.1 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.256 0.48 . . . . 0.0 110.943 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.22 -28.2 34.95 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.419 0.554 . . . . 0.0 111.355 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.11 -40.78 37.18 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.884 -0.51 . . . . 0.0 110.39 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 61.3 m -68.25 -36.18 79.05 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.13 -43.22 95.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.837 -0.539 . . . . 0.0 109.738 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.3 -14.18 79.36 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.619 -1.1 . . . . 0.0 114.094 -173.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -128.54 -10.71 5.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.093 1.446 . . . . 0.0 113.77 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.85 -18.5 29.12 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.301 0.955 . . . . 0.0 109.852 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -85.79 153.42 22.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 171.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 57.51 15.97 3.05 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 562' ' ' TYR . . . . . 0.414 ' CZ ' ' CE2' ' A' ' 573' ' ' TYR . 0.0 OUTLIER -79.15 151.48 31.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.38 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -112.27 136.28 51.9 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.076 0.95 . . . . 0.0 110.576 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.9 ttt -64.23 176.11 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.775 0.83 . . . . 0.0 111.227 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -73.69 11.79 0.77 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.516 0.726 . . . . 0.0 112.874 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -64.86 144.88 99.02 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.401 0.546 . . . . 0.0 110.646 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.79 -27.78 4.59 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.428 2.752 . . . . 0.0 113.676 -170.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -120.97 -3.29 9.64 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.197 0.453 . . . . 0.0 111.955 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.87 39.71 97.64 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.751 -1.027 . . . . 0.0 113.211 -177.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 93.9 Cg_endo -71.29 -7.97 22.43 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.847 2.365 . . . . 0.0 112.115 -176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -144.22 147.78 38.65 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.157 0.435 . . . . 0.0 110.4 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.32 160.9 38.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.086 3.191 . . . . 0.0 110.902 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 573' ' ' TYR . . . . . 0.414 ' CE2' ' CZ ' ' A' ' 562' ' ' TYR . 42.4 t80 -141.77 -2.62 1.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.7 t -66.4 132.08 47.51 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 575' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 575' ' ' LEU . 2.1 pp -120.23 144.61 47.66 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.748 0.819 . . . . 0.0 110.197 175.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -76.07 148.58 37.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.22 145.0 48.76 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.524 0.729 . . . . 0.0 109.661 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.5 p -163.39 161.37 24.37 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -74.33 131.75 41.42 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 39.4 t -135.63 137.69 42.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 66.2 m -79.27 102.4 8.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.012 0.435 . . . . 0.0 110.901 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 159.49 40.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.127 0.971 . . . . 0.0 109.245 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -85.99 -25.13 26.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.341 -0.225 . . . . 0.0 110.781 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -164.18 168.6 18.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.625 0.77 . . . . 0.0 109.954 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.22 76.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.179 -179.676 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 22.6 t0 . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.385 0.136 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -144.48 8.27 1.34 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.124 0.57 . . . . 0.0 110.654 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 89.42 -159.95 28.85 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.12 171.01 10.8 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.154 3.236 . . . . 0.0 111.459 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -146.6 163.11 36.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.873 0.469 . . . . 0.0 111.378 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -96.92 165.4 12.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.335 1.054 . . . . 0.0 110.997 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.78 8.03 4.83 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.378 0.671 . . . . 0.0 110.282 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.2 m -146.38 154.67 49.52 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.169 0.588 . . . . 0.0 110.573 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.18 4.52 6.99 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.225 3.283 . . . . 0.0 112.825 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.5 162.28 35.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 119.164 0.893 . . . . 0.0 112.672 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.04 166.06 26.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 109.644 173.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.2 mmm -121.89 150.81 41.44 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.7 0.8 . . . . 0.0 110.149 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.32 145.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -142.79 166.66 24.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.907 0.483 . . . . 0.0 109.898 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.53 -0.6 84.98 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.607 173.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.737 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.11 177.42 5.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.175 0.988 . . . . 0.0 110.727 176.622 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.46 136.5 52.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.781 0.432 . . . . 0.0 110.231 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -75.77 4.4 8.01 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 18.3 t -112.53 -8.04 13.87 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.753 0.421 . . . . 0.0 111.556 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 -8.42 4.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 111.216 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.1 tpt -142.51 121.0 12.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.576 0.75 . . . . 0.0 109.211 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -141.9 -178.82 5.87 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.765 0.426 . . . . 0.0 110.406 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.2 m -60.5 -22.13 63.2 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.8 -25.88 19.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.829 -0.544 . . . . 0.0 111.637 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -87.82 -23.55 23.99 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.666 0.666 . . . . 0.0 109.873 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.2 p -78.38 -33.9 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.29 -33.77 76.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -71.33 -29.63 65.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.996 -0.44 . . . . 0.0 111.507 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 42.3 t -85.43 -13.02 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.058 -0.401 . . . . 0.0 111.592 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -118.94 -7.07 10.47 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.4 -35.47 75.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.332 0.969 . . . . 0.0 111.204 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.28 12.26 1.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.837 -0.539 . . . . 0.0 112.095 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -121.46 -4.74 9.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.481 0.712 . . . . 0.0 111.132 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.94 175.7 20.08 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.1 146.26 43.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.599 -0.353 . . . . 0.0 110.539 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.95 150.67 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -98.46 -60.48 1.54 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -167.51 166.1 14.37 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.576 0.75 . . . . 0.0 110.474 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.33 146.65 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 123.087 0.555 . . . . 0.0 110.312 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.489 ' HE2' ' CD1' ' A' ' 471' ' ' TYR . 39.0 ttmt -150.22 148.58 29.08 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.184 0.194 . . . . 0.0 111.135 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -82.48 149.07 27.77 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.555 ' HE1' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -135.66 141.43 45.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -168.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt 60.12 33.81 21.19 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 126.713 2.005 . . . . 0.0 114.13 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.7 m 52.91 18.03 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.62 157.59 87.88 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 118.587 0.63 . . . . 0.0 110.393 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.63 -18.82 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.601 2.868 . . . . 0.0 111.948 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -179.24 100.9 0.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.555 ' HB1' ' HE1' ' A' ' 412' ' ' MET . . . -160.91 143.42 12.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.26 171.49 19.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.314 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.0 ptm -144.44 143.96 31.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.35 151.67 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 C-N-CA 123.145 0.578 . . . . 0.0 110.284 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -129.52 137.5 50.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 90.5 mmm -109.22 164.04 12.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.431 0.692 . . . . 0.0 110.025 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.58 64.29 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.457 -0.152 . . . . 0.0 111.078 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -159.73 161.61 34.79 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.494 0.717 . . . . 0.0 109.404 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.96 -16.11 68.01 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.249 -0.751 . . . . 0.0 112.905 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 427' ' ' TYR . 2.5 p90 -65.45 -28.36 69.17 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.048 1.424 . . . . 0.0 110.925 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.0 -19.77 43.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.3 t -80.28 -23.75 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.9 -38.38 88.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.51 -26.37 45.87 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.98 -36.2 59.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.039 0.381 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.5 tp -85.16 -30.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 122.251 -0.281 . . . . 0.0 111.54 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.8 m -91.38 -21.51 20.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -124.57 -14.32 6.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 436' ' ' LEU . 2.4 tm? -115.56 -19.05 10.77 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.947 0.794 . . . . 0.0 110.389 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.97 139.07 23.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.383 0.611 . . . . 0.0 111.36 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.432 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 69.7 m-20 56.76 1.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.212 1.805 . . . . 0.0 115.735 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.77 142.46 27.81 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 120.869 1.668 . . . . 0.0 109.144 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.297 0.1 OUTLIER -130.9 163.84 26.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 174.547 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.2 ptm -125.29 143.33 51.01 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.029 1.331 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 63.05 33.07 14.99 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.33 15.6 78.05 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.95 140.9 32.53 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.323 1.061 . . . . 0.0 109.496 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -77.72 141.38 39.36 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.81 125.34 41.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -168.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -140.71 112.07 7.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.432 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.71 134.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.054 0.388 . . . . 0.0 110.715 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 81.6 m -149.52 165.04 33.37 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 124.394 1.078 . . . . 0.0 109.855 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.8 156.8 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.0 t -135.26 159.59 41.07 Favored 'General case' 0 C--O 1.23 0.046 0 C-N-CA 122.961 0.504 . . . . 0.0 110.333 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -99.3 5.76 46.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -67.03 144.92 98.75 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.796 -0.565 . . . . 0.0 109.551 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.92 -26.1 8.29 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.079 2.519 . . . . 0.0 112.244 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.6 173.59 11.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.051 0.54 . . . . 0.0 110.328 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.04 141.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.68 153.2 55.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 C-N-CA 122.208 0.203 . . . . 0.0 111.138 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.41 156.45 65.59 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.51 2.807 . . . . 0.0 111.231 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.25 169.14 28.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -78.28 157.82 29.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.752 0.421 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.9 p -134.27 159.78 39.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.987 0.515 . . . . 0.0 110.662 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -155.73 168.07 28.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.07 0.548 . . . . 0.0 109.732 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -76.91 140.83 25.44 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.69 170.75 13.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.874 0.87 . . . . 0.0 109.418 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.4 -20.03 65.48 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -90.14 5.27 47.59 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.24 85.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.017 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.4 m -89.14 155.76 19.23 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 118.413 1.107 . . . . 0.0 110.201 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.9 m -81.79 150.36 27.93 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.145 -0.347 . . . . 0.0 111.162 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -73.21 -10.37 59.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.785 0.434 . . . . 0.0 111.969 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.489 ' CD1' ' HE2' ' A' ' 410' ' ' LYS . 41.8 t80 -139.05 141.11 38.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.68 0.792 . . . . 0.0 110.699 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -156.77 153.35 28.22 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.807 0.443 . . . . 0.0 110.603 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.06 154.07 40.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.194 0.998 . . . . 0.0 109.701 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -135.93 -3.77 2.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 78.4 p -75.32 -9.34 58.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -109.13 3.91 22.43 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.659 0.383 . . . . 0.0 111.594 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.8 t -84.62 141.64 30.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.964 0.347 . . . . 0.0 110.49 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -119.37 16.25 13.03 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.724 0.809 . . . . 0.0 110.554 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -113.71 14.72 18.82 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.51 0.724 . . . . 0.0 111.257 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -83.88 172.37 12.19 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.528 0.331 . . . . 0.0 110.242 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -69.85 -6.16 30.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.568 1.147 . . . . 0.0 113.2 -174.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.68 22.24 0.4 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.285 0.493 . . . . 0.0 111.847 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 67.6 p -88.34 15.07 8.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 67.6 p -135.01 153.78 78.72 Favored Pre-proline 0 C--O 1.231 0.109 0 C-N-CA 123.284 0.633 . . . . 0.0 109.476 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.19 -4.19 13.16 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.306 2.671 . . . . 0.0 112.224 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -103.29 -31.01 10.28 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.069 0.395 . . . . 0.0 111.093 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -90.68 -23.54 20.71 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.957 0.344 . . . . 0.0 111.09 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.7 -20.55 61.9 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.233 -0.292 . . . . 0.0 110.747 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.54 0.45 49.84 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.023 0.529 . . . . 0.0 110.868 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -127.18 23.82 6.42 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.067 0.947 . . . . 0.0 110.78 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -65.34 160.53 21.58 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 111.035 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -135.45 38.78 2.89 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.378 0.671 . . . . 0.0 110.707 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.98 122.92 36.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -163.02 176.99 9.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -74.28 157.91 86.03 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.808 0.843 . . . . 0.0 109.786 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.38 133.88 31.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.978 2.452 . . . . 0.0 110.401 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.0 m -124.17 23.99 8.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.885 0.874 . . . . 0.0 111.73 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.31 17.63 3.81 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.675 1.59 . . . . 0.0 114.674 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.9 t -140.57 144.66 26.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.446 HD12 ' CH2' ' A' ' 546' ' ' TRP . 70.5 mt -123.31 163.56 20.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.14 0.576 . . . . 0.0 110.465 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.24 160.6 41.76 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.69 0.396 . . . . 0.0 110.523 174.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -136.59 155.53 49.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.336 0.654 . . . . 0.0 110.821 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -146.12 173.92 11.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.484 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.6 t30 62.35 33.98 16.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.373 1.069 . . . . 0.0 112.566 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -90.0 158.7 44.03 Favored Pre-proline 0 N--CA 1.454 -0.251 0 C-N-CA 122.744 0.418 . . . . 0.0 110.203 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 153.16 72.54 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.362 2.042 . . . . 0.0 109.558 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -70.93 -1.21 11.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.75 8.26 20.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.4 p -79.16 151.92 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.324 0.511 . . . . 0.0 110.938 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.3 p -144.72 171.93 13.71 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.437 0.695 . . . . 0.0 110.274 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.44 -19.87 65.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.88 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -72.33 -23.91 61.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.42 -31.48 26.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -70.66 -29.87 66.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.953 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -84.17 -36.2 23.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.435 0.561 . . . . 0.0 111.668 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.71 -21.89 59.13 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.384 0.538 . . . . 0.0 111.752 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.8 mt -92.77 -33.96 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 117.854 0.297 . . . . 0.0 110.614 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 87.4 m -68.29 -21.03 64.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.445 -0.784 . . . . 0.0 110.74 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.15 -30.8 65.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.378 -0.201 . . . . 0.0 111.507 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.03 -13.42 33.27 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.31 0.505 . . . . 0.0 111.997 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.25 -11.03 33.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.519 0.328 . . . . 0.0 111.102 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.72 4.67 62.3 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.408 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.9 162.06 3.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 118.24 1.02 . . . . 0.0 110.697 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -69.49 142.91 53.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -92.32 151.47 41.53 Favored Pre-proline 0 CA--C 1.528 0.132 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.08 154.7 71.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.204 2.603 . . . . 0.0 110.329 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 99.0 m -89.95 -26.76 20.23 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 122.722 0.409 . . . . 0.0 110.859 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 52.0 m -141.51 152.76 44.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 3.5 p -149.56 147.12 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.878 0.471 . . . . 0.0 110.72 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 122.55 9.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.77 145.93 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.79 0.436 . . . . 0.0 110.329 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -155.12 151.37 28.21 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.88 0.472 . . . . 0.0 110.38 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.3 m -104.64 144.08 32.2 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.918 0.487 . . . . 0.0 110.892 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.16 148.57 33.07 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.74 132.11 41.37 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.2 m 54.37 19.17 2.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.652 0.781 . . . . 0.0 112.881 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -107.06 -17.35 14.2 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.84 0.456 . . . . 0.0 110.884 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 53.03 25.4 4.05 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.284 1.034 . . . . 0.0 112.964 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 69.8 m -139.27 162.74 34.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.15 0.58 . . . . 0.0 110.487 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 35.1 t -127.39 158.44 37.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.672 0.789 . . . . 0.0 111.877 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -154.29 168.32 26.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.103 1.361 . . . . 0.0 109.59 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.31 -178.86 48.28 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.911 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.22 154.24 28.24 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.3 mt -139.2 134.47 32.79 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.441 1.096 . . . . 0.0 108.703 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.85 114.89 17.8 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.446 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.3 p90 -166.11 155.0 11.28 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -150.66 117.48 5.85 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.979 1.104 . . . . 0.0 113.979 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 48.2 t -159.49 153.05 22.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 168.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -65.87 -42.41 90.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.389 0.54 . . . . 0.0 110.491 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 71.9 p -82.29 -26.3 33.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -81.94 -35.24 29.31 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.63 0.65 . . . . 0.0 110.89 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -77.65 -29.6 51.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.407 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.28 -28.22 23.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.397 0.544 . . . . 0.0 111.568 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -75.19 -34.84 61.57 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.458 0.572 . . . . 0.0 110.041 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 41.3 m -72.88 -40.99 65.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 28.7 tp -59.92 -52.26 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.242 -0.911 . . . . 0.0 109.164 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.6 -11.69 72.95 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.591 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.43 -4.27 2.64 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 119.476 1.638 . . . . 0.0 113.869 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 559' ' ' LEU . 2.0 tm? -97.48 -30.28 12.98 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.771 0.714 . . . . 0.0 109.561 176.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -67.42 155.86 37.96 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.355 -0.841 . . . . 0.0 109.279 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 34.4 m80 61.25 18.82 9.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.396 1.078 . . . . 0.0 113.643 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.46 151.45 27.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.332 0.587 . . . . 0.0 112.308 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -120.71 136.36 54.88 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.189 0.996 . . . . 0.0 110.734 -175.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 564' ' ' MET . . . . . 0.441 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 6.3 ttt -64.21 175.39 1.29 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.657 0.783 . . . . 0.0 111.575 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 565' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 564' ' ' MET . 48.6 mtmt -70.32 5.82 1.59 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.053 0.941 . . . . 0.0 113.233 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -64.52 142.54 98.45 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.058 0.844 . . . . 0.0 110.895 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.57 -28.23 3.63 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.662 2.908 . . . . 0.0 113.782 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.09 1.27 10.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.257 0.48 . . . . 0.0 111.788 -175.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.444 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.52 40.14 98.29 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.293 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.2 Cg_endo -68.26 -9.07 24.72 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.076 2.517 . . . . 0.0 111.802 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -145.53 145.94 27.82 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.55 156.46 40.57 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.801 3.0 . . . . 0.0 110.848 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -142.29 -1.59 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.2 m -66.47 120.92 14.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 29.3 mt -98.82 144.49 27.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.563 0.745 . . . . 0.0 110.329 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -93.77 136.8 33.68 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.58 156.33 43.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.843 0.354 . . . . 0.0 111.647 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 22.4 p -163.72 -179.99 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.763 0.825 . . . . 0.0 110.084 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -75.6 143.63 42.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.518 0.327 . . . . 0.0 111.163 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.1 t -135.52 142.84 45.49 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.253 0.621 . . . . 0.0 110.501 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 59.8 m -90.75 102.21 14.97 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.2 161.51 34.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.558 0.743 . . . . 0.0 110.663 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -110.76 -8.24 14.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.868 0.467 . . . . 0.0 110.59 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -159.82 161.95 34.63 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.22 1.008 . . . . 0.0 109.394 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -83.67 76.41 9.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.466 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 28.0 t0 . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -140.35 17.46 2.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.313 0.645 . . . . 0.0 111.229 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -70.75 169.94 47.28 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.352 0.501 . . . . 0.0 112.592 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -80.52 -15.68 10.97 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 124.705 3.603 . . . . 0.0 112.24 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -154.85 153.44 31.15 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.001 0.521 . . . . 0.0 110.127 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -88.64 162.68 16.19 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.012 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.9 -6.69 42.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.559 0.344 . . . . 0.0 111.624 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.8 m -147.22 152.37 42.78 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -86.42 0.17 8.08 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.787 3.658 . . . . 0.0 112.246 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.8 151.74 36.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 118.472 0.578 . . . . 0.0 111.244 -174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -146.71 169.14 19.66 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.205 0.602 . . . . 0.0 110.183 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.4 mtp -135.08 154.06 51.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.286 0.234 . . . . 0.0 110.853 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.1 p -144.41 150.76 16.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 122.711 0.404 . . . . 0.0 110.948 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.17 168.78 18.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.856 0.862 . . . . 0.0 109.141 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.56 -3.29 86.9 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.766 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.734 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.2 pt? -72.7 176.65 5.36 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.654 0.727 . . . . 0.0 110.319 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -145.12 134.89 23.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -70.03 -5.06 23.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 97.1 p -93.86 -11.72 30.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 0.61 0.92 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.5 tpt -136.85 123.94 21.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -141.93 177.24 8.33 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.42 0.288 . . . . 0.0 111.029 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 77.1 m -59.03 -26.38 64.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.063 0.545 . . . . 0.0 111.897 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -82.92 -22.68 33.79 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.27 -0.269 . . . . 0.0 111.078 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -85.95 -36.45 19.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.87 -28.37 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.65 -38.27 83.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.095 -0.378 . . . . 0.0 110.038 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -80.73 -29.68 36.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.735 0.698 . . . . 0.0 112.664 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.41 -20.74 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 118.628 0.649 . . . . 0.0 110.789 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -113.69 -19.93 11.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 44.9 t -73.87 -26.81 60.76 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.564 1.075 . . . . 0.0 111.14 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.49 7.47 1.83 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.498 -0.751 . . . . 0.0 111.406 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.41 -0.04 9.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.014 0.926 . . . . 0.0 111.463 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 428' ' ' ALA . . . 155.01 170.88 21.15 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.38 150.1 48.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.033 0.444 . . . . 0.0 111.338 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 7.2 m -117.67 164.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -134.92 -52.23 0.79 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.171 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -163.8 163.18 24.01 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.655 0.661 . . . . 0.0 112.176 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.82 153.3 13.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.853 0.861 . . . . 0.0 110.44 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -151.97 145.58 24.96 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.47 0.308 . . . . 0.0 110.335 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.36 163.24 25.01 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 30.6 ttp -123.14 141.11 52.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 49.47 33.93 6.19 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.2 1.4 . . . . 0.0 112.311 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 24.3 m 52.95 18.23 1.04 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.146 0.978 . . . . 0.0 113.303 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.38 147.21 67.93 Favored Pre-proline 0 N--CA 1.456 -0.125 0 O-C-N 121.929 -0.482 . . . . 0.0 109.859 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -79.18 -2.44 12.36 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.495 2.797 . . . . 0.0 110.678 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -137.62 30.67 2.57 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.427 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.31 137.03 22.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.158 0.979 . . . . 0.0 110.149 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.11 167.72 29.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.74 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.8 ptm -142.54 142.02 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.776 0.831 . . . . 0.0 109.663 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.81 147.49 23.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.65 0.38 . . . . 0.0 110.916 -173.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -124.88 145.12 49.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.983 0.513 . . . . 0.0 111.154 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 78.5 mmm -111.61 162.74 14.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.334 1.054 . . . . 0.0 109.397 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.84 -20.84 62.51 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.027 -0.421 . . . . 0.0 111.8 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.23 161.4 39.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.119 0.568 . . . . 0.0 109.791 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.59 -12.92 70.84 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.177 -0.79 . . . . 0.0 113.553 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.49 -27.3 66.89 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.411 1.605 . . . . 0.0 110.24 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 404' ' ' GLY . . . -78.7 -28.74 45.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.687 0.28 . . . . 0.0 110.256 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.0 t -75.66 -24.83 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.37 -39.88 67.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.127 -0.358 . . . . 0.0 110.957 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.68 67.93 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.87 -33.39 34.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.14 -0.35 . . . . 0.0 111.931 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -83.06 -30.98 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.871 -0.518 . . . . 0.0 111.36 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.8 m -98.62 -14.14 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.35 -8.43 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.69 -20.11 10.25 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.281 0.946 . . . . 0.0 109.578 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -52.01 143.63 13.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.703 0.801 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.2 1.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.367 2.267 . . . . 0.0 115.971 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.77 142.32 27.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.647 1.567 . . . . 0.0 108.679 169.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.363 0.0 OUTLIER -130.92 165.07 23.9 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.9 ptp -125.13 143.53 50.88 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.011 1.324 . . . . 0.0 109.632 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 66.18 26.45 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.12 15.76 74.65 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -83.0 161.89 21.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.531 1.166 . . . . 0.0 110.087 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -83.79 132.4 34.83 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.48 133.83 42.3 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.76 117.23 10.79 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.69 143.73 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.236 0.471 . . . . 0.0 110.19 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 26.3 t -158.94 160.41 36.01 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.666 0.386 . . . . 0.0 110.057 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.14 158.22 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.677 0.391 . . . . 0.0 110.055 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.8 t -133.1 158.76 41.97 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.262 0.625 . . . . 0.0 109.837 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -110.86 14.02 22.17 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -66.94 151.07 97.44 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.31 -28.5 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.783 2.322 . . . . 0.0 111.862 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.66 172.23 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.284 0.634 . . . . 0.0 110.254 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.6 mm -66.44 137.81 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -89.01 149.3 43.01 Favored Pre-proline 0 N--CA 1.455 -0.179 0 O-C-N 122.404 -0.185 . . . . 0.0 110.869 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.17 162.77 39.83 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.665 2.91 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 168.03 -177.55 42.19 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -75.78 162.64 28.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.5 p -136.9 162.62 32.76 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.843 0.457 . . . . 0.0 110.914 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.55 163.42 32.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.569 0.748 . . . . 0.0 109.617 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.68 134.34 13.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.76 171.11 11.16 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.493 0.717 . . . . 0.0 110.063 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.02 -20.47 66.2 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.557 0.343 . . . . 0.0 111.432 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.72 1.94 47.43 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.838 0.455 . . . . 0.0 111.603 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.24 -3.68 85.5 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.874 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 68.4 m -91.38 159.14 16.14 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 118.196 0.998 . . . . 0.0 110.525 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.8 m -80.0 153.46 28.85 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.511 0.324 . . . . 0.0 110.478 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.0 p -70.01 -10.41 58.57 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.339 0.656 . . . . 0.0 111.656 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -126.53 139.28 53.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.307 1.043 . . . . 0.0 109.272 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -155.83 156.15 34.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.231 0.212 . . . . 0.0 110.845 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.22 156.37 35.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.879 0.872 . . . . 0.0 110.704 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -139.93 16.91 2.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.395 0.678 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p -68.59 3.15 1.97 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.12 -6.22 58.58 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.932 -0.48 . . . . 0.0 110.401 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 22.8 t -86.29 7.81 23.88 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.457 0.703 . . . . 0.0 111.558 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.02 10.99 0.99 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.008 0.523 . . . . 0.0 111.866 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -125.94 8.06 7.4 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.975 0.91 . . . . 0.0 110.792 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -78.74 170.1 17.19 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.775 0.83 . . . . 0.0 110.805 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -70.15 1.59 4.57 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.773 0.829 . . . . 0.0 113.139 -175.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -144.62 29.23 1.26 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.092 0.557 . . . . 0.0 110.396 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.2 p -65.9 -12.47 54.88 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.6 0.76 . . . . 0.0 112.559 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 6.8 t -144.73 151.2 49.22 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 123.724 0.809 . . . . 0.0 109.084 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.41 -19.56 36.25 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.085 2.523 . . . . 0.0 113.411 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -78.39 -31.94 48.61 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 117.845 0.293 . . . . 0.0 110.957 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -90.63 -23.45 20.8 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.64 0.376 . . . . 0.0 111.225 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.67 -20.48 63.57 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.359 -0.213 . . . . 0.0 110.613 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -89.15 0.52 56.67 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.143 0.577 . . . . 0.0 111.125 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -115.8 7.61 14.63 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.099 0.959 . . . . 0.0 110.809 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -130.64 14.97 5.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.586 0.754 . . . . 0.0 110.562 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 46.72 59.75 3.75 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.79 1.236 . . . . 0.0 112.867 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.77 106.21 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -144.55 178.08 8.22 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.778 0.831 . . . . 0.0 110.231 -173.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -66.93 164.89 30.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.637 0.775 . . . . 0.0 110.044 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.9 145.75 23.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.915 3.076 . . . . 0.0 113.523 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 49.1 m -124.11 23.7 8.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.729 0.812 . . . . 0.0 111.809 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 60.54 10.23 2.44 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.22 1.408 . . . . 0.0 114.306 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 29.8 t -140.41 144.96 26.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' LEU . . . . . 0.444 HD12 ' CH2' ' A' ' 546' ' ' TRP . 65.5 mt -122.79 150.53 42.69 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.804 0.441 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.92 150.12 50.02 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.212 0.605 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.71 151.91 47.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -145.47 169.21 18.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.85 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.7 t30 58.56 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.023 0.929 . . . . 0.0 112.487 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.8 163.41 49.08 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 122.778 0.431 . . . . 0.0 109.863 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.83 150.53 62.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.853 2.369 . . . . 0.0 111.549 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.47 ' H ' ' CD2' ' A' ' 507' ' ' LEU . 1.8 pt? -72.85 -1.09 15.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.48 13.58 5.0 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -76.26 154.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.129 0.422 . . . . 0.0 110.578 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 66.3 p -142.22 171.04 14.6 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.961 0.504 . . . . 0.0 110.088 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.64 -22.03 66.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.097 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.81 -26.08 56.92 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.24 -0.287 . . . . 0.0 110.71 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -79.04 -30.98 44.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.77 -30.02 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.398 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -76.78 -39.85 50.19 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.1 0.409 . . . . 0.0 111.672 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.94 -18.19 56.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.732 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.23 -33.9 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.222 0.464 . . . . 0.0 110.251 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.84 -21.65 65.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.556 -0.715 . . . . 0.0 110.174 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.96 -28.86 60.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.769 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.99 -14.35 31.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.345 0.521 . . . . 0.0 111.892 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.6 mt -95.4 -7.05 39.49 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.566 0.346 . . . . 0.0 110.903 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.36 4.72 61.14 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.224 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.6 m -80.67 169.47 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.092 0.946 . . . . 0.0 111.033 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -80.91 147.62 30.24 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.984 0.513 . . . . 0.0 110.736 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -88.29 147.53 40.42 Favored Pre-proline 0 C--O 1.232 0.132 0 C-N-CA 123.064 0.546 . . . . 0.0 109.964 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.53 156.13 61.96 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.534 2.823 . . . . 0.0 110.195 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.43 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.2 m -86.95 -25.91 24.12 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.341 0.256 . . . . 0.0 110.608 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.7 m -144.52 151.76 39.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.865 0.466 . . . . 0.0 109.824 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.57 144.56 29.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 123.496 0.718 . . . . 0.0 109.124 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 124.13 11.45 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.08 151.57 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -145.66 147.51 32.07 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.941 0.4 . . . . 0.0 111.694 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.7 t -130.81 146.0 52.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.924 0.889 . . . . 0.0 109.066 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . 168.55 -21.6 0.09 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -152.23 159.62 43.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.74 1.216 . . . . 0.0 108.024 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 20.4 m 54.55 28.75 10.21 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.094 0.407 . . . . 0.0 110.604 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -57.83 -7.53 0.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.669 1.588 . . . . 0.0 114.189 -169.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.01 -10.35 52.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.65 0.659 . . . . 0.0 110.532 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 79.8 p -152.52 175.32 12.88 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.595 1.158 . . . . 0.0 109.898 177.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 69.2 m -132.16 161.18 33.98 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.885 0.474 . . . . 0.0 110.934 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.2 m -145.53 159.59 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.912 0.885 . . . . 0.0 109.606 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -174.86 -175.74 42.6 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.638 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.78 155.37 34.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.898 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.4 mt -135.91 132.6 36.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.489 1.116 . . . . 0.0 108.042 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.76 112.56 14.93 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.444 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.2 p90 -166.04 155.42 11.81 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.59 1.556 . . . . 0.0 107.368 168.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -150.01 122.89 8.73 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.2 t -159.53 152.97 22.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.64 -46.83 77.72 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.778 0.717 . . . . 0.0 111.213 -174.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 78.2 p -84.34 -25.4 29.22 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -85.36 -28.58 25.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.725 0.693 . . . . 0.0 111.271 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.247 0.476 . . . . 0.0 110.663 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.97 -29.84 35.22 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.19 0.45 . . . . 0.0 111.045 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -77.83 -38.56 45.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.352 0.524 . . . . 0.0 110.179 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 38.2 m -73.21 -42.64 62.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 556' ' ' LEU . . . . . 0.446 ' C ' HD13 ' A' ' 556' ' ' LEU . 2.3 tm? -60.54 -46.61 89.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -67.53 -14.87 65.38 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.355 -1.247 . . . . 0.0 114.032 -172.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.07 -6.81 2.69 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.327 1.564 . . . . 0.0 113.976 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.95 -22.3 25.69 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.557 0.617 . . . . 0.0 109.749 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.08 151.51 30.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.22 -0.3 . . . . 0.0 111.023 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 49.24 30.0 2.9 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 151.42 25.65 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -110.91 136.33 50.1 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.213 1.405 . . . . 0.0 110.628 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.2 ttt -64.28 174.95 1.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.154 0.982 . . . . 0.0 112.18 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.87 12.58 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.37 1.068 . . . . 0.0 112.835 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.48 141.41 88.05 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.21 0.604 . . . . 0.0 111.147 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.55 -29.8 2.18 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.356 2.704 . . . . 0.0 113.021 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -121.05 -7.9 9.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.395 0.516 . . . . 0.0 112.395 -177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.12 42.84 97.9 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.412 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 88.8 Cg_endo -71.9 -6.55 19.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.134 2.556 . . . . 0.0 112.208 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.1 149.98 47.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.135 0.574 . . . . 0.0 110.341 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.44 156.24 41.03 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.627 2.885 . . . . 0.0 110.595 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -137.87 -2.46 1.91 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.524 0.33 . . . . 0.0 111.478 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.0 t -66.69 131.95 47.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.164 0.507 . . . . 0.0 110.73 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 575' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 575' ' ' LEU . 0.9 OUTLIER -125.03 144.6 50.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.595 1.158 . . . . 0.0 109.638 177.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -72.48 147.08 46.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 54.9 tp -142.05 144.7 33.73 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.97 172.64 13.64 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 111.502 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -88.46 132.94 34.27 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.2 t -135.57 150.67 49.77 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.068 0.147 . . . . 0.0 110.783 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 40.9 m -87.1 102.56 14.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.945 0.403 . . . . 0.0 111.154 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.39 34.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.697 0.799 . . . . 0.0 109.892 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -109.7 -14.06 14.4 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.939 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -160.84 164.83 31.05 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.485 0.714 . . . . 0.0 109.457 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.52 102.9 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.645 -178.448 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.775 -0.155 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.58 10.28 4.36 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.86 0.464 . . . . 0.0 111.629 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 85.86 151.11 16.18 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.73 0.681 . . . . 0.0 112.118 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.26 -1.55 10.33 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 124.526 3.484 . . . . 0.0 112.157 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -149.12 170.73 17.74 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.095 0.474 . . . . 0.0 111.641 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -125.93 165.37 18.87 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.958 0.903 . . . . 0.0 109.478 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.0 1.4 3.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 50.0 m -145.42 151.7 47.97 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 117.872 0.306 . . . . 0.0 111.285 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.26 -3.06 10.17 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 124.339 3.36 . . . . 0.0 111.934 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.03 151.74 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.286 0.494 . . . . 0.0 111.585 -173.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.72 174.58 11.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.728 0.811 . . . . 0.0 110.27 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.7 mtp -135.4 149.89 49.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.422 0.289 . . . . 0.0 111.207 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.5 148.77 28.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.574 0.75 . . . . 0.0 109.971 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -139.4 168.4 19.9 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.992 0.517 . . . . 0.0 110.289 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.03 -6.05 68.65 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.411 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.615 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.3 pt? -71.85 -175.48 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.163 0.982 . . . . 0.0 110.598 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -146.12 149.7 34.51 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 121.981 -0.449 . . . . 0.0 110.559 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -76.2 -2.08 29.47 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 m -108.89 -4.1 17.07 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.608 0.363 . . . . 0.0 111.701 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -130.27 -12.28 4.04 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.014 0.526 . . . . 0.0 111.011 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 85.5 mtp -141.28 135.25 30.43 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.923 0.489 . . . . 0.0 110.342 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 29.0 m120 -141.87 174.14 10.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.35 -31.15 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.783 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.18 -25.3 29.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ARG . . . . . 0.402 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 59.6 mtt85 -89.15 -28.72 19.85 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 122.234 0.214 . . . . 0.0 110.902 -178.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.73 -26.76 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -66.8 -35.56 80.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.46 -30.4 70.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.195 -0.316 . . . . 0.0 110.83 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.74 -21.6 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -110.44 -10.69 14.55 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.0 t -70.4 -36.38 74.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.851 0.75 . . . . 0.0 111.977 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.96 13.29 1.45 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.715 -0.616 . . . . 0.0 112.251 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -121.41 -1.27 9.66 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.469 0.707 . . . . 0.0 110.861 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 141.16 174.1 14.0 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -75.83 145.16 40.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.534 -0.392 . . . . 0.0 110.685 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.59 154.28 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -105.02 -55.86 2.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 110.523 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -164.47 162.25 21.83 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.105 0.479 . . . . 0.0 111.202 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 15.0 p -145.88 151.28 14.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.8 0.84 . . . . 0.0 110.249 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -154.07 147.19 24.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.335 0.254 . . . . 0.0 110.928 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -76.77 146.99 37.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' MET . . . . . 0.47 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -133.12 141.54 48.22 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -167.811 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.36 33.99 20.74 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.343 1.457 . . . . 0.0 112.647 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 54.59 19.94 2.66 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -103.82 141.27 22.17 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.02 -14.63 21.03 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.915 2.41 . . . . 0.0 109.622 171.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.05 65.96 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.378 0.989 . . . . 0.0 112.418 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ALA . . . . . 0.47 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -147.75 129.91 15.52 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.303 1.052 . . . . 0.0 111.17 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -150.75 167.37 27.62 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.326 0.651 . . . . 0.0 110.891 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 20.2 ptm -144.78 143.98 30.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.656 0.382 . . . . 0.0 110.207 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.64 143.06 41.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.08 0.552 . . . . 0.0 110.694 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -126.54 138.0 53.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.201 0.6 . . . . 0.0 110.135 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 85.6 mmm -102.52 164.95 11.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.0 110.322 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.3 -20.74 62.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.451 -0.155 . . . . 0.0 111.221 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -158.06 161.54 38.03 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.302 0.641 . . . . 0.0 109.74 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.24 -14.33 68.62 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.414 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -67.44 -25.59 65.98 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.064 1.432 . . . . 0.0 110.446 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.58 -18.1 28.79 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.17 0.188 . . . . 0.0 111.182 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.72 -31.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.86 -31.86 71.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -79.62 -29.18 40.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.823 0.449 . . . . 0.0 110.864 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.34 -32.23 26.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.251 0.478 . . . . 0.0 110.819 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 433' ' ' ILE . 6.9 tp -79.22 -31.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 122.166 -0.334 . . . . 0.0 111.279 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -97.1 -21.33 17.42 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -122.54 -12.68 8.12 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.3 -20.21 10.43 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 118.864 0.756 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -55.58 144.82 25.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.794 0.838 . . . . 0.0 110.581 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 60.01 1.31 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.772 2.029 . . . . 0.0 114.89 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -88.14 142.68 27.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.397 1.453 . . . . 0.0 109.047 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.307 0.1 OUTLIER -130.81 163.93 26.29 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.5 ptm -125.36 143.43 50.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.655 1.182 . . . . 0.0 108.804 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 62.86 28.42 16.38 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.86 72.24 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -83.07 152.58 25.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.432 1.616 . . . . 0.0 111.095 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 141.83 36.26 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.5 122.02 35.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -168.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.96 118.88 11.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.437 0.695 . . . . 0.0 109.28 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 3.1 p -154.47 138.23 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.164 0.438 . . . . 0.0 110.275 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.9 m -147.69 155.51 41.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.38 157.06 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 48.1 t -130.1 167.57 18.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.118 0.567 . . . . 0.0 109.991 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -119.47 12.43 12.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.848 0.459 . . . . 0.0 111.997 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -63.94 150.79 90.92 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.51 -30.58 9.78 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.472 2.114 . . . . 0.0 111.849 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.58 164.78 10.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.711 0.405 . . . . 0.0 110.77 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.7 mm -70.56 140.31 18.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.0 mmt -102.26 130.38 24.3 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.97 -31.52 9.8 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.6 2.2 . . . . 0.0 112.196 -172.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 58.52 -152.48 30.33 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -101.67 -15.41 17.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.737 0.415 . . . . 0.0 110.543 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 3.1 m 55.86 176.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.671 1.588 . . . . 0.0 113.442 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -153.8 165.34 36.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.519 0.728 . . . . 0.0 109.275 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -86.61 123.85 6.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.97 176.48 7.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.932 0.493 . . . . 0.0 111.228 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -59.96 -24.57 64.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.1 -0.61 25.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.912 -0.492 . . . . 0.0 111.389 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.98 -3.8 78.5 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.614 0.626 . . . . 0.0 112.112 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 23.2 t -93.64 170.32 9.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.515 0.726 . . . . 0.0 110.329 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 16.4 p -85.67 153.32 22.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.99 0.424 . . . . 0.0 111.165 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.0 m -71.7 -10.39 59.69 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.546 0.738 . . . . 0.0 112.576 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -120.14 143.48 48.17 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.068 0.547 . . . . 0.0 110.87 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -153.8 156.55 37.9 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.692 0.397 . . . . 0.0 110.354 177.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -133.17 156.43 47.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.82 15.13 1.94 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.978 0.511 . . . . 0.0 111.608 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.7 p -67.69 0.96 2.76 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -108.91 2.0 21.16 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.257 0.623 . . . . 0.0 111.235 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.6 m -82.91 36.28 0.5 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.598 0.759 . . . . 0.0 111.324 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -77.98 29.23 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.458 1.103 . . . . 0.0 112.398 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -136.31 32.48 2.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.613 0.365 . . . . 0.0 111.205 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -94.93 21.55 7.5 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.69 0.396 . . . . 0.0 111.902 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 62.46 -0.22 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.073 1.349 . . . . 0.0 114.381 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -156.22 16.31 0.34 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.485 0.584 . . . . 0.0 110.605 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 11.0 p -83.76 2.74 36.52 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 34.9 p -140.23 160.01 61.6 Favored Pre-proline 0 CA--C 1.524 -0.056 0 CA-C-N 118.394 0.543 . . . . 0.0 109.89 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.18 -14.21 22.99 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.555 2.837 . . . . 0.0 112.823 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.63 -24.72 15.87 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.485 0.314 . . . . 0.0 110.94 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -90.46 -25.56 20.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.795 0.438 . . . . 0.0 110.154 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -75.61 1.29 14.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.224 0.61 . . . . 0.0 111.564 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -91.15 1.71 56.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.006 0.522 . . . . 0.0 111.233 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.44 6.34 8.33 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.856 0.862 . . . . 0.0 111.342 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -149.22 170.44 18.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.753 0.821 . . . . 0.0 109.334 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -137.81 143.52 41.06 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.735 0.414 . . . . 0.0 110.691 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 42.6 mm -113.57 131.16 66.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -146.01 179.4 7.51 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.378 0.671 . . . . 0.0 110.004 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -65.61 162.87 39.15 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.078 0.551 . . . . 0.0 110.3 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.37 145.97 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.519 2.813 . . . . 0.0 112.489 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.7 m -124.05 24.0 8.34 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.452 0.701 . . . . 0.0 111.402 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.81 12.04 2.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.538 1.135 . . . . 0.0 113.618 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.71 151.18 22.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.3 mt -132.4 151.22 51.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.652 0.781 . . . . 0.0 109.689 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -121.09 142.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 544' ' ' LEU . 11.3 m-85 -125.33 148.02 48.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.206 0.602 . . . . 0.0 110.503 -175.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -144.6 172.71 12.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.737 0.415 . . . . 0.0 111.035 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 66.8 t30 62.23 32.21 17.28 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.325 1.05 . . . . 0.0 113.126 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -89.22 158.29 46.7 Favored Pre-proline 0 N--CA 1.454 -0.242 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 156.81 52.07 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.242 1.961 . . . . 0.0 109.645 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.9 pt? -68.33 -1.17 5.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.666 0.787 . . . . 0.0 112.866 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.52 11.58 12.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.6 p -76.59 153.63 5.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 118.287 0.494 . . . . 0.0 110.725 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 78.4 p -143.76 169.24 18.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.278 0.631 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.04 -24.62 68.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.253 -0.28 . . . . 0.0 110.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.13 -26.01 60.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -78.31 -32.22 49.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.85 -28.54 64.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.236 -0.29 . . . . 0.0 110.708 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -80.37 -36.43 33.97 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.024 0.375 . . . . 0.0 111.941 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.65 -19.5 38.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 80.6 mt -86.86 -34.46 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.11 -21.73 64.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.693 -0.629 . . . . 0.0 109.824 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.54 -31.17 68.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -91.14 -15.9 28.64 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.209 0.459 . . . . 0.0 111.947 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.5 mt -91.52 -9.73 43.32 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.637 0.199 . . . . 0.0 111.201 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.53 4.63 57.98 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.958 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.51 165.64 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.998 0.899 . . . . 0.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -72.2 123.95 24.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -76.59 150.79 82.37 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -63.71 151.03 86.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.84 2.36 . . . . 0.0 110.721 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 527' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.6 m -88.23 -19.99 26.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.866 0.467 . . . . 0.0 110.903 -175.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.1 t -146.64 154.16 41.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.37 138.9 46.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 122.413 0.285 . . . . 0.0 110.896 -175.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -147.1 125.49 12.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.191 0.996 . . . . 0.0 108.352 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.63 150.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 C-N-CA 122.728 0.411 . . . . 0.0 110.333 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -145.0 161.12 40.18 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.779 0.832 . . . . 0.0 109.119 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 19.5 m -118.96 142.15 48.04 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.403 0.281 . . . . 0.0 111.075 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.68 150.5 34.66 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -78.35 132.99 37.64 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 21.0 m 54.35 19.61 2.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.965 0.906 . . . . 0.0 112.786 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -110.63 -14.5 14.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.744 0.418 . . . . 0.0 111.109 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 50.28 31.26 5.06 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.991 0.916 . . . . 0.0 112.868 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.3 t -140.61 158.13 44.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.979 0.512 . . . . 0.0 110.147 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.8 m -125.13 153.43 43.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.612 0.765 . . . . 0.0 112.034 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.0 m -147.9 162.14 39.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.478 1.511 . . . . 0.0 108.528 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.07 177.8 39.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.475 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.488 ' C ' HD22 ' A' ' 544' ' ' LEU . 84.6 mt -98.91 139.47 34.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.817 -173.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 502' ' ' PHE . 3.6 mm? -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -127.87 116.37 20.03 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 546' ' ' TRP . . . . . 0.411 ' HB3' ' H ' ' A' ' 527' ' ' THR . 3.0 p90 -166.09 150.47 8.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.744 1.618 . . . . 0.0 107.058 168.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.58 120.83 7.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 548' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 42.3 t -159.48 152.9 22.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -66.45 -46.1 77.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.97 0.804 . . . . 0.0 111.17 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 68.6 p -84.34 -33.3 23.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.859 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 551' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 38.3 m-20 -76.5 -31.31 57.63 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.843 0.747 . . . . 0.0 110.903 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.95 -31.28 58.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.052 0.387 . . . . 0.0 110.752 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.13 -29.73 38.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.132 0.424 . . . . 0.0 111.575 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -71.86 -40.7 68.8 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.39 . . . . 0.0 109.992 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 33.1 m -70.1 -31.68 69.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.41 -45.87 85.74 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.335 -0.853 . . . . 0.0 110.529 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.21 -27.19 70.51 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.041 -0.866 . . . . 0.0 113.421 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.75 -10.7 13.58 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.627 1.213 . . . . 0.0 114.198 -176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 559' ' ' LEU . 0.4 OUTLIER -99.62 -26.84 13.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.304 0.956 . . . . 0.0 110.941 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -60.39 138.21 58.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.059 -1.026 . . . . 0.0 110.951 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 40.3 m170 51.61 26.33 3.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.409 1.084 . . . . 0.0 113.544 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.4 151.36 47.57 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.173 0.511 . . . . 0.0 112.336 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -103.69 136.4 43.46 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.183 0.993 . . . . 0.0 110.694 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 564' ' ' MET . . . . . 0.401 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.4 ttt -64.34 174.92 1.47 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.06 0.544 . . . . 0.0 111.255 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -75.32 11.91 1.09 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -68.68 146.67 97.75 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 118.271 0.487 . . . . 0.0 110.332 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.39 -37.95 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.252 2.634 . . . . 0.0 113.831 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -121.03 6.83 10.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 569' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.1 45.24 92.52 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.107 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 570' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.4 Cg_endo -68.99 -9.8 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.22 2.613 . . . . 0.0 111.866 -178.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -146.17 149.07 37.22 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.011 0.524 . . . . 0.0 109.721 174.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.83 148.96 41.83 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.903 3.068 . . . . 0.0 110.97 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 573' ' ' TYR . . . . . 0.401 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.5 t80 -149.92 15.47 0.84 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.847 0.459 . . . . 0.0 110.932 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 81.9 p -80.18 91.06 5.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.123 -0.986 . . . . 0.0 110.752 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.94 144.55 38.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -107.61 154.02 22.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 577' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 577' ' ' LEU . 2.1 pt? -143.44 151.54 40.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 111.437 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.64 163.79 39.47 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.699 0.8 . . . . 0.0 110.032 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.38 140.58 50.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 73.8 p -135.58 143.47 45.66 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.553 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 28.0 p -84.4 102.26 12.62 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.45 34.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.664 0.786 . . . . 0.0 110.976 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.67 -8.64 12.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.036 0.535 . . . . 0.0 110.595 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -160.92 162.9 32.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.016 0.926 . . . . 0.0 109.326 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.93 76.4 9.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.866 178.857 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.981 0.42 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.86 -5.88 24.24 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.077 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.6 m -148.47 152.73 39.1 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -85.48 2.35 7.77 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.659 3.573 . . . . 0.0 112.34 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.94 152.23 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.906 0.482 . . . . 0.0 111.356 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.1 pp -142.54 170.3 15.96 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.719 0.807 . . . . 0.0 110.445 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.38 149.71 47.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.916 0.486 . . . . 0.0 110.207 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.99 150.39 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.794 0.438 . . . . 0.0 110.952 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -140.25 168.99 18.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.82 0.848 . . . . 0.0 109.514 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.99 -5.1 77.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.945 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.761 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -72.0 176.68 4.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.83 0.815 . . . . 0.0 110.586 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.06 131.85 25.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -68.12 -7.88 33.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.7 t -91.81 -15.69 27.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.663 0.665 . . . . 0.0 112.104 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.38 5.26 1.24 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 15.4 tpt -150.9 102.52 2.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -141.86 -166.44 2.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.941 0.497 . . . . 0.0 110.342 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 78.0 m -52.53 -27.08 15.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.13 -28.2 24.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.378 0.536 . . . . 0.0 111.674 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -83.91 -31.85 25.45 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.23 -26.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.4 -30.58 62.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -81.5 -17.77 47.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.318 -0.372 . . . . 0.0 111.914 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.27 -22.2 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -110.95 -18.8 12.99 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.94 -21.89 60.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.327 0.967 . . . . 0.0 112.333 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.57 10.43 1.72 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.618 -0.676 . . . . 0.0 112.467 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -121.43 -2.71 9.45 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.923 0.889 . . . . 0.0 110.975 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 152.0 154.43 6.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.23 134.95 51.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.277 0.538 . . . . 0.0 110.298 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.07 154.02 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.05 -59.6 1.67 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.018 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . 0.439 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.1 pttm -160.93 162.33 31.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.648 0.379 . . . . 0.0 111.296 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.35 150.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 123.924 0.889 . . . . 0.0 109.792 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.23 145.3 26.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.505 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.24 145.34 27.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.595 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -132.1 141.66 49.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -167.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.19 33.93 21.06 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 125.769 1.628 . . . . 0.0 112.371 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 53.02 14.79 0.5 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 142.83 57.89 Favored Pre-proline 0 N--CA 1.456 -0.144 0 CA-C-N 118.802 0.728 . . . . 0.0 109.956 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.9 -0.19 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.412 2.741 . . . . 0.0 110.471 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.13 31.92 2.4 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.479 -0.623 . . . . 0.0 112.887 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.595 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -148.34 134.08 18.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.001 0.901 . . . . 0.0 110.154 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.8 170.93 19.09 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.951 0.405 . . . . 0.0 111.642 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -141.5 144.21 34.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.95 0.9 . . . . 0.0 109.505 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.93 146.73 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.145 0.578 . . . . 0.0 111.031 -171.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -131.01 145.26 51.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.482 0.713 . . . . 0.0 109.758 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 76.8 mtp -126.52 164.41 21.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.665 0.386 . . . . 0.0 110.758 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.29 -19.31 64.69 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.85 154.81 31.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.23 0.468 . . . . 0.0 110.243 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.72 -14.41 78.05 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.92 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -70.68 -20.14 62.72 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.341 1.57 . . . . 0.0 110.707 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.68 -31.98 18.23 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.1 t -67.73 -37.59 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -67.06 -30.65 70.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.501 0.321 . . . . 0.0 111.145 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -37.1 65.95 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.56 -24.85 41.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.437 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 8.2 mm -77.13 -30.92 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.708 0.803 . . . . 0.0 110.56 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.9 m -93.17 -21.64 19.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -138.7 -19.17 1.05 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -95.76 -15.14 22.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.222 0.919 . . . . 0.0 109.158 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -54.08 142.97 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.116 0.966 . . . . 0.0 110.153 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.15 1.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -87.81 142.53 27.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.735 1.607 . . . . 0.0 109.522 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.409 ' HB2' ' HG3' ' A' ' 446' ' ' MET 0.298 0.1 OUTLIER -130.88 164.04 26.13 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 171.726 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.14 143.35 50.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.909 1.283 . . . . 0.0 108.573 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 63.64 32.52 13.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.23 15.99 80.85 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 116.039 1.175 . . . . 0.0 116.039 168.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -83.17 153.0 25.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.392 1.596 . . . . 0.0 110.557 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 141.87 34.89 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . 0.409 ' HG3' ' HB2' ' A' ' 440' ' ' PHE . 1.6 mpt? -96.29 122.09 38.78 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -140.72 115.74 9.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.08 142.06 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.057 0 CA-C-N 118.348 0.522 . . . . 0.0 110.234 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 98.2 m -147.19 168.83 20.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.704 0.802 . . . . 0.0 110.054 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 152.67 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 27.1 t -126.51 163.14 24.02 Favored 'General case' 0 CA--C 1.526 0.027 0 CA-C-N 117.845 0.293 . . . . 0.0 110.582 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -103.88 8.89 36.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.805 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -65.56 149.99 96.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.924 -0.485 . . . . 0.0 109.782 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.05 -27.5 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.855 2.37 . . . . 0.0 111.992 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.48 171.65 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.161 0.585 . . . . 0.0 110.357 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . 0.439 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 40.6 mm -68.89 135.67 27.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.4 mtt -95.72 150.31 37.23 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 122.07 0.148 . . . . 0.0 110.819 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.94 163.81 37.04 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.887 3.058 . . . . 0.0 111.494 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.72 -174.56 44.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.93 151.47 38.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.4 p -140.12 159.06 43.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.127 0.571 . . . . 0.0 110.365 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.09 167.7 28.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.216 0.607 . . . . 0.0 109.895 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.59 141.44 25.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.59 168.09 13.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.793 0.837 . . . . 0.0 109.54 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.6 -20.17 66.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.072 -0.392 . . . . 0.0 111.519 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.22 -1.3 44.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.83 0.452 . . . . 0.0 111.392 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.72 -4.5 86.19 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.632 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.1 m -93.33 160.79 14.66 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.23 1.015 . . . . 0.0 110.276 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 73.2 m -81.38 153.37 27.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.009 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.6 p -71.13 -10.8 60.37 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.82 0.448 . . . . 0.0 111.625 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -129.88 141.78 50.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.354 1.061 . . . . 0.0 109.393 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -154.51 158.89 40.55 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.416 0.286 . . . . 0.0 110.715 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -131.04 148.55 52.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.127 0.971 . . . . 0.0 109.355 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -136.85 7.81 2.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.687 0.395 . . . . 0.0 111.855 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.454 -0.256 0 C-N-CA 122.576 0.35 . . . . 0.0 111.209 -175.074 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -66.2 162.62 45.92 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.93 150.15 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.154 3.236 . . . . 0.0 113.499 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 37.9 m -123.95 18.92 9.3 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.548 0.739 . . . . 0.0 111.566 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.1 m120 59.92 10.78 2.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.407 1.083 . . . . 0.0 113.559 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.4 t -142.12 145.27 24.11 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 48.9 mt -117.55 166.56 12.23 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.201 0.524 . . . . 0.0 111.557 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 503' ' ' PHE . 1.5 t60 -137.56 148.81 46.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.784 0.834 . . . . 0.0 109.027 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -133.57 153.25 51.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.663 0.385 . . . . 0.0 110.882 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . 0.528 ' CZ ' ' CD2' ' A' ' 501' ' ' HIS . 75.4 m-85 -147.64 171.29 15.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.624 0.369 . . . . 0.0 111.33 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 24.9 m120 61.57 16.54 7.74 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -79.96 156.19 74.79 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.24 157.09 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.671 2.248 . . . . 0.0 111.888 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.3 pt? -72.45 -1.26 15.08 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.64 8.73 29.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.967 0.349 . . . . 0.0 111.93 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.42 150.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.91 0.323 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 71.8 p -145.9 175.63 10.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.787 0.835 . . . . 0.0 109.693 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.38 -25.65 68.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.446 -0.158 . . . . 0.0 111.019 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -74.99 -24.64 58.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.614 0.188 . . . . 0.0 110.714 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -79.41 -29.96 42.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -73.26 -25.46 60.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.297 -0.252 . . . . 0.0 110.44 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -78.95 -36.58 41.35 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.983 -0.448 . . . . 0.0 111.661 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.12 -15.7 55.15 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.143 0.428 . . . . 0.0 111.612 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.97 -35.09 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.199 0.454 . . . . 0.0 109.832 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.8 m -70.52 -17.8 62.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.736 -0.602 . . . . 0.0 110.215 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.43 -30.27 61.83 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.578 -0.249 . . . . 0.0 111.512 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.05 -14.8 30.64 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.373 0.533 . . . . 0.0 111.421 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.62 -13.05 24.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.865 0.466 . . . . 0.0 111.301 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 70.57 6.52 58.89 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.82 -0.433 . . . . 0.0 112.791 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.2 m -85.93 167.31 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.679 0.739 . . . . 0.0 110.802 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -74.64 150.01 39.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 111.063 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.31 150.71 41.9 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 123.498 0.719 . . . . 0.0 110.283 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.9 156.56 65.42 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.472 2.781 . . . . 0.0 110.669 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.8 m -86.26 -22.8 26.65 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.864 0.466 . . . . 0.0 110.605 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 14.8 t -149.38 155.23 40.14 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.53 144.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.769 0.427 . . . . 0.0 110.457 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -134.58 130.53 36.65 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.23 143.45 35.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.754 0.422 . . . . 0.0 109.919 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -154.0 135.11 13.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.028 0.531 . . . . 0.0 110.025 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.9 m . . . . . 0 C--O 1.23 0.078 0 C-N-CA 122.51 0.324 . . . . 0.0 110.25 -179.535 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 75.2 p -145.13 168.28 20.73 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.895 0.378 . . . . 0.0 111.321 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 48.4 t -133.38 150.65 51.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.159 0.984 . . . . 0.0 110.781 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 37.0 m -145.55 162.97 36.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.031 1.333 . . . . 0.0 109.055 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.57 -168.8 41.26 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.485 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.29 159.74 22.21 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.091 0.556 . . . . 0.0 111.403 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 87.6 mt -137.38 135.06 36.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.694 1.198 . . . . 0.0 107.836 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.78 110.36 12.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.458 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.1 p90 -165.99 156.03 12.46 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.425 1.49 . . . . 0.0 107.477 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.73 117.1 6.49 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.652 0.66 . . . . 0.0 112.719 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 28.7 m -159.54 153.06 22.57 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 126.149 1.78 . . . . 0.0 106.28 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.83 -51.39 49.08 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.512 0.596 . . . . 0.0 111.509 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 50.2 m -79.71 -24.33 41.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.92 -34.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.39 0.541 . . . . 0.0 111.677 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.41 -26.42 38.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.015 0.37 . . . . 0.0 111.038 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.1 tp -85.12 -29.52 24.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.255 0.48 . . . . 0.0 111.73 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -75.45 -38.5 59.66 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.088 0.404 . . . . 0.0 110.042 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.0 m -70.15 -33.93 72.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.7 -42.75 90.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.18 -24.7 75.04 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.292 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -113.86 -14.78 12.47 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.627 1.214 . . . . 0.0 114.105 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.43 -20.65 17.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.524 1.056 . . . . 0.0 111.085 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -74.41 139.44 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.6 t60 52.23 35.88 17.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.587 0.755 . . . . 0.0 112.122 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -99.2 151.32 21.14 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.25 136.31 36.91 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.585 1.554 . . . . 0.0 111.139 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . 0.422 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.7 ttt -64.07 174.51 1.52 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.438 0.695 . . . . 0.0 112.078 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.5 ttmm -68.65 -2.1 8.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.174 0.99 . . . . 0.0 112.504 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -60.96 141.95 93.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 121.492 -0.755 . . . . 0.0 110.569 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.18 -28.54 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.74 2.96 . . . . 0.0 113.918 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -121.01 -0.94 9.92 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.07 0.395 . . . . 0.0 111.829 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.39 41.27 99.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.997 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 79.1 Cg_endo -69.9 -10.7 29.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.884 2.39 . . . . 0.0 111.888 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.46 148.41 47.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.187 0.595 . . . . 0.0 109.959 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.63 153.36 38.81 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.707 2.938 . . . . 0.0 111.149 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -147.99 0.7 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.081 0.553 . . . . 0.0 111.41 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 12.3 t -66.43 125.55 26.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.283 -0.885 . . . . 0.0 110.781 -170.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.14 144.63 50.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.355 1.062 . . . . 0.0 109.991 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.6 157.82 16.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.285 0.234 . . . . 0.0 110.732 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.43 144.97 50.86 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.229 0.611 . . . . 0.0 109.689 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 27.9 p -160.49 167.37 27.36 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.159 0.584 . . . . 0.0 110.408 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -82.07 139.0 34.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 38.0 t -135.6 145.13 46.58 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.148 0.179 . . . . 0.0 110.883 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 19.3 p -79.98 102.28 9.15 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.12 161.56 34.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.954 0.902 . . . . 0.0 110.325 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 -12.44 11.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.782 0.433 . . . . 0.0 110.987 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -161.13 162.48 31.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.681 0.792 . . . . 0.0 109.538 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -91.35 76.83 5.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.518 0.327 . . . . 0.0 110.132 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.217 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.529 179.672 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.54 -7.4 59.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.965 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.6 m -147.49 152.15 41.34 Favored Pre-proline 0 C--N 1.34 0.156 0 C-N-CA 123.15 0.58 . . . . 0.0 110.89 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -82.5 3.34 7.89 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.446 3.431 . . . . 0.0 112.631 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.8 164.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 112.464 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 381' ' ' LEU . 4.3 pp -149.45 171.23 16.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.23 1.012 . . . . 0.0 109.149 174.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . 0.407 ' CE ' ' HE1' ' A' ' 412' ' ' MET . 80.8 mtp -138.11 152.12 48.45 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.411 0.284 . . . . 0.0 111.257 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.02 144.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -135.86 168.03 20.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.953 0.501 . . . . 0.0 110.411 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.31 69.26 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.972 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.757 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -70.06 170.71 10.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.501 0.65 . . . . 0.0 111.741 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -127.01 130.85 50.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.613 0.765 . . . . 0.0 109.434 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -71.87 6.83 1.82 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.6 p -121.28 0.67 10.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.98 -13.12 2.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.164 0.586 . . . . 0.0 110.704 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -141.84 121.02 12.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.133 0.973 . . . . 0.0 108.795 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.565 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 19.4 m120 -141.89 -179.97 6.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.87 0.868 . . . . 0.0 109.337 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.99 -22.79 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.982 0.113 . . . . 0.0 111.231 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -88.03 -26.06 22.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.014 -0.429 . . . . 0.0 111.717 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . 0.565 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.4 mpt_? -83.36 -32.0 26.45 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.271 0.487 . . . . 0.0 109.702 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.9 p -72.44 -31.46 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -69.09 -29.57 67.7 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -80.78 -17.3 51.36 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.6 t -109.62 -23.78 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 118.437 0.562 . . . . 0.0 112.378 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.96 -16.37 14.16 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.689 0.677 . . . . 0.0 112.423 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 t -77.49 -16.02 58.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.124 0.875 . . . . 0.0 110.977 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.6 10.72 1.58 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.803 -0.561 . . . . 0.0 112.296 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 -3.17 9.38 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.721 0.808 . . . . 0.0 111.071 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.07 164.54 11.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.45 147.26 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.9 0.85 . . . . 0.0 111.702 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.49 155.47 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -96.76 -63.88 1.1 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -163.1 166.57 23.35 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.4 0.68 . . . . 0.0 110.338 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.51 151.7 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.214 0.606 . . . . 0.0 110.501 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -149.99 139.49 21.51 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.301 0.241 . . . . 0.0 110.822 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -77.25 152.28 34.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.407 ' HE1' ' CE ' ' A' ' 382' ' ' MET . 6.0 ptm -130.85 141.64 50.33 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -167.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 60.28 33.76 20.89 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.77 1.228 . . . . 0.0 112.275 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.3 m 55.42 14.79 1.22 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.296 1.039 . . . . 0.0 113.435 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -89.02 137.6 29.54 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.35 -8.56 18.57 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.964 2.443 . . . . 0.0 109.332 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.65 23.3 17.83 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.69 1.138 . . . . 0.0 113.128 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -150.75 137.27 18.78 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.973 1.387 . . . . 0.0 111.268 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -159.61 170.61 21.24 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.128 0.489 . . . . 0.0 111.363 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.5 ptm -139.39 147.44 41.46 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.375 0.67 . . . . 0.0 109.96 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.5 t -128.23 152.15 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.24 0.616 . . . . 0.0 110.76 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -129.58 141.46 50.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.585 0.754 . . . . 0.0 109.4 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 97.9 mmm -114.43 162.53 16.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.849 0.46 . . . . 0.0 110.719 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.83 60.74 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.318 0.247 . . . . 0.0 111.604 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.91 160.88 40.51 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.86 -12.22 84.76 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.199 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -75.38 -17.63 60.16 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.857 1.328 . . . . 0.0 111.32 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -89.84 -26.23 20.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.249 -0.282 . . . . 0.0 110.486 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.22 -34.27 37.07 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.29 -26.64 56.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.517 0.199 . . . . 0.0 110.625 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -25.74 48.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.68 31.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.038 0.135 . . . . 0.0 110.766 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 433' ' ' ILE . 3.1 tp -82.65 -30.95 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 121.813 -0.554 . . . . 0.0 111.121 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 24.0 m -94.82 -19.69 20.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -136.22 -5.91 2.07 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.59 -19.21 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.168 0.895 . . . . 0.0 109.461 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -51.95 143.13 14.22 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.895 0.878 . . . . 0.0 110.629 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.8 1.42 0.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.819 1.648 . . . . 0.0 114.992 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -88.47 142.76 27.45 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.544 -1.348 . . . . 0.0 109.117 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.271 0.1 OUTLIER -130.94 163.98 26.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 171.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.25 143.47 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.175 0.99 . . . . 0.0 109.625 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 64.72 30.5 12.4 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.368 1.467 . . . . 0.0 114.45 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.43 15.64 77.3 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 168.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.25 161.28 21.55 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.506 1.153 . . . . 0.0 110.19 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.587 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -91.63 128.59 37.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.329 0.513 . . . . 0.0 110.825 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.62 142.42 30.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -140.71 127.2 20.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.34 140.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-N 118.359 0.527 . . . . 0.0 110.718 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.7 m -150.59 163.69 37.86 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.26 1.024 . . . . 0.0 109.923 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.86 156.43 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.8 t -131.23 162.99 28.75 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 122.912 0.485 . . . . 0.0 109.725 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -105.69 5.69 31.3 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -67.42 144.93 98.24 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 121.694 -0.629 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.96 -24.68 11.13 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.151 2.567 . . . . 0.0 111.692 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.89 173.2 12.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.841 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.7 mm -71.33 142.52 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.43 154.89 37.85 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 117.472 0.124 . . . . 0.0 111.268 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.65 165.37 8.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.104 3.203 . . . . 0.0 112.477 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.89 177.86 37.77 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -81.81 166.07 20.31 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.834 0.453 . . . . 0.0 110.199 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.3 p -143.04 159.94 41.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.75 0.42 . . . . 0.0 110.973 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -151.33 173.15 14.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.768 0.827 . . . . 0.0 109.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.66 135.07 13.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.99 173.1 12.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.345 0.658 . . . . 0.0 109.828 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.4 -23.02 67.14 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.703 0.401 . . . . 0.0 111.329 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -81.7 -1.4 46.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.017 0.527 . . . . 0.0 111.332 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.27 84.43 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.087 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 77.6 p -84.06 163.96 19.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.537 0.668 . . . . 0.0 110.78 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.72 151.83 28.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 111.056 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 75.5 m -73.16 -10.45 59.79 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.435 0.694 . . . . 0.0 111.841 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -133.73 143.45 48.48 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.665 0.786 . . . . 0.0 109.762 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -157.18 156.86 33.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.733 0.413 . . . . 0.0 110.551 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -127.65 149.28 50.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.269 1.028 . . . . 0.0 109.503 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.99 13.89 2.87 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.84 0.456 . . . . 0.0 111.413 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 CA--C 1.53 0.197 0 O-C-N 122.079 -0.388 . . . . 0.0 111.784 -174.546 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -62.35 159.41 40.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.44 131.32 36.21 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.304 2.669 . . . . 0.0 112.492 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.6 m -124.07 23.86 8.37 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.691 0.796 . . . . 0.0 111.464 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 60.75 10.99 2.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.891 1.276 . . . . 0.0 114.043 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.53 141.78 36.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 40.8 mt -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.326 0.65 . . . . 0.0 110.283 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 580' ' ' SER . 0.6 OUTLIER -141.51 161.98 36.59 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.377 0.271 . . . . 0.0 110.956 173.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -139.06 157.06 46.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.726 0.41 . . . . 0.0 111.328 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -150.53 174.3 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.203 0.601 . . . . 0.0 111.066 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 11.7 t30 64.98 11.35 6.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.911 1.284 . . . . 0.0 113.656 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -73.2 161.66 78.19 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -70.33 155.68 63.51 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.903 1.735 . . . . 0.0 110.18 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.9 pt? -69.73 -1.12 8.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.31 9.0 18.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.95 151.21 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 118.009 0.368 . . . . 0.0 110.932 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.9 p -142.15 173.28 11.67 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.361 0.664 . . . . 0.0 110.516 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.18 -21.31 64.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.885 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.05 -22.81 58.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.348 -0.22 . . . . 0.0 110.487 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -82.34 -30.19 30.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.79 -25.66 61.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.761 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -84.34 -34.96 23.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.11 0.414 . . . . 0.0 111.468 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -76.88 -21.99 54.1 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.281 0.491 . . . . 0.0 111.133 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 74.0 mt -84.83 -37.88 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.937 0.335 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.5 m -66.64 -24.68 66.33 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.113 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.91 -30.42 63.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.245 -0.284 . . . . 0.0 111.761 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -91.04 -11.09 39.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.375 0.534 . . . . 0.0 112.0 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.6 mt -96.19 -7.7 35.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.774 0.429 . . . . 0.0 111.084 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.88 7.97 81.73 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.77 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -97.78 165.2 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 117.83 0.815 . . . . 0.0 110.645 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -83.19 151.67 25.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.742 0.417 . . . . 0.0 111.065 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -91.08 155.2 44.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.474 0.71 . . . . 0.0 110.717 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.95 158.74 45.73 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.296 2.664 . . . . 0.0 111.285 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 81.5 m -89.96 -26.39 20.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.0 m -139.38 150.06 44.87 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.06 144.27 25.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 123.042 0.537 . . . . 0.0 110.849 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -142.16 138.89 31.89 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 29.6 t -136.39 145.77 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 122.595 0.358 . . . . 0.0 110.425 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -151.94 164.19 37.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 79.4 p . . . . . 0 N--CA 1.457 -0.085 0 O-C-N 121.867 -0.52 . . . . 0.0 111.242 -178.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 99.0 p -137.47 169.58 17.55 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.802 0.441 . . . . 0.0 111.538 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.6 t -125.43 153.88 42.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.371 1.068 . . . . 0.0 110.799 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 78.4 p -152.88 171.22 18.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.72 1.208 . . . . 0.0 109.627 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 166.63 -172.91 41.97 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.129 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.54 152.68 32.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 66.8 mt -136.71 134.89 37.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.73 1.212 . . . . 0.0 107.856 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -127.78 113.1 15.53 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -166.09 153.94 10.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.639 1.576 . . . . 0.0 106.775 167.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -148.87 118.6 7.04 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.3 t -159.46 153.1 22.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.582 1.553 . . . . 0.0 107.025 168.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.38 -63.8 1.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.971 0.35 . . . . 0.0 111.739 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 74.2 p -82.28 -17.25 46.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.09 -41.35 28.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.298 0.499 . . . . 0.0 110.682 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -78.14 -31.78 49.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.596 -0.24 . . . . 0.0 110.968 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.5 tp -77.25 -30.49 54.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.671 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -74.8 -40.2 61.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.94 -0.475 . . . . 0.0 110.548 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.3 m -63.99 -49.98 70.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.59 -0.243 . . . . 0.0 110.347 -175.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 556' ' ' LEU . 3.5 pp -77.51 -18.9 56.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.833 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -69.21 -26.58 74.51 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.12 -7.38 11.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.596 0.698 . . . . 0.0 112.604 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 46.3 tp -98.23 -19.36 17.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 0.0 111.701 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -74.48 144.43 44.17 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 80.2 t60 51.11 35.83 14.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.019 0.528 . . . . 0.0 112.039 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -97.27 151.42 19.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.709 0.804 . . . . 0.0 111.691 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -102.6 136.33 42.62 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.181 1.392 . . . . 0.0 110.549 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.3 ttt -64.11 173.87 1.77 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.066 0.547 . . . . 0.0 111.499 -174.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -70.25 9.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -66.5 146.84 99.09 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 118.55 0.614 . . . . 0.0 110.081 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.84 -30.02 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.42 2.747 . . . . 0.0 113.917 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -121.06 2.18 10.41 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.438 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.14 40.16 98.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.686 -1.064 . . . . 0.0 112.891 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 80.9 Cg_endo -69.45 -9.99 27.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.272 2.648 . . . . 0.0 112.073 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -142.61 148.26 45.92 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 122.823 0.449 . . . . 0.0 110.086 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.84 156.69 43.72 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.603 2.868 . . . . 0.0 111.477 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -148.59 6.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.038 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 3.0 t -66.48 122.1 16.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.611 -0.681 . . . . 0.0 110.118 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.9 pt? -124.97 144.6 50.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 109.78 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -96.16 142.12 28.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.526 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.62 144.91 41.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 41.8 t -163.14 163.2 25.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -75.83 148.37 38.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.448 ' HB3' ' CG ' ' A' ' 501' ' ' HIS . 92.9 p -135.4 149.16 49.58 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.171 0.188 . . . . 0.0 110.606 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 31.3 p -90.02 102.19 14.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.36 161.47 34.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.654 0.782 . . . . 0.0 111.156 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -97.73 -25.79 14.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -163.85 152.72 13.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.506 1.122 . . . . 0.0 108.57 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -85.94 76.51 9.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.942 0.401 . . . . 0.0 110.35 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 36.3 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.869 177.484 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.777 0.323 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -144.79 17.03 1.61 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.22 0.608 . . . . 0.0 110.535 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.2 m -143.44 152.8 57.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 122.395 0.278 . . . . 0.0 111.13 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.209 3.273 . . . . 0.0 112.831 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 89.3 t -123.28 148.13 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 118.684 0.675 . . . . 0.0 110.811 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.3 164.12 30.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 110.692 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 73.6 mmm -127.33 149.38 50.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.505 0.722 . . . . 0.0 110.331 -176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.36 148.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.645 0.259 . . . . 0.0 110.743 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -141.13 170.99 14.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.702 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.46 -4.54 81.3 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.299 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -71.72 175.75 5.43 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.038 0.919 . . . . 0.0 110.522 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.69 135.57 44.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.802 0.441 . . . . 0.0 109.889 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -73.46 4.84 4.29 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -172.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.9 m -115.36 -2.11 12.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.076 0.398 . . . . 0.0 111.845 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -138.12 -0.95 2.0 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.435 0.694 . . . . 0.0 110.685 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -154.53 121.11 5.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -141.97 -176.52 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.79 0.436 . . . . 0.0 110.62 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 25.5 p -57.01 -30.22 64.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.301 0.641 . . . . 0.0 112.671 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.0 -25.92 25.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.023 -0.423 . . . . 0.0 110.756 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -79.99 -32.48 39.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -75.6 -27.05 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -68.82 -29.42 67.76 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 171.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.38 -23.05 47.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.026 -0.421 . . . . 0.0 111.981 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 71.4 t -94.61 -21.36 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -114.59 -13.93 12.11 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.2 t -73.9 -21.92 59.89 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.306 0.957 . . . . 0.0 111.085 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.48 10.41 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.645 -0.659 . . . . 0.0 112.385 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.45 -11.41 8.73 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.248 0.619 . . . . 0.0 111.434 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 160.97 174.61 31.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -68.41 141.47 55.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.535 -0.391 . . . . 0.0 110.871 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.6 t -104.56 147.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -101.38 -58.32 1.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.231 -0.293 . . . . 0.0 110.351 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -165.3 169.41 15.89 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.957 0.503 . . . . 0.0 110.685 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.35 150.88 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.069 0 C-N-CA 123.739 0.816 . . . . 0.0 110.216 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 411' ' ' PHE . 51.4 tptt -147.18 137.54 23.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.749 0.82 . . . . 0.0 109.093 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . 0.405 ' O ' ' HE3' ' A' ' 410' ' ' LYS . 4.3 m-85 -76.53 136.2 39.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 22.1 ttp -93.64 140.97 29.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 47.42 33.84 3.01 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 112.248 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.5 m 52.95 17.99 1.0 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.443 1.097 . . . . 0.0 113.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -75.95 149.53 82.82 Favored Pre-proline 0 N--CA 1.456 -0.159 0 CA-C-N 118.564 0.62 . . . . 0.0 109.897 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.43 4.4 6.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.882 3.055 . . . . 0.0 110.975 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.51 32.06 1.36 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.299 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.83 141.76 25.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.187 0.993 . . . . 0.0 110.439 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.37 170.28 22.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.941 0.4 . . . . 0.0 111.373 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.4 ptm -145.76 145.06 30.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.733 0.813 . . . . 0.0 109.512 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.37 153.22 38.58 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.299 0.639 . . . . 0.0 110.32 -173.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -127.67 143.67 51.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.691 0.797 . . . . 0.0 110.07 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 79.4 mtp -129.38 166.64 19.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.425 0.69 . . . . 0.0 110.134 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.54 -23.82 65.47 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.17 160.21 38.52 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.252 0.478 . . . . 0.0 110.576 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.77 -12.35 80.82 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.451 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -67.93 -25.56 65.53 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.231 1.515 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.9 -27.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.5 t -73.54 -32.96 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.75 -25.96 66.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.048 0.539 . . . . 0.0 110.212 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -82.43 -27.19 32.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.375 -0.203 . . . . 0.0 110.691 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.21 -28.34 29.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.464 0.173 . . . . 0.0 110.56 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.84 -31.11 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.336 0.654 . . . . 0.0 110.853 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 m -98.88 -19.55 17.3 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -135.59 -4.28 2.3 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.72 -15.29 11.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.857 0.753 . . . . 0.0 109.458 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -58.02 149.87 22.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.481 0.658 . . . . 0.0 111.954 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 56.83 1.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.024 1.73 . . . . 0.0 114.616 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -88.04 142.56 27.68 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.961 1.255 . . . . 0.0 109.46 168.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.321 0.1 OUTLIER -130.93 164.03 26.2 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 170.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 18.7 ptm -125.26 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 66.07 24.01 11.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.01 16.01 80.98 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -83.2 156.31 23.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.085 1.443 . . . . 0.0 111.811 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.86 139.96 49.1 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.58 0.752 . . . . 0.0 109.592 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.96 122.04 39.5 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -140.75 119.75 12.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.12 142.61 20.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 118.008 0.367 . . . . 0.0 110.751 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 73.3 m -148.41 174.92 11.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.682 0.793 . . . . 0.0 110.715 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.71 156.05 13.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 34.9 t -137.27 146.12 44.34 Favored 'General case' 0 N--CA 1.461 0.101 0 O-C-N 122.1 -0.375 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -85.43 6.56 26.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.076 0.551 . . . . 0.0 112.237 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 454' ' ' PRO . 47.4 mt-30 -62.09 132.24 93.69 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 453' ' ' GLN . 37.0 Cg_exo -62.02 -32.05 84.01 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.691 2.261 . . . . 0.0 112.515 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -161.79 171.55 17.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.792 0.437 . . . . 0.0 110.9 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.74 143.26 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.81 149.61 44.07 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 122.227 0.211 . . . . 0.0 110.745 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.91 161.92 43.47 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.761 2.974 . . . . 0.0 111.765 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 166.39 -179.51 40.35 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -80.89 173.54 12.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.815 0.446 . . . . 0.0 109.834 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.1 p -140.43 161.86 36.71 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -150.99 165.18 34.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.722 0.809 . . . . 0.0 109.632 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 137.88 20.0 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.98 174.71 8.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.202 1.001 . . . . 0.0 109.437 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -68.41 -21.78 64.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.85 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -83.08 4.24 27.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.103 0.561 . . . . 0.0 111.792 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.62 -2.42 73.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.622 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.2 p -90.82 163.02 14.58 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.074 0.937 . . . . 0.0 110.222 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.3 m -81.28 153.41 27.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.032 -0.417 . . . . 0.0 111.114 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 89.5 p -71.18 -8.88 56.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -130.65 142.79 50.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.386 1.074 . . . . 0.0 109.036 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -153.21 157.38 40.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.721 0.408 . . . . 0.0 110.278 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.31 148.46 50.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.77 0.828 . . . . 0.0 109.812 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -137.2 14.93 3.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.999 0.52 . . . . 0.0 111.583 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.1 p . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.595 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 121.194 0.521 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -82.48 167.59 29.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 124.936 1.295 . . . . 0.0 109.991 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -49.82 125.67 14.93 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.099 2.533 . . . . 0.0 111.62 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.2 m -124.07 23.85 8.37 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.621 0.768 . . . . 0.0 112.292 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.6 m120 61.65 8.18 2.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.219 1.008 . . . . 0.0 113.52 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.98 146.27 20.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.851 0.86 . . . . 0.0 108.902 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.36 151.58 42.37 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.973 0.509 . . . . 0.0 110.667 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . 0.465 ' CE1' ' HB3' ' A' ' 580' ' ' SER . 0.3 OUTLIER -126.03 143.55 51.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -129.7 152.04 49.64 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.416 0.15 . . . . 0.0 110.829 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -150.12 172.27 15.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.815 0.446 . . . . 0.0 111.246 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.18 30.19 19.91 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.766 0.826 . . . . 0.0 112.791 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -94.16 153.98 40.6 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -56.55 150.87 49.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.732 2.288 . . . . 0.0 111.937 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -70.03 -0.98 8.53 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.96 6.95 23.58 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.41 151.61 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.964 -0.46 . . . . 0.0 110.826 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 59.9 p -143.73 171.39 14.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.421 0.689 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.32 -24.48 67.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.683 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.08 -22.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.187 -0.321 . . . . 0.0 110.447 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -81.35 -29.23 34.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.76 -25.13 58.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.054 -0.404 . . . . 0.0 110.875 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -80.96 -37.72 28.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.107 0.412 . . . . 0.0 111.246 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -76.34 -21.75 55.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.076 0.398 . . . . 0.0 111.199 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 64.0 mt -82.02 -37.77 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.2 m -66.82 -25.78 66.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.852 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.14 -30.16 64.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.77 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -91.06 -11.91 37.3 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.405 0.548 . . . . 0.0 111.818 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.7 mt -91.36 -10.32 41.62 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.991 0.517 . . . . 0.0 110.992 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.04 71.09 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.747 -0.474 . . . . 0.0 112.33 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.0 m -94.96 167.75 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 117.683 0.742 . . . . 0.0 110.438 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.42 147.41 27.88 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.91 0.386 . . . . 0.0 111.12 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -82.23 157.18 68.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.789 0.835 . . . . 0.0 111.25 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.16 155.16 69.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.414 2.743 . . . . 0.0 110.327 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.457 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -86.0 -24.9 26.27 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.716 0.406 . . . . 0.0 110.93 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 22.0 t -144.04 152.46 41.03 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -140.34 142.71 30.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.06 0.544 . . . . 0.0 109.975 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 129.52 21.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.39 147.8 32.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.826 0.451 . . . . 0.0 110.785 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -149.74 154.93 39.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.321 0.648 . . . . 0.0 109.947 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.231 0.08 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.863 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.5 t -145.33 162.23 37.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.622 0.369 . . . . 0.0 110.987 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 45.8 t -131.0 154.76 47.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.976 0.91 . . . . 0.0 111.435 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.9 p -149.39 171.21 16.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.073 1.349 . . . . 0.0 109.063 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.89 37.82 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.739 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.72 150.86 48.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.367 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.57 133.18 39.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -127.65 108.22 10.58 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.457 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -165.98 154.01 10.69 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.705 1.602 . . . . 0.0 106.926 167.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.21 122.75 7.92 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 551' ' ' ASP . 46.3 t -159.56 153.37 23.01 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.007 1.723 . . . . 0.0 106.504 168.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.44 -54.72 39.82 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.322 0.51 . . . . 0.0 111.572 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.6 p -87.34 -21.5 25.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 548' ' ' SER . 10.9 t70 -79.67 -36.67 37.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.243 0.474 . . . . 0.0 110.801 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.56 -32.63 28.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.675 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.73 -27.32 60.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.991 0.359 . . . . 0.0 110.75 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.91 -43.96 33.54 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.037 -0.414 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 95.7 m -70.44 -31.05 68.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.0 tm? -65.25 -42.16 93.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.56 -28.67 69.01 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.364 -0.686 . . . . 0.0 112.81 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.13 -13.43 15.44 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.0 -23.48 14.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.411 1.005 . . . . 0.0 112.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -69.95 142.35 52.9 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 48.96 35.29 6.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.817 0.847 . . . . 0.0 113.025 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -95.96 151.39 19.47 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -92.14 136.34 33.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.286 1.434 . . . . 0.0 111.324 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.2 ttt -64.36 176.0 1.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.251 0.62 . . . . 0.0 111.828 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -71.86 6.54 1.98 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -67.34 142.79 96.92 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.667 0.667 . . . . 0.0 110.6 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.45 -29.74 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.464 2.776 . . . . 0.0 113.672 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -120.58 1.01 10.58 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.968 0.349 . . . . 0.0 111.744 -174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.439 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.77 40.81 98.66 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.749 -1.029 . . . . 0.0 113.092 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 78.8 Cg_endo -69.16 -10.55 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.852 2.368 . . . . 0.0 111.993 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -144.24 147.57 37.77 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.053 0.541 . . . . 0.0 109.807 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.48 153.07 39.26 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.52 2.813 . . . . 0.0 111.3 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -149.03 -0.84 0.5 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.174 0.589 . . . . 0.0 111.583 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 10.2 t -66.49 124.86 23.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.521 -0.737 . . . . 0.0 109.687 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.8 pt? -124.99 144.56 50.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 0.0 110.939 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -82.66 147.6 28.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 49.5 tp -139.68 144.91 37.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.5 p -163.81 167.06 21.31 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -84.63 125.66 32.67 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 501' ' ' HIS . 31.8 t -135.69 148.79 49.03 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 85.0 m -79.53 105.43 10.83 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.556 0.217 . . . . 0.0 110.762 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.17 161.45 34.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.016 0.927 . . . . 0.0 109.75 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -126.67 -1.57 6.73 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.592 0.357 . . . . 0.0 110.996 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -148.82 161.62 41.46 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.881 0.872 . . . . 0.0 110.031 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.48 0.99 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.32 -1.324 . . . . 0.0 110.163 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.88 -8.67 55.49 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.504 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 40.7 m -148.06 152.48 40.02 Favored Pre-proline 0 N--CA 1.456 -0.146 0 C-N-CA 122.657 0.383 . . . . 0.0 111.205 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -83.57 0.28 9.49 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.276 3.318 . . . . 0.0 112.816 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.16 164.37 33.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.697 0.681 . . . . 0.0 112.465 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.28 164.16 35.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.087 0.955 . . . . 0.0 108.933 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 79.4 mtp -133.29 150.85 51.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.642 0.377 . . . . 0.0 110.811 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.92 149.15 23.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.868 0.467 . . . . 0.0 110.638 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -139.38 163.98 31.07 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.648 0.779 . . . . 0.0 110.113 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.34 -2.86 69.45 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.734 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.627 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.64 171.76 11.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.021 0.911 . . . . 0.0 110.98 178.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -126.09 137.4 53.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.688 0.395 . . . . 0.0 110.016 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -67.82 -7.86 31.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 60.9 p -99.11 -8.78 24.72 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -134.35 -8.46 2.57 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.174 0.443 . . . . 0.0 111.317 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.5 tpt -147.97 108.34 4.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.142 0.577 . . . . 0.0 109.588 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.452 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 51.4 p-10 -141.91 -173.12 3.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.328 0.651 . . . . 0.0 109.884 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 24.4 p -56.03 -27.66 54.08 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.864 0.466 . . . . 0.0 112.154 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.05 -37.96 21.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.071 -0.393 . . . . 0.0 110.891 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . 0.452 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 7.8 mpt_? -75.76 -29.81 58.95 Favored 'General case' 0 C--O 1.23 0.041 0 O-C-N 122.206 -0.309 . . . . 0.0 110.805 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.42 -30.75 26.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -73.91 -27.48 61.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.642 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.16 -26.54 59.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.849 -0.532 . . . . 0.0 111.703 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.3 -24.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -106.24 -10.92 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.785 0.721 . . . . 0.0 112.846 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.51 -23.21 58.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.767 0.712 . . . . 0.0 111.772 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 402' ' ' LEU . 1.7 pp -77.28 12.56 1.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.631 -0.668 . . . . 0.0 112.263 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -120.74 -5.98 9.66 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.181 0.592 . . . . 0.0 111.088 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 151.85 -179.63 28.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -73.51 150.89 41.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.4 t -118.08 155.17 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.7 -57.45 2.25 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 118.712 0.687 . . . . 0.0 112.006 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . 0.426 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.9 pttm -161.72 164.06 29.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.986 0.422 . . . . 0.0 111.782 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.66 150.88 16.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.93 0.892 . . . . 0.0 109.871 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -151.91 145.07 24.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.01 144.5 30.82 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.724 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -126.11 141.54 51.9 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -167.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.21 34.08 21.03 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.576 1.55 . . . . 0.0 112.565 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.4 m 53.46 15.06 0.64 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.053 1.341 . . . . 0.0 114.201 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -82.7 136.95 44.49 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 118.444 0.566 . . . . 0.0 109.582 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.86 -9.56 16.9 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.873 2.382 . . . . 0.0 109.571 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.22 19.66 24.47 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.202 0.906 . . . . 0.0 112.977 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.724 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -152.24 143.2 23.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.61 1.205 . . . . 0.0 110.848 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.89 167.61 29.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.846 0.355 . . . . 0.0 111.672 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 24.5 ptm -142.38 146.45 34.94 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.118 0.567 . . . . 0.0 109.812 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.6 154.96 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 122.601 0.361 . . . . 0.0 110.982 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.84 141.71 51.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.846 0.858 . . . . 0.0 110.714 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 66.9 mtp -119.02 163.36 17.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.853 0.461 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.99 67.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.21 164.35 30.48 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.724 0.409 . . . . 0.0 110.159 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.12 -8.09 61.01 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.333 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -69.69 -28.28 65.71 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.55 1.675 . . . . 0.0 110.218 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -87.21 -24.8 24.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.8 t -75.88 -25.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.89 -42.61 73.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.243 -0.285 . . . . 0.0 110.431 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -69.05 -26.81 65.16 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.76 -40.22 33.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.095 -0.378 . . . . 0.0 111.294 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 433' ' ' ILE . 4.4 tp -81.38 -30.99 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.572 0.349 . . . . 0.0 111.902 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -99.9 -20.12 16.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -129.67 -8.59 4.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -174.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.48 -20.92 10.03 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.314 0.961 . . . . 0.0 109.635 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.31 144.79 12.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 58.02 1.38 0.14 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.235 2.214 . . . . 0.0 115.374 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -88.08 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.337 1.426 . . . . 0.0 108.307 168.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.308 0.0 OUTLIER -130.93 163.93 26.42 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 174.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.6 ptm -125.39 143.39 51.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.582 1.553 . . . . 0.0 109.86 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 63.92 32.59 13.09 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.121 1.368 . . . . 0.0 114.551 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.06 15.92 80.85 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.542 -0.588 . . . . 0.0 114.267 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.16 153.97 24.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.124 0.962 . . . . 0.0 110.122 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.578 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -88.85 131.28 35.17 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 175.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.59 130.92 45.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -140.76 113.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.15 139.93 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.415 0.552 . . . . 0.0 110.523 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 84.4 m -149.13 161.54 41.77 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.038 0.935 . . . . 0.0 110.113 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.4 p -82.47 156.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 43.9 t -132.94 157.9 43.99 Favored 'General case' 0 N--CA 1.459 0.024 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -99.57 6.21 45.83 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -65.66 142.59 98.3 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.49 -25.72 10.85 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.942 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.11 15.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 110.066 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . 0.426 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 37.0 mm -69.35 138.57 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.68 151.22 42.13 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 122.395 0.278 . . . . 0.0 110.468 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.33 164.13 36.2 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.606 2.871 . . . . 0.0 110.81 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.87 -177.42 41.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -76.29 155.42 34.3 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.85 0.46 . . . . 0.0 110.032 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.6 p -133.09 165.57 24.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.625 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -147.38 161.16 41.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -83.41 135.29 13.67 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.93 168.85 13.0 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.539 0.735 . . . . 0.0 110.013 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -20.81 64.92 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.343 -0.223 . . . . 0.0 111.224 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.22 0.81 23.65 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 111.267 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.18 -3.15 82.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 123.542 0.591 . . . . 0.0 112.598 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.0 t -93.98 163.57 13.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.603 0.702 . . . . 0.0 110.286 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.42 153.39 21.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.722 0.296 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -66.19 -10.46 41.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.526 0.33 . . . . 0.0 111.601 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -120.62 141.87 49.95 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.141 0.976 . . . . 0.0 109.115 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -151.62 156.87 41.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.619 0.247 . . . . 0.0 110.464 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -126.31 150.16 48.68 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.637 0.775 . . . . 0.0 110.17 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -140.05 12.8 2.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.25 0.62 . . . . 0.0 111.566 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 22.4 t . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -173.968 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -60.95 159.72 25.41 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.215 0.606 . . . . 0.0 110.544 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.19 147.69 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.372 2.715 . . . . 0.0 112.93 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 55.7 m -124.0 19.4 9.22 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.34 0.656 . . . . 0.0 111.169 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.28 3.81 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.179 1.392 . . . . 0.0 114.591 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 37.0 t -141.54 147.38 22.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.475 HD12 ' CH2' ' A' ' 546' ' ' TRP . 53.2 mt -121.8 163.38 19.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.895 0.478 . . . . 0.0 110.457 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.58 158.66 43.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.566 0.346 . . . . 0.0 110.807 174.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -137.59 153.83 49.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.407 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -148.39 169.65 19.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.143 0.577 . . . . 0.0 110.33 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 15.8 t30 62.51 18.92 10.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.877 0.871 . . . . 0.0 113.324 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -77.52 164.63 56.92 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.48 152.91 37.59 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.728 2.285 . . . . 0.0 111.995 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.51 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -74.66 -1.77 23.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.838 0.455 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -125.13 16.78 8.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.496 0.719 . . . . 0.0 111.421 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.64 151.32 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 122.019 -0.426 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 74.7 p -141.75 170.46 15.67 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 123.125 0.57 . . . . 0.0 110.69 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.2 -22.6 66.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.98 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.91 -24.48 48.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.205 -0.309 . . . . 0.0 110.493 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.44 -32.04 37.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -73.41 -29.88 62.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.235 -0.291 . . . . 0.0 110.747 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -77.88 -37.28 48.43 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.149 0.431 . . . . 0.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.91 -25.23 43.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.859 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.91 -40.66 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.4 m -65.11 -29.01 69.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.277 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.21 -29.3 61.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.854 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.98 -10.94 40.48 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.415 0.552 . . . . 0.0 112.014 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 85.2 mt -91.1 -3.71 56.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.758 0.423 . . . . 0.0 110.768 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.9 80.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.779 -0.456 . . . . 0.0 112.499 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -112.81 172.14 3.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.524 0.662 . . . . 0.0 111.403 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.18 149.19 41.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.207 0.603 . . . . 0.0 110.073 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -98.06 151.55 37.6 Favored Pre-proline 0 CA--C 1.528 0.13 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.54 147.17 93.22 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.788 2.325 . . . . 0.0 110.492 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.416 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.3 m -82.71 -28.4 30.54 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 122.938 0.495 . . . . 0.0 110.997 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -140.32 147.32 39.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 2.4 p -154.36 144.63 13.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 122.744 0.418 . . . . 0.0 110.799 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -149.2 156.47 42.2 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.354 0.662 . . . . 0.0 109.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.59 145.51 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.416 0.686 . . . . 0.0 109.23 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -150.63 142.52 23.86 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.735 0.302 . . . . 0.0 110.95 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 123.366 0.666 . . . . 0.0 111.555 -179.223 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 59.3 m -148.9 -178.1 6.17 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.882 1.673 . . . . 0.0 108.784 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 8.6 t -140.26 160.86 39.02 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.116 -0.365 . . . . 0.0 110.981 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.8 m -146.35 164.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.698 0.799 . . . . 0.0 110.741 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 176.2 -166.52 37.65 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.591 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 63.3 mt -120.62 155.65 33.31 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.437 0.695 . . . . 0.0 111.265 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 91.9 mt -140.31 132.19 27.6 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.012 0.925 . . . . 0.0 108.816 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -127.89 119.48 25.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.475 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.6 p90 -166.05 150.47 8.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.385 1.474 . . . . 0.0 107.08 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -145.84 110.39 5.09 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -172.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.0 t -159.5 153.0 22.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -67.33 -42.02 84.28 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.528 0.604 . . . . 0.0 110.437 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 31.6 m -83.92 -30.55 26.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.808 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.81 -30.21 26.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.69 0.677 . . . . 0.0 111.48 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.73 -30.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.162 0.437 . . . . 0.0 111.316 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 29.8 tp -83.55 -29.29 27.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.879 0.763 . . . . 0.0 111.793 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.4 -42.67 43.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.256 0.48 . . . . 0.0 110.02 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 55.5 m -68.99 -31.85 71.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.9 -41.84 58.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.01 -19.99 75.9 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.366 -0.686 . . . . 0.0 113.115 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.71 -11.65 13.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.326 1.063 . . . . 0.0 113.052 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 30.4 tp -104.97 -16.88 14.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.087 0.858 . . . . 0.0 112.386 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -72.59 143.81 48.1 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.748 -0.595 . . . . 0.0 109.545 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 51.11 21.18 0.98 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.879 0.872 . . . . 0.0 113.128 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -78.43 151.44 32.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.11 136.38 50.24 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.095 1.358 . . . . 0.0 109.181 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 49.9 ttm -64.24 162.15 15.2 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.252 0.549 . . . . 0.0 110.915 -173.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -66.69 15.66 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.866 1.666 . . . . 0.0 114.055 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -65.09 152.86 90.46 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.75 -46.89 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.728 2.286 . . . . 0.0 113.951 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -121.13 16.19 11.55 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.94 47.91 84.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.088 -0.84 . . . . 0.0 112.761 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 -10.09 21.97 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.147 2.565 . . . . 0.0 111.122 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -148.55 149.49 31.36 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 123.829 0.852 . . . . 0.0 109.603 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.86 156.37 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.577 2.851 . . . . 0.0 111.632 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 573' ' ' TYR . 79.6 t80 -144.79 1.27 1.0 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.849 0.86 . . . . 0.0 110.588 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 57.3 m -66.44 116.53 7.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.7 pt? -124.89 144.53 50.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.508 0.723 . . . . 0.0 111.961 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.05 143.59 31.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.6 mt -131.21 144.73 51.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 36.8 t -163.8 176.34 9.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.34 145.31 28.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.928 0.491 . . . . 0.0 110.933 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 35.0 t -135.54 147.22 48.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.094 0.558 . . . . 0.0 110.112 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 25.4 m -89.61 102.13 14.81 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.62 34.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.598 0.759 . . . . 0.0 110.293 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -96.43 -21.52 17.7 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -164.26 153.81 14.0 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.073 0.949 . . . . 0.0 109.962 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -109.97 76.32 0.98 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.465 -1.255 . . . . 0.0 110.631 178.58 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.19 6.44 5.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.826 0.451 . . . . 0.0 111.946 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.4 m -142.92 146.03 35.77 Favored Pre-proline 0 C--O 1.232 0.133 0 O-C-N 121.93 -0.481 . . . . 0.0 111.389 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -82.0 1.8 8.97 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 124.598 3.532 . . . . 0.0 112.834 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.26 146.35 28.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-N 118.374 0.534 . . . . 0.0 110.943 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.4 pp -141.84 167.68 21.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.695 0.798 . . . . 0.0 109.609 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.9 mtp -138.83 151.17 46.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.672 0.273 . . . . 0.0 110.856 -175.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.09 150.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.043 0.537 . . . . 0.0 110.63 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.76 166.52 24.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.489 0.716 . . . . 0.0 109.519 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.08 89.46 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.701 -0.499 . . . . 0.0 112.934 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.765 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.15 175.71 7.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.774 0.787 . . . . 0.0 110.689 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -138.3 142.08 39.8 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.544 0.338 . . . . 0.0 110.103 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -73.94 -2.35 23.61 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.8 p -110.38 -2.68 16.52 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.205 0.457 . . . . 0.0 112.126 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -131.65 -5.72 3.66 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.164 0.586 . . . . 0.0 110.922 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.8 tpt -146.19 123.33 11.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.216 0.606 . . . . 0.0 109.545 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.454 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 22.5 m120 -141.94 176.26 9.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.883 0.873 . . . . 0.0 109.082 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 81.6 m -59.54 -25.97 64.96 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.225 -0.297 . . . . 0.0 110.94 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.14 -23.12 26.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.255 -0.278 . . . . 0.0 111.593 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . 0.454 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 49.0 mmt-85 -82.16 -31.3 30.57 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.418 0.554 . . . . 0.0 109.586 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.43 -30.0 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.94 -30.89 68.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -71.96 -32.03 66.87 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.94 -0.475 . . . . 0.0 110.889 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.3 t -88.03 -27.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -104.95 -8.41 18.62 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.36 -39.46 78.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.825 0.739 . . . . 0.0 110.967 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.03 14.96 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.936 -0.478 . . . . 0.0 112.145 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.31 -1.89 9.63 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.188 0.595 . . . . 0.0 111.067 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.83 174.19 19.48 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -74.71 136.03 41.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.317 -0.52 . . . . 0.0 110.957 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 474' ' ' PHE . 7.7 m -94.44 164.52 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 124.571 1.148 . . . . 0.0 110.365 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -129.91 -63.34 0.92 Allowed 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.261 0.224 . . . . 0.0 110.884 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -163.32 166.04 23.48 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.771 0.429 . . . . 0.0 111.353 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.54 153.27 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.553 0.741 . . . . 0.0 110.625 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -149.65 145.06 26.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -77.47 155.2 31.87 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.521 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 8.3 ttm -107.78 141.11 39.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -168.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 48.72 33.99 4.77 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.217 1.007 . . . . 0.0 112.64 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.9 m 53.03 17.64 0.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.828 0.851 . . . . 0.0 113.099 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.66 147.77 53.07 Favored Pre-proline 0 N--CA 1.455 -0.204 0 CA-C-N 118.023 0.374 . . . . 0.0 110.428 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -81.61 -1.63 11.07 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.43 2.753 . . . . 0.0 110.427 170.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -124.54 17.28 7.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.587 -173.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.521 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -149.79 143.91 25.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.747 1.274 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.95 168.66 26.83 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.8 ptm -141.6 145.14 34.67 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.427 0.691 . . . . 0.0 109.946 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 14.6 t -131.95 150.96 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 122.746 0.418 . . . . 0.0 110.838 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -128.24 143.26 51.02 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.389 0.675 . . . . 0.0 110.311 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 81.3 mmm -117.1 162.64 17.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.434 0.694 . . . . 0.0 109.323 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -73.25 -19.28 61.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.055 -0.403 . . . . 0.0 111.921 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -156.62 162.5 39.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.776 0.43 . . . . 0.0 110.172 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.64 -17.95 73.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.458 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -67.49 -26.52 66.4 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.976 1.388 . . . . 0.0 110.172 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.57 -24.17 45.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.416 0.286 . . . . 0.0 110.621 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.25 -31.81 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.75 -32.38 73.9 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -82.22 -30.5 30.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.349 0.26 . . . . 0.0 111.681 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.59 -28.22 31.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.33 0.514 . . . . 0.0 111.073 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.4 tp -82.59 -31.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.918 0.487 . . . . 0.0 110.992 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.0 m -93.74 -21.99 18.99 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -124.24 -13.32 7.24 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.66 -20.47 10.11 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.072 0.851 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -52.28 143.26 15.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.963 0.905 . . . . 0.0 111.497 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 14.3 p30 56.91 1.53 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.004 2.522 . . . . 0.0 115.864 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -88.04 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.183 1.356 . . . . 0.0 108.184 168.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.286 0.0 OUTLIER -130.95 163.95 26.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 176.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.7 ptm -125.28 143.44 50.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.162 1.385 . . . . 0.0 109.946 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 65.07 31.57 10.98 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.025 1.33 . . . . 0.0 114.042 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.02 15.86 72.25 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.344 -0.698 . . . . 0.0 114.805 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -83.27 162.05 21.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.427 1.114 . . . . 0.0 110.337 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 131.68 35.66 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.961 0.41 . . . . 0.0 110.527 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.61 132.96 43.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -169.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.68 117.46 11.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.7 139.9 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 118.393 0.542 . . . . 0.0 110.523 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.4 m -150.23 161.98 41.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.982 0.913 . . . . 0.0 110.162 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.9 p -84.82 155.5 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 38.3 t -134.38 142.54 47.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.977 0.353 . . . . 0.0 111.246 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -85.7 65.95 9.4 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.03 0.532 . . . . 0.0 110.43 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -127.81 143.78 48.91 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.18 -26.54 6.25 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.878 2.386 . . . . 0.0 111.805 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.02 170.51 15.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.558 0.343 . . . . 0.0 111.031 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.1 mm -71.62 147.02 11.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.33 151.98 41.07 Favored Pre-proline 0 C--O 1.231 0.128 0 C-N-CA 122.416 0.286 . . . . 0.0 110.239 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.41 164.49 32.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.673 2.915 . . . . 0.0 111.874 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 171.21 -174.35 44.87 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -74.12 148.85 41.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.844 0.322 . . . . 0.0 110.25 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 24.9 m -142.59 160.89 39.42 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.249 0.62 . . . . 0.0 109.919 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -150.91 164.23 36.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.463 0.305 . . . . 0.0 110.568 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.14 135.27 16.27 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.95 169.5 12.42 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.539 0.736 . . . . 0.0 109.702 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.15 -20.31 65.73 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.081 -0.387 . . . . 0.0 111.376 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.0 -0.9 26.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.962 0.505 . . . . 0.0 111.283 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 85.73 -7.58 76.32 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.635 0.636 . . . . 0.0 112.783 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.7 m -93.83 156.19 16.79 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 117.896 0.848 . . . . 0.0 110.397 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 47.5 t -77.44 153.26 33.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.398 0.279 . . . . 0.0 110.261 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -68.14 -10.42 53.96 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.249 0.619 . . . . 0.0 111.678 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -123.48 136.27 54.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.11 0.964 . . . . 0.0 109.297 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -155.72 159.26 39.35 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -125.0 157.4 36.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.927 0.891 . . . . 0.0 110.454 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' A' ' 406' ' ' VAL . 24.5 m-85 -139.56 13.53 2.54 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.107 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -61.43 163.82 10.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.139 0.975 . . . . 0.0 110.828 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.22 143.06 20.12 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.23 2.62 . . . . 0.0 112.258 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 51.3 m -119.77 23.58 11.03 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.261 0.624 . . . . 0.0 112.259 -172.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 61.96 -7.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.42 1.488 . . . . 0.0 114.098 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.72 147.65 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.757 0.708 . . . . 0.0 109.661 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.416 HD12 ' CH2' ' A' ' 546' ' ' TRP . 59.5 mt -119.1 151.64 37.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.786 0.434 . . . . 0.0 110.222 177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . 0.51 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 11.7 m170 -119.55 155.41 32.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.25 149.91 44.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.333 0.253 . . . . 0.0 110.524 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -145.78 169.28 18.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.747 0.419 . . . . 0.0 110.987 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 46.4 t30 56.68 33.12 22.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.994 0.918 . . . . 0.0 112.843 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.82 163.74 39.74 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.94 151.0 68.64 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.007 2.472 . . . . 0.0 111.847 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -75.27 -1.19 22.38 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.34 9.59 11.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.899 0.48 . . . . 0.0 111.919 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.6 149.49 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 118.019 0.372 . . . . 0.0 111.058 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.8 p -142.07 173.98 11.02 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.536 0.735 . . . . 0.0 110.265 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.63 -21.74 65.9 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.77 -22.08 58.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.234 -0.291 . . . . 0.0 110.407 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -83.25 -32.17 26.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.86 -27.63 63.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -84.53 -37.54 21.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.135 0.425 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -76.03 -21.28 57.01 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.756 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.6 mt -92.1 -36.14 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.922 0.328 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 18.2 p -70.31 -20.85 62.98 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.47 -29.03 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.567 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.99 -12.93 34.41 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.447 0.567 . . . . 0.0 111.333 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.06 -9.58 55.1 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.716 0.406 . . . . 0.0 110.838 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.22 11.08 82.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.765 -0.464 . . . . 0.0 112.803 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.5 m -98.8 169.82 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.103 0 CA-C-N 117.738 0.769 . . . . 0.0 111.291 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.54 151.68 42.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.343 0.657 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -101.04 151.98 37.76 Favored Pre-proline 0 C--O 1.231 0.111 0 C-N-CA 122.729 0.412 . . . . 0.0 109.899 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.31 153.38 78.26 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.962 2.442 . . . . 0.0 110.471 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 80.6 m -86.14 -24.84 26.05 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.621 0.368 . . . . 0.0 110.53 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -142.84 150.35 39.78 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.168 0.587 . . . . 0.0 109.599 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.55 147.97 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 120.872 0.368 . . . . 0.0 110.387 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -142.28 132.26 24.46 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.91 142.4 39.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -154.24 150.65 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 110.468 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.909 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.2 t -149.52 162.88 39.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.922 0.489 . . . . 0.0 110.433 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 42.2 t -124.82 152.59 43.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.47 0.708 . . . . 0.0 111.519 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 52.5 m -147.73 165.26 31.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.73 1.212 . . . . 0.0 108.93 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.81 -165.88 37.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.745 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -127.41 156.28 42.32 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.755 0.822 . . . . 0.0 110.351 -176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.86 133.62 30.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.482 1.113 . . . . 0.0 108.004 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.83 113.3 15.77 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.416 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.9 p90 -166.02 151.35 8.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 168.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -150.77 116.2 5.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 35.2 t -159.41 152.92 22.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.93 -38.0 79.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.746 0.703 . . . . 0.0 111.432 -174.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 47.4 m -87.78 -28.6 21.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -85.37 -28.32 25.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.414 0.552 . . . . 0.0 111.12 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.17 -34.42 37.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 117.949 0.341 . . . . 0.0 110.397 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.88 -30.73 45.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.439 0.563 . . . . 0.0 112.016 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -72.72 -43.73 62.6 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.261 0.482 . . . . 0.0 109.979 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 44.4 m -69.27 -40.26 77.91 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -42.79 98.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.901 -0.499 . . . . 0.0 109.864 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.15 -21.57 77.11 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.86 -0.966 . . . . 0.0 113.447 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -117.68 -14.97 10.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.857 1.329 . . . . 0.0 113.276 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 17.4 tp -88.22 -21.93 24.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.347 0.976 . . . . 0.0 110.623 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -76.49 151.32 36.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 39.8 t60 55.91 22.66 5.89 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.64 151.46 37.77 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.194 0.598 . . . . 0.0 112.537 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -110.78 136.18 50.23 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.06 0.944 . . . . 0.0 111.433 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.25 176.83 0.94 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.076 0.95 . . . . 0.0 111.417 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.9 10.71 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.709 0.803 . . . . 0.0 112.459 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.04 146.71 87.43 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 123.288 0.635 . . . . 0.0 111.051 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.92 -40.63 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.134 2.556 . . . . 0.0 112.734 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -120.96 2.38 10.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 65.82 60.26 6.71 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.767 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.67 -8.5 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.322 2.681 . . . . 0.0 110.984 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.45 151.03 46.16 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 123.576 0.75 . . . . 0.0 109.74 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.58 154.33 39.75 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.637 2.892 . . . . 0.0 110.356 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -133.16 -4.58 3.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.8 t -66.55 131.95 47.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.668 -0.645 . . . . 0.0 110.653 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 575' ' ' LEU . 1.8 pp -116.43 144.67 44.01 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.373 0.669 . . . . 0.0 110.79 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.64 138.09 39.85 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.03 155.89 43.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 111.412 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.9 p -163.76 167.98 20.27 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.23 131.61 39.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.51 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 26.2 t -135.64 150.13 49.53 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.521 0.201 . . . . 0.0 111.247 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.2 m -84.77 102.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.16 161.63 34.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.742 0.817 . . . . 0.0 110.061 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -109.75 -11.9 14.68 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.422 0.289 . . . . 0.0 111.634 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -160.52 162.83 33.11 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.079 0.552 . . . . 0.0 109.995 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -95.83 76.5 3.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.268 0.627 . . . . 0.0 109.717 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.252 1.204 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.222 -179.677 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.724 0.297 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -142.32 14.46 2.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.044 0.538 . . . . 0.0 111.192 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.1 m -141.38 150.11 56.9 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 122.126 -0.359 . . . . 0.0 111.379 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.39 -5.6 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.137 3.225 . . . . 0.0 111.98 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.89 151.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 122.832 0.453 . . . . 0.0 111.276 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.42 167.88 21.88 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.71 0.804 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 74.6 mtp -133.61 150.41 51.61 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.359 0.264 . . . . 0.0 111.316 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.05 151.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.161 0.584 . . . . 0.0 110.603 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -140.05 164.95 28.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.472 0.709 . . . . 0.0 109.637 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 78.94 -2.69 67.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.384 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.8 pt? -71.41 134.64 46.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.988 0.894 . . . . 0.0 109.794 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -83.48 122.65 28.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -75.03 6.79 3.79 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.9 p -116.0 -1.02 12.6 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.788 0.435 . . . . 0.0 111.658 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -130.3 -9.09 4.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.791 0.836 . . . . 0.0 110.472 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 11.0 tpt -139.86 128.08 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.24 1.016 . . . . 0.0 108.785 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -141.92 -172.92 3.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.132 0.573 . . . . 0.0 109.822 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.22 -22.65 64.97 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.19 -33.27 20.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.964 -0.46 . . . . 0.0 110.851 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 41.2 mmt-85 -81.66 -25.35 35.64 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.275 -0.266 . . . . 0.0 110.987 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.43 -30.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.018 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.22 -25.49 63.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -75.09 -39.81 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.14 -0.35 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.3 -20.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.994 -0.441 . . . . 0.0 111.979 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -109.81 -18.02 13.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.65 -21.6 57.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.16 0.891 . . . . 0.0 111.499 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.404 ' C ' HD12 ' A' ' 402' ' ' LEU . 1.1 pp -72.23 7.3 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.705 -0.622 . . . . 0.0 112.469 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -121.62 -1.85 9.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.538 0.735 . . . . 0.0 111.41 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.96 173.31 20.21 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -68.28 146.97 52.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.346 -0.502 . . . . 0.0 111.23 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.51 155.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.783 0.833 . . . . 0.0 108.813 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -101.02 -65.37 0.97 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -163.31 164.41 24.86 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.595 0.758 . . . . 0.0 110.232 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 11.2 p -144.2 151.27 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 C-N-CA 123.116 0.566 . . . . 0.0 110.437 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.07 139.77 19.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.924 0.14 . . . . 0.0 111.282 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.71 152.3 28.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -133.86 141.42 47.39 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 60.0 33.74 21.4 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 126.472 1.909 . . . . 0.0 114.231 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.1 m 52.84 16.0 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -72.0 158.38 87.77 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.613 0.642 . . . . 0.0 110.712 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.77 -22.4 44.67 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.223 2.615 . . . . 0.0 112.023 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -171.06 97.9 0.13 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -158.67 134.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -153.89 168.31 26.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.367 0.603 . . . . 0.0 112.462 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.9 ptp -139.63 145.34 38.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.147 0.979 . . . . 0.0 109.038 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.07 146.6 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.949 0.404 . . . . 0.0 110.617 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -124.94 146.41 49.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 109.866 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 75.3 mtp -122.35 164.12 18.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.793 0.437 . . . . 0.0 110.431 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.93 61.87 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -156.93 158.04 35.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.051 0.387 . . . . 0.0 110.181 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.13 80.67 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.116 -0.824 . . . . 0.0 113.578 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -69.17 -25.77 64.52 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.198 1.499 . . . . 0.0 110.839 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.29 -25.24 27.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.14 -27.51 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.25 -37.33 77.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.324 -0.235 . . . . 0.0 110.449 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -71.96 -30.79 65.65 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.84 57.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.314 -0.241 . . . . 0.0 111.078 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.2 tp -83.65 -30.9 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.6 m -99.02 -16.27 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.93 -6.68 2.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.62 -20.57 10.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.251 0.932 . . . . 0.0 109.56 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -52.77 142.32 19.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.044 0.938 . . . . 0.0 110.872 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.09 1.28 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.101 2.16 . . . . 0.0 115.659 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -87.84 142.52 27.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 120.242 1.383 . . . . 0.0 108.507 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -130.84 164.06 26.03 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.2 ptm -125.43 143.47 50.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.991 1.316 . . . . 0.0 108.985 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 67.01 25.7 9.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.05 80.54 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 168.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -83.06 159.77 22.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.014 1.407 . . . . 0.0 110.65 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 141.93 32.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.19 0.596 . . . . 0.0 111.025 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -98.22 124.15 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -140.68 111.3 6.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 169.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.09 140.2 17.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 CA-C-N 118.118 0.417 . . . . 0.0 109.957 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 96.8 m -149.47 159.94 43.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.775 0.83 . . . . 0.0 110.352 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.0 p -80.12 160.4 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 46.2 t -134.29 168.47 18.84 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 122.811 0.444 . . . . 0.0 110.515 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.08 12.71 11.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.566 0.746 . . . . 0.0 112.337 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.05 147.06 99.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.39 -36.5 77.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.81 2.34 . . . . 0.0 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.01 173.69 6.77 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.622 0.769 . . . . 0.0 110.047 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.4 mm -68.77 144.69 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.6 mtt -105.55 146.66 33.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 117.646 0.203 . . . . 0.0 110.994 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.2 172.85 15.55 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.253 3.302 . . . . 0.0 111.457 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.06 46.82 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.377 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 55.15 21.78 4.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.04 0.936 . . . . 0.0 112.857 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.5 p -79.42 153.93 29.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.716 0.293 . . . . 0.0 110.928 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -154.09 163.45 40.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.146 0.579 . . . . 0.0 110.343 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.2 136.0 16.56 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.92 169.32 12.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.277 0.631 . . . . 0.0 110.12 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.67 -21.13 66.66 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 110.316 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -77.94 -1.38 31.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.666 0.787 . . . . 0.0 111.452 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.76 70.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.398 0.523 . . . . 0.0 113.16 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.1 m -93.77 163.79 13.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.642 0.721 . . . . 0.0 110.798 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.51 153.33 37.55 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.7 p -70.23 -10.57 59.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -119.68 146.57 45.47 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.593 0.633 . . . . 0.0 112.156 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -157.0 156.12 32.4 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 110.142 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -124.49 152.31 43.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.798 0.839 . . . . 0.0 109.713 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.93 10.04 2.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.013 0.525 . . . . 0.0 111.282 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 94.3 p . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.286 8.5 pt20 . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -141.19 95.84 7.33 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.78 138.49 16.91 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.487 2.792 . . . . 0.0 110.255 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 56.4 m -124.04 23.93 8.37 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.362 0.665 . . . . 0.0 111.4 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.45 18.91 9.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.811 0.844 . . . . 0.0 112.717 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.9 t -134.42 146.82 30.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.477 HD12 ' CH2' ' A' ' 546' ' ' TRP . 28.8 mt -118.22 160.61 21.3 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.8 0.44 . . . . 0.0 110.196 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -121.64 157.41 30.88 Favored 'General case' 0 N--CA 1.46 0.059 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -142.73 152.85 42.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.852 0.461 . . . . 0.0 110.409 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.85 173.07 12.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.126 0.57 . . . . 0.0 110.549 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 64.8 t30 66.5 28.41 9.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.451 1.1 . . . . 0.0 113.329 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.14 160.42 46.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 122.12 -0.363 . . . . 0.0 110.723 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 156.0 39.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.08 2.52 . . . . 0.0 111.644 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -77.97 -0.76 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -122.52 13.1 10.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.174 0.589 . . . . 0.0 111.548 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.57 152.68 7.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 O-C-N 122.081 -0.387 . . . . 0.0 110.926 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.6 p -142.39 170.99 14.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.489 0.715 . . . . 0.0 110.437 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.74 -20.65 65.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.819 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -72.89 -23.65 60.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.6 -33.37 28.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -69.46 -28.66 66.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.514 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -82.26 -35.64 27.91 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.965 -0.46 . . . . 0.0 111.788 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -78.27 -17.3 56.83 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.329 0.513 . . . . 0.0 112.006 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.01 -25.36 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.122 0.419 . . . . 0.0 110.663 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.18 -24.24 63.1 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.404 -0.81 . . . . 0.0 109.753 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.94 -10.78 54.62 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.04 -18.82 23.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 110.332 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.7 mt -112.92 -0.44 14.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.75 5.77 70.15 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.678 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.86 169.75 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.852 0.826 . . . . 0.0 111.044 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.49 145.37 34.99 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.882 0.473 . . . . 0.0 110.275 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.67 146.67 47.19 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.944 0.498 . . . . 0.0 110.218 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 158.22 58.12 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.251 2.634 . . . . 0.0 110.685 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 61.8 m -90.4 -28.34 18.72 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.015 0.526 . . . . 0.0 110.698 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.2 m -142.35 153.67 44.02 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.142 0.577 . . . . 0.0 109.505 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 94.8 t -139.13 146.62 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 122.976 0.51 . . . . 0.0 110.284 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . 0.442 ' HE2' ' N ' ' A' ' 586' ' ' SER . 30.0 ttmt -138.24 140.01 39.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.71 145.16 31.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -136.04 157.99 45.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -172.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.1 p . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 123.906 0.882 . . . . 0.0 110.198 177.164 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 65.2 m -141.15 167.0 23.23 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.661 1.184 . . . . 0.0 109.575 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.1 t -132.0 166.01 22.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.016 0.526 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 77.6 p -153.47 172.35 17.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.495 1.118 . . . . 0.0 110.111 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.35 -161.05 33.43 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.63 -0.795 . . . . 0.0 114.028 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.09 157.18 32.02 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.57 1.148 . . . . 0.0 110.523 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.46 133.31 30.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 124.232 1.013 . . . . 0.0 108.345 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -127.8 119.37 25.55 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.477 ' CH2' HD12 ' A' ' 500' ' ' LEU . 3.0 p90 -166.09 153.21 9.82 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.418 1.487 . . . . 0.0 107.498 168.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -148.98 118.62 6.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.671 -0.811 . . . . 0.0 112.974 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.0 t -159.6 152.97 22.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 169.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -65.01 -53.0 53.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.716 0.689 . . . . 0.0 111.03 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 53.0 m -81.49 -23.85 37.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -91.48 -28.75 17.41 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.518 0.599 . . . . 0.0 111.966 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.58 38.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.335 0.516 . . . . 0.0 110.529 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 50.6 tp -82.25 -31.93 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.17 -36.72 47.16 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.825 -0.547 . . . . 0.0 110.273 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.5 m -72.52 -42.54 64.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . 0.453 ' C ' HD13 ' A' ' 556' ' ' LEU . 2.8 tm? -60.44 -47.83 84.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.34 -15.07 67.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.097 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.9 2.19 2.84 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.688 1.744 . . . . 0.0 114.377 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 559' ' ' LEU . 2.5 tm? -104.05 -26.5 12.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.531 0.605 . . . . 0.0 109.727 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -65.16 155.17 35.79 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.686 -0.634 . . . . 0.0 110.369 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 55.4 20.84 3.85 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.33 151.26 35.03 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -110.93 136.51 49.84 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.902 1.681 . . . . 0.0 110.184 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . 0.46 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.6 ttt -64.16 171.92 2.72 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.245 0.618 . . . . 0.0 111.006 -175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -75.73 15.5 0.5 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -65.94 149.94 97.06 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.325 0.512 . . . . 0.0 110.132 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.53 -45.8 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.956 2.437 . . . . 0.0 113.347 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -121.04 13.69 11.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.63 52.23 50.22 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.237 -0.757 . . . . 0.0 112.263 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.82 -8.81 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.196 2.597 . . . . 0.0 111.315 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -146.31 149.43 37.89 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 123.698 0.799 . . . . 0.0 109.315 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.73 147.03 39.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.425 2.75 . . . . 0.0 110.881 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . 0.46 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.0 t80 -144.88 -2.6 0.81 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.27 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 62.3 m -66.37 110.63 3.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.41 144.55 25.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.901 0.48 . . . . 0.0 111.208 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -103.33 122.48 44.91 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.03 146.87 37.78 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 58.8 m -153.98 -178.14 6.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.67 1.188 . . . . 0.0 109.019 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.9 149.75 49.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.5 t -135.49 160.08 39.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.732 0.813 . . . . 0.0 110.328 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 87.8 m -105.82 102.13 11.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.38 161.56 34.67 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.213 1.005 . . . . 0.0 110.186 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -87.09 -38.25 16.67 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -158.06 153.02 25.28 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.985 1.314 . . . . 0.0 109.377 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -99.66 76.5 2.0 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.442 ' N ' ' HE2' ' A' ' 530' ' ' LYS . 78.3 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.122 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.935 0.397 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -123.94 -0.51 8.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.249 0.62 . . . . 0.0 111.809 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 31.2 t -164.06 150.93 10.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.253 0.621 . . . . 0.0 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.42 2.78 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.579 2.853 . . . . 0.0 111.617 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.02 151.15 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.837 0.855 . . . . 0.0 109.904 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -139.51 165.08 28.17 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.633 0.773 . . . . 0.0 109.706 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 64.8 mtp -136.43 149.91 48.49 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.617 0.246 . . . . 0.0 111.223 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.9 148.53 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.729 0.812 . . . . 0.0 109.591 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -140.03 162.99 33.88 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.972 0.509 . . . . 0.0 109.86 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.49 -0.34 86.87 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.713 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.748 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.68 176.82 5.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.063 0.932 . . . . 0.0 110.264 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -139.77 141.59 36.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.265 -0.272 . . . . 0.0 110.562 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -71.7 -1.73 14.87 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 46.7 m -104.99 -9.12 18.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.049 0.386 . . . . 0.0 111.92 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -136.22 -2.86 2.24 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.059 0.544 . . . . 0.0 111.222 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -145.2 122.72 11.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.573 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 20.2 m120 -141.83 177.01 8.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.631 0.773 . . . . 0.0 109.204 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -58.16 -28.13 64.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -91.73 -25.91 18.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.81 -0.556 . . . . 0.0 111.751 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . 0.573 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.8 mpt_? -73.59 -31.54 63.64 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.06 -32.33 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -68.1 -30.98 70.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.68 -27.53 62.15 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.13 -35.03 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.387 0.54 . . . . 0.0 111.829 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -89.93 -8.97 50.53 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.0 t -70.2 -26.94 64.12 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.525 0.602 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 26.8 mt -67.11 -4.46 10.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.749 -0.594 . . . . 0.0 111.822 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -121.45 4.05 10.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.84 -132.39 3.56 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -141.33 157.02 45.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 6.2 m -115.87 156.46 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.477 0.711 . . . . 0.0 111.003 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -110.04 -51.15 2.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.082 0.553 . . . . 0.0 110.908 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -167.6 167.6 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.476 0.711 . . . . 0.0 111.0 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.85 151.61 16.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.969 0.908 . . . . 0.0 110.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -149.94 143.82 25.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.151 0.58 . . . . 0.0 110.144 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -87.2 102.99 15.0 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.502 ' HE1' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -81.46 141.48 33.84 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.152 1.381 . . . . 0.0 112.966 -171.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 60.09 33.93 21.25 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.93 1.292 . . . . 0.0 112.47 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 92.0 p 52.88 12.37 0.27 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.839 1.656 . . . . 0.0 115.317 172.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -84.85 126.5 68.06 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-N 118.753 0.706 . . . . 0.0 110.308 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.96 -9.95 18.63 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.26 2.64 . . . . 0.0 111.853 171.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -106.9 17.23 38.75 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.359 0.98 . . . . 0.0 112.726 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.502 ' HB1' ' HE1' ' A' ' 412' ' ' MET . . . -146.25 140.38 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.412 1.106 . . . . 0.0 110.934 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.29 158.23 39.88 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.946 0.498 . . . . 0.0 111.316 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.1 ptm -140.7 147.59 39.46 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.599 0.36 . . . . 0.0 110.251 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.82 148.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.78 0.432 . . . . 0.0 110.775 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -114.72 139.02 50.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.479 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 86.6 mmm -104.49 161.29 14.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.519 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.49 -18.97 61.62 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.45 -0.157 . . . . 0.0 111.395 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -156.57 158.92 37.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.159 0.584 . . . . 0.0 109.893 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.57 -17.54 74.82 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.166 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -24.02 62.83 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 119.002 1.401 . . . . 0.0 110.767 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.72 -22.5 37.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.292 0.237 . . . . 0.0 111.03 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.79 -36.65 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -68.6 -26.76 65.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.91 -26.0 29.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 121.933 0.093 . . . . 0.0 110.945 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.52 50.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.65 -31.07 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.83 0.852 . . . . 0.0 110.783 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 22.5 m -98.84 -20.4 16.87 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -134.34 -7.32 2.59 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.67 -19.85 10.37 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.196 0.907 . . . . 0.0 109.441 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -52.47 145.79 10.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.835 0.854 . . . . 0.0 111.567 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 56.87 1.54 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.13 2.172 . . . . 0.0 115.408 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -88.08 142.51 27.72 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.578 1.535 . . . . 0.0 108.772 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.309 0.0 OUTLIER -130.97 163.9 26.52 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.0 ptm -125.21 143.35 50.99 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.038 1.335 . . . . 0.0 109.385 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . 0.408 ' H ' ' CG ' ' A' ' 554' ' ' GLU . 97.0 m-85 67.52 28.54 7.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.33 1.452 . . . . 0.0 114.192 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 68.39 16.01 68.79 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -83.3 162.07 21.24 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.422 1.111 . . . . 0.0 110.318 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.2 133.52 34.59 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.47 134.14 41.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -140.69 123.58 16.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.58 144.34 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.028 0 CA-C-N 118.116 0.416 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 t -158.5 165.56 34.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.2 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.9 152.97 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.262 0.625 . . . . 0.0 109.615 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 13.1 t -100.51 -167.0 1.38 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 110.475 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -138.41 6.18 2.52 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.938 0.895 . . . . 0.0 110.857 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -80.04 144.63 59.41 Favored Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.22 -24.86 12.08 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.873 2.382 . . . . 0.0 111.101 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.49 169.01 17.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.699 0.799 . . . . 0.0 109.489 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.09 142.55 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.2 mtt -111.34 159.56 32.5 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 122.417 0.287 . . . . 0.0 110.735 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -55.61 160.08 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.926 3.084 . . . . 0.0 112.646 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 172.29 179.57 43.23 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -74.96 153.54 38.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 48.2 t -138.23 157.14 46.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.051 0.54 . . . . 0.0 109.841 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -146.13 161.79 39.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.309 0.644 . . . . 0.0 110.17 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 135.06 14.83 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 70.7 mt -86.86 173.81 9.15 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.454 0.702 . . . . 0.0 109.513 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.222 -0.299 . . . . 0.0 111.414 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.4 -1.34 49.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.042 0.537 . . . . 0.0 111.178 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.66 -1.05 88.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.402 0.525 . . . . 0.0 112.578 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.8 t -93.63 160.15 14.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.775 0.787 . . . . 0.0 110.226 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.7 m -78.35 153.3 31.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.953 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 84.8 p -73.26 -10.6 59.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.858 0.463 . . . . 0.0 111.913 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -120.63 138.55 53.86 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -155.86 157.29 36.13 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.495 0.318 . . . . 0.0 110.776 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.15 156.96 32.56 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.467 0.707 . . . . 0.0 110.404 176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -140.07 11.14 2.39 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 122.903 0.481 . . . . 0.0 111.886 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -173.686 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 120.706 0.289 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -64.64 167.57 8.68 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.696 1.198 . . . . 0.0 109.56 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.55 137.91 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.39 2.726 . . . . 0.0 112.554 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 49.6 m -123.97 24.01 8.4 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.585 0.754 . . . . 0.0 112.848 -168.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.4 -14.74 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 113.779 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 29.9 t -134.09 151.66 32.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 118.648 0.658 . . . . 0.0 109.994 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.433 HD12 ' CH2' ' A' ' 546' ' ' TRP . 27.4 mt -126.18 138.63 53.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.771 0.829 . . . . 0.0 109.718 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . 0.444 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 16.0 m170 -105.65 154.82 19.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -137.34 147.41 45.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.465 0.174 . . . . 0.0 110.789 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -148.77 168.02 24.05 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.448 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.4 t30 58.18 30.52 19.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.327 1.051 . . . . 0.0 113.191 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.35 156.64 51.03 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.27 155.63 34.18 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.131 2.554 . . . . 0.0 111.805 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -77.11 -1.24 28.17 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.88 9.1 24.6 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.08 151.43 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 118.011 0.369 . . . . 0.0 111.11 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.2 p -142.88 172.03 13.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.557 0.743 . . . . 0.0 110.241 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.25 -20.55 64.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.55 -24.92 59.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -81.62 -29.78 33.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -70.52 -30.81 67.67 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.824 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.48 -36.59 26.34 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.334 0.515 . . . . 0.0 111.772 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -76.54 -23.87 53.61 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.06 0.391 . . . . 0.0 111.783 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.4 mt -88.85 -33.49 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 117.932 0.333 . . . . 0.0 110.16 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 75.6 m -65.47 -22.99 66.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.868 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.13 -34.7 75.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.09 -12.75 34.69 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.07 -7.53 59.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.878 0.308 . . . . 0.0 111.36 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.37 11.15 75.88 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.761 -0.466 . . . . 0.0 112.907 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.4 m -111.16 171.18 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 117.852 0.826 . . . . 0.0 111.177 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -68.5 154.55 41.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.415 0.686 . . . . 0.0 110.51 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -108.25 151.07 41.27 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.14 153.5 75.92 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.217 2.612 . . . . 0.0 111.339 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 83.9 m -94.59 -21.58 18.74 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.209 0.604 . . . . 0.0 111.244 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 50.8 m -142.31 153.87 44.24 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.15 150.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.166 0.508 . . . . 0.0 111.878 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -145.4 140.65 27.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.19 140.99 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -153.66 156.5 38.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.251 0.62 . . . . 0.0 110.089 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.456 -0.137 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.748 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.1 m -138.13 160.29 39.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.13 0.572 . . . . 0.0 110.371 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.8 t -120.4 150.42 40.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.694 0.798 . . . . 0.0 111.236 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 57.0 m -147.21 164.32 33.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.231 1.412 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.84 -162.41 33.15 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.658 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 87.6 mt -128.57 151.31 49.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.095 0.958 . . . . 0.0 110.767 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.7 mt -142.28 133.39 26.03 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -127.81 124.7 38.26 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.433 ' CH2' HD12 ' A' ' 500' ' ' LEU . 4.2 p90 -166.02 149.06 7.41 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -146.77 114.1 6.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 34.7 t -159.56 152.91 22.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 168.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -66.99 -36.82 83.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.469 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 45.9 m -83.92 -36.18 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.184 0.194 . . . . 0.0 111.354 -176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.4 -24.57 31.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.568 0.622 . . . . 0.0 111.612 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.63 21.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.491 0.587 . . . . 0.0 111.557 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.48 -23.79 24.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.053 0.842 . . . . 0.0 111.61 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.408 ' CG ' ' H ' ' A' ' 442' ' ' PHE . 65.4 mt-10 -77.93 -44.71 26.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.985 -0.447 . . . . 0.0 109.891 175.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 60.9 m -69.15 -31.87 70.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.3 tm? -68.9 -43.41 75.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.63 -19.32 72.91 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.28 -0.733 . . . . 0.0 112.757 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -114.39 -9.78 12.72 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.172 0.986 . . . . 0.0 113.046 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 13.7 tp -112.69 4.84 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.848 0.749 . . . . 0.0 112.18 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -92.9 143.01 26.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.333 -0.855 . . . . 0.0 109.675 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 49.13 35.94 8.07 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.644 0.777 . . . . 0.0 112.684 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . 0.404 ' HD1' ' H ' ' A' ' 562' ' ' TYR . 3.3 p90 -92.18 151.35 20.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -97.98 136.44 38.26 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.76 1.624 . . . . 0.0 111.389 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . 0.463 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.06 173.93 1.73 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.72 0.808 . . . . 0.0 111.354 -177.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -70.05 14.34 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.859 0.864 . . . . 0.0 113.106 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.46 140.62 92.02 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.939 0.495 . . . . 0.0 111.065 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -81.0 -29.53 2.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.299 2.666 . . . . 0.0 112.766 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -121.01 -11.37 8.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.409 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.12 43.83 95.02 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 82.9 Cg_endo -72.41 -6.6 19.38 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.32 2.68 . . . . 0.0 112.047 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -142.61 150.82 55.5 Favored Pre-proline 0 N--CA 1.455 -0.189 0 C-N-CA 123.559 0.744 . . . . 0.0 109.689 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 152.27 34.24 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.505 2.804 . . . . 0.0 110.738 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . 0.463 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 80.0 t80 -146.38 -2.66 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.518 0.327 . . . . 0.0 111.619 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.37 122.35 17.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.72 -0.613 . . . . 0.0 109.825 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.0 144.61 50.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.228 1.011 . . . . 0.0 109.324 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.89 158.11 17.58 Favored 'General case' 0 CA--C 1.523 -0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 111.247 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.62 155.74 47.03 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.169 0.988 . . . . 0.0 108.789 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 42.6 t -163.55 146.32 9.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -76.69 127.55 32.99 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 23.1 t -135.68 154.7 51.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.73 0.3 . . . . 0.0 111.091 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 37.0 m -83.59 103.4 12.89 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -133.98 161.16 35.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.498 0.719 . . . . 0.0 109.662 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -93.87 -26.1 17.05 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.406 -0.184 . . . . 0.0 111.172 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -160.66 157.83 27.81 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.966 0.506 . . . . 0.0 109.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -89.73 76.4 7.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.36 -1.305 . . . . 0.0 110.154 178.846 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -141.36 7.19 1.95 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 30.7 m -146.94 154.19 46.7 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 122.509 0.324 . . . . 0.0 110.551 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.45 -0.55 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.61 3.54 . . . . 0.0 113.399 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.78 162.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 118.686 0.676 . . . . 0.0 112.203 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -147.18 167.22 24.72 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.935 0.894 . . . . 0.0 109.122 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . 0.412 ' HE2' ' SD ' ' A' ' 412' ' ' MET . 73.8 mtp -133.57 151.24 51.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.404 0.282 . . . . 0.0 110.576 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.1 148.93 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.978 0.511 . . . . 0.0 110.827 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.95 167.55 21.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.474 0.71 . . . . 0.0 109.55 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.66 88.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.586 -0.563 . . . . 0.0 112.897 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -70.2 173.56 6.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.828 0.814 . . . . 0.0 110.326 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -136.66 139.78 42.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -71.96 -3.98 25.79 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.1 p -109.83 -1.19 18.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.378 0.535 . . . . 0.0 112.407 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -133.5 -6.44 2.91 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.288 0.635 . . . . 0.0 110.969 175.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.5 tpt -148.5 122.25 9.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.225 0.61 . . . . 0.0 109.47 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -141.88 -173.37 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.106 0.562 . . . . 0.0 109.768 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 72.3 m -59.54 -23.61 63.0 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -92.03 -23.8 19.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.231 0.468 . . . . 0.0 111.5 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -83.93 -29.71 26.89 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 409' ' ' VAL . 10.1 p -77.52 -32.58 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -68.85 -31.17 69.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.38 -46.43 55.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.172 -0.33 . . . . 0.0 111.329 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.18 -20.32 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 122.233 -0.292 . . . . 0.0 111.48 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -110.47 -7.33 14.77 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.24 -31.7 55.22 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.843 0.747 . . . . 0.0 110.958 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 11.38 1.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.805 -0.56 . . . . 0.0 112.18 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -121.51 -5.34 9.28 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.743 0.817 . . . . 0.0 110.931 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.68 177.94 24.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -75.49 148.67 38.83 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.376 -0.485 . . . . 0.0 110.834 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.05 154.26 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.597 0.759 . . . . 0.0 109.413 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -104.02 -58.79 1.82 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.212 -0.305 . . . . 0.0 110.552 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -165.78 166.65 17.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.973 0.509 . . . . 0.0 110.736 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 396' ' ' VAL . 7.6 p -147.92 150.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 122.985 0.514 . . . . 0.0 110.345 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -151.88 144.34 24.13 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.343 0.257 . . . . 0.0 110.599 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -79.06 152.0 31.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.412 ' SD ' ' HE2' ' A' ' 382' ' ' MET . 25.3 ptt? -129.97 141.49 50.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -168.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 60.01 34.0 21.4 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.923 1.289 . . . . 0.0 111.802 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m 52.77 16.67 0.71 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.883 1.273 . . . . 0.0 114.035 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.76 143.21 46.37 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 118.357 0.526 . . . . 0.0 109.903 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.34 -1.14 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.651 2.901 . . . . 0.0 110.262 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -132.54 27.68 3.52 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.739 0.685 . . . . 0.0 113.071 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.69 133.92 19.46 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.08 0.94 . . . . 0.0 110.333 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.12 168.67 26.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.5 ptm -144.32 146.99 32.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.19 151.62 27.65 Favored 'Isoleucine or valine' 0 C--N 1.337 0.028 0 C-N-CA 123.161 0.585 . . . . 0.0 110.736 -170.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -128.38 136.77 51.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.5 mmm -107.72 162.64 13.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.644 0.378 . . . . 0.0 110.565 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.95 61.14 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.158 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -157.73 161.76 38.51 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.429 0.691 . . . . 0.0 109.578 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.97 -14.54 70.83 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.391 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -67.96 -30.57 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.134 1.467 . . . . 0.0 110.46 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.33 -20.56 51.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.51 -31.78 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.32 -36.05 66.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -32.2 67.02 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.011 -0.43 . . . . 0.0 110.508 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.22 -38.05 25.09 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.12 -0.363 . . . . 0.0 111.862 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 7.5 tp -72.87 -32.02 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.529 -0.732 . . . . 0.0 111.803 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.1 m -93.66 -21.14 19.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -117.97 -14.09 10.02 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.75 -17.4 11.07 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.941 0.791 . . . . 0.0 110.507 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -51.73 142.01 15.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.46 0.648 . . . . 0.0 111.702 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 57.08 1.54 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.787 2.035 . . . . 0.0 115.742 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -87.91 142.49 27.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.719 1.6 . . . . 0.0 108.667 169.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -130.85 163.84 26.53 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.34 143.43 50.97 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.397 1.479 . . . . 0.0 109.576 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 67.77 27.12 7.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.989 1.316 . . . . 0.0 114.486 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.48 15.86 75.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 168.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -83.25 160.76 21.68 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.683 1.242 . . . . 0.0 110.074 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.62 132.46 34.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.54 133.26 43.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -140.69 120.43 13.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.06 141.92 15.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-N 118.263 0.483 . . . . 0.0 110.346 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 25.6 t -160.13 162.37 33.95 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.791 0.436 . . . . 0.0 110.166 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.07 158.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 109.949 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.1 t -137.67 151.28 48.1 Favored 'General case' 0 C--N 1.337 0.032 0 O-C-N 121.991 -0.443 . . . . 0.0 110.451 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -89.37 -0.58 57.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.683 0.793 . . . . 0.0 112.654 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -62.14 144.39 94.45 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 121.478 -0.764 . . . . 0.0 109.654 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.1 -25.04 12.09 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.832 2.355 . . . . 0.0 112.013 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.86 173.78 12.31 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.013 0.525 . . . . 0.0 110.214 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -66.68 138.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -90.07 163.03 33.45 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.813 0.445 . . . . 0.0 110.699 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.21 -42.5 64.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.14 2.56 . . . . 0.0 112.009 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 50.23 -142.75 13.46 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.252 0.453 . . . . 0.0 112.442 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -133.65 160.5 37.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.214 1.006 . . . . 0.0 108.536 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.0 p -143.3 156.04 44.62 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.693 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -155.19 163.34 40.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.36 136.68 17.79 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.96 165.86 15.54 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.174 0.59 . . . . 0.0 110.232 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.92 -20.13 65.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.243 0.217 . . . . 0.0 111.463 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -80.35 1.25 29.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 111.476 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.91 0.63 85.76 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 39.6 m -91.37 165.05 13.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.419 0.688 . . . . 0.0 110.528 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.36 153.34 22.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.74 0.305 . . . . 0.0 110.5 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.3 p -69.89 -10.25 57.84 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.027 0.531 . . . . 0.0 111.697 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -118.47 138.06 52.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.99 0.916 . . . . 0.0 109.87 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -154.42 155.2 34.54 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.423 0.289 . . . . 0.0 110.661 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -124.61 156.6 37.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 110.415 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.81 15.92 2.31 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.041 0.536 . . . . 0.0 111.334 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 91.2 p . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.617 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . 0.425 ' CG ' ' HD2' ' A' ' 496' ' ' PRO . 67.8 t60 -59.87 148.56 76.11 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 495' ' ' HIS . 87.1 Cg_exo -46.3 140.73 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.45 2.767 . . . . 0.0 112.817 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.1 m -123.99 24.05 8.37 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.606 0.762 . . . . 0.0 111.34 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.52 7.86 2.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 113.987 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 32.3 t -141.54 147.02 22.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 123.41 0.684 . . . . 0.0 109.233 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.482 HD12 ' CH2' ' A' ' 546' ' ' TRP . 91.5 mt -129.38 160.35 33.35 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.62 0.768 . . . . 0.0 110.086 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.65 163.16 34.03 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.285 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -135.94 156.94 48.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.407 0.683 . . . . 0.0 111.133 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -147.3 170.76 16.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.46 26.19 15.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 0.0 113.281 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.95 158.3 70.41 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -68.99 159.43 54.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.282 1.988 . . . . 0.0 110.602 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -71.58 -1.09 12.32 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -112.0 7.1 19.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -173.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.45 148.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 118.308 0.504 . . . . 0.0 111.209 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.5 p -142.98 173.3 11.68 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.925 0.89 . . . . 0.0 110.313 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.4 -22.79 65.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.752 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.68 -23.71 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -82.95 -31.78 27.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -68.82 -28.34 66.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.964 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.37 -35.07 18.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.192 0.451 . . . . 0.0 112.087 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -75.85 -18.87 59.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.458 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.79 -35.53 5.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 117.884 0.311 . . . . 0.0 110.868 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 17.3 p -70.1 -21.84 63.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.167 0.894 . . . . 0.0 110.643 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.38 -28.44 61.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 119.552 -0.261 . . . . 0.0 111.633 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.07 -12.6 35.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.278 0.49 . . . . 0.0 111.205 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.12 -9.9 51.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.523 0.329 . . . . 0.0 110.489 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.28 6.41 65.11 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.704 -0.498 . . . . 0.0 112.927 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.2 m -89.17 170.88 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.938 0.869 . . . . 0.0 111.161 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -71.11 146.77 49.01 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.356 0.663 . . . . 0.0 110.044 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -91.94 153.11 43.46 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.625 0.37 . . . . 0.0 110.256 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 155.55 69.34 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.555 2.17 . . . . 0.0 109.535 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 82.2 m -95.1 -19.12 20.38 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.955 0.502 . . . . 0.0 110.763 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.0 t -148.76 152.73 37.07 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.945 0.498 . . . . 0.0 109.762 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.9 t -140.62 140.9 33.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 123.097 0.559 . . . . 0.0 110.084 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.25 126.35 12.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.48 152.36 37.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.829 0.452 . . . . 0.0 110.971 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -144.23 160.82 40.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.984 0.914 . . . . 0.0 109.438 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.231 0.097 0 C-N-CA 122.827 0.451 . . . . 0.0 110.293 -178.286 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 71.1 m -138.22 157.96 45.25 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.987 0.515 . . . . 0.0 110.734 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 156.01 40.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.525 0.73 . . . . 0.0 111.192 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.5 m -147.72 166.53 27.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.887 1.275 . . . . 0.0 108.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.62 -176.75 47.48 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.2 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.2 mp -111.57 154.93 24.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.282 1.033 . . . . 0.0 110.132 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.3 mt -138.35 134.38 34.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.72 117.99 22.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.482 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.9 p90 -165.71 153.63 10.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 168.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -146.81 115.11 6.65 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.9 t -159.52 153.04 22.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 168.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -69.79 -48.38 59.4 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 118.637 0.653 . . . . 0.0 110.722 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 44.7 m -82.71 -22.96 34.29 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -89.28 -33.17 17.05 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.711 0.687 . . . . 0.0 111.481 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -72.13 -33.92 68.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.798 0.726 . . . . 0.0 110.477 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.52 -35.68 58.16 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.034 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.99 -40.37 53.87 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.102 -0.374 . . . . 0.0 110.604 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 98.6 m -65.95 -49.23 68.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.159 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 556' ' ' LEU . 2.0 pp -70.15 -22.4 62.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.109 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -64.72 -31.39 80.74 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.427 -0.652 . . . . 0.0 111.83 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -116.36 -6.86 11.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.912 0.856 . . . . 0.0 113.103 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.5 tp -95.93 -13.47 23.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.66 0.664 . . . . 0.0 111.664 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -81.16 151.44 28.23 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.695 -0.628 . . . . 0.0 110.199 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 31.4 m80 51.18 22.97 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 151.23 29.81 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -102.13 136.33 42.15 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.381 1.472 . . . . 0.0 110.683 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . 0.466 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 6.2 ttt -64.17 173.24 2.03 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.15 0.58 . . . . 0.0 111.612 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -75.4 14.78 0.54 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.932 . . . . 0.0 112.564 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -66.11 149.93 97.26 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 118.03 0.377 . . . . 0.0 110.137 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.87 -46.92 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.895 2.397 . . . . 0.0 113.898 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -121.08 13.3 11.26 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 63.34 52.8 44.05 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.312 -0.716 . . . . 0.0 112.594 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.62 -9.42 19.9 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.539 2.826 . . . . 0.0 111.44 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -148.42 151.41 36.5 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.671 0.788 . . . . 0.0 109.676 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.26 151.1 37.98 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.563 2.842 . . . . 0.0 110.821 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . 0.466 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 91.0 t80 -143.03 -6.45 0.84 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.758 0.423 . . . . 0.0 111.902 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 75.2 p -66.48 132.02 47.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.891 -0.506 . . . . 0.0 110.233 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 575' ' ' LEU . 1.6 pp -125.03 144.55 50.34 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.595 0.758 . . . . 0.0 110.791 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -77.28 144.38 38.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.76 144.97 50.4 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 2.8 p -163.92 172.09 14.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.703 0.401 . . . . 0.0 110.331 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -82.82 148.91 27.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.734 0.414 . . . . 0.0 111.207 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.7 t -135.6 137.71 42.21 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 122.575 0.35 . . . . 0.0 110.971 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 16.5 p -82.45 102.13 11.12 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.18 161.57 34.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.353 0.661 . . . . 0.0 111.59 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.77 -3.31 7.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.402 0.681 . . . . 0.0 110.294 173.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -157.68 165.91 34.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.754 1.222 . . . . 0.0 109.777 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.12 76.68 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.247 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.888 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.878 0.37 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -140.36 6.1 2.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.199 0.6 . . . . 0.0 110.917 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.6 m -152.91 157.01 33.21 Favored Pre-proline 0 N--CA 1.456 -0.157 0 C-N-CA 123.711 0.805 . . . . 0.0 110.207 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.69 2.51 8.48 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.614 3.543 . . . . 0.0 112.938 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.0 p -126.17 148.33 30.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 118.736 0.698 . . . . 0.0 111.478 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.38 167.3 23.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.222 0.609 . . . . 0.0 110.094 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . 0.405 ' CE ' ' SD ' ' A' ' 412' ' ' MET . 77.1 mtp -132.96 152.0 51.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.539 0.335 . . . . 0.0 110.571 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.6 149.45 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.761 0.425 . . . . 0.0 110.693 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -141.21 166.38 24.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.407 0.683 . . . . 0.0 110.1 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.13 -0.11 84.5 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.847 -0.418 . . . . 0.0 112.67 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.758 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.24 -179.65 4.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.503 0.651 . . . . 0.0 110.687 176.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -139.62 134.62 32.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -69.82 -11.73 61.08 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.5 p -93.44 -9.92 36.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -132.56 -8.87 3.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.268 0.486 . . . . 0.0 111.654 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.7 tpt -147.73 104.84 3.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.317 0.647 . . . . 0.0 109.497 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.435 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 23.4 p30 -141.97 -173.59 3.85 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.878 0.871 . . . . 0.0 109.669 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 64.4 m -55.33 -28.83 56.33 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.96 -27.69 21.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.215 0.461 . . . . 0.0 110.994 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . 0.435 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 2.2 mmp_? -78.11 -33.44 50.58 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 122.123 -0.361 . . . . 0.0 110.038 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.89 -31.31 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -64.82 -35.24 80.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -72.1 -31.04 65.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.43 -0.319 . . . . 0.0 111.398 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.77 -26.61 5.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.151 0.432 . . . . 0.0 111.875 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.52 -10.07 20.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 p -65.68 -37.8 87.51 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.041 0.837 . . . . 0.0 111.565 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.81 14.43 1.75 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.322 0.51 . . . . 0.0 112.156 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -121.46 -1.91 9.55 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.604 0.762 . . . . 0.0 109.93 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 140.45 167.08 10.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -74.83 146.54 41.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.156 -0.614 . . . . 0.0 111.167 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.29 154.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.498 0.719 . . . . 0.0 109.095 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -104.2 -60.1 1.63 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.62 0.368 . . . . 0.0 110.013 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -165.42 163.66 19.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.434 0.694 . . . . 0.0 110.703 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.488 HG22 HG23 ' A' ' 421' ' ' VAL . 92.0 t -136.28 146.83 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.215 1.006 . . . . 0.0 109.344 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -148.45 144.18 27.24 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 172.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -86.53 155.67 20.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.405 ' SD ' ' CE ' ' A' ' 382' ' ' MET . 26.0 ptt? -136.02 141.43 44.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -167.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt 60.22 34.04 21.01 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.849 1.26 . . . . 0.0 112.339 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.8 m 52.97 16.29 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -94.21 142.53 25.03 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 118.405 0.548 . . . . 0.0 110.461 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.48 -3.81 13.65 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.555 2.837 . . . . 0.0 110.357 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -115.49 19.69 14.33 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.234 0.921 . . . . 0.0 112.795 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -145.68 131.85 19.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.204 1.002 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.86 168.3 27.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -145.54 150.19 35.98 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.35 0.66 . . . . 0.0 110.028 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . 0.488 HG23 HG22 ' A' ' 409' ' ' VAL . 3.4 p -144.42 151.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.951 0.5 . . . . 0.0 111.076 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -126.56 146.86 49.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.04 0.936 . . . . 0.0 109.615 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 91.1 mmm -112.28 163.28 14.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.601 0.76 . . . . 0.0 110.482 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.7 -15.36 61.69 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -155.1 156.96 36.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.86 0.464 . . . . 0.0 109.886 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.01 -17.59 75.7 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.166 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -29.81 66.54 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.882 1.341 . . . . 0.0 110.13 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.09 61.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.507 0.194 . . . . 0.0 110.536 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.2 t -78.99 -38.07 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.91 -25.88 68.35 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.771 0.26 . . . . 0.0 110.667 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -82.81 -35.04 26.77 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.156 0.582 . . . . 0.0 110.563 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -74.96 -29.63 60.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.873 -0.517 . . . . 0.0 110.009 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 14.7 mm -77.83 -30.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.854 1.262 . . . . 0.0 111.701 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.9 m -106.5 -14.75 14.98 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -134.17 -9.54 2.61 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.72 -16.52 11.24 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.763 0.711 . . . . 0.0 109.633 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -54.02 142.09 26.12 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.27 1.028 . . . . 0.0 111.832 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.81 1.51 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.564 1.946 . . . . 0.0 115.927 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -88.03 142.55 27.69 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.794 1.634 . . . . 0.0 108.532 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.1 OUTLIER -130.81 163.87 26.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.512 1.125 . . . . 0.0 109.384 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 63.64 22.95 13.35 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.154 1.382 . . . . 0.0 114.589 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.15 15.91 61.77 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 169.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -83.2 150.99 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.987 1.393 . . . . 0.0 110.961 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.08 138.7 38.07 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -98.07 122.01 40.68 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -140.72 116.92 10.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.37 140.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 118.774 0.715 . . . . 0.0 110.691 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.8 m -148.71 159.41 44.15 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.166 0.986 . . . . 0.0 109.841 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.23 156.13 3.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.3 t -130.22 161.36 31.34 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.862 0.465 . . . . 0.0 110.418 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.56 10.94 27.03 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.501 0.72 . . . . 0.0 112.519 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -67.66 147.51 98.65 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 118.105 0.411 . . . . 0.0 109.95 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.39 -36.0 80.51 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.802 2.335 . . . . 0.0 112.348 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.95 176.04 7.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.559 0.744 . . . . 0.0 109.92 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 136.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -84.85 149.8 54.43 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.337 0.255 . . . . 0.0 110.614 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.39 167.23 25.85 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.721 2.948 . . . . 0.0 111.223 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 167.59 179.35 40.3 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -77.12 154.53 33.16 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.701 0.4 . . . . 0.0 109.937 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 83.1 p -134.08 159.37 41.02 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.962 0.505 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -155.26 164.3 38.98 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 109.805 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.62 136.73 19.0 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 79.3 mt -86.25 169.61 12.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.974 0.91 . . . . 0.0 109.672 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.22 -20.16 65.65 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.85 4.07 42.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.665 0.386 . . . . 0.0 111.522 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.97 -6.38 79.22 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.376 0.512 . . . . 0.0 112.647 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 52.9 m -83.77 155.39 23.05 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 117.838 0.819 . . . . 0.0 109.942 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.3 153.29 24.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 99.4 p -72.6 -10.34 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 111.664 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -137.0 139.59 41.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.226 1.011 . . . . 0.0 109.477 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -155.16 157.32 37.23 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.18 0.192 . . . . 0.0 110.928 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.71 150.45 51.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.231 1.012 . . . . 0.0 109.937 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -142.45 14.33 1.99 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 CA--C 1.527 0.063 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.226 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 111.31 0.115 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -147.96 150.63 36.17 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.236 0.614 . . . . 0.0 109.391 -174.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.21 147.73 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 112.691 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 62.9 m -124.18 24.0 8.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.269 0.628 . . . . 0.0 112.092 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.6 3.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.377 1.071 . . . . 0.0 113.461 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.4 152.04 21.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.439 HD22 ' CH2' ' A' ' 546' ' ' TRP . 4.7 mp -132.69 164.18 27.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.291 0.637 . . . . 0.0 109.669 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.92 149.33 36.68 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.001 0.429 . . . . 0.0 111.957 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -114.74 145.56 41.94 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.759 1.223 . . . . 0.0 109.599 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.77 165.41 30.62 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.374 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 58.02 23.78 10.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.403 1.081 . . . . 0.0 113.422 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -81.74 157.89 68.84 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.86 156.35 28.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -80.38 -1.17 40.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -103.53 5.26 36.64 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.662 0.385 . . . . 0.0 111.983 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -89.79 152.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.061 0.391 . . . . 0.0 111.672 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 68.5 p -144.86 175.62 10.07 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.181 0.992 . . . . 0.0 109.654 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.78 -26.25 68.62 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.439 -0.163 . . . . 0.0 111.149 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.58 -26.22 60.72 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.439 -0.163 . . . . 0.0 110.574 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -79.64 -31.67 41.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.59 -26.52 62.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.22 -0.3 . . . . 0.0 110.486 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -80.03 -39.36 30.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.933 0.333 . . . . 0.0 111.558 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.11 -17.1 53.49 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.24 0.473 . . . . 0.0 112.275 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.21 -36.53 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 82.2 m -67.95 -22.15 65.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.676 -0.64 . . . . 0.0 110.573 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.44 -30.5 63.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 119.658 -0.21 . . . . 0.0 111.565 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.12 -11.73 37.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.108 0.413 . . . . 0.0 111.527 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.32 -7.15 48.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.657 0.383 . . . . 0.0 110.411 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.9 11.33 78.39 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.855 -0.414 . . . . 0.0 112.665 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.6 m -95.58 170.83 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 117.817 0.809 . . . . 0.0 111.61 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -74.14 147.91 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.477 0.711 . . . . 0.0 110.236 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -97.07 146.17 30.85 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.21 148.97 92.61 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.01 2.473 . . . . 0.0 110.375 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 84.7 m -82.11 -25.01 34.83 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.467 0.307 . . . . 0.0 110.841 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 51.1 m -143.4 151.63 40.61 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.936 0.494 . . . . 0.0 109.848 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.59 141.82 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 122.952 0.501 . . . . 0.0 110.328 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.7 120.18 7.42 Favored 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.09 147.53 30.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 C-N-CA 123.353 0.661 . . . . 0.0 109.557 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -148.65 130.05 14.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.513 0.196 . . . . 0.0 111.317 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 CA--C 1.533 0.324 0 C-N-CA 123.005 0.522 . . . . 0.0 110.983 176.501 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 85.4 p -145.4 173.22 12.18 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.386 1.475 . . . . 0.0 109.119 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -124.3 148.38 47.47 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 122.631 0.372 . . . . 0.0 111.65 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.4 m -145.16 158.53 43.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.268 1.027 . . . . 0.0 109.12 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 179.45 178.48 48.39 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.943 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.497 ' C ' HD22 ' A' ' 544' ' ' LEU . 8.6 mp -116.9 144.64 44.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 109.82 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.497 HD22 ' C ' ' A' ' 543' ' ' LEU . 3.2 mm? -128.93 142.04 51.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.87 113.2 15.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.439 ' CH2' HD22 ' A' ' 500' ' ' LEU . 4.2 p90 -165.93 149.13 7.57 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -155.35 126.34 7.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 43.6 t -159.53 161.32 35.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 169.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.56 -51.21 45.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.881 0.764 . . . . 0.0 110.448 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 72.5 p -89.28 -27.24 20.69 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 25.0 m-20 -82.42 -27.57 31.9 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.987 0.812 . . . . 0.0 110.802 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -85.58 -31.99 22.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.432 0.56 . . . . 0.0 110.576 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 41.6 tp -73.92 -30.09 62.38 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.228 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.52 -42.7 58.44 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.6 m -68.24 -39.16 82.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.71 -42.21 82.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.96 -19.49 77.09 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.145 -0.808 . . . . 0.0 113.582 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -113.86 -16.95 12.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.685 1.242 . . . . 0.0 112.903 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.67 -21.79 22.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.061 0.846 . . . . 0.0 111.801 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -74.21 147.83 42.15 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.573 0.624 . . . . 0.0 109.721 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.8 t60 53.81 29.01 9.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.92 0.888 . . . . 0.0 113.259 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.98 151.39 24.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -117.51 136.42 53.25 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.873 1.269 . . . . 0.0 110.427 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . 0.411 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 4.8 ttt -64.18 169.47 4.48 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.767 0.827 . . . . 0.0 111.464 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -79.39 22.99 0.41 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 112.831 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 36.5 p30 -64.65 147.52 97.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 122.109 -0.369 . . . . 0.0 110.331 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.72 -32.31 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.419 2.746 . . . . 0.0 113.872 -169.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -121.04 2.02 10.41 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.46 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.53 37.92 95.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.072 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 92.6 Cg_endo -71.37 -9.05 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.97 2.446 . . . . 0.0 112.291 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -145.75 150.39 42.99 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.311 0.505 . . . . 0.0 110.765 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.77 156.21 39.57 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.059 3.173 . . . . 0.0 110.634 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . 0.411 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 70.4 t80 -140.86 -1.44 1.41 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 4.9 t -66.39 131.92 47.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.484 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.93 144.65 50.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.917 0.887 . . . . 0.0 109.086 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -89.7 134.75 34.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 153.19 39.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.944 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 32.1 p -163.36 176.76 9.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.861 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -72.19 143.19 48.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.8 t -135.64 146.27 47.68 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.363 0.665 . . . . 0.0 110.451 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 51.8 m -87.17 102.16 14.2 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.25 161.47 34.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.997 0.919 . . . . 0.0 110.053 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -93.92 -19.6 20.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -161.27 162.45 31.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.141 0.976 . . . . 0.0 109.441 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.17 76.48 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.637 -1.173 . . . . 0.0 110.253 -179.472 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 120.769 0.318 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.1 -2.95 53.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.7 m -152.06 153.86 31.81 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.158 0.583 . . . . 0.0 110.979 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.44 -5.03 10.16 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.507 3.471 . . . . 0.0 113.546 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.2 t -126.91 151.33 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 118.498 0.59 . . . . 0.0 111.176 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . 0.403 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.6 pp -138.12 164.46 29.08 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.71 0.804 . . . . 0.0 109.531 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.3 mtp -136.45 148.29 47.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.736 0.414 . . . . 0.0 110.11 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.56 149.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 122.85 0.46 . . . . 0.0 110.424 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -140.44 165.85 26.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.666 0.786 . . . . 0.0 109.286 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 81.9 -1.21 87.15 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.703 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.72 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.0 pt? -71.64 172.39 9.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.194 0.997 . . . . 0.0 110.048 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -130.42 127.25 38.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -68.11 -2.91 8.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 87.8 p -108.29 -2.84 18.9 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -130.13 -12.23 4.12 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.376 0.67 . . . . 0.0 111.055 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.07 125.95 10.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.372 0.669 . . . . 0.0 109.328 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -141.87 -172.16 3.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.0 -25.65 61.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.83 -25.78 24.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.879 -0.513 . . . . 0.0 111.799 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -91.97 -25.2 18.98 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 122.265 -0.272 . . . . 0.0 111.178 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.8 -27.26 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.55 -42.89 67.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.695 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -80.63 -8.64 59.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.564 0.62 . . . . 0.0 112.653 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.78 -24.35 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 118.214 0.461 . . . . 0.0 110.932 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -107.33 -13.72 15.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.4 t -69.56 -28.71 66.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.27 0.941 . . . . 0.0 111.562 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.76 14.2 1.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.734 -0.604 . . . . 0.0 112.209 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -119.59 -2.75 10.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.419 0.688 . . . . 0.0 110.22 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 143.07 165.84 10.85 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.17 152.67 44.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.212 -0.581 . . . . 0.0 110.957 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.07 146.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.82 -57.75 2.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.997 -0.439 . . . . 0.0 109.905 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -166.38 164.83 17.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.971 0.509 . . . . 0.0 110.687 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.89 149.73 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.483 0.713 . . . . 0.0 110.105 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -152.22 144.18 23.75 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -75.52 154.52 36.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.654 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 9.1 tmm? -129.33 141.16 51.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.285 0.564 . . . . 0.0 112.51 -168.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.51 33.75 19.6 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.69 1.596 . . . . 0.0 111.885 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.2 m 52.91 15.84 0.62 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.354 1.062 . . . . 0.0 113.59 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.74 145.63 75.04 Favored Pre-proline 0 C--N 1.339 0.122 0 CA-C-N 118.156 0.435 . . . . 0.0 110.086 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 4.03 6.97 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.83 3.02 . . . . 0.0 110.604 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -146.84 30.73 1.51 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.278 -0.735 . . . . 0.0 113.209 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.654 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -149.78 138.31 20.75 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.355 1.078 . . . . 0.0 110.537 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.89 19.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.034 0.445 . . . . 0.0 111.808 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 7.6 ptp -135.76 150.6 49.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.806 0.843 . . . . 0.0 110.394 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.47 149.47 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.286 0.634 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -130.71 133.44 46.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.531 0.732 . . . . 0.0 109.913 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.1 mmm -106.1 161.29 14.63 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.943 0.497 . . . . 0.0 110.981 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.79 -18.79 60.41 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.448 0.299 . . . . 0.0 111.762 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -154.28 155.86 35.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.679 0.392 . . . . 0.0 110.222 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.44 -15.95 75.39 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.429 -0.65 . . . . 0.0 113.078 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -26.45 59.62 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.057 1.428 . . . . 0.0 110.701 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.78 -27.23 60.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.72 -29.79 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.39 -40.54 73.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.187 -0.321 . . . . 0.0 110.626 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.45 -34.92 35.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.52 -29.96 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 121.964 -0.46 . . . . 0.0 111.404 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 17.7 m -95.26 -18.9 20.45 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -136.46 -10.78 1.89 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -108.03 -21.76 12.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.376 0.989 . . . . 0.0 108.802 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -51.87 143.46 13.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.218 1.007 . . . . 0.0 110.956 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 57.11 1.47 0.1 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.535 1.934 . . . . 0.0 115.733 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.88 142.43 27.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 120.757 1.617 . . . . 0.0 107.968 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.332 0.0 OUTLIER -130.88 163.88 26.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 175.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 20.5 ptm -125.37 143.34 51.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.651 1.18 . . . . 0.0 110.405 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.73 28.3 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.96 15.71 64.63 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.14 151.02 25.9 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.093 1.447 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -84.7 137.91 32.95 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -94.54 123.97 38.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -168.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -140.72 115.87 9.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 141.01 16.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.214 0.461 . . . . 0.0 110.178 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.41 163.34 37.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.663 0.785 . . . . 0.0 110.126 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.1 p -84.57 155.64 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.6 t -136.6 155.37 50.01 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.073 0.397 . . . . 0.0 111.22 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -93.17 7.04 45.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -66.54 140.02 96.33 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.94 -25.8 10.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.944 2.429 . . . . 0.0 111.319 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.1 171.28 15.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.487 0.715 . . . . 0.0 109.87 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 41.9 mm -68.68 136.91 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -91.73 153.85 43.85 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.32 164.4 8.85 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.847 3.031 . . . . 0.0 112.53 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 163.84 174.73 34.0 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.31 160.97 29.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.1 p -137.33 153.87 50.17 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.048 0.539 . . . . 0.0 110.512 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -144.59 165.09 29.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.249 0.62 . . . . 0.0 109.848 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.62 137.66 17.78 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.22 167.34 14.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 109.551 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.97 -20.0 65.01 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.056 -0.403 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.87 0.88 37.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.909 0.322 . . . . 0.0 111.235 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.7 -2.04 87.17 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.594 -0.559 . . . . 0.0 113.211 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.39 163.19 13.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.103 0.952 . . . . 0.0 110.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.3 m -84.54 153.36 23.31 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.811 0.444 . . . . 0.0 110.902 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.8 p -73.09 -10.33 59.67 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.025 0.53 . . . . 0.0 111.577 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -132.8 143.65 49.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.151 0.98 . . . . 0.0 109.747 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -156.1 159.24 38.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.578 0.351 . . . . 0.0 110.3 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.95 153.23 52.15 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.189 0.595 . . . . 0.0 110.851 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.63 15.49 2.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.034 0.534 . . . . 0.0 111.282 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.0 p . . . . . 0 CA--C 1.53 0.19 0 C-N-CA 123.361 0.664 . . . . 0.0 112.544 -175.426 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.97 119.75 44.28 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.564 1.075 . . . . 0.0 110.324 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.08 113.35 3.59 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.567 2.845 . . . . 0.0 110.804 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 52.4 m -123.96 13.42 9.13 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.388 0.675 . . . . 0.0 111.942 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 57.14 16.91 3.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.725 1.21 . . . . 0.0 113.722 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 74.1 t -134.51 141.44 43.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 118.419 0.554 . . . . 0.0 109.886 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.58 163.69 18.5 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 108.7 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.26 146.88 35.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.864 0.364 . . . . 0.0 111.729 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -112.71 150.01 32.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.572 1.149 . . . . 0.0 109.565 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -147.63 169.95 18.54 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 122.674 0.39 . . . . 0.0 111.175 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 29.0 m120 59.71 17.91 6.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.599 1.16 . . . . 0.0 113.747 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.69 156.09 73.08 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.85 154.79 36.07 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.921 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.5 pt? -72.69 -1.08 14.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.94 4.74 32.15 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.084 0.402 . . . . 0.0 111.723 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -81.64 148.69 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 O-C-N 122.062 -0.398 . . . . 0.0 110.6 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 72.4 p -144.14 174.01 11.25 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.849 0.86 . . . . 0.0 109.93 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.5 -24.59 67.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.796 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.97 -23.11 55.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.428 -0.17 . . . . 0.0 110.657 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -82.05 -28.88 32.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.85 -31.36 66.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -74.74 -38.7 62.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.753 0.252 . . . . 0.0 111.187 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.86 -14.4 59.26 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.09 0.405 . . . . 0.0 111.569 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.69 -38.51 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.617 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.5 m -67.06 -24.69 66.0 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.826 0.739 . . . . 0.0 110.537 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.16 -28.1 61.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.98 -17.5 26.22 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . 0.437 HD11 HG22 ' A' ' 523' ' ' VAL . 4.3 pp -102.58 5.24 39.16 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 79.45 35.25 29.87 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.867 1.107 . . . . 0.0 115.867 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.437 HG22 HD11 ' A' ' 521' ' ' LEU . 11.1 m -130.47 168.3 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.2 1.5 . . . . 0.0 111.833 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.29 150.64 31.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.973 0.909 . . . . 0.0 110.855 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -87.58 152.89 52.58 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.364 0.666 . . . . 0.0 110.186 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.61 153.4 75.29 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.516 2.811 . . . . 0.0 111.105 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.427 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 86.4 m -82.34 -25.03 34.24 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.679 0.392 . . . . 0.0 110.707 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 13.6 t -142.83 156.48 44.96 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.562 0.345 . . . . 0.0 110.115 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.9 p -149.51 141.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.094 0.558 . . . . 0.0 110.758 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 121.59 8.85 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.16 144.63 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 122.848 0.459 . . . . 0.0 110.997 -173.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -149.89 159.22 44.55 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.271 1.028 . . . . 0.0 109.547 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--O 1.232 0.171 0 C-N-CA 122.979 0.511 . . . . 0.0 110.942 -178.978 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.5 m -137.75 161.15 37.31 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.532 0.333 . . . . 0.0 111.349 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.9 t -132.07 155.0 48.86 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.179 0.991 . . . . 0.0 111.071 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 80.3 p -152.95 166.69 31.6 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.231 1.012 . . . . 0.0 110.37 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.01 177.89 44.45 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.873 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.43 ' C ' HD22 ' A' ' 544' ' ' LEU . 11.2 mp -112.79 144.28 42.6 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.84 0.856 . . . . 0.0 110.196 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.43 HD22 ' C ' ' A' ' 543' ' ' LEU . 3.2 mm? -127.06 139.86 52.7 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.78 108.35 10.66 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.427 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.9 OUTLIER -166.1 155.72 11.95 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.548 1.539 . . . . 0.0 107.347 168.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -153.87 126.01 7.89 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.9 t -159.63 153.05 22.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.603 1.561 . . . . 0.0 107.013 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.46 -52.24 64.3 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.096 0.407 . . . . 0.0 111.728 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 38.8 m -85.4 -21.9 28.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -78.95 -35.43 43.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.175 -0.328 . . . . 0.0 110.795 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.96 39.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.28 -0.391 . . . . 0.0 111.166 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 47.1 tp -76.22 -29.7 57.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.776 0.716 . . . . 0.0 111.48 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.81 -40.1 55.61 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.826 -0.546 . . . . 0.0 110.221 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 49.0 m -68.73 -36.8 78.87 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.1 -41.74 99.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.61 -23.02 78.56 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.784 -172.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.14 -20.37 7.42 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.095 1.447 . . . . 0.0 113.883 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 37.3 tp -93.73 -23.16 18.31 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.635 1.107 . . . . 0.0 112.022 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -75.18 136.42 41.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 53.15 27.14 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.845 0.858 . . . . 0.0 113.093 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -78.19 151.38 33.22 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.185 0.594 . . . . 0.0 112.169 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -101.58 136.41 41.46 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.838 1.255 . . . . 0.0 110.03 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.4 ttt -64.17 169.56 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.645 0.378 . . . . 0.0 111.032 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -75.61 17.49 0.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -69.0 145.64 96.76 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.872 -0.518 . . . . 0.0 109.764 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.97 -30.56 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.487 2.791 . . . . 0.0 113.924 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -120.89 0.57 10.31 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.157 0.435 . . . . 0.0 112.114 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 39.81 97.76 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.77 -1.017 . . . . 0.0 112.75 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 74.9 Cg_endo -69.56 -10.11 27.88 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 112.016 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -142.67 148.35 46.1 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.28 154.41 36.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.921 3.081 . . . . 0.0 111.333 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -148.34 -0.7 0.56 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.904 0.482 . . . . 0.0 111.534 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 48.1 p -66.38 129.28 39.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.11 144.56 50.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.647 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -96.09 139.81 31.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.516 0.726 . . . . 0.0 109.09 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.66 151.94 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.578 0.228 . . . . 0.0 111.007 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.2 p -161.7 178.96 8.52 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.974 0.509 . . . . 0.0 110.082 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -71.64 144.27 49.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.442 0.297 . . . . 0.0 110.48 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 30.9 t -135.55 145.04 46.59 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 122.888 0.475 . . . . 0.0 110.782 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 88.5 m -93.88 102.22 14.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.3 161.53 34.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.904 0.882 . . . . 0.0 110.258 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.44 -14.47 17.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -161.36 166.85 26.81 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.586 1.154 . . . . 0.0 108.655 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -79.24 76.39 5.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.447 -1.263 . . . . 0.0 110.031 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -142.87 12.53 1.86 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.095 0.558 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 39.8 t -155.98 147.41 16.84 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 123.462 0.705 . . . . 0.0 110.044 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 4.86 5.22 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.635 2.89 . . . . 0.0 111.454 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.54 151.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.694 0.798 . . . . 0.0 110.382 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.5 pp -142.7 167.95 20.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.728 0.811 . . . . 0.0 109.771 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 71.6 mtp -135.57 152.8 51.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.637 0.256 . . . . 0.0 111.052 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.06 149.02 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 122.901 0.48 . . . . 0.0 110.413 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -141.41 168.75 19.02 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.477 0.711 . . . . 0.0 109.5 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.87 -2.0 87.34 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.874 -0.403 . . . . 0.0 112.616 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.775 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -74.44 171.97 12.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.48 0.64 . . . . 0.0 110.649 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -132.57 132.26 42.37 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -68.58 -4.51 15.59 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.5 t -102.11 -12.2 18.26 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.616 0.366 . . . . 0.0 111.9 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -131.98 -13.9 3.14 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.139 0.427 . . . . 0.0 111.876 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.0 tpt -148.59 106.01 3.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.758 0.823 . . . . 0.0 109.242 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -141.81 -166.78 2.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.766 0.426 . . . . 0.0 110.397 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 73.2 m -53.93 -27.74 32.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.118 0.567 . . . . 0.0 112.509 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.43 -34.12 28.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.922 -0.486 . . . . 0.0 111.007 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -83.51 -28.4 28.69 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.266 -0.271 . . . . 0.0 110.322 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.08 -30.29 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -68.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -70.51 -27.9 64.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.297 -0.382 . . . . 0.0 111.901 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 75.1 t -95.11 -21.55 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -109.51 -12.05 14.74 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.94 -27.34 65.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.143 0.883 . . . . 0.0 111.418 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.46 14.57 1.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.46 2.87 10.24 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.8 0.84 . . . . 0.0 109.982 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 130.6 158.32 9.26 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -172.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -68.96 153.57 43.56 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.056 0.928 . . . . 0.0 111.228 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.72 154.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -97.84 -60.75 1.5 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -164.18 163.42 22.93 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.466 0.706 . . . . 0.0 110.854 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.36 150.74 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -152.13 145.35 24.66 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.509 0.324 . . . . 0.0 110.181 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -79.34 158.91 27.36 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -136.66 141.4 43.17 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -168.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 59.79 33.95 21.81 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 125.136 1.374 . . . . 0.0 112.505 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 23.2 m 53.01 15.39 0.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -81.87 132.56 53.91 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 118.691 0.678 . . . . 0.0 110.043 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.61 -3.68 8.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.543 2.828 . . . . 0.0 112.351 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.19 33.35 2.25 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.478 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.77 133.7 19.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.125 0.962 . . . . 0.0 110.357 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.38 169.17 24.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.198 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.2 ptm -143.49 146.56 33.49 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.278 0.631 . . . . 0.0 109.658 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.31 147.79 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.12 0.568 . . . . 0.0 110.586 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -122.18 135.96 54.84 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.5 mmm -105.25 164.25 11.98 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.485 0.314 . . . . 0.0 110.878 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.99 66.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.99 159.2 36.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.35 0.66 . . . . 0.0 109.333 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.33 -17.0 69.9 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.068 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -68.37 -29.92 68.74 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.004 1.402 . . . . 0.0 110.178 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -73.51 -21.82 60.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.197 -0.314 . . . . 0.0 110.707 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.71 -35.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.88 -36.5 78.14 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.666 0.212 . . . . 0.0 110.677 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.08 -35.01 78.88 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.05 56.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.099 -0.376 . . . . 0.0 110.621 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -29.12 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.184 0.516 . . . . 0.0 111.855 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.8 p -91.17 -13.22 33.32 Favored 'General case' 0 C--N 1.342 0.277 0 O-C-N 121.067 -1.021 . . . . 0.0 113.592 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -138.44 -10.62 1.42 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.3 -14.52 13.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.226 0.921 . . . . 0.0 110.456 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -56.1 142.38 36.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 56.96 1.42 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.72 1.608 . . . . 0.0 114.991 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -87.77 142.6 27.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 120.058 1.299 . . . . 0.0 109.164 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.263 0.1 OUTLIER -130.91 164.0 26.23 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.4 ptm -125.18 143.42 50.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.86 1.264 . . . . 0.0 108.44 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 68.76 21.87 7.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.359 1.463 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.94 15.8 78.35 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -83.07 162.14 21.45 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.815 1.308 . . . . 0.0 110.68 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.46 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -79.71 132.34 36.17 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.292 0.237 . . . . 0.0 110.493 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.58 135.69 39.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -170.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -140.72 120.19 13.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.36 145.27 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 118.316 0.507 . . . . 0.0 110.378 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -157.68 161.25 38.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.754 0.422 . . . . 0.0 110.408 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.6 p -83.15 151.44 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 21.1 t -100.58 -169.03 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.639 0.375 . . . . 0.0 110.018 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -136.83 0.21 2.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.826 0.45 . . . . 0.0 110.691 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -74.27 148.94 86.62 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.29 -24.77 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.868 2.378 . . . . 0.0 111.794 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.09 170.11 15.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.319 0.647 . . . . 0.0 110.352 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.3 mm -67.14 143.92 15.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.1 mtt -107.77 156.89 37.26 Favored Pre-proline 0 C--O 1.232 0.15 0 C-N-CA 122.338 0.255 . . . . 0.0 111.109 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.68 157.88 21.98 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.928 3.085 . . . . 0.0 112.604 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.3 -179.13 42.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -74.02 150.13 40.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.615 -0.344 . . . . 0.0 110.481 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.9 m -143.69 147.66 34.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -145.97 167.88 22.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.861 0.464 . . . . 0.0 110.477 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.98 137.47 20.0 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.3 167.44 14.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.287 0.635 . . . . 0.0 110.007 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.72 -20.19 65.23 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.368 0.267 . . . . 0.0 111.379 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.1 -1.22 31.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.997 0.519 . . . . 0.0 110.954 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.2 -5.2 73.19 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.89 -0.506 . . . . 0.0 112.237 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 63.9 m -87.2 161.2 18.17 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.799 0.8 . . . . 0.0 110.072 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 80.3 m -85.22 153.35 22.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.48 0.181 . . . . 0.0 110.582 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.5 p -73.01 -10.48 59.85 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.466 0.306 . . . . 0.0 111.416 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.25 141.64 51.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.127 0.971 . . . . 0.0 109.487 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -155.25 156.84 36.31 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.548 0.339 . . . . 0.0 110.191 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.89 154.65 50.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.462 0.705 . . . . 0.0 110.547 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.12 15.85 2.08 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 122.723 0.409 . . . . 0.0 111.514 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.771 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -103.4 120.97 50.18 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.92 131.55 15.81 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.015 2.477 . . . . 0.0 110.557 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 87.8 p -124.16 -1.3 8.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.544 0.738 . . . . 0.0 112.119 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.53 16.21 5.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.069 0.948 . . . . 0.0 112.167 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.2 t -135.97 138.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.418 HD12 ' CH2' ' A' ' 546' ' ' TRP . 46.9 mt -120.26 152.69 37.41 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.08 145.8 49.02 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -131.93 151.71 51.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.613 0.244 . . . . 0.0 110.576 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -147.36 171.08 16.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 111.094 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.46 25.95 14.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.512 1.125 . . . . 0.0 113.236 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.74 63.93 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.88 159.7 52.36 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.206 1.938 . . . . 0.0 110.194 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.2 pt? -73.95 -1.07 18.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.87 4.51 42.81 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -86.41 150.22 3.93 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 CA-C-N 118.251 0.478 . . . . 0.0 111.347 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -147.2 174.34 11.7 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.939 0.896 . . . . 0.0 109.522 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.23 -24.67 67.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.499 -0.126 . . . . 0.0 110.925 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.1 -24.95 51.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.179 -0.325 . . . . 0.0 110.718 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.3 -28.35 38.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -73.71 -30.79 63.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.203 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -75.25 -36.32 61.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.287 -0.258 . . . . 0.0 111.544 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.46 -21.24 42.24 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.266 0.485 . . . . 0.0 111.55 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.91 -37.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 86.8 m -67.38 -26.48 66.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.091 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.42 -29.12 62.37 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -91.06 -11.84 37.49 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.526 0.603 . . . . 0.0 111.895 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 86.3 mt -100.7 -5.44 26.5 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.644 0.377 . . . . 0.0 111.277 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.24 5.62 72.27 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.866 -0.408 . . . . 0.0 112.907 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.4 m -91.43 167.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 117.65 0.725 . . . . 0.0 110.953 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -76.63 151.84 36.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.384 0.674 . . . . 0.0 110.173 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 526' ' ' PRO . 4.7 ptp180 -102.16 150.9 37.91 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 525' ' ' ARG . 32.1 Cg_exo -60.15 158.98 27.89 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.404 2.736 . . . . 0.0 112.64 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.501 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 91.4 m -86.36 -25.07 25.55 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.072 0.549 . . . . 0.0 110.499 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.1 t -145.23 152.25 39.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.1 t -141.37 140.93 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.348 0.659 . . . . 0.0 109.775 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.97 126.51 15.94 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.8 t -132.05 149.43 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.032 0 C-N-CA 122.667 0.387 . . . . 0.0 110.673 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -152.3 153.75 34.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.272 0.629 . . . . 0.0 110.17 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 62.5 p . . . . . 0 N--CA 1.457 -0.117 0 C-N-CA 123.106 0.563 . . . . 0.0 109.907 178.288 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 36.2 m -139.61 164.45 29.89 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.396 0.678 . . . . 0.0 110.351 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 34.3 t -132.91 153.7 51.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 111.089 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 67.6 m -146.65 164.61 32.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.059 1.343 . . . . 0.0 108.854 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -179.26 -175.07 45.91 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.01 -1.091 . . . . 0.0 113.857 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.11 153.49 42.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.188 0.995 . . . . 0.0 109.763 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 72.8 mt -136.52 136.9 39.76 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.043 0.937 . . . . 0.0 108.903 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -127.86 109.2 11.38 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.501 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.8 OUTLIER -166.12 155.01 11.28 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.826 1.25 . . . . 0.0 108.579 168.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -149.78 121.02 7.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 37.8 t -159.55 153.22 22.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -66.47 -46.92 74.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.767 0.712 . . . . 0.0 111.211 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 67.7 p -85.89 -27.84 24.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 48.6 m-20 -84.05 -30.01 26.41 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.578 0.626 . . . . 0.0 111.078 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.04 27.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.339 0.518 . . . . 0.0 111.236 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.74 -30.6 28.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.853 0.751 . . . . 0.0 112.024 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.82 -42.58 49.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.475 0.58 . . . . 0.0 110.482 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 43.3 m -68.88 -36.38 78.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.68 -41.48 83.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.7 -17.3 76.53 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.957 -0.913 . . . . 0.0 113.544 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.92 -19.22 7.33 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.757 1.279 . . . . 0.0 114.29 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -90.82 -31.25 16.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.056 0.844 . . . . 0.0 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -62.29 139.58 58.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 51.39 23.23 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.366 1.066 . . . . 0.0 113.604 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -74.4 151.33 39.69 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -99.87 136.25 40.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.482 1.113 . . . . 0.0 109.733 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . 0.421 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.3 ttt -64.34 172.42 2.55 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.311 0.577 . . . . 0.0 112.208 -172.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.3 ptmt -66.94 3.43 1.09 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.699 1.2 . . . . 0.0 113.712 -176.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -67.86 144.74 97.53 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 118.634 0.652 . . . . 0.0 110.727 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.98 -27.32 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.542 2.828 . . . . 0.0 113.784 -171.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -121.08 -3.06 9.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.205 0.457 . . . . 0.0 112.026 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.06 40.52 98.24 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.69 -1.061 . . . . 0.0 112.806 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 83.5 Cg_endo -69.69 -9.64 26.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.103 2.535 . . . . 0.0 111.823 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -142.19 147.74 45.18 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.023 0.529 . . . . 0.0 109.648 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.48 152.85 34.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.805 3.004 . . . . 0.0 111.565 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -148.83 -3.21 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.133 0.573 . . . . 0.0 111.493 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.44 120.94 14.22 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.701 -0.624 . . . . 0.0 110.044 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.96 144.63 50.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.093 0.957 . . . . 0.0 109.934 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -86.3 154.55 21.16 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 55.0 tp -144.12 144.84 31.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.96 168.38 19.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -77.07 130.86 37.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.9 t -135.57 138.2 42.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 32.9 p -79.7 102.25 8.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.336 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 159.92 39.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 109.144 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -81.85 -32.47 31.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.189 -0.319 . . . . 0.0 110.228 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -153.66 165.81 34.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.944 0.898 . . . . 0.0 109.571 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.43 76.32 7.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.354 -179.473 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.89 0.376 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.43 -0.58 57.35 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.336 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 43.0 t -160.27 146.56 11.81 Favored Pre-proline 0 N--CA 1.456 -0.164 0 C-N-CA 123.197 0.599 . . . . 0.0 110.355 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.14 4.34 6.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.118 3.212 . . . . 0.0 112.091 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.05 151.79 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 123.364 0.666 . . . . 0.0 110.699 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 381' ' ' LEU . 4.5 pp -141.58 167.07 23.03 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.807 0.843 . . . . 0.0 109.627 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 70.0 mtp -134.19 151.08 51.15 Favored 'General case' 0 N--CA 1.458 -0.042 0 C-N-CA 122.459 0.304 . . . . 0.0 111.084 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.9 148.15 19.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.834 0.454 . . . . 0.0 110.427 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -140.11 168.06 20.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.488 0.715 . . . . 0.0 109.369 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.45 -6.44 80.04 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.354 -0.692 . . . . 0.0 113.05 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.71 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -68.98 177.67 2.54 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.998 0.899 . . . . 0.0 110.387 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -142.78 136.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -73.63 -7.14 50.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 96.0 p -93.2 -12.03 31.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.605 0.639 . . . . 0.0 112.592 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.47 5.89 0.94 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.5 ttt -141.26 129.14 21.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.94 177.81 7.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.755 0.422 . . . . 0.0 110.213 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.57 -28.06 63.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.56 0.344 . . . . 0.0 111.203 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.66 -23.08 29.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.052 -0.405 . . . . 0.0 111.376 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -83.85 -34.5 24.62 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.1 -27.48 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.5 -33.84 73.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.018 -0.427 . . . . 0.0 110.183 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -67.88 -29.54 68.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.853 -0.529 . . . . 0.0 111.086 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 80.3 t -90.36 -29.64 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -101.72 -8.68 21.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 53.0 t -71.55 -38.34 71.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.872 0.76 . . . . 0.0 111.333 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.66 12.92 1.45 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.731 -0.606 . . . . 0.0 112.407 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.21 0.75 11.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.278 0.631 . . . . 0.0 111.152 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.16 170.05 14.52 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -70.26 136.42 49.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.351 -0.5 . . . . 0.0 110.759 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 4.5 m -95.1 164.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.773 1.229 . . . . 0.0 110.321 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -125.8 -65.54 0.99 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.325 0.25 . . . . 0.0 110.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -163.37 165.54 23.9 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.067 0.547 . . . . 0.0 111.194 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.63 151.63 14.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.674 0.79 . . . . 0.0 110.363 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.05 147.64 26.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -78.17 158.98 28.85 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.23 141.46 42.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.05 33.9 21.33 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.845 1.258 . . . . 0.0 112.402 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.4 m 53.06 16.06 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 114.129 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -80.61 144.73 57.12 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 118.449 0.568 . . . . 0.0 109.599 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.18 1.83 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.843 3.029 . . . . 0.0 110.831 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -143.27 33.41 1.81 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.164 -173.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.03 19.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.933 0.867 . . . . 0.0 110.133 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.28 170.6 21.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.073 0.464 . . . . 0.0 110.808 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 17.7 ptm -145.05 146.53 31.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.983 0.513 . . . . 0.0 109.672 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.25 147.75 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.026 0 C-N-CA 123.322 0.649 . . . . 0.0 110.742 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -124.58 142.42 51.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.535 0.734 . . . . 0.0 109.773 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.0 mmm -115.63 164.21 14.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 109.797 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.85 64.18 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.392 -0.192 . . . . 0.0 111.251 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.86 160.13 33.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.12 -14.51 63.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.377 -0.679 . . . . 0.0 113.097 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -64.38 -31.19 72.29 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.398 1.599 . . . . 0.0 110.233 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.67 -23.78 45.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.52 -0.113 . . . . 0.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.03 -31.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.04 -31.18 62.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.134 0.425 . . . . 0.0 110.865 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -29.62 65.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.067 -0.396 . . . . 0.0 109.986 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.66 -28.8 40.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.735 0.243 . . . . 0.0 110.59 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.8 tp -81.83 -35.25 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 122.775 0.43 . . . . 0.0 110.059 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 m -89.24 -26.09 21.38 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.91 -11.09 6.6 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.78 -16.76 11.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.424 1.011 . . . . 0.0 110.339 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -54.05 141.67 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.83 0.852 . . . . 0.0 111.514 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 57.04 1.39 0.09 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.045 2.138 . . . . 0.0 115.956 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.75 142.59 27.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 120.786 1.63 . . . . 0.0 108.01 169.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.276 0.0 OUTLIER -130.98 163.86 26.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.3 ptm -125.25 143.47 50.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.466 1.106 . . . . 0.0 109.607 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 66.46 32.94 7.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.178 1.391 . . . . 0.0 113.784 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.0 15.88 72.23 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.654 169.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -83.02 152.82 25.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.521 1.161 . . . . 0.0 110.736 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.564 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -75.42 136.19 40.73 Favored 'General case' 0 C--N 1.337 0.028 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -97.21 127.16 42.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -140.6 115.87 9.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.83 139.44 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.5 m -148.17 164.37 34.15 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.579 0.752 . . . . 0.0 109.99 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.62 151.9 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.5 t -102.29 -174.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.085 0.554 . . . . 0.0 110.304 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -135.4 7.12 3.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.799 0.84 . . . . 0.0 110.341 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -78.86 147.56 70.74 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.79 -25.46 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.835 2.357 . . . . 0.0 111.978 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.46 170.75 12.58 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.155 0.582 . . . . 0.0 110.443 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -68.22 140.61 18.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.6 mtt -102.37 151.45 38.17 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.416 0.286 . . . . 0.0 110.723 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 161.54 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.729 2.952 . . . . 0.0 111.337 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.65 -175.68 44.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -72.96 158.26 35.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.664 0.385 . . . . 0.0 110.17 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.1 p -146.41 162.49 38.11 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.167 0.587 . . . . 0.0 110.543 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -150.15 163.7 37.53 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.96 0.504 . . . . 0.0 110.208 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.87 135.42 17.88 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.4 mt -86.97 176.4 7.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.904 0.882 . . . . 0.0 109.954 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -65.27 -20.29 66.35 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.392 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.23 0.15 49.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.359 0.664 . . . . 0.0 111.573 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.52 -3.52 77.95 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.286 0.469 . . . . 0.0 112.504 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 60.5 m -93.82 156.69 16.52 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.681 0.74 . . . . 0.0 110.269 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.81 153.35 36.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.456 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.0 p -66.33 -10.39 42.44 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.775 0.43 . . . . 0.0 111.79 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -118.52 137.48 53.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.174 0.99 . . . . 0.0 109.391 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -151.87 154.92 37.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -124.28 152.36 43.11 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.02 0.928 . . . . 0.0 109.84 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -137.94 12.57 2.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.144 0.578 . . . . 0.0 112.276 -175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 97.2 p . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.316 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 . . . . . 0 CA--C 1.529 0.159 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -65.37 163.96 28.38 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.401 0.681 . . . . 0.0 110.756 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.61 151.86 13.66 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.764 2.976 . . . . 0.0 112.764 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 45.1 p -124.05 23.89 8.38 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.907 0.883 . . . . 0.0 112.122 -173.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 54.67 13.13 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.792 1.637 . . . . 0.0 115.051 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.85 150.24 22.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.96 143.84 50.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -109.37 152.48 25.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.731 0.413 . . . . 0.0 109.92 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -130.38 135.71 48.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.09 0.956 . . . . 0.0 108.482 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -146.56 168.18 21.88 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.858 0.463 . . . . 0.0 111.073 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.8 m120 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.906 0.882 . . . . 0.0 112.623 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.42 156.35 50.96 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 122.984 0.514 . . . . 0.0 109.765 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.18 156.95 64.04 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.286 1.99 . . . . 0.0 110.407 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.5 -1.19 26.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.17 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.6 7.8 28.83 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.095 -0.378 . . . . 0.0 111.983 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.51 153.09 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.168 0.44 . . . . 0.0 111.668 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 75.5 p -146.91 172.6 13.43 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.935 0.894 . . . . 0.0 110.114 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 511' ' ' GLU . 3.6 pm0 -60.79 -24.31 65.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.796 177.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -73.59 -26.69 60.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.178 -0.326 . . . . 0.0 110.455 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.37 -28.93 37.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.47 -29.43 63.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.6 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.81 -38.99 31.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.575 0.625 . . . . 0.0 111.605 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.91 -18.96 52.99 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.174 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.5 mt -90.85 -33.5 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 118.285 0.493 . . . . 0.0 110.095 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.33 -22.27 64.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.635 -0.666 . . . . 0.0 110.285 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.58 -30.55 64.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.13 -13.0 33.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.365 0.53 . . . . 0.0 112.075 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.5 mt -91.82 -6.53 51.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.517 0.327 . . . . 0.0 110.428 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.41 7.73 64.77 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.693 -0.504 . . . . 0.0 112.966 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.1 m -87.54 169.13 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 117.833 0.817 . . . . 0.0 111.222 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -71.16 132.33 44.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -76.81 147.0 77.07 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.92 148.29 91.77 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.909 2.406 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.1 m -89.55 -19.9 24.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.544 0.337 . . . . 0.0 110.431 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.5 t -147.25 148.98 32.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.41 138.93 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.656 0.382 . . . . 0.0 110.328 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -142.91 139.92 30.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.32 154.97 41.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 110.428 -175.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -152.05 161.15 43.07 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.441 1.096 . . . . 0.0 109.166 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.695 178.818 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 158.26 44.55 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.81 0.444 . . . . 0.0 111.411 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -115.8 157.38 24.47 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.07 0.948 . . . . 0.0 111.884 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -149.88 175.15 11.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.256 1.422 . . . . 0.0 109.199 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.7 45.7 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.647 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.484 ' C ' HD12 ' A' ' 544' ' ' LEU . 6.3 mp -129.25 132.79 47.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.632 0.773 . . . . 0.0 109.01 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 543' ' ' LEU . 9.4 mp -128.12 144.78 51.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.76 120.46 27.95 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.468 ' HB3' ' H ' ' A' ' 527' ' ' THR . 9.6 p90 -164.94 147.4 8.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -156.21 123.4 5.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 17.3 m -159.64 152.89 22.16 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.341 1.856 . . . . 0.0 106.304 169.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -59.95 -54.26 48.22 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.718 0.69 . . . . 0.0 111.897 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 26.9 m -83.5 -27.28 29.51 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.96 -30.82 31.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.06 0.391 . . . . 0.0 111.024 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -30.36 38.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.9 tp -78.08 -29.61 49.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.624 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -71.98 -41.72 67.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 O-C-N 121.938 -0.476 . . . . 0.0 109.983 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 24.1 m -73.44 -39.24 65.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.992 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 556' ' ' LEU . 3.0 tm? -66.66 -46.78 74.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.676 -0.64 . . . . 0.0 109.815 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.15 -16.41 78.58 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.552 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -123.7 -6.18 8.03 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.795 1.298 . . . . 0.0 113.48 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.87 -16.36 14.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.3 0.5 . . . . 0.0 111.265 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -68.07 143.6 55.42 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.266 -0.896 . . . . 0.0 109.924 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 52.64 29.41 7.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.06 0.944 . . . . 0.0 113.354 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . 0.406 ' H ' ' HD1' ' A' ' 562' ' ' TYR . 0.4 OUTLIER -74.7 151.42 39.23 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -103.76 136.42 43.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.063 1.745 . . . . 0.0 110.635 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . 0.447 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.13 173.68 1.85 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.935 0.494 . . . . 0.0 111.202 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 564' ' ' MET . 65.2 pttt -73.3 9.77 1.19 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -66.28 143.86 98.48 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.715 0.688 . . . . 0.0 110.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.0 -29.58 3.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.569 2.846 . . . . 0.0 114.04 -169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -121.02 1.37 10.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.961 0.346 . . . . 0.0 111.912 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.428 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.74 41.55 99.09 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.929 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.6 Cg_endo -68.94 -10.87 30.37 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.247 2.631 . . . . 0.0 112.048 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.11 147.61 38.38 Favored Pre-proline 0 N--CA 1.455 -0.201 0 C-N-CA 122.832 0.453 . . . . 0.0 109.824 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.81 152.37 41.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.859 3.039 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . 0.447 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.7 t80 -144.17 -2.79 0.88 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 126.17 28.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.809 -0.557 . . . . 0.0 109.998 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.14 144.71 50.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.232 1.013 . . . . 0.0 110.372 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -79.46 135.98 36.81 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.5 pp -146.99 146.85 30.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 25.5 p -163.72 169.99 17.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.082 0.553 . . . . 0.0 110.304 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -73.78 130.67 40.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 74.6 m -135.55 140.07 44.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.79 0.436 . . . . 0.0 110.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 65.0 m -79.82 102.34 9.03 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.012 0.434 . . . . 0.0 110.573 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 161.6 34.44 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.076 0.95 . . . . 0.0 109.43 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . 0.508 ' H ' ' CD ' ' A' ' 583' ' ' GLN . 0.0 OUTLIER -98.87 -15.92 19.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.573 0.349 . . . . 0.0 111.511 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -160.58 164.56 31.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.205 0.602 . . . . 0.0 109.824 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.17 76.4 9.24 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.945 179.113 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.744 0.306 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -139.08 10.75 2.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.29 0.636 . . . . 0.0 110.917 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 37.6 t -155.71 150.71 20.78 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.177 0.591 . . . . 0.0 110.323 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.34 -4.39 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.562 2.841 . . . . 0.0 111.473 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.77 145.3 17.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.098 0.559 . . . . 0.0 111.019 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.99 165.16 27.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.243 1.017 . . . . 0.0 109.43 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.2 mtp -137.87 153.17 49.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.674 0.274 . . . . 0.0 111.58 -175.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.63 150.39 15.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.064 0.546 . . . . 0.0 110.357 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.24 166.16 24.89 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.59 86.93 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.115 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.769 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.58 178.14 4.27 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.209 1.005 . . . . 0.0 110.992 177.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.44 143.8 35.78 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -73.29 0.22 12.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.4 p -113.67 -4.33 13.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.552 0.614 . . . . 0.0 112.376 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -131.81 -6.9 3.58 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.141 0.577 . . . . 0.0 110.882 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 27.8 ttt -145.43 128.19 16.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.433 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 32.8 m-80 -141.88 176.75 8.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.701 0.801 . . . . 0.0 109.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.0 m -57.98 -27.84 63.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.314 0.246 . . . . 0.0 111.142 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -85.15 -26.21 26.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.267 -0.271 . . . . 0.0 111.451 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . 0.433 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 48.8 mmt-85 -81.07 -33.85 33.12 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.194 0.452 . . . . 0.0 109.804 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -25.12 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -71.52 -29.33 64.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.66 -26.74 50.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.684 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 74.5 t -90.18 -21.28 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.298 0.499 . . . . 0.0 112.301 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -114.43 -12.91 12.29 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.79 -25.65 62.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.44 1.018 . . . . 0.0 111.754 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.6 pp -77.67 11.16 2.22 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.649 -0.657 . . . . 0.0 112.164 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.75 -7.78 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.454 0.701 . . . . 0.0 110.609 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.32 170.71 19.81 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -70.41 138.49 51.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.065 -0.668 . . . . 0.0 111.008 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 62.0 t -97.25 145.14 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.07 -57.89 1.98 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.323 -0.236 . . . . 0.0 110.721 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -160.0 165.23 32.36 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.972 0.415 . . . . 0.0 111.54 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.21 151.8 15.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 123.85 0.86 . . . . 0.0 109.987 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -151.64 144.56 24.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.762 0.425 . . . . 0.0 110.007 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -76.05 157.4 33.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 34.4 ttp -119.67 141.15 49.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -168.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt 51.93 33.88 12.54 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.722 1.209 . . . . 0.0 112.26 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.8 m 55.68 15.76 1.7 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 113.323 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -81.29 142.18 50.46 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.42 -2.47 11.98 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.467 2.778 . . . . 0.0 109.518 169.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.01 15.79 10.99 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.556 1.074 . . . . 0.0 113.822 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.181 1.49 . . . . 0.0 111.129 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -158.89 168.06 27.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.169 0.509 . . . . 0.0 111.964 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.2 ptp -136.07 148.79 48.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.913 0.885 . . . . 0.0 109.93 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.53 151.35 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.556 0.742 . . . . 0.0 109.834 -175.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -130.77 145.04 51.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.736 0.414 . . . . 0.0 110.493 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 73.7 mtp -124.34 165.43 17.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.02 66.58 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -158.81 160.79 36.63 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.73 -13.33 78.35 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.509 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -65.51 -26.79 68.07 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.166 1.483 . . . . 0.0 110.741 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.98 -25.61 25.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.219 0.208 . . . . 0.0 110.841 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.39 -30.36 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.6 -33.4 72.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.497 0.319 . . . . 0.0 110.355 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -76.08 -25.35 55.42 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.175 -0.328 . . . . 0.0 110.514 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.84 -28.57 44.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.984 -0.448 . . . . 0.0 109.868 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -80.47 -31.04 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.102 0.961 . . . . 0.0 111.096 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 45.7 p -100.54 -13.17 18.74 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -134.05 -11.97 2.55 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.049 1.295 . . . . 0.0 114.391 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.82 -10.45 11.71 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.96 0.8 . . . . 0.0 109.718 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -58.88 145.24 41.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.403 0.62 . . . . 0.0 112.443 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 21.3 m120 56.9 1.35 0.09 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.543 1.937 . . . . 0.0 115.536 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -87.95 142.52 27.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.55 1.523 . . . . 0.0 108.493 169.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.0 OUTLIER -130.69 163.97 26.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 174.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.3 ptm -125.26 143.36 50.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.642 1.177 . . . . 0.0 109.171 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 63.86 27.09 14.46 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.953 1.301 . . . . 0.0 114.483 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.83 15.92 76.4 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -83.04 150.63 26.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.979 1.389 . . . . 0.0 110.14 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 141.49 38.28 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.79 122.99 40.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -140.73 115.72 9.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.14 140.22 24.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.926 0.33 . . . . 0.0 110.341 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 99.4 m -149.43 168.21 24.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.878 0.871 . . . . 0.0 110.158 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.68 153.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 23.2 t -105.82 -168.23 1.42 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.653 0.381 . . . . 0.0 110.276 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -141.57 4.43 1.75 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.115 0.566 . . . . 0.0 111.146 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -74.38 150.93 87.46 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -27.7 12.35 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.646 2.231 . . . . 0.0 112.382 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.71 170.15 14.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.298 0.499 . . . . 0.0 111.28 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 30.0 mm -71.82 151.49 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.01 133.07 23.15 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.22 158.55 41.29 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.523 2.815 . . . . 0.0 111.427 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 151.84 160.23 9.4 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 48.27 -95.9 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.703 1.201 . . . . 0.0 112.741 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.0 t 63.14 146.75 0.02 OUTLIER 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.653 1.581 . . . . 0.0 112.938 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -148.31 165.3 31.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.913 0.885 . . . . 0.0 109.699 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.45 132.65 11.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.1 mt -87.06 172.5 9.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.315 0.646 . . . . 0.0 110.341 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.48 -22.12 66.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.848 0.459 . . . . 0.0 110.951 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.7 1.2 35.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.199 0.599 . . . . 0.0 111.41 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.45 -2.11 79.1 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.076 0.369 . . . . 0.0 112.402 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.35 156.59 16.7 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.655 0.727 . . . . 0.0 110.067 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 83.9 m -78.77 150.42 32.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.447 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 86.3 p -73.22 -10.33 59.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.455 0.302 . . . . 0.0 111.464 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -119.44 130.59 55.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.561 0.744 . . . . 0.0 109.062 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -151.62 159.44 44.06 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -130.62 147.88 52.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.794 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -136.2 12.77 3.3 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.052 0.541 . . . . 0.0 111.415 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.53 0.189 0 C-N-CA 122.913 0.485 . . . . 0.0 111.594 -174.879 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.965 0.412 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -89.1 166.48 21.64 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.29 1.036 . . . . 0.0 109.882 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.03 129.96 30.02 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.0 2.467 . . . . 0.0 111.412 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 70.8 m -123.99 22.73 8.74 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.195 0.598 . . . . 0.0 112.291 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 60.2 3.29 0.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.06 1.344 . . . . 0.0 114.012 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.6 t -142.29 146.96 21.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 49.1 mt -121.48 162.1 21.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.036 0.534 . . . . 0.0 110.545 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -141.96 152.78 43.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.502 0.321 . . . . 0.0 110.676 175.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -138.01 154.25 49.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.837 0.455 . . . . 0.0 111.344 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -146.01 172.17 13.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.048 0.539 . . . . 0.0 111.197 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.4 m120 61.08 27.66 17.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -82.64 160.55 61.29 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 122.44 0.296 . . . . 0.0 110.609 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.92 152.71 62.38 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.692 2.261 . . . . 0.0 110.7 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -73.46 -2.56 23.0 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.23 9.22 13.41 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.204 0.602 . . . . 0.0 111.88 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.9 152.44 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.121 -0.362 . . . . 0.0 110.298 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.6 p -145.65 170.97 15.41 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.061 0.544 . . . . 0.0 110.442 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.87 -23.25 66.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.894 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.16 -26.07 58.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.657 0.208 . . . . 0.0 110.492 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -78.56 -30.57 46.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -73.48 -27.04 61.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.303 -0.248 . . . . 0.0 110.878 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -78.85 -39.52 35.09 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.972 -0.455 . . . . 0.0 111.178 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -78.89 -21.74 46.96 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 84.1 mt -86.36 -35.89 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.281 0.491 . . . . 0.0 110.315 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.87 -28.45 68.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.086 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.58 -28.62 65.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.84 -12.18 37.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.557 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.41 -2.89 58.59 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.882 0.473 . . . . 0.0 111.257 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.32 79.94 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.929 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.77 165.07 22.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 117.817 0.809 . . . . 0.0 110.885 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -73.83 146.66 43.99 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.922 0.392 . . . . 0.0 110.605 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 525' ' ' ARG . 0.4 OUTLIER -88.07 152.92 51.35 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.27 0.628 . . . . 0.0 110.354 176.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.85 152.47 69.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.252 2.635 . . . . 0.0 111.413 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 95.4 m -85.51 -27.8 25.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.359 0.263 . . . . 0.0 111.171 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.6 m -140.35 149.43 42.7 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.529 . . . . 0.0 109.813 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.9 t -141.76 147.02 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.971 0.509 . . . . 0.0 110.472 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.31 124.63 10.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.39 144.65 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.586 0.354 . . . . 0.0 110.921 -175.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -149.58 161.38 42.28 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.749 0.82 . . . . 0.0 109.661 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 82.6 p . . . . . 0 C--O 1.233 0.222 0 C-N-CA 122.917 0.487 . . . . 0.0 110.926 179.797 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 98.4 p -147.92 170.23 18.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.798 0.439 . . . . 0.0 111.089 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.2 m -131.37 160.83 33.91 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.661 0.784 . . . . 0.0 111.77 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.9 p -149.33 165.39 32.14 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.592 1.157 . . . . 0.0 109.79 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.08 40.87 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.691 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.98 157.82 39.55 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.74 0.816 . . . . 0.0 110.309 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 71.3 mt -133.51 134.98 44.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.347 1.059 . . . . 0.0 108.43 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.77 111.84 14.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -166.01 153.76 10.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.71 1.604 . . . . 0.0 106.898 167.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.17 124.75 8.35 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 551' ' ' ASP . 39.6 t -159.56 153.04 22.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 168.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -50.67 70.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.606 0.639 . . . . 0.0 111.7 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 52.1 m -87.75 -29.44 21.05 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 548' ' ' SER . 12.1 t70 -71.0 -34.28 71.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.268 0.486 . . . . 0.0 110.441 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.64 -34.32 35.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.33 -0.367 . . . . 0.0 110.555 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 38.0 tp -75.96 -29.94 58.46 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.757 0.708 . . . . 0.0 111.241 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -68.61 -43.48 76.31 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.8 m -72.79 -34.76 67.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.41 -42.27 98.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.755 -0.591 . . . . 0.0 109.601 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.78 -23.05 78.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.833 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -112.15 -7.48 14.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.504 1.152 . . . . 0.0 113.457 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.3 tp -112.52 -9.85 13.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.001 0.819 . . . . 0.0 111.927 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -78.05 140.74 39.13 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.232 -0.918 . . . . 0.0 108.823 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 50.72 26.95 2.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.695 0.798 . . . . 0.0 112.652 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.84 151.32 44.9 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -103.79 136.51 43.33 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.751 1.621 . . . . 0.0 111.085 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . 0.467 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.0 ttt -64.21 173.45 1.97 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.181 0.592 . . . . 0.0 111.307 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -74.02 11.5 0.89 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.8 p30 -65.85 143.53 98.53 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.41 0.55 . . . . 0.0 110.179 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.21 -30.53 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.36 2.707 . . . . 0.0 114.132 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -121.06 1.7 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.211 0.459 . . . . 0.0 112.043 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 40.61 98.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.775 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 84.7 Cg_endo -69.56 -9.5 26.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.984 2.456 . . . . 0.0 112.319 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.23 147.94 39.26 Favored Pre-proline 0 N--CA 1.455 -0.185 0 C-N-CA 122.74 0.416 . . . . 0.0 109.968 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.33 153.01 45.1 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.767 2.978 . . . . 0.0 111.127 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.9 t80 -148.28 0.81 0.61 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.729 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 66.7 p -66.42 125.83 26.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.398 -0.814 . . . . 0.0 110.261 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 24.5 mt -99.58 144.54 28.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.452 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -81.36 122.61 27.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -133.61 144.63 49.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 18.6 t -164.02 175.82 9.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.251 0.62 . . . . 0.0 110.18 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.46 144.53 33.95 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.014 0.525 . . . . 0.0 109.801 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 37.6 t -135.63 142.35 45.19 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.427 0.158 . . . . 0.0 111.427 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.7 p -79.89 102.27 9.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.14 161.58 34.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.192 0.597 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -123.89 -1.42 8.36 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.344 0.657 . . . . 0.0 109.979 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -159.93 167.21 28.55 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.529 1.132 . . . . 0.0 109.864 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.47 0.99 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.759 0.424 . . . . 0.0 109.93 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.884 -179.773 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.658 0.266 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.26 -1.15 4.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.849 0.46 . . . . 0.0 111.633 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.3 m -146.7 148.83 34.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 C-N-CA 122.596 0.359 . . . . 0.0 110.528 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -82.41 -5.49 11.81 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.253 3.302 . . . . 0.0 112.49 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 72.9 t -119.25 147.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 118.472 0.578 . . . . 0.0 111.229 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.46 166.06 25.74 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.012 0.925 . . . . 0.0 109.382 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 85.5 mtp -135.17 150.49 50.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.517 0.199 . . . . 0.0 111.245 -175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 30.9 t -140.21 145.18 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.323 0.649 . . . . 0.0 109.951 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -137.26 165.05 27.07 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.427 0.691 . . . . 0.0 109.564 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.31 0.15 89.97 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.355 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.75 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -73.88 177.97 5.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.989 0.895 . . . . 0.0 110.976 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.83 137.23 50.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.678 0.391 . . . . 0.0 110.266 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.93 -1.64 23.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 23.1 t -112.62 -13.56 13.28 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.354 0.525 . . . . 0.0 111.59 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -114.58 -9.92 12.58 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.736 0.415 . . . . 0.0 110.32 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.3 ttt -150.88 126.98 10.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.281 0.633 . . . . 0.0 109.898 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -141.94 -174.43 4.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.208 0.603 . . . . 0.0 109.449 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 22.3 p -57.97 -30.42 66.01 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.09 -21.67 23.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.735 -0.603 . . . . 0.0 111.496 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -94.71 -19.36 20.47 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.457 0.303 . . . . 0.0 110.697 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.92 -30.43 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.09 -31.33 71.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -66.92 -42.37 85.5 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.133 -0.354 . . . . 0.0 110.848 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 65.3 t -79.45 -26.09 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 119.278 -0.391 . . . . 0.0 112.002 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -101.97 -10.01 20.15 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 19.7 t -74.01 -33.57 63.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.961 0.801 . . . . 0.0 111.59 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.36 12.54 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.687 -0.633 . . . . 0.0 111.369 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.47 -2.15 9.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 110.656 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.96 173.3 18.06 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -80.35 155.49 27.17 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.389 0.595 . . . . 0.0 110.053 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.33 155.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.304 0.642 . . . . 0.0 110.141 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -102.39 -58.36 1.89 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.717 0.407 . . . . 0.0 110.084 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.16 167.91 17.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.432 0.693 . . . . 0.0 110.466 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.25 148.57 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 122.995 0.518 . . . . 0.0 110.181 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -155.61 148.9 24.76 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 110.844 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -77.92 156.44 30.28 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 171.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.703 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -141.02 141.41 34.34 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -169.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.22 33.94 21.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.3 m 52.84 13.45 0.35 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.33 138.12 45.23 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-N 119.083 0.856 . . . . 0.0 109.837 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.17 -6.86 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.185 2.59 . . . . 0.0 110.181 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -114.41 18.19 18.13 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.26 0.933 . . . . 0.0 112.717 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.703 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -150.42 142.73 24.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.747 1.274 . . . . 0.0 111.528 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.54 169.03 25.23 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.729 0.411 . . . . 0.0 111.468 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.4 ptp -136.26 149.43 48.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.594 . . . . 0.0 110.535 176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.77 148.21 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.072 0.549 . . . . 0.0 110.289 -174.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -127.23 131.37 50.61 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 87.4 mmm -100.4 162.83 12.69 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.449 0.3 . . . . 0.0 110.874 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.86 61.82 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -157.92 163.06 38.25 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.25 -16.21 70.87 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.102 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -68.46 -24.19 64.68 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.139 1.469 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -86.76 -22.27 26.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.254 0.222 . . . . 0.0 110.594 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.5 t -78.08 -33.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.44 -28.88 67.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.155 0.182 . . . . 0.0 110.525 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.412 ' HA ' ' NE ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -86.73 -29.38 22.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.104 -0.372 . . . . 0.0 111.194 -177.198 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.83 -26.94 40.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -84.55 -30.95 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 122.143 -0.348 . . . . 0.0 111.585 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.3 p -99.04 -11.18 21.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -132.33 -11.03 3.24 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.8 -21.28 9.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.401 1.0 . . . . 0.0 110.477 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -51.46 142.29 14.07 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.539 0.736 . . . . 0.0 112.226 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.491 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 77.0 m-20 58.41 1.69 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.89 142.52 27.74 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 121.14 1.791 . . . . 0.0 109.287 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 0.1 OUTLIER -130.86 164.05 26.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.3 ptm -125.39 143.43 50.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.548 1.139 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . 0.45 ' CE1' ' CD1' ' A' ' 558' ' ' PHE . 37.5 m-85 62.91 27.88 16.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 177.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.8 15.88 58.98 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.314 0.885 . . . . 0.0 115.314 168.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -83.09 141.78 31.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.833 1.317 . . . . 0.0 109.756 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -74.85 139.01 42.9 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.19 121.94 39.64 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -140.77 115.74 9.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 107.871 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.491 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 1.9 p -153.34 139.82 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 118.692 0.678 . . . . 0.0 110.594 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -158.24 161.63 37.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.438 0.695 . . . . 0.0 109.796 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.41 155.68 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 36.0 t -133.43 144.23 49.38 Favored 'General case' 0 CA--C 1.522 -0.115 0 O-C-N 122.102 -0.374 . . . . 0.0 111.318 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -87.92 65.1 8.16 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.283 0.633 . . . . 0.0 111.12 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -127.38 144.06 49.48 Favored Pre-proline 0 CA--C 1.529 0.144 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.74 -25.24 9.44 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.281 2.654 . . . . 0.0 111.76 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.48 172.42 14.49 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.79 0.436 . . . . 0.0 110.617 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.37 140.41 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.99 151.74 42.21 Favored Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 122.425 0.29 . . . . 0.0 110.925 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.96 158.98 55.79 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.93 3.087 . . . . 0.0 111.189 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.08 -172.4 43.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -77.83 164.87 24.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.645 0.378 . . . . 0.0 110.8 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 77.6 p -145.71 158.58 43.84 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.387 0.675 . . . . 0.0 110.114 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -154.16 165.66 35.54 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.742 0.417 . . . . 0.0 110.258 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.02 137.44 22.13 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -86.96 176.14 7.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.628 0.771 . . . . 0.0 110.354 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.97 -20.12 66.09 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.474 0.309 . . . . 0.0 111.441 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -85.65 -0.07 54.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 0.98 89.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.256 0.455 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 24.4 t -93.55 160.76 14.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.195 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.76 153.21 35.21 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.921 0.391 . . . . 0.0 110.824 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.9 p -72.54 -10.46 59.82 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.745 0.418 . . . . 0.0 111.807 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -117.39 141.7 48.01 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.692 0.797 . . . . 0.0 110.112 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -154.68 154.41 32.87 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.776 0.43 . . . . 0.0 110.185 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -127.25 155.1 44.01 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.118 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -138.05 1.76 2.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 85.0 p . . . . . 0 CA--C 1.528 0.122 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.592 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.286 0.565 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . 0.401 ' HB2' ' HD2' ' A' ' 496' ' ' PRO . 49.0 p-80 -80.74 162.39 60.44 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.156 0.982 . . . . 0.0 108.551 170.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 495' ' ' HIS . 47.4 Cg_endo -63.54 138.41 64.83 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.159 1.906 . . . . 0.0 110.55 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 69.2 m -124.08 23.97 8.32 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.04 5.83 4.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.182 0.993 . . . . 0.0 113.321 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 54.9 t -140.07 142.31 32.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 O-C-N 121.706 -0.621 . . . . 0.0 109.748 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.472 HD12 ' CH2' ' A' ' 546' ' ' TRP . 89.1 mt -130.86 163.48 27.33 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.187 0.995 . . . . 0.0 108.826 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.34 165.75 28.38 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 122.01 -0.431 . . . . 0.0 112.004 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.52 156.93 47.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.237 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -147.51 170.63 17.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.285 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.5 t30 61.01 26.57 16.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.274 1.03 . . . . 0.0 113.607 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.42 157.8 55.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.14 161.33 16.46 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 0.0 111.955 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.2 pt? -83.06 -1.16 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.52 5.69 31.68 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.603 0.361 . . . . 0.0 111.873 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.32 150.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.918 0.326 . . . . 0.0 111.602 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -143.44 172.21 13.09 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.581 0.752 . . . . 0.0 110.471 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 2.9 pm0 -61.49 -19.88 62.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.511 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.86 -25.75 60.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.017 0.371 . . . . 0.0 110.134 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -81.99 -28.54 32.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -72.9 -29.11 62.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.806 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -83.33 -37.52 23.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 111.503 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.23 -24.36 51.22 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.98 -33.07 5.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.165 0.439 . . . . 0.0 110.187 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 67.7 m -67.25 -21.48 65.72 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.948 174.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.96 -33.61 73.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -90.99 -13.2 33.8 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.69 -9.97 47.51 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.666 0.386 . . . . 0.0 110.841 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.04 62.24 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.175 0.417 . . . . 0.0 112.724 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -87.65 160.44 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.964 0.882 . . . . 0.0 110.645 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.46 120.22 18.77 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -71.18 150.75 94.58 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.97 149.28 92.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.859 2.373 . . . . 0.0 110.563 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 94.1 m -84.78 -21.04 30.12 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.76 0.424 . . . . 0.0 110.839 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 15.3 t -146.04 153.45 40.75 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.34 140.71 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 122.995 0.518 . . . . 0.0 110.359 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.18 124.13 12.04 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.3 148.93 30.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.695 0.398 . . . . 0.0 111.082 -172.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -151.81 151.02 30.79 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.544 0.738 . . . . 0.0 110.418 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 109.939 177.25 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.4 m -145.49 167.98 21.69 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.539 0.736 . . . . 0.0 110.449 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.6 t -135.36 155.11 51.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.495 0.718 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.5 m -145.35 163.71 33.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.399 1.079 . . . . 0.0 109.542 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -178.6 177.54 48.46 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 119.993 -1.098 . . . . 0.0 114.359 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.6 mp -112.98 156.5 22.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.012 . . . . 0.0 109.59 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.9 mt -138.61 143.19 39.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.434 1.094 . . . . 0.0 109.078 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -127.8 109.43 11.62 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.472 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.2 p90 -166.04 153.4 10.07 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 168.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -154.46 118.79 4.78 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.8 t -159.6 153.53 23.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.62 -40.02 95.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.619 0.645 . . . . 0.0 110.613 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 66.8 p -85.28 -27.26 26.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -83.68 -29.59 27.47 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.728 0.695 . . . . 0.0 110.859 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.74 26.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.986 0.357 . . . . 0.0 111.402 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.4 tp -84.7 -27.8 26.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.336 0.516 . . . . 0.0 112.047 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -77.36 -39.1 48.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.293 0.497 . . . . 0.0 110.273 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 89.7 m -67.84 -38.78 83.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.5 tp -60.63 -42.91 97.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.523 -0.735 . . . . 0.0 110.176 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -75.5 -14.17 82.25 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.244 -173.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . 0.45 ' CD1' ' CE1' ' A' ' 442' ' ' PHE . 23.5 m-85 -126.39 -12.28 6.21 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.763 1.282 . . . . 0.0 113.379 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 18.4 tp -105.79 -14.93 15.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.19 0.904 . . . . 0.0 112.567 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.44 136.4 40.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.2 m170 50.21 34.94 9.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.831 0.852 . . . . 0.0 113.003 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.71 151.29 28.97 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.246 0.618 . . . . 0.0 112.37 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -101.24 136.41 41.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.999 1.719 . . . . 0.0 110.999 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . 0.408 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.3 ttt -64.07 179.93 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.846 0.858 . . . . 0.0 111.367 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 564' ' ' MET . 19.7 ptpt -64.27 6.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.59 143.17 93.85 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.115 0.416 . . . . 0.0 110.924 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.55 -30.44 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.389 2.726 . . . . 0.0 112.917 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -121.05 -7.18 9.45 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.7 44.06 96.91 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.007 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 86.7 Cg_endo -72.01 -6.24 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.325 2.683 . . . . 0.0 112.042 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -138.88 150.33 65.0 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.928 0.491 . . . . 0.0 109.917 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.88 144.09 30.29 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.161 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . 0.408 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 89.8 t80 -145.09 -3.63 0.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.306 0.643 . . . . 0.0 111.27 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 132.02 47.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.872 -0.518 . . . . 0.0 110.764 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.8 pp -125.04 144.59 50.32 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.526 0.73 . . . . 0.0 111.125 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.04 140.46 33.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.263 0.625 . . . . 0.0 109.977 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.55 144.99 46.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 1.9 p -163.93 173.02 13.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.568 0.347 . . . . 0.0 110.982 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -84.12 148.69 26.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.919 0.39 . . . . 0.0 110.711 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 28.0 t -135.53 159.93 40.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.502 0.721 . . . . 0.0 109.8 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 44.5 m -117.32 101.96 8.86 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.56 34.61 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.164 0.986 . . . . 0.0 109.928 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -78.85 -31.03 45.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -153.57 162.35 41.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.772 1.229 . . . . 0.0 109.054 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.62 76.49 7.49 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.185 179.153 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.031 0.444 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.82 -13.35 39.54 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.425 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 m -148.7 155.31 41.45 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 122.846 0.458 . . . . 0.0 110.691 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.91 -0.84 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.659 3.573 . . . . 0.0 113.242 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.17 158.85 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.551 0.614 . . . . 0.0 110.969 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.3 pp -145.32 170.28 16.62 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.157 0.583 . . . . 0.0 110.606 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 77.5 mtp -135.15 153.36 52.01 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.761 0.424 . . . . 0.0 111.099 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.7 149.62 18.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.211 0.604 . . . . 0.0 110.25 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -141.89 167.57 21.83 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.037 0.535 . . . . 0.0 110.152 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.57 76.87 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.15 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -67.85 165.33 17.77 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.798 0.799 . . . . 0.0 111.002 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -119.72 128.4 53.75 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.66 1.68 5.01 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 84.0 p -116.62 0.59 12.68 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.55 -6.42 3.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.169 0.588 . . . . 0.0 110.591 174.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 9.3 tpt -150.11 122.95 8.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.701 0.8 . . . . 0.0 109.4 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -141.94 -174.78 4.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.086 0.555 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.6 p -60.73 -23.99 65.36 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.887 0.475 . . . . 0.0 112.023 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.0 -30.73 21.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.917 0.326 . . . . 0.0 111.63 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -82.07 -30.76 31.15 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.571 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.98 -28.48 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -70.02 -33.87 72.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.963 -0.461 . . . . 0.0 110.052 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.23 -16.38 52.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.3 -18.88 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.716 0.407 . . . . 0.0 110.942 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -116.95 -18.96 10.01 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.26 -20.89 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.658 1.117 . . . . 0.0 111.057 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.955 -0.466 . . . . 0.0 111.887 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -121.46 -1.42 9.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.827 0.851 . . . . 0.0 111.268 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.56 169.6 16.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -65.67 142.67 57.95 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.468 -0.431 . . . . 0.0 111.493 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.08 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.652 0.781 . . . . 0.0 109.306 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -99.83 -65.92 0.94 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -165.13 168.52 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 110.313 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 9.3 p -147.18 151.75 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -152.47 144.71 23.93 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.647 0.379 . . . . 0.0 110.374 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.64 160.32 25.09 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 3.3 ptp -136.4 141.42 43.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 56.76 33.82 23.62 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.8 1.64 . . . . 0.0 114.217 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.0 m 52.77 17.81 0.91 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -71.11 158.13 88.79 Favored Pre-proline 0 CA--C 1.528 0.118 0 CA-C-N 118.367 0.53 . . . . 0.0 110.405 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.11 -19.25 32.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -177.53 102.2 0.16 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -157.8 136.71 11.5 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 109.088 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.83 171.28 20.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.231 0.539 . . . . 0.0 110.897 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.6 ptm -143.63 144.34 31.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.602 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.8 t -130.69 139.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 C-N-CA 122.857 0.463 . . . . 0.0 110.395 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -118.06 141.19 48.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.121 0.568 . . . . 0.0 110.062 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 92.3 mmm -111.01 161.85 15.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.139 0.576 . . . . 0.0 110.121 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.33 -22.94 63.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.13 -0.356 . . . . 0.0 111.138 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -159.46 160.34 34.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.518 0.727 . . . . 0.0 109.398 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.74 69.02 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.841 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.432 1.616 . . . . 0.0 110.671 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.46 -25.91 30.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.564 0.221 . . . . 0.0 110.51 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.6 -28.15 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.17 -42.8 71.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.291 -0.256 . . . . 0.0 110.849 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.62 84.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.102 0.41 . . . . 0.0 110.013 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.4 -34.55 58.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.6 tp -79.85 -30.92 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 O-C-N 122.184 -0.323 . . . . 0.0 111.525 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.7 t -94.94 -12.24 27.14 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -138.89 -24.4 0.91 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -95.67 -20.15 19.15 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.064 0.847 . . . . 0.0 108.997 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -51.82 142.66 14.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.502 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.08 1.59 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.617 1.967 . . . . 0.0 115.565 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -87.92 142.62 27.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.274 1.397 . . . . 0.0 108.847 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . 0.45 ' HB2' ' HG3' ' A' ' 446' ' ' MET 0.328 0.0 OUTLIER -131.0 164.14 26.02 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 175.339 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.7 ptm -125.16 143.28 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.476 1.11 . . . . 0.0 109.263 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 64.42 30.12 13.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.89 81.26 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 167.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -83.14 156.9 23.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.499 1.649 . . . . 0.0 111.359 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.606 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -77.76 141.97 38.96 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.902 0.881 . . . . 0.0 110.627 178.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . 0.45 ' HG3' ' HB2' ' A' ' 440' ' ' PHE . 1.9 mpt? -98.5 122.01 41.16 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -140.69 110.75 6.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.53 139.43 17.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 92.7 m -149.66 160.43 43.52 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.596 0.759 . . . . 0.0 110.23 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -85.09 154.23 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.0 t -144.68 163.26 34.5 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.457 0.703 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -121.17 30.18 6.95 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.511 0.596 . . . . 0.0 112.25 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -63.64 147.91 94.97 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.56 -25.24 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.701 2.267 . . . . 0.0 111.88 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.98 170.22 13.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.453 0.701 . . . . 0.0 109.913 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.01 137.12 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 147.72 57.66 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 110.729 -0.101 . . . . 0.0 110.729 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.84 168.41 23.04 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.098 3.199 . . . . 0.0 111.973 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 177.56 170.99 40.56 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -84.82 -12.72 53.01 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.944 0.372 . . . . 0.0 111.701 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 7.4 m 57.72 169.32 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.145 1.378 . . . . 0.0 113.296 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -155.74 168.31 27.59 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.138 0.575 . . . . 0.0 109.9 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.54 137.79 17.36 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.92 170.24 11.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.313 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.23 -22.79 65.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.545 0.338 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.28 4.69 25.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.529 0.332 . . . . 0.0 111.467 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.57 -0.49 87.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.504 -0.609 . . . . 0.0 113.151 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.9 p -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 117.977 0.889 . . . . 0.0 110.556 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.16 152.4 30.74 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 122.245 -0.285 . . . . 0.0 110.382 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 90.1 p -73.39 -10.37 59.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.532 0.333 . . . . 0.0 111.774 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -127.67 145.21 50.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.797 0.839 . . . . 0.0 110.437 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.09 158.11 38.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.964 0.506 . . . . 0.0 110.058 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.64 148.26 51.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.466 0.706 . . . . 0.0 109.974 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.56 13.69 2.97 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.996 0.518 . . . . 0.0 111.128 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.3 p . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.631 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -60.98 159.62 26.23 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.72 145.13 31.87 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.703 2.935 . . . . 0.0 112.606 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.1 m -124.01 23.9 8.4 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.711 0.804 . . . . 0.0 110.89 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 61.21 14.74 5.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.676 1.191 . . . . 0.0 112.883 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 47.3 t -139.07 141.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.418 HD12 ' CH2' ' A' ' 546' ' ' TRP . 58.6 mt -119.42 148.48 43.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.968 0.507 . . . . 0.0 109.923 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -114.87 151.54 33.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 151.21 46.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.534 0.207 . . . . 0.0 110.677 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -147.89 173.63 12.66 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.635 0.374 . . . . 0.0 111.217 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.2 t30 56.39 34.03 23.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.216 1.006 . . . . 0.0 112.825 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -91.67 157.32 41.98 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.82 148.89 63.76 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.81 2.34 . . . . 0.0 111.588 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -73.7 -1.28 18.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.82 8.27 15.99 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.15 151.16 4.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 118.007 0.367 . . . . 0.0 110.814 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.4 p -142.32 171.87 13.47 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.348 0.659 . . . . 0.0 110.529 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 -22.17 66.73 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -71.2 -25.03 62.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -83.65 -30.13 27.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.17 -27.1 63.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.03 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.7 -38.12 18.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.488 0.586 . . . . 0.0 111.522 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -74.95 -20.08 59.83 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.467 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.23 -33.88 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 117.792 0.269 . . . . 0.0 110.723 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 69.1 m -67.71 -21.68 65.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.974 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.49 -30.44 63.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.07 -13.13 33.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 111.916 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 99.8 mt -91.57 -9.84 42.77 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.791 0.436 . . . . 0.0 111.057 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.68 5.15 63.36 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.752 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.0 m -87.08 168.4 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.777 0.789 . . . . 0.0 110.836 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -77.28 146.59 36.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.763 0.425 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -96.13 151.64 38.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.573 0.349 . . . . 0.0 110.099 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.25 156.0 68.12 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.186 2.591 . . . . 0.0 111.122 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -89.54 -23.32 22.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.916 0.486 . . . . 0.0 110.696 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.1 t -143.84 156.87 44.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.01 144.93 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.221 0.534 . . . . 0.0 110.954 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -141.2 128.81 21.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.6 144.07 35.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 122.597 0.359 . . . . 0.0 110.132 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -154.88 153.66 31.47 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.172 0.589 . . . . 0.0 110.034 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.232 0.132 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.468 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.1 t -143.08 158.93 43.16 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.192 0.597 . . . . 0.0 110.642 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 47.1 t -122.16 150.73 41.82 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.78 0.832 . . . . 0.0 111.109 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.7 m -147.07 168.47 21.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.085 1.354 . . . . 0.0 109.185 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.51 -169.2 42.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.891 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.02 154.05 47.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.385 1.074 . . . . 0.0 109.686 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.39 140.47 39.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.007 0.923 . . . . 0.0 108.723 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -127.8 109.75 11.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.423 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.9 p90 -166.13 152.83 9.44 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.019 1.328 . . . . 0.0 107.77 168.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.31 123.73 7.13 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 39.6 t -159.62 152.97 22.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -47.48 80.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.474 0.579 . . . . 0.0 111.348 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.5 p -85.82 -26.2 25.86 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 54.3 m-20 -82.73 -29.13 29.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.231 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.78 30.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.103 0.411 . . . . 0.0 110.931 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.85 -28.05 36.24 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.406 0.548 . . . . 0.0 111.599 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -76.65 -41.05 47.13 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.133 0.424 . . . . 0.0 110.558 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.5 m -68.73 -34.97 76.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.93 -52.17 65.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.855 -0.528 . . . . 0.0 110.12 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.66 -17.1 76.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.005 -0.886 . . . . 0.0 114.258 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -119.22 -9.2 10.0 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.742 1.271 . . . . 0.0 113.67 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.7 tp -89.61 -21.7 22.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.439 1.018 . . . . 0.0 110.328 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.57 147.66 50.45 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.138 -0.351 . . . . 0.0 110.479 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 51.24 24.79 2.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.448 1.099 . . . . 0.0 113.607 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.31 151.38 38.3 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.247 0.546 . . . . 0.0 112.222 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -111.38 136.24 50.79 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.949 0.9 . . . . 0.0 110.855 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.0 ttt -64.7 178.32 0.79 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.852 0.861 . . . . 0.0 111.006 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -68.18 7.95 0.5 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.28 140.0 91.58 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.31 -28.95 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.472 2.782 . . . . 0.0 112.86 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -121.04 -7.14 9.46 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.41 44.23 97.92 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.926 -0.93 . . . . 0.0 113.421 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 94.0 Cg_endo -71.27 -7.01 20.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.128 2.552 . . . . 0.0 111.993 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -143.82 149.27 45.81 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.125 0.57 . . . . 0.0 109.867 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.53 154.23 39.91 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.601 2.867 . . . . 0.0 110.796 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -136.54 -0.83 2.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.64 0.376 . . . . 0.0 111.604 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 8.3 t -68.31 132.03 46.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.931 -0.481 . . . . 0.0 111.222 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.94 144.62 50.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 0.0 109.701 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -85.11 145.16 27.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 577' ' ' LEU . 2.0 pt? -147.12 146.79 30.05 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.098 0.559 . . . . 0.0 110.683 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.29 169.71 21.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.896 0.478 . . . . 0.0 110.898 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -72.65 133.51 44.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 25.7 t -135.66 148.43 48.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 60.7 m -89.82 102.34 15.04 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.978 0.418 . . . . 0.0 110.587 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 161.53 34.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.817 0.847 . . . . 0.0 109.456 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -99.38 -15.36 18.8 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.175 0.19 . . . . 0.0 110.919 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -160.22 160.59 32.9 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.193 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.01 76.41 0.99 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.88 0.472 . . . . 0.0 110.087 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.54 -1.219 . . . . 0.0 110.489 -179.423 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.691 0.281 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -132.07 19.98 4.5 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.927 0.491 . . . . 0.0 111.145 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 47.0 t -148.81 145.91 20.78 Favored Pre-proline 0 N--CA 1.453 -0.283 0 O-C-N 122.219 -0.301 . . . . 0.0 111.018 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.0 -0.96 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.778 2.985 . . . . 0.0 112.66 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.2 m -124.83 163.06 25.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 119.18 0.9 . . . . 0.0 112.786 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -149.4 161.92 41.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.293 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 75.1 mmm -118.93 144.45 46.43 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.667 0.787 . . . . 0.0 110.099 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.54 144.81 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.048 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -139.32 166.94 23.23 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.383 0.673 . . . . 0.0 109.23 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.82 86.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.318 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.737 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.6 173.86 10.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.924 0.862 . . . . 0.0 110.501 176.008 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.39 146.56 51.24 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.019 0.528 . . . . 0.0 110.271 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -81.98 -4.83 57.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.9 t -104.68 -9.2 18.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.883 0.31 . . . . 0.0 111.447 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.31 -5.55 3.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.219 0.608 . . . . 0.0 111.109 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -142.13 126.69 17.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -141.68 -174.97 4.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.019 0.528 . . . . 0.0 109.992 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.61 -26.81 65.76 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.941 0.496 . . . . 0.0 112.036 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.14 -38.39 27.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.99 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -74.79 -28.96 60.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.106 0.412 . . . . 0.0 110.954 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.93 -28.66 24.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . 0.407 ' CD1' HG21 ' A' ' 406' ' ' VAL . 4.3 t80 -72.1 -30.29 64.93 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 172.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -76.25 -24.82 54.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.6 t -96.58 -26.43 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.399 0.545 . . . . 0.0 112.184 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.27 -14.2 17.07 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 35.3 t -78.57 -17.6 55.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.09 0.859 . . . . 0.0 112.473 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 10.72 1.22 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.272 -0.892 . . . . 0.0 112.171 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -121.38 -1.59 9.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.765 0.826 . . . . 0.0 110.819 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.44 165.5 12.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.44 164.47 22.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.009 0.433 . . . . 0.0 111.161 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . 0.407 HG21 ' CD1' ' A' ' 397' ' ' PHE . 5.4 m -121.11 161.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 C-N-CA 124.237 1.015 . . . . 0.0 109.789 -177.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.58 -52.22 2.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.324 -0.235 . . . . 0.0 111.289 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.16 164.34 27.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.493 0.317 . . . . 0.0 110.795 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.59 151.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.398 0.679 . . . . 0.0 110.262 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.03 148.55 27.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 419' ' ' ALA . 3.9 m-30 -78.65 145.79 34.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 25.1 ttp -99.4 141.04 32.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -168.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 49.8 33.95 7.0 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 112.031 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 83.7 p 52.88 16.02 0.64 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.362 1.465 . . . . 0.0 113.409 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -77.84 132.75 67.19 Favored Pre-proline 0 C--N 1.34 0.192 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.43 -7.43 17.69 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.659 2.239 . . . . 0.0 111.494 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.96 16.54 10.15 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.772 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -144.33 145.33 31.92 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 119.212 1.506 . . . . 0.0 111.056 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 411' ' ' PHE . . . -154.52 163.93 39.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.243 0.544 . . . . 0.0 111.7 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 23.0 ptm -145.23 143.57 30.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.723 0.809 . . . . 0.0 109.757 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.2 p -136.71 153.29 30.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.72 0.408 . . . . 0.0 110.446 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -125.08 138.48 54.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.947 0.499 . . . . 0.0 110.663 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 77.0 mmm -104.42 161.63 13.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.455 0.702 . . . . 0.0 110.145 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.19 -18.67 62.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -157.67 158.85 36.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.974 0.51 . . . . 0.0 109.782 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.6 -14.95 72.86 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.201 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -70.69 -19.82 62.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.03 1.415 . . . . 0.0 111.095 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.44 -24.43 31.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.72 -26.98 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.02 -36.78 82.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.262 -0.274 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -80.13 -31.77 39.05 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.296 -0.253 . . . . 0.0 110.535 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.03 70.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.999 -0.438 . . . . 0.0 110.116 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 433' ' ' ILE . 5.6 tp -85.49 -30.93 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.2 m -95.04 -19.99 19.7 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -130.63 -12.04 3.88 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.7 -17.9 10.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.114 0.87 . . . . 0.0 110.031 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.17 142.2 21.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.509 0.724 . . . . 0.0 111.439 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.427 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 76.1 m-20 57.15 1.63 0.1 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.952 1.701 . . . . 0.0 115.214 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.92 142.42 27.81 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 120.579 1.536 . . . . 0.0 108.899 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 0.1 OUTLIER -130.68 163.91 26.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 174.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.7 ptm -125.39 143.52 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.651 1.58 . . . . 0.0 109.314 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 64.12 30.91 13.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.002 1.321 . . . . 0.0 114.454 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.93 79.9 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.17 145.02 29.42 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.357 1.079 . . . . 0.0 109.789 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 141.62 37.97 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.051 -0.405 . . . . 0.0 109.934 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.86 122.0 40.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -168.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -140.68 114.37 8.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.427 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.99 141.69 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 CA-C-N 118.29 0.496 . . . . 0.0 110.493 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 34.1 t -160.04 162.71 34.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.379 0.671 . . . . 0.0 109.617 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.18 158.68 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 110.265 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 45.6 t -138.01 151.41 47.87 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -89.43 4.95 47.42 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -59.6 139.11 89.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -23.43 11.55 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.921 2.414 . . . . 0.0 112.249 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.05 170.62 14.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 110.806 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.57 147.41 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.2 mmt -104.62 150.19 38.29 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.432 0.293 . . . . 0.0 110.56 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.29 177.82 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 124.161 3.24 . . . . 0.0 111.927 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 73.78 -176.72 45.57 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.475 0.559 . . . . 0.0 112.354 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 56.77 19.95 4.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.244 1.018 . . . . 0.0 113.62 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.9 m -97.12 142.67 28.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.247 0.476 . . . . 0.0 111.116 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -148.19 174.26 12.15 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.742 1.217 . . . . 0.0 109.217 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.4 135.96 15.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.74 171.39 10.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.729 0.812 . . . . 0.0 110.44 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -68.6 -20.46 64.5 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.645 0.378 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -80.59 1.3 30.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.108 0.563 . . . . 0.0 111.604 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.84 -2.76 72.86 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 122.054 -0.404 . . . . 0.0 112.231 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 28.0 t -93.36 163.4 13.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.182 0.593 . . . . 0.0 109.453 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 48.6 t -84.3 153.19 23.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.043 0.449 . . . . 0.0 110.645 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 59.5 m -64.79 -10.42 27.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.001 0.92 . . . . 0.0 111.343 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -119.2 142.14 48.27 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.801 0.84 . . . . 0.0 110.137 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.16 156.22 38.19 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.675 0.274 . . . . 0.0 110.703 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -124.73 151.03 45.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.24 1.016 . . . . 0.0 109.941 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.02 10.88 2.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.389 0.676 . . . . 0.0 111.755 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 CA--C 1.533 0.3 0 O-C-N 122.056 -0.403 . . . . 0.0 111.732 -173.786 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -69.07 148.25 97.74 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.875 0.87 . . . . 0.0 109.32 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.09 152.44 14.47 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.702 2.935 . . . . 0.0 113.211 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.2 m -123.95 22.01 8.91 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.057 0.543 . . . . 0.0 112.04 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 19.1 m120 59.72 12.55 2.99 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.77 152.35 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.0 mt -125.42 155.49 40.33 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.942 0.497 . . . . 0.0 111.053 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . 0.433 ' CD2' ' CZ ' ' A' ' 503' ' ' PHE . 2.2 t-160 -132.26 137.71 47.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -124.92 149.94 47.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.033 0.533 . . . . 0.0 110.858 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 501' ' ' HIS . 79.3 m-85 -144.3 172.79 12.44 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 111.251 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 49.4 t30 57.57 31.78 20.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.407 1.083 . . . . 0.0 112.993 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -85.14 157.44 59.5 Favored Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.84 158.89 55.25 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.608 2.205 . . . . 0.0 110.446 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 22.1 tp -70.89 -0.97 10.31 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.013 1.325 . . . . 0.0 112.856 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.47 9.53 7.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.99 151.82 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 118.334 0.516 . . . . 0.0 111.259 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.7 p -142.6 171.43 14.06 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.651 0.78 . . . . 0.0 110.071 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.1 -24.29 67.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.519 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.91 -24.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.355 -0.215 . . . . 0.0 110.67 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -76.77 -35.05 57.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -71.13 -23.79 62.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.909 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -79.42 -40.7 29.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.172 0.442 . . . . 0.0 111.009 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.92 -13.04 60.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 85.4 mt -95.5 -32.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.262 0.483 . . . . 0.0 110.403 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.8 m -68.42 -22.8 64.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.408 -0.807 . . . . 0.0 109.568 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.02 -28.78 61.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.645 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -90.98 -12.83 34.73 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.637 0.653 . . . . 0.0 111.636 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.85 -8.96 27.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.966 0.506 . . . . 0.0 111.257 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.19 64.58 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.248 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.1 168.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.156 0.978 . . . . 0.0 111.212 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -68.34 133.93 49.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.029 0.532 . . . . 0.0 110.119 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -78.22 149.34 75.91 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 148.86 90.21 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.811 2.341 . . . . 0.0 110.138 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.417 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.9 m -93.83 -18.97 21.45 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.848 0.459 . . . . 0.0 110.847 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.3 t -149.47 148.79 29.84 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.01 137.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.211 0.604 . . . . 0.0 109.609 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -148.28 104.58 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 89.9 t -126.88 148.01 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.265 0.626 . . . . 0.0 109.925 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -147.64 161.92 40.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.105 0.479 . . . . 0.0 111.937 -176.7 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 89.6 p -140.24 171.54 14.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.5 0.72 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 60.1 m -128.04 150.87 49.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.56 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 58.4 m -147.83 159.9 43.34 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 125.005 1.322 . . . . 0.0 109.353 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.29 -174.97 44.99 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.278 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.4 146.39 28.9 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.33 1.052 . . . . 0.0 110.236 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 5.8 mp -137.66 138.04 39.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -127.74 126.34 41.63 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.417 ' HB3' ' H ' ' A' ' 527' ' ' THR . 8.9 p90 -165.56 148.69 7.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.88 120.4 7.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 42.3 t -159.57 153.34 22.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 168.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -64.79 -52.21 58.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.916 0.78 . . . . 0.0 111.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.9 p -78.7 -27.2 44.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -84.97 -31.11 23.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.786 0.721 . . . . 0.0 111.463 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.41 -30.88 60.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.208 0.458 . . . . 0.0 110.641 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -83.48 -27.15 29.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.37 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -77.37 -39.01 48.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.087 0.403 . . . . 0.0 110.523 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 30.2 m -73.76 -38.66 64.65 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.059 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.0 tm? -65.98 -47.3 75.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.15 -17.29 75.67 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.542 -173.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.47 -11.67 8.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.916 1.358 . . . . 0.0 113.173 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -95.84 -18.05 20.67 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.382 0.537 . . . . 0.0 110.65 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -65.55 144.89 56.7 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.747 -0.596 . . . . 0.0 109.452 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 60.5 t60 55.61 24.72 7.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.569 1.147 . . . . 0.0 113.252 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 151.33 34.69 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -117.76 136.35 53.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.845 1.258 . . . . 0.0 110.701 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 3.7 ttt -64.2 176.4 1.04 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 111.323 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -65.86 141.26 97.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.092 0.86 . . . . 0.0 110.288 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -79.91 -29.42 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.659 2.906 . . . . 0.0 113.796 -169.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -121.05 2.79 10.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.06 0.391 . . . . 0.0 112.029 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 59.45 42.57 97.62 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.768 -1.018 . . . . 0.0 112.792 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.7 Cg_endo -68.67 -9.96 27.67 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.244 2.63 . . . . 0.0 111.608 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -144.12 147.06 36.16 Favored Pre-proline 0 N--CA 1.454 -0.26 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.91 150.61 38.89 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.689 2.926 . . . . 0.0 110.546 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -143.44 -4.15 0.89 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.679 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 72.5 p -66.56 126.46 28.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 35.8 mt -99.47 144.55 28.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.873 0.469 . . . . 0.0 111.905 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -82.01 130.59 35.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -146.45 147.26 31.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 112.016 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.1 p -161.37 169.72 21.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.952 0.901 . . . . 0.0 109.319 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -74.95 140.57 43.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.6 t -135.39 143.6 46.12 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 35.3 m -81.37 102.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.1 161.5 34.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.975 0.91 . . . . 0.0 110.325 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -109.64 -12.13 14.69 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.925 0.49 . . . . 0.0 110.669 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -160.54 168.55 24.79 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.998 0.919 . . . . 0.0 109.132 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -78.74 77.29 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.891 0.476 . . . . 0.0 109.797 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.417 ' HA ' ' HE3' ' A' ' 530' ' ' LYS . 74.7 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.476 -1.25 . . . . 0.0 110.002 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.136 0.493 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -141.17 18.5 2.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.096 0.958 . . . . 0.0 109.814 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.1 m -142.7 153.87 62.07 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 122.848 0.459 . . . . 0.0 110.609 -174.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.38 3.09 7.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.117 3.212 . . . . 0.0 113.225 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.64 161.83 39.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 118.893 0.769 . . . . 0.0 112.866 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . 0.403 ' C ' HD12 ' A' ' 381' ' ' LEU . 3.1 pp -144.81 170.46 16.07 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.23 1.012 . . . . 0.0 109.227 172.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.1 mtp -137.16 148.04 46.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.9 149.21 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.861 0.464 . . . . 0.0 110.661 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -140.01 164.99 28.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.651 0.78 . . . . 0.0 109.823 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.41 -6.79 75.23 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.304 0.478 . . . . 0.0 112.828 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.5 pt? -69.42 174.62 4.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.916 0.858 . . . . 0.0 110.648 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -134.61 146.74 49.86 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -74.66 -1.91 23.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 93.7 p -117.99 -8.49 10.73 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.027 0.376 . . . . 0.0 111.646 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.4 -17.53 13.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 83.0 mmm -139.21 141.28 37.92 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.946 . . . . 0.0 109.758 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.89 173.93 11.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.39 -27.06 67.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.815 0.28 . . . . 0.0 110.947 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -79.37 -33.41 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.213 0.205 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -79.17 -35.57 41.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.746 0.248 . . . . 0.0 110.9 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.8 p -73.87 -26.7 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -66.89 -41.83 86.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.954 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.0 -8.3 57.32 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.0 112.915 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.34 -22.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.706 0.684 . . . . 0.0 110.231 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.52 -14.99 13.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 50.9 t -71.45 -25.59 62.37 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.071 0.851 . . . . 0.0 111.345 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.09 13.39 1.11 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.537 -0.727 . . . . 0.0 112.068 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -121.43 -3.62 9.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 110.841 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.91 165.43 12.79 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.91 150.03 46.14 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.067 -0.666 . . . . 0.0 110.826 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.42 148.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.87 -53.33 2.63 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.954 -0.466 . . . . 0.0 111.212 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.91 162.78 26.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.003 0.43 . . . . 0.0 111.448 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.6 p -143.23 150.42 17.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.08 142.65 22.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.347 0.259 . . . . 0.0 110.388 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -76.89 146.38 37.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 168.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.637 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -130.09 141.48 50.7 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 59.99 33.92 21.43 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.065 1.746 . . . . 0.0 112.495 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 36.7 m 52.97 14.02 0.41 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -77.3 146.96 75.27 Favored Pre-proline 0 N--CA 1.455 -0.218 0 CA-C-N 118.673 0.67 . . . . 0.0 110.1 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.9 -0.81 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.686 2.924 . . . . 0.0 110.849 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.44 40.0 1.01 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.004 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.637 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -148.9 134.84 19.01 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.93 0.865 . . . . 0.0 110.593 174.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.52 169.19 23.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 22.1 ptm -143.19 147.36 34.77 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.316 0.646 . . . . 0.0 110.028 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.5 t -127.87 153.17 36.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.172 0.589 . . . . 0.0 110.333 -172.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -129.48 135.3 48.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.947 0.499 . . . . 0.0 110.59 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.3 165.0 11.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.805 0.842 . . . . 0.0 109.956 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.56 -20.83 62.76 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -156.54 159.64 38.75 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.9 -15.73 71.84 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.215 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -69.29 -28.63 66.45 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 119.116 1.458 . . . . 0.0 110.383 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -76.26 -20.08 57.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 77.7 t -81.18 -28.13 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.98 -34.99 66.8 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -72.63 -31.85 65.46 Favored 'General case' 0 N--CA 1.457 -0.08 0 O-C-N 122.146 -0.347 . . . . 0.0 110.341 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.82 -29.22 58.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.326 -0.234 . . . . 0.0 110.977 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.4 tp -86.33 -30.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 O-C-N 122.36 -0.212 . . . . 0.0 111.112 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 82.7 p -94.83 -6.8 42.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -136.0 -15.63 1.74 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.62 -20.07 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.93 0.786 . . . . 0.0 110.027 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -51.59 144.31 10.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.704 0.802 . . . . 0.0 111.206 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 57.51 1.39 0.12 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.92 2.088 . . . . 0.0 115.526 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.86 142.5 27.76 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.873 1.669 . . . . 0.0 108.726 169.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.298 0.0 OUTLIER -130.94 163.9 26.49 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 172.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 19.2 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.159 1.384 . . . . 0.0 109.904 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . 0.25 29.0 m-85 66.16 27.02 10.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.976 1.311 . . . . 0.0 114.143 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.7 81.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 168.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -83.04 160.54 21.93 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.909 1.354 . . . . 0.0 110.543 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.598 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -86.31 129.41 34.86 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.596 0.758 . . . . 0.0 110.191 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.58 130.35 45.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -140.61 123.61 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.1 140.97 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.396 0.544 . . . . 0.0 110.655 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 71.5 m -147.11 165.24 30.57 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.88 0.872 . . . . 0.0 110.005 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 p -90.64 155.96 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.851 0.46 . . . . 0.0 109.912 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.6 t -133.89 158.95 42.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 123.12 0.568 . . . . 0.0 109.765 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.62 9.41 39.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -68.25 144.52 96.8 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.78 -24.36 11.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.918 2.412 . . . . 0.0 111.772 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -162.86 172.77 14.64 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.151 0.58 . . . . 0.0 109.992 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.71 143.55 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -100.21 155.98 35.8 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.132 0.173 . . . . 0.0 111.334 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.28 164.01 9.36 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.773 2.982 . . . . 0.0 112.227 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.37 178.97 38.25 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -72.66 163.55 27.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.949 0.5 . . . . 0.0 110.786 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.4 p -144.28 160.36 41.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.898 0.479 . . . . 0.0 110.745 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -151.81 165.04 35.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.557 0.743 . . . . 0.0 110.107 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.74 137.92 18.08 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 67.7 mt -87.06 170.47 11.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.719 0.808 . . . . 0.0 110.188 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.23 -20.41 64.82 Favored 'General case' 0 N--CA 1.461 0.115 0 O-C-N 122.142 -0.349 . . . . 0.0 111.752 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -88.39 6.0 39.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.974 0.509 . . . . 0.0 111.664 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.58 84.74 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.468 0.556 . . . . 0.0 112.797 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.8 m -88.76 161.55 16.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.125 0.963 . . . . 0.0 110.527 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.1 m -82.87 153.34 25.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 110.735 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.2 p -67.83 -10.28 51.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.321 0.649 . . . . 0.0 111.531 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -127.62 137.79 52.65 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.141 0.976 . . . . 0.0 110.123 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -156.36 157.58 35.89 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 122.59 0.356 . . . . 0.0 110.922 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.39 156.64 41.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.688 0.795 . . . . 0.0 110.878 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.64 13.71 2.32 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.324 0.649 . . . . 0.0 111.54 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 122.928 0.491 . . . . 0.0 112.025 -174.58 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.45 121.14 79.56 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 119.363 0.983 . . . . 0.0 110.145 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.94 135.15 15.34 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.992 2.462 . . . . 0.0 109.81 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 97.1 p -124.17 -7.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.042 0.537 . . . . 0.0 112.208 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 58.45 18.42 5.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.595 0.758 . . . . 0.0 111.759 -170.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.78 136.71 55.32 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 123.404 0.682 . . . . 0.0 109.7 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.452 HD12 ' CH2' ' A' ' 546' ' ' TRP . 59.0 mt -118.91 148.59 42.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . 0.514 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 16.0 m170 -114.83 154.55 28.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -135.8 149.16 49.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.455 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -146.69 171.74 14.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.822 0.449 . . . . 0.0 110.714 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 26.4 m120 60.73 21.81 11.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.981 . . . . 0.0 113.42 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -78.48 163.35 62.03 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.96 154.43 50.71 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.001 2.467 . . . . 0.0 111.605 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -77.84 -1.0 29.46 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -123.71 12.04 9.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.737 0.415 . . . . 0.0 111.976 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.79 154.99 4.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 121.904 -0.498 . . . . 0.0 111.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.9 p -144.67 170.24 16.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.472 0.709 . . . . 0.0 110.437 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 3.1 pm0 -62.37 -21.97 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.629 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.96 -30.82 69.33 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.976 -0.452 . . . . 0.0 109.921 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -78.36 -32.73 49.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.63 -28.62 67.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.184 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -84.08 -37.57 21.9 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.714 -0.616 . . . . 0.0 111.522 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.5 -9.09 59.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.355 0.525 . . . . 0.0 112.148 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.49 -32.51 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 117.783 0.265 . . . . 0.0 110.387 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 60.2 m -67.39 -21.61 65.59 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.0 -29.84 64.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.93 -16.54 27.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.554 0.615 . . . . 0.0 111.776 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.19 -11.85 42.59 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.53 0.332 . . . . 0.0 111.199 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 4.63 58.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.848 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.65 169.67 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 118.013 0.906 . . . . 0.0 110.603 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.74 153.42 35.04 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -102.43 153.21 38.28 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.459 0.304 . . . . 0.0 110.361 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.5 148.85 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.1 2.533 . . . . 0.0 111.143 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.47 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.5 m -81.97 -25.07 35.11 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.72 0.408 . . . . 0.0 110.555 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.9 t -144.53 158.46 43.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.84 145.31 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 122.84 0.456 . . . . 0.0 110.599 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -144.28 127.15 16.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.681 0.792 . . . . 0.0 108.983 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 32.9 t -130.64 149.03 33.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -143.41 165.87 26.32 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.779 0.324 . . . . 0.0 111.697 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.233 0.186 0 C-N-CA 123.653 0.781 . . . . 0.0 110.526 -179.323 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 49.8 m -141.86 168.48 19.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.372 1.069 . . . . 0.0 109.391 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 23.2 t -127.75 160.07 32.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.275 0.56 . . . . 0.0 111.226 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.1 p -149.64 167.05 27.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.233 1.013 . . . . 0.0 109.785 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.99 -172.88 45.49 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.344 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.51 153.91 39.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.915 0.886 . . . . 0.0 110.365 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.8 mt -138.07 142.22 40.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.383 1.073 . . . . 0.0 108.693 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -127.79 106.49 9.16 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.47 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -166.02 153.49 10.18 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.961 1.304 . . . . 0.0 107.853 168.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -152.82 122.64 6.92 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 45.2 t -159.6 153.04 22.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -66.45 -42.29 87.82 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.545 0.611 . . . . 0.0 110.943 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.4 p -85.76 -29.02 24.18 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -83.39 -28.74 28.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.543 0.611 . . . . 0.0 111.267 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -84.72 -30.0 25.1 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.256 0.48 . . . . 0.0 110.943 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.22 -28.2 34.95 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.419 0.554 . . . . 0.0 111.355 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.11 -40.78 37.18 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.884 -0.51 . . . . 0.0 110.39 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 61.3 m -68.25 -36.18 79.05 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.13 -43.22 95.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.837 -0.539 . . . . 0.0 109.738 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.3 -14.18 79.36 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.619 -1.1 . . . . 0.0 114.094 -173.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -128.54 -10.71 5.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.093 1.446 . . . . 0.0 113.77 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.85 -18.5 29.12 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.301 0.955 . . . . 0.0 109.852 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.477 HD22 ' CD2' ' A' ' 561' ' ' HIS . 1.2 t30 -85.79 153.42 22.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 171.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . 0.477 ' CD2' HD22 ' A' ' 560' ' ' ASN . 78.0 m-70 57.51 15.97 3.05 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . 0.414 ' CZ ' ' CE2' ' A' ' 573' ' ' TYR . 0.0 OUTLIER -79.15 151.48 31.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -112.27 136.28 51.9 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.076 0.95 . . . . 0.0 110.576 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.9 ttt -64.23 176.11 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.775 0.83 . . . . 0.0 111.227 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -73.69 11.79 0.77 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.516 0.726 . . . . 0.0 112.874 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -64.86 144.88 99.02 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.401 0.546 . . . . 0.0 110.646 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.79 -27.78 4.59 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.428 2.752 . . . . 0.0 113.676 -170.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -120.97 -3.29 9.64 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.197 0.453 . . . . 0.0 111.955 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.87 39.71 97.64 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.751 -1.027 . . . . 0.0 113.211 -177.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 93.9 Cg_endo -71.29 -7.97 22.43 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.847 2.365 . . . . 0.0 112.115 -176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -144.22 147.78 38.65 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.157 0.435 . . . . 0.0 110.4 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.32 160.9 38.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.086 3.191 . . . . 0.0 110.902 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . 0.414 ' CE2' ' CZ ' ' A' ' 562' ' ' TYR . 42.4 t80 -141.77 -2.62 1.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.7 t -66.4 132.08 47.51 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 575' ' ' LEU . 2.1 pp -120.23 144.61 47.66 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.748 0.819 . . . . 0.0 110.197 175.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -76.07 148.58 37.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.22 145.0 48.76 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.524 0.729 . . . . 0.0 109.661 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.5 p -163.39 161.37 24.37 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -74.33 131.75 41.42 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.514 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 39.4 t -135.63 137.69 42.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 66.2 m -79.27 102.4 8.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.012 0.435 . . . . 0.0 110.901 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 159.49 40.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.127 0.971 . . . . 0.0 109.245 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -85.99 -25.13 26.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.341 -0.225 . . . . 0.0 110.781 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -164.18 168.6 18.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.625 0.77 . . . . 0.0 109.954 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.22 76.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.179 -179.676 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.139 0.495 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.78 8.03 4.83 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.378 0.671 . . . . 0.0 110.282 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.2 m -146.38 154.67 49.52 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.169 0.588 . . . . 0.0 110.573 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.18 4.52 6.99 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.225 3.283 . . . . 0.0 112.825 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.5 162.28 35.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 119.164 0.893 . . . . 0.0 112.672 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.04 166.06 26.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 109.644 173.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.2 mmm -121.89 150.81 41.44 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.7 0.8 . . . . 0.0 110.149 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.32 145.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -142.79 166.66 24.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.907 0.483 . . . . 0.0 109.898 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.53 -0.6 84.98 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.607 173.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.737 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.11 177.42 5.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.175 0.988 . . . . 0.0 110.727 176.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.46 136.5 52.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.781 0.432 . . . . 0.0 110.231 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -75.77 4.4 8.01 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 18.3 t -112.53 -8.04 13.87 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.753 0.421 . . . . 0.0 111.556 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 -8.42 4.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 111.216 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.1 tpt -142.51 121.0 12.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.576 0.75 . . . . 0.0 109.211 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -141.9 -178.82 5.87 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.765 0.426 . . . . 0.0 110.406 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.2 m -60.5 -22.13 63.2 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.8 -25.88 19.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.829 -0.544 . . . . 0.0 111.637 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -87.82 -23.55 23.99 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.666 0.666 . . . . 0.0 109.873 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.2 p -78.38 -33.9 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.29 -33.77 76.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -71.33 -29.63 65.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.996 -0.44 . . . . 0.0 111.507 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 42.3 t -85.43 -13.02 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.058 -0.401 . . . . 0.0 111.592 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -118.94 -7.07 10.47 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.4 -35.47 75.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.332 0.969 . . . . 0.0 111.204 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.28 12.26 1.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.837 -0.539 . . . . 0.0 112.095 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -121.46 -4.74 9.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.481 0.712 . . . . 0.0 111.132 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.94 175.7 20.08 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.1 146.26 43.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.599 -0.353 . . . . 0.0 110.539 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.95 150.67 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -98.46 -60.48 1.54 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -167.51 166.1 14.37 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.576 0.75 . . . . 0.0 110.474 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.33 146.65 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 123.087 0.555 . . . . 0.0 110.312 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.489 ' HE2' ' CD1' ' A' ' 471' ' ' TYR . 39.0 ttmt -150.22 148.58 29.08 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.184 0.194 . . . . 0.0 111.135 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -82.48 149.07 27.77 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.555 ' HE1' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -135.66 141.43 45.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -168.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt 60.12 33.81 21.19 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 126.713 2.005 . . . . 0.0 114.13 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.7 m 52.91 18.03 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.62 157.59 87.88 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 118.587 0.63 . . . . 0.0 110.393 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.63 -18.82 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.601 2.868 . . . . 0.0 111.948 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -179.24 100.9 0.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.555 ' HB1' ' HE1' ' A' ' 412' ' ' MET . . . -160.91 143.42 12.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.26 171.49 19.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.314 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.0 ptm -144.44 143.96 31.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.35 151.67 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 C-N-CA 123.145 0.578 . . . . 0.0 110.284 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -129.52 137.5 50.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 90.5 mmm -109.22 164.04 12.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.431 0.692 . . . . 0.0 110.025 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.58 64.29 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.457 -0.152 . . . . 0.0 111.078 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -159.73 161.61 34.79 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.494 0.717 . . . . 0.0 109.404 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.96 -16.11 68.01 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.249 -0.751 . . . . 0.0 112.905 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 427' ' ' TYR . 2.5 p90 -65.45 -28.36 69.17 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.048 1.424 . . . . 0.0 110.925 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.0 -19.77 43.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.3 t -80.28 -23.75 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.9 -38.38 88.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.51 -26.37 45.87 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.98 -36.2 59.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.039 0.381 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.5 tp -85.16 -30.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 122.251 -0.281 . . . . 0.0 111.54 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.8 m -91.38 -21.51 20.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -124.57 -14.32 6.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 436' ' ' LEU . 2.4 tm? -115.56 -19.05 10.77 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.947 0.794 . . . . 0.0 110.389 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.97 139.07 23.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.383 0.611 . . . . 0.0 111.36 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.432 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 69.7 m-20 56.76 1.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.212 1.805 . . . . 0.0 115.735 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.77 142.46 27.81 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 120.869 1.668 . . . . 0.0 109.144 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.297 0.1 OUTLIER -130.9 163.84 26.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 174.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.2 ptm -125.29 143.33 51.01 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.029 1.331 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 63.05 33.07 14.99 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.33 15.6 78.05 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.95 140.9 32.53 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.323 1.061 . . . . 0.0 109.496 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -77.72 141.38 39.36 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.81 125.34 41.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -168.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -140.71 112.07 7.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.432 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.71 134.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.054 0.388 . . . . 0.0 110.715 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 81.6 m -149.52 165.04 33.37 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 124.394 1.078 . . . . 0.0 109.855 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.8 156.8 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.0 t -135.26 159.59 41.07 Favored 'General case' 0 C--O 1.23 0.046 0 C-N-CA 122.961 0.504 . . . . 0.0 110.333 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -99.3 5.76 46.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -67.03 144.92 98.75 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.796 -0.565 . . . . 0.0 109.551 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.92 -26.1 8.29 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.079 2.519 . . . . 0.0 112.244 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.6 173.59 11.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.051 0.54 . . . . 0.0 110.328 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.04 141.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.68 153.2 55.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 C-N-CA 122.208 0.203 . . . . 0.0 111.138 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.41 156.45 65.59 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.51 2.807 . . . . 0.0 111.231 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.25 169.14 28.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -78.28 157.82 29.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.752 0.421 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.9 p -134.27 159.78 39.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.987 0.515 . . . . 0.0 110.662 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -155.73 168.07 28.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.07 0.548 . . . . 0.0 109.732 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -76.91 140.83 25.44 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.69 170.75 13.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.874 0.87 . . . . 0.0 109.418 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.4 -20.03 65.48 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -90.14 5.27 47.59 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.24 85.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.017 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.4 m -89.14 155.76 19.23 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 118.413 1.107 . . . . 0.0 110.201 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.9 m -81.79 150.36 27.93 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.145 -0.347 . . . . 0.0 111.162 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -73.21 -10.37 59.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.785 0.434 . . . . 0.0 111.969 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . 0.489 ' CD1' ' HE2' ' A' ' 410' ' ' LYS . 41.8 t80 -139.05 141.11 38.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.68 0.792 . . . . 0.0 110.699 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -156.77 153.35 28.22 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.807 0.443 . . . . 0.0 110.603 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.06 154.07 40.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.194 0.998 . . . . 0.0 109.701 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -135.93 -3.77 2.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.034 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -74.28 157.91 86.03 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.808 0.843 . . . . 0.0 109.786 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.38 133.88 31.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.978 2.452 . . . . 0.0 110.401 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.0 m -124.17 23.99 8.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.885 0.874 . . . . 0.0 111.73 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.31 17.63 3.81 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.675 1.59 . . . . 0.0 114.674 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.9 t -140.57 144.66 26.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.446 HD12 ' CH2' ' A' ' 546' ' ' TRP . 70.5 mt -123.31 163.56 20.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.14 0.576 . . . . 0.0 110.465 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.24 160.6 41.76 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.69 0.396 . . . . 0.0 110.523 174.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -136.59 155.53 49.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.336 0.654 . . . . 0.0 110.821 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -146.12 173.92 11.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.484 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.6 t30 62.35 33.98 16.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.373 1.069 . . . . 0.0 112.566 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -90.0 158.7 44.03 Favored Pre-proline 0 N--CA 1.454 -0.251 0 C-N-CA 122.744 0.418 . . . . 0.0 110.203 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 153.16 72.54 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.362 2.042 . . . . 0.0 109.558 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -70.93 -1.21 11.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.75 8.26 20.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.4 p -79.16 151.92 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.324 0.511 . . . . 0.0 110.938 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.3 p -144.72 171.93 13.71 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.437 0.695 . . . . 0.0 110.274 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.44 -19.87 65.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.88 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -72.33 -23.91 61.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.42 -31.48 26.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -70.66 -29.87 66.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.953 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -84.17 -36.2 23.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.435 0.561 . . . . 0.0 111.668 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.71 -21.89 59.13 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.384 0.538 . . . . 0.0 111.752 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.8 mt -92.77 -33.96 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 117.854 0.297 . . . . 0.0 110.614 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 87.4 m -68.29 -21.03 64.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.445 -0.784 . . . . 0.0 110.74 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.15 -30.8 65.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.378 -0.201 . . . . 0.0 111.507 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.03 -13.42 33.27 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.31 0.505 . . . . 0.0 111.997 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.25 -11.03 33.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.519 0.328 . . . . 0.0 111.102 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.72 4.67 62.3 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.408 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.9 162.06 3.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 118.24 1.02 . . . . 0.0 110.697 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -69.49 142.91 53.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -92.32 151.47 41.53 Favored Pre-proline 0 CA--C 1.528 0.132 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.08 154.7 71.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.204 2.603 . . . . 0.0 110.329 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 99.0 m -89.95 -26.76 20.23 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 122.722 0.409 . . . . 0.0 110.859 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 52.0 m -141.51 152.76 44.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 3.5 p -149.56 147.12 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.878 0.471 . . . . 0.0 110.72 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 122.55 9.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.77 145.93 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.79 0.436 . . . . 0.0 110.329 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -155.12 151.37 28.21 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.88 0.472 . . . . 0.0 110.38 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.232 0.156 0 C-N-CA 122.918 0.487 . . . . 0.0 110.892 -178.766 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 69.8 m -139.27 162.74 34.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.15 0.58 . . . . 0.0 110.487 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 35.1 t -127.39 158.44 37.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.672 0.789 . . . . 0.0 111.877 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -154.29 168.32 26.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.103 1.361 . . . . 0.0 109.59 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.31 -178.86 48.28 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.911 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.22 154.24 28.24 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.3 mt -139.2 134.47 32.79 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.441 1.096 . . . . 0.0 108.703 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.85 114.89 17.8 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.446 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.3 p90 -166.11 155.0 11.28 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -150.66 117.48 5.85 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.979 1.104 . . . . 0.0 113.979 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 48.2 t -159.49 153.05 22.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 168.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -65.87 -42.41 90.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.389 0.54 . . . . 0.0 110.491 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 71.9 p -82.29 -26.3 33.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -81.94 -35.24 29.31 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.63 0.65 . . . . 0.0 110.89 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -77.65 -29.6 51.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.407 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.28 -28.22 23.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.397 0.544 . . . . 0.0 111.568 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -75.19 -34.84 61.57 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.458 0.572 . . . . 0.0 110.041 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 41.3 m -72.88 -40.99 65.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 28.7 tp -59.92 -52.26 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.242 -0.911 . . . . 0.0 109.164 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.6 -11.69 72.95 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.591 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.43 -4.27 2.64 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 119.476 1.638 . . . . 0.0 113.869 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 559' ' ' LEU . 2.0 tm? -97.48 -30.28 12.98 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.771 0.714 . . . . 0.0 109.561 176.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -67.42 155.86 37.96 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.355 -0.841 . . . . 0.0 109.279 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 34.4 m80 61.25 18.82 9.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.396 1.078 . . . . 0.0 113.643 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.46 151.45 27.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.332 0.587 . . . . 0.0 112.308 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -120.71 136.36 54.88 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.189 0.996 . . . . 0.0 110.734 -175.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . 0.441 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 6.3 ttt -64.21 175.39 1.29 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.657 0.783 . . . . 0.0 111.575 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 564' ' ' MET . 48.6 mtmt -70.32 5.82 1.59 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.053 0.941 . . . . 0.0 113.233 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -64.52 142.54 98.45 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.058 0.844 . . . . 0.0 110.895 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.57 -28.23 3.63 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.662 2.908 . . . . 0.0 113.782 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.09 1.27 10.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.257 0.48 . . . . 0.0 111.788 -175.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.444 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.52 40.14 98.29 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.293 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.2 Cg_endo -68.26 -9.07 24.72 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.076 2.517 . . . . 0.0 111.802 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -145.53 145.94 27.82 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.55 156.46 40.57 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.801 3.0 . . . . 0.0 110.848 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -142.29 -1.59 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.2 m -66.47 120.92 14.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 29.3 mt -98.82 144.49 27.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.563 0.745 . . . . 0.0 110.329 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -93.77 136.8 33.68 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.58 156.33 43.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.843 0.354 . . . . 0.0 111.647 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 22.4 p -163.72 -179.99 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.763 0.825 . . . . 0.0 110.084 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -75.6 143.63 42.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.518 0.327 . . . . 0.0 111.163 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.1 t -135.52 142.84 45.49 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.253 0.621 . . . . 0.0 110.501 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 59.8 m -90.75 102.21 14.97 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.2 161.51 34.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.558 0.743 . . . . 0.0 110.663 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -110.76 -8.24 14.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.868 0.467 . . . . 0.0 110.59 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -159.82 161.95 34.63 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.22 1.008 . . . . 0.0 109.394 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -83.67 76.41 9.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.466 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.9 -6.69 42.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.559 0.344 . . . . 0.0 111.624 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.8 m -147.22 152.37 42.78 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -86.42 0.17 8.08 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.787 3.658 . . . . 0.0 112.246 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.8 151.74 36.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 118.472 0.578 . . . . 0.0 111.244 -174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -146.71 169.14 19.66 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.205 0.602 . . . . 0.0 110.183 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.4 mtp -135.08 154.06 51.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.286 0.234 . . . . 0.0 110.853 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.1 p -144.41 150.76 16.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 122.711 0.404 . . . . 0.0 110.948 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.17 168.78 18.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.856 0.862 . . . . 0.0 109.141 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.56 -3.29 86.9 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.766 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.734 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.2 pt? -72.7 176.65 5.36 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.654 0.727 . . . . 0.0 110.319 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -145.12 134.89 23.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -70.03 -5.06 23.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 97.1 p -93.86 -11.72 30.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 0.61 0.92 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.5 tpt -136.85 123.94 21.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -141.93 177.24 8.33 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.42 0.288 . . . . 0.0 111.029 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 77.1 m -59.03 -26.38 64.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.063 0.545 . . . . 0.0 111.897 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -82.92 -22.68 33.79 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.27 -0.269 . . . . 0.0 111.078 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -85.95 -36.45 19.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.87 -28.37 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.65 -38.27 83.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.095 -0.378 . . . . 0.0 110.038 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -80.73 -29.68 36.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.735 0.698 . . . . 0.0 112.664 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.41 -20.74 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 118.628 0.649 . . . . 0.0 110.789 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -113.69 -19.93 11.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 44.9 t -73.87 -26.81 60.76 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.564 1.075 . . . . 0.0 111.14 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.49 7.47 1.83 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.498 -0.751 . . . . 0.0 111.406 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.41 -0.04 9.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.014 0.926 . . . . 0.0 111.463 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 428' ' ' ALA . . . 155.01 170.88 21.15 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.38 150.1 48.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.033 0.444 . . . . 0.0 111.338 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 7.2 m -117.67 164.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -134.92 -52.23 0.79 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.171 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -163.8 163.18 24.01 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.655 0.661 . . . . 0.0 112.176 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.82 153.3 13.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.853 0.861 . . . . 0.0 110.44 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -151.97 145.58 24.96 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.47 0.308 . . . . 0.0 110.335 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.36 163.24 25.01 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 30.6 ttp -123.14 141.11 52.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 49.47 33.93 6.19 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.2 1.4 . . . . 0.0 112.311 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 24.3 m 52.95 18.23 1.04 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.146 0.978 . . . . 0.0 113.303 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.38 147.21 67.93 Favored Pre-proline 0 N--CA 1.456 -0.125 0 O-C-N 121.929 -0.482 . . . . 0.0 109.859 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -79.18 -2.44 12.36 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.495 2.797 . . . . 0.0 110.678 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -137.62 30.67 2.57 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.427 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.31 137.03 22.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.158 0.979 . . . . 0.0 110.149 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.11 167.72 29.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.74 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.8 ptm -142.54 142.02 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.776 0.831 . . . . 0.0 109.663 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.81 147.49 23.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.65 0.38 . . . . 0.0 110.916 -173.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -124.88 145.12 49.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.983 0.513 . . . . 0.0 111.154 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 78.5 mmm -111.61 162.74 14.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.334 1.054 . . . . 0.0 109.397 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.84 -20.84 62.51 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.027 -0.421 . . . . 0.0 111.8 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.23 161.4 39.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.119 0.568 . . . . 0.0 109.791 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.59 -12.92 70.84 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.177 -0.79 . . . . 0.0 113.553 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.49 -27.3 66.89 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.411 1.605 . . . . 0.0 110.24 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 404' ' ' GLY . . . -78.7 -28.74 45.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.687 0.28 . . . . 0.0 110.256 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.0 t -75.66 -24.83 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.37 -39.88 67.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.127 -0.358 . . . . 0.0 110.957 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.68 67.93 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.87 -33.39 34.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.14 -0.35 . . . . 0.0 111.931 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -83.06 -30.98 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.871 -0.518 . . . . 0.0 111.36 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.8 m -98.62 -14.14 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.35 -8.43 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.69 -20.11 10.25 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.281 0.946 . . . . 0.0 109.578 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -52.01 143.63 13.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.703 0.801 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.2 1.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.367 2.267 . . . . 0.0 115.971 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.77 142.32 27.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.647 1.567 . . . . 0.0 108.679 169.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.363 0.0 OUTLIER -130.92 165.07 23.9 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.9 ptp -125.13 143.53 50.88 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.011 1.324 . . . . 0.0 109.632 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 66.18 26.45 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.12 15.76 74.65 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -83.0 161.89 21.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.531 1.166 . . . . 0.0 110.087 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -83.79 132.4 34.83 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.48 133.83 42.3 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.76 117.23 10.79 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.69 143.73 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.236 0.471 . . . . 0.0 110.19 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 26.3 t -158.94 160.41 36.01 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.666 0.386 . . . . 0.0 110.057 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.14 158.22 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.677 0.391 . . . . 0.0 110.055 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.8 t -133.1 158.76 41.97 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.262 0.625 . . . . 0.0 109.837 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -110.86 14.02 22.17 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -66.94 151.07 97.44 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.31 -28.5 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.783 2.322 . . . . 0.0 111.862 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.66 172.23 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.284 0.634 . . . . 0.0 110.254 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.6 mm -66.44 137.81 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -89.01 149.3 43.01 Favored Pre-proline 0 N--CA 1.455 -0.179 0 O-C-N 122.404 -0.185 . . . . 0.0 110.869 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.17 162.77 39.83 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.665 2.91 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 168.03 -177.55 42.19 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -75.78 162.64 28.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.5 p -136.9 162.62 32.76 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.843 0.457 . . . . 0.0 110.914 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.55 163.42 32.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.569 0.748 . . . . 0.0 109.617 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.68 134.34 13.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.76 171.11 11.16 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.493 0.717 . . . . 0.0 110.063 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.02 -20.47 66.2 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.557 0.343 . . . . 0.0 111.432 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.72 1.94 47.43 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.838 0.455 . . . . 0.0 111.603 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.24 -3.68 85.5 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.874 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 68.4 m -91.38 159.14 16.14 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 118.196 0.998 . . . . 0.0 110.525 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.8 m -80.0 153.46 28.85 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.511 0.324 . . . . 0.0 110.478 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.0 p -70.01 -10.41 58.57 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.339 0.656 . . . . 0.0 111.656 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -126.53 139.28 53.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.307 1.043 . . . . 0.0 109.272 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -155.83 156.15 34.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.231 0.212 . . . . 0.0 110.845 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.22 156.37 35.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.879 0.872 . . . . 0.0 110.704 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -139.93 16.91 2.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.395 0.678 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.741 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.723 0.296 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -66.93 164.89 30.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.637 0.775 . . . . 0.0 110.044 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.9 145.75 23.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.915 3.076 . . . . 0.0 113.523 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 49.1 m -124.11 23.7 8.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.729 0.812 . . . . 0.0 111.809 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 60.54 10.23 2.44 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.22 1.408 . . . . 0.0 114.306 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 29.8 t -140.41 144.96 26.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . 0.444 HD12 ' CH2' ' A' ' 546' ' ' TRP . 65.5 mt -122.79 150.53 42.69 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.804 0.441 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.92 150.12 50.02 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.212 0.605 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.71 151.91 47.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -145.47 169.21 18.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.85 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.7 t30 58.56 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.023 0.929 . . . . 0.0 112.487 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.8 163.41 49.08 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 122.778 0.431 . . . . 0.0 109.863 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.83 150.53 62.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.853 2.369 . . . . 0.0 111.549 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.47 ' H ' ' CD2' ' A' ' 507' ' ' LEU . 1.8 pt? -72.85 -1.09 15.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.48 13.58 5.0 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -76.26 154.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.129 0.422 . . . . 0.0 110.578 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 66.3 p -142.22 171.04 14.6 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.961 0.504 . . . . 0.0 110.088 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.64 -22.03 66.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.097 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.81 -26.08 56.92 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.24 -0.287 . . . . 0.0 110.71 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -79.04 -30.98 44.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.77 -30.02 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.398 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -76.78 -39.85 50.19 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.1 0.409 . . . . 0.0 111.672 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.94 -18.19 56.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.732 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.23 -33.9 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.222 0.464 . . . . 0.0 110.251 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.84 -21.65 65.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.556 -0.715 . . . . 0.0 110.174 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.96 -28.86 60.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.769 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.99 -14.35 31.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.345 0.521 . . . . 0.0 111.892 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.6 mt -95.4 -7.05 39.49 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.566 0.346 . . . . 0.0 110.903 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.36 4.72 61.14 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.224 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.6 m -80.67 169.47 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.092 0.946 . . . . 0.0 111.033 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -80.91 147.62 30.24 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.984 0.513 . . . . 0.0 110.736 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -88.29 147.53 40.42 Favored Pre-proline 0 C--O 1.232 0.132 0 C-N-CA 123.064 0.546 . . . . 0.0 109.964 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.53 156.13 61.96 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.534 2.823 . . . . 0.0 110.195 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.43 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.2 m -86.95 -25.91 24.12 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.341 0.256 . . . . 0.0 110.608 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.7 m -144.52 151.76 39.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.865 0.466 . . . . 0.0 109.824 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.57 144.56 29.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 123.496 0.718 . . . . 0.0 109.124 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 124.13 11.45 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.08 151.57 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -145.66 147.51 32.07 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.941 0.4 . . . . 0.0 111.694 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.7 t . . . . . 0 N--CA 1.454 -0.256 0 C-N-CA 123.924 0.889 . . . . 0.0 109.066 172.221 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 79.8 p -152.52 175.32 12.88 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.595 1.158 . . . . 0.0 109.898 177.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 69.2 m -132.16 161.18 33.98 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.885 0.474 . . . . 0.0 110.934 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.2 m -145.53 159.59 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.912 0.885 . . . . 0.0 109.606 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -174.86 -175.74 42.6 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.638 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.78 155.37 34.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.898 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.4 mt -135.91 132.6 36.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.489 1.116 . . . . 0.0 108.042 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.76 112.56 14.93 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.444 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.2 p90 -166.04 155.42 11.81 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.59 1.556 . . . . 0.0 107.368 168.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -150.01 122.89 8.73 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.2 t -159.53 152.97 22.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.64 -46.83 77.72 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.778 0.717 . . . . 0.0 111.213 -174.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 78.2 p -84.34 -25.4 29.22 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -85.36 -28.58 25.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.725 0.693 . . . . 0.0 111.271 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.247 0.476 . . . . 0.0 110.663 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.97 -29.84 35.22 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.19 0.45 . . . . 0.0 111.045 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -77.83 -38.56 45.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.352 0.524 . . . . 0.0 110.179 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 38.2 m -73.21 -42.64 62.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . 0.446 ' C ' HD13 ' A' ' 556' ' ' LEU . 2.3 tm? -60.54 -46.61 89.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -67.53 -14.87 65.38 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.355 -1.247 . . . . 0.0 114.032 -172.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.07 -6.81 2.69 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.327 1.564 . . . . 0.0 113.976 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.95 -22.3 25.69 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.557 0.617 . . . . 0.0 109.749 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.08 151.51 30.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.22 -0.3 . . . . 0.0 111.023 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 49.24 30.0 2.9 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 151.42 25.65 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -110.91 136.33 50.1 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.213 1.405 . . . . 0.0 110.628 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.2 ttt -64.28 174.95 1.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.154 0.982 . . . . 0.0 112.18 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.87 12.58 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.37 1.068 . . . . 0.0 112.835 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.48 141.41 88.05 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.21 0.604 . . . . 0.0 111.147 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.55 -29.8 2.18 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.356 2.704 . . . . 0.0 113.021 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -121.05 -7.9 9.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.395 0.516 . . . . 0.0 112.395 -177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.12 42.84 97.9 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.412 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 88.8 Cg_endo -71.9 -6.55 19.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.134 2.556 . . . . 0.0 112.208 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.1 149.98 47.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.135 0.574 . . . . 0.0 110.341 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.44 156.24 41.03 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.627 2.885 . . . . 0.0 110.595 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -137.87 -2.46 1.91 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.524 0.33 . . . . 0.0 111.478 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.0 t -66.69 131.95 47.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.164 0.507 . . . . 0.0 110.73 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 575' ' ' LEU . 0.9 OUTLIER -125.03 144.6 50.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.595 1.158 . . . . 0.0 109.638 177.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -72.48 147.08 46.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 54.9 tp -142.05 144.7 33.73 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.97 172.64 13.64 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 111.502 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -88.46 132.94 34.27 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.2 t -135.57 150.67 49.77 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.068 0.147 . . . . 0.0 110.783 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 40.9 m -87.1 102.56 14.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.945 0.403 . . . . 0.0 111.154 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.39 34.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.697 0.799 . . . . 0.0 109.892 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -109.7 -14.06 14.4 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.939 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -160.84 164.83 31.05 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.485 0.714 . . . . 0.0 109.457 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.52 102.9 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.645 -178.448 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.0 1.4 3.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 50.0 m -145.42 151.7 47.97 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 117.872 0.306 . . . . 0.0 111.285 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.26 -3.06 10.17 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 124.339 3.36 . . . . 0.0 111.934 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.03 151.74 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.286 0.494 . . . . 0.0 111.585 -173.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.72 174.58 11.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.728 0.811 . . . . 0.0 110.27 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.7 mtp -135.4 149.89 49.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.422 0.289 . . . . 0.0 111.207 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.5 148.77 28.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.574 0.75 . . . . 0.0 109.971 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -139.4 168.4 19.9 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.992 0.517 . . . . 0.0 110.289 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.03 -6.05 68.65 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.411 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.615 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.3 pt? -71.85 -175.48 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.163 0.982 . . . . 0.0 110.598 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -146.12 149.7 34.51 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 121.981 -0.449 . . . . 0.0 110.559 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -76.2 -2.08 29.47 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 m -108.89 -4.1 17.07 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.608 0.363 . . . . 0.0 111.701 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -130.27 -12.28 4.04 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.014 0.526 . . . . 0.0 111.011 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 85.5 mtp -141.28 135.25 30.43 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.923 0.489 . . . . 0.0 110.342 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 29.0 m120 -141.87 174.14 10.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.35 -31.15 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.783 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.18 -25.3 29.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . 0.402 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 59.6 mtt85 -89.15 -28.72 19.85 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 122.234 0.214 . . . . 0.0 110.902 -178.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.73 -26.76 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -66.8 -35.56 80.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.46 -30.4 70.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.195 -0.316 . . . . 0.0 110.83 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.74 -21.6 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -110.44 -10.69 14.55 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.0 t -70.4 -36.38 74.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.851 0.75 . . . . 0.0 111.977 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.96 13.29 1.45 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.715 -0.616 . . . . 0.0 112.251 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -121.41 -1.27 9.66 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.469 0.707 . . . . 0.0 110.861 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 141.16 174.1 14.0 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -75.83 145.16 40.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.534 -0.392 . . . . 0.0 110.685 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.59 154.28 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -105.02 -55.86 2.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 110.523 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -164.47 162.25 21.83 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.105 0.479 . . . . 0.0 111.202 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 15.0 p -145.88 151.28 14.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.8 0.84 . . . . 0.0 110.249 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -154.07 147.19 24.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.335 0.254 . . . . 0.0 110.928 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -76.77 146.99 37.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' MET . . . . . 0.47 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -133.12 141.54 48.22 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -167.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.36 33.99 20.74 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.343 1.457 . . . . 0.0 112.647 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 54.59 19.94 2.66 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -103.82 141.27 22.17 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.02 -14.63 21.03 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.915 2.41 . . . . 0.0 109.622 171.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.05 65.96 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.378 0.989 . . . . 0.0 112.418 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . 0.47 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -147.75 129.91 15.52 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.303 1.052 . . . . 0.0 111.17 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -150.75 167.37 27.62 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.326 0.651 . . . . 0.0 110.891 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 20.2 ptm -144.78 143.98 30.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.656 0.382 . . . . 0.0 110.207 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.64 143.06 41.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.08 0.552 . . . . 0.0 110.694 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -126.54 138.0 53.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.201 0.6 . . . . 0.0 110.135 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 85.6 mmm -102.52 164.95 11.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.0 110.322 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.3 -20.74 62.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.451 -0.155 . . . . 0.0 111.221 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -158.06 161.54 38.03 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.302 0.641 . . . . 0.0 109.74 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.24 -14.33 68.62 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.414 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -67.44 -25.59 65.98 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.064 1.432 . . . . 0.0 110.446 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.58 -18.1 28.79 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.17 0.188 . . . . 0.0 111.182 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.72 -31.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.86 -31.86 71.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -79.62 -29.18 40.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.823 0.449 . . . . 0.0 110.864 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.34 -32.23 26.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.251 0.478 . . . . 0.0 110.819 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 433' ' ' ILE . 6.9 tp -79.22 -31.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 122.166 -0.334 . . . . 0.0 111.279 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -97.1 -21.33 17.42 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -122.54 -12.68 8.12 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.3 -20.21 10.43 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 118.864 0.756 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -55.58 144.82 25.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.794 0.838 . . . . 0.0 110.581 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 60.01 1.31 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.772 2.029 . . . . 0.0 114.89 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -88.14 142.68 27.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.397 1.453 . . . . 0.0 109.047 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.307 0.1 OUTLIER -130.81 163.93 26.29 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.5 ptm -125.36 143.43 50.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.655 1.182 . . . . 0.0 108.804 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 62.86 28.42 16.38 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.86 72.24 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -83.07 152.58 25.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.432 1.616 . . . . 0.0 111.095 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 141.83 36.26 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.5 122.02 35.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -168.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.96 118.88 11.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.437 0.695 . . . . 0.0 109.28 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 3.1 p -154.47 138.23 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.164 0.438 . . . . 0.0 110.275 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.9 m -147.69 155.51 41.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.38 157.06 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 48.1 t -130.1 167.57 18.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.118 0.567 . . . . 0.0 109.991 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -119.47 12.43 12.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.848 0.459 . . . . 0.0 111.997 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -63.94 150.79 90.92 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.51 -30.58 9.78 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.472 2.114 . . . . 0.0 111.849 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.58 164.78 10.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.711 0.405 . . . . 0.0 110.77 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.7 mm -70.56 140.31 18.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.0 mmt -102.26 130.38 24.3 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.97 -31.52 9.8 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.6 2.2 . . . . 0.0 112.196 -172.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 58.52 -152.48 30.33 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -101.67 -15.41 17.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.737 0.415 . . . . 0.0 110.543 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 3.1 m 55.86 176.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.671 1.588 . . . . 0.0 113.442 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -153.8 165.34 36.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.519 0.728 . . . . 0.0 109.275 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -86.61 123.85 6.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.97 176.48 7.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.932 0.493 . . . . 0.0 111.228 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -59.96 -24.57 64.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.1 -0.61 25.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.912 -0.492 . . . . 0.0 111.389 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.98 -3.8 78.5 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.614 0.626 . . . . 0.0 112.112 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 23.2 t -93.64 170.32 9.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.515 0.726 . . . . 0.0 110.329 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 16.4 p -85.67 153.32 22.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.99 0.424 . . . . 0.0 111.165 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.0 m -71.7 -10.39 59.69 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.546 0.738 . . . . 0.0 112.576 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -120.14 143.48 48.17 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.068 0.547 . . . . 0.0 110.87 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -153.8 156.55 37.9 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.692 0.397 . . . . 0.0 110.354 177.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -133.17 156.43 47.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.82 15.13 1.94 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.978 0.511 . . . . 0.0 111.608 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.7 p . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.045 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -65.61 162.87 39.15 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.078 0.551 . . . . 0.0 110.3 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.37 145.97 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.519 2.813 . . . . 0.0 112.489 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.7 m -124.05 24.0 8.34 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.452 0.701 . . . . 0.0 111.402 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.81 12.04 2.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.538 1.135 . . . . 0.0 113.618 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.71 151.18 22.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.3 mt -132.4 151.22 51.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.652 0.781 . . . . 0.0 109.689 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -121.09 142.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 544' ' ' LEU . 11.3 m-85 -125.33 148.02 48.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.206 0.602 . . . . 0.0 110.503 -175.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -144.6 172.71 12.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.737 0.415 . . . . 0.0 111.035 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 66.8 t30 62.23 32.21 17.28 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.325 1.05 . . . . 0.0 113.126 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -89.22 158.29 46.7 Favored Pre-proline 0 N--CA 1.454 -0.242 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 156.81 52.07 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.242 1.961 . . . . 0.0 109.645 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.9 pt? -68.33 -1.17 5.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.666 0.787 . . . . 0.0 112.866 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.52 11.58 12.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.6 p -76.59 153.63 5.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 118.287 0.494 . . . . 0.0 110.725 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 78.4 p -143.76 169.24 18.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.278 0.631 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.04 -24.62 68.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.253 -0.28 . . . . 0.0 110.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.13 -26.01 60.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -78.31 -32.22 49.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.85 -28.54 64.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.236 -0.29 . . . . 0.0 110.708 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -80.37 -36.43 33.97 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.024 0.375 . . . . 0.0 111.941 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.65 -19.5 38.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 80.6 mt -86.86 -34.46 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.11 -21.73 64.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.693 -0.629 . . . . 0.0 109.824 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.54 -31.17 68.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -91.14 -15.9 28.64 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.209 0.459 . . . . 0.0 111.947 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.5 mt -91.52 -9.73 43.32 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.637 0.199 . . . . 0.0 111.201 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.53 4.63 57.98 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.958 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.51 165.64 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.998 0.899 . . . . 0.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -72.2 123.95 24.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -76.59 150.79 82.37 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -63.71 151.03 86.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.84 2.36 . . . . 0.0 110.721 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.6 m -88.23 -19.99 26.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.866 0.467 . . . . 0.0 110.903 -175.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.1 t -146.64 154.16 41.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.37 138.9 46.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 122.413 0.285 . . . . 0.0 110.896 -175.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -147.1 125.49 12.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.191 0.996 . . . . 0.0 108.352 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.63 150.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 C-N-CA 122.728 0.411 . . . . 0.0 110.333 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -145.0 161.12 40.18 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.779 0.832 . . . . 0.0 109.119 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.457 -0.115 0 C-N-CA 122.403 0.281 . . . . 0.0 111.075 -176.675 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.3 t -140.61 158.13 44.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.979 0.512 . . . . 0.0 110.147 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.8 m -125.13 153.43 43.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.612 0.765 . . . . 0.0 112.034 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.0 m -147.9 162.14 39.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.478 1.511 . . . . 0.0 108.528 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.07 177.8 39.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.475 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.488 ' C ' HD22 ' A' ' 544' ' ' LEU . 84.6 mt -98.91 139.47 34.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.817 -173.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 502' ' ' PHE . 3.6 mm? -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -127.87 116.37 20.03 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' TRP . . . . . 0.411 ' HB3' ' H ' ' A' ' 527' ' ' THR . 3.0 p90 -166.09 150.47 8.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.744 1.618 . . . . 0.0 107.058 168.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.58 120.83 7.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 42.3 t -159.48 152.9 22.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -66.45 -46.1 77.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.97 0.804 . . . . 0.0 111.17 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 68.6 p -84.34 -33.3 23.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.859 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 38.3 m-20 -76.5 -31.31 57.63 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.843 0.747 . . . . 0.0 110.903 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.95 -31.28 58.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.052 0.387 . . . . 0.0 110.752 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.13 -29.73 38.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.132 0.424 . . . . 0.0 111.575 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -71.86 -40.7 68.8 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.39 . . . . 0.0 109.992 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 33.1 m -70.1 -31.68 69.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.41 -45.87 85.74 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.335 -0.853 . . . . 0.0 110.529 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.21 -27.19 70.51 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.041 -0.866 . . . . 0.0 113.421 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.75 -10.7 13.58 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.627 1.213 . . . . 0.0 114.198 -176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 559' ' ' LEU . 0.4 OUTLIER -99.62 -26.84 13.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.304 0.956 . . . . 0.0 110.941 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -60.39 138.21 58.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.059 -1.026 . . . . 0.0 110.951 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 40.3 m170 51.61 26.33 3.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.409 1.084 . . . . 0.0 113.544 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.4 151.36 47.57 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.173 0.511 . . . . 0.0 112.336 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -103.69 136.4 43.46 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.183 0.993 . . . . 0.0 110.694 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 564' ' ' MET . . . . . 0.401 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.4 ttt -64.34 174.92 1.47 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.06 0.544 . . . . 0.0 111.255 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -75.32 11.91 1.09 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -68.68 146.67 97.75 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 118.271 0.487 . . . . 0.0 110.332 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.39 -37.95 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.252 2.634 . . . . 0.0 113.831 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -121.03 6.83 10.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 569' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.1 45.24 92.52 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.107 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 570' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.4 Cg_endo -68.99 -9.8 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.22 2.613 . . . . 0.0 111.866 -178.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -146.17 149.07 37.22 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.011 0.524 . . . . 0.0 109.721 174.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.83 148.96 41.83 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.903 3.068 . . . . 0.0 110.97 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 573' ' ' TYR . . . . . 0.401 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.5 t80 -149.92 15.47 0.84 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.847 0.459 . . . . 0.0 110.932 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 81.9 p -80.18 91.06 5.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.123 -0.986 . . . . 0.0 110.752 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.94 144.55 38.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -107.61 154.02 22.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 577' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 577' ' ' LEU . 2.1 pt? -143.44 151.54 40.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 111.437 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.64 163.79 39.47 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.699 0.8 . . . . 0.0 110.032 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.38 140.58 50.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 73.8 p -135.58 143.47 45.66 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.553 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 28.0 p -84.4 102.26 12.62 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.45 34.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.664 0.786 . . . . 0.0 110.976 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.67 -8.64 12.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.036 0.535 . . . . 0.0 110.595 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -160.92 162.9 32.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.016 0.926 . . . . 0.0 109.326 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.93 76.4 9.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.866 178.857 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -145.17 136.54 25.12 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.919 0.488 . . . . 0.0 109.979 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 67.12 -179.21 14.72 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.675 0.655 . . . . 0.0 112.741 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.21 -172.89 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 125.028 3.819 . . . . 0.0 110.217 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -138.1 150.76 47.16 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.613 0.365 . . . . 0.0 110.568 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -81.01 167.1 20.18 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.925 0.49 . . . . 0.0 111.125 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.86 -5.88 24.24 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.077 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.6 m -148.47 152.73 39.1 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -85.48 2.35 7.77 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.659 3.573 . . . . 0.0 112.34 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.94 152.23 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 122.906 0.482 . . . . 0.0 111.356 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.1 pp -142.54 170.3 15.96 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.719 0.807 . . . . 0.0 110.445 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.38 149.71 47.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.916 0.486 . . . . 0.0 110.207 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.99 150.39 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.794 0.438 . . . . 0.0 110.952 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -140.25 168.99 18.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.82 0.848 . . . . 0.0 109.514 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.99 -5.1 77.82 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.945 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.761 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -72.0 176.68 4.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.83 0.815 . . . . 0.0 110.586 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.06 131.85 25.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -68.12 -7.88 33.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.7 t -91.81 -15.69 27.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.663 0.665 . . . . 0.0 112.104 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.38 5.26 1.24 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 15.4 tpt -150.9 102.52 2.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -141.86 -166.44 2.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.941 0.497 . . . . 0.0 110.342 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 78.0 m -52.53 -27.08 15.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.13 -28.2 24.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.378 0.536 . . . . 0.0 111.674 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -83.91 -31.85 25.45 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.23 -26.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.4 -30.58 62.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -81.5 -17.77 47.42 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.318 -0.372 . . . . 0.0 111.914 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.27 -22.2 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -110.95 -18.8 12.99 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.94 -21.89 60.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.327 0.967 . . . . 0.0 112.333 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.57 10.43 1.72 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.618 -0.676 . . . . 0.0 112.467 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -121.43 -2.71 9.45 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.923 0.889 . . . . 0.0 110.975 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 152.0 154.43 6.62 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -68.23 134.95 51.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.277 0.538 . . . . 0.0 110.298 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.07 154.02 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.05 -59.6 1.67 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.018 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . 0.439 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.1 pttm -160.93 162.33 31.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.648 0.379 . . . . 0.0 111.296 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.35 150.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 123.924 0.889 . . . . 0.0 109.792 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.23 145.3 26.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.505 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.24 145.34 27.0 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.607 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -132.1 141.66 49.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -167.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.19 33.93 21.06 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 125.769 1.628 . . . . 0.0 112.371 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 53.02 14.79 0.5 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 142.83 57.89 Favored Pre-proline 0 N--CA 1.456 -0.144 0 CA-C-N 118.802 0.728 . . . . 0.0 109.956 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.9 -0.19 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.412 2.741 . . . . 0.0 110.471 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.13 31.92 2.4 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.479 -0.623 . . . . 0.0 112.887 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.607 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -148.34 134.08 18.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.001 0.901 . . . . 0.0 110.154 174.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.8 170.93 19.09 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.951 0.405 . . . . 0.0 111.642 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -141.5 144.21 34.22 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.95 0.9 . . . . 0.0 109.505 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.93 146.73 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.145 0.578 . . . . 0.0 111.031 -171.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -131.01 145.26 51.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.482 0.713 . . . . 0.0 109.758 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 76.8 mtp -126.52 164.41 21.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.665 0.386 . . . . 0.0 110.758 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.29 -19.31 64.69 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.85 154.81 31.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.23 0.468 . . . . 0.0 110.243 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.72 -14.41 78.05 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.174 -0.792 . . . . 0.0 112.92 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -70.68 -20.14 62.72 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.341 1.57 . . . . 0.0 110.707 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.68 -31.98 18.23 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.1 t -67.73 -37.59 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -67.06 -30.65 70.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.501 0.321 . . . . 0.0 111.145 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -37.1 65.95 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 -175.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.56 -24.85 41.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.437 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 8.2 mm -77.13 -30.92 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.708 0.803 . . . . 0.0 110.56 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 81.9 m -93.17 -21.64 19.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -138.7 -19.17 1.05 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -95.76 -15.14 22.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.222 0.919 . . . . 0.0 109.158 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -54.08 142.97 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.116 0.966 . . . . 0.0 110.153 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.15 1.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -87.81 142.53 27.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.735 1.607 . . . . 0.0 109.522 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.409 ' HB2' ' HG3' ' A' ' 446' ' ' MET 0.298 0.1 OUTLIER -130.88 164.04 26.13 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 171.726 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.14 143.35 50.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.909 1.283 . . . . 0.0 108.573 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 63.64 32.52 13.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.23 15.99 80.85 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 116.039 1.175 . . . . 0.0 116.039 168.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -83.17 153.0 25.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.392 1.596 . . . . 0.0 110.557 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.41 141.87 34.89 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . 0.409 ' HG3' ' HB2' ' A' ' 440' ' ' PHE . 1.6 mpt? -96.29 122.09 38.78 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -140.72 115.74 9.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.08 142.06 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.057 0 CA-C-N 118.348 0.522 . . . . 0.0 110.234 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 98.2 m -147.19 168.83 20.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.704 0.802 . . . . 0.0 110.054 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 152.67 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 27.1 t -126.51 163.14 24.02 Favored 'General case' 0 CA--C 1.526 0.027 0 CA-C-N 117.845 0.293 . . . . 0.0 110.582 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -103.88 8.89 36.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.805 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -65.56 149.99 96.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 O-C-N 121.924 -0.485 . . . . 0.0 109.782 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.05 -27.5 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.855 2.37 . . . . 0.0 111.992 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.48 171.65 11.64 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.161 0.585 . . . . 0.0 110.357 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.439 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 40.6 mm -68.89 135.67 27.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.4 mtt -95.72 150.31 37.23 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 122.07 0.148 . . . . 0.0 110.819 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.94 163.81 37.04 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.887 3.058 . . . . 0.0 111.494 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.72 -174.56 44.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.93 151.47 38.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.4 p -140.12 159.06 43.02 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.127 0.571 . . . . 0.0 110.365 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -154.09 167.7 28.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.216 0.607 . . . . 0.0 109.895 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.59 141.44 25.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.59 168.09 13.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.793 0.837 . . . . 0.0 109.54 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.6 -20.17 66.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.072 -0.392 . . . . 0.0 111.519 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.22 -1.3 44.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.83 0.452 . . . . 0.0 111.392 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.72 -4.5 86.19 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.632 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.1 m -93.33 160.79 14.66 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.23 1.015 . . . . 0.0 110.276 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 73.2 m -81.38 153.37 27.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.009 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.6 p -71.13 -10.8 60.37 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.82 0.448 . . . . 0.0 111.625 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -129.88 141.78 50.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.354 1.061 . . . . 0.0 109.393 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -154.51 158.89 40.55 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.416 0.286 . . . . 0.0 110.715 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -131.04 148.55 52.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.127 0.971 . . . . 0.0 109.355 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -136.85 7.81 2.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.687 0.395 . . . . 0.0 111.855 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 13.5 t -70.2 -13.74 62.31 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.576 0.35 . . . . 0.0 111.209 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -93.45 2.77 56.36 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.007 0.523 . . . . 0.0 111.642 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.2 t -73.85 140.05 45.49 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.122 -0.361 . . . . 0.0 110.995 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -122.07 12.13 10.32 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 123.706 0.802 . . . . 0.0 111.4 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -87.07 11.29 14.13 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.127 0.571 . . . . 0.0 112.398 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -126.47 148.82 49.62 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.387 0.613 . . . . 0.0 111.662 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -82.08 9.65 8.11 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.258 1.023 . . . . 0.0 110.855 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -138.84 18.31 2.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.197 0.999 . . . . 0.0 110.667 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.8 p -79.53 -3.05 45.05 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.918 0.487 . . . . 0.0 111.295 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 5.7 t -146.12 143.78 20.1 Favored Pre-proline 0 N--CA 1.456 -0.175 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.66 -12.89 37.16 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.041 2.494 . . . . 0.0 113.334 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.46 -27.04 25.96 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.964 0.802 . . . . 0.0 111.42 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -90.61 -26.74 19.51 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 117.614 0.188 . . . . 0.0 110.581 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.96 36.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.668 0.387 . . . . 0.0 111.243 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -98.64 -2.35 38.64 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.575 0.75 . . . . 0.0 111.547 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -127.02 16.92 7.29 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.709 0.804 . . . . 0.0 110.909 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -142.23 161.13 38.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.41 1.084 . . . . 0.0 108.336 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -129.81 159.84 35.32 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 122.095 -0.378 . . . . 0.0 111.955 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.7 mm -113.68 141.69 28.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -151.42 157.48 42.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -66.2 162.62 45.92 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.93 150.15 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.154 3.236 . . . . 0.0 113.499 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 37.9 m -123.95 18.92 9.3 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.548 0.739 . . . . 0.0 111.566 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.1 m120 59.92 10.78 2.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.407 1.083 . . . . 0.0 113.559 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.4 t -142.12 145.27 24.11 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 48.9 mt -117.55 166.56 12.23 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.201 0.524 . . . . 0.0 111.557 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 503' ' ' PHE . 1.5 t60 -137.56 148.81 46.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.784 0.834 . . . . 0.0 109.027 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -133.57 153.25 51.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.663 0.385 . . . . 0.0 110.882 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . 0.528 ' CZ ' ' CD2' ' A' ' 501' ' ' HIS . 75.4 m-85 -147.64 171.29 15.85 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.624 0.369 . . . . 0.0 111.33 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 24.9 m120 61.57 16.54 7.74 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -79.96 156.19 74.79 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.24 157.09 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.671 2.248 . . . . 0.0 111.888 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.3 pt? -72.45 -1.26 15.08 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.64 8.73 29.25 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.967 0.349 . . . . 0.0 111.93 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.42 150.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.91 0.323 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 71.8 p -145.9 175.63 10.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.787 0.835 . . . . 0.0 109.693 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.38 -25.65 68.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.446 -0.158 . . . . 0.0 111.019 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -74.99 -24.64 58.45 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.614 0.188 . . . . 0.0 110.714 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -79.41 -29.96 42.17 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -73.26 -25.46 60.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.297 -0.252 . . . . 0.0 110.44 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -78.95 -36.58 41.35 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.983 -0.448 . . . . 0.0 111.661 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.12 -15.7 55.15 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.143 0.428 . . . . 0.0 111.612 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.97 -35.09 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.199 0.454 . . . . 0.0 109.832 173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.8 m -70.52 -17.8 62.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.736 -0.602 . . . . 0.0 110.215 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.43 -30.27 61.83 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 119.578 -0.249 . . . . 0.0 111.512 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.05 -14.8 30.64 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.373 0.533 . . . . 0.0 111.421 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.62 -13.05 24.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.865 0.466 . . . . 0.0 111.301 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 70.57 6.52 58.89 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.82 -0.433 . . . . 0.0 112.791 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.2 m -85.93 167.31 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.679 0.739 . . . . 0.0 110.802 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -74.64 150.01 39.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 111.063 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -91.31 150.71 41.9 Favored Pre-proline 0 C--O 1.231 0.125 0 C-N-CA 123.498 0.719 . . . . 0.0 110.283 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.9 156.56 65.42 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.472 2.781 . . . . 0.0 110.669 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.8 m -86.26 -22.8 26.65 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.864 0.466 . . . . 0.0 110.605 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 14.8 t -149.38 155.23 40.14 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.53 144.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.769 0.427 . . . . 0.0 110.457 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -134.58 130.53 36.65 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.23 143.45 35.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 122.754 0.422 . . . . 0.0 109.919 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -154.0 135.11 13.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.028 0.531 . . . . 0.0 110.025 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.9 m -105.12 138.31 41.52 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 122.51 0.324 . . . . 0.0 110.25 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -82.69 148.17 25.88 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -79.86 133.75 36.28 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 37.9 m 55.11 18.6 2.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -109.93 -8.0 14.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.628 0.371 . . . . 0.0 111.185 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 48.44 29.51 2.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.392 1.077 . . . . 0.0 113.459 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 75.2 p -145.13 168.28 20.73 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.895 0.378 . . . . 0.0 111.321 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 48.4 t -133.38 150.65 51.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.159 0.984 . . . . 0.0 110.781 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 37.0 m -145.55 162.97 36.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.031 1.333 . . . . 0.0 109.055 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.57 -168.8 41.26 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.485 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.29 159.74 22.21 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.091 0.556 . . . . 0.0 111.403 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 87.6 mt -137.38 135.06 36.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.694 1.198 . . . . 0.0 107.836 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.78 110.36 12.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.458 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.1 p90 -165.99 156.03 12.46 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.425 1.49 . . . . 0.0 107.477 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.73 117.1 6.49 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.652 0.66 . . . . 0.0 112.719 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 28.7 m -159.54 153.06 22.57 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 126.149 1.78 . . . . 0.0 106.28 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -67.83 -51.39 49.08 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.512 0.596 . . . . 0.0 111.509 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 50.2 m -79.71 -24.33 41.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.92 -34.35 22.53 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.39 0.541 . . . . 0.0 111.677 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.41 -26.42 38.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.015 0.37 . . . . 0.0 111.038 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.1 tp -85.12 -29.52 24.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.255 0.48 . . . . 0.0 111.73 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -75.45 -38.5 59.66 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.088 0.404 . . . . 0.0 110.042 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.0 m -70.15 -33.93 72.4 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.7 -42.75 90.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.18 -24.7 75.04 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.292 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -113.86 -14.78 12.47 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.627 1.214 . . . . 0.0 114.105 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.43 -20.65 17.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.524 1.056 . . . . 0.0 111.085 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -74.41 139.44 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.6 t60 52.23 35.88 17.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.587 0.755 . . . . 0.0 112.122 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -99.2 151.32 21.14 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.25 136.31 36.91 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.585 1.554 . . . . 0.0 111.139 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . 0.422 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.7 ttt -64.07 174.51 1.52 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.438 0.695 . . . . 0.0 112.078 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.5 ttmm -68.65 -2.1 8.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.174 0.99 . . . . 0.0 112.504 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -60.96 141.95 93.08 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 121.492 -0.755 . . . . 0.0 110.569 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.18 -28.54 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.74 2.96 . . . . 0.0 113.918 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -121.01 -0.94 9.92 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.07 0.395 . . . . 0.0 111.829 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.435 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.39 41.27 99.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.997 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 79.1 Cg_endo -69.9 -10.7 29.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.884 2.39 . . . . 0.0 111.888 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.46 148.41 47.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 123.187 0.595 . . . . 0.0 109.959 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.63 153.36 38.81 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.707 2.938 . . . . 0.0 111.149 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -147.99 0.7 0.64 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.081 0.553 . . . . 0.0 111.41 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 12.3 t -66.43 125.55 26.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.283 -0.885 . . . . 0.0 110.781 -170.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.14 144.63 50.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.355 1.062 . . . . 0.0 109.991 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.6 157.82 16.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.285 0.234 . . . . 0.0 110.732 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.43 144.97 50.86 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.229 0.611 . . . . 0.0 109.689 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 27.9 p -160.49 167.37 27.36 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.159 0.584 . . . . 0.0 110.408 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -82.07 139.0 34.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 38.0 t -135.6 145.13 46.58 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.148 0.179 . . . . 0.0 110.883 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 19.3 p -79.98 102.28 9.15 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.12 161.56 34.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.954 0.902 . . . . 0.0 110.325 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.64 -12.44 11.57 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.782 0.433 . . . . 0.0 110.987 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -161.13 162.48 31.47 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.681 0.792 . . . . 0.0 109.538 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -91.35 76.83 5.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.518 0.327 . . . . 0.0 110.132 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.217 0 CA-C-O 116.687 -1.625 . . . . 0.0 111.529 179.672 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -136.91 21.08 3.05 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.309 0.643 . . . . 0.0 110.983 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 84.16 156.16 23.34 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.36 -178.15 4.42 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.494 3.463 . . . . 0.0 111.096 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -98.25 157.27 16.27 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.212 0.605 . . . . 0.0 110.389 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -77.05 163.4 26.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.804 0.441 . . . . 0.0 110.509 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.54 -7.4 59.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.965 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.6 m -147.49 152.15 41.34 Favored Pre-proline 0 C--N 1.34 0.156 0 C-N-CA 123.15 0.58 . . . . 0.0 110.89 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -82.5 3.34 7.89 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.446 3.431 . . . . 0.0 112.631 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.8 164.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.416 0.627 . . . . 0.0 112.464 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 381' ' ' LEU . 4.3 pp -149.45 171.23 16.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.23 1.012 . . . . 0.0 109.149 174.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . 0.407 ' CE ' ' HE1' ' A' ' 412' ' ' MET . 80.8 mtp -138.11 152.12 48.45 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.411 0.284 . . . . 0.0 111.257 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.02 144.26 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -135.86 168.03 20.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.953 0.501 . . . . 0.0 110.411 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.31 69.26 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.972 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.757 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -70.06 170.71 10.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.501 0.65 . . . . 0.0 111.741 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -127.01 130.85 50.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.613 0.765 . . . . 0.0 109.434 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -71.87 6.83 1.82 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.6 p -121.28 0.67 10.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.98 -13.12 2.83 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.164 0.586 . . . . 0.0 110.704 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -141.84 121.02 12.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.133 0.973 . . . . 0.0 108.795 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.565 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 19.4 m120 -141.89 -179.97 6.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.87 0.868 . . . . 0.0 109.337 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.2 m -58.99 -22.79 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 121.982 0.113 . . . . 0.0 111.231 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -88.03 -26.06 22.78 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.014 -0.429 . . . . 0.0 111.717 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . 0.565 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.4 mpt_? -83.36 -32.0 26.45 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.271 0.487 . . . . 0.0 109.702 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.9 p -72.44 -31.46 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -69.09 -29.57 67.7 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -80.78 -17.3 51.36 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.6 t -109.62 -23.78 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 118.437 0.562 . . . . 0.0 112.378 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -108.96 -16.37 14.16 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.689 0.677 . . . . 0.0 112.423 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 t -77.49 -16.02 58.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.124 0.875 . . . . 0.0 110.977 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.6 10.72 1.58 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.803 -0.561 . . . . 0.0 112.296 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 -3.17 9.38 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.721 0.808 . . . . 0.0 111.071 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.07 164.54 11.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -66.45 147.26 53.55 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.9 0.85 . . . . 0.0 111.702 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.49 155.47 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -96.76 -63.88 1.1 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -163.1 166.57 23.35 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.4 0.68 . . . . 0.0 110.338 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.51 151.7 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.214 0.606 . . . . 0.0 110.501 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -149.99 139.49 21.51 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.301 0.241 . . . . 0.0 110.822 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -77.25 152.28 34.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.407 ' HE1' ' CE ' ' A' ' 382' ' ' MET . 6.0 ptm -130.85 141.64 50.33 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -167.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 60.28 33.76 20.89 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.77 1.228 . . . . 0.0 112.275 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.3 m 55.42 14.79 1.22 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.296 1.039 . . . . 0.0 113.435 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -89.02 137.6 29.54 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.35 -8.56 18.57 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.964 2.443 . . . . 0.0 109.332 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.65 23.3 17.83 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.69 1.138 . . . . 0.0 113.128 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -150.75 137.27 18.78 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.973 1.387 . . . . 0.0 111.268 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -159.61 170.61 21.24 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.128 0.489 . . . . 0.0 111.363 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.5 ptm -139.39 147.44 41.46 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.375 0.67 . . . . 0.0 109.96 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.5 t -128.23 152.15 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.24 0.616 . . . . 0.0 110.76 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -129.58 141.46 50.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.585 0.754 . . . . 0.0 109.4 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 97.9 mmm -114.43 162.53 16.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.849 0.46 . . . . 0.0 110.719 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.41 -17.83 60.74 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.318 0.247 . . . . 0.0 111.604 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.91 160.88 40.51 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.86 -12.22 84.76 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.319 -0.712 . . . . 0.0 113.199 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -75.38 -17.63 60.16 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.857 1.328 . . . . 0.0 111.32 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -89.84 -26.23 20.63 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.249 -0.282 . . . . 0.0 110.486 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.22 -34.27 37.07 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.29 -26.64 56.09 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.517 0.199 . . . . 0.0 110.625 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.01 -25.74 48.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.68 31.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.038 0.135 . . . . 0.0 110.766 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 433' ' ' ILE . 3.1 tp -82.65 -30.95 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 121.813 -0.554 . . . . 0.0 111.121 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 24.0 m -94.82 -19.69 20.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -136.22 -5.91 2.07 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.59 -19.21 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.168 0.895 . . . . 0.0 109.461 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -51.95 143.13 14.22 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.895 0.878 . . . . 0.0 110.629 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.8 1.42 0.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.819 1.648 . . . . 0.0 114.992 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -88.47 142.76 27.45 Favored 'General case' 0 C--N 1.348 0.527 0 O-C-N 120.544 -1.348 . . . . 0.0 109.117 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.271 0.1 OUTLIER -130.94 163.98 26.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 171.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.4 ptm -125.25 143.47 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.175 0.99 . . . . 0.0 109.625 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 64.72 30.5 12.4 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.368 1.467 . . . . 0.0 114.45 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.43 15.64 77.3 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 168.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.25 161.28 21.55 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.506 1.153 . . . . 0.0 110.19 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.587 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -91.63 128.59 37.52 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.329 0.513 . . . . 0.0 110.825 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.62 142.42 30.23 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -140.71 127.2 20.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.34 140.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.09 0 CA-C-N 118.359 0.527 . . . . 0.0 110.718 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.7 m -150.59 163.69 37.86 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.26 1.024 . . . . 0.0 109.923 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.86 156.43 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.8 t -131.23 162.99 28.75 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 122.912 0.485 . . . . 0.0 109.725 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -105.69 5.69 31.3 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -67.42 144.93 98.24 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 121.694 -0.629 . . . . 0.0 109.756 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.96 -24.68 11.13 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.151 2.567 . . . . 0.0 111.692 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.89 173.2 12.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.491 0.716 . . . . 0.0 109.841 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.7 mm -71.33 142.52 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -97.43 154.89 37.85 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 117.472 0.124 . . . . 0.0 111.268 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.65 165.37 8.03 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.104 3.203 . . . . 0.0 112.477 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.89 177.86 37.77 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -81.81 166.07 20.31 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.834 0.453 . . . . 0.0 110.199 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.3 p -143.04 159.94 41.31 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.75 0.42 . . . . 0.0 110.973 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -151.33 173.15 14.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.768 0.827 . . . . 0.0 109.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.66 135.07 13.57 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.99 173.1 12.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.345 0.658 . . . . 0.0 109.828 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -64.4 -23.02 67.14 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.703 0.401 . . . . 0.0 111.329 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -81.7 -1.4 46.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.017 0.527 . . . . 0.0 111.332 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.27 84.43 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.087 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 77.6 p -84.06 163.96 19.55 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.537 0.668 . . . . 0.0 110.78 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.72 151.83 28.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 111.056 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 75.5 m -73.16 -10.45 59.79 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.435 0.694 . . . . 0.0 111.841 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -133.73 143.45 48.48 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.665 0.786 . . . . 0.0 109.762 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -157.18 156.86 33.35 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.733 0.413 . . . . 0.0 110.551 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -127.65 149.28 50.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.269 1.028 . . . . 0.0 109.503 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -137.99 13.89 2.87 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.84 0.456 . . . . 0.0 111.413 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 29.2 t -66.22 -16.55 64.09 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.079 -0.388 . . . . 0.0 111.784 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -79.79 -11.76 59.81 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.966 -0.459 . . . . 0.0 111.178 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.9 m -87.97 17.63 4.79 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.23 0.612 . . . . 0.0 111.47 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -75.0 8.97 2.16 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.396 0.679 . . . . 0.0 112.011 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -110.5 17.18 21.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.961 0.904 . . . . 0.0 110.544 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -81.37 23.43 0.61 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.987 0.915 . . . . 0.0 112.455 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 53.71 29.52 9.63 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.86 19.14 0.69 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.959 0.345 . . . . 0.0 111.802 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 67.2 p -84.56 4.24 32.94 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -171.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 39.4 p -136.47 159.35 70.94 Favored Pre-proline 0 C--O 1.231 0.082 0 CA-C-N 118.378 0.536 . . . . 0.0 110.055 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.63 -17.14 33.67 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.47 2.78 . . . . 0.0 112.863 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -94.69 -26.39 16.33 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 117.827 0.285 . . . . 0.0 111.06 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -90.5 -24.08 20.76 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 122.351 0.26 . . . . 0.0 110.8 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.12 62.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.302 -0.249 . . . . 0.0 110.982 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -80.42 -16.02 55.41 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.348 -0.22 . . . . 0.0 110.604 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -96.27 -13.82 23.09 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 123.431 0.692 . . . . 0.0 110.577 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.62 7.2 45.42 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.573 0.749 . . . . 0.0 109.43 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 50.81 54.06 11.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.668 1.187 . . . . 0.0 112.229 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 48.1 mm -80.92 108.61 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -155.75 167.99 28.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.683 0.793 . . . . 0.0 109.034 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -62.35 159.41 40.66 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.44 131.32 36.21 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.304 2.669 . . . . 0.0 112.492 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.6 m -124.07 23.86 8.37 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.691 0.796 . . . . 0.0 111.464 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 60.75 10.99 2.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.891 1.276 . . . . 0.0 114.043 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.53 141.78 36.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 40.8 mt -118.18 165.13 14.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.326 0.65 . . . . 0.0 110.283 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 580' ' ' SER . 0.6 OUTLIER -141.51 161.98 36.59 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.377 0.271 . . . . 0.0 110.956 173.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -139.06 157.06 46.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.726 0.41 . . . . 0.0 111.328 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -150.53 174.3 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.203 0.601 . . . . 0.0 111.066 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 11.7 t30 64.98 11.35 6.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.911 1.284 . . . . 0.0 113.656 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -73.2 161.66 78.19 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -70.33 155.68 63.51 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.903 1.735 . . . . 0.0 110.18 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.9 pt? -69.73 -1.12 8.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.31 9.0 18.23 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.95 151.21 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 118.009 0.368 . . . . 0.0 110.932 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.9 p -142.15 173.28 11.67 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.361 0.664 . . . . 0.0 110.516 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.18 -21.31 64.99 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.885 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.05 -22.81 58.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.348 -0.22 . . . . 0.0 110.487 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -82.34 -30.19 30.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.79 -25.66 61.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.761 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -84.34 -34.96 23.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.11 0.414 . . . . 0.0 111.468 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -76.88 -21.99 54.1 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.281 0.491 . . . . 0.0 111.133 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 74.0 mt -84.83 -37.88 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 117.937 0.335 . . . . 0.0 110.235 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.5 m -66.64 -24.68 66.33 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.113 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.91 -30.42 63.89 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.245 -0.284 . . . . 0.0 111.761 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -91.04 -11.09 39.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.375 0.534 . . . . 0.0 112.0 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 93.6 mt -96.19 -7.7 35.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.774 0.429 . . . . 0.0 111.084 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.88 7.97 81.73 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.77 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -97.78 165.2 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 117.83 0.815 . . . . 0.0 110.645 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -83.19 151.67 25.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.742 0.417 . . . . 0.0 111.065 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -91.08 155.2 44.97 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.474 0.71 . . . . 0.0 110.717 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.95 158.74 45.73 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.296 2.664 . . . . 0.0 111.285 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 81.5 m -89.96 -26.39 20.41 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.0 m -139.38 150.06 44.87 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 66.4 t -142.06 144.27 25.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 123.042 0.537 . . . . 0.0 110.849 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -142.16 138.89 31.89 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 29.6 t -136.39 145.77 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 122.595 0.358 . . . . 0.0 110.425 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -151.94 164.19 37.66 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.117 0.967 . . . . 0.0 109.223 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 79.4 p -122.31 144.82 48.77 Favored 'General case' 0 N--CA 1.457 -0.085 0 O-C-N 121.867 -0.52 . . . . 0.0 111.242 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -83.34 149.54 26.28 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.0 130.74 35.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 21.2 m 56.22 15.06 1.73 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.401 1.08 . . . . 0.0 113.589 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -105.38 -10.27 17.07 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.841 0.457 . . . . 0.0 111.043 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 49.4 33.17 5.19 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.871 0.868 . . . . 0.0 112.103 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 99.0 p -137.47 169.58 17.55 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.802 0.441 . . . . 0.0 111.538 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.6 t -125.43 153.88 42.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.371 1.068 . . . . 0.0 110.799 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 78.4 p -152.88 171.22 18.63 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.72 1.208 . . . . 0.0 109.627 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 166.63 -172.91 41.97 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.129 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.54 152.68 32.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 66.8 mt -136.71 134.89 37.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.73 1.212 . . . . 0.0 107.856 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -127.78 113.1 15.53 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -166.09 153.94 10.43 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.639 1.576 . . . . 0.0 106.775 167.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -148.87 118.6 7.04 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.3 t -159.46 153.1 22.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.582 1.553 . . . . 0.0 107.025 168.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.38 -63.8 1.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.971 0.35 . . . . 0.0 111.739 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 74.2 p -82.28 -17.25 46.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.09 -41.35 28.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.298 0.499 . . . . 0.0 110.682 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -78.14 -31.78 49.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.596 -0.24 . . . . 0.0 110.968 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.5 tp -77.25 -30.49 54.46 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.671 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -74.8 -40.2 61.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.94 -0.475 . . . . 0.0 110.548 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.3 m -63.99 -49.98 70.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.59 -0.243 . . . . 0.0 110.347 -175.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 556' ' ' LEU . 3.5 pp -77.51 -18.9 56.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.833 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -69.21 -26.58 74.51 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -117.12 -7.38 11.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 117.596 0.698 . . . . 0.0 112.604 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 46.3 tp -98.23 -19.36 17.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 0.0 111.701 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -74.48 144.43 44.17 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 80.2 t60 51.11 35.83 14.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.019 0.528 . . . . 0.0 112.039 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -97.27 151.42 19.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.709 0.804 . . . . 0.0 111.691 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -102.6 136.33 42.62 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.181 1.392 . . . . 0.0 110.549 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.3 ttt -64.11 173.87 1.77 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.066 0.547 . . . . 0.0 111.499 -174.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -70.25 9.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -66.5 146.84 99.09 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 118.55 0.614 . . . . 0.0 110.081 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.84 -30.02 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.42 2.747 . . . . 0.0 113.917 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -121.06 2.18 10.41 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.438 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.14 40.16 98.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.686 -1.064 . . . . 0.0 112.891 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 80.9 Cg_endo -69.45 -9.99 27.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.272 2.648 . . . . 0.0 112.073 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -142.61 148.26 45.92 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 122.823 0.449 . . . . 0.0 110.086 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.84 156.69 43.72 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.603 2.868 . . . . 0.0 111.477 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -148.59 6.39 0.73 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.038 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 3.0 t -66.48 122.1 16.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.611 -0.681 . . . . 0.0 110.118 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.9 pt? -124.97 144.6 50.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 109.78 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -96.16 142.12 28.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.526 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.62 144.91 41.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 41.8 t -163.14 163.2 25.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -75.83 148.37 38.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.448 ' HB3' ' CG ' ' A' ' 501' ' ' HIS . 92.9 p -135.4 149.16 49.58 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.171 0.188 . . . . 0.0 110.606 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 31.3 p -90.02 102.19 14.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.36 161.47 34.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.654 0.782 . . . . 0.0 111.156 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -97.73 -25.79 14.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -163.85 152.72 13.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.506 1.122 . . . . 0.0 108.57 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -85.94 76.51 9.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.942 0.401 . . . . 0.0 110.35 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 36.3 t . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.869 177.484 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -136.65 6.46 2.96 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.936 0.494 . . . . 0.0 111.962 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -179.36 175.85 47.36 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.41 169.15 23.17 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.4 3.4 . . . . 0.0 110.94 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -155.84 168.84 25.93 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.091 0.556 . . . . 0.0 110.322 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -123.32 158.47 30.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.79 0.436 . . . . 0.0 110.443 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -144.79 17.03 1.61 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.22 0.608 . . . . 0.0 110.535 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.2 m -143.44 152.8 57.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 122.395 0.278 . . . . 0.0 111.13 -175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.209 3.273 . . . . 0.0 112.831 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 89.3 t -123.28 148.13 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 118.684 0.675 . . . . 0.0 110.811 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.3 164.12 30.06 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 110.692 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 73.6 mmm -127.33 149.38 50.07 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.505 0.722 . . . . 0.0 110.331 -176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -147.36 148.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.645 0.259 . . . . 0.0 110.743 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -141.13 170.99 14.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.702 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.46 -4.54 81.3 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.299 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -71.72 175.75 5.43 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.038 0.919 . . . . 0.0 110.522 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -133.69 135.57 44.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.802 0.441 . . . . 0.0 109.889 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -73.46 4.84 4.29 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -172.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.9 m -115.36 -2.11 12.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.076 0.398 . . . . 0.0 111.845 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -138.12 -0.95 2.0 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.435 0.694 . . . . 0.0 110.685 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -154.53 121.11 5.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -141.97 -176.52 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.79 0.436 . . . . 0.0 110.62 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 25.5 p -57.01 -30.22 64.0 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.301 0.641 . . . . 0.0 112.671 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.0 -25.92 25.72 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.023 -0.423 . . . . 0.0 110.756 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -79.99 -32.48 39.74 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -75.6 -27.05 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -68.82 -29.42 67.76 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 171.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.38 -23.05 47.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.026 -0.421 . . . . 0.0 111.981 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 71.4 t -94.61 -21.36 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -114.59 -13.93 12.11 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.2 t -73.9 -21.92 59.89 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.306 0.957 . . . . 0.0 111.085 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.48 10.41 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.645 -0.659 . . . . 0.0 112.385 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -121.45 -11.41 8.73 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.248 0.619 . . . . 0.0 111.434 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 160.97 174.61 31.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -68.41 141.47 55.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.535 -0.391 . . . . 0.0 110.871 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 39.6 t -104.56 147.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -101.38 -58.32 1.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.231 -0.293 . . . . 0.0 110.351 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -165.3 169.41 15.89 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.957 0.503 . . . . 0.0 110.685 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.35 150.88 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.069 0 C-N-CA 123.739 0.816 . . . . 0.0 110.216 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 411' ' ' PHE . 51.4 tptt -147.18 137.54 23.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.749 0.82 . . . . 0.0 109.093 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . 0.405 ' O ' ' HE3' ' A' ' 410' ' ' LYS . 4.3 m-85 -76.53 136.2 39.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 22.1 ttp -93.64 140.97 29.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 47.42 33.84 3.01 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 125.073 1.349 . . . . 0.0 112.248 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.5 m 52.95 17.99 1.0 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.443 1.097 . . . . 0.0 113.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -75.95 149.53 82.82 Favored Pre-proline 0 N--CA 1.456 -0.159 0 CA-C-N 118.564 0.62 . . . . 0.0 109.897 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.43 4.4 6.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.882 3.055 . . . . 0.0 110.975 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.51 32.06 1.36 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.299 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.83 141.76 25.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.187 0.993 . . . . 0.0 110.439 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.37 170.28 22.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.941 0.4 . . . . 0.0 111.373 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.4 ptm -145.76 145.06 30.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.733 0.813 . . . . 0.0 109.512 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.37 153.22 38.58 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.299 0.639 . . . . 0.0 110.32 -173.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -127.67 143.67 51.14 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.691 0.797 . . . . 0.0 110.07 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 79.4 mtp -129.38 166.64 19.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.425 0.69 . . . . 0.0 110.134 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.54 -23.82 65.47 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.17 160.21 38.52 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.252 0.478 . . . . 0.0 110.576 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.77 -12.35 80.82 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.451 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -67.93 -25.56 65.53 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.231 1.515 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.9 -27.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.5 t -73.54 -32.96 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.75 -25.96 66.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.048 0.539 . . . . 0.0 110.212 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -82.43 -27.19 32.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.375 -0.203 . . . . 0.0 110.691 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.21 -28.34 29.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.464 0.173 . . . . 0.0 110.56 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.84 -31.11 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.336 0.654 . . . . 0.0 110.853 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 16.7 m -98.88 -19.55 17.3 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -135.59 -4.28 2.3 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.72 -15.29 11.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.857 0.753 . . . . 0.0 109.458 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -58.02 149.87 22.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.481 0.658 . . . . 0.0 111.954 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 56.83 1.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.024 1.73 . . . . 0.0 114.616 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -88.04 142.56 27.68 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.961 1.255 . . . . 0.0 109.46 168.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.321 0.1 OUTLIER -130.93 164.03 26.2 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 170.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 18.7 ptm -125.26 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 66.07 24.01 11.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -172.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.01 16.01 80.98 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 168.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -83.2 156.31 23.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.085 1.443 . . . . 0.0 111.811 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.86 139.96 49.1 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.58 0.752 . . . . 0.0 109.592 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.96 122.04 39.5 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -140.75 119.75 12.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.12 142.61 20.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 118.008 0.367 . . . . 0.0 110.751 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 73.3 m -148.41 174.92 11.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.682 0.793 . . . . 0.0 110.715 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.71 156.05 13.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 123.802 0.841 . . . . 0.0 108.784 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 34.9 t -137.27 146.12 44.34 Favored 'General case' 0 N--CA 1.461 0.101 0 O-C-N 122.1 -0.375 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -85.43 6.56 26.19 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.076 0.551 . . . . 0.0 112.237 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 454' ' ' PRO . 47.4 mt-30 -62.09 132.24 93.69 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 453' ' ' GLN . 37.0 Cg_exo -62.02 -32.05 84.01 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.691 2.261 . . . . 0.0 112.515 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -161.79 171.55 17.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.792 0.437 . . . . 0.0 110.9 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.74 143.26 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.81 149.61 44.07 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 122.227 0.211 . . . . 0.0 110.745 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.91 161.92 43.47 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.761 2.974 . . . . 0.0 111.765 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 166.39 -179.51 40.35 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -80.89 173.54 12.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.815 0.446 . . . . 0.0 109.834 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.1 p -140.43 161.86 36.71 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -150.99 165.18 34.52 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.722 0.809 . . . . 0.0 109.632 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 137.88 20.0 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 91.2 mt -86.98 174.71 8.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.202 1.001 . . . . 0.0 109.437 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -68.41 -21.78 64.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.85 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -83.08 4.24 27.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.103 0.561 . . . . 0.0 111.792 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.62 -2.42 73.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.622 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.2 p -90.82 163.02 14.58 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.074 0.937 . . . . 0.0 110.222 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.3 m -81.28 153.41 27.11 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.032 -0.417 . . . . 0.0 111.114 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 89.5 p -71.18 -8.88 56.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -130.65 142.79 50.45 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.386 1.074 . . . . 0.0 109.036 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -153.21 157.38 40.15 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.721 0.408 . . . . 0.0 110.278 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.31 148.46 50.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.77 0.828 . . . . 0.0 109.812 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -137.2 14.93 3.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.999 0.52 . . . . 0.0 111.583 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.1 p -68.41 -5.35 18.58 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -88.59 -2.42 58.58 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.727 0.411 . . . . 0.0 111.228 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.4 m -89.15 11.17 19.37 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.42 0.688 . . . . 0.0 111.933 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -75.89 31.21 0.11 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.83 0.852 . . . . 0.0 112.617 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -136.28 41.85 2.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.918 0.887 . . . . 0.0 109.493 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -118.32 -174.68 2.71 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.714 0.806 . . . . 0.0 110.531 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -64.42 -18.79 65.06 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -171.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -149.41 10.49 0.76 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 119.474 1.034 . . . . 0.0 112.886 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.4 p -86.27 2.71 46.18 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 121.951 -0.468 . . . . 0.0 111.301 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 5.0 t -139.67 141.96 29.85 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.35 -10.63 29.33 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.233 2.622 . . . . 0.0 113.765 -172.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -88.92 -26.48 21.54 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.028 0.831 . . . . 0.0 111.381 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -90.47 -27.0 19.53 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.978 0.353 . . . . 0.0 110.853 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.36 -6.76 31.92 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.696 0.398 . . . . 0.0 111.875 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -89.49 -0.94 57.85 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.995 0.518 . . . . 0.0 111.38 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -127.11 8.15 6.64 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.826 0.85 . . . . 0.0 111.333 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -139.53 171.92 13.55 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.436 0.694 . . . . 0.0 110.071 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -140.39 157.99 44.7 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.63 137.81 45.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -148.69 160.85 42.77 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 121.194 0.521 . . . . 0.0 111.436 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -82.48 167.59 29.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 124.936 1.295 . . . . 0.0 109.991 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -49.82 125.67 14.93 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.099 2.533 . . . . 0.0 111.62 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.2 m -124.07 23.85 8.37 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.621 0.768 . . . . 0.0 112.292 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.6 m120 61.65 8.18 2.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.219 1.008 . . . . 0.0 113.52 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.98 146.27 20.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 123.851 0.86 . . . . 0.0 108.902 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.36 151.58 42.37 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.973 0.509 . . . . 0.0 110.667 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.465 ' CE1' ' HB3' ' A' ' 580' ' ' SER . 0.3 OUTLIER -126.03 143.55 51.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -129.7 152.04 49.64 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.416 0.15 . . . . 0.0 110.829 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -150.12 172.27 15.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.815 0.446 . . . . 0.0 111.246 -175.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.18 30.19 19.91 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.766 0.826 . . . . 0.0 112.791 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -94.16 153.98 40.6 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -56.55 150.87 49.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.732 2.288 . . . . 0.0 111.937 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -70.03 -0.98 8.53 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.96 6.95 23.58 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.41 151.61 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.964 -0.46 . . . . 0.0 110.826 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 59.9 p -143.73 171.39 14.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.421 0.689 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.32 -24.48 67.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.683 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.08 -22.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.187 -0.321 . . . . 0.0 110.447 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -81.35 -29.23 34.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.76 -25.13 58.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.054 -0.404 . . . . 0.0 110.875 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -80.96 -37.72 28.91 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.107 0.412 . . . . 0.0 111.246 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -76.34 -21.75 55.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.076 0.398 . . . . 0.0 111.199 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 64.0 mt -82.02 -37.77 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 91.2 m -66.82 -25.78 66.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.852 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.14 -30.16 64.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.77 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -91.06 -11.91 37.3 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.405 0.548 . . . . 0.0 111.818 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.7 mt -91.36 -10.32 41.62 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.991 0.517 . . . . 0.0 110.992 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.04 71.09 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 119.747 -0.474 . . . . 0.0 112.33 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.0 m -94.96 167.75 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 117.683 0.742 . . . . 0.0 110.438 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.42 147.41 27.88 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.91 0.386 . . . . 0.0 111.12 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -82.23 157.18 68.57 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 123.789 0.835 . . . . 0.0 111.25 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.16 155.16 69.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.414 2.743 . . . . 0.0 110.327 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.457 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -86.0 -24.9 26.27 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.716 0.406 . . . . 0.0 110.93 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 22.0 t -144.04 152.46 41.03 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -140.34 142.71 30.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 123.06 0.544 . . . . 0.0 109.975 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.7 129.52 21.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 175.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.39 147.8 32.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 122.826 0.451 . . . . 0.0 110.785 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -149.74 154.93 39.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.321 0.648 . . . . 0.0 109.947 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.0 m -130.84 135.05 47.36 Favored 'General case' 0 C--O 1.231 0.08 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -81.14 153.34 33.87 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -79.66 143.61 34.48 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.548 -0.384 . . . . 0.0 110.26 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 36.9 m 54.22 19.37 2.15 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.621 0.768 . . . . 0.0 112.772 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -111.89 -16.84 13.05 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.036 0.534 . . . . 0.0 111.42 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 50.19 33.63 7.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.75 0.82 . . . . 0.0 112.162 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.5 t -145.33 162.23 37.72 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.622 0.369 . . . . 0.0 110.987 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 45.8 t -131.0 154.76 47.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.976 0.91 . . . . 0.0 111.435 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.9 p -149.39 171.21 16.91 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.073 1.349 . . . . 0.0 109.063 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.94 -165.89 37.82 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.739 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.72 150.86 48.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.077 0.951 . . . . 0.0 110.367 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.57 133.18 39.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -127.65 108.22 10.58 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.457 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -165.98 154.01 10.69 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.705 1.602 . . . . 0.0 106.926 167.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.21 122.75 7.92 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 551' ' ' ASP . 46.3 t -159.56 153.37 23.01 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.007 1.723 . . . . 0.0 106.504 168.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -61.44 -54.72 39.82 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.322 0.51 . . . . 0.0 111.572 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.6 p -87.34 -21.5 25.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 548' ' ' SER . 10.9 t70 -79.67 -36.67 37.34 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.243 0.474 . . . . 0.0 110.801 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.56 -32.63 28.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.675 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.73 -27.32 60.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.991 0.359 . . . . 0.0 110.75 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.91 -43.96 33.54 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.037 -0.414 . . . . 0.0 110.673 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 95.7 m -70.44 -31.05 68.07 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.0 tm? -65.25 -42.16 93.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.56 -28.67 69.01 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.364 -0.686 . . . . 0.0 112.81 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.13 -13.43 15.44 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.0 -23.48 14.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.411 1.005 . . . . 0.0 112.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -69.95 142.35 52.9 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 48.96 35.29 6.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.817 0.847 . . . . 0.0 113.025 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -95.96 151.39 19.47 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -92.14 136.34 33.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.286 1.434 . . . . 0.0 111.324 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.2 ttt -64.36 176.0 1.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.251 0.62 . . . . 0.0 111.828 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -71.86 6.54 1.98 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -67.34 142.79 96.92 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.667 0.667 . . . . 0.0 110.6 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.45 -29.74 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.464 2.776 . . . . 0.0 113.672 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -120.58 1.01 10.58 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.968 0.349 . . . . 0.0 111.744 -174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.439 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.77 40.81 98.66 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.749 -1.029 . . . . 0.0 113.092 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 78.8 Cg_endo -69.16 -10.55 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.852 2.368 . . . . 0.0 111.993 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -144.24 147.57 37.77 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.053 0.541 . . . . 0.0 109.807 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.48 153.07 39.26 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.52 2.813 . . . . 0.0 111.3 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -149.03 -0.84 0.5 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.174 0.589 . . . . 0.0 111.583 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 10.2 t -66.49 124.86 23.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.521 -0.737 . . . . 0.0 109.687 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.8 pt? -124.99 144.56 50.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 0.0 110.939 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -82.66 147.6 28.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 49.5 tp -139.68 144.91 37.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.5 p -163.81 167.06 21.31 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -84.63 125.66 32.67 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 501' ' ' HIS . 31.8 t -135.69 148.79 49.03 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 85.0 m -79.53 105.43 10.83 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.556 0.217 . . . . 0.0 110.762 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.17 161.45 34.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.016 0.927 . . . . 0.0 109.75 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -126.67 -1.57 6.73 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.592 0.357 . . . . 0.0 110.996 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -148.82 161.62 41.46 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.881 0.872 . . . . 0.0 110.031 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.48 0.99 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.32 -1.324 . . . . 0.0 110.163 -179.34 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 119.618 -0.229 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 55.98 15.2 1.65 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.502 1.121 . . . . 0.0 113.455 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 162.04 160.38 10.95 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.19 -168.23 0.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.45 3.434 . . . . 0.0 110.326 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -105.63 145.58 30.83 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -70.63 152.84 43.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 111.002 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -87.88 -8.67 55.49 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.504 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 40.7 m -148.06 152.48 40.02 Favored Pre-proline 0 N--CA 1.456 -0.146 0 C-N-CA 122.657 0.383 . . . . 0.0 111.205 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -83.57 0.28 9.49 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.276 3.318 . . . . 0.0 112.816 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.16 164.37 33.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.697 0.681 . . . . 0.0 112.465 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.28 164.16 35.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.087 0.955 . . . . 0.0 108.933 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 79.4 mtp -133.29 150.85 51.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.642 0.377 . . . . 0.0 110.811 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.92 149.15 23.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.868 0.467 . . . . 0.0 110.638 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -139.38 163.98 31.07 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.648 0.779 . . . . 0.0 110.113 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.34 -2.86 69.45 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.734 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.627 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.64 171.76 11.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.021 0.911 . . . . 0.0 110.98 178.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -126.09 137.4 53.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.688 0.395 . . . . 0.0 110.016 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -67.82 -7.86 31.31 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 60.9 p -99.11 -8.78 24.72 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -134.35 -8.46 2.57 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.174 0.443 . . . . 0.0 111.317 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.5 tpt -147.97 108.34 4.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.142 0.577 . . . . 0.0 109.588 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.452 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 51.4 p-10 -141.91 -173.12 3.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.328 0.651 . . . . 0.0 109.884 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 24.4 p -56.03 -27.66 54.08 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.864 0.466 . . . . 0.0 112.154 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.05 -37.96 21.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.071 -0.393 . . . . 0.0 110.891 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . 0.452 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 7.8 mpt_? -75.76 -29.81 58.95 Favored 'General case' 0 C--O 1.23 0.041 0 O-C-N 122.206 -0.309 . . . . 0.0 110.805 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.42 -30.75 26.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -73.91 -27.48 61.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.642 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -75.16 -26.54 59.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.849 -0.532 . . . . 0.0 111.703 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.3 -24.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -106.24 -10.92 16.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.785 0.721 . . . . 0.0 112.846 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.51 -23.21 58.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.767 0.712 . . . . 0.0 111.772 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 402' ' ' LEU . 1.7 pp -77.28 12.56 1.45 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.631 -0.668 . . . . 0.0 112.263 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -120.74 -5.98 9.66 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.181 0.592 . . . . 0.0 111.088 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 151.85 -179.63 28.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -73.51 150.89 41.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 110.669 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.4 t -118.08 155.17 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.7 -57.45 2.25 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 118.712 0.687 . . . . 0.0 112.006 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . 0.426 ' HE2' ' HB ' ' A' ' 456' ' ' ILE . 23.9 pttm -161.72 164.06 29.29 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.986 0.422 . . . . 0.0 111.782 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.66 150.88 16.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 C-N-CA 123.93 0.892 . . . . 0.0 109.871 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -151.91 145.07 24.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.01 144.5 30.82 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.724 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -126.11 141.54 51.9 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -167.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.21 34.08 21.03 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 125.576 1.55 . . . . 0.0 112.565 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.4 m 53.46 15.06 0.64 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.053 1.341 . . . . 0.0 114.201 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -82.7 136.95 44.49 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 118.444 0.566 . . . . 0.0 109.582 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.86 -9.56 16.9 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.873 2.382 . . . . 0.0 109.571 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -111.22 19.66 24.47 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.202 0.906 . . . . 0.0 112.977 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.724 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -152.24 143.2 23.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.61 1.205 . . . . 0.0 110.848 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.89 167.61 29.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.846 0.355 . . . . 0.0 111.672 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 24.5 ptm -142.38 146.45 34.94 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.118 0.567 . . . . 0.0 109.812 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.6 154.96 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 122.601 0.361 . . . . 0.0 110.982 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.84 141.71 51.49 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.846 0.858 . . . . 0.0 110.714 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 66.9 mtp -119.02 163.36 17.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.853 0.461 . . . . 0.0 109.843 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.01 -26.99 67.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -161.21 164.35 30.48 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.724 0.409 . . . . 0.0 110.159 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.12 -8.09 61.01 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.333 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -69.69 -28.28 65.71 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.55 1.675 . . . . 0.0 110.218 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -87.21 -24.8 24.3 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.8 t -75.88 -25.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.89 -42.61 73.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.243 -0.285 . . . . 0.0 110.431 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -69.05 -26.81 65.16 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.76 -40.22 33.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.095 -0.378 . . . . 0.0 111.294 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 433' ' ' ILE . 4.4 tp -81.38 -30.99 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 122.572 0.349 . . . . 0.0 111.902 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -99.9 -20.12 16.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -129.67 -8.59 4.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -174.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.48 -20.92 10.03 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.314 0.961 . . . . 0.0 109.635 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.31 144.79 12.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.315 1.046 . . . . 0.0 111.24 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 58.02 1.38 0.14 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.235 2.214 . . . . 0.0 115.374 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -88.08 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.337 1.426 . . . . 0.0 108.307 168.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.308 0.0 OUTLIER -130.93 163.93 26.42 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 174.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.6 ptm -125.39 143.39 51.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.582 1.553 . . . . 0.0 109.86 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 63.92 32.59 13.09 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.121 1.368 . . . . 0.0 114.551 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.06 15.92 80.85 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.542 -0.588 . . . . 0.0 114.267 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.16 153.97 24.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.124 0.962 . . . . 0.0 110.122 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.578 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -88.85 131.28 35.17 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 175.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.59 130.92 45.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -140.76 113.1 7.94 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.15 139.93 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.415 0.552 . . . . 0.0 110.523 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 84.4 m -149.13 161.54 41.77 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.038 0.935 . . . . 0.0 110.113 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.4 p -82.47 156.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 43.9 t -132.94 157.9 43.99 Favored 'General case' 0 N--CA 1.459 0.024 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -99.57 6.21 45.83 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -65.66 142.59 98.3 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.49 -25.72 10.85 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.942 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.11 15.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 110.066 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.426 ' HB ' ' HE2' ' A' ' 408' ' ' LYS . 37.0 mm -69.35 138.57 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -91.68 151.22 42.13 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 122.395 0.278 . . . . 0.0 110.468 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.33 164.13 36.2 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.606 2.871 . . . . 0.0 110.81 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.87 -177.42 41.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -76.29 155.42 34.3 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.85 0.46 . . . . 0.0 110.032 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 84.6 p -133.09 165.57 24.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.38 0.672 . . . . 0.0 110.625 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -147.38 161.16 41.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.152 0.581 . . . . 0.0 110.305 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -83.41 135.29 13.67 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.93 168.85 13.0 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.539 0.735 . . . . 0.0 110.013 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -20.81 64.92 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.343 -0.223 . . . . 0.0 111.224 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -78.22 0.81 23.65 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 111.267 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.18 -3.15 82.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 123.542 0.591 . . . . 0.0 112.598 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.0 t -93.98 163.57 13.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.603 0.702 . . . . 0.0 110.286 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.42 153.39 21.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.722 0.296 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 98.5 p -66.19 -10.46 41.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.526 0.33 . . . . 0.0 111.601 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -120.62 141.87 49.95 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.141 0.976 . . . . 0.0 109.115 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -151.62 156.87 41.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.619 0.247 . . . . 0.0 110.464 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -126.31 150.16 48.68 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.637 0.775 . . . . 0.0 110.17 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -140.05 12.8 2.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.25 0.62 . . . . 0.0 111.566 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 22.4 t -65.94 -9.67 31.91 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -173.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.88 -6.91 59.52 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.722 0.409 . . . . 0.0 110.858 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.6 m -87.21 13.53 9.41 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.621 0.768 . . . . 0.0 111.833 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -73.87 12.35 0.7 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.394 0.678 . . . . 0.0 112.44 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -103.16 4.54 37.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.812 0.845 . . . . 0.0 111.476 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -73.75 153.66 39.92 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.749 -0.595 . . . . 0.0 110.078 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.0 7.12 4.34 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.39 0.676 . . . . 0.0 112.257 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -138.44 29.38 2.43 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.558 0.743 . . . . 0.0 111.05 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 39.2 m -76.8 2.61 13.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.97 0.508 . . . . 0.0 112.338 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 52.7 p -134.37 154.65 79.97 Favored Pre-proline 0 C--O 1.231 0.089 0 C-N-CA 123.052 0.541 . . . . 0.0 109.877 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -68.85 -11.12 31.05 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.14 2.56 . . . . 0.0 111.767 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.11 -32.69 14.34 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.032 0.378 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -90.46 -19.17 24.18 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 122.174 -0.329 . . . . 0.0 110.894 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -67.51 -16.05 63.99 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.062 -0.399 . . . . 0.0 111.12 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -81.33 -2.39 48.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.91 0.484 . . . . 0.0 111.544 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -115.96 9.21 14.84 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.756 0.823 . . . . 0.0 111.109 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -130.65 20.87 5.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.58 0.752 . . . . 0.0 111.122 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 51.99 45.5 28.2 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.956 0.903 . . . . 0.0 112.635 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 51.5 mm -81.0 93.93 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -156.59 -171.49 3.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.848 0.859 . . . . 0.0 109.96 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -60.95 159.72 25.41 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.215 0.606 . . . . 0.0 110.544 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -51.19 147.69 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.372 2.715 . . . . 0.0 112.93 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 55.7 m -124.0 19.4 9.22 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.34 0.656 . . . . 0.0 111.169 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.28 3.81 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.179 1.392 . . . . 0.0 114.591 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 37.0 t -141.54 147.38 22.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.475 HD12 ' CH2' ' A' ' 546' ' ' TRP . 53.2 mt -121.8 163.38 19.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.895 0.478 . . . . 0.0 110.457 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.58 158.66 43.9 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.566 0.346 . . . . 0.0 110.807 174.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -137.59 153.83 49.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.407 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -148.39 169.65 19.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.143 0.577 . . . . 0.0 110.33 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 15.8 t30 62.51 18.92 10.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.877 0.871 . . . . 0.0 113.324 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -77.52 164.63 56.92 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.48 152.91 37.59 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.728 2.285 . . . . 0.0 111.995 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.51 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -74.66 -1.77 23.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.838 0.455 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -125.13 16.78 8.45 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.496 0.719 . . . . 0.0 111.421 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.64 151.32 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 O-C-N 122.019 -0.426 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 74.7 p -141.75 170.46 15.67 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 123.125 0.57 . . . . 0.0 110.69 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.2 -22.6 66.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.98 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.91 -24.48 48.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.205 -0.309 . . . . 0.0 110.493 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.44 -32.04 37.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -73.41 -29.88 62.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.235 -0.291 . . . . 0.0 110.747 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -77.88 -37.28 48.43 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.149 0.431 . . . . 0.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.91 -25.23 43.76 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.859 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.91 -40.66 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.4 m -65.11 -29.01 69.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.277 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.21 -29.3 61.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.854 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.98 -10.94 40.48 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.415 0.552 . . . . 0.0 112.014 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 85.2 mt -91.1 -3.71 56.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.758 0.423 . . . . 0.0 110.768 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.9 80.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.779 -0.456 . . . . 0.0 112.499 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -112.81 172.14 3.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.524 0.662 . . . . 0.0 111.403 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.18 149.19 41.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.207 0.603 . . . . 0.0 110.073 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -98.06 151.55 37.6 Favored Pre-proline 0 CA--C 1.528 0.13 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.54 147.17 93.22 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.788 2.325 . . . . 0.0 110.492 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.416 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.3 m -82.71 -28.4 30.54 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 122.938 0.495 . . . . 0.0 110.997 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -140.32 147.32 39.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 2.4 p -154.36 144.63 13.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 122.744 0.418 . . . . 0.0 110.799 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -149.2 156.47 42.2 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.354 0.662 . . . . 0.0 109.523 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.59 145.51 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.416 0.686 . . . . 0.0 109.23 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -150.63 142.52 23.86 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.735 0.302 . . . . 0.0 110.95 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p -130.78 50.61 2.2 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.366 0.666 . . . . 0.0 111.555 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -73.66 -13.06 80.58 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.889 -0.507 . . . . 0.0 111.837 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -155.07 169.86 23.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.122 1.369 . . . . 0.0 108.307 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 18.4 m 58.31 29.58 18.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.13 0.423 . . . . 0.0 110.962 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.19 -9.92 1.09 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.695 1.598 . . . . 0.0 114.821 -169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -67.58 -10.99 56.97 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.045 0.839 . . . . 0.0 110.38 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 59.3 m -148.9 -178.1 6.17 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.882 1.673 . . . . 0.0 108.784 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 8.6 t -140.26 160.86 39.02 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.116 -0.365 . . . . 0.0 110.981 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.8 m -146.35 164.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.698 0.799 . . . . 0.0 110.741 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 176.2 -166.52 37.65 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.591 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 63.3 mt -120.62 155.65 33.31 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.437 0.695 . . . . 0.0 111.265 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 91.9 mt -140.31 132.19 27.6 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.012 0.925 . . . . 0.0 108.816 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -127.89 119.48 25.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.475 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.6 p90 -166.05 150.47 8.06 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.385 1.474 . . . . 0.0 107.08 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -145.84 110.39 5.09 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -172.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.0 t -159.5 153.0 22.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -67.33 -42.02 84.28 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.528 0.604 . . . . 0.0 110.437 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 31.6 m -83.92 -30.55 26.23 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.808 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.81 -30.21 26.72 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.69 0.677 . . . . 0.0 111.48 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.73 -30.3 29.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 118.162 0.437 . . . . 0.0 111.316 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 29.8 tp -83.55 -29.29 27.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.879 0.763 . . . . 0.0 111.793 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.4 -42.67 43.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.256 0.48 . . . . 0.0 110.02 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 55.5 m -68.99 -31.85 71.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.9 -41.84 58.94 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.01 -19.99 75.9 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.366 -0.686 . . . . 0.0 113.115 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -111.71 -11.65 13.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.326 1.063 . . . . 0.0 113.052 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 30.4 tp -104.97 -16.88 14.7 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.087 0.858 . . . . 0.0 112.386 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -72.59 143.81 48.1 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.748 -0.595 . . . . 0.0 109.545 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 51.11 21.18 0.98 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.879 0.872 . . . . 0.0 113.128 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -78.43 151.44 32.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.11 136.38 50.24 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.095 1.358 . . . . 0.0 109.181 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 49.9 ttm -64.24 162.15 15.2 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.252 0.549 . . . . 0.0 110.915 -173.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -66.69 15.66 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.866 1.666 . . . . 0.0 114.055 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -65.09 152.86 90.46 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.75 -46.89 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.728 2.286 . . . . 0.0 113.951 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -121.13 16.19 11.55 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.94 47.91 84.96 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.088 -0.84 . . . . 0.0 112.761 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 -10.09 21.97 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.147 2.565 . . . . 0.0 111.122 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -148.55 149.49 31.36 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 123.829 0.852 . . . . 0.0 109.603 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.86 156.37 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.577 2.851 . . . . 0.0 111.632 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 573' ' ' TYR . 79.6 t80 -144.79 1.27 1.0 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.849 0.86 . . . . 0.0 110.588 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 57.3 m -66.44 116.53 7.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 575' ' ' LEU . 1.7 pt? -124.89 144.53 50.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.508 0.723 . . . . 0.0 111.961 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.05 143.59 31.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.6 mt -131.21 144.73 51.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 36.8 t -163.8 176.34 9.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.34 145.31 28.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.928 0.491 . . . . 0.0 110.933 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 35.0 t -135.54 147.22 48.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.094 0.558 . . . . 0.0 110.112 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 25.4 m -89.61 102.13 14.81 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.62 34.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.598 0.759 . . . . 0.0 110.293 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -96.43 -21.52 17.7 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 174.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -164.26 153.81 14.0 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.073 0.949 . . . . 0.0 109.962 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -109.97 76.32 0.98 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.465 -1.255 . . . . 0.0 110.631 178.58 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 39.5 t80 52.72 26.1 4.24 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.595 0.758 . . . . 0.0 112.285 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -172.51 -170.49 36.37 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.51 166.77 1.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.863 3.709 . . . . 0.0 113.841 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 57.26 52.32 8.99 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.1 0.96 . . . . 0.0 111.795 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -58.09 156.37 9.61 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.81 0.444 . . . . 0.0 110.42 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.19 6.44 5.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.826 0.451 . . . . 0.0 111.946 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.4 m -142.92 146.03 35.77 Favored Pre-proline 0 C--O 1.232 0.133 0 O-C-N 121.93 -0.481 . . . . 0.0 111.389 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -82.0 1.8 8.97 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 124.598 3.532 . . . . 0.0 112.834 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.26 146.35 28.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 CA-C-N 118.374 0.534 . . . . 0.0 110.943 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.4 pp -141.84 167.68 21.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.695 0.798 . . . . 0.0 109.609 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.9 mtp -138.83 151.17 46.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.672 0.273 . . . . 0.0 110.856 -175.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.4 p -142.09 150.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 123.043 0.537 . . . . 0.0 110.63 -176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.76 166.52 24.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.489 0.716 . . . . 0.0 109.519 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.08 89.46 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.701 -0.499 . . . . 0.0 112.934 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.765 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.15 175.71 7.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.774 0.787 . . . . 0.0 110.689 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -138.3 142.08 39.8 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 122.544 0.338 . . . . 0.0 110.103 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -73.94 -2.35 23.61 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.8 p -110.38 -2.68 16.52 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.205 0.457 . . . . 0.0 112.126 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -131.65 -5.72 3.66 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.164 0.586 . . . . 0.0 110.922 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.8 tpt -146.19 123.33 11.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.216 0.606 . . . . 0.0 109.545 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.454 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 22.5 m120 -141.94 176.26 9.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.883 0.873 . . . . 0.0 109.082 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 81.6 m -59.54 -25.97 64.96 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.225 -0.297 . . . . 0.0 110.94 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.14 -23.12 26.71 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.255 -0.278 . . . . 0.0 111.593 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . 0.454 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 49.0 mmt-85 -82.16 -31.3 30.57 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.418 0.554 . . . . 0.0 109.586 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.43 -30.0 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -69.94 -30.89 68.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -71.96 -32.03 66.87 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.94 -0.475 . . . . 0.0 110.889 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 72.3 t -88.03 -27.36 5.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -104.95 -8.41 18.62 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.36 -39.46 78.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.825 0.739 . . . . 0.0 110.967 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.03 14.96 1.22 Allowed 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.936 -0.478 . . . . 0.0 112.145 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.31 -1.89 9.63 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.188 0.595 . . . . 0.0 111.067 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 147.83 174.19 19.48 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -74.71 136.03 41.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.317 -0.52 . . . . 0.0 110.957 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 474' ' ' PHE . 7.7 m -94.44 164.52 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 124.571 1.148 . . . . 0.0 110.365 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -129.91 -63.34 0.92 Allowed 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.261 0.224 . . . . 0.0 110.884 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -163.32 166.04 23.48 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.771 0.429 . . . . 0.0 111.353 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.54 153.27 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 123.553 0.741 . . . . 0.0 110.625 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -149.65 145.06 26.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -77.47 155.2 31.87 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.521 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 8.3 ttm -107.78 141.11 39.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -168.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 48.72 33.99 4.77 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.217 1.007 . . . . 0.0 112.64 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.9 m 53.03 17.64 0.95 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.828 0.851 . . . . 0.0 113.099 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.66 147.77 53.07 Favored Pre-proline 0 N--CA 1.455 -0.204 0 CA-C-N 118.023 0.374 . . . . 0.0 110.428 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -81.61 -1.63 11.07 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.43 2.753 . . . . 0.0 110.427 170.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -124.54 17.28 7.38 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.587 -173.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.521 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -149.79 143.91 25.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.747 1.274 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.95 168.66 26.83 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.8 ptm -141.6 145.14 34.67 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.427 0.691 . . . . 0.0 109.946 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 14.6 t -131.95 150.96 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 122.746 0.418 . . . . 0.0 110.838 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -128.24 143.26 51.02 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.389 0.675 . . . . 0.0 110.311 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 81.3 mmm -117.1 162.64 17.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.434 0.694 . . . . 0.0 109.323 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -73.25 -19.28 61.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.055 -0.403 . . . . 0.0 111.921 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -156.62 162.5 39.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.776 0.43 . . . . 0.0 110.172 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.64 -17.95 73.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.458 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -67.49 -26.52 66.4 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.976 1.388 . . . . 0.0 110.172 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.57 -24.17 45.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.416 0.286 . . . . 0.0 110.621 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.25 -31.81 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.75 -32.38 73.9 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -82.22 -30.5 30.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.349 0.26 . . . . 0.0 111.681 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.59 -28.22 31.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.33 0.514 . . . . 0.0 111.073 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.4 tp -82.59 -31.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.918 0.487 . . . . 0.0 110.992 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.0 m -93.74 -21.99 18.99 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -124.24 -13.32 7.24 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.66 -20.47 10.11 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.072 0.851 . . . . 0.0 110.293 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -52.28 143.26 15.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.963 0.905 . . . . 0.0 111.497 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 14.3 p30 56.91 1.53 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.004 2.522 . . . . 0.0 115.864 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -88.04 142.64 27.62 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.183 1.356 . . . . 0.0 108.184 168.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.286 0.0 OUTLIER -130.95 163.95 26.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 176.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.7 ptm -125.28 143.44 50.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.162 1.385 . . . . 0.0 109.946 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 65.07 31.57 10.98 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.025 1.33 . . . . 0.0 114.042 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.02 15.86 72.25 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.344 -0.698 . . . . 0.0 114.805 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -83.27 162.05 21.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.427 1.114 . . . . 0.0 110.337 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 131.68 35.66 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.961 0.41 . . . . 0.0 110.527 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.61 132.96 43.61 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -169.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.68 117.46 11.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.7 p -147.7 139.9 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 118.393 0.542 . . . . 0.0 110.523 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.4 m -150.23 161.98 41.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.982 0.913 . . . . 0.0 110.162 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.9 p -84.82 155.5 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 38.3 t -134.38 142.54 47.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.977 0.353 . . . . 0.0 111.246 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -85.7 65.95 9.4 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.03 0.532 . . . . 0.0 110.43 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -127.81 143.78 48.91 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.18 -26.54 6.25 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.878 2.386 . . . . 0.0 111.805 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.02 170.51 15.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.558 0.343 . . . . 0.0 111.031 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.1 mm -71.62 147.02 11.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.33 151.98 41.07 Favored Pre-proline 0 C--O 1.231 0.128 0 C-N-CA 122.416 0.286 . . . . 0.0 110.239 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.41 164.49 32.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.673 2.915 . . . . 0.0 111.874 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 171.21 -174.35 44.87 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -74.12 148.85 41.41 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.844 0.322 . . . . 0.0 110.25 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 24.9 m -142.59 160.89 39.42 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.249 0.62 . . . . 0.0 109.919 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -150.91 164.23 36.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.463 0.305 . . . . 0.0 110.568 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.14 135.27 16.27 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.95 169.5 12.42 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.539 0.736 . . . . 0.0 109.702 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.15 -20.31 65.73 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.081 -0.387 . . . . 0.0 111.376 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.0 -0.9 26.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.962 0.505 . . . . 0.0 111.283 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 85.73 -7.58 76.32 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.635 0.636 . . . . 0.0 112.783 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.7 m -93.83 156.19 16.79 Favored 'General case' 0 C--N 1.338 0.068 0 CA-C-N 117.896 0.848 . . . . 0.0 110.397 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 47.5 t -77.44 153.26 33.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.398 0.279 . . . . 0.0 110.261 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -68.14 -10.42 53.96 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.249 0.619 . . . . 0.0 111.678 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -123.48 136.27 54.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.11 0.964 . . . . 0.0 109.297 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -155.72 159.26 39.35 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -125.0 157.4 36.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.927 0.891 . . . . 0.0 110.454 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' A' ' 406' ' ' VAL . 24.5 m-85 -139.56 13.53 2.54 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.6 p -69.81 1.72 4.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -85.36 11.95 9.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.693 0.797 . . . . 0.0 110.686 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 77.4 p -72.06 22.29 0.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.222 1.409 . . . . 0.0 112.587 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -76.07 30.84 0.11 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.025 0.93 . . . . 0.0 112.66 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -134.0 31.13 3.6 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.747 0.819 . . . . 0.0 110.533 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -138.45 172.76 12.42 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.838 0.455 . . . . 0.0 110.682 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -62.55 -13.73 34.2 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.12 0.968 . . . . 0.0 112.632 -174.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.93 24.89 11.64 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.662 0.385 . . . . 0.0 111.984 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 41.3 t -60.6 -23.08 64.42 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.032 0.533 . . . . 0.0 111.365 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 72.5 p -137.16 155.84 75.79 Favored Pre-proline 0 N--CA 1.456 -0.13 0 C-N-CA 123.564 0.745 . . . . 0.0 109.389 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -70.54 -9.02 24.95 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.183 2.589 . . . . 0.0 111.517 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.13 -30.02 16.19 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.872 0.305 . . . . 0.0 110.707 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -90.43 -24.75 20.65 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.36 -13.83 62.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.288 0.235 . . . . 0.0 110.733 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.38 3.09 37.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.156 0.582 . . . . 0.0 111.131 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -118.47 22.28 12.17 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.948 0.899 . . . . 0.0 110.887 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -78.84 171.68 14.84 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.745 0.418 . . . . 0.0 111.812 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -135.51 37.87 2.9 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.653 0.781 . . . . 0.0 109.823 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 46.6 mm -80.97 130.87 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 O-C-N 122.034 -0.417 . . . . 0.0 110.008 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -156.64 -174.04 4.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.592 0.757 . . . . 0.0 110.031 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -61.43 163.82 10.5 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 124.139 0.975 . . . . 0.0 110.828 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.22 143.06 20.12 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.23 2.62 . . . . 0.0 112.258 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 51.3 m -119.77 23.58 11.03 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.261 0.624 . . . . 0.0 112.259 -172.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 61.96 -7.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.42 1.488 . . . . 0.0 114.098 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.72 147.65 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 118.757 0.708 . . . . 0.0 109.661 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.416 HD12 ' CH2' ' A' ' 546' ' ' TRP . 59.5 mt -119.1 151.64 37.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.786 0.434 . . . . 0.0 110.222 177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.51 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 11.7 m170 -119.55 155.41 32.24 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.25 149.91 44.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.333 0.253 . . . . 0.0 110.524 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -145.78 169.28 18.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.747 0.419 . . . . 0.0 110.987 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 46.4 t30 56.68 33.12 22.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.994 0.918 . . . . 0.0 112.843 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.82 163.74 39.74 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -58.94 151.0 68.64 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.007 2.472 . . . . 0.0 111.847 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -75.27 -1.19 22.38 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.34 9.59 11.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.899 0.48 . . . . 0.0 111.919 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.6 149.49 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 118.019 0.372 . . . . 0.0 111.058 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.8 p -142.07 173.98 11.02 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.536 0.735 . . . . 0.0 110.265 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.63 -21.74 65.9 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.792 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.77 -22.08 58.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.234 -0.291 . . . . 0.0 110.407 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -83.25 -32.17 26.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.86 -27.63 63.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.531 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -84.53 -37.54 21.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.135 0.425 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -76.03 -21.28 57.01 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.756 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.6 mt -92.1 -36.14 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.922 0.328 . . . . 0.0 110.859 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 18.2 p -70.31 -20.85 62.98 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.524 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.47 -29.03 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.567 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.99 -12.93 34.41 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.447 0.567 . . . . 0.0 111.333 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.06 -9.58 55.1 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.716 0.406 . . . . 0.0 110.838 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.22 11.08 82.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.765 -0.464 . . . . 0.0 112.803 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.5 m -98.8 169.82 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.103 0 CA-C-N 117.738 0.769 . . . . 0.0 111.291 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.54 151.68 42.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.343 0.657 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -101.04 151.98 37.76 Favored Pre-proline 0 C--O 1.231 0.111 0 C-N-CA 122.729 0.412 . . . . 0.0 109.899 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.31 153.38 78.26 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.962 2.442 . . . . 0.0 110.471 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 80.6 m -86.14 -24.84 26.05 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.621 0.368 . . . . 0.0 110.53 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.2 m -142.84 150.35 39.78 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.168 0.587 . . . . 0.0 109.599 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.55 147.97 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 120.872 0.368 . . . . 0.0 110.387 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -142.28 132.26 24.46 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.91 142.4 39.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -154.24 150.65 28.28 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.002 0.521 . . . . 0.0 110.468 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m -130.82 133.2 45.74 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.05 158.0 45.7 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -71.22 130.55 41.72 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 26.3 m 55.68 15.31 1.52 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -86.54 -15.4 40.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.707 0.685 . . . . 0.0 111.328 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 49.42 29.28 2.77 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.967 0.907 . . . . 0.0 112.757 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 25.2 t -149.52 162.88 39.27 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.922 0.489 . . . . 0.0 110.433 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 42.2 t -124.82 152.59 43.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.47 0.708 . . . . 0.0 111.519 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 52.5 m -147.73 165.26 31.05 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.73 1.212 . . . . 0.0 108.93 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.81 -165.88 37.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.745 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -127.41 156.28 42.32 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.755 0.822 . . . . 0.0 110.351 -176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 83.1 mt -139.86 133.62 30.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.482 1.113 . . . . 0.0 108.004 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.83 113.3 15.77 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.416 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.9 p90 -166.02 151.35 8.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 168.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -150.77 116.2 5.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 35.2 t -159.41 152.92 22.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.93 -38.0 79.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.746 0.703 . . . . 0.0 111.432 -174.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 47.4 m -87.78 -28.6 21.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -85.37 -28.32 25.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.414 0.552 . . . . 0.0 111.12 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.17 -34.42 37.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 117.949 0.341 . . . . 0.0 110.397 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.5 tp -78.88 -30.73 45.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.439 0.563 . . . . 0.0 112.016 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -72.72 -43.73 62.6 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.261 0.482 . . . . 0.0 109.979 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 44.4 m -69.27 -40.26 77.91 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -63.67 -42.79 98.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.901 -0.499 . . . . 0.0 109.864 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.15 -21.57 77.11 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.86 -0.966 . . . . 0.0 113.447 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -117.68 -14.97 10.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.857 1.329 . . . . 0.0 113.276 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 17.4 tp -88.22 -21.93 24.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.347 0.976 . . . . 0.0 110.623 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -76.49 151.32 36.47 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 39.8 t60 55.91 22.66 5.89 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.64 151.46 37.77 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.194 0.598 . . . . 0.0 112.537 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -110.78 136.18 50.23 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.06 0.944 . . . . 0.0 111.433 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.25 176.83 0.94 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.076 0.95 . . . . 0.0 111.417 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.9 10.71 0.65 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.709 0.803 . . . . 0.0 112.459 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.04 146.71 87.43 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 123.288 0.635 . . . . 0.0 111.051 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.92 -40.63 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.134 2.556 . . . . 0.0 112.734 -177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -120.96 2.38 10.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 65.82 60.26 6.71 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.767 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.67 -8.5 15.86 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.322 2.681 . . . . 0.0 110.984 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.45 151.03 46.16 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 123.576 0.75 . . . . 0.0 109.74 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.58 154.33 39.75 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.637 2.892 . . . . 0.0 110.356 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -133.16 -4.58 3.07 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.8 t -66.55 131.95 47.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.668 -0.645 . . . . 0.0 110.653 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 575' ' ' LEU . 1.8 pp -116.43 144.67 44.01 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.373 0.669 . . . . 0.0 110.79 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.64 138.09 39.85 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.03 155.89 43.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 111.412 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.9 p -163.76 167.98 20.27 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.23 131.61 39.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.51 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 26.2 t -135.64 150.13 49.53 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.521 0.201 . . . . 0.0 111.247 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.2 m -84.77 102.38 12.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.16 161.63 34.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.742 0.817 . . . . 0.0 110.061 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -109.75 -11.9 14.68 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.422 0.289 . . . . 0.0 111.634 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -160.52 162.83 33.11 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.079 0.552 . . . . 0.0 109.995 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -95.83 76.5 3.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.268 0.627 . . . . 0.0 109.717 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.252 1.204 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.222 -179.677 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 119.587 -0.244 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -80.41 -27.08 38.13 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.981 0.355 . . . . 0.0 110.582 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -96.66 -150.09 26.41 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 172.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -54.1 164.09 2.86 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.915 3.077 . . . . 0.0 112.278 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 54.14 91.72 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.861 1.264 . . . . 0.0 112.389 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -71.54 159.72 33.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.56 0.344 . . . . 0.0 110.495 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -142.32 14.46 2.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.044 0.538 . . . . 0.0 111.192 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.1 m -141.38 150.11 56.9 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 122.126 -0.359 . . . . 0.0 111.379 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.39 -5.6 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.137 3.225 . . . . 0.0 111.98 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 11.7 p -132.89 151.25 34.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 122.832 0.453 . . . . 0.0 111.276 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.42 167.88 21.88 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.71 0.804 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 74.6 mtp -133.61 150.41 51.61 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.359 0.264 . . . . 0.0 111.316 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.05 151.04 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.161 0.584 . . . . 0.0 110.603 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -140.05 164.95 28.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.472 0.709 . . . . 0.0 109.637 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 78.94 -2.69 67.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.384 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.8 pt? -71.41 134.64 46.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.988 0.894 . . . . 0.0 109.794 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -83.48 122.65 28.81 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -75.03 6.79 3.79 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.9 p -116.0 -1.02 12.6 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.788 0.435 . . . . 0.0 111.658 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -130.3 -9.09 4.22 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.791 0.836 . . . . 0.0 110.472 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 11.0 tpt -139.86 128.08 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.24 1.016 . . . . 0.0 108.785 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -141.92 -172.92 3.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.132 0.573 . . . . 0.0 109.822 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.22 -22.65 64.97 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.19 -33.27 20.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.964 -0.46 . . . . 0.0 110.851 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 41.2 mmt-85 -81.66 -25.35 35.64 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.275 -0.266 . . . . 0.0 110.987 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.43 -30.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.018 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.22 -25.49 63.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -75.09 -39.81 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.14 -0.35 . . . . 0.0 111.256 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.3 -20.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 121.994 -0.441 . . . . 0.0 111.979 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -109.81 -18.02 13.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 42.4 t -75.65 -21.6 57.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.16 0.891 . . . . 0.0 111.499 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.404 ' C ' HD12 ' A' ' 402' ' ' LEU . 1.1 pp -72.23 7.3 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.705 -0.622 . . . . 0.0 112.469 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -121.62 -1.85 9.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.538 0.735 . . . . 0.0 111.41 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.96 173.31 20.21 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -68.28 146.97 52.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.346 -0.502 . . . . 0.0 111.23 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.51 155.55 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.783 0.833 . . . . 0.0 108.813 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -101.02 -65.37 0.97 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -163.31 164.41 24.86 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.595 0.758 . . . . 0.0 110.232 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 11.2 p -144.2 151.27 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 C-N-CA 123.116 0.566 . . . . 0.0 110.437 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.07 139.77 19.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.924 0.14 . . . . 0.0 111.282 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.71 152.3 28.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -133.86 141.42 47.39 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 60.0 33.74 21.4 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 126.472 1.909 . . . . 0.0 114.231 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 25.1 m 52.84 16.0 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -72.0 158.38 87.77 Favored Pre-proline 0 C--O 1.231 0.115 0 CA-C-N 118.613 0.642 . . . . 0.0 110.712 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.77 -22.4 44.67 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.223 2.615 . . . . 0.0 112.023 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -171.06 97.9 0.13 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -158.67 134.04 8.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -153.89 168.31 26.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.367 0.603 . . . . 0.0 112.462 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.9 ptp -139.63 145.34 38.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.147 0.979 . . . . 0.0 109.038 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.07 146.6 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.949 0.404 . . . . 0.0 110.617 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -124.94 146.41 49.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.792 0.837 . . . . 0.0 109.866 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 75.3 mtp -122.35 164.12 18.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.793 0.437 . . . . 0.0 110.431 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.68 -20.93 61.87 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -156.93 158.04 35.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.051 0.387 . . . . 0.0 110.181 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.13 80.67 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.116 -0.824 . . . . 0.0 113.578 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -69.17 -25.77 64.52 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.198 1.499 . . . . 0.0 110.839 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.29 -25.24 27.34 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.14 -27.51 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.25 -37.33 77.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.324 -0.235 . . . . 0.0 110.449 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -71.96 -30.79 65.65 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.84 57.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.314 -0.241 . . . . 0.0 111.078 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.2 tp -83.65 -30.9 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.6 m -99.02 -16.27 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.93 -6.68 2.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.62 -20.57 10.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.251 0.932 . . . . 0.0 109.56 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -52.77 142.32 19.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.044 0.938 . . . . 0.0 110.872 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.09 1.28 0.09 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.101 2.16 . . . . 0.0 115.659 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -87.84 142.52 27.75 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 120.242 1.383 . . . . 0.0 108.507 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -130.84 164.06 26.03 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 176.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.2 ptm -125.43 143.47 50.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.991 1.316 . . . . 0.0 108.985 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 67.01 25.7 9.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.05 80.54 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.797 1.079 . . . . 0.0 115.797 168.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -83.06 159.77 22.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.014 1.407 . . . . 0.0 110.65 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.37 141.93 32.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.19 0.596 . . . . 0.0 111.025 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -98.22 124.15 42.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -140.68 111.3 6.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 169.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.09 140.2 17.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 CA-C-N 118.118 0.417 . . . . 0.0 109.957 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 96.8 m -149.47 159.94 43.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.775 0.83 . . . . 0.0 110.352 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.0 p -80.12 160.4 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 46.2 t -134.29 168.47 18.84 Favored 'General case' 0 C--N 1.334 -0.08 0 C-N-CA 122.811 0.444 . . . . 0.0 110.515 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.08 12.71 11.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.566 0.746 . . . . 0.0 112.337 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.05 147.06 99.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.39 -36.5 77.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.81 2.34 . . . . 0.0 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.01 173.69 6.77 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.622 0.769 . . . . 0.0 110.047 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.4 mm -68.77 144.69 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.6 mtt -105.55 146.66 33.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 117.646 0.203 . . . . 0.0 110.994 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.2 172.85 15.55 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.253 3.302 . . . . 0.0 111.457 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.06 46.82 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.377 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 55.15 21.78 4.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.04 0.936 . . . . 0.0 112.857 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 65.5 p -79.42 153.93 29.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.716 0.293 . . . . 0.0 110.928 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -154.09 163.45 40.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.146 0.579 . . . . 0.0 110.343 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.2 136.0 16.56 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.92 169.32 12.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.277 0.631 . . . . 0.0 110.12 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.67 -21.13 66.66 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.941 0.401 . . . . 0.0 110.316 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -77.94 -1.38 31.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.666 0.787 . . . . 0.0 111.452 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.76 70.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.398 0.523 . . . . 0.0 113.16 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.1 m -93.77 163.79 13.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.642 0.721 . . . . 0.0 110.798 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.51 153.33 37.55 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.7 p -70.23 -10.57 59.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -119.68 146.57 45.47 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.593 0.633 . . . . 0.0 112.156 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -157.0 156.12 32.4 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 110.142 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -124.49 152.31 43.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.798 0.839 . . . . 0.0 109.713 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -138.93 10.04 2.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.013 0.525 . . . . 0.0 111.282 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 94.3 p -67.61 -11.18 57.56 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.72 -3.7 39.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.614 0.366 . . . . 0.0 111.202 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 19.9 t -104.85 18.23 22.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.783 0.833 . . . . 0.0 110.989 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -73.95 0.99 11.8 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.906 -0.496 . . . . 0.0 111.197 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -100.94 6.28 43.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.814 0.446 . . . . 0.0 110.684 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -81.25 166.15 20.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.882 0.473 . . . . 0.0 110.277 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -72.8 5.35 3.25 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.06 23.3 4.17 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.571 0.623 . . . . 0.0 112.45 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 88.5 p -73.67 -8.03 54.36 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.991 -0.443 . . . . 0.0 111.806 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 53.4 p -140.94 154.61 68.63 Favored Pre-proline 0 C--O 1.232 0.139 0 C-N-CA 123.764 0.826 . . . . 0.0 109.386 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.68 -11.66 31.42 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.014 2.476 . . . . 0.0 111.662 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -90.49 -29.93 17.62 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.171 0.442 . . . . 0.0 111.381 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -90.56 -27.88 18.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.775 0.261 . . . . 0.0 110.469 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.53 -19.7 62.14 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.567 0.347 . . . . 0.0 111.666 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -73.57 1.12 10.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.203 0.601 . . . . 0.0 111.77 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -120.19 12.75 11.89 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.102 0.961 . . . . 0.0 111.049 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -132.9 27.08 4.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.0 0.52 . . . . 0.0 111.109 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.528 ' HD2' ' H ' ' A' ' 581' ' ' THR . 64.3 mtm-85 58.64 22.65 10.1 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.054 0.942 . . . . 0.0 113.281 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.4 mm -81.02 148.86 5.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 125.029 1.332 . . . . 0.0 110.763 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.286 8.5 pt20 64.69 14.41 9.05 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.545 1.938 . . . . 0.0 115.213 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -141.19 95.84 7.33 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.78 138.49 16.91 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.487 2.792 . . . . 0.0 110.255 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 56.4 m -124.04 23.93 8.37 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.362 0.665 . . . . 0.0 111.4 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.45 18.91 9.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.811 0.844 . . . . 0.0 112.717 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.9 t -134.42 146.82 30.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.477 HD12 ' CH2' ' A' ' 546' ' ' TRP . 28.8 mt -118.22 160.61 21.3 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.8 0.44 . . . . 0.0 110.196 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -121.64 157.41 30.88 Favored 'General case' 0 N--CA 1.46 0.059 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -142.73 152.85 42.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.852 0.461 . . . . 0.0 110.409 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.85 173.07 12.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.126 0.57 . . . . 0.0 110.549 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 64.8 t30 66.5 28.41 9.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.451 1.1 . . . . 0.0 113.329 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.14 160.42 46.01 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 122.12 -0.363 . . . . 0.0 110.723 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 156.0 39.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.08 2.52 . . . . 0.0 111.644 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.7 pt? -77.97 -0.76 28.95 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -122.52 13.1 10.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.174 0.589 . . . . 0.0 111.548 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.57 152.68 7.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 O-C-N 122.081 -0.387 . . . . 0.0 110.926 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.6 p -142.39 170.99 14.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.489 0.715 . . . . 0.0 110.437 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.74 -20.65 65.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.819 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -72.89 -23.65 60.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.6 -33.37 28.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -69.46 -28.66 66.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.514 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -82.26 -35.64 27.91 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.965 -0.46 . . . . 0.0 111.788 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -78.27 -17.3 56.83 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.329 0.513 . . . . 0.0 112.006 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.01 -25.36 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.122 0.419 . . . . 0.0 110.663 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.18 -24.24 63.1 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.404 -0.81 . . . . 0.0 109.753 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.94 -10.78 54.62 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.04 -18.82 23.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.289 1.035 . . . . 0.0 110.332 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.7 mt -112.92 -0.44 14.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.75 5.77 70.15 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.678 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.86 169.75 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.852 0.826 . . . . 0.0 111.044 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -78.49 145.37 34.99 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.882 0.473 . . . . 0.0 110.275 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.67 146.67 47.19 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.944 0.498 . . . . 0.0 110.218 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.52 158.22 58.12 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.251 2.634 . . . . 0.0 110.685 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 61.8 m -90.4 -28.34 18.72 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.015 0.526 . . . . 0.0 110.698 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.2 m -142.35 153.67 44.02 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.142 0.577 . . . . 0.0 109.505 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 94.8 t -139.13 146.62 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 122.976 0.51 . . . . 0.0 110.284 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . 0.442 ' HE2' ' N ' ' A' ' 586' ' ' SER . 30.0 ttmt -138.24 140.01 39.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.71 145.16 31.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -136.04 157.99 45.5 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -172.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.1 p -130.77 153.02 49.48 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.906 0.882 . . . . 0.0 110.198 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . 173.16 -147.18 9.45 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.04 160.6 12.23 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 23.0 m 61.68 29.01 17.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.198 0.454 . . . . 0.0 111.961 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.84 -7.51 0.74 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.954 1.302 . . . . 0.0 113.858 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -65.95 -10.88 43.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.469 0.577 . . . . 0.0 110.28 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 65.2 m -141.15 167.0 23.23 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.661 1.184 . . . . 0.0 109.575 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.1 t -132.0 166.01 22.66 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.016 0.526 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 77.6 p -153.47 172.35 17.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.495 1.118 . . . . 0.0 110.111 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.35 -161.05 33.43 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.63 -0.795 . . . . 0.0 114.028 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.09 157.18 32.02 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.57 1.148 . . . . 0.0 110.523 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.46 133.31 30.76 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 124.232 1.013 . . . . 0.0 108.345 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -127.8 119.37 25.55 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.477 ' CH2' HD12 ' A' ' 500' ' ' LEU . 3.0 p90 -166.09 153.21 9.82 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.418 1.487 . . . . 0.0 107.498 168.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -148.98 118.62 6.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.671 -0.811 . . . . 0.0 112.974 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.0 t -159.6 152.97 22.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 169.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -65.01 -53.0 53.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.716 0.689 . . . . 0.0 111.03 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 53.0 m -81.49 -23.85 37.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -91.48 -28.75 17.41 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.518 0.599 . . . . 0.0 111.966 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.58 38.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.335 0.516 . . . . 0.0 110.529 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 50.6 tp -82.25 -31.93 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.17 -36.72 47.16 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.825 -0.547 . . . . 0.0 110.273 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 87.5 m -72.52 -42.54 64.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . 0.453 ' C ' HD13 ' A' ' 556' ' ' LEU . 2.8 tm? -60.44 -47.83 84.42 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.34 -15.07 67.52 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.097 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.9 2.19 2.84 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.688 1.744 . . . . 0.0 114.377 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 559' ' ' LEU . 2.5 tm? -104.05 -26.5 12.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.531 0.605 . . . . 0.0 109.727 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -65.16 155.17 35.79 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.686 -0.634 . . . . 0.0 110.369 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 55.4 20.84 3.85 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.33 151.26 35.03 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -110.93 136.51 49.84 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.902 1.681 . . . . 0.0 110.184 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . 0.46 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.6 ttt -64.16 171.92 2.72 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.245 0.618 . . . . 0.0 111.006 -175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -75.73 15.5 0.5 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -65.94 149.94 97.06 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.325 0.512 . . . . 0.0 110.132 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.53 -45.8 0.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.956 2.437 . . . . 0.0 113.347 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -121.04 13.69 11.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 62.63 52.23 50.22 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.237 -0.757 . . . . 0.0 112.263 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.82 -8.81 20.62 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.196 2.597 . . . . 0.0 111.315 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -146.31 149.43 37.89 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 123.698 0.799 . . . . 0.0 109.315 175.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.73 147.03 39.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.425 2.75 . . . . 0.0 110.881 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . 0.46 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.0 t80 -144.88 -2.6 0.81 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.27 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 62.3 m -66.37 110.63 3.16 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.41 144.55 25.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.901 0.48 . . . . 0.0 111.208 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -103.33 122.48 44.91 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.03 146.87 37.78 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 58.8 m -153.98 -178.14 6.88 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.67 1.188 . . . . 0.0 109.019 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.9 149.75 49.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.5 t -135.49 160.08 39.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.732 0.813 . . . . 0.0 110.328 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . 0.528 ' H ' ' HD2' ' A' ' 492' ' ' ARG . 87.8 m -105.82 102.13 11.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 173.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.38 161.56 34.67 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.213 1.005 . . . . 0.0 110.186 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -87.09 -38.25 16.67 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -158.06 153.02 25.28 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.985 1.314 . . . . 0.0 109.377 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -99.66 76.5 2.0 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.442 ' N ' ' HE2' ' A' ' 530' ' ' LYS . 78.3 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.968 -1.015 . . . . 0.0 111.122 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -87.96 -10.75 49.52 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.891 0.476 . . . . 0.0 111.533 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 76.27 174.14 37.45 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.49 172.3 15.99 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.535 3.49 . . . . 0.0 111.021 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -148.58 157.81 43.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.264 0.626 . . . . 0.0 109.794 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -81.62 165.7 20.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.89 0.476 . . . . 0.0 111.149 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -123.94 -0.51 8.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.249 0.62 . . . . 0.0 111.809 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 31.2 t -164.06 150.93 10.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 123.253 0.621 . . . . 0.0 109.955 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.42 2.78 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.579 2.853 . . . . 0.0 111.617 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.02 151.15 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.837 0.855 . . . . 0.0 109.904 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -139.51 165.08 28.17 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.633 0.773 . . . . 0.0 109.706 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 64.8 mtp -136.43 149.91 48.49 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.617 0.246 . . . . 0.0 111.223 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.9 148.53 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.729 0.812 . . . . 0.0 109.591 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -140.03 162.99 33.88 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.972 0.509 . . . . 0.0 109.86 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.49 -0.34 86.87 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.713 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.748 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.68 176.82 5.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.063 0.932 . . . . 0.0 110.264 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -139.77 141.59 36.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.265 -0.272 . . . . 0.0 110.562 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -71.7 -1.73 14.87 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 46.7 m -104.99 -9.12 18.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.049 0.386 . . . . 0.0 111.92 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -136.22 -2.86 2.24 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.059 0.544 . . . . 0.0 111.222 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -145.2 122.72 11.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.573 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 20.2 m120 -141.83 177.01 8.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.631 0.773 . . . . 0.0 109.204 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -58.16 -28.13 64.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -91.73 -25.91 18.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.81 -0.556 . . . . 0.0 111.751 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . 0.573 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 8.8 mpt_? -73.59 -31.54 63.64 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.06 -32.33 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -68.1 -30.98 70.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.68 -27.53 62.15 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.13 -35.03 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.387 0.54 . . . . 0.0 111.829 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -89.93 -8.97 50.53 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 51.0 t -70.2 -26.94 64.12 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.525 0.602 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 26.8 mt -67.11 -4.46 10.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.749 -0.594 . . . . 0.0 111.822 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -121.45 4.05 10.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.84 -132.39 3.56 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -141.33 157.02 45.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 6.2 m -115.87 156.46 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.477 0.711 . . . . 0.0 111.003 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -110.04 -51.15 2.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.082 0.553 . . . . 0.0 110.908 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -167.6 167.6 13.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.476 0.711 . . . . 0.0 111.0 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.85 151.61 16.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.969 0.908 . . . . 0.0 110.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -149.94 143.82 25.48 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.151 0.58 . . . . 0.0 110.144 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -87.2 102.99 15.0 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.502 ' HE1' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -81.46 141.48 33.84 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.152 1.381 . . . . 0.0 112.966 -171.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 60.09 33.93 21.25 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.93 1.292 . . . . 0.0 112.47 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 92.0 p 52.88 12.37 0.27 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.839 1.656 . . . . 0.0 115.317 172.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -84.85 126.5 68.06 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-N 118.753 0.706 . . . . 0.0 110.308 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.96 -9.95 18.63 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.26 2.64 . . . . 0.0 111.853 171.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -106.9 17.23 38.75 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.359 0.98 . . . . 0.0 112.726 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.502 ' HB1' ' HE1' ' A' ' 412' ' ' MET . . . -146.25 140.38 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.412 1.106 . . . . 0.0 110.934 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.29 158.23 39.88 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.946 0.498 . . . . 0.0 111.316 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 21.1 ptm -140.7 147.59 39.46 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.599 0.36 . . . . 0.0 110.251 177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.82 148.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.78 0.432 . . . . 0.0 110.775 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -114.72 139.02 50.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.479 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 86.6 mmm -104.49 161.29 14.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.519 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.49 -18.97 61.62 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.45 -0.157 . . . . 0.0 111.395 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -156.57 158.92 37.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.159 0.584 . . . . 0.0 109.893 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.57 -17.54 74.82 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.166 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -24.02 62.83 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 119.002 1.401 . . . . 0.0 110.767 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.72 -22.5 37.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.292 0.237 . . . . 0.0 111.03 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.79 -36.65 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -68.6 -26.76 65.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.91 -26.0 29.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 121.933 0.093 . . . . 0.0 110.945 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.52 50.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.65 -31.07 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.83 0.852 . . . . 0.0 110.783 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 22.5 m -98.84 -20.4 16.87 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -134.34 -7.32 2.59 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.67 -19.85 10.37 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.196 0.907 . . . . 0.0 109.441 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -52.47 145.79 10.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.835 0.854 . . . . 0.0 111.567 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 56.87 1.54 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.13 2.172 . . . . 0.0 115.408 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -88.08 142.51 27.72 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.578 1.535 . . . . 0.0 108.772 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.309 0.0 OUTLIER -130.97 163.9 26.52 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.0 ptm -125.21 143.35 50.99 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.038 1.335 . . . . 0.0 109.385 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . 0.408 ' H ' ' CG ' ' A' ' 554' ' ' GLU . 97.0 m-85 67.52 28.54 7.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.33 1.452 . . . . 0.0 114.192 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 68.39 16.01 68.79 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 169.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -83.3 162.07 21.24 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.422 1.111 . . . . 0.0 110.318 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.2 133.52 34.59 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.47 134.14 41.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -140.69 123.58 16.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.58 144.34 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.028 0 CA-C-N 118.116 0.416 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 t -158.5 165.56 34.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.2 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.9 152.97 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.262 0.625 . . . . 0.0 109.615 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 13.1 t -100.51 -167.0 1.38 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 110.475 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -138.41 6.18 2.52 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.938 0.895 . . . . 0.0 110.857 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -80.04 144.63 59.41 Favored Pre-proline 0 N--CA 1.455 -0.224 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.22 -24.86 12.08 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.873 2.382 . . . . 0.0 111.101 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.49 169.01 17.74 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.699 0.799 . . . . 0.0 109.489 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.09 142.55 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 65.2 mtt -111.34 159.56 32.5 Favored Pre-proline 0 N--CA 1.456 -0.17 0 C-N-CA 122.417 0.287 . . . . 0.0 110.735 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -55.61 160.08 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.926 3.084 . . . . 0.0 112.646 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 172.29 179.57 43.23 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -74.96 153.54 38.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 48.2 t -138.23 157.14 46.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.051 0.54 . . . . 0.0 109.841 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -146.13 161.79 39.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.309 0.644 . . . . 0.0 110.17 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -78.87 135.06 14.83 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 70.7 mt -86.86 173.81 9.15 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.454 0.702 . . . . 0.0 109.513 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.222 -0.299 . . . . 0.0 111.414 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -82.4 -1.34 49.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.042 0.537 . . . . 0.0 111.178 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.66 -1.05 88.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.402 0.525 . . . . 0.0 112.578 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.8 t -93.63 160.15 14.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.775 0.787 . . . . 0.0 110.226 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.7 m -78.35 153.3 31.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.953 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 84.8 p -73.26 -10.6 59.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.858 0.463 . . . . 0.0 111.913 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -120.63 138.55 53.86 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.38 0.672 . . . . 0.0 109.608 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -155.86 157.29 36.13 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.495 0.318 . . . . 0.0 110.776 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.15 156.96 32.56 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.467 0.707 . . . . 0.0 110.404 176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -140.07 11.14 2.39 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 122.903 0.481 . . . . 0.0 111.886 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 89.5 p -65.55 -15.3 62.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -85.11 -2.99 58.63 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.832 0.453 . . . . 0.0 110.932 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 43.0 m -103.77 21.21 16.64 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.044 0.937 . . . . 0.0 110.544 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 35.8 ptt-85 -73.93 7.42 2.61 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.913 0.885 . . . . 0.0 112.511 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -84.63 10.73 10.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.451 0.701 . . . . 0.0 111.777 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -66.39 153.4 42.84 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -10.31 59.38 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -172.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -136.35 34.54 2.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.281 0.632 . . . . 0.0 111.163 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 81.7 p -74.82 -5.59 44.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 55.1 p -135.82 155.13 78.18 Favored Pre-proline 0 CA--C 1.523 -0.082 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.58 -10.93 30.5 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.771 2.314 . . . . 0.0 111.534 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -89.88 -32.09 17.02 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.935 0.334 . . . . 0.0 110.728 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -90.56 -19.1 24.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.405 0.282 . . . . 0.0 110.552 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -74.85 -1.45 22.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.784 0.433 . . . . 0.0 111.315 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.37 -4.64 59.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.796 0.438 . . . . 0.0 111.081 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -109.2 7.95 25.63 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.576 0.75 . . . . 0.0 110.938 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -145.56 176.62 9.47 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.57 1.148 . . . . 0.0 108.18 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 492' ' ' ARG . 0.4 OUTLIER -142.96 147.95 36.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.776 -0.577 . . . . 0.0 110.373 176.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.55 145.87 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.534 0.734 . . . . 0.0 109.305 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -156.82 158.38 36.69 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.706 0.289 . . . . 0.0 111.061 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -64.64 167.57 8.68 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.696 1.198 . . . . 0.0 109.56 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.55 137.91 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.39 2.726 . . . . 0.0 112.554 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 49.6 m -123.97 24.01 8.4 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.585 0.754 . . . . 0.0 112.848 -168.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 7.3 t30 64.4 -14.74 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.821 1.248 . . . . 0.0 113.779 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 29.9 t -134.09 151.66 32.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 118.648 0.658 . . . . 0.0 109.994 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.433 HD12 ' CH2' ' A' ' 546' ' ' TRP . 27.4 mt -126.18 138.63 53.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.771 0.829 . . . . 0.0 109.718 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.444 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 16.0 m170 -105.65 154.82 19.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -137.34 147.41 45.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.465 0.174 . . . . 0.0 110.789 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -148.77 168.02 24.05 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.448 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.4 t30 58.18 30.52 19.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.327 1.051 . . . . 0.0 113.191 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.35 156.64 51.03 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.27 155.63 34.18 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.131 2.554 . . . . 0.0 111.805 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -77.11 -1.24 28.17 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.88 9.1 24.6 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.08 151.43 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 118.011 0.369 . . . . 0.0 111.11 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.2 p -142.88 172.03 13.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.557 0.743 . . . . 0.0 110.241 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.25 -20.55 64.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.55 -24.92 59.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -81.62 -29.78 33.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -70.52 -30.81 67.67 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.824 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.48 -36.59 26.34 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.334 0.515 . . . . 0.0 111.772 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -76.54 -23.87 53.61 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.06 0.391 . . . . 0.0 111.783 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.4 mt -88.85 -33.49 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 117.932 0.333 . . . . 0.0 110.16 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 75.6 m -65.47 -22.99 66.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.868 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.13 -34.7 75.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.09 -12.75 34.69 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.07 -7.53 59.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.878 0.308 . . . . 0.0 111.36 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.37 11.15 75.88 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.761 -0.466 . . . . 0.0 112.907 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 27.4 m -111.16 171.18 3.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 117.852 0.826 . . . . 0.0 111.177 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -68.5 154.55 41.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.415 0.686 . . . . 0.0 110.51 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -108.25 151.07 41.27 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.14 153.5 75.92 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.217 2.612 . . . . 0.0 111.339 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 83.9 m -94.59 -21.58 18.74 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.209 0.604 . . . . 0.0 111.244 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 50.8 m -142.31 153.87 44.24 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.15 150.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.166 0.508 . . . . 0.0 111.878 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -145.4 140.65 27.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.19 140.99 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -153.66 156.5 38.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.251 0.62 . . . . 0.0 110.089 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 50.8 m -130.73 137.66 49.61 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -76.23 151.19 39.92 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -69.53 130.43 42.44 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.4 m 55.27 13.6 0.9 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -90.41 -16.18 29.55 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.623 0.647 . . . . 0.0 111.06 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 51.38 26.74 3.26 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.224 1.009 . . . . 0.0 113.057 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.1 m -138.13 160.29 39.8 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.13 0.572 . . . . 0.0 110.371 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 46.8 t -120.4 150.42 40.8 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.694 0.798 . . . . 0.0 111.236 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 57.0 m -147.21 164.32 33.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.231 1.412 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.84 -162.41 33.15 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.658 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 87.6 mt -128.57 151.31 49.61 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.095 0.958 . . . . 0.0 110.767 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.7 mt -142.28 133.39 26.03 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -127.81 124.7 38.26 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.433 ' CH2' HD12 ' A' ' 500' ' ' LEU . 4.2 p90 -166.02 149.06 7.41 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -146.77 114.1 6.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 34.7 t -159.56 152.91 22.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 168.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -66.99 -36.82 83.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.469 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 45.9 m -83.92 -36.18 23.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.184 0.194 . . . . 0.0 111.354 -176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.4 -24.57 31.9 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.568 0.622 . . . . 0.0 111.612 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.63 21.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.491 0.587 . . . . 0.0 111.557 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.48 -23.79 24.32 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.053 0.842 . . . . 0.0 111.61 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.408 ' CG ' ' H ' ' A' ' 442' ' ' PHE . 65.4 mt-10 -77.93 -44.71 26.12 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.985 -0.447 . . . . 0.0 109.891 175.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 60.9 m -69.15 -31.87 70.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.3 tm? -68.9 -43.41 75.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -68.63 -19.32 72.91 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.28 -0.733 . . . . 0.0 112.757 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -114.39 -9.78 12.72 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.172 0.986 . . . . 0.0 113.046 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 13.7 tp -112.69 4.84 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.848 0.749 . . . . 0.0 112.18 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -92.9 143.01 26.68 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.333 -0.855 . . . . 0.0 109.675 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 49.13 35.94 8.07 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.644 0.777 . . . . 0.0 112.684 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . 0.404 ' HD1' ' H ' ' A' ' 562' ' ' TYR . 3.3 p90 -92.18 151.35 20.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -97.98 136.44 38.26 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.76 1.624 . . . . 0.0 111.389 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . 0.463 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.06 173.93 1.73 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.72 0.808 . . . . 0.0 111.354 -177.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -70.05 14.34 0.12 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.859 0.864 . . . . 0.0 113.106 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.46 140.62 92.02 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.939 0.495 . . . . 0.0 111.065 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -81.0 -29.53 2.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.299 2.666 . . . . 0.0 112.766 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -121.01 -11.37 8.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.409 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.12 43.83 95.02 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 82.9 Cg_endo -72.41 -6.6 19.38 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.32 2.68 . . . . 0.0 112.047 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -142.61 150.82 55.5 Favored Pre-proline 0 N--CA 1.455 -0.189 0 C-N-CA 123.559 0.744 . . . . 0.0 109.689 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 152.27 34.24 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.505 2.804 . . . . 0.0 110.738 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . 0.463 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 80.0 t80 -146.38 -2.66 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.518 0.327 . . . . 0.0 111.619 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.37 122.35 17.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.72 -0.613 . . . . 0.0 109.825 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.0 144.61 50.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.228 1.011 . . . . 0.0 109.324 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.89 158.11 17.58 Favored 'General case' 0 CA--C 1.523 -0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 111.247 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.62 155.74 47.03 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.169 0.988 . . . . 0.0 108.789 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 42.6 t -163.55 146.32 9.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -76.69 127.55 32.99 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 23.1 t -135.68 154.7 51.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.73 0.3 . . . . 0.0 111.091 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 37.0 m -83.59 103.4 12.89 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -133.98 161.16 35.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.498 0.719 . . . . 0.0 109.662 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -93.87 -26.1 17.05 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.406 -0.184 . . . . 0.0 111.172 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -160.66 157.83 27.81 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.966 0.506 . . . . 0.0 109.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -89.73 76.4 7.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.36 -1.305 . . . . 0.0 110.154 178.846 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -134.42 11.03 3.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.779 0.432 . . . . 0.0 111.799 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -78.53 -67.22 1.64 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -83.53 6.88 5.53 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.549 3.5 . . . . 0.0 112.62 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -148.63 160.47 43.11 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.386 0.539 . . . . 0.0 111.708 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -130.93 150.89 51.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.595 0.758 . . . . 0.0 109.738 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -141.36 7.19 1.95 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 30.7 m -146.94 154.19 46.7 Favored Pre-proline 0 CA--C 1.53 0.184 0 C-N-CA 122.509 0.324 . . . . 0.0 110.551 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.45 -0.55 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.61 3.54 . . . . 0.0 113.399 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.78 162.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 118.686 0.676 . . . . 0.0 112.203 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -147.18 167.22 24.72 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.935 0.894 . . . . 0.0 109.122 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . 0.412 ' HE2' ' SD ' ' A' ' 412' ' ' MET . 73.8 mtp -133.57 151.24 51.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.404 0.282 . . . . 0.0 110.576 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.1 148.93 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.978 0.511 . . . . 0.0 110.827 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.95 167.55 21.86 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.474 0.71 . . . . 0.0 109.55 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.66 88.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.586 -0.563 . . . . 0.0 112.897 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -70.2 173.56 6.54 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.828 0.814 . . . . 0.0 110.326 175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -136.66 139.78 42.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -71.96 -3.98 25.79 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 95.1 p -109.83 -1.19 18.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.378 0.535 . . . . 0.0 112.407 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -133.5 -6.44 2.91 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.288 0.635 . . . . 0.0 110.969 175.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 8.5 tpt -148.5 122.25 9.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.225 0.61 . . . . 0.0 109.47 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -141.88 -173.37 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.106 0.562 . . . . 0.0 109.768 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 72.3 m -59.54 -23.61 63.0 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -92.03 -23.8 19.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.231 0.468 . . . . 0.0 111.5 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -83.93 -29.71 26.89 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 409' ' ' VAL . 10.1 p -77.52 -32.58 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -68.85 -31.17 69.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -72.38 -46.43 55.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.172 -0.33 . . . . 0.0 111.329 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.18 -20.32 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 122.233 -0.292 . . . . 0.0 111.48 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -110.47 -7.33 14.77 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 43.6 t -77.24 -31.7 55.22 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.843 0.747 . . . . 0.0 110.958 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 11.38 1.36 Allowed 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.805 -0.56 . . . . 0.0 112.18 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -121.51 -5.34 9.28 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.743 0.817 . . . . 0.0 110.931 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.68 177.94 24.2 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -75.49 148.67 38.83 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.376 -0.485 . . . . 0.0 110.834 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.05 154.26 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 123.597 0.759 . . . . 0.0 109.413 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -104.02 -58.79 1.82 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.212 -0.305 . . . . 0.0 110.552 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -165.78 166.65 17.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.973 0.509 . . . . 0.0 110.736 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 396' ' ' VAL . 7.6 p -147.92 150.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 122.985 0.514 . . . . 0.0 110.345 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -151.88 144.34 24.13 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.343 0.257 . . . . 0.0 110.599 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -79.06 152.0 31.13 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.412 ' SD ' ' HE2' ' A' ' 382' ' ' MET . 25.3 ptt? -129.97 141.49 50.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -168.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 60.01 34.0 21.4 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 124.923 1.289 . . . . 0.0 111.802 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m 52.77 16.67 0.71 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.883 1.273 . . . . 0.0 114.035 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.76 143.21 46.37 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 118.357 0.526 . . . . 0.0 109.903 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.34 -1.14 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.651 2.901 . . . . 0.0 110.262 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -132.54 27.68 3.52 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 123.739 0.685 . . . . 0.0 113.071 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.69 133.92 19.46 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.08 0.94 . . . . 0.0 110.333 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.12 168.67 26.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.5 ptm -144.32 146.99 32.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.19 151.62 27.65 Favored 'Isoleucine or valine' 0 C--N 1.337 0.028 0 C-N-CA 123.161 0.585 . . . . 0.0 110.736 -170.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -128.38 136.77 51.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.5 mmm -107.72 162.64 13.8 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.644 0.378 . . . . 0.0 110.565 -176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.95 61.14 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.158 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -157.73 161.76 38.51 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.429 0.691 . . . . 0.0 109.578 176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.97 -14.54 70.83 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.391 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -67.96 -30.57 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.134 1.467 . . . . 0.0 110.46 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.33 -20.56 51.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.51 -31.78 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.32 -36.05 66.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -32.2 67.02 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.011 -0.43 . . . . 0.0 110.508 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -82.22 -38.05 25.09 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.12 -0.363 . . . . 0.0 111.862 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 7.5 tp -72.87 -32.02 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.529 -0.732 . . . . 0.0 111.803 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 28.1 m -93.66 -21.14 19.55 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -117.97 -14.09 10.02 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.75 -17.4 11.07 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.941 0.791 . . . . 0.0 110.507 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -51.73 142.01 15.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.46 0.648 . . . . 0.0 111.702 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 57.08 1.54 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.787 2.035 . . . . 0.0 115.742 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -87.91 142.49 27.76 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.719 1.6 . . . . 0.0 108.667 169.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.251 0.1 OUTLIER -130.85 163.84 26.53 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.34 143.43 50.97 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.397 1.479 . . . . 0.0 109.576 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 67.77 27.12 7.58 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.989 1.316 . . . . 0.0 114.486 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.48 15.86 75.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 168.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -83.25 160.76 21.68 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.683 1.242 . . . . 0.0 110.074 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.62 132.46 34.49 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.54 133.26 43.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -169.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -140.69 120.43 13.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.06 141.92 15.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-N 118.263 0.483 . . . . 0.0 110.346 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 25.6 t -160.13 162.37 33.95 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.791 0.436 . . . . 0.0 110.166 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.07 158.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.115 0.566 . . . . 0.0 109.949 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.1 t -137.67 151.28 48.1 Favored 'General case' 0 C--N 1.337 0.032 0 O-C-N 121.991 -0.443 . . . . 0.0 110.451 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -89.37 -0.58 57.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.683 0.793 . . . . 0.0 112.654 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -62.14 144.39 94.45 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 121.478 -0.764 . . . . 0.0 109.654 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.1 -25.04 12.09 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.832 2.355 . . . . 0.0 112.013 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.86 173.78 12.31 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.013 0.525 . . . . 0.0 110.214 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -66.68 138.35 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -90.07 163.03 33.45 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.813 0.445 . . . . 0.0 110.699 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.21 -42.5 64.54 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.14 2.56 . . . . 0.0 112.009 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 50.23 -142.75 13.46 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.252 0.453 . . . . 0.0 112.442 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -133.65 160.5 37.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.214 1.006 . . . . 0.0 108.536 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.0 p -143.3 156.04 44.62 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.693 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -155.19 163.34 40.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.687 0.795 . . . . 0.0 109.847 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -79.36 136.68 17.79 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 80.0 mt -86.96 165.86 15.54 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.174 0.59 . . . . 0.0 110.232 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.92 -20.13 65.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.243 0.217 . . . . 0.0 111.463 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -80.35 1.25 29.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.938 0.495 . . . . 0.0 111.476 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.91 0.63 85.76 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 39.6 m -91.37 165.05 13.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.419 0.688 . . . . 0.0 110.528 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.36 153.34 22.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.74 0.305 . . . . 0.0 110.5 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.3 p -69.89 -10.25 57.84 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.027 0.531 . . . . 0.0 111.697 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -118.47 138.06 52.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.99 0.916 . . . . 0.0 109.87 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -154.42 155.2 34.54 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.423 0.289 . . . . 0.0 110.661 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -124.61 156.6 37.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 110.415 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.81 15.92 2.31 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.041 0.536 . . . . 0.0 111.334 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 91.2 p -66.58 -3.4 6.3 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -97.36 3.86 50.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.222 0.609 . . . . 0.0 110.86 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 11.2 t -84.05 22.32 1.2 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.581 0.752 . . . . 0.0 111.003 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 -73.95 -2.8 25.56 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.429 0.691 . . . . 0.0 111.002 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -88.25 2.43 52.34 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.376 0.671 . . . . 0.0 110.605 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -65.17 154.39 38.15 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.934 -0.479 . . . . 0.0 109.945 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -83.15 0.82 43.48 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -142.84 33.26 1.4 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.885 0.474 . . . . 0.0 111.013 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 84.0 p -71.22 -3.27 19.38 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.221 0.608 . . . . 0.0 112.624 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 485' ' ' PRO . 7.1 t -142.14 147.63 44.9 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 123.234 0.613 . . . . 0.0 109.401 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 484' ' ' THR . 75.5 Cg_exo -55.74 -24.39 46.02 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.771 2.981 . . . . 0.0 114.659 -175.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.88 -25.08 35.34 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.69 0.677 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.63 -22.34 21.24 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.628 0.371 . . . . 0.0 110.482 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.28 -16.76 62.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.212 -0.305 . . . . 0.0 111.482 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -79.5 -6.81 57.75 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.747 0.419 . . . . 0.0 111.056 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -109.06 5.53 24.2 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.761 0.824 . . . . 0.0 110.88 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -128.05 14.19 6.78 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.458 0.703 . . . . 0.0 110.943 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 51.66 46.0 27.23 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.187 0.995 . . . . 0.0 112.437 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 41.2 mm -80.84 94.12 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -148.51 -176.49 5.33 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.098 0.959 . . . . 0.0 109.944 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . 0.425 ' CG ' ' HD2' ' A' ' 496' ' ' PRO . 67.8 t60 -59.87 148.56 76.11 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 495' ' ' HIS . 87.1 Cg_exo -46.3 140.73 10.95 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.45 2.767 . . . . 0.0 112.817 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 66.1 m -123.99 24.05 8.37 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.606 0.762 . . . . 0.0 111.34 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 8.2 m120 61.52 7.86 2.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 113.987 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 32.3 t -141.54 147.02 22.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 123.41 0.684 . . . . 0.0 109.233 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.482 HD12 ' CH2' ' A' ' 546' ' ' TRP . 91.5 mt -129.38 160.35 33.35 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.62 0.768 . . . . 0.0 110.086 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.65 163.16 34.03 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.285 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -135.94 156.94 48.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.407 0.683 . . . . 0.0 111.133 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -147.3 170.76 16.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 43.7 t30 59.46 26.19 15.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 0.0 113.281 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.95 158.3 70.41 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -68.99 159.43 54.01 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.282 1.988 . . . . 0.0 110.602 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -71.58 -1.09 12.32 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -112.0 7.1 19.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -173.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.45 148.81 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 118.308 0.504 . . . . 0.0 111.209 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 82.5 p -142.98 173.3 11.68 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.925 0.89 . . . . 0.0 110.313 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.4 -22.79 65.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.752 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.68 -23.71 60.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -82.95 -31.78 27.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -68.82 -28.34 66.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.964 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -87.37 -35.07 18.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.192 0.451 . . . . 0.0 112.087 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -75.85 -18.87 59.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.458 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.79 -35.53 5.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 117.884 0.311 . . . . 0.0 110.868 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 17.3 p -70.1 -21.84 63.09 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.167 0.894 . . . . 0.0 110.643 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.38 -28.44 61.11 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 119.552 -0.261 . . . . 0.0 111.633 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.07 -12.6 35.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.278 0.49 . . . . 0.0 111.205 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.12 -9.9 51.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.523 0.329 . . . . 0.0 110.489 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.28 6.41 65.11 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.704 -0.498 . . . . 0.0 112.927 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.2 m -89.17 170.88 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.938 0.869 . . . . 0.0 111.161 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 30.0 tptp -71.11 146.77 49.01 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.356 0.663 . . . . 0.0 110.044 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -91.94 153.11 43.46 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.625 0.37 . . . . 0.0 110.256 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.89 155.55 69.34 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.555 2.17 . . . . 0.0 109.535 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 82.2 m -95.1 -19.12 20.38 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.955 0.502 . . . . 0.0 110.763 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.0 t -148.76 152.73 37.07 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.945 0.498 . . . . 0.0 109.762 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 60.9 t -140.62 140.9 33.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 123.097 0.559 . . . . 0.0 110.084 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.25 126.35 12.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.48 152.36 37.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 122.829 0.452 . . . . 0.0 110.971 -174.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -144.23 160.82 40.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.984 0.914 . . . . 0.0 109.438 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.2 t -128.98 135.32 48.81 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.827 0.451 . . . . 0.0 110.293 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.3 147.0 31.01 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -78.46 135.04 37.29 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 25.2 m 54.14 20.34 2.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.636 0.774 . . . . 0.0 112.791 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -110.91 -17.44 13.31 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.048 0.539 . . . . 0.0 111.134 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 52.19 27.19 4.44 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.324 1.05 . . . . 0.0 113.209 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 71.1 m -138.22 157.96 45.25 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.987 0.515 . . . . 0.0 110.734 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 156.01 40.52 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.525 0.73 . . . . 0.0 111.192 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.5 m -147.72 166.53 27.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.887 1.275 . . . . 0.0 108.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.62 -176.75 47.48 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.2 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.2 mp -111.57 154.93 24.11 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.282 1.033 . . . . 0.0 110.132 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.3 mt -138.35 134.38 34.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.72 117.99 22.95 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.482 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.9 p90 -165.71 153.63 10.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 168.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -146.81 115.11 6.65 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 30.9 t -159.52 153.04 22.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 168.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -69.79 -48.38 59.4 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 118.637 0.653 . . . . 0.0 110.722 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 44.7 m -82.71 -22.96 34.29 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -89.28 -33.17 17.05 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.711 0.687 . . . . 0.0 111.481 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -72.13 -33.92 68.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.798 0.726 . . . . 0.0 110.477 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.52 -35.68 58.16 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.034 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.99 -40.37 53.87 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.102 -0.374 . . . . 0.0 110.604 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 98.6 m -65.95 -49.23 68.62 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.159 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 556' ' ' LEU . 2.0 pp -70.15 -22.4 62.99 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.109 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -64.72 -31.39 80.74 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.427 -0.652 . . . . 0.0 111.83 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -116.36 -6.86 11.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.912 0.856 . . . . 0.0 113.103 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.5 tp -95.93 -13.47 23.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.66 0.664 . . . . 0.0 111.664 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -81.16 151.44 28.23 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.695 -0.628 . . . . 0.0 110.199 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 31.4 m80 51.18 22.97 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.19 151.23 29.81 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -102.13 136.33 42.15 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.381 1.472 . . . . 0.0 110.683 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . 0.466 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 6.2 ttt -64.17 173.24 2.03 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.15 0.58 . . . . 0.0 111.612 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -75.4 14.78 0.54 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.031 0.932 . . . . 0.0 112.564 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -66.11 149.93 97.26 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 118.03 0.377 . . . . 0.0 110.137 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.87 -46.92 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.895 2.397 . . . . 0.0 113.898 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -121.08 13.3 11.26 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . 63.34 52.8 44.05 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.312 -0.716 . . . . 0.0 112.594 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.62 -9.42 19.9 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.539 2.826 . . . . 0.0 111.44 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -148.42 151.41 36.5 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.671 0.788 . . . . 0.0 109.676 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.26 151.1 37.98 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.563 2.842 . . . . 0.0 110.821 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . 0.466 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 91.0 t80 -143.03 -6.45 0.84 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.758 0.423 . . . . 0.0 111.902 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 75.2 p -66.48 132.02 47.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.891 -0.506 . . . . 0.0 110.233 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 575' ' ' LEU . 1.6 pp -125.03 144.55 50.34 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.595 0.758 . . . . 0.0 110.791 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -77.28 144.38 38.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.76 144.97 50.4 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 2.8 p -163.92 172.09 14.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.703 0.401 . . . . 0.0 110.331 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -82.82 148.91 27.48 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.734 0.414 . . . . 0.0 111.207 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.7 t -135.6 137.71 42.21 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 122.575 0.35 . . . . 0.0 110.971 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 16.5 p -82.45 102.13 11.12 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.18 161.57 34.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.353 0.661 . . . . 0.0 111.59 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.77 -3.31 7.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.402 0.681 . . . . 0.0 110.294 173.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -157.68 165.91 34.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.754 1.222 . . . . 0.0 109.777 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.12 76.68 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.247 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.888 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 119.803 -0.141 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -135.54 9.16 3.39 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.987 0.515 . . . . 0.0 111.617 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -72.31 172.0 48.2 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.15 165.04 33.79 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.232 3.288 . . . . 0.0 111.123 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -156.81 171.2 20.82 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.521 0.729 . . . . 0.0 110.024 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -117.29 156.67 27.4 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.848 0.459 . . . . 0.0 110.519 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -140.36 6.1 2.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.199 0.6 . . . . 0.0 110.917 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.6 m -152.91 157.01 33.21 Favored Pre-proline 0 N--CA 1.456 -0.157 0 C-N-CA 123.711 0.805 . . . . 0.0 110.207 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.69 2.51 8.48 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.614 3.543 . . . . 0.0 112.938 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.0 p -126.17 148.33 30.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 118.736 0.698 . . . . 0.0 111.478 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.38 167.3 23.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.222 0.609 . . . . 0.0 110.094 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . 0.405 ' CE ' ' SD ' ' A' ' 412' ' ' MET . 77.1 mtp -132.96 152.0 51.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.539 0.335 . . . . 0.0 110.571 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.6 149.45 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.761 0.425 . . . . 0.0 110.693 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -141.21 166.38 24.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.407 0.683 . . . . 0.0 110.1 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.13 -0.11 84.5 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.847 -0.418 . . . . 0.0 112.67 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.758 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.24 -179.65 4.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.503 0.651 . . . . 0.0 110.687 176.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -139.62 134.62 32.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -69.82 -11.73 61.08 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 80.5 p -93.44 -9.92 36.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -132.56 -8.87 3.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.268 0.486 . . . . 0.0 111.654 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 13.7 tpt -147.73 104.84 3.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.317 0.647 . . . . 0.0 109.497 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.435 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 23.4 p30 -141.97 -173.59 3.85 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.878 0.871 . . . . 0.0 109.669 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 64.4 m -55.33 -28.83 56.33 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.96 -27.69 21.95 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.215 0.461 . . . . 0.0 110.994 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . 0.435 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 2.2 mmp_? -78.11 -33.44 50.58 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 122.123 -0.361 . . . . 0.0 110.038 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.89 -31.31 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -64.82 -35.24 80.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -72.1 -31.04 65.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.43 -0.319 . . . . 0.0 111.398 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.77 -26.61 5.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.151 0.432 . . . . 0.0 111.875 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.52 -10.07 20.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 29.7 p -65.68 -37.8 87.51 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.041 0.837 . . . . 0.0 111.565 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.81 14.43 1.75 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.322 0.51 . . . . 0.0 112.156 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -121.46 -1.91 9.55 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.604 0.762 . . . . 0.0 109.93 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 140.45 167.08 10.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -74.83 146.54 41.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.156 -0.614 . . . . 0.0 111.167 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.29 154.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.498 0.719 . . . . 0.0 109.095 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -104.2 -60.1 1.63 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.62 0.368 . . . . 0.0 110.013 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -165.42 163.66 19.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.434 0.694 . . . . 0.0 110.703 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.488 HG22 HG23 ' A' ' 421' ' ' VAL . 92.0 t -136.28 146.83 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.215 1.006 . . . . 0.0 109.344 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -148.45 144.18 27.24 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 172.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -86.53 155.67 20.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.405 ' SD ' ' CE ' ' A' ' 382' ' ' MET . 26.0 ptt? -136.02 141.43 44.33 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -167.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt 60.22 34.04 21.01 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.849 1.26 . . . . 0.0 112.339 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.8 m 52.97 16.29 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -94.21 142.53 25.03 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 118.405 0.548 . . . . 0.0 110.461 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.48 -3.81 13.65 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.555 2.837 . . . . 0.0 110.357 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -115.49 19.69 14.33 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.234 0.921 . . . . 0.0 112.795 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -145.68 131.85 19.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.204 1.002 . . . . 0.0 111.171 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.86 168.3 27.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.1 ptm -145.54 150.19 35.98 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.35 0.66 . . . . 0.0 110.028 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . 0.488 HG23 HG22 ' A' ' 409' ' ' VAL . 3.4 p -144.42 151.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.951 0.5 . . . . 0.0 111.076 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -126.56 146.86 49.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.04 0.936 . . . . 0.0 109.615 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 91.1 mmm -112.28 163.28 14.56 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.601 0.76 . . . . 0.0 110.482 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -72.7 -15.36 61.69 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -155.1 156.96 36.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.86 0.464 . . . . 0.0 109.886 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.01 -17.59 75.7 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.166 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -29.81 66.54 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.882 1.341 . . . . 0.0 110.13 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.09 61.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.507 0.194 . . . . 0.0 110.536 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.2 t -78.99 -38.07 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.91 -25.88 68.35 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.771 0.26 . . . . 0.0 110.667 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -82.81 -35.04 26.77 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.156 0.582 . . . . 0.0 110.563 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -74.96 -29.63 60.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.873 -0.517 . . . . 0.0 110.009 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 14.7 mm -77.83 -30.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.854 1.262 . . . . 0.0 111.701 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.9 m -106.5 -14.75 14.98 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -134.17 -9.54 2.61 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -115.72 -16.52 11.24 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.763 0.711 . . . . 0.0 109.633 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -54.02 142.09 26.12 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.27 1.028 . . . . 0.0 111.832 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.81 1.51 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.564 1.946 . . . . 0.0 115.927 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -88.03 142.55 27.69 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.794 1.634 . . . . 0.0 108.532 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.1 OUTLIER -130.81 163.87 26.43 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.8 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.512 1.125 . . . . 0.0 109.384 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 63.64 22.95 13.35 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.154 1.382 . . . . 0.0 114.589 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.15 15.91 61.77 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 169.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -83.2 150.99 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.987 1.393 . . . . 0.0 110.961 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -79.08 138.7 38.07 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -98.07 122.01 40.68 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -140.72 116.92 10.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.37 140.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 118.774 0.715 . . . . 0.0 110.691 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.8 m -148.71 159.41 44.15 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.166 0.986 . . . . 0.0 109.841 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.23 156.13 3.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.3 t -130.22 161.36 31.34 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.862 0.465 . . . . 0.0 110.418 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -108.56 10.94 27.03 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.501 0.72 . . . . 0.0 112.519 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -67.66 147.51 98.65 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 118.105 0.411 . . . . 0.0 109.95 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.39 -36.0 80.51 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.802 2.335 . . . . 0.0 112.348 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.95 176.04 7.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.559 0.744 . . . . 0.0 109.92 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 136.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -84.85 149.8 54.43 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.337 0.255 . . . . 0.0 110.614 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.39 167.23 25.85 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.721 2.948 . . . . 0.0 111.223 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 167.59 179.35 40.3 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -77.12 154.53 33.16 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.701 0.4 . . . . 0.0 109.937 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 83.1 p -134.08 159.37 41.02 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.962 0.505 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -155.26 164.3 38.98 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.564 0.746 . . . . 0.0 109.805 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.62 136.73 19.0 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 79.3 mt -86.25 169.61 12.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.974 0.91 . . . . 0.0 109.672 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.22 -20.16 65.65 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -86.85 4.07 42.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.665 0.386 . . . . 0.0 111.522 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.97 -6.38 79.22 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.376 0.512 . . . . 0.0 112.647 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 52.9 m -83.77 155.39 23.05 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 117.838 0.819 . . . . 0.0 109.942 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.3 153.29 24.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 99.4 p -72.6 -10.34 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.798 0.439 . . . . 0.0 111.664 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -137.0 139.59 41.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.226 1.011 . . . . 0.0 109.477 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -155.16 157.32 37.23 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.18 0.192 . . . . 0.0 110.928 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.71 150.45 51.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.231 1.012 . . . . 0.0 109.937 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -142.45 14.33 1.99 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p -68.35 -6.41 24.19 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -77.45 -4.41 45.31 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.198 0.599 . . . . 0.0 111.15 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 88.6 p -90.93 14.72 13.01 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.095 0.558 . . . . 0.0 111.643 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -73.97 0.9 12.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -94.3 9.95 36.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.453 0.701 . . . . 0.0 110.819 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -67.47 162.66 22.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.075 0.95 . . . . 0.0 111.576 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -85.6 4.71 34.95 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.982 0.913 . . . . 0.0 112.691 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.06 34.46 1.0 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.159 0.504 . . . . 0.0 110.946 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 84.1 p -77.44 -1.82 32.21 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 51.0 p -136.63 157.4 75.18 Favored Pre-proline 0 CA--C 1.527 0.069 0 C-N-CA 123.033 0.533 . . . . 0.0 110.28 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -60.36 -19.9 60.51 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.482 2.788 . . . . 0.0 112.863 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -87.9 -30.1 20.36 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.708 0.231 . . . . 0.0 110.933 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -90.51 -22.29 21.41 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 122.264 -0.272 . . . . 0.0 110.537 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -72.87 -16.48 61.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.302 0.241 . . . . 0.0 110.789 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -82.12 -4.21 56.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.955 0.502 . . . . 0.0 111.019 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -105.75 9.4 33.03 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.592 0.757 . . . . 0.0 110.864 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -137.81 171.42 14.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.77 0.828 . . . . 0.0 110.058 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -85.31 27.64 0.79 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.781 0.832 . . . . 0.0 112.019 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 46.0 mm -80.94 93.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 O-C-N 122.09 -0.381 . . . . 0.0 110.437 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -162.75 -65.92 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.31 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -147.96 150.63 36.17 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.236 0.614 . . . . 0.0 109.391 -174.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.21 147.73 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 112.691 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 62.9 m -124.18 24.0 8.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.269 0.628 . . . . 0.0 112.092 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.6 3.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.377 1.071 . . . . 0.0 113.461 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.4 152.04 21.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.439 HD22 ' CH2' ' A' ' 546' ' ' TRP . 4.7 mp -132.69 164.18 27.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.291 0.637 . . . . 0.0 109.669 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.92 149.33 36.68 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.001 0.429 . . . . 0.0 111.957 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -114.74 145.56 41.94 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.759 1.223 . . . . 0.0 109.599 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -147.77 165.41 30.62 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.374 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 58.02 23.78 10.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.403 1.081 . . . . 0.0 113.422 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -81.74 157.89 68.84 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.86 156.35 28.73 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.143 2.562 . . . . 0.0 111.26 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -80.38 -1.17 40.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -103.53 5.26 36.64 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.662 0.385 . . . . 0.0 111.983 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -89.79 152.01 3.4 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.061 0.391 . . . . 0.0 111.672 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 68.5 p -144.86 175.62 10.07 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.181 0.992 . . . . 0.0 109.654 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.78 -26.25 68.62 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.439 -0.163 . . . . 0.0 111.149 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.58 -26.22 60.72 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.439 -0.163 . . . . 0.0 110.574 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -79.64 -31.67 41.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -71.59 -26.52 62.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.22 -0.3 . . . . 0.0 110.486 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -80.03 -39.36 30.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.933 0.333 . . . . 0.0 111.558 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.11 -17.1 53.49 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.24 0.473 . . . . 0.0 112.275 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.2 mt -90.21 -36.53 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 82.2 m -67.95 -22.15 65.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.676 -0.64 . . . . 0.0 110.573 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -73.44 -30.5 63.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 119.658 -0.21 . . . . 0.0 111.565 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.12 -11.73 37.67 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.108 0.413 . . . . 0.0 111.527 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.32 -7.15 48.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.657 0.383 . . . . 0.0 110.411 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.9 11.33 78.39 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.855 -0.414 . . . . 0.0 112.665 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.6 m -95.58 170.83 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 117.817 0.809 . . . . 0.0 111.61 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -74.14 147.91 42.24 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.477 0.711 . . . . 0.0 110.236 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -97.07 146.17 30.85 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.21 148.97 92.61 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 123.01 2.473 . . . . 0.0 110.375 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 84.7 m -82.11 -25.01 34.83 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.467 0.307 . . . . 0.0 110.841 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 51.1 m -143.4 151.63 40.61 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.936 0.494 . . . . 0.0 109.848 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.59 141.82 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 122.952 0.501 . . . . 0.0 110.328 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.7 120.18 7.42 Favored 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.09 147.53 30.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 C-N-CA 123.353 0.661 . . . . 0.0 109.557 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -148.65 130.05 14.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.513 0.196 . . . . 0.0 111.317 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.6 p -130.98 50.58 2.22 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.005 0.522 . . . . 0.0 110.983 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -82.07 -11.78 81.96 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -151.07 155.65 39.43 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 124.532 1.133 . . . . 0.0 108.003 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 14.8 t 55.27 28.86 11.87 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.881 0.309 . . . . 0.0 111.014 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -57.98 -7.09 0.68 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.895 1.278 . . . . 0.0 113.909 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -66.4 -9.76 36.91 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.452 0.569 . . . . 0.0 110.303 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 85.4 p -145.4 173.22 12.18 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.386 1.475 . . . . 0.0 109.119 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -124.3 148.38 47.47 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 122.631 0.372 . . . . 0.0 111.65 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.4 m -145.16 158.53 43.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.268 1.027 . . . . 0.0 109.12 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 179.45 178.48 48.39 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.943 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.497 ' C ' HD22 ' A' ' 544' ' ' LEU . 8.6 mp -116.9 144.64 44.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 109.82 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.497 HD22 ' C ' ' A' ' 543' ' ' LEU . 3.2 mm? -128.93 142.04 51.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.87 113.2 15.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.439 ' CH2' HD22 ' A' ' 500' ' ' LEU . 4.2 p90 -165.93 149.13 7.57 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 168.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -155.35 126.34 7.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 43.6 t -159.53 161.32 35.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 169.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.56 -51.21 45.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.881 0.764 . . . . 0.0 110.448 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 72.5 p -89.28 -27.24 20.69 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 25.0 m-20 -82.42 -27.57 31.9 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 118.987 0.812 . . . . 0.0 110.802 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -85.58 -31.99 22.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.432 0.56 . . . . 0.0 110.576 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 41.6 tp -73.92 -30.09 62.38 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.228 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.52 -42.7 58.44 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 58.6 m -68.24 -39.16 82.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.71 -42.21 82.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -70.96 -19.49 77.09 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.145 -0.808 . . . . 0.0 113.582 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -113.86 -16.95 12.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.685 1.242 . . . . 0.0 112.903 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.67 -21.79 22.58 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.061 0.846 . . . . 0.0 111.801 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -74.21 147.83 42.15 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.573 0.624 . . . . 0.0 109.721 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.8 t60 53.81 29.01 9.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.92 0.888 . . . . 0.0 113.259 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.98 151.39 24.24 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -117.51 136.42 53.25 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.873 1.269 . . . . 0.0 110.427 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . 0.411 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 4.8 ttt -64.18 169.47 4.48 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.767 0.827 . . . . 0.0 111.464 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -79.39 22.99 0.41 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.596 0.758 . . . . 0.0 112.831 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 36.5 p30 -64.65 147.52 97.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 O-C-N 122.109 -0.369 . . . . 0.0 110.331 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.72 -32.31 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.419 2.746 . . . . 0.0 113.872 -169.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -121.04 2.02 10.41 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.46 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.53 37.92 95.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.072 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 92.6 Cg_endo -71.37 -9.05 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.97 2.446 . . . . 0.0 112.291 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -145.75 150.39 42.99 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.311 0.505 . . . . 0.0 110.765 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.77 156.21 39.57 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.059 3.173 . . . . 0.0 110.634 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . 0.411 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 70.4 t80 -140.86 -1.44 1.41 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 4.9 t -66.39 131.92 47.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.484 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.93 144.65 50.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.917 0.887 . . . . 0.0 109.086 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -89.7 134.75 34.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 153.19 39.76 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.944 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 32.1 p -163.36 176.76 9.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.861 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -72.19 143.19 48.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 29.8 t -135.64 146.27 47.68 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.363 0.665 . . . . 0.0 110.451 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 51.8 m -87.17 102.16 14.2 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.25 161.47 34.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.997 0.919 . . . . 0.0 110.053 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -93.92 -19.6 20.79 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -161.27 162.45 31.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.141 0.976 . . . . 0.0 109.441 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.17 76.48 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.637 -1.173 . . . . 0.0 110.253 -179.472 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.416 0.151 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -144.54 143.22 30.72 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . 0.436 ' N ' ' CD ' ' A' ' 374' ' ' PRO . . . 67.69 37.49 89.07 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.49 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 373' ' ' GLY . 86.5 Cg_endo -72.76 -27.94 14.31 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.238 2.019 . . . . 0.0 111.626 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -163.41 161.39 24.34 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.565 0.746 . . . . 0.0 110.38 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -80.77 163.93 23.12 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.961 0.504 . . . . 0.0 110.194 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.1 -2.95 53.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.7 m -152.06 153.86 31.81 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.158 0.583 . . . . 0.0 110.979 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.44 -5.03 10.16 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.507 3.471 . . . . 0.0 113.546 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.2 t -126.91 151.33 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 118.498 0.59 . . . . 0.0 111.176 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . 0.403 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.6 pp -138.12 164.46 29.08 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.71 0.804 . . . . 0.0 109.531 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.3 mtp -136.45 148.29 47.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.736 0.414 . . . . 0.0 110.11 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.56 149.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 122.85 0.46 . . . . 0.0 110.424 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -140.44 165.85 26.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.666 0.786 . . . . 0.0 109.286 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 81.9 -1.21 87.15 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.703 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.72 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.0 pt? -71.64 172.39 9.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.194 0.997 . . . . 0.0 110.048 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -130.42 127.25 38.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -68.11 -2.91 8.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 87.8 p -108.29 -2.84 18.9 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -130.13 -12.23 4.12 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.376 0.67 . . . . 0.0 111.055 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.1 ttt -150.07 125.95 10.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.372 0.669 . . . . 0.0 109.328 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -141.87 -172.16 3.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.0 -25.65 61.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -86.83 -25.78 24.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.879 -0.513 . . . . 0.0 111.799 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -91.97 -25.2 18.98 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 122.265 -0.272 . . . . 0.0 111.178 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.8 -27.26 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 172.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.55 -42.89 67.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.695 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -80.63 -8.64 59.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.564 0.62 . . . . 0.0 112.653 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.78 -24.35 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 118.214 0.461 . . . . 0.0 110.932 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -107.33 -13.72 15.05 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.4 t -69.56 -28.71 66.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.27 0.941 . . . . 0.0 111.562 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.76 14.2 1.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.734 -0.604 . . . . 0.0 112.209 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -119.59 -2.75 10.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.419 0.688 . . . . 0.0 110.22 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 143.07 165.84 10.85 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.17 152.67 44.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.212 -0.581 . . . . 0.0 110.957 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.1 t -110.07 146.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -89.82 -57.75 2.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.997 -0.439 . . . . 0.0 109.905 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -166.38 164.83 17.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.971 0.509 . . . . 0.0 110.687 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.89 149.73 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.483 0.713 . . . . 0.0 110.105 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -152.22 144.18 23.75 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -75.52 154.52 36.83 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.654 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 9.1 tmm? -129.33 141.16 51.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.285 0.564 . . . . 0.0 112.51 -168.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.51 33.75 19.6 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.69 1.596 . . . . 0.0 111.885 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.2 m 52.91 15.84 0.62 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.354 1.062 . . . . 0.0 113.59 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.74 145.63 75.04 Favored Pre-proline 0 C--N 1.339 0.122 0 CA-C-N 118.156 0.435 . . . . 0.0 110.086 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.37 4.03 6.97 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.83 3.02 . . . . 0.0 110.604 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -146.84 30.73 1.51 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.278 -0.735 . . . . 0.0 113.209 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.654 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -149.78 138.31 20.75 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.355 1.078 . . . . 0.0 110.537 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.89 19.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.034 0.445 . . . . 0.0 111.808 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 7.6 ptp -135.76 150.6 49.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.806 0.843 . . . . 0.0 110.394 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.47 149.47 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.286 0.634 . . . . 0.0 110.437 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -130.71 133.44 46.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.531 0.732 . . . . 0.0 109.913 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.1 mmm -106.1 161.29 14.63 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.943 0.497 . . . . 0.0 110.981 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -74.79 -18.79 60.41 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.448 0.299 . . . . 0.0 111.762 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -154.28 155.86 35.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.679 0.392 . . . . 0.0 110.222 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.44 -15.95 75.39 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.429 -0.65 . . . . 0.0 113.078 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -26.45 59.62 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.057 1.428 . . . . 0.0 110.701 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -74.78 -27.23 60.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.72 -29.79 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.39 -40.54 73.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.187 -0.321 . . . . 0.0 110.626 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.45 -34.92 35.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.52 -29.96 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 121.964 -0.46 . . . . 0.0 111.404 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 17.7 m -95.26 -18.9 20.45 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -136.46 -10.78 1.89 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -108.03 -21.76 12.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.376 0.989 . . . . 0.0 108.802 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -51.87 143.46 13.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.218 1.007 . . . . 0.0 110.956 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 57.11 1.47 0.1 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.535 1.934 . . . . 0.0 115.733 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.88 142.43 27.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 120.757 1.617 . . . . 0.0 107.968 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.332 0.0 OUTLIER -130.88 163.88 26.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 175.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 20.5 ptm -125.37 143.34 51.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.651 1.18 . . . . 0.0 110.405 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.73 28.3 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.96 15.71 64.63 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 168.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.14 151.02 25.9 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.093 1.447 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -84.7 137.91 32.95 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -94.54 123.97 38.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -168.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -140.72 115.87 9.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 141.01 16.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.214 0.461 . . . . 0.0 110.178 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 90.5 m -148.41 163.34 37.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.663 0.785 . . . . 0.0 110.126 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.1 p -84.57 155.64 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.6 t -136.6 155.37 50.01 Favored 'General case' 0 C--O 1.228 -0.075 0 CA-C-N 118.073 0.397 . . . . 0.0 111.22 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -93.17 7.04 45.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -66.54 140.02 96.33 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.94 -25.8 10.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.944 2.429 . . . . 0.0 111.319 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.1 171.28 15.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.487 0.715 . . . . 0.0 109.87 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 41.9 mm -68.68 136.91 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.5 mmt -91.73 153.85 43.85 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.32 164.4 8.85 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.847 3.031 . . . . 0.0 112.53 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 163.84 174.73 34.0 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.31 160.97 29.71 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 80.1 p -137.33 153.87 50.17 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.048 0.539 . . . . 0.0 110.512 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -144.59 165.09 29.0 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.249 0.62 . . . . 0.0 109.848 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.62 137.66 17.78 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.22 167.34 14.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 109.551 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.97 -20.0 65.01 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 122.056 -0.403 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.87 0.88 37.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.909 0.322 . . . . 0.0 111.235 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.7 -2.04 87.17 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.594 -0.559 . . . . 0.0 113.211 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.39 163.19 13.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.103 0.952 . . . . 0.0 110.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.3 m -84.54 153.36 23.31 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.811 0.444 . . . . 0.0 110.902 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 91.8 p -73.09 -10.33 59.67 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.025 0.53 . . . . 0.0 111.577 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -132.8 143.65 49.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.151 0.98 . . . . 0.0 109.747 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -156.1 159.24 38.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.578 0.351 . . . . 0.0 110.3 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.95 153.23 52.15 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.189 0.595 . . . . 0.0 110.851 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.63 15.49 2.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.034 0.534 . . . . 0.0 111.282 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.0 p -66.88 -11.08 54.72 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.361 0.664 . . . . 0.0 112.544 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -81.67 -4.86 57.33 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.925 -0.485 . . . . 0.0 110.773 177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.5 m -107.8 20.12 19.2 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.661 0.784 . . . . 0.0 111.453 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -73.9 -2.43 23.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.688 0.395 . . . . 0.0 111.226 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -82.56 5.48 20.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.434 0.694 . . . . 0.0 111.095 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -59.43 155.04 15.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.968 0.907 . . . . 0.0 110.79 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -81.09 4.54 19.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.581 0.752 . . . . 0.0 112.509 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -146.52 30.49 1.0 Allowed 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.081 -0.387 . . . . 0.0 110.697 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 79.5 p -76.07 -9.75 58.87 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.051 -0.405 . . . . 0.0 111.664 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 485' ' ' PRO . 5.1 t -150.81 149.7 26.18 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 123.483 0.713 . . . . 0.0 109.249 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 484' ' ' THR . 75.7 Cg_exo -56.03 -20.7 31.31 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.717 2.945 . . . . 0.0 114.481 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.37 -22.49 30.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.462 0.573 . . . . 0.0 111.531 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -90.49 -27.31 19.3 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -78.17 22.48 0.31 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.839 0.855 . . . . 0.0 111.656 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -104.91 -7.52 19.27 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.403 0.681 . . . . 0.0 111.218 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -104.77 4.89 32.81 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.608 0.763 . . . . 0.0 110.202 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -152.72 171.96 17.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.536 1.135 . . . . 0.0 109.132 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -123.15 136.8 54.93 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.4 mm -113.56 148.56 16.38 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 123.455 0.702 . . . . 0.0 110.638 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? 60.8 -17.59 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.101 1.76 . . . . 0.0 115.373 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.97 119.75 44.28 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.564 1.075 . . . . 0.0 110.324 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.08 113.35 3.59 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.567 2.845 . . . . 0.0 110.804 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 52.4 m -123.96 13.42 9.13 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.388 0.675 . . . . 0.0 111.942 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 57.14 16.91 3.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.725 1.21 . . . . 0.0 113.722 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 74.1 t -134.51 141.44 43.41 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 CA-C-N 118.419 0.554 . . . . 0.0 109.886 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 56.5 mt -121.58 163.69 18.5 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 108.7 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.26 146.88 35.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.864 0.364 . . . . 0.0 111.729 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -112.71 150.01 32.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.572 1.149 . . . . 0.0 109.565 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -147.63 169.95 18.54 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 122.674 0.39 . . . . 0.0 111.175 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 29.0 m120 59.71 17.91 6.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.599 1.16 . . . . 0.0 113.747 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -80.69 156.09 73.08 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.85 154.79 36.07 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.921 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.5 pt? -72.69 -1.08 14.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.94 4.74 32.15 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.084 0.402 . . . . 0.0 111.723 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.9 p -81.64 148.69 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 O-C-N 122.062 -0.398 . . . . 0.0 110.6 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 72.4 p -144.14 174.01 11.25 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.849 0.86 . . . . 0.0 109.93 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.5 -24.59 67.56 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.796 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.97 -23.11 55.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.428 -0.17 . . . . 0.0 110.657 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -82.05 -28.88 32.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.85 -31.36 66.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -74.74 -38.7 62.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.753 0.252 . . . . 0.0 111.187 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -78.86 -14.4 59.26 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.09 0.405 . . . . 0.0 111.569 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.69 -38.51 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.617 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 97.5 m -67.06 -24.69 66.0 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 118.826 0.739 . . . . 0.0 110.537 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.16 -28.1 61.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.98 -17.5 26.22 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . 0.437 HD11 HG22 ' A' ' 523' ' ' VAL . 4.3 pp -102.58 5.24 39.16 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 79.45 35.25 29.87 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.867 1.107 . . . . 0.0 115.867 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.437 HG22 HD11 ' A' ' 521' ' ' LEU . 11.1 m -130.47 168.3 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.2 1.5 . . . . 0.0 111.833 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.29 150.64 31.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.973 0.909 . . . . 0.0 110.855 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -87.58 152.89 52.58 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.364 0.666 . . . . 0.0 110.186 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.61 153.4 75.29 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.516 2.811 . . . . 0.0 111.105 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.427 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 86.4 m -82.34 -25.03 34.24 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.679 0.392 . . . . 0.0 110.707 -176.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 13.6 t -142.83 156.48 44.96 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.562 0.345 . . . . 0.0 110.115 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 4.9 p -149.51 141.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 123.094 0.558 . . . . 0.0 110.758 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 121.59 8.85 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.16 144.63 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 122.848 0.459 . . . . 0.0 110.997 -173.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -149.89 159.22 44.55 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.271 1.028 . . . . 0.0 109.547 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.2 p -121.62 150.65 41.41 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.979 0.511 . . . . 0.0 110.942 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -89.65 151.86 22.1 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -82.55 141.06 32.9 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 27.1 m 56.33 11.1 0.74 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.309 1.044 . . . . 0.0 113.785 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -106.49 -10.27 16.33 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.05 0.387 . . . . 0.0 111.103 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 48.98 28.62 2.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.445 1.098 . . . . 0.0 113.125 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.5 m -137.75 161.15 37.31 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.532 0.333 . . . . 0.0 111.349 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.9 t -132.07 155.0 48.86 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.179 0.991 . . . . 0.0 111.071 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 80.3 p -152.95 166.69 31.6 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.231 1.012 . . . . 0.0 110.37 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 175.01 177.89 44.45 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.873 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.43 ' C ' HD22 ' A' ' 544' ' ' LEU . 11.2 mp -112.79 144.28 42.6 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.84 0.856 . . . . 0.0 110.196 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.43 HD22 ' C ' ' A' ' 543' ' ' LEU . 3.2 mm? -127.06 139.86 52.7 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -127.78 108.35 10.66 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.427 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.9 OUTLIER -166.1 155.72 11.95 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.548 1.539 . . . . 0.0 107.347 168.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -153.87 126.01 7.89 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.9 t -159.63 153.05 22.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.603 1.561 . . . . 0.0 107.013 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.46 -52.24 64.3 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.096 0.407 . . . . 0.0 111.728 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 38.8 m -85.4 -21.9 28.6 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -78.95 -35.43 43.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.175 -0.328 . . . . 0.0 110.795 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -79.97 -31.96 39.86 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.28 -0.391 . . . . 0.0 111.166 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 47.1 tp -76.22 -29.7 57.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.776 0.716 . . . . 0.0 111.48 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.81 -40.1 55.61 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.826 -0.546 . . . . 0.0 110.221 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 49.0 m -68.73 -36.8 78.87 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.1 -41.74 99.43 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.61 -23.02 78.56 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.784 -172.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.14 -20.37 7.42 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.095 1.447 . . . . 0.0 113.883 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 37.3 tp -93.73 -23.16 18.31 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.635 1.107 . . . . 0.0 112.022 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -75.18 136.42 41.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 53.15 27.14 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.845 0.858 . . . . 0.0 113.093 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -78.19 151.38 33.22 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.185 0.594 . . . . 0.0 112.169 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -101.58 136.41 41.46 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.838 1.255 . . . . 0.0 110.03 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.4 ttt -64.17 169.56 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.645 0.378 . . . . 0.0 111.032 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -75.61 17.49 0.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -69.0 145.64 96.76 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.872 -0.518 . . . . 0.0 109.764 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.97 -30.56 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.487 2.791 . . . . 0.0 113.924 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -120.89 0.57 10.31 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.157 0.435 . . . . 0.0 112.114 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.445 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 39.81 97.76 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.77 -1.017 . . . . 0.0 112.75 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 74.9 Cg_endo -69.56 -10.11 27.88 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.053 2.502 . . . . 0.0 112.016 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -142.67 148.35 46.1 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.28 154.41 36.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.921 3.081 . . . . 0.0 111.333 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -148.34 -0.7 0.56 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.904 0.482 . . . . 0.0 111.534 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 48.1 p -66.38 129.28 39.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.11 144.56 50.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.647 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -96.09 139.81 31.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.516 0.726 . . . . 0.0 109.09 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.66 151.94 38.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.578 0.228 . . . . 0.0 111.007 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.2 p -161.7 178.96 8.52 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.974 0.509 . . . . 0.0 110.082 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -71.64 144.27 49.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.442 0.297 . . . . 0.0 110.48 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 30.9 t -135.55 145.04 46.59 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 122.888 0.475 . . . . 0.0 110.782 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 88.5 m -93.88 102.22 14.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.3 161.53 34.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.904 0.882 . . . . 0.0 110.258 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.44 -14.47 17.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -161.36 166.85 26.81 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.586 1.154 . . . . 0.0 108.655 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -79.24 76.39 5.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.447 -1.263 . . . . 0.0 110.031 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -137.39 8.5 2.89 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.775 0.43 . . . . 0.0 111.781 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 176.87 177.21 45.65 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.23 168.63 23.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.876 3.05 . . . . 0.0 111.094 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -148.76 152.9 37.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.272 0.629 . . . . 0.0 109.75 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -91.12 156.78 17.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.99 0.424 . . . . 0.0 111.118 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -142.87 12.53 1.86 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.095 0.558 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 39.8 t -155.98 147.41 16.84 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 123.462 0.705 . . . . 0.0 110.044 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 4.86 5.22 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.635 2.89 . . . . 0.0 111.454 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.54 151.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.694 0.798 . . . . 0.0 110.382 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 381' ' ' LEU . 4.5 pp -142.7 167.95 20.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.728 0.811 . . . . 0.0 109.771 177.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 71.6 mtp -135.57 152.8 51.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.637 0.256 . . . . 0.0 111.052 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.06 149.02 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 122.901 0.48 . . . . 0.0 110.413 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -141.41 168.75 19.02 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.477 0.711 . . . . 0.0 109.5 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.87 -2.0 87.34 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.874 -0.403 . . . . 0.0 112.616 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.775 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -74.44 171.97 12.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.48 0.64 . . . . 0.0 110.649 175.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -132.57 132.26 42.37 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -68.58 -4.51 15.59 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -171.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.5 t -102.11 -12.2 18.26 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.616 0.366 . . . . 0.0 111.9 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -131.98 -13.9 3.14 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.139 0.427 . . . . 0.0 111.876 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.0 tpt -148.59 106.01 3.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.758 0.823 . . . . 0.0 109.242 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -141.81 -166.78 2.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.766 0.426 . . . . 0.0 110.397 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 73.2 m -53.93 -27.74 32.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.118 0.567 . . . . 0.0 112.509 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.43 -34.12 28.32 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.922 -0.486 . . . . 0.0 111.007 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -83.51 -28.4 28.69 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.266 -0.271 . . . . 0.0 110.322 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.08 -30.29 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -68.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -70.51 -27.9 64.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 119.297 -0.382 . . . . 0.0 111.901 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 75.1 t -95.11 -21.55 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -109.51 -12.05 14.74 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.94 -27.34 65.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.143 0.883 . . . . 0.0 111.418 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.46 14.57 1.21 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.46 2.87 10.24 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.8 0.84 . . . . 0.0 109.982 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 130.6 158.32 9.26 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -172.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -68.96 153.57 43.56 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.056 0.928 . . . . 0.0 111.228 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.72 154.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -97.84 -60.75 1.5 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -164.18 163.42 22.93 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.466 0.706 . . . . 0.0 110.854 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.36 150.74 19.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -152.13 145.35 24.66 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.509 0.324 . . . . 0.0 110.181 176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -79.34 158.91 27.36 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -136.66 141.4 43.17 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -168.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 59.79 33.95 21.81 Favored 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 125.136 1.374 . . . . 0.0 112.505 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 23.2 m 53.01 15.39 0.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -81.87 132.56 53.91 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 118.691 0.678 . . . . 0.0 110.043 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.61 -3.68 8.32 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.543 2.828 . . . . 0.0 112.351 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -138.19 33.35 2.25 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.478 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.77 133.7 19.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.125 0.962 . . . . 0.0 110.357 174.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.38 169.17 24.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 111.198 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.2 ptm -143.49 146.56 33.49 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.278 0.631 . . . . 0.0 109.658 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.31 147.79 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.12 0.568 . . . . 0.0 110.586 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -122.18 135.96 54.84 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 93.5 mmm -105.25 164.25 11.98 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.485 0.314 . . . . 0.0 110.878 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.63 -22.99 66.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.99 159.2 36.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.35 0.66 . . . . 0.0 109.333 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.33 -17.0 69.9 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.068 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -68.37 -29.92 68.74 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.004 1.402 . . . . 0.0 110.178 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -73.51 -21.82 60.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.197 -0.314 . . . . 0.0 110.707 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.71 -35.64 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.88 -36.5 78.14 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 117.666 0.212 . . . . 0.0 110.677 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.08 -35.01 78.88 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.05 56.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.099 -0.376 . . . . 0.0 110.621 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -29.12 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.184 0.516 . . . . 0.0 111.855 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 40.8 p -91.17 -13.22 33.32 Favored 'General case' 0 C--N 1.342 0.277 0 O-C-N 121.067 -1.021 . . . . 0.0 113.592 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -138.44 -10.62 1.42 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -112.3 -14.52 13.31 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.226 0.921 . . . . 0.0 110.456 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -56.1 142.38 36.83 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 56.96 1.42 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.72 1.608 . . . . 0.0 114.991 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -87.77 142.6 27.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 120.058 1.299 . . . . 0.0 109.164 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.263 0.1 OUTLIER -130.91 164.0 26.23 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 174.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.4 ptm -125.18 143.42 50.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.86 1.264 . . . . 0.0 108.44 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 68.76 21.87 7.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.359 1.463 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 72.94 15.8 78.35 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -83.07 162.14 21.45 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.815 1.308 . . . . 0.0 110.68 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.46 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -79.71 132.34 36.17 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.292 0.237 . . . . 0.0 110.493 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -98.58 135.69 39.74 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -170.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -140.72 120.19 13.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.1 p -147.36 145.27 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 118.316 0.507 . . . . 0.0 110.378 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -157.68 161.25 38.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.754 0.422 . . . . 0.0 110.408 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.6 p -83.15 151.44 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 21.1 t -100.58 -169.03 1.66 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.639 0.375 . . . . 0.0 110.018 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -136.83 0.21 2.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.826 0.45 . . . . 0.0 110.691 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -74.27 148.94 86.62 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.29 -24.77 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.868 2.378 . . . . 0.0 111.794 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.09 170.11 15.41 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.319 0.647 . . . . 0.0 110.352 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.3 mm -67.14 143.92 15.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.1 mtt -107.77 156.89 37.26 Favored Pre-proline 0 C--O 1.232 0.15 0 C-N-CA 122.338 0.255 . . . . 0.0 111.109 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.68 157.88 21.98 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.928 3.085 . . . . 0.0 112.604 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.3 -179.13 42.66 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -74.02 150.13 40.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.615 -0.344 . . . . 0.0 110.481 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 52.9 m -143.69 147.66 34.6 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -145.97 167.88 22.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.861 0.464 . . . . 0.0 110.477 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -77.98 137.47 20.0 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.3 167.44 14.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.287 0.635 . . . . 0.0 110.007 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -67.72 -20.19 65.23 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.368 0.267 . . . . 0.0 111.379 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.1 -1.22 31.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.997 0.519 . . . . 0.0 110.954 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 82.2 -5.2 73.19 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.89 -0.506 . . . . 0.0 112.237 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 63.9 m -87.2 161.2 18.17 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.799 0.8 . . . . 0.0 110.072 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 80.3 m -85.22 153.35 22.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.48 0.181 . . . . 0.0 110.582 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.5 p -73.01 -10.48 59.85 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.466 0.306 . . . . 0.0 111.416 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.25 141.64 51.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.127 0.971 . . . . 0.0 109.487 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -155.25 156.84 36.31 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.548 0.339 . . . . 0.0 110.191 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.89 154.65 50.18 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.462 0.705 . . . . 0.0 110.547 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.12 15.85 2.08 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 122.723 0.409 . . . . 0.0 111.514 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 87.8 p -65.65 -12.49 53.88 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.23 -6.62 59.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.992 0.36 . . . . 0.0 111.376 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.5 m -96.66 15.55 21.47 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.488 0.715 . . . . 0.0 111.321 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -74.13 -1.07 18.68 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.126 0.571 . . . . 0.0 111.756 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -94.9 19.99 9.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.319 0.648 . . . . 0.0 110.942 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -69.73 163.94 24.6 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.02 0.528 . . . . 0.0 111.025 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.08 -2.54 21.73 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.773 0.829 . . . . 0.0 112.919 -176.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -149.7 29.26 0.76 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.103 0.411 . . . . 0.0 111.549 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.3 p -72.91 -6.99 48.87 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 46.2 p -139.65 159.15 66.44 Favored Pre-proline 0 C--O 1.231 0.094 0 C-N-CA 122.894 0.478 . . . . 0.0 109.959 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -60.99 -14.03 30.71 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.282 2.655 . . . . 0.0 112.643 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -90.71 -31.01 16.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.479 0.312 . . . . 0.0 111.032 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -90.56 -23.82 20.77 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.428 0.291 . . . . 0.0 110.346 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -83.74 26.03 0.73 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.686 0.794 . . . . 0.0 111.569 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -101.5 2.71 39.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.311 0.644 . . . . 0.0 111.533 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -119.23 4.4 11.29 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 123.315 0.646 . . . . 0.0 111.662 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -139.34 -17.9 1.0 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 59.6 146.58 0.01 OUTLIER 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.723 1.609 . . . . 0.0 113.33 -175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.7 mm -113.6 148.77 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.971 0.908 . . . . 0.0 111.141 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . 0.258 0.0 OUTLIER 55.04 11.63 0.53 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.848 2.059 . . . . 0.0 115.352 175.17 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -103.4 120.97 50.18 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.92 131.55 15.81 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.015 2.477 . . . . 0.0 110.557 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 87.8 p -124.16 -1.3 8.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.544 0.738 . . . . 0.0 112.119 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 59.53 16.21 5.12 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.069 0.948 . . . . 0.0 112.167 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 39.2 t -135.97 138.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.418 HD12 ' CH2' ' A' ' 546' ' ' TRP . 46.9 mt -120.26 152.69 37.41 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.08 145.8 49.02 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -131.93 151.71 51.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.613 0.244 . . . . 0.0 110.576 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -147.36 171.08 16.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.984 0.421 . . . . 0.0 111.094 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.5 t30 59.46 25.95 14.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.512 1.125 . . . . 0.0 113.236 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.74 63.93 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.88 159.7 52.36 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.206 1.938 . . . . 0.0 110.194 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.2 pt? -73.95 -1.07 18.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.87 4.51 42.81 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -86.41 150.22 3.93 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 CA-C-N 118.251 0.478 . . . . 0.0 111.347 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -147.2 174.34 11.7 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.939 0.896 . . . . 0.0 109.522 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.23 -24.67 67.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.499 -0.126 . . . . 0.0 110.925 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.1 -24.95 51.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.179 -0.325 . . . . 0.0 110.718 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.3 -28.35 38.29 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -73.71 -30.79 63.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.203 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -75.25 -36.32 61.3 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.287 -0.258 . . . . 0.0 111.544 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.46 -21.24 42.24 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.266 0.485 . . . . 0.0 111.55 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 55.8 mt -78.91 -37.69 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 86.8 m -67.38 -26.48 66.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.091 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.42 -29.12 62.37 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -91.06 -11.84 37.49 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.526 0.603 . . . . 0.0 111.895 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 86.3 mt -100.7 -5.44 26.5 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.644 0.377 . . . . 0.0 111.277 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 74.24 5.62 72.27 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.866 -0.408 . . . . 0.0 112.907 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.4 m -91.43 167.0 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 117.65 0.725 . . . . 0.0 110.953 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -76.63 151.84 36.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.384 0.674 . . . . 0.0 110.173 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 526' ' ' PRO . 4.7 ptp180 -102.16 150.9 37.91 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 525' ' ' ARG . 32.1 Cg_exo -60.15 158.98 27.89 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.404 2.736 . . . . 0.0 112.64 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.501 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 91.4 m -86.36 -25.07 25.55 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.072 0.549 . . . . 0.0 110.499 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 23.1 t -145.23 152.25 39.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.1 t -141.37 140.93 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.348 0.659 . . . . 0.0 109.775 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.97 126.51 15.94 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 25.8 t -132.05 149.43 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.032 0 C-N-CA 122.667 0.387 . . . . 0.0 110.673 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -152.3 153.75 34.32 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.272 0.629 . . . . 0.0 110.17 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 62.5 p -130.84 141.37 50.32 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.106 0.563 . . . . 0.0 109.907 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -80.99 157.51 39.35 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -72.42 130.67 41.24 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.45 -0.441 . . . . 0.0 110.052 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 27.0 m 55.94 14.93 1.53 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -90.58 -9.97 45.12 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.291 0.496 . . . . 0.0 111.356 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 44.43 26.95 0.2 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.132 1.373 . . . . 0.0 113.626 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 36.2 m -139.61 164.45 29.89 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.396 0.678 . . . . 0.0 110.351 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 34.3 t -132.91 153.7 51.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 111.089 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 67.6 m -146.65 164.61 32.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.059 1.343 . . . . 0.0 108.854 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -179.26 -175.07 45.91 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.01 -1.091 . . . . 0.0 113.857 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.11 153.49 42.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.188 0.995 . . . . 0.0 109.763 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 72.8 mt -136.52 136.9 39.76 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.043 0.937 . . . . 0.0 108.903 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -127.86 109.2 11.38 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.501 ' HB3' ' H ' ' A' ' 527' ' ' THR . 0.8 OUTLIER -166.12 155.01 11.28 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.826 1.25 . . . . 0.0 108.579 168.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -149.78 121.02 7.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 37.8 t -159.55 153.22 22.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -66.47 -46.92 74.75 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.767 0.712 . . . . 0.0 111.211 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 67.7 p -85.89 -27.84 24.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 48.6 m-20 -84.05 -30.01 26.41 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 118.578 0.626 . . . . 0.0 111.078 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.04 27.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.339 0.518 . . . . 0.0 111.236 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.74 -30.6 28.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.853 0.751 . . . . 0.0 112.024 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -75.82 -42.58 49.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.475 0.58 . . . . 0.0 110.482 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 43.3 m -68.88 -36.38 78.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.68 -41.48 83.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.7 -17.3 76.53 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.957 -0.913 . . . . 0.0 113.544 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.92 -19.22 7.33 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.757 1.279 . . . . 0.0 114.29 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -90.82 -31.25 16.55 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.056 0.844 . . . . 0.0 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -62.29 139.58 58.51 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 51.39 23.23 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.366 1.066 . . . . 0.0 113.604 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -74.4 151.33 39.69 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -99.87 136.25 40.07 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.482 1.113 . . . . 0.0 109.733 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . 0.421 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 5.3 ttt -64.34 172.42 2.55 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.311 0.577 . . . . 0.0 112.208 -172.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 564' ' ' MET . 21.3 ptmt -66.94 3.43 1.09 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.699 1.2 . . . . 0.0 113.712 -176.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -67.86 144.74 97.53 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 118.634 0.652 . . . . 0.0 110.727 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.98 -27.32 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.542 2.828 . . . . 0.0 113.784 -171.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -121.08 -3.06 9.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.205 0.457 . . . . 0.0 112.026 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.06 40.52 98.24 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.69 -1.061 . . . . 0.0 112.806 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 83.5 Cg_endo -69.69 -9.64 26.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.103 2.535 . . . . 0.0 111.823 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -142.19 147.74 45.18 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 123.023 0.529 . . . . 0.0 109.648 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.48 152.85 34.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.805 3.004 . . . . 0.0 111.565 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -148.83 -3.21 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.133 0.573 . . . . 0.0 111.493 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 38.6 p -66.44 120.94 14.22 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.701 -0.624 . . . . 0.0 110.044 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.96 144.63 50.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.093 0.957 . . . . 0.0 109.934 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -86.3 154.55 21.16 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 55.0 tp -144.12 144.84 31.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.96 168.38 19.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -77.07 130.86 37.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.9 t -135.57 138.2 42.75 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 32.9 p -79.7 102.25 8.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.336 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 159.92 39.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 109.144 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -81.85 -32.47 31.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.189 -0.319 . . . . 0.0 110.228 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -153.66 165.81 34.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.944 0.898 . . . . 0.0 109.571 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.43 76.32 7.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.354 -179.473 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -144.69 0.76 0.99 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.864 0.466 . . . . 0.0 111.993 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -71.5 136.02 24.3 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.64 -175.3 2.67 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.851 3.701 . . . . 0.0 110.298 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.49 149.08 38.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -70.25 158.31 36.09 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.89 0.376 . . . . 0.0 111.064 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.43 -0.58 57.35 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.336 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 43.0 t -160.27 146.56 11.81 Favored Pre-proline 0 N--CA 1.456 -0.164 0 C-N-CA 123.197 0.599 . . . . 0.0 110.355 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.14 4.34 6.65 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.118 3.212 . . . . 0.0 112.091 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.05 151.79 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 123.364 0.666 . . . . 0.0 110.699 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 381' ' ' LEU . 4.5 pp -141.58 167.07 23.03 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.807 0.843 . . . . 0.0 109.627 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 70.0 mtp -134.19 151.08 51.15 Favored 'General case' 0 N--CA 1.458 -0.042 0 C-N-CA 122.459 0.304 . . . . 0.0 111.084 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.9 148.15 19.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.834 0.454 . . . . 0.0 110.427 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -140.11 168.06 20.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.488 0.715 . . . . 0.0 109.369 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 85.45 -6.44 80.04 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.354 -0.692 . . . . 0.0 113.05 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.71 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.1 pt? -68.98 177.67 2.54 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.998 0.899 . . . . 0.0 110.387 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -142.78 136.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -73.63 -7.14 50.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 96.0 p -93.2 -12.03 31.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.605 0.639 . . . . 0.0 112.592 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.47 5.89 0.94 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.5 ttt -141.26 129.14 21.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 172.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.94 177.81 7.94 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.755 0.422 . . . . 0.0 110.213 -172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.57 -28.06 63.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.56 0.344 . . . . 0.0 111.203 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.66 -23.08 29.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.052 -0.405 . . . . 0.0 111.376 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -83.85 -34.5 24.62 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.2 p -73.1 -27.48 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.5 -33.84 73.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.018 -0.427 . . . . 0.0 110.183 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -67.88 -29.54 68.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.853 -0.529 . . . . 0.0 111.086 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 80.3 t -90.36 -29.64 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -101.72 -8.68 21.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 53.0 t -71.55 -38.34 71.03 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.872 0.76 . . . . 0.0 111.333 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.66 12.92 1.45 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.731 -0.606 . . . . 0.0 112.407 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.21 0.75 11.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.278 0.631 . . . . 0.0 111.152 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.16 170.05 14.52 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -70.26 136.42 49.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 122.351 -0.5 . . . . 0.0 110.759 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 4.5 m -95.1 164.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.773 1.229 . . . . 0.0 110.321 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -125.8 -65.54 0.99 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.325 0.25 . . . . 0.0 110.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -163.37 165.54 23.9 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.067 0.547 . . . . 0.0 111.194 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.63 151.63 14.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.674 0.79 . . . . 0.0 110.363 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.05 147.64 26.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -78.17 158.98 28.85 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.23 141.46 42.05 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 60.05 33.9 21.33 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.845 1.258 . . . . 0.0 112.402 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.4 m 53.06 16.06 0.69 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.812 1.245 . . . . 0.0 114.129 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -80.61 144.73 57.12 Favored Pre-proline 0 N--CA 1.455 -0.22 0 CA-C-N 118.449 0.568 . . . . 0.0 109.599 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.18 1.83 8.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.843 3.029 . . . . 0.0 110.831 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -143.27 33.41 1.81 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.164 -173.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.03 19.23 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.933 0.867 . . . . 0.0 110.133 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.28 170.6 21.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.073 0.464 . . . . 0.0 110.808 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 17.7 ptm -145.05 146.53 31.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.983 0.513 . . . . 0.0 109.672 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 18.6 t -125.25 147.75 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.026 0 C-N-CA 123.322 0.649 . . . . 0.0 110.742 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -124.58 142.42 51.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.535 0.734 . . . . 0.0 109.773 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 84.0 mmm -115.63 164.21 14.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 109.797 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.85 64.18 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.392 -0.192 . . . . 0.0 111.251 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.86 160.13 33.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.12 -14.51 63.86 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.377 -0.679 . . . . 0.0 113.097 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -64.38 -31.19 72.29 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 119.398 1.599 . . . . 0.0 110.233 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -78.67 -23.78 45.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.52 -0.113 . . . . 0.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 88.8 t -75.03 -31.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.04 -31.18 62.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.134 0.425 . . . . 0.0 110.865 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -29.62 65.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.067 -0.396 . . . . 0.0 109.986 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.66 -28.8 40.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.735 0.243 . . . . 0.0 110.59 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.8 tp -81.83 -35.25 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 122.775 0.43 . . . . 0.0 110.059 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 18.9 m -89.24 -26.09 21.38 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.91 -11.09 6.6 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -115.78 -16.76 11.18 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.424 1.011 . . . . 0.0 110.339 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -54.05 141.67 27.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.83 0.852 . . . . 0.0 111.514 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 57.04 1.39 0.09 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.045 2.138 . . . . 0.0 115.956 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.75 142.59 27.71 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 120.786 1.63 . . . . 0.0 108.01 169.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.276 0.0 OUTLIER -130.98 163.86 26.63 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 26.3 ptm -125.25 143.47 50.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.466 1.106 . . . . 0.0 109.607 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 66.46 32.94 7.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.178 1.391 . . . . 0.0 113.784 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 70.0 15.88 72.23 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.654 169.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -83.02 152.82 25.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.521 1.161 . . . . 0.0 110.736 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.564 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -75.42 136.19 40.73 Favored 'General case' 0 C--N 1.337 0.028 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -97.21 127.16 42.91 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -140.6 115.87 9.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.83 139.44 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 86.5 m -148.17 164.37 34.15 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.579 0.752 . . . . 0.0 109.99 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.7 p -83.62 151.9 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.5 t -102.29 -174.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.085 0.554 . . . . 0.0 110.304 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -135.4 7.12 3.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.799 0.84 . . . . 0.0 110.341 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -78.86 147.56 70.74 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.79 -25.46 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.835 2.357 . . . . 0.0 111.978 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.46 170.75 12.58 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.155 0.582 . . . . 0.0 110.443 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 37.1 mm -68.22 140.61 18.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 64.6 mtt -102.37 151.45 38.17 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.416 0.286 . . . . 0.0 110.723 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.09 161.54 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.729 2.952 . . . . 0.0 111.337 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.65 -175.68 44.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -72.96 158.26 35.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.664 0.385 . . . . 0.0 110.17 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.1 p -146.41 162.49 38.11 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.167 0.587 . . . . 0.0 110.543 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -150.15 163.7 37.53 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.96 0.504 . . . . 0.0 110.208 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.87 135.42 17.88 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 72.4 mt -86.97 176.4 7.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.904 0.882 . . . . 0.0 109.954 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -65.27 -20.29 66.35 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.775 0.43 . . . . 0.0 111.392 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.23 0.15 49.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.359 0.664 . . . . 0.0 111.573 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.52 -3.52 77.95 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.286 0.469 . . . . 0.0 112.504 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 60.5 m -93.82 156.69 16.52 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.681 0.74 . . . . 0.0 110.269 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.81 153.35 36.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.456 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 87.0 p -66.33 -10.39 42.44 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.775 0.43 . . . . 0.0 111.79 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -118.52 137.48 53.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.174 0.99 . . . . 0.0 109.391 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -151.87 154.92 37.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -124.28 152.36 43.11 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.02 0.928 . . . . 0.0 109.84 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -137.94 12.57 2.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.144 0.578 . . . . 0.0 112.276 -175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 97.2 p -70.38 4.53 2.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -107.93 17.31 22.58 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.493 0.717 . . . . 0.0 111.176 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.8 t -58.8 142.19 50.98 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.684 0.394 . . . . 0.0 111.161 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -122.07 22.47 10.25 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.02 0.928 . . . . 0.0 112.276 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -63.15 -30.62 71.74 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.888 0.313 . . . . 0.0 110.643 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 55.18 2.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.197 1.799 . . . . 0.0 115.732 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -89.88 -13.69 35.88 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.091 0.859 . . . . 0.0 110.744 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -165.2 18.43 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.908 0.883 . . . . 0.0 110.823 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 21.0 m -76.66 -1.52 28.18 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.817 0.447 . . . . 0.0 112.196 -176.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 70.7 p -139.61 156.72 71.11 Favored Pre-proline 0 C--O 1.233 0.22 0 C-N-CA 123.658 0.783 . . . . 0.0 109.15 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.15 -8.84 23.96 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.789 2.326 . . . . 0.0 111.209 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.87 -28.02 15.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.096 -0.378 . . . . 0.0 110.949 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -90.43 -25.7 20.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.872 0.306 . . . . 0.0 110.481 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -75.93 -9.71 58.83 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.392 0.277 . . . . 0.0 111.395 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -95.93 -14.13 23.35 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.846 0.458 . . . . 0.0 111.211 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -107.55 11.73 28.42 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 123.603 0.761 . . . . 0.0 110.861 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -140.62 161.52 37.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.111 0.964 . . . . 0.0 108.83 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -134.97 142.08 46.4 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.931 0.492 . . . . 0.0 110.388 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 50.2 mm -113.65 138.9 41.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 123.668 0.787 . . . . 0.0 109.674 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -146.3 177.25 9.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.509 0.724 . . . . 0.0 110.195 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -65.37 163.96 28.38 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.401 0.681 . . . . 0.0 110.756 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.61 151.86 13.66 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.764 2.976 . . . . 0.0 112.764 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 45.1 p -124.05 23.89 8.38 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.907 0.883 . . . . 0.0 112.122 -173.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 54.67 13.13 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.792 1.637 . . . . 0.0 115.051 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.85 150.24 22.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.96 143.84 50.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -109.37 152.48 25.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.731 0.413 . . . . 0.0 109.92 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -130.38 135.71 48.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.09 0.956 . . . . 0.0 108.482 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -146.56 168.18 21.88 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.858 0.463 . . . . 0.0 111.073 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.8 m120 58.18 29.95 18.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.906 0.882 . . . . 0.0 112.623 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -88.42 156.35 50.96 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 122.984 0.514 . . . . 0.0 109.765 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.18 156.95 64.04 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.286 1.99 . . . . 0.0 110.407 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.5 -1.19 26.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.17 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.6 7.8 28.83 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.095 -0.378 . . . . 0.0 111.983 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.51 153.09 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.168 0.44 . . . . 0.0 111.668 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 75.5 p -146.91 172.6 13.43 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.935 0.894 . . . . 0.0 110.114 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 511' ' ' GLU . 3.6 pm0 -60.79 -24.31 65.7 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.796 177.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -73.59 -26.69 60.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.178 -0.326 . . . . 0.0 110.455 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -80.37 -28.93 37.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.47 -29.43 63.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.6 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.81 -38.99 31.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.575 0.625 . . . . 0.0 111.605 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.91 -18.96 52.99 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.174 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 76.5 mt -90.85 -33.5 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 118.285 0.493 . . . . 0.0 110.095 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.33 -22.27 64.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.635 -0.666 . . . . 0.0 110.285 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.58 -30.55 64.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.13 -13.0 33.82 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.365 0.53 . . . . 0.0 112.075 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.5 mt -91.82 -6.53 51.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.517 0.327 . . . . 0.0 110.428 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.41 7.73 64.77 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.693 -0.504 . . . . 0.0 112.966 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.1 m -87.54 169.13 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 117.833 0.817 . . . . 0.0 111.222 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -71.16 132.33 44.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -76.81 147.0 77.07 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.92 148.29 91.77 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.909 2.406 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.1 m -89.55 -19.9 24.45 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.544 0.337 . . . . 0.0 110.431 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.5 t -147.25 148.98 32.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.41 138.93 36.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.656 0.382 . . . . 0.0 110.328 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -142.91 139.92 30.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.32 154.97 41.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 122.784 0.434 . . . . 0.0 110.428 -175.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -152.05 161.15 43.07 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.441 1.096 . . . . 0.0 109.166 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 74.9 p -130.82 141.96 50.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.918 0.39 . . . . 0.0 110.695 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -82.3 179.46 53.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -111.56 139.6 46.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.737 0.415 . . . . 0.0 110.55 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 23.6 m 54.29 10.25 0.3 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.967 1.307 . . . . 0.0 114.174 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -111.96 -7.64 14.12 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.366 0.53 . . . . 0.0 111.918 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 47.8 42.09 15.24 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.999 0.919 . . . . 0.0 112.517 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 158.26 44.55 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.81 0.444 . . . . 0.0 111.411 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 31.3 t -115.8 157.38 24.47 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.07 0.948 . . . . 0.0 111.884 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -149.88 175.15 11.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.256 1.422 . . . . 0.0 109.199 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.7 45.7 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.647 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.484 ' C ' HD12 ' A' ' 544' ' ' LEU . 6.3 mp -129.25 132.79 47.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.632 0.773 . . . . 0.0 109.01 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 543' ' ' LEU . 9.4 mp -128.12 144.78 51.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -127.76 120.46 27.95 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.468 ' HB3' ' H ' ' A' ' 527' ' ' THR . 9.6 p90 -164.94 147.4 8.2 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 168.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -156.21 123.4 5.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 17.3 m -159.64 152.89 22.16 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.341 1.856 . . . . 0.0 106.304 169.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -59.95 -54.26 48.22 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.718 0.69 . . . . 0.0 111.897 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 26.9 m -83.5 -27.28 29.51 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.96 -30.82 31.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.06 0.391 . . . . 0.0 111.024 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.25 -30.36 38.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 37.9 tp -78.08 -29.61 49.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.624 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -71.98 -41.72 67.34 Favored 'General case' 0 CA--C 1.521 -0.157 0 O-C-N 121.938 -0.476 . . . . 0.0 109.983 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 24.1 m -73.44 -39.24 65.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.992 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 556' ' ' LEU . 3.0 tm? -66.66 -46.78 74.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.676 -0.64 . . . . 0.0 109.815 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.15 -16.41 78.58 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.031 -0.872 . . . . 0.0 113.552 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -123.7 -6.18 8.03 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.795 1.298 . . . . 0.0 113.48 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.87 -16.36 14.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.3 0.5 . . . . 0.0 111.265 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -68.07 143.6 55.42 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.266 -0.896 . . . . 0.0 109.924 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 52.64 29.41 7.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.06 0.944 . . . . 0.0 113.354 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . 0.406 ' H ' ' HD1' ' A' ' 562' ' ' TYR . 0.4 OUTLIER -74.7 151.42 39.23 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -103.76 136.42 43.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.063 1.745 . . . . 0.0 110.635 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . 0.447 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.6 ttt -64.13 173.68 1.85 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.935 0.494 . . . . 0.0 111.202 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 564' ' ' MET . 65.2 pttt -73.3 9.77 1.19 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -66.28 143.86 98.48 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.715 0.688 . . . . 0.0 110.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -79.0 -29.58 3.21 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.569 2.846 . . . . 0.0 114.04 -169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -121.02 1.37 10.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.961 0.346 . . . . 0.0 111.912 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.428 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 60.74 41.55 99.09 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.929 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.6 Cg_endo -68.94 -10.87 30.37 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.247 2.631 . . . . 0.0 112.048 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.11 147.61 38.38 Favored Pre-proline 0 N--CA 1.455 -0.201 0 C-N-CA 122.832 0.453 . . . . 0.0 109.824 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.81 152.37 41.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.859 3.039 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . 0.447 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.7 t80 -144.17 -2.79 0.88 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 126.17 28.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.809 -0.557 . . . . 0.0 109.998 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.14 144.71 50.3 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.232 1.013 . . . . 0.0 110.372 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -79.46 135.98 36.81 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.5 pp -146.99 146.85 30.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 25.5 p -163.72 169.99 17.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.082 0.553 . . . . 0.0 110.304 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -73.78 130.67 40.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 74.6 m -135.55 140.07 44.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.79 0.436 . . . . 0.0 110.199 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 65.0 m -79.82 102.34 9.03 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.012 0.434 . . . . 0.0 110.573 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 161.6 34.44 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.076 0.95 . . . . 0.0 109.43 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . 0.508 ' H ' ' CD ' ' A' ' 583' ' ' GLN . 0.0 OUTLIER -98.87 -15.92 19.02 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.573 0.349 . . . . 0.0 111.511 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -160.58 164.56 31.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.205 0.602 . . . . 0.0 109.824 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.17 76.4 9.24 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.945 179.113 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.02 7.84 2.94 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.928 0.491 . . . . 0.0 111.866 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 75.1 -172.75 53.25 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.7 171.97 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 124.309 3.339 . . . . 0.0 110.934 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -148.42 162.81 38.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.139 0.576 . . . . 0.0 110.768 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -95.57 156.72 16.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.563 0.345 . . . . 0.0 111.189 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -139.08 10.75 2.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.29 0.636 . . . . 0.0 110.917 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 37.6 t -155.71 150.71 20.78 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.177 0.591 . . . . 0.0 110.323 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.34 -4.39 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.562 2.841 . . . . 0.0 111.473 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.77 145.3 17.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.098 0.559 . . . . 0.0 111.019 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.99 165.16 27.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.243 1.017 . . . . 0.0 109.43 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.2 mtp -137.87 153.17 49.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.674 0.274 . . . . 0.0 111.58 -175.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.2 p -146.63 150.39 15.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.064 0.546 . . . . 0.0 110.357 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -138.24 166.16 24.89 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.59 86.93 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.547 -0.585 . . . . 0.0 113.115 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.769 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -72.58 178.14 4.27 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.209 1.005 . . . . 0.0 110.992 177.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -140.44 143.8 35.78 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -73.29 0.22 12.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 88.4 p -113.67 -4.33 13.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.552 0.614 . . . . 0.0 112.376 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -131.81 -6.9 3.58 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.141 0.577 . . . . 0.0 110.882 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 27.8 ttt -145.43 128.19 16.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.433 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 32.8 m-80 -141.88 176.75 8.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.701 0.801 . . . . 0.0 109.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.0 m -57.98 -27.84 63.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.314 0.246 . . . . 0.0 111.142 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -85.15 -26.21 26.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.267 -0.271 . . . . 0.0 111.451 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . 0.433 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 48.8 mmt-85 -81.07 -33.85 33.12 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.194 0.452 . . . . 0.0 109.804 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -25.12 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -71.52 -29.33 64.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.66 -26.74 50.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.684 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 74.5 t -90.18 -21.28 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 118.298 0.499 . . . . 0.0 112.301 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -114.43 -12.91 12.29 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.79 -25.65 62.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.44 1.018 . . . . 0.0 111.754 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.6 pp -77.67 11.16 2.22 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.649 -0.657 . . . . 0.0 112.164 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -119.75 -7.78 9.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.454 0.701 . . . . 0.0 110.609 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 153.32 170.71 19.81 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -70.41 138.49 51.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.065 -0.668 . . . . 0.0 111.008 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 62.0 t -97.25 145.14 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.07 -57.89 1.98 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.323 -0.236 . . . . 0.0 110.721 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -160.0 165.23 32.36 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.972 0.415 . . . . 0.0 111.54 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.21 151.8 15.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 123.85 0.86 . . . . 0.0 109.987 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -151.64 144.56 24.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.762 0.425 . . . . 0.0 110.007 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -76.05 157.4 33.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 34.4 ttp -119.67 141.15 49.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -168.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt 51.93 33.88 12.54 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.722 1.209 . . . . 0.0 112.26 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.8 m 55.68 15.76 1.7 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 113.323 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -81.29 142.18 50.46 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.42 -2.47 11.98 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.467 2.778 . . . . 0.0 109.518 169.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.01 15.79 10.99 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.556 1.074 . . . . 0.0 113.822 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.181 1.49 . . . . 0.0 111.129 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -158.89 168.06 27.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.169 0.509 . . . . 0.0 111.964 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.2 ptp -136.07 148.79 48.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.913 0.885 . . . . 0.0 109.93 175.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.53 151.35 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.037 0 C-N-CA 123.556 0.742 . . . . 0.0 109.834 -175.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -130.77 145.04 51.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.736 0.414 . . . . 0.0 110.493 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 73.7 mtp -124.34 165.43 17.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.156 0.582 . . . . 0.0 110.125 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.02 66.58 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -158.81 160.79 36.63 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.73 -13.33 78.35 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.509 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -65.51 -26.79 68.07 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.166 1.483 . . . . 0.0 110.741 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -85.98 -25.61 25.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.219 0.208 . . . . 0.0 110.841 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.39 -30.36 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.6 -33.4 72.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.497 0.319 . . . . 0.0 110.355 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -76.08 -25.35 55.42 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 122.175 -0.328 . . . . 0.0 110.514 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -78.84 -28.57 44.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.984 -0.448 . . . . 0.0 109.868 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 1.2 mp -80.47 -31.04 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.102 0.961 . . . . 0.0 111.096 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 45.7 p -100.54 -13.17 18.74 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -134.05 -11.97 2.55 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.049 1.295 . . . . 0.0 114.391 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.82 -10.45 11.71 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.96 0.8 . . . . 0.0 109.718 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -58.88 145.24 41.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.403 0.62 . . . . 0.0 112.443 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 21.3 m120 56.9 1.35 0.09 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.543 1.937 . . . . 0.0 115.536 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -87.95 142.52 27.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.55 1.523 . . . . 0.0 108.493 169.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.303 0.0 OUTLIER -130.69 163.97 26.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 174.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.3 ptm -125.26 143.36 50.99 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.642 1.177 . . . . 0.0 109.171 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 63.86 27.09 14.46 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.953 1.301 . . . . 0.0 114.483 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.83 15.92 76.4 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 115.054 0.781 . . . . 0.0 115.054 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -83.04 150.63 26.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.979 1.389 . . . . 0.0 110.14 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 141.49 38.28 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.79 122.99 40.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -140.73 115.72 9.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.14 140.22 24.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.926 0.33 . . . . 0.0 110.341 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 99.4 m -149.43 168.21 24.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.878 0.871 . . . . 0.0 110.158 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -97.68 153.57 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 23.2 t -105.82 -168.23 1.42 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.653 0.381 . . . . 0.0 110.276 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -141.57 4.43 1.75 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.115 0.566 . . . . 0.0 111.146 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -74.38 150.93 87.46 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -27.7 12.35 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.646 2.231 . . . . 0.0 112.382 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.71 170.15 14.38 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.298 0.499 . . . . 0.0 111.28 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 30.0 mm -71.82 151.49 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 63.5 mtt -117.01 133.07 23.15 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.22 158.55 41.29 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.523 2.815 . . . . 0.0 111.427 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 151.84 160.23 9.4 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 48.27 -95.9 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.703 1.201 . . . . 0.0 112.741 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 33.0 t 63.14 146.75 0.02 OUTLIER 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.653 1.581 . . . . 0.0 112.938 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -148.31 165.3 31.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.913 0.885 . . . . 0.0 109.699 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.45 132.65 11.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.1 mt -87.06 172.5 9.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.315 0.646 . . . . 0.0 110.341 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.48 -22.12 66.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.848 0.459 . . . . 0.0 110.951 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -81.7 1.2 35.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.199 0.599 . . . . 0.0 111.41 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.45 -2.11 79.1 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.076 0.369 . . . . 0.0 112.402 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 22.9 t -93.35 156.59 16.7 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.655 0.727 . . . . 0.0 110.067 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 83.9 m -78.77 150.42 32.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.189 -0.319 . . . . 0.0 110.447 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 86.3 p -73.22 -10.33 59.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.455 0.302 . . . . 0.0 111.464 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -119.44 130.59 55.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.561 0.744 . . . . 0.0 109.062 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -151.62 159.44 44.06 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -130.62 147.88 52.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.794 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -136.2 12.77 3.3 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.052 0.541 . . . . 0.0 111.415 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 14.8 t -72.14 164.42 26.24 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.913 0.485 . . . . 0.0 111.594 -174.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 53.18 25.96 4.68 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.133 0.973 . . . . 0.0 113.28 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.9 t -65.38 150.02 49.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.98 -0.45 . . . . 0.0 110.533 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -122.01 7.52 9.81 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.619 0.768 . . . . 0.0 111.383 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -93.88 14.52 19.24 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.403 0.681 . . . . 0.0 111.333 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -144.41 155.43 43.75 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 121.866 -0.521 . . . . 0.0 111.346 -178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -89.63 -9.97 47.68 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.711 0.804 . . . . 0.0 111.538 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -130.69 38.64 3.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.569 0.748 . . . . 0.0 110.376 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.6 p -71.33 -3.27 19.72 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.216 0.606 . . . . 0.0 112.5 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 36.2 p -139.05 154.79 72.78 Favored Pre-proline 0 C--O 1.231 0.131 0 C-N-CA 123.146 0.579 . . . . 0.0 109.513 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.1 -6.05 18.35 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.143 2.562 . . . . 0.0 111.514 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.33 -30.59 13.33 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.558 0.343 . . . . 0.0 110.924 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -90.56 -17.44 26.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.299 -0.251 . . . . 0.0 110.474 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -68.85 -8.29 42.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -76.2 -11.78 59.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.444 0.298 . . . . 0.0 110.967 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -94.63 6.21 49.54 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.556 0.742 . . . . 0.0 111.181 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -141.21 171.38 14.14 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.835 0.854 . . . . 0.0 109.413 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -132.56 155.7 48.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.305 0.642 . . . . 0.0 109.912 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.05 147.89 12.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -140.69 158.75 43.52 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.965 0.412 . . . . 0.0 110.915 -176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -89.1 166.48 21.64 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.29 1.036 . . . . 0.0 109.882 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.03 129.96 30.02 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.0 2.467 . . . . 0.0 111.412 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 70.8 m -123.99 22.73 8.74 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.195 0.598 . . . . 0.0 112.291 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 60.2 3.29 0.51 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.06 1.344 . . . . 0.0 114.012 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 43.6 t -142.29 146.96 21.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 49.1 mt -121.48 162.1 21.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.036 0.534 . . . . 0.0 110.545 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -141.96 152.78 43.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.502 0.321 . . . . 0.0 110.676 175.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -138.01 154.25 49.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.837 0.455 . . . . 0.0 111.344 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -146.01 172.17 13.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.048 0.539 . . . . 0.0 111.197 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 25.4 m120 61.08 27.66 17.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -82.64 160.55 61.29 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 122.44 0.296 . . . . 0.0 110.609 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.92 152.71 62.38 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.692 2.261 . . . . 0.0 110.7 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -73.46 -2.56 23.0 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.23 9.22 13.41 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.204 0.602 . . . . 0.0 111.88 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 4.3 p -77.9 152.44 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 122.121 -0.362 . . . . 0.0 110.298 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.6 p -145.65 170.97 15.41 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.061 0.544 . . . . 0.0 110.442 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.87 -23.25 66.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.894 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.16 -26.07 58.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.657 0.208 . . . . 0.0 110.492 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -78.56 -30.57 46.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -73.48 -27.04 61.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.303 -0.248 . . . . 0.0 110.878 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -78.85 -39.52 35.09 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.972 -0.455 . . . . 0.0 111.178 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -78.89 -21.74 46.96 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 84.1 mt -86.36 -35.89 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.281 0.491 . . . . 0.0 110.315 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 90.3 m -65.87 -28.45 68.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.086 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.58 -28.62 65.02 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.84 -12.18 37.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.557 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.41 -2.89 58.59 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.882 0.473 . . . . 0.0 111.257 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.32 79.94 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.929 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.77 165.07 22.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-N 117.817 0.809 . . . . 0.0 110.885 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -73.83 146.66 43.99 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 120.922 0.392 . . . . 0.0 110.605 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 525' ' ' ARG . 0.4 OUTLIER -88.07 152.92 51.35 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.27 0.628 . . . . 0.0 110.354 176.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.85 152.47 69.96 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.252 2.635 . . . . 0.0 111.413 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 95.4 m -85.51 -27.8 25.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.359 0.263 . . . . 0.0 111.171 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 49.6 m -140.35 149.43 42.7 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.021 0.529 . . . . 0.0 109.813 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 61.9 t -141.76 147.02 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.971 0.509 . . . . 0.0 110.472 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.31 124.63 10.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.39 144.65 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.586 0.354 . . . . 0.0 110.921 -175.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -149.58 161.38 42.28 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.749 0.82 . . . . 0.0 109.661 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 82.6 p -99.5 150.12 22.53 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 122.917 0.487 . . . . 0.0 110.926 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -89.46 147.27 19.4 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -74.69 130.49 39.59 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.6 m 57.12 12.18 1.22 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -97.5 -13.16 21.87 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.583 0.628 . . . . 0.0 111.069 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 52.23 28.88 5.98 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.939 0.896 . . . . 0.0 111.95 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 98.4 p -147.92 170.23 18.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.798 0.439 . . . . 0.0 111.089 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.2 m -131.37 160.83 33.91 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.661 0.784 . . . . 0.0 111.77 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.9 p -149.33 165.39 32.14 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.592 1.157 . . . . 0.0 109.79 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.08 40.87 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.691 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.98 157.82 39.55 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.74 0.816 . . . . 0.0 110.309 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 71.3 mt -133.51 134.98 44.12 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.347 1.059 . . . . 0.0 108.43 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.77 111.84 14.11 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -166.01 153.76 10.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.71 1.604 . . . . 0.0 106.898 167.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.17 124.75 8.35 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 551' ' ' ASP . 39.6 t -159.56 153.04 22.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 168.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -50.67 70.48 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.606 0.639 . . . . 0.0 111.7 -172.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 52.1 m -87.75 -29.44 21.05 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 548' ' ' SER . 12.1 t70 -71.0 -34.28 71.2 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.268 0.486 . . . . 0.0 110.441 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -80.64 -34.32 35.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.33 -0.367 . . . . 0.0 110.555 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 38.0 tp -75.96 -29.94 58.46 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.757 0.708 . . . . 0.0 111.241 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -68.61 -43.48 76.31 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.8 m -72.79 -34.76 67.14 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.41 -42.27 98.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.755 -0.591 . . . . 0.0 109.601 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.78 -23.05 78.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.833 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -112.15 -7.48 14.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.504 1.152 . . . . 0.0 113.457 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 15.3 tp -112.52 -9.85 13.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.001 0.819 . . . . 0.0 111.927 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -78.05 140.74 39.13 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.232 -0.918 . . . . 0.0 108.823 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 50.72 26.95 2.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.695 0.798 . . . . 0.0 112.652 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.84 151.32 44.9 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -103.79 136.51 43.33 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.751 1.621 . . . . 0.0 111.085 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . 0.467 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.0 ttt -64.21 173.45 1.97 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.181 0.592 . . . . 0.0 111.307 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -74.02 11.5 0.89 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 42.8 p30 -65.85 143.53 98.53 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.41 0.55 . . . . 0.0 110.179 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.21 -30.53 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.36 2.707 . . . . 0.0 114.132 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -121.06 1.7 10.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.211 0.459 . . . . 0.0 112.043 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.33 40.61 98.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.775 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 84.7 Cg_endo -69.56 -9.5 26.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.984 2.456 . . . . 0.0 112.319 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.23 147.94 39.26 Favored Pre-proline 0 N--CA 1.455 -0.185 0 C-N-CA 122.74 0.416 . . . . 0.0 109.968 175.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.33 153.01 45.1 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.767 2.978 . . . . 0.0 111.127 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 87.9 t80 -148.28 0.81 0.61 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.729 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 66.7 p -66.42 125.83 26.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.398 -0.814 . . . . 0.0 110.261 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 24.5 mt -99.58 144.54 28.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.452 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -81.36 122.61 27.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -133.61 144.63 49.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -173.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 18.6 t -164.02 175.82 9.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.251 0.62 . . . . 0.0 110.18 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.46 144.53 33.95 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.014 0.525 . . . . 0.0 109.801 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 37.6 t -135.63 142.35 45.19 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.427 0.158 . . . . 0.0 111.427 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 26.7 p -79.89 102.27 9.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.14 161.58 34.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.192 0.597 . . . . 0.0 111.215 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -123.89 -1.42 8.36 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.344 0.657 . . . . 0.0 109.979 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -159.93 167.21 28.55 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.529 1.132 . . . . 0.0 109.864 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.04 76.47 0.99 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.759 0.424 . . . . 0.0 109.93 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.884 -179.773 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.476 0.179 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -88.43 -19.76 26.12 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.269 0.228 . . . . 0.0 111.131 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 154.46 -174.28 32.84 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.43 -13.11 20.65 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.57 2.847 . . . . 0.0 110.963 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -156.28 164.12 38.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.645 0.778 . . . . 0.0 109.891 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -83.38 170.36 14.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.743 0.417 . . . . 0.0 110.367 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.26 -1.15 4.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.849 0.46 . . . . 0.0 111.633 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.3 m -146.7 148.83 34.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 C-N-CA 122.596 0.359 . . . . 0.0 110.528 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -82.41 -5.49 11.81 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.253 3.302 . . . . 0.0 112.49 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 72.9 t -119.25 147.85 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 118.472 0.578 . . . . 0.0 111.229 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.46 166.06 25.74 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.012 0.925 . . . . 0.0 109.382 174.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 85.5 mtp -135.17 150.49 50.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.517 0.199 . . . . 0.0 111.245 -175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 30.9 t -140.21 145.18 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.323 0.649 . . . . 0.0 109.951 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -137.26 165.05 27.07 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.427 0.691 . . . . 0.0 109.564 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 83.31 0.15 89.97 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.355 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.75 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -73.88 177.97 5.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.989 0.895 . . . . 0.0 110.976 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.83 137.23 50.35 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.678 0.391 . . . . 0.0 110.266 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -74.93 -1.64 23.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 23.1 t -112.62 -13.56 13.28 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.354 0.525 . . . . 0.0 111.59 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -114.58 -9.92 12.58 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.736 0.415 . . . . 0.0 110.32 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 28.3 ttt -150.88 126.98 10.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.281 0.633 . . . . 0.0 109.898 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -141.94 -174.43 4.08 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.208 0.603 . . . . 0.0 109.449 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 22.3 p -57.97 -30.42 66.01 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -89.09 -21.67 23.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.735 -0.603 . . . . 0.0 111.496 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -94.71 -19.36 20.47 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.457 0.303 . . . . 0.0 110.697 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.4 p -80.92 -30.43 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -67.09 -31.33 71.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -66.92 -42.37 85.5 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.133 -0.354 . . . . 0.0 110.848 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 65.3 t -79.45 -26.09 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-O 119.278 -0.391 . . . . 0.0 112.002 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -101.97 -10.01 20.15 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 19.7 t -74.01 -33.57 63.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.961 0.801 . . . . 0.0 111.59 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.36 12.54 1.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.687 -0.633 . . . . 0.0 111.369 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.47 -2.15 9.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 110.656 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.96 173.3 18.06 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -80.35 155.49 27.17 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.389 0.595 . . . . 0.0 110.053 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.33 155.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 C-N-CA 123.304 0.642 . . . . 0.0 110.141 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -102.39 -58.36 1.89 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.717 0.407 . . . . 0.0 110.084 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.16 167.91 17.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.432 0.693 . . . . 0.0 110.466 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.25 148.57 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 122.995 0.518 . . . . 0.0 110.181 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -155.61 148.9 24.76 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 110.844 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -77.92 156.44 30.28 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 171.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.703 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -141.02 141.41 34.34 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -169.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 60.22 33.94 21.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.3 m 52.84 13.45 0.35 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.33 138.12 45.23 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-N 119.083 0.856 . . . . 0.0 109.837 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.17 -6.86 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.185 2.59 . . . . 0.0 110.181 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -114.41 18.19 18.13 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 124.26 0.933 . . . . 0.0 112.717 -176.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.703 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -150.42 142.73 24.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.747 1.274 . . . . 0.0 111.528 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.54 169.03 25.23 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.729 0.411 . . . . 0.0 111.468 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 8.4 ptp -136.26 149.43 48.48 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.594 . . . . 0.0 110.535 176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.77 148.21 33.23 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.072 0.549 . . . . 0.0 110.289 -174.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -127.23 131.37 50.61 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 87.4 mmm -100.4 162.83 12.69 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.449 0.3 . . . . 0.0 110.874 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.86 61.82 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -157.92 163.06 38.25 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.25 -16.21 70.87 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.102 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -68.46 -24.19 64.68 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.139 1.469 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -86.76 -22.27 26.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.254 0.222 . . . . 0.0 110.594 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 97.5 t -78.08 -33.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.44 -28.88 67.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.155 0.182 . . . . 0.0 110.525 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.412 ' HA ' ' NE ' ' A' ' 431' ' ' ARG . 0.0 OUTLIER -86.73 -29.38 22.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.104 -0.372 . . . . 0.0 111.194 -177.198 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -79.83 -26.94 40.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -84.55 -30.95 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 122.143 -0.348 . . . . 0.0 111.585 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.3 p -99.04 -11.18 21.72 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -132.33 -11.03 3.24 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.8 -21.28 9.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.401 1.0 . . . . 0.0 110.477 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -51.46 142.29 14.07 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.539 0.736 . . . . 0.0 112.226 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.491 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 77.0 m-20 58.41 1.69 0.18 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -87.89 142.52 27.74 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 121.14 1.791 . . . . 0.0 109.287 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.291 0.1 OUTLIER -130.86 164.05 26.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.3 ptm -125.39 143.43 50.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.548 1.139 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . 0.45 ' CE1' ' CD1' ' A' ' 558' ' ' PHE . 37.5 m-85 62.91 27.88 16.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 177.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.8 15.88 58.98 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.314 0.885 . . . . 0.0 115.314 168.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -83.09 141.78 31.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.833 1.317 . . . . 0.0 109.756 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -74.85 139.01 42.9 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.19 121.94 39.64 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -140.77 115.74 9.76 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 107.871 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.491 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 1.9 p -153.34 139.82 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 118.692 0.678 . . . . 0.0 110.594 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 23.8 t -158.24 161.63 37.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.438 0.695 . . . . 0.0 109.796 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.41 155.68 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 36.0 t -133.43 144.23 49.38 Favored 'General case' 0 CA--C 1.522 -0.115 0 O-C-N 122.102 -0.374 . . . . 0.0 111.318 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -87.92 65.1 8.16 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.283 0.633 . . . . 0.0 111.12 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -127.38 144.06 49.48 Favored Pre-proline 0 CA--C 1.529 0.144 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.74 -25.24 9.44 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.281 2.654 . . . . 0.0 111.76 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -163.48 172.42 14.49 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.79 0.436 . . . . 0.0 110.617 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.37 140.41 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -91.99 151.74 42.21 Favored Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 122.425 0.29 . . . . 0.0 110.925 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.96 158.98 55.79 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.93 3.087 . . . . 0.0 111.189 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 170.08 -172.4 43.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -77.83 164.87 24.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.645 0.378 . . . . 0.0 110.8 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 77.6 p -145.71 158.58 43.84 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.387 0.675 . . . . 0.0 110.114 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -154.16 165.66 35.54 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.742 0.417 . . . . 0.0 110.258 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -75.02 137.44 22.13 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 90.8 mt -86.96 176.14 7.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.628 0.771 . . . . 0.0 110.354 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.97 -20.12 66.09 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.474 0.309 . . . . 0.0 111.441 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -85.65 -0.07 54.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 0.98 89.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.256 0.455 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 24.4 t -93.55 160.76 14.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.195 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.76 153.21 35.21 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.921 0.391 . . . . 0.0 110.824 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 88.9 p -72.54 -10.46 59.82 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.745 0.418 . . . . 0.0 111.807 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -117.39 141.7 48.01 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.692 0.797 . . . . 0.0 110.112 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -154.68 154.41 32.87 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 122.776 0.43 . . . . 0.0 110.185 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -127.25 155.1 44.01 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.385 0.674 . . . . 0.0 110.118 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -138.05 1.76 2.28 Favored 'General case' 0 N--CA 1.457 -0.077 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 85.0 p -68.36 -10.79 57.4 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.04 11.94 4.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.945 0.898 . . . . 0.0 110.729 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 44.3 t -85.2 162.52 19.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.034 0.533 . . . . 0.0 110.991 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -119.43 9.33 11.56 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.524 0.73 . . . . 0.0 110.922 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -83.69 -0.52 51.11 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.997 0.519 . . . . 0.0 111.353 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -67.74 148.36 51.39 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -72.71 -8.54 55.89 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -143.16 35.2 1.35 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.33 0.652 . . . . 0.0 110.356 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 91.8 p -65.48 -12.58 53.93 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.928 0.891 . . . . 0.0 112.684 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 5.7 t -145.1 148.11 37.07 Favored Pre-proline 0 C--O 1.232 0.164 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -56.18 -22.76 41.68 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.823 3.015 . . . . 0.0 113.967 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.05 -24.8 35.09 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.595 0.634 . . . . 0.0 111.337 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -90.54 -22.28 21.38 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.936 0.335 . . . . 0.0 110.345 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -72.35 -10.61 60.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.899 0.48 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -95.61 3.35 54.1 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.268 0.627 . . . . 0.0 110.526 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -126.77 6.98 6.74 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.92 0.888 . . . . 0.0 110.56 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -147.24 147.87 30.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.463 0.705 . . . . 0.0 110.014 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.28 160.44 41.49 Favored 'General case' 0 C--O 1.23 0.067 0 C-N-CA 123.531 0.733 . . . . 0.0 109.777 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.7 mm -101.61 121.0 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -160.99 171.92 17.81 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.286 0.565 . . . . 0.0 111.524 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . 0.401 ' HB2' ' HD2' ' A' ' 496' ' ' PRO . 49.0 p-80 -80.74 162.39 60.44 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.156 0.982 . . . . 0.0 108.551 170.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 495' ' ' HIS . 47.4 Cg_endo -63.54 138.41 64.83 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.159 1.906 . . . . 0.0 110.55 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 69.2 m -124.08 23.97 8.32 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.04 5.83 4.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.182 0.993 . . . . 0.0 113.321 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 54.9 t -140.07 142.31 32.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 O-C-N 121.706 -0.621 . . . . 0.0 109.748 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.472 HD12 ' CH2' ' A' ' 546' ' ' TRP . 89.1 mt -130.86 163.48 27.33 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.187 0.995 . . . . 0.0 108.826 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.34 165.75 28.38 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 122.01 -0.431 . . . . 0.0 112.004 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.52 156.93 47.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.237 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -147.51 170.63 17.02 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.285 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.5 t30 61.01 26.57 16.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.274 1.03 . . . . 0.0 113.607 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -86.42 157.8 55.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.14 161.33 16.46 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 0.0 111.955 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.2 pt? -83.06 -1.16 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -105.52 5.69 31.68 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.603 0.361 . . . . 0.0 111.873 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.32 150.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 117.918 0.326 . . . . 0.0 111.602 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.7 p -143.44 172.21 13.09 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.581 0.752 . . . . 0.0 110.471 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 2.9 pm0 -61.49 -19.88 62.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.511 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.86 -25.75 60.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.017 0.371 . . . . 0.0 110.134 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -81.99 -28.54 32.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -72.9 -29.11 62.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.806 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -83.33 -37.52 23.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 111.503 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.23 -24.36 51.22 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 71.6 mt -89.98 -33.07 5.79 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 118.165 0.439 . . . . 0.0 110.187 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 67.7 m -67.25 -21.48 65.72 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.948 174.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.96 -33.61 73.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -90.99 -13.2 33.8 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.69 -9.97 47.51 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.666 0.386 . . . . 0.0 110.841 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.42 5.04 62.24 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.175 0.417 . . . . 0.0 112.724 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.6 m -87.65 160.44 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.964 0.882 . . . . 0.0 110.645 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -73.46 120.22 18.77 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -71.18 150.75 94.58 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.97 149.28 92.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.859 2.373 . . . . 0.0 110.563 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 94.1 m -84.78 -21.04 30.12 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.76 0.424 . . . . 0.0 110.839 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 15.3 t -146.04 153.45 40.75 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.34 140.71 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 122.995 0.518 . . . . 0.0 110.359 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.18 124.13 12.04 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.3 148.93 30.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 122.695 0.398 . . . . 0.0 111.082 -172.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -151.81 151.02 30.79 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.544 0.738 . . . . 0.0 110.418 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 76.1 p -130.76 138.19 49.83 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.115 0.566 . . . . 0.0 109.939 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -81.63 161.64 42.65 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -72.88 141.11 47.92 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.263 0.532 . . . . 0.0 109.994 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 21.8 m 54.32 18.03 1.73 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -88.19 -18.58 28.4 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.174 -0.329 . . . . 0.0 111.029 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 54.89 14.42 0.91 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.552 1.141 . . . . 0.0 113.528 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 70.4 m -145.49 167.98 21.69 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.539 0.736 . . . . 0.0 110.449 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 22.6 t -135.36 155.11 51.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.495 0.718 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.5 m -145.35 163.71 33.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.399 1.079 . . . . 0.0 109.542 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -178.6 177.54 48.46 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 119.993 -1.098 . . . . 0.0 114.359 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.6 mp -112.98 156.5 22.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.231 1.012 . . . . 0.0 109.59 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.9 mt -138.61 143.19 39.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.434 1.094 . . . . 0.0 109.078 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -127.8 109.43 11.62 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.472 ' CH2' HD12 ' A' ' 500' ' ' LEU . 2.2 p90 -166.04 153.4 10.07 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 168.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -154.46 118.79 4.78 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 37.8 t -159.6 153.53 23.19 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 168.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.62 -40.02 95.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.619 0.645 . . . . 0.0 110.613 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 66.8 p -85.28 -27.26 26.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -83.68 -29.59 27.47 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 118.728 0.695 . . . . 0.0 110.859 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.74 26.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.986 0.357 . . . . 0.0 111.402 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.4 tp -84.7 -27.8 26.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.336 0.516 . . . . 0.0 112.047 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -77.36 -39.1 48.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.293 0.497 . . . . 0.0 110.273 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 89.7 m -67.84 -38.78 83.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.5 tp -60.63 -42.91 97.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.523 -0.735 . . . . 0.0 110.176 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -75.5 -14.17 82.25 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.244 -173.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . 0.45 ' CD1' ' CE1' ' A' ' 442' ' ' PHE . 23.5 m-85 -126.39 -12.28 6.21 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.763 1.282 . . . . 0.0 113.379 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 18.4 tp -105.79 -14.93 15.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.19 0.904 . . . . 0.0 112.567 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.44 136.4 40.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.278 -0.889 . . . . 0.0 110.124 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 42.2 m170 50.21 34.94 9.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.831 0.852 . . . . 0.0 113.003 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.71 151.29 28.97 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.246 0.618 . . . . 0.0 112.37 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -101.24 136.41 41.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.999 1.719 . . . . 0.0 110.999 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . 0.408 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 5.3 ttt -64.07 179.93 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.846 0.858 . . . . 0.0 111.367 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 564' ' ' MET . 19.7 ptpt -64.27 6.72 0.17 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.59 143.17 93.85 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.115 0.416 . . . . 0.0 110.924 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.55 -30.44 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.389 2.726 . . . . 0.0 112.917 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -121.05 -7.18 9.45 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.414 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.7 44.06 96.91 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.007 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 86.7 Cg_endo -72.01 -6.24 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.325 2.683 . . . . 0.0 112.042 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -138.88 150.33 65.0 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.928 0.491 . . . . 0.0 109.917 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.88 144.09 30.29 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.161 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . 0.408 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 89.8 t80 -145.09 -3.63 0.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.306 0.643 . . . . 0.0 111.27 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 67.5 p -66.5 132.02 47.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.872 -0.518 . . . . 0.0 110.764 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 3.8 pp -125.04 144.59 50.32 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.526 0.73 . . . . 0.0 111.125 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.04 140.46 33.89 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.263 0.625 . . . . 0.0 109.977 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.55 144.99 46.76 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 1.9 p -163.93 173.02 13.15 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.568 0.347 . . . . 0.0 110.982 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -84.12 148.69 26.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.919 0.39 . . . . 0.0 110.711 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 28.0 t -135.53 159.93 40.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.502 0.721 . . . . 0.0 109.8 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 44.5 m -117.32 101.96 8.86 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.56 34.61 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.164 0.986 . . . . 0.0 109.928 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -78.85 -31.03 45.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -153.57 162.35 41.34 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.772 1.229 . . . . 0.0 109.054 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -80.62 76.49 7.49 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.185 179.153 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 120.512 0.196 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -144.16 142.43 30.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.898 0.479 . . . . 0.0 110.072 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . 0.416 ' N ' ' CD ' ' A' ' 374' ' ' PRO . . . 65.24 42.26 96.38 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.979 -0.901 . . . . 0.0 113.191 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 373' ' ' GLY . 94.6 Cg_endo -75.19 -24.54 12.44 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.139 1.893 . . . . 0.0 111.516 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -161.64 156.65 23.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.691 0.397 . . . . 0.0 110.225 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -80.21 166.31 21.54 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.031 0.444 . . . . 0.0 110.904 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.82 -13.35 39.54 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.425 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 m -148.7 155.31 41.45 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 122.846 0.458 . . . . 0.0 110.691 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.91 -0.84 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.659 3.573 . . . . 0.0 113.242 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.17 158.85 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.551 0.614 . . . . 0.0 110.969 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.3 pp -145.32 170.28 16.62 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.157 0.583 . . . . 0.0 110.606 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 77.5 mtp -135.15 153.36 52.01 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.761 0.424 . . . . 0.0 111.099 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 14.5 p -142.7 149.62 18.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.211 0.604 . . . . 0.0 110.25 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -141.89 167.57 21.83 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.037 0.535 . . . . 0.0 110.152 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.57 76.87 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.15 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 386' ' ' LEU . 1.9 pt? -67.85 165.33 17.77 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.798 0.799 . . . . 0.0 111.002 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -119.72 128.4 53.75 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.66 1.68 5.01 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 84.0 p -116.62 0.59 12.68 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -132.55 -6.42 3.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.169 0.588 . . . . 0.0 110.591 174.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 9.3 tpt -150.11 122.95 8.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.701 0.8 . . . . 0.0 109.4 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -141.94 -174.78 4.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.086 0.555 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.6 p -60.73 -23.99 65.36 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.887 0.475 . . . . 0.0 112.023 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.0 -30.73 21.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.917 0.326 . . . . 0.0 111.63 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -82.07 -30.76 31.15 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.571 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.98 -28.48 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -70.02 -33.87 72.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.963 -0.461 . . . . 0.0 110.052 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.23 -16.38 52.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.3 -18.88 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.716 0.407 . . . . 0.0 110.942 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -116.95 -18.96 10.01 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.26 -20.89 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.658 1.117 . . . . 0.0 111.057 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.955 -0.466 . . . . 0.0 111.887 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -121.46 -1.42 9.62 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.827 0.851 . . . . 0.0 111.268 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 149.56 169.6 16.13 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -65.67 142.67 57.95 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.468 -0.431 . . . . 0.0 111.493 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.08 154.66 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 123.652 0.781 . . . . 0.0 109.306 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -99.83 -65.92 0.94 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -165.13 168.52 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.677 0.791 . . . . 0.0 110.313 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 9.3 p -147.18 151.75 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -152.47 144.71 23.93 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 122.647 0.379 . . . . 0.0 110.374 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.64 160.32 25.09 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 3.3 ptp -136.4 141.42 43.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt 56.76 33.82 23.62 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.8 1.64 . . . . 0.0 114.217 168.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.0 m 52.77 17.81 0.91 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -71.11 158.13 88.79 Favored Pre-proline 0 CA--C 1.528 0.118 0 CA-C-N 118.367 0.53 . . . . 0.0 110.405 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.11 -19.25 32.54 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.331 2.687 . . . . 0.0 111.966 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -177.53 102.2 0.16 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -157.8 136.71 11.5 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 109.088 174.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.83 171.28 20.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.231 0.539 . . . . 0.0 110.897 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 18.6 ptm -143.63 144.34 31.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.602 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 29.8 t -130.69 139.3 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 C-N-CA 122.857 0.463 . . . . 0.0 110.395 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -118.06 141.19 48.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.121 0.568 . . . . 0.0 110.062 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 92.3 mmm -111.01 161.85 15.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.139 0.576 . . . . 0.0 110.121 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.33 -22.94 63.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.13 -0.356 . . . . 0.0 111.138 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -159.46 160.34 34.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.518 0.727 . . . . 0.0 109.398 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.74 69.02 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.157 -0.801 . . . . 0.0 113.841 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -68.23 -28.72 67.48 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.432 1.616 . . . . 0.0 110.671 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.46 -25.91 30.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.564 0.221 . . . . 0.0 110.51 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 87.4 t -70.6 -28.15 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.17 -42.8 71.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.291 -0.256 . . . . 0.0 110.849 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -36.62 84.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.102 0.41 . . . . 0.0 110.013 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -76.4 -34.55 58.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 6.6 tp -79.85 -30.92 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 O-C-N 122.184 -0.323 . . . . 0.0 111.525 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.7 t -94.94 -12.24 27.14 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -138.89 -24.4 0.91 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -95.67 -20.15 19.15 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.064 0.847 . . . . 0.0 108.997 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -51.82 142.66 14.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.502 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.08 1.59 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.617 1.967 . . . . 0.0 115.565 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -87.92 142.62 27.66 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.274 1.397 . . . . 0.0 108.847 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . 0.45 ' HB2' ' HG3' ' A' ' 446' ' ' MET 0.328 0.0 OUTLIER -131.0 164.14 26.02 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 175.339 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 21.7 ptm -125.16 143.28 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.476 1.11 . . . . 0.0 109.263 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 64.42 30.12 13.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.89 81.26 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 167.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -83.14 156.9 23.01 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.499 1.649 . . . . 0.0 111.359 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.606 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -77.76 141.97 38.96 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.902 0.881 . . . . 0.0 110.627 178.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . 0.45 ' HG3' ' HB2' ' A' ' 440' ' ' PHE . 1.9 mpt? -98.5 122.01 41.16 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -140.69 110.75 6.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 168.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.53 139.43 17.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 92.7 m -149.66 160.43 43.52 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.596 0.759 . . . . 0.0 110.23 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -85.09 154.23 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.0 t -144.68 163.26 34.5 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.457 0.703 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -121.17 30.18 6.95 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.511 0.596 . . . . 0.0 112.25 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -63.64 147.91 94.97 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.56 -25.24 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.701 2.267 . . . . 0.0 111.88 -175.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.98 170.22 13.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.453 0.701 . . . . 0.0 109.913 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.01 137.12 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -82.27 147.72 57.66 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 110.729 -0.101 . . . . 0.0 110.729 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.84 168.41 23.04 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.098 3.199 . . . . 0.0 111.973 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 177.56 170.99 40.56 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -84.82 -12.72 53.01 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.944 0.372 . . . . 0.0 111.701 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 7.4 m 57.72 169.32 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.145 1.378 . . . . 0.0 113.296 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -155.74 168.31 27.59 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.138 0.575 . . . . 0.0 109.9 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -82.54 137.79 17.36 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.92 170.24 11.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.576 0.75 . . . . 0.0 110.313 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.23 -22.79 65.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.545 0.338 . . . . 0.0 111.238 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.28 4.69 25.98 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.529 0.332 . . . . 0.0 111.467 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.57 -0.49 87.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.504 -0.609 . . . . 0.0 113.151 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 72.9 p -92.71 164.69 13.29 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 117.977 0.889 . . . . 0.0 110.556 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 84.5 m -79.16 152.4 30.74 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 122.245 -0.285 . . . . 0.0 110.382 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 90.1 p -73.39 -10.37 59.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.532 0.333 . . . . 0.0 111.774 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -127.67 145.21 50.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.797 0.839 . . . . 0.0 110.437 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.09 158.11 38.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.964 0.506 . . . . 0.0 110.058 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.64 148.26 51.52 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.466 0.706 . . . . 0.0 109.974 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.56 13.69 2.97 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 122.996 0.518 . . . . 0.0 111.128 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 99.3 p -65.48 -14.46 61.03 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -90.08 -1.71 57.99 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.105 0.562 . . . . 0.0 111.248 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 57.0 m -85.36 13.7 6.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.621 0.368 . . . . 0.0 111.506 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -74.26 5.26 4.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.315 0.646 . . . . 0.0 111.363 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -80.38 34.13 0.31 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.84 0.856 . . . . 0.0 110.686 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -139.12 159.73 41.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.225 1.01 . . . . 0.0 109.35 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 53.5 ttp85 -80.18 38.23 0.41 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.021 0.928 . . . . 0.0 112.371 -173.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.1 17.29 1.92 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.164 0.586 . . . . 0.0 111.748 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.7 p -73.88 -2.82 25.41 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.961 0.505 . . . . 0.0 111.837 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 4.9 t -148.09 145.25 20.28 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.119 0.968 . . . . 0.0 108.786 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.44 -17.44 57.85 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.315 2.677 . . . . 0.0 113.478 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.8 -25.21 32.94 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 119.073 0.851 . . . . 0.0 111.429 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -90.51 -29.75 17.7 Favored 'General case' 0 C--N 1.338 0.092 0 O-C-N 122.24 -0.288 . . . . 0.0 110.453 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -70.44 -21.23 62.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.433 0.293 . . . . 0.0 111.392 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -75.63 -4.15 38.49 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.973 0.509 . . . . 0.0 111.077 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -127.06 19.07 7.08 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.517 1.127 . . . . 0.0 110.187 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -116.58 23.96 11.65 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.804 0.842 . . . . 0.0 110.83 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 56.24 27.45 11.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.193 0.997 . . . . 0.0 113.397 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.6 mm -80.97 118.33 28.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -161.26 167.74 25.4 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.397 0.679 . . . . 0.0 109.266 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -60.98 159.62 26.23 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.72 145.13 31.87 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.703 2.935 . . . . 0.0 112.606 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.1 m -124.01 23.9 8.4 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.711 0.804 . . . . 0.0 110.89 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 61.21 14.74 5.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.676 1.191 . . . . 0.0 112.883 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 47.3 t -139.07 141.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.418 HD12 ' CH2' ' A' ' 546' ' ' TRP . 58.6 mt -119.42 148.48 43.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.968 0.507 . . . . 0.0 109.923 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -114.87 151.54 33.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 151.21 46.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.534 0.207 . . . . 0.0 110.677 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -147.89 173.63 12.66 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.635 0.374 . . . . 0.0 111.217 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.2 t30 56.39 34.03 23.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.216 1.006 . . . . 0.0 112.825 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -91.67 157.32 41.98 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.82 148.89 63.76 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.81 2.34 . . . . 0.0 111.588 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.1 pt? -73.7 -1.28 18.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.82 8.27 15.99 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.15 151.16 4.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 118.007 0.367 . . . . 0.0 110.814 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.4 p -142.32 171.87 13.47 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.348 0.659 . . . . 0.0 110.529 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 -22.17 66.73 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -71.2 -25.03 62.34 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -83.65 -30.13 27.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.17 -27.1 63.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.03 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -85.7 -38.12 18.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.488 0.586 . . . . 0.0 111.522 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -74.95 -20.08 59.83 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.467 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.23 -33.88 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 117.792 0.269 . . . . 0.0 110.723 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 69.1 m -67.71 -21.68 65.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.974 176.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.49 -30.44 63.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.07 -13.13 33.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 118.452 0.569 . . . . 0.0 111.916 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 99.8 mt -91.57 -9.84 42.77 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.791 0.436 . . . . 0.0 111.057 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.68 5.15 63.36 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.752 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 30.0 m -87.08 168.4 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.777 0.789 . . . . 0.0 110.836 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -77.28 146.59 36.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.763 0.425 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -96.13 151.64 38.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 122.573 0.349 . . . . 0.0 110.099 177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.25 156.0 68.12 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.186 2.591 . . . . 0.0 111.122 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 93.3 m -89.54 -23.32 22.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.916 0.486 . . . . 0.0 110.696 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.1 t -143.84 156.87 44.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.01 144.93 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.221 0.534 . . . . 0.0 110.954 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -141.2 128.81 21.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.6 144.07 35.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 122.597 0.359 . . . . 0.0 110.132 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -154.88 153.66 31.47 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.172 0.589 . . . . 0.0 110.034 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.8 m -130.82 133.77 46.24 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.22 150.08 34.9 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -74.34 139.02 43.87 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 14.4 m 57.86 11.23 1.32 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -100.05 -10.15 21.87 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.229 0.468 . . . . 0.0 111.367 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 43.15 34.05 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.84 1.256 . . . . 0.0 113.368 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.1 t -143.08 158.93 43.16 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.192 0.597 . . . . 0.0 110.642 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 47.1 t -122.16 150.73 41.82 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.78 0.832 . . . . 0.0 111.109 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.7 m -147.07 168.47 21.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.085 1.354 . . . . 0.0 109.185 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 173.51 -169.2 42.28 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.891 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 5.7 mp -130.02 154.05 47.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.385 1.074 . . . . 0.0 109.686 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.39 140.47 39.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.007 0.923 . . . . 0.0 108.723 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -127.8 109.75 11.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.423 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.9 p90 -166.13 152.83 9.44 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.019 1.328 . . . . 0.0 107.77 168.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.31 123.73 7.13 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 39.6 t -159.62 152.97 22.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -47.48 80.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.474 0.579 . . . . 0.0 111.348 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.5 p -85.82 -26.2 25.86 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 54.3 m-20 -82.73 -29.13 29.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.231 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -82.34 -30.78 30.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.103 0.411 . . . . 0.0 110.931 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 27.6 tp -80.85 -28.05 36.24 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.406 0.548 . . . . 0.0 111.599 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -76.65 -41.05 47.13 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.133 0.424 . . . . 0.0 110.558 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 39.5 m -68.73 -34.97 76.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.93 -52.17 65.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.855 -0.528 . . . . 0.0 110.12 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.66 -17.1 76.31 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.005 -0.886 . . . . 0.0 114.258 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -119.22 -9.2 10.0 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.742 1.271 . . . . 0.0 113.67 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.7 tp -89.61 -21.7 22.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.439 1.018 . . . . 0.0 110.328 175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -69.57 147.66 50.45 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.138 -0.351 . . . . 0.0 110.479 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 51.24 24.79 2.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.448 1.099 . . . . 0.0 113.607 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.31 151.38 38.3 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.247 0.546 . . . . 0.0 112.222 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -111.38 136.24 50.79 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.949 0.9 . . . . 0.0 110.855 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.0 ttt -64.7 178.32 0.79 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.852 0.861 . . . . 0.0 111.006 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -68.18 7.95 0.5 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.28 140.0 91.58 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.31 -28.95 2.12 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.472 2.782 . . . . 0.0 112.86 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -121.04 -7.14 9.46 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 62.41 44.23 97.92 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.926 -0.93 . . . . 0.0 113.421 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 94.0 Cg_endo -71.27 -7.01 20.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.128 2.552 . . . . 0.0 111.993 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -143.82 149.27 45.81 Favored Pre-proline 0 C--O 1.232 0.17 0 C-N-CA 123.125 0.57 . . . . 0.0 109.867 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.53 154.23 39.91 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.601 2.867 . . . . 0.0 110.796 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -136.54 -0.83 2.35 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.64 0.376 . . . . 0.0 111.604 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 8.3 t -68.31 132.03 46.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.931 -0.481 . . . . 0.0 111.222 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.94 144.62 50.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.327 1.051 . . . . 0.0 109.701 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -85.11 145.16 27.78 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 577' ' ' LEU . 2.0 pt? -147.12 146.79 30.05 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.098 0.559 . . . . 0.0 110.683 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.29 169.71 21.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.896 0.478 . . . . 0.0 110.898 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -72.65 133.51 44.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 25.7 t -135.66 148.43 48.95 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 60.7 m -89.82 102.34 15.04 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.978 0.418 . . . . 0.0 110.587 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.07 161.53 34.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.817 0.847 . . . . 0.0 109.456 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -99.38 -15.36 18.8 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.175 0.19 . . . . 0.0 110.919 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -160.22 160.59 32.9 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.553 0.741 . . . . 0.0 110.193 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -110.01 76.41 0.99 Allowed 'General case' 0 C--O 1.233 0.197 0 C-N-CA 122.88 0.472 . . . . 0.0 110.087 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 48.0 m . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.54 -1.219 . . . . 0.0 110.489 -179.423 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 119.677 -0.201 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -133.96 -2.81 2.88 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -82.12 177.07 53.83 Favored Glycine 0 CA--C 1.527 0.804 0 O-C-N 122.285 -0.259 . . . . 0.0 112.631 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.68 -175.77 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.732 3.621 . . . . 0.0 111.256 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 64.6 t60 57.53 58.21 3.91 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.407 1.083 . . . . 0.0 110.939 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -59.52 156.51 13.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.018 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -132.07 19.98 4.5 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.927 0.491 . . . . 0.0 111.145 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 47.0 t -148.81 145.91 20.78 Favored Pre-proline 0 N--CA 1.453 -0.283 0 O-C-N 122.219 -0.301 . . . . 0.0 111.018 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.0 -0.96 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.778 2.985 . . . . 0.0 112.66 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.2 m -124.83 163.06 25.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 119.18 0.9 . . . . 0.0 112.786 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.5 pp -149.4 161.92 41.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.293 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 75.1 mmm -118.93 144.45 46.43 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.667 0.787 . . . . 0.0 110.099 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.54 144.81 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.048 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -139.32 166.94 23.23 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.383 0.673 . . . . 0.0 109.23 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.82 86.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.318 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.737 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -75.6 173.86 10.48 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.924 0.862 . . . . 0.0 110.501 176.008 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.39 146.56 51.24 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.019 0.528 . . . . 0.0 110.271 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -81.98 -4.83 57.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.9 t -104.68 -9.2 18.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.883 0.31 . . . . 0.0 111.447 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.31 -5.55 3.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.219 0.608 . . . . 0.0 111.109 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.9 tpt -142.13 126.69 17.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -141.68 -174.97 4.21 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.019 0.528 . . . . 0.0 109.992 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 76.5 m -59.61 -26.81 65.76 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.941 0.496 . . . . 0.0 112.036 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -81.14 -38.39 27.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.99 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -74.79 -28.96 60.94 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.106 0.412 . . . . 0.0 110.954 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.93 -28.66 24.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . 0.407 ' CD1' HG21 ' A' ' 406' ' ' VAL . 4.3 t80 -72.1 -30.29 64.93 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 172.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -76.25 -24.82 54.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 89.6 t -96.58 -26.43 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.399 0.545 . . . . 0.0 112.184 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.27 -14.2 17.07 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 35.3 t -78.57 -17.6 55.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.09 0.859 . . . . 0.0 112.473 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 10.72 1.22 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.272 -0.892 . . . . 0.0 112.171 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -121.38 -1.59 9.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.765 0.826 . . . . 0.0 110.819 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.44 165.5 12.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.44 164.47 22.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.009 0.433 . . . . 0.0 111.161 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . 0.407 HG21 ' CD1' ' A' ' 397' ' ' PHE . 5.4 m -121.11 161.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 C-N-CA 124.237 1.015 . . . . 0.0 109.789 -177.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.58 -52.22 2.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.324 -0.235 . . . . 0.0 111.289 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.16 164.34 27.93 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.493 0.317 . . . . 0.0 110.795 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.59 151.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.398 0.679 . . . . 0.0 110.262 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -152.03 148.55 27.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 419' ' ' ALA . 3.9 m-30 -78.65 145.79 34.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 170.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 25.1 ttp -99.4 141.04 32.7 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -168.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 49.8 33.95 7.0 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 112.031 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 83.7 p 52.88 16.02 0.64 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.362 1.465 . . . . 0.0 113.409 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -77.84 132.75 67.19 Favored Pre-proline 0 C--N 1.34 0.192 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.43 -7.43 17.69 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.659 2.239 . . . . 0.0 111.494 170.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.96 16.54 10.15 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.772 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -144.33 145.33 31.92 Favored 'General case' 0 N--CA 1.458 -0.059 0 CA-C-N 119.212 1.506 . . . . 0.0 111.056 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 411' ' ' PHE . . . -154.52 163.93 39.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.243 0.544 . . . . 0.0 111.7 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 23.0 ptm -145.23 143.57 30.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.723 0.809 . . . . 0.0 109.757 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.2 p -136.71 153.29 30.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.72 0.408 . . . . 0.0 110.446 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -125.08 138.48 54.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.947 0.499 . . . . 0.0 110.663 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 77.0 mmm -104.42 161.63 13.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.455 0.702 . . . . 0.0 110.145 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.19 -18.67 62.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -157.67 158.85 36.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.974 0.51 . . . . 0.0 109.782 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.6 -14.95 72.86 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.353 -0.693 . . . . 0.0 113.201 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -70.69 -19.82 62.74 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.03 1.415 . . . . 0.0 111.095 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -83.44 -24.43 31.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.72 -26.98 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.02 -36.78 82.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.262 -0.274 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -80.13 -31.77 39.05 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.296 -0.253 . . . . 0.0 110.535 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -70.7 -33.03 70.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.999 -0.438 . . . . 0.0 110.116 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 433' ' ' ILE . 5.6 tp -85.49 -30.93 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -177.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.2 m -95.04 -19.99 19.7 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -130.63 -12.04 3.88 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.7 -17.9 10.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.114 0.87 . . . . 0.0 110.031 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.17 142.2 21.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.509 0.724 . . . . 0.0 111.439 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.427 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 76.1 m-20 57.15 1.63 0.1 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.952 1.701 . . . . 0.0 115.214 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.92 142.42 27.81 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 120.579 1.536 . . . . 0.0 108.899 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.265 0.1 OUTLIER -130.68 163.91 26.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 174.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 24.7 ptm -125.39 143.52 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.651 1.58 . . . . 0.0 109.314 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 64.12 30.91 13.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.002 1.321 . . . . 0.0 114.454 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.81 15.93 79.9 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.17 145.02 29.42 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.357 1.079 . . . . 0.0 109.789 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 141.62 37.97 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.051 -0.405 . . . . 0.0 109.934 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -97.86 122.0 40.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -168.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -140.68 114.37 8.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 168.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.427 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.99 141.69 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 CA-C-N 118.29 0.496 . . . . 0.0 110.493 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 34.1 t -160.04 162.71 34.26 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.379 0.671 . . . . 0.0 109.617 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.18 158.68 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 110.265 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 45.6 t -138.01 151.41 47.87 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -89.43 4.95 47.42 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -59.6 139.11 89.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -23.43 11.55 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.921 2.414 . . . . 0.0 112.249 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -165.05 170.62 14.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 110.806 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.57 147.41 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.2 mmt -104.62 150.19 38.29 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.432 0.293 . . . . 0.0 110.56 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.29 177.82 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 124.161 3.24 . . . . 0.0 111.927 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 73.78 -176.72 45.57 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.475 0.559 . . . . 0.0 112.354 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 56.77 19.95 4.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.244 1.018 . . . . 0.0 113.62 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 23.9 m -97.12 142.67 28.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.247 0.476 . . . . 0.0 111.116 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -148.19 174.26 12.15 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.742 1.217 . . . . 0.0 109.217 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.4 135.96 15.32 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.74 171.39 10.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.729 0.812 . . . . 0.0 110.44 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -68.6 -20.46 64.5 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.645 0.378 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -80.59 1.3 30.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.108 0.563 . . . . 0.0 111.604 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 79.84 -2.76 72.86 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 122.054 -0.404 . . . . 0.0 112.231 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 28.0 t -93.36 163.4 13.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.182 0.593 . . . . 0.0 109.453 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 48.6 t -84.3 153.19 23.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.043 0.449 . . . . 0.0 110.645 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 59.5 m -64.79 -10.42 27.75 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.001 0.92 . . . . 0.0 111.343 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -119.2 142.14 48.27 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.801 0.84 . . . . 0.0 110.137 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.16 156.22 38.19 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.675 0.274 . . . . 0.0 110.703 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -124.73 151.03 45.57 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.24 1.016 . . . . 0.0 109.941 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -138.02 10.88 2.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.389 0.676 . . . . 0.0 111.755 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 16.8 t -70.2 -1.37 10.01 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.056 -0.403 . . . . 0.0 111.732 -173.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -121.91 15.7 10.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.902 0.881 . . . . 0.0 110.815 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 89.6 p -68.51 155.61 39.59 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.991 0.516 . . . . 0.0 111.705 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.06 34.49 5.15 Favored 'General case' 0 C--N 1.335 -0.03 0 C-N-CA 124.289 1.036 . . . . 0.0 110.827 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -65.26 -8.53 18.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.976 0.511 . . . . 0.0 112.229 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 59.01 176.25 0.07 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.115 1.366 . . . . 0.0 113.567 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? 60.69 -20.16 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.676 1.99 . . . . 0.0 114.617 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -160.11 8.9 0.1 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.573 0.624 . . . . 0.0 112.047 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 70.8 p -74.88 -0.06 17.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.536 0.607 . . . . 0.0 111.885 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 485' ' ' PRO . 5.4 t -149.83 146.85 21.18 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 484' ' ' THR . 65.9 Cg_exo -57.25 -20.02 37.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.555 2.837 . . . . 0.0 114.368 -175.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.47 -22.26 28.33 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.574 0.625 . . . . 0.0 111.431 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -90.57 -28.42 18.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 117.966 0.348 . . . . 0.0 110.312 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.34 -6.11 27.6 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.924 0.489 . . . . 0.0 111.936 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -104.18 -3.67 24.08 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.94 0.496 . . . . 0.0 111.115 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -98.1 -0.41 44.48 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.28 0.632 . . . . 0.0 111.198 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -142.52 169.05 18.31 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -131.65 157.46 43.65 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 31.3 mm -110.68 141.09 27.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -149.9 171.42 16.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.076 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -69.07 148.25 97.74 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.875 0.87 . . . . 0.0 109.32 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.09 152.44 14.47 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.702 2.935 . . . . 0.0 113.211 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 50.2 m -123.95 22.01 8.91 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.057 0.543 . . . . 0.0 112.04 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 19.1 m120 59.72 12.55 2.99 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.77 152.35 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.0 mt -125.42 155.49 40.33 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.942 0.497 . . . . 0.0 111.053 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.433 ' CD2' ' CZ ' ' A' ' 503' ' ' PHE . 2.2 t-160 -132.26 137.71 47.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -124.92 149.94 47.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.033 0.533 . . . . 0.0 110.858 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 501' ' ' HIS . 79.3 m-85 -144.3 172.79 12.44 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 111.251 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 49.4 t30 57.57 31.78 20.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.407 1.083 . . . . 0.0 112.993 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -85.14 157.44 59.5 Favored Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.84 158.89 55.25 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.608 2.205 . . . . 0.0 110.446 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 22.1 tp -70.89 -0.97 10.31 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.013 1.325 . . . . 0.0 112.856 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -125.47 9.53 7.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.99 151.82 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 118.334 0.516 . . . . 0.0 111.259 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 62.7 p -142.6 171.43 14.06 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.651 0.78 . . . . 0.0 110.071 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.1 -24.29 67.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.519 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.91 -24.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 122.355 -0.215 . . . . 0.0 110.67 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -76.77 -35.05 57.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -71.13 -23.79 62.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.909 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -79.42 -40.7 29.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.172 0.442 . . . . 0.0 111.009 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -78.92 -13.04 60.02 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 85.4 mt -95.5 -32.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.262 0.483 . . . . 0.0 110.403 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 94.8 m -68.42 -22.8 64.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.408 -0.807 . . . . 0.0 109.568 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.02 -28.78 61.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.645 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -90.98 -12.83 34.73 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.637 0.653 . . . . 0.0 111.636 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.85 -8.96 27.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.966 0.506 . . . . 0.0 111.257 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 73.0 5.19 64.58 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.248 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.1 168.6 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.156 0.978 . . . . 0.0 111.212 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -68.34 133.93 49.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.029 0.532 . . . . 0.0 110.119 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -78.22 149.34 75.91 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 148.86 90.21 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.811 2.341 . . . . 0.0 110.138 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.417 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 87.9 m -93.83 -18.97 21.45 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 122.848 0.459 . . . . 0.0 110.847 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.3 t -149.47 148.79 29.84 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.01 137.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.211 0.604 . . . . 0.0 109.609 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -148.28 104.58 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 89.9 t -126.88 148.01 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.265 0.626 . . . . 0.0 109.925 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -147.64 161.92 40.19 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.3 p -90.04 149.11 22.66 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.105 0.479 . . . . 0.0 111.937 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -86.54 147.79 21.57 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.75 131.04 37.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.182 0.491 . . . . 0.0 110.109 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.4 m 55.65 18.53 2.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -111.07 -11.36 14.29 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.114 0.416 . . . . 0.0 111.692 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 50.29 31.02 4.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.508 0.723 . . . . 0.0 112.692 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 89.6 p -140.24 171.54 14.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.5 0.72 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 60.1 m -128.04 150.87 49.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.56 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 58.4 m -147.83 159.9 43.34 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 125.005 1.322 . . . . 0.0 109.353 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 171.29 -174.97 44.99 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.278 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.4 146.39 28.9 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.33 1.052 . . . . 0.0 110.236 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 5.8 mp -137.66 138.04 39.03 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -127.74 126.34 41.63 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.417 ' HB3' ' H ' ' A' ' 527' ' ' THR . 8.9 p90 -165.56 148.69 7.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.88 120.4 7.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 42.3 t -159.57 153.34 22.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 168.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -64.79 -52.21 58.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.916 0.78 . . . . 0.0 111.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.9 p -78.7 -27.2 44.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -84.97 -31.11 23.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.786 0.721 . . . . 0.0 111.463 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.41 -30.88 60.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.208 0.458 . . . . 0.0 110.641 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 30.6 tp -83.48 -27.15 29.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.37 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -77.37 -39.01 48.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.087 0.403 . . . . 0.0 110.523 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 30.2 m -73.76 -38.66 64.65 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.059 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 556' ' ' LEU . 3.0 tm? -65.98 -47.3 75.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.15 -17.29 75.67 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.542 -173.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.47 -11.67 8.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.916 1.358 . . . . 0.0 113.173 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -95.84 -18.05 20.67 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.382 0.537 . . . . 0.0 110.65 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -65.55 144.89 56.7 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.747 -0.596 . . . . 0.0 109.452 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 60.5 t60 55.61 24.72 7.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.569 1.147 . . . . 0.0 113.252 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.48 151.33 34.69 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -117.76 136.35 53.44 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.845 1.258 . . . . 0.0 110.701 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 3.7 ttt -64.2 176.4 1.04 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.855 0.862 . . . . 0.0 111.323 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -72.36 7.68 1.68 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -65.86 141.26 97.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.092 0.86 . . . . 0.0 110.288 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -79.91 -29.42 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.659 2.906 . . . . 0.0 113.796 -169.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -121.05 2.79 10.46 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.06 0.391 . . . . 0.0 112.029 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.432 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 59.45 42.57 97.62 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.768 -1.018 . . . . 0.0 112.792 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 71.7 Cg_endo -68.67 -9.96 27.67 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.244 2.63 . . . . 0.0 111.608 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -144.12 147.06 36.16 Favored Pre-proline 0 N--CA 1.454 -0.26 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.91 150.61 38.89 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.689 2.926 . . . . 0.0 110.546 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -143.44 -4.15 0.89 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.679 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 72.5 p -66.56 126.46 28.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 35.8 mt -99.47 144.55 28.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.873 0.469 . . . . 0.0 111.905 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -82.01 130.59 35.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 170.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -146.45 147.26 31.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 112.016 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.1 p -161.37 169.72 21.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.952 0.901 . . . . 0.0 109.319 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -74.95 140.57 43.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.6 t -135.39 143.6 46.12 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 35.3 m -81.37 102.18 10.3 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.1 161.5 34.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.975 0.91 . . . . 0.0 110.325 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -109.64 -12.13 14.69 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.925 0.49 . . . . 0.0 110.669 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -160.54 168.55 24.79 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.998 0.919 . . . . 0.0 109.132 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -78.74 77.29 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.891 0.476 . . . . 0.0 109.797 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.417 ' HA ' ' HE3' ' A' ' 530' ' ' LYS . 74.7 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.476 -1.25 . . . . 0.0 110.002 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -135.81 6.54 3.18 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.54 0.336 . . . . 0.0 111.806 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 178.2 176.46 46.16 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.07 172.73 13.32 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.313 3.342 . . . . 0.0 111.303 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -152.78 164.57 37.55 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.867 0.867 . . . . 0.0 109.3 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -132.45 148.65 52.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.136 0.493 . . . . 0.0 111.281 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -141.17 18.5 2.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.096 0.958 . . . . 0.0 109.814 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.1 m -142.7 153.87 62.07 Favored Pre-proline 0 N--CA 1.454 -0.242 0 C-N-CA 122.848 0.459 . . . . 0.0 110.609 -174.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.38 3.09 7.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.117 3.212 . . . . 0.0 113.225 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.64 161.83 39.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 118.893 0.769 . . . . 0.0 112.866 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . 0.403 ' C ' HD12 ' A' ' 381' ' ' LEU . 3.1 pp -144.81 170.46 16.07 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.23 1.012 . . . . 0.0 109.227 172.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.1 mtp -137.16 148.04 46.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.9 149.21 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.861 0.464 . . . . 0.0 110.661 -175.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -140.01 164.99 28.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.651 0.78 . . . . 0.0 109.823 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.41 -6.79 75.23 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.304 0.478 . . . . 0.0 112.828 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.5 pt? -69.42 174.62 4.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.916 0.858 . . . . 0.0 110.648 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -134.61 146.74 49.86 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -74.66 -1.91 23.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 93.7 p -117.99 -8.49 10.73 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.027 0.376 . . . . 0.0 111.646 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.4 -17.53 13.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 83.0 mmm -139.21 141.28 37.92 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.946 . . . . 0.0 109.758 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -141.89 173.93 11.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 74.3 m -60.39 -27.06 67.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.815 0.28 . . . . 0.0 110.947 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -79.37 -33.41 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.213 0.205 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -79.17 -35.57 41.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.746 0.248 . . . . 0.0 110.9 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.8 p -73.87 -26.7 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -66.89 -41.83 86.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.954 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.0 -8.3 57.32 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.997 0.817 . . . . 0.0 112.915 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.34 -22.95 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 118.706 0.684 . . . . 0.0 110.231 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.52 -14.99 13.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 50.9 t -71.45 -25.59 62.37 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.071 0.851 . . . . 0.0 111.345 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.09 13.39 1.11 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.537 -0.727 . . . . 0.0 112.068 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -121.43 -3.62 9.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.061 0.944 . . . . 0.0 110.841 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 150.91 165.43 12.79 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.91 150.03 46.14 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.067 -0.666 . . . . 0.0 110.826 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.42 148.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.87 -53.33 2.63 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.954 -0.466 . . . . 0.0 111.212 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -162.91 162.78 26.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.003 0.43 . . . . 0.0 111.448 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.6 p -143.23 150.42 17.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -152.08 142.65 22.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.347 0.259 . . . . 0.0 110.388 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -76.89 146.38 37.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 168.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.637 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -130.09 141.48 50.7 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 59.99 33.92 21.43 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.065 1.746 . . . . 0.0 112.495 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 36.7 m 52.97 14.02 0.41 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -77.3 146.96 75.27 Favored Pre-proline 0 N--CA 1.455 -0.218 0 CA-C-N 118.673 0.67 . . . . 0.0 110.1 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.9 -0.81 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.686 2.924 . . . . 0.0 110.849 175.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -147.44 40.0 1.01 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.004 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.637 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -148.9 134.84 19.01 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.93 0.865 . . . . 0.0 110.593 174.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -152.52 169.19 23.24 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 22.1 ptm -143.19 147.36 34.77 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.316 0.646 . . . . 0.0 110.028 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 13.5 t -127.87 153.17 36.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 C-N-CA 123.172 0.589 . . . . 0.0 110.333 -172.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -129.48 135.3 48.46 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.947 0.499 . . . . 0.0 110.59 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.3 165.0 11.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.805 0.842 . . . . 0.0 109.956 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.56 -20.83 62.76 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -156.54 159.64 38.75 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.9 -15.73 71.84 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.215 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -69.29 -28.63 66.45 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 119.116 1.458 . . . . 0.0 110.383 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -76.26 -20.08 57.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 77.7 t -81.18 -28.13 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.98 -34.99 66.8 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -72.63 -31.85 65.46 Favored 'General case' 0 N--CA 1.457 -0.08 0 O-C-N 122.146 -0.347 . . . . 0.0 110.341 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.82 -29.22 58.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.326 -0.234 . . . . 0.0 110.977 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.4 tp -86.33 -30.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 O-C-N 122.36 -0.212 . . . . 0.0 111.112 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 82.7 p -94.83 -6.8 42.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -136.0 -15.63 1.74 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.62 -20.07 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.93 0.786 . . . . 0.0 110.027 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -51.59 144.31 10.85 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.704 0.802 . . . . 0.0 111.206 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 57.51 1.39 0.12 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.92 2.088 . . . . 0.0 115.526 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.86 142.5 27.76 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.873 1.669 . . . . 0.0 108.726 169.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.298 0.0 OUTLIER -130.94 163.9 26.49 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 172.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 19.2 ptm -125.27 143.45 50.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.159 1.384 . . . . 0.0 109.904 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . 0.25 29.0 m-85 66.16 27.02 10.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.976 1.311 . . . . 0.0 114.143 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.7 81.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 168.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -83.04 160.54 21.93 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.909 1.354 . . . . 0.0 110.543 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.598 ' CD ' ' H ' ' A' ' 445' ' ' LYS . 0.0 OUTLIER -86.31 129.41 34.86 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.596 0.758 . . . . 0.0 110.191 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.58 130.35 45.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -170.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -140.61 123.61 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.1 140.97 16.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.396 0.544 . . . . 0.0 110.655 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 71.5 m -147.11 165.24 30.57 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.88 0.872 . . . . 0.0 110.005 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 p -90.64 155.96 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.851 0.46 . . . . 0.0 109.912 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 41.6 t -133.89 158.95 42.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 123.12 0.568 . . . . 0.0 109.765 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.62 9.41 39.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -68.25 144.52 96.8 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.78 -24.36 11.71 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.918 2.412 . . . . 0.0 111.772 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -162.86 172.77 14.64 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.151 0.58 . . . . 0.0 109.992 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.71 143.55 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.6 mmt -100.21 155.98 35.8 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 122.132 0.173 . . . . 0.0 111.334 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.28 164.01 9.36 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.773 2.982 . . . . 0.0 112.227 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 164.37 178.97 38.25 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -72.66 163.55 27.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.949 0.5 . . . . 0.0 110.786 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.4 p -144.28 160.36 41.12 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.898 0.479 . . . . 0.0 110.745 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -151.81 165.04 35.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.557 0.743 . . . . 0.0 110.107 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.74 137.92 18.08 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 67.7 mt -87.06 170.47 11.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.719 0.808 . . . . 0.0 110.188 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.23 -20.41 64.82 Favored 'General case' 0 N--CA 1.461 0.115 0 O-C-N 122.142 -0.349 . . . . 0.0 111.752 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -88.39 6.0 39.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.974 0.509 . . . . 0.0 111.664 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.64 -3.58 84.74 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.468 0.556 . . . . 0.0 112.797 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 67.8 m -88.76 161.55 16.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.125 0.963 . . . . 0.0 110.527 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 79.1 m -82.87 153.34 25.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.799 0.333 . . . . 0.0 110.735 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.2 p -67.83 -10.28 51.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.321 0.649 . . . . 0.0 111.531 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -127.62 137.79 52.65 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.141 0.976 . . . . 0.0 110.123 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -156.36 157.58 35.89 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 122.59 0.356 . . . . 0.0 110.922 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.39 156.64 41.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.688 0.795 . . . . 0.0 110.878 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.64 13.71 2.32 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.324 0.649 . . . . 0.0 111.54 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 15.8 t -62.76 162.28 11.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.928 0.491 . . . . 0.0 112.025 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 57.76 17.5 4.19 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.862 1.265 . . . . 0.0 113.816 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 44.0 t -77.88 137.06 38.16 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.975 -0.453 . . . . 0.0 110.479 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -122.01 0.06 9.59 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.598 0.759 . . . . 0.0 111.582 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -86.35 60.41 6.22 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.262 0.625 . . . . 0.0 111.988 -174.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -145.86 163.08 36.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.08 0.552 . . . . 0.0 110.331 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -86.79 27.99 0.93 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.488 0.715 . . . . 0.0 112.684 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.38 16.8 1.17 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.153 -0.342 . . . . 0.0 111.22 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.3 p -72.16 -9.48 58.49 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.726 0.41 . . . . 0.0 111.636 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 37.7 p -142.84 157.85 60.58 Favored Pre-proline 0 C--O 1.231 0.127 0 C-N-CA 123.844 0.858 . . . . 0.0 108.867 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.26 -8.44 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.733 2.289 . . . . 0.0 111.177 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -93.86 -23.97 17.91 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.497 0.319 . . . . 0.0 111.13 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -90.49 -35.6 15.01 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.495 0.318 . . . . 0.0 110.262 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -70.12 -23.06 62.96 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.436 -0.165 . . . . 0.0 111.356 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.9 -10.52 57.02 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -117.56 11.99 13.95 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.15 0.58 . . . . 0.0 111.734 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.25 -36.25 0.81 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.052 0.541 . . . . 0.0 110.544 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 60.51 157.98 0.04 OUTLIER 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.776 1.631 . . . . 0.0 113.315 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.54 148.66 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.982 0.913 . . . . 0.0 110.083 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 63.25 -26.32 0.07 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.451 1.901 . . . . 0.0 115.467 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.45 121.14 79.56 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 119.363 0.983 . . . . 0.0 110.145 -178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.94 135.15 15.34 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.992 2.462 . . . . 0.0 109.81 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 97.1 p -124.17 -7.09 7.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.042 0.537 . . . . 0.0 112.208 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 58.45 18.42 5.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.595 0.758 . . . . 0.0 111.759 -170.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.78 136.71 55.32 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 C-N-CA 123.404 0.682 . . . . 0.0 109.7 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.452 HD12 ' CH2' ' A' ' 546' ' ' TRP . 59.0 mt -118.91 148.59 42.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.514 ' CD2' ' HB3' ' A' ' 580' ' ' SER . 16.0 m170 -114.83 154.55 28.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -135.8 149.16 49.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.455 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -146.69 171.74 14.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.822 0.449 . . . . 0.0 110.714 -176.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 26.4 m120 60.73 21.81 11.79 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.151 0.981 . . . . 0.0 113.42 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -78.48 163.35 62.03 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.96 154.43 50.71 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.001 2.467 . . . . 0.0 111.605 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.6 pt? -77.84 -1.0 29.46 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -123.71 12.04 9.17 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.737 0.415 . . . . 0.0 111.976 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.79 154.99 4.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 O-C-N 121.904 -0.498 . . . . 0.0 111.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 70.9 p -144.67 170.24 16.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.472 0.709 . . . . 0.0 110.437 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 511' ' ' GLU . 3.1 pm0 -62.37 -21.97 65.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.629 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.96 -30.82 69.33 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.976 -0.452 . . . . 0.0 109.921 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -78.36 -32.73 49.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.63 -28.62 67.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.184 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -84.08 -37.57 21.9 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.714 -0.616 . . . . 0.0 111.522 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.5 -9.09 59.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.355 0.525 . . . . 0.0 112.148 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.49 -32.51 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 117.783 0.265 . . . . 0.0 110.387 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 60.2 m -67.39 -21.61 65.59 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.0 -29.84 64.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.93 -16.54 27.92 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.554 0.615 . . . . 0.0 111.776 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 96.7 mt -89.19 -11.85 42.59 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.53 0.332 . . . . 0.0 111.199 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 4.63 58.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.848 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.65 169.67 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 118.013 0.906 . . . . 0.0 110.603 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -76.74 153.42 35.04 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -102.43 153.21 38.28 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 122.459 0.304 . . . . 0.0 110.361 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.5 148.85 73.82 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.1 2.533 . . . . 0.0 111.143 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.47 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 89.5 m -81.97 -25.07 35.11 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.72 0.408 . . . . 0.0 110.555 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 11.9 t -144.53 158.46 43.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.84 145.31 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 122.84 0.456 . . . . 0.0 110.599 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -144.28 127.15 16.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.681 0.792 . . . . 0.0 108.983 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 32.9 t -130.64 149.03 33.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -143.41 165.87 26.32 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.779 0.324 . . . . 0.0 111.697 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 51.0 m -130.8 154.71 47.73 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.653 0.781 . . . . 0.0 110.526 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . 174.09 -146.4 8.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -63.65 168.64 4.62 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.305 0.552 . . . . 0.0 109.75 175.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 25.1 m 58.54 29.0 17.8 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.82 -7.5 0.74 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.829 1.252 . . . . 0.0 114.084 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.81 -7.81 47.93 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.647 0.658 . . . . 0.0 110.705 175.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 49.8 m -141.86 168.48 19.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.372 1.069 . . . . 0.0 109.391 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 23.2 t -127.75 160.07 32.84 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.275 0.56 . . . . 0.0 111.226 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 75.1 p -149.64 167.05 27.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.233 1.013 . . . . 0.0 109.785 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.99 -172.88 45.49 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.344 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.51 153.91 39.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.915 0.886 . . . . 0.0 110.365 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 93.8 mt -138.07 142.22 40.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.383 1.073 . . . . 0.0 108.693 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -127.79 106.49 9.16 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.47 ' HB3' ' H ' ' A' ' 527' ' ' THR . 1.2 p90 -166.02 153.49 10.18 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.961 1.304 . . . . 0.0 107.853 168.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -152.82 122.64 6.92 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 45.2 t -159.6 153.04 22.42 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -66.45 -42.29 87.82 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.545 0.611 . . . . 0.0 110.943 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 77.4 p -85.76 -29.02 24.18 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -83.39 -28.74 28.71 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.543 0.611 . . . . 0.0 111.267 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -84.72 -30.0 25.1 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.256 0.48 . . . . 0.0 110.943 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 33.6 tp -81.22 -28.2 34.95 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.419 0.554 . . . . 0.0 111.355 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.11 -40.78 37.18 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.884 -0.51 . . . . 0.0 110.39 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 61.3 m -68.25 -36.18 79.05 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.13 -43.22 95.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.837 -0.539 . . . . 0.0 109.738 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -73.3 -14.18 79.36 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.619 -1.1 . . . . 0.0 114.094 -173.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -128.54 -10.71 5.08 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.093 1.446 . . . . 0.0 113.77 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.85 -18.5 29.12 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.301 0.955 . . . . 0.0 109.852 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.477 HD22 ' CD2' ' A' ' 561' ' ' HIS . 1.2 t30 -85.79 153.42 22.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 171.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . 0.477 ' CD2' HD22 ' A' ' 560' ' ' ASN . 78.0 m-70 57.51 15.97 3.05 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . 0.414 ' CZ ' ' CE2' ' A' ' 573' ' ' TYR . 0.0 OUTLIER -79.15 151.48 31.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -112.27 136.28 51.9 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.076 0.95 . . . . 0.0 110.576 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 5.9 ttt -64.23 176.11 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.775 0.83 . . . . 0.0 111.227 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -73.69 11.79 0.77 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.516 0.726 . . . . 0.0 112.874 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -64.86 144.88 99.02 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.401 0.546 . . . . 0.0 110.646 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.79 -27.78 4.59 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.428 2.752 . . . . 0.0 113.676 -170.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -120.97 -3.29 9.64 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.197 0.453 . . . . 0.0 111.955 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 63.87 39.71 97.64 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.751 -1.027 . . . . 0.0 113.211 -177.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 93.9 Cg_endo -71.29 -7.97 22.43 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.847 2.365 . . . . 0.0 112.115 -176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -144.22 147.78 38.65 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.157 0.435 . . . . 0.0 110.4 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.32 160.9 38.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.086 3.191 . . . . 0.0 110.902 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . 0.414 ' CE2' ' CZ ' ' A' ' 562' ' ' TYR . 42.4 t80 -141.77 -2.62 1.18 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 9.7 t -66.4 132.08 47.51 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 575' ' ' LEU . 2.1 pp -120.23 144.61 47.66 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.748 0.819 . . . . 0.0 110.197 175.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -76.07 148.58 37.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.22 145.0 48.76 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.524 0.729 . . . . 0.0 109.661 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.5 p -163.39 161.37 24.37 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -74.33 131.75 41.42 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.514 ' HB3' ' CD2' ' A' ' 501' ' ' HIS . 39.4 t -135.63 137.69 42.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 66.2 m -79.27 102.4 8.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.012 0.435 . . . . 0.0 110.901 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.13 159.49 40.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.127 0.971 . . . . 0.0 109.245 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -85.99 -25.13 26.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.341 -0.225 . . . . 0.0 110.781 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -164.18 168.6 18.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.625 0.77 . . . . 0.0 109.954 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.22 76.64 1.59 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.179 -179.676 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 22.6 t0 . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.385 0.136 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -144.48 8.27 1.34 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.124 0.57 . . . . 0.0 110.654 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 89.42 -159.95 28.85 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.12 171.01 10.8 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.154 3.236 . . . . 0.0 111.459 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -146.6 163.11 36.86 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.873 0.469 . . . . 0.0 111.378 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -96.92 165.4 12.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.335 1.054 . . . . 0.0 110.997 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.78 8.03 4.83 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.378 0.671 . . . . 0.0 110.282 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.2 m -146.38 154.67 49.52 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.169 0.588 . . . . 0.0 110.573 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.18 4.52 6.99 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.225 3.283 . . . . 0.0 112.825 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.5 162.28 35.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 119.164 0.893 . . . . 0.0 112.672 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.04 166.06 26.42 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.031 0.932 . . . . 0.0 109.644 173.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 83.2 mmm -121.89 150.81 41.44 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.7 0.8 . . . . 0.0 110.149 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.32 145.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-O 120.855 0.36 . . . . 0.0 110.297 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -142.79 166.66 24.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.907 0.483 . . . . 0.0 109.898 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 80.53 -0.6 84.98 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.607 173.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.737 ' H ' HD13 ' A' ' 386' ' ' LEU . 0.0 OUTLIER -74.11 177.42 5.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.175 0.988 . . . . 0.0 110.727 176.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.46 136.5 52.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.781 0.432 . . . . 0.0 110.231 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -75.77 4.4 8.01 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 18.3 t -112.53 -8.04 13.87 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.753 0.421 . . . . 0.0 111.556 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.54 -8.42 4.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 111.216 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 10.1 tpt -142.51 121.0 12.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.576 0.75 . . . . 0.0 109.211 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -141.9 -178.82 5.87 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.765 0.426 . . . . 0.0 110.406 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.2 m -60.5 -22.13 63.2 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.8 -25.88 19.71 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.829 -0.544 . . . . 0.0 111.637 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -87.82 -23.55 23.99 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.666 0.666 . . . . 0.0 109.873 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 8.2 p -78.38 -33.9 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.29 -33.77 76.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -71.33 -29.63 65.23 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.996 -0.44 . . . . 0.0 111.507 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 42.3 t -85.43 -13.02 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.058 -0.401 . . . . 0.0 111.592 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -118.94 -7.07 10.47 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.4 -35.47 75.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.332 0.969 . . . . 0.0 111.204 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.28 12.26 1.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.837 -0.539 . . . . 0.0 112.095 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -121.46 -4.74 9.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.481 0.712 . . . . 0.0 111.132 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 146.94 175.7 20.08 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.1 146.26 43.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.599 -0.353 . . . . 0.0 110.539 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.95 150.67 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -98.46 -60.48 1.54 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -167.51 166.1 14.37 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.576 0.75 . . . . 0.0 110.474 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.33 146.65 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 123.087 0.555 . . . . 0.0 110.312 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.489 ' HE2' ' CD1' ' A' ' 471' ' ' TYR . 39.0 ttmt -150.22 148.58 29.08 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.184 0.194 . . . . 0.0 111.135 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -82.48 149.07 27.77 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.555 ' HE1' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -135.66 141.43 45.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -168.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt 60.12 33.81 21.19 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 126.713 2.005 . . . . 0.0 114.13 174.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.7 m 52.91 18.03 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.62 157.59 87.88 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 118.587 0.63 . . . . 0.0 110.393 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.63 -18.82 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.601 2.868 . . . . 0.0 111.948 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -179.24 100.9 0.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.555 ' HB1' ' HE1' ' A' ' 412' ' ' MET . . . -160.91 143.42 12.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.26 171.49 19.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.232 0.539 . . . . 0.0 111.314 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.0 ptm -144.44 143.96 31.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.35 151.67 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 C-N-CA 123.145 0.578 . . . . 0.0 110.284 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -129.52 137.5 50.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 90.5 mmm -109.22 164.04 12.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.431 0.692 . . . . 0.0 110.025 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.58 64.29 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.457 -0.152 . . . . 0.0 111.078 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -159.73 161.61 34.79 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.494 0.717 . . . . 0.0 109.404 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.96 -16.11 68.01 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.249 -0.751 . . . . 0.0 112.905 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' A' ' 427' ' ' TYR . 2.5 p90 -65.45 -28.36 69.17 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.048 1.424 . . . . 0.0 110.925 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -81.0 -19.77 43.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 40.3 t -80.28 -23.75 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -65.9 -38.38 88.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.51 -26.37 45.87 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -75.98 -36.2 59.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.039 0.381 . . . . 0.0 110.691 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 4.5 tp -85.16 -30.93 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 O-C-N 122.251 -0.281 . . . . 0.0 111.54 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.8 m -91.38 -21.51 20.96 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -124.57 -14.32 6.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 436' ' ' LEU . 2.4 tm? -115.56 -19.05 10.77 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 118.947 0.794 . . . . 0.0 110.389 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -51.97 139.07 23.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.383 0.611 . . . . 0.0 111.36 -176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.432 ' H ' ' CG1' ' A' ' 448' ' ' VAL . 69.7 m-20 56.76 1.61 0.09 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.212 1.805 . . . . 0.0 115.735 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -87.77 142.46 27.81 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 120.869 1.668 . . . . 0.0 109.144 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.297 0.1 OUTLIER -130.9 163.84 26.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 174.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 22.2 ptm -125.29 143.33 51.01 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.029 1.331 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 63.05 33.07 14.99 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.33 15.6 78.05 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.74 0.656 . . . . 0.0 114.74 168.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.95 140.9 32.53 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.323 1.061 . . . . 0.0 109.496 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -77.72 141.38 39.36 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.81 125.34 41.19 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -168.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -140.71 112.07 7.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.432 ' CG1' ' H ' ' A' ' 438' ' ' ASN . 2.4 p -151.71 134.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.054 0.388 . . . . 0.0 110.715 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 81.6 m -149.52 165.04 33.37 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 124.394 1.078 . . . . 0.0 109.855 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.8 156.8 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 42.0 t -135.26 159.59 41.07 Favored 'General case' 0 C--O 1.23 0.046 0 C-N-CA 122.961 0.504 . . . . 0.0 110.333 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -99.3 5.76 46.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -67.03 144.92 98.75 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.796 -0.565 . . . . 0.0 109.551 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.92 -26.1 8.29 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.079 2.519 . . . . 0.0 112.244 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -164.6 173.59 11.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.051 0.54 . . . . 0.0 110.328 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.04 141.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.3 mmt -86.68 153.2 55.25 Favored Pre-proline 0 N--CA 1.453 -0.284 0 C-N-CA 122.208 0.203 . . . . 0.0 111.138 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.41 156.45 65.59 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.51 2.807 . . . . 0.0 111.231 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 165.25 169.14 28.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -78.28 157.82 29.1 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.752 0.421 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 79.9 p -134.27 159.78 39.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.987 0.515 . . . . 0.0 110.662 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -155.73 168.07 28.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.07 0.548 . . . . 0.0 109.732 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -76.91 140.83 25.44 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.69 170.75 13.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.874 0.87 . . . . 0.0 109.418 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.4 -20.03 65.48 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -90.14 5.27 47.59 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.24 85.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.317 -0.713 . . . . 0.0 114.017 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.4 m -89.14 155.76 19.23 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 118.413 1.107 . . . . 0.0 110.201 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 81.9 m -81.79 150.36 27.93 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.145 -0.347 . . . . 0.0 111.162 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 93.2 p -73.21 -10.37 59.7 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.785 0.434 . . . . 0.0 111.969 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.489 ' CD1' ' HE2' ' A' ' 410' ' ' LYS . 41.8 t80 -139.05 141.11 38.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.68 0.792 . . . . 0.0 110.699 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -156.77 153.35 28.22 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.807 0.443 . . . . 0.0 110.603 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.06 154.07 40.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.194 0.998 . . . . 0.0 109.701 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -135.93 -3.77 2.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 78.4 p -75.32 -9.34 58.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -109.13 3.91 22.43 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.659 0.383 . . . . 0.0 111.594 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.8 t -84.62 141.64 30.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.964 0.347 . . . . 0.0 110.49 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -119.37 16.25 13.03 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.724 0.809 . . . . 0.0 110.554 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -113.71 14.72 18.82 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.51 0.724 . . . . 0.0 111.257 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -83.88 172.37 12.19 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.528 0.331 . . . . 0.0 110.242 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -69.85 -6.16 30.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.568 1.147 . . . . 0.0 113.2 -174.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.68 22.24 0.4 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.285 0.493 . . . . 0.0 111.847 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 67.6 p -88.34 15.07 8.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 67.6 p -135.01 153.78 78.72 Favored Pre-proline 0 C--O 1.231 0.109 0 C-N-CA 123.284 0.633 . . . . 0.0 109.476 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.19 -4.19 13.16 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.306 2.671 . . . . 0.0 112.224 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -103.29 -31.01 10.28 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.069 0.395 . . . . 0.0 111.093 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -90.68 -23.54 20.71 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.957 0.344 . . . . 0.0 111.09 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -71.7 -20.55 61.9 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.233 -0.292 . . . . 0.0 110.747 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -84.54 0.45 49.84 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.023 0.529 . . . . 0.0 110.868 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -127.18 23.82 6.42 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.067 0.947 . . . . 0.0 110.78 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -65.34 160.53 21.58 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 111.035 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -135.45 38.78 2.89 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.378 0.671 . . . . 0.0 110.707 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.98 122.92 36.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -163.02 176.99 9.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.091 0.472 . . . . 0.0 111.342 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -74.28 157.91 86.03 Favored Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 123.808 0.843 . . . . 0.0 109.786 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.38 133.88 31.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.978 2.452 . . . . 0.0 110.401 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.0 m -124.17 23.99 8.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.885 0.874 . . . . 0.0 111.73 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.31 17.63 3.81 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.675 1.59 . . . . 0.0 114.674 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 26.9 t -140.57 144.66 26.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.446 HD12 ' CH2' ' A' ' 546' ' ' TRP . 70.5 mt -123.31 163.56 20.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.14 0.576 . . . . 0.0 110.465 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.24 160.6 41.76 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.69 0.396 . . . . 0.0 110.523 174.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -136.59 155.53 49.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.336 0.654 . . . . 0.0 110.821 -176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -146.12 173.92 11.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.484 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 48.6 t30 62.35 33.98 16.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.373 1.069 . . . . 0.0 112.566 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -90.0 158.7 44.03 Favored Pre-proline 0 N--CA 1.454 -0.251 0 C-N-CA 122.744 0.418 . . . . 0.0 110.203 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 153.16 72.54 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.362 2.042 . . . . 0.0 109.558 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 507' ' ' LEU . 2.0 pt? -70.93 -1.21 11.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.75 8.26 20.57 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.4 p -79.16 151.92 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.324 0.511 . . . . 0.0 110.938 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 81.3 p -144.72 171.93 13.71 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.437 0.695 . . . . 0.0 110.274 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.44 -19.87 65.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.88 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -72.33 -23.91 61.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -83.42 -31.48 26.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -70.66 -29.87 66.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.953 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -84.17 -36.2 23.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.435 0.561 . . . . 0.0 111.668 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.71 -21.89 59.13 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.384 0.538 . . . . 0.0 111.752 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 72.8 mt -92.77 -33.96 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 117.854 0.297 . . . . 0.0 110.614 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 87.4 m -68.29 -21.03 64.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.445 -0.784 . . . . 0.0 110.74 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.15 -30.8 65.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.378 -0.201 . . . . 0.0 111.507 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.03 -13.42 33.27 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.31 0.505 . . . . 0.0 111.997 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.25 -11.03 33.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.519 0.328 . . . . 0.0 111.102 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.72 4.67 62.3 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.408 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.9 162.06 3.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 118.24 1.02 . . . . 0.0 110.697 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -69.49 142.91 53.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -92.32 151.47 41.53 Favored Pre-proline 0 CA--C 1.528 0.132 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.08 154.7 71.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.204 2.603 . . . . 0.0 110.329 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . . . . . . . . . 99.0 m -89.95 -26.76 20.23 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 122.722 0.409 . . . . 0.0 110.859 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 52.0 m -141.51 152.76 44.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 3.5 p -149.56 147.12 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.878 0.471 . . . . 0.0 110.72 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.23 122.55 9.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.77 145.93 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.79 0.436 . . . . 0.0 110.329 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -155.12 151.37 28.21 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.88 0.472 . . . . 0.0 110.38 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.3 m -104.64 144.08 32.2 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.918 0.487 . . . . 0.0 110.892 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.16 148.57 33.07 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.74 132.11 41.37 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 24.2 m 54.37 19.17 2.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.652 0.781 . . . . 0.0 112.881 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -107.06 -17.35 14.2 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.84 0.456 . . . . 0.0 110.884 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 53.03 25.4 4.05 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.284 1.034 . . . . 0.0 112.964 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 69.8 m -139.27 162.74 34.27 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.15 0.58 . . . . 0.0 110.487 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 35.1 t -127.39 158.44 37.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.672 0.789 . . . . 0.0 111.877 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 76.4 p -154.29 168.32 26.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.103 1.361 . . . . 0.0 109.59 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 177.31 -178.86 48.28 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.911 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.22 154.24 28.24 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 124.439 1.096 . . . . 0.0 110.201 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 94.3 mt -139.2 134.47 32.79 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.441 1.096 . . . . 0.0 108.703 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -127.85 114.89 17.8 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.446 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.3 p90 -166.11 155.0 11.28 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -150.66 117.48 5.85 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 113.979 1.104 . . . . 0.0 113.979 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 48.2 t -159.49 153.05 22.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 168.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -65.87 -42.41 90.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.389 0.54 . . . . 0.0 110.491 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 71.9 p -82.29 -26.3 33.21 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -81.94 -35.24 29.31 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.63 0.65 . . . . 0.0 110.89 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -77.65 -29.6 51.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.407 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.28 -28.22 23.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.397 0.544 . . . . 0.0 111.568 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -75.19 -34.84 61.57 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.458 0.572 . . . . 0.0 110.041 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 41.3 m -72.88 -40.99 65.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 28.7 tp -59.92 -52.26 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.242 -0.911 . . . . 0.0 109.164 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -71.6 -11.69 72.95 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.591 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.43 -4.27 2.64 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 119.476 1.638 . . . . 0.0 113.869 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 559' ' ' LEU . 2.0 tm? -97.48 -30.28 12.98 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.771 0.714 . . . . 0.0 109.561 176.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -67.42 155.86 37.96 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.355 -0.841 . . . . 0.0 109.279 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 34.4 m80 61.25 18.82 9.53 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.396 1.078 . . . . 0.0 113.643 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.46 151.45 27.84 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.332 0.587 . . . . 0.0 112.308 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -120.71 136.36 54.88 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.189 0.996 . . . . 0.0 110.734 -175.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . 0.441 ' HG2' ' H ' ' A' ' 565' ' ' LYS . 6.3 ttt -64.21 175.39 1.29 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.657 0.783 . . . . 0.0 111.575 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . 0.441 ' H ' ' HG2' ' A' ' 564' ' ' MET . 48.6 mtmt -70.32 5.82 1.59 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.053 0.941 . . . . 0.0 113.233 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -64.52 142.54 98.45 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.058 0.844 . . . . 0.0 110.895 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.57 -28.23 3.63 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.662 2.908 . . . . 0.0 113.782 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -121.09 1.27 10.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.257 0.48 . . . . 0.0 111.788 -175.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.444 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 61.52 40.14 98.29 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.883 -0.954 . . . . 0.0 113.293 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.2 Cg_endo -68.26 -9.07 24.72 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.076 2.517 . . . . 0.0 111.802 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -145.53 145.94 27.82 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.55 156.46 40.57 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.801 3.0 . . . . 0.0 110.848 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -142.29 -1.59 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.2 m -66.47 120.92 14.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 29.3 mt -98.82 144.49 27.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.563 0.745 . . . . 0.0 110.329 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -93.77 136.8 33.68 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 4.4 pp -145.58 156.33 43.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.843 0.354 . . . . 0.0 111.647 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 22.4 p -163.72 -179.99 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.763 0.825 . . . . 0.0 110.084 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -75.6 143.63 42.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.518 0.327 . . . . 0.0 111.163 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.1 t -135.52 142.84 45.49 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.253 0.621 . . . . 0.0 110.501 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 59.8 m -90.75 102.21 14.97 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.2 161.51 34.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.558 0.743 . . . . 0.0 110.663 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -110.76 -8.24 14.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.868 0.467 . . . . 0.0 110.59 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -159.82 161.95 34.63 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.22 1.008 . . . . 0.0 109.394 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -83.67 76.41 9.98 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.25 1.098 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.466 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 28.0 t0 . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -140.35 17.46 2.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.313 0.645 . . . . 0.0 111.229 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -70.75 169.94 47.28 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.352 0.501 . . . . 0.0 112.592 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -80.52 -15.68 10.97 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 124.705 3.603 . . . . 0.0 112.24 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -154.85 153.44 31.15 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.001 0.521 . . . . 0.0 110.127 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -88.64 162.68 16.19 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.012 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.9 -6.69 42.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.559 0.344 . . . . 0.0 111.624 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.8 m -147.22 152.37 42.78 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -86.42 0.17 8.08 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.787 3.658 . . . . 0.0 112.246 175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.8 151.74 36.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 118.472 0.578 . . . . 0.0 111.244 -174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 4.4 pp -146.71 169.14 19.66 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.205 0.602 . . . . 0.0 110.183 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 80.4 mtp -135.08 154.06 51.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.286 0.234 . . . . 0.0 110.853 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 13.1 p -144.41 150.76 16.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 122.711 0.404 . . . . 0.0 110.948 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.17 168.78 18.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.856 0.862 . . . . 0.0 109.141 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 84.56 -3.29 86.9 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.766 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.734 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.2 pt? -72.7 176.65 5.36 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.654 0.727 . . . . 0.0 110.319 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -145.12 134.89 23.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -70.03 -5.06 23.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -172.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 97.1 p -93.86 -11.72 30.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 0.61 0.92 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 14.5 tpt -136.85 123.94 21.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -141.93 177.24 8.33 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.42 0.288 . . . . 0.0 111.029 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 77.1 m -59.03 -26.38 64.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.063 0.545 . . . . 0.0 111.897 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -82.92 -22.68 33.79 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.27 -0.269 . . . . 0.0 111.078 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -85.95 -36.45 19.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 13.4 p -71.87 -28.37 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.65 -38.27 83.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.095 -0.378 . . . . 0.0 110.038 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -80.73 -29.68 36.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.735 0.698 . . . . 0.0 112.664 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.41 -20.74 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 118.628 0.649 . . . . 0.0 110.789 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -113.69 -19.93 11.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 44.9 t -73.87 -26.81 60.76 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.564 1.075 . . . . 0.0 111.14 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.49 7.47 1.83 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.498 -0.751 . . . . 0.0 111.406 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.41 -0.04 9.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.014 0.926 . . . . 0.0 111.463 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 428' ' ' ALA . . . 155.01 170.88 21.15 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.38 150.1 48.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.033 0.444 . . . . 0.0 111.338 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 7.2 m -117.67 164.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 125.127 1.371 . . . . 0.0 109.968 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -134.92 -52.23 0.79 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 119.055 -0.498 . . . . 0.0 112.171 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -163.8 163.18 24.01 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.655 0.661 . . . . 0.0 112.176 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.82 153.3 13.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.853 0.861 . . . . 0.0 110.44 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -151.97 145.58 24.96 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.47 0.308 . . . . 0.0 110.335 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.36 163.24 25.01 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . . . . . . . . . 30.6 ttp -123.14 141.11 52.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 49.47 33.93 6.19 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.2 1.4 . . . . 0.0 112.311 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 24.3 m 52.95 18.23 1.04 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.146 0.978 . . . . 0.0 113.303 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.38 147.21 67.93 Favored Pre-proline 0 N--CA 1.456 -0.125 0 O-C-N 121.929 -0.482 . . . . 0.0 109.859 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -79.18 -2.44 12.36 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.495 2.797 . . . . 0.0 110.678 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -137.62 30.67 2.57 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.427 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.31 137.03 22.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.158 0.979 . . . . 0.0 110.149 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -155.11 167.72 29.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.74 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 19.8 ptm -142.54 142.02 32.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.776 0.831 . . . . 0.0 109.663 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.81 147.49 23.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.65 0.38 . . . . 0.0 110.916 -173.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -124.88 145.12 49.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.983 0.513 . . . . 0.0 111.154 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 78.5 mmm -111.61 162.74 14.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.334 1.054 . . . . 0.0 109.397 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -70.84 -20.84 62.51 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.027 -0.421 . . . . 0.0 111.8 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.23 161.4 39.23 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.119 0.568 . . . . 0.0 109.791 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -70.59 -12.92 70.84 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.177 -0.79 . . . . 0.0 113.553 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.49 -27.3 66.89 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.411 1.605 . . . . 0.0 110.24 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 404' ' ' GLY . . . -78.7 -28.74 45.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.687 0.28 . . . . 0.0 110.256 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 92.0 t -75.66 -24.83 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.37 -39.88 67.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.127 -0.358 . . . . 0.0 110.957 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.68 67.93 Favored 'General case' 0 CA--C 1.526 0.056 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -80.87 -33.39 34.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.14 -0.35 . . . . 0.0 111.931 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 5.0 tp -83.06 -30.98 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.871 -0.518 . . . . 0.0 111.36 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 14.8 m -98.62 -14.14 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.35 -8.43 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.69 -20.11 10.25 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.281 0.946 . . . . 0.0 109.578 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -52.01 143.63 13.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.703 0.801 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.2 1.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.367 2.267 . . . . 0.0 115.971 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -87.77 142.32 27.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 120.647 1.567 . . . . 0.0 108.679 169.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.363 0.0 OUTLIER -130.92 165.07 23.9 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.9 ptp -125.13 143.53 50.88 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.011 1.324 . . . . 0.0 109.632 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 66.18 26.45 10.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 71.12 15.76 74.65 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -83.0 161.89 21.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.531 1.166 . . . . 0.0 110.087 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 445' ' ' LYS . 0.1 OUTLIER -83.79 132.4 34.83 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -98.48 133.83 42.3 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.76 117.23 10.79 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.69 143.73 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 118.236 0.471 . . . . 0.0 110.19 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 26.3 t -158.94 160.41 36.01 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.666 0.386 . . . . 0.0 110.057 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.14 158.22 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.677 0.391 . . . . 0.0 110.055 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 47.8 t -133.1 158.76 41.97 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.262 0.625 . . . . 0.0 109.837 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -110.86 14.02 22.17 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -66.94 151.07 97.44 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.31 -28.5 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.783 2.322 . . . . 0.0 111.862 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -166.66 172.23 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.284 0.634 . . . . 0.0 110.254 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.6 mm -66.44 137.81 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.4 mmt -89.01 149.3 43.01 Favored Pre-proline 0 N--CA 1.455 -0.179 0 O-C-N 122.404 -0.185 . . . . 0.0 110.869 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.17 162.77 39.83 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.665 2.91 . . . . 0.0 111.324 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 168.03 -177.55 42.19 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -75.78 162.64 28.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 81.5 p -136.9 162.62 32.76 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.843 0.457 . . . . 0.0 110.914 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.55 163.42 32.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.569 0.748 . . . . 0.0 109.617 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -81.68 134.34 13.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.76 171.11 11.16 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.493 0.717 . . . . 0.0 110.063 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.02 -20.47 66.2 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.557 0.343 . . . . 0.0 111.432 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.72 1.94 47.43 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.838 0.455 . . . . 0.0 111.603 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.24 -3.68 85.5 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.874 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 68.4 m -91.38 159.14 16.14 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 118.196 0.998 . . . . 0.0 110.525 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 82.8 m -80.0 153.46 28.85 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.511 0.324 . . . . 0.0 110.478 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 95.0 p -70.01 -10.41 58.57 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.339 0.656 . . . . 0.0 111.656 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -126.53 139.28 53.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.307 1.043 . . . . 0.0 109.272 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -155.83 156.15 34.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.231 0.212 . . . . 0.0 110.845 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -123.22 156.37 35.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.879 0.872 . . . . 0.0 110.704 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -139.93 16.91 2.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.395 0.678 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 83.9 p -68.59 3.15 1.97 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.12 -6.22 58.58 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.932 -0.48 . . . . 0.0 110.401 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 22.8 t -86.29 7.81 23.88 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.457 0.703 . . . . 0.0 111.558 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.02 10.99 0.99 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.008 0.523 . . . . 0.0 111.866 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -125.94 8.06 7.4 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.975 0.91 . . . . 0.0 110.792 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -78.74 170.1 17.19 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.775 0.83 . . . . 0.0 110.805 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -70.15 1.59 4.57 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.773 0.829 . . . . 0.0 113.139 -175.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -144.62 29.23 1.26 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.092 0.557 . . . . 0.0 110.396 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 80.2 p -65.9 -12.47 54.88 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.6 0.76 . . . . 0.0 112.559 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 6.8 t -144.73 151.2 49.22 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 123.724 0.809 . . . . 0.0 109.084 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.41 -19.56 36.25 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.085 2.523 . . . . 0.0 113.411 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -78.39 -31.94 48.61 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 117.845 0.293 . . . . 0.0 110.957 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -90.63 -23.45 20.8 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.64 0.376 . . . . 0.0 111.225 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -69.67 -20.48 63.57 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.359 -0.213 . . . . 0.0 110.613 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -89.15 0.52 56.67 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.143 0.577 . . . . 0.0 111.125 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -115.8 7.61 14.63 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.099 0.959 . . . . 0.0 110.809 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -130.64 14.97 5.42 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.586 0.754 . . . . 0.0 110.562 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 46.72 59.75 3.75 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.79 1.236 . . . . 0.0 112.867 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.77 106.21 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -144.55 178.08 8.22 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.778 0.831 . . . . 0.0 110.231 -173.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -66.93 164.89 30.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 123.637 0.775 . . . . 0.0 110.044 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.9 145.75 23.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.915 3.076 . . . . 0.0 113.523 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 49.1 m -124.11 23.7 8.39 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.729 0.812 . . . . 0.0 111.809 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 60.54 10.23 2.44 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.22 1.408 . . . . 0.0 114.306 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 29.8 t -140.41 144.96 26.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . 0.444 HD12 ' CH2' ' A' ' 546' ' ' TRP . 65.5 mt -122.79 150.53 42.69 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.804 0.441 . . . . 0.0 110.541 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.92 150.12 50.02 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.212 0.605 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -138.71 151.91 47.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -145.47 169.21 18.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.85 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 44.7 t30 58.56 33.5 23.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.023 0.929 . . . . 0.0 112.487 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -83.8 163.41 49.08 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 122.778 0.431 . . . . 0.0 109.863 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.83 150.53 62.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.853 2.369 . . . . 0.0 111.549 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.47 ' H ' ' CD2' ' A' ' 507' ' ' LEU . 1.8 pt? -72.85 -1.09 15.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.48 13.58 5.0 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.8 p -76.26 154.04 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.129 0.422 . . . . 0.0 110.578 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 66.3 p -142.22 171.04 14.6 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.961 0.504 . . . . 0.0 110.088 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.64 -22.03 66.68 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.097 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.81 -26.08 56.92 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.24 -0.287 . . . . 0.0 110.71 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -79.04 -30.98 44.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.77 -30.02 66.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.398 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -76.78 -39.85 50.19 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.1 0.409 . . . . 0.0 111.672 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.94 -18.19 56.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.732 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.23 -33.9 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 118.222 0.464 . . . . 0.0 110.251 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.84 -21.65 65.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.556 -0.715 . . . . 0.0 110.174 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.96 -28.86 60.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.769 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.99 -14.35 31.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.345 0.521 . . . . 0.0 111.892 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 94.6 mt -95.4 -7.05 39.49 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.566 0.346 . . . . 0.0 110.903 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 72.36 4.72 61.14 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.224 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 34.6 m -80.67 169.47 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.092 0.946 . . . . 0.0 111.033 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -80.91 147.62 30.24 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.984 0.513 . . . . 0.0 110.736 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -88.29 147.53 40.42 Favored Pre-proline 0 C--O 1.232 0.132 0 C-N-CA 123.064 0.546 . . . . 0.0 109.964 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.53 156.13 61.96 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.534 2.823 . . . . 0.0 110.195 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.43 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.2 m -86.95 -25.91 24.12 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.341 0.256 . . . . 0.0 110.608 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 48.7 m -144.52 151.76 39.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.865 0.466 . . . . 0.0 109.824 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.57 144.56 29.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 123.496 0.718 . . . . 0.0 109.124 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 124.13 11.45 Favored 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.08 151.57 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -145.66 147.51 32.07 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.941 0.4 . . . . 0.0 111.694 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 36.7 t -130.81 146.0 52.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.924 0.889 . . . . 0.0 109.066 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . 168.55 -21.6 0.09 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -152.23 159.62 43.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.74 1.216 . . . . 0.0 108.024 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 20.4 m 54.55 28.75 10.21 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.094 0.407 . . . . 0.0 110.604 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -57.83 -7.53 0.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.669 1.588 . . . . 0.0 114.189 -169.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.01 -10.35 52.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.65 0.659 . . . . 0.0 110.532 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 79.8 p -152.52 175.32 12.88 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.595 1.158 . . . . 0.0 109.898 177.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 69.2 m -132.16 161.18 33.98 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.885 0.474 . . . . 0.0 110.934 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 55.2 m -145.53 159.59 42.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.912 0.885 . . . . 0.0 109.606 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -174.86 -175.74 42.6 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.638 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.78 155.37 34.15 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.188 0.995 . . . . 0.0 109.898 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 78.4 mt -135.91 132.6 36.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.489 1.116 . . . . 0.0 108.042 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -127.76 112.56 14.93 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.444 ' CH2' HD12 ' A' ' 500' ' ' LEU . 1.2 p90 -166.04 155.42 11.81 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.59 1.556 . . . . 0.0 107.368 168.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -150.01 122.89 8.73 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . . . . . . . . . 40.2 t -159.53 152.97 22.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 169.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.64 -46.83 77.72 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.778 0.717 . . . . 0.0 111.213 -174.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 78.2 p -84.34 -25.4 29.22 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -85.36 -28.58 25.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.725 0.693 . . . . 0.0 111.271 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.247 0.476 . . . . 0.0 110.663 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.97 -29.84 35.22 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.19 0.45 . . . . 0.0 111.045 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -77.83 -38.56 45.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.352 0.524 . . . . 0.0 110.179 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 38.2 m -73.21 -42.64 62.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . 0.446 ' C ' HD13 ' A' ' 556' ' ' LEU . 2.3 tm? -60.54 -46.61 89.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 175.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -67.53 -14.87 65.38 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-O 118.355 -1.247 . . . . 0.0 114.032 -172.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.07 -6.81 2.69 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.327 1.564 . . . . 0.0 113.976 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.95 -22.3 25.69 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.557 0.617 . . . . 0.0 109.749 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.08 151.51 30.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.22 -0.3 . . . . 0.0 111.023 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 49.24 30.0 2.9 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.24 151.42 25.65 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -110.91 136.33 50.1 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.213 1.405 . . . . 0.0 110.628 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . . . . . . . . . 4.2 ttt -64.28 174.95 1.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.154 0.982 . . . . 0.0 112.18 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.87 12.58 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.37 1.068 . . . . 0.0 112.835 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.48 141.41 88.05 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.21 0.604 . . . . 0.0 111.147 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.55 -29.8 2.18 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.356 2.704 . . . . 0.0 113.021 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -121.05 -7.9 9.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.395 0.516 . . . . 0.0 112.395 -177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 64.12 42.84 97.9 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.412 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 88.8 Cg_endo -71.9 -6.55 19.35 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.134 2.556 . . . . 0.0 112.208 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -144.1 149.98 47.36 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 123.135 0.574 . . . . 0.0 110.341 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.44 156.24 41.03 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.627 2.885 . . . . 0.0 110.595 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -137.87 -2.46 1.91 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.524 0.33 . . . . 0.0 111.478 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 7.0 t -66.69 131.95 47.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.164 0.507 . . . . 0.0 110.73 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 575' ' ' LEU . 0.9 OUTLIER -125.03 144.6 50.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.595 1.158 . . . . 0.0 109.638 177.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -72.48 147.08 46.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.557 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . . . . . . . . . 54.9 tp -142.05 144.7 33.73 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 28.1 p -163.97 172.64 13.64 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 111.502 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -88.46 132.94 34.27 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 33.2 t -135.57 150.67 49.77 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.068 0.147 . . . . 0.0 110.783 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 40.9 m -87.1 102.56 14.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.945 0.403 . . . . 0.0 111.154 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.09 161.39 34.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.697 0.799 . . . . 0.0 109.892 176.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -109.7 -14.06 14.4 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.939 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -160.84 164.83 31.05 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.485 0.714 . . . . 0.0 109.457 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -87.52 102.9 15.02 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.645 -178.448 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.775 -0.155 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.58 10.28 4.36 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.86 0.464 . . . . 0.0 111.629 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 85.86 151.11 16.18 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.73 0.681 . . . . 0.0 112.118 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.26 -1.55 10.33 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 124.526 3.484 . . . . 0.0 112.157 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -149.12 170.73 17.74 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.095 0.474 . . . . 0.0 111.641 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -125.93 165.37 18.87 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.958 0.903 . . . . 0.0 109.478 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.0 1.4 3.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 50.0 m -145.42 151.7 47.97 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 117.872 0.306 . . . . 0.0 111.285 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.26 -3.06 10.17 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 124.339 3.36 . . . . 0.0 111.934 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.03 151.74 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-N 118.286 0.494 . . . . 0.0 111.585 -173.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.72 174.58 11.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.728 0.811 . . . . 0.0 110.27 176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' MET . . . . . . . . . . . . . 78.7 mtp -135.4 149.89 49.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.422 0.289 . . . . 0.0 111.207 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.5 148.77 28.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 123.574 0.75 . . . . 0.0 109.971 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -139.4 168.4 19.9 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.992 0.517 . . . . 0.0 110.289 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . 82.03 -6.05 68.65 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.411 175.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.615 ' H ' HD23 ' A' ' 386' ' ' LEU . 2.3 pt? -71.85 -175.48 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.163 0.982 . . . . 0.0 110.598 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -146.12 149.7 34.51 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 121.981 -0.449 . . . . 0.0 110.559 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -76.2 -2.08 29.47 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 m -108.89 -4.1 17.07 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.608 0.363 . . . . 0.0 111.701 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -130.27 -12.28 4.04 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.014 0.526 . . . . 0.0 111.011 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' MET . . . . . . . . . . . . . 85.5 mtp -141.28 135.25 30.43 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.923 0.489 . . . . 0.0 110.342 176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' A' ' 395' ' ' ARG . 29.0 m120 -141.87 174.14 10.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.35 -31.15 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.966 0.348 . . . . 0.0 111.783 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -84.18 -25.3 29.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . 0.402 ' HB2' ' H ' ' A' ' 392' ' ' ASN . 59.6 mtt85 -89.15 -28.72 19.85 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 122.234 0.214 . . . . 0.0 110.902 -178.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.73 -26.76 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -66.8 -35.56 80.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -67.46 -30.4 70.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.195 -0.316 . . . . 0.0 110.83 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.74 -21.6 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -110.44 -10.69 14.55 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' CYS . . . . . . . . . . . . . 45.0 t -70.4 -36.38 74.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.851 0.75 . . . . 0.0 111.977 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.96 13.29 1.45 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.715 -0.616 . . . . 0.0 112.251 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -121.41 -1.27 9.66 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.469 0.707 . . . . 0.0 110.861 177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' GLY . . . . . . . . . . . . . . . 141.16 174.1 14.0 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -75.83 145.16 40.85 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 122.534 -0.392 . . . . 0.0 110.685 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.59 154.28 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -105.02 -55.86 2.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.058 0.39 . . . . 0.0 110.523 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -164.47 162.25 21.83 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 121.105 0.479 . . . . 0.0 111.202 177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 15.0 p -145.88 151.28 14.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 123.8 0.84 . . . . 0.0 110.249 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -154.07 147.19 24.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.335 0.254 . . . . 0.0 110.928 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -76.77 146.99 37.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' MET . . . . . 0.47 ' HE3' ' HB1' ' A' ' 418' ' ' ALA . 0.0 OUTLIER -133.12 141.54 48.22 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -167.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.36 33.99 20.74 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.343 1.457 . . . . 0.0 112.647 -174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 21.2 m 54.59 19.94 2.66 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 172.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -103.82 141.27 22.17 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.02 -14.63 21.03 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.915 2.41 . . . . 0.0 109.622 171.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.05 65.96 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.378 0.989 . . . . 0.0 112.418 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . 0.47 ' HB1' ' HE3' ' A' ' 412' ' ' MET . . . -147.75 129.91 15.52 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.303 1.052 . . . . 0.0 111.17 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -150.75 167.37 27.62 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.326 0.651 . . . . 0.0 110.891 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 20.2 ptm -144.78 143.98 30.93 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.656 0.382 . . . . 0.0 110.207 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.64 143.06 41.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.08 0.552 . . . . 0.0 110.694 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -126.54 138.0 53.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.201 0.6 . . . . 0.0 110.135 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' MET . . . . . . . . . . . . . 85.6 mmm -102.52 164.95 11.37 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.0 110.322 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -71.3 -20.74 62.16 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.451 -0.155 . . . . 0.0 111.221 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -158.06 161.54 38.03 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.302 0.641 . . . . 0.0 109.74 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.24 -14.33 68.62 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.414 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -67.44 -25.59 65.98 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.064 1.432 . . . . 0.0 110.446 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -88.58 -18.1 28.79 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.17 0.188 . . . . 0.0 111.182 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.72 -31.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.86 -31.86 71.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -79.62 -29.18 40.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.823 0.449 . . . . 0.0 110.864 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -83.34 -32.23 26.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.251 0.478 . . . . 0.0 110.819 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 433' ' ' ILE . 6.9 tp -79.22 -31.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 122.166 -0.334 . . . . 0.0 111.279 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.8 m -97.1 -21.33 17.42 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -122.54 -12.68 8.12 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -115.3 -20.21 10.43 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 118.864 0.756 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -55.58 144.82 25.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.794 0.838 . . . . 0.0 110.581 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 60.01 1.31 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.772 2.029 . . . . 0.0 114.89 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -88.14 142.68 27.57 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.397 1.453 . . . . 0.0 109.047 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' PHE . . . . . . . . . . . . 0.307 0.1 OUTLIER -130.81 163.93 26.29 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 170.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' MET . . . . . . . . . . . . . 23.5 ptm -125.36 143.43 50.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.655 1.182 . . . . 0.0 108.804 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 62.86 28.42 16.38 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.86 72.24 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -83.07 152.58 25.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.432 1.616 . . . . 0.0 111.095 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 141.83 36.26 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -93.5 122.02 35.51 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -168.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -140.96 118.88 11.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.437 0.695 . . . . 0.0 109.28 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 3.1 p -154.47 138.23 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 118.164 0.438 . . . . 0.0 110.275 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.9 m -147.69 155.51 41.82 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 10.4 p -76.38 157.06 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 48.1 t -130.1 167.57 18.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.118 0.567 . . . . 0.0 109.991 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -119.47 12.43 12.4 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.848 0.459 . . . . 0.0 111.997 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -63.94 150.79 90.92 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.51 -30.58 9.78 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.472 2.114 . . . . 0.0 111.849 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -169.58 164.78 10.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.711 0.405 . . . . 0.0 110.77 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 32.7 mm -70.56 140.31 18.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 170.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' MET . . . . . . . . . . . . . 26.0 mmt -102.26 130.38 24.3 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.97 -31.52 9.8 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.6 2.2 . . . . 0.0 112.196 -172.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' GLY . . . . . . . . . . . . . . . 58.52 -152.48 30.33 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -101.67 -15.41 17.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.737 0.415 . . . . 0.0 110.543 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 3.1 m 55.86 176.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.671 1.588 . . . . 0.0 113.442 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -153.8 165.34 36.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.519 0.728 . . . . 0.0 109.275 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -86.61 123.85 6.69 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.97 176.48 7.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.932 0.493 . . . . 0.0 111.228 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -59.96 -24.57 64.5 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -172.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.1 -0.61 25.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.912 -0.492 . . . . 0.0 111.389 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 81.98 -3.8 78.5 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.614 0.626 . . . . 0.0 112.112 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 23.2 t -93.64 170.32 9.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.515 0.726 . . . . 0.0 110.329 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' CYS . . . . . . . . . . . . . 16.4 p -85.67 153.32 22.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.99 0.424 . . . . 0.0 111.165 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 69.0 m -71.7 -10.39 59.69 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.546 0.738 . . . . 0.0 112.576 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -120.14 143.48 48.17 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.068 0.547 . . . . 0.0 110.87 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -153.8 156.55 37.9 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 122.692 0.397 . . . . 0.0 110.354 177.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -133.17 156.43 47.49 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.82 15.13 1.94 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.978 0.511 . . . . 0.0 111.608 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 80.7 p -67.69 0.96 2.76 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -108.91 2.0 21.16 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.257 0.623 . . . . 0.0 111.235 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.6 m -82.91 36.28 0.5 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.598 0.759 . . . . 0.0 111.324 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -77.98 29.23 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.458 1.103 . . . . 0.0 112.398 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -136.31 32.48 2.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.613 0.365 . . . . 0.0 111.205 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -94.93 21.55 7.5 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.69 0.396 . . . . 0.0 111.902 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 62.46 -0.22 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.073 1.349 . . . . 0.0 114.381 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -156.22 16.31 0.34 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.485 0.584 . . . . 0.0 110.605 174.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 11.0 p -83.76 2.74 36.52 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' THR . . . . . . . . . . . . . 34.9 p -140.23 160.01 61.6 Favored Pre-proline 0 CA--C 1.524 -0.056 0 CA-C-N 118.394 0.543 . . . . 0.0 109.89 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.18 -14.21 22.99 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.555 2.837 . . . . 0.0 112.823 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.63 -24.72 15.87 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.485 0.314 . . . . 0.0 110.94 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -90.46 -25.56 20.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.795 0.438 . . . . 0.0 110.154 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . . . . . . . . . . . -75.61 1.29 14.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.224 0.61 . . . . 0.0 111.564 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' ALA . . . . . . . . . . . . . . . -91.15 1.71 56.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.006 0.522 . . . . 0.0 111.233 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -124.44 6.34 8.33 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.856 0.862 . . . . 0.0 111.342 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -149.22 170.44 18.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.753 0.821 . . . . 0.0 109.334 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -137.81 143.52 41.06 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.735 0.414 . . . . 0.0 110.691 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 42.6 mm -113.57 131.16 66.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -146.01 179.4 7.51 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.378 0.671 . . . . 0.0 110.004 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -65.61 162.87 39.15 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.078 0.551 . . . . 0.0 110.3 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.37 145.97 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.519 2.813 . . . . 0.0 112.489 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 65.7 m -124.05 24.0 8.34 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.452 0.701 . . . . 0.0 111.402 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.81 12.04 2.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.538 1.135 . . . . 0.0 113.618 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 38.4 t -139.71 151.18 22.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 46.3 mt -132.4 151.22 51.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.652 0.781 . . . . 0.0 109.689 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -121.09 142.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 544' ' ' LEU . 11.3 m-85 -125.33 148.02 48.9 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.206 0.602 . . . . 0.0 110.503 -175.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -144.6 172.71 12.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.737 0.415 . . . . 0.0 111.035 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ASN . . . . . . . . . . . . . 66.8 t30 62.23 32.21 17.28 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.325 1.05 . . . . 0.0 113.126 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -89.22 158.29 46.7 Favored Pre-proline 0 N--CA 1.454 -0.242 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.95 156.81 52.07 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.242 1.961 . . . . 0.0 109.645 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 507' ' ' LEU . 1.9 pt? -68.33 -1.17 5.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.666 0.787 . . . . 0.0 112.866 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.52 11.58 12.96 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 5.6 p -76.59 153.63 5.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 118.287 0.494 . . . . 0.0 110.725 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 78.4 p -143.76 169.24 18.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.278 0.631 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.04 -24.62 68.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.253 -0.28 . . . . 0.0 110.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.13 -26.01 60.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -78.31 -32.22 49.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.85 -28.54 64.66 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.236 -0.29 . . . . 0.0 110.708 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -80.37 -36.43 33.97 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.024 0.375 . . . . 0.0 111.941 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.65 -19.5 38.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' ILE . . . . . . . . . . . . . 80.6 mt -86.86 -34.46 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.11 -21.73 64.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.693 -0.629 . . . . 0.0 109.824 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.54 -31.17 68.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -91.14 -15.9 28.64 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.209 0.459 . . . . 0.0 111.947 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' LEU . . . . . . . . . . . . . 95.5 mt -91.52 -9.73 43.32 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.637 0.199 . . . . 0.0 111.201 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.53 4.63 57.98 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.646 -0.53 . . . . 0.0 112.958 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 33.3 m -87.51 165.64 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.998 0.899 . . . . 0.0 110.794 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -72.2 123.95 24.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -76.59 150.79 82.37 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -63.71 151.03 86.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.84 2.36 . . . . 0.0 110.721 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 546' ' ' TRP . 95.6 m -88.23 -19.99 26.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.866 0.467 . . . . 0.0 110.903 -175.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' SER . . . . . . . . . . . . . 26.1 t -146.64 154.16 41.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.37 138.9 46.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 122.413 0.285 . . . . 0.0 110.896 -175.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -147.1 125.49 12.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.191 0.996 . . . . 0.0 108.352 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' VAL . . . . . . . . . . . . . 60.3 t -138.63 150.21 23.93 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 C-N-CA 122.728 0.411 . . . . 0.0 110.333 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -145.0 161.12 40.18 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.779 0.832 . . . . 0.0 109.119 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 19.5 m -118.96 142.15 48.04 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.403 0.281 . . . . 0.0 111.075 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' GLY . . . . . . . . . . . . . . . -78.68 150.5 34.66 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -78.35 132.99 37.64 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' SER . . . . . . . . . . . . . 21.0 m 54.35 19.61 2.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.965 0.906 . . . . 0.0 112.786 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -110.63 -14.5 14.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.744 0.418 . . . . 0.0 111.109 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 50.28 31.26 5.06 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.991 0.916 . . . . 0.0 112.868 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 33.3 t -140.61 158.13 44.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.979 0.512 . . . . 0.0 110.147 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' SER . . . . . . . . . . . . . 58.8 m -125.13 153.43 43.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.612 0.765 . . . . 0.0 112.034 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 49.0 m -147.9 162.14 39.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.478 1.511 . . . . 0.0 108.528 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 168.07 177.8 39.54 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.475 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.488 ' C ' HD22 ' A' ' 544' ' ' LEU . 84.6 mt -98.91 139.47 34.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.817 -173.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 502' ' ' PHE . 3.6 mm? -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -127.87 116.37 20.03 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' TRP . . . . . 0.411 ' HB3' ' H ' ' A' ' 527' ' ' THR . 3.0 p90 -166.09 150.47 8.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.744 1.618 . . . . 0.0 107.058 168.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -150.58 120.83 7.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 551' ' ' ASP . 42.3 t -159.48 152.9 22.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -66.45 -46.1 77.58 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.97 0.804 . . . . 0.0 111.17 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' SER . . . . . . . . . . . . . 68.6 p -84.34 -33.3 23.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.859 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 548' ' ' SER . 38.3 m-20 -76.5 -31.31 57.63 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.843 0.747 . . . . 0.0 110.903 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' ALA . . . . . . . . . . . . . . . -75.95 -31.28 58.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.052 0.387 . . . . 0.0 110.752 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.13 -29.73 38.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.132 0.424 . . . . 0.0 111.575 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -71.86 -40.7 68.8 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 118.058 0.39 . . . . 0.0 109.992 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 33.1 m -70.1 -31.68 69.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.41 -45.87 85.74 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.335 -0.853 . . . . 0.0 110.529 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -72.21 -27.19 70.51 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.041 -0.866 . . . . 0.0 113.421 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.75 -10.7 13.58 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.627 1.213 . . . . 0.0 114.198 -176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 559' ' ' LEU . 0.4 OUTLIER -99.62 -26.84 13.95 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.304 0.956 . . . . 0.0 110.941 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -60.39 138.21 58.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.059 -1.026 . . . . 0.0 110.951 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 561' ' ' HIS . . . . . . . . . . . . . 40.3 m170 51.61 26.33 3.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.409 1.084 . . . . 0.0 113.544 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 562' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.4 151.36 47.57 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.173 0.511 . . . . 0.0 112.336 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -103.69 136.4 43.46 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.183 0.993 . . . . 0.0 110.694 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 564' ' ' MET . . . . . 0.401 ' HB2' ' CG ' ' A' ' 573' ' ' TYR . 3.4 ttt -64.34 174.92 1.47 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.06 0.544 . . . . 0.0 111.255 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -75.32 11.91 1.09 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -68.68 146.67 97.75 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 118.271 0.487 . . . . 0.0 110.332 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 567' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.39 -37.95 0.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.252 2.634 . . . . 0.0 113.831 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -121.03 6.83 10.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 570' ' ' PRO . . . 65.1 45.24 92.52 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.107 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 570' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 569' ' ' GLY . 73.4 Cg_endo -68.99 -9.8 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.22 2.613 . . . . 0.0 111.866 -178.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -146.17 149.07 37.22 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.011 0.524 . . . . 0.0 109.721 174.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.83 148.96 41.83 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.903 3.068 . . . . 0.0 110.97 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' TYR . . . . . 0.401 ' CG ' ' HB2' ' A' ' 564' ' ' MET . 71.5 t80 -149.92 15.47 0.84 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.847 0.459 . . . . 0.0 110.932 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' THR . . . . . . . . . . . . . 81.9 p -80.18 91.06 5.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.123 -0.986 . . . . 0.0 110.752 -174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.94 144.55 38.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -107.61 154.02 22.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 577' ' ' LEU . 2.1 pt? -143.44 151.54 40.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.782 0.325 . . . . 0.0 111.437 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' CYS . . . . . . . . . . . . . 26.7 p -155.64 163.79 39.47 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.699 0.8 . . . . 0.0 110.032 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -71.38 140.58 50.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 73.8 p -135.58 143.47 45.66 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.553 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' THR . . . . . . . . . . . . . 28.0 p -84.4 102.26 12.62 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' ALA . . . . . . . . . . . . . . . -134.29 161.45 34.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.664 0.786 . . . . 0.0 110.976 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -114.67 -8.64 12.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.036 0.535 . . . . 0.0 110.595 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -160.92 162.9 32.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.016 0.926 . . . . 0.0 109.326 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -82.93 76.4 9.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.866 178.857 . . . . . . . . 0 0 . 1 stop_ save_